<SEC-DOCUMENT>0001564590-22-006312.txt : 20220223
<SEC-HEADER>0001564590-22-006312.hdr.sgml : 20220223
<ACCEPTANCE-DATETIME>20220223165322
ACCESSION NUMBER:		0001564590-22-006312
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		106
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220223
DATE AS OF CHANGE:		20220223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEVRO CORP
		CENTRAL INDEX KEY:			0001444380
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				562568057
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36715
		FILM NUMBER:		22664699

	BUSINESS ADDRESS:	
		STREET 1:		1800 BRIDGE PARKWAY
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
		BUSINESS PHONE:		650-251-0005

	MAIL ADDRESS:	
		STREET 1:		1800 BRIDGE PARKWAY
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>nvro-10k_20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-22T19:55:30.8819573+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 3affc067051b45aa87ab8e436534d58c -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:nvro="http://www.nevro.com/20211231" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
nvro-10k_20211231.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001444380_20210101_20211231">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:DocumentFiscalPeriodFocus" contextRef="C_0001444380_20210101_20211231">FY</ix:nonNumeric>
			<ix:nonNumeric id="F_000007" name="dei:EntityCentralIndexKey" contextRef="C_0001444380_20210101_20211231">0001444380</ix:nonNumeric>
			<ix:nonNumeric id="F_000008" name="dei:CurrentFiscalYearEndDate" contextRef="C_0001444380_20210101_20211231">--12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000481" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" contextRef="C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20211231">true</ix:nonNumeric>
			<ix:nonNumeric id="F_000483" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" contextRef="C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20211231">true</ix:nonNumeric>
			<ix:nonNumeric id="F_000510" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" contextRef="C_0001444380_20210101_20211231">true</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000987" name="nvro:TargetedNumberOfSharesGrantedRatio" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331" decimals="INF">0.00</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000988" name="nvro:TargetedNumberOfSharesGrantedRatio" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331" decimals="INF">3.50</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000991" name="nvro:TargetedNumberOfSharesGrantedRatio" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331" decimals="INF">1.50</ix:nonFraction>
			<ix:nonNumeric id="F_001062" name="nvro:RecognitionPeriodOfStockBasedCompensationExpense" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">P2Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000478" name="nvro:EmployeeStockPurchasePlanOfferingPeriod" contextRef="C_0001444380_20210101_20211231">P6M</ix:nonNumeric>
			<ix:nonNumeric id="F_000667" name="nvro:LeaseEffectiveDate" contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150301_20150331">2015-06-30</ix:nonNumeric>
			<ix:nonNumeric id="F_000682" name="nvro:LeaseEffectiveDate" contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831">2021-04-30</ix:nonNumeric>
			<ix:nonNumeric id="F_000986" name="nvro:TargetedCompositeIndexPeriod" contextRef="C_0001444380_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">P3Y</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000987_2" name="nvro:TargetedNumberOfSharesGrantedRatio" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331" decimals="INF">0.00</ix:nonFraction>
			<ix:nonNumeric id="F_000989" name="nvro:TargetedCompositeIndexPeriod" contextRef="C_0001444380_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001024" name="nvro:EmployeeStockPurchasePlanOfferingPeriod" contextRef="C_0001444380_20141001_20141031">P6M</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000076" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001444380_20211231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000077" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001444380_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000078" name="us-gaap:PreferredStockValue" contextRef="C_0001444380_20211231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000079" name="us-gaap:PreferredStockValue" contextRef="C_0001444380_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonNumeric id="F_000531" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_0001444380_20211231">http://fasb.org/us-gaap/2021-01-31#OtherCurrentLiabilitiesMember</ix:nonNumeric>
			<ix:nonNumeric id="F_000532" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_0001444380_20201231">http://fasb.org/us-gaap/2021-01-31#OtherCurrentLiabilitiesMember</ix:nonNumeric>
			<ix:nonNumeric id="F_000883" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_20180101_20181231">P6Y8M12D</ix:nonNumeric>
			<ix:nonNumeric id="F_000884" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_20190101_20191231">P6Y3M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_000885" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_20200101_20201231">P5Y10M24D</ix:nonNumeric>
			<ix:nonNumeric id="F_000886" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_20210101_20211231">P4Y9M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_000887" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001444380_20210101_20211231">P4Y4M24D</ix:nonNumeric>
			<ix:nonNumeric id="F_000888" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" contextRef="C_0001444380_20210101_20211231">P4Y9M18D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000902" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20210101_20211231" decimals="INF">3.60</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000908" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20210101_20211231" decimals="INF">36.55</ix:nonFraction>
			<ix:nonNumeric id="F_000922" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20210101_20211231">P3Y1M24D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000903" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20210101_20211231" decimals="INF">38.79</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000909" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20210101_20211231" decimals="INF">45.04</ix:nonFraction>
			<ix:nonNumeric id="F_000923" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20210101_20211231">P5Y6M7D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000904" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20210101_20211231" decimals="INF">45.07</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000910" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20210101_20211231" decimals="INF">63.23</ix:nonFraction>
			<ix:nonNumeric id="F_000924" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20210101_20211231">P4Y5M23D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000905" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20210101_20211231" decimals="INF">63.39</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000911" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20210101_20211231" decimals="INF">64.95</ix:nonFraction>
			<ix:nonNumeric id="F_000925" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20210101_20211231">P6Y11M8D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000906" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20210101_20211231" decimals="INF">65.51</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000912" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20210101_20211231" decimals="INF">87.62</ix:nonFraction>
			<ix:nonNumeric id="F_000926" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20210101_20211231">P3Y11M12D</ix:nonNumeric>
			<ix:nonNumeric id="F_000927" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20210101_20211231">P4Y7M13D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000907" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20210101_20211231" decimals="INF">3.60</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000913" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20210101_20211231" decimals="INF">97.52</ix:nonFraction>
			<ix:nonNumeric id="F_000928" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20210101_20211231">P4Y9M21D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000914" name="nvro:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20210101_20211231" decimals="INF">97.52</ix:nonFraction>
			<ix:nonNumeric id="F_001037" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">P5Y8M12D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001038" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF">0.51</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001040" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF">0.014</ix:nonFraction>
			<ix:nonNumeric id="F_001043" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231">P6M</ix:nonNumeric>
			<ix:nonNumeric id="F_001044" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231">P6M</ix:nonNumeric>
			<ix:nonNumeric id="F_001045" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231">P6M</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001046" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231" decimals="INF">0.36</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001047" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF">0.39</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001048" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231" decimals="INF">0.48</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001039" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF">0.52</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001041" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF">0.026</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001049" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231" decimals="INF">0.49</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001050" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF">0.68</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001051" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231" decimals="INF">0.61</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001053" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF">0.001</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001054" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231" decimals="INF">0.016</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001055" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF">0.002</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001056" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231" decimals="INF">0.024</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001064" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="2">0.51</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001065" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="2">0.44</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001068" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="2">0.49</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001069" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="2">0.57</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001072" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="3">0.001</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001073" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="3">0.001</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001076" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="4">0.0032</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001077" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="4">0.0038</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001066" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="2">0.53</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001067" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="2">0.51</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001070" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="2">0.54</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001071" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="2">0.59</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001074" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="3">0.003</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001075" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="3">0.002</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001078" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="4">0.0035</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001079" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="4">0.0041</ix:nonFraction>
			<ix:nonNumeric id="F_001118" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231">P1Y2M12D</ix:nonNumeric>
			<ix:nonNumeric id="F_001119" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231">P2Y1M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_001120" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231">P8M12D</ix:nonNumeric>
			<ix:nonNumeric id="F_001121" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231">P4M24D</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="nvro-20211231.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001444380_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlishares">
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_20220216">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-02-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD">
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD_xbrlishares">
				<xbrli:divide>
					<xbrli:unitNumerator>
						<xbrli:measure>iso4217:USD</xbrli:measure>
					</xbrli:unitNumerator>
					<xbrli:unitDenominator>
						<xbrli:measure>xbrli:shares</xbrli:measure>
					</xbrli:unitDenominator>
				</xbrli:divide>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlipure">
				<xbrli:measure>xbrli:pure</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160601_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-06-01</xbrli:startDate>
					<xbrli:endDate>2016-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_nvroSubsidiary">
				<xbrli:measure>nvro:Subsidiary</xbrli:measure>
			</xbrli:unit>
			<xbrli:unit id="U_nvroBusiness">
				<xbrli:measure>nvro:Business</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
							<us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
						</xbrldi:typedMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMinimumMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceBasedRestrictedStockUnitsRSUMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceBasedRestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201912Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_countryUS_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_countryUS_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_countryUS_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_nvroCustomer">
				<xbrli:measure>nvro:Customer</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_srtProductOrServiceAxis_nvroPainfulDiabeticNeuropathyMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvro:PainfulDiabeticNeuropathyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nvro:AgencyBondsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nvro:AgencyBondsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nvro:AgencyBondsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nvro:AgencyBondsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_us-gaapCertificatesOfDepositMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_us-gaapCertificatesOfDepositMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_utrsqft">
				<xbrli:measure>utr:sqft</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2015-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nvro:FirstAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150301_20150331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2015-03-01</xbrli:startDate>
					<xbrli:endDate>2015-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nvro:FirstAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161201_20161231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nvro:FirstAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-12-01</xbrli:startDate>
					<xbrli:endDate>2016-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20170201_20170228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:FacilityLeaseAgreementThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-02-01</xbrli:startDate>
					<xbrli:endDate>2017-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20211031_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:FacilityLeaseAgreementThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nvro:FirstAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-31</xbrli:startDate>
					<xbrli:endDate>2021-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-08-31</xbrli:startDate>
					<xbrli:endDate>2020-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nvro:SupplyAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nvro:SupplyAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nvro:SupplyAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtCounterpartyNameAxis_nvroMayoAndVglMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nvro:MayoAndVglMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nvro:MayoFoundationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_srtRangeAxis_srtMinimumMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nvro:MayoFoundationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20141101_20141130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nvro:MayoFoundationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2014-11-01</xbrli:startDate>
					<xbrli:endDate>2014-11-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20170731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-07-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20170701_20170731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-07-01</xbrli:startDate>
					<xbrli:endDate>2017-07-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_nvroConvertibleNote">
				<xbrli:measure>nvro:ConvertibleNote</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_us-gaapIndemnificationGuaranteeMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_nvroPatent">
				<xbrli:measure>nvro:Patent</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20161209">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nvro:BostonScientificCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-12-09</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20180427">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nvro:BostonScientificCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-04-27</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20211101_20211101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nvro:BostonScientificCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-11-01</xbrli:startDate>
					<xbrli:endDate>2021-11-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_nvroPatentInfringementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">nvro:PatentInfringementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-06-01</xbrli:startDate>
					<xbrli:endDate>2016-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_utrD">
				<xbrli:measure>utr:D</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">nvro:OneHundredThirtyPercentApplicableConversionPriceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-06-01</xbrli:startDate>
					<xbrli:endDate>2016-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">nvro:NinetyEightPercentApplicableConversionPriceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-06-01</xbrli:startDate>
					<xbrli:endDate>2016-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-06-01</xbrli:startDate>
					<xbrli:endDate>2016-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601_20210601">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-06-01</xbrli:startDate>
					<xbrli:endDate>2021-06-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">nvro:OneHundredThirtyPercentApplicableConversionPriceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">nvro:NinetyEightPercentApplicableConversionPriceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20141110_20141111">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2014-11-10</xbrli:startDate>
					<xbrli:endDate>2014-11-11</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20141111">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2014-11-11</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_20141110">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2014-11-10</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandSevenPlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandSevenPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20141031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2014-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroIncentiveStockOptionsMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:IncentiveStockOptionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroNonQualifiedStockOptionsMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range1Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range2Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range3Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range4Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range5Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range7Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range6Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range1Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range2Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range3Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range4Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range5Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range6Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range7Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-03-01</xbrli:startDate>
					<xbrli:endDate>2019-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-03-01</xbrli:startDate>
					<xbrli:endDate>2019-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-03-01</xbrli:startDate>
					<xbrli:endDate>2019-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-03-01</xbrli:startDate>
					<xbrli:endDate>2021-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-03-01</xbrli:startDate>
					<xbrli:endDate>2021-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-03-01</xbrli:startDate>
					<xbrli:endDate>2021-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2014-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141001_20141031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2014-10-01</xbrli:startDate>
					<xbrli:endDate>2014-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_20141001_20141031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2014-10-01</xbrli:startDate>
					<xbrli:endDate>2014-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190301_20190331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-03-01</xbrli:startDate>
					<xbrli:endDate>2019-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-03-01</xbrli:startDate>
					<xbrli:endDate>2019-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-03-01</xbrli:startDate>
					<xbrli:endDate>2019-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapIncomeTaxAuthorityNameAxis_us-gaapCaliforniaFranchiseTaxBoardMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapLongtermDebtTypeAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvro:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvro:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvro:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001444380</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000000" fromRefs="F_000540 F_000541 F_000553 F_000554"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000001" fromRefs="F_000542 F_000543 F_000544 F_000545 F_000548 F_000549 F_000555 F_000556 F_000557 F_000558 F_000559 F_000560 F_000561 F_000562"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000002" fromRefs="F_000546 F_000547"></ix:relationship>
		</ix:resources>
	</ix:header>
</div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington,&#160;D.C. 20549</p>
<p style="margin-bottom:2pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:35.83%;margin-right:35.83%;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM&#160;<ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001444380_20210101_20211231">10-K</ix:nonNumeric></p>
<p style="margin-bottom:2pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:35.83%;margin-right:35.83%;text-indent:0%;font-size:2pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.93%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:10.5pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10.5pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000031" name="dei:DocumentAnnualReport" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">Annual report pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</p></td></tr></table></div>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the fiscal year ended <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001444380_20210101_20211231" format="ixt:datemonthdayyearen">December&#160;31, <ix:nonNumeric id="F_000003" name="dei:DocumentFiscalYearFocus" contextRef="C_0001444380_20210101_20211231">2021</ix:nonNumeric></ix:nonNumeric></p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">or</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.93%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:bold;font-size:10.5pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10.5pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000032" name="dei:DocumentTransitionReport" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10.5pt;">Transition report pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</p></td></tr></table></div>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commission File Number:&#160;<ix:nonNumeric id="F_000022" name="dei:EntityFileNumber" contextRef="C_0001444380_20210101_20211231">001-36715</ix:nonNumeric></p>
<p style="margin-bottom:2pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:35.83%;margin-right:35.83%;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:20pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityRegistrantName" contextRef="C_0001444380_20210101_20211231">NEVRO CORP.</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="margin-bottom:2pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:35.83%;margin-right:35.83%;text-indent:0%;font-size:2pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000023" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="top" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000024" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001444380_20210101_20211231">56-2568057</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">incorporation or organization)</p></td>
<td valign="top" style="width:50%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000025" name="dei:EntityAddressAddressLine1" contextRef="C_0001444380_20210101_20211231">1800 Bridge Parkway</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000026" name="dei:EntityAddressCityOrTown" contextRef="C_0001444380_20210101_20211231">Redwood City</ix:nonNumeric>, <ix:nonNumeric id="F_000027" name="dei:EntityAddressStateOrProvince" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric id="F_000028" name="dei:EntityAddressPostalZipCode" contextRef="C_0001444380_20210101_20211231">94065</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices and zip code)</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonNumeric id="F_000029" name="dei:CityAreaCode" contextRef="C_0001444380_20210101_20211231">650</ix:nonNumeric>)&#160;<ix:nonNumeric id="F_000030" name="dei:LocalPhoneNumber" contextRef="C_0001444380_20210101_20211231">251-0005</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Registrant&#8217;s telephone number, including area code)</p>
<p style="text-align:center;margin-bottom:3pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:38.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each clas<span style="text-decoration:underline;">s</span></p></td>
<td valign="top" style="width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:7.5pt;">&#160;</p></td>
<td valign="bottom" style="width:21.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol</p></td>
<td valign="top" style="width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:7.5pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:38.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:38.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0001444380_20210101_20211231">Common Stock, par value $0.001 per share</ix:nonNumeric></p></td>
<td valign="top" style="width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:21.16%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:TradingSymbol" contextRef="C_0001444380_20210101_20211231">NVRO</ix:nonNumeric></p></td>
<td valign="top" style="width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:38.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:SecurityExchangeName" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(g) of the Act: None</p>
<p style="margin-bottom:2pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:35.83%;margin-right:35.83%;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000009" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_0001444380_20210101_20211231">Yes</ix:nonNumeric>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span>&#160;&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act of 1934 (the &#8220;Exchange Act&#8221;).&#160;&#160;&#160;&#160;Yes&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span>&#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000011" name="dei:EntityVoluntaryFilers" contextRef="C_0001444380_20210101_20211231">No</ix:nonNumeric>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Exchange Act during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports) and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000010" name="dei:EntityCurrentReportingStatus" contextRef="C_0001444380_20210101_20211231">Yes</ix:nonNumeric>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span>&#160;&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000019" name="dei:EntityInteractiveDataCurrent" contextRef="C_0001444380_20210101_20211231">Yes</ix:nonNumeric>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span>&#160;&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-bottom:2pt;margin-top:2pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:17.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000012" name="dei:EntityFilerCategory" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:entityfilercategoryen">Large&#160;accelerated&#160;filer</ix:nonNumeric></p></td>
<td valign="bottom" style="width:51.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p></td>
<td valign="bottom" style="width:29.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated&#160;filer</p></td>
<td valign="bottom" style="width:1.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
</tr>
<tr>
<td valign="middle" style="width:17.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:3pt;">&#160;</p></td>
<td valign="middle" style="width:51.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:3pt;">&#160;</p></td>
<td valign="middle" style="width:29.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:3pt;">&#160;</p></td>
<td valign="middle" style="width:1.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:3pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:17.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-accelerated filer</p></td>
<td valign="bottom" style="width:51.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p></td>
<td valign="bottom" style="width:29.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smaller&#160;reporting&#160;company</p></td>
<td valign="bottom" style="width:1.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntitySmallBusiness" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:17.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="bottom" style="width:51.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="bottom" style="width:29.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth&#160;company</p></td>
<td valign="bottom" style="width:1.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000014" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;<span style="color:#000000;font-family:'Times New Roman';"><span style="font-size:8pt;font-family:'Times New Roman'">&#9744;</span></span></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. &#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000018" name="dei:IcfrAuditorAttestationFlag" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000015" name="dei:EntityShellCompany" contextRef="C_0001444380_20210101_20211231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June&#160;30, 2021, the last business day of the Registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000017" name="dei:EntityPublicFloat" contextRef="C_0001444380_20210630" decimals="-6" format="ixt:numdotdecimal" scale="6">5,695</ix:nonFraction> million based on the closing sale price for the registrant&#8217;s common stock on The New York Stock Exchange on that date of $165.79 per share.</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of February&#160;16, 2022, there were <ix:nonFraction unitRef="U_xbrlishares" id="F_000016" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_0001444380_20220216" decimals="INF" format="ixt:numdotdecimal">35,049,108</ix:nonFraction> shares of the registrant&#8217;s Common Stock outstanding.</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DOCUMENTS INCORPORATED BY REFERENCE</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000033" name="dei:DocumentsIncorporatedByReferenceTextBlock" contextRef="C_0001444380_20210101_20211231">Portions of the registrant&#8217;s Proxy Statement for the registrant&#8217;s 2022 Annual Meeting of Stockholders are incorporated by reference into Part&#160;III of this Form&#160;10-K to the extent stated herein. The Proxy Statement will be filed within 120&#160;days of the registrant&#8217;s fiscal year ended December&#160;31, 2021.</ix:nonNumeric></p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:2pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:13.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Auditor Firm Id:</p></td>
<td valign="top" style="width:12.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000034" name="dei:AuditorFirmId" contextRef="C_0001444380_20210101_20211231">238</ix:nonNumeric></p></td>
<td valign="top" style="width:12.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Auditor Name: </p></td>
<td valign="top" style="width:29.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000035" name="dei:AuditorName" contextRef="C_0001444380_20210101_20211231">PricewaterhouseCoopers LLP</ix:nonNumeric></p></td>
<td valign="top" style="width:14.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Auditor Location:</p></td>
<td valign="top" style="width:18.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000036" name="dei:AuditorLocation" contextRef="C_0001444380_20210101_20211231">San Jose, California</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.93%;font-size:2pt;">&#160;</p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NEVRO CORP.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td colspan="2" valign="top" style="width:90.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page&#160;No.</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:90.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART I</p></td>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;">
<p style="line-height:2pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:20pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:9.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1_BUSINESS"><span style="text-decoration:underline;">Business</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1A.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1A_RISK_FACTORS"><span style="text-decoration:underline;">Risk Factors</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1B.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1B_UNRESOLVED_STAFF_COMMENTS"><span style="text-decoration:underline;">Unresolved Staff Comments</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_2_PROPERTIES"><span style="text-decoration:underline;">Properties</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;3.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_3_LEGAL_PROCEEDINGS"><span style="text-decoration:underline;">Legal Proceedings</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;4.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_4_MINE_SAFETY_DISCLOSURES"><span style="text-decoration:underline;">Mine Safety Disclosures</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:90.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PART&#160;II</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;">
<p style="text-align:right;line-height:2pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:-12.25pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:9.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;5.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU"><span style="text-decoration:underline;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;6.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_6_SELECTED_FINANCIAL_DATA"><span style="text-decoration:underline;">[Reserved]</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F"><span style="text-decoration:underline;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7A.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS"><span style="text-decoration:underline;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;8.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR"><span style="text-decoration:underline;">Financial Statements and Supplementary Data</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC"><span style="text-decoration:underline;">Changes in and Disagreements with Accountants On Accounting and Financial Disclosure</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9A.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9A_CONTROLS_PROCEDURES"><span style="text-decoration:underline;">Controls and Procedures</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9B.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9B_OR_INFORMATION"><span style="text-decoration:underline;">Other Information</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9C.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9C_DISCL_FOREIGN"><span style="text-decoration:underline;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</p></td>
</tr>
<tr style="height:6pt;">
<td colspan="2" valign="middle" style="width:90.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:-12.25pt;;font-size:1pt;">&#160;</p></td>
<td valign="bottom" style="width:9.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:90.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PART&#160;III</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;">
<p style="text-align:right;line-height:2pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:-12.25pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:9.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;10.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO"><span style="text-decoration:underline;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">133</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;11.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_11_EXECUTIVE_COMPENSATION"><span style="text-decoration:underline;">Executive Compensation</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">133</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;12.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF"><span style="text-decoration:underline;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">133</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;13.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR"><span style="text-decoration:underline;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">133</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;14.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_14_PRINCIPAL_ACCOUNTANT_FEES_SERVIC"><span style="text-decoration:underline;">Principal Accountant Fees and Services</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">133</p></td>
</tr>
<tr style="height:6pt;">
<td colspan="2" valign="middle" style="width:90.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:-12.25pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:9.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:90.78%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PART&#160;IV</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;">
<p style="text-align:right;line-height:2pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:-12.25pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:9.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;15.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH"><span style="text-decoration:underline;">Exhibits and Financial Statement Schedules</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134</p></td>
</tr>
<tr>
<td valign="top" style="width:8.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;16.</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_16_FORM_10K_SUMMARY"><span style="text-decoration:underline;">Form 10-K Summary</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.14%;">
<p style="line-height:2pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:82.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#SIGNATURES"><span style="text-decoration:underline;">Signatures</span></a></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.22%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_I">PART&#160;I</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1_BUSINESS">ITEM&#160;1.&#160;<span style="font-style:italic;">BUSINESS</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment.&#160;&#160;We have developed and commercialized the Senza&#174; spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain, with the Senza&#174; Omnia&#8482; platform being our latest addition to the Senza family of products. Our proprietary, paresthesia-free 10 kHz Therapy, delivered by our Senza system, was demonstrated in our SENZA randomized controlled trial (RCT) to be superior to traditional SCS therapy, with 10 kHz Therapy being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy.&#160;&#160;In addition to the original approval of our therapy in back and leg pain, we received approval of unilateral or bilateral pain, associated with painful diabetic neuropathy (PDN) in July 2021 and we received expanded labeling in non-surgical refractory back pain (NSRBP) in January 2022. Our SENZA-RCT study, along with our SENZA-PDN clinical study, SENZA-NSRBP clinical study and European studies, represents what we believe is the most robust body of clinical evidence for any SCS therapy. We believe the superiority of 10 kHz Therapy over traditional SCS therapies will allow us to capitalize on and expand the approximately $2.3 billion global SCS market by treating patients with debilitating chronic pain, including back and leg pain, NSRBP and PDN.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We launched Senza commercially in the United States in May 2015, after receiving a label from the U.S. Food and Drug Administration (FDA) supporting the superiority of our 10 kHz Therapy over traditional SCS.&#160;&#160;The Senza system has been commercially available in certain European markets since November 2010 and in Australia since August 2011. We have experienced significant revenue growth in the United States since commercial launch. Senza is currently reimbursed by all of the major insurance providers.&#160;&#160;In early 2017, we commenced a controlled commercial launch of our family of surgical leads, marketed as the Surpass surgical lead, and in April 2020 received FDA approval for our reduced-size Surpass-C surgical lead.&#160;&#160;In January 2018, we received FDA approval of our next generation Senza II SCS system.&#160;&#160;In the fourth quarter of 2019, we received FDA approval of our next generation product platform, Senza Omnia, which we launched in the United States in the fourth quarter of 2019.&#160;&#160;Additionally, we received approval to commercially launch Senza Omnia in Europe during the second quarter of 2020 and in Australia in July 2020.&#160;&#160;In the first quarter of 2021, we received FDA approval for our first Senza Omnia upgrade, Omnia&#8482; Powered by HFX Connect&#8482;, and our next generation trial stimulator. In July 2021, we received FDA approval of our 10 kHz Therapy for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with PDN. This approval is specific to our unique 10 kHz stimulation, and the Senza system was the first spinal cord stimulation system approved by the FDA with a specific indication to treat certain forms of pain associated with PDN.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The tables below set forth our revenue from U.S. and international sales the past three years on a quarterly basis and total revenue for each of the past five years. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.9%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q1 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q2 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q3 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q4 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q1 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q2 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q3 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q4 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q1 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q2 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q3 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q4 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Revenue from:</span></p></td>
<td colspan="47" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. sales</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65.8</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78.1</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84.2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97.9</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.3</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.0</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90.9</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94.6</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74.7</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85.0</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78.1</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88.4</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.5</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.0</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.5</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.5</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.9</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.9%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82.1</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93.6</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100.2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114.4</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87.5</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.4</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108.5</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109.7</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88.6</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102.3</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93.2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102.8</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Revenue from:</span></p></td>
<td colspan="18" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.72%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. sales</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">263.5</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">321.8</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326.0</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">311.9</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326.2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63.2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65.5</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.7</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326.7</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">387.3</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">390.3</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">362.0</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386.9</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2021 global market for SCS therapy was estimated to be approximately $2.3 billion.&#160;&#160;Throughout 2021, the COVID-19 pandemic negatively impacted the global SCS therapy market, which we estimate decreased by approximately 5% to 10%. We believe the superiority of 10 kHz Therapy over traditional SCS therapies will allow us to capitalize on the addressable trunk and limb chronic pain market, which is estimated to be approximately 14% penetrated in the United States, as well as expand the SCS market by treating other pain-related indications, such as PDN and NSRBP, among others. The United States represents approximately 80% of this global market due in part to governmental reimbursement restraints in international markets. We believe that due to factors such as an aging population, an increasing number of failed back surgeries and an increasing prevalence of diabetes, there is continuing opportunity for an SCS therapy that effectively treats back pain to increase the size of the existing SCS market over time.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that we will continue to both take share of and expand the SCS therapy market due to the unique benefits of 10 kHz Therapy, as well as the broad therapy versatility of our product platform.&#160;&#160;10 kHz Therapy is paresthesia-free therapy and has demonstrated superior efficacy when compared to traditional SCS therapies. Traditional SCS therapy generates paresthesia, a sensation typically experienced as tingling, numbness and buzzing, which overlaps the pain area. Paresthesia is often considered unpleasant or uncomfortable.&#160;&#160;Compared to traditional SCS therapy, which typically operates at 50 Hz to 60 Hz, 10 kHz Therapy delivers spinal cord stimulation at a lower amplitude and a higher frequency waveform of 10,000 Hz. In addition, 10 kHz Therapy relies on consistent anatomical placement of the stimulation leads across patients, thus reducing procedure variability relative to traditional SCS therapy which requires individualized lead placement to properly map paresthesia coverage. We believe the ability of 10 kHz Therapy to deliver pain relief without paresthesia provides a substantial benefit over traditional SCS therapy to patients and physicians. However, despite its shortcomings traditional SCS therapy has a long track record of safety and, together with our product platform, can be made available to the subgroup of patients who do not receive adequate relief with 10 kHz Therapy alone.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe the clinical results from our SENZA-RCT study, along with our European studies, position us with superior and compelling efficacy data. The following charts provide a comparison of 10 kHz Therapy in both pain reduction and responder rates against the other prospective Level 1 studies conducted. </p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu1405a4gpzj000001.jpg" title="" alt="" style="width:624px;height:295px;" /></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:6pt;color:#000000;">Al-Kaisy A, et. al. Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study. </span><span style="font-style:italic;font-size:6pt;color:#000000;">Pain Med</span><span style="font-size:6pt;color:#000000;">. 2014&#59;15:347-354.&#160;&#160;Internal data on file.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:6pt;color:#000000;">Kapural, Leonardo et. al. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. </span><span style="font-style:italic;font-size:6pt;color:#000000;">Anesthesiology</span><span style="font-size:6pt;color:#000000;"> Vol. 123 No 4. October 2015.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:6pt;color:#000000;">Kumar K et al., Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome, </span><span style="font-style:italic;font-size:6pt;color:#000000;">Pain</span><span style="font-size:6pt;color:#000000;"> (2007), doi:10.1016/j.pain.2007.07.028.&#160;&#160;6-month data shown.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:6pt;color:#000000;">St. Jude Medical Proclaim&#8482; Implantable Pulse Generator Clinician's Manual, Models 3660, 3662, 3665, 3667. Published on www.sjm.com October 2016.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu1405a4gpzj000002.jpg" title="" alt="" style="width:624px;height:310px;" /></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:6pt;color:#000000;">Al-Kaisy A, et. al. Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study. </span><span style="font-style:italic;font-size:6pt;color:#000000;">Pain Med</span><span style="font-size:6pt;color:#000000;">. 2014&#59;15:347-354.&#160;&#160;Internal data on file.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:6pt;color:#000000;">Kapural, Leonardo et. al. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. </span><span style="font-style:italic;font-size:6pt;color:#000000;">Anesthesiology</span><span style="font-size:6pt;color:#000000;"> Vol. 123 No 4. October 2015.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:6pt;color:#000000;">Kumar K et al., Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome, </span><span style="font-style:italic;font-size:6pt;color:#000000;">Pain</span><span style="font-size:6pt;color:#000000;"> (2007), doi:10.1016/j.pain.2007.07.028.&#160;&#160;6-month data shown.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:6pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:6pt;color:#000000;">St. Jude Medical Proclaim&#8482; Implantable Pulse Generator Clinician's Manual, Models 3660, 3662, 3665, 3667. Published on www.sjm.com October 2016.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe we have built competitive advantages through our proprietary technology, clinical evidence base, strong track record of execution with approximately 80,000 patients implanted with Senza systems, extensive intellectual property and a proven management team with substantial medical device experience. With the well-demonstrated superior efficacy of our 10 kHz Therapy, we aim to continue to drive adoption and penetration in the U.S. market, which represents the largest opportunity in SCS, and expand patient access to 10 kHz Therapy by investing in the development of evidence for new indications such as chronic painful neuropathies (including PDN) and NSRBP. On this front, we conducted two randomized controlled trials, SENZA-PDN and SENZA-NSRBP, which are evaluating 10 kHz Therapy for the treatment of PDN and NSRBP, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The SENZA-PDN study is one of the largest randomized controlled trials (RCT) conducted in the field of spinal cord stimulation with 216 randomized patients. The study is evaluating paresthesia-free SCS 10 kHz Therapy among patients diagnosed with PDN and refractory to conventional medical management (CMM). Patients were randomized one to one to CMM alone or CMM with 10 kHz Therapy. We presented the complete six-month and preliminary twelve-month data in January 2021 at the North American Neuromodulation Society (NANS) conference. The primary outcome was a composite endpoint of safety and efficacy, specifically including greater than or equal to 50% pain relief and no worsening in neurological deficit versus the baseline. Eighty-six percent (86%) of patients in the 10 kHz Therapy plus CMM arm met the three-month endpoint, compared with 5% in the CMM only arm. At six months, patients in the 10 kHz Therapy plus CMM arm had a response rate of 85%, compared with 5% in the CMM only arm. In April 2021, the six-month data were published online in JAMA Neurology. In June 2021, the complete 12-month data, including the six-month crossover patient data, was presented at the American Diabetes Association 81st Scientific Sessions. These 12-month results, including six-month crossover data, demonstrated significantly improved and sustained outcomes with 10 kHz Therapy, including substantial, sustained pain relief and improved health-related quality of life measures. In November 2021, the 12-month results and six-month crossover data were published online in <span style="font-style:italic;">Diabetes Care</span>. In July 2021, the FDA approved the Senza System for the treatment of chronic intractable pain of the lower limbs, including unilateral and bilateral pain, associated with PDN. This approval is specific to Nevro&#8217;s unique 10 kHz stimulation, and the Senza system was the first spinal cord stimulation system approved by the FDA with a specific indication to treat PDN.&#160;&#160;The study continues such that future follow-ups will be utilized for publication and expanded reimbursement payor coverage. In January 2022, we announced that UnitedHealthcare will provide coverage for our 10 kHz Therapy for the treatment of PDN for dates of service on or after March 1, 2022.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the 2021 NANS conference we also presented our three-month primary endpoint data of SENZA-NSRBP study, which includes patients with chronic back pain but, based on an assessment from a spine surgeon, are not surgical candidates. The study compares patients receiving 10 kHz Therapy plus CMM to patients receiving CMM alone. At the three-month primary endpoint</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> patients who received 10 kHz Therapy plus CMM had a response rate of 80.9% compared to 1.3% for the CMM alone group.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2022, the FDA approved th</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senza System</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">an aid</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the management of NSRBP (intractable back pain without prior surgery and not a candidate for back surgery).</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect that th</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e 12-month follow-up </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">data </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will be utilized for publications and to seek expanded payor coverage for this patient cohort.&#160;&#160;</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, at the 2022 NANS conference we presented the complete 18-month results, including the 12-month crossover patient data, for our SENZA-PDN study. Key findings at 18 months included significant and sustained outcomes with 10 kHz SCS. In addition, analysis of healthcare resource utilization through the first 12 months of the SENZA-PDN trial showed reduced spending associated with 10 kHz Therapy, particularly for hospitalizations. We also presented our 12-month results, including six-month crossover patient data, for our SENZA-NSRBP study. Key findings at 12 months showed profound improvements in pain relief, function, quality of life measures, awareness of positive change and reduction in daily opioid use in NSRBP patients receiving 10 kHz Therapy at 12-months post-implant. Results also included comparable improvements for patients that crossed over from CMM to 10 kHz after 6 months. In February 2022, the SENZA-NSRBP 12-month results were published online in the <span style="font-style:italic;">Journal of Neurosurgery: Spine</span>. Patients in the SENZA-PDN and SENZA NSRBP studies will be followed for 24 months.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Market Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Existing Treatments for Chronic Pain and Limitations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:normal;color:#auto;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Chronic pain has been defined as pain that lasts longer than the time required for tissues to heal, which is often considered to be three months.&#160;&#160;Patients who present with chronic pain are typically placed on a treatment progression plan. Initial medical management typically includes behavioral modification, exercise, physical therapy and over-the-counter analgesics and non-steroidal anti-inflammatory drugs. When early-stage medical management is not sufficient for the treatment of chronic leg and back pain, patients may progress to interventional techniques including steroid injections or nerve blocks. Patients who do not respond to these more conservative treatments are considered candidates for more advanced therapies.&#160;&#160;These more advanced therapies include spine surgery, treatment with oral opioids and SCS.&#160;&#160;Spine surgery, while a common invasive procedure, can result in complications such as Failed Back Surgery Syndrome (FBSS) a condition where pain persists despite the procedure, and spinal surgery often fails to treat certain types of chronic pain such as severe neuropathic back pain.&#160;&#160;Oral opioids, while reducing the patient&#8217;s perception of pain, lack clinical evidence to support long-term usage and can cause multiple complications and side-effects including nausea, vomiting and dizziness.&#160;&#160;Further, opioids present a high risk of addiction and abuse.&#160;&#160;&#160;&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Traditional Spinal Cord Stimulation and Limitations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SCS is a type of neuromodulation technology that utilizes an implantable, pacemaker-like device to deliver electrical impulses to the spinal cord to treat chronic pain.&#160;&#160;Traditional SCS therapy is designed to induce paresthesia, a sensation typically experienced as tingling, numbness and buzzing, which overlaps the area of pain with the intent of masking pain perception. The electrical pulses are delivered by small electrodes on leads that are placed near the spinal cord and are connected to a battery-powered generator implanted under the skin. Traditional SCS therapy is currently indicated as a treatment for chronic pain of the trunk and limbs in patients who failed CMM. Traditional SCS therapy is considered to be a minimally invasive and reversible therapy that may provide greater long-term benefits over more invasive surgical approaches or opioids. The most common use for traditional SCS therapy is for neuropathic pain conditions such as FBSS.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Traditional SCS therapy generally consists of two phases, an evaluation period, also called the trial period, which typically lasts several days, followed by a permanent implant for those patients who experience a successful trial period. The trial period involves a percutaneously placed insulated wire, called a lead, which a physician implants near the spinal cord using a needle. During the trial period, a temporary external system is used by patients and physicians for evaluating whether traditional SCS therapy is effective. If the trial period is successful, a permanent system is implanted in the patient. The success criterion is typically an approximate 50% reduction in </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pain during the evaluation period.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For those patients that proceed to the permanent implant procedure, we believe that approximately 30%</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to 40%</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of U.S. procedures are completed using surgical leads and the remaining are completed using percutaneous leads.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A key part of the permanent system is the implantable pulse generator (IPG) which is a miniaturized version of the external stimulator. The IPG should provide the patient with multiple years of use and can be either rechargeable or non-rechargeable (primary cell). Due to payor constraints in certain European countries, the transition from primary cell IPGs to rechargeable IPGs has been slow in those markets. In the United States and Australia, the majority of IPGs implanted are rechargeable.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Traditional SCS products have required paresthesia to provide pain relief, and consequently, paresthesia coverage has been used as a surrogate metric for successful pain relief. <span style="Background-color:#FFFFFF;color:#000000;">Paresthesia, however, is often considered unpleasant or uncomfortable and is sometimes made worse by a shocking or jolting sensation with changes in posture. Unpleasant sensations can be caused by lead movement closer to the spinal cord or away from it as the patient moves, resulting in variation in paresthesia intensity. Paresthesia is also a constant reminder of the patient&#8217;s chronic condition. These limitations of paresthesia-based therapy are particularly true for PDN patients, who are already suffering from paresthesia-like symptoms. Due to the distraction of paresthesia, patients with traditional SCS devices are instructed not to drive or operate machinery when the device is active. Medtronic plc (Medtronic) has released a survey showing that 71% of patients find paresthesia uncomfortable at times. </span>As such, innovation in the SCS market has historically focused on technologies that optimize traditional SCS therapy&#8217;s ability to create more precise paresthesia fields. Even with successful paresthesia coverage, patients still may not receive pain relief or often lose pain relief after a period of time.<span style="Background-color:#FFFFFF;color:#000000;"> </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Traditional SCS procedures also require physicians to perform the complex and often time-consuming process of paresthesia mapping.<span style="Background-color:#FFFFFF;color:#000000;"> This mapping process requires a patient to be sedated for the lead placement, then awakened and repeatedly questioned in order for the physician to assess paresthesia coverage over the patient&#8217;s area of pain and reposition and reprogram the leads to redirect the paresthesia. This process creates variability in the procedure and a complicated anesthesia management process, impacting the physician&#8217;s schedule and patient comfort. The primary objective of traditional SCS therapy is to create a stimulation program that covers the areas of pain without creating paresthesia beyond the pain areas, given that this can be uncomfortable and difficult to tolerate.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Traditional SCS technology involves the delivery of low frequency electrical impulses, or waveforms, to the spinal cord.&#160;&#160;Recent developments in traditional SCS have resulted in alternative waveforms, some of which are variations of low frequency waveforms, some at sub-threshold amplitudes aimed at reducing the reliance on paresthesia.&#160;&#160;Abbott Laboratories has developed a SCS system that offers an alternate low frequency waveform called BurstDR.&#160;&#160;Medtronic is promoting a programming approach called DTM&#8482; (Differential Target Multiplexed) which involves frequencies up to 1,200 Hz. Additionally, Boston Scientific is now offering sub-threshold therapy at frequencies below 1.2 kHz.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our Solution for Chronic Pain</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">10 kHz Therapy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our 10 kHz Therapy is designed to deliver innovative neuromodulation solutions for treating chronic pain based on what we believe to be the best clinical evidence available. By overcoming many of the limitations of traditional SCS therapy, our 10 kHz Therapy offers superior efficacy for patients and provides significant advantages to physicians and hospitals. We believe the advantages of our proprietary 10 kHz Therapy over traditional SCS include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Demonstrated superior efficacy data for both leg and back pain:</span><span style="color:#000000;">&#160;In our SENZA-RCT pivotal study, 10 kHz Therapy was demonstrated to provide significant and sustained back pain relief in addition to leg pain relief. 10 kHz Therapy was shown in both number of patients that respond and in treatment efficacy to be superior to traditional SCS therapy as it was nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain. Our SENZA-RCT study, along with the previously completed European studies, represent what we believe is the most robust body of clinical evidence for any SCS therapy. We believe that the superior efficacy results and robust data provided in our pivotal </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="color:#000000;">clinical trial</span><span style="color:#000000;">s</span><span style="color:#000000;"> </span><span style="color:#000000;">will drive increased adoption of our</span><span style="color:#000000;"> 10 kHz T</span><span style="color:#000000;">herapy among patients, payors and providers and </span><span style="color:#000000;">may enable us to gain significant market share in the approximately </span><span style="color:#000000;">$2.</span><span style="color:#000000;">3</span><span style="color:#000000;"> </span><span style="color:#000000;">billion global SCS </span><span style="color:#000000;">back and leg pain </span><span style="color:#000000;">market. In addition, we believe our efficacy data in back pain will allow us to expand the SCS market under current reimbursement </span><span style="color:#000000;">regimes </span><span style="color:#000000;">by meeting demand from back pain patients who are largely untreated by traditional SCS therapies.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">FDA-approved for use in PDN and NSRBP patients: </span><span style="color:#000000;">In our SENZA-PDN and SENZA-NSRBP studies, 10 kHz Therapy provided significant and sustained pain relief to patients suffering from PDN and NSRBP compared to CMM.&#160;&#160;Based on this evidence, we received FDA approval for specific indications to treat PDN and NSRBP patients in July 2021 and January 2022, respectively. We believe that the results and robust data provided in our SENZA-PDN and SENZA-NSRBP clinical trials will support increased adoption of our 10 kHz Therapy among patients, payors and providers and may enable us to gain significant market share in the PDN and NSRBP markets.&#160;&#160;In addition, we believe our efficacy data in back pain will allow us to expand the SCS market under current reimbursement regimes by meeting demand from back pain patients who are largely untreated by traditional SCS therapies. For example, in January 2022, we announced that UnitedHealthcare will provide coverage for our 10 kHz Therapy for the treatment of PDN for dates of service on or after March 1, 2022.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Paresthesia free pain relief for patients:</span><span style="color:#000000;">&#160; 10 kHz Therapy offers the notable benefit to patients of achieving significant and sustained pain relief without paresthesia, thus enabling our patients to avoid the uncomfortable shocking or jolting sensations commonly associated with paresthesia, and removing a major barrier for many patients who may otherwise benefit from SCS therapy. This is particularly true for PDN patients who are already suffering from uncomfortable paresthesia-like symptoms.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Anatomical lead placement for physicians.</span><span style="color:#000000;">&#160;Since 10 kHz Therapy relies on consistent anatomical lead placement, it removes the cumbersome process of paresthesia mapping that is required by traditional SCS therapy, reducing variability in the operating procedure and offering a significant benefit to both physicians and hospitals by reducing variability of procedures.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Ability to treat a broader group of chronic pain patients:</span><span style="color:#000000;">&#160;Our 10 kHz Therapy is a platform technology that we believe can provide treatment benefits for a broader group of chronic pain indications. Based on analysis from our SENZA-RCT and European studies, as well as our SENZA-PDN and SENZA-NSRBP RCTs, we believe 10 kHz Therapy may be an attractive treatment option for patients. Due to the removal of paresthesia, we believe 10 kHz Therapy may also be an effective therapy for patients with chronic upper limb and neck pain as it does not create the intense discomfort that traditional SCS generates for patients with chronic upper limb and neck pain when leads are placed in the cervical spine. We are currently investigating the use of 10 kHz Therapy to address chronic pain conditions such as chronic upper limb and neck pain. </span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our Growth Strategy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By combining the brightest talent with the strongest foundation of clinical evidence, our mission is to deliver comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To accomplish this objective we intend to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Earn market share through leveraging the Senza Omnia platform:</span><span style="color:#000000;">&#160;Senza Omnia offers the most versatile platform in SCS as it includes the broadest frequency range, the most waveform capabilities and the unique ability to offer 10 kHz Therapy. In 2022, we will continue to expand our commercialization of Omnia and our HFX Connect platform and continue to position Omnia as the most versatile product available in the market, and we believe that it will have broad appeal to clinicians offering SCS.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Expand the existing SCS market by treating back pain and PDN:</span><span style="color:#000000;">&#160;We believe we are expanding the existing SCS market by delivering a system that provides meaningful treatment for chronic back pain, including NSRBP, and PDN, which we believe represents a significant opportunity in the global SCS market. With traditional SCS therapy, patients who experience predominant back pain are often </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="color:#000000;">associated with lower levels of treatment success. Consequently</span><span style="color:#000000;">, patients with back pain</span><span style="color:#000000;"> are typically not recommended for treatment with traditional SCS therapy due to the difficulty of achieving and maintaining pain coverage. </span><span style="color:#000000;">We are also currently running the SENZA-NSRBP study, which has been shown to demonstrate significant pain relief for patients suffering from back pain when that patient is not a candidate for spine surgery. </span><span style="color:#000000;">In contrast to traditional SCS therapy, w</span><span style="color:#000000;">e believe </span><span style="color:#000000;">10 kHz T</span><span style="color:#000000;">herapy is positioned to </span><span style="color:#000000;">help continue </span><span style="color:#000000;">expand</span><span style="color:#000000;">ing</span><span style="color:#000000;"> the existing SCS market by effectively treating back pain in addition to leg pain.</span><span style="font-weight:bold;color:#000000;"> </span><span style="color:#000000;">With respect to PDN, </span><span style="color:#000000;">our</span><span style="color:#000000;"> SENZA-PDN study demonstrated significantly improved and sustained outcomes with 10 kHz Therapy for patients suffering from PDN. This data was used to support our PDN label expansion and will be used to expand payor coverage for, and the broader adoption of, 10 kHz Therapy in treating PDN patients.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Communicate the clinically demonstrated, superior efficacy of 10 kHz Therapy to patients, physicians and payors globally:</span><span style="color:#000000;">&#160;Given our robust clinical evidence that demonstrates the superior efficacy of our 10 kHz Therapy, we believe we will be able to position our therapy with patients, providers and payors in a differentiated way. Given that our SENZA-RCT pivotal study has demonstrated superiority for both back and leg pain in a head-to-head comparison with traditional SCS, we are able to differentiate 10 kHz Therapy by communicating its superior clinical benefits and advantages to patients, physicians and payors.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Invest in research and development to drive innovation:</span><span style="color:#000000;">&#160;We are extending our novel and proprietary technologies into a series of product enhancements with the goal of improving the treatment of chronic pain. We also expect to continue developing enhancements to Senza to further increase performance and introduce new benefits including next generation IPGs, enhanced software, updated accessories and enhanced MRI capabilities.&#160;&#160;We believe that further product enhancements if and when completed will drive continued adoption of our technology platform and further validate the advantages and benefits of our 10 kHz Therapy.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-weight:bold;color:#000000;">Scale our business to achieve cost and production efficiencies:</span><span style="color:#000000;">&#160;We plan to improve the efficiency of our manufacturing processes, which we believe will lower our per unit manufacturing cost. We expect to continue to scale our manufacturing operations as we expand Senza sales volumes in the United States. For example, in the third quarter of 2020, we made the strategic decision to vertically integrate the assembly of IPG&#8217;s, peripherals and various other manufacturing related activities to mitigate our reliance on third-party manufacturers and improve our long-term gross margins.&#160;&#160;We plan on conducting these manufacturing activities in a facility in Costa Rica. The integration process is expected to be completed in mid-2022.&#160;&#160;Even after this integration process is completed, we expect that we will continue to rely on third-party manufacturers to provide key components to support the assembly process.&#160;&#160;We may incur significant capital expenditures and implementation costs to initiate the manufacturing operations in Costa Rica.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Growth Opportunities in Other Chronic Pain Indications</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We plan to use our platform technology to generate evidence on 10 kHz Therapy for use in other chronic pain indications and painful neuropathies. There can be no assurance that we will be successful in generating evidence for 10 kHz Therapy in other indications or in receiving additional regulatory approvals and reimbursement coverage to promote Senza and 10 kHz Therapy for use in other indications. Below are two areas where results have been successful:</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:normal;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Non-Surgical Back Pain</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">One of the most common uses for SCS is for neuropathic pain conditions such as FBSS. The incidence of patients that will develop FBSS following lumbar spinal surgery is estimated to be within the range of 10% to 40%. However, in addition to having applicability for treating FBSS patients, there is a potential for SCS to provide benefit for patients suffering from chronic pain who are not surgical candidates.&#160;&#160;10 kHz Therapy could provide an attractive treatment option for these patients, as a subset analysis of non-surgical patients from our SENZA-RCT and European studies, respectively, found a decrease in back pain VAS scores from 7.2 to 2.6 (12&#160;months, n&#61;12) and 8.1 to 3.4 (24&#160;months, n&#61;14), as well as a decrease in leg pain VAS scores from 7.2 to 2.8 (12&#160;months, n&#61;12) and 7.4 to 2.3 (24&#160;months, n&#61;11). More recent results in patients who were not candidates for major spine surgery and treated </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 kHz T</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">herapy </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a study led by </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dr. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adnan Al-Kaisy </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">demonstrated </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">similar promising results</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. In this study, patients experienced reduced back pain VAS and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Oswestry Disability Index (</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ODI</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> scores</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from baseline </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% respectively</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> at </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> months (n&#61;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. In</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">addition</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to pain reduction and reduced disability, a reduction in opioid use </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was observed with 90% of the patients using opioids at the start of the study compared to 12% at the end of th</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> study.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The results of this study led to the initiation of the SENZA-NSRBP RCT</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">which</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> compare</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 kHz T</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">herapy </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delivered in conjunction with CMM to CMM alone</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NSRBP</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> patients</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the 2021 NANS conference, we presented our three-month primary endpoint data of SENZA-NSRBP study. The study compar</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">es</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> patients receiving </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 kHz T</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">herapy plus CMM to </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patients receiving </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CMM alone</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> among </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">those</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> suffering from chronic back pain who are not surgical candidates based upon an assessment from a spine surgeon. At the three-month primary endpoint patients who received </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 kHz T</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">herapy plus CMM had a response rate of 80.9% compared to 1.3% for the CMM alone group.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2021, we presented our six-month data for the SENZA-NSRBP study at the American Society of Interventional Pain Physicians. At the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NANS conference in January 2022, we presented our 12-month data for the SENZA-NSRBP study at the 2022 NANS conference, which demonstrated profound improvements in pain relief, function, quality of life</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> measures</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, awareness of positive change and reduction in daily opioid use in NSRBP patients receiving 10 kHz Therapy at 12-months post-implant.&#160;&#160;Results also included comparable improvements for patients that crossed over from CMM to 10 kHz after 6 months.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Painful Neuropathies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The American Chronic Pain Association estimates that more than 15 million people in the United States and Europe have some degree of neuropathic pain. More than two out of every 100 people are estimated to have peripheral neuropathy, with the incidence rate increasing to eight in every 100 for people aged 55 or older. The</span><span style="color:#000000;"> diminished quality of life and increased disability associated with peripheral neuropathy results in significant workforce and healthcare costs. Various treatments currently exist, but have limited efficacy. As such, we have initiated an initial study to determine if 10 kHz Therapy could help this patient group. Results of a prospective, multicenter feasibility study treating chronic intractable pain of the limbs from peripheral polyneuropathy using 10 kHz Therapy demonstrated a decrease in mean VAS pain score from 7.5 at baseline (N&#61;18) to 1.9 at three months post-implant (the primary endpoint), 2.8 at twelve months and 1.4 at twenty-four months.&#160;&#160;Subject deemed responders was 78% at three months, 69% at twelve months and 88% at twenty-four months (presented at NANS in January 2019). The results from this study led to the initiation of the SENZA-PDN RCT.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2020, we presented the preliminary outcome data from SENZA-PDN which demonstrated greater than or equal to 50% pain relief and no worsening in neurological deficit versus baseline was achieved, with 86% of patients in the 10 kHz Therapy plus CMM arm reaching the endpoint, compared with 5% in the CMM only arm at three months. At the 2021 NANS conference, we presented the six-month data, which showed that patients in the 10 kHz Therapy plus CMM arm had a response rate of 85%, compared with 5% in the CMM only arm. The response rate and level of pain relief was maintained through twelve months in the 10 kHz Therapy plus CMM arm. At the American Diabetes Association 81st Scientific Sessions in June 2021, we presented the complete 12-month data, including the six-month crossover data, which showed the response rate and level of pain relief was maintained in the 10 kHz Therapy plus CMM arm and in the crossover arm. The 12-month outcomes in our SENZA-PDN study were published in <span style="font-style:italic;">Diabetes Care</span> in November 2021, which showed that 86% of participants in the 10 kHz SCS study arm reported pain relief &#62;50%, while the average pain relief was 77.1% (% reduction of VAS from baseline). After six months with 10 kHz SCS therapy, 84% of participants in the crossover arm reported pain relief &#62;50%, and average pain relief was 70.3% (% reduction of VAS from baseline). At the NANS conference in January 2022, we presented the 18-month data, which included significant and sustained outcomes with 10 kHz SCS. In addition, analysis of healthcare resource utilization through the first 12 months of the trial indicated reduced spending associated with 10 kHz SCS treatment, particularly for hospitalizations. We expect to publish our 24-month data as it becomes available.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Clinical Data</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:normal;font-style:italic;color:#auto;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Back Pain</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To support development of our proprietary 10 kHz Therapy, the technology was evaluated in preclinical studies and further studied in prospective clinical trials, some of which have been published. Key highlights of our SENZA-RCT pivotal study are as follows:</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">Our</span><span style="color:#000000;"> SENZA-RCT study results demonstrated the superiority of </span><span style="color:#000000;">10 kHz Therapy</span><span style="color:#000000;"> to traditional SCS therapy on all primary and secondary endpoints</span><span style="color:#000000;"> through 24 months</span><span style="color:#000000;">.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">10 kHz Therapy was nearly twice as successful in treating back pain as traditional SCS therapy, with 84.3% of patients receiving10 kHz Therapy reporting 50% or more pain relief at three months, as compared to 43.8% of patients receiving traditional SCS therapy. The superiority of 10 kHz Therapy for treating back pain was maintained through the 24-month follow-up period of the study.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">10 kHz Therapy was 1.5 times as successful in treating leg pain as traditional SCS therapy, with 83.1% of patients receiving 10 kHz Therapy, as compared to 55.5% of patients receiving traditional SCS therapy, reporting 50% or more pain relief at three months, results that were superior. The superiority of 10 kHz Therapy for treating leg pain was maintained through the 24-month follow-up period of the study.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">10 kHz Therapy provided a 69.2% reduction in back pain as measured by VAS, versus 44.2% for traditional SCS therapy, at three months, results that were superior. The superiority of 10 kHz Therapy for reducing back pain was maintained through the 24-month follow-up period of the study.&#160;&#160;10 kHz Therapy provided a 72.8% reduction in leg pain as measured by VAS, versus 51.5% for traditional SCS therapy, at three months, results that were superior. The superiority of 10 kHz Therapy for reducing leg pain was maintained through the 24-month follow-up period of the study.&#160;&#160;Superiority of 10 kHz Therapy to traditional SCS therapy demonstrated for both back and leg pain at each designated study endpoint throughout 24 months.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Patients receiving 10 kHz Therapy did not report paresthesia or uncomfortable stimulation at three months. In comparison, 46.5% of patients receiving traditional SCS therapy reported uncomfortable stimulation at three months.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Two-thirds of 10 kHz Therapy patients had a VAS pain score of less than or equal to 2.5 on a scale of 0 to 10 for back pain at three months (which we define as achieving remitter status), which is nearly twice the number of traditional SCS therapy patients (35%) with a VAS pain score of less than or equal to 2.5, results that were statistically superior. The superiority of 10 kHz Therapy for achieving remitter status for back pain was maintained through the 24-month follow-up period of the study.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Two-thirds of 10 kHz Therapy patients had a VAS pain score of less than or equal to 2.5 on a scale of 0 to 10 for leg pain at three months, a much greater number than traditional SCS therapy patients (40%) with a VAS pain score of less than or equal to 2.5, results that were statistically superior. The superiority of 10 kHz Therapy for achieving remitter status for leg pain was maintained through the 24-month follow-up period of the study.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Safety outcomes were consistent across the treatment groups, with the exception of uncomfortable paresthesia in traditional SCS patients, which was not in 10 kHz Therapy patients.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The results from the clinical studies have been consistent across studies and across outcome measures. Our initial prospective multicenter European clinical study (the EU study) were consistent with our subsequent findings in our prospective, comparative, randomized, controlled U.S. pivotal study (SENZA-RCT study). In the two-year follow up of the EU study, average back pain VAS was reduced from 8.4 at baseline to 2.8 at 12 months to 3.3 at 24 months. Average leg pain was reduced from 5.4 VAS pain level at baseline to 2.0 at 12 months to 2.3 at 24 months. Additionally, for responder rates, 60% of the implanted patients had at least 50% back pain relief and 71% had at least 50% leg pain relief. Disability as measured by Oswestry Disability Index (ODI) improved by an average of 15 points at 24 months, a clinically and statistically significant improvement. The following table summarizes key outcomes for implanted subjects in our EU and SENZA-RCT studies.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:31.38%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:17.18%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Month 3</p></td>
<td colspan="2" valign="top" style="width:17.18%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Month 6</p></td>
<td colspan="2" valign="top" style="width:17.18%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Month 12</p></td>
<td colspan="2" valign="top" style="width:17.06%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Month 24</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EU</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RCT</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EU</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RCT</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EU</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RCT</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EU</p></td>
<td valign="top" style="width:8.64%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RCT</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Back pain responders</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 kHz Therapy (%)</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82.9</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84.3</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73.6</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76.4</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.1</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78.7</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.0</p></td>
<td valign="top" style="width:8.64%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76.5</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Traditional SCS (%)</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43.8</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52.5</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.3</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49.3</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Superiority p-value</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leg pain responders</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 kHz Therapy (%)</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82.9</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83.1</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86.0</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80.9</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65.0</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80.9</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71.1</p></td>
<td valign="top" style="width:8.64%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72.9</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Traditional SCS (%)</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.0</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.0</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49.3</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Superiority p-value</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Back pain reduction from Baseline</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 kHz Therapy (%)</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71.3</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69.2</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67.7</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62.4</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.9</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.4</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.6</p></td>
<td valign="top" style="width:8.64%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.9</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Traditional SCS (%)</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44.2</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44.3</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44.7</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.1</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Superiority p-value</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leg pain reduction from Baseline</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.42%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 kHz Therapy (%)</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.3</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72.8</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73.4</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.9</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61.6</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69.5</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61.6</p></td>
<td valign="top" style="width:8.64%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65.1</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Traditional SCS (%)</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.5</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49.9</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48.0</p></td>
<td valign="top" style="width:8.42%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.0</p></td>
</tr>
<tr>
<td valign="top" style="width:31.38%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.1pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Superiority p-value</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.002</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.76%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#60;0.001</p></td>
<td valign="top" style="width:8.42%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:8.64%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.002</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our SENZA-RCT pivotal study was a prospective, randomized, multi-center study, conducted across 11 U.S. clinical trial sites, comparing the safety and effectiveness of Senza delivering 10 kHz Therapy, which we refer to as the test to Boston Scientific&#8217;s FDA-approved Precision Plus system, delivering traditional SCS therapy, which we refer to as the control. Each included patient was required to have a leg and back pain VAS score of at least 5. Among the 198 chronic pain patients who were randomized for treatments, 171 had a successful therapy evaluation phase, or trial phase, and were implanted with an SCS system. The study was designed as a non-inferiority trial and met its primary and secondary endpoints. Statistical analysis also demonstrated the superior efficacy of 10 kHz Therapy over traditional SCS therapy for all primary and secondary endpoints. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 12-month outcomes for 10 kHz Therapy in our SENZA-RCT pivotal study were published in <span style="font-style:italic;">Anesthesiology</span> and are consistent with the outcomes from our European clinical study, the two year results of which have been published in the <span style="font-style:italic;">Pain Medicine</span> journal of the American Academy of Pain Medicine. The 24-month SENZA-RCT results were presented in December 2015 at the annual meeting of the North American Neuromodulation Society, showing sustained superiority of 10 kHz Therapy compared with traditional SCS in treating both back and leg pain over the 24-month follow-up period. The 24-month outcomes in our SENZA-RCT pivotal study were published in <span style="font-style:italic;">Neurosurgery</span>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patients with chronic pain are generally classified by physicians based on the location of their pain, for example whether their worst pain is predominant back, predominant leg, mixed back and leg, upper limb, neck or other. The adoption of SCS to date has been driven primarily by the treatment of patients whose worst pain is in their legs and for whom other treatment approaches have failed. We believe that broader utilization of traditional SCS therapy has been restrained by the lack of prospective randomized clinical evidence supporting SCS broadly and, in particular, demonstrating an ability to treat back pain.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:normal;font-style:italic;color:#auto;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Safety Data (EU and RCT Studies)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Safety results of our SENZA-RCT pivotal study were generally consistent between the test and control groups. Study-related serious adverse events (SAEs) occurred in 4.0% of 10 kHz Therapy subjects (n&#61;4) compared with 7.2% of traditional SCS therapy subjects (n&#61;7&#59; <span style="font-style:italic;">p</span>&#160;&#61; 0.37). In addition to the SAEs described above, there were two deaths, one of which was study-related and resulted from a myocardial infarction of a subject randomized to traditional SCS therapy that occurred during the implant procedure. The other death occurred outside the study period in the test group and resulted from a malignant hepatic neoplasm. The most common study-related AEs were implant site pain (in 11.9% of 10 kHz Therapy and 10.3% of traditional SCS therapy subjects) and uncomfortable paresthesia (in 11.3% of traditional SCS therapy subjects and in no 10 kHz Therapy subjects). Lead migration leading to revision occurred in 3.0% of 10 kHz Therapy and 5.2% of traditional SCS therapy participants. </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Importantly, neurological assessment revealed no stimulation-related neurological deficits in either treatment group. Also, there were no stimulation-related SAEs in either arm.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Safety results of our EU study demonstrated no evidence of neurologic deficit or dysfunction attributable to prolonged delivery of 10 kHz Therapy. Further, investigators reported that adverse events were similar in nature and frequency to those seen with traditional SCS therapy. The most common adverse events in both arms of the study were implant site pain, infection and lead migration.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:normal;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Painful Diabetic Neuropathy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our SENZA-PDN study is a prospective, randomized, multi-center study, comparing 10 kHz SCS plus CMM to CMM alone in 216 patients at 18 centers in the United States. The primary endpoint of the study is a composite endpoint that includes the difference in proportion of treatment responders without deterioration of neurological deficits at three-month follow-up. Subjects could opt to crossover to the other treatment arm if they had insufficient pain relief (&#60;50%), were dissatisfied with treatment, and were appropriate to proceed as determined by their physician.&#160;&#160;At six months, 82% of patients who met criteria in the CMM arm elected to crossover, vs none in the 10 kHz SCS + CMM treatment arm. Study participants continue to be followed out to 24 months. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 12-month outcomes for 10 kHz Therapy in our SENZA-PDN study were presented at the American Diabetes Association 81<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup> Scientific Sessions in June 2021 and were published in <span style="font-style:italic;">Diabetes Care </span>in November 2021. The SENZA-PDN RCT 12-month data demonstrated the following benefits of 10 kHz SCS: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">At 12 months, 86% of participants in the 10 kHz SCS study arm reported pain relief </span><span style="text-decoration:underline;color:#000000;">&#62;</span><span style="color:#000000;">50%, while the average pain relief was 77.1% (% reduction of VAS from baseline).</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">After six months with 10 kHz SCS therapy, 84% of participants in the crossover arm reported pain relief </span><span style="text-decoration:underline;color:#000000;">&#62;</span><span style="color:#000000;">50%, and average pain relief was 70.3% (% reduction of VAS from baseline).&#160;&#160;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">5 of 154 permanent SCS devices were explanted for a 3.2% explant rate (all explants were due to infection).</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">At 12 months, 68% of the 10 kHz SCS treatment group had observed improvement upon an investigator-assessed neurological examination, which included testing lower limb motor strength, sensory function, and reflexes.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">After six months with 10 kHz SCS therapy, 62% of the crossover arm had observed improvement upon an investigator-assessed neurological examination, which included testing lower limb motor strength, sensory function, and reflexes.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Data from the SENZA-PDN trial supported the FDA&#8217;s July 2021 approval of the Senza System for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with PDN.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Non-Surgical Refractory Back Pain</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our SENZA-NSRBP study is a prospective, randomized, multi-center study, comparing 10 kHz SCS plus CMM to CMM alone in 159 randomized patients at 15 study centers.&#160;&#160;The primary endpoint of the study is responder rate (&#8805;50% pain relief) at three months. Subjects could opt to crossover to the other treatment arm if they had insufficient pain relief (&#60;50%), were dissatisfied with treatment, and were appropriate to proceed as determined by their physician. At six months, 75% of patients who met criteria in the CMM arm elected to crossover and were implanted&#59; no one in the 10 kHz SCS + CMM treatment arm elected to stop 10 kHz Therapy. Study participants continue to be followed out to 24 months. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 12-month outcomes for 10 kHz Therapy in our SENZA-NSRBP study were presented at the NANS meeting in January 2022 and were published in the<span style="font-style:italic;"> Journal of Neurosurgery: Spine </span>in February 2022. The SENZA-NSRBP RCT 12-month data demonstrated the following benefits of 10 kHz SCS:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">At 12 months, 78.2% of participants in the 10 kHz SCS study arm reported pain relief </span><span style="text-decoration:underline;color:#000000;">&#62;</span><span style="color:#000000;">50%, while the average pain relief was 72.1% (% reduction of VAS from baseline). </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">After 6 months with 10 kHz Therapy, 78.2% of participants in the crossover arm reported pain relief </span><span style="text-decoration:underline;color:#000000;">&#62;</span><span style="color:#000000;">50%, and average pain relief was 70.4% (% reduction of VAS from baseline).&#160;&#160; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">3 of 145 permanent SCS devices were explanted for a 2.1% explant rate (all explants were due to wound complications).</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">There were no explants due to loss of efficacy.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">The average score on the Oswestry Disability Index (ODI) at baseline indicated severe disability, while post-implant the scores improved to borderline minimum/moderate disability (an average 20 point reduction).</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Three-quarters of the subjects receiving 10 kHz Therapy had clinically significant improvement (&#8805;10 points) in ODI or were in the minimally disabled category at the end of 12 months of follow-up for the 10 kHz SCS group (6 months post-implant for the crossover group).</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Despite no specified opioid weaning protocol, usage in this study declined by 46% on average in subjects receiving treatment, while increasing among subjects receiving CMM alone.&#160;&#160;The changes were significant even with the high variation in prescribed opioid dose across subjects in both groups.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.85%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Data from the SENZA-NSRBP trial supported the company FDA January 2022 approval of the 10 kHz Senza System for the management of for NSRBP (back pain without prior surgery and not a candidate for back surgery).&#160;&#160;Nevro is the only SCS company with a product having an approved indication for treating patients with NSRBP.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our HFX Solution</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HFX is a comprehensive solution that includes a Senza spinal cord stimulation system and support services for treatment of chronic pain and is approved to deliver a versatile range of waveforms. HFX delivers traditional low frequency therapies and our proprietary 10 kHz Therapy, and is the only SCS solution with the ability to pair high and low frequencies and multiple waveforms and mechanisms of action.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The HFX solution includes all necessary components that enable physicians to place leads and conduct SCS trials, as well as permanent implants of the Omnia implantable pulse generator, and enable patients to interact with the system. Below is a depiction of our Omnia powered by HFX Connect IPG, the patient remote control and the wireless trialing system.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu1405a4gpzj000003.jpg" title="" alt="" style="width:357px;height:262px;" /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Implantable Pulse Generator (IPG):<span style="font-style:normal;">&#160;The rechargeable IPG delivers electrical pulses to the lead. It can connect to one or two leads, and up to 16 electrodes. The programming of this device is customizable for each patient and their appropriate pain area. The IPG is placed surgically under the skin, usually above the buttock or the abdomen. The Senza, Senza II and Omnia SCS IPGs are all approved with a 10-year battery life.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu1405a4gpzj000004.jpg" title="" alt="" style="width:359px;height:160px;" /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Surpass Surgical Leads<span style="font-style:normal;">: The Surpass and Surpass-C surgical leads are Nevro&#8217;s surgical lead options when appropriately needed. Our Surpass surgical leads received initial approval from the FDA in late 2016 with a further approval received in January 2017.&#160;&#160;In April of 2017, the surgical lead was certified by our notified body (the British Standards Institution, or BSI), allowing us to apply the CE mark and to market our products in the European Union and received TGA approval in Australia.&#160;&#160;We believe the Surpass leads give us access to up to approximately 30% to 40% of the U.S. SCS market that we previously did not address without a surgical lead. In 2020, we also launched our Surpass-C surgical lead, designed for patients who have a compact epidural space that cannot be addressed by other lead options. Our Surpass-C surgical lead is currently approved in the United States, Europe and Australia, where it will be available starting in late first quarter of 2022. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu1405a4gpzj000005.jpg" title="" alt="" style="width:235px;height:191px;" /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Percutaneous Leads:<span style="font-style:normal;">&#160;Nevro also offers multiple lengths of percutaneous leads to accommodate patient anatomy.&#160;&#160;These are available in the United States, Europe and Australia.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu1405a4gpzj000006.jpg" title="" alt="" style="width:197px;height:172px;" /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Trial Stimulator:<span style="font-style:normal;">&#160;The trial stimulator is an external device that is worn around the waist during an evaluation period (SCS trial) that typically lasts five to seven days. Nevro&#8217;s wireless trial stimulator uniquely offers both low and high frequencies and is available in the United States and Europe. It will be available in Australia pending regulatory approval.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Programmer:<span style="font-style:normal;"> &#160;The clinician laptop programmer contains proprietary software that allows for customized patient therapy programming of the IPG. It can non-invasively interrogate the IPG and transmit programming information as well as download diagnostic information. With the Nevro HFX solution, the patient&#8217;s IPG can be wireless updated with new programming without the need for additional surgery.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Patient Remote Control:<span style="font-style:normal;">&#160;The patient remote control is a handheld device that allows patients to turn their stimulation on and off and change programs uploaded to their IPG.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Charger:<span style="font-style:normal;">&#160;The charger recharges the IPG from outside the body. The charger is mobile and can be worn around the waist using a belt, so that the patient can perform various tasks while charging. The Nevro IPG has patented rapid recharge coil technology designed for convenient charging that delivers the fastest charge rates in the market. </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Surgical Tools:<span style="font-style:normal;">&#160;Surgical tools include percutaneous insertion needles used to introduce the lead into the epidural space, a variety of stylets that give physicians the ability to steer and deliver the lead to the desired location, anchors to secure the leads and tunneling tools that provide access from the lead insertion site to the location of the IPG.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the Nevro HFX product portfolio, Nevro also has both in-person and remote teams of representatives to support procedures and patient therapy. The remote HFX Coach&#8482; team consists of patient support representatives who are trained to help patients change their therapy program remotely, according to a proprietary algorithm, to optimize programming for patient pain relief when they need it, without the need for an in-clinic visit.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Third-Party Coverage and Reimbursement</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, the primary purchasers of Senza are hospitals, outpatient surgery centers and physician offices. These purchasers bill various third-party payors, such as Medicare, Medicaid and private health insurance plans for the healthcare services associated with the SCS procedure. Government agencies and private payors determine whether to provide coverage for specific procedures. In the United States, the Centers for Medicare &#38; Medicaid Services (CMS) administers the Medicare and Medicaid programs (the latter, along with applicable state governments). As the single largest payor, this program has a significant impact on other payors&#8217; payment systems.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Generally, reimbursement for services performed are reported using billing codes issued by the American Medical Association (AMA) known as Current Procedural Terminology (CPT) codes. Physician reimbursement under Medicare generally is based on a fee schedule that is set annually by CMS.&#160;&#160;Hospital outpatient services, reported by CPT codes, are assigned to clinically relevant Ambulatory Payment Classifications (APCs) used to determine the Medicare payment amount for services provided.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, although CMS initially approved a transitional pass-through payment for High-Frequency Stimulation under the&#160;Medicare&#160;hospital outpatient prospective payment system effective January 1, 2016 through December 31, 2017, healthcare providers who purchase our products currently do not receive separate reimbursement for our products and rely on third-party payors, including Medicare, Medicaid and private health insurance plans, to reimburse for the procedure under their payment methodologies, many of which are bundled fee schedules and include both the devise, supplies and facility overhead. Accordingly, the additional cost associated with the use of our products can impact the profit margin of the hospital or surgery center where the surgery is performed. Medicare reimbursement rates for the same or similar procedures vary due to geographic location, nature of the facility in which the procedure is performed (i.e.,&#160;hospital outpatient department or outpatient surgery centers) and other factors.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although private payors&#8217; coverage policies and reimbursement rates can differ significantly from payor to payor, the Medicare program is frequently used as a model for how private payors and other governmental payors develop their coverage and reimbursement policies for healthcare items and services, including SCS procedures. For example, certain regional Blue Cross Blue Shield plans previously denied coverage for Senza on the basis that high-frequency neuromodulation is investigational and/or experimental. We continue to engage in efforts to educate such payors on the advantages of 10 kHz Therapy. However, there can be no assurances that we are successful in overturning any negative coverage decisions by private health insurance plans, should they arise. In addition, payors continually review new technologies for possible coverage and can deny coverage for these new products and procedures. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained, or maintained if obtained. In January 2022, we announced that UnitedHealthcare will provide coverage for our 10 kHz Therapy for the treatment of PDN for dates of service on or after March 1, 2022.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outside the United States, reimbursement levels vary significantly by country, and by region within some countries. Reimbursement is obtained from a variety of sources, including government-sponsored and private health insurance plans, and combinations of both. Some countries will require us to gather additional clinical data before granting broader coverage and reimbursement for our products. It is our intent to complete the requisite clinical studies and obtain coverage and reimbursement approval beyond what we have today in countries where it makes economic sense to do so.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Product Development and Research Development</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our objective is to continue to improve patient outcomes and further expand patient access to 10 kHz Therapy through enhancements to Senza and the development of new indications. Research and development (R&#38;D) expenses were $59.0 million, $45.6 million and $47.7 million, for the years ended December&#160;31, 2019, 2020 and 2021, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since the launch of the initial Senza system, we have introduced a number of product enhancements. These include a short-tip version of the lead, new lengths of the lead, a surgically placed paddle lead, an active anchor with </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">improved performance over silicon anchors, a second generation active anchor with smaller volume, lead adaptors that allow use of competitor leads already implanted in patients, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">upgraded </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">clinician programmer software, a </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">number of next </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">generation IPG</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s which are conditionally safe for MRI scans anywhere on the body,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our Surpass </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">urgical </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">l</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ead </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to complement our percutaneous lead</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and our </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recent Omnia upgrade powered by HFX Connect</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">new trial stimulator</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. We also expect to continue developing enhancements to further increase performance and introduce new benefits </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including next generation IPGs </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">enhanced</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> MRI </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">capabilities</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. There can be no assurance that we will be successful in these efforts or in receiving any required regulatory approvals.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Sales and Marketing</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">United States</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, we maintained the overall size of our U.S. sales organization, which represents our main channel to communicate with our customers. Our sales representatives target physician specialties involved in SCS treatment decisions, including neurosurgeons, physiatrists, interventional pain specialists and orthopedic spine surgeons. In addition, our commercial team plans to continue to create demand for Senza among additional stakeholders involved in the SCS treatment decision, including third-party payors, hospitals administrators and SCS patients and their families. We have also developed a clinical support team and HFX coaches in order to provide ongoing support to physicians and patients for the use of Senza.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, in 2021, we established a new sales organization to support the launch of our PDN indication in the U.S. This sales organization targets physician specialties involved in PDN treatment decisions, including primary care physicians, endocrinologists, internal medicine and podiatrists, to create awareness of 10 kHz Therapy to treat PDN patients.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">International</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We sell Senza in Europe and Australia through a combination of our direct sales force and a network of sales agents and independent distributors. We began our direct sales operations in the United Kingdom in late 2010 and to date have expanded our direct sales operations to Austria, Australia, Belgium, Germany, Luxembourg, Netherlands, Norway, Sweden and Switzerland. We utilize sales agents and independent distributors to sell in other countries.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Competition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We compete in the SCS market for chronic pain. We also compete with spine surgeries, in particular re-operations. Currently, our major competitors are Medtronic, Boston Scientific and Abbott Laboratories, who have obtained regulatory approval for SCS systems. We believe that the primary competitive factors in the market are:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Sales force experience and access</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Published clinical efficacy data</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Product support and service</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Effective marketing and education</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Company brand recognition</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Clinical research leadership</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Technological innovation, product enhancements and speed of innovation</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Pricing and reimbursement</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Product reliability, safety and durability</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Ease of use</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Physician advocacy and support</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many of our competitors have greater capital resources, more established operations, longer commercial histories and more extensive relationships with physicians. They also have wider product offerings within neuromodulation and in other product categories, providing them with greater supplier power and with more opportunities to interact with stakeholders involved in purchasing decisions. We also face competition to recruit and retain qualified sales and other personnel.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect our competitors to periodically launch new products and release additional clinical evidence. For example, Abbott Laboratories received FDA approval for a SCS system that offers an alternate low frequency waveform called BurstDR, and in February 2016, the company gained approval for a neuromodulation system that stimulates the dorsal root ganglion for treatment of focal pain and complex regional pain syndrome, in each case, using pivotal clinical studies for each therapy to support the FDA approval process.&#160;&#160;Medtronic gained FDA approval for the Intellis&#8482; spinal cord stimulator in September of 2017, and in January of 2020 announced the purchase a company called Stimgenics, which includes a proprietary SCS waveform called Differential Target Multiplexed (DTM). Medtronic also gained FDA approval for its Intellis&#8482; and Vanta&#8482; spinal cord stimulators for the treatment of chronic pain associated with diabetic peripheral neuropathy in January 2022.&#160;&#160;Additionally, Boston Scientific broadly launched the WaveWriter&#8482; SCS system in January 2019, the WaveWriter&#8482; Alpha SCS system and its Fast Acting Sub-perception Therapy (FAST&#8482;) in January 2021, and also promotes the results of a sub-threshold therapy through their WHISPER, COMBO and HALO studies. Additionally, there are a number of emerging competitors at various stages of development. Stimwave has developed and is commercializing a minimally invasive stimulation system that employs an externally worn power source and radio frequency transmitter.&#160;&#160;Nalu Medical, Inc. (Nalu Medical) and Neuspera Medical Inc. (Neuspera Medical) are also pursuing a similar approach as well.&#160;&#160;Saluda is developing and testing a low frequency closed loop system for the treatment of chronic pain that currently has approval in Europe and Australia.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Intellectual Property</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We actively seek to protect the intellectual property and proprietary technology that we believe is important to our business, which includes seeking and maintaining patents covering our technology and products, proprietary processes and any other inventions that are commercially or strategically important to the development of our business. We also rely upon trademarks to build and maintain the integrity of our brand, and we seek to protect the confidentiality of trade secrets that may be important to the development of our business. For more information, please see &#8220;Risk Factors&#8212;Risks Related to Intellectual Property.&#8221;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Patents, Trademarks and Proprietary Technology</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, we owned 257 issued patents globally, of which 155 were issued U.S. utility patents, two were issued U.S. design patents, 53 were issued Australian utility patents, five were Australian design patent, 19 were issued European utility patents, seven were European design patents, four were issued Japanese patents, two were issued Korean utility patents, one was an issued Korean design patent, two were issued Chinese utility patents, three were issued Chinese design patents, two were Canadian utility patents and one was a United Kingdom utility patent. In general, our patents cover SCS systems that are configured to generate non-paresthesia producing therapy signals at frequencies between 1,500 Hz to 100,000 Hz, as well as additional aspects, algorithms and components of the Senza system and 10 kHz Therapy. As of December 31, 2021, we held 123 patent applications pending globally, of which 58 were patent applications pending in the United States, and 65 were PCT patent applications or patent applications pending across Europe, Australia, Canada, Japan, China, Costa Rica, India and Korea. We also have an exclusive license from the Mayo Foundation to two U.S. issued patents and one U.S. pending patent application. All of our current issued patents are projected to expire between 2028 and 2041.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, our trademark portfolio contained 109 trademark registrations, of which there were nine U.S. trademark registrations, 16 Australian trademark registrations, 13 European trademark registrations, 24 U.K. trademark registration, eight Japanese trademark registrations, six Norwegian trademark registration, eight Swiss trademark registration, 14 Kuwaiti registration, three Canadian registrations and eight Turkish trademark registrations.&#160;&#160;Our trademark portfolio also contained 112 pending applications, of which 12 are pending U.S. trademark applications and 100 are pending foreign trademark applications.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term of individual patents depends on the legal term for patents in t</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he countries in which they are granted. In most countries, including the United States, the patent term is generally 20&#160;years from the earliest claimed filing date of a non-provisional</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or priority</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> patent application. We cannot assure that patents will be issued from any of our pending applications or that, if patents are issued, they will be of sufficient scope or strength to provide meaningful protection for our technology. Notwithstanding the scope of the patent protection available to us, a competitor could develop treatment methods or devices that are not covered by our patents. Furthermore, numerous U.S. and foreign issued patents and patent applications owned by third parties exist in the fields in which we are developing products. Because patent applications can take many years to issue, there may be applications unknown to us, which applications may later result in issued patents that our existing or future products or proprietary technologies may be alleged to infringe.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There has been substantial litigation regarding patent and other intellectual property rights in the medical device industry. In the future, we may need to engage in litigation to enforce patents issued or licensed to us, to protect our trade secrets or know-how, to defend against claims of infringement of the rights of others or to determine the scope and validity of the proprietary rights of others. Litigation could be costly and could divert our attention from other functions and responsibilities. Adverse determinations in litigation could subject us to significant liabilities to third parties, could require us to seek licenses from third parties and could prevent us from manufacturing, selling or using Senza, any of which could severely harm our business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also rely upon trade secrets, know-how and continuing technological innovation, and may rely upon licensing opportunities in the future, to develop and maintain our competitive position. We seek to protect our proprietary rights through a variety of methods, including confidentiality agreements and proprietary information agreements with suppliers, employees, consultants and others who may have access to proprietary information, under which they are bound to assign to us inventions made during the term of their employment.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">The Mayo License</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2006, we entered into a license agreement (the Mayo License) with the Venturi Group,&#160;LLC (VGL) and the Mayo Foundation for Medical Education and Research (the Mayo Foundation) pursuant to which the Mayo Foundation committed to confer with us exclusively to develop products for the treatment of autonomic and peripheral nervous system disorders, including pain, using devices to modulate nerve signaling, and non-exclusively to test such devices, and VGL committed to confer with us non-exclusively to develop such devices, and exclusively to test such devices. These commitments to confer expired in January 2011. We were granted a worldwide license to make, use, sell, offer for sale, and import products incorporating or using the know-how developed for and provided to us by the Mayo Foundation or VGL in the course of such development and testing activities, exclusively for product development and non-exclusively for product testing. Pursuant to the Mayo License, we are obligated to pay royalties in the low single digits to the Mayo Foundation, on a country-by-country and product-by-product basis, based on a percentage of net sales of licensed products, subject to reduction under certain circumstances. We are also required under the Mayo License to use commercially reasonable efforts to research, develop and commercialize licensed products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Mayo License terminates upon the expiration of (1)&#160;the last to expire of the licensed patents or (2)&#160;our obligation to pay royalties, whichever is later. As of Jan. 1, 2021, we do not have an existing obligation to pay royalties under the Mayo License. Such obligations may be subject to change if: (1) additional relevant patents issue that are subject to the Mayo License&#59; or (2) we launch an SCS product, which is subject to the Mayo License, in another country.&#160;&#160; We, the Mayo Foundation or VGL may terminate the Mayo License upon 60&#160;days&#8217; notice of a party&#8217;s material breach if such breach remains uncured after such 60-day period. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing and Supply</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely upon third-party suppliers for the manufacture and assembly of our Senza SCS system and its components, some of which are single- or sole-sources of the relevant product component. We are in the process of identifying and qualifying second-source alternatives for several of our critical single-source suppliers. Thus, in the event that our relationship with any of our single- or sole-source suppliers terminates in the future, we feel confident that sufficient production capacity is available to build products at the standards we require. We believe that existing third-party facilities will be adequate to meet our current and anticipated manufacturing needs.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In the third quarter of 2020, we made the strategic decision to vertically integrate the assembly of IPG&#8217;s, peripherals and various other manufacturing related activities to mitigate our reliance on third-party manufacturers and improve our long-term gross margins.&#160;&#160;We plan on conducting these manufacturing activities in a facility in Costa Rica. The integration process is expected to be completed in </span><span style="Background-color:#FFFFFF;">the mid-</span><span style="Background-color:#FFFFFF;">2022.&#160;&#160;Even after this integration process is completed, we expect that we will continue to rely on third-party manufacturers to provide key components to support the assembly process.&#160;&#160;We may incur significant capital expenditures and implementation costs to initiate the manufacturing operations in Costa Rica.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe our manufacturing operations, and those of our suppliers, are in compliance with regulations mandated by the FDA. Manufacturing facilities that produce medical devices or their component parts intended for distribution world-wide are subject to regulation and periodic unannounced inspection by the FDA and other domestic and international regulatory agencies. For products distributed in the United States, we are required to manufacture any products that we sell in compliance with the FDA&#8217;s Quality System Regulation (QSR) which covers the methods used in, and the facilities used for, the design, testing, control, manufacturing, labeling, quality assurance, packaging, storage and shipping of our products. In international markets, we are required to obtain and maintain various quality assurance and quality management certifications. We have obtained the following international certifications: Quality Management System ISO13485, Full Quality Assurance Certification for the design and manufacture of spinal cord stimulator systems and accessories and a Design Examination certificate for Implantable Pulse Generator and Accessories. We are required to demonstrate continuing compliance with applicable regulatory requirements to maintain these certifications and will continue to be periodically inspected by international regulatory authorities for certification purposes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our material supply contracts are as follows:</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Pro-Tech Design and Manufacturing</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2014, we entered into a supply agreement with Pro-Tech Design and Manufacturing,&#160;Inc. (Pro-Tech) pursuant to which Pro-Tech, as a single-source supplier, conducts the inspection, labeling, packaging and sterilization of our Senza SCS system. In June 2020, we entered into an amendment to extend the terms of our original agreement and to provide for automatic one-year annual renewals, unless if a notice of termination is provided 30 days prior to the expiration of the then current term.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Stellar (Cirtec) Technologies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July&#160;1, 2009, we entered into a manufacturing agreement with Stellar Technologies,&#160;Inc. (Stellar) our single-source supplier of our percutaneous leads, percutaneous lead extenders and surgical leads for our neurological stimulator products. On June&#160;30, 2014, the agreement&#8217;s initial term expired, and the agreement automatically renewed for the first time. On July&#160;1, 2014, we entered into a first amendment to the manufacturing agreement with Stellar, which provides for an additional five-year term commencing from the date of the amendment, after which the agreement automatically renews for successive one-year terms unless either party provides written notice of intent not to renew at least 30&#160;days before the expiration of the then-current term. On January 28, 2016, we entered into a second amendment to this agreement, which provides for the purchase of certain supplementary products pursuant to the agreement. We refer to the manufacturing agreement as amended by the first and second amendments as the Stellar Agreement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Either we or Stellar may terminate the Stellar Agreement at will upon one year&#8217;s advance notice, subject to certain remaining rights and payment obligations, including an early cancellation fee payable by us to Stellar. We may also terminate the Stellar Agreement if Stellar is unable to perform its obligations under the Stellar Agreement for 60&#160;days or more, or if Stellar is unwilling to perform its obligations under the Stellar Agreement and does not cure such defect within 60&#160;days of our providing written notice to cure. Stellar may terminate the Stellar Agreement in the event of our default of certain specified obligations, including our payment obligations, material violation of a warranty or law, our material breach, and our insolvency.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;"><span style="font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">CCC Supply Agreement</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely upon C.C.C. Del Uruguay&#160;S.A. (CCC), a subsidiary of Integer Holdings Corporation (formerly Greatbatch Ltd.), as one of our manufacturers of our IPGs. We currently have a multi-year supply agreement with CCC with regard to the manufacture and supply of our IPGs.&#160;&#160;The agreement was effective as of November 11, 2016. On April 30, 2019, we entered into the first amendment to the supply agreement with CCC, incorporating new product models and adjusting unit cost.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The agreement continues for ten years unless terminated earlier. The term of the agreement automatically renews for additional two-year terms unless one party provides the other party with written notice of termination at least one year prior to the end of the initial term or the applicable renewal period. In the event of a change of control of CCC, the agreement may be terminated by us upon three years&#8217; written notice to CCC, provided that such notice period shall be one year in the event CCC is acquired by certain competitors to us. In addition, the agreement may be terminated by mutual agreement of the parties, or by either party, with written notice, upon the other party&#8217;s cessation of business or other termination of its business operations, uncured material breach or insolvency of the other party. Upon termination of the agreement, CCC shall, subject to certain exceptions and unless otherwise agreed to by the parties, fulfill all purchase orders placed by us and accepted by CCC prior to the effective date of termination.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The agreement contains, among other provisions, customary representations and warranties by the parties, ordering and payment and shipping terms, customary provisions with respect to the ownership of any intellectual property created during the term of the agreement, certain indemnification rights in favor of both parties, limitations of liability and customary confidentiality provisions.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">EaglePicher Medical Power Supply Agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2009, we entered into a product supply and development agreement with EaglePicher Medical Power&#160;LLC (EaglePicher) our single-source supplier of the batteries and related products for our IPG. Pursuant to the agreement, EaglePicher must use its best efforts to supply these batteries and related products in sufficient quantity to meet our demand. The agreement also provides that, upon our written request, EaglePicher will conduct development of a modified version of these products to our specifications, if we so desire. The initial term of our supply agreement with EaglePicher expired in November 2010, and the term had been automatically renewing for successive one-year periods.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March&#160;2015, we entered into a first amendment to the product supply and development agreement with EaglePicher.&#160;The amendment committed us to specified minimum purchase amounts until the end of 2017 and adjusts EaglePicher&#8217;s production capacity and facilities commitments under the agreement as well as certain pricing, purchasing, delivery and cancellation terms.&#160;The amendment also extends the term of the agreement to December&#160;31, 2019, with an additional two-year automatic renewal period unless we or EaglePicher provide notice of intent not to renew prior to the commencement of such renewal term. The amendment further provides us with the right to place a final order with EaglePicher following termination of the agreement, as amended and modifies certain warranty and assignment terms and the parties&#8217; limitations of liability.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2015, we entered into a second amendment to the agreement, which increased our pre-existing specified minimum purchase amounts and increased EaglePicher&#8217;s production capacity commitments under the agreement, as well as specifying certain purchasing and purchase order protocols.&#160;&#160;The amendment obligated EaglePicher to establish and qualify an additional battery production operation and commits us to fund approximately $1.0 million of such production operation paid in three milestone installments.&#160;&#160;The amendment also establishes EaglePicher as our exclusive battery supplier through the initial five-year term of the agreement, ending December 31, 2019.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2017, we entered into a third amendment to the agreement, which changed the renewal term of the agreement such that the agreement will automatically renew for a period of one year unless we or EaglePicher provides notice of intent to terminate the agreement six months prior to the commencement of such renewal term.&#160;&#160;In 2019, we notified EaglePicher of our intent to not renew the agreement upon its expiration on December 31, 2019.&#160;&#160;We are currently in discussions with EaglePicher on a revised agreement.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;"><span style="font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Vention </span><span style="font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">(Nordson) </span><span style="font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Supply Agreement</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2015, we entered into a Manufacturing and Supply Agreement with Vention Medical Design and Development, Inc. (Vention) pursuant to which Vention agreed to manufacture and supply our IPGs. We are obligated to purchase from Vention specified minimum purchase quantities of IPGs for the duration of the Vention agreement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The agreement continues for five years unless terminated earlier. The term of the agreement automatically renews for additional one-year terms unless one party provides the other party with written notice of termination at least one year prior to the end of the applicable renewal period. The agreement may be terminated by us for any reason upon 180 days&#8217; written notice to Vention. In addition, the agreement may be terminated by mutual agreement of the parties, or by either party, with written notice, upon uncured material breach or insolvency of the other party. Upon termination of the agreement, Vention shall, upon our request, manufacture an additional 24 months of continuous supply of IPGs based on the preceding forecast average or such other amount as agreed upon by the parties.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2017, we entered into a first amendment to the Manufacturing and Supply Agreement with Vention, which changed the unit costs of the products supplied by Vention.&#160;&#160;In April 2018, we entered into a second amendment to the Manufacturing and Supply Agreement, which acknowledged that Vention changed its name to Nordson MEDICAL Design and Development, Inc (Nordson) and which changed the unit cost of the products supplied by Nordson.&#160;&#160;In August 2021, we terminated the agreement with Vention with an effective date of December 31, 2021, as we continue to receive IPGs from one of our alternative suppliers and as we transition IPG manufacturing to our Costa Rica manufacturing facility.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Other Suppliers</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also have other suppliers, including some sole-source suppliers, for certain of our components, with whom we do not have agreements.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Product Liability and Insurance</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The manufacture and sale of our products subjects us to the risk of financial exposure to product liability claims. Our products are used in situations in which there is a risk of serious injury or death. We carry insurance policies which we believe to be customary for similar companies in our industry. We cannot assure you that these policies will be sufficient to cover all or substantially all losses that we experience.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We endeavor to maintain executive and organization liability insurance in a form and with aggregate coverage limits that we believe are adequate for our business purposes, but our coverage limits may prove not to be adequate in some circumstances.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Government Regulations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">United States</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our products and operations are subject to extensive and rigorous regulation by the FDA under the Federal Food, Drug, and Cosmetic Act (FFDCA) and its implementing regulations, guidance, and standards. The FDA regulates the research, testing, manufacturing, safety, labeling, storage, recordkeeping, promotion, distribution, and production of medical devices in the United States to ensure that medical products distributed domestically are safe and effective for their intended uses. The FDA also regulates the export of medical devices manufactured in the United States to international markets. Any violations of these laws and regulations could result in a material adverse effect on our business, financial condition and results of operations. In addition, if there is a change in law, regulation or judicial interpretation, we may be required to change our business practices, which could have a material adverse effect on our business, financial condition and results of operations.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the FFDCA, medical devices are classified into one of three classes&#8212;Class&#160;I, Class&#160;II or Class&#160;III&#8212;depending on the degree of risk associated with each medical device and the extent of control needed to ensure safety and effectiveness.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class&#160;I devices are those for which safety and effectiveness can be assured by adherence to FDA&#8217;s &#8220;general controls&#8221; for medical devices, which include compliance with the applicable portions of the QSR facility registration and product listing, reporting of adverse medical events, and appropriate, truthful and non-misleading labeling, advertising, and promotional materials. Some Class&#160;I devices also require premarket clearance by the FDA through the 510(k) premarket notification process described below.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class&#160;II devices are subject to FDA&#8217;s general controls, and any other &#8220;special controls&#8221; deemed necessary by FDA to ensure the safety and effectiveness of the device. These special controls can include performance standards, post-market surveillance, patient registries, and FDA guidance documents. While most Class I devices are exempt from the 510(k) premarket notification requirement, manufacturers of most Class II devices are required to submit to the FDA a premarket notification under Section 510(k) of the FDCA requesting permission to commercially distribute the device. The FDA&#8217;s permission to commercially distribute a device subject to a 510(k) premarket notification is generally known as 510(k) clearance. When a 510(k) is required, the manufacturer must submit to the FDA a premarket notification submission demonstrating that the device is &#8220;substantially equivalent&#8221; to a legally marketed device, which in some cases may require submission of clinical data. A legally marketed device is defined by statute to mean a device that was legally marketed prior to May 28, 1976, the date upon which the Medical Device Amendments of 1976 were enacted, or another commercially available, similar device that was cleared through the 510(k) process. Unless a specific exemption applies, 510(k) premarket notification submissions are subject to user fees. If the FDA determines that the device, or its intended use, is not substantially equivalent to a legally marketed device, the FDA will place the device, or the particular use of the device, into Class&#160;III, and the device sponsor must then fulfill much more rigorous premarketing requirements in the form of a premarket approval (PMA).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A Class&#160;III device includes devices deemed by the FDA to pose the greatest risk such as life-supporting or life-sustaining devices, or implantable devices, in addition to a device that has a new intended use or utilizes advanced technology that is not substantially equivalent to that of a legally marketed device. The safety and effectiveness of Class&#160;III devices cannot be assured solely by general and special controls. These devices almost always require formal clinical studies to demonstrate safety and effectiveness. Class III devices require PMA approval before they can be marketed although some pre-amendment Class III devices for which the FDA has not yet required a PMA are cleared through the 510(k) process.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">PMA Approval</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Senza SCS system is a Class&#160;III device subject to review and approval through the PMA pathway. PMA applications must be supported by, among other things, valid scientific evidence, which typically requires extensive data, including technical, preclinical, clinical and manufacturing data, to demonstrate to the FDA&#8217;s satisfaction the safety and effectiveness of the device. A PMA application must also include, among other things, a complete description of the device and its components, a detailed description of the methods, facilities and controls used to manufacture the device and proposed labeling. As with 510(k) submissions, unless subject to an exemption, PMA submissions are subject to user fees.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA has 45&#160;days from its receipt of a PMA to determine whether the application will be accepted for filing based on the agency&#8217;s threshold determination that it is sufficiently complete to permit substantive review. Once the submission is accepted for filing, the FDA begins an in-depth review. The FDA has 180 days to review a PMA application that has been filed by the FDA, although the review of an application more often occurs over a significantly longer period of time, and can take up to several years. During this review period, the FDA may request additional information or clarification of information already provided. An advisory panel of experts from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. The FDA may or may not accept the panel&#8217;s recommendation. In addition, the FDA will conduct a pre-approval inspection of the applicant and/or its third-party manufacturers&#8217; or suppliers&#8217; manufacturing facility or facilities to ensure compliance with the QSR, which requires manufacturers to follow design, testing, control, documentation and other quality assurance procedures.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the FDA evaluations of both the PMA application and the manufacturing facilities are favorable, the FDA will either issue an approval </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">order</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or an approvable letter, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the latter of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">which usually contains a number of conditions that must be met in order to secure final approval of the PMA. If the FDA&#8217;s evaluation of the PMA or manufacturing facilities is not favorable, the FDA will deny approval of the PMA or issue a not approvable letter. A not approvable letter will outline the deficiencies in the application and, where practical, will identify what is necessary to make the PMA approvable. The FDA may also determine that additional clinical trials are necessary, in which case the PMA approval may be delayed for several months or years while the trials are conducted and the data is then submitted in an amendment to the PMA. Once granted, PMA approval may be withdrawn by the FDA if compliance with post approval requirements, conditions of approval or other regulatory standards is not maintained or problems are identified following initial marketing.&#160;&#160;In May 2015, we received approval for our PMA application</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the Senza SCS system</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approval by the FDA of new PMA applications or PMA supplements may be required for modifications to the manufacturing process, labeling, device specifications, materials or design of a device that is approved through the PMA process. Certain other changes to an approved device also require the submission of a new PMA, such as when the design change causes a different intended use, mode of operation, and technical basis of operation, or when the design change is so significant that a new generation of the device will be developed, and the data that were submitted with the original PMA are not applicable for the change in demonstrating a reasonable assurance of safety and effectiveness. PMA supplements often require submission of the same type of information as an initial PMA application, except that the supplement is limited to information needed to support any changes from the device covered by the original PMA application and may not require as extensive clinical data.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Clinical Studies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical trials are almost always required to support a PMA and are sometimes required to support a 510(k) submission. In the United States, human clinical trials intended to support medical device clearance or approval require compliance with the FDA&#8217;s investigational device exemption (IDE) regulations. For a device that presents a &#8220;significant risk&#8221; to human health, the device sponsor is required to file an IDE application with the FDA and obtain IDE approval prior to commencing the human clinical trial, as well as obtain approval of an Institutional Review Board (IRB) at each institution where the study will be conducted. If the device is considered a &#8220;non-significant risk,&#8221; IDE approval from FDA is not required. Instead, only approval from the IRB overseeing the investigation at each clinical trial site is required, though the sponsor must still comply with abbreviated IDE requirements, such as protection of human subjects and informed consent. Human clinical studies are generally required in connection with approval of Class&#160;III devices and may be required for Class&#160;I and II devices. An IDE application must be supported by appropriate data, such as animal and laboratory test results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. The IDE will automatically become effective 30 days after receipt by the FDA unless the FDA notifies the company that the investigation may not begin. If the FDA determines that there are deficiencies or other concerns with an IDE for which it requires modification, the FDA may permit a clinical trial to proceed under a conditional approval.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an IDE application is approved by the FDA, human clinical trials may begin at a specific number of investigational sites with a specific number of patients, as approved by the FDA. If the device presents a non-significant risk to the patient, a sponsor may begin the clinical trial after obtaining approval for the trial by one or more IRBs without separate approval from the FDA, but must still follow abbreviated IDE requirements, such as monitoring the investigation, ensuring that the investigators obtain informed consent, and labeling and record-keeping requirements. Submission of an IDE application for review does not guarantee that the FDA will approve the IDE and permit the conduct of clinical trials and, even if the IDE is approved, the FDA may or may not determine that the data derived from the trials support the safety and effectiveness of the device or warrant the continuation of clinical trials. An IDE supplement must be submitted to, and approved by, the FDA before a sponsor or investigator may make a change to the investigational plan that may affect its scientific soundness, study plan or the rights, safety or welfare of human subjects.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During a study, the sponsor is required to comply with the applicable FDA requirements, including, for example, trial monitoring, selecting clinical investigators and providing them with the investigational plan, ensuring IRB review, adverse event reporting, record keeping, and prohibitions on the promotion of investigational devices or on making safety or effectiveness claims for them. The clinical investigators in the clinical study are also subject to </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FDA regulations and must obtain patient informed consent, rigorously follow the investigational plan and study protocol, control the disposition of the investigational device, and comply with all reporting and recordkeeping requirements. Additionally, after a trial begins, we, the FDA or the IRB could suspend or terminate a clinical trial at any time for various reasons, including a belief that the risks to study subjects outweigh the anticipated benefits.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Continuing Regulation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After the FDA permits a device to enter commercial distribution, numerous regulatory requirements apply. These include: compliance with the QSR, which requires manufacturers to follow elaborate design, testing, control, documentation and other quality assurance procedures during the manufacturing process&#59; labeling regulations&#59; the FDA&#8217;s general prohibition against promoting products for unapproved or &#8220;off-label&#8221; uses&#59; the reports of Corrections and Removals regulation, which requires manufacturers to report recalls and field actions to the FDA if initiated to reduce a risk of health posed by the device or to remedy a violation of the Federal Food, Drug and Cosmetic Act&#59; and the Medical Device Reporting regulation, which requires that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to reoccur. Manufacturers are also required to register and list their devices with the FDA, based on which the FDA will conduct inspections to ensure continued compliance with applicable regulatory requirements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA has broad post-market and regulatory and enforcement powers. Failure to comply with the applicable U.S. medical device regulatory requirements could result in, among other things, warning letters&#59; fines&#59; injunctions&#59; consent decrees&#59; civil penalties&#59; repairs, replacements or refunds&#59; recalls, corrections or seizures of products&#59; total or partial suspension of production&#59; the FDA&#8217;s refusal to grant future premarket clearances or approvals&#59; withdrawals or suspensions of current product applications&#59; and criminal prosecution. If any of these events were to occur, they could have a material adverse effect on our business, financial condition and results of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">International</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our international sales are subject to regulatory requirements in the countries in which our products are sold. The regulatory review process varies from country to country and may in some cases require the submission of clinical data. In addition, the FDA must be notified of, or approve the export to certain countries of devices that require a PMA, and not yet approved in the United States.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Regulation of Medical Devices in the European Union</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The European Union (EU) has adopted specific directives and regulations regulating the design, manufacture, clinical investigation, conformity assessment, labeling and adverse event reporting for medical devices. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Until May 25, 2021, medical devices and implantable active medical devices were respectively regulated by Council Directive 93/42/EEC (the EU Medical Devices Directive) and Council Directive 90/385/EEC (the EU Active Implantable Medical Devices Directive, or the EU AIMD) (together the Medical Devices Directives), which have been repealed and replaced by Regulation (EU) No 2017/745 (the EU Medical Devices Regulation). Our current certificates have been granted under the EU AIMD whose regime is described below. However, as of May 26, 2021, some of the EU Medical Devices Regulation requirements apply in place of the corresponding requirements of the EU Medical Devices Directives with regard to registration of economic operators and of devices, post-market surveillance and vigilance requirements. Pursuing marketing of medical devices in the EU will notably require that our devices be certified under the new regime set forth in the EU Medical Devices Regulation when our current certificates expire.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Active Implantable Medical Devices Directive</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the EU AIMD, all medical devices placed on the market in the EU must meet the relevant essential requirements laid down in Annex I to the EU AIMD, including the requirement that a medical device must be designed and manufactured in such a way that it will not compromise the clinical condition or safety of patients, or </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the safety and health of users and others. In addition, the device must achieve the performance intended by the manufacturer and be designed, manufactured, and packaged in a suitable manner. The European Commission has adopted various standards applicable to medical devices. These include standards governing common requirements, such as sterilization and safety of medical electrical equipment and product standards for certain types of medical devices. There are also harmonized standards relating to design and manufacture. While not mandatory, compliance with these standards is viewed as the easiest way to satisfy the essential requirements as a practical matter as it creates a rebuttable presumption that the device satisfies that essential requirement.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To demonstrate compliance with the essential requirements laid down in Annex I EU AIMD, medical device manufacturers must undergo a conformity assessment procedure, which varies according to the type of medical device and its (risk) classification. As a general rule, demonstration of conformity of medical devices and their manufacturers with the essential requirements must be based, among other things, on the evaluation of clinical data supporting the safety and performance of the products during normal conditions of use. Specifically, a manufacturer must demonstrate that the device achieves its intended performance during normal conditions of use and that the known and foreseeable risks, and that any adverse events, are minimized and acceptable when weighed against the benefits of its intended performance, and that any claims made about the performance and safety of the device (e.g.,&#160;product labeling and instructions for use) are supported by suitable evidence. This assessment must be based on clinical data, which can be obtained from (1)&#160;clinical investigations conducted on the devices being assessed, (2)&#160;scientific literature from similar devices whose equivalence with the assessed device can be demonstrated or (3)&#160;both clinical studies and scientific literature. With respect to active implantable medical devices or Class&#160;III devices, the manufacturer must conduct clinical studies to obtain the required clinical data, unless reliance on existing clinical data from equivalent devices can be justified. The conduct of clinical investigations in the EU is governed by detailed regulatory obligations. These may include the requirement of prior authorization by the competent authorities of the EU member states in which the investigation takes place and the requirement to obtain a positive opinion from a competent ethics committee.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A conformity assessment procedure with the essential requirements generally requires the intervention of a notified body. Notified bodies are independent organizations designated by EU member states to assess the conformity of devices before being placed on the market. A notified body would typically audit and examine a product&#8217;s technical dossiers and the manufacturers&#8217; quality system (the notified body must presume that quality systems which implement the relevant harmonized standards &#8211; which is ISO 13485:2016 for Medical Devices Quality Management Systems &#8211; conform to these requirements). If satisfied that the relevant product conforms to the relevant essential requirements, the notified body issues a certificate of conformity, which the manufacturer uses as a basis for its own declaration of conformity. The manufacturer may then apply the CE mark to the device, which allows the device to be placed on the market throughout the EU. The assessment of the conformity of Senza has been certified by our notified body (the British Standards Institution, or BSI).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Throughout the term of the certificate of conformity, the manufacturer will be subject to periodic surveillance audits to verify continued compliance with the applicable requirements. In particular, there will be a new audit by the notified body before it will renew the relevant certificate(s).</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Medical<span style="Background-color:#FFFFFF;color:#000000;"> Devices Regulation</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="Background-color:#FFFFFF;color:#000000;"> regulatory landscape related to medical devices in the EU recently evolved. On April 5, 2017, the EU Medical Devices Regulation was adopted with the aim of ensuring better protection of public health and patient safety. The EU Medical Devices Regulation establishes a uniform, transparent, predictable and sustainable regulatory framework across the EU for medical devices and ensure a high level of safety and health while supporting innovation. Unlike the EU Medical Devices Directives, the EU Medical Devices Regulation is directly applicable in EU member states without the need for member states to implement into national law. This aims at increasing harmonization across the EU.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The EU Medical Devices Regulation became effective on May 26, 2021. The Regulation among other things:</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">strengthens the rules on placing devices on the market (e.g. reclassification of certain devices and wider scope than the </span><span style="Background-color:#FFFFFF;">EU </span><span style="Background-color:#FFFFFF;">Medical Devices Directive</span><span style="Background-color:#FFFFFF;">s</span><span style="Background-color:#FFFFFF;">) and reinforces surveillance once they are available&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">establishes explicit provisions on manufacturers&#8217; responsibilities for the follow-up of the quality, performance and safety of devices placed on the market&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">establishes explicit provisions on importers&#8217; and distributors&#8217; obligations and responsibilities&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">imposes an obligation to identify a responsible person who is ultimately responsible for all aspects of compliance with the requirements of the new regulation&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">improves the traceability of medical devices throughout the supply chain to the end-user or patient through the introduction of a unique identification number, to increase the ability of manufacturers and regulatory authorities to trace specific devices through the supply chain and to facilitate the prompt and efficient recall of medical devices that have been found to present a safety risk&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">sets up a central database (Eudamed) to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">strengthens rules for the assessment of certain high-risk devices, such as implants, which may have to undergo a clinical evaluation consultation procedure by experts before they are placed on the market.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Devices lawfully placed on the market pursuant to the EU Medical Devices Directives prior to May 26, 2021 may generally continue to be made available on the market or put into service until May 26, 2025, provided that the requirements of the transitional provisions are fulfilled. In particular, the certificate in question must still be valid. However, even in this case, manufacturers must comply with a number of new or reinforced requirements set forth in the EU Medical Devices Regulation, in particular the obligations described below.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The EU Medical Devices Regulation requires that before placing a device, other than a custom-made device, on the market, manufacturers (as well as other economic operators such as authorized representatives and importers) must register by submitting identification information to the electronic system (Eudamed), unless they have already registered. The information to be submitted by manufacturers (and authorized representatives) also includes the name, address and contact details of the person or persons responsible for regulatory compliance. The new Regulation also requires that before placing a device, other than a custom-made device, on the market, manufacturers must assign a unique identifier to the device and provide it along with other core data to the unique device identifier (UDI) database. These new requirements aim at ensuring better identification and traceability of the devices. Each device &#8211; and as applicable, each package &#8211; will have a UDI composed of two parts: a device identifier (UDI-DI) specific to a device, and a production identifier (UDI-PI) to identify the unit producing the device. Manufacturers are also notably responsible for entering the necessary data on Eudamed, which includes the UDI database, and for keeping it up to date. The obligations for registration in Eudamed will become applicable at a later date (as Eudamed is not yet fully functional). Until Eudamed is fully functional, the corresponding provisions of the EU Medical Devices Directive continue to apply for the purpose of meeting the obligations laid down in the provisions regarding exchange of information, including, and in particular, information regarding registration of devices and economic operators.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">All manufacturers placing medical devices on the market in the EU must comply with the EU medical device vigilance system which has been reinforced by the EU Medical Devices Regulation. Under this system, serious incidents and Field Safety Corrective Actions (FSCAs) must be reported to the relevant authorities of the EU member states.</span><span style="color:#000000;"> </span><span style="Background-color:#FFFFFF;">These reports will have to be submitted through Eudamed &#8211; once functional &#8211; and aim to ensure that, in addition to reporting to the relevant authorities of the EU member states, other actors such as the economic operators in the supply chain will also be informed. Until Eudamed is fully functional, the corresponding provisions of the EU Medical Devices Directives continue to apply. A serious incident is defined as any malfunction or deterioration in the characteristics or performance of a device made available on the market, including use-error due to ergonomic features, as well as any inadequacy in the information supplied by the manufacturer and any undesirable side-effect, which, directly or indirectly, might have led or might lead to the death of a patient or user or of other persons or to a temporary or permanent serious deterioration of a patient's, user's or other person's state of health or&#160;&#160;a serious public health threat. Manufacturers are required to take FSCAs defined as any corrective action for technical or medical reasons to prevent or reduce a risk of a serious incident associated with the use of a medical </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">device that is made available on the market. An FSCA may include the recall, modification, exchange, destruction or retrofitting of the device. FSCAs must be communicated by the manufacturer or its legal representative to its customers and/or to the end users of the device through Field Safety Notices. For similar serious incidents that occur with the same device or device type and for which the root cause has been identified or a FSCA implemented or where the incidents are common and well documented, manufacturers may provide periodic summary reports instead of individual serious incident reports.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The advertising and promotion of medical devices is subject to some general principles set forth in EU legislation. According to the EU Medical Devices Regulation, only devices that are CE marked may be marketed and advertised in the EU in accordance with their intended purpose. Directive 2006/114/EC concerning misleading and comparative advertising and Directive 2005/29/EC on unfair commercial practices, while not specific to the advertising of medical devices, also apply to the advertising thereof and contain general rules, for example, requiring that advertisements are evidenced, balanced and not misleading. Specific requirements are defined at a national level. EU member states&#8217; laws related to the advertising and promotion of medical devices, which vary between jurisdictions, may limit or restrict the advertising and promotion of products to the general public and may impose limitations on promotional activities with healthcare professionals. </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Many EU member states have adopted specific anti-gift statutes that further limit commercial practices for medical devices, in particular vis-&#224;-vis healthcare professionals and organizations. Additionally, there has been a recent trend of increased regulation of payments and transfers of value provided to healthcare professionals or entities and many EU member states have adopted national &#8220;Sunshine Acts&#8221; which impose reporting and transparency requirements (often on an annual basis), similar to the requirements in the United States, on medical device manufacturers. Certain countries also mandate implementation of commercial compliance programs.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The aforementioned EU rules are generally applicable in the European Economic Area (EEA) which consists of the 27 EU member states plus Norway, Liechtenstein and Iceland.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Brexit</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Since January 1, 2021, the Medicines and Healthcare Products Regulatory Agency (MHRA) has become the sovereign regulatory authority responsible for Great Britain (i.e. England, Wales and Scotland) medical device market according to the requirements provided in the&#8239;Medical Devices Regulations 2002&#8239;(SI 2002 No 618, as amended) that sought to give effect to the three pre-existing EU directives governing active implantable medical devices, general medical devices and in vitro diagnostic medical devices whereas Northern Ireland continues to be governed by EU rules according to the Northern Ireland Protocol. Following the end of the Brexit transitional period on January 1, 2021, new regulations require medical devices to be registered with the MHRA (but manufacturers were given a grace period of four to 12 months to comply with the new registration process) before being placed on Great Britain market. The MHRA only registers devices where the manufacturer or their United Kingdom (UK) Responsible Person has a registered place of business in the UK. Manufacturers based outside the UK need to appoint a UK Responsible Person that has a registered place of business in the UK to register devices with the MHRA in line with the grace periods. By July 1, 2023, in Great Britain, all medical devices will require a UKCA (UK Conformity Assessed) mark but CE marks issued by EU notified bodies will remain valid until this time. Manufacturers may choose to use the UKCA mark on a voluntary basis until June 30, 2023. However, UKCA marking will not be recognized in the EU. The rules for placing medical devices on the market in Northern Ireland, which is part of the UK, differ from those in the rest of the UK. Compliance with this legislation is a prerequisite to be able to affix the UKCA mark to our products, without which they cannot be sold or marketed in Great Britain.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">An MHRA public consultation was opened until end of November 2021 on the post-Brexit regulatory framework for medical devices and diagnostics. MHRA seeks to amend the UK Medical Devices Regulations 2002 (which are based on EU legislation, primarily the EU Medical Devices Directive, the EU AIMD and the EU In Vitro Diagnostic Medical Devices Directive 98/79/EC), in particular to create a new access pathways to support innovation, create an innovative framework for regulating software and artificial intelligence as&#160;&#160;medical devices, reform in vitro diagnostic medical devices regulation, and foster sustainability through the reuse and remanufacture of medical devices. The regime is expected to come into force in July 2023, coinciding with the end of the acceptance period for EU CE marks in Great Britain, subject to appropriate transitional arrangements. The </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">consultation indicated that the MHRA will publish guidance in relation to the changes to the regulatory framework and may rely more heavily on guidance to add flexibility to the regime.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In addition, the Trade Deal between the UK and the EU generally provides for cooperation and exchange of information between the parties in the areas of product safety and compliance, including market surveillance, enforcement activities and measures, standardization-related activities, exchanges of officials, and coordinated product recalls. As such, processes for compliance and reporting should reflect requirements from regulatory authorities.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#auto;font-size:10pt;font-family:Times New Roman;font-weight:bold;text-transform:none;font-variant: normal;">Other Regulations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are also subject to healthcare fraud and abuse regulation in the jurisdictions in which we will conduct our business. These laws include, without limitation, applicable anti-kickback, false claims, physician sunshine and data privacy and security laws and regulations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Anti-Kickback Statute:<span style="font-style:normal;">&#160;The federal Anti-Kickback Statute prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving or paying any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, in exchange for or to induce either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service for which payment may be made, in whole or in part, under federal healthcare programs such as Medicare and Medicaid. The federal Anti-Kickback Statute is broad and prohibits many arrangements and practices that are lawful in businesses outside of the healthcare industry. The term &#8220;remuneration&#8221; includes kickbacks, bribes, or rebates and also has been broadly interpreted to include anything of value, including for example, gifts, discounts, the furnishing of supplies or equipment, credit arrangements, payments of cash, waivers of payments, ownership interests and providing anything at less than its fair market value. There are a number of statutory exceptions and regulatory safe harbors protecting certain business arrangements from prosecution under the federal Anti-Kickback Statute. These statutory exceptions and safe harbors set forth provisions that, if all their applicable requirements are met, will assure healthcare providers and other parties that they may not be prosecuted under the federal Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more applicable statutory exceptions or safe harbors does not necessarily mean that it is illegal or that prosecution will be pursued. However, conduct and business arrangements that do not fully satisfy all requirements of an applicable safe harbor may result in increased scrutiny by government enforcement authorities and will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. Further, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Penalties for violations of the Anti-Kickback Statute include, but are not limited to, criminal, civil and/or administrative penalties, damages, fines, disgorgement, individual imprisonment, possible exclusion from Medicare, Medicaid and other federal healthcare programs, and the curtailment or restructuring of operations.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Federal Civil False Claims Act:<span style="font-style:normal;">&#160;The federal civil False Claims Act prohibits, among other things, persons or entities from knowingly presenting or causing to be presented a false or fraudulent claim to, or the knowing use of false statements to obtain payment from or approval by, the federal government. In addition, private individuals have the ability to bring actions under the civil False Claims Act in the name of the government alleging false and fraudulent claims presented to or paid by the government (or other violations of the statutes) and to share in any amounts paid by the entity to the government in fines or settlement. Such suits, known as qui tam actions, have increased significantly in the healthcare industry in recent years. Manufacturers can be held liable under these laws if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims by, for example, providing inaccurate billing or coding information to customers or promoting a product off-label. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. Penalties for a federal civil False Claims Act violation include three times the actual damages sustained by the government, plus mandatory civil penalties for each separate false claim, the potential for exclusion from participation in federal healthcare programs and criminal liability. </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Health Insurance Portability and Accountability Act of 1996:<span style="font-style:normal;">&#160;The federal Health Insurance Portability and Accountability Act (HIPAA) created several new federal crimes, including healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully executing, or </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services.</span><span style="font-style:normal;"> </span><span style="font-style:normal;">Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation</span><span style="font-style:normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, HIPAA and its implementing regulations established uniform standards for certain covered entities, which are healthcare providers, health plans and healthcare clearinghouses, as well as their business associates, governing the conduct of specified electronic healthcare transactions and protecting the security and privacy of protected health information. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, created four new tiers of civil monetary penalties and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">EU Data Protection Laws:<span style="font-style:normal;">&#160;We are subject to laws and regulations in non-U.S. countries covering data privacy and the protection of health-related and other personal information. EU member states and other jurisdictions have adopted data protection laws and regulations, which impose significant compliance obligations. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure and security of personal information that identifies or may be used to identify an individual, such as names, contact information and sensitive personal data such as health data. These laws and regulations are subject to frequent revisions and differing interpretations, and have generally become more stringent over time. </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For example, the EU General Data Protection Regulation (GDPR) became applicable on May 25, 2018, implementing more stringent operational requirements for processors and controllers of personal data, including, for example, expanded disclosures about how personal information is to be used, limitations on retention of information, increased requirements pertaining to health data and pseudonymized (i.e., key-coded) data, mandatory data breach notification requirements, more robust rights for individuals over their personal data and higher standards for data controllers to demonstrate that they have obtained valid consent for certain data processing activities. We are subject to evolving EU and EEA laws on data export, as we may transfer personal data from the EU and EEA to other jurisdictions, for example, in July 2020, the Court of Justice of the European Union limited how organizations could lawfully transfer personal data from the EEA to the United States by invalidating the Privacy Shield and imposing further restrictions on use of the standard contractual clauses, which could increase our costs and our ability to efficiently process personal data from the EEA. The GDPR also provides that EU and EEA member states may make their own further laws and regulations limiting the processing of genetic, biometric or health data, which could limit our ability to use and share personal data or could cause our costs could increase, and harm our business and financial condition.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following Brexit, we have to comply with the GDPR and the UK GDPR, with each regime having the ability to fine up to the greater of &#8364;20 million/ &#163;17.5 million or 4% of global turnover. The relationship between the UK and the EU in relation to certain aspects of data protection law remains unclear and it is unclear how UK data protection laws and regulations will develop in the medium to longer term. The European Commission has adopted an adequacy decision in favor of the UK, enabling data transfers from EU member states to the UK without additional safeguards. However, the UK adequacy decision will automatically expire in June 2025 unless the European Commission re-assesses and renews/extends that decision, and remains under review by the Commission during this period. In September 2021, the UK government launched a consultation on its proposals for wide-ranging reform of UK data protection laws following Brexit. There is a risk that any material changes which are made to the UK data protection regime could result in the European Commission reviewing the UK adequacy decision, and the UK losing its adequacy decision if the European Commission deems the UK to no longer provide adequate protection for personal data.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In recent years, U.S. and European lawmakers and regulators have expressed concern over electronic marketing and the use of third-party cookies, web beacons and similar technology for online behavioral advertising. In the EU, informed consent is required for the placement of a cookie on a user&#8217;s device. The current EU laws that cover the use of cookies and similar technology and marketing online or by electronic means are under reform. A draft of the new ePrivacy Regulation is currently going through the European legislative process.&#160;&#160;Unlike the current ePrivacy Directive, the ePrivacy Regulation will be directly implemented into the laws of each of the EU member </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tates, without the need for further enactment. When implemented, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">it </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is expected to alter rules on third-party cookies, web beacons and similar technology for online behavioral advertising and to impose stricter requirements on companies using these tools.&#160;&#160;The </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">current provisions of the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">draft</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ePrivacy Regulation</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> also extend the strict opt-in marketing rules </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to business-to-business communications</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and significantly increase penalties.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While the text of the draft ePrivacy Regulation is still under development, a recent European court decision and regulators&#8217; recent guidance are driving increased attention to cookies and tracking technologies. If regulators start to enforce the strict approach in recent guidance, this could lead to substantial costs, require significant systems changes, limit the effectiveness of our marketing activities, divert the attention of our technology personnel, adversely affect our margins, increase costs and subject us to additional liabilities.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any failure or perceived failure by us to comply with privacy or security laws, policies, legal obligations or industry standards or any security incident that results in the unauthorized release or transfer of personally identifiable information may result in governmental enforcement actions and investigations including by European Data Protection Authorities, fines and penalties (for example, of up to 20 million Euros or up to 4% of the total worldwide annual turnover of the preceding financial year (whichever is higher) under the GDPR and draft ePrivacy Regulation, and &#163;17.5 million or 4% of the total worldwide annual turnover for breaches of the UK legislation), litigation and/or adverse publicity, including by consumer advocacy groups, and could cause our customers to lose trust in us, which could have an adverse effect on our reputation and business. Such failures could have a material adverse effect on our financial condition and operations. If the third parties we work with violate applicable laws, contractual obligations or suffer a security breach, such violations may also put us in breach of our obligations under privacy laws and regulations and/or could in turn have a material adverse effect on our business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The Federal Physician Payments Sunshine Act:<span style="font-style:normal;">&#160;The federal Physician Payments Sunshine Act requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with certain exceptions, to report annually to CMS information related to &#8220;payments or other transfers of value&#8221; made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain non-physician practitioners (physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists, anesthesiology assistants and certified nurse midwives), and teaching hospitals, and to report annually to CMS certain ownership and investment interests held by physicians and their immediate family members. </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Analogous State and Foreign Law Equivalents<span style="font-style:normal;">:&#160;&#160;We may be subject to state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers&#59; state laws that require device companies to comply with the industry&#8217;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources&#59; state laws that require device manufacturers to report information related to payments and other &#8220;transfers of value&#8221; to physicians and other healthcare providers or marketing expenditures&#59; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. For example, the California Consumer Privacy Act, or CCPA, which went into effect January 1, 2020, among other things, creates new data privacy obligations for covered companies and provides new privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. Although the law includes limited exceptions, including for &#8220;protected health information&#8221; maintained by a covered entity or business associate, it may regulate or impact our processing of personal information depending on the context. Further, the California Privacy Rights Act (CPRA) recently passed in California. The CPRA will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. The majority of the provisions will go into effect on January 1, 2023, and additional compliance investment and potential business process changes may be required.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Healthcare Reform:<span style="font-style:normal;">&#160;In March 2010, the Affordable Care Act (the ACA) was signed into law, which has the potential to substantially change healthcare financing and delivery by both governmental and private insurers, and </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">significantly impact the medical device industry. The A</span><span style="font-style:normal;">CA</span><span style="font-style:normal;"> impacted existing government healthcare programs and resulted in the development of new programs.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since its enactment, there have been judicial and congressional challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#8217;s decision, President Biden issued an executive order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, other legislative changes have been proposed and adopted since the ACA was enacted. These changes included an aggregate reduction in Medicare payments to providers of 2% per fiscal year, which went into effect on April 1, 2013 and will remain in effect through 2030, with the exception of a temporary suspension from May 1, 2020 through March 31, 2022, unless additional Congressional action is taken. The Medicare Access and CHIP Reauthorization Act of 2015, enacted on April 16, 2015 (MACRA), repealed the formula by which Medicare made annual payment adjustments to physicians and replaced the former formula with fixed annual updates and a new system of incentive payments that began in 2019 that are based on various performance measures and physicians&#8217; participation in alternative payment models such as accountable care organizations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any regulatory or legislative developments in domestic or foreign markets that eliminates or reduces reimbursement rates for procedures performed with our products could harm our ability to sell our products or cause downward pressure on the prices of our products, either of which would affect our ability to generate the revenues necessary to support our business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The Foreign Corrupt Practices Act:<span style="font-style:normal;">&#160;The Foreign Corrupt Practices Act (FCPA) prohibits any U.S. individual or business from paying, offering or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">The UK Bribery Act.<span style="font-style:normal;">&#160;The UK Bribery Act prohibits giving, offering or promising bribes (which includes anything of value) to any person, including private persons, as well as requesting, agreeing to receive, or accepting bribes from any person. In addition, under the UK Bribery Act, companies which carry on a business or part of a business in the UK, as we do, may be held liable not only for bribes given, offered, promised, requested or accepted to any person, including private persons, by employees and persons associated with the company in order to obtain or retain business or a business advantage for the company, but also for failing to prevent the bribe in the first place. Liability for the offence of failing to prevent bribery is strict, with no element of a corrupt state of mind, but a defense of having in place adequate procedures designed to prevent bribery is available. Furthermore, under the UK Bribery Act there is no exception for facilitation payments.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Employees and Human Capital</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, we had 945 employees globally. We believe the success of our business depends, in part, on our ability to attract and retain qualified personnel. We are committed to developing our employees and providing them with opportunities to contribute to our growth and success. Our employees are not subject to a collective bargaining agreement, and we believe that we have good relations with our employees.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and additional employees. We strive to attract and retain the most talented employees in the industry by offering competitive compensation and benefits that support their health, financial and emotional </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">well-being.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The principal purposes of our </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">compensation</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> plans are to attract, retain and motivate selected employees and directors</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use a combination of fixed and variable </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">compensation including base salary, cash-based performance bonuses and stock-based compensation awards.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">About Us</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We were incorporated in Minnesota in March 2006 and reincorporated in Delaware in October 2006. We completed the initial public offering of our common stock in November 2014. Our common stock is currently listed on the New York Stock Exchange (NYSE) under the symbol &#8220;NVRO.&#8221; Our principal executive offices are located at 1800 Bridge Parkway, Redwood City, California 94065. Our telephone number is (650)&#160;251-0005. Our website address is www.nevro.com. The information on, or that can be accessed through, our website is not incorporated by reference into this Annual Report on Form 10-K, or Annual Report, or any other filings we make with the U.S. Securities and Exchange Commission, or SEC.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Available Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We make available on or through our website certain reports and amendments to those reports that we file with, or furnish to, the SEC in accordance with the Securities Exchange Act of 1934, as amended, or the Exchange Act. These include our Annual Reports on Form 10-K, our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section&#160;13(a) or 15(d) of the Exchange Act. We make this information available on or through our website free of charge as soon as reasonably practicable after we electronically file the information with, or furnish it to, the SEC. This information is also available by writing to us at the address on the cover of this Annual Report.&#160;&#160;The SEC maintains a website that contains reports, proxy and information statements, and other information regarding our filings, at www.sec.gov. The information on, or that can be accessed through, our website is not incorporated by reference into this Annual Report or any other filings we make with the SEC.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1A_RISK_FACTORS">ITEM&#160;1A.<span style="font-style:italic;">&#160;RISK FACTORS</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Our business involves significant risks, some of which are described below. You should carefully consider these risks, as well as the other information in this Annual Report, including our financial statements, the related notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and growth prospects. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risk Factor Summary</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Below is a summary of the principal factors that make an investment in our common stock speculative or risky. This summary does not address all of the risks that we face. Additional discussion of the risks summarized in this risk factor summary, and other risks that we face, can be found below under the heading &#8220;Risk Factors&#8221; and should be carefully considered together with other information in this Annual Report on Form 10-K and our other filings with the Securities and Exchange Commission (SEC) before making investment decisions regarding our common stock:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">The COVID-19 pandemic has harmed and continues to affect our business, financial condition, results of operations, and growth.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">We are substantially dependent on continued market acceptance in the United States for our 10 kHz Therapy, and the failure of our 10 kHz Therapy to continue to gain market acceptance would negatively impact our business.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">Our success depends on our ability to grow the SCS market by generating awareness and demonstrating the benefits of our therapy for treating PDN and NSRBP.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">We must educate physicians and demonstrate to them the merits of our 10 kHz Therapy compared to those of our competitors.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">If our competitors, who are large, well-established companies with substantially greater resources than ours and a long history of competing in the SCS market, are better able to develop and market neuromodulation products (including for new indications, such as PDN) that are safer, more effective, less costly, easier to use or otherwise more attractive than our Senza systems, our business will be adversely impacted.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">We have a history of significant losses. If we do not achieve and sustain profitability, our financial condition could suffer.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">If third-party payors do not provide adequate coverage and reimbursement for the use of Senza, our revenue will be negatively impacted.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">We currently are, and may in the future become, involved in lawsuits to defend ourselves against intellectual property disputes, which could be expensive and time consuming, and ultimately unsuccessful, and could result in the diversion of significant resources, and hinder our ability to commercialize our existing or future products.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">If we fail to maintain FDA approval or foreign approval or certification to market and sell Senza, or if such approval or certification is impacted in the future, we will be unable to commercially distribute and market Senza in the United States and abroad. Further, we may not be able to obtain required regulatory approvals or certifications to expand the indications for which we may market and sell Senza.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">We are in the process of developing internal manufacturing capabilities for our products, but expect to remain dependent upon third-party manufacturers and suppliers, in some cases sole- or single-source suppliers, making us vulnerable to supply shortages and problems and price fluctuations, which could harm our business.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">If we fail to receive access to hospital facilities, our sales may decrease.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">If clinical studies for future indications do not produce results necessary to support regulatory clearance, approval or certification in the United States or elsewhere, we will be unable to commercialize our products for these indications.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">We are required to maintain high levels of inventory, which could consume a significant amount of our resources, reduce our cash flows and lead to inventory impairment charges.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">Senza is subject to extensive governmental regulation, both in the United States and in foreign jurisdictions, such as Europe, and our failure to comply with applicable requirements could cause our business to suffer.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">We may be subject to federal, state and foreign healthcare laws and regulations, and a finding of failure to comply with such laws and regulations could have a material adverse effect on our business.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;">Our stock price has experienced significant volatility and may continue to be volatile.&#160;&#160;As a result, our stockholders may not be able to resell shares of our common stock at or above the price they paid and such volatility may also adversely impact the value of the 2025 Notes.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to our Business</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our business, financial condition, results of operations and growth have been harmed by the effects of the COVID-19 pandemic and the pandemic continues to affect our business.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to risks related to the global pandemic associated with COVID-19, as well as similar future public health crises. The COVID-19 outbreak has negatively impacted, and continues to negatively impact our operations and revenues and overall financial condition as demand for elective procedures remains unpredictable and the number of Senza trials and permanent system implant procedures has not recovered to pre-pandemic levels.&#160;&#160;The magnitude of the risks and uncertainties are unpredictable and could be further aggravated by the spread of new variants of the COVID-19 virus such as the Delta and Omicron variants, which may be more contagious and/or virulent.&#160;&#160;During the initial stages of the pandemic, the number of Senza systems procedures performed, similar to other elective surgical procedures, decreased significantly as health care organizations globally prioritized the treatment of patients with COVID-19. For example, in the United States in the first half of 2020 and more recently in connection with the spread of the Omicron variant, governmental authorities recommended, and in certain cases required, that elective, specialty and other procedures and appointments, be suspended or canceled to avoid non-essential patient exposure to medical environments and potential infection with COVID-19 and to focus limited resources and personnel capacity toward the treatment of COVID-19. Additionally, overall patient willingness to pursue elective procedures has decreased due to the pandemic. Throughout 2021, the COVID-19 pandemic negatively impacted the global SCS therapy market, which we estimate decreased by approximately 5% to 10%. These challenges may arise again at any time throughout the duration of the pandemic, which is uncertain, and could reduce our revenue while the pandemic continues.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notably, the predictably of trial and permanent implant procedures continues to be challenging to forecast in light of the ongoing pandemic and recent surges in cases caused by the Delta and then Omicron variants. Even if the severity of the pandemic subsides, we are unable to predict the timing that demand for Senza system procedures may return to historic levels as prospective patients may decide to delay their procedures. As a result of the spread of more contagious and virulent variants, the COVID-19 pandemic could continue to result in a meaningful delay in patients seeking to have a Senza system trial. Further, we anticipate that the substantial backlog of patients seeking appointments with physicians and surgeries to be performed at hospitals and ambulatory surgery centers relating to a variety of medical conditions will result in patients seeking to have Senza system trials or implant procedures performed having to navigate limited provider capacity, due to, among other reasons, a growing trend of labor shortages with nurses and other healthcare facility staff. We believe these factors may have an adverse effect on the recovery of the global SCS therapy market and, as a result, the amount of time we predict for our sales to recover following the end of the pandemic.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further, numerous state and local jurisdictions have imposed, and others in the future may impose, &#8220;shelter-in-place&#8221; orders, quarantines, executive orders and similar government orders and restrictions for their residents to control the spread of COVID-19. Multiple times in 2020, the governor of California, where our headquarters are located, issued &#8220;shelter-in-place&#8221; or &#8220;stay at home&#8221; orders restricting non-essential activities, travel and business operations for an indefinite period of time, subject to certain exceptions for necessary activities. Such orders or </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">restrictions resulted in our headquarters closing, work stoppages, slowdowns and delays, travel restrictions and cancellation of events, among other effects, thereby negatively impacting our operations. Other disruptions or potential disruptions include restrictions on our personnel and personnel of partners to travel and access customers for training and case support&#59; delays in approvals or certifications by regulatory authorities and notified bodies&#59; delays in product development efforts&#59; and additional government requirements or other incremental mitigation efforts that may further impact our capacity to manufacture, sell and support the use of our Senza systems. For instance</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the EU, notified bodies must be officially designated to certify products and services in accordance with the Medical Devices Regulation (EU) No 2017/745 (the EU Medical Devices Regulation). While several notified bodies have been designated</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the COVID-19 pandemic has significantly slowed down their designation process and the current designated notified bodies are facing a large amount of requests with the new regulation as a consequence of which review times have lengthened. This situation could impact our ability to grow our business in the EU and EEA. In addition, even after the lift of &#8220;shelter-in-place&#8221; orders, quarantines, executive orders and similar government orders and restrictions for their residents to control the spread of COVID-19, we continue to experience disruptions to our business as a result of patients and customers continuing to be cautious in restarting elective procedures in light of the continued risk posed by the virus.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Global and domestic supply chains and the timely availability of raw materials and products may be materially disrupted by quarantines, factory slowdowns or shutdowns, border closings and travel restrictions resulting from the COVID-19 pandemic. Any manufacturing supply interruption of materials could adversely affect our ability to conduct ongoing and future activities.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While the potential economic impact brought by and the duration of COVID-19 may be difficult to assess or predict, the widespread pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity, including our ability to repay our 2.75% convertible senior convertible notes due 2025 (the 2025 Notes). We expect any further shelter-in-place policies and restrictions on elective surgical procedures worldwide to have a substantial impact on our revenue. In addition, a recession or market correction resulting from the spread of COVID-19 could materially affect our business and the value of our common stock. During the COVID-19 pandemic, our customers, including hospitals, ASCs and physician offices, have experienced financial hardship and some of them may not fully recover.&#160;&#160;This could lead to some of these customers temporarily or permanently shutting down, filing for bankruptcy or being acquired by larger health systems, leading to reduced procedures and/or additional pricing pressure on our products. The COVID-19 pandemic has also resulted in a significant increase in unemployment in the United States, Europe and Australia, which may continue even after the pandemic. The occurrence of any such events may lead to reduced disposable income and access to health insurance which could adversely affect the number of Senza systems sold after the pandemic has ended.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are substantially dependent on continued market acceptance in the United States for our 10 kHz Therapy, and the failure of our 10 kHz Therapy to continue to gain market acceptance would negatively impact our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since our inception, we have devoted substantially all of our efforts to the development and commercialization of Senza and 10 kHz Therapy for the treatment of chronic leg and back pain. We have expanded our commercial efforts since our initial PMA in May 2015, however, we are still in the early stages of our overall commercialization efforts. For example, in July 2021, we received the first FDA approval for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with painful diabetic neuropathy (PDN) utilizing SCS therapy, and we just recently initiated our commercial rollout. In addition, in January 2022, we received FDA approval of our 10 kHz Therapy for the management of non-surgical refractory back pain (NSRBP) (intractable back pain without prior surgery and not a candidate for back surgery), for which we intend to initiate a commercial rollout. The expansion of our commercial efforts, particularly into the PDN indication, is at a very early stage. While we believe the market for SCS in PDN is substantial, it is undeveloped and will require substantial marketing and education efforts by our sales force to develop this market, the success of which is very uncertain. We have incurred significant costs, including costs to continue to build our sales force in the United States, and we expect these costs to continue as we initiate our commercial rollout for the PDN and NSRBP markets. If we are unable to achieve significant market acceptance in the United States, our results of operations will be adversely affected as the United States is the principal market for Senza. If we are unsuccessful in our continuing efforts to commercialize our products or are unable to market our products as a result of a quality </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">problem, failure to maintain or obtain additional regulatory approvals or certifications, unexpected or serious complications or other unforeseen negative effects related to our 10 kHz Therapy or the other factors discussed in these risk factors, we would lose our only source of revenue, and our business will be materially adversely affected.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may be unable to gain broader market acceptance for a number of reasons, including due to the below and as a result of other factors set forth herein:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">established competitors with strong relationships with customers, including physicians, hospitals and third-party suppliers&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">limitations in our ability to demonstrate differentiation and advantages of our product compared to competing products and the relative safety, efficacy and ease of use of our product&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the limited size of our sales force and the learning curve required to gain experience selling our product&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">difficulties and challenges in developing and addressing the PDN and NSRBP markets as the first neuromodulation therapy approved for these indications, some of which may be difficult to predict or foresee until later in the commercial rollout&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the inability to obtain sufficient supply of the components for our Senza systems or secure second-source suppliers if our main suppliers are unable to fulfill our orders&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">insufficient financial or other resources to support our commercialization efforts necessary to reach profitability&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the introduction and market acceptance of new, more effective or less expensive competing products and technologies.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Moreover, physicians and hospitals may not perceive the benefits of our products and may be unwilling to change from the SCS devices they are currently using. Communicating the benefits of Senza and the 10 kHz Therapy to these physicians and hospitals requires a significant commitment by our marketing team and sales organization. Physicians and hospitals may be slow to change their practices because of perceived risks arising from the use of new products. Physicians may not recommend or use Senza until there is more long-term commercial experience to convince them to alter their existing treatment methods, or until they receive additional recommendations from other physicians that our product is effective. We cannot predict when, if ever, physicians and hospitals may adopt use of our product. If we are unable to educate physicians and hospitals about the advantages of our 10 kHz Therapy, do not continue to gain market acceptance of our product, or fail to significantly grow our market share, we will not be able to grow our revenue and our business and financial condition will be adversely affected.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We must educate physicians and demonstrate to them the merits of our 10 kHz Therapy compared to those of our competitors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Physicians play a significant role in determining the course of a patient&#8217;s treatment and the type of product that will be used to treat a patient. An important part of our sales process includes the education of physicians on the safe and effective use of our 10 kHz Therapy and our Senza systems, particularly because Senza and high-frequency neuromodulation treatment is relatively new as compared to existing low-frequency traditional SCS systems, and is the first non-drug product approved for use in the management of certain types of chronic pain associated with PDN, as well as being the only SCS therapy for the management of NSRBP.&#160;&#160;As a result, our ability to address, develop and grow the markets for our 10 kHz Therapy and, ultimately our success, depends, in large part, on effectively educating physicians about our 10 kHz Therapy, including the results of our pivotal clinical studies. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order for us to sell our products, we must successfully demonstrate to physicians the merits of our 10 kHz Therapy compared to our competitors&#8217; products. Acceptance of our 10 kHz Therapy depends on educating physicians as to the distinctive characteristics, perceived benefits, safety, ease of use and cost-effectiveness of Senza as compared to our competitors&#8217; products, as well as in new indications such as those we have received with respect to PDN and NSRBP, and then communicating to physicians the proper application of our 10 kHz Therapy. Physicians typically need to perform several procedures to become comfortable using 10 kHz Therapy and Senza. If a physician experiences difficulties during an initial procedure or otherwise, that physician may be less likely to </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">continue to use our product or to recommend it to other physicians. As a result, educating physicians on the proper use of Senza is critical to the success of our commercialization efforts. If we are not successful in educating physicians and convincing them of the merits of our 10 kHz Therapy or educating them on the use of Senza, they may not use our Senza systems and we may be unable to increase our sales, sustain our growth or achieve profitability.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we believe receiving support of our products from physicians is essential for market acceptance and adoption. If we do not receive support from physicians or long-term data does not show the benefits of using our 10 kHz Therapy, physicians may not use Senza. In such circumstances, our results of operations would be materially adversely affected. It is also important for our growth that these physicians advocate for the benefits of our products in the broader marketplace. If physicians misuse or ineffectively use our products, it could result in unsatisfactory patient outcomes, patient injuries, negative publicity or lawsuits against us, any of which could have an adverse effect on our business.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our competitors are large, well-established companies with substantially greater resources than we have and have a long history of competing in the SCS market.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our most significant competitors are publicly traded, or are divisions of publicly traded, major medical device companies that have substantially greater financial, technical, sales and marketing resources than we have. The 2019 global SCS market, before the COVID-19 pandemic, was estimated to be approximately $2.5 billion, with the United States comprising approximately 80% of the market at that time. Given the size of the existing and potential market in the United States, we expect that as we work to increase our market position and penetration in the United States our competitors will take aggressive action to protect their current market position.&#160;&#160;For example, in May 2015, a unit of Boston Scientific, one of our principal competitors, filed with the USPTO two petitions for <span style="font-style:italic;">inter partes</span> review challenging the validity of our U.S. Patent No. 8,359,102 (the &#8216;102 patent), which the Patent Trial and Appeals Board (PTAB) at the USPTO denied in November 2015, and, in December 2016 and April 2018, filed lawsuits against us in the U.S. District Court for the District of Delaware alleging that we infringed their patents covering technology related to stimulation leads, batteries and telemetry units, and alleging theft of trade secrets and tortious interference with contract.&#160;&#160;We will face significant competition in establishing our market share in the United States and may encounter unforeseen obstacles and competitive challenges in the United States.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we face a particular challenge overcoming the long-standing practices by some physicians of using the neuromodulation products of our larger, more established competitors. Physicians who have completed many successful implants using the neuromodulation products made by these competitors may be reluctant to try new products from a source with which they are less familiar. If these physicians do not try and subsequently adopt our product, then our revenue growth will slow or decline.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further, a number of our competitors are currently conducting, or we anticipate will be conducting, clinical studies to demonstrate the results of their SCS systems. The results of these studies may be equivalent to, or potentially better than, the results of our pivotal U.S. trial.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If our competitors are better able to develop and market neuromodulation products that are safer, more effective, less costly, easier to use or otherwise more attractive than our Senza systems, our business will be adversely impacted.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The medical device industry is highly competitive and subject to technological change. Our success depends, in part, upon our ability to establish a competitive position in the neuromodulation market by securing broad market acceptance of our 10 kHz Therapy and our Senza systems for the treatment of approved chronic pain conditions. Any product we develop that achieves regulatory clearance, approval or certification will have to compete for market acceptance and market share. We believe that the primary competitive factors in the neuromodulation market are demonstrated clinical effectiveness, product safety, reliability and durability, ease of use, product support and service, minimal side effects, pricing and contracting, and salesforce experience and relationships. We face significant competition in the United States and internationally, which we believe will continue to intensify. For example, our major competitors, Medtronic, Boston Scientific and Abbott Laboratories, each has approved neuromodulation systems in at least the United States, Europe, and Australia and have been established for several years. Further, since the launch of our product, these major competitors have all launched new SCS systems: </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Medtronic launched the Intellis system, Boston Scientific launched the Spectra WaveWriter SCS system, the W</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">veWriter Alpha SCS system and the Fast</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acting Sub-perception Therapy, and Abbott Laboratories launched the Proclaim system. We believe these competitors will continue to launch new products, waveforms, and datasets to remain competitive. For example, in early 2020 Medtronic announced the acquisition of Stimgenics, a company that has developed a specific waveform (DTM) with a purported mechanism of action, and the results of an RCT which had </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">superior</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> results versus traditional SCS. The DTM waveforms have been launched, and launches such as these could result in a reduction of our differentiation in the marketplace. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, in January 2022, Medtronic announced that it had received FDA approval of its Intellis rechargeable neurostimulator and Vanda recharge-free neurostimulator for the treatment of chronic pain associate with diabetic peripheral neuropathy, which will directly compete with Senza in the new PDN market.&#160;&#160; </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to these major competitors, we also face competition from companies such as Stimwave, Saluda, Mainstay Medical and Nalu Medical, and may face competition from Neuspera Medical and Biotronik in the future. These companies are becoming more active in the SCS market. For instance, in the first quarter of 2019, Stimwave received FDA clearance for 10 kHz stimulation, expanding their previous clearance for low frequency therapy, Nalu Medical received FDA clearance in the first quarter of 2019 for their SCS system, and Saluda Medical received certification in the European Union (EU) in the third quarter of 2019 for their SCS system, were added to the Prostheses List for the same system in Australia in July of 2020 and could potentially launch their SCS system in the United States as early as the end of 2021. Additionally, there are other emerging competitors with active neuromodulation system development programs that may emerge in the future. Many of the companies developing or marketing competing products either enjoy or may develop several advantages over us, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">more experienced sales forces&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">greater name recognition&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">more established sales and marketing programs and distribution networks&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">earlier regulatory approval or certification&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">long established relationships with physicians and hospitals&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability to offer competitive products at a lower price&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">significant patent portfolios, including issued U.S. and foreign patents and pending patent applications, as well as the resources to enforce patents against us or any of our third-party suppliers and distributors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability to acquire and integrate our competitors and/or their technology&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">demonstrated ability to develop product enhancements and new product offerings&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">established history of product reliability, safety and durability&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability to offer rebates or bundle multiple product offerings to offer greater discounts or incentives&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">greater financial and human resources for product development, sales, and marketing&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">greater experience in and resources for conducting R&#38;D, clinical studies, manufacturing, preparing regulatory submissions, obtaining regulatory clearance, approval or certification for products and marketing approved or certified products.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our competitors may develop and patent processes or products earlier than we do, obtain patents that may apply to us at any time, obtain regulatory clearances, approvals or certifications for competing products more rapidly than we do or develop more effective or less expensive products or technologies that render our technology or products obsolete or less competitive. We also face fierce competition in recruiting and retaining qualified sales, scientific, and management personnel, establishing clinical studies sites and enrolling patients in clinical studies. If our competitors are more successful than we are in these matters, our business may be harmed.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have a history of significant losses. If we do not achieve and sustain profitability, our financial condition could suffer.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have experienced significant net losses, and have no assurance that we will achieve profitability. We expect to continue to incur losses as we build our U.S. commercial operations and continue to investigate the use of our 10 kHz Therapy to treat other chronic pain conditions. We incurred net losses of $131.4 million, $83.1 million and $103.7 million for the years ended December&#160;31, 2021, 2020 and 2019, respectively. As of December 31, 2021, our accumulated deficit was $624.2 million. Our prior losses have had, and will continue to have, an adverse effect on our stockholders&#8217; equity and working capital. If our revenue grows more slowly than we anticipate, or if our operating expenses are higher than we expect, we may not be able to achieve profitability and our financial condition could suffer. Our patent infringement lawsuits with Boston Scientific Corporation have caused us to, and may continue to cause us to, incur substantial legal expenses.&#160;&#160;Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our ability to achieve profitability will depend, in part, on our ability to reduce the per unit manufacturing cost of our products.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Currently, the gross profit generated from the sale of our Senza systems is not sufficient to cover our operating expenses. To achieve our operating and strategic goals, we will, among other things, need to reduce the per-unit manufacturing cost of Senza. This cannot be achieved without increasing the volume of components that we purchase in order to take advantage of volume-based pricing discounts, improving manufacturing efficiency or increasing our volume to leverage manufacturing overhead costs. While we made the strategic decision in the third quarter of 2020 to reduce our reliance on third party manufacturers by initiating a plan to establish manufacturing operations in Costa Rica, which is, at least in part, intended to improve our long-term gross margin, there can be no assurance such actions will be successful or not ultimately result in us incurring more costs. If we are unable to improve manufacturing efficiency and reduce manufacturing overhead costs per unit, our ability to achieve profitability will be severely constrained. Any increase in manufacturing volumes is dependent upon a corresponding increase in sales. The occurrence of one or more factors that negatively impact the manufacturing or sales of Senza or reduce our manufacturing efficiency may prevent us from achieving our desired reduction in manufacturing costs, which would negatively affect our operating results and may prevent us from attaining profitability.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If third-party payors do not provide adequate coverage and reimbursement for the use of Senza, our revenue will be negatively impacted.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success in marketing our products depends and will depend in large part on whether U.S. and international government health administrative authorities, private health insurers and other organizations adequately cover and reimburse customers for the cost of our products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, we expect to derive nearly all our revenue from sales of our products to hospitals and outpatient medical facilities who typically bill various third-party payors, including Medicare, Medicaid, private commercial insurance companies, health maintenance organizations and other healthcare-related organizations, to cover all or a portion of the costs and fees associated with our products and bill patients for any applicable deductibles or co-payments. Access to adequate coverage and reimbursement for SCS procedures using Senza (and our other products in development) by third-party payors is essential to the acceptance of our products by our customers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that SCS procedures using our products are adequately described by existing CPT, HCPCS II and ICD-10-CM codes for the implantation of spinal cord stimulators and related leads performed in various sites of care, although such codes generally do not specifically describe procedures using either low-frequency or high-frequency stimulation. In the United States, although CMS approved a transitional pass-through payment for High-Frequency Stimulation under the&#160;Medicare&#160;hospital outpatient prospective payment system effective as of&#160;January 1, 2016 through December 31, 2017, our customers currently do not receive separate reimbursement for our products. In addition, effective July 1, 2021, Medicare now requires Prior Authorization for certain hospital outpatient procedures, including SCS procedures.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accordingly, we believe that some of our target customers may be unwilling to adopt Senza over more established or lower-cost therapeutic alternatives already available or that may subsequently become available. Further, any decline in the amount payors are willing to reimburse our customers for SCS procedures using Senza could make it difficult for new customers to adopt Senza and could create additional pricing pressure for us, which could adversely affect our ability to invest in and grow our business.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third-party payors, whether foreign or domestic, or governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In addition, in the United States, no uniform policy of coverage and reimbursement for medical device products and services exists among third-party payors. Therefore, coverage and reimbursement for medical device products and services can differ significantly from payor to payor. For our traditional chronic back and leg pain market, we believe that favorable coverage and reimbursement of procedures using our products from Medicare and certain commercial payors, such as Aetna, Cigna, Humana, Blue Cross Blue Shield and Kaiser, have contributed to our increase in revenue to date, while we continue to engage in efforts to educate payors on the advantages of 10 kHz Therapy.&#160;&#160;However, there can be no assurance that all private health insurance plans will cover procedures using the product.&#160;&#160;We currently have more limited coverage and reimbursement for use of our therapy in PDN and NSRBP patients and are working to expand payor coverage to include the use of our 10 kHz Therapy in this patient population. This effort could be costly and could take many years to gain broad acceptance, and there can be no guarantee that it will be successful. A significant number of negative coverage and reimbursement decisions by private insurers may impair our ability or delay our ability to grow our revenue. In addition, payors continually review new technologies for possible coverage and can, without notice, deny coverage for these new products and procedures. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained, or maintained if obtained.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reimbursement systems in international markets vary significantly by country and by region within some countries, and reimbursement approvals must be obtained on a country-by-country basis. Further, many international markets have government-managed healthcare systems that control reimbursement for new devices and procedures. In most markets, there are private insurance systems as well as government-managed systems. If sufficient coverage and reimbursement is not available for our current or future products, in either the United States or internationally, the demand for our products and our revenues will be adversely affected.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are currently, and may in the future become, involved in lawsuits to protect or enforce our intellectual property, which are expensive and time consuming, and ultimately unsuccessful, and could result in the diversion of significant resources, thereby hindering our ability to effectively grow sales of our Senza systems or commercialize future products, if any. If we are unable to obtain, maintain, protect, and enforce our intellectual property, our business will be negatively affected.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The market for medical devices is subject to rapid technological change and frequent litigation regarding patent and other intellectual property rights. It is possible that our patents or licenses may not withstand challenges made by others or protect our rights adequately.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success depends in large part on our ability to secure effective patent protection for our products and processes in the United States and internationally. We have filed and intend to continue to file patent applications for various aspects of our technology and trademark applications to protect our brand and business. We seek to obtain and maintain patents and other intellectual property rights to restrict the ability of others to market products or services that misappropriate our technology and/or infringe our intellectual property to compete with our products. We are currently involved in, and in the future may become involved in additional, lawsuits and/or proceedings to protect and enforce our intellectual property rights. These lawsuits and proceedings are expensive and require substantial attention of management.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">However, we face the risks that:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may fail to secure necessary patents, potentially permitting competitors to market competing products and make, use or sell products that are substantially the same as ours without incurring the sizeable development costs that we have incurred, which would adversely affect our ability to compete.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Patents may not issue from any of our currently pending or future patent applications.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Our already-granted patents and any future patents may not survive legal challenges, including challenges in the ongoing lawsuit with Boston Scientific, to their scope, validity or enforceability, or provide significant protection for us, and they may be re-examined or invalidated, and/or may be found to be unenforceable or not cover competing products.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Even if our patents are determined by a court to be valid and enforceable, they may not be drafted or interpreted broadly enough to prevent others from marketing products and services similar to ours.&#160;&#160;Similarly, others may simply design around our patents. For example, third parties may be able to make systems or devices that are similar to ours but that are not covered by the claims of our patents. Third parties may assert that we or our licensors were not the first to make the inventions covered by our issued patents or pending patent applications. The claims of our issued patents or patent applications when issued may not cover our commercial technology or the future products and services that we develop. We may not have freedom to operate unimpeded by the patent rights of others. Third parties may have dominating, blocking or other patents relevant to our technology of which we are not aware. In addition, because patent applications in the United States and many foreign jurisdictions are typically not published until 18&#160;months after the filing of certain priority documents (or, in some cases, are not published until they issue as patents) and because publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed patent applications for our technology or our contemplated technology. Any such patent applications may have priority over our patent applications or issued patents, which could further require us to obtain rights to issued patents covering such technologies. If another party has filed a U.S. patent application on inventions similar to ours, depending on when the timing of the filing date falls under certain patent laws, we may have to participate in a priority contest (such as an interference proceeding) declared by the USPTO, to determine priority of invention in the United States. There may be prior public disclosures that could invalidate our inventions or parts of our inventions of which we are not aware. Further, we may not develop additional proprietary technologies and, even if we do, they may not be patentable.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Patent law can be highly uncertain and involve complex legal and factual questions for which important principles remain unresolved. In the United States and in many foreign jurisdictions, policies regarding the breadth of claims allowed in patents can be inconsistent. The U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit have made, and will likely continue to make, changes in how the patent laws of the United States are interpreted. Similarly, foreign courts have made, and will likely continue to make, changes in how the patent laws in their respective jurisdictions are interpreted. We cannot predict future changes in the interpretation of patent laws or changes to patent laws that might be enacted into law by U.S. and foreign legislative bodies. Those changes may materially affect our patents or patent applications, our ability to obtain patents or the patents and patent applications of our licensors. Future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage, which could adversely affect our financial condition and results of operations.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Monitoring unauthorized uses of our intellectual property is difficult and costly. From time to time, we seek to analyze our competitors&#8217; products and services.&#160;&#160;For example, we filed a lawsuit in November 2016 against Boston Scientific Corporation in order to enforce certain of our patents, we filed a lawsuit in February 2019 for patent infringement and false advertisement against Stimwave, we filed a lawsuit in February 2020 for patent infringement against Nalu Medical, and we filed another lawsuit in February 2021 for patent infringement against Boston Scientific.&#160;&#160;We may in the future seek to enforce our patents or other proprietary rights against other potential infringements. However, the steps we have taken to protect our proprietary rights may not be adequate to prevent misappropriation of our intellectual property. We may not be able to detect unauthorized use of, or take appropriate steps to enforce, our intellectual property rights. Our competitors may also independently develop similar </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="color:#000000;">technology. Any inability to meaningfully protect our intellectual property could result in competitors offering products that incorporate our product features, which could reduce demand for our products. In addition, we may need to defend our patents from third-party challenges, including interferences, derivation proceedings, re-examination proceedings, post-grant review, </span><span style="font-style:italic;color:#000000;">inter partes</span><span style="color:#000000;"> review, third-party submissions, oppositions, nullity actions, or other patent proceedings. We may also need to initiate infringement claims or litigation. Adverse proceedings such as litigation or challenges to the validity of our patents can be expensive, time consuming and may divert the efforts of our technical and managerial personnel, which could in turn harm our business, whether or not we receive a determination favorable to us. In addition, in an infringement or other adverse proceeding, a court may decide that the patent we seek to enforce is invalid or unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that the patent in question does not cover the technology in question. An adverse result in any litigation or proceeding could place one or more of our patents at risk of being invalidated, interpreted narrowly or found unenforceable. Some of our competitors may be able to devote significantly more resources to intellectual property litigation, and may have significantly broader patent portfolios to assert against us, if we assert our rights against them. Further, because of the substantial discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be disclosed or otherwise compromised during litigation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may not be able to accurately estimate or control our future operating expenses in relation to obtaining, enforcing and/or defending intellectual property, which could lead to cash shortfalls. Our operating expenses may fluctuate significantly in the future as a result of the costs of preparing, filing, prosecuting, defending and enforcing patent claims and other patent related costs, including litigation costs and the results of such litigation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may also be forced to enter into cross-license agreements with competitors in order to manufacture, use, sell, import and/or export products or services that are covered by our competitors&#8217; intellectual property rights. If we need to use our intellectual property to enter such cross-license agreements, it may compromise the value of our intellectual property due to the fact that our competitors may be able to manufacture, use, sell, import and/or export our patented technology.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For additional information regarding risks related to our intellectual property, see &#8220;Risks Related to Intellectual Property.&#8221;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we fail to develop and retain an effective direct sales force in the United States, our business could suffer.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As we increase our commercial and marketing efforts, we will need to retain, develop and grow the number of direct sales personnel that we employ. We continue to make a significant investment in recruiting and training sales representatives and clinical representatives. There is significant competition for sales personnel experienced in relevant medical device sales. Once hired, the training process is lengthy because it requires significant education for new sales representatives to achieve the level of clinical competency with our products expected by physicians. Upon completion of the training, our sales representatives typically require lead time in the field to grow their network of accounts and achieve the productivity levels we expect them to reach in any individual territory. Furthermore, the use of our products often requires or benefits from direct support from us. If we are unable to attract, motivate, develop and retain a sufficient number of qualified sales personnel, or if our sales representatives do not achieve the productivity levels we expect them to reach, our revenue will not grow at the rate we expect and our financial performance will suffer. For example, during the first half of 2018, we hired sales personnel at a slower rate that we had expected, which, among other factors, caused us to lower our expectations for full year 2018 worldwide revenue. Also, to the extent we hire personnel from our competitors, our new sales representatives will usually be subject to restrictive covenants with their former employers, including non-competition, non-solicitation and/or confidentiality provisions.&#160;&#160;As a result, we may have to wait until applicable non-competition provisions have expired before deploying such personnel in restricted territories or incur costs to relocate personnel outside of such territories. We and certain of our new sales representatives have been, continue to be, and may in the future be, subject to allegations that these new hires have violated the non-competition clauses, been improperly solicited or divulged to us proprietary or other confidential information of their former employers. Any of these risks may adversely affect our business.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we fail to maintain FDA approval</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> or foreign approval or certification</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> to market and sell Senza, or if such approval </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">or certification </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">is impacted in the future, we will be unable to commercially distribute and market Senza in the United States</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> and abroad</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">. Further, we may not be able to obtain required regulatory approvals</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> or certifications</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> to expand the indications for which we may market and sell Senza.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We and our products are subject to extensive regulation in the U.S. and elsewhere, including by the FDA and its foreign counterparts.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The regulations to which we are subject are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales. The FDA and foreign regulatory authorities enforce these regulatory requirements through periodic unannounced inspections. We do not know whether we will pass any future FDA or foreign regulatory authorities inspections.&#160;&#160;For example, while we have received FDA approval of our Senza PMA application, there can be no assurance that approval will be maintained. For example:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may not be able to maintain to the FDA&#8217;s satisfaction that our product is safe and effective for its intended use&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may fail to comply with the guidelines required by FDA and other agencies to maintain our PMA approval&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the manufacturing processes and facilities we and our vendors use may not meet applicable requirements to maintain our PMA approval.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we may suffer from product liability or other issues that impact our ability to continue to market the Senza systems in the United States.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Failing to maintain FDA approval or foreign approval or certification could result in unexpected and significant costs for us and consume management&#8217;s time and other resources. The FDA or foreign regulatory authorities or notified bodies could ask us to improve or augment manufacturing processes, collect and provide data on the quality or safety of our product or issue us warning letters relating to matters that may result in removal of our product from the market. Additionally, we will be required to obtain FDA approval or notified body certification prior to making any modification to the device, and the FDA or foreign regulatory authorities may revoke the approval or certification or impose other restrictions if post-market data demonstrates safety issues or lack of effectiveness. If we are unable to obtain and maintain the necessary regulatory approvals or certifications, our financial condition may be adversely affected, and our ability to grow domestically and internationally would likely be limited. Further, the failure to obtain approval or certification for new products and new indications, such as painful diabetic neuropathy, on existing products could have an adverse effect on our business, financial condition or results of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Modifications to our products may require us to obtain new PMA approvals or approvals of a PMA supplement, or any similar approval or certification and if we market modified products without obtaining necessary approvals or certifications, we may be required to cease marketing or recall the modified products until required approvals or certifications are obtained.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain modifications to a PMA-approved device may require approval of a new PMA or a PMA supplement, or alternatively a notification or other submission to the FDA. The FDA may not agree with our decisions regarding whether a new PMA or PMA supplement is necessary. We may make modifications to our approved devices in the future that we believe do not require approval of a new PMA or PMA supplement. If the FDA disagrees with our determination and requires us to submit a new PMA or PMA supplement for modifications to our previously approved products, we may be required to cease marketing or to recall the modified product until we obtain approval, and we may be subject to significant regulatory fines or penalties. In addition, the FDA may not approve our products for the indications that are necessary or desirable for successful commercialization or could require clinical trials to support any modifications. With respect to PMA-approved devices, any changes to the manufacturing processes, including manufacturing site changes such as the planned change to assemble our Senza systems at our Costa Rica facility when completed, may require prior approval of a PMA supplement before such </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">changes may </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">be </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">implemented. Any delay or failure in obtaining required approvals would adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn would harm our future growth.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the EU, we must inform the notified body that carried out the conformity assessment of the medical devices that we market or sell in the EU and the European Economic Area (EEA) (which consists of the 27 EU member states plus Norway, Liechtenstein and Iceland), of any planned substantial changes to our quality system or substantial changes to our medical devices that could affect compliance with the general safety and performance requirements laid down in Annex I to the EU Medical Devices Regulation or cause a substantial change to the intended use for which the device has been CE marked. The notified body will then assess the planned changes and verify whether they affect the products&#8217; ongoing conformity with the EU Medical Devices Regulation. If the assessment is favorable, the notified body will issue a new certificate of conformity or an addendum to the existing certificate attesting compliance with the general safety and performance requirements and quality system requirements laid down in the Annexes to the EU Medical Devices Regulation.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our growth and success depends on physicians&#8217; use of our 10 kHz Therapy to treat chronic back pain, as well as the development and success in the PDN and NSRBP markets.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our growth and success is dependent on physicians&#8217; acceptance and use of our 10 kHz Therapy to treat chronic back pain and our development and success in the markets for our newest indications, PDN and NSRBP. We believe a significant limitation of current neuromodulation systems is the limited evidence supporting efficacy of traditional SCS products. Senza utilizes high-frequency stimulation technology capable of delivering waveform of up to 10,000 Hz for spinal cord stimulation that has been shown to be effective in the treatment of both leg and back pain and the management of chronic pain associated with PDN and NSRBP. However, we may face challenges convincing physicians, many of whom have extensive experience with competitors&#8217; SCS products and established relationships with other companies, to appreciate the benefits of the 10 kHz Therapy and, in particular, its ability to treat back pain as well as leg pain, and adopt it for treatment of their patients. If Senza is unable to gain acceptance by physicians for the treatment of PDN, NSRBP or other pain indications for which its use is approved or certified, our potential to expand the existing neuromodulation market will be significantly limited and our revenue potential will be negatively impacted.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our international operations subject us to certain operating risks, which could adversely impact our results of operations and&#160;financial condition.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, we sell Senza directly in the Netherlands, Austria, Switzerland, United Kingdom, Sweden, Australia, Belgium, Luxembourg, Norway and Germany and through distributors and agents located in Spain, Italy, Slovakia, Turkey and Kuwait. The sale and shipment of Senza across international borders, as well as the purchase of components from international sources, subject us to United States and foreign governmental trade, import and export and customs regulations and laws.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Other laws and regulations that can significantly impact us include various anti-bribery laws, including the U.S. Foreign Corrupt Practices Act, as well as export controls laws. Any failure to comply with applicable legal and regulatory obligations could impact us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments, restrictions on certain business activities and exclusion or debarment from government contracting.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our international operations expose us and our distributors to risks inherent in operating in foreign jurisdictions. These risks include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">difficulties in enforcing our intellectual property rights and in defending against third-party threats and intellectual property enforcement actions against us, our distributors, or any of our third-party suppliers&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">reduced or varied protection for intellectual property rights in some countries&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">pricing pressure that we may experience internationally&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">foreign currency exchange rate fluctuations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">a shortage of high-quality sales people and distributors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">third-party reimbursement policies that may require some of the patients who receive our products to directly absorb medical costs or that may necessitate the reduction of the selling prices of Senza&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">relative disadvantages compared to competitors with established business and customer relationships&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the imposition of additional U.S. and foreign governmental controls or regulations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">economic instability&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">virus epidemics and pandemics such as the COVID-19 outbreak&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in duties and tariffs, license obligations and other non-tariff barriers to international trade, including any retaliatory tariffs or other actions taken by foreign countries in response to the U.S. tariffs imposed and threatened by the United States presidential administration&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the imposition of restrictions on the activities of foreign agents, representatives and distributors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">scrutiny of foreign tax authorities that could result in significant fines, penalties and additional taxes being imposed on us&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">laws and business practices favoring local companies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">longer payment cycles&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">difficulties in maintaining consistency with our internal guidelines&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">difficulties in enforcing agreements and collecting receivables through certain foreign legal systems&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the imposition of costly and lengthy new export licensing requirements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the imposition of U.S. or international sanctions against a country, company, person or entity with whom we do business that would restrict or prohibit continued business with the sanctioned country, company, person or entity&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the imposition of new trade restrictions.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we experience any of these risks, our sales in non-U.S. jurisdictions may be harmed and our results of operations would suffer.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are in the process of developing internal manufacturing capabilities for our products, but expect to remain dependent upon third-party manufacturers and suppliers, in some cases sole- or single-source suppliers, making us vulnerable to supply shortages and problems and price fluctuations, which could harm our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not currently operate manufacturing facilities for our products, and to date, have outsourced all our manufacturing operations to third parties. We are in the process of developing our first in-house manufacturing capabilities in our new product manufacturing facility in Costa Rica, which we expect, if successfully completed, will enable us to partially reduce our reliance on our third-party manufacturers and improve our long-term gross margins. In order to develop internal manufacturing expertise, we may be forced to devote greater resources and management time than anticipated, particularly in areas relating to operations, quality, regulatory, facilities and information technology. We also may encounter problems hiring and retaining the experienced scientific, quality control and manufacturing personnel needed to operate our manufacturing processes. If we experience unanticipated employee shortage or turnover in any of these areas, we may not be able to effectively manage our planned manufacturing operations and we may not achieve the operating efficiencies that we anticipate from developing these capabilities, which may negatively affect our product manufacturing processes or result in difficulties in maintaining compliance with applicable regulatory requirements. Further, we have never developed or conducted any manufacturing activities in-house, and as a result, our inexperience could exacerbate the likelihood and/or impact of any of the above factors occurring. Any such problems could seriously harm our business. Even if we are </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">successful in developing our internal manufacturing capabilities, we will continue to rely on a limited number of suppliers who manufacture and assemble certain components of our products.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The facilities used by us and third-party manufacturers to manufacture our products must be approved by the FDA and any comparable foreign regulatory authority or notified body pursuant to inspections or audits that will be conducted after we submit a PMA to the FDA or any comparable filing to a foreign regulatory authority or notified body. We do not control the manufacturing process of, and are completely dependent on, any third-party manufacturers we utilize for compliance with current Good Manufacturing Practice (cGMP) requirements or similar foreign requirements for manufacture of our products. If we or our third-party manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or any comparable foreign regulatory authority or notified body, we or they will not be able to secure and/or maintain regulatory approval or certification for use of these manufacturing facilities. In addition, we have no control over the ability of third-party manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or any comparable foreign regulatory authority or notified body does not approve or certify these facilities for the manufacture of our products or if it withdraws any such approval or certification in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval or certification for or market our products. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals or certifications, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, our suppliers may encounter problems during manufacturing for a variety of reasons, including, for example, failure to follow specific protocols and procedures, failure to comply with applicable legal and regulatory requirements, equipment malfunction and environmental factors, failure to properly conduct their own business affairs and infringement of third-party intellectual property rights, any of which could delay or impede their ability to meet our requirements. Our suppliers may also encounter problems sourcing key components due to supply shortages.&#160;&#160;For example, in 2021, there is a global shortage of microchips.&#160;&#160;Should this shortage continue, our ability to produce and sell goods could be significantly impacted.&#160;&#160;Our reliance on these third-party suppliers also subjects us to other risks that could harm our business, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">third parties may threaten or enforce their intellectual property rights against our suppliers, which may cause disruptions or delays in shipment, or may force our suppliers to cease conducting business with us&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may not be able to obtain adequate supplies from one or more vendors in a timely manner or on commercially reasonable terms&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we are not a major customer of many of our suppliers, and these suppliers may therefore give other customers&#8217; needs higher priority than ours&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our suppliers, especially new suppliers, may make errors in manufacturing that could negatively affect the efficacy or safety of our products, impacting our ability to maintain our PMA approval or similar foreign approval or certification, or cause delays in shipment, impacting our ability to meet demand in the United States or international markets&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may have difficulty locating and qualifying alternative suppliers&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">switching components or suppliers, including our planned vertical integration of certain manufacturing capabilities at our new Costa Rica facility, may require product redesign and possibly submission to FDA, notified bodies or other foreign regulatory bodies, which could significantly impede or delay our commercial activities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may incur additional costs in switching from certain existing suppliers in connection with our planned build-out of our Costa Rica manufacturing facility&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">one or more of our sole- or single-source suppliers may be unwilling or unable to supply components of our products, or may supply products that do not meet our product requirements&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">other customers may use fair or unfair negotiation tactics and/or pressures to impede our use of the supplier&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the occurrence of epidemic or pandemics, such as the COVID-19 outbreak, which may cause one or more of our suppliers to close their operations either temporarily or permanently&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the occurrence of a fire, natural disaster or other catastrophe impacting one or more of our suppliers may affect their ability to deliver products to us in a timely manner&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our suppliers may encounter financial or other business hardships unrelated to our demand, which could inhibit their ability to fulfill our orders and meet our requirements.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may not be able to quickly establish additional or alternative suppliers for commercialization in the United States if necessary, in part because we may need to undertake additional activities to qualify such suppliers as required by the regulatory approval process. Similar risk may exist in foreign jurisdictions. Any interruption or delay in obtaining products from our third-party suppliers, or our inability to obtain products from qualified alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to switch to competing products. Given our reliance on certain single-source suppliers, we are especially susceptible to supply shortages because we do not have alternate suppliers currently available.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We rely upon third-party, single-source, and in certain cases sole-source, suppliers for many of the components and materials used in our products, and for critical manufacturing and packaging services, and the loss of any of these suppliers could harm our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A number of the critical components used in our products are supplied to us from single-source, or in certain cases sole-source, suppliers, including leads, lead extenders, surgical leads, neurostimulator components and telemetry modules. Our ability to supply our products commercially depends, in part, on our ability to obtain a supply of these components that have been manufactured in accordance with regulatory requirements and in sufficient quantities for commercialization and clinical testing. In some cases, we have not entered into manufacturing, supply or quality agreements with our single-source and sole-source suppliers, some of which supply components critical to our products. We are not certain that our single-source or sole-source suppliers will be able to meet our demand for their products and services, either because of the nature of our agreements with those suppliers, or our limited experience with those suppliers, or due to our relative importance as a customer to those suppliers or otherwise. It may be difficult for us to assess their ability to timely meet our demand in the future based on past performance. While our suppliers have generally met our demand for their products on a timely basis in the past, they may subordinate our needs in the future to the needs of their other customers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Establishing additional or replacement suppliers for the components or processes used in Senza systems, if required, may not be accomplished quickly. If we are able to find a replacement supplier, such replacement supplier would need to be qualified and may require additional regulatory authority approval or certification, which could result in further delay. While we seek to maintain adequate inventory of the single-source or sole-source components and materials used in our products, any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders.&#160;&#160;In addition, from time to time, certain of our suppliers experience interruptions and variances in their manufacturing processes, including suppliers of our leads and batteries.&#160;&#160;Because we are reliant on these single source suppliers, we are particularly susceptible to supply shortages and, if one of our suppliers were to experience an ongoing or continued manufacturing problem, and, in particular, our leads and battery suppliers, our ability to meet our forecasted commercial demand could be materially and negatively impacted.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our third-party suppliers fail to deliver the required commercial quantities of materials, or the level of services we require, on a timely basis and at commercially reasonable prices, and we are unable to find one or more replacement suppliers capable of production at a substantially equivalent cost in substantially equivalent volumes and quality, and on a timely basis, the continued commercialization of Senza would be impeded, delayed, limited or prevented, which could harm our business, results of operations, financial condition and prospects.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we fail to properly manage our anticipated growth, our business could suffer.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To achieve our revenue goals, we must successfully increase manufacturing output to meet expected customer demand. In the future, we may experience difficulties with manufacturing yields, quality control, component supply and shortages of qualified personnel, among other problems. These problems could result in delays in product availability and increases in expenses. Any such delay or increased expense could adversely affect our ability to generate revenue.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future growth will also impose significant added responsibilities on management, including the need to identify, recruit, train and integrate additional employees. In addition, rapid and significant growth will place a strain on our administrative and operational infrastructure.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to manage our operations and growth we will need to continue to improve our operational and management controls, reporting and information technology systems and financial internal control procedures. If we are unable to manage our growth effectively, it may be difficult for us to execute our business strategy and our operating results and business could suffer.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we fail to receive access to hospital facilities, our sales may decrease.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, in order for physicians to use Senza, the hospital facilities where these physicians treat patients typically require us to enter into purchasing contracts. The process of securing a satisfactory contract can be lengthy and time-consuming and require extensive negotiations and management time. In the EU, from time to time, certain institutions require us to engage in a contract bidding process in the event that such institutions are considering making purchase commitments that exceed specified cost thresholds, which vary by jurisdiction. These processes are only open at certain periods of time, and we may not be successful in the bidding process. If we do not receive access to hospital facilities via these contracting processes or otherwise, or if we are unable to secure contracts or tender successful bids, our sales may stagnate or decrease and our operating results may be harmed. Furthermore, we may expend significant effort in these time-consuming processes and still may not obtain a purchase contract from such hospitals.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We rely in part on a small group of third-party distributors to effectively distribute our products in certain countries outside the United States.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We depend in part on medical device distributors for the marketing and sales of our products in certain territories in Europe. We depend on these distributors&#8217; efforts to market our products, yet we are unable to control their efforts completely. These distributors typically sell a variety of other, non-competing products that may limit the resources they dedicate to selling Senza. In addition, we are unable to ensure that our distributors comply with all applicable laws regarding the sale of our products. If our distributors fail to effectively market and sell Senza in full compliance with applicable laws, our operating results and business may suffer. Recruiting and retaining qualified third-party distributors and training them in our technology and product offering requires time and resources. To develop and expand our distribution, we must continue to scale and improve our processes and procedures that support our distributors. Further, if our relationship with a successful distributor terminates, we may be unable to replace that distributor without disruption to our business. If we fail to maintain positive relationships with our distributors, fail to develop new relationships with other distributors, including in new markets, fail to manage, train or incentivize existing distributors effectively, or fail to provide distributors with competitive products on attractive terms, or if these distributors are not successful in their sales efforts, our revenue may decrease and our operating results, reputation and business may be harmed.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may face product liability claims that could result in costly litigation and significant liabilities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing and marketing Senza, and clinical testing of our 10 kHz Therapy, may expose us to product liability and other tort claims. Although we have, and intend to maintain, liability insurance, the coverage limits of our insurance policies may not be adequate and one or more successful claims brought against us may have a material adverse effect on our business and results of operations. For example, in 2014, the U.S. Supreme Court declined to hear an appeal where the U.S. Court of Appeals for the Ninth Circuit ruled that the Medical Device Amendments of 1976 to the FFDCA did not preempt state laws in a product liability case involving a medical device </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">company. If other courts in the United States adopt similar rulings, we may be subject to increased litigation risk in connection with our products. Product liability claims could negatively affect our reputation, continued product sales, and our ability to obtain and maintain regulatory approval for our products.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If clinical studies for future indications do not produce results necessary to support regulatory clearance, approval or certification in the United States or elsewhere, we will be unable to commercialize our products for these indications.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical studies are necessary to support PMA applications or similar foreign applications or submissions and may be necessary to support PMA supplements or similar foreign applications or submissions for modified versions of our marketed device products. This would require the enrollment of large numbers of suitable subjects, which may be difficult to identify, recruit and maintain as participants in the clinical study. Adverse outcomes in the post-approval studies could also result in restrictions or withdrawal of approval of the PMA or similar foreign approval or certification. We will likely need to conduct additional clinical studies in the future to support new indications for our products or for approvals, clearances or certifications of new product lines, or for the approval or certification of the use of our products in some foreign countries. For example, we are currently conducting clinical studies for Senza to explore the potential for 10 kHz Therapy to treat certain chronic pain conditions, including chronic upper limb and neck pain and non-surgical refractory back pain. We will likely need to conduct additional clinical studies in the future to support regulatory approval or certification for the use of our products to treat some of these new indications. Clinical testing can take many years, is expensive and carries uncertain outcomes. The initiation and completion of any of these studies may be prevented, delayed, or halted for numerous reasons, including, but not limited to, the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA, Institutional Review Boards (IRBs), Ethics Committees, competent authorities of the EU member states or other regulatory authorities do not approve a clinical study protocol, force us to modify a previously approved protocol, or place a clinical study on hold&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">patients do not enroll in, or enroll at a lower rate than we expect, or do not complete a clinical study&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">patients or investigators do not comply with study protocols&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the FDA may disagree with our interpretation of the data from our pre-clinical studies and clinical trials, or may find the clinical trial design, conduct or results inadequate to prove safety or efficacy, and may require us to pursue additional pre-clinical studies or clinical trials, which could further delay the clearance or approval of our products and similar risk exists in foreign jurisdictions&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">patients do not return for post-treatment follow-up at the expected rate&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">patients experience serious or unexpected adverse side effects for a variety of reasons that may or may not be related to our products such as the advanced stage of co-morbidities that may exist at the time of treatment, causing a clinical study to be put on hold&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">sites participating in an ongoing clinical study withdraw, requiring us to engage new sites&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">difficulties or delays associated with establishing additional clinical sites&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">third-party clinical investigators decline to participate in our clinical studies, do not perform the clinical studies on the anticipated schedule, or perform in a manner inconsistent with the investigator agreement, clinical study protocol, good clinical practices, other FDA, IRB or Ethics Committee requirements, and other foreign regulations governing clinical studies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">third-party organizations do not perform data collection and analysis in a timely or accurate manner&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">regulatory inspections of our clinical studies or manufacturing facilities require us to undertake corrective action or suspend or terminate our clinical studies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in federal, state, or foreign governmental statutes, regulations or policies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">interim or final results are inconclusive or unfavorable as to immediate and long-term safety or efficacy&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the study design is inadequate to demonstrate safety and efficacy&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the statistical endpoints are not met.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, disruptions caused by the COVID-19 pandemic may increase the likelihood that we encounter such difficulties or delays in initiating, enrolling, conducting or completing our planned and ongoing clinical studies. Clinical failure can occur at any stage of the testing. Our clinical studies may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical or non-clinical studies in addition to those we have planned. Our failure to adequately demonstrate the safety and effectiveness of any of our devices would prevent receipt of regulatory clearance, approval or certification and, ultimately, the commercialization of that device or indication for use.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We could also encounter delays if the FDA or foreign regulatory authorities concludes that our financial relationships with investigators results in a perceived or actual conflict of interest that may have affected the interpretation of a study, the integrity of the data generated at the applicable clinical study site or the utility of the clinical study itself. Principal investigators for our clinical studies may serve as scientific advisors or consultants to us from time to time and receive cash compensation and/or equity-based awards in connection with such services. If these relationships and any related compensation to or ownership interest by the clinical investigator carrying out the study result in perceived or actual conflicts of interest, or if the FDA or foreign regulatory authorities concludes that the financial relationship may have affected interpretation of the study, the integrity of the data generated at the applicable clinical study site may be questioned and the utility of the clinical study itself may be jeopardized, which could result in the FDA or foreign regulatory authorities or notified bodies refusing to accept the data as support for our future applications. Any such delay or rejection could prevent us from commercializing any of our products currently in development.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if our products are approved in the United States, Australia and certified in the EEA, comparable regulatory authorities of additional foreign countries and/or notified bodies must also approve the manufacturing and marketing of our products in those countries. Approval or certification procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States, Australia or the EEA, including additional preclinical studies or clinical studies. Any of these occurrences may harm our business, financial condition and prospects significantly.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Even though we may generate positive data to support the use of our therapy and products for market expansion opportunities, and receive approval or certification to expand our indications for use to include additional indications, internal and external factors may make it more difficult for these additional indications and market expansion opportunities, or any other indications or other market expansion opportunities we may pursue in the future, to be commercially successful.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if we get approval or certification to expand our indications for use or generate positive data to support the use of our therapy and products for other market expansion opportunities, internal and external factors may make it more difficult for such expanded indications or uses to be commercially successful.&#160;&#160;These factors include, among others, the following: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the perceived efficacy and safety of our therapy and products for such additional indications or uses by healthcare professionals&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the scope, effectiveness and strength of product education, marketing and distribution support, including our sales and marketing team, for such new additional indications or uses&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to offer our therapy and products for such additional indications or uses for sale at competitive prices&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">education and awareness of patients, treating physicians and referring physicians concerning the use of our therapy and products for such additional indications or uses&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">sufficient third-party coverage or reimbursement for such additional indications or uses&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">natural disasters, including pandemics such as the COVID-19 pandemic, and political unrest that could inhibit our ability to promote such new indications or uses and can negatively affect product demand by creating obstacles for patients to seek treatment and undergo elective procedures&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the ability of our competitors to obtain similar approvals, such as Medtronic&#8217;s recent PDN approval, and to more successfully commercialize on such market expansion opportunities.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For example, even though we have received approval for 10 kHz Therapy for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with PDN and the management of NSRBP (intractable back pain without prior surgery and not a candidate for back surgery), we will still be required to educate patients and healthcare professionals of the benefits of our therapy and products for the treatment of PDN and NSRBP.&#160;&#160;If we are unable to successfully educate patients and healthcare professionals, including referring physicians, we will not be able to establish our 10 kHz Therapy as a viable treatment option for eligible PDN and NSRBP patients.&#160;&#160; Further, we will also be required to either engage and build, or to otherwise contract, a salesforce network to market 10 kHz Therapy for the treatment of PDN.&#160;&#160;Any such effort could be costly and time-consuming, and there can be no guarantee that it will be successful.&#160;&#160;In addition, we will also need to establish payor acceptance of 10 kHz Therapy as a treatment option within the PDN and NSRBP patient communities, a process that may not be successful and could take many years to gain broad acceptance.&#160;&#160;In addition to the foregoing factors, for our therapy for patients with NSRBP to be commercially successful it will require physicians who treat chronic back pain patients with back surgery to refer those patients to other physicians to perform an SCS procedure.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the above factors, any future indications or uses of our therapy and products we may pursue may not be successfully commercialized and as a result, our business and operating results may be harmed.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we fail to retain our key executives or recruit and hire new employees, our operations and financial results may be adversely effected while we attract other highly qualified personnel.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future success depends, in part, on our ability to continue to retain our executive officers and other key employees, and recruit and hire new employees. All of our executive officers and other employees are at-will employees, and therefore may terminate employment with us at any time with no advance notice. The replacement of any of our key personnel likely would involve significant time and costs, may significantly delay or prevent the achievement of our business objectives and may harm our business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, many of our employees have become, or will soon become, vested in a substantial amount of our stock or be able to exercise a substantial number of stock options. Our employees may be more likely to leave us if the shares they own or the shares underlying their vested options have significantly appreciated in value relative to the original purchase prices of the shares or the exercise prices of the options, or if the exercise prices of the options that they hold are significantly below the market price of our common stock. Further, our employees&#8217; ability to exercise those options and sell their stock in a public market may result in a higher than normal turnover rate.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future success also depends on our ability to retain executive officers and other key employees and attract new key employees. Many executive officers and other employees in the neuromodulation and medical device industry are subject to strict non-competition, non-solicitation and/or confidentiality agreements with their employers, including our main competitors Medtronic plc, Boston Scientific and Abbott Laboratories. Our competitors may allege breaches of, and seek to enforce, such non-competition, non-solicitation and/or confidentiality agreements or initiate litigation based on such agreements, particularly now that we have entered the U.S. market. Such litigation, whether or not meritorious, may impede our ability to attract, hire or utilize executive officers and other key employees who have been or are currently employed by our competitors.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to Intellectual Property</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We currently are, and may in the future become, involved in lawsuits to defend ourselves against intellectual property disputes, which could be expensive and time consuming, and ultimately unsuccessful, and could result in the diversion of significant resources, and hinder our ability to commercialize our existing or future products.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success depends in part on not infringing the patents or violating the other proprietary rights of others. Intellectual property disputes can be costly to defend and may cause our business, operating results and financial condition to suffer. Significant litigation regarding patent rights occurs in the medical industry. Whether merited or not, it is possible that U.S. and foreign patents and pending patent applications controlled by third parties may be alleged to cover our products. We may also face allegations that our employees have misappropriated the intellectual property rights of their former employers or other third parties. For example, on December 9, 2016, Boston Scientific filed a patent infringement lawsuit alleging our manufacture, use and sale of the Senza system infringes certain of Boston Scientific&#8217;s patents covering technology related to stimulation leads, batteries and telemetry units. O<span style="color:#000000;">n April 27, 2018, Boston Scientific filed a second lawsuit alleging patent infringement, theft of trade secrets, and tortious interference with contract. </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial investments in patent portfolios and competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit, or otherwise interfere with our ability to make, use, sell, and/or export our products. For example, our major competitors, Medtronic, Boston Scientific and Abbott Laboratories, each have significant patent portfolios covering systems, sub-systems, methods, and manufacturing processes. These competitors may have one or more patents for which they can threaten and/or initiate patent infringement actions against us and/or any of our third-party suppliers. Our ability to defend ourselves and/or our third-party suppliers may be limited by our financial and human resources, the availability of reasonable defenses, and the ultimate acceptance of our defenses by the courts or juries. Further, if such patents are successfully asserted against us, this may result in an adverse impact on our business, including injunctions, damages and/or attorneys&#8217; fees. From time to time and in the ordinary course of business, we may develop non-infringement and/or invalidity positions with respect to third-party patents, which may or not be ultimately adjudicated as successful by a judge or jury if such patents were asserted against us.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may receive in the future, particularly as a public company, communications from patent holders, including non-practicing entities, alleging infringement of patents or other intellectual property rights or misappropriation of trade secrets, or offering licenses to such intellectual property. Any claims that we assert against perceived infringers could also provoke these parties to assert counterclaims against us alleging that we infringe their intellectual property rights. At any given time, we may be involved as either a plaintiff or a defendant in a number of patent infringement actions, the outcomes of which may not be known for prolonged periods of time. We may also become involved in disputes with others regarding the ownership of intellectual property rights. For example, we jointly develop intellectual property with certain parties, and disagreements may therefore arise as to the ownership of the intellectual property developed pursuant to these relationships. If we are unable to resolve these disputes, we could lose valuable intellectual property rights.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The large number of patents, the rapid rate of new patent applications and issuances, the complexities of the technologies involved and the uncertainty of litigation significantly increase the risks related to any patent litigation. Any potential intellectual property litigation also could force us to do one or more of the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">stop selling, making, using, or exporting products that use the disputed intellectual property&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">obtain a license from the intellectual property owner to continue selling, making, exporting, or using products, which license may require substantial royalty payments and may not be available on reasonable terms, or at all&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">incur significant legal expenses&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">pay substantial damages or royalties to the party whose intellectual property rights we may be found to be infringing, potentially including treble damages if the court finds that the infringement was willful&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">if a license is available from a third-party, we may have to pay substantial royalties, upfront fees or grant cross-licenses to intellectual property rights for our products and services&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="color:#000000;">pay the attorney fees and costs of litigation to the party whose intellectual property rights we may be found to be infringing&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">find non-infringing substitute products, which could be costly and create significant delay due to the need for prior FDA authorization&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">find alternative supplies for infringing products or processes, which could be costly and create significant delay due to the need for FDA regulatory clearance&#59; and/or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">redesign those products or processes that infringe any third-party intellectual property, which could be costly, disruptive, and/or infeasible.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, we may be subject to legal proceedings and claims with respect to intellectual property.<span style="color:#000000;">&#160;&#160;</span>For more information regarding our ongoing litigation with Boston Scientific, see the section titled &#8220;Legal Proceedings&#8221; included under Part I, Item&#160;3 of this Annual Report. Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, that we do not control. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock and the value of the 2025 Notes. Additionally, because we often do not control the timing of the public announcements, there is the potential for these announcements to be made during market hours, necessitating a halt in the trading of our common stock for periods of time.&#160;&#160;Finally, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If any of the foregoing occurs, we may have to withdraw existing products from the market or may be unable to commercialize one or more of our products, all of which could have a material adverse effect on our business, results of operations and financial condition. Any litigation or claim against us, even those without merit, may cause us to incur substantial costs, and could place a significant strain on our financial resources, divert the attention of management from our core business and harm our reputation. Further, as the number of participants in the neuromodulation industry grows, the possibility of intellectual property infringement claims against us increases.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we may indemnify our customers, suppliers and international distributors against claims relating to the infringement of the intellectual property rights of third parties relating to our products, methods, and/or manufacturing processes. Third parties may assert infringement claims against our customers, suppliers, or distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers, suppliers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers, suppliers, or distributors or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our products, or our suppliers may be forced to stop providing us with products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Similarly, interference or derivation proceedings provoked by third parties or brought by the USPTO or any foreign patent authority may be necessary to determine the priority of inventions or other matters of inventorship with respect to our patents or patent applications. An unfavorable outcome in these or any other such proceedings could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms, if any license is offered at all.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may also become involved in other proceedings, such as re-examination or opposition proceedings, before the USPTO or its foreign counterparts relating to our intellectual property or the intellectual property rights of others. For example, two of our competitors, Boston Scientific and Medtronic, have filed oppositions in the EU with respect to certain of our patents. Boston Scientific has filed an entitlement action against us in the German courts. In addition, an anonymous petitioner has filed an opposition before the China National Intellectual Property Administration against one of our patents in China (which was dismissed, but for which the anonymous petitioner has filed an appeal). Defending our position in proceedings such as these will require management&#8217;s time and attention, as well as financial costs. Given the competitive environment in which we operate, we expect additional </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">challenges to our intellectual property portfolio as we continue commercialization of Senza in the United States and abroad. An unfavorable outcome in these or any other such proceedings could cause us to lose valuable intellectual property rights and/or be unable to enforce our intellectual property rights, which could invite increased competition thereby materially harming our business.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Changes in patent law could diminish the value of patents in general, thereby impairing our ability to protect our existing and future&#160;products.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents. On September&#160;16, 2011, the Leahy-Smith America Invents Act (the Leahy-Smith Act) was signed into law. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications are prosecuted, redefine prior art and may affect patent litigation. The changes also switched the United States patent system from a &#8220;first-to-invent&#8221; system to a &#8220;first-to-file&#8221; system. Under a &#8220;first-to-file&#8221; system, assuming the other requirements for patentability are met, the first inventor to file&#160;a patent application generally will be entitled to the patent on an invention regardless of whether another inventor had made the invention earlier. The USPTO recently developed new regulations and procedures to govern administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, in particular, the first-to-file provisions, only became effective on March&#160;16, 2013. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. The Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business and financial condition.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, patent reform legislation may pass in the future that could lead to additional uncertainties and increased costs surrounding the prosecution, enforcement and defense of our patents and applications. Furthermore, the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit have made, and will likely continue to make, changes in how the patent laws of the United States are interpreted. Similarly, foreign courts have made, and will likely continue to make, changes in how the patent laws in their respective jurisdictions are interpreted. We cannot predict future changes in the interpretation of patent laws or changes to patent laws that might be enacted into law by United States and foreign legislative bodies. Those changes may materially affect our patents or patent applications and our ability to obtain additional patent protection in the future.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our competitors or are in breach of non-competition or non-solicitation agreements with our competitors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We could in the future be subject to claims that we or our employees have inadvertently or otherwise used or disclosed alleged trade secrets or other proprietary information of former employers or competitors. In addition, many of our executive officers and key employees have worked for our major competitors (or companies acquired by these competitors), which include Boston Scientific, Medtronic and Abbott Laboratories. Although we have procedures in place that seek to prevent our employees and consultants from using the intellectual property, proprietary information, know-how or trade secrets of others in their work for us, we may in the future be subject to claims that we caused an employee to breach the terms of his or her non-competition or non-solicitation agreement, or that we or these individuals have, inadvertently or otherwise, used or disclosed the alleged trade secrets or other proprietary information of a former employer or competitor. Litigation may be necessary to defend against these claims. For example, in April 2018, Boston Scientific filed such suit against us, claiming trade secret misappropriation.&#160;&#160;While we believe the Boston Scientific claim lacks merit, even if we are successful in defending against the Boston Scientific claim or any other such claims, litigation necessarily results in substantial costs and could be a distraction to management. If our defense to litigation claims fails, in addition to paying monetary damages, a court could prohibit us from using technologies or features that are essential to our products, if such technologies or features are found to incorporate or be derived from the trade secrets or other proprietary information of the former employers. An inability to incorporate technologies or features that are important or essential to our products would have a material adverse effect on our business, and may prevent us from selling our products or from practicing our processes. In addition, we may lose valuable intellectual property rights or personnel. Moreover, any such litigation or the threat thereof may adversely affect our ability to hire employees or contract with independent sales representatives. A loss of key personnel or their work product could hamper or </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">prevent our ability to commercialize our products, which could have an adverse effect on our business, results of operations and financial condition.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position may be harmed.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to patent and trademark protection, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect our trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our consultants and vendors, or our former or current employees. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these efforts, however, any of these parties may breach the agreements and disclose our trade secrets and other unpatented or unregistered proprietary information, and once disclosed, we are likely to lose trade secret protection. Monitoring unauthorized uses and disclosures of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our intellectual property will be effective. In addition, we may not be able to obtain adequate remedies for any such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to enforce trade secret protection.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further, our competitors may independently develop knowledge, methods and know-how similar, equivalent, or superior to our proprietary technology. Competitors could purchase our products and attempt to replicate some or all of the competitive advantages we derive from our development efforts, willfully infringe our intellectual property rights, design around our protected technology or develop their own competitive technologies that fall outside of our intellectual property rights. In addition, our key employees, consultants, suppliers or other individuals with access to our proprietary technology and know-how may incorporate that technology and know-how into projects and inventions developed independently or with third parties. As a result, disputes may arise regarding the ownership of the proprietary rights to such technology or know-how, and any such dispute may not be resolved in our favor. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us and our competitive position could be adversely affected. If our intellectual property is not adequately protected so as to protect our market against competitors&#8217; products and methods, our competitive position could be adversely affected, as could our business.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to our Financial and Operating Results</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our operating results may vary significantly from quarter to quarter, which may negatively impact our stock price in the future.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our quarterly revenue and results of operations may fluctuate from quarter to quarter due to, among others, the following reasons:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">effects of the ongoing COVID-19 pandemic, including, among others, surges of cases related to new variants, suspensions of non-essential or elective procedures to reduce non-critical hospitalizations, reduced demand for elective procedures and delays in trials and permanent implants&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">physician and payor acceptance of our products and 10 kHz Therapy&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our success in initiating patient trials for the 10 kHz Therapy and converting those trials into permanent implants&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to develop and grow the SCS market by convincing physicians and patients to use our therapy to treat PDN and NSRBP, and convincing payors to cover such procedures&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the effectiveness of the development of new markets for SCS, including PDN and NSRBP&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fluctuations in our expenses associated with inventory buildup or write-downs from analyzing our inventory for obsolescence or conformity with our product requirements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fluctuations in the average sales prices of our products, in particular due to pricing pressure from competitors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fluctuations in the expenses related to initiating, pursuing and defending lawsuits&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">buying patterns of our customers&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the timing, expense and results of our commercialization efforts in the United States and elsewhere, R&#38;D activities, clinical studies and regulatory approvals or certifications&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the introduction of new products and technologies by our competitors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the productivity of our sales representatives&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">difficulties in collecting receivables related to our sales in the United States&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fluctuations in expenses as a result of expanding our commercial operations and operating as a public company&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">supplier, manufacturing or quality problems with our products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in our pricing policies or strategies or in the pricing policies or strategies of our competitors&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in coverage amounts or government and third-party payors&#8217; reimbursement policies&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">market volatility impacted by the COVID-19 pandemic</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of these and other factors, it is likely that in some future period our operating results will not meet investor expectations or those of public market analysts.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any unanticipated change in revenues or operating results is likely to cause our stock price to fluctuate. New information may cause investors and analysts to revalue our business, which could cause a decline in our stock price.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may choose, or need, to obtain additional funds in the future, and these funds may not be available on acceptable terms or at all.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our operations have consumed substantial amounts of cash since inception, and we anticipate our expenses will increase as we continue to build a commercial sales force in the United States, including for our recently </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">approved indications of PDN and NSRBP</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, investigate the use of our </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 kHz</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">herapy for the treatment of other chronic pain conditions, continue to otherwise grow our business, including potentially acquiring other businesses or technologies, manage the maturity of the 2025 Notes, and continue to operate as a public company. In particular, we believe that we will continue to expend substantial resources for the foreseeable future on the commercialization of Senza in the United States, as well as the growth of our sales and marketing efforts and sales representative training, seeking additional foreign regulatory approvals</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or certifications</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the preparation and submission of regulatory filings and the clinical development of any other product candidates or indications we may choose to pursue. These expenditures will also include costs associated with manufacturing and supply as well as marketing and selling Senza in the United States and elsewhere, and any other future products approved for sale, R&#38;D, conducting preclinical studies and clinical </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">studies</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and obtaining regulatory approvals</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or certifications</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that our growth will depend, in part, on our ability to fund our commercialization efforts, particularly in the United States, and our efforts to develop our Senza systems and 10 kHz Therapy for the treatment of additional chronic pain indications and develop technology complementary to our current product. In order to further enhance our R&#38;D efforts, pursue product expansion opportunities or acquire a new business or products that are complementary to our business, we may choose to seek additional funds. If we are unable to raise funds on favorable terms, or at all, the long-term growth of our business may be negatively impacted. As a result, we may be unable to compete effectively. Our cash requirements in the future may be significantly different from our current estimates and depend on many factors, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the costs of commercializing our products in the United States and elsewhere, including costs associated with product sales, marketing, manufacturing and distribution&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to maintain the average sales price of our products, in particular if we face pricing pressure from competitors&#8217; products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights, including, in particular, the costs of enforcing our patent rights in the action we filed against Boston Scientific and in defending against Boston Scientific&#8217;s action against us&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the R&#38;D activities we intend to undertake in order to expand the chronic pain indications and product enhancements that we intend to pursue&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">whether or not we pursue acquisitions or investments in businesses, products or technologies that are complementary to our current business&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the degree and rate of market acceptance of our products in the United States and elsewhere&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes or fluctuations in our inventory supply needs and forecasts of our supply needs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our need to implement additional infrastructure and internal systems&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to hire additional personnel to support our operations as a public company&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the emergence of competing technologies or other adverse market developments.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To finance these activities, we may seek funds through borrowings or through additional rounds of financing, including private or public equity or debt offerings and collaborative arrangements with corporate partners. We may be unable to raise funds on favorable terms, or at all.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The sale of additional equity or convertible debt securities could result in additional dilution to our stockholders. If we borrow additional funds or issue debt securities, these securities could have rights superior to holders of our common stock and the 2025 Notes, and could contain covenants that will restrict our operations. We might have to obtain funds through arrangements with collaborative partners or others that may require us to relinquish rights to our technologies, product candidates, or products that we otherwise would not relinquish. If we do not obtain additional resources, our ability to capitalize on business opportunities will be limited, we may be unable to compete effectively and the growth of our business will be harmed.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are required to maintain high levels of inventory, which could consume a significant amount of our resources, reduce our cash flows and lead to inventory impairment charges.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the need to maintain substantial levels of inventory, we are subject to the risk of inventory obsolescence and expiration, which may lead to inventory impairment charges. Our products consist of a substantial number of individual components. In order to market and sell Senza effectively, we often must maintain high levels of inventory. In particular, as we continue to market and sell Senza in the United States, we intend to maintain our high levels of inventory in order to meet our estimated demand and, as a result, incur significant expenditures associated with such levels of inventory. The manufacturing process requires lengthy lead times, during which components of our products may become obsolete, and we may over- or underestimate the amount needed of a given component, in which case we may expend extra resources or be constrained in the amount of end product that we can produce. As compared to direct manufacturers, our dependence on third-party manufacturers exposes us to greater lead times increasing our risk of inventory obsolescence comparatively, and we would be required to record an impairment charge, as we did in the first quarter of 2019 and the second quarter of 2020. Furthermore, our products have a limited shelf life due to sterilization requirements, and part or all of a given product or component may expire and its value would become impaired. We have also experienced inventory write-downs as a result of inventory that did not meet our product requirements. In addition, as we release later generations of products that contain advancements or additional features, the earlier generations may become obsolete. If our estimates of required inventory are too high, we may be exposed to further inventory obsolescence risk. In the event that a substantial portion of our inventory becomes obsolete or expires, or in the event we experience a supply chain imbalance as described above, it could have a material adverse effect on our earnings and cash flows due to the resulting costs associated with the inventory impairment charges and costs required to replace such inventory.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The seasonality of our business creates variance in our quarterly revenue, which makes it difficult to compare or forecast our financial results.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our revenue fluctuates on a seasonal basis, which affects the comparability of our results between periods. For example, due to the seasonality of buying patterns and implant volumes of distributors, hospitals and clinics, the industry generally experiences lower revenues in the first and third quarters of the year and higher revenues in the fourth quarter. We have experienced these industry trends to a greater degree than in our initial U.S. commercial launch phase, although normal purchasing patterns have been disrupted since the COVID-19 pandemic. These seasonal variations are difficult to predict accurately, may vary amongst different markets, and at times may be entirely unpredictable, which introduce additional risk into our business as we rely upon forecasts of customer demand to build inventory in advance of anticipated sales.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are subject to risks associated with currency fluctuations, and changes in foreign currency exchange rates could impact our results of operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A portion of our business is located outside the United States and, as a result, we generate revenue and incur expenses denominated in currencies other than the U.S. dollar, a majority of which is denominated in Euros, British Pounds and Australian Dollars. As a result, changes in the exchange rates between such foreign currencies and the U.S. dollar could materially impact our reported results of operations and distort period to period comparisons. Fluctuations in foreign currency exchange rates also impact the reporting of our receivables and payables in non-U.S. currencies. As a result of such foreign currency fluctuations, it could be more difficult to detect underlying trends in our business and results of operations. In addition, to the extent that fluctuations in currency exchange rates cause our results of operations to differ from our expectations or the expectations of our investors, the trading price of our common stock and the value of the 2025 Notes could be adversely affected.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the future, we may engage in exchange rate hedging activities in an effort to mitigate the impact of exchange rate fluctuations. If our hedging activities are not effective, changes in currency exchange rates may have a more significant impact on our results of operations.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our ability to use our net operating losses and tax credits to offset future taxable income and taxes may be subject to certain limitations.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In general, under Section&#160;382 of the U.S. Internal Revenue Code of 1986, as amended (the Code), a corporation that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to utilize its pre-change net operating loss (NOL) carryforwards and other tax attributes, such as research and development tax credits, to offset post-change taxable income and taxes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of our June 2015 underwritten public offering, we have experienced a Section&#160;382 &#8220;ownership change.&#8221; We currently believe that this &#8220;ownership change&#8221; will not inhibit our ability to utilize our NOLs prior to expiration.&#160;&#160;However, we may experience additional ownership changes as a result of subsequent changes in our stock ownership, some of which changes may be outside our control.&#160;&#160;As a result, we may not be able to utilize a material portion of our NOLs and tax credits, even if we achieve profitability and generate sufficient taxable income in the future. If we are limited in our ability to use our NOLs and tax credits in future years as a result of ownership changes, we will pay more taxes than if we were able to fully utilize our NOLs and tax credits. This could materially and adversely affect our results of operations. As of December&#160;31, 2021, we had federal NOLs of $588.4 million, of which $329.4 million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the Tax Cuts and Jobs Act (the 2017 Tax Act), as well as state NOLs of $336.5 million, of which $54.3 million may be carried forward indefinitely.&#160;&#160;If not utilized, the remaining federal NOLs will begin to expire in 2026 and the state NOLs will begin to expire in 2022.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to Regulation of our Industry</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Senza is subject to extensive governmental regulation, and our failure to comply with applicable requirements could cause our business to suffer.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The medical device industry is regulated extensively by governmental authorities, principally the FDA and corresponding state and foreign regulatory agencies and authorities, such as the competent authorities of the EU member states. The FDA and other U.S. and foreign governmental agencies and authorities and notified bodies regulate and oversee, among other things, with respect to medical devices:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">design, development and manufacturing&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">testing, labeling, content and language of instructions for use and storage&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">clinical studies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">product safety&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">marketing, sales and distribution&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">pre-market regulatory clearance, approval and certification&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">conformity assessment procedures&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">record-keeping procedures&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">advertising and promotion&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">recalls and other field safety corrective actions&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">post-market studies&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">product import and export.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The laws and regulations to which we are subject are complex and have tended to become more stringent over time. Legislative or regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our failure to comply with U.S. federal and state regulations or other foreign regulations applicable in the countries where we operate could lead to the issuance of warning letters or untitled letters, the imposition of injunctions, suspensions </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or loss of regulatory clearance, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">approvals</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or certifications</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, product recalls, termination of distribution, product seizures or civil penalties. In the most extreme cases, criminal sanctions or closure of our manufacturing facilities are possible. If any of these risks materialize, our business would be adversely affected.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our business is subject to extensive governmental regulation that could make it more expensive and time consuming for us to expand the potential indications for which Senza is approved or certified or introduce new or improved products.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our products must comply with regulatory requirements imposed by the FDA in the United States and similar agencies or bodies in foreign jurisdictions. These requirements involve lengthy and detailed laboratory and clinical testing procedures, sampling activities, extensive agency review processes or notified bodies review processes, and other costly and time-consuming procedures. It often takes several years to satisfy these requirements, depending on the complexity and novelty of the product. We also are subject to numerous additional licensing and regulatory requirements relating to safe working conditions, manufacturing practices, environmental protection, fire hazard control and disposal of hazardous or potentially hazardous substances. Some of the most important requirements we must comply with include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">FFDCA and the FDA&#8217;s implementing regulations (Title&#160;21&#160;CFR)&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">EU legislation on medical devices&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Medical Device Quality Management System Requirements (ISO&#160;13485:2016)&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Occupational Safety and Health Administration requirements&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">California Department of Health Services requirements.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government regulation may impede our ability to conduct clinical studies and to manufacture and sell our existing and future products. Government regulation also could delay our marketing of new products for a considerable period of time and impose costly procedures on our activities. Foreign regulatory agencies or notified bodies may not approve or certify Senza and any of our future products on a timely basis, if at all. Any delay in obtaining, or failure to obtain, such approvals or certifications could negatively impact our marketing of any future products and reduce our product revenues.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our products remain subject to strict regulatory controls on manufacturing, marketing and use. We may be forced to modify or recall a product after release in response to regulatory action or unanticipated difficulties encountered in general use. Any such action could have a material effect on the reputation of our products and on our business and financial position.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further, regulations may change, and any additional regulation could limit or restrict our ability to use any of our technologies, which could harm our business. We could also be subject to new international, federal, state or local regulations that could affect our R&#38;D programs and harm our business in unforeseen ways. If this happens, we may have to incur significant costs to comply with such laws and regulations, which will harm our results of operations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad. For example, the results of the 2020 Presidential election may impact our business and industry.&#160;&#160;Namely, the previous presidential administration took several executive actions, including the issuance of a number of Executive Orders, that could impose significant burdens on, or otherwise materially delay, the FDA&#8217;s ability to engage in routine regulatory and oversight activities such as implementing statutes through rulemaking, issuance of guidance, and review and approval of marketing applications.&#160;&#160;It is difficult to predict whether or how these Executive Orders will be implemented, or whether they will be rescinded and replaced under the Biden administration.&#160;&#160;The policies and priorities of an incoming presidential administration are unknown and could materially impact the regulations governing our products.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For</span><span style="color:#000000;"> instance, </span><span style="color:#000000;">the EU landscape concerning medical devices recently evolved. On May 25, 2017, the EU Medical Devices Regulation</span><span style="color:#000000;"> entered into force, which repeals and </span><span style="color:#000000;">replaces the EU Medical Devices Directive</span><span style="color:#000000;"> and the EU Active Implantable Medical Devices Directive</span><span style="color:#000000;">. Unlike directives, which must be implemented</span><span style="color:#000000;"> into the national laws of the EU member states, regulations are directly applicable (i.e., without the need for adoption of EU member state laws implementing them) in all EU member states and are intended to eliminate current differences in the regulation of medical devices among EU member states. Devices lawfully placed on the market pursuant to the EU Medical Devices Directive</span><span style="color:#000000;"> </span><span style="color:#000000;">or EU Active Implantable Medical Devices Directive</span><span style="color:#000000;"> prior to May 26, 2021 may generally continue to be made available on the market or put into service until May 26, 2025, provided that the requirements of the transitional provisions are fulfilled. In particular, the certificate in question must still be valid. However, even in this case, manufacturers must comply with a number of new or reinforced requirements set forth in the EU Medical Devices Regulation with regard to registration of economic operators and of devices, post-market surveillance, market surveillance and vigilance requirements.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-<span style="color:#000000;">compliance</span> with the EU Medical Devices Regulation may affect our business or the way we intend to conduct our business in the EU. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aforementioned EU rules are generally applicable in the EEA. Non-compliance with the above requirements would also prevent us from selling our products in these three countries.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Senza is subject to extensive governmental regulation in foreign jurisdictions, such as Europe, and our failure to comply with applicable requirements could cause our business to suffer.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the transitional provisions and in order to sell our products in EU member states, our products must comply with the general safety and performance requirements of the EU Medical Devices Regulation, which repeals and replaces EU Medical Devices Directive and the EU Active Implantable Medical Devices Directive. Compliance with these requirements is a prerequisite to be able to affix the European Conformity (CE) mark to our products, without which they cannot be sold or marketed in the EU. All medical devices placed on the market in the EU must meet the general safety and performance requirements laid down in Annex I to the EU Medical Devices Regulation including the requirement that a medical device must be designed and manufactured in such a way that, during normal conditions of use, it is suitable for its intended purpose. Medical devices must be safe and effective and must not compromise the clinical condition or safety of patients, or the safety and health of users and &#8211; where applicable &#8211; other persons, provided that any risks which may be associated with their use constitute acceptable risks when weighed against the benefits to the patient and are compatible with a high level of protection of health and safety, taking into account the generally acknowledged state of the art. To demonstrate compliance with the general safety and performance requirements, we must undergo a conformity assessment procedure, which varies according to the type of medical device and its (risk) classification. Except for low risk medical devices (Class I), where the manufacturer can self-assess the conformity of its products with the general safety and performance requirements (except for any parts which relate to sterility, metrology or reuse aspects), a conformity assessment procedure requires the intervention of a notified body. The notified body would typically audit and examine the technical file and the quality system for the manufacture, design and final inspection of our devices. If satisfied that the relevant product conforms to the relevant general safety and performance requirements, the notified body issues a certificate of conformity, which the manufacturer uses as a basis for its own declaration of conformity. The manufacturer may then apply the CE mark to the device, which allows the device to be placed on the market throughout the EU. If we fail to comply with applicable laws and regulations, we would be unable to affix the CE mark to our products, which would prevent us from selling them within the EU.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following a national referendum and enactment of legislation by the government of the United Kingdom (UK), the UK formally withdrew from the EU and ratified a trade and cooperation agreement governing its relationship with the EU. The EU&#8211;UK Trade and Cooperation Agreement (TCA) was applied provisionally as of January 1, 2021 and entered into force on May 1, 2021. The TCA does not specifically refer to medical devices. However, as a result of Brexit, the EU Medical Devices Regulation will not be implemented in the UK, and previous legislation that sought to mirror the EU Medical Devices Regulation in the UK law has been revoked. The regulatory regime for medical devices in Great Britain (England, Scotland and Wales) continues to be based on the requirements derived from previous EU legislation, and the UK may choose to retain regulatory flexibility or align with the EU Medical Devices Regulation going forward. CE markings will continue to be recognized in the UK, and certificates issued by EU-recognized notified bodies will be valid in the UK, until June 30, 2023. For medical </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">devices placed on the market in Great Britain after this period, the UK Conformity Assessed (UCKA) marking will be mandatory. In contrast, UKCA marking and certificates issued by UK notified bodies will not be recognized on the EU market. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UK-based notified bodies, which were designated to independently assess the conformity of certain products requiring CE marking before being placed on the EU market, are no longer established in the EU, and accordingly, the conformity assessments carried out by such UK</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> notified</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> bodies, including those assessments carried out prior to 1 January 2021, are no longer valid for the EU compliance regime. Manufacturers whose products currently rely on third-party conformity assessments carried out by UK notified bodies require new conformity assessments to be carried out by EU-based notified bodies in order to ensure continuing compliance with the EU regime and to continue to place t</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hose products on the EU market. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The TCA does provide for cooperation and exchange of information in the area of product safety and compliance, including market surveillance, enforcement activities and measures, standardization related activities, exchanges of officials, and coordinated product recalls (or other similar actions). For medical devices that are locally manufactured but use components from other countries, the &#8220;rules of origin&#8221; criteria will need to be reviewed. Depending on which countries products will be ultimately sold in, manufacturers may start seeking alternative sources for components if this would allow them to benefit from no tariffs. The rules for placing medical devices on the Northern Ireland market will differ fro</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">m those in Great Britain.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to continue to sell Senza in Europe, we must maintain our certification and continue to comply with EU legislation and also the UK legislation. Our failure to continue to comply with applicable foreign regulatory requirements, including those administered by authorities of the EU member states or the MHRA, could result in enforcement actions against us, including refusal, suspension or withdrawal of our certificates issued by our notified bodies, which could impair our ability to market products in the Europe in the future.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we are subject to the EU General Data Protection Regulation (GDPR), which imposes obligations on companies that operate in our industry with respect to the processing of personal data of individuals within the EEA and the cross-border transfer of such data. The GDPR imposes onerous accountability obligations requiring data controllers and processors to maintain a record of their data processing and policies. If our or our partners&#8217; or service providers&#8217; privacy or data security measures fail to comply with the GDPR requirements, we may be subject to litigation, regulatory investigations, enforcement notices requiring us to change the way we use personal data and/or fines of up to 20 million Euros or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher, as well as compensation claims by affected individuals, negative publicity, reputational harm and a potential loss of business and goodwill. Data privacy laws in the EU are developing rapidly and, in July 2020, the Court of Justice of the EU limited how organizations could lawfully transfer personal data from the EEA to the United States by invalidating the Privacy Shield and imposing further restrictions on use of the standard contractual clauses, which could increase our costs and our ability to efficiently process personal data from the EEA.&#160;&#160;Further, from January 1, 2021, companies have had to comply with the GDPR and the GDPR as incorporated into the UK national law, with each regime having the ability to fine up to the greater of &#8364;20 million/ &#163;17.5 million or 4% of global turnover. The relationship between the UK and the EU in relation to certain aspects of data protection law remains unclear and it is unclear how UK data protection laws and regulations will develop in the medium to longer term. These changes may lead to additional costs and increase our overall risk exposure. On June 28, 2021, the European Commission adopted an adequacy decision in favor of the United Kingdom, enabling data transfers from member states in the EU to the United Kingdom without additional safeguards. However, the United Kingdom adequacy decision will automatically expire in June 2025 unless the European Commission renews or extends that decision and remains under review by the Commission during this period.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the EU, according to the EU Medical Devices Regulation, only devices that are CE marked may be marketed and advertised in the EU in accordance with their intended purpose. We are also subject to Directive 2006/114/EC concerning misleading and comparative advertising, and Directive 2005/29/EC on unfair commercial practices, as well as other EU member state legislation governing the advertising and promotion of medical devices. EU member state legislation may also restrict or impose limitations on our ability to advertise our products directly to the general public. In addition, voluntary EU and national Codes of Conduct provide guidelines on the advertising and promotion of our products and may impose limitations on our promotional activities with healthcare professionals.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aforementioned EU rules are generally applicable in the EEA. Non-compliance with the above requirements would also affect our business in these three countries.&#160;&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The misuse or off-label use of our product may harm our image in the marketplace, result in injuries that lead to product liability suits, which could be costly to our business, or result in costly investigations and sanctions from the FDA and other regulatory bodies if we are deemed to have engaged in off-label promotion.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senza has been approved for marketing in the United States, certified in the EU and approved by the TGA in Australia for specific treatments and anatomies. We may only promote or market the Senza SCS system for its specifically approved indications as described on the approved label. We train our marketing and sales force against promoting our products for uses outside of the approved indications for use, known as &#8220;off-label uses.&#8221; We cannot, however, prevent a physician from using our product off-label, when in the physician&#8217;s independent professional medical judgement he or she deems the use of the product in the non-approved indication as appropriate. There may be increased risk of injury to patients if physicians attempt to use our product off-label. Furthermore, the use of our product for indications other than those approved or certified by the applicable regulatory authority or notified body may not effectively treat such conditions, which could harm our reputation in the marketplace among physicians and patients.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Physicians may also misuse our product or use improper techniques if they are not adequately trained, potentially leading to injury and an increased risk of product liability. If our product is misused or used with improper technique, we may become subject to costly litigation by our customers or their patients. Product liability claims could divert management&#8217;s attention from our core business, be expensive to defend, and result in sizable damage awards against us that may not be covered by insurance. In addition, if the FDA or foreign regulatory authorities determines that our promotional materials, training or physician support activities constitute promotion of an off-label use, it could request that we modify our training, promotional materials or physician support activities or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties, including, but not limited to, criminal, civil and/or administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, and the curtailment of our operations. Further, regulators or legislators may also enhance the enforcement of, and attempt to curtail, any off-label use by physicians of medical devices in the future. Any of these events could significantly harm our business and results of operations and cause our stock price to decline.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our products may in the future be subject to notifications, recalls, or voluntary market withdrawals that could harm our reputation, business and financial results.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA, competent authorities of the EU member states and similar foreign governmental authorities have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture that could affect patient safety. In the case of the FDA, the authority to require a recall must be based on an FDA finding that there is a reasonable probability that the device would cause serious adverse health consequences or death. Manufacturers may, under their own initiative, conduct a product notification or recall to inform physicians of changes to instructions for use, or if a deficiency in a device is found or suspected. A government-mandated recall or voluntary recall by us or one of our distributors could occur as a result of component failures, manufacturing errors, design or labeling defects or other issues. Recalls, which include certain notifications and corrections as well as removals, of Senza could divert managerial and financial resources and could have an adverse effect on our financial condition, harm our reputation with customers, and reduce our ability to achieve expected revenue.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the manufacturing of our products is subject to extensive post-market regulation by the FDA and foreign regulatory authorities, and any failure by us or our contract manufacturers or suppliers to comply with regulatory requirements could result in recalls, facility closures, and other penalties. We and our suppliers and contract manufacturers are subject to the Quality System Regulation (QSR), and comparable foreign regulations which govern the methods used in, and the facilities and controls used for, the design, manufacture, quality assurance, labeling, packaging, sterilization, storage, shipping, and servicing of medical devices. These regulations are enforced through periodic inspections or audits of manufacturing facilities. Any manufacturing issues at our or our suppliers&#8217; or contract manufacturers&#8217; facilities, including failure to comply with regulatory requirements, may result in warning or untitled letters, manufacturing restrictions, voluntary or mandatory recalls or corrections, fines, </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">withdrawals of regulatory clearances</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> approvals</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or certifications</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, product seizures, injunctions, or the imposition of civil or criminal penalties, which would adversely affect our business results and prospects.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are required to report certain malfunctions, deaths, and serious injuries associated with our products, which can result in voluntary corrective actions or agency enforcement actions.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the FDA medical device reporting regulations, medical device manufacturers are required to submit information to the FDA when they receive a report or become aware that a device has or may have caused or contributed to a death or serious injury or has or may have a malfunction that would likely cause or contribute to death or serious injury if the malfunction were to recur. All manufacturers placing medical devices on the market in the EU are legally bound to report serious incidents and Field Safety Corrective Actions (FSCAs) involving devices they produce or sell to the relevant authorities of the EU member states, in whose jurisdiction the incident occurred.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Malfunction of our products could result in future voluntary corrective actions, such as recalls, including corrections, or customer notifications, or agency action, such as inspection or enforcement actions. If malfunctions do occur, we may be unable to correct the malfunctions adequately or prevent further malfunctions, in which case we may need to cease manufacture and distribution of the affected products, initiate voluntary recalls, and redesign the products. Regulatory authorities may also take actions against us, such as ordering recalls, imposing fines, or seizing the affected products. Any corrective action, whether voluntary or involuntary, will require the dedication of our time and capital, distract management from operating our business, and may harm our reputation and financial results.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">A recall of our products, either voluntarily or at the direction of the FDA or another governmental authority, or the discovery of serious safety issues with our products, could have a significant adverse impact on us.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA and similar foreign governmental authorities such as the relevant authorities of the EU member states have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture or in the event that a product poses an unacceptable risk to health. Manufacturers may, under their own initiative, recall a product if any material deficiency in a device is found. A government-mandated or voluntary recall by us or one of our distributors could occur as a result of an unacceptable risk to health, component failures, manufacturing errors, design or labeling defects or other deficiencies and issues. Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our reputation, results of operations and financial condition, which could impair our ability to produce our products in a cost-effective and timely manner in order to meet our customers&#8217; demands. We may also be required to bear other costs or take other actions that may have a negative impact on our future sales and our ability to generate profits.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may be subject to federal, state and foreign healthcare and data privacy and security laws and regulations, and a finding of failure to comply with such laws and regulations could have a material adverse effect on our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to healthcare fraud and abuse regulation and enforcement by federal, state and foreign governments, as well as data privacy and security laws and regulations that govern the collection, use, disclosure and protection of personal information, including health-related information, which could significantly impact our business. In the United States, the laws that may affect our ability to operate include, but are not limited to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in cash or in kind, in exchange for or to induce either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service for which payment may be made, in whole or in part, under federal healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of this statute or specific intent to violate it in order to have committed a violation&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">federal civil and criminal false claims laws, including the False Claims Act, that prohibit, among other things, knowingly presenting, or causing to be presented, claims for payment or approval to the federal government that are false or fraudulent, knowingly making a false statement material to an obligation to </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="color:#000000;">pay or transmit money or property to the federal government or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay or transmit money or property to the federal government. In addition</span><span style="color:#000000;">, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act</span><span style="color:#000000;">&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Health Insurance Portability and Accountability Act of 1996 (HIPAA), which created federal criminal laws that prohibit executing a scheme to defraud any federal healthcare benefit program or making false statements relating to healthcare matters submitted for payment. A person or entity does not need to have actual knowledge of these statutes or specific intent to violate them in order to have committed a violation&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and their respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans and healthcare clearinghouses as well as their business associates that perform services for them that involve individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization, including mandatory contractual terms as well as directly applicable privacy and security standards and requirements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the federal physician sunshine requirements under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, collectively, the ACA, which require certain manufacturers of drugs, devices, biologics, and medical supplies to report annually to the U.S. Department of Health and Human Services information related to payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain other healthcare professionals (physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists, anesthesiology assistants and certified nurse midwives), and teaching hospitals, and ownership and investment interests held by physicians and their immediate family members&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">state and foreign law equivalents of each of the above federal laws, such as state anti-kickback and false claims laws that may apply to items or services reimbursed by any third-party payor, including commercial insurers&#59; state laws that require device companies to comply with the industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources&#59; state laws that require device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures&#59; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">federal and state laws and regulations governing the collection, use, disclosure and protection of health-related and other personal information that could apply to our operations or the operations of our partners, including state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws and regulations (e.g. Section 5 of the FTC Act), that govern the collection, use, disclosure, and protection of health-related and other personal information. For example, the California Consumer Privacy Act (CCPA), which took effect on January 1, 2020, creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. Further, the California Privacy Rights Act (CPRA) recently passed in California. The CPRA will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. The majority of the provisions will go into effect on January 1, 2023, and additional compliance investment and potential business process changes may be required. The CCPA and the CPRA may increase our compliance costs and potential liability. Similar laws have been passed in Virginia and Colorado and proposed at the federal level and in other states. The legislative and regulatory landscape for privacy and </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="color:#000000;">data protection continues to evolve, and there has been an increasing focus on privacy and data protection issues, which may affect our business and is expected to increase our compliance costs and exposure to liability.&#160;&#160;In the event that we are subject to or affected by HIPAA, the CCPA, the CPRA or other domestic privacy and data protection laws, any liability from failure to comply with the requirements of these laws could adversely affect our financial condition.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Responding to investigations can be time-and resource-consuming and can divert management&#8217;s attention from the business. Additionally, as a result of these investigations, healthcare providers and entities may have to agree to additional onerous compliance and reporting requirements as part of a consent decree or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us now or in the future, we may be subject to penalties, including civil and criminal penalties, damages, fines, disgorgement, exclusion from governmental health care programs, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our financial results.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Healthcare legislative reform measures may have a material adverse effect on us.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs. In March 2010, the ACA was signed into law, which included, among other things, comparative effectiveness research initiatives and payment system reforms, including shared savings pilots and other provisions. Since its enactment, there have been judicial and Congressional challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#8217;s decision, President Biden issued an executive order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how other healthcare reform measures of the Biden administration or other efforts, if any, to challenge, repeal or replace the ACA will impact the ACA or our business. Any new limitations on, changes to, or uncertainty with respect to the ability of individuals to enroll in governmental reimbursement programs or other third-party payor insurance plans could impact demand for our product.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. These changes included an aggregate reduction in Medicare payments to providers of 2% per fiscal year, which went into effect on April 1, 2013 and will remain in effect through 2030, with the exception of a temporary suspension from May 1, 2020 through March 31, 2022, unless additional Congressional action is taken. In addition, on January&#160;2, 2013, the American Taxpayer Relief Act of 2012, was signed into law which, among other things, further reduced Medicare payments to certain providers, including hospitals. The Medicare Access and CHIP Reauthorization Act of 2015, enacted on April 16, 2015 (MACRA), repealed the formula by which Medicare made annual payment adjustments to physicians and replaced the former formula with fixed annual updates and a new system of incentive payments that began in 2019 that are based on various performance measures and physicians&#8217; participation in alternative payment models such as accountable care organizations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our products or additional pricing pressures.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our future success depends on our ability to develop, receive regulatory clearance</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">,</span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> approval </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">or certification </span><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">for, additional chronic pain indications for Senza and introduce new products or product enhancements that will be accepted by the market in a timely manner.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It is important to our business that we build a pipeline of product offerings for treatment of chronic pain. As such, our success will depend in part on our ability to expand the chronic pain indications for which our products may be used and/or develop and introduce new products. However, we may not be able to successfully develop and obtain regulatory clearance, approval or certification for expanded indications or product enhancements, or new products, or these products may not be accepted by physicians or the payors who financially support many of the procedures performed with our products.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The success of any new product offering or enhancement to an existing product will depend on a number of factors, including our ability to:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">identify and anticipate physician and patient needs properly&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">develop and introduce new products or product enhancements in a timely manner&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">avoid infringing upon the intellectual property rights of third parties&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">demonstrate, if required, the safety and efficacy of new products with data from preclinical and clinical studies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">obtain the necessary regulatory clearances, approvals or certifications for new products or product enhancements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">comply fully with FDA and foreign regulations on marketing of new devices or modified products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">provide adequate training to potential users of our products&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">receive adequate coverage and reimbursement for procedures performed with our products.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we do not develop new products or product enhancements in time to meet market demand or if there is insufficient demand for these products or enhancements, or if our competitors introduce new products with functionalities that are superior to ours, our results of operations will suffer.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to Our Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our stock price has experienced significant volatility and may continue to be volatile. As a result, our stockholders may not be able to resell shares of our common stock at or above the price they paid and such volatility may also adversely impact the value of the 2025 Notes.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The trading price of our common stock could be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. These factors include those discussed in this &#8220;Risk Factors&#8221; section of this Annual Report and others such as:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">achievement of expected product sales and profitability, including the effects of seasonality on our results of operations, as well as adjustments to our sales forecasts&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="color:#000000;">the ongoing&#160;COVID-19&#160;pandemic, see &#8220;&#8212;Risks Related to our Business&#8212;Our business, financial condition, results of operations and growth could be harmed by the effects of the&#160;COVID-19&#160;pandemic&#8221;&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">delays or setbacks in the commercialization of Senza or the expansion of indications for which Senza is approved&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">announcements of new products by us or our competitors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">announcements or developments in any intellectual property infringement actions in which we may become involved, including our lawsuits with Boston Scientific&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">manufacture, supply or distribution shortages&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">fluctuations in our expenses associated with inventory buildup or write-downs from analyzing our inventory for obsolescence or conformity with our product requirements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">adverse actions taken by regulatory agencies with respect to our clinical trials, manufacturing supply chain or sales and marketing activities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our operating results&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">results from, or any delays in, clinical trial programs relating to our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes or developments in laws or regulations applicable to our products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">any adverse changes in our relationship with any manufacturers or suppliers&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the success of our efforts to acquire or develop additional products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">announcements concerning our competitors or the medical device industry in general&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">actual or anticipated fluctuations in our operating results&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">FDA or other U.S. or foreign regulatory actions affecting us or our industry or other healthcare reform measures in the United States&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes in financial estimates or recommendations by securities analysts, as well as publications from research analysts associated with short selling&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">trading volume of our common stock&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">trading activity in our common stock by the option counterparties to our convertible note hedge transactions to unwind or modify their hedge positions&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">sales of our common stock by us, our executive officers and directors or our stockholders in the future&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">general economic and market conditions and overall fluctuations in the United States equity markets, i</span><span style="color:#000000;">ncluding as a result of volatility related to the recent coronavirus outbreak and related health concerns</span><span style="color:#000000;">&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the loss of any of our key management personnel.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because the 2025 Notes are convertible into shares of common stock, volatility or depressed market prices of our common stock could have a similar effect on the value of the 2025 Notes.&#160;&#160;Holders who receive shares of our common stock upon conversion of the 2025 Notes will also be subject to the risk of volatility and depressed market prices of our common stock.&#160;&#160;Similarly, the liquidity of the trading market in the 2025 Notes, and the market price quoted for the 2025 Notes, may be adversely affected by changes in the overall market for this type of security and by changes in our financial performance or prospects or in the prospects for companies in our industry generally.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the stock markets in general, and the markets for medical device stocks in particular, have experienced volatility that may have been unrelated to the operating performance of the issuer. These broad market fluctuations may adversely affect the trading price or liquidity of our common stock and the value of the 2025 Notes. In the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted securities class action litigation against the issuer. If any of our stockholders were to bring such a lawsuit against us, we could incur substantial costs defending the lawsuit and the attention of our management would be diverted from the operation of our business, which could seriously harm our financial position. Any adverse determination in litigation could also subject us to significant liabilities.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the 2025 Notes, or to make cash payments in connection with any conversion of the 2025 Notes, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to service our </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">debt and make necessary capital expenditures. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, restructuring debt or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Regulatory actions and other events may adversely affect the value and liquidity of the 2025 Notes.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect that many investors in, and potential purchasers of, the 2025 Notes will employ, or seek to employ, a convertible arbitrage strategy with respect to the 2025 Notes. Investors would typically implement such a strategy by selling short the common stock underlying the notes and dynamically adjusting their short position while continuing to hold the 2025 Notes. Investors may also implement this type of strategy by entering into swaps on our common stock in lieu of or in addition to short selling the common stock.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The SEC and other regulatory and self-regulatory authorities have implemented various rules and taken certain actions, and may in the future adopt additional rules and take other actions, that may impact those engaging in short selling activity involving equity securities (including our common stock). Such rules and actions include Rule 201 of SEC Regulation SHO, the adoption by the Financial Industry Regulatory Authority, Inc., or FINRA, and the national securities exchanges of a &#8220;Limit&#160;Up-Limit&#160;Down&#8221; program, the imposition of market-wide circuit breakers that halt trading of securities for certain periods following specific market declines, and the implementation of certain regulatory reforms required by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Any governmental or regulatory action that restricts the ability of investors in, or potential purchasers of, the notes to effect short sales of our common stock, borrow our common stock or enter into swaps on our common stock could adversely affect the trading price and the liquidity of the 2025 Notes.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may incur substantially more debt or take other actions which would intensify the risks discussed above.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We and our subsidiaries may incur substantial additional debt in the future, subject to the restrictions contained in any debt instruments we may have, some of which debt may be secured debt. We are not restricted under the terms of the indenture governing the 2025 Notes from incurring additional debt, securing existing or future debt, recapitalizing our debt or taking a number of other actions that are not limited by the terms of the indenture governing the 2025 Notes that could have the effect of diminishing our ability to make payments on these notes when due.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we are unable to maintain effective internal control over financial reporting in the future, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock and the value of the 2025 Notes could be adversely affected.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a public company, we are required to maintain internal control over financial reporting and to report any material weaknesses in such internal control. Section&#160;404 of the Sarbanes-Oxley Act requires that we evaluate and determine the effectiveness of our internal control over financial reporting and provide a management report on internal control over financial reporting.&#160;&#160;Further, the Sarbanes-Oxley Act also requires that our internal control over financial reporting be attested to by our independent registered public accounting firm.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we have a material weakness in our internal control over financial reporting, we may not detect errors on a timely basis and our financial statements may be materially misstated. The process of designing and implementing the internal control over financial reporting required to comply with this obligation is time consuming, costly and complicated. If we identify material weaknesses in our internal control over financial reporting, if we are unable to comply with the requirements of Section&#160;404 in a timely manner, if we are unable to assert that our internal control over financial reporting are effective, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock and the value of the 2025 Notes could be adversely affected, and we could become subject to investigations by the stock exchange on which our securities are listed, the SEC, or other regulatory authorities, which could require additional financial and management resources.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The accounting method for convertible debt securities that may be settled in cash, such as the 2025 Notes, could have a material effect on our reported financial results.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under Accounting Standards Codification&#160;470-20,&#160;Debt with Conversion and Other Options (&#8220;ASC&#160;470-20&#8221;),&#160;an entity must separately account for the liability and equity components of the convertible debt instruments (such as the 2025 Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer&#8217;s economic interest cost. The effect of ASC&#160;470-20&#160;on the accounting for the 2025 Notes is that the equity component is required to be included in the additional&#160;paid-in&#160;capital section of stockholders&#8217; equity on our consolidated balance sheet, and the value of the equity component would be treated as debt discount for purposes of accounting for the debt component of the 2025 Notes. As a result, we will be required to record a greater amount of&#160;non-cash&#160;interest expense in current periods presented as a result of the amortization of the discounted carrying value of the 2025 Notes to their face amount over the respective terms of the 2025 Notes. We will report lower net income (or larger net losses) in our financial results because ASC&#160;470-20&#160;will require interest to include both the current period&#8217;s amortization of the debt discount and the instrument&#8217;s&#160;non-convertible&#160;interest rate, which could adversely affect our reported or future financial results, the trading price of our common stock and the trading price of the notes.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, under certain circumstances, convertible debt instruments (such as the 2025 Notes) that may be settled entirely or partly in cash are currently accounted for utilizing the treasury stock method, the effect of which is that the shares issuable upon conversion of the 2025 Notes are not included in the calculation of diluted earnings per share except to the extent that the respective conversion values of the 2025 Notes exceeds their respective principal amounts. Under the treasury stock method, for diluted earnings per share purposes, the transaction is accounted for as if the number of shares of common stock that would be necessary to settle such excess, if we elected to settle such excess in shares, are issued.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, the FASB issued a new standard that proposes to change the accounting for the convertible debt instruments described above. Under the new standard, an entity may no longer be required to separately account for the liability and equity components of convertible debt instruments. This could have the impact of reducing&#160;non-cash&#160;interest expense, and thereby increasing net income (or decreasing net losses). Additionally, the treasury stock method for calculating earnings per share will no longer be allowed for convertible debt instruments whose principal amount may be settled using shares. Rather, the&#160;if-converted&#160;method may be required, which could decrease our diluted earnings per share. The new standard is effective for fiscal years beginning after December 15, 2021 and interim periods within that year, with early adoption permitted, and can either be adopted on a modified retrospective or full retrospective basis.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we sell shares of our common stock in future financings, stockholders may experience immediate dilution and, as a result, our stock price and the value of the 2025 Notes may decline.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may from time to time issue additional shares of common stock at a discount from the current trading price of our common stock. As a result, our stockholders would experience immediate dilution upon the purchase of any shares of our common stock sold at such discount. In addition, as opportunities present themselves, we may enter into financing or similar arrangements in the future, including the issuance of debt securities, preferred stock or common stock. If we issue common stock or securities convertible into common stock, our common stockholders would experience additional dilution and, as a result, our stock price and the value of the 2025 Notes may decline.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Sales of a substantial number of shares of our common stock in the public market could cause our stock price and the value of the 2025 Notes to fall.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the future, we may sell additional shares of our common stock to raise capital. In addition, a substantial number of shares of our common stock is reserved for issuance upon the exercise of stock options, upon the vesting of restricted stock units, upon conversion of the 2025 Notes, upon exercise of the warrants in the warrant transactions we entered into in connection with the offering of the 2021 Notes and 2025 Notes. We cannot predict the size of future issuances or the effect, if any, that they may have on the market price for our common stock. The issuance and sale of substantial amounts of common stock, or the perception that such issuances and sales may occur, could adversely affect the trading price of the notes and the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market, the trading price of our common stock and the value of the 2025 Notes could decline. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 202</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, we had outstanding a total of approximately&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35.0</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million shares of common stock, and approximately </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.4</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million shares of common stock that are either subject to outstanding options or reserved for future issuance under our equity incentive plans will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, and Rule&#160;144 and Rule&#160;701 under the Securities Act.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock and the value of the 2025 Notes could decline.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our amended and restated certificate of incorporation and amended and restated bylaws provide that we will indemnify our directors and officers to the fullest extent permitted by Delaware law.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, as permitted by Section&#160;145 of the Delaware General Corporation Law, our amended and restated bylaws and our indemnification agreements that we have entered into with our directors and officers provide that:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we will not be obligated pursuant to our amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person against us or our other indemnitees, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the rights conferred in our amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">we may not retroactively amend our amended and restated bylaw provisions to reduce our indemnification obligations to directors, officers, employees and agents.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We do not currently intend to pay dividends on our common stock, and, consequently, our stockholders&#8217; ability to achieve a return on their investment will depend on appreciation in the price of our common stock.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not currently intend to pay any cash dividends on our common stock for the foreseeable future. We currently intend to invest our future earnings, if any, to fund our growth. Therefore, our stockholders are not likely to receive any dividends on our common stock for the foreseeable future. Since we do not intend to pay dividends, our stockholders&#8217; ability to receive a return on their investment will depend on any future appreciation in the market value of our common stock. There is no guarantee that our common stock will appreciate or even maintain the price at which our stockholders have purchased it.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">General Risk Factors</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Changes in tax laws, tax rulings or trade policies may have a material adverse effect on our business, financial condition and results of operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in laws and policy relating to taxes or trade may have an adverse effect on our business, financial condition and results of operations. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The tax regimes we are subject to or operate under, including income and non-income taxes, are unsettled and may be subject to significant change. Changes in tax laws or tax rulings, or changes in interpretations of existing laws, could materially affect our financial position, results of operations, and cash flows. Recently enacted legislation and associated regulations have significantly changed U.S. federal income tax laws, with potential impact to state and local taxation.&#160;&#160;Further, many countries in Europe have recently proposed or recommended changes to existing tax laws or have enacted new laws that may increase our tax obligations in those countries.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, changes in U.S. trade policies could materially and adversely impact our effective tax rate, increase our costs and reduce the competitiveness of our products.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Failure to protect our information technology infrastructure, and those of our third-party service providers, against cyber-based attacks, network security breaches, service interruptions, or data corruption could significantly disrupt our operations and adversely affect our business and operating results.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely on information technology and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, including sales, billing, marketing, procurement and supply chain, manufacturing and distribution. We use enterprise information technology systems to record, process and summarize financial information and results of operations for internal reporting purposes and to comply with regulatory, financial reporting, legal and tax requirements. Our information technology systems, some of which are managed by third-parties, may be susceptible to damage, disruptions or shutdowns due to computer viruses, &#8220;phishing&#8221; attacks, attacks by computer hackers, unauthorized access, natural disasters, terrorism, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors or catastrophic events. Attacks upon information technology systems are increasing in their frequency, levels of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise. As a result of the COVID-19 pandemic, we may also face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities. Furthermore, because the techniques used to obtain unauthorized access to, or to sabotage, systems change frequently and often are not recognized until launched against a target, we may be unable to anticipate these techniques or implement adequate preventative measures. We may also experience security breaches that may remain undetected for an extended period. Despite the precautionary measures we have taken to prevent breakdowns in our information technology and telephone systems, if our systems suffer severe damage, disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may suffer.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In addition, periodic maintenance fees on issued patents often must be paid to the USPTO and foreign patent agencies over the lifetime of the patent. While an unintentional lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. If we fail to maintain the patents and </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patent applications covering our products or procedures, we may not be able to stop a competitor from marketing products that are the same as or similar to our own, which would have a material adverse effect on our business.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may not be able to adequately protect our intellectual property rights throughout the world.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filing, prosecuting and defending patents on our products in all countries throughout the world would be prohibitively expensive. The requirements for patentability may differ in certain countries, particularly developing countries, and the breadth of patent claims allowed can be inconsistent. In addition, the laws of some foreign countries may not protect our intellectual property rights to the same extent as laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories in which we have patent protection that may not be sufficient to terminate infringing activities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not have patent rights in certain foreign countries in which a market may exist. Moreover, in foreign jurisdictions where we do have patent rights, proceedings to enforce such rights could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, and our patent applications at risk of not issuing. Additionally, such proceedings could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and if we do prevail, the damages or other remedies awarded, if any, may not be commercially meaningful. Thus, we may not be able to stop a competitor from marketing and selling in foreign countries products that are the same as or similar to our products, and our competitive position in the international market would be harmed.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented, declared generic or determined to be infringing on other marks. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition with potential partners or customers in our markets of interest. In addition, third parties have registered trademarks similar and identical to our trademarks in foreign jurisdictions, and may in the future file for registration of such trademarks. If they succeed in registering or developing common law rights in such trademarks, and if we were not successful in challenging such third-party rights, we may not be able to use these trademarks to market our products in those countries. In any case, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If securities or industry analysts issue an adverse or misleading opinion regarding our stock, our stock price and trading volume could decline.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The trading market for our common stock is influenced by the research and reports that industry or securities analysts publish about us or our business. If any of the analysts who cover us issues an adverse or misleading opinion regarding us, our business model, our intellectual property or our stock performance, or if our clinical trials and operating results fail to meet the expectations of analysts, our stock price would likely decline. For example, in the fourth quarter of 2020, a research analyst associated with short selling activity published a report that resulted in short term volatility in our stock. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We incur significantly increased costs and devote substantial management time as a result of operating as a public company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company. For example, we are subject to the reporting requirements of the Exchange Act, and are required to comply with the applicable requirements of the Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley Act), and the Dodd-Frank Act, as well as rules and regulations subsequently implemented by the SEC and the NYSE, including the </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. We expect that compliance with these requirements will increase our legal and financial compliance costs and will make some activities more time consuming and costly.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, our management and other personnel divert attention from operational and other business matters to devote substantial time to these public company requirements. In particular, we incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act. We continue to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. We cannot predict or estimate the amount of additional costs we will incur in order to remain compliant with our public company reporting requirements or the timing of such costs. Additional compensation costs and any future equity awards will increase our compensation expense, which would increase our general and administrative expense and could adversely affect our profitability.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1B_UNRESOLVED_STAFF_COMMENTS">ITEM&#160;1B. <span style="font-style:italic;">UNRESOLVED STAFF COMMENTS</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_2_PROPERTIES">ITEM&#160;2.&#160;<span style="font-style:italic;">PROPERTIES</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our corporate headquarters and R&#38;D facilities are located in Redwood City, California, where we lease and currently occupy approximately 50,740 square feet of office and laboratory space. In December 2016, we amended the original lease for our corporate headquarters in order to increase the space we occupy by approximately 49,980 square feet of office space adjacent to our corporate headquarters.&#160;&#160;Our obligations under the amended lease for the new space commenced on June 1, 2018. The term of the lease for our corporate headquarters and the new adjacent space ends on May 31, 2025.&#160;&#160;In April 2017, we entered into a second amendment to the original lease for a temporary space of approximately 8,171 square feet of office space for the period from May 2017 until June 1, 2018, the commencement of the term for the additional adjacent space.&#160;&#160;We believe our current headquarters, together with our additional adjacent space, is sufficient for our current and foreseeable business needs. We also lease a small storage facility in Australia and a small amount of warehouse space in San Carlos, California. In August 2020, we entered into a lease for approximately 35,411 square feet of manufacturing space to begin in April 2021 and to last through June 2031 at a facility in Costa Rica. We plan to use this facility to build-out certain manufacturing capabilities so that we can vertically integrate the assembly of IPG&#8217;s, peripherals and various other manufacturing related activities for products that we currently purchase from third-parties. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For additional information, see Note 7, <span style="font-style:italic;">Commitments and Contingencies</span>, of Notes to Consolidated Financial Statements in Part II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_3_LEGAL_PROCEEDINGS">ITEM&#160;3.&#160;<span style="font-style:italic;">LEGAL PROCEEDINGS</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The legal proceedings information set forth in Note 7</span><span style="font-style:italic;color:#000000;"> Commitments and Contingencies</span><span style="color:#000000;">, of Notes to Consolidated Financial Statements in Part II, Item&#160;8 of this Annual Report</span><span style="Background-color:#FFFFFF;"> is incorporated herein by reference.</span><span style="color:#000000;"> </span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_4_MINE_SAFETY_DISCLOSURES">ITEM&#160;4.&#160;<span style="font-style:italic;">MINE SAFETY DISCLOSURES</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_II">PART&#160;II</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU">ITEM&#160;5. <span style="font-style:italic;">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Market Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock has been publicly traded on the NYSE under the symbol &#8220;NVRO&#8221; since the initial public offering (IPO) of our common stock on November&#160;6, 2014. Prior to that time, there was no public market for our common stock.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Holders of Record</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of February 16, 2022, there were approximately 15 stockholders of record of our common stock, and the closing price per share of our common stock was $70.98. Since many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dividends</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have never declared or paid cash dividends on our common stock. Because we currently intend to retain all future earnings to finance future growth, we do not anticipate paying any cash dividends in the near future.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Securities Authorized for Issuance under Equity Compensation Plans</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item 5 regarding equity compensation plans is incorporated by reference from the information under the captions &#8220;Equity Compensation Plan Information&#8221; and &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; that will be contained in the Proxy Statement.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Performance Graph</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following graph illustrates a comparison of the total cumulative five-year stockholder return on our common stock to two indices: the S&#38;P 500 Composite Index and the S&#38;P Healthcare Equipment Index. An investment of $100 is assumed to have been made in our common stock and in each of the indices on December 31, 2015 and its relative performance is tracked through December 31, 2021.&#160;&#160;The stockholder return shown in the graph below is not necessarily indicative of future performance, and we do not make or endorse any predictions as to future stockholder returns. This graph shall not be deemed &#8220;soliciting material&#8221; or be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu1405a4gpzj000007.jpg" title="" alt="" style="width:603px;height:276px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:36.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">$100 investment in stock or index</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nevro Corp. (NVRO)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100.00</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95.02</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53.52</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">161.77</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">238.23</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111.57</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S&#38;P 500 (GSPC)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100.00</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119.42</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111.97</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">144.31</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167.77</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212.89</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S&#38;P Healthcare Equipment (SPSIHE)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100.00</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129.98</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141.99</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173.80</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">230.87</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.3%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">238.52</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Sales of Unregistered Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_6_SELECTED_FINANCIAL_DATA">ITEM&#160;6.&#160;<span style="font-style:italic;">[RESERVED]</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F">ITEM&#160;7. <span style="font-style:italic;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Annual Report includes &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws, particularly statements referencing our expectations relating to the productivity of our sales force, revenues, deferred revenues, cost of revenues, operating expenses, stock-based compensation and provision for income taxes&#59; the </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">growth of our customer base and customer demand for our products&#59; the sufficiency of our cash balances and cash flows&#59; the impact of recent changes in accounting standards&#59; </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the impact of changes in the tax code as a result of recent federal tax legislation and uncertainty as to how some of those changes may be applied&#59; </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">market risk sensitive instruments</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#59;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> contractual obligations&#59; and assumptions underlying any of the foregoing. In some cases, forward-looking statements can be identified by the use of terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; or the negative thereof, or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, these expectations or any of the forward-looking statements could prove to be incorrect, and actual results could differ materially from those projected or assumed in the forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to risks and uncertainties, including but not limited to the factors set forth in this </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Annual </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Report under Part&#160;I, Item&#160;1A. </span><span style="font-style:italic;">Risk Factors</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. All forward-looking statements and reasons why results may differ included in this</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Annual</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Report are made as of the date of the filing of this </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Annual </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Report, and we assume no obligation to update any such forward-looking statements or reasons why actual results may differ.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following discussion should be read in conjunction with our consolidated financial statements and notes thereto appearing in Part II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment.&#160;&#160;We have developed and commercialized the Senza&#174; spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain, with the Senza&#174; Omnia&#8482; platform being our latest addition to the Senza family of products. Our proprietary, paresthesia-free 10 kHz Therapy, delivered by our Senza system, was demonstrated in our SENZA randomized controlled trial (RCT) to be superior to traditional SCS therapy, with 10 kHz Therapy being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. In addition to the original approval of our therapy in back and leg pain, we received approval of unilateral or bilateral pain, associated with painful diabetic neuropathy (PDN) in July 2021 and we received expanded labeling in non-surgical refractory back pain (NSRBP) in January 2022. Our SENZA-RCT study, along with our SENZA-PDN clinical study, SENZA-NSRBP clinical study and European studies, represents what we believe is the most robust body of clinical evidence for any SCS therapy. We believe the superiority of 10 kHz Therapy over traditional SCS therapies will allow us to capitalize on and expand the approximately $2.3 billion global SCS market by treating patients with debilitating chronic pain, including back and leg pain, NSRBP and PDN.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We launched Senza commercially in the United States in May 2015, after receiving a label from the U.S. Food and Drug Administration (FDA) supporting the superiority of our 10 kHz Therapy over traditional SCS.&#160;&#160;The Senza system has been commercially available in certain European markets since November 2010 and in Australia since August 2011. We have experienced significant revenue growth in the United States since commercial launch. Senza is currently reimbursed by all of the major insurance providers. In early 2017, we commenced a controlled commercial launch of our family of surgical leads, marketed as the Surpass surgical lead, and in April 2020 received FDA approval for our reduced-size Surpass-C surgical lead.&#160;&#160;In January 2018, we received FDA approval of our next generation Senza II SCS system.&#160;&#160;In the fourth quarter of 2019, we received FDA approval of our next generation product platform, Senza Omnia, which we launched in the United States in the fourth quarter of 2019.&#160;&#160;Additionally, we received approval to commercially launch Senza Omnia in Europe during the second quarter of 2020 and in Australia in July 2020. In the first quarter of 2021, we received FDA approval for our first Senza Omnia upgrade, Omnia&#8482; Powered by HFX Connect&#8482;, and our next generation trial stimulator. In July 2021, we received FDA approval of our 10 kHz Therapy for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with PDN. This approval is specific to our unique 10 kHz stimulation, and the Senza system was the first spinal cord stimulation system approved by the FDA with a specific indication to treat certain forms of pain associated with PDN.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The tables below set forth our revenue from U.S. and international sales the past three years on a quarterly basis and total revenue for each of the past five years.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.9%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q1 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q2 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q3 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q4 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q1 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q2 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q3 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q4 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q1 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q2 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q3 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.36%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Q4 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Revenue from:</span></p></td>
<td colspan="47" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. sales</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65.8</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78.1</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84.2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97.9</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.3</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.0</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90.9</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94.6</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74.7</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85.0</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78.1</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88.4</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.5</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.0</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.5</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.5</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.9</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.9%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82.1</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93.6</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100.2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114.4</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87.5</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.4</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108.5</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109.7</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88.6</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102.3</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93.2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102.8</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Revenue from:</span></p></td>
<td colspan="18" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.72%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. sales</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">263.5</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">321.8</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326.0</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">311.9</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326.2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63.2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65.5</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.7</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326.7</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">387.3</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">390.3</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">362.0</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386.9</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since our inception, we have financed our operations primarily through equity and debt financings and borrowings under a debt facility. Our accumulated deficit as of December 31, 2021 was $624.2 million. A significant amount of our capital resources has been used to support the development of our Senza products and our 10 kHz Therapy, and we have also made a significant investment building our U.S. commercial infrastructure and sales force to support our commercialization efforts in the United States. We intend to continue to make significant investments in our U.S. commercial infrastructure, including a sales organization that targets physician specialties involved in PDN treatment decisions, as well as in research and development (R&#38;D) to develop Senza to treat other chronic pain indications, including conducting clinical trials to support our future regulatory submissions. In order to further enhance our R&#38;D efforts, pursue product expansion opportunities or acquire a new business or products that are complementary to our business, we may choose to raise additional funds, which may include future equity and debt financings.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, we issued $165.0 million aggregate principal amount of 2.75% convertible senior notes due 2025 (the 2025 Notes) in a registered underwritten public offering and an additional $24.8 million aggregate principal amount of such notes pursuant to the underwriters&#8217; exercise in full of their option to purchase additional 2025 Notes. The 2025 Notes&#8217; interest rates are fixed at 2.75%&#160;per annum, with interest payable semi-annually in arrears on April 1 and October&#160;1 of each year, which commenced on October 1, 2020.&#160;&#160;The total net proceeds from the 2025 Notes, after deducting initial purchase discounts and debt issuance costs, were approximately $183.6 million. In connection with the offering of the 2025 Notes, we entered into convertible note hedge transactions in which we have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of common stock at a price of approximately $105.00 per share. The total cost of the convertible note hedge transactions was $52.4 million.&#160;&#160;In addition, we sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of our common stock at a price of $147.00 per share. We received $34.9 million in cash proceeds from the sale of these warrants.&#160;&#160;The net cost incurred in connection with the convertible note hedge and warrant transactions was $17.5 million. Concurrent with the registered underwritten public offering of the 2025 Notes, we completed an underwritten public offering of common stock and issued 1,868,750 shares of common stock, including 243,750 shares issued pursuant to the exercise in full of the underwriters&#8217; option to purchase additional shares. As a result of this public offering of common stock, we received cash proceeds of $147.1 million, net of underwriting discounts and commissions and offering costs. On June 1, 2021, our outstanding 1.75% convertible senior notes due 2021 (2021 Notes) matured, and we paid $172.5 million to settle the outstanding principal and issued 682,912 shares of common stock to holders who elected to convert the 2021 Notes.&#160;&#160;In addition, we exercised our option under the bond hedge and received 682,916 shares of common stock from the bank counterparties.&#160;&#160;As of December 31, 2021, the 2021 Notes were no longer outstanding.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely on third-party suppliers for all of the components of our Senza products, and currently for the assembly of these systems. Several of these suppliers are currently single-source suppliers. We have entered into and/or amended several supply agreements in an effort to reinforce our supply chain.&#160;&#160;We are also required to maintain high levels of inventory, and, as a result, we are subject to the risk of inventory obsolescence and expiration, which may lead to inventory impairment charges. Additionally, as compared to direct manufacturers, our dependence on third-party manufacturers makes us vulnerable to supply shortage problems and exposes us to greater lead times, increasing our risk of inventory obsolescence.&#160;&#160;In the third quarter of 2020, we made the strategic decision to vertically integrate the assembly of IPG&#8217;s, peripherals and various other manufacturing related activities </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to mitigate our reliance on third-party manufacturers and improve our long-term gross margins.&#160;&#160;We plan on conducting these manufacturing activities in a facility in Costa Rica, for which our lease began in April 2021. The integration process is expected to be completed in </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">mid-</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022.&#160;&#160;Even after this integration process is completed, we expect that we will continue to rely on third-party manufacturers to provide key components to support the assembly process.&#160;&#160;We may incur significant capital expenditures and implementation costs to initiate the manufacturing operations in Costa Rica.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">COVID-19 Pandemic</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to risks related to the public health crises such as the global pandemic associated with COVID-19. The COVID-19 outbreak has negatively impacted, and continues to negatively impact our operations and revenues and overall financial condition as demand for elective procedures remains unpredictable and the number of Senza trials and permanent system implant procedures has not recovered to pre-pandemic levels.<span style="font-size:12pt;color:#000000;"> </span>The magnitude of the risks and uncertainties related to the pandemic are unpredictable and could be further aggravated by the spread of new variants of the COVID-19 virus such as the Delta and Omicron variants, which may be more contagious and/or virulent.<span style="font-size:12pt;color:#000000;"> </span>During the initial stages of the pandemic, the number of Senza systems procedures performed, similar to other elective surgical procedures, decreased significantly as health care organizations globally prioritized the treatment of patients with COVID-19. For example, in the United States in the first half of 2020 and more recently in connection with the spread of the Omicron variant, governmental authorities recommended, and in certain cases required, that elective, specialty and other procedures and appointments, be suspended or canceled to avoid non-essential patient exposure to medical environments and potential infection with COVID-19 and to focus limited resources and personnel capacity toward the treatment of COVID-19. Additionally, overall patient willingness to pursue elective procedures has decreased due to the pandemic.<span style="font-size:12pt;color:#000000;"> </span>Throughout 2021, the COVID-19 pandemic negatively impacted the global SCS therapy market, which we estimate decreased by approximately 5% to 10%. These challenges may arise again at any time throughout the duration of the pandemic, which is uncertain, and could reduce our revenue while the pandemic continues.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notably, the predictably of trial and permanent implant procedures continues to be challenging to forecast in light of the ongoing pandemic and recent surges in cases caused by the Delta and then Omicron variants. Even if the severity of the pandemic subsides, we are unable to predict the timing that demand for Senza system procedures may return to historic levels as prospective patients may decide to delay their procedures.&#160;&#160;As a result of the spread of more contagious and virulent variants, the COVID-19 pandemic could continue to result in a meaningful delay in patients seeking to have a Senza system trial.&#160;&#160;Further, we anticipate that the substantial backlog of patients seeking appointments with physicians and surgeries to be performed at hospitals and ambulatory surgery centers relating to a variety of medical conditions will result in patients seeking to have Senza system trials or implant procedures performed having to navigate limited provider capacity, due to, among other reasons, a growing trend of labor shortages with nurses and other healthcare facility staff. We believe these factors may have an adverse effect on the recovery of the global SCS therapy market and, as a result, the amount of time we predict for our sales to recover following the end of the pandemic.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further, numerous state&#160;and local jurisdictions have imposed, and others in the future may impose, &#8220;shelter-in-place&#8221; orders, quarantines, executive orders and similar government orders and restrictions for their residents to control the spread of&#160;COVID-19. Multiple times in 2020, the governor of California, where our headquarters are located, issued a &#8220;shelter-in-place&#8221; or &#8220;stay at home&#8221; orders restricting non-essential activities, travel and business operations for an indefinite period of time, subject to certain exceptions for necessary activities.&#160;Such orders or restrictions have resulted in our headquarters closing, work stoppages, slowdowns and delays, travel restrictions and cancellation of events, among other effects, thereby negatively impacting our operations.&#160;Other disruptions or potential disruptions include restrictions on our personnel and personnel of partners to travel and access customers for training and case support&#59; delays in approvals or certifications by regulatory authorities and notified bodies&#59; delays in product development efforts&#59; and additional government requirements or other incremental mitigation efforts that may further impact our capacity to manufacture, sell and support the use of our Senza systems.<span style="font-size:12pt;color:#000000;"> </span>For instance, in the EU, notified bodies must be officially designated to certify products and services in accordance with the Medical Devices Regulation (EU) No 2017/745 (the EU Medical Devices Regulation). While several notified bodies have been designated, the COVID-19 pandemic has significantly slowed down their designation process and the current designated notified bodies are facing a large amount of requests with the new regulation as a consequence of which review times have lengthened. This situation could impact our ability to grow our business in </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the EU and EEA. In addition, even after the lift of &#8220;shelter-in-place&#8221; orders, quarantines, executive orders and similar government orders and restrictions for their residents to co</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ntrol the spread of COVID-19, we continue to experience disruptions to our business as a result of patients and customers continuing to be cautious in restarting elective procedures in light of the continued risk posed by the virus.</span></p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Global and domestic supply chains and the timely availability of raw materials and products may be materially disrupted by quarantines, factory slowdowns or shutdowns, border closings and travel restrictions resulting from the COVID-19 pandemic. Any manufacturing supply interruption of materials could adversely affect our ability to conduct ongoing and future activities.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While the potential economic impact brought by and the duration of COVID-19 may be difficult to assess or predict, the widespread pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity, including our ability to repay our 2.75% convertible senior convertible notes due 2025 (the 2025 Notes). We expect any further shelter-in-place policies and restrictions on elective surgical procedures worldwide to have a substantial impact on our revenue. In addition, a recession or market correction resulting from the spread of COVID-19 could materially affect our business and the value of our common stock. During the COVID-19 pandemic, our customers, including hospitals, ASCs and physician offices, have experienced financial hardship and some of them may not fully recover.&#160;&#160;This could lead to some of these customers temporarily or permanently shutting down, filing for bankruptcy or being acquired by larger health systems, leading to reduced procedures and/or additional pricing pressure on our products. The COVID-19 pandemic has also resulted in a significant increase in unemployment in the United States, Europe and Australia, which may continue even after the pandemic. The occurrence of any such events may lead to reduced disposable income and access to health insurance which could adversely affect the number of Senza systems sold after the pandemic has ended.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Important Factors Affecting our Results of Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the impact of COVID-19, we believe that the following factors have impacted, and we expect will continue to impact, our results of operations.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Importance of Physician Awareness and Acceptance of Our Products</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We continue to invest in programs to educate physicians who treat chronic back and leg pain about the advantages of Senza. This requires significant commitment by our marketing team and sales organization, and can vary depending upon the physician&#8217;s practice specialization, personal preferences and geographic location. Further, we are competing with well-established companies in our industry that have strong existing relationships with many of these physicians. Educating physicians about the advantages of our Senza products, including our latest product, Senza Omnia, and influencing these physicians to use these products to treat chronic pain, is required to grow our revenue.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2021, we received FDA approval of our 10 kHz Therapy for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with PDN, and we have initiated a commercial rollout. In order to successfully commercialize our PDN opportunity, we will need to invest in and incur significant costs for this new indication and patient population, including costs to continue to build our sales force, marketing efforts and continuing clinical activities.&#160;&#160;Our success in the PDN market will be dependent on, among other factors, the perceived efficacy of our therapy for PDN patients, our ability to educate and generate awareness of our therapy for referring physicians, treating physicians and patients, and our ability to obtain sufficient third-party coverage or reimbursement for use of our therapy in PDN patients.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reimbursement and Coverage Decisions by Third-Party Payors</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Healthcare providers in the United States generally rely on third-party payors, principally federal Medicare, state Medicaid and private health insurance plans, to cover and reimburse all or part of the cost of our products and the related implant procedure for patients. The revenue we are able to generate from sales of our products depends in large part on the availability of reimbursement from such payors. While we currently have a favorable National </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Coverage Determination (NCD) and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reimbursement </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">by </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Medicare</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for chronic back and leg pain, we have more limited coverage for PDN </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and NSRBP </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">procedures</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">decisions of coverage and reimbursement for Senza and the related implant procedure from private health insurance providers can vary. In general, these decisions require that such payors perform analyses to determine if the procedure is medically necessary and if our technology is covered under their existing coverage policies. These payors may deny reimbursement if they determine that the device or procedure was not </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">medically necessary for the patient and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">used in accordance wit</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">h the payor&#8217;s coverage policy.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A significant component of our commercial efforts includes working with private payors to ensure positive coverage decisions for our products. For our traditional chronic back and leg pain market, we believe that favorable coverage and reimbursement for procedures using our products from Medicare and certain commercial payors, such as Aetna, Cigna, Humana, Blue Cross Blue Shield and Kaiser, have contributed to our increase in revenue to date.&#160;&#160;Although the largest commercial payors and Medicare cover procedures using Senza, there can be no assurance that all private health insurance plans will cover the therapy. Effective July 1, 2021, Medicare now requires Prior Authorization for certain hospital outpatient procedures, including SCS procedures. In January 2022, we announced that UnitedHealthcare will provide coverage for our 10 kHz Therapy for the treatment of PDN for dates of service on or after March 1, 2022. A significant number of negative coverage and reimbursement decisions by private insurers may impair our ability or delay our ability to grow our revenue.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are working to expand payor coverage to include the use of our 10 kHz Therapy for the management of PDN and NSRBP. This effort could be costly and could take many years to gain broad acceptance, and there can be no guarantee that it will be successful.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Inventory Buildup and Supply Chain Management</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our products are composed of a substantial number of individual components and, in order to market and sell them effectively, we must maintain high levels of inventory. In particular, since our commercial launch of Senza in the United States, we have continued to add suppliers to fortify our supply chain and we have maintained increased levels of inventory. As a result, a significant amount of our cash used in operations has been associated with maintaining these levels of inventory. There may also be times in which we determine that our inventory does not meet our product requirements. Further, the manufacturing process for our products requires lengthy lead times, during which components may become obsolete. We may also over- or underestimate the quantities of required components, in which case we may expend extra resources or be constrained in the amount of end product that we can produce. These factors subject us to the risk of inventory obsolescence and expiration, which may lead to inventory impairment charges. The sum of the charges for the items listed above were $2.5 million and $2.7 million for the years ended December 31, 2021 and 2020, respectively. Additionally, as we release later generations of products that contain advancements or additional features, the earlier generations may become obsolete, as was the case in the years ended December 31, 2021 and 2020, when we recorded a charge of $1.8 million and $2.6 million, respectively. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Investment in Research and Clinical Trials</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We intend to continue investing in R&#38;D to help our commercialization efforts around and to expand into new indications and chronic pain conditions, as well as develop product enhancements to improve outcomes and enhance the physician and patient experience. For example, we commenced commercial launches of Surpass, our surgical lead product family in early 2017 and Senza II SCS System in late 2017.&#160;&#160;Most recently, we launched our next generation product platform, Senza Omnia, in the United States in late 2019, in Europe during the second quarter of 2020 and in Australia in July 2020.&#160;&#160;In the first quarter of 2021, we received FDA approvals for our first Senza Omnia upgrade and a new trial stimulator. In July 2021, we received FDA approval of our 10 kHz Therapy for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with PDN. We are continuing to invest in product improvements to Senza, including enhanced MRI capabilities and next generation IPGs. While R&#38;D and clinical testing are time consuming and costly, we believe expanding into new indications, implementing product improvements and continuing to demonstrate the efficacy, safety and cost effectiveness of the 10 kHz Therapy through clinical data are all critical to increasing the adoption of this therapy.&#160;&#160;We initiated two randomized controlled trials in 2018, SENZA-PDN and SENZA-NSRBP, which evaluate the 10 kHz Therapy for the treatment of PDN and NSRBP, respectively. In January 2020 at NANS 2020, we presented the three-month data from our SENZA-PDN study, which was the largest SCS randomized controlled trial conducted to </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">date</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for PDN</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2021, we presented the six-month data from our SENZA-PDN study at NANS 2021. In April 2021, the six-month data from the SENZA-PDN study was additionally published in JAMA Neurology, an international peer-reviewed journal. In June 2021, we presented the 12-month follow-up results and the 6-month crossover patient data at the American Diabetes Association 81st Scientific Sessions. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With regard to the SENZA-NSRBP study, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we presented the three-month primary endpoint results in January 2021 at NANS 2021, representing the first release of data from this randomized controlled trial.&#160;&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2021, we presented the 6-month data from SENZA-NSRB</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">P</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> at the American Society of Interventional Pain Physicians 23rd annual meeting.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Both the SENZA-PDN and SENZA-NSRBP studies are ongoing, and further data will be presented and published in leading journals as the data becomes available.&#160;&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 2021, we received FDA approval of our 10</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">kHz </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">herapy for the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with PDN.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Significant Investment in U.S. Sales Organization</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, we established a sales organization to support the launch of our PDN indication in the U.S. This sales organization targets physician specialties involved in PDN treatment decisions, including primary care physicians, endocrinologists, internal medicine and podiatrists, to create awareness of 10 kHz Therapy to treat PDN patients. We are continuing to make investments in building our U.S. commercial infrastructure and recruiting and training our U.S. sales force. This is a lengthy process that requires recruiting appropriate sales representatives, establishing and, on occasion, refining a commercial infrastructure in the United States and training our sales representatives. Following initial training for Senza, our sales representatives typically require lead time in the field to grow their network of accounts and produce sales results. Successfully recruiting and training a sufficient number of productive sales representatives has been required to achieve growth at the rate we expect.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Access to Hospital Facilities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, in order for physicians to use our products, the hospital facilities where these physicians treat patients often require us to enter into purchasing contracts directly with the hospital facilities or with the Group Purchasing Organizations of which the hospital facilities are members. This process can be lengthy and time-consuming and requires extensive negotiations and management time. In Europe, we may be required to engage in a contract bidding process in order to sell our products, where the bidding processes are only open at certain periods of time, and we may not be successful in the bidding process.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Critical Accounting Policies, Significant Judgments and Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management&#8217;s discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, we evaluate our critical accounting policies and estimates. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions and conditions. We believe that the estimates, judgments and assumptions involved in the accounting for revenue recognition, inventory, stock-based compensation, income taxes and allowance for doubtful accounts have the greatest potential impact on our consolidated financial statements, so we consider these to be our critical accounting policies. We discuss below the critical accounting estimates associated with these policies. Historically, our estimates, judgments, and assumptions relative to our critical accounting policies have not differed materially from actual results. Our significant accounting policies are more fully described in Note 2, <span style="font-style:italic;">Summary of Significant Accounting Policies</span>, of Notes to Consolidated Financial Statements in Part II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#8217;s goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration we expect to receive in exchange for transferring the goods. Under ASC 606,<span style="font-style:italic;color:#000000;"> Revenue from Contracts </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;color:#000000;">with Customers</span><span style="color:#000000;">,</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">assuming all other revenue recognition criteria have been met, </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">also </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recognize revenue for arrangements where </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we have satisfied the performance obligations but have not issued invoices</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;These amounts are recorded as unbilled receivables, which are included in accounts receivable on the consolidated balance sheet, as we have an unconditional right to payment at the end of the applicable period.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For a majority of sales, where our sales representative delivers our product at the point of implantation at hospitals or medical facilities, we recognize revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the remaining sales, which are sent from the Company&#8217;s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.&#160;&#160;These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. We do not offer rights of return or price protection.<span style="color:#FF0000;"> </span>To the extent that we have a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, we defer revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold. The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.&#160;&#160;Product revenue is recorded net of such incentive offers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.&#160;&#160;As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Inventory Valuation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We contract with third parties for the manufacturing and packaging of all of the components of our Senza products. We plan the manufacture of our systems based on estimates of market demand. The nature of our business requires that we maintain sufficient inventory on hand to meet the requirements of our customers. Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method, which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We regularly review inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. Inventory write-downs are recorded for excess and obsolete inventory. We estimate forecasted sales by considering:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">product acceptance in the marketplace&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">customer demand&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">historical sales&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">product obsolescence&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">technological innovations.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any inventory write-downs are recorded in cost of revenue within the statements of operations during the period in which such write-downs are determined necessary by management.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation costs related to stock options granted to employees are measured at the date of grant based on the estimated fair value of the award, net of estimated forfeitures. We estimate the grant date fair value, and the resulting stock-based compensation expense, using the Black-Scholes option-pricing model.&#160;&#160;The fair value is recognized on a straight-line basis over the requisite service period of the stock option award, which is generally the vesting term of four years, with the exception of performance based stock option awards, whose fair value is recognized as expenses when it is determined that achieving the performance metrics are probable.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Black-Scholes option-pricing model requires the use of highly subjective assumptions which determine the fair value of stock-based awards. The assumptions used in our option-pricing model represent management&#8217;s best estimates. These estimates are complex, involve a number of variables, uncertainties and assumptions and the application of management&#8217;s judgment, so that they are inherently subjective. If factors change and different assumptions are used, our stock-based compensation expense could be materially different in the future. These assumptions are estimated as follows:</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Risk-Free Interest Rate<span style="font-style:normal;">.&#160;We base the risk-free interest rate used in the Black-Scholes valuation model on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent remaining term of the options for each option group.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected Term<span style="font-style:normal;">.&#160;The expected term represents the period that our stock-based awards are expected to be outstanding. We utilize our historical data for the calculation of expected term.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Volatility<span style="font-style:normal;">.&#160;We have incorporated our historical stock trading volatility with those of our peer group for the calculation of volatility.&#160;&#160;Industry peers consist of several public companies in the medical device technology industry with comparable characteristics including enterprise value, risk profiles and position within the industry. We regularly evaluate our peer group to assess changes in circumstances where identified companies may no longer be similar to us, in which case, more suitable companies whose share prices are publicly available would be utilized in the calculation.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Dividend Yield<span style="font-style:normal;">.&#160;The expected dividend assumption is based on our current expectations about our anticipated dividend policy. We currently do not expect to issue any dividends.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to assumptions used in the Black-Scholes option-pricing model, we must also estimate a forfeiture rate to calculate the stock-based compensation for our awards. We will continue to use judgment in evaluating the assumptions related to our stock-based compensation on a prospective basis. As we continue to accumulate additional data, we may have refinements to our estimates, which could materially impact our future stock-based compensation expense.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2015, we began issuing restricted stock units (RSUs).&#160;&#160;We account for stock-based compensation for the RSUs at their fair value, based on the closing market price of our common stock on the grant date.&#160;&#160;These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2016, we granted performance based RSUs to our former CEO that only vest upon the achievement of specific operational performance criteria.&#160;&#160;The stock-based compensation for these performance based RSUs are recognized as expenses when it is determined that achieving the performance metrics are probable. Upon the former CEO&#8217;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2019, we granted performance stock units (PSUs) to our current CEO, which entitle him to receive a number of shares of our common stock based on our stock price performance compared to a specified target composite index over a three-year period.&#160;&#160;The number of shares to be issued upon vesting ranges from zero to 3.5 times the number of PSUs granted, depending on the relative performance of our common stock compared to the targeted composite index.&#160;&#160;In 2020 and 2021, the Company granted PSUs to certain member of the management team, subject to continued service to the Company and based on the total shareholder return of the Company&#8217;s </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">common stock price compared to the targeted composite index over a three-year period.&#160;&#160;The number of shares to be issued upon vesting of these PSUs range from 0 to 1.5 times the target number of shares granted, depending on the Company&#8217;s performance against the targeted composite index. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of these </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSUs</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.&#160;&#160;The e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">xpected volatility of our stock </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the target composite index</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The risk-free interest rate is based upon the treasury yield </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">consistent with the vesting </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">term of the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">grant</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The expected dividend yield is&#160;zero.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;Stock-based compensation for these </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSUs </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">is recognized over the specified performance measurement.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We estimate the fair value of the rights to purchase shares by employees under our Employee Stock Purchase Plan using the Black-Scholes option pricing formula. Our Employee Stock Purchase Plan provides for consecutive six-month offering periods and we use our own historical volatility data in the valuation.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Income Tax</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize deferred income taxes for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. We periodically evaluate the positive and negative evidence bearing upon realizability of our deferred tax assets. Based upon the weight of available evidence, which includes our historical operating performance, reported cumulative net losses since inception and difficulty in accurately forecasting our future results, we maintained a full valuation allowance on our net U.S. federal and state deferred tax assets as of December&#160;31, 2021 and 2020. We intend to maintain a full valuation allowance on the federal and state deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, we had federal net operating loss carryforwards (NOLs) of $588.4 million, of which $329.4 million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the 2017 Tax Act, as well as state NOLs of $336.5 million, of which $54.3 million may be carried forward indefinitely.&#160;&#160;If not utilized, the remaining federal NOLs will begin to expire in 2026 and the state NOLs will begin to expire in 2022.  We have no significant foreign NOL carryforwards.&#160;&#160;We also have federal research tax credit carryforwards that will begin to expire in 2026 and California research tax credits that do not expire. Realization of these NOL and research tax credit carryforwards depends on future income, and there is a risk that our existing carryforwards could expire unused and be unavailable to reduce future income tax liabilities, which could materially and adversely affect our results of operations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, under Section&#160;382 of the Internal Revenue Code of 1986, as amended (the Code) our ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if we experience, or have experienced, a Section 382 &#8220;ownership change.&#8221; A Section&#160;382 &#8220;ownership change&#8221; generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of our stock, increase their ownership by a greater than 50&#160;percentage point change (by value) over a rolling three-year period. Similar rules may apply under state tax laws.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No deferred tax assets have been recognized on our balance sheet related to our federal and state NOLs and tax credits, as they are fully reserved by a valuation allowance. We experienced a Section 382 &#8220;ownership change&#8221; as a result of our June 2015 underwritten public offering.&#160;&#160;We currently estimate this &#8220;ownership change&#8221; will not inhibit our ability to utilize our NOLs.&#160;&#160;However, we may, in the future, experience one or more additional Section&#160;382 &#8220;ownership changes&#8221; as a result of subsequent changes in our stock ownership, some of which changes are outside our control. If so, we may not be able to utilize a material portion of our NOLs and tax credits even if we achieve profitability and generate sufficient taxable income. If we are limited in our ability to use our NOLs and tax credits in future years in which we have taxable income, we will pay more taxes than if we were able to fully utilize our NOLs and tax credits. This could materially and adversely affect our results of operations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We record unrecognized tax benefits as liabilities and adjust these liabilities when our judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the unrecognized tax benefit liabilities. These differences will be reflected as increases or decreases to income tax </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">expense in the period in which new information is available. Our policy is to recognize interest and penalties related to income taxes as a component of income tax expense.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Allowance for Doubtful Accounts</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We make estimates as to the overall collectability of accounts receivable and provide an allowance for accounts receivable considered uncollectible based on current expected credit losses. We specifically analyze accounts receivable based on historical bad debt experience, customer concentrations, customer credit-worthiness, the age of the receivable, current economic trends, and changes in customer payment terms when evaluating the adequacy of the allowance for doubtful accounts. We record the adjustment in general and administrative expense. Our accounts receivable balance was $70.5 million, net of allowance of $1.4 million, as of December 31, 2021 and $77.7 million, net of allowance of $3.0 million, as of December 31, 2020.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Components of Results of Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our revenue is generated primarily from sales to two types of customers: hospitals and outpatient medical facilities, with each being served primarily through a direct sales force. Sales to these entities are billed to, and paid by, the hospitals and outpatient medical facilities as part of their normal payment processes, with payment received by us in the form of an electronic transfer, check or credit card payment. Product sales to third-party distributors are billed to and paid by the distributors as part of their normal payment processes, with payment received by us in the form of an electronic transfer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. revenue is generally recognized after our sales representatives deliver our product at the point of implantation and upon the completion and authorization of the implant procedure.&#160;&#160;In response to competitive practices and pressures, we have offered some volume price discounting for larger orders, where products are ordered in advance of an implantation and revenue is recognized when the transfer of control occurs at the time of shipment.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from sales of our Senza products fluctuate based on the selling price of the system, as the average sales price of a system varies geographically and by the type of system sold, and based on the mix of sales by geography. Our revenue from international sales can also be significantly impacted by fluctuations in foreign currency exchange rates, as our sales are denominated in the local currency in the countries in which we sell our products.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect our revenue to fluctuate from quarter to quarter due to a variety of factors, including seasonality.&#160;&#160;For example, the industry generally experiences lower revenues in the first and third quarters of the year and higher revenues in the fourth quarter.&#160;&#160;Our revenue has historically been impacted by these industry trends. Further, the impact of the buying patterns and implant volumes of hospitals and medical facilities, and third-party distributors may vary, and as a result could have an effect on our revenue from quarter to quarter. The normal seasonal fluctuations of our revenue have been disrupted by the COVID-19 pandemic, as we have seen significant fluctuations in our quarterly revenue based on current events directly caused by the pandemic. We have recorded revenue of approximately $326.0 million, $311.9 million and $326.2 million for the years ended December 31, 2019, 2020 and 2021, respectively, for sales in the United States.&#160;&#160;We anticipate that our total revenue will increase as we continue our commercialization in the United States.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cost of Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We utilize contract manufacturers for the production of Senza products. Cost of revenue consists primarily of acquisition costs of the components of Senza, manufacturing overhead, royalty payments, scrap and inventory excess and obsolescence charges, as well as distribution-related expenses, such as logistics and shipping costs, net of costs charged to customers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We calculate gross margin as revenue less cost of revenue divided by revenue. Our gross margin has been and will continue to be affected by a variety of factors, but primarily by our average sales price and the costs to have our </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">products manufactured. While costs are primarily incurred in U.S. dollars, international revenue may be impacted by the appreciation or depreciation of the U.S. dollar, which may impact our overall gross margin. Our gross margin is also affected by our ability to reduce manufacturing costs as a percentage of revenue.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Operating Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our operating expenses consist of R&#38;D expense, and sales, general and administrative (SG&#38;A) expense. Personnel costs are the most significant component of operating expenses and consist primarily of salaries, bonus incentives, benefits, stock-based compensation and sales commissions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Research and Development<span style="font-style:normal;">. R&#38;D costs are expensed as incurred. R&#38;D expense consists primarily of personnel costs, including salary, employee benefits and stock-based compensation expenses for our R&#38;D employees. R&#38;D expense also includes costs associated with product design efforts, development prototypes, testing, clinical trial programs and regulatory activities, contractors and consultants, equipment and software to support our development, facilities and information technology. We expect product development expenses to increase in absolute dollars as we continue to develop product enhancements to Senza. Our R&#38;D expenses may fluctuate from period to period due to the timing and extent of our R&#38;D and clinical trial expenses.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Sales, General and Administrative<span style="font-style:normal;">. SG&#38;A expense consists primarily of personnel costs, including salary, employee benefits and stock-based compensation expenses for our sales and marketing personnel, including sales commissions, and for administrative personnel that support our general operations, such as information technology, executive management, financial accounting, customer service and human resources personnel. We expense commissions at the time of the sale. SG&#38;A expense also includes costs attributable to marketing, as well as travel, intellectual property and other legal fees, financial audit fees, insurance, fees for other consulting services, depreciation and facilities.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We significantly increased the size of our sales presence worldwide during 2019, and we have maintained the overall size of our sales organization in 2020.&#160;&#160;In 2021, we established a sales organization to support the launch of our PDN indication in the U.S. This sales organization targets physician specialties involved in PDN treatment decisions, including primary care physicians, endocrinologists, internal medicine and podiatrists, to create awareness of 10 kHz Therapy to treat PDN patients. In the last three years, we have increased marketing spending in order to generate additional sales opportunities. Additionally, we have made substantial investments in our U.S. commercial infrastructure to support our commercialization efforts in the United States. We expect SG&#38;A expenses to decrease as a percent of revenue as we engage in activities that leverage our existing sales and marketing personnel to support the commercialization of our products in the United States.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During 2019, 2020 and 2021 we had experienced significant legal expenses associated with our intellectual property litigation with Boston Scientific. We anticipate significant continued expenses associated with these legal activities. Additionally, we continue to incur significant expenses related to audit, legal, regulatory and tax-related services associated with maintaining compliance with exchange listing and SEC requirements, including compliance under the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act), director and officer insurance premiums and investor relations costs associated with being a public company. Our SG&#38;A expense may fluctuate from period to period due to the seasonality of our revenue, the timing and extent of our SG&#38;A expense, and the direct impact of the COVID-19 pandemic on certain discretionary spend items such as travel and trade shows.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Certain litigation charges</span><span style="Background-color:#FFFFFF;font-style:normal;">.&#160;We record a liability for loss contingencies related to legal actions when a loss is known or considered probable and the amount may be reasonably estimated. When determining the estimated loss or range of loss, significant judgment is required.&#160;We record litigation charges that we consider to be unusual or infrequent and significant as&#160;</span><span style="Background-color:#FFFFFF;">Certain litigation charges</span><span style="Background-color:#FFFFFF;font-style:normal;">&#160;in our consolidated statements of operations.&#160;&#160;All other legal expenses are recorded within SG&#38;A expense.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Interest Income and Interest Expense</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income consists primarily of interest income earned on our investments and interest expense consists of interest paid on our outstanding debt and the amortization of debt discount and debt issuance costs.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Other Income (Expense), Net</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense), net consists primarily of foreign currency transaction gains and losses and the gains and losses from the remeasurement of foreign-denominated balances to the U.S. dollar.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Provision for Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The provision for income taxes consists primarily of income taxes in foreign jurisdictions in which we conduct business as well as states where we have determined we have state nexus. We maintain a full valuation allowance for substantially all of our deferred tax assets including net operating loss (NOL) carryforwards and federal and state tax credits.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For recent accounting pronouncements, see Note&#160;2, <span style="font-style:italic;">Summary of Significant Accounting Policies</span>, of Notes to Consolidated Financial Statements in Part&#160;II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Comparison of the Years Ended December&#160;31, 2021 and 2020</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Revenue, Cost of Revenue, Gross Profit and Gross Margin</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386,905</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">362,048</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,857</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,863</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112,146</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,717</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross profit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">266,042</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">249,902</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,140</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross margin</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:double 2.5pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:double 2.5pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:double 2.5pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0)%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Revenue<span style="font-style:normal;">.&#160;Revenue increased to $386.9 million in 2021 from $362.0&#160;million in 2020, an increase of $24.9&#160;million, or 7%.  Revenue in the United States was $326.2 million in 2021, a 5% increase from $311.9 million in the 2020.&#160;&#160;International revenue was $60.7 million in 2021, compared to $50.2 million in 2020. Our revenue in 2020 was negatively impacted by the COVID-19 pandemic, when we experienced worldwide decline in procedure volume in the first half of 2020, as healthcare systems diverted resources to meet the increasing demands of managing COVID-19 and as elective procedures were significantly limited or halted, which was offset by some recovery in revenue in the second half of 2020 due to the rescheduling of implant procedures from the first half of 2020. We experienced some recovery from the pandemic in the first half of 2021, although the Delta and Omicron variants disrupted the pace of this recovery in the second half of 2021. Compared to 2020, our overall unit shipments increased in 2021. </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Cost of Revenue, Gross Profit and Gross Margin<span style="font-style:normal;">.&#160;Cost of revenue increased to $120.9 million in 2021, compared to $112.1 million in 2020, an increase of $8.7 million, or 8%.&#160;&#160;This increase was primarily due to an increase of $9.1 million in the costs of manufactured product components and $4.3 million related to costs associated to initiating the manufacturing facility in Costa Rica, offset by a decrease of $3.1 million in royalty expenses and $1.6 million under-absorption of overhead in 2020. Gross profit increased to $266.0 million in 2021 from $249.9 million in 2020, an increase of $16.1 million, or 6%.&#160;&#160;Gross profit as a percentage of revenue, or gross margin, remained steady at 69% in 2021 and 2020.</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Operating Expenses</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">% of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">% of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,665</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,600</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,065</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, general and administrative</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">309,311</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267,154</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,157</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain litigation charges</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">376,976</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">312,754</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,222</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Research and Development (R&#38;D) Expenses<span style="font-style:normal;">.&#160;R&#38;D expenses increased to $47.7 million in 2021 from $45.6 million in 2020, an increase of $2.1 million, or 5%. The increase was primarily due to an increase in development activities of $2.5 million and personnel costs of $1.7 million, which were partially offset by a decrease in clinical and regulatory expenses of $2.1 million. </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Sales, General and Administrative (SG&#38;A) Expenses<span style="font-style:normal;">.&#160;SG&#38;A expenses increased to $309.3 million in 2021 from $267.2 million in 2020, an increase of $42.2 million, or 23%. This increase was primarily driven by increased legal expenses of $13.9 million related to ongoing intellectual property litigation efforts, marketing and PDN related initiative expenses of $12.8 million, consulting and contract labor expenses of $5.7 million, personnel expenses of $6.3 million, and travel and meeting expenses of $3.5 million.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Certain litigation charges<span style="font-style:normal;">.&#160;Certain litigation charges in 2021 relates to the jury award of $20.0 million to Boston Scientific in connection with our patent infringement proceedings. We plan to appeal the decision, which may take approximately 18 to 24 months to resolve.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Interest Income, Interest Expense, Other Income (Expense), Net, Loss on Extinguishment of Debt and Provision for Income Taxes</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">671</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,956</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,285</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,749</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,806</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,057</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense), net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(814</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(495</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(319</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision for income taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">534</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">868</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(334</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Interest Income<span style="font-style:normal;">.&#160;Interest income decreased to $0.7 million in 2021 from $3.0 million in 2020, primarily as a result of a decrease in our investment yield rate, as well as a decreased cash balance from the settlement of our 2021 Notes.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Interest Expense<span style="font-style:normal;">.&#160;Interest expense decreased to $19.7 million in 2021 from $21.8 million in 2020. There was a $6.5 million</span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;"> decrease in expenses for the </span><span style="font-style:normal;">interest and amortization of debt discount and debt issuance costs related to the 2021 Notes, which were settled in June 2021.&#160;&#160;This decrease was offset by an increase of $4.4 million for similar expenses related to the 2025 Notes, which was outstanding for the full year in 2021 compared to nine months in 2020</span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Other Income (Expense), Net<span style="font-style:normal;">.&#160;Other income (expense), net was primarily comprised of foreign currency transaction gains and losses, and the gains and losses from the remeasurement of foreign-denominated balances. We recorded a net loss of $0.7 million in 2021 and a net gain of $41,000 in 2020 relation to the two items previously mentioned.&#160;&#160;Our remeasurement gains and losses are affected by changes in the foreign currency translation rates of </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">the countries in which we conduct business.</span><span style="font-style:normal;"> </span><span style="font-style:normal;">Additionally, </span><span style="font-style:normal;">in 2</span><span style="font-style:normal;">020, we recorded a net expense of $0.4 million for the impairment charge related to the value of the right to acquire a privately-held company.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Income Tax Expense<span style="font-style:normal;">.&#160;Income tax expense was $0.5 million in 2021 and $0.9 million in 2020. Our income tax expense is associated primarily with foreign and state income taxes. We continue to generate tax losses for U.S. federal and state tax purposes and have NOL carryforwards creating a deferred tax asset. We have a full valuation allowance on the majority of our deferred tax assets. The change in income tax expense was primarily due to changes in foreign income taxes on profits realized by our foreign subsidiaries.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liquidity, Capital Resources and Plan of Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since our inception, we have financed our operations through private placements of preferred stock, the issuance of common stock in our IPO in November 2014 and our underwritten public offering in June 2015, borrowings under our credit facility, which we have subsequently repaid, and the June 2016 issuance of convertible senior notes due 2021. In April 2020, we completed a concurrent underwritten public offering of common stock and convertible senior notes due 2025.&#160;&#160;Our total net proceeds from the April 2020 offerings, after giving effect to the note hedge transactions and warrant transactions and associated offering expense was $313.3 million. On June 1, 2021, our outstanding 2021 Notes matured and we paid $172.5 million to settle the outstanding principal and issued 682,912 shares of common stock to holders who elected to convert the 2021 Notes. At December 31, 2021, we had cash, cash equivalents and short-term investments of $362.0 million. Based on our current operating plan, we expect that our cash and cash equivalents on hand, together with the anticipated funds from the collection of our receivables, will be sufficient to fund our operations through at least the next 12 months.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">We expect to incur continued expenditures in the future in support of our commercial infrastructure and sales force. In addition, we intend to continue to make investments in the further development of our Senza product platform and 10 kHz Therapy for the treatment of other chronic pain conditions, including ongoing R&#38;D programs and conducting clinical trials. Further, we expect to expend significant cash resources pursuing and defending our ongoing intellectual property lawsuits. In order to further enhance our R&#38;D efforts, pursue product expansion opportunities or acquire a new business or products that are complementary to our business, we may choose to raise additional funds.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">We may continue to seek funds through equity or debt financings, or through other sources of financing. Adequate additional funding may not be available to us on acceptable terms or at all. Our failure to raise capital in the future could have a negative impact on our financial condition and our ability to pursue our business strategies. Should we choose to raise additional capital, the requirements will depend on many factors, including:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the impact and duration of the ongoing COVID-19 pandemic and any recession or other market correction resulting from the pandemic&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">the costs related to the continued commercialization of our products in the United States and elsewhere, including product sales, marketing, manufacturing and distribution&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">the cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights, including, in particular, the costs of enforcing our patent rights in the action we filed against Boston Scientific and in defending against Boston Scientific&#8217;s action against us&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;">the R&#38;D activities we intend to undertake in order to expand the chronic pain indications and product enhancements that we intend to pursue&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">whether or not we pursue acquisitions or investments in businesses, products or technologies that are complementary to our current business&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the degree and rate of market acceptance of our products in the United States and elsewhere&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">changes or fluctuations in our inventory supply needs and forecasts of our supply needs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">costs related to the development of our internal manufacturing capabilities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our need to implement additional infrastructure and internal systems&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our ability to hire additional personnel to support our operations as a public company&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the emergence of competing technologies or other adverse market developments.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Our success depends, in part, upon our ability to establish a competitive position in the neuromodulation market by securing broad market acceptance of our 10 kHz Therapy and our Senza product platform for the treatment of chronic pain conditions. Any product we develop that achieves regulatory clearance or approval will have to compete for market acceptance and market share. We face significant competition in the United States and internationally, which we believe will intensify as we continue to commercialize in the United States.&#160;&#160;For example, our major competitors, Medtronic, Boston Scientific and Abbott Laboratories, each have approved neuromodulation systems in at least the United States, Europe and Australia and have been established for several years. In addition to these major competitors, we may also face competition from other emerging competitors and smaller companies with active neuromodulation system development programs that may emerge in the future.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">If we are unable to raise, or have access, to sufficient funds when needed, we may be required to delay, reduce, or terminate some or all of our commercial development plans.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the primary sources and uses of cash for each of the periods presented below:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by (used in)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(41,881</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,191</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(50,225</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201,715</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(369,868</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,330</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(169,381</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">346,905</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,093</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of exchange rate on cash flows</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(340</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">646</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">259</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net increase (decrease) in cash, cash equivalents and restricted cash</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,887</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,126</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,457</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Cash Provided by (Used in) Operating Activities<span style="font-style:normal;">.&#160;Net cash used in operating activities was $41.9 million for the year ended December&#160;31, 2021, primarily due to the net losses during the period of $131.4 million. The cash used in operating activities for the year ended December&#160;31, 2021 was also affected by an increase in inventories of $17.2 million.&#160;&#160;These changes were offset by a net increase in accounts payable and accrued liabilities of $12.2 million, an increase in other long-term liabilities of $14.2 million and a decrease in accounts receivable of $8.2 million, as well as non-cash stock based compensation expense of $44.4 million, non-cash interest expense of $13.3 million, depreciation and amortization of $4.9 million, write-down of inventories of $4.3 million and amortization of operating lease assets of $3.8 million. Net cash provided by operating activities was $1.2 million for the year ended December 31, 2020. The cash provided by operating activities for the year ended December&#160;31, 2020 was affected by a decrease in prepaids and other assets of $7.5 million, a decrease in accounts receivable of $3.4 million, and a decrease in inventory of $2.5 million, as well as non-cash stock based compensation expense of $42.7 million, non-cash interest expense of $14.9 million, inventory write-down of $5.4 million, depreciation and amortization of $4.8 million, amortization of operating lease assets of $3.4 million and provision of doubtful accounts of $2.2 million.&#160;&#160;These changes were offset by a net loss of $83.1 million for the year and a decrease in long term liabilities of $2.4 million. Net cash used in operating activities was $50.2 million for the year ended December&#160;31, 2019, primarily due to the net losses during the period of $103.7 million. The cash used in operating activities for the year ended December&#160;31, 2019 was affected by an increase in accounts receivable of $2.2 million and an increase in prepaids and other assets of $3.2 million.&#160;&#160;These changes were offset by a net increase in accounts payable and accrued liabilities of $5.7 million and write-down of inventories of $1.5 million, as well as non-cash stock based compensation expense of $41.7 million, non-cash interest expense of $7.9 million, depreciation and amortization of $4.6 million and amortization of operating lease assets of $3.2 million.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Cash Used in Investing Activities<span style="font-style:normal;">.&#160;Investing activities consisted primarily of changes in investment balances, including purchases and maturities of short-term investments, and purchases of property and equipment. For the year ended December 31, 2021, we had net proceeds from the sales and maturity of investments of $214.1 million and purchases in property and equipment of $12.3 million. For the year ended December 31, 2020, we had net purchases of investments of $371.3 million and purchases in property and equipment of $6.0 million, offset by the receipt of </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">$7.5 million for the repayment of secured convertible notes from a private company</span><span style="font-style:normal;">.</span><span style="font-style:normal;"> </span><span style="font-style:normal;">For the year ended December 31, 2019, we had </span><span style="font-style:normal;">net</span><span style="font-style:normal;"> proceeds from the sales and maturity of investments of $43.3 million, offset by purchases in property and equipment of $3.5 million.&#160;&#160;Additionally, we purchased secured convertible notes totaling $7.5 million in the year ended December 31, 2019.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Cash Provided by Financing Activities<span style="font-style:normal;">.&#160;Cash used in financing activities was $169.4 million for the year ended December 31, 2021. We paid $172.5 million to settle the principal for our 2021 Notes. Additionally, we had tax withholdings of $8.1 million, offset by proceeds from issuance of common stock of $11.2 million.&#160;&#160;Cash provided by financing activities was $346.9 million for the year ended December 31, 2020. The majority of this cash was from the proceeds of $183.6 million, net of issuance costs, from the 2025 Notes and the proceeds of $147.1 million, net of issuance costs, from the concurrent public common stock offering.&#160;&#160;The cash received from these activities was offset by a net $17.5 million cost of convertible note hedge and warrant transactions, which included the $52.4 million purchase of convertible note hedges and proceeds of $34.9 million related to the sale of warrants.&#160;&#160;Additionally, we received cash of $33.6 million from the issuance of common stock to employees pursuant to the exercise of employee stock options and our employee stock purchase plan, net of tax withholdings. Cash provided by financing activities was $32.1 million for the year ended December 31, 2019, primarily due to the cash received from the issuance of common stock to employees of $35.2 million pursuant to the exercise of employee stock options and our employee stock purchase plan, offset by $3.1 million for tax withholdings paid on behalf of employees for net share settlement.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Contractual Obligations and Commitments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have lease obligations primarily consisting of operating leases for our principal offices, which expire as set forth below, and for our warehouse space that expires in 2022. In 2020, we also entered into an operating lease for a manufacturing facility with a planned commencement date of April 2021 and a planned expiration date of June 2031.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In March 2015, we entered into a lease agreement for approximately 50,740 square feet of office space located in Redwood City, California for a period beginning in June 2015 and ending in May 2022, with initial annual payments of approximately $2.0 million, increasing to $2.4 million annually in the final year of the lease term.&#160;&#160;In December 2016, we entered into a first amendment to the lease for an additional approximately 49,980 square feet of office space adjacent to the premises under the original lease (the Expansion Premises) with initial annual payments of $1.2 million, increasing to $2.9 million in the final year of the amended lease term.&#160;&#160;</span><span style="Background-color:#FFFFFF;color:#000000;">The lease for the Expansion Premises commenced on June 1, 2018</span><span style="Background-color:#FFFFFF;">.&#160;&#160;The first amendment also extends the lease term for the original premises to terminate on the same date as the amended lease, which is May 31, 2025.&#160;&#160;In April 2017, we entered into a second amendment to the lease for a temporary space of approximately 8,171 square feet for a period beginning in May 2017, and which ended on June 1, 2018, the Commencement Date of the Expansion Premises.&#160;&#160;</span><span style="color:#000000;">See Note 7,</span><span style="font-style:italic;color:#000000;"> Commitments and Contingencies</span><span style="color:#000000;">,</span><span style="color:#000000;"> of Notes to Consolidated Financial Statements for additional information.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2017, we entered into a separate non-cancellable facility lease for warehouse space beginning March 1, 2017 through February 28, 2022, under which we are obligated to pay approximately $0.4 million in lease payments over the term of the lease. In October 2021, we extended our warehouse lease through May 2025, under which we are obligated to pay approximately $0.4 million over the extended term.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, we entered into a lease for approximately 35,411 square feet of manufacturing space to begin in April 2021 and to last through June 2031 at a facility in Costa Rica, under which we are obligated to pay approximately $3.9 million in lease payments over the term of the lease. We plan to use this facility to build-out certain manufacturing capabilities so that we can vertically integrate the assembly of IPG&#8217;s, peripherals and various other manufacturing related activities.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have also entered into a service agreement for which we are committed to pay $2.5 million in each of the next three years over the term of the service agreement, as well as a license agreement for which we are committed to pay $0.2 million over the remaining term of license agreement.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 202</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, our contractual obligations related to the 2025 Notes are payments of interest of $5.2 million due each year from 202</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> through 2024, and payments of interest and principal totaling $192.4 million due in 2025.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes our contractual obligations as of December&#160;31, 2021 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="18" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Payment date by period</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Less&#160;than&#160;1&#160;year</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1 to 3 years</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4 to 5 years</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">More&#160;than&#160;5&#160;years</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="18" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notes payable, including contractual interest</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">208,013</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,218</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,436</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,359</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,173</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,720</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,220</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,254</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,979</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase obligations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,520</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,506</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,014</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">239,706</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,444</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,670</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">195,613</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,979</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Off-Balance Sheet Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Through December&#160;31, 2021, we did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For information regarding indemnification obligations, refer to Note 7, <span style="font-style:italic;">Commitments and Contingencies</span>, of Notes to the Consolidated Financial Statements within Part II, Item&#160;8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Segment Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have one primary business activity and operate as one reportable segment.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS">ITEM&#160;7A.&#160;<span style="font-style:italic;">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Interest Rate Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are exposed to limited market risk related to fluctuations in interest rates and market prices. Our primary exposure to market risk is interest rate sensitivity, which is affected by changes in the general level of U.S. interest rates. The primary objective of our investment activities is to preserve our capital to fund our operations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also seek to maximize income from our investments without assuming significant risk. To achieve our objectives, we maintain a portfolio of cash equivalents and investments in a variety of securities of high credit quality. As of December&#160;31, 2021, we had cash and cash equivalents of $34.7&#160;million, consisting of cash, corporate notes and money market funds, and short-term investments of $327.3&#160;million, consisting of agency bonds, commercial paper, corporate notes and treasury bonds. We maintained investments in money market funds that were not federally insured during the year ended December&#160;31, 2021 and held cash in foreign banks of approximately $8.6 million at December&#160;31, 2021 that was not federally insured. A portion of our investments may be subject to interest rate risk and could fall in value if market interest rates increase. However, because our investments are primarily short-term in duration, we believe that our exposure to interest rate risk is not significant. We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure. A hypothetical 1% change in interest rates during any of the periods presented would not have had a material impact on our consolidated financial statements.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Foreign Currency Exchange Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, a portion of our revenue and operating expenses are incurred outside the United States and are denominated in foreign currencies and are subject to fluctuations due to changes in foreign currency exchange rates, particularly changes in the Australian dollar, the Euro and the United Kingdom pound sterling. Additionally, fluctuations in foreign currency exchange rates may cause us to recognize transaction gains and losses in our statement of operations. As a component of other income (expense), we recognized net foreign currency transaction </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.7</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the year ended December 31, 202</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains of $41,000 for the year ended December 31, 2020 and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$0.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">each of the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">year</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ended December 31, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. A hypothetical 10% favorable or unfavorable change in the weighted average foreign exchange rates for the year ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21 </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">would have affected the Company&#8217;s net loss by approximately </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%. To date, we have not engaged in any foreign currency hedging transactions. As our international operations grow, we will continue to reassess our approach to managing the risks relating to fluctuations in currency rates.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not believe that inflation and change in prices had a significant impact on our results of operations for any periods presented in our consolidated financial statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 2, <span style="font-style:italic;">Summary of Significant Accounting Policies</span>, of Notes to Consolidated Financial Statements for further information on foreign currency translation.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Market Risk and Market Interest Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, we issued $172.5 million aggregate principal amount of 1.75% convertible senior notes due 2021. On June 1, 2021, these 2021 Notes matured and we settled the 2021 Notes by paying $172.5 million to settle the outstanding principal and issuing 682,912 shares of common stock to holders who elected to convert the 2021 Notes. In addition, we exercised our option under the bond hedge and received 682,916 shares of common stock from the bank counterparties. None of the holders of the warrants associated with the 2021 Notes exercised the option to purchase shares.&#160;&#160;As of December 31, 2021, the 2021 Notes were no longer outstanding. In April 2020, we issued $189.8 million aggregate principal amount of 2.75% convertible senior notes due 2025. The fair value of these convertible senior notes is subject to interest rate risk, market risk and other factors due to the convertible feature.&#160;&#160;The fair value of the convertible senior notes will generally increase as our common stock price increases and will generally decrease as our common stock price declines in value.&#160;&#160;The interest and market value changes affect the fair value of our convertible senior notes but do not impact our financial position, cash flows or results of operations due to the fixed nature of the debt obligation.&#160;&#160;Additionally, we carry the convertible senior notes at face value less unamortized discount on our balance sheet, and we present the fair value for required disclosure purposes only.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 8, <span style="font-style:italic;">Long-term Debt</span>, of Notes to Consolidated Financial Statements for further information.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR">ITEM&#160;8.&#160;<span style="font-style:italic;">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following consolidated financial statements, and the related notes thereto, of Nevro Corp. and the Report of the Company&#8217;s Independent Registered Public Accounting Firm are filed as a part of this Annual Report.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#333333;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#333333;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Report of Independent Registered Public Accounting Firm</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11.5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To<span style="letter-spacing:-0.15pt;"> </span>the<span style="letter-spacing:-0.1pt;"> </span>Board<span style="letter-spacing:-0.1pt;"> </span>of<span style="letter-spacing:-0.15pt;"> </span>Directors<span style="letter-spacing:-0.1pt;"> </span>and<span style="letter-spacing:-0.1pt;"> </span>Stockholders<span style="letter-spacing:-0.15pt;"> </span>of<span style="letter-spacing:-0.15pt;"> </span>Nevro<span style="letter-spacing:-0.2pt;"> </span>Corp.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Opinions on the Financial Statements and Internal Control over Financial Reporting</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:1.07%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have audited the accompanying consolidated balance sheets of Nevro Corp. and its<span style="letter-spacing:0.05pt;"> </span>subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, and the related consolidated<span style="letter-spacing:0.05pt;"> </span>statements<span style="letter-spacing:-0.2pt;"> </span>of<span style="letter-spacing:-0.2pt;"> </span>operations<span style="letter-spacing:-0.15pt;"> </span>and<span style="letter-spacing:-0.15pt;"> </span>comprehensive<span style="letter-spacing:-0.15pt;"> </span>loss,<span style="letter-spacing:-0.2pt;"> </span>of<span style="letter-spacing:-0.2pt;"> </span>stockholders&#8217;<span style="letter-spacing:-0.2pt;"> </span>equity<span style="letter-spacing:-0.25pt;"> </span>and<span style="letter-spacing:-0.15pt;"> </span>of<span style="letter-spacing:-0.2pt;"> </span>cash<span style="letter-spacing:-0.2pt;"> </span>flows<span style="letter-spacing:-0.2pt;"> </span>for<span style="letter-spacing:0.05pt;"> </span>each of the three years in the period ended December 31, 2021, including the related notes<span style="letter-spacing:0.05pt;"> </span>(collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the<span style="letter-spacing:0.05pt;"> </span>Company's internal control over financial reporting as of December 31, 2021, based on criteria<span style="letter-spacing:0.05pt;"> </span>established in <span style="font-style:italic;">Internal Control - Integrated Framework </span>(2013) issued by the Committee of<span style="letter-spacing:0.05pt;"> </span>Sponsoring<span style="letter-spacing:-0.1pt;"> </span>Organizations<span style="letter-spacing:-0.05pt;"> </span>of<span style="letter-spacing:-0.05pt;"> </span>the<span style="letter-spacing:-0.05pt;"> </span>Treadway<span style="letter-spacing:-0.05pt;"> </span>Commission<span style="letter-spacing:-0.05pt;"> </span>(COSO).</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In our opinion, the consolidated financial statements referred to above present fairly, in all<span style="letter-spacing:0.05pt;"> </span>material respects, the financial position of the Company as of December 31, 2021 and 2020, and<span style="letter-spacing:0.05pt;"> </span>the results of its operations and its cash flows for each of the three years in the period ended<span style="letter-spacing:0.05pt;"> </span>December 31, 2021 in conformity with accounting principles generally accepted in the United<span style="letter-spacing:0.05pt;"> </span>States<span style="letter-spacing:-0.2pt;"> </span>of<span style="letter-spacing:-0.1pt;"> </span>America.<span style="letter-spacing:-0.15pt;"> </span>Also<span style="letter-spacing:-0.1pt;"> </span>in<span style="letter-spacing:-0.15pt;"> </span>our<span style="letter-spacing:-0.15pt;"> </span>opinion,<span style="letter-spacing:-0.15pt;"> </span>the<span style="letter-spacing:-0.15pt;"> </span>Company<span style="letter-spacing:-0.15pt;"> </span>maintained,<span style="letter-spacing:-0.2pt;"> </span>in<span style="letter-spacing:-0.15pt;"> </span>all<span style="letter-spacing:-0.1pt;"> </span>material<span style="letter-spacing:-0.15pt;"> </span>respects,<span style="letter-spacing:-0.15pt;"> </span>effective<span style="letter-spacing:-2.3pt;"> </span>internal control over financial reporting as of December 31, 2021, based on criteria established in<span style="letter-spacing:0.05pt;"> </span><span style="font-style:italic;">Internal</span><span style="font-style:italic;letter-spacing:-0.05pt;"> </span><span style="font-style:italic;">Control -</span><span style="font-style:italic;letter-spacing:-0.1pt;"> </span><span style="font-style:italic;">Integrated</span><span style="font-style:italic;letter-spacing:-0.05pt;"> </span><span style="font-style:italic;">Framework</span><span style="font-style:italic;letter-spacing:-0.05pt;"> </span>(2013) issued<span style="letter-spacing:-0.05pt;"> </span>by<span style="letter-spacing:-0.1pt;"> </span>the<span style="letter-spacing:-0.05pt;"> </span>COSO.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Basis for Opinions</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:1.07%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company's management is responsible for these consolidated financial statements, for<span style="letter-spacing:0.05pt;"> </span>maintaining effective internal control over financial reporting, and for its assessment of the<span style="letter-spacing:0.05pt;"> </span>effectiveness of internal control over financial reporting, included in Management&#8217;s Annual<span style="letter-spacing:0.05pt;"> </span>Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility<span style="letter-spacing:-2.35pt;"> </span>is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's<span style="letter-spacing:0.05pt;"> </span>internal control over financial reporting based on our audits. We are a public accounting firm<span style="letter-spacing:0.05pt;"> </span>registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and<span style="letter-spacing:0.05pt;"> </span>are required to be independent with respect to the Company in accordance with the U.S. federal<span style="letter-spacing:0.05pt;"> </span>securities laws and the applicable rules and regulations of the Securities and Exchange<span style="letter-spacing:0.05pt;"> </span>Commission<span style="letter-spacing:-0.1pt;"> </span>and the PCAOB.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:4.27%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We conducted our audits in accordance with the standards of the PCAOB. Those standards<span style="letter-spacing:0.05pt;"> </span>require that we plan and perform the audits to obtain reasonable assurance about whether the<span style="letter-spacing:-2.35pt;"> </span>consolidated financial statements are free of material misstatement, whether due to error or<span style="letter-spacing:0.05pt;"> </span>fraud, and whether effective internal control over financial reporting was maintained in all<span style="letter-spacing:0.05pt;"> </span>material<span style="letter-spacing:-0.05pt;"> </span>respects.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Definition and Limitations of Internal Control over Financial Reporting</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company&#59; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">only in accordance with authorizations of management and directors of the company&#59; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or d</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">isposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Critical Audit Matters</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Inventory Valuation - Excess and Obsolete Inventory</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As described in Notes 2 and 6 to the consolidated financial statements, inventories are stated at the lower of cost or net realizable value. Management regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. Inventory write downs are recorded for excess and obsolete inventory. Management estimates forecasted sales considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence, and technological innovations. As of December 31, 2021, total inventories were $93.5 million. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The principal considerations for our determination that performing procedures relating to inventory valuation - excess and obsolete inventory is a critical audit matter are the significant judgment by management to estimate the excess and obsolete inventory provision, related to an analysis of forecasted sales. This in turn led to significant auditor judgment, subjectivity, and effort in performing procedures to test management&#8217;s estimates about forecasted sales and in evaluating the audit evidence obtained. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to inventory valuation and the excess and obsolete inventory provision, including controls over development of the forecasted sales. These procedures also included, among others, testing management&#8217;s process for estimating the excess and obsolete inventory provision, including evaluating the appropriateness of the analysis of forecasted sales and testing the completeness, accuracy and relevance of underlying data used in the analysis.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Evaluating management&#8217;s analysis of forecasted sales involved evaluating whether the assumptions used by management were reasonable considering management&#8217;s forecasting accuracy and whether these assumptions were consistent with evidence obtained in other areas of the audit.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ PricewaterhouseCoopers LLP </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">San Jose, California</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have served as the Company&#8217;s auditor since 2008.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nevro Corp.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_BALANCE_SHEETS">Consolidated Balance Sheets</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share data)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000037" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,710</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000038" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">44,597</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000039" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">327,317</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000040" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">543,373</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000092" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,385</ix:nonFraction></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000093" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,000</ix:nonFraction> at December 31, 2021 and 2020, respectively</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000041" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">70,475</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000042" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">77,667</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000043" name="us-gaap:InventoryNet" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">93,517</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000044" name="us-gaap:InventoryNet" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">83,296</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000045" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,185</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000046" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,173</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000047" name="us-gaap:AssetsCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">531,204</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000048" name="us-gaap:AssetsCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">753,106</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000049" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,664</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000050" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,531</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000051" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,577</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000052" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,142</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000053" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,493</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000054" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,043</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000055" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_0001444380_20211231" decimals="-3" scale="3">606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000056" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_0001444380_20201231" decimals="-3" scale="3">606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000057" name="us-gaap:Assets" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">574,544</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000058" name="us-gaap:Assets" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">789,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities and stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000059" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000060" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,109</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000061" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,517</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000062" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,305</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term debt</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000063" name="us-gaap:ShortTermBorrowings" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">168,776</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000064" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,687</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000065" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,975</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000066" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">82,203</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000067" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">239,165</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term debt</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000068" name="us-gaap:LongTermDebtNoncurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">151,310</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000069" name="us-gaap:LongTermDebtNoncurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">141,771</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000070" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,402</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000071" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,689</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000072" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,013</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000073" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000074" name="us-gaap:Liabilities" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">270,928</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000075" name="us-gaap:Liabilities" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">400,968</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies (Note 7)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000076">&#160;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000077">&#160;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000094" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001444380_20211231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000095" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001444380_20201231" decimals="INF">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="U_xbrlishares" id="F_000096" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000097" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001444380_20201231" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized at</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December 31, 2021 and 2020, respectively&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000098" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001444380_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000099" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001444380_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000100" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001444380_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000101" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001444380_20201231" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; outstanding at December 31, 2021 and 2020, respectively</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000078">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000079">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000102" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001444380_20211231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000103" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001444380_20201231" decimals="INF">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="U_xbrlishares" id="F_000104" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000105" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001444380_20201231" decimals="INF" format="ixt:numdotdecimal">290,000,000</ix:nonFraction></ix:nonFraction> shares authorized at</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December 31, 2021 and 2020, respectively&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000106" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal">35,709,570</ix:nonFraction> shares issued and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; <ix:nonFraction unitRef="U_xbrlishares" id="F_000108" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal">35,026,654</ix:nonFraction> shares outstanding at December 31, 2021&#59;&#160;&#160;<ix:nonFraction unitRef="U_xbrlishares" id="F_000107" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001444380_20201231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000109" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001444380_20201231" decimals="INF" format="ixt:numdotdecimal">34,583,064</ix:nonFraction></ix:nonFraction> shares</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; issued and outstanding at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000080" name="us-gaap:CommonStockValue" contextRef="C_0001444380_20211231" decimals="-3" scale="3">35</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000081" name="us-gaap:CommonStockValue" contextRef="C_0001444380_20201231" decimals="-3" scale="3">35</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000082" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">928,138</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000083" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">880,660</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive income / (loss)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000084" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001444380_20211231" decimals="-3" sign="-" scale="3">364</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000085" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001444380_20201231" decimals="-3" scale="3">598</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000086" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001444380_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">624,193</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000087" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001444380_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">492,833</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000088" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">303,616</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000089" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">388,460</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000090" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">574,544</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000091" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">789,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nevro Corp.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STATEMENTS_OPERATIONS_COMPR">Consolidated Statements of Operations and Comprehensive Loss</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share data)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000110" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">386,905</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000111" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">362,048</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000112" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">390,255</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000113" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">120,863</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000114" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">112,146</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000115" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">121,905</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross profit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000116" name="us-gaap:GrossProfit" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">266,042</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000117" name="us-gaap:GrossProfit" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">249,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000118" name="us-gaap:GrossProfit" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">268,350</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000119" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">47,665</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000120" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,600</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000121" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">59,017</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, general and administrative</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000122" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">309,311</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000123" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">267,154</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000124" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">305,812</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain litigation charges</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000125" name="us-gaap:LitigationSettlementExpense" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000126" name="us-gaap:OperatingExpenses" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">376,976</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000127" name="us-gaap:OperatingExpenses" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">312,754</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000128" name="us-gaap:OperatingExpenses" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">364,829</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000129" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">110,934</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000130" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">62,852</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000131" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">96,479</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000132" name="us-gaap:InvestmentIncomeInterest" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">671</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000133" name="us-gaap:InvestmentIncomeInterest" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,956</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000134" name="us-gaap:InvestmentIncomeInterest" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,020</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000135" name="us-gaap:InterestExpense" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,749</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000136" name="us-gaap:InterestExpense" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,806</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000137" name="us-gaap:InterestExpense" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,931</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense), net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000138" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" scale="3">814</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000139" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" scale="3">495</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000140" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" scale="3">697</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000141" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">130,826</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000142" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">82,197</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000143" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">102,087</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision for income taxes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000144" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">534</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000145" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">868</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000146" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,599</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000147" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">131,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000148" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">83,065</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000149" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">103,686</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive loss:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in foreign currency translation adjustment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000150" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" scale="3">469</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000151" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">991</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000152" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">449</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in unrealized gains (losses) on short-term investments, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000153" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" scale="3">493</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000154" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" scale="3">80</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000155" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">315</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net change in other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000156" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" scale="3">962</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000157" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">911</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000158" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">764</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000159" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">132,322</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000160" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">82,154</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000161" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">102,922</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000162" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001444380_20210101_20211231" decimals="2" sign="-">3.77</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000163" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001444380_20200101_20201231" decimals="2" sign="-">2.47</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000164" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001444380_20190101_20191231" decimals="2" sign="-">3.37</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of common shares used to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; compute basic and diluted net loss per share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000165" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001444380_20210101_20211231" decimals="0" format="ixt:numdotdecimal">34,823,258</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000166" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001444380_20200101_20201231" decimals="0" format="ixt:numdotdecimal">33,677,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.2%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000167" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001444380_20190101_20191231" decimals="0" format="ixt:numdotdecimal">30,803,872</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nevro Corp.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Stockholders&#8217; Equity</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share data)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common&#160;Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-In</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other&#160;Comprehensive</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders'</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Income (Loss)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balances at December 31, 2018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000168" name="us-gaap:SharesOutstanding" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231" decimals="INF" format="ixt:numdotdecimal">30,263,536</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000169" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231" decimals="-3" scale="3">30</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000170" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">552,612</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000171" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">306,082</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000172" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,077</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000173" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">245,483</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercise of common stock options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000174" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">828,722</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000175" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000176" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">28,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000177" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">28,607</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon release of restricted stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000178" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">325,839</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares withheld for tax obligations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000179" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">38,696</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000180" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,057</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000181" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,057</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under employee stock purchase plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000182" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">164,960</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000183" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000184" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,544</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000185" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,545</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000186" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,696</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000187" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,696</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000188" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">103,686</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000189" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">103,686</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000190" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" scale="3">764</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000191" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">764</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balances at December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000192" name="us-gaap:SharesOutstanding" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="INF" format="ixt:numdotdecimal">31,544,361</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000193" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="-3" scale="3">32</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000194" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">626,401</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000195" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">409,768</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000196" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231" decimals="-3" sign="-" scale="3">313</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000197" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">216,352</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon underwritten public offering, net of issuance costs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000198" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,868,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000199" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000200" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">147,142</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000201" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">147,144</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion feature of convertible senior notes due 2025, net of allocated costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000202" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">48,340</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000203" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">48,340</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase of bond hedges</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000204" name="nvro:AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">52,390</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000205" name="nvro:AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">52,390</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales of warrants</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000206" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,933</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000207" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,933</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercise of common stock options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000208" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">756,797</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000209" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000210" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,624</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000211" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,625</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon release of restricted stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000212" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">395,971</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares withheld for tax obligations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000213" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">62,782</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000214" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,564</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000215" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,564</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under employee stock purchase plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000216" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">79,967</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000217" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,513</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000218" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,513</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000219" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,661</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000220" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,661</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000221" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">83,065</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000222" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">83,065</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000223" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" scale="3">911</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000224" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">911</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balances at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000225" name="us-gaap:SharesOutstanding" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="INF" format="ixt:numdotdecimal">34,583,064</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000226" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="-3" scale="3">35</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000227" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">880,660</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000228" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">492,833</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000229" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231" decimals="-3" scale="3">598</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000230" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">388,460</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercise of common stock options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000231" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">90,582</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000232" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,331</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000233" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,331</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon release of restricted stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000234" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">346,602</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares withheld for tax obligations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000235" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">58,787</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000236" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,062</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000237" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,062</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under employee stock purchase plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000238" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">65,197</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000239" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,849</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000240" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,849</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock from conversion of convertible senior notes due 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000241" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">682,912</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000242" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000243" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" sign="-" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercise of bond hedge for convertible senior notes due 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000244" name="nvro:ExerciseOfBondHedgeForConvertibleSeniorNotes" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">682,916</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000245" name="nvro:ExerciseOfBondHedgeValueForConvertibleSeniorNotes" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000246" name="nvro:ExerciseOfBondHedgeValueForConvertibleSeniorNotes" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000247" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">44,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000248" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">44,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000249" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">131,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000250" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">131,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000251" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231" decimals="-3" sign="-" scale="3">962</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000252" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" scale="3">962</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balances at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000253" name="us-gaap:SharesOutstanding" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231" decimals="INF" format="ixt:numdotdecimal">35,026,654</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000254" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231" decimals="-3" scale="3">35</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000255" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">928,138</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000256" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">624,193</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000257" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231" decimals="-3" sign="-" scale="3">364</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000258" name="us-gaap:StockholdersEquity" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">303,616</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nevro Corp.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STATEMENTS_CASH_FLOWS">Consolidated Statements of Cash Flows</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:4pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000259" name="us-gaap:ProfitLoss" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">131,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000260" name="us-gaap:ProfitLoss" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">83,065</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000261" name="us-gaap:ProfitLoss" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">103,686</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to reconcile net loss to net cash used in operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000262" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,882</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000263" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,794</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000264" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,563</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of operating lease assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000265" name="nvro:AmortizationOfOperatingLeaseAsset" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,796</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000266" name="nvro:AmortizationOfOperatingLeaseAsset" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,392</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000267" name="nvro:AmortizationOfOperatingLeaseAsset" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,237</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000268" name="us-gaap:ShareBasedCompensation" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">44,367</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000269" name="us-gaap:ShareBasedCompensation" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,655</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000270" name="us-gaap:ShareBasedCompensation" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,697</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of premium (accretion of discount) on short-term investments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000271" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,510</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000272" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">320</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000273" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,037</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision for (recovery of) doubtful accounts</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000274" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,528</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000275" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,165</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000276" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" scale="3">27</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Write-down of inventory</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000277" name="us-gaap:InventoryWriteDown" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,257</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000278" name="us-gaap:InventoryWriteDown" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,366</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000279" name="us-gaap:InventoryWriteDown" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,456</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on disposal of equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000280" name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt discount and issuance costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000281" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,263</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000282" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,946</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000283" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,912</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gains (losses) on foreign currency transactions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000284" name="nvro:UnrealizedGainsAndLossesOnForeignCurrencyTranslation" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,083</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000285" name="nvro:UnrealizedGainsAndLossesOnForeignCurrencyTranslation" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">184</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000286" name="nvro:UnrealizedGainsAndLossesOnForeignCurrencyTranslation" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">450</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in operating assets and liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000287" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">8,205</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000288" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,369</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000289" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,153</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000290" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,225</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000291" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,523</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000292" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">938</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000293" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,027</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000294" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">5,666</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000295" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,222</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000296" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">451</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000297" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,802</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000298" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">514</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000299" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,006</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000300" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000301" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">7,472</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000302" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,185</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000303" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">7,897</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000304" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,205</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000305" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,156</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000306" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,351</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000307" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,824</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by / (used in) operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000308" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">41,881</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000309" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,191</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000310" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">50,225</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from investing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of short-term investments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000311" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">446,916</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000312" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">668,371</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000313" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">211,006</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from maturity of short-term investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000314" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">660,971</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000315" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">297,028</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000316" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">254,308</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repayment from (investment in) private company</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000317" name="nvro:RepaymentFromInvestmentInPrivateCompany" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">7,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000318" name="nvro:RepaymentFromInvestmentInPrivateCompany" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property and equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000319" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,340</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000320" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,025</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000321" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,472</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by / (used in) investing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000322" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">201,715</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000323" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">369,868</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000324" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,330</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from financing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of common stock in public offering, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000325" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">147,144</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of convertible notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000326" name="us-gaap:ProceedsFromConvertibleDebt" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">189,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible notes debt issuance costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000327" name="nvro:PaymentsOfConvertibleNotesDebtIssuanceCosts" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,105</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of warrants</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000328" name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,933</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase of convertible note hedges</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000329" name="us-gaap:PaymentsForHedgeFinancingActivities" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">52,390</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repayment of convertible notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000330" name="us-gaap:RepaymentsOfConvertibleDebt" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">172,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Minimum tax withholding paid on behalf of employees for net share settlement</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000331" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,062</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000332" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,564</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000333" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,057</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuance of common stock to employees</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000334" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,181</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000335" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,137</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000336" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000337" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">169,381</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000338" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">346,905</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000339" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,093</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of exchange rate changes on cash, cash equivalents and restricted cash</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000340" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" scale="3">340</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000341" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">646</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000342" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">259</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net increase in cash, cash equivalents and restricted cash</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000343" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">9,887</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000344" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">21,126</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000345" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,457</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and restricted cash</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and restricted cash at beginning of year</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000346" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,203</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000347" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001444380_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">66,329</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000348" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001444380_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">51,872</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and restricted cash at end of year</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000349" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,316</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000350" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,203</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000351" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0001444380_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">66,329</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosures of cash flow information</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for income taxes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000352" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,283</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000353" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,307</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000354" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,338</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for interest</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000355" name="us-gaap:InterestPaidNet" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,728</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000356" name="us-gaap:InterestPaidNet" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,555</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000357" name="us-gaap:InterestPaidNet" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,019</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant non-cash transactions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.82%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property and equipment in accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000358" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">526</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000359" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">850</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000360" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">285</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nevro Corp.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</p><ix:nonNumeric id="F_000361" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. Formation and Business of the Company</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company was incorporated in Minnesota on March&#160;10, 2006 to manufacture and market innovative active implantable medical devices for the treatment of neurological disorders initially focusing on the treatment of chronic pain. Subsequently, the Company was reincorporated in Delaware on October&#160;4, 2006 and relocated to California.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since inception, the Company has incurred net losses. During the year ended December&#160;31, 2021, the Company incurred a net loss of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000435" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20210101_20211231" decimals="-5" sign="-" format="ixt:numdotdecimal" scale="6">131.4</ix:nonFraction>&#160;million and had $<ix:nonFraction unitRef="U_iso4217USD" id="F_000436" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001444380_20210101_20211231" decimals="-5" sign="-" scale="6">41.9</ix:nonFraction> million of cash used in operations. At December&#160;31, 2021, the Company had an accumulated deficit of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000437" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001444380_20211231" decimals="-5" sign="-" format="ixt:numdotdecimal" scale="6">624.2</ix:nonFraction>&#160;million. The Company has financed operations to date primarily through private placements of equity securities, borrowings under a debt agreement, the issuance of common stock in its November 2014 initial public offering, its June 2015 underwritten public offering and its June 2016 underwritten public offering of convertible senior notes due in <ix:nonNumeric id="F_000438" name="nvro:DebtInstrumentMaturityYear" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20210101_20211231">2021</ix:nonNumeric> (2021 Notes). Additionally, in April 2020, the Company issued a total of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000439" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200430" decimals="-5" scale="6">189.8</ix:nonFraction> million aggregate principal amount of convertible senior notes due 2025 (2025 Notes).&#160;&#160;The total net proceeds from this debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000440" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200401_20200430" decimals="-5" scale="6">183.6</ix:nonFraction> million. Concurrent with this debt offering, the Company also completed an underwritten public offering for <ix:nonFraction unitRef="U_xbrlishares" id="F_000441" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001444380_20200401_20200430" decimals="INF" format="ixt:numdotdecimal">1,868,750</ix:nonFraction> shares of its common stock, from which the Company received cash proceeds of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000442" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="C_0001444380_20200401_20200430" decimals="-5" scale="6">147.1</ix:nonFraction> million, net of underwriting discounts and commissions and offering costs. The Company&#8217;s ability to continue to meet its obligations and to achieve its business objectives for the foreseeable future is dependent upon, amongst other things, generating sufficient revenues and its ability to continue to control expenses to meet its obligations as they become due. Failure to increase sales of its products, manage discretionary expenditures or raise additional financing, if required, may adversely impact the Company&#8217;s ability to achieve its intended business objectives.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Public Offerings</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Company issued $<ix:nonFraction unitRef="U_iso4217USD" id="F_000443" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630" decimals="INF" scale="6">150.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="U_xbrlipure" id="F_000444" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630" decimals="INF" scale="-2">1.75</ix:nonFraction>% convertible senior notes due <ix:nonNumeric id="F_000445" name="nvro:DebtInstrumentMaturityYear" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160601_20160630">2021</ix:nonNumeric> in a registered underwritten public offering and an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000446" name="nvro:DebtInstrumentAdditionalAggregatePrincipalAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630" decimals="-5" scale="6">22.5</ix:nonFraction> million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75%&#160;per annum and are payable <ix:nonNumeric id="F_000447" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20210101_20211231">semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016</ix:nonNumeric>.&#160;&#160;The total net proceeds from the debt offering, after deducting transaction costs, were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000448" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160601_20160630" decimals="-5" scale="6">166.2</ix:nonFraction> million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, the Company issued $<ix:nonFraction unitRef="U_iso4217USD" id="F_000449" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200430" decimals="INF" scale="6">165.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="U_xbrlipure" id="F_000450" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200430" decimals="4" scale="-2">2.75</ix:nonFraction>% convertible senior notes due 2025 in a registered underwritten public offering and an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000451" name="nvro:DebtInstrumentAdditionalAggregatePrincipalAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200430" decimals="-5" scale="6">24.8</ix:nonFraction> million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the <ix:nonNumeric id="F_000452" name="nvro:DebtInstrumentMaturityYear" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200401_20200430">2025</ix:nonNumeric> Notes).&#160;&#160;The interest rates are fixed at 2.75% per annum and are payable <ix:nonNumeric id="F_000453" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200401_20200430">semi-annually in arrears on April 1 and October 1 of each year, commencing on October 1, 2020</ix:nonNumeric>.&#160;&#160;The total net proceeds from the debt offering, after deducting transaction costs, were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000454" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200401_20200430" decimals="-5" scale="6">183.6</ix:nonFraction> million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concurrent with the 2025 Notes, the Company completed an underwritten public offering of its common stock and issued <ix:nonFraction unitRef="U_xbrlishares" id="F_000455" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200401_20200430" decimals="INF" format="ixt:numdotdecimal">1,868,750</ix:nonFraction> shares of common stock, including <ix:nonFraction unitRef="U_xbrlishares" id="F_000456" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200401_20200430" decimals="INF" format="ixt:numdotdecimal">243,750</ix:nonFraction> shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares.&#160;&#160;The Company received cash proceeds of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000457" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="C_0001444380_20200401_20200430" decimals="-5" scale="6">147.1</ix:nonFraction> million, net of underwriting discounts and commissions and offering costs paid by the Company.</p></ix:nonNumeric><ix:nonNumeric id="F_000362" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000362_dcnt_ada9ebcb-1fe5-4d0e-857b-547a6b9499b5">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p><ix:nonNumeric id="F_000374" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S.&#160;GAAP). The consolidated financial statements include the Company&#8217;s accounts and those of its <ix:nonFraction unitRef="U_nvroSubsidiary" id="F_000458" name="nvro:NumberOfOperationalWhollyOwnedSubsidiaries" contextRef="C_0001444380_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">five</ix:nonFraction> operational wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.</p></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000362_dcnt_ada9ebcb-1fe5-4d0e-857b-547a6b9499b5" continuedAt="F_000362_dcnt_3cb75f59-18b4-456b-b79e-165ac2e3d6bc"><ix:nonNumeric id="F_000375" name="nvro:OtherRisksAndUncertainties1PolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to risks related to the public health crises such as the global pandemic associated with COVID-19, which has spread to most countries and all 50 states within the United States. The COVID-19 outbreak has negatively impacted, and continues to negatively impact, our operations, revenues and overall financial condition and demand for elective procedures remains unpredictable. Additionally, overall patient willingness to pursue elective procedures has decreased due to the pandemic. Although some restrictions on elective procedures have eased, the effect of the pandemic and recent surges in cases continue to affect patient willingness for interventional therapy for chronic pain and the number of elective procedures being performed. These challenges will likely continue for the duration of the pandemic, which is uncertain, and will affect our revenue while the pandemic continues.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the Company is also subject to risks common to medical device companies, including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, manufacturing quality and scaling, continued reimbursement from third-party payors,<span style="color:#1F497D;"> </span>uncertainty of market acceptance of products and the need to obtain additional financing. The Company is currently dependent on third-party suppliers, which, in some cases, are sole- or single-source suppliers.&#160;&#160;Although the Company is in the process of initiating the development of internal manufacturing capabilities, it will remain dependent on third-party manufacturers until such internal manufacturing capabilities are fully operational.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There can be no assurance that the Company&#8217;s products or services will continue to be accepted in its existing marketplaces, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company may choose to raise additional funds to further enhance its research and development efforts, for product expansion opportunities or to acquire a new business or products that are complementary to its business. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.</p></ix:nonNumeric><ix:nonNumeric id="F_000376" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Segments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has <ix:nonFraction unitRef="U_nvroBusiness" id="F_000459" name="us-gaap:NumberOfOperatingSegments" contextRef="C_0001444380_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates.&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.&#160;&#160;In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company&#8217;s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-lived assets and operating income outside the United States are not material&#59; therefore, disclosures have been limited to revenue.</p></ix:nonNumeric><ix:nonNumeric id="F_000377" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000377_dcnt_ef4c0a9c-cca0-43fd-9bbb-ad183b6e34fa">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries in Europe and Australia use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000362_dcnt_3cb75f59-18b4-456b-b79e-165ac2e3d6bc" continuedAt="F_000362_dcnt_19747626-8a00-456d-9cb5-aca78431f529"><ix:continuation id="F_000377_dcnt_ef4c0a9c-cca0-43fd-9bbb-ad183b6e34fa">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000460" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="C_0001444380_20210101_20211231" decimals="-5" sign="-" scale="6">3.3</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">during the yea</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">r ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span><ix:nonFraction unitRef="U_iso4217USD" id="F_000461" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="C_0001444380_20200101_20201231" decimals="-5" scale="6">0.3</ix:nonFraction><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million during the year en</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ded December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of $</span><ix:nonFraction unitRef="U_iso4217USD" id="F_000462" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" contextRef="C_0001444380_20190101_20191231" decimals="-5" scale="6">1.0</ix:nonFraction><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million during the year ended December&#160;31, 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other in</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">come (expense), net</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The Company recorded realized foreign currency transaction </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000463" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" contextRef="C_0001444380_20210101_20211231" decimals="-5" scale="6">2.6</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> during the year ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span><ix:nonFraction unitRef="U_iso4217USD" id="F_000464" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" contextRef="C_0001444380_20200101_20201231" decimals="-5" sign="-" scale="6">0.2</ix:nonFraction><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">during the year ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span><ix:nonFraction unitRef="U_iso4217USD" id="F_000465" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" contextRef="C_0001444380_20190101_20191231" decimals="-5" sign="-" scale="6">1.6</ix:nonFraction><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million during the year ended December&#160;31, 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that the Company&#8217;s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company&#8217;s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.</p></ix:continuation><ix:nonNumeric id="F_000378" name="us-gaap:UseOfEstimates" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts&#59; warranty obligations&#59; stock-based compensation&#59; depreciation and amortization lives&#59; inventory valuation&#59; valuation of investments&#59; loss contingencies&#59; and accounting for income taxes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</p></ix:nonNumeric><ix:nonNumeric id="F_000379" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company&#8217;s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December&#160;31, 2021 and 2020, and held cash in foreign banks of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000466" name="us-gaap:CashUninsuredAmount" contextRef="C_0001444380_20211231" decimals="-5" scale="6">8.6</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000467" name="us-gaap:CashUninsuredAmount" contextRef="C_0001444380_20201231" decimals="-5" scale="6">17.6</ix:nonFraction> million at December&#160;31, 2021 and 2020, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s convertible note hedge transactions, entered into in connection with the <ix:nonNumeric id="F_000468" name="nvro:DebtInstrumentMaturityYear" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20210101_20211231">2025</ix:nonNumeric> Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.&#160;&#160;The associated risk is mitigated by limiting the counterparties to major financial institutions. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company generally utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</p></ix:nonNumeric><ix:nonNumeric id="F_000380" name="us-gaap:CreditLossFinancialInstrumentPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Credit Losses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, <span style="font-style:italic;">Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span>, which replaces existing incurred loss impairment guidance and establishes a single allowance framework for financial assets carried at amortized cost. The Company adopted Topic 326 on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The Company did not have any cumulative-effect adjustments.</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000362_dcnt_19747626-8a00-456d-9cb5-aca78431f529" continuedAt="F_000362_dcnt_9e045873-9d22-4953-938d-b141938973f1"><ix:nonNumeric id="F_000381" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying amounts of certain of the Company&#8217;s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.</p></ix:nonNumeric><ix:nonNumeric id="F_000382" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents.</p></ix:nonNumeric><ix:nonNumeric id="F_000383" name="us-gaap:InvestmentPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations.&#160;Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12&#160;months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company&#8217;s investment securities are recorded at fair value based on the fair value hierarchy.&#160;&#160;Money market funds and treasury bonds are classified within Level 1 of the fair value hierarchy, and agency bonds, commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.</p></ix:nonNumeric><ix:nonNumeric id="F_000384" name="us-gaap:InventoryPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company&#8217;s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company&#8217;s estimation of the future demand for a particular component of the Company&#8217;s products may vary and may result in changes in estimates in any particular period.</p></ix:nonNumeric><ix:nonNumeric id="F_000385" name="nvro:RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shipping and Handling Costs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shipping and handling costs are expensed as incurred and are included in cost of revenue.</p></ix:nonNumeric><ix:nonNumeric id="F_000386" name="us-gaap:RevenueRecognitionPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000386_dcnt_481ce3ea-847e-4e5c-a5ea-38bd216addf5">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000362_dcnt_9e045873-9d22-4953-938d-b141938973f1" continuedAt="F_000362_dcnt_c943c1c8-cf0f-4ff4-8bda-55a5425acb3a"><ix:continuation id="F_000386_dcnt_481ce3ea-847e-4e5c-a5ea-38bd216addf5">
<p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">revenue at the point in time when it transfers control of promised goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#8217;s goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For a majority of sales, where the Company&#8217;s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the remaining sales, which are sent from the Company&#8217;s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.&#160;&#160;These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection.<span style="color:#FF0000;"> </span>To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note&#160;7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.&#160;&#160;Product revenue is recorded net of such incentive offers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Practical Expedients and Exemptions<span style="font-weight:bold;font-style:normal;"> - </span><ix:nonNumeric id="F_000470" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0001444380_20210101_20211231"><span style="font-style:normal;">The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.&#160;&#160;As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of <ix:nonNumeric id="F_000469" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="C_0001444380_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231" format="ixt-sec:durwordsen">one year</ix:nonNumeric> or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year</span>.</ix:nonNumeric></p></ix:continuation><ix:nonNumeric id="F_000387" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Allowance for Doubtful Accounts</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company makes estimates of the collectability of accounts receivable and provide an allowance for accounts receivable considered uncollectible based on current expected credit losses. In doing so, the Company analyzes historical bad debt trends, customer concentrations, customer credit worthiness, the age of the receivable, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts. For the years ended December 31, 2021, 2020 and 2019, the Company recognized bad debt expenses of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000471" name="nvro:BadDebtExpense1" contextRef="C_0001444380_20210101_20211231" decimals="-5" scale="6">0.1</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000472" name="nvro:BadDebtExpense1" contextRef="C_0001444380_20200101_20201231" decimals="-5" scale="6">2.8</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000473" name="nvro:BadDebtExpense1" contextRef="C_0001444380_20190101_20191231" decimals="-5" scale="6">1.3</ix:nonFraction> million, respectively.</p></ix:nonNumeric><ix:nonNumeric id="F_000388" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets&#8217; estimated useful lives of <ix:nonNumeric id="F_000474" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_20210101_20211231" format="ixt-sec:durwordsen" continuedAt="C_83d083ab-07a2-4493-982c-4000b2fd0529">three</ix:nonNumeric> to <ix:nonNumeric id="F_000475" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_20210101_20211231" format="ixt-sec:durwordsen">five<ix:continuation id="C_83d083ab-07a2-4493-982c-4000b2fd0529"> years</ix:continuation></ix:nonNumeric>. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.</p></ix:nonNumeric><ix:nonNumeric id="F_000389" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000389_dcnt_46a4c602-121a-4f69-9b9c-e725201c280d">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000362_dcnt_c943c1c8-cf0f-4ff4-8bda-55a5425acb3a" continuedAt="F_000362_dcnt_87ad5344-c7ec-483a-bf1e-513330edae28"><ix:continuation id="F_000389_dcnt_46a4c602-121a-4f69-9b9c-e725201c280d">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cash flows to the related asset group&#8217;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000476" name="us-gaap:AssetImpairmentCharges" contextRef="C_0001444380_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> impairment charges, or changes in estimated useful lives</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> recorded through December&#160;31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></ix:continuation><ix:nonNumeric id="F_000390" name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Lease Accounting</p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has operating leases for office space, warehouse, research and development facilities, manufacturing facilities and equipment. Leases with terms of <ix:nonNumeric id="F_000477" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_20211231" format="ixt-sec:durmonth">12</ix:nonNumeric> months or less are not recorded on the balance sheet, as the related lease expenses are recognized on a straight-line basis over the lease term.&#160;&#160;The Company accounts for lease components (such as fixed payments) separately from nonlease components (such as common area expenses).<span style="color:#000000;"> Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.&#160;&#160;The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.&#160;&#160;Lease cost is recognized on a straight-line basis over the expected lease term.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000391" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#8217;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records uncertain tax positions on the basis of a two-step process whereby (1)&#160;a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2)&#160;for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company&#8217;s policy is to recognize interest and penalties related to income taxes as a component of income tax expense.</p></ix:nonNumeric><ix:nonNumeric id="F_000392" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Comprehensive Income (Loss)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income (loss) represents all changes in stockholders&#8217; equity except those resulting from distributions to stockholders. The Company&#8217;s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.</p></ix:nonNumeric><ix:nonNumeric id="F_000393" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Research and Development</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000362_dcnt_87ad5344-c7ec-483a-bf1e-513330edae28" continuedAt="F_000362_dcnt_9f036070-3622-4ff6-8b1f-759f1251ac58"><ix:nonNumeric id="F_000394" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000394_dcnt_c2348120-e1c6-40a8-897b-14d9b7a89f1c">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, <span style="font-style:italic;">Compensation&#8212;Stock Compensation.</span> ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, <span style="font-style:italic;">Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting</span>, which the Company adopted on January 1, 2017.&#160;&#160;Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.&#160;&#160;ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of subjective variables. The expected term that the award will remain outstanding is based on the Company&#8217;s own historical data. The expected volatility over the term of the awards is based on the Company&#8217;s own common stock volatility and those of its peer group. The risk-free interest rate is based on the U.S. Treasury yield for zero-coupon U.S. Treasury notes with maturities.&#160;&#160;The expected dividend is zero, as the Company has never paid dividends and has no current plans to do so.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive <span style="-sec-ix-hidden:F_000478">six-month</span> offering periods and the Company uses its own historical volatility data in the valuation.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company&#8217;s common stock on the grant date.&#160;&#160;These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of <ix:nonNumeric id="F_000479" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" format="ixt-sec:durwordsen">four years</ix:nonNumeric>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.&#160;&#160;Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company additionally grants performance stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.&#160;&#160;The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000362_dcnt_9f036070-3622-4ff6-8b1f-759f1251ac58"><ix:continuation id="F_000394_dcnt_c2348120-e1c6-40a8-897b-14d9b7a89f1c">
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.&#160;&#160;The e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">xpected volatility of our stock </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the target composite index</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000480" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceBasedRestrictedStockUnitsRSUMember_20210101_20211231" decimals="2" format="ixt-sec:numwordsen" scale="-2">zero</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Stock-based compensation for these </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">performance</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> stock units is recognized over the specified performance measurement period</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.</p></ix:continuation><ix:nonNumeric id="F_000395" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net Loss per Share of Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units, common stock options and the conversion spread for the Company&#8217;s outstanding convertible senior notes are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.</p></ix:nonNumeric><ix:nonNumeric id="F_000396" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Pronouncements Recently Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This ASU eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The Company adopted ASU 2019-12 on <ix:nonNumeric id="F_000482" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" contextRef="C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20211231" format="ixt:datemonthdayyearen">January 1, 2021</ix:nonNumeric>.&#160;&#160;The adoption of ASU 2019-12 did not have a material effect on the consolidated financial statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Pronouncements Not Yet Effective</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, the FASB issued ASU No. 2020-06, <span style="font-style:italic;">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span>.&#160;&#160;This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity&#8217;s own equity.&#160;&#160;The ASU also modifies the impact on the diluted EPS calculations from particular convertible instruments and certain contracts that may be settled in cash or shares. The ASU is effective for public entities for annual reporting period beginning after December 15, 2021, with early adoption permitted for annual periods beginning after December 15, 2020. The Company does not expect to early adopt this guidance and has not determined the potential effects of the guidance on its consolidated financial statements.</p></ix:nonNumeric></ix:continuation><ix:nonNumeric id="F_000363" name="us-gaap:RevenueFromContractWithCustomerTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000363_dcnt_4ac6111f-b94a-469a-90d6-9dd985f32aa6">
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3. Revenue</p><ix:nonNumeric id="F_000397" name="us-gaap:DisaggregationOfRevenueTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents revenue by geography, based on the billing address of the customer (in thousands):</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000484" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">326,216</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000485" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">311,873</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000486" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">326,012</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000487" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">60,689</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000488" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">50,175</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000489" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">64,243</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000490" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">386,905</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000491" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">362,048</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000492" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">390,255</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000363_dcnt_4ac6111f-b94a-469a-90d6-9dd985f32aa6">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000398" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The United States is the only country that accounts for 10% or more of the revenue during the periods presented:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000493" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20210101_20211231" decimals="2" scale="-2">84</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000494" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20200101_20201231" decimals="2" scale="-2">86</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000495" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20190101_20191231" decimals="2" scale="-2">84</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were <ix:nonFraction unitRef="U_nvroCustomer" id="F_000502" name="nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_nvroCustomer" id="F_000503" name="nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_nvroCustomer" id="F_000501" name="nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> customers that accounted for <span><ix:nonFraction unitRef="U_xbrlipure" id="F_000496" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231" decimals="INF" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000497" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231" decimals="INF" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000498" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231" decimals="INF" scale="-2">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>%</span> or more of the Company&#8217;s revenue for each of the years ended December&#160;31, 2021, 2020 and 2019.&#160;&#160;Additionally, there were <ix:nonFraction unitRef="U_nvroCustomer" id="F_000504" name="nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_nvroCustomer" id="F_000505" name="nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> customers that accounted for <span><ix:nonFraction unitRef="U_xbrlipure" id="F_000499" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20210101_20211231" decimals="INF" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000500" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20200101_20201231" decimals="INF" scale="-2">10</ix:nonFraction></ix:nonFraction>%</span> or more of the Company&#8217;s accounts receivable balance as of December 31, 2021 and 2020.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In July 2021, the Company received FDA approval of its proprietary 10 kHz Therapy for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with painful diabetic neuropathy (PDN). For the year ended December 31, 2021, worldwide revenue includes approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000506" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001444380_srtProductOrServiceAxis_nvroPainfulDiabeticNeuropathyMember_20210101_20211231" decimals="-5" scale="6">5.7</ix:nonFraction>&#160;million of revenue for PDN indication since the July 2021 FDA approval</span>.</p></ix:continuation><ix:nonNumeric id="F_000364" name="us-gaap:LesseeOperatingLeasesTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000364_dcnt_bbd56475-f0c1-45ba-8a92-de89d12f352f">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4. Leases</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000511" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="C_0001444380_20210101_20211231">As of December 31, 2021, the Company has leases with remaining terms of <ix:nonNumeric id="F_000507" name="nvro:LesseeOperatingLeaseRemainingTermOfContract" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_20210101_20211231" format="ixt-sec:duryear">3</ix:nonNumeric> year to <ix:nonNumeric id="F_000508" name="nvro:LesseeOperatingLeaseRemainingTermOfContract" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_20210101_20211231" format="ixt-sec:duryear">10</ix:nonNumeric> years, some of which may include options to extend the lease term for up to <ix:nonNumeric id="F_000509" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_20211231" format="ixt-sec:duryear">5</ix:nonNumeric> years.</ix:nonNumeric></p><ix:nonNumeric id="F_000399" name="nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average lease terms and discounts rates are as follows:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Lease Term and Discount Rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000512" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0001444380_20211231" format="ixt-sec:duryear">4.20</ix:nonNumeric> years</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000513" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0001444380_20201231" format="ixt-sec:duryear">4.32</ix:nonNumeric> years</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000514" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_0001444380_20211231" decimals="3" scale="-2">7.0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000515" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_0001444380_20201231" decimals="3" scale="-2">7.0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric><ix:nonNumeric id="F_000400" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, t<span style="color:#000000;">he maturity of lease liabilities are as follows (in thousands):</span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000516" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,720</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000517" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,019</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000518" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,201</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000519" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,849</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000520" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="C_0001444380_20211231" decimals="-3" scale="3">405</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000521" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,979</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000522" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,173</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000523" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,183</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of lease liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000524" name="us-gaap:OperatingLeaseLiability" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,990</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric><ix:nonNumeric id="F_000401" name="us-gaap:LeaseCostTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental lease cost information are as follows (in thousands):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease cost</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000525" name="us-gaap:OperatingLeaseCost" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,243</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000526" name="us-gaap:OperatingLeaseCost" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,936</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric><ix:nonNumeric id="F_000402" name="nvro:ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000402_dcnt_d7061156-aa76-4a75-9006-3caa0ff43a1b">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental balance sheet information are as follows (in thousands):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000364_dcnt_bbd56475-f0c1-45ba-8a92-de89d12f352f"><ix:continuation id="F_000402_dcnt_d7061156-aa76-4a75-9006-3caa0ff43a1b">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000527" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,577</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000528" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,142</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000529" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,588</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000530" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,876</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long term operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000533" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,402</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000534" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,689</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000535" name="us-gaap:OperatingLeaseLiability" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,990</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000536" name="us-gaap:OperatingLeaseLiability" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,565</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation><ix:nonNumeric id="F_000403" name="nvro:ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow information are as follows (in thousands):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flow from operating leases</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000537" name="us-gaap:OperatingLeasePayments" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,253</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000538" name="us-gaap:OperatingLeasePayments" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,923</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 7 for further details of the Company&#8217;s lease commitments.</p></ix:continuation><ix:nonNumeric id="F_000365" name="us-gaap:FairValueDisclosuresTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000365_dcnt_2b99234a-d489-473a-8f67-806c59dad08c">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5. Fair Value Measurements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Level&#160;1 &#8212; Observable inputs, such as quoted prices in active markets for identical assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Level&#160;2 &#8212;&#160;Observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Level&#160;3 &#8212;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></td></tr></table></div></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000365_dcnt_2b99234a-d489-473a-8f67-806c59dad08c">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash Equivalents and Short Term Investments</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s cash equivalents include investments in money market funds that which are unrestricted as to withdrawal or use and are classified as Level&#160;1 of the fair value hierarchy. To value its money market funds, the Company values the funds at $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000539" name="nvro:MoneyMarketFundsNetAssetValuePerShare" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20210101_20211231" decimals="0">1</ix:nonFraction> stable net asset value, which is the quoted price in active markets for identical assets that the Company has the ability to access. At December&#160;31, 2021 and 2020, the Company&#8217;s cash equivalents were held in institutions in the United States. The Company&#8217;s cash equivalents and short-term investments also includes agency bonds, commercial paper, corporate notes and treasury bonds, which have been classified within Level 1 or Level&#160;2 of the fair value hierarchy because of the sufficient observable inputs for revaluation. The Company&#8217;s Level&#160;2 investments are valued using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades of any broker/dealer quotes on the same or similar investments, issuer credit spreads, benchmark investments, prepayment/default projections based on historical data and other observable inputs. <ix:nonNumeric id="F_000404" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000404_cnt_1">The following table sets forth the Company&#8217;s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):</ix:nonNumeric></p><ix:continuation id="F_000404_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000540" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,562</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000541" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,562</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds (ii)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000542" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,538</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000543" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,538</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (ii)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000544" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">61,884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000545" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">61,884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (iii)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000546" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,351</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000547" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,351</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds (ii)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000548" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">197,552</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000549" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">197,552</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000550" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">207,114</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000551" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">134,773</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000552" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">341,887</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December&#160;31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000553" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,273</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000554" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,273</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds (ii)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000555" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">210,302</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000556" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">210,302</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (ii)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000557" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">277,602</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000558" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">277,602</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (ii)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000559" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,395</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000560" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,395</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds (ii)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000561" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000562" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000563" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">46,347</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000564" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">513,299</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000565" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">559,646</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:58.64%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><ix:footnote id="FNT_000000" xml:lang="en-US">Included in cash and cash equivalents on the consolidated balance sheets.</ix:footnote></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><ix:footnote id="FNT_000001" xml:lang="en-US">Included in short-term investments on the consolidated balance sheets.</ix:footnote></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><ix:footnote id="FNT_000002" xml:lang="en-US">Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets</ix:footnote>.</p></td></tr></table></div></ix:continuation>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Convertible Senior Notes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 1, 2021, the Company settled the 2021 Notes at maturity, and as of December 31, 2021, the 2021 Notes were no longer outstanding. As of December 31, 2020, the fair value of the <ix:nonFraction unitRef="U_xbrlipure" id="F_000566" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20201231" decimals="INF" scale="-2">1.75</ix:nonFraction>% convertible senior notes due<ix:nonNumeric id="F_000567" name="nvro:DebtInstrumentMaturityYear" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20200101_20201231"> 2021</ix:nonNumeric> was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000568" name="us-gaap:DebtInstrumentFairValue" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20201231" decimals="-5" scale="6">312.8</ix:nonFraction> million. As of December 31, 2021 and 2020, the fair value of the <ix:nonFraction unitRef="U_xbrlipure" id="F_000570" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20201231" decimals="INF" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000569" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20211231" decimals="INF" scale="-2">2.75</ix:nonFraction></ix:nonFraction>% convertible senior notes due <ix:nonNumeric id="F_000572" name="nvro:DebtInstrumentMaturityYear" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200101_20201231"><ix:nonNumeric id="F_000571" name="nvro:DebtInstrumentMaturityYear" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20210101_20211231">2025</ix:nonNumeric></ix:nonNumeric> was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000573" name="us-gaap:DebtInstrumentFairValue" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20211231" decimals="-5" scale="6">212.0</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000574" name="us-gaap:DebtInstrumentFairValue" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20201231" decimals="-5" scale="6">348.1</ix:nonFraction> million, respectively. The fair value was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy.</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000366" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000366_dcnt_fbe93fbe-e1d3-4462-b2f9-505fc96a5c4c">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6. Balance Sheet Components</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the Company&#8217;s cash equivalents and short-term investments approximates their respective carrying amounts due to their short-term maturity. <ix:nonNumeric id="F_000405" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000405_cnt_1">The following is a summary of the gross unrealized gains and unrealized losses on the Company&#8217;s investment securities (in thousands):</ix:nonNumeric></p><ix:continuation id="F_000405_cnt_1" continuedAt="F_000405_cnt_2">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000575" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,546</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000583" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231" decimals="-3" scale="3">8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000588" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,538</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000576" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">61,886</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000580" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000584" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000589" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">61,884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000577" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,371</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000585" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231" decimals="-3" scale="3">20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000590" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,351</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000578" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">197,889</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000581" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000586" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231" decimals="-3" scale="3">339</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000591" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">197,552</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000579" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">332,692</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000582" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001444380_20211231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000587" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001444380_20211231" decimals="-3" scale="3">371</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000592" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">332,325</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation><ix:continuation id="F_000405_cnt_2">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000593" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">210,225</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000598" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231" decimals="-3" scale="3">79</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000603" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000607" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">210,302</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000594" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">277,593</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000599" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" scale="3">23</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000604" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" scale="3">14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000608" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">277,602</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000595" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,364</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000600" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231" decimals="-3" scale="3">40</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000605" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000609" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,395</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000596" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,064</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000601" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000610" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000597" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">543,246</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000602" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001444380_20201231" decimals="-3" scale="3">152</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000606" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001444380_20201231" decimals="-3" scale="3">25</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000611" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">543,373</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Realized gains or losses from the sale of investments and other-than-temporary impairments, if any, on available-for-sale securities are reported in other income (expense), net as incurred. The cost of securities sold was determined based on the specific identification method. The amount of realized gains and realized losses on investments for the periods presented have not been material.</p><ix:nonNumeric id="F_000406" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amortized costs and estimated fair values of the Company&#8217;s available-for-sale securities by contractual maturities as of December 31, 2021 were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts maturing within one year</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000612" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">305,844</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000615" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">305,535</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts after one year through five years</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000613" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">26,848</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000616" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">26,790</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total investment securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000614" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">332,692</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000617" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">332,325</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000407" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories (in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000618" name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">50,160</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000619" name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,405</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000620" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,357</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000621" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">48,891</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventories</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000622" name="us-gaap:InventoryNet" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">93,517</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000623" name="us-gaap:InventoryNet" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">83,296</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically evaluates the carrying value of inventory on hand for potential excess amount over demand using the same lower of cost or net realizable value approach as that has been used to value the inventory. </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000366_dcnt_fbe93fbe-e1d3-4462-b2f9-505fc96a5c4c">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also periodically evaluates inventory quantities in consideration of actual loss experience. As a result of these evaluations, for the year ended December&#160;31, 2021, the Company recognized total write-downs of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000624" name="nvro:InventoryWriteDownCashAndNonCash" contextRef="C_0001444380_20210101_20211231" decimals="-5" scale="6">4.3</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million for its inventories.&#160;&#160;For the years ended December 31, 2020 and 2019, the Company recognized total write-downs of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000625" name="nvro:InventoryWriteDownCashAndNonCash" contextRef="C_0001444380_20200101_20201231" decimals="-5" scale="6">5.4</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million and $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000626" name="nvro:InventoryWriteDownCashAndNonCash" contextRef="C_0001444380_20190101_20191231" decimals="-5" scale="6">1.6</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, respectively, for its inventories.</span></p><ix:nonNumeric id="F_000408" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment, Net (in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000627" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,722</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000628" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,072</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000629" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,349</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000630" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,671</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000631" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,215</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000632" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,918</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000633" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,316</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000634" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,289</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in process</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000635" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,717</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000636" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,354</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000637" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,319</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000638" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,304</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation and amortization</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000639" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,655</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000640" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,773</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000641" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,664</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000642" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,531</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization expense for the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000643" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001444380_20210101_20211231" decimals="-5" scale="6">4.9</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000644" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001444380_20200101_20201231" decimals="-5" scale="6">4.8</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000645" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001444380_20190101_20191231" decimals="-5" scale="6">4.6</ix:nonFraction> million, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Restricted Cash</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash as of December 31, 2021 and 2020 includes certificates of deposit of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000646" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_0001444380_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_us-gaapCertificatesOfDepositMember_20211231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000647" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_0001444380_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_us-gaapCertificatesOfDepositMember_20201231" decimals="-5" scale="6">0.6</ix:nonFraction></ix:nonFraction> million representing collateral for the Company&#8217;s Redwood City, CA building lease pursuant to an agreement dated March 5, 2015.</p><ix:nonNumeric id="F_000409" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Accrued Liabilities (in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and related expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000648" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,957</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000649" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,971</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional fees</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000650" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,547</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000651" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,101</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000652" name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000653" name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,191</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued clinical and research expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000654" name="nvro:AccruedClinicalAndResearchExpensesCurrent" contextRef="C_0001444380_20211231" decimals="-3" scale="3">305</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000655" name="nvro:AccruedClinicalAndResearchExpensesCurrent" contextRef="C_0001444380_20201231" decimals="-3" scale="3">668</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000656" name="us-gaap:InterestPayableCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,305</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000657" name="us-gaap:InterestPayableCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,548</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued warranty</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000658" name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="C_0001444380_20211231" decimals="-3" scale="3">664</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000659" name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="C_0001444380_20201231" decimals="-3" scale="3">699</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000660" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,665</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000661" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,127</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000662" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,517</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000663" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,305</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p><ix:nonNumeric id="F_000367" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000367_dcnt_6bad149a-e554-444e-ba63-dc3f8f02d0b3">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7. Commitments and Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <ix:nonNumeric id="F_000664" name="nvro:LeaseCommencementPeriod" contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20210101_20211231" format="ixt:datemonthyearen">March 2015</ix:nonNumeric>, the Company entered into a lease agreement for approximately<ix:nonFraction unitRef="U_utrsqft" id="F_000665" name="us-gaap:AreaOfLand" contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150331" decimals="INF" format="ixt:numdotdecimal"> 50,740</ix:nonFraction> square feet of office space located in Redwood City, California for a period beginning in <span style="-sec-ix-hidden:F_000667">June 2015</span> through <ix:nonNumeric id="F_000668" name="nvro:OperatingLeasesExpirationDate" contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150301_20150331" format="ixt:datemonthyearen">May 2022</ix:nonNumeric> with initial annual payments of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000669" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150331" decimals="-5" scale="6">2.0</ix:nonFraction> million, increasing to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000671" name="nvro:OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150331" decimals="-5" scale="6">2.4</ix:nonFraction> million annually during the final year of the lease term. In December 2016, the Company entered into an amendment for an additional approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000666" name="us-gaap:AreaOfLand" contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161231" decimals="INF" format="ixt:numdotdecimal">49,980</ix:nonFraction> square feet of office space adjacent to the premises under the original lease (the Expansion Premises), with initial annual payments of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000670" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161231" decimals="-5" scale="6">1.2</ix:nonFraction> million, increasing to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000672" name="nvro:OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161231" decimals="-5" scale="6">2.9</ix:nonFraction> million in the final year of the amended lease term.&#160; <ix:nonNumeric id="F_000673" name="nvro:LeaseCommencementDateDescription" contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20210101_20211231"><span style="color:#000000;">The lease for the Expansion Premises commenced on <ix:nonNumeric id="F_000674" name="us-gaap:OperationsCommencedDate1" contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161201_20161231" format="ixt:datemonthdayyearen">June 1, 2018</ix:nonNumeric>. </span></ix:nonNumeric>&#160;&#160;The amendment also extends the lease term for the original premises to terminate on the same date as the amended lease, which is <ix:nonNumeric id="F_000675" name="us-gaap:LeaseExpirationDate1" contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161201_20161231" format="ixt:datemonthdayyearen">May 31, 2025</ix:nonNumeric>.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000367_dcnt_6bad149a-e554-444e-ba63-dc3f8f02d0b3" continuedAt="F_000367_dcnt_6a9a7d67-0d28-411a-8410-1bf7ed8635b0">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2017, the Company entered into a separate non-cancellable facility lease for warehouse space beginning <ix:nonNumeric id="F_000676" name="nvro:LeaseEffectiveDate" contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20170201_20170228" format="ixt:datemonthdayyearen">March 1, 2017</ix:nonNumeric> through <ix:nonNumeric id="F_000677" name="us-gaap:LeaseExpirationDate1" contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20170201_20170228" format="ixt:datemonthdayyearen">February 28, 2022</ix:nonNumeric>, under which the Company is obligated to pay approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000678" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20170201_20170228" decimals="-5" scale="6">0.4</ix:nonFraction> million in lease payments over the term of the lease.&#160;&#160;In October 2021, the Company entered into an amendment to extend the lease term to <ix:nonNumeric id="F_000679" name="us-gaap:LeaseExpirationDate1" contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20211031_20211031" format="ixt:datemonthdayyearen">May 31, 2025</ix:nonNumeric>. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <ix:nonNumeric id="F_000680" name="nvro:LeaseCommencementPeriod" contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831" format="ixt:datemonthyearen">August 2020</ix:nonNumeric>, the Company entered into a lease for approximately <ix:nonFraction unitRef="U_utrsqft" id="F_000681" name="us-gaap:AreaOfLand" contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831" decimals="INF" format="ixt:numdotdecimal">35,411</ix:nonFraction> square feet of space for a manufacturing facility in Costa Rica for a period of <span style="-sec-ix-hidden:F_000682">April 2021</span> through <ix:nonNumeric id="F_000683" name="nvro:OperatingLeasesExpirationDate" contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831" format="ixt:datemonthyearen">June 2031</ix:nonNumeric>, under which it is obligated to pay approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000684" name="us-gaap:OperatingLeaseExpense" contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831" decimals="-5" scale="6">3.9</ix:nonFraction> million in lease payments over the term of the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 4 for further discussion on Leases.</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warranty Obligations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company warrants that its products will operate substantially in conformity with product specifications and provides a <ix:nonNumeric id="F_000685" name="us-gaap:StandardProductWarrantyDescription" contextRef="C_0001444380_20210101_20211231">limited one- to five-year warranty</ix:nonNumeric>.&#160;&#160;<ix:nonNumeric id="F_000410" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000410_cnt_1">Activities related to warranty obligations were as follows (in thousands):</ix:nonNumeric></p><ix:continuation id="F_000410_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning Balance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000686" name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="C_0001444380_20201231" decimals="-3" scale="3">699</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000687" name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="C_0001444380_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,178</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision for warranty</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000688" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,846</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000689" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000690" name="us-gaap:StandardProductWarrantyAccrualPayments" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,881</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000691" name="us-gaap:StandardProductWarrantyAccrualPayments" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,629</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending Balance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000692" name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="C_0001444380_20211231" decimals="-3" scale="3">664</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000693" name="us-gaap:StandardProductWarrantyAccrualCurrent" contextRef="C_0001444380_20201231" decimals="-3" scale="3">699</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supply Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;" id="OLE_LINK1">The Company has entered into supply agreements with certain of the Company&#8217;s suppliers that required certain minimum annual purchase agreements.&#160;&#160;As of December 31, 2021, the Company had $<ix:nonFraction unitRef="U_iso4217USD" id="F_000694" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" contextRef="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20211231" decimals="-5" scale="6">0.9</ix:nonFraction> million of annual purchase commitments. As of December 31, 2020, the Company had <ix:nonFraction unitRef="U_iso4217USD" id="F_000695" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" contextRef="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> annual purchase commitments. For the year ended December 31, 2019, the Company recorded a charge of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000696" name="us-gaap:InventoryFirmPurchaseCommitmentLoss" contextRef="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20200101_20201231" decimals="-5" scale="6">3.6</ix:nonFraction> million related to the cancellation of firm purchase commitments for inventory related items.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;" id="OLE_LINK2">The Company also entered into a service agreement in January 2020 for which it is committed to pay $<span><ix:nonFraction unitRef="U_iso4217USD" id="F_000698" name="nvro:ServiceAgreementCommitmentAmountYearTwo" contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000699" name="nvro:ServiceAgreementCommitmentAmountYearThree" contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000697" name="nvro:ServiceAgreementCommitmentAmountYearOne" contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000700" name="nvro:ServiceAgreementCommitmentAmountYearFour" contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231" decimals="-5" scale="6">2.5</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million</span> annually in each of the next four years. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">License Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2006, the Company entered into an amended and restated license agreement with the Mayo Foundation for Medical Education and Research (Mayo) and Venturi Group&#160;LLC (VGL), which provides the Company access to the certain know how and licensed patents owned by Mayo and VGL for treatment of central, autonomic and peripheral nervous system disorders, including pain, using devices to modulate nerve signaling. The licenses granted are exclusive and the Company has the right to sub-license. <ix:nonNumeric id="F_000701" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoAndVglMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231">The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL.</ix:nonNumeric></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per terms of the license, the Company is required to pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty will be based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum royalty payment will be based on royalty periods as defined in the agreement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2011, the Company entered into a Phase&#160;II License Agreement with Mayo which provides the Company access to the certain know how and licensed patents owned by Mayo. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier.</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000367_dcnt_6a9a7d67-0d28-411a-8410-1bf7ed8635b0" continuedAt="F_000367_dcnt_15e92b31-4716-4ed2-bc1c-4eafe714656b">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per terms of the license, the Company is required to:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Pay a retainer fee of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000702" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231" decimals="0" format="ixt:numdotdecimal">40,000</ix:nonFraction> per annum starting March 2011 and ending February 2013&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty is based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum annual royalty payment is $<ix:nonFraction unitRef="U_iso4217USD" id="F_000703" name="us-gaap:RoyaltyExpense" contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_srtRangeAxis_srtMinimumMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">200,000</ix:nonFraction>.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Mayo License terminates upon the expiration of (1)&#160;the last to expire of the licensed patents or (2)&#160;our obligation to pay royalties, whichever is later. Such obligations may be subject to change if: (1) additional relevant patents issue that are subject to the Mayo License&#59; or (2) we launch an SCS product, which is subject to the Mayo License, in another country. As of Jan. 1, 2021, the Company does not have an existing obligation to pay royalties under the Mayo License. Therefore, there were <ix:nonFraction unitRef="U_iso4217USD" id="F_000704" name="us-gaap:RoyaltyExpense" contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction> royalties expenses during the year ended December 31, 2021.&#160;&#160;Royalties expenses during the years ended December&#160;31, 2020 and 2019 were $<ix:nonFraction unitRef="U_iso4217USD" id="F_000705" name="us-gaap:RoyaltyExpense" contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20200101_20201231" decimals="-5" scale="6">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000706" name="us-gaap:RoyaltyExpense" contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20190101_20191231" decimals="-5" scale="6">3.2</ix:nonFraction> million, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2014, the Company issued Mayo <ix:nonFraction unitRef="U_xbrlishares" id="F_000707" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20141101_20141130" decimals="INF" format="ixt:numdotdecimal">20,833</ix:nonFraction> shares of common stock owed in connection with the IPO pursuant to the terms of the license, and recorded noncash research and development expense of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000708" name="nvro:NonCashResearchAndDevelopmentExpense" contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20141101_20141130" decimals="-5" scale="6">0.5</ix:nonFraction> million for the fair value of the shares on the date of issuance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2017, the Company entered into a license agreement for which it is committed to pay $<ix:nonFraction unitRef="U_iso4217USD" id="F_000709" name="nvro:LicenseAgreementCommitmentAmount" contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20170731" decimals="-5" scale="6">0.1</ix:nonFraction> million over the remaining term of this license agreement, which ends in <ix:nonNumeric id="F_000710" name="nvro:LicenseAgreementExpirationYear" contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20170701_20170731">2022</ix:nonNumeric>.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Contingent Consideration</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2019, the Company entered into an agreement with a privately-held company to, among other things, provide the privately-held company financing in the form of a secured convertible note.&#160;&#160;Through March 31, 2020, the Company has provided financing totaling $<ix:nonFraction unitRef="U_iso4217USD" id="F_000711" name="nvro:ContingentConsiderationPaymentSecuredByConvertibleNotes" contextRef="C_0001444380_20210101_20211231" decimals="-5" scale="6">8.5</ix:nonFraction> million in the form of <ix:nonFraction unitRef="U_nvroConvertibleNote" id="F_000712" name="nvro:NumberOfSecuredConvertibleNotes" contextRef="C_0001444380_20191231" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction> secured convertible notes. The agreement additionally provides the Company with the exclusive right, but not the obligation, to acquire the privately-held company.&#160;&#160;As of December 31, 2019, the value of the secured convertible notes, measured at amortized cost, was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000713" name="nvro:SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" contextRef="C_0001444380_20191231" decimals="-5" scale="6">7.9</ix:nonFraction> million, while the value of certain rights in relation to the agreement, measured at cost and monitored for impairment on an ongoing basis, was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000714" name="nvro:ValueOfCertainRightsMeasuredAtCost" contextRef="C_0001444380_20191231" decimals="-5" scale="6">1.0</ix:nonFraction> million.&#160;&#160;These amounts are reported in Other Assets on the Condensed Consolidated Balance Sheet.&#160;&#160;The accretion of amortized cost is recorded in Interest Income, while any changes in value from impairment assessment are recorded in Other Income (Expense) in the Consolidated Statements of Operations and Comprehensive Income.&#160;&#160;The Company concluded that the privately-held company is a variable interest entity&#59; however, the Company is not the primary beneficiary as it does not retain power to direct the activities that most significantly impact its economic performance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, the Company elected not to exercise its option to make a further investment in the privately-held company pursuant to the agreement.&#160;&#160;In connection with this decision, the Company no longer has the exclusive right to acquire the privately-held company.&#160;&#160;In June 2020, the privately-held company paid off the outstanding principal and accrued interest of its secured convertible notes in full.&#160;&#160;As a result of these two events, the Company recorded a net expense of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000715" name="nvro:ContingentConsiderationExpensesNetSecuredByConvertibleNotes" contextRef="C_0001444380_20200101_20201231" decimals="-5" scale="6">0.4</ix:nonFraction> million in Other Income (Expense) in the Consolidated Statements of Operations and Comprehensive Income in the year ended December 31, 2020.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been <ix:nonFraction unitRef="U_iso4217USD" id="F_000716" name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="C_0001444380_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000717" name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="C_0001444380_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> contingent liabilities requiring accrual at December&#160;31, 2021 and 2020.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Indemnification</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000367_dcnt_15e92b31-4716-4ed2-bc1c-4eafe714656b" continuedAt="F_000367_dcnt_90c0b1e8-7f27-40ed-ae46-00ffef4ab922">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for losses suffered or incurred by the indemnified party, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including, among other circumstances, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#8217;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited&#59; however, the Company has director and officer insurance coverage that reduces the Company&#8217;s exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. <ix:nonFraction unitRef="U_iso4217USD" id="F_000718" name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_us-gaapIndemnificationGuaranteeMember_20211231" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction> liability associated with such indemnifications has been recorded to date.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Legal Matters</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Boston Scientific Litigations</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">California Litigation Related to High Frequency</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 28, 2016, the Company filed a lawsuit for patent infringement against Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation (collectively, Boston Scientific). The lawsuit, filed in the U.S. District Court for the Northern District of California (the California Court), asserted that Boston Scientific was infringing, or would soon begin infringing, seven of the Company&#8217;s patents covering inventions relating to the Senza system and 10 kHz Therapy. Shortly after the Company filed this lawsuit in 2016, Boston Scientific cancelled its original launch plan and modified its SCS system to avoid infringing the asserted patents. On July 24, 2018, the California Court issued an order on claim construction and summary judgment.&#160;&#160;In the order, the California Court ruled that the Company&#8217;s asserted method claims were patent eligible and not invalid as indefinite.&#160;&#160;Collectively, the asserted method claims cover methods for delivering SCS therapy at frequencies between 1.5 kHz and 100 kHz.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The California Court, however, found that Boston Scientific was not currently infringing the six upheld method claims because Boston Scientific cancelled its original launch plans and ultimately never practiced the asserted method claims in the United States.&#160;&#160;Specifically, the California Court found that Boston Scientific's sale of the Spectra WaveWriter systems for commercial use in the United States did not infringe the upheld method claims because Boston Scientific modified the Spectra WaveWriter systems to prevent them from being programmed to generate signals above 1.2 kHz. The California Court also found that the Company&#8217;s asserted system claims were invalid as indefinite.&#160; As discussed below, the California Court&#8217;s finding of invalidity was overturned by the U.S. Court of Appeals for the Federal Circuit (the Federal Circuit).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 31, 2018, the parties entered into an agreement to dismiss the Company&#8217;s declaratory judgment claims, without prejudice, so that the Company and Boston Scientific could each appeal portions of the California Court&#8217;s July 24th ruling to the Federal Circuit.&#160;&#160;On April 9, 2020, the Federal Circuit returned its ruling, which vacated and remanded the California Court&#8217;s judgment of invalidity.&#160;&#160;As a result of the Federal Circuit&#8217;s ruling, the system claims invalidated by the California Court were reinstated, and thus all of the Company&#8217;s asserted claims remain valid and enforceable.&#160;&#160;On December 14, 2020, the parties agreed to the final dismissal of all remaining claims before the California Court based on Boston Scientific&#8217;s assertion to the court that it did not have any current plans to commercially launch a high frequency SCS system in the United States.&#160;&#160;The California Court entered the agreed upon dismissal on December 16, 2020.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Delaware Litigations Unrelated to High Frequency</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000367_dcnt_90c0b1e8-7f27-40ed-ae46-00ffef4ab922" continuedAt="F_000367_dcnt_f1ca87da-440f-4e1d-b646-d38fb89580b2">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 9, 2016, Boston Scientific filed a patent infringement lawsuit alleging the Company&#8217;s manufacture, use and sale of the Senza system infringes <ix:nonFraction unitRef="U_nvroPatent" id="F_000719" name="nvro:PatentInfringementLawsuitAllegationAgainstNumberOfPatents" contextRef="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20161209" decimals="INF" format="ixt-sec:numwordsen">ten</ix:nonFraction> of Boston Scientific&#8217;s patents covering spinal cord stimulation technology related to stimulation leads, rechargeable batteries and telemetry (the <span style="font-style:italic;">Delaware I</span> litigation). On April 27, 2018, Boston Scientific filed a second lawsuit alleging patent infringement of <ix:nonFraction unitRef="U_nvroPatent" id="F_000720" name="nvro:PatentInfringementLawsuitAllegationAgainstNumberOfPatents" contextRef="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20180427" decimals="INF" format="ixt-sec:numwordsen">nine</ix:nonFraction> patents, trade secret misappropriation and tortious interference with contract (the <span style="font-style:italic;">Delaware II</span> litigation).&#160; Both lawsuits were filed in the U.S. District Court for the District of Delaware.&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In relation to the <span style="font-style:italic;">Delaware I</span> litigation, the Company filed petitions for <span style="font-style:italic;">inter partes</span> review at the U.S. Patent and Trademark Office (USPTO), which resulted in the invalidation of all of the asserted claims of Boston Scientific&#8217;s U.S. Patent Nos. 7,587,241 and 6,895,280, in February 2019.&#160;&#160;The invalidity rulings by the Patent Trial and Appeal Board (PTAB) at the USPTO were later affirmed by the Federal Circuit on May 18, 2020 and May 29, 2020, respectively.&#160;&#160; In relation to the <span style="font-style:italic;">Delaware II</span> litigation, the Company filed seven petitions for <span style="font-style:italic;">inter partes</span> review at the PTAB against seven of the nine patents asserted by Boston Scientific.&#160;&#160;As a result of those petitions, in January 2021, the PTAB invalidated all but two of the challenged Boston Scientific claims across the seven <span style="font-style:italic;">inter partes</span> reviews. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Through various orders from the court, portions of Boston Scientific&#8217;s <span style="font-style:italic;">Delaware I</span> case were dismissed, and portions of Boston Scientific&#8217;s <span style="font-style:italic;">Delaware II </span>case have been stayed for future litigation.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In relation to the <span style="font-style:italic;">Delaware I</span> case, of the ten patents originally asserted on December 9, 2016, Boston Scientific proceeded to trial with four patents directed to SCS leads and lead manufacturing techniques. On November 1, 2021, a Delaware jury found that the Company infringed Boston Scientific&#8217;s patents U.S. 7,891,085 (&#8220;the &#8216;085 patent&#8221;) and U.S. 8,019,439, and that the Company did not infringe Boston Scientific&#8217;s patents U.S. 8,646,172 and U.S. 8,650,747.&#160;&#160;With regard to the &#8216;085 patent, the jury found that the infringement was willful, though the infringement of the &#8216;085 patent was only directed to a limited number of SCS leads that the Company sold internationally between 2012 and 2014.&#160;&#160;Boston Scientific does not assert that the Company continues to infringe the &#8216;085 patent.&#160;&#160;The Delaware jury awarded Boston Scientific $<ix:nonFraction unitRef="U_iso4217USD" id="F_000721" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" contextRef="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20211101_20211101" decimals="-5" scale="6">20.0</ix:nonFraction> million.&#160;&#160;The Company disagrees with this decision and plans to appeal, which could take approximately 18-24 months to resolve.&#160;&#160;The jury award will not be paid until after the conclusion of the appeal process.&#160;&#160;The Company recorded a liability of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000722" name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_nvroPatentInfringementMember_20211231" decimals="-5" scale="6">20.0</ix:nonFraction> million in relation to the aforementioned <span style="font-style:italic;">Delaware I</span> case.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In relation to the <span style="font-style:italic;">Delaware II</span> litigation, the Company also filed counterclaims against Boston Scientific, alleging patent infringement of five Nevro patents.&#160;&#160;In March 2021, on the basis of Boston Scientific&#8217;s petition, the PTAB initiated <span style="font-style:italic;">inter partes</span> reviews of two of Nevro&#8217;s five counterclaim patents.&#160;&#160;The Delaware court later stayed Nevro&#8217;s five counterclaim patents for future litigation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 23, 2021, the Company filed a patent infringement lawsuit against Boston Scientific alleging that its January 2021 launch of the WaveWriter Alpha&#8482; SCS System infringes five of the Company&#8217;s patents covering spinal cord stimulation technology related to delivering paresthesia-free therapy at frequencies below 1,200 Hz.&#160;&#160;The lawsuit, filed in the U.S. District Court for the District of Delaware (<span style="font-style:italic;">the Delaware III</span> litigation), seeks unspecified damages and attorney&#8217;s fees, as well as preliminary and/or permanent injunctive relief against further infringement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, <span style="color:#000000;">the Company recorded a liability of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000723" name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_nvroPatentInfringementMember_20211231" decimals="-5" scale="6">20.0</ix:nonFraction> million in relation to the aforementioned </span><span style="font-style:italic;color:#000000;">Delaware I</span><span style="color:#000000;"> case</span>.&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Stimwave Litigation</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 14, 2019, the Company filed a lawsuit for patent infringement against Stimwave Technologies, Inc. (Stimwave) in the Delaware Court asserting that Stimwave was infringing the Company&#8217;s patents covering inventions related to its 10 kHz Therapy and the Senza system, as well as a claim for false advertising under the Lanham Action Section 43(a), 15 U.S.C. &#167; 1125(a).&#160;&#160;In relation to this lawsuit, on July 24, 2019, the Delaware Court granted the Company&#8217;s motion for preliminary injunction, and issued an order barring Stimwave, and all affiliated persons and entities, from infringing patent claims covering frequencies between 3 kHz and 10 kHz. On February 27, 2020, the Company and Stimwave entered into a Settlement Agreement, in which Stimwave agreed to cease commercialization of all high frequency spinal cord stimulation systems worldwide.&#160;&#160;Stimwave also agreed to entry of a permanent injunction in the Delaware Court, under which Stimwave&#8217;s products will not deliver spinal cord </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000367_dcnt_f1ca87da-440f-4e1d-b646-d38fb89580b2">
<p style="margin-bottom:0pt;margin-top:6pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">stimulation therapy that includes pulse frequencies between 1,500 Hz and 100,000 Hz. The permanent injunction w</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">filed with the Delaware </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">C</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ourt</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and entered on March 2, 2020</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&#160;&#160;A</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fter the Delaware C</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ourt enter</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ed </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the permanent injunction, the case (including Stimwave&#8217;s appeal of the preliminary injunction order) </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">were </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dismissed.&#160;&#160;As part of the permanent injunction filing, Stimwave acknowledge</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the validity of the patents Nevro asserted in the litigation.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company&#8217;s</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> request, the </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">permanent injunction</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> order does not enjoin Stimwave from providing follow-up care and programming for any patients who were already programmed with high frequency therapy</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the United States prior to March 6, 2020, and in the rest of the world prior to April 30, 2020</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Nalu Litigation</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 28, 2020, the Company filed a lawsuit in the Delaware Court for patent infringement against Nalu Medical, Inc. (Nalu) asserting that Nalu is infringing the Company&#8217;s patents covering inventions related to its 10 kHz Therapy and the Senza system.<span style="font-size:12pt;color:#000000;"> </span>The Company&#8217;s patent infringement assertions were based, in part, on Nalu imbedding a high frequency SCS therapy in a version of its &#8220;PSP&#8221; waveform.&#160;&#160;During the litigation, Nalu modified its PSP waveform so that it no longer included an imbedded high frequency signal.&#160;&#160;As a result, on December 21, 2021, the Company announced that it had reached a favorable settlement agreement with Nalu to terminate the litigation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is and may from time to time continue to be involved in various legal proceedings to defend its intellectual property, including several pending European patent oppositions at the European Patent Office (EPO) initiated by the Company&#8217;s competitors Medtronic and Boston Scientific, an entitlement action filed by Boston Scientific in Germany, and an invalidity proceeding in China.&#160;&#160;In addition, the Company is and may from time to time also be involved in various legal proceedings of a character normally incident to the ordinary course of business, such as employment matters, product liability matters, and professional liability matters, which the Company does not deem to be material to its business and condensed consolidated financial statements at this stage.</p></ix:continuation><ix:nonNumeric id="F_000368" name="us-gaap:DebtDisclosureTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000368_dcnt_1e326010-fdc7-4563-8624-535053a0af4f">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8. Long-term Debt</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021 Notes and Convertible Note Hedge and Warrant Transactions</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Company issued $<ix:nonFraction unitRef="U_iso4217USD" id="F_000724" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="INF" scale="6">150.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="U_xbrlipure" id="F_000725" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="INF" scale="-2">1.75</ix:nonFraction>% convertible senior notes due in <ix:nonNumeric id="F_000726" name="nvro:DebtInstrumentMaturityMonthAndYear" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" format="ixt:datemonthyearen">June 2021</ix:nonNumeric> in a registered underwritten public offering and an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000727" name="nvro:DebtInstrumentAdditionalAggregatePrincipalAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="-5" scale="6">22.5</ix:nonFraction> million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75%&#160;per annum and are payable <ix:nonNumeric id="F_000728" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20210101_20211231">semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016</ix:nonNumeric>.&#160;&#160;The total net proceeds from the debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000729" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="-5" scale="6">166.2</ix:nonFraction> million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each $<ix:nonFraction unitRef="U_iso4217USD" id="F_000730" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="INF" format="ixt:numdotdecimal">1,000</ix:nonFraction> principal amount of the 2021 Notes will initially be convertible into <ix:nonFraction unitRef="U_xbrlishares" id="F_000731" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="INF">10.3770</ix:nonFraction> shares of the Company&#8217;s <ix:nonNumeric id="F_000732" name="us-gaap:DebtInstrumentConvertibleTypeOfEquitySecurity" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20210101_20211231">common stock</ix:nonNumeric>, which is equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000733" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="2">96.37</ix:nonFraction> per share, subject to adjustment upon the occurrence of specified events. The 2021 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding December 1, 2020, only under the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on September&#160;30, 2016 (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock for at least <ix:nonFraction unitRef="U_utrD" id="F_000734" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="INF">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="U_utrD" id="F_000735" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="INF">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000736" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="2" scale="-2">130</ix:nonFraction>% of the conversion price on each applicable trading day&#59; (2)&#160;during the <ix:nonFraction unitRef="U_utrD" id="F_000737" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="INF" format="ixt-sec:numwordsen">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="U_utrD" id="F_000738" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="INF" format="ixt-sec:numwordsen">ten</ix:nonFraction> consecutive trading day period (the measurement period) in which the trading price (as defined in the indenture to the 2021 Notes) per $1,000 principal amount of notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="U_xbrlipure" id="F_000739" name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="INF" scale="-2">98</ix:nonFraction>% of the product of the last reported sale price of the Company&#8217;s common stock and the conversion rate on each such trading day&#59; or (3)&#160;upon the occurrence of specified corporate events.&#160; On or after December&#160;1, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2021 Notes at any time, regardless of the foregoing circumstances.&#160;&#160;Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s election.&#160;&#160;If the Company undergoes a fundamental change prior to the maturity date, holders of the notes may require the Company to repurchase for cash all or any portion of their notes at a repurchase price equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000740" name="nvro:PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="INF" scale="-2">100</ix:nonFraction>% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000368_dcnt_1e326010-fdc7-4563-8624-535053a0af4f" continuedAt="F_000368_dcnt_f1dab2f5-1f3a-4140-86a9-0eaf440502ef">
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">addition, if specific corporate events occur prior to the applicable maturity date, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event in certain circumstances.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the offering of the 2021 Notes, the Company entered into convertible note hedge transactions with certain bank counterparties in which the Company has the option to purchase initially (subject to adjustment for certain specified events) a total of approximately <ix:nonFraction unitRef="U_xbrlishares" id="F_000741" name="nvro:NoteHedgesNumberOfSharesContractedToBuy" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="-5" scale="6">1.8</ix:nonFraction>&#160;million shares of the Company&#8217;s common stock at a price of approximately $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000742" name="nvro:PurchasePricePerCommonStock" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="INF">96.37</ix:nonFraction> per share. The total cost of the convertible note hedge transactions was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000743" name="nvro:NoteHedgesTransactionCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="-5" scale="6">45.1</ix:nonFraction> million.&#160;&#160;In addition, the Company sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately <ix:nonFraction unitRef="U_xbrlishares" id="F_000744" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630" decimals="-5" scale="6">1.8</ix:nonFraction>&#160;million shares of the Company&#8217;s common stock at a price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000745" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630" decimals="INF">127.28</ix:nonFraction> per share. The Company received $<ix:nonFraction unitRef="U_iso4217USD" id="F_000746" name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="-5" scale="6">33.1</ix:nonFraction> million in cash proceeds from the sale of these warrants.&#160;&#160;Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of these notes and to effectively increase the overall conversion price from $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000747" name="nvro:ConversionPricePerShare" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630" decimals="INF">96.37</ix:nonFraction> to $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000748" name="nvro:ConversionPricePerShare" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630" decimals="INF">127.28</ix:nonFraction> per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded in stockholders&#8217; equity&#160;and are not accounted for as derivatives. The net cost of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000749" name="nvro:AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630" decimals="-5" scale="6">12.0</ix:nonFraction> million incurred in connection with the convertible note hedge and warrant transactions was recorded as a reduction to additional paid-in capital on the consolidated balance sheet.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the issuance of the convertible senior notes, the Company separated the 2021 Notes into liability and equity components.&#160;&#160;The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000750" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="-5" scale="6">32.9</ix:nonFraction> million and was determined by deducting the fair value of the liability component from the par value of the 2021 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (debt discount) is amortized to interest expense over the term of the 2021 Notes expense at an effective interest rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000751" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="4" scale="-2">6.29</ix:nonFraction>% over the contractual terms of the notes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the debt issuance costs of&#160;$<ix:nonFraction unitRef="U_iso4217USD" id="F_000752" name="us-gaap:DeferredFinanceCostsNet" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="-5" scale="6">6.2</ix:nonFraction> million&#160;related to the 2021 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2021 Notes based on their relative values. Issuance costs attributable to the liability component were $<ix:nonFraction unitRef="U_iso4217USD" id="F_000753" name="us-gaap:DeferredFinanceCostsNoncurrentGross" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630" decimals="-5" scale="6">5.0</ix:nonFraction> million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2021 Notes. &#160;Issuance costs attributable to the equity component were netted with the equity component in stockholders&#8217; equity.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 1, 2021, the 2021 Notes matured and the Company settled the 2021 Notes.&#160;&#160;The Company paid $<ix:nonFraction unitRef="U_iso4217USD" id="F_000754" name="us-gaap:DebtInstrumentCarryingAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601" decimals="-5" scale="6">172.5</ix:nonFraction> million to settle the outstanding principal and issued <ix:nonFraction unitRef="U_xbrlishares" id="F_000755" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601_20210601" decimals="INF" format="ixt:numdotdecimal">682,912</ix:nonFraction> shares of common stock to holders who elected to convert the 2021 Notes. In addition, the Company exercised its option under the bond hedge and received <ix:nonFraction unitRef="U_xbrlishares" id="F_000756" name="nvro:ExerciseOfBondHedgeForConvertibleSeniorNotes" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601_20210601" decimals="INF" format="ixt:numdotdecimal">682,916</ix:nonFraction> shares of common stock from the bank counterparties. <ix:nonFraction unitRef="U_iso4217USD" id="F_000757" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601_20210601" decimals="-3" format="ixt-sec:numwordsen" scale="3">None</ix:nonFraction> of the holders of the warrants associated with the 2021 Notes exercised the option to purchase shares.&#160;&#160;As of December 31, 2021, the 2021 Notes were no longer outstanding. </p><ix:nonNumeric id="F_000411" name="us-gaap:ConvertibleDebtTableTextBlock" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000758" name="us-gaap:DebtInstrumentCarryingAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">172,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000759" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,182</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized issuance cost</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000760" name="us-gaap:DeferredFinanceCostsNoncurrentGross" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231" decimals="-3" scale="3">542</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000761" name="us-gaap:LongTermDebt" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">168,776</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000368_dcnt_f1dab2f5-1f3a-4140-86a9-0eaf440502ef" continuedAt="F_000368_dcnt_30c4af1d-c2af-4e14-b955-aeee7f0e6c3b">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000412" name="us-gaap:ConvertibleDebtTableTextBlock" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt discount related to value of conversion option</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000762" name="nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,945</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000763" name="nvro:DebtInstrumentConvertibleEquityComponentIssuanceCost" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,179</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000764" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,766</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2025 Notes and Convertible Note Hedge and Warrant Transactions</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, the Company issued $<ix:nonFraction unitRef="U_iso4217USD" id="F_000765" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430" decimals="INF" scale="6">165.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="U_xbrlipure" id="F_000766" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430" decimals="INF" scale="-2">2.75</ix:nonFraction>% convertible senior notes due <ix:nonNumeric id="F_000767" name="nvro:DebtInstrumentMaturityYear" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430">2025</ix:nonNumeric> in a registered underwritten public offering and an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000768" name="nvro:DebtInstrumentAdditionalAggregatePrincipalAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430" decimals="-5" scale="6">24.8</ix:nonFraction> million aggregate principal amount of such notes pursuant to underwriters&#8217; exercise in full of their option to purchase additional 2025 Notes. The interest rates are fixed at 2.75%&#160;per annum and are payable <ix:nonNumeric id="F_000769" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20210101_20211231">semi-annually in arrears on April 1 and October&#160;1 of each year, commencing on October 1, 2020</ix:nonNumeric>.&#160;&#160;The total net proceeds from the debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000770" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="-5" scale="6">183.6</ix:nonFraction> million. &#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each $<ix:nonFraction unitRef="U_iso4217USD" id="F_000771" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="INF" format="ixt:numdotdecimal">1,000</ix:nonFraction> principal amount of the 2025 Notes will initially be convertible into <ix:nonFraction unitRef="U_xbrlishares" id="F_000772" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="INF">9.5238</ix:nonFraction> shares of the Company&#8217;s <ix:nonNumeric id="F_000773" name="us-gaap:DebtInstrumentConvertibleTypeOfEquitySecurity" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20210101_20211231">common stock</ix:nonNumeric>, which is equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000774" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430" decimals="2">105.00</ix:nonFraction> per share, subject to adjustment upon the occurrence of specified events. The 2025 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding October 1, 2024, only under the following circumstances: <span style="Background-color:#FFFFFF;">(1)&#160;during any calendar quarter commencing after the calendar quarter ending on June&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock for at least <ix:nonFraction unitRef="U_utrD" id="F_000775" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="INF">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="U_utrD" id="F_000776" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="INF">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000777" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="2" scale="-2">130</ix:nonFraction>% of the conversion price on each applicable trading day&#59; (2)&#160;during the <ix:nonFraction unitRef="U_utrD" id="F_000778" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="INF" format="ixt-sec:numwordsen">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="U_utrD" id="F_000779" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="INF" format="ixt-sec:numwordsen">ten</ix:nonFraction> consecutive trading day period (the measurement period) in which the trading price (as defined in the indenture to the 2025 Notes) per $1,000 principal amount of notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="U_xbrlipure" id="F_000780" name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="INF" scale="-2">98</ix:nonFraction>% of the product of the last reported sale price of the Company&#8217;s common stock and the conversion rate on each such trading day&#59; or (3)&#160;upon the occurrence of specified corporate events.&#160;</span> <span style="color:#000000;">On or after October&#160;1, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2025 Notes at any time, regardless of the foregoing circumstances.&#160;&#160;</span>Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s election.&#160;&#160;<span style="Background-color:#FFFFFF;">If the Company undergoes a fundamental change prior to the maturity date, holders of the notes may require the Company to repurchase for cash all or any portion of their notes at a repurchase price equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000781" name="nvro:PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="INF" scale="-2">100</ix:nonFraction>% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. </span>In addition, if specific corporate events occur prior to the applicable maturity date, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event in certain circumstances.<span style="Background-color:#FFFFFF;"> </span>During the three months ended December 31, 2021 the conditions allowing holders of the 2025 Notes to convert have not been met. Therefore, the 2025 Notes may not be converted during the three months ended March 31, 2022. As of December 31, 2021, the if-converted value of the 2025 Notes did <ix:nonFraction unitRef="U_iso4217USD" id="F_000782" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20210101_20211231" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction>t exceeded the principal value of those notes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the offering of the 2025 Notes, the Company entered into convertible note hedge transactions with certain bank counterparties in which the Company has the option to purchase initially (subject to adjustment for certain specified events) a total of approximately <ix:nonFraction unitRef="U_xbrlishares" id="F_000783" name="nvro:NoteHedgesNumberOfSharesContractedToBuy" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430" decimals="-5" scale="6">1.8</ix:nonFraction>&#160;million shares of the Company&#8217;s common stock at a price of approximately $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000784" name="nvro:PurchasePricePerCommonStock" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430" decimals="INF">105.00</ix:nonFraction> per share. The total cost of the convertible note hedge transactions was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000785" name="nvro:NoteHedgesTransactionCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="-5" scale="6">52.4</ix:nonFraction> million.&#160;&#160;In addition, the Company sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately <ix:nonFraction unitRef="U_xbrlishares" id="F_000786" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430" decimals="-5" scale="6">1.8</ix:nonFraction>&#160;million shares of the Company&#8217;s common stock at a price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000787" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430" decimals="INF">147.00</ix:nonFraction> per share. The Company received $<ix:nonFraction unitRef="U_iso4217USD" id="F_000788" name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="-5" scale="6">34.9</ix:nonFraction> million in cash proceeds from the sale of these warrants.&#160;&#160;Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of these notes and to effectively increase the overall conversion price from $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000789" name="nvro:ConversionPricePerShare" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430" decimals="INF">105.00</ix:nonFraction> to $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000790" name="nvro:ConversionPricePerShare" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430" decimals="INF">147.00</ix:nonFraction> per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded in stockholders&#8217; equity&#160;and will not be subsequently remeasured as long as they continue to meet the conditions for equity classification. The net </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000368_dcnt_30c4af1d-c2af-4e14-b955-aeee7f0e6c3b">
<p style="margin-top:12pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cost of $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000791" name="nvro:AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430" decimals="-5" scale="6">17.5</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million incurred in connection with the convertible note hedge and warrant transactions was recorded as a reduction to additional paid-in capital on the consolidated balance sheet.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the issuance of the convertible senior notes, the Company separated the 2025 Notes into liability and equity components.&#160;&#160;The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000792" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430" decimals="-5" scale="6">49.9</ix:nonFraction> million and was determined by deducting the fair value of the liability component from the par value of the 2025 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (debt discount) is amortized to interest expense over the term of the 2025 Notes expense at an effective interest rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000793" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430" decimals="3" scale="-2">10.2</ix:nonFraction>% over the contractual terms of the notes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the debt issuance costs of&#160;$<ix:nonFraction unitRef="U_iso4217USD" id="F_000794" name="us-gaap:DeferredFinanceCostsNet" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20200430" decimals="-5" scale="6">6.1</ix:nonFraction> million&#160;related to the 2025 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2025 Notes based on the same proportion as the accounting for the proceeds from the issuance of the 2025 Notes.&#160;&#160;Issuance costs attributable to the liability component were $<ix:nonFraction unitRef="U_iso4217USD" id="F_000795" name="us-gaap:DeferredFinanceCostsNoncurrentGross" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20200430" decimals="-5" scale="6">4.5</ix:nonFraction> million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2025 Notes.<span style="font-weight:bold;"> </span>&#160;Issuance costs attributable to the equity component were netted with the equity component in stockholders&#8217; equity.</p><ix:nonNumeric id="F_000413" name="us-gaap:ConvertibleDebtTableTextBlock" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the liability component of the 2025 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000796" name="us-gaap:DebtInstrumentCarryingAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">189,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000797" name="us-gaap:DebtInstrumentCarryingAmount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">189,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000798" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,079</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000799" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">43,919</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized issuance cost</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000800" name="us-gaap:DeferredFinanceCostsNoncurrentGross" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,361</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000801" name="us-gaap:DeferredFinanceCostsNoncurrentGross" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,060</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000802" name="us-gaap:LongTermDebt" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">151,310</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000803" name="us-gaap:LongTermDebt" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">141,771</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000414" name="us-gaap:ConvertibleDebtTableTextBlock" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20210101_20211231" escape="true" continuedAt="F_000414_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the equity component of the 2025 Notes was as follows (in thousands):</p></ix:nonNumeric><ix:continuation id="F_000414_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt discount related to value of conversion option</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000804" name="nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">49,947</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000805" name="nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">49,947</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000806" name="nvro:DebtInstrumentConvertibleEquityComponentIssuanceCost" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,607</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000807" name="nvro:DebtInstrumentConvertibleEquityComponentIssuanceCost" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,607</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000808" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">48,340</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000809" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">48,340</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000415" name="nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the interest expense recognized related to the 2021 Notes and 2025 Notes (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual interest expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000810" name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,484</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000811" name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000812" name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,019</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt discount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000813" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,023</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000814" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,308</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000815" name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,843</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000816" name="us-gaap:AmortizationOfFinancingCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,240</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000817" name="us-gaap:AmortizationOfFinancingCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,634</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000818" name="us-gaap:AmortizationOfFinancingCosts" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,063</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total interest expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000819" name="us-gaap:InterestExpenseDebt" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,747</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000820" name="us-gaap:InterestExpenseDebt" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,802</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000821" name="us-gaap:InterestExpenseDebt" contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,925</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000369" name="us-gaap:PreferredStockTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9. Convertible Preferred Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to its initial public offering, the Company had outstanding <ix:nonFraction unitRef="U_xbrlishares" id="F_000822" name="us-gaap:ConversionOfStockSharesConverted1" contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20141110_20141111" decimals="INF" format="ixt:numdotdecimal">15,208,048</ix:nonFraction> shares of convertible preferred stock. Each share of preferred stock was convertible to <ix:nonFraction unitRef="U_xbrlishares" id="F_000823" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20141111" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock. Upon the closing of the Company&#8217;s initial public offering on November&#160;11, 2014, all shares of outstanding redeemable convertible preferred stock were automatically converted to <ix:nonFraction unitRef="U_xbrlishares" id="F_000824" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001444380_20141110" decimals="INF" format="ixt:numdotdecimal">15,208,048</ix:nonFraction> shares of the Company&#8217;s common stock.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000370" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000370_dcnt_10db5ecd-95d6-4700-bd17-e3cac88407d9">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10. Stock-Based Compensation</p><ix:nonNumeric id="F_000416" name="nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock reserved for future issuance as of December 31, 2021 was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.8%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding stock options and awards</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000825" name="nvro:CommonStockOptionsAndAwardsOutstanding" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal">1,713,145</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for grants of future stock options and awards</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000826" name="nvro:CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal">6,078,869</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for employee stock purchase plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000827" name="nvro:CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal">1,567,514</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total common stock reserved for future issuance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000828" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal">9,359,528</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Plans</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s Board of Directors (Board) and stockholders previously approved the 2007 Stock Option Plan (the 2007 Plan). In October 2014, the Board adopted the 2014 Equity Incentive Award Plan (the 2014 Plan and, together with the 2007 Plan, the Stock Plans).&#160;&#160;As of the effective date of the 2014 Plan, the Company suspended the 2007 Plan and <ix:nonFraction unitRef="U_xbrlishares" id="F_000829" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandSevenPlanMember_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> additional awards may be granted under the 2007 Plan. Any shares of common stock covered by awards granted under the 2007 Plan that terminate after the effective date of the 2014 Plan by expiration, forfeiture, cancellation or other means without the issuance of such shares, will be added to the 2014 Plan reserve.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the 2014 Plan, <ix:nonFraction unitRef="U_xbrlishares" id="F_000830" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20141031" decimals="INF" format="ixt:numdotdecimal">1,854,166</ix:nonFraction> shares of common stock were initially reserved for issuance, plus the number of shares remaining available for future awards under the 2007 Plan, as of the pricing of the IPO. <ix:nonNumeric id="F_000831" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" contextRef="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i)&#160;the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii)&#160;an annual increase on January&#160;1 of each year.</ix:nonNumeric></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the 2014 Plan, the Company may grant awards such as incentive stock options, nonstatutory stock options, restricted stock units, performance stock units and stock appreciation rights. Incentive stock options (ISO) may be granted only to Company employees (including directors who are also employees). Nonqualified stock options (NSO) may be granted to Company employees, directors and consultants.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Options</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options under the 2014 Plan may be granted for periods of up to <ix:nonNumeric id="F_000832" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231" format="ixt-sec:durwordsen">ten years</ix:nonNumeric> and at prices no less than <ix:nonFraction unitRef="U_xbrlipure" id="F_000833" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" scale="-2">100</ix:nonFraction>% of the estimated fair market value of the shares on the date of grant as determined by the Board, provided, however, that the exercise price of an ISO or an NSO granted to a <ix:nonFraction unitRef="U_xbrlipure" id="F_000834" name="nvro:PercentageOfShareholderOptionsGranted" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroIncentiveStockOptionsMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231" decimals="2" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000835" name="nvro:PercentageOfShareholderOptionsGranted" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroNonQualifiedStockOptionsMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231" decimals="2" scale="-2">10</ix:nonFraction></ix:nonFraction>% stockholder shall not be less than <ix:nonFraction unitRef="U_xbrlipure" id="F_000836" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231" decimals="INF" scale="-2">110</ix:nonFraction>% of the estimated fair market value of the shares on the date of grant. Upon the exercise of options, the Company issues new common stock from its authorized shares. The vesting provisions of individual options vary but are generally over <ix:nonNumeric id="F_000837" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20210101_20211231" format="ixt-sec:durwordsen">four years</ix:nonNumeric>, with the exception of performance based stock options.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the 2014 Plan, the Company granted performance based stock options to the Company&#8217;s former CEO in March 2016. This performance based stock option award was subject to the CEO&#8217;s continued service to the Company through each applicable vesting date. Upon the former CEO&#8217;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.</p><ix:nonNumeric id="F_000417" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000417_dcnt_9ae7260c-657d-4585-91aa-16fbfac9a175">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of shares available for grant under the Stock Plans is as follows:</p></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000370_dcnt_10db5ecd-95d6-4700-bd17-e3cac88407d9" continuedAt="F_000370_dcnt_44951312-ff2b-4594-8816-82b0b1d75003"><ix:continuation id="F_000417_dcnt_9ae7260c-657d-4585-91aa-16fbfac9a175">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Available</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Grant</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000838" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231" decimals="INF" format="ixt:numdotdecimal">2,980,762</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000839" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">1,210,541</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000840" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">277,778</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000841" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">38,696</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs granted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000842" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">1,077,178</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs cancelled</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000843" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">527,963</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000844" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231" decimals="INF" format="ixt:numdotdecimal">3,403,006</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000845" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,261,774</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000846" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">43,966</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000847" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">62,782</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs granted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000848" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">341,901</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs cancelled</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000849" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">258,486</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000850" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231" decimals="INF" format="ixt:numdotdecimal">4,600,181</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000851" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">1,383,322</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000852" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">24,830</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000853" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">58,787</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs granted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000854" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">425,266</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs cancelled</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000855" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">140,101</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000856" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20211231" decimals="INF" format="ixt:numdotdecimal">5,732,295</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation><ix:nonNumeric id="F_000418" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock option activity under the Stock Plans is as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options&#160;Outstanding</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise&#160;Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Term</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic&#160;Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000857" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001444380_20181231" decimals="INF" format="ixt:numdotdecimal">2,529,740</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000870" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001444380_20181231" decimals="2">46.72</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000883">6.7</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000889" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001444380_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,866</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000858" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001444380_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">244,075</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000871" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_0001444380_20190101_20191231" decimals="2">56.71</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000859" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001444380_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">828,722</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000872" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_0001444380_20190101_20191231" decimals="2">34.52</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000890" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,695</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000860" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_0001444380_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">298,908</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000873" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_0001444380_20190101_20191231" decimals="2">66.22</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000861" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001444380_20191231" decimals="INF" format="ixt:numdotdecimal">1,646,185</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000874" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001444380_20191231" decimals="2">50.80</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000884">6.3</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000891" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001444380_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">109,870</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000862" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001444380_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">756,797</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000875" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_0001444380_20200101_20201231" decimals="2">45.75</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000892" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">62,367</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000863" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_0001444380_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">76,238</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000876" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_0001444380_20200101_20201231" decimals="2">59.38</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000864" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001444380_20201231" decimals="INF" format="ixt:numdotdecimal">813,150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000877" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001444380_20201231" decimals="2">54.69</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000885">5.9</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000893" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">96,286</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000865" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001444380_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">90,582</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000878" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_0001444380_20210101_20211231" decimals="2">47.82</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000894" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,948</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000866" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_0001444380_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">21,914</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000879" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_0001444380_20210101_20211231" decimals="2">43.52</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000867" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal">700,654</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000880" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001444380_20211231" decimals="2">55.93</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000886">4.8</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000895" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,287</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable as of December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000868" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal">599,295</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000881" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_0001444380_20211231" decimals="2">56.06</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000887">4.4</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000896" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,656</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested, exercisable or expected to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; vest as of December 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000869" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001444380_20211231" decimals="INF" format="ixt:numdotdecimal">696,003</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000882" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="C_0001444380_20211231" decimals="2">55.92</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000888">4.8</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000897" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,173</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of the Company&#8217;s common stock at the date of exercise and the exercise price for in-the-money options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The weighted-average grant-date fair value of options granted during the year ended December&#160;31, 2019 was $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000898" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_20190101_20191231" decimals="2">27.91</ix:nonFraction> per share. No options were granted during the years ended December 31, 2021 and 2020.&#160;&#160;The total fair value of options vested during the years ended December 31, 2021, 2020 and 2019 was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000899" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="C_0001444380_20210101_20211231" decimals="-5" scale="6">3.1</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000900" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="C_0001444380_20200101_20201231" decimals="-5" scale="6">6.6</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000901" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="C_0001444380_20190101_20191231" decimals="-5" scale="6">8.3</ix:nonFraction> million, respectively, based on the grant date fair value.</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000370_dcnt_44951312-ff2b-4594-8816-82b0b1d75003" continuedAt="F_000370_dcnt_e61745b9-1aa6-4afb-8ed3-5d19a16f4690"><ix:nonNumeric id="F_000419" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The options outstanding and vested under the Stock Plans by exercise price, at December&#160;31, 2021, were as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="8" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.84%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Vested</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Exercise Price</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000902">$3.60 &#8212; $36.55</span></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000915" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231" decimals="INF" format="ixt:numdotdecimal">116,179</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000922">3.15</span></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000929" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231" decimals="2">19.18</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000936" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231" decimals="INF" format="ixt:numdotdecimal">111,929</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000943" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231" decimals="2">18.52</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000903">$38.79 &#8212; $45.04</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000916" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231" decimals="INF" format="ixt:numdotdecimal">114,032</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000923">5.52</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000930" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231" decimals="2">47.12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000937" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231" decimals="INF" format="ixt:numdotdecimal">94,094</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000944" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231" decimals="2">42.08</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000904">$45.07 &#8212; $63.23</span></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000917" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231" decimals="INF" format="ixt:numdotdecimal">156,883</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000924">4.48</span></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000931" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231" decimals="2">57.56</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000938" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231" decimals="INF" format="ixt:numdotdecimal">129,344</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000945" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231" decimals="2">59.12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000905">$63.39 &#8212; $64.95</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000918" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231" decimals="INF" format="ixt:numdotdecimal">141,004</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000925">6.94</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000932" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231" decimals="2">64.28</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000939" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231" decimals="INF" format="ixt:numdotdecimal">91,835</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000946" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231" decimals="2">64.21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000906">$65.51 &#8212; $87.62</span></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000919" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231" decimals="INF" format="ixt:numdotdecimal">152,556</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000926">3.95</span></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000933" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231" decimals="2">79.37</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000940" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231" decimals="INF" format="ixt:numdotdecimal">152,093</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000947" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231" decimals="2">79.36</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$97.52</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000920" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231" decimals="INF" format="ixt:numdotdecimal">20,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000927">4.62</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000934" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231" decimals="2">97.52</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000941" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231" decimals="INF" format="ixt:numdotdecimal">20,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000948" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231" decimals="2">97.52</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000907">$3.60 &#8212; $97.52</span></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000921" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231" decimals="INF" format="ixt:numdotdecimal">700,654</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000928">4.81</span></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000935" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231" decimals="2">55.93</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000942" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231" decimals="INF" format="ixt:numdotdecimal">599,295</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000949" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231" decimals="2">56.06</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Stock Units</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2015, the Company began granting restricted stock units (RSUs) under the 2014 Plan.&#160;&#160;Holders of RSUs do not have stockholder rights.&#160;&#160;Upon the release of RSUs, the Company issues new common stock from its authorized shares. RSUs generally vest four years from the date of grant.</p><ix:nonNumeric id="F_000420" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of RSU activity under the Stock Plans was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant&#160;Date</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic&#160;Value</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock&#160;Units</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair&#160;Value</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in&#160;thousands)</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000950" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231" decimals="INF" format="ixt:numdotdecimal">1,002,161</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000964" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231" decimals="2">72.55</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000978" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,974</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000951" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">721,992</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000965" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="2">58.37</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000952" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">321,858</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000966" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="2">70.89</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000979" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,064</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000953" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">225,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000967" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="2">70.51</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000954" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231" decimals="INF" format="ixt:numdotdecimal">1,177,221</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000968" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231" decimals="2">64.70</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000980" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">138,371</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000955" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">252,703</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000969" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="2">123.31</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000956" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">395,971</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000970" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="2">66.42</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000981" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,789</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000957" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">180,976</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000971" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="2">71.26</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000958" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231" decimals="INF" format="ixt:numdotdecimal">852,977</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000972" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231" decimals="2">79.87</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000982" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">147,650</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000959" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">368,230</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000973" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" decimals="2">146.64</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000960" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">346,602</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000974" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" decimals="2">76.26</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000983" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000961" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">110,799</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000975" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" decimals="2">98.76</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000962" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231" decimals="INF" format="ixt:numdotdecimal">763,806</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000976" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231" decimals="2">110.96</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000984" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">61,922</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock expected to vest as of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000963" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231" decimals="INF" format="ixt:numdotdecimal">696,348</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000977" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231" decimals="2">109.78</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000985" name="nvro:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">56,453</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of RSUs released is calculated using the fair market value of the Company&#8217;s common stock at the date of release. The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company&#8217;s common stock as of the date outstanding.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Performance Stock Units</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the 2014 Plan, the Company granted performance based RSUs to the former CEO in March 2016. The performance based RSUs are subject to the former CEO&#8217;s continued service to the Company through each applicable vesting date. If a performance metric is not met within the time limits specified in the RSU agreement, the shares subject to vesting under the vesting tranche for that performance metric will be cancelled. Upon the former CEO&#8217;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled. </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000370_dcnt_e61745b9-1aa6-4afb-8ed3-5d19a16f4690" continuedAt="F_000370_dcnt_00cb8306-0aa7-4aac-a3c8-61bde8cf5886">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2019, the Company granted performance stock units (PSUs) to the current CEO, subject to his continued service to the Company and based on the total shareholder return (the TSR) of the Company&#8217;s common stock price compared to the S&#38;P Healthcare Equipment Select Industry Index (the Index) over a <span style="-sec-ix-hidden:F_000986">three-year</span> period.&#160;&#160;The number of shares to be issued upon vesting of these PSUs range from <span style="-sec-ix-hidden:F_000987_2">0 to 3.5 times</span> the target number of shares granted, depending on the Company&#8217;s performance against the targeted composite index.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the Company granted PSUs to certain members of the management team.&#160;&#160;The number of shares to be issued upon vesting was based on the total shareholder return of the Company&#8217;s common stock compared to the Index, as well as certain performance criteria related to a specific financial target over a two-year performance period. For the three months ended March 31, 2020, the Company determined that the achievement status for these PSUs was not possible, and therefore did not record stock-based compensation expenses related to these grants.&#160;&#160;During the three months ended June 30, 2020, the Company modified the performance criteria for these PSUs to reflect the changed market conditions as a result of the COVID-19 pandemic, such that the remaining performance criteria is based on total shareholder return compared to the Index.&#160;&#160;The Company also granted PSUs that incorporated the same modified performance criteria to the Company&#8217;s Chief Executive Officer PSUs. Additional similar PSUs were issued to new members of management in the year ended December 31, 2020.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, the Company granted PSUs to certain member of the management team, subject to continued service to the Company and based on the TSR of the Company&#8217;s common stock price compared to the Index over a <span style="-sec-ix-hidden:F_000989">three-year</span> period.&#160;&#160;The number of shares to be issued upon vesting of these PSUs range from <ix:nonFraction unitRef="U_xbrlipure" id="F_000990" name="nvro:TargetedNumberOfSharesGrantedRatio" contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331" decimals="INF" scale="-2">0</ix:nonFraction> to 1.5 times the target number of shares granted, depending on the Company&#8217;s performance against the targeted composite index.</p><ix:nonNumeric id="F_000421" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of PSU activity under the Stock Plans was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant&#160;Date</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic&#160;Value</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock&#160;Units</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair&#160;Value</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in&#160;thousands)</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000992" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20181231" decimals="INF" format="ixt:numdotdecimal">7,962</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001004" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20181231" decimals="2">54.50</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001016" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20181231" decimals="-3" scale="3">310</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU granted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000993" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">111,111</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001005" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="2">67.29</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU released</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000994" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">3,981</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001006" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="2">54.50</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU cancelled</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000995" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">3,981</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001007" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="2">54.50</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000996" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20191231" decimals="INF" format="ixt:numdotdecimal">111,111</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001008" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20191231" decimals="2">67.29</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001017" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,060</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU granted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000997" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">89,198</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001009" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="2">128.71</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU cancelled</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000998" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,272</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001010" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="2">125.27</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000999" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20201231" decimals="INF" format="ixt:numdotdecimal">199,037</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001011" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20201231" decimals="2">94.20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001018" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,453</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001000" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">57,036</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001012" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="2">183.20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU cancelled</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001001" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">7,388</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001013" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="2">136.77</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001002" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231" decimals="INF" format="ixt:numdotdecimal">248,685</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001014" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231" decimals="2">113.35</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001019" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,161</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU expected to vest as of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001003" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231" decimals="INF" format="ixt:numdotdecimal">247,815</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001015" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231" decimals="2">113.22</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001020" name="nvro:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,090</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of outstanding PSUs is calculated based on the closing price of the Company&#8217;s common stock as of the date outstanding.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014 Employee Stock Purchase Plan</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2014, the Board adopted the 2014 Employee Stock Purchase Plan (the ESPP). A total of <ix:nonFraction unitRef="U_xbrlishares" id="F_001021" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141031" decimals="INF" format="ixt:numdotdecimal">196,666</ix:nonFraction> shares of common stock were initially available for future issuance under the 2014 Employee Stock Purchase Plan, subject to an annual increase on January&#160;1 of each year. The ESPP provides eligible employees with an opportunity to purchase shares of the Company&#8217;s common stock through payroll deductions of up to <ix:nonFraction unitRef="U_xbrlipure" id="F_001022" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141031" decimals="INF" scale="-2">15</ix:nonFraction>% of their eligible compensation, subject to plan limitations.&#160;&#160;Under the ESPP, the purchase price of the Company stock is equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_001023" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141001_20141031" decimals="INF" scale="-2">85</ix:nonFraction>%&#160;of the lower of its fair market value at the start and end of a&#160;<span style="-sec-ix-hidden:F_001024">six-month</span> purchase period.</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000370_dcnt_00cb8306-0aa7-4aac-a3c8-61bde8cf5886" continuedAt="F_000370_dcnt_75b14fe8-a767-4491-8f24-3195d5908bdb"><ix:nonNumeric id="F_000422" name="us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of ESPP activity was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001025" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">235,590</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001026" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">315,443</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001027" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">302,635</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issued</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001028" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">65,197</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001029" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">79,967</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001030" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">164,960</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future issuance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001031" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20211231" decimals="INF" format="ixt:numdotdecimal">1,567,514</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001032" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">1,397,121</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001033" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20191231" decimals="INF" format="ixt:numdotdecimal">1,161,645</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee contributions for shares issued (in thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001034" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,849</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001035" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,513</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001036" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,544</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimated the fair value of stock options granted to employees and shares purchased by employees under the ESPP using the Black-Scholes option valuation model. The fair value is amortized on a straight-line basis over the requisite service period of the awards, with the exception of performance based stock options whose fair value is recorded as expenses based on the probability that the performance metrics will be achieved. <ix:nonNumeric id="F_000423" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000423_cnt_1">The following assumptions were used in estimating the fair value:</ix:nonNumeric></p><ix:continuation id="F_000423_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Options:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001037">5.7</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001038">51%&#160;&#8212;&#160;52%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001040">1.4%&#160;&#8212;&#160;2.6%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001042" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="2" scale="-2">0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESPP:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001043">0.5</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001044">0.5</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001045">0.5</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001046">36% &#8212; 49%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001047">39% &#8212; 68%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001048">48% &#8212; 61%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001052" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231" decimals="INF" scale="-2">0.1</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1% &#8212; 0.2%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6% &#8212; 2.4%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001057" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231" decimals="2" scale="-2">0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001058" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231" decimals="2" scale="-2">0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001059" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231" decimals="2" scale="-2">0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for RSUs at their fair value, based on the closing market price of the Company&#8217;s common stock on the grant date. The fair value is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting term of <ix:nonNumeric id="F_001060" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" format="ixt-sec:durwordsen">four years</ix:nonNumeric>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2016, the Company granted performance based RSUs to its former CEO that only vest upon the achievement of specific operational performance criteria.&#160;&#160;The stock-based compensation for these performance based RSUs are recognized as expenses when it is determined that achieving the performance metrics are probable. Upon the former CEO&#8217;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the former CEO&#8217;s resignation in March 2019, the Company amended the terms of his then vested nonqualified stock options such that they remain exercisable through the second anniversary of his separation date.&#160;&#160;This modification resulted in a charge of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001061" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190301_20190331" decimals="-5" scale="6">1.6</ix:nonFraction> million in stock-based compensation.&#160;&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2019, the Company granted PSUs to its current CEO that only vest based on the total shareholder return (TSR) of the Company common stock price relative to that of the Index.&#160;&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2020 and 2021, the Company granted PSUs to the CEO and other members of its management team that vest based on the total shareholder return of the Company common stock price relative to that of the Index.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000424" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" escape="true" continuedAt="F_000424_cnt_1">The company estimates the grant-date fair value of these PSUs based on the Monte Carlo simulation model and records the related stock-based compensation over the period for which the TSR is measured against the Index, which is generally two to <ix:nonNumeric id="F_001063" name="nvro:RecognitionPeriodOfStockBasedCompensationExpense" contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331" format="ixt-sec:durwordsen">three years</ix:nonNumeric>. The use of the Monte Carlo simulation model requires the input the following assumptions: </ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000370_dcnt_75b14fe8-a767-4491-8f24-3195d5908bdb">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000424_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="7" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Index volatility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001064">51% &#8212; 53%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001065">44% &#8212; 51%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001083" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="2" scale="-2">36</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company volatility</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001068">49% &#8212; 54%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001069">57% &#8212; 59%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001084" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="2" scale="-2">45</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001072">0.1% &#8212; 0.3%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001073">0.1% &#8212; 0.2%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001085" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="3" scale="-2">2.4</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Correlation with index</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001076">0.32 &#8212; 0.35</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001077">0.38 &#8212; 0.41</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001086" name="nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="4" scale="-2">0.28</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001080" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="2" scale="-2">0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001081" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="2" scale="-2">0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001082" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="2" scale="-2">0</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000425" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000425_cnt_1">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock-based compensation expense by line items in the consolidated statements of operations is as follows (in thousands):</p></ix:nonNumeric><ix:continuation id="F_000425_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001087" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,637</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001088" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,433</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001089" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,061</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001090" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,455</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001091" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,141</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001092" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,323</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, general and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001093" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,273</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001094" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,081</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001095" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,313</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001096" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">44,365</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001097" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,655</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001098" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,697</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation><ix:nonNumeric id="F_000426" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001099" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,997</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001100" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,289</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001101" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,312</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001102" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,234</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001103" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,977</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001104" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">26,854</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Performance stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001105" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,017</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001106" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,694</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001107" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,991</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001108" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,117</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001109" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,695</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001110" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,540</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001111" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">44,365</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001112" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,655</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001113" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,697</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000427" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, total stock-based compensation expense not yet recognized, net of estimated forfeitures, are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Compensation</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization&#160;Period</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001114" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,597</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001118">1.2</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001115" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">61,107</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001119">2.1</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Performance stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001116" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,389</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001120">0.7</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001117" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,219</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001121">0.4</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000371" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000371_dcnt_226f3ef7-c0e2-4e89-b9d9-f88b096cb77c">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">11. Income Taxes</p><ix:nonNumeric id="F_000428" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the Company&#8217;s income / (loss) before income taxes were as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001122" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">129,135</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001123" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">83,893</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001124" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">106,010</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001125" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,691</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001126" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_0001444380_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,696</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001127" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,923</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loss before income taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001128" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">130,826</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001129" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">82,197</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001130" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">102,087</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000371_dcnt_226f3ef7-c0e2-4e89-b9d9-f88b096cb77c" continuedAt="F_000371_dcnt_f9099f23-efb1-4537-96bd-73037f0fba08">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000429" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the expense / (benefit) for income taxes are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001131" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" scale="3">103</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001132" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">244</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001133" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">188</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001134" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">187</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001135" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">585</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001136" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">656</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001137" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,644</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current income tax expense / (benefit)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001138" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">829</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001139" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">844</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001140" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,728</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001141" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" scale="3">295</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001142" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">24</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001143" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" scale="3">129</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred income tax expense / (benefit)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001144" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" scale="3">295</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001145" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">24</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001146" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" scale="3">129</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax expense / (benefit)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001147" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">534</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001148" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">868</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001149" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,599</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000430" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax at statutory federal rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001150" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001444380_20210101_20211231" decimals="INF" scale="-2">21.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001151" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001444380_20200101_20201231" decimals="INF" scale="-2">21.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001152" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001444380_20190101_20191231" decimals="INF" scale="-2">21.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax, net of federal benefit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001153" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="C_0001444380_20210101_20211231" decimals="3" sign="-" scale="-2">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001154" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="C_0001444380_20200101_20201231" decimals="3" sign="-" scale="-2">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001155" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="C_0001444380_20190101_20191231" decimals="3" sign="-" scale="-2">0.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001156" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="C_0001444380_20210101_20211231" decimals="3" sign="-" scale="-2">0.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001157" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="C_0001444380_20200101_20201231" decimals="3" sign="-" scale="-2">0.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001158" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="C_0001444380_20190101_20191231" decimals="3" sign="-" scale="-2">0.7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001159" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" contextRef="C_0001444380_20210101_20211231" decimals="3" sign="-" format="ixt:numdotdecimal" scale="-2">3.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001160" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" contextRef="C_0001444380_20200101_20201231" decimals="3" sign="-" format="ixt:numdotdecimal" scale="-2">1.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001161" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" contextRef="C_0001444380_20190101_20191231" decimals="3" sign="-" format="ixt:numdotdecimal" scale="-2">3.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001162" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0001444380_20210101_20211231" decimals="3" sign="-" scale="-2">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001163" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0001444380_20200101_20201231" decimals="3" scale="-2">9.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001164" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0001444380_20190101_20191231" decimals="3" scale="-2">3.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001165" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001444380_20210101_20211231" decimals="3" sign="-" scale="-2">23.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001166" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001444380_20200101_20201231" decimals="3" sign="-" scale="-2">33.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001167" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001444380_20190101_20191231" decimals="3" sign="-" scale="-2">26.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001168" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="C_0001444380_20210101_20211231" decimals="3" sign="-" scale="-2">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001169" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="C_0001444380_20200101_20201231" decimals="3" scale="-2">0.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001170" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="C_0001444380_20190101_20191231" decimals="3" sign="-" scale="-2">2.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001171" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001444380_20210101_20211231" decimals="3" sign="-" scale="-2">0.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001172" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001444380_20200101_20201231" decimals="3" sign="-" scale="-2">1.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlipure" id="F_001173" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0001444380_20190101_20191231" decimals="3" sign="-" scale="-2">1.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000431" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001174" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">154,614</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001175" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">127,347</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001176" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,087</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001177" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,919</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001178" name="nvro:DeferredTaxAssetsDepreciation" contextRef="C_0001444380_20211231" decimals="-3" scale="3">650</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001179" name="nvro:DeferredTaxAssetsDepreciation" contextRef="C_0001444380_20201231" decimals="-3" scale="3">662</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001180" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,969</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001181" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,390</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accruals and reserves</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001182" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,404</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001183" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,531</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001184" name="nvro:DeferredTaxLiabilitiesRightOfUseAsset" contextRef="C_0001444380_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,225</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001185" name="nvro:DeferredTaxLiabilitiesRightOfUseAsset" contextRef="C_0001444380_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">5,055</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001186" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,130</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001187" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001444380_20201231" decimals="-3" scale="3">869</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross deferred tax assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001188" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">206,079</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001189" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">169,773</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001190" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">201,088</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001191" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">164,278</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001192" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,991</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001193" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,495</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001194" name="nvro:DeferredTaxAssetsLeaseLiabilities" contextRef="C_0001444380_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,660</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001195" name="nvro:DeferredTaxAssetsLeaseLiabilities" contextRef="C_0001444380_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,459</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001196" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,660</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001197" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,459</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001198" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,331</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001199" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,036</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000371_dcnt_f9099f23-efb1-4537-96bd-73037f0fba08" continuedAt="F_000371_dcnt_bed675c9-7dce-43b1-a23a-51869ef284e6">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, substantially all of the net deferred tax assets have been offset by a valuation allowance. The valuation allowance increased by $<ix:nonFraction unitRef="U_iso4217USD" id="F_001200" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001444380_20210101_20211231" decimals="-5" scale="6">36.8</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001201" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001444380_20200101_20201231" decimals="-5" scale="6">32.5</ix:nonFraction> million for the years ended December&#160;31, 2021 and 2020, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, the Company had federal net operating loss carryforwards (NOLs) of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001202" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231" decimals="-5" scale="6">588.4</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_001204" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20181231" decimals="-5" scale="6">329.4</ix:nonFraction> million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the 2017 Tax Act, as well as state NOLs of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001203" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20211231" decimals="-5" scale="6">336.5</ix:nonFraction> million, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_001205" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001444380_20211231" decimals="-5" scale="6">54.3</ix:nonFraction> million may be carried forward indefinitely. If not utilized, the remaining federal NOLs will begin to expire in <ix:nonNumeric id="F_001206" name="nvro:FederalAndStateNetOperatingLossCarryForwardsExpirationYear" contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231">2026</ix:nonNumeric>, and the remaining state NOLs will begin to expire in <ix:nonNumeric id="F_001207" name="nvro:FederalAndStateNetOperatingLossCarryForwardsExpirationYear" contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20210101_20211231">2022</ix:nonNumeric>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, the Company had research and development credit carryforwards of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001208" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20211231" decimals="-5" scale="6">20.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001209" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="C_0001444380_us-gaapIncomeTaxAuthorityNameAxis_us-gaapCaliforniaFranchiseTaxBoardMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20211231" decimals="-5" scale="6">13.9</ix:nonFraction>&#160;million for federal and California state income tax purposes, respectively. The federal credit carryforward begins expiring in 2026, and the state credits carry forward indefinitely.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under Section&#160;382 of the Internal Revenue Code of 1986, as amended, the Company&#8217;s ability to utilize NOLs or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, a Section 382 &#8220;ownership change.&#8221; A Section&#160;382 &#8220;ownership change&#8221; generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company&#8217;s stock, increase their ownership by a greater than 50 percentage point change (by value) over a rolling three-year period. Similar rules may apply under state tax laws. As a result of the Company&#8217;s June 2015 underwritten public offering, the Company experienced a Section 382 &#8220;ownership change.&#8221;&#160;&#160;The Company currently estimates that this &#8220;ownership change&#8221; will not inhibit its ability to utilize its NOLs.  However, the Company may, in the future, experience one or more additional Section&#160;382 &#8220;ownership changes&#8221; as a result of subsequent changes in its stock ownership, some of which changes are outside the Company&#8217;s control.&#160;&#160;If so, the Company may not be able to utilize a material portion of its NOLs and tax credits, even if the Company achieves profitability.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had unrecognized tax benefits (UTBs) of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001210" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001444380_20211231" decimals="-5" scale="6">10.4</ix:nonFraction>&#160;million as of December&#160;31, 2021. <ix:nonNumeric id="F_000432" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true" continuedAt="F_000432_cnt_1">The following table summarizes the activity related to UTBs (in thousands):</ix:nonNumeric></p><ix:continuation id="F_000432_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001211" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001444380_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001212" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001444380_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,611</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001213" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0001444380_20190101_20191231" decimals="-3" scale="3">572</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001214" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001444380_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,383</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001215" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">891</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001216" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0001444380_20200101_20201231" decimals="-3" scale="3">54</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001217" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001444380_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,220</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001218" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001444380_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,412</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001219" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001220" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0001444380_20210101_20211231" decimals="-3" scale="3">62</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001221" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001444380_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,430</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If these UTBs were recognized, approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001222" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001444380_20211231" decimals="-5" scale="6">10.4</ix:nonFraction> million would affect the effective tax rate before consideration of the valuation allowance. The Company files U.S. federal and state income tax and foreign income tax returns with varying statutes of limitations. The Company&#8217;s U.S. federal and the majority of state tax years from inception in 2006 onward will remain open to examination due to the carryover of the unused NOLs and tax credits. The Company does not have any material active tax audits or other proceedings pending, and believes it has provided adequate reserves for all tax deficiencies or reductions in tax benefits that could result from federal, state and foreign tax audits. The Company does not expect any material changes to the estimated amount of liability associated with its uncertain tax positions within the next twelve months.</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000371_dcnt_bed675c9-7dce-43b1-a23a-51869ef284e6">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC 740, <span style="font-style:italic;">Income Taxes</span>, the Company is classifying interest and penalties as a component of tax expense. There was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001223" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="C_0001444380_20211231" decimals="-5" scale="6">0.2</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001224" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="C_0001444380_20201231" decimals="-5" scale="6">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001225" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="C_0001444380_20191231" decimals="-5" scale="6">0.1</ix:nonFraction> million of interest and penalties accrued at each of December 31, 2021, 2020 and 2019, respectively.</p></ix:continuation><ix:nonNumeric id="F_000372" name="us-gaap:EarningsPerShareTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">12. Net Loss Per Share</p><ix:nonNumeric id="F_000433" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001226" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">131,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001227" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">83,065</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001228" name="us-gaap:NetIncomeLoss" contextRef="C_0001444380_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">103,686</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute basic and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; diluted net loss per share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001229" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001444380_20210101_20211231" decimals="0" format="ixt:numdotdecimal">34,823,258</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001230" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001444380_20200101_20201231" decimals="0" format="ixt:numdotdecimal">33,677,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001231" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001444380_20190101_20191231" decimals="0" format="ixt:numdotdecimal">30,803,872</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001232" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001444380_20210101_20211231" decimals="2" sign="-">3.77</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001233" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001444380_20200101_20201231" decimals="2" sign="-">2.47</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001234" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001444380_20190101_20191231" decimals="2" sign="-">3.37</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period, determined using the treasury-stock method, if inclusion of these is dilutive. <span style="color:#000000;">The conversion spread for the Company&#8217;s outstanding convertible senior notes will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company&#8217;s common stock for a given period exceeds the conversion price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001235" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="C_0001444380_us-gaapLongtermDebtTypeAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20211231" decimals="2">105.00</ix:nonFraction> for the 2025 Notes.</span> This condition was not met in the three months ended December 31, 2021.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the issuance of the 2021 Notes and 2025 Notes, the Company entered into convertible bond hedges. The convertible bond hedges are not included for purposes of calculating the number of diluted shares outstanding for the periods presented, as their effect would be anti-dilutive. The convertible bond hedges are generally expected, but not guaranteed, to reduce the potential dilution and/or offset the cash payments the Company is required to make upon conversion of the 2021 Notes and 2025 Notes. When the 2021 Notes matured on June 1, 2021, the Company exercised its option under the bond hedge. As of December 31, 2021, the bond hedges related to the 2021 Notes are <ix:nonFraction unitRef="U_iso4217USD" id="F_001236" name="us-gaap:NotesPayable" contextRef="C_0001444380_20211231" decimals="-3" format="ixt-sec:numwordsen" scale="3">no</ix:nonFraction> longer outstanding. <span style="color:#000000;">Because the Company has reported a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.</span></p><ix:nonNumeric id="F_000434" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unreleased restricted and performance stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001237" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">1,012,491</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001238" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,052,014</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001239" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">1,288,332</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options to purchase common stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001240" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">700,654</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001241" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">813,150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001242" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">1,646,185</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible senior notes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001243" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">1,807,141</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001244" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">3,597,174</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001245" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">1,790,033</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants related to the issuance of convertible senior notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001246" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">1,807,141</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001247" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">3,597,174</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001248" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">1,790,033</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001249" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">5,327,427</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001250" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">9,059,512</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001251" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001444380_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">6,514,583</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</p></ix:nonNumeric><ix:nonNumeric id="F_000373" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" contextRef="C_0001444380_20210101_20211231" escape="true">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13. Employee Benefit Plan.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2007, the Company adopted a 401(K) plan for its employees whereby eligible employees may contribute up to the maximum amount permitted by the Internal Revenue Code of 1986, as amended.&#160;&#160;In June 2016, the Company adopted a policy to match a portion of employee contributions for all qualified employees participating in the 401(k) plan.&#160;&#160;For the years ended December 31, 2021, 2020 and 2019, the Company recorded expenses of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001252" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="C_0001444380_20210101_20211231" decimals="-5" scale="6">2.9</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001253" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="C_0001444380_20200101_20201231" decimals="-5" scale="6">2.6</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001254" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="C_0001444380_20190101_20191231" decimals="-5" scale="6">3.1</ix:nonFraction> million for matching contributions, respectively.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">130</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC">ITEM&#160;9. <span style="font-style:italic;">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9A_CONTROLS_PROCEDURES">ITEM&#160;9A.&#160;<span style="font-style:italic;">CONTROLS AND PROCEDURES</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Evaluation of Disclosure Controls and Procedures</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act) refers to controls and procedures that are designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their control objectives.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of December&#160;31, 2021, the end of the period covered by this Annual Report. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of such date.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Pertain to the maintenance of records that accurately and fairly reflect in reasonable detail the transactions and dispositions of the assets of our company&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Provide reasonable assurances regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material adverse effect on our financial statements.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management assessed our internal control over financial reporting as of December 31, 2021, the end of the period covered by this Annual Report. Management based its assessment on criteria established in &#8220;Internal Control&#8212;Integrated Framework (2013)&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on management's assessment of our internal control over financial reporting, management concluded that, as of December 31, 2021, our internal control over financial reporting was effective.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Internal control over financial reporting has inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">improper management override. Because of such limitations, there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effectiveness of the Company&#8217;s internal control over financial reporting as of December 31, 2021 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears in Part II, Item 8 of this Annual Report.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Changes in Internal Control over Financial Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There was no change in our internal control over financial reporting that occurred during the most recent fiscal quarter covered by this Annual Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9B_OR_INFORMATION">ITEM&#160;9B.&#160;<span style="font-style:italic;">OTHER INFORMATION</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9C_DISCL_FOREIGN">ITEM&#160;9C.&#160;<span style="font-style:italic;">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_III">PART&#160;III</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO">ITEM&#160;10.&#160;<span style="font-style:italic;">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Executive Officers, Significant Employee and Non-Employee Directors of the Registrant</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item&#160;10 is hereby incorporated by reference from the information under the captions &#8220;Executive Officers,&#8221; &#8220;Election of Directors&#8221;, &#8220;Corporate Governance&#8221; and &#8220;Section 16(a) Beneficial Ownership Reporting Compliance&#8221; that will be contained in the Proxy Statement for our 2022 Annual Meeting of Stockholders (or the Proxy Statement).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have adopted a written code of conduct and ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons serving similar functions. The text of our code of business conduct and ethics has been posted on our website at http://www.nevro.com. We intend to satisfy the disclosure requirements under Item 5.05 of the SEC Form 8-K regarding an amendment to, or waiver from, a provision of our Code of Conduct by posting such information on our website at the website address specified above.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_11_EXECUTIVE_COMPENSATION">ITEM&#160;11.&#160;<span style="font-style:italic;">EXECUTIVE COMPENSATION</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item&#160;11 is incorporated by reference from the information under the captions &#8220;Director Compensation,&#8221; &#8220;Executive Compensation&#8221; and &#8220;Corporate Governance&#8221; that will be contained in the Proxy Statement.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF">ITEM&#160;12. <span style="font-style:italic;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item&#160;12 is incorporated by reference from the information under the captions &#8220;Equity Compensation Plan Information&#8221; and &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; that will be contained in the Proxy Statement.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR">ITEM&#160;13.&#160;<span style="font-style:italic;">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item&#160;13 is incorporated by reference from the information under the captions &#8220;Certain Relationships and Related Transactions&#8221; and &#8220;Corporate Governance&#8221; that will be contained in the Proxy Statement.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_14_PRINCIPAL_ACCOUNTANT_FEES_SERVIC">ITEM&#160;14.&#160;<span style="font-style:italic;">PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item&#160;14 is incorporated by reference from the information under the caption &#8220;Ratification of Appointment of Independent Registered Public Accounting Firm&#8221; that will be contained in the Proxy Statement.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">133</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="PART_IV">PART&#160;IV</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH">ITEM&#160;15.&#160;<span style="font-style:italic;">EXHIBITS and FINANCIAL STATEMENT SCHEDULES</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:3.78%;text-indent:-3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)The following documents are filed as part of this Annual Report:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Consolidated Financial Statements:</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reference is made to the Index to consolidated financial statements of Nevro Corp. under Item&#160;8 of Part&#160;II hereof.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Financial Statement Schedule:</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All schedules are omitted because they are not applicable or the amounts are immaterial or the required information is presented in the consolidated financial statements and notes thereto in Part&#160;II, Item&#160;8 above.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.</span></p></td>
<td valign="top">
<p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Exhibits</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Exhibit&#160;Index below.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Index</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Description</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">by</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reference</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed&#160;Herewith</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000110465914079803/a14-24281_1ex3d1.htm"><span style="text-decoration:underline;">Amended and Restated </span><span style="text-decoration:underline;">Certificate</span><span style="text-decoration:underline;"> of Incorporation of Nevro Corp.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/12/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459019020480/nvro-ex31_7.htm"><span style="text-decoration:underline;">Certificate of Amendment to Amended and Restated Certificate of Incorporation of Nevro Corp.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/24/2019</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000110465914079803/a14-24281_1ex3d2.htm"><span style="text-decoration:underline;">Amended and Restated Bylaws of Nevro Corp.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/12/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.2(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459019020480/nvro-ex32_6.htm"><span style="text-decoration:underline;">Amendment to Amended and Restated Bylaws of Nevro Corp.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/24/2019</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000110465914079803/a14-24281_1ex3d1.htm"><span style="text-decoration:underline;">Reference is made to exhibits&#160;3.1</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><a href="http://www.sec.gov/Archives/edgar/data/1444380/000110465914079803/a14-24281_1ex3d2.htm"><span style="text-decoration:underline;">3.2.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008547/a2221875zex-4_2.htm"><span style="text-decoration:underline;">Form of Common Stock Certificate.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/27/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex41.htm"><span style="text-decoration:underline;">Indenture, dated as of June 13, 2016, by and between the Company and Wilmington Trust, National Association.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.4</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex42.htm"><span style="text-decoration:underline;">First Supplemental Indenture, dated as of June 13, 2016, by and between the Company and Wilmington Trust, National Association.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.5</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex42.htm"><span style="text-decoration:underline;">Form of 1.75% Convertible Senior Note Due 2021.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.6</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex42.htm"><span style="text-decoration:underline;">Second Supplemental Indenture, dated as of April 6, 2020, by and between the Company and Wilmington Trust, National Association, as Trustee.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.7</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex42.htm"><span style="text-decoration:underline;">Form of 2.75% Convertible Senior Note Due 2025 (included in Exhibit 4.6).</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.8</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459020006427/nvro-ex46_607.htm"><span style="text-decoration:underline;">Description of Nevro Corp.&#8217;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/25/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Description</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">by</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reference</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed&#160;Herewith</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.1&#8224;</span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008300/a2221785zex-10_1.htm"><span style="text-decoration:underline;">Amended and Restated License Agreement, dated October&#160;2, 2006, by and among the Company and Mayo Foundation for Medical Education and Research, Venturi Group,&#160;LLC.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.2(a)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008300/a2221785zex-10_2a.htm"><span style="text-decoration:underline;">Stellar Manufacturing Agreement, dated as of July&#160;1, 2009, by and between the Company and Stellar Technologies,&#160;Inc.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.2(b)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008300/a2221785zex-10_2b.htm"><span style="text-decoration:underline;">First Amendment to Stellar Manufacturing Agreement, dated as of July&#160;1, 2014, by and between the Company and Stellar Technologies,&#160;Inc.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.2(c)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516485541/d102615dex102c.htm"><span style="text-decoration:underline;">Second Amendment to Stellar Manufacturing Agreement, dated as of January 28, 2016, by and between the Company and Stellar Technologies, Inc.</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/29/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.3(a)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008300/a2221785zex-10_3.htm"><span style="text-decoration:underline;">Supply Agreement, dated as of July&#160;23, 2014 by and between the Company and Pro-Tech Design and Manufacturing,&#160;Inc.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.3(b)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459020036912/nvro-ex104_14.htm"><span style="text-decoration:underline;">Amendment to Supply Agreement, effective as of July 23, 2019, by and between the Company and Pro-Tech Design and Manufacturing, Inc.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/5/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.4(a)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008300/a2221785zex-10_4a.htm"><span style="text-decoration:underline;">Supply Agreement, dated April&#160;1, 2012, by and between the Company and CCC del Uruguay&#160;S.A.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.4(b)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008300/a2221785zex-10_4b.htm"><span style="text-decoration:underline;">Amendment to Supply Agreement, dated as of March&#160;20, 2013, by and between the Company and CCC del Uruguay&#160;S.A.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.4(c)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459020021316/nvro-ex1010_280.htm"><span style="text-decoration:underline;">Assignment, Assumption and Amendment to Supply Agreement, effective as of December 31, 2019, by and between the Company, Greatbatch Ltd. and Centro de Construccion de Cardioestimuladores del Uruguay&#160;S.A.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/5/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.10</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.5(a)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008300/a2221785zex-10_5.htm"><span style="text-decoration:underline;">Product Supply and Development Agreement, dated as of April&#160;15, 2009, by and between the Company and EaglePicher Medical Power LLC.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.5(b)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312515097120/d850984dex105b.htm"><span style="text-decoration:underline;">First Amendment to the Product Supply and Development Agreement, dated as of March 4, 2015, by and between the Company and EaglePicher Medical Power LLC.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3/18/2015</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.5(c)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516485541/d102615dex105c.htm"><span style="text-decoration:underline;">Second Amendment to the Product Supply and Development Agreement, dated as of October 23, 2015, by and between the Company and EaglePicher Medical Power LLC.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/29/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">135</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Description</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">by</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reference</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed&#160;Herewith</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.5(d)</span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459017021848/nvro-ex101_104.htm"><span style="text-decoration:underline;">Third Amendment to the Product Supply and Development Agreement, dated as of September 15, 2017, by and between the Company and EaglePicher Medical Power LLC.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/6/2017</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.6(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_6a.htm"><span style="text-decoration:underline;">Amended and Restated Registration Rights Agreement, dated February&#160;8, 2013, by and among the Company and the investors listed therein.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.6(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_6b.htm"><span style="text-decoration:underline;">Amendment to Amended and Restated Registration Rights Agreement, dated March&#160;5, 2013, by and among the Company and the investors listed therein.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.6(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008803/a2222013zex-10_6c.htm"><span style="text-decoration:underline;">Second Amendment to Amended and Restated Registration Rights Agreement, dated October&#160;24, 2014, by and among the Company and the investors listed therein.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/04/14</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.7(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_7a.htm"><span style="text-decoration:underline;">Multi-Tenant Space Lease, dated as of March&#160;15, 2010, by and between Deerfield Campbell&#160;LLC and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.7(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_7b.htm"><span style="text-decoration:underline;">First Amendment to Lease, dated as of October&#160;18, 2012, by and between Deerfield Campbell&#160;LLC and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.7(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312515097120/d850984dex107c.htm"><span style="text-decoration:underline;">Second Amendment to Lease, dated as of February&#160;18, 2015, by and between Deerfield Campbell LLC and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3/18/2015</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:16pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.8(a)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_8a.htm"><span style="text-decoration:underline;">Nevro Corp. 2007 Stock Incentive Plan, as amended as of March&#160;5, 2013.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.8(b)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_8b.htm"><span style="text-decoration:underline;">Form of Incentive Stock Option Agreement (ISO) under the 2007 Stock Incentive Plan, as amended.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.8(c)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_8c.htm"><span style="text-decoration:underline;">Form of Non-Incentive Stock Option Agreement (NSO) under the 2007 Stock Incentive Plan, as amended.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.8(d)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_8d.htm"><span style="text-decoration:underline;">Form of Stock Purchase Right Grant Notice and Restricted Stock Purchase Agreement under the 2007 Stock Incentive Plan, as amended.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8(d)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.9(a)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000110465914079808/a14-24263_1ex99d2a.htm"><span style="text-decoration:underline;">Nevro Corp. 2014 Equity Incentive Award Plan.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-8</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/12/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.2(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.9(b)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008248/a2221713zex-10_9b.htm"><span style="text-decoration:underline;">Form of Stock Option Grant Notice and Stock Option Agreement under the 2014 Equity Incentive Award Plan.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/10/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.9(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.9(c)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008248/a2221713zex-10_9c.htm"><span style="text-decoration:underline;">Form of Restricted Stock Award Agreement and Restricted Stock Award Grant Notice under the 2014 Equity Incentive Award Plan.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/10/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.9(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.9(d)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008248/a2221713zex-10_9d.htm"><span style="text-decoration:underline;">Form of Restricted Stock Unit Award Agreement and Restricted Stock Unit Award Grant Notice under the 2014 Equity Incentive Award Plan.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/10/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.9(d)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Description</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">by</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reference</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed&#160;Herewith</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.9(e)#</span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459020021316/nvro-ex101_161.htm"><span style="text-decoration:underline;">Form of Performance Stock Award Agreement and Performance Stock Award Grant Notice under the 2014 Equity Incentive Award Plan.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/5/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.10#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000110465914079808/a14-24263_1ex99d3.htm"><span style="text-decoration:underline;">Nevro Corp. 2014 Employee Stock Purchase Plan.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-8</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/12/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.11#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008248/a2221713zex-10_11.htm"><span style="text-decoration:underline;">Form of Indemnification Agreement for directors and officers.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/10/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.11</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.12#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459018011287/nvro-ex101_84.htm"><span style="text-decoration:underline;">Amended and Restated Company Bonus Plan.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/7/2018</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.12(b)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459020036912/nvro-ex101_16.htm"><span style="text-decoration:underline;">Second Amended and Restated Company Bonus Plan.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/5/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.13#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nvro-ex1013_296.htm"><span style="text-decoration:underline;">Nevro Corp. Non-Employee Director Compensation Program, as amended.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.14#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459019018079/nvro-ex101_30.htm"><span style="text-decoration:underline;">Employment Agreement by and between D. Keith Grossman and the Company, effective as of March 19, 2019.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/9/2019</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.15#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459020036912/nvro-ex102_15.htm"><span style="text-decoration:underline;">Offer Letter, dated as of May&#160;5, 2020, by and between Roderick H. MacLeod and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/5/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.16(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_15a.htm"><span style="text-decoration:underline;">Amended and Restated Stockholders&#8217; Agreement, dated February&#160;8, 2013, by and among the Company and the stockholders listed therein.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.15(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.16(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008081/a2221630zex-10_15b.htm"><span style="text-decoration:underline;">Amendment to Amended and Restated Stockholders&#8217; Agreement, dated March&#160;5, 2013, by and among the Company and the stockholders listed therein.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/03/2014</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.15(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.16(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000104746914008803/a2222013zex-10_18c.htm"><span style="text-decoration:underline;">Second Amendment to Amended and Restated Stockholders&#8217; Agreement, dated October 24, 2014, by and among the Company and the investors listed therein.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S-1/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/04/14</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.18(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.17(a)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516583945/d152001dex104.htm"><span style="text-decoration:underline;">Form of Amended and Restated Change in Control Severance Agreement for certain executive officers.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/9/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.17(b)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459019041110/nvro-ex103_17.htm"><span style="text-decoration:underline;">Amended and Restated Change in Control Severance Agreement, dated as of July 22, 2019, by and between Patrick Schmitz and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/6/2019</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.17(c)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459018002905/nvro-ex1018e_558.htm"><span style="text-decoration:underline;">Amended and Restated Change in Control Severance Agreement, dated as of August 3, 2016, by and between Christofer Christoforou and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/22/2018</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.18(e)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.17(d)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459019041110/nvro-ex102_14.htm"><span style="text-decoration:underline;">Amended and Restated Change in Control Severance Agreement, dated as of July 22, 2019, by and between Kashif Rashid and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/6/2019</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.17(e)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459020006427/nvro-ex1018g_523.htm"><span style="text-decoration:underline;">Change in Control Severance Agreement, dated as of September 16, 2019, by and between Niamh Pellegrini and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/25/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.18(g)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.17(f)#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459020036912/nvro-ex103_13.htm"><span style="text-decoration:underline;">Change in Control Severance Agreement, dated as of June 15, 2020, by and between Roderick H. MacLeod and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/5/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">137</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Description</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">by</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reference</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed&#160;Herewith</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.18(a)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312515206848/d933907dex1022.htm"><span style="text-decoration:underline;">Supply Agreement, dated March&#160;13, 2015, by and between the Company and Centro de Construccion de Cardioestimuladores del Uruguay S.A.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K/A</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/29/2015</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.22</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.18(b)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459017002237/nvro-ex1022b_706.htm"><span style="text-decoration:underline;">Supply Agreement, effective as of November 11, 2016, by and between the Company and Centro de Construccion de Cardioestimuladores del Uruguay S.A.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/23/2017</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.22(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.18(c)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459019030876/nvro-ex103_278.htm"><span style="text-decoration:underline;">First Amendment to Supply Agreement, effective as of April 30, 2019, by and between the Company and Centro de Construccion de Cardioestimuladores del Uruguay S.A.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/8/2019</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.19(a)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312515097120/d850984dex1023.htm"><span style="text-decoration:underline;">Lease Agreement, dated as of March 5, 2015, by and between the Company and Westport Office Park, LLC.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3/18/2015</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.23</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.19(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459017002237/nvro-ex1023b_704.htm"><span style="text-decoration:underline;">First Amendment to Lease, effective as of December 9, 2016, by and between the Company and Westport Office Park, LLC.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/23/2017</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.23(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.19(c)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459017016041/nvro-ex101_170.htm"><span style="text-decoration:underline;">Second Amendment to Lease, effective as of April 13, 2017, by and between the Company and Westport Office Park, LLC.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/7/2017</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.19(d)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459018002905/nvro-ex1021d_658.htm"><span style="text-decoration:underline;">Third Amendment to Lease, effective as of December 6, 2017, by and between the Company and Westport Office Park, LLC.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/22/2018</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.21(d)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.20#</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459020006427/nvro-ex1021b_524.htm"><span style="text-decoration:underline;">Transition and Separation Agreement, dated as of January 7, 2020, by and between the Company and Doug Alleavitch.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/25/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.21(b)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.21(a)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516485541/d102615dex1025.htm"><span style="text-decoration:underline;">Manufacturing and Supply Agreement, dated as of December 18, 2015, by and between the Company and Vention Medical Design and Development, Inc.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/29/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.25</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.21(b)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459017021848/nvro-ex102_310.htm"><span style="text-decoration:underline;">First Amendment to the Manufacturing and Supply Agreement, dated as of September 30, 2017, by and between the Company and Vention Medical Design and Development, Inc.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11/6/2017</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.21(c)&#8224;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000156459018018945/nvro-ex102_235.htm"><span style="text-decoration:underline;">Second Amendment to the Manufacturing and Supply Agreement, dated April 2018, by and between the Company and Nordson MEDICAL Design and Development, Inc., fka Vention Medical Design and Development, Inc.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-Q</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8/2/2018</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.22</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312519080196/d710346dex101.htm"><span style="text-decoration:underline;">Settlement Agreement, dated March 19, 2019, by and among Broadfin Capital, LLC and certain of its affiliates named therein and the Company.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3/20/2019</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Description</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">by</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reference</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed&#160;Herewith</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex101.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 7, 2016, between Morgan Stanley &#38; Co. International plc and the Company, regarding the Base Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.24</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex102.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 7, 2016, between Bank of America, N.A. and the Company, regarding the Base Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.25</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex103.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 7, 2016, between Goldman, Sachs &#38; Co. and the Company, regarding the Base Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.26</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex104.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 7, 2016, between Morgan Stanley &#38; Co. International plc and the Company, regarding the Base Call Option Transaction.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.27</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex105.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 7, 2016, between Bank of America, N.A. and the Company, regarding the Base Call Option Transaction.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.28</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex106.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 7, 2016, between Goldman, Sachs &#38; Co. and the Company, regarding the Base Call Option Transaction.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.29</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex107.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 8, 2016, between Morgan Stanley &#38; Co. International plc and the Company, regarding the Additional Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.30</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex108.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 8, 2016, between Bank of America, N.A. and the Company, regarding the Additional Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.31</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex109.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 8, 2016, between Goldman, Sachs &#38; Co. and the Company, regarding the Additional Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.9</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.32</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex1010.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 8, 2016, between Morgan Stanley &#38; Co. International plc and the Company, regarding the Additional Call Option Transaction.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.10</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.33</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex1011.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 8, 2016, between Bank of America, N.A. and the Company, regarding the Additional Call Option Transaction.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.11</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.34</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312516620290/d211326dex1012.htm"><span style="text-decoration:underline;">Letter Agreement, dated June 8, 2016, between Goldman, Sachs &#38; Co. and the Company, regarding the Additional Call Option Transaction.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6/13/2016</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.12</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.35</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex101.htm"><span style="text-decoration:underline;">Letter Agreement, dated April 1, 2020, between Goldman Sachs &#38; Co. LLC and Nevro Corp., regarding the Base Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.36</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex102.htm"><span style="text-decoration:underline;">Letter Agreement, dated April 1, 2020, between Goldman Sachs &#38; Co. LLC and Nevro Corp., regarding the Base Call Option Transaction.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Description</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">by</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reference</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed&#160;Herewith</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex103.htm"><span style="text-decoration:underline;">Letter Agreement, dated April 1, 2020, between Morgan Stanley &#38; Co. International plc and Nevro Corp., regarding the Base Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.38</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex104.htm"><span style="text-decoration:underline;">Letter Agreement, dated April 1, 2020, between Morgan Stanley &#38; Co. International plc and Nevro Corp., regarding the Base Call Option Transaction.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.39</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex105.htm"><span style="text-decoration:underline;">Letter Agreement, dated April 2, 2020, between Goldman Sachs &#38; Co. LLC and Nevro Corp., regarding the Additional Call Option Transaction</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.40</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex106.htm"><span style="text-decoration:underline;">Letter Agreement, dated April 2, 2020, between Goldman Sachs &#38; Co. LLC and Nevro Corp., regarding the Additional Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.41</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex107.htm"><span style="text-decoration:underline;">Letter Agreement, dated April 2, 2020, between Morgan Stanley &#38; Co. International plc and Nevro Corp., regarding the Additional Call Option Transaction.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.42</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1444380/000119312520099922/d924665dex108.htm"><span style="text-decoration:underline;">Letter Agreement, dated April 2, 2020, between Morgan Stanley &#38; Co. International plc and Nevro Corp., regarding the Additional Warrants.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8-K</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4/7/2020</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;21.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nvro-ex211_7.htm"><span style="text-decoration:underline;">List of Subsidiaries.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;23.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nvro-ex231_297.htm"><span style="text-decoration:underline;">Consent of Independent Registered Public Accounting Firm.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;24.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#SIGNATURES"><span style="text-decoration:underline;">Power of Attorney (included on signature page to this Annual Report on Form 10-K).</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nvro-ex311_6.htm"><span style="text-decoration:underline;">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.2</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nvro-ex312_9.htm"><span style="text-decoration:underline;">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;32.1**</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="nvro-ex321_10.htm"><span style="text-decoration:underline;">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.INS</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Instance Document.</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.SCH</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Schema Document.</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.CAL</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.LAB</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Label Linkbase Document.</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.PRE</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit Description</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incorporated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">by</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reference</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Filed&#160;Herewith</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.DEF</span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Definition Linkbase Document.</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">X</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:44.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:8.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:0.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:58.64%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Confidential treatment has been granted for certain information contained in this exhibit. Such information</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has been omitted and filed separately with the Securities and Exchange Commission.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">#</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Indicates management contract or compensatory plan.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.78%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">**</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The certification attached as Exhibit 32.1 that accompanies this Form 10-K is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Nevro Corp. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-K, irrespective of any general incorporation language contained in such filing.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_16_FORM_10K_SUMMARY">ITEM&#160;16.&#160;<span style="font-style:italic;">FORM 10-K SUMMARY</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;" id="SIGNATURES">SIGNATURES</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, as amended the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February&#160;23, 2022:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:45%;">
<tr>
<td colspan="3" valign="top" style="width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NEVRO CORP.</p></td>
</tr>
<tr style="height:9.75pt;">
<td valign="middle" style="width:11.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="width:86.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:11.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top" style="width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:86.66%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ D. Keith Grossman</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:86.66%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">D. Keith Grossman</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">POWER OF ATTORNEY</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of D. Keith Grossman and Roderick H. MacLeod his or her true and lawful attorney-in-fact and agent, with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.</p>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, each of the undersigned has executed this Power of Attorney as of the date indicated opposite his/her name.</p>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Act, this report has been signed by the following persons in the capacities and on the dates indicated.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:8pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:72.22%;">
<tr>
<td style="width:33.09%;"></td>
<td style="width:25.36%;"></td>
<td style="width:13.77%;"></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Signature</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;D. KEITH GROSSMAN</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">D. Keith Grossman</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;RODERICK H. MACLEOD</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Roderick H. MacLeod</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Financial and</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounting Officer)</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;MICHAEL DEMANE</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lead Director</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael DeMane</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ FRANK FISCHER</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Frank Fischer</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ SRI KOSARAJU</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sri Kosaraju</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ SHAWN T MCCORMICK</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shawn T McCormick</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ KEVIN O&#8217;BOYLE</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Kevin O&#8217;Boyle</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ KAREN PRANGE</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Karen Prange</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:72.22%;">
<tr>
<td style="width:33.09%;"></td>
<td style="width:25.36%;"></td>
<td style="width:13.77%;"></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Signature</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ SUSAN E. SIEGEL</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Susan E. Siegel</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ BRAD H. VALE</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Brad H. Vale, Ph.D., D.V.M</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ ELIZABETH WEATHERMAN</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2022</p></td>
</tr>
<tr>
<td valign="bottom" style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Elizabeth Weatherman</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">143</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>2
<FILENAME>nvro-ex1013_296.htm
<DESCRIPTION>EX-10.13
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nvro-ex1013_296.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.13</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman Bold;text-transform:uppercase;font-style:normal;font-variant: normal;">NEVRO CORP.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;text-transform:uppercase;font-family:Times New Roman;font-style:normal;font-variant: normal;">Non-Employee<font style="text-transform:none;"> DIRECTOR COMPENSATION PROGRAM</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-employee members of the board of directors (the &#8220;<font style="font-weight:bold;font-style:italic;">Board</font>&#8221;) of Nevro Corp. (the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>&#8221;) shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this &#8220;<font style="font-weight:bold;font-style:italic;">Program</font>&#8221;), as amended by the Board and effective December 7, 2021 (the &#8220;<font style="font-weight:bold;font-style:italic;">Effective Date</font>&#8221;).&nbsp;&nbsp;The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a &#8220;<font style="font-weight:bold;font-style:italic;">Non-Employee Director</font>&#8221;) who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company.&nbsp;&nbsp;This Program shall remain in effect <font style="color:#000000;">until it is revised or rescinded by further action of the Board.&nbsp;&nbsp;This Program may be amended, modified or terminated by the Board at any time, without advance notice, in its sole discretion. </font> The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-right:7.69%;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Cash Compensation</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Annual Retainers</font>.&nbsp;&nbsp;Each Non-Employee Director shall be eligible to receive an annual retainer of $55,000 for service on the Board.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Additional Annual Retainers</font>.&nbsp;&nbsp;In addition, a Non-Employee Director shall receive the following annual retainers:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Non-Executive Chair or Lead Director</font>.&nbsp;&nbsp;A Non-Employee Director serving as Non-Executive Chair or Lead Director of the Board shall receive an additional annual retainer of $50,000 for such service.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;"> Audit Committee</font>.&nbsp;&nbsp; A Non-Employee Director serving as Chairperson of the Audit Committee shall receive an additional annual retainer of $25,000 for such service.&nbsp;&nbsp;A Non-Employee Director serving as a member of the Audit Committee (other than the Chairperson) shall receive an additional annual retainer of $12,000 for such service.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Compensation Committee</font>.&nbsp;&nbsp;A Non-Employee Director serving as Chairperson of the Compensation Committee shall receive an additional annual retainer of $18,250 for such service.&nbsp;&nbsp;A Non-Employee Director serving as a member of the Compensation Committee (other than the Chairperson) shall receive an additional annual retainer of $8,000 for such service.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv) <font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Nominating and Corporate Governance Committee</font>.&nbsp;&nbsp; A Non-Employee Director serving as Chairperson of the Nominating and Corporate Governance Committee shall receive an additional annual retainer of $12,000 for such service.&nbsp;&nbsp;A Non-Employee Director serving as a member of the Nominating and Corporate Governance Committee (other than the Chairperson) shall receive an additional annual retainer of $6,000 for such service.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;">(c)</font><font style="text-decoration:underline;">Payment of Retainers</font>.&nbsp;&nbsp;The annual retainers described in Sections 1(a) and 1(b) shall be earned on a quarterly basis based on a calendar quarter and shall be paid by the Company in arrears not later than the fifteenth day following the end of each calendar quarter.&nbsp;&nbsp;In the event a Non-Employee Director does not serve as a Non-Employee Director, or in the applicable positions described in Section 1(b), for an entire calendar quarter, the retainer paid to such Non-Employee Director shall be prorated for </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">US-DOCS\107514504.5</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the portion of such calendar quarter actually served as a Non-Employee Director, or in such position, as ap</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">plicable. A director may elect, at his or her option</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> by delivering an election form no later than the 60</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup></font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> day of a calendar quarter</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, to receive the payment of all or a portion of the </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-Employee Director&#8217;s aggregate </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">annual retainer in </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">shares of fully vested common stock </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">issued </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">under the Equity Plan with such election remaining in place unless changed by the Non-Employee Director (the &#8220;</font><font style="font-weight:bold;font-style:italic;">Stock Payment</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;)</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The number of shares shall be calculated by dividing (i) </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the percentage of </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the quarterly portion of the annual retainer elected to be received as a </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Payment</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (denominated in dollars) </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">by</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (ii) </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">per share </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair Market Value (as defined in the Equity Plan) </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Company&#8217;s common stock on the last trading day of the applicable fiscal quarter</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, rounded down to the next whole number of shares</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Payment</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">made</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> on the </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">same </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">date the </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company makes the </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cash </font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">payment of the annual retainers.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Equity Compensation</font>.&nbsp;&nbsp;Non-Employee Directors shall be granted the equity awards described below.&nbsp;&nbsp;The awards described below shall be granted under and shall be subject to the terms and provisions of the Company&#8217;s 2014 Equity Incentive Award Plan or any other applicable Company equity incentive plan then-maintained by the Company (the &#8220;<font style="font-weight:bold;font-style:italic;">Equity Plan</font>&#8221;) and shall be evidenced by the execution and delivery of award agreements, including attached exhibits, in substantially the forms previously approved by the Board.&nbsp;&nbsp;All applicable terms of the Equity Plan apply to this Program as if fully set forth herein, and all grants of equity awards hereby are subject in all respects to the terms of the Equity Plan.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Initial Awards</font><font style="color:#000000;">.&#160; Each Non-Employee Director who is initially elected or appointed to the Board on or after the Effective Date shall automatically be granted, on the date of such initial election or appointment, an award of restricted stock units (an &#8220;</font><font style="font-weight:bold;font-style:italic;color:#000000;">Initial Award</font><font style="color:#000000;">&#8221;) with respect to that number of shares of Company common stock calculated by dividing (x) $300,000 by (y) the per share Fair Market Value (as defined in the Equity Plan) of the Company&#8217;s common stock on the date of grant, rounded down to the next whole number of shares. No Non-Employee Director shall be granted more than one Initial Award.&#160; </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Annual Awards</font><font style="color:#000000;">. A Non-Employee Director who has served at least six (6) months prior to, and will continue to serve as a Non-Employee Director immediately following, any annual meeting of the Company&#8217;s stockholders after the Effective Date (an &#8220;</font><font style="font-weight:bold;font-style:italic;color:#000000;">Annual Meeting</font><font style="color:#000000;">&#8221;) shall be automatically granted, on the date of such Annual Meeting, an award of restricted stock units (a &#8220;</font><font style="font-weight:bold;font-style:italic;color:#000000;">Annual Award</font><font style="color:#000000;">&#8221;) with respect to that number of shares of Company common stock calculated by dividing (x) $180,000 by (y) the per share Fair Market Value (as defined in the Equity Plan) of the Company&#8217;s common stock on the date of grant, rounded down to the next whole number of shares.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Pro-rata Awards</font><font style="color:#000000;">. Any Non-Employee Director who is elected or appointed to the Board after January 1, 2019 and prior to May 20, 2019, shall be granted, on May 20, 2019, an award of restricted stock units (a &#8220;</font><font style="font-weight:bold;font-style:italic;color:#000000;">Pro-rata Award</font><font style="color:#000000;">&#8221;) with respect to that number of shares of Company common stock calculated by subtracting the number of shares of Company common stock subject to restricted stock units previously granted to the Non-Employee Director from the quotient obtained by dividing (i) $300,000 by (ii) the per share Fair Market Value of the Company&#8217;s common stock on the date of the Non-Employee Director was initially elected or appointed to the Board, rounded down to the next whole number of shares.&nbsp;&nbsp; </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Vesting</font><font style="color:#000000;">.&nbsp;&nbsp;Each Initial Award and Pro-Rata Award shall vest in three (3) equal annual installments on the anniversary of the date the Non-Employee Director was initially elected or appointed to the Board, subject to the Non-Employee Director continuing to provide services to the Company through such vesting date. Each Annual Award shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the next Annual Meeting following the date of grant, subject to the Non-Employee Director continuing to provide services to the Company through such vesting date.&nbsp;&nbsp;Each Initial Award,&#160;Annual Award and Pro-rata Award, along with any other stock options or other equity-based </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">US-DOCS\107514504.5</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="color:#000000;">awards held by any Non-Employee Director, shall vest in full immediately prior to the occurrence of a Change in Control (as defined in the Equity Plan), to the extent outstanding at such time.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><font style="text-decoration:underline;">Reimbursements</font>.&nbsp;&nbsp;The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company&#8217;s applicable expense reimbursement policies and procedures as in effect from time to time. </p></td></tr></table></div>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* * * * *</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">US-DOCS\107514504.5</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>nvro-ex211_7.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nvro-ex211_7.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 21.1</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:85.17%;">
<tr>
<td style="width:41.25%;"></td>
<td style="width:2.24%;"></td>
<td style="width:41.68%;"></td>
</tr>
<tr>
<td colspan="3" valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">List of Subsidiaries of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Nevro Corp.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Subsidiary</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Jurisdiction of Incorporation or Organization</p></td>
</tr>
<tr style="height:3pt;">
<td valign="bottom" >
<p style="text-align:center;border-top:Solid 1pt;padding-top:1pt;margin-top:1pt;line-height:1pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.74%;text-indent:0pt;;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom" >
<p style="text-align:center;border-top:Solid 1pt;padding-top:1pt;margin-top:1pt;line-height:1pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.74%;text-indent:0pt;;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:85.17%;">
<tr>
<td style="width:41.25%;"></td>
<td style="width:2.24%;"></td>
<td style="width:41.68%;"></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nevro Medical Sarl</p></td>
<td valign="top"  BGCOLOR="#CFF0FC">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Switzerland</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nevro Medical Limited</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United Kingdom</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nevro Medical Pty Ltd.</p></td>
<td valign="top"  BGCOLOR="#CFF0FC">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Australia</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nevro Germany GmbH</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Germany</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#B6DDE8">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nevro Medical, S.R.L.</p></td>
<td valign="top"  BGCOLOR="#B6DDE8">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#B6DDE8">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Costa Rica</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>nvro-ex231_297.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nvro-ex231_297.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 23.1</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:24pt;text-indent:0%;font-size:10pt;font-family:Georgia;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p>
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Georgia;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_3znysh7"></a>We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-237482 and 333-211864) and Form S-8 (Nos. 333-253467, 333-236632, 333-229778, 333-223159, 333-216206, 333-209816, 333-202857 and 333-200145) of Nevro Corp. of our report dated February 23, 2022 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</p>
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:0%;font-size:10pt;font-family:Georgia;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_2et92p0"></a>/s/ PricewaterhouseCoopers LLP<br />San Jose, California<br />February 23, 2022</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>nvro-ex311_6.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nvro-ex311_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.1</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, D. Keith Grossman, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">I have reviewed this Annual Report on Form 10-K of Nevro Corp.;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 23, 2022</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="top"  style="width:auto; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ D. Keith Grossman</p></td>
</tr>
<tr>
<td valign="top"  style="width:auto; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">D. Keith Grossman</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief&#160;Executive&#160;Officer</p>
<p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>nvro-ex312_9.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nvro-ex312_9.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.2</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION OF THE CHIEF FINANCIAL OFFICER</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Roderick H. MacLeod, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">I have reviewed this Annual Report on Form 10-K of Nevro Corp.;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 23, 2022</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td style="width:40%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:0.5pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Roderick H. MacLeod</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Roderick H. MacLeod</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief&#160;Financial&#160;Officer</p>
<p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Financial and Accounting Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>nvro-ex321_10.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
nvro-ex321_10.htm
</title>
</head>
<!-- NG Converter v5.0.2.70 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.1</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Annual Report of Nevro Corp. (the &#8220;Company&#8221;) on Form 10-K for the fiscal year ended December&#160;31, 2021, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), D. Keith Grossman, Chief Executive Officer of the Company, and Roderick H. MacLeod, Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 23, 2022</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="top"  style="width:auto; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ D. Keith Grossman&#160;</p></td>
</tr>
<tr>
<td valign="top"  style="width:auto; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">D. Keith Grossman</p></td>
</tr>
<tr>
<td valign="top"  style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(principal executive officer)</p></td>
</tr>
<tr style="height:12pt;">
<td valign="middle"  style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:auto; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Roderick H. MacLeod</p></td>
</tr>
<tr>
<td valign="top"  style="width:auto; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Roderick H. MacLeod</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief&#160;Financial&#160;Officer</p></td>
</tr>
<tr>
<td valign="top"  style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(principal financial and accounting officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>gu1405a4gpzj000004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu1405a4gpzj000004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'S!& # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'Z4[>M,0^BF*ZM]TYIV: %HI,TM !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)32X7J: 'TA.*HW
M>I0VPQ)*BGTSS7,ZGXSM[-PC +N.%+G[WTQ_6DVD-)LZ\S*.G)]!4#WT:]7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1132PQF@!U,=U7&3C-9U]JT%M)Y D0RXSAFP!7.R>(A#NN+N4A1]U .6/L
M*ER2&HMG4RW1&X#M7):UXG D%E8/)-=,?F2 9(].>U/2UU3Q OFW9>QL)/F6
M!#\[C_:/8'TZULVFF6>F(D5M D2 8&!GGW)YJ=679(Y"W\/ZWJC>;>SBRC;G
M:IW2$>Y[4:QX)LH;426QE\SH[LVXD^M=V.>1S5+5WC739P[HIVG 9@,_G1R]
M6.,I/9'F7A2X71==2 N0LK;-F[K7K6T \5XA>WNG6.M0W,]]'$\$FX*OSEOH
M1D5>U7XR2-NBT^R )&/-<\$^H%)31NL'5EJSV+ [5')/! ,RRI&.OS-7SW>>
M,?%^LNB*]SM)&U88CC/UQ4D7@;QMK&Z62"?;+]YY)\9_#/%'/V-?J48_'(]I
MN_%_AZR8B?5K96'4>8":RIOBAX4A)_T]I%_Z9IN%<+:?!;494!N]3@0G[RA6
M)'XUKVOP1TJ/FXU*ZD/H@4#^5%Y$NGAH]34E^,/AA"?+:[<_]<2*HR?&O1E/
MR6-P_P!>*M1_!SPXN"T]VV/[Q'/Z5:3X3>%E.3;2-GCENM/WPOAD9 ^-FEG[
MVFW _'_ZU3Q?&;17/[RTN5'TS58>!?!LNM7&DF.:&YC4,,M@$?[.:R];\ ^%
MM+N+2WBDO)9[B3:J)(IV_P"T:CFE<T2PUMCJX_BQX;D;#2SQ_6.M6U^('AF[
M ":I$K-V9@#7,S?!;19%^2^O4;'4E<?RK+N?@G("39:N@]Y4.?T%5>1/+A6>
MIP:M87(#07D$@/<,*M[ACT'K7@MW\*/%MA+FR9;L#^**79_Z$:RV?QWX2D1"
M+Z#G. /-'YC-'.^J)^JTY?#(^CMPP3FO&-:E:[UJ^GSA5<@D_I6;9_&/7K >
M7J-E%/ZR.I5S_2JL'BO1[YIS-,]H\[[RLJEASU VTG),E8:<3VKPQ:&VT"U#
M;M[KO;)SBM@C%8^BZQI]WIUN;6[@EC$8 VN,_EUK9# GJ/I6B2:.:49)ZF9>
MZ+:WFYMICE(QO3C\ZQ'TK5=,.ZWD\^,<Y!P3^%=?@4F.*3@)2[G-6'B-T<),
MCJPZG;73V>J0W2@B0'W'2LV_TFVO<F1-KCHZ\&N4O;:]T&<2*6>#/#BH4I)V
M97+%['IH.:6N3T7Q&L\:*[ @X (-=3&ZN@9&!4]*V,V/HH'2B@04444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M??3@^X[&J\B9J**3R+E')P"=I_&C9D=#:HIH.>G-.JB0HHHH **** "BBB@
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M@C)_6G["I+XF3];I0^"!\\-:^(;UOF@NW)_O@_\ LU68/!?B6Z&\64VWKDL
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M:7J])8_XO9A_$*=[!HSLZ*P]'UQ[E_L>H1B"]4=C\DH]5/\ 2MRJ):L%%%%
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MQ!1110 4444 %%%% !574/\ CT:K55K_ /X]&H Y\=.:8V!R/PJ0=*8PR"*
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M_3X4TR\U*>'YIY#%&3P54<-^'2N>SJ3NSZ)SC@\)[N[+J:S!X+O(=*39';K
M'.!R[<Y=CWST_"L_4/BA>B0&T2';N !*CH37*^,&%UXIOX]VP"7')Z8QTK)6
MR4)DR1D!A_%VKI6A\\WS.[/6-(\8'4-<FL;P+&D; H1T;;U)KMCJ%E!:-,YC
M"#G ZG)KQ#2;FVC\6Q32;/+8LS*QP#TKM-?U"UFT7444Q#RT0@J>$RPX6B]B
M&CMXM<TV66.-3AG.!D"L36=3M-+\7Z7=38$,T$BEU'!PN:\U\*W\+>(;,2N/
M+$NU@S8R*W?B/J%NZ6I@=2T4C+MS\H&!T--L%$] M/%.C7MRMO#(I=NA(%4I
M]1M-.\73R2D*DEJ&+#O@?_7KRSP7?P-XEM/.$)CW'AF]C6YXQU*W.MF>%A)#
M]F>,!CD G'%)MA9)GI-GX@TS4)A%%*"Q[-Q6=>7EG8>,4>9D2-[)V+GIPRBO
M-/"6J6KZW")1$8^>IQDXXK3\6:Q:&^6>(K(5B:'8YR%)(/\ 2AL+*YZ7:ZQI
MUQ-Y:2*2>0"!G%8]Y=VECXV%Q,%6-[+&[U^?I7"^&]7M+G5H8Y(;;86ZJ<8_
M'-6_%.LV::I%-;/'-&(BI5CE5(:ES.PU%7/28]9TV61$CE4NYP%Q^M9<ES;V
MGC&25PHC:S!+?0FN!T#7;>ZURTBGM[959^J<<_GTJYXCUFV'B""ZMWAEACB>
M-D9LKG!P*;;L'*KGI4.J:=.RJDT;,WW5/<53N+FWL_$8ED=45X.>>PKSSP]X
MCAN-3@2:.W4,<?*<"M;Q/JD$=]9W$3*Z!7 3>"O;K1S.P<JN>@1:A:SXVN&S
MTK,>:.U\07#YP)(@21[5Q>BZ[#-J,*R!%RV#SVJ7Q/K,%G?F2)\Y@=!S]TY%
M)R;0<NIUSZY$TZPHQ\QN,'I6?'/(?%4R';F2VSD]."!7G^AZN9=43SI05+?>
MSR*ZV2ZMO^$JLV67.^!D+9XZYI7=RFE8ZO@CI0,9ZU5,UN6C6.<L68 #.<U<
MP<5JF8M"4F:=M-)BF(3-4-8VC0[XM]T0G-:'\JQ_$;EM(GC1AAAM8X[>AI/8
MJ.Y9TF VVFPQEB6V\GWJZ0/R]*;&H$<8Z80?RI_TIQT"3NSG_&'AF#Q5H<EH
MX47,:E[:0_PMZ?0]Z^?=&OKSPSXI@N%7RKBWEV2 \#&<'/X5]1 ?G7B/QA\/
MI8ZM!J\"[4O/ED '!<?_ %A4374[<)4O>F^I[=;727EK%<)]R1 X_&N-\83^
M3KUC\W "'\2V*@^%FN-JGA00RY,MF_EN?4'[OZ"H/&4@N?&%M:+*%=889#D]
MMY_G0WI<YY0Y9M,].TR02V2'=EAU]JNBN?\ #4NY;E,]&!'Y5OBK6QB]Q:**
M*8@HHHH **** "JM_P#\>C5:JM?_ /'HU &$.@]J8WK4B]*:P./I0!3E /?\
MZSY^ <=#Z5HR]..OI5&;G([^E %$]<<<TA/N.?2E/#9!Z>HHY"XP/09H XS5
MAJ4GCTC0985O([!C<FY^YLXX'O5[P$$7PT8P'\V.X=9MW_/3C.WVZ5>U30+7
M4Y5G,L]M<A=AF@<*[+Z$XY%7=/TZVTK3TM+1/+C4=3U)/<^_O0!:ZCYL8)S2
M_P 7R]21G'454TW3DTZQ,"2RRKN8[I6RP+9)Y_&ETZPBTNU6WBDFD'F,^^<Y
M;YNWT':@"T>,Y/'L<TT%CQC)QTSUJII^GP:79M:1/*Z.[,&E;+ D4FF:?%IE
ME]FA>25&=VS*V3\Q)//XT 7"/E)!''2F%1M.<$#IM/)JMIVGPZ9:BUA:1TW%
MPTK9;)]Z98:9#861M(GD:(EB&=\D9))_G0!<^;=DX(R.,]?K2[AC*88>N<Y_
M&JME90V%K]EMQ(8R6;<QR03UINGZ;;Z;8&TM@XB.0=S?-SUH M,!P58$@8)!
MH&T$$G..XZ57M-/M[&Q^R6RE8<MQG)R<DYINFZ?:Z98"VMP5A!+$$Y()ZT 6
MCM.#O5@?0UE:W%!<Z/<M(D;F-"R'KL/K['WJY8Z=;:?9_9+6/;;DM\N>I/7^
M=-@TJRM+)K"& );L26CSU+<G]: *'A'!\'Z3R6_T<8 '?)K8QTP<#W[U!:V\
M-C:16MN@6WB3:B]@*L9& ,]N!0!C>)-/74]#GM6N!;[B")'X4'L#7+M=265S
M=:7>Z=8QW5Q8.4N+'!#*JD_-P,=*[B]M+:\M3!=PK/"2-Z-R*HVVAZ39"3R+
M"*/S4V.0.6![?2@#SN[:\T30+739$:33KM(IK6?/^K? W(?8DDY]J]'UA+!M
M*F_M'#6B 2.I/7;R*GET^RFM$LYK>*2VCQLB89"D=,4Z\LK>_MC;7<"RP,03
M&_()'3- '*Z5IMO=0W^O:A!''',N8[8-PJ)T+>YVC\Z70;2"31+K6]0@!6>4
MW.PC[BKG81[8-;\6BZ7;++'%8Q1B5/+D&#AAGO5I[*U-I]B>!#;! GE?PE>P
MH Y'3;.QBT=-0U41"XU*X\Z$E?E#G 4?@0#4-I+96AUR;6VAGGM[F-UV#"N^
MSY0HZ9KLI]/L[F%;:>WCD@Z%6Y'X5 N@Z.MK]D&G0&WW[PA7@MZT 4?"]I-%
M:3WMP%6YOI#/)$AXBST7ZUML>^.!45I86=@'%E;1P!AEU3O4QR2>.GM0!#)]
MP< ^N*R+L]?ZUJRGY#[UD7;#<<Y]CZ4 94X^;G%4\'U'6K<WU)JJ< ^N: )K
M7EQFOH?2?^0/9?\ 7!/Y"OGJUSYH%?0NE?\ ((L_^N"?^@B@"Y1110 4444
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M2D'(Z<@@CZ5!8ZWX/@C7[1H5U/(#DL\K$'_@.['Z4XU8K<4L-4?0]AG\8:)
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M,<BCF0?4ZG8T-%\'6UE>&75]0@^S\Q[8RV=QXSQT%:GC32].N'T^RT^ZB1F
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M:Z6=M,B+(=PW-D?RZ>U+GU*^HS2-OP_H$D%^)+R\7R48AF0')XK5\66<%_\
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MC(QNCW ?CQ^E=8.E<CI?_(Q(RD#Y"A&,9YKKATK2)SR%HHHJA!1110 4444
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MQS0 <[L#IWJ/#,,E@/7\ZD.-X(].@[TTJ 0,<@_K0 ''.!@GI3#][(P1[T[
M.#GKD9IAP%R/7@&@!O!^H-+SG))/;ZFDXS\O7/.*0#&T\C!(Y_6@ (.WYN_0
MT#C:&(SVQ2E0!P?SZ4F,\]23S0 )C!YZGN*=]X'';I4;8XXZC!Y[U(N0!@=.
MU "@D+@;223@X]:1@-O7'K0WW>/R]*3@D^I''I0!'(% .>>*R+KDMQ6O)C'.
M2<5D71X+8H R9NO;/M5,]?2K<^ 2*ID_-CO0!9M3^\7ZU]#:9_R"[/\ ZX)_
MZ"*^>+;F5?K7T/IO_(+M/^N"?R% %JBBB@ HHHH **** "BBB@"*Z_X]9?\
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M=* &#L .]&1GGD?2G$';[#B@#!#'HU #<_F:7@E>#R#2E><8[>M'49/'&!0
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M5UZ[@![UT%P,+]>*P[D=2>M &3(#G-18P?:K$H^8U7]O>@#HO!V/^$FL,?\
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MF)(YN8-)8WEM(UTJW&Z[:0E2I(VOU ..<8K7CT73X;9K<+*8'0)Y<D[LH';
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M(3\WJ#GH: .TQQD$@#BD(W,/EZ_=QUK#\4>)(?#>F+.R^9<2$K#"?^6GKGT
MKCH?''BRX FM]/S"W1DC! 'MGF@#TWT!['J*;DL 5/7K^%>:R>+?&H"[=-;(
M/!\H8Q73^%-6US5(9VUBR\ADQY;,H7?ZC ].N: .B^8NI_AQD$FEV%F'(Y4Y
MXKA]<\7W^A>+8[.YB7^RWV[>.6!')S[&NU60/'O5MX;D%3P<4 !)![^HSTI0
M-BK\V[O^=<KXW\3R:!8QPVCH+^7_ %8(R4'KCOZ5MZ+->7.B6D]XBK<O&'?
MQGCK]30!> SQUQQ33DD9X(;K^%>=ZOXVUJ[U:;3O#L7$3%"X0,7([\] *I-J
MGQ$7@02DDX)\A,&@#T\Y()V]!TI <#']X=?I7EX\7^+=#F236(@\<IPB3($'
M'7E:]'CO89],74(C^Y,9E!]0!D_R- %Q5^?@'WSTIC*0P()R#WKRV7Q9XLUZ
M]F_L1"EM&<%8T#8]"2?6I/.^(I.2)LD8_P!2F: /3SC@D$[NI(YI,<XS\H_6
MO-;+Q7XDT35H;;Q!"YBF(**R@$9.-P(Z\UZ4S?, #\N<DXH <2>,X+=B*3'
MSQ[49(&&QD<<4 Y&,YSUXZ4 * 5X!!PQQFC^'G!]1BE^]U.,\' Z'VI/X<D=
M\<T 12Y!'"XXX%9-X,$C(K7D& <CM6-=XP">>* ,J<X.*IO[]*M39#"JQ!]:
M +.G@_:DYXW#^=?0UC_QX6__ %R7^5?/5AQ<1G_:'\Z^A;'_ (\+?_KDO\J
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M-69<<U!WH Z#P:!_PD]@?^FG]#7NU>%>#?\ D9[#_KI_0U[K0 4444 %%%%
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MIU3^RAK3:;#_ &5GE1(?,V?WL8_K2>&N/!>K=\R3]?H:JOD?"4Y_Y]A@#\*
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M7!4]>",C']:;[C'')!- #R&R/FZC(/:F<;N3D+U]Z7H>%) ]?3UH;'.._K0
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M+O[N!6'/]XY[T 53UIR]*;WIXZ8I@>D?#G_D&7?_ %U'\J[2N+^'/_(+N_\
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MUL_RK&N?XN] &7-U-0'K4\HY-04 ='X)_P"1IL?]_P#H:]R%>'^"/^1IL?\
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MX?\ B\D1_P"FR?\ H-"!F]\3L?\ "*+UYN$K3\%_\B9IN.\9_P#0C65\3?\
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M)9@\\C;I'7@#V^@K&\6^!!J]PVH:<ZQ7G1HV.%D]P>U=J,#D ]/FI5.>/U-
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M-8_@KPFNF)'J>H1_Z:X_=HP_U0/?ZD?SKG==A_M;XG)973.L<LD<6 ?X<=J
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M/='YC6M/Z=*R+@\F@"A+U-0CKUJ24D&HDSG)% '6^ N?%-K]3_(U[4.E>+^
M?^1IM?Q_D:]I% !1110 4444 %%%% !56_\ ^/-JM56O_P#CS>@#!'04A]*!
MTH;IQ0!4DSM]AUK+NC\I/;M6K-G/7/O69<<K[ GG% &<<X (ZGO2\D] QSP"
M:3YL#!P>YSVI/1LX4=: %'S=LCOSZ]* !P><Y)]\=J7!SUQ@=J7+-'M/\)[=
MLT ,&>N.>G7\:3=R01QU^N:"<GIW_*FDD#'\./QH #R>1G'3'-*2%X)^7T/(
MI 2>3C/KBDXQGC;WQZ4  Z#G.,?Y-!((Z$YZXI.V #R.#WH#D<@C [4 +]W/
M'UY[4#)'J#[4BY#X&<'@X[TAY]  >U "G&> 3D=":;W4X# '.11U&/0?E29)
M&03@'UH 3'## QG@4I;<>H&1U)H/'!SDF@]/Z4 )GTSC&*?P"5/&?7K48//X
M\9I3\V3Z')Q0 *V[OQVSTI5Z?[HYQVI"S [L@-GM2L=N[H.U !]#^5*N<,5&
M,G !'IWIF0<D%OF&*!C.,#:!QD4 /!&.#QTY/6ERP7 /!ZTP !0. .E*/0$9
M'&/:@!>#'D9;(QGOFE' / SC'!IF54L<' !R.E.  3.>0,_2@ D.."=V./K[
M4P_>SCG'%.SD'DCGH>U(5/+9]NO6@"&7;M*D8R,<>M9%T03DC)/M6O(>A..M
M8]R<$G.* ,R7J?:J_.:L3,"<]?:JWMDG- %[3O\ C_MA_P!-D_\ 0A7T3%_J
MD_W17SIIW-];8Z>?'_Z$*^BXO]6OT% #Z*** "BBB@ HHHH **** $;[I^E<
M;;G]Z_\ O'^==G7%G,.H3Q^DAJ9%1-6/.T4K=.:BB<8!Z5(3D4AE6<\&L>8G
M?_*M:?&#S61.V6J64AG..O% Y&>])V_^M2YZ"D 8[YX]*0YQ[4N:3 QU)% "
M$?2FC.:7OG'%!% P'/&.>U)D]<T=P<G(HP<8'% AOX<FCGG)_&CK_P#JHZ9Q
M^5 P[CKTH/YT#D#WHZ'Z=: &\$$=/6CCG)R*,\<CCUI,\GCF@!!G.#C(I>1Q
M[4AST_*DY/)_'- "_='\C2$C'0_XT \X.<>E&#F@ _BXI"/?GVHR#UR!US3L
M=>V3T% "<''^-!Z<4G'/3GTI>^<_AVH /?\ K1VSGBCH.OX4F>>G%  <BCC
MR>?2@8I#ZDT *.3G]:.G?BCH/>DS@9S0(IWIP3VS6+-P:U[PGIG'TK'EZGOF
M@"OGFI%Q35!..F*D"F@#TKX=C_B3W![&;^E=C7-^![<P>&HF(P979_Z?TKI*
MU6QF]PHHHIB"BBB@ HHHH *S-6X\OW-:=4-43="K?W30!D\XII/M3O\ "FGH
M: *\E9EU]W-:D@XK.NQ\G>@"@V"?84WM3OI_.D/ZT ,)].](>F>N>_I3N<<?
ME3&R?\*  ]/4U3U*_@TS3YKR9':.)<L$ZFK63SFHIH8IXFBFC62-A@HXR"*
M.)_X6CI#J4;3;UD;^$A"/QYKCO$VK:?KUW;#2-->V<;E=0HS(3C' XXKU?\
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M96C6)LC;1?9<;3#CY?RHL[.TT^W\BSMDABW;RJ# )/>@"P3QQ1VYIOUR:.]
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M4++P3Y?<"NHN[2&^MI+6X3?!("K#.,BF3Z=9W/V;SU#K;G,0/&T@8% '&_\
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M5<2<G!QB@RCUYQS0!8+#L>::9%/'(/\ *JS28'H2<TWS!R3SGO0!;R-W)_\
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M#(#]*@.I,.L<@_X":^DJ*.0.<^:3J;=HY/\ ODTY+JYFXCA8_4@?SKZ4HHY
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M(DAB?/J@K-N/"6@W3;I]+@<_0BMJB@#G3X%\,-UT>W_7_&F_\(#X6/71;?\
M-O\ &NDHH Y@_#WPH?\ F"V_YM_C33\.O"A_Y@T'YM_C74T4 <F?AKX2)S_8
M\7_?3?XTA^&?A(_\PB+_ +Z;_&NMHH Y#_A6/A'_ *!,?_?3?XTW_A5_A$_\
MPI/^^F_QKL:* .-_X5;X2_Z!:_\ ?3?XTG_"K/"7_0,7_OL_XUV=% '%_P#"
MJ_"7_0-'_?9_QI/^%5>$O^@=_P"/FNUHH XK_A5/A+_H'_\ CYI/^%4^$_\
MH'_^/FNVHH XG_A5'A/_ )\#_P!]FD_X51X3_P"? _\ ?9KMZ* .)_X51X3Q
M_P @_P#\?-'_  JCPG_T#_\ Q\UVU% '$_\ "J/"7_0._P#'S2_\*I\(_P#0
M,'_?9_QKM:* .,'PL\(#_F$I_P!]-_C5N'X=^%+<@QZ+!D=R6/\ 6NHHH IV
M^F65I&([>T@C4= $%6=O([8["GT4 )2T44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>gu1405a4gpzj000007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu1405a4gpzj000007.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" -E!V # 2(  A$! Q$!_\0
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M=XD\&Z7K&K:=/<7]U)J"S2I?WL"L+?4;JWBQ%#.D:[8HD4[5&2-QR237>?\
M"E/AY_T"+G_P:ZE_\DU)\%_^2=:'_P!==6_].]]7J= 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
MBY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?
M_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/
MAY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_
M ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\
MR37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% '
ME'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY
M_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\
M&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'
M_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T
M"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&N
MI?\ R37J]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J
M]% 'E'_"E/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"
ME/AY_P! BY_\&NI?_)-'_"E/AY_T"+G_ ,&NI?\ R37J]% 'E'_"E/AY_P!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR7@FMKB3=^+GQ,A^$?@76?'$W@CXD_$4Z3:WMQ#X0^$_@V_\<^-]:FL]-O\
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M5X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 10![I17A?_""?%?\
MZ*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \10![I17A?\ P@GQ7_Z*7_Y+R_\
MQ%'_  @GQ7_Z*7_Y+R__ !% 'NE%>%_\()\5_P#HI?\ Y+R__$4?\()\5_\
MHI?_ )+R_P#Q% 'NE%>%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\
M$4 >Z45X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$4 >Z45X7_
M ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 10![I17A?_""?%?\ Z*7_
M .2\O_Q%'_""?%?_ **7_P"2\O\ \10![I17A?\ P@GQ7_Z*7_Y+R_\ Q%'_
M  @GQ7_Z*7_Y+R__ !% 'NE%>%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_
M )+R_P#Q% 'NE%>%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $4 >
MZ45X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$4 >Z45X7_ ,()
M\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 10![I17A?_""?%?\ Z*7_ .2\
MO_Q%'_""?%?_ **7_P"2\O\ \10![I17A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @G
MQ7_Z*7_Y+R__ !% 'NE%>%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R
M_P#Q% 'NE%>%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $4 >Z45X
M7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$4 >Z45X7_ ,()\5_^
MBE_^2\O_ ,11_P ()\5_^BE_^2\O_P 10![I17A?_""?%?\ Z*7_ .2\O_Q%
M'_""?%?_ **7_P"2\O\ \10![I17A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z
M*7_Y+R__ !% 'NE%>%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q
M% 'NE%>%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $4 >Z45X7_P@
MGQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$4 >Z45X7_ ,()\5_^BE_^
M2\O_ ,11_P ()\5_^BE_^2\O_P 10![I17A?_""?%?\ Z*7_ .2\O_Q%'_""
M?%?_ **7_P"2\O\ \10![I17A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y
M+R__ !% 'NE%>%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q% 'N
ME%>%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $4 >Z45X7_P@GQ7_
M .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$4 >Z45X7_ ,()\5_^BE_^2\O_
M ,11_P ()\5_^BE_^2\O_P 10![I17A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_
M **7_P"2\O\ \10![I17A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__
M !% 'NE%>%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q% 'NE%>%
M_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $4 >Z45X7_P@GQ7_ .BE
M_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$4 >Z45X7_ ,()\5_^BE_^2\O_ ,11
M_P ()\5_^BE_^2\O_P 10![I17A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7
M_P"2\O\ \10![I17A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !%
M'NE%>%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q% 'NE%>%_P#"
M"?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $4 >Z45X7_P@GQ7_ .BE_P#D
MO+_\11_P@GQ7_P"BE_\ DO+_ /$4 >Z45X7_ ,()\5_^BE_^2\O_ ,11_P (
M)\5_^BE_^2\O_P 10![I17A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2
M\O\ \10![I17A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !% 'NE%
M>%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q% 'NE%>%_P#""?%?
M_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $4 >Z45X7_P@GQ7_ .BE_P#DO+_\
M11_P@GQ7_P"BE_\ DO+_ /$4 >Z45X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_
M^BE_^2\O_P 10![I17A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\
M\10![I17A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !% 'NE%>%_\
M()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q% 'NE%>%_P#""?%?_HI?
M_DO+_P#$4?\ ""?%?_HI?_DO+_\ $4 >Z45X7_P@GQ7_ .BE_P#DO+_\11_P
M@GQ7_P"BE_\ DO+_ /$4 >Z45X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_
M^2\O_P 10![I17A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \10!
M[I17A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !% 'NE%>%_\()\5
M_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q% 'NE%>%_P#""?%?_HI?_DO+
M_P#$4?\ ""?%?_HI?_DO+_\ $4 >Z45X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7
M_P"BE_\ DO+_ /$4 >Z45X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O
M_P 10![I17A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \10![I17
MA?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !% 'NE%>%_\()\5_P#H
MI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q% 'NE%>%_P#""?%?_HI?_DO+_P#$
M4?\ ""?%?_HI?_DO+_\ $4 >Z45X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"B
ME_\ DO+_ /$4 >Z45X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 1
M0![I17A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \10![I17A?\
MP@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !% 'NE%>%_\()\5_P#HI?\
MY+R__$4?\()\5_\ HI?_ )+R_P#Q% 'NE%>%_P#""?%?_HI?_DO+_P#$4?\
M""?%?_HI?_DO+_\ $4 >Z45X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\
MDO+_ /$4 >Z45X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 10![I
M17A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \10![I17A?\ P@GQ
M7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !% 'NE%>%_\()\5_P#HI?\ Y+R_
M_$4?\()\5_\ HI?_ )+R_P#Q% 'NE%>%_P#""?%?_HI?_DO+_P#$4?\ ""?%
M?_HI?_DO+_\ $4 >Z45X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_
M /$4 >Z45X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 10![I17A?
M_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \10![I17A?\ P@GQ7_Z*
M7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !% 'NE%>%_\()\5_P#HI?\ Y+R__$4?
M\()\5_\ HI?_ )+R_P#Q% 'NE%>%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI
M?_DO+_\ $4 >Z45X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$4
M >Z45X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 10![I17A?_""?
M%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \10![I17A?\ P@GQ7_Z*7_Y+
MR_\ Q%'_  @GQ7_Z*7_Y+R__ !% 'NE%>%_\()\5_P#HI?\ Y+R__$4?\()\
M5_\ HI?_ )+R_P#Q% 'NE%>%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO
M+_\ $4 >Z45X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$4 >Z4
M5X7_ ,()\5_^BE_^2\O_ ,16KHG@_P"(]CJUA=ZIX^_M+3K>Y22[L?(D7[5"
MN=T.2@ W<<DT >OT444 %%%% !7@OQ>_Y&SX2_\ 8Q3?^G+PU7O5>"_%[_D;
M/A+_ -C%-_Z<O#5 '3_!?_DG6A_]==6_].]]7J=>6?!?_DG6A_\ 775O_3O?
M5ZG0!YW\7/B-I'P@^%_Q ^*OB$[= ^'7A'7?&FNN$NI3%HWAS3Y]5U28165O
M>7DS06-M/,L-I:W%S,4$<$,DC*A^=_VG5TKQ!XY_835TL-:T36?VK-0RCI;Z
MAI>JZ9J'['7[61PR.);6]L;VUEZ,)(+B"3D/&_/U-XS\'>&?B'X1\3^ _&FC
MVWB#PAXRT'5?#'B?0KPS+::QH.N64VG:KIMRUO+!<+#>V5Q-;R-!-%,JR$QR
M(X##XBO?V"/#OAT?L^:#\'OB9\5O 7P[^"7Q5/CBV\$7_P 1=?\ &EII&@+\
M)/BI\-X=&^'^J>/(_&'B'PQ+ _CZT@M[2/7%T.R\.KK4&G6-EK,VF:G9 'P_
M^Q]\%=!_9X_X*\_M9_#G]GU3IWP%U7X >$_&_P 2/!6A+"WA+X=?%37_ !#H
ME]X0\*N%FF.F73:3=^./$OA/0T^R1:7X=\4ZEIFG:=%HVF6;1?N^DT4C2)')
M&[0N(YE1U9HG*JX20*24<HRN%8 [65L8(->3?![X%?"_X#Z)JVB?#3P]/I9\
M1ZU=>)?%OB#6M>\0^,O&OC7Q)>DFZ\0>-?'?C'5=>\8>+-7=<007>O:U?M86
M,<&FZ<+33;:VM(?#M&_85^#OA#XZ^._VB?AUX@^+/PU^(GQ1OUU/XD)X0^(F
MIKX4\;WHN'N?/U_PCX@@U_0[ATEFNC9^1:6_]D"]OO[$_LQKRX:0 ^,?VIOV
M<[7Q3_P5?_8&^*GPXT-[?Q=IWAOXK>)_CMX@TC%NEC\/_A_IVFZ=X U/Q*JR
MK"T_B36O&&O>!+.[^SOJNKV2PZ?)+<:3X<7^R>._X+8_#O4])T?]DO\ ;'TK
M1];U^U_9%^/?A[Q)XYTS1?L$CQ?#_7_$?@_6+S6Y+:^EMVN)K#Q-X$\,Z%:"
MWN4CB;Q7-=:E'_9]O-?Z9^SWACP+X:\)76KZEI5E))KOB%K-O$7B34[JYU7Q
M'KQT]9TTZ/5-9OY)[V:STU;JZ32=+22+2='BNKB#2;&Q@E>(ZWB+P[H'B[0-
M:\*^*M%TKQ)X9\2:5?Z'X@\/ZY86NJZ+K>BZK:RV6IZ5JNFWL4UG?Z=?V<TU
MK>6=U#+;W%O+)%+&R,RD \Y^,WQ.\-_#OX$_$WXOW^HVS^%O"7PO\5^.VU&$
MFYM[O3--\,WNL6TEH(-S7AU"..%+**WW27<D\,4 9Y4!_''_ ()G?L7:[<?\
M$D/B#\,=>GF\/>)?VPO#/Q/\;:;+J"07<7AZQ^(?@G3_  ?\,]5^SV=VB76F
MWNB^'_#OCH6[W5O>RVVO-8W<MG+&(K7],$_8A^!T_@OPY\*-=3QSXP^"/A"^
MTZ^\-? [QEXYUSQ)\,+!=&N7O-"T;4]*U&635_&7@_P]=&";P[X#\>:[XI\#
M^'SIFAQZ/X=LH?#^AQ:?]=HBQHL<:JB(JHB(H5$10%5550 JJ  J@    #%
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MGPMTZ/X<:[:RPRI'(AAU;PM=^3(R>7=VK07UL\UI=03R_"O_  3?\"77Q/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5X+\7O^1L^$O_ &,4W_IR\-5[U7@OQ>_Y&SX2
M_P#8Q3?^G+PU0!T_P7_Y)UH?_775O_3O?5ZG7EGP7_Y)UH?_ %UU;_T[WU>I
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !117G'Q6^*OA'X->#+_QQXTN;F'2K.6&T
M@M[&W^U:CJ>I70D-IIFGP%XHWNKGRI6#3SV]M#%%+/<W$,,3R+SXO%X; 87$
M8W&UZ6%PF$HU,1B<37FJ=&A0I1<ZE6I.348PA%.4FWHD*4HPBY2:C&*;E)NR
M26[;9Z/17X[77_!3;QC_ &W))9?#/PT/#8OE,5I=:IJC:V^F+(NZ.3482MA'
M?2PABLJZ7+;V\CJ##<K&3+^G?PD^+G@SXT^#[3QEX*OGN+*20VFH6%T@AU31
M-4CBBEN-*U6V#.L5U"LT;J\4DUK=0217-I//;RI(?C^&/$;@[C#&8G 9#F\,
M5C,+%U)8>K0Q.$JU:*DXRKX:&+I498BE!V]I*DI.DIP=2,%.-^7#X[#8F4H4
MIWE%7LXN+:[Q4DKI=>JNKH].HHHK[@ZPHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *\%^+W_ "-GPE_[&*;_ -.7AJO>J\%^+W_(V?"7_L8IO_3EX:H
MZ?X+_P#).M#_ .NNK?\ IWOJ]3KRSX+_ /).M#_ZZZM_Z=[ZO4Z "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"UU'@I/8ZE;LTVJZE9W,3/&WV[5Y[FV9A<:?<V=W'#<1_<G_  4OUO[-\+?
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MV/)Y<88@N^R-WV+EMB.V,*2/._C#\3=$^"OPF^)GQ@\2VFHW_A_X7> _%GQ
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M.I:/'XT\&+?/_;D7@?QA>:)K8T6'7K>WU*QU+1=>T=WU*'2X-9U( ^[****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU5$3Q%H[+;7\R1H66&+44^SZO;P GR+;4(8B=R&O=Z_(7_@FI\3+:QU7QO\
M"?4+@12:V(/&'AN-N$FOK" 6'B*V!+?-<S:>FDW<,:J#]GTR_D9B$4#]>J_N
MSPTXE?%?!61YM5JJMC?JWU/,I73G_:&!;PV(G52MRSQ')'%\MDN3$0:]UH^L
MP-?ZQA:51N\N7DGU?/#W6WYRLI?]O!1117W9UA1110!Y5\8_C!X2^"7@F_\
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M]<_;'UGP)H_[+GQVC^(VGS:[X:\0_#+Q?X-_X1+3Y2GB#QWK7C+1+WPUX<\
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M\O\ \17NE% 'A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !%>Z44
M>%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q%>Z44 >%_P#""?%?
M_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $5[I10!X7_P@GQ7_ .BE_P#DO+_\
M11_P@GQ7_P"BE_\ DO+_ /$5[I10!X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_
M^BE_^2\O_P 17NE% 'A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\
M\17NE% 'A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !%>Z44 >%_\
M()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q%>Z44 >%_P#""?%?_HI?
M_DO+_P#$4?\ ""?%?_HI?_DO+_\ $5[I10!X7_P@GQ7_ .BE_P#DO+_\11_P
M@GQ7_P"BE_\ DO+_ /$5[I10!X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_
M^2\O_P 17NE% 'A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \17N
ME% 'A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !%>Z44 >%_\()\5
M_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q%>Z44 >%_P#""?%?_HI?_DO+
M_P#$4?\ ""?%?_HI?_DO+_\ $5[I10!X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7
M_P"BE_\ DO+_ /$5[I10!X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O
M_P 17NE% 'A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \17NE% '
MA?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !%>Z44 >%_\()\5_P#H
MI?\ Y+R__$4?\()\5_\ HI?_ )+R_P#Q%>Z44 >%_P#""?%?_HI?_DO+_P#$
M4?\ ""?%?_HI?_DO+_\ $5[I10!X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"B
ME_\ DO+_ /$5[I10!X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 1
M7NE% 'A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \17NE% 'A?\
MP@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !%>Z44 >%_\()\5_P#HI?\
MY+R__$4?\()\5_\ HI?_ )+R_P#Q%>Z44 >%_P#""?%?_HI?_DO+_P#$4?\
M""?%?_HI?_DO+_\ $5[I10!X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\
MDO+_ /$5[I10!X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 17NE%
M 'A?_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \17NE% 'A?\ P@GQ
M7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !%>Z44 >%_\()\5_P#HI?\ Y+R_
M_$4?\()\5_\ HI?_ )+R_P#Q%>Z44 >%_P#""?%?_HI?_DO+_P#$4?\ ""?%
M?_HI?_DO+_\ $5[I10!X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_
M /$5[I10!X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 17NE% 'A?
M_""?%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \17NE% 'A?\ P@GQ7_Z*
M7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !%>Z44 >%_\()\5_P#HI?\ Y+R__$4?
M\()\5_\ HI?_ )+R_P#Q%>Z44 >%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI
M?_DO+_\ $5[I10!X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$5
M[I10!X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 17NE% 'A?_""?
M%?\ Z*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \17NE% 'A?\ P@GQ7_Z*7_Y+
MR_\ Q%'_  @GQ7_Z*7_Y+R__ !%>Z44 >%_\()\5_P#HI?\ Y+R__$4?\()\
M5_\ HI?_ )+R_P#Q%>Z44 >%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO
M+_\ $5[I10!X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$5[I10
M!X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 17NE% 'A?_""?%?\
MZ*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \17NE% 'A?\ P@GQ7_Z*7_Y+R_\
MQ%'_  @GQ7_Z*7_Y+R__ !%>Z44 >%_\()\5_P#HI?\ Y+R__$4?\()\5_\
MHI?_ )+R_P#Q%>Z44 >%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\
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M0]_',JD>9"K90?I#\/O@O\3? ?@GPQX/L_B1;QP>'M(M-."VEK<);&2),SO
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#HOAR*75+V*(0?VA>W=K:W%W86=K?3_FK7)^,/\ @I+^TM\=/BKJ.E7OC/\
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MW&,5"<='8XZ&9U_:X:C%Q5%?5Z4DXJ[24(5'S;ZOF:?30W?VQOB!JOCWX_\
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M(N\925HQVU44W[R=VFV[7TU5PHHHK]E/3"BBB@ HHHH **** "BBOQ5^+_\
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MEH^HWL-BUK8B\N[2T^TRQ&ZNK:W\R>/\F+77/C%^U!X2_P""?'QZ\9_&+7O
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M\'O%,.FZUX)\=6^A2.EUHOBO2M!\2>$['XF:39P2^&['7]<TN[\.ZA)8ZO\
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M00^1*?)A>1FCBR$P?+0JGX57_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
M]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_
M .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_
M -%+_P#)>7_XB@#W2BO"_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7
M_P"(H ]THKPO_A!/BO\ ]%+_ /)>7_XBC_A!/BO_ -%+_P#)>7_XB@#W2BO"
M_P#A!/BO_P!%+_\ )>7_ .(H_P"$$^*__12__)>7_P"(H ]THKPO_A!/BO\
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M1ZQ[I17A?_""?%?_ **7_P"2\O\ \11_P@GQ7_Z*7_Y+R_\ Q% 'NE%>%_\
M""?%?_HI?_DO+_\ $4?\()\5_P#HI?\ Y+R__$4 >Z45X7_P@GQ7_P"BE_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJW%?F.=<!XB%:G+)8QJ8>4(0J4Z^(2K0JN<E.I><80=%0<&U&3J)J=H/1/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8*O*E%J+J1H\WM'34FDYJ/*FTF[L7-'FY;KF:ORW7-;O;>QTU%%%;#"BBB@
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M;?PCTBY:Y\5^*?%_B]5FE:&QB>R\.:>UNTC&&*[%E'=ZG--'%L1Y[75+!)9
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MB]M+7[9?W.H:S/:WZ:1I&G0M;K=WL6FZI="XOK&&#3IQ-+)!^27CSXK>&O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8;(V(_);1?\ @I5\8+0A=<\'?#[681CYK2UU_1[MOO9WS?VWJ-K_ '=NRQ3
M#9W%@5]#BSQ*X3X*QV"R_/\ &UL/B,=0GBJ:H82MBE2P\:CI1JUXT(SJ0C5J
M1J0I<M.;FZ-71*.MXC'8?"SC"M*2<ES*T7*RO:[MJKN]M'LS]L:*X;X9>-$^
M(OP\\%>.DMDLCXK\-:1KDUC%,;F.PN[^RBFO;%+@QQ-.ME=M/:K,T432"+>T
M4;$HO<U]MAL11Q>'P^+P\_:8?%4:6(H5+2CST:U.-2E/EDE)<T)1E:24E>S2
M>AU1DI14EJI)23\FKK\ I&8*"S$*J@LS,<!0!DDD\  <DG@"E)P"3P!R2>
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MZYFOD_,^!;BXN+N9[BZGFN;B4AI9[B1YII" %!>61F=R%  +,3@ =!6_X/\
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MGQ<<7XSO[2ACYK5?:P6227_DLJ&GI?S/Z/:***_E(_H<**** "BBB@ HHHH
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MT^ZF^)GBB75HO!,$U];6]Z;#2_#=H=&UW6KBVMY_L]]<7FK:!'IVI)+:FTU
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MX2_]C%-_Z<O#5 '3_!?_ ))UH?\ UUU;_P!.]]7J=>6?!?\ Y)UH?_775O\
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M.I:/'XT\&+?/_;D7@?QA>:)K8T6'7K>WU*QU+1=>T=WU*'2X-9U( ^[****
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M*%7$8BK))R:IT:,9U)M13DU&+:2;V3/6*^%?VX?V[_AO^Q7X/L+K6[*7Q?\
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M3BJU#%*C.I3G[2G4Y7+V5/EJ0M**<DU*\7'A/A?\/]$^%'PX\#?#/PXFW0_
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M]]7J=>6?!?\ Y)UH?_775O\ T[WU>IT <;\1? 7AGXJ^ /&_PQ\:V+ZEX/\
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M-WXX\2^$]#3[)%I?AWQ3J6F:=IT6C:99M%^V?Q#_ .1 \<?]B?XF_P#3+>T
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M%KGCB[TRZ7'ES-;VOC6U@>YMI+BT-W#>6:7#3V5S%#X_\/\ P)=?'S_@M_\
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M[<RWC^&H?VEI+VWTJ*Y\T31Z?#IXM= CLG>2V30X#I21+8&."+]Q_P#@J/\
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M!X7_ ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 17NE% 'A?_""?%?\
MZ*7_ .2\O_Q%'_""?%?_ **7_P"2\O\ \17NE% 'A?\ P@GQ7_Z*7_Y+R_\
MQ%'_  @GQ7_Z*7_Y+R__ !%>Z44 >%_\()\5_P#HI?\ Y+R__$4?\()\5_\
MHI?_ )+R_P#Q%>Z44 >%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\
M$5[I10!X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$5[I10!X7_
M ,()\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 17NE% 'A?_""?%?\ Z*7_
M .2\O_Q%'_""?%?_ **7_P"2\O\ \17NE% 'A?\ P@GQ7_Z*7_Y+R_\ Q%'_
M  @GQ7_Z*7_Y+R__ !%>Z44 >%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_
M )+R_P#Q%>Z44 >%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $5[I
M10!X7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$5[I10!X7_ ,()
M\5_^BE_^2\O_ ,11_P ()\5_^BE_^2\O_P 17NE% 'A?_""?%?\ Z*7_ .2\
MO_Q%'_""?%?_ **7_P"2\O\ \17NE% 'A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @G
MQ7_Z*7_Y+R__ !%>Z44 >%_\()\5_P#HI?\ Y+R__$4?\()\5_\ HI?_ )+R
M_P#Q%>Z44 >%_P#""?%?_HI?_DO+_P#$4?\ ""?%?_HI?_DO+_\ $5[I10!X
M7_P@GQ7_ .BE_P#DO+_\11_P@GQ7_P"BE_\ DO+_ /$5[I10!X7_ ,()\5_^
MBE_^2\O_ ,11_P ()\5_^BE_^2\O_P 17NE% 'A?_""?%?\ Z*7_ .2\O_Q%
M'_""?%?_ **7_P"2\O\ \17NE% 'A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z
M*7_Y+R__ !%?)7Q6_P""C7A;PMJFL>'?A_X)U#Q3J.DZC>Z5-K6N7]OI&@-<
M6,TMO+=:?!8_VEJ&JV;31$1&9]%:6,^:K!0@D]X_9G_:M\+?M!6,^E2V@\-?
M$'2+)+O5_#CS>=:W]JK)#-J_AZY<B6YL%FDB6ZM+A1>Z9)/%#*UW"T5]/\/E
M_B1P3FN>/AS+\_PN)S:]2,:,88B-&K5HMJI0P^+J4883$5XJ,I>RH5JDI1C)
MPYN65N2&.PM2K[&%52J:V5I)-K=*32C)];)OKV9WO_""?%?_ **7_P"2\O\
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M+_X03XK_ /12_P#R7E_^(H_X03XK_P#12_\ R7E_^(KW2B@#PO\ X03XK_\
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M3HH98K"TF2UDU"8M<ZG<QEH(I'%UJ$US.))465Q(#( V0/JRBOZKX+\,.%^
M\1BL7DD,=4Q>+PT,)6Q./Q,<14]A&HJKA!4Z-"G3]I4C3E4Y::YG3A:RC9^_
MA<!0PDI2I<[E*/*Y3DF[7OT44KM*^G1'A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @G
MQ7_Z*7_Y+R__ !%>Z45^AG:>%_\ ""?%?_HI?_DO+_\ $4?\()\5_P#HI?\
MY+R__$5[I10!X7_P@GQ7_P"BE_\ DO+_ /$4?\()\5_^BE_^2\O_ ,17NE%
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MY#D69UL/++:N,H8R>+Q=&A[=?7:&62IT*BC7C5BN:M6H4IQIP>'KXN#YZ?\
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MZ9Z*^RR_@3*,'5IUZ\\1CJE.2FH5G3CAW*+O%NC"'-))V;A.K.$K6E%IM/\
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M\O\ \17NE% 'A?\ P@GQ7_Z*7_Y+R_\ Q%'_  @GQ7_Z*7_Y+R__ !%>Z44
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M\L4Y6OUM;S/TWHKX2^&O_!0/X,^.=8M]"U^VUKX>7=Y(D5IJ/B)K";PZ\SJ
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M;,L;'"\.TYQA*"Y/]FIU<75G[-5*KE&I[6E"-*THKE332E-S:E%1\SA7Z.G
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MM-LH/A'<>#=5MO$GAW5M==;N:^O?&,=UHUOJT6@0^78V,5O8KIVK-+=W5_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=UC5G=E1$4N[N0JHJ@EF9B0%50"220  23BOY9M&_P""Z/Q4\-?#W2/"&A_
MKP$-:\/^&-$\/:3XAUCQ/K^H:?YNCZ;;Z=_:&I>'[&ST>:\%R+=9S9VFO::(
MG9D%PZXQ\6?'+_@IW^V'\??"NL^!/%?Q"L?#_@KQ%%);:[X<\">'-+\-1:K8
M2/&[:7=ZTD5WXI;2W6-K>[TY->2TU2TGGL]8BU"VD\I?Q7'<></T'5^J3Q.-
MLZGL5"A.BI6DU3526(5)P4E9RDH3<4V^64ERGZ_D/T5_%+,J]&&<4LGX=P_M
M:4<37Q>9T,?5C1?*ZU7"X;*I8R-><$Y*E1KXC"*I42C.M2IOVR_JV\;?MZ?L
M;_#R[U'3_%/[1?PQ@U'299H-2T[1]='BK4+.YMO/%Q:36/A2'6KH7L#V\L4U
MF(3=1SA+=XA/+%&_P+\7/^"Y?[-G@^2XLOA1X*\>_&.]BC#PZE+'%\.O"=RS
M,RB)-1U^UU#Q5'(H7?(9? Z1!9(O+DE<RI#_ "O^'_"WB?Q9=FP\+>'->\2W
MZA"UEX?T?4-9NU$C^7&3;:=;W,P$DGR(2GS/\JY/%?7?PD_X)T_ME_&::$^&
M?@7XOT/2I+A(9?$'Q"M5^'FCPQ.BR?;(SXN;2M1U6S177=+H&G:N[/NCCC>5
M'1?E)<:<1Y@_99;E\(.;:C+#X:MBZJUZ.?-1T^TY4;*UW97/W"C]&_P<X17U
MSC3BS$XF%"$)5J6;9UEV08"=TFVZ=#V&/3J/2E"GF/,U+DC[2;C(_3V\_P""
M_7BQ[B-M/_9E\.VMJ)&,L-Y\4=2O[AX2X*)'<P>!].CCD6/<C2M:2JSD2"%%
M4Q-X5^T;_P %K/CM\7O"">#_ (4>$;3X 1W]O-;^)O$NC>*IO%GC"_23"B#P
M[K4OA[PVGA&!XRZSW%G97VN;_+DT_7--VR),MG_P0K_:\N+=YKCQS^S]I\H7
M]W:W'B[Q]+*[YC.'>S^&%U;QH4:3#":1C+&$,:QR"99?"W_!#']JO4O$=MI_
MBOQI\'O"_AL3P#4?$5CKGB+Q)=I:/@SR:/H*^&M(?4;R '"VFIZEH%M,RL!J
M*+M9LZM3Q!Q%.5"<<=R5TH2Y*&$H2L_^GU.G3G13^U+GIJUU)V;OUX'!?1*R
MC%4LSPM;A9U\L;Q%-8C-,_S2FY03:?\ 9^-Q>,P^83C>].G+"XJ7.HNG#VD8
MV_'K2]*\6>/_ !/!IFCZ?X@\9^,?%&IR?9['3[;4/$'B/Q!K%]))<3M';P)=
MZEJFH7<K2W$SA9KB9S+-(6.]J_=?X'?\$)_''BGP[X:\3?'#XNP_#B_U*!+[
M6/AWX:\+V_B;7M+@FRT.FW?BN;Q%::)9:PL11[[['H_B"QM)@UK%/>\W"?M_
M^RQ^Q-\!OV1O#T6G_#7PQ#=^+;FS2W\1?$KQ!%;ZAXW\0NRQ?:4?4S$HT?2)
M98DDC\/Z*ECI491)9H+J]\Z]F^N*]W)N \+1C[;.6L97FD_J].=2%"B[J3YJ
MD)0G7GT>L:6LERU-)GY;XC_2HSS,:_\ 9WAS"7#V5T)3A+-\7A<'B,SS""BZ
M<50PF)HXG"Y9AK-R@E&MC9<M*:K8-J=!_&7P^_83^ WPF_9Y^(/[/7P\T%]*
MTOXF^!_$/@[QEXVU'[-J7CGQ++K^AW^BG6]=UA+:T6XNM/\ [0EN],TZRMM/
MT32YRYTO3;(33>9_%5\9?A%XW^ _Q,\7_"?XB:8=+\6>#=5ETV_C0O)9WL!5
M9].UC2[ATC-WI&LZ?+;:II=T8XVFLKJ%I(H9O,AC_P!"*OQ)_P""S/[(NL?&
M+X<^#OC/\+? &K>+OBEX#UBW\.>(K/PCH>H:WXHUWX=:NMX\9_LS1K.]U+5U
M\*^(GMKJ!5@8:9I>M>(;]Y([:*:NCC#AZEB<KI5\#15*KE5.2IX>C3M&IA6X
M^TIQA%7YZ=O:P:O?]ZFG*::\KZ//B]CLGXXQN6<49A4QN#XYQ=)XO-<QQ/-6
MPN>4X3A@\76Q%>=G0Q<9+ 5XR:4']2G3<*6'E3J?CCKW_!5/]JN^^ WPU^"W
MAWQMJO@[4?!=AJNA^)?B1H]Y$_C3QSH"QV-MX2MKK6;JSDU70]0\/6,5Y9WF
MLZ/J4.JZ\QL;Z]O5NX;EKKXG/QT^-9TOQ;H;_%[XFR:-X^5U\<:5-X[\3S:=
MXO\ ,$"2MXDLY=4>WUJ26*VA@EEU".XEDM4-J[M;N\396D_"KXE:YX]TGX6Z
M9X$\5S?$;7-1@TG2_!4NAZA9^([F_N-Q2$Z7>P6]S;HD:2SW%Q=)#;6EK#/=
MW<T-K!-,G[Z:G_P3L_8B_9,^!'PM\6_MMZKXSN?B#X@U"72?$)\ ZOKDVCW.
MOZA;ZGKD>BV^FZ5;W%T]CX8TJVCTNZUVTGL8=2U"-;LQI%?P6\?QF29-Q;QG
MC88'+OKN-Q,(1PU*FY8EWE&FJ:PU*G1A4E.O*C&4ZL8TW.<8SJ5FY2O/^H.,
M^+_!?P/RRGC<TR[*,#3SK&U\T=+*\#EN)QE=U,15QTLUKU,37H1A@*.-E"E@
MZM3$QHX>I/#X;+Z<*&':P_X!>%OB7\1_ UI?V'@KX@>-O!]CJJ3QZI9>%O%6
MN^'[34H[JW%I=1W]OI-_:0WB7-H!;3K<)(LUN!#(&C&VK'PU^%GQ%^,7BB'P
M5\+O!NO^.O%4]CJ&IQZ'X=L);^^_L_2[=KF^O)%3"0V\$85/,F>-9;F:VLH3
M)>7=M!+^Z'AC]GO_ ((Y_M'^+?"_PP^%'BOXS> /'GB:];2]!M],F\7C^V+V
MWT^:];[9=_$#P[XPT.W6>*UG(1;O27EN1Y%N(_,MXW_=[]G/]EWX,?LL>"X_
M!7P@\*0:-#,L+Z]XAO674/%GBR^A4C^T?$FNR1I/>R[GD>WLH%M=(TT2O!I.
MG6%L1"/HL1X5<497CJ."XFH5\IIJDJ].%>EB85ZM&4W%O#4<51HM0E*$X.LX
MNFIP:2J.,HK\PS#Z8'AS7R3%YGP#E]?.L\Q5;ZO.&*I8+#82C5I4TX5\TQF7
M8S&O$NE"K&5+"4:OMIQDXSK8.,HU)?P7:)KGB+P=KUAKWAW5M8\,>)=!O4N]
M,UC1[V\T?6M(U"V8[+BSOK22WO;&[A;($D,D<J'<N1DBOU@\+?\ !8C]M.VT
MSPU%>>)/!NLIH+6UMJUQ?^"-)&H>*([-K9I/[:N[?RTAFO+93%-=Z1;:5*9)
M[F95\U8G3AO^"L/[+>A_LU?M&6UUX+\]/ OQ:T.\\<Z/83KQX?UIM=U&#Q+X
M<M)@2;G3;&:73]0TQW"2VMAJUOI;B;^SA>7?Y>U/#?$N'\,>,<SY\KPO&&4T
MZ>*P7]GYK'ZE1Q<*T85,'CIT_9XWZKBZ"Y)/V+F[2K4:>(=.I[1_:<8<!97]
M)SPIX6S&ICJW!.<XV& S;#9UE,*>:8_**M*I4HYQDM/$3EESQN K5HXC#SC7
M5*G*K2H8N>$5>C&G'^U7X1_\%4OV.OBD#::E\1(_A5K4&DPZE=6'Q4C@\)V+
M/LM5O;/3?$,]U+H6HW-G<W(@6V%[!?WD<<MW:6,MM#-)%R'Q6_X+#?L5_#*_
MU+2--\4^*?BKJ>F2"WE3X7^'(]5TJ>X)4$67B77]2\->'-2MH@P>6^TK5+^U
M9 XM9+J9?)/\;->N?!SX#?&#]H'Q%=>%/@WX UWQ]KMA9?VEJ%KH\=O'!IM@
M9DMUNM2U+4+BRTO3H9)Y%AA:]O8//DW+#O*/MG,O$/%9ABY1R')(9=3K22H8
M2IB:V<8B#Y7>-.K&A@O:MOWH\V'DTKI\VY\=E7T3>!^'\(\?QIQIF698;!T_
M:8S%N.7<,9:DIPM4Q4ZM3'NA2M>$^7&T;RFG&I"RB_?OVT/VM9/VKOCMXC^)
MS?\ "2V7A006&B^ ?#6M+8&;PQX9L+2(&R\JRO[BS2XU#57U'6K^2*>X,EYJ
M,B^>T,5O'%X+I&F:%JO@KQ=XK?Q?HNFZIX6U/PK;6W@W4G-MX@\3:7K_ /;T
M.I:MX?4N;>^/AJ\T[1H=2TZ*1[MK7Q#'J0\NTTR^9?MBW_X(_P#[>4NA2ZS+
M\+-#L[B.UN;H>'[CXB^!)-=E\A9'CMXH[+7;O3/M5XJ+]FADU2/:TL<=TUM(
M)$C_ #M\8^#/%OP]\2:KX/\ '/AO6_"/BG0[EK35O#_B'3;K2M5L)UP0MQ9W
MD<4RK(A66"4*8;B!XYX))(9$=OT#+?I$>,'"N!PF"J4\NAEU#!PP>!HXWAZC
MAX452A%4YPJ8>.%G4Q"Y>:K[>55U>>I.I'VLE5C\Q4^B%]%7Q#Q>*GP]F&(Q
M6:T,;3QV:5\@XZK9M7KTG67MZ6(H8G$YE1I8/$+FI4Z^"I8=49>S6'JJG!49
M5;;Q)KNG:C;ZII&JZAHU_9RF:QN](O+C3KNRDPZJ]O=V<D%PDJQR/'YXD\TH
MS*7PQ!]AC_:M_:CAL8],B_:3^/L6FQ!1%I\?QB^(B6,83&P1VB^(A;H$P-H6
M,;<#&,5^CG_!.C_@EUXN^/.N^'OB]\>?#5WX>^ 5N#J=AH&K2:CHWB'XJDI_
MH$.G6]I+8ZKI7@Z1V6\N_$37%E-JUM'#:^'A=07T^KZ9^SR_\$?/V"%U"6]/
MPGUU[:0@KI+?$WXCC3X0&1B(I$\3)JI#!60^=J<IVR.5*N(V3\PCE/&?$\ZN
M>8_-<35Q>.J.=7%9MC\:\9B4TFJTI.%:;I._+34I1M%+V<%3Y6_T[B'Q>\#?
M#?%4>"L-PYA\9ALBPT:-+"\+9!D.(RG*JD9SC/+8.MC,#2AC*3BJF)C0A4A"
MI-PKUEBU6IP_DU/[2O[1#^&_$'@^;XZ?%RZ\*>*K!],\0^';WXA^++[1M6L)
M98I9[:ZT^[U6:V9+CR5ANBL:/=6;W%C<-)975S;RL^ W[/?Q:_:5\>6?P[^$
M'A2Z\2Z].J7.H7!=+/1/#NE><D,^N>(]8N-MII6EVI<%I)&>ZNY-MEIEI?ZC
M-;6<W]6OB;_@C5^PKKUS93Z7X(\:^"XK6>*6>R\,_$?Q1=6VHQQ_?MKU_&-W
MXLO$@GZ2MIUW87(_Y87$-?;GP#_9J^"O[,?A6Z\'_!7P19>$-)U&]_M+5YQ=
MZCJ^LZW?B/RDN=7UW6KN_P!6OO(CW)9VLEW]AL$>6.PM;5)9%;HPO >:5\53
M_M;'4I82EHW1KUJU:4+\WLZ/MJ,8THR;?-*7PMMJG-L^4SOZ5/!&6Y)BY<!\
M,XZEGV-DI0I9EE>79;E]&LHQI?6\Q>6YA6J8RI3I1BJ5&C+]XHQA4Q5",4G_
M "V>,?\ @BS^VSX6T6?5]+TWX9^/KF J3H'@[QR8]:EC+*))8%\8Z-X0TJ40
MH6E:%=5^U2K&R6UO/.T4,GYH?$3X9_$'X1^*+SP5\3?!OB+P+XJL%26XT/Q+
MIESI=Z;:1Y8X+VV6X14O=.N6AE%IJ-D]Q8W8C=K:XE52:_>S]N__ (*R>.[C
MQOJ/PN_9;UW_ (1/PYX-UR>RU[XH6L%AJ.K>,=7TBZ:":T\-+?VU[I]CX0@N
MX9%:_P#(N+SQ,(XI()K/1&DAUCRCX&_MRW7[67Q$^&?[//[<'@3X5?%_X>>-
M-:3PI;>-M3\,2>&/B!X:\2ZY VG^'=0TGQ'X2O\ 1;?1UU+6GL-)U2;1M/T2
MY%O?F\_M*&&SDM[G]DS#Z+W$M3AM\19=*C@YQPE7&RRK&8F=3&_5:5)UE.5*
M.&2IU:E).:H+$5,0O<IO#*M*4(_A/"7[0*&%XEAD'&65T,YP-3%T\'+-LCPG
MU&I1KU:D*+5)UL=4PN,I4JEX^_0P5.<I3J?VA[&,6_Q=\4>/?'/CA-%C\:>,
M_%GB]/#6EIHGAQ/%'B+6/$":!HL<C2QZ1HJZM>78TK2XY7:1-/L1!:)(S.L0
M8DG]._V)O^"3WQ0_:F\.Z+\4_&GB2W^%?P@U>:=M*O'L)=3\;>+;*SN?L\UW
MX?T:;[+I]AI%U+%=6UKK^K7K[Y(?M5EHFJV+QSO^]/AG_@DS^PEX6\3:?XGM
M/@Y)JLFFD26^B>)O&'B_Q+X9DN!D+/J&AZUK5Y::J "0;+5!>:8^0TEB[JC+
M^B>FZ;IVC:?8Z1I%A9:5I6F6EOI^FZ9IMK!8Z?IUA9PI;VEE8V5K'%;6EI:P
M1QP6]M;Q1PP0HD<2*BA1^3Y3P%*.(E7SRM2Q4(VY*&'JUY*I)<MI5JTX4:G)
M&*<53A9O2\U%<LOU3C[Z56'JY11ROPPRW&Y)7J2;Q.9YK@,MI/!TI>TE.CEV
M7T,3C\*\15J352>*KWA3_>*%"=2HJ]+\2?#G_!"/]F_3=8LK[Q#\4OB]XETJ
MUFCFN=#2?PKHL>I".1'^RW6H6F@3WL5G.JM%<BP>SO3&Y-K?VDH64?1FN_\
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MFY8_%-YC5JW]I4QUZO\ M<Y\TN>5?VCE=W;NPHHHK<\H**** "OR _X*;?\
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M\%K#6KSQ'9> M:M-,M=;O[.&PO-2@N]%TS5X[B>SMYKB&!BNHA L<S@HBO\
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MGA3XGWMIXS\)^$;::(Q7IT#3+W38I;B\NOE>+5/$EUKVJZ6Z!]'O=/=Y'?\
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MCZ/PG+K T5?BK-IFEP^%@[3_ &==:DTU]5'B&+PR7Q*=0ETY-1CMC]HET6-
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MBVFNS/YDO^'&/QO_ .BT?"K_ , ?%W_RJKX'^$7PR\1?!C]OWX-_"KQ8L/\
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MH)XTEAGT;5(9HI%#))%)8SI)&ZGAD=&*LIX()!K^5;_@FOX_\2Z;_P $9/\
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M"NO^.O".M1R2^5:SZ9KWA[3+R -=G:T6G:E'IVM1"1$O-+M9F\H?V8?\(/\
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MQ@_9'^'WPK\4^ -#;X^_#WXA:<)/BNWA3PW/K'B_X66WAOQ+:PVFJ>+&M_\
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M=?\ ROH_X0?XQ?\ 11+;_ONZ_P#E?3(/?:*\"_X0?XQ?]%$MO^^[K_Y7T?\
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M-?7>IV23XT_R8OU3KP+_ (0?XQ?]%$MO^^[K_P"5]'_"#_&+_HHEM_WW=?\
MROKP\_S>6?9UF6<SPM'!SS+%3Q53#X?F=*%6I9U'%R]Z4JE3FJU)/652<I/<
M];)\N6497@<KC7JXJ.!P\,-"O6M[2=.G=4TTM$H0Y:<(K2,(Q2V/?:*\"_X0
M?XQ?]%$MO^^[K_Y7T?\ "#_&+_HHEM_WW=?_ "OKQSTCWVBO O\ A!_C%_T4
M2V_[[NO_ )7T?\(/\8O^BB6W_?=U_P#*^@#WVBO O^$'^,7_ $42V_[[NO\
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MEM_WW=?_ "OH_P"$'^,7_11+;_ONZ_\ E?0![[17@7_"#_&+_HHEM_WW=?\
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MZ_\ E?7Y^_\ !4#P]\2-&_8P^)MQXA\:0:KI4^J_#ZVN-/3[0S7+-X_\.3P
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M'ZQ2ISP]22DJ56?)*WOM%>!?\(/\8O\ HHEM_P!]W7_ROH_X0?XQ?]%$MO\
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M2V_[[NO_ )7T >^T5X%_P@_QB_Z*);?]]W7_ ,KZ/^$'^,7_ $42V_[[NO\
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MBOP,_80HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-R<7##NDJ=-03=1<M23IN+A*[1117Y(?HP4444 %%%% !1110 4444 %%%%
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M0M.@54BLM)T6Q@T_3[9 BJN(;6WB0D*-Q!8C)-;Z(D2)%$BQQQJJ1QHH1$1
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM'1Y)3K>VIN,9.+E*-2+NY3J*T8_N%1117\]'[0%%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"_%[_ )&SX2_]
MC%-_Z<O#5>]5X+\7O^1L^$O_ &,4W_IR\-4 =/\ !?\ Y)UH?_775O\ T[WU
M>IUY9\%_^2=:'_UUU;_T[WU>IT %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?%3PW+XY\8^*=,>Y?PH?'>L:/J&G^$7NH)[66[TJST7P_H*W6I_9;J>VBO\
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M1110 4444 %%%% !1110 4444 %>"_%[_D;/A+_V,4W_ *<O#5>]5X+\7O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW7_ROKWVB@#P+_A!_C%_T42V_P"^[K_Y7T?\(/\ &+_HHEM_WW=?_*^O?:*
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M?\(/\8O^BB6W_?=U_P#*^O?:* / O^$'^,7_ $42V_[[NO\ Y7T?\(/\8O\
MHHEM_P!]W7_ROKWVB@#P+_A!_C%_T42V_P"^[K_Y7T?\(/\ &+_HHEM_WW=?
M_*^O?:* / O^$'^,7_11+;_ONZ_^5]'_  @_QB_Z*);?]]W7_P KZ]]HH \"
M_P"$'^,7_11+;_ONZ_\ E?1_P@_QB_Z*);?]]W7_ ,KZ]]HH \"_X0?XQ?\
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M_HHEM_WW=?\ ROKWVB@#P+_A!_C%_P!%$MO^^[K_ .5]'_"#_&+_ **);?\
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MW7_ROKWVB@#P+_A!_C%_T42V_P"^[K_Y7T?\(/\ &+_HHEM_WW=?_*^O?:*
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M?\(/\8O^BB6W_?=U_P#*^O?:* / O^$'^,7_ $42V_[[NO\ Y7T?\(/\8O\
MHHEM_P!]W7_ROKWVB@#P+_A!_C%_T42V_P"^[K_Y7T?\(/\ &+_HHEM_WW=?
M_*^O?:* / O^$'^,7_11+;_ONZ_^5]'_  @_QB_Z*);?]]W7_P KZ]]HH \"
M_P"$'^,7_11+;_ONZ_\ E?1_P@_QB_Z*);?]]W7_ ,KZ]]HH \"_X0?XQ?\
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M8(;;2/%2:?>B*/Q;XXT."$KH/C_XAMXQ\=:)+<ZC=Z7XCM+W5-2N+OZ:HHH
M^8O^&3/AA87/Q!_X0W4_B%\,]#^+6M:KXD^)GA+X:^.-7\(>&_%7B+7;*VL-
M<U^UAL&_M/P'KFMPVD<VMZS\+]4\#:GK.I//K.JW5YJ]Q-?/[AX$\!^#?ACX
M0T#P#\/?#.C^#_!GA;3XM+\/^&]!LHK#2M+L82S+#;6T( W22/)/<3R%[BZN
M99KJZEFN)I97ZVB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP7XO?\
MC9\)?^QBF_\ 3EX:KWJO!?B]_P C9\)?^QBF_P#3EX:H Z?X+_\ ).M#_P"N
MNK?^G>^KU.O+/@O_ ,DZT/\ ZZZM_P"G>^KU.@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O!
M?B]_R-GPE_[&*;_TY>&J]ZKP7XO?\C9\)?\ L8IO_3EX:H Z?X+_ /).M#_Z
MZZM_Z=[ZO4Z\L^"__).M#_ZZZM_Z=[ZO4Z "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\%^+W
M_(V?"7_L8IO_ $Y>&J]ZKP7XO?\ (V?"7_L8IO\ TY>&J .G^"__ "3K0_\
MKKJW_IWOJ]3KRSX+_P#).M#_ .NNK?\ IWOJ]3H **** "BBB@ HHHH ****
M "BBB@ HHHH **0D $D@ #))X  ZDD] *;'(DJ)+$Z21R(LD<D;!TD1P&1T=
M259&4AE920P(()!H ?1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUKG_ ,K*/^%>_&?_ **#!_X.M<_^5E 'T?17SA_PKWXS_P#108/_  =:Y_\
M*RC_ (5[\9_^B@P?^#K7/_E90!]'T5\X?\*]^,__ $4&#_P=:Y_\K*/^%>_&
M?_HH,'_@ZUS_ .5E 'T?17SA_P *]^,__108/_!UKG_RLH_X5[\9_P#HH,'_
M (.M<_\ E90!]'T5\X?\*]^,_P#T4&#_ ,'6N?\ RLH_X5[\9_\ HH,'_@ZU
MS_Y64 ?1]%?.'_"O?C/_ -%!@_\ !UKG_P K*/\ A7OQG_Z*#!_X.M<_^5E
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M,'_@ZUS_ .5E'_"O?C/_ -%!@_\ !UKG_P K* /H^BOG#_A7OQG_ .B@P?\
M@ZUS_P"5E'_"O?C/_P!%!@_\'6N?_*R@#Z/HKYP_X5[\9_\ HH,'_@ZUS_Y6
M4?\ "O?C/_T4&#_P=:Y_\K* /H^BOG#_ (5[\9_^B@P?^#K7/_E91_PKWXS_
M /108/\ P=:Y_P#*R@#Z/HKYP_X5[\9_^B@P?^#K7/\ Y64?\*]^,_\ T4&#
M_P '6N?_ "LH ^CZ*^</^%>_&?\ Z*#!_P"#K7/_ )64?\*]^,__ $4&#_P=
M:Y_\K* /H^BOG#_A7OQG_P"B@P?^#K7/_E91_P *]^,__108/_!UKG_RLH ^
MCZ*^</\ A7OQG_Z*#!_X.M<_^5E'_"O?C/\ ]%!@_P#!UKG_ ,K* /H^BOD+
MPG8?%;Q@NJ-IWCB>W&DWQL+C[;JVJ(9)@&):'R+6XW1_+P7\MO\ 9KKO^%>_
M&?\ Z*#!_P"#K7/_ )64 ?1]%?.'_"O?C/\ ]%!@_P#!UKG_ ,K*/^%>_&?_
M **#!_X.M<_^5E 'T?17SA_PKWXS_P#108/_  =:Y_\ *RC_ (5[\9_^B@P?
M^#K7/_E90!]'T5\X?\*]^,__ $4&#_P=:Y_\K*/^%>_&?_HH,'_@ZUS_ .5E
M 'T?17SA_P *]^,__108/_!UKG_RLH_X5[\9_P#HH,'_ (.M<_\ E90!]'T5
M\X?\*]^,_P#T4&#_ ,'6N?\ RLH_X5[\9_\ HH,'_@ZUS_Y64 ?1]%?.'_"O
M?C/_ -%!@_\ !UKG_P K*/\ A7OQG_Z*#!_X.M<_^5E 'T?17SA_PKWXS_\
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M; ;Y,@ @'U[17SA_PKWXS_\ 108/_!UKG_RLH_X5[\9_^B@P?^#K7/\ Y64
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MZUS_ .5E 'T?17SA_P *]^,__108/_!UKG_RLH_X5[\9_P#HH,'_ (.M<_\
ME90!]'T5\A26'Q5B\80>"F\<3G4[BQ-^ER-7U3["(5BFE*M(;07 DVP.,"V9
M<E?GP21UW_"O?C/_ -%!@_\ !UKG_P K* /H^BOG#_A7OQG_ .B@P?\ @ZUS
M_P"5E'_"O?C/_P!%!@_\'6N?_*R@#Z/HKYP_X5[\9_\ HH,'_@ZUS_Y64?\
M"O?C/_T4&#_P=:Y_\K* /H^BOG#_ (5[\9_^B@P?^#K7/_E91_PKWXS_ /10
M8/\ P=:Y_P#*R@#Z/HKYP_X5[\9_^B@P?^#K7/\ Y64?\*]^,_\ T4&#_P '
M6N?_ "LH ^CZ*^</^%>_&?\ Z*#!_P"#K7/_ )64?\*]^,__ $4&#_P=:Y_\
MK* /H^BOG#_A7OQG_P"B@P?^#K7/_E91_P *]^,__108/_!UKG_RLH ^CZ*^
M</\ A7OQG_Z*#!_X.M<_^5E'_"O?C/\ ]%!@_P#!UKG_ ,K* /H^BOG#_A7O
MQG_Z*#!_X.M<_P#E91_PKWXS_P#108/_  =:Y_\ *R@#Z/HKYP_X5[\9_P#H
MH,'_ (.M<_\ E91_PKWXS_\ 108/_!UKG_RLH ^CZ*^</^%>_&?_ **#!_X.
MM<_^5E<AX>L?BKXDU;Q'H]EXXGAN?#%Z;&^DNM6U1()I1<WEKNM&BM9I'C\R
MRE;,T<+;&C.W)95 /KZBOG#_ (5[\9_^B@P?^#K7/_E91_PKWXS_ /108/\
MP=:Y_P#*R@#Z/HKYP_X5[\9_^B@P?^#K7/\ Y64?\*]^,_\ T4&#_P '6N?_
M "LH ^CZ*^</^%>_&?\ Z*#!_P"#K7/_ )64?\*]^,__ $4&#_P=:Y_\K* /
MH^BOG#_A7OQG_P"B@P?^#K7/_E91_P *]^,__108/_!UKG_RLH ^CZ*^</\
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M^#K7/_E91_PKWXS_ /108/\ P=:Y_P#*R@#Z/HKYP_X5[\9_^B@P?^#K7/\
MY64?\*]^,_\ T4&#_P '6N?_ "LH ^CZ*^</^%>_&?\ Z*#!_P"#K7/_ )64
M?\*]^,__ $4&#_P=:Y_\K* /H^BOG#_A7OQG_P"B@P?^#K7/_E91_P *]^,_
M_108/_!UKG_RLH ^CZ*^</\ A7OQG_Z*#!_X.M<_^5E'_"O?C/\ ]%!@_P#!
MUKG_ ,K* /H^BOG#_A7OQG_Z*#!_X.M<_P#E91_PKWXS_P#108/_  =:Y_\
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M\7BP:KIUWIYO->:XM1=0O"9X"LF)8@X&Y.1R/6O9:** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .7\;6MS?>$/$EG9P27-U<Z-?P6]O
M"A>6::2W=4CC0<L[,0% Y)K*^&%A>Z7X%T"PU&UGLKVWCOA/;7,;131%]4O9
M4#HP#+NC='7(Y5@>AKO:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]@J*:CK(BR1LKHZJZ.A#(Z, RLK*2&5@058$@@@@XIU !1110 4444 %%%%
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MB#7;.TAD>/PYI&KW<@$%M*P^8/\ @G3_ ,%%O"_[:7A?5?!?C32H_AA^U/\
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MXJO3?_$KP9J%]\+?BC>M"87U/Q?X5LM,NHO$#A;.QM'G\4^%]8\.>)-0_LR
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MPT^ ?BCXDVNFV:QZ+!\=]2UOXL3:U8VL]KY-C!KLWA>+2?'GBS37CN]3:_\
MB39Z_?3647B"T2__ $IH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MLS6]9T[P[HVK^(-8N4LM(T+3+_6-5O) QCM--TRUEO;ZY<*"Q2"V@EE8*"Q"
M' )XK^>BS\=?\%B_V_;*?X[_ +,?C#X<?LE_L\ZC?:C_ ,*A\,>/Q:6WCCQ[
MX8L;F2&P\7ZS.OPY^)]U)/K#PR+"DESX9\-21*K:3:ZQI9M_%&L 'Z&_\%5+
MWQMX8_9$U;XJ> M+GU[6?@/\5?@C\>+G0(2ZIK&C_"GXH^&?%6I17K1P7$D>
MF:;%9KK^J7"1DV>GZ1<7K!TMGBD^KO@#\<OAO^U-\%/!GQC^'MS%J_@KXA^'
MX[J33-0%C<7VCW<T)MM?\'>*+.VGOK*'7- OOM>B:[8I<7=H;FWE:VN+RPFM
M[F?X"_8+_:<^-/Q:UOXR?L2_MW^"=&LOVB_A?X6AN];DDLM&'AOXX?"/Q&O]
M@7GBF'2M/5=!U2U>2^L[+7KK0K*W\.WT'B&SLVTO1]2MM6TFW_-CQ'X0_:%_
MX(=_'C7OB5\.=%\3?%K_ ()T_$[Q-9W'C'PO;74FIWGPXFU:ZATZS::6[F/]
M@^,]#+VFC^'?%>I26_A[XE:6NC^$O%6J6WB7^Q=1T( ZS]L7]D7XG_\ !,;X
MQK_P4"_8/L9X_A MY%)^T)\ ;.65?#VCZ!=7]N^JR:=8QBX=_ACK<KL\]G!:
M7%]\(==:'7O#N?!;_P!G>!OZ"?@%\;/!?[1OP:^'/QO^'MRUQX3^)'AFQ\1:
M?#-/97%]I%S*&M]9\-ZPVFW5[8Q:_P"%M;M]1\.>(+6VN[F.RUO2[^T$TGD[
MCS'P3_:#_9__ &OOAC/XI^%7C'PQ\2O!.O:;/I/B;1':WEO],CU.P":EX9\;
M^%KS_3]&O)+&\\J]TO6+2-;FTN%EB^TV5Q#/+\Y_\$R_A;%\'/@'XY\">']2
M&I_"S2OVDOV@XO@?-]GU))(OA-:_$/4=,T.)]0U2^O)_$4;:SI_B&YL?$\$=
MG8>(-,N;+4[".^M;B+6M5 /T1HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ***^)_V]_VK-7_ &2O@9%XM\$>$HOB#\8_B)XW\+_![X&> [F+49;'Q1\5
M/'$MS'H=MJ2:7Y=[-I^GV-AJFKR:?%>:3)K]S86GABWUS0[S7+;5;0 ^V*^0
M/VH/V'/V?OVQ?L:?'WPU>^+8?#_A?5_#O@9K36]9T*[\"7GB34M,U/Q)XFT"
M?2=0MK>37=6D\-^$(#-JUEJ-O;V7A]].6"33->UZQO\ \A?$_@W_ (."?A_I
MT_Q\?XL_!SX@2:?M\1ZC^SCX>M?#6H7B:3-<K=WOA5=(?X=>&],U"/1+.62&
M7_A'OBM>>+;RTL7BT77];UB6W-[^S?[&_P"TWX>_; _9S^''Q]\/:8^@#QCI
MUW!K_AF6Z6^D\,^+-"U"ZT3Q-H@O!%;M>6EMJUC<3:1?RVMG-J6BW&FZC-96
M4EVUK$ ?D1\!?CU\6/\ @E/\6- _8W_;(U^\\5_LH^*[Q[#]F']I^_246/@V
MQ$JI:> O'MV[2IIGA_3%E@M9([J=F^'C/#/!-=?#*ZM+OP9_0C#-%<0Q7%O+
M'/!/&DT$\+K+#-#*H>.6*1"R21R(RNCHQ5U(9200:\;_ &@/V?\ X6_M.?"W
MQ)\'_C!X;M_$G@_Q);X93MAU31-4A5_[.\1>'=1V/+I.OZ3*YGL+^ '&9;6Z
MBN;"YN[2?\3_ ( ?'3XZ?\$N_C1X7_86_:7LO&WQP^!'CZ2\M_V/OBQX-T2Y
M\3>-([.RN+2!?AO?^';>9]1O]/TDZCIUBVF6[W%YX$NKNPCT\ZA\/M5TIO"8
M!_0Q16-X>OM5U/1=-U'6]$D\-ZI>VR7-UH$]_::G=:0TQ+QV-]>Z>7TZ;4;>
M$QIJ*Z;<7VG0WPN(+#4]4LXH=1NMF@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **_-+]OC]J3X]?#CQ%\)?V9_V0?!%AXR_:<^/T?B+4-&UGQ!#!+X
M/^%/@'PO]C@\0?$#Q*MU-%:;XI]06/13J,=UI GL+Y;JQUG4GT3PSXA_.?Q+
MXT_X+/?L#&T_: _:(\=_#[]J_P" 6DW=JWQ=\(^ H],GU;PMX;O+NWBO/$EJ
MY^&'PTUK2+C2E)6&]TE]=\+V7GM/XCTZ+3$;4]/ /T>_;&_X)C_!#]KZS\:>
M*=?NM9\,_'O43I=S\/?C3IM_JC:K\/)O#-A#!X7T*ST9-2ATZ\\'0W\=UJFL
MZ4BVFH7FIZUK&KZ9JVCZO)87UAX%^PS^W-\3?"/Q-E_8%_;ZB3PE^TWX22"Q
M^'/Q&OI_^*9_: \,_O8=#U+3=<FBM;;4O$.I6]K(=,U,1VS^*WMKS3M1L]+\
M>:7K.C3_ *_^#/%_A_X@^#_"OCSPEJ,&K^%O&GAS1/%?AO5;9TDM]2T+Q#IM
MMJVDWT+QL\;1W5A=P3(4=EPXPQZU\C_MS?L,_#+]M_X91>&/$\LGA'XE>$I)
M]8^$7Q=T>#_BIOA[XF_=31NDD,MK<ZEX9U*XM;-?$/AYKRV2]2VM=0T^ZTOQ
M#I>BZUIH!]NT5^'_ .QA^W9^T1X6^(6K?L"_M9?"/QSXQ_:O^'>G%_"GCKPE
M;V]_X,^)_@6VET^UTSQQXQ\73O:Q>']*6QO8M2NO'UQI<EMK%G:W.D7VF0?%
MEK/P5XE_;]2VT;@ V!N"DLH;'(#%5+ '@$JI(Y*CI0 M%%% !7@OQ>_Y&SX2
M_P#8Q3?^G+PU7O5>"_%[_D;/A+_V,4W_ *<O#5 '3_!?_DG6A_\ 775O_3O?
M5ZG7EGP7_P"2=:'_ -==6_\ 3O?5ZG0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %<3\0/B5\._A/X;N?&/Q0\=^#_ASX3LY((+KQ+XX\2:/X5T*"XN
MI%AM;9]5UR\L;(75W.Z06EL)C/=3ND,$<DKJA[:OS5T_QOX(\5_\%.OB=\(/
MBGIFB:IXA\-_LO\ PT\1?L]Z?XCL+'5+>'0]5\5^,W^.FJ^'?M=E+!8ZWK^H
M)\-M/U2W^T+JNH:+X$6YMXI=+TZ_:V /M/X9?';X)?&RVOKGX/\ Q=^&?Q3M
M]-?RM4/P_P#''AKQ>=-=@-L6IQ:%J5_)8/(K*Z)>)"9(G21 T<B,W!?M._LG
M_!G]K/X,ZG\$?BIX;@D\-RP12>%M3TB&UL==^'VNV-K)::+XD\%7?V>2+2=2
MTB*1K=+<02:7J.ER76A:O8WVB7U[83_G[^V?_P $E_!?Q(U>+]H+]CW4D_9C
M_:L\'2:AX@\/:S\/W3PAX0\<:W(LUP\7B*QT:&W3P_K^IR2WED_B[1%MTU"'
M6=3B\:Z5XIMIK9],F_X)D?\ !1/Q;\>M6\4?LH_M4:-/X&_;&^#D-_:^(+>_
MTV'1X/B7I7A^XAL-6UN&RLH8])TKQEH[SVDOB31--,>DZY8747C+P3$^@G6M
M,\*@'CG[+/[4WQ=_8&^+NB?L#_M\:V=1\'ZB?L7[+?[4E[Y\/AGQ?X:AGALM
M+\+>*=4O9I_L$EAY]EI9&J7L^H>"M0GL]%UJ\U#PKJ'A;Q3<?NOXD\->&_&G
MA_5_"OB[0-$\5^%O$.GW&EZ[X=\1:78ZYH.MZ7>1F*ZT_5=)U*"YT_4;"ZB8
MI/:W=O-;S(2KHRG%>&?M5?LM_"#]KWX0:]\(OC+HRWNAWJMJ.B>(;0V]MXD\
M"^)+:WFCT_Q?X5U2>*8:;J^FB:59!+'-IVJ:=->Z-K5GJ&C:A?6-Q\3_ /!,
M?X<?MD^&?ARVA_M ?&"T\6?!WX?>+/$&@? &YM='6+QO\4/AUH5YJ&A^%O%_
MBKQ)=7NHW,7PTU?3X;3Q)\/=!1?^$HO=/FTR;6/%%SX2AL-$U, ]7A_X).?\
M$[(/'B?$9/V6? ;>(([S[<NGS:CXQN/ 9G%I]BV/\++CQ-+\,9+/R?G_ +.D
M\(-IYN_^)@;7[?\ Z37Z&0PQ6\,5O;Q1P001I#!!"BQ0PPQ*$CBBC0*D<<:*
MJ(B*%10%4  "I** "BBB@ HHHH **** "BBB@ HHHH **** "BBHIWEC@FD@
MA^T3)%(\,'F+%Y\JH6CA\UP4C\QP$\Q@53=N88!H \6^)?[3'[.OP9U>ST#X
MN?'?X0?#'7=0MUO++1/'GQ&\(^%-7N;)W,:7T>FZWJUE>&Q:1607IA%J75E\
MW<I ]'\.^(?!GQ!T30_%_A+7/#'C?PY>+%K'AKQ1X=U/2O$NB727-G+##JNA
MZUID][83K<:??3Q17UA<L);.\EC65H+AP_YF_P#!.?\ X41^UO\ L9V'BSQM
M\// ?CGQIX]\2>.%_:8T[QIX>T+Q-K6H_&-O$%RWB;_A+X=6BU.^MA+IW_"/
MWG@G1M2F$OA7X>MX)T+28-.TS1M,L[3\^?VE_P!D7X]_\$I_$MS^UQ_P3UUG
MQ-JO[/=C)]O^._[->N:OK7BO0]#T6+R!>>)ULK^ZN]0U_P (0V5K'#J?B62:
M?XA_#58WUPZ[JW@B\\2-X5 /T+_X*!_\$_-1^.VHZ#^TO^S1KQ^$G[:7PD,.
MK>!O'.DS0Z7#X\ATN&1(?"'B^9XWLYY)[-Y]*TS4]5@N]/ET^[N?#'BBVO\
MPI?S0V'3_P#!/S_@H'IW[5FG:]\*/BOH(^$G[7?PD$VE?%[X0ZI#-I<UY-I<
MT>GWOC/P99:A(]Y/X?GO'B75M):6[U#PCJ%W;V5[<7^DW_A[Q#KWTA^R'^U;
M\-/VRO@EX;^-'PSNPEMJ&[2_%?A>XN8I]:\">,K*"WEUGPGKBQK&1=68N;>[
ML;OR88=7T6]TS6;2,6FH0@?"/_!4/]C.;QQ:>%OVKOV<+^]^'G[;GPT\0^%K
M+X8ZYX49;+4_BK=7>I0:7%X'UB)+6YMM2OX=$N-5FL]1UFW?0(_#MKK&D?$"
MZM?AR^KZGH(!^Q=<I?>!?!VI^,O#WQ#U#PWI%YXX\)Z+XA\.^&O%%Q9Q2:QH
MNB>+)]%N?$>G:?=L"\%OJTWA[1VN@OSE;,1HR1SW*3>>_ 3P_P#&K1_ 6E7O
M[0WC+P_XM^+FL:=ID_BV#P-I,NA?#GPW>P6Q5M#\&:==SW>J75O!)+*^J^(M
M8NY+_P 1:FTMY;V/A_1$T;PSHOMM !1110 4444 %%%% !1110 4444 %%%%
M !1110 5\\^(?VN?V5O"7C.?X=^*OVDO@3X;\>6MY!IUYX/UWXL>!=)\166I
M72H]KIM]I-]KL%Y9:C=+- UM8744-W.+FU\J%_M-OYG(?MY>./&7PV_8R_:9
M\<_#ZYNK#QCX;^#OC2_T/5+&>.VOM%G.E36\^OV4\JNL=YH%G-<ZS:D*9#/8
MQK"1*4(Y30OV<_V*?VIOV7_AMI%E\'/AKXI^!?BGX?\ AW5/ $-KX;L])U#0
M='U#08XM/NM"UFPM=,\2^%/%&GVES-8WUY976E^(+*_&H6>HF*Y-[ 0#[3A7
M3KU[36+=;*[D-G)'8ZI"L%PYT^_:UN)H[2]0.QL[U[2RGD6&7R+AK:UE8.88
MF7\/_P!LG]C;XN?LT_%S4/\ @H1_P3WT\V_CRW-QJ/[1/[.NG6\S>&OC5X::
M;[=XAUS0_#UCM\_Q//MEU#7M!T^);_6K]?\ A+/"?D^.H;ZQ\9_)'B;3_P!I
MO_@AI\1/#6L^&_$?C+]H3_@G1XO\02Z;JWA76GL+CQ'\--2UJZDN9%M9TALM
M.T'Q:2MQJNE:CIL6@^!?B'=2:KI&OZ3X>U^YTG7+'^DWX:_$?P7\7_ '@_XH
M?#K7;?Q+X&\>>']-\3^%]<MH[B!+_2-5MTN;9Y;2\AM[_3[R(.;?4-+U&VM=
M2TN_AN=.U*TM;ZVN+>, \"_8V_;)^$?[;'PCT_XH?"_4!;WMN+?3_'/@;4+B
M%O$O@'Q*T/F3:/K$,>TSVD^V6?1-;@B6PUNP7S[?R;F&]L;/ZTK\,/VH/V+O
MBA\(_P!L;X3_ +1/_!/'Q!H_PY^+_P ;?%6HZ/\ '?X::G:?:/A1KO@ZWM9=
M9\5?&'Q9X?M;BS:VT6TU$:7I7BRTTSRK[6_&GBGPMJOABXT;QAJ&KZCK?[3^
M#M%UK0/#]EI_B3Q/=^,?$&9KK6?$-U9VNEQWNH7<KSSIIFCV6;71M$LRXLM%
MTM9KVYM--M[9=3U76M6-]K%^ 0Z3X!\%:#XM\7>/=&\*Z%IGC7Q]#X>MO&OB
MFRTVV@UWQ3;^$K.ZL/#%OKFI1QBZU"'0;*]O+;2HKB1X[**ZN%@5/.DW==11
M0 4444 %%%% !1110 4444 %%%% !1110 5EZUKFB^&M(U'7_$>KZ7H&A:/:
M3:AJVMZU?VFE:1I=A;(9+B]U'4KZ6"SLK2",%YKFYFBAB0%G=5&:U*_-;]L+
MXF^#]!_:V_8"^%'Q<T^PO/A%\4_$_P 8[N)=?>U/A*?XX>#]#\&K\%5\36M_
M*FG:F(-2\2:_%X0TC4(+\3?$?4?!7B'2[:+6?"=E?V8!]7_#S]JC]F7XN:\W
MA7X6_M"_!3XB>)U@FNAX<\%?$_P7XEUY[2WDABGO(='TC6KO4)[*&6XMXI;R
M&WDMHY)X$:4-+&&]"\;_  T\ _$GP1XG^&WCGPEH?B3P+XRL]2L?$WAG4+&%
MM,U:'5IY+N_EGBC6,I?37TKZDNHPM%J$&J;=3@N8K]$N%^%OVR/^"8'[.'[6
MND/K,.@6GP>^-^C6S3>!_C7\.=/BT+7])UFV-M/I,WB?3=(ETJS\:Z;8W=A9
M>5'J<D.OZ5:+<Q>%/$?AN>\N+F3X0_85_;J^/G[/GQ]3_@G;_P %%+IX_'\,
MECI/P4^->LWTMY:^/K:[E>R\*6%[XLO(+8^,=-\9"W>V\%>-M1%OXBN/$,%S
MX*\:P)XV6YLM/ .<T;6/BO\ \$3?BO;^%/%=QXI^*G_!-#XJ>*91X:\2F&ZU
MSQ1^S9XGURZDN9;6ZBMHWEFTF:5Y;G5=*MHDM_%=NESXG\,6T'C>#Q#X>\5?
MT+>%_%'ASQMX<T/Q?X0US2O$WA;Q-I5CKGA[Q#H=];ZEH^M:/J5O'=V&I:;?
MVDDMM=V=W;2QS03PR,DB,"#67\0/A_X+^*O@OQ)\._B)X;TOQ=X*\7:7<:-X
MB\.ZS;K<Z?J6GW*X>.1#AXIHG"7%I=V[PWEC=Q07EG/!=00S)^-'[$?[*G[4
MG[._Q\^.?P(^&GQF+?\ !/SPSXEM=3\+WFN6DNN?$*R\3:O!#JWBCX8?#76;
MJ.TL?#ITC5)Y].^)/BBU@\0:() J^&;30_BMJWCJ]\% 'V5KG_!,?]C[5_BE
MXF^,.F>"/&/@#QMXVNWO_&ES\*/B[\5?A3IWB>[GE2>\FU#2_A_XP\/6EL=0
MN4^W:DNCIIB7^IR7.KW2RZK=W=[/]M^$?"'A;P#X<TKPAX*\/:1X5\,:);FU
MTG0="L+?3=,L86EDGE$%K;)'&)+BXEFNKJ=@T]W=SSW=S)+<32ROT=% !111
M0 4444 %%%% !1110 4444 %%%% !1110!POQ#^*'PU^$?AZ3Q;\5/B!X+^&
M_A>*:*V?Q#XZ\3Z+X4T874[!+>U74M<O;&T>ZN)&6.WMDE:>>1E2*-V(!Q?A
MO\:O@K\<--U"\^$OQ4^&GQ7TNT>2RU>3P'XS\->,[:RD:.(R6>JIH>H:@+.1
MX+F!VMKU8G>"YA<H8IXR_P 0^!/&?A'QU_P4N_:@^&'Q4\/Z5=>*O /P4^!C
M_ &W\3WND:[;7WPUUFVUS7?B[KO@SP[=Z<9?#FI7OC_5?#FA^.;N.[N[WQ+8
M>$/!+7,-II_AVP:Y\'_;._X)/:/XFU>']HS]A;5D_9B_:C\'RWFN6<?@*3_A
M$_!GQ)E$,UQ+H]]8:9+9:;X5U_5+M8HVUNVMG\.Z[!<:EI?C?0-6BU6/7-#
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MM:\8:U\2M6U:YTY].GU.[B\7KJ8U2WBU2STW4KSYX=8\8W^B^%=3_2[]A_\
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M%^-?V<M<U35]<N?V6/CS\5/@?I>M:[>&_P!3U3P9%>Z;\3?AK=7%R(XX@O\
MPK;XE^$88+*U2.STBWABT>T@M;?3X[2  I_\$\/^"B7PS_;O^&J7UDUCX2^,
MWA:SM8OB7\,9+L-<65RRB,>)?"WGO]IU;P=JLRLUM<CS+O1KACI.KD3K:WFH
M_.?_  4X_9N'@_QW\%/^"C?P<L-0T[XT_ #XD_#/3_B/:^'H)9Y_B7\(=>\6
M67@[5+"[TR*WN4N-<TJT\4W.CSZO'':SR^ ]9UZWUJ]N;7P[X9_L;N_VB?\
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M?[3XE_3O]JKX$>$_A?\ M<?LH?MQ^!-(?P[XTOOC+X4_9Y^.LN@3-I=E\1/
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MKAKO7;!3\J_LS_L^Z-X0_:P_;D^.'BSP[;7'Q8\??%#PAIOA;QAJ%M%/J/\
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M:9X3\ >!Y?$'BZ_TFWN]3U6^UOQ5KNO>+/$OB3Q3K$EHMUJ=GX<T#PEX9\.
M'T$5!*DJ"5.Y20"5;:5RI/0[69<CG:Q'0FEHHH **** "BBB@ HHHH ****
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MO[>'QW^%GPQTN7PW\'?VE?@[I'[1/A3P38W#IX0\$^/?AQXX'@3XJZ9X0T%
M+/PYI6IQ?$OX?:Q%8VBPVD$%Q;:!I,-MX>\+Z-I>D^V?MD_L'?LT?MM:/IOA
MWXR:(UCXWL+*^?P9\0?"E[::+\1=#M;>2W%\EE=SVUY;:YH4,U[:_;=&UW3=
M7TF"6\CN;>"QU*6VOHP#>_;B_8_\"_MK? +Q3\(_%D%I9^(!;7.L_#3QE):K
M/?>!_'EK:RKH^L0,"D\FF74C?V;XDTV.:$:KH=S=VRRP78L[RU\:_8RL?$?[
M4O\ P31\)?#?XZ2>*-#\0>+OA5\5/V:OB=?6^KVU]XQ3_A#=<\<? 'Q#JZZ[
MJUGK-I=>*+RR\-SWUWJ&H6FLP_VY-<O<G551I[G+^#W[)_[=7P=T6?X:67[?
M6G^-OA>OG6/A_7OB)\ [?Q5\;?!?AZ2<I#IWAWQM??$@Z)JFNV&G.4TOQ#\0
M/#?CC1[&_AM7/@JXT*%?#H_0?X=^ O#WPN\#>%?AYX4BO(_#WA#1;+0],;4[
M^YU;5KJ*SB"R:AK.KWKRWVKZUJ=P9M1UG5[Z66]U35+J[O[N62XN)'8 SOA-
M\)OAW\#/AWX5^%'PH\*Z9X+\ >"],32O#_A_2DD$-M")))[FZNKF>2:]U35]
M4O9KG4];UO4[F\U?7-7O+W5M6O;S4;RYN9?1*** "BBB@ HHHH **** "BBB
M@ HHHH **** "O+_ (S_ !E^''[/WPS\5_%[XL^)+7PGX"\&6"W^M:O<I-.X
M,]Q#96&GV%E;)+=ZEJVJZC<VNFZ5IMG#+=7]_=6]M#&7DX]%OY[FVL;VYL[-
MM0N[>TN9[6P2:*W>^N(H7D@LTN)R(8&N956%9IB(HBX>0A%-?E]^T!X>\)_M
MZ?"?]ASQIJ6CWA^#%_\ M(> O&WQD^'VNB![K2[G3O"OQ#\+1_#7XA:61);3
MW>@?'.XT+X5^/O#5W'FWU2YU6QNH8I[)Q$ ?( _X+^>!K'7="\0>)_V1/C[X
M5_9X\2W2:?HGQLU0V8N+^_EGGV1VGA?^RD\+ZC#'I]I>7]R-&^*.J:DHLKR&
MTTN]\AI3[W_P4F_9WUK]L;X$?!S]K#]CWQ6+SXU_ ]H_B]\$O$_A>2Y-YXY\
M&:M9V>KZGX=T, I$VO7$VF:+K?A^UUC3KT37NF:EX0N;*S'BC49X/UG\4>"/
M!WC;PCJW@'Q=X8T+Q'X)UW2)M UCPKK&F6E[H.H:-/!]FDTVXTR:)K5K3R,1
MQQ","$*AAV,B%?@O_@G%\/[_ . 7AO\ :*_96,\]WX2_9Y_:,\3Z5\*9[B*Y
M6XC^%'Q2\*^#_C5X6TZ[NKB>X&JZAI%_\0=>T[4-6A>&.]N[>1GL[6X2=" <
MA_P37_X*5>#OVVO!\O@[QC#8^ /VG? =G]G^(WPWG\S3UUU=/=;*\\:^![._
M?[;-HLMV/+U[0)3/J_@?5I1I>JM<Z=<Z'KNM^;_\%=/V:+K4O &@?MR_!N.P
M\._M(_L?7^E_$NT\01V\L<OC'X;>$[YM7\0^%-?FL[_39+NQT&-[CQ/:BZEN
M_,TBW\4^%K>!$\737-MZ3^UA_P $MO@#^TM\0I_BYX%\7>*/V;OVH-)AL]8A
M^+GP>U(Z9K!U">'5;+0?$/BSPS97^E/?733V]Z@U_1-5\(^*M9BTQ].N/%,M
MM8QQVOI'@_\ 9E_:C\3>%8?AA^U5^T]X*^-OPK_T*+Q+IOASX%VWP_\ &?Q1
MT[3[VPOHO#?Q!\1'QOK_ (;;P=JWV-]/\7Z#H7@?3]1\6:3--IFH>)4TZ_U6
MSU  ^@?C3\ _AI^U1X,\ ^'OBWI-[J_@K1?&GA7XI7G@>62T&B>+-0T+2]5.
MC^&_&]O<6-Q/JGA>UU/6+;6[_1[.?2_[7U#0M.T_5Y[WPU<:YH&L>_0PQ6\,
M5O;Q1P001I#!!"BQ0PPQ*$CBBC0*D<<:*J(B*%10%4  "I** "BBB@ HHHH
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M.:V6U &_#K]F\?L8?\%2['4OA!8:AIWP&_;B^&_Q.U'Q9X.L(99O#G@GXO\
MPQFL?&EQ?POY#1Z-HFJ6VM:E+X3T@WBP65[XI\7Z3HUE:>'M*TC3],_2Y/V=
M/A4?V@KW]IV^T!=6^+TOP_T;X9:1K^J&&[C\)^$])U'7]4GMO"UL8$_LN\UR
MZ\17@UO4C)/?75I'#80SVU@]W;7/*?"[X(>/K3QWIGQC^/WQ(T+XH_%70/!N
MN> ?!X\%>!IOAQ\/? OAOQ9JOA_6?&<FA^'+_P 4>-M>U/Q-XRO/"/A!-?\
M$.N^*;NW@T_PQING^%M"\,0WOB9O$7T]0 4444 %%%% !1110 4444 %%%%
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MEK$-Q<Z1JMM:1I+=7&FWT%M'))Y,<EQ+:RQPI)-LD\I'D95:3RWV*2VQL;2
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MWEQIVES_ !7O=?M-"\5ZIY#0V=[XEEO=)N;F<:>=9\%:?>:AK$>[_P $^?\
M@IU;?M.^*O$'[-_Q_P#!$GP2_:X\ PWT/B'P3=VUW8Z!XV;0F:'Q%<>%(-3E
MN+_2=;T<JM[J_@W5+J\NO[(G76_#NJ^(M+L]??P^ ?JIX8\2>'_&7AOP_P"+
M_">K6&O>%_%>BZ7XD\.:[I5Q%=Z9K6AZ[90:II6K:?=P,T-U9:C8W4%Y;7$3
M-'-#,DBL0P-?,W[:-K;S?"GP%>7+1(NC_M8_L/:DDLRIMB8_MC? W3Y)!+(0
M+?;;:A/OF!!\KS(V(CD<UR7[,$S_  6^)7Q5_8\U1A!HGA*2?XR_LWF3;%#>
M? #Q_KMTVJ>!-*0R*KCX"?$JXU;P3#I6FVD&F^%?A;XB^".GC][?8KI/V\/@
M1X]_:9_9>\=_!/X9^(K/P?XR\8^(OA+<:9XPO;V_L%\)P^$?C#X"\<:IXCM)
MM+7^T)-4T?2O#5[>Z1;6<]E<76J16D$>H6+.+J( _.S]M']I;XD_MD?%:3_@
MGK^PKJ,CZ_HOB3PUKO[27[26G7=['X3^"5EX-\4Z?K]MX>T?6-*FA.I>*X?$
M6AVD>M06MV8YKJRN/ EM%>7MQXNNO!G[DV4=U#9VD-[<I>WL5M!'=WD=N+1+
MNZ2)%N+E+59)EMDGE#RK;B:40AQ&)'"[C\U_LE?LE?"/]C3X1:3\)?A+I'E6
M\/EW_BKQ5?QP-XF\>>)F@2*]\2>)+V)%\ZYFV^586$6W3]&T]8=-TV&&WA^?
MZ=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BOA#XAZN_Q\_:@\6?L
MK7?Q#\<_#WP?\.O@AX*^*OB.S^&'C/5OA[XZ^(.L_$'QEXKT.RM#XS\._P!G
M^+O#_A3P#9^"K*\U*'PIKNFR^*=2\>6&FZ[<?V)I-WI&N_!W[0W[.O\ P4(_
M8K.K_'3]B7]HOXJ_M%?#W1_M>N>,_P!F;]HG6-3^,^L#38SJ%Q=GP-JVHW-M
MXFU?1]-MIK=X_#7AW5/#OCV4:9YJ:_XUOK^73J /T%^-/_%B?VA?AE^TC;?Z
M-X%^*'_"+_LR_M![>+>S_MSQ'=_\,W?$N[_UCC_A%?BCXJU;X3ZBMI!%Y^E_
M'.W\0Z_?)HWP]M_L_P!M       8  P !T  Z 5^:_[*_P"UM\ ?^"J/[-7C
M_P ,3:<^CZEKGA'4? /QP^$=[J?FZYX6A\7Z3?:7)>Z1JT$5E-J6@:G']LG\
M+>++.VL;F*[LV2XMM+UG3YK:'W_]D3XD>+/&'PWU3P%\4K[[?\;_ -G_ ,57
MWP4^,-ZT*6S^)-?\,V&FZAX8^)<-M#!;VL%C\8/AWK'@_P"*5O:6"RV6C3^+
M+SPSY[WV@WR1 %;XK_\ ",>%OVF/@M\6_%OB?1/"F@>"?@#^U18:[J6O3V6E
M:7:Z-?Z[^SIXHU#6]3U^^O+:VT[3_#FG^!]0NKH7"/ MI>7=])<V<5C,+G\X
M_@Q\?OCQ_P %%OVU/ 7QB^!(U+X;?L,_LL:YXPL(O&GB"QU6SOOVCO$_B+0;
MGPWK<%OH$TVGG^QX["YCF\/6.HPM/X0MMGB?Q-&GB[6-,\&^&/K#]OS]B'5_
MVXM:_9]\$ZIXED\*?!GPCXD\6^)/C+<Z7K%W9^*/$ND"/PK)X>\":+ID5C+8
MW=OX@U6PFU'4M:U.^CA\,2>'].OK/2=8U.>S;3_N[X?_  _\%_"KP7X;^'?P
M[\-Z7X1\%>$=+M]&\.^'=&MUMM/TW3[9<)'&@R\LTKE[B[N[AYKR^NY9[R\G
MGNIYIG .QHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***_-#PC86'[=O
MB;]J!=<^-/Q<\+^#?@I^T!XF_9Z\)>#_ ((?$7QG\'+OP[JOPT\,Z!'XM\4>
M+=8\.PZ#KOB_Q/K7C7Q%KWV&WOM3U[X;V?AKP]X0_LK1SXA3Q7>Z@ ?I?7Q'
MX* ^ /[57BSX83 6OPM_:I.N?&3X6[AY>F^'OCSX=M+4_'7X?V>?)L[(_$;0
M8]'^.?AG1K..XU'6O$]A^T9XKOY%CA2ORW^,NO\ _!1#_@E/KEM\0['X@^,/
MVY/V)(Y&_P"$JMOBI?IJWQ>^&%O<:A&JC6O&QBG\1LKM?)%HGBQ5UOP8L=O=
M:/KOA'P>5\-W=_\ HO?^/_!W_!0K]D31?C1^R]K\ \>>'-7TKXI?!NY\0Q?V
M=J_@/X[_  TG_M&#P%X[M[66>ZT>VUU)=3^&?Q$CTJ]EMO$/PT\;Z^="U75/
M#?B2QU*_ /T-KX@\:?&CX/?LU_$C]JGXJ_%/QAHOA7PYH?PW^ ?BKQ*TCVYU
M>5[Y_BWX<T"TM-*@<ZCK&K^(YO"TVD^';>.%KC5+JPFL+3='IL[0?1?P0^+?
MA[X[?"?P+\6?#$%Y8Z9XTT.'4)]%U18H];\+:[;R2Z=XH\%^)+:"69+#Q3X*
M\2V6K>%/%&F&5Y-,\0:/J6GRGS;9Z^ ?CM_P3=T/]J']N/1OV@/C9J$&L_ G
MP-\,?AUI&D_!V.\NYM/^)7Q(\)>(_B7JMKJWQ#TYHXM/?PKX3L/&LD6GZ1F^
MN/$L^KZG8:C/8^&_[9T;Q2 <-_P3XUW]IO\ :<^/_P 6OV]OB!ITOPD_9\^*
MWPV\-_"SX(?!O5[1;CQ1XI\$^#?$>I^(O!OQ.UF[!A;3(()_$OCJ?1Y%6X@\
M2GQ_K5SI\0\-:3X7UWQ!^Q=1PPQ6\,5O;Q1P001I#!!"BQ0PPQ*$CBBC0*D<
M<:*J(B*%10%4  "I* "BBB@ HHHH **** "BBB@ HHHH **** "BBO%?VD/B
MV?@+\ /C-\:4TR/6KCX7?#3QEXWL=&FGEM8-8U+P]H5[J&EZ5<7<,%S+:6^H
MZC#:V=Q=I;SFUAG>X\J3R]I /:JXCXE_#SPK\6_A[XW^%WCG3O[6\'?$+PMK
MO@[Q-IPFFM9+K1?$.G7&EZ@EO=VSQ75E=K;W+R6=]:2Q7=E=)#=6LT5Q#'(O
MY\^,OV&M=^.7PXT#QUH/[;7[5W@_XS>(/#VC>*[+XJ^ _C%XHT[X=:CK&H:
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MKRPL[?1=*L-,T*W:WOOU0H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN8;4:EXAT?0UM9?#E\ZNWC[P/_8_B2PO-8O3J5[=?H;^W9^Q+\-_VZ?@G?\
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M#HEU=PZK+-((DM&=75<+X^_$;5?B'^R]\>[S]GCQ2UMXYL1X\^$=CXA:TO\
M2+SP1X[T;Q/-\.O%6HS6^KVEE>V\W@^Z_M#6[&_2W:WU*QM+#7-"N+_3;_3;
MVY^.+S_@AW^P9+\$9/A7:> -5MO&(T@"'XV-XH\1R_$+_A+DT@:<OBFXC?53
MX;>TEN +VY\&0Z)#X.,C/+;Z-;W^S4$ /4O^"K'[.?Q"^/7[,]MXB^"]WJEI
M\<_V=?'WAS]H+X2KH^TZEJ7B+P(MXUWI5A"UEJ#7.KMI5[=ZOX9LX;=9-0\6
MZ-H&GR3Q65W>;[W_  3;_P""A?@;]NKX265Q<7>E:%\>/!NEV-O\6O $!:U"
MWRA;4^,_"MI<SSW-SX,U^X GMU%Q>3^';VX.@ZI<SRQV6HZI\P? ?_@KI^R#
M\&OAW\)/V?OCS\8]>?XR?##PAX?^%/Q7\3-X.^('B+0+;Q_X"MK3P9XAGU+Q
M9+H1U#73=:GIMS>3^(X+*_M[X+<:A=7Q>4/-F?M(?\$RG^(OQ"T?]NO_ ()K
M?&;P_P#!OXW>)(K7QA!<Z3?VL_P<^)T/B"-I]1\5Z=>Z3I7B.RT^_P#%6FWA
MNM9MI-$\1>"?&UVD5SJFDZ5J>IZYXCO@#T#_ (*Q?L$W_P =O">E_M1_ ,?\
M(Q^UC^SR;'QOX:UC2+5AJWCW0O!$\GB.W\.1O;AF/C+P]?6T>O?#_49K74&F
MU"SE\)3P1VNOV^JZ#]#^$=:U[]L7]G3]D']K+X<1:1I'Q>\/W7@CXD6=J]_+
M;Z-=6.N"+P5^T-\+[S4EA\YM$UG0)?%,&E^?;O#!XS\,^"-=NK2231(XQ@?!
M_P#:/_;^N]!E\%_&?]@Z^L/B[:0SZ?I_CWPK\7?A;'\!-?NXHFAM?$_B"\F\
M6ZKX[\%:'<W:-->Z1H'AOXD^)(+#9<VFERW5RNDVWU_^S=\&K/\ 9[^!'PM^
M#%G>V.IMX \):?H^IZOIFC6GAS3=:\0R>9J/BC7-/\.V!-CH%CK?B.]U75;3
M1+,M:Z3;WD=A;LT5NC$ ]NHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MP_$WB?PYX+\/ZQXL\8:_HWA7PMX>T^YU;7_$?B+4[+1="T72[.,S7>HZKJVH
MS6UCI]E;1*TD]U=3Q0Q("SN!6?X[\<^%?AGX.\2>/_'&KPZ!X0\(Z3=:[XDU
MNYBN)K72=(L4\V]U&[6UAGF2TM(@T]U<>68K6W26YN'BMXI94^ /VU/@$W[7
M?QO_ &8?V?/'.K:U#^S;-X<^-/QO^+GAO0KG4=-C^)^I_#2]^$?A;X?>"]1\
M2:-J&GWVCZ=%J?Q6O/%3I!+-)JL&B7 L([;4K"SU[0@#ZB^#W[6_[,G[0&M:
MEX:^"_QT^&GQ(\2:1:76HZAX=\,>*-.O=>ATNQO+?3[O6(]&,L>I7.BV][>6
M5M)K-K;3Z6LM]8+]K_TZT\[\@_\ @H!K_P 3/^">7[:_@[_@H9X$\/:YXM^!
M/QD\/Z!\*/VJ_"VC$^6+_P .BSTOPKXDN1-?I91Z[<>&[;3+/P/J%Y9VUA9Z
MKX3U3PWJ&O:=%X_CCF[;]J+]B3]EC]AKQ#\%/V^?@UH47P,A_9Z^+?PZM/B[
M9:'-XBUKPYXD^#OQ0\3Z3\'?&M^?#\LNNZG%XF\,Z/XYGU6SF\-0B;7--&N:
M9J6E:OJ=WHVH:-]!_#__ (*._P#!.O\ ;HN]9_9K/C*R\0O\1+&\\/+X$^)_
MA#7/"^F^/;:8I']AT+4-9LX-,FUB25H;C1M/&I:?XJ-U"E[HUE]JL6FMP#[_
M /A%\7OAM\?_ (:^&/BK\*O$^F^-/ 'C331?:1K%B28Y(R7@O=-U*RG1+K3-
M7TRZ2?3=;T34H+?4=*U&WNM/U"U@N8)8E_#+QG^S_+_P3$_X*$?!?X\? O3=
M0TW]E3]K_P ?Z?\  KXO_#K2#''X8^''CWQYJ,<7@^ZTS2UO[6&S\.-K]Q+X
ME\.)%I][#X.T_2O'/A/2'T[3/$7AK0VN:#^P?^W!_P $X_B/XF\;_P#!/CQ#
MH7QX_9_\7ZY;ZSXI_97^)^OP>']<AC,^GVMP?#7B35K_ $WP[+KUEI0NX;+Q
MJ-5T#5VTZRT;3?$/A?XB2:3:17GZ!S2_&;]L#3?AWX3^)G[,_C+]G+PEX3^)
MOPR^*WCZ_P#B%XR^&GB2^UG4?A3XKM/'GA_P=\-X/ VO>*+Z]M]2\9^'/#\'
MBGQ1XITSP4@\%2:O8Z!:7FJZQ%>:* >^^&/A;XC\!_M(_$'QWX82R_X5?\;/
M!VEZY\0--:]2WN-%^-O@1M'\*Z3XGTS3!:.U^/B/\-I['1_$MRMY:Q:5/\)?
M#TWV:\N?$MU<6_T=110 4444 %%%% !1110 4444 %%%% !1110 445Q7BKX
MB>#_  5K7P^\/^)]7&EZK\4O%ESX'\#0266H3PZUXIM/"/B?QS+I+7MK:SV.
MF2OX9\&^(KZVEU:XL;:\FL%TVTFGU.\LK.X ,_XH?%WX7_!/PK<>-_B[X_\
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M/B%?^+K?P<EO+]EM?!%]X=T.&W@&AEY_,?!GAOXB?'7XY_"_X_\ Q)^#U_\
M!+0/@KX(^).B> O"/CO4/ GB'XHZUXS^*[^$M/\ $'B.^N/ FK^+-&\&^%/#
MWA;PG<:/INE6_C"_U3QM?^+;K4/$>A>&U\$^'7US[9H **** "BBB@ HHHH
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M)J&AZ5;Z#_:EIJWQ"\2Z1K4.E%;NZU+2KO5H= TNQU.QLH_8OVEOV+_V9O\
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MKNK1Z)8W=KXGT32;!8+LZEJ,NE3+K%GHWV+4!XCGT-/##Z?>1ZV\#>?>*O\
M@A[^POJ?P*F^%?AOP%?:%XZL_#TEOH?QLG\1Z_>>.F\81Z:UO!XG\1(FH0Z!
MJ]I>7^+O5O#$.B67AU8I9HM#TW198[&>TX[X _\ !9;]C[PYX ^"WPJ^.?Q=
MUVP^-&A_#[P+X/\ BYX@U#P/XFN?#=A\5-&T32- \9Q:KXCTK2)=-FW>)X=2
MFN]?T>"Y\([8[F^M]7_LPV]Q* ?7'_!/7]OSX;_MV?".U\0Z1<66@_%KPM96
M%G\6/ANTX%]H&KNGE#7-'BD<S:AX-UZ:*6?1=43S/LS&32-1:+4[.9&^3?\
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M/&WBWQEXGTZWET+PMJU]X:\%Z!X4FOY_&-SXAOM0\-:?X5\3?IDJA5"JH55
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MAM1M(=(U/6[/5I)A'9L#Y3_P3(_X*+Z!^V+X&D^'7Q$9?!W[57PMLFTSXH^
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M>.?BIXZ\1?$CQA;^'X'@MIH/#&E^(/%-_I'A:&ZA%_%X<T_2TU&2XU 75S,
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M%KQO;ZCJ^G7/AKX?^)[>#Q1X/TC0=.\'W^K^-](T77-5TNWTKPOI<OBK]2:
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M#<WT]O>:7_:@LI-/2#_A']9DN_*A .&_X)Y?#ZZ^ R?M1_LPZ=K^M>(_AM\
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M:K\$-&!6RT<[?L:2-C \4#BW<Q-'#(L:NL#;"L;B(X1A$<,(SA2%VG ->?\
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M76VDD.BZ(D>@>&-!\3Z2U[XU\.:]X>U36K?PIJWP\O?$$VK@'Z*?ME_!*/\
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M,MG92Z9H/CFVFTZ"-+O0;'P_X9\<VEC#J-YX*\37'B2;2[*&S\>?V;/VD_\
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M:[K-X(@SQ:=8W&L:I?RZ;H]LSVVDV#V^GQ23"W\^0 ^@:*** "BBB@ HHHH
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MUXJU*;5-;U%FNKF_N[FXGE9DM;9[Z]N1IFCV8BTS0=+%GHFDP6^FV%K"GME
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MNM0N(KO49;JVMO[/G^P       ,  8  Z  = *       ,  8  Z  = *6@
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MQ$DT99>5)2167(['&1VI\:)$B11(D<<:+'''&H1(T0!41$4!515 554 *
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MJ\57\<#>)O'GB9H$BO?$GB2]B1?.N9MOE6%A%MT_1M/6'3=-AAMX?G[+X!_
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M3PA#JNHPZ/;33W-]J.LZ_J&LZ[J?V-110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %>"_%[_D;/A+_ -C%-_Z<O#5>]5X+\7O^1L^$O_8Q3?\ IR\-
M4 =/\%_^2=:'_P!==6_].]]7J=>6?!?_ ))UH?\ UUU;_P!.]]7J= !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %>"_%[_ )&SX2_]C%-_Z<O#5>]5X+\7O^1L^$O_ &,4W_IR
M\-4 =/\ !?\ Y)UH?_775O\ T[WU>IUY9\%_^2=:'_UUU;_T[WU>IT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5X+\7O^1L^$O\ V,4W_IR\-5[U7@OQ>_Y&SX2_]C%-_P"G
M+PU0!T_P7_Y)UH?_ %UU;_T[WU>IUY9\%_\ DG6A_P#775O_ $[WU>IT %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5X+\7O\ D;/A+_V,4W_IR\-5[U7@OQ>_Y&SX2_\ 8Q3?
M^G+PU0!T_P %_P#DG6A_]==6_P#3O?5ZG7EGP7_Y)UH?_775O_3O?5ZG0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN._MU#VE_<7MGI+>; 9=0B6>)G /0J*^&OV#OVX_"_[>GP_^(?Q-\%^!-?\
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X+\7O^1L^$O\
MV,4W_IR\-5[U7@OQ>_Y&SX2_]C%-_P"G+PU0!T_P7_Y)UH?_ %UU;_T[WU>I
MUY9\%_\ DG6A_P#775O_ $[WU>IT %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%_I#1ZDVD/Y#(MM$?$O@K4?'_@>]UF]OK*.SNO\ A#;.%GGNHVB_H)\)^*=
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M]^.W_1:OBU_X<?QC_P#+FC_A?OQV_P"BU?%K_P ./XQ_^7-'_$1\-_T*Z_\
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MTM]'.WCC6XXC#=6VI7T]]#9W%W=6D<5E7(VZ_ _X:_MT_'_6/V?M$\7?&?\
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M>MEH;Z586WVO\#_V!_AQ\"?VF/'_ .U-#\8OC9\0OC%\7/"][X9\8GX@ZO\
M"NT\/Z_:FX\+7)U2/PK\-OA3\.;*/5-,3PMI5O;S6B+96\%S>R3V,EW>_:E
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MF/S-<DB%[J?AGQ)X=A2XL+B?Q+X)\2^)_#T-CK'AW4I-473?$WAV[U3\Y/\
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MIT5K;.!!,FL7^DWK2L#;VD\&Z9?Q!_X.,O\ DT+X/?\ 9R.A?^JQ^*-?T#T
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MWGTK7_#^J:5KNF_:[:QU**QU&"'5=-TS4X[O3[;[KHH *_%Z?_@F.W_#U_\
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MF7X;F;E)R]AA,51I<SE*4F^6[<I-ZMGYQ_\ #I/_ ()\_P#1O_\ YE7XV_\
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MQ]\5?#WCR[\0:-H5JVL0)I_@C4-#U.74-*M7\317!UA=+X;_ ()6^#?C_P#
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MUY\*M,AFD)+)I.M^+-!LQN8L=FGZ'K^G6$0R3@1VR!5PJ@* !F?\,-_LM_\
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M5Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P?
M_P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X
M,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_
MPL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ
M#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE
M '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\
M"P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0U
MZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\
MXY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? _
M_0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RM
MO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17
M'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_
M /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@R
MMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"
MP? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/
M_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4
M=A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +
M!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H
M/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#C
ME'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]
M#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_
M^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?
M_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\
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M5Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P?
M_P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X
M,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_
MPL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ
M#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE
M '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\
M"P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0U
MZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\
MXY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? _
M_0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RM
MO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17
M'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_
M /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@R
MMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"
MP? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/
M_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4
M=A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +
M!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H
M/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#C
ME'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]
M#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_
M^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?
M_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\
M]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V
M_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!
M\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^
M#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V
M%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'
MP/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_
M^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4
M?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T-
M>@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_X
MY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__
M  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T
M->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_
M ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P
M/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,
MK;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '84
M5Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P?
M_P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X
M,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_
MPL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ
M#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE
M '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\
M"P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0U
MZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\
MXY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"P? _
M_0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RM
MO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17
M'_\ "P? _P#T->@_^#*V_P#CE'_"P? __0UZ#_X,K;_XY0!V%%<?_P +!\#_
M /0UZ#_X,K;_ ..4?\+!\#_]#7H/_@RMO_CE '845Q__  L'P/\ ]#7H/_@R
MMO\ XY1_PL'P/_T->@_^#*V_^.4 =A17'_\ "P? _P#T->@_^#*V_P#CE'_"
MP? __0UZ#_X,K;_XY0!V%%<?_P +!\#_ /0UZ#_X,K;_ ..4?\+!\#_]#7H/
M_@RMO_CE '845Q__  L'P/\ ]#7H/_@RMO\ XY1_PL'P/_T->@_^#*V_^.4
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>gu1405a4gpzj000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu1405a4gpzj000002.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /+!YX# 2(  A$! Q$!_\0
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MJ15YPL[_ "VZVW[^6L](#G/L<4F"5P:.$'?K^-+7I;^K?\'\ NK7=U_744G
MS0#G_/-(,-D\CMGU'_ZZ0  X!/0CI[^OK^%*7/IRI7OK>^G?\0NK+SVOI?Y;
M[_>/HII;'&#TSP*7KT)_S]13=[:;_@ N:*12,<=*6A7LK[]; %%%%, HHHH
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M;ZO/%X2,U)1Y9XFA&5Y<J7NRJ*5WVMO=>2]6W;LG:R^S"G[MBAL<8Y_O$YZ
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M^'7GI_*I7(XSVSG]*Q=2UK3-)@ENM3OK#3;2%2S7%[<0VZJ!GYBTS(..>A_
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MN,$C;SGC( ['/O7EW@_XO?#7Q^SIX+\>>&?$HAP)(M,U2UN&7/\ L^8)"1[
MC^5>E^:/+:7=E54< C8N/XBW8#&6/  YZ&KJX3$85J-2%2#DHM1J4Y0EJE9J
M,TG9ZVW6EE=F6&S+!X^+EAZU*K&+:E*E4IU8^[;F]Z$I*\>S=UIW0N]FQD!2
M0"JGJ%/8^C =>>#Z"E#G+( #P"/0?[WIG'%<?HOC/P?XBN+[3_#WB/1=:N-,
MN7BUFWLM0BGN;"<-S',B,S1D.=N&Z<8/-<_XL^,/PK\#74=AXP^('A7P[=W
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M'*N0JC'&XD] ..O;K7E_BKXP?"[P9=06OBWX@>%M GN76.*VO]6M(9))6/R
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M5T<&$S? 8[$3H4,1AZDHIOEI8BC4E9:7Y(2E)+;=;M7-5FXQWXR>QX[4QFV
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ML>+O@QH^MWNJ>$_#VIW]QYUU#<W%])IEN\SNUO+$6)E=R4.5SU!ZG]]I\*\
M9#P1POQ1Q-@.(<5B.(:=9J665J-.GSTZU2-XQJ22:C&GRV=VWK;<_DG$<>^+
M_%/BIQMP9P?C^',LR[AB5)N&;49RJ3@Z5!M<]*E4JKFE43;37+?>RU]7^ O_
M  5 _9(^/.HVVAZ)\1;+P[XBOKM;/3M#\5/'I]]J,SG;&MHH9HV\WDIN=<@>
MN!7Z&)<QRQB:$^:CC<AB8,KIV(*G#!AR,'G\J_DY_P""H_\ P2S\!?L\>#+;
M]H+]F^.Y\+:3I&I6L6K>'[>>;?I;2N9(]1L;P-]JC$#(=_SCR^!G!!/Z:?\
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M"\<G/7VKQWP_\??@QXHU;^Q-!^)_@[5M4=BO]G6NL6C3[@<%=C.N6R<8SG/
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MIIMSJEP3@P6:J[[Y1G 5MO4=Z_3F.0R)E7#1NH:-E.2Q(S^6WD?6OR&\>_\
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MY(^1 I;C '/I7]1G[9.__AFOXQ_W?^$,UD_^2<H(_G[FO$\3L#E=/Q)X=QF
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M:?P^UYXBN)[I-%N9I5CL]0TS5KIY+B^ANY'AA"R/L&[CG%?UOLH4$-EQRRY
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M6RWX4QG[^02#S_7C^RW\9[/]H3X"_#;XP6*&-/&?AZUO[B(\&WNT'D7:LHX
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M:TJ6$S:OG&!SB.6XIPIU(YCC^'\)BXPG4P[YE.=185OVLO=NKI-[OR;X>_\
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M(O\ Q#I%U:_\+$\2$Z7X+TV8AI7E?Y+G4HHCGS1IRLLK*WR,>#P*_!/]E?\
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MKE\"O^"*WQ<^#_Q$^&WQ0E^..HZKK&B:I::CXFLI-2NO)F5)8YYXDD#EKGS
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M ^77?#IL[KXC^+[Z+1?#&FS2 S0_: \4FM"#_EI#8OMW[ODW-@]J\C_X(L_
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M4;E;G0"TA:WN8M,@N7M;W38$ %V9@0H(+"O=O!7_  51_;E\,^#?"GA;1?\
M@GYJAL=%\.Z/INFRQW>HQQWMA96,-M;3JJ$('NHHQ*H& =WI7+_&#_@H[^W+
M\8_A7XY^&6M_\$^M>T_3O&.@:AX=GU$37]S-8C4K=K<WD<$A*O-;;R\>?XE!
M!SBO3H9EXD2XBJTY/**'#M3'?4*F4N62.A3RVI4]FK-PYW*GA[/VD'[TKIK7
ME/F\RRKPLCP/COJCX@?%\\JCF,.))3S6,Y9S]7IUHQA&-5TE2G7<HJ"IKEB[
MMM7/V!_X)I_MD1_MB_ 33/$^K312>/?"OD:-XTBAPL;7NS;%?(H^Z;Y4,S)C
M"Y^4XQ7XB_\ !>4EOVD/@3CC"N!^$@/^?>OI;_@@-\*/C%\*M/\ C[IWQ%\
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M/V^75LHXCR>JL/G64UK^TP=9W5/E3UY)5*<U",K-;.^[OY8.95!8,GW>N?\
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MWH]S^J'S?;MS:7MM>WR_X<****8@HHHH **** "BBB@ HHHH **** "BBB@
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M3X?> -$L]!\,>'K2*TTW3;9%1(XXD5?/D*J#+<RD;I96&]W.6/:O@3_@J/\
MLE?$_P#;!^!=O\.?A5+HT6OQ:O::@YUZ\^QVXC@<LX$G.2>W3WP.*X,!QW0S
M;Q>H<5YERY?ET,5.="=22Y,/A88:I1P]._O6DGRN2NUSR?DSV<P\,\;PSX X
MK@G*Z5?-LUJX2G#%QP\5.MBL95K4I8B4(=8:>[=7<87:*?\ P1P)_P"&'? (
MQ_S%M;P<==TD7T_"OK']L@%OV8/C8<$$> ]> SWS8S=NWH>/QK@O^"?_ , ?
M&O[,G[,_A3X3^.I=.G\4:/<WUS>G3)Q<V6;QD("38^8 ISQZ>]>Y_M >!]9^
M)_P<^(OP_P!#:V76O%'A35M'L#=2>3:K>7UK)# 99?X4#L,G'3//2OD<SS3!
MXOQ+Q6=JM&>#GQ%''_6FW[%X:6/A5E4<HZ<K@KRWM'[C[OAK(,?E_@MEO#E;
M!UWF-+@^>6?4I04,3'$K!5::IN&EI*4DEKOYG\ZG_!NPV+[X_ 8.Z+0^<9Y^
MU2CC\3Z]J_J#O-S6MTIR/W+8/T'7&._/_P!<"OQ;_P""27_!/[XW?L51_%&Y
M^,%YX:ENO&,EE'ID/A_4/MT<=O93R2>;.^,K(ZL/EQQTP:_:9I#,'4A#;LA0
MNK9;<1C[N,8!/7)/OS79XHY[E^<\=9GFV78B&+PF*J825.=)WBHJE0C)NUK<
MCC*+NK:6U/,\"^'<WX<\+LNX<SK"5\)F,*6.C['%Q]G./M:E24+=7I*+5M?F
M?QP?LA$K_P %OM=/5C\1_B:,>N;%0?T&?R]:_J/_ &R21^S/\8MH)SX.UG=Z
MK_HDW'T)_E[U^1'P#_X)C?M"?#/_ (*9:W^U7K]UX3G^%5YXF\8:[9"UU0/K
MB1Z_;"&UC>S ZJPS)SP/3.*_73]L:3'[-/QD4=7\&ZR6..O^B2_J/;BOK^.\
MZRG/>+N *^58RCCJ.#R/AO!XIT'>-'%4<;/VV'GM:I3C)2:[R6MFCX/PNX8S
MGA3PS\4<OS_#XS+*V,SSB;$8/ZQ3M*KAJF I*GBL/?XJ%3EFH5.MGUW_ )</
M^"*G[5GPR_9_^+OB[P-\3+Z'P[!\4,:=X>\3W#*EA!J<>HO*+75)W(2TBF++
M';2$D-+A2!P:_L(DUO3(-..MM?61LOLQNWOQ<1&V%C'&9S<ARVSRQ%F0R$@%
M,DD 9K^++_@FG^Q!X _;:\)_&SPUXFNKK0?%OAJ-;_P3XML3NGT74FU69!(]
MJ<).ARH4GF+ =.17U%J7_!+'_@J-+"_PSL_C3;WOPMBO9HX-2N/'U_;:V--P
M8XW>$2[V66(['M6.Q4^7&#7W7BEPSP/GO&>/J4^*L+D&/PL<)'-:.;QE[.O+
MZO2E&I@9QNYSY)<DX-VYHWLKIO\ ,?!7C'Q*X-\/L#EV'X/Q7%F59C4Q=3)L
M;D_OU\'6G7FG#&J*2C0TYG+2:O[KMM\__MO>/9/V[/\ @I1X,\)_"I[?6;;P
MWK.C^#M*U&U_TBSUJ#P_K%OJ6HW5O*N5$*I',-XP"RD=AG]\/^"JOBSQ=\+_
M -@;QK8^#_M6F7$_AW3/#]YJ=E<2V]SI%HD5O'/+%+"5<>9L:W8 C<CE3D-B
MN8_X)X_\$K/!W[']S-\0_%^I0^-OB]=JZ)K,L:_9O#L,FXR0Z?Q\TSEF\RY&
M'D!Y)R0/TE^./PA\*?'WX7>+_A3X[L/M_AKQ9ID^EZ@/N21DKOMKV!AU>WN!
M'*HR,[ K<$U\3Q;QMPS'B/@?*\FJ5<QX<X-I8>FIU*<8K$5X5H3Q->G37NSA
M'EA*FYQBJE134;PDG+],X+\,N*_]4O$/.LYG'+.,>.O;U:JHSFW1C.'[NFZT
MK5(.IK"I%2]U--_#8_";_@A!\%?@CK'P.\7?$75O#WASQ7\0KOQ9/I]_>ZQ8
M6-_<6-J8A.L<5I=QR+;L\K/(TZ /(23NZ@_I-_P4*\3_  5^%'[+OQ&;Q2GA
M/P]/K'A^\TW0=+M[33[:^U749%7R;73((HU=[CG=^[ "J#D\\_BQ'_P2!_;W
M_9Y\>S:K^R;\7=(G\/FXFGCN=:\0R: EV)9&\M+K187%M+):P,(A,P8R>7UP
M<U]!^!?^"/\ \;OB]KVI>-/VV/BS>_$#4K/3KMO#W@S3]:N)M CUV6VE6UNS
M)O9+7RYS$"T8R5'<$U[^=2X3QW&-/C7$>(&'>6U\PP^/ED^'=:>:X9THTI1P
MWU?F]C&G[6%G:-XQD[J%G(^*R.EQQE_AS7\.,/X4XG^W)8'$X"/$=;"4XY7B
M55E5E+%O&M+$3Q$J<FHJ4N1N,;-QM$\S_P"#?"59+_XSW+,9$N;B2:-F&TV2
M/<DQVKJ.-VTJQSS_  ]J_4+_ (*^I_QA!\3F_P"G+'!SGD$'ITX'Y?6O'/\
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MT!\9-"M? )._49M#\42W4ZL6RPEL%8)?Q8!_=2@J<C/2O7X6X?X;RK,<LS[
M>)6 RO#86>&Q%?!5I5*.:-1=.>(P_L8WI5.;WJ251<KC*THL\/CWBSC+/<GS
MCA3,?!S,,ZQF,6(PV$S##89XC)^6;E##XB6+?[^C**Y*DI4I)IKW96=CN?\
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MZ/9F0W=MIVJNRO+?75\^7U&XWKN6:;<V[!W9&:_>Z*)47# _*@V*>$/&,>A
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M1<?7[0HK^T"[::>&X@^0*R>67W?.6;C!7J,GKC/;VK^>3]G?_@EI^T-\+O\
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M$8*LDO8U91:?-%+E2LI14:<M4Y(,]R7CSPN\3\TX]X4X6K<6Y-Q;@Z$,[R_
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M^(GQ=_:#U>V?_A&+BUN/#VC7MS"4DN-:?5)KJY<%_NLMK,JET]AGG%/\"_\
M!&7]KWXV^.K'6/VQ_BZLOA:QO3<3:5H_B.X\0+?6_&^"&&>0I823*#&\T>&
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M.M1PE[<KG"=.,73Y>7FE>[3/V5B2&V@A@@18X;>-8X8(P%XC3&Q$ "JJ@8X
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M1[*TTS3[:.VL+*WBL[&TMHU2"TMK>-8H8HPF%C1(P%55  4!?2ORZ_X*8_\
M!.FU_;B\-^&]4T#5HO#/Q)\""Z;0+YX4:TU2&Z(,EAJ$IY$<F,!R28_;BOG.
M N-\!2\3\9Q%GE2>!R[.ZN;PQ5>*3AAHYDINFY27V(SE!3=K**<EHF?9>*7A
MGF<_!G+.$^&Z4L7FG#=+)*F&PZE*4\5/+*E.514-W[22C)P5TY-)6N['Z"_"
M?6--UWX8> M:L+Q;FPU'PGH%U9W*2QL'AFTZ&2&1OGY.UP67L<@\@UX/^WSX
M0N/&O[)?QDTRU6>YDA\&ZMJ"PVR9EN&LK627RT5.29 #R!D]LXQ7X1?"W_@F
M5_P5(T36_"GA/Q!\8--T3X2:;X@TN]OH-(\<WDNH6FEZ;,I^S6<*R F&2)0O
MV4?NU VXQ7]/>F:!!%X2LO">JO\ VM#'HB:)??;1N?588[86]P\P?)/G+N9R
MWWMQKP.(,#D_"'$. S+*^)<JXAI?VDL>GE\IM4Z5.M3K*G6Y]%5E"T$D[75]
M%<^EX5QF><?<%9GD.?<+YQPI5JY"LN<LTBZ<Z^.>&]C*K3AJW1Y[34M7R>ZU
M??\ F1_X-\_BMX>TJ\^+?PJUF[CTSQ%?)IE[HFEW<WEM<Q6JO_:"PQ28(GMB
MP$P'S\9/3(_HL^-?QK^'OP,\$:UX\^(GB33/#^@Z-93W2W-Y=Q137LD,32&S
MMX2V9YY2@2)%!)8KSCFOY_OVDO\ @B?\8M)^*^M_%;]COQ_;:#-X@U&[U1M
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M_P"OGUKXGE:YDN:]26MW=*_*K*[NM.W2]W9GZ:N=045:+Y5&]ES*VWZ.RO\
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MTOU[NVJ(I)"I 9,@G XZ9QSQ[<\5$R$,#&2<\[1GC&>I_D/U%6<$ #[RGW'
MX_'\L?EB@IQE,]LCOP/3H<^N/K6M:G"M!0ORN+WW6EGJGL[?CUN1:C5LI4W2
MJQMJG;9+9[/_ (?J598GF R"%4[L E2&'T'.??KG\*2**.+I"P&\LQ8YRQ/+
M?YX /M5X;PO)Z8[?RX[?YQ2J<]3G/3O^O; ZU"E*$5"<O:36D&KI*]EK;OU;
M_ N<JUHPCB'",=XJ,?WFVKTWMH[/KWL0$8&78L,G*[005/08]O?^M1R1N74J
MGR$#+EBNT<8PO(__ %@U<.T'&#GVYS^=(QYZG!P<<_YSWJ>6M4]VK)1C?14]
M';S:2\]AQDX?;MW;_P"#Y+;R*F"BG< 1NZ9Z@?Q>I8_Y%10AC)N9F=2QQQM*
M@]%(_BZ]\CFKNQF/(R,<<?U_SVI-N!@8';_/T[5I"FL/2=/#1@G+=SE)W;MJ
M_BD[^5E:_0S;I3]Z=*I5FOA;C;M9Q2:^3WW[#6)&6!PB]%49)S_GI^/O0I)(
M .<^HP1V'YYZ?_KIR@*I)_/WXQ_4=^](#CE>F.2>IQZ>X/?_ .O2@YI*$ITI
M56T[;1Z:K2]UTOV[ZEQJKE3E"7-=)123DD[>]:VRUN^Y78%Y'&"I4 *Z_-SG
MNG3CN34ZG.$;]Z8\!F9=JG!SQG() YQ3A(F2=IW <^_OP/;UQ2[5=2N?E<EL
M@X*D<]L8QC_/2JG>HN5J*5*<9:.]N6TK?W6UK;[B8JK3CRU'*3YI.+:2Y>=W
ML[?=H?Q]_M^^%_$U[_P54\"RV>@ZSJ%I/JOAN7S[2QED411ZK:L?*N%!"K&H
MS)@CY1SQ7]>5K&XL;)< A;*S78_3Y8(\DD]6!X&>>_-<O>>!?!>HZ]#K]_X8
MT"]UZT;;!K%UIMG-J$&T@CRKN2%ITP1_"X'';@UVORC/50B@9(PFT8QM'0^V
M.F..E?<\6<8UN(LNX=P<X>SCD. E@Z<JDU*,XU?8V<4E>/\ !5KZZ^1^8>'?
MAW4X&SGC'-ZE6G7GQ5F-#&<M./O05-U.52T6MJNK3^>ND +,VS[ZL,!\88)U
M W=3M.?;^=6%C5<[3M)0#=@$D@YP<YST'/\ ^ND!  =?X@-H QCIU Z8_#VS
M4[ ]<8'7\_4_TKX.E4G**56-*FU)N,H.\7+I*TE;5[VWZL_3HPJQ]K><G&K.
M;4*ON\NJT33NDO+7R1 Z,5!C0.RGH6\L$GJ3^N*4JY #;1ZC:& /ISZ>N?TI
MQR.,JH_7_"F"1%ZDL<],'^>3W]*RE'#MIUJBG.^D4VM=-+0MMVL6VHTE%U%#
M96@VWTVD]M.WXH4[@<DL>,#'J?4>WZ?I4<*,F_)+/SGC"G/(_+IG/3\,60=_
MS$X_#_#_ #TH!P<C_/XUO&I*<)P4.2/N\LM^:S7S7GJ^SU"'NT[4VU&>LY2;
M<GHE&U]K>5NCL5W23:OS$'=DL(PV>O'^R!ZY/IVI^UPK*22< Y(QCIGG'KT-
M3M)QQQ[_ /UN::75QMQGOU(_I1%RC#V=H-;:]=D]U^MM;; HMTO9ZN+T>B<O
MLZW>O;KW]2#,BQA8^?4D9P/8=^?QX_"HMS ^88SMVC)P<XXYV=!U)P.N*L8<
MOA2, <#//X_A_.I<'I@=?49_0_EFI2KQDO>HQA=7C!6;ORV3;M:_EI^+)A*$
M5[-T)M1LE*:UMIJM7\OZM!\S$;2%P00?XMOH>I&>XIL?S-(YC;YACYR<DKZ+
MD[<>W7/7M5@1[>=O;U_^O_GUH+ D#//J>"<_GP*+4W43B^65I77,_>T6N^^G
M3;H)JUFI2LY)<LHQZM)1VO8J.FYLA25P R$<$]NW(]?UIS%B"NS"*0$&,Y8C
MJ./X<58RL9R23GWX'N#^.,4_J22,\9Q^6/RSS135*AS2@I2YFG)R<WKI>U[V
MTZ>=NQ:DW6NJEX4XK]TDDE?9]'UZ]#-??Y@'E8/'S ;@??W[8_NYJ=86;DY5
MLDD9Y<KG9D]O7'K^8F+#KG@=O_U\_P!/SIZ%<YS[8QZ^_;_..]9OZO7YG&A-
MS3[S2OWU?*EJ^C3^\B$JD)S<L7S*;<H4^6'NQDE:/-:^EE;6VSWN0%68KN!.
M01)G^$@< <8QZ'V]J3:QV!1E%W9W\D$<@CZGIC\,&K9;!.!R>,Y]*B;LQ)P.
M2!DDGM^OUJJL85:<:5>;A&Z;49<M[.+4=.ZTTW70<::A.51-P<D];7VL]+W^
M735[#%0#L>G7KDGJ=O8^G%(8SG<">3G&!GGKE!G\?7IZ4))N."I YP<?S]_\
M/RG"D\@]/KG\O7\?QI1=%15.A+D46O=YI).UM+-OIII9JW8JC44O>YW-.ZO*
M"5MM-K_IJ>=_%&?Q7:^!?%DW@JR34/%0T'4XO#=G))Y,4NL26DB:>TL@P8T2
MY:-G;J IYQ7X^?\ !-/_ ()Y?$3X4_$+XB_M._M366D7GQV\:ZU?SZ3;V<ZZ
ME;>';:>9B]Y#<,#B[O(!&DO.1R.N*_<EAD+Z^_!/YG_.:BW#EAG(&TC]!Q_G
MJ?I7TF"XCQF7Y1F638)4J']L1ITL5B8J7UA4:4HSC2A)-*$)23YW:\DW%Z;?
M'YIP7E.=Y[E&=9FIXFODF(JXO+:55J5".)J4_9N;@[IRC%IQ?+[O+%HK1,/,
M9U)7>23&.0'[G<<?ETJZ>@/ ..1WP>.@X[U"L: [@-I.21VYQGW_ $_2I\J1
M@\$#K]/3'7Z=Z^>E.3E*,8MQII1YI;MJR>RL]&G;I\SZZFZW+%8EQ<T[7CLX
MJUETNTBE(=C@(CN,DLPY_#].G'IQ2H@#!E#[G49WYV@#''/ )_3&1WJSC;@*
MV1[=3GMQ0^?4CZ\G'/7W)Y_2JC[&7-"$8Q>JE)-INZ6K:W:[WL-QHZ?NU3Y&
MOWCD]=M6M>]NG;4@$0)Y!5V.XE3N .3W'MU%/9#D,6.T_>!4'?T'3\<CUZYI
M%<9^_P#I@_I4A.0,\]^>:BG!4N;EJMRDEK)N5MOYO=Z]=M=F%3DKV_>1J<EK
M+F:5_=6ZM_71[.)XWW(T<:L.C$OM 7V7H3Q[8I2&/4C Z87)^O7C\.U*2W=@
M,#@#KU_/]:195'0ECZX/K[^W':H?U?F4IS52HM=)23TMK:-ETV:VUOI<)M*"
MBZJC?>,'K:ROKND^RTU^0#*L=VX[C@<Y'U.>G/X\^_#63Y%'W=I+;%)]3V!_
M_75CCJ?0X&/J/Y_TJ,H"0QR,<9'^>?7_ #FFYU-*M.C!5$^2[=FZ3:=]+6UU
MMT''EA%*$;K1M2;=]%=^\WY^7Y$#F0,7,8=5&4[L/<+ZCMW ^E,&Y@6"MN)'
MRN,J1UVG/"\]?P]\VBO.X':?\\]OS]NE&-_\7!([8''^>_3Z4ZBH^WIWHR<I
MK5QYN16LKSBFHO:UTM?750E*%2\<0XTWJZ3C'=M.R;UM>W5^0Z-0"/FYXRHZ
M ]Q_0?C4<B G_6%<=NA!^G].:E5,,=N02<G(QT_.AE#,>.?;/I^%:.TW:<+J
MW]W35=W9;[W\M1OW_P"-?1V7(VFUI;:VK6Y$HVDMN8G@9^\",=UZ+W&>N/R,
M!C)8G#$B125S@ 'DG.?G^AZ?A5K[F<$+^OY'/\J<N3\P[=QP.G^>/SK.5*,H
MM*,J25FIJ;W5K62T>SO=?,TA)QNH*<8M63DM[=F[N_1==]BHPE!VC+,,$R;%
M *G^#'&<="?;ZTR4H'"^22<###H"?;IQZ_X59>5%/.<YQTSEN_\ GI4HP0#C
MGL3V_#'^/7WIU/K'LZ:BX0BI)RGS-.<4U=-VZ_=U1-2$TKT[X>4FKU$D^?:]
MTW\[)+YD$0W#>P"$8 ..6QTS^0]ATJR>$^7 SZG].<?3_&F%@<@@DKSGCJ>?
M3_"C(=0"<9Z#'T_']">_>J]^=G3<8T=+))NRZNUOFO\ @C:=E[26FD>:ZN[I
M*^G5[]%IVLB J<#(+88X*\8YP0?7IU/_ -:H4AQ.TJLPV\[6YS_>P3T[]/6K
MF!&V,DDXZ=LYQS@4YB5'9G'H,@_4>OU_$T:0O",JCE+97:3>E[]+/KTT>A*J
M2HW4*[E2A:,Z<HW;B[-K_+7NM]!FT2<C@XZ?X>O^?H&/%(0NUBA!R6VY+#TY
MZ>F>>/2IDRPY&T]B!C'Y>O3D_3K3OGS_ !'GWYI5:?MH>SD^5JTM]4U9V].W
MYV)IQAS>VIWC=7M+9[:6>GI;?N5TC.XY(VY. Q+>G.3TZ?A3SO#'!SCHI7 )
M]FX_SCWJ1@,Y((/49YZ^_;Z8^OLP;AR2/PZ_T/XX/IFJ@YTXP3G":5E>I[K^
MSHGN]6U?316'*4Y-Q=.7O65X1BU96U;T=UYWT^2;'5G .U0V0VTXP#GDACWZ
M_H:9M1"[HK%SA"6) ZY)';Z'KQ[@U9# #&,_7_)II) X&?Y_AQ4P@W4]K)0M
M:RY7Z*]]&[>6^Q3565/D4G%M<K;23UMHUY:=]>[(P,CY<*1SO^\23UW ]3[F
MF[)-Y##"[>&5L$^VWMT_IS4N<<'@^E/^4]<G)SGI_(D&E.K0D[*$:EWJ[.^Z
M;:>E[>=U9F<:;7\6K>UM(R=M%'=;=E?\W8AP#PJNQCY&<@%N_(^\!T_QII+D
M!V(0D_.F,@J#TQW/0Y%6,X^Z3^('^?TII7>?4]?3/^?_ -5-)K6E/D=E[DO?
M3VU:EMIY_+9EWCRJ,(Q=VK\TG=K3KK;37U1#@Y V[5ZANN'[#'11U_'MVI L
M@"N<*<Y=% ;S!TYYSD_7WJT4R,8]^3^G'YU$5V'(8#Z<\_XTXQE+6IRW5O?4
MI+16^[7>X6AOS.D^GO>ZGIJ[^?7_ ("",#<3MV 8 '\..IX/'/KV_D]N&/U_
MGS34.X[=V3G)X&?KU_S^-3E0?8^M)2M.S?/3:M?=:VZVZ;_EL3;F@K5/:.+T
MDGVL[>OW?F5I$8G>F2<C<O7@8R?KQD>OMTI-I9E?: <?-)@;Q_LXQGGU/Z'-
M38*GTH;=CL">_ /MGZ?2JE!OX*CBFK*TK*VC]Y=?Z]&W4YH\LZ;E*%FGRINZ
MLTU=+7339HKA&0-T.22JLVX$GIR>F?\ ]=(S2*A9E#L>0F< #//S=>1^1J=%
M)^]@X.?R],=_3'YTK!&/.<?3C]#2YYV]F_97LD^63[+1+^NGS<YSJ0<H0<:E
MEK**NK6WO?IKN_*Z*\2AU) 96;DJ&R#C/&>W?IU[TH67DA2"HQRQ)'N >OX?
M_7J887[@Z=_;\>F!G_ZW2E#<G!)/3\>@[<U7+*-/D4N6.S_F=[72UTO]_IH.
M+JJ"=1*<]N?1N&BWVV7D]>R(55CN8;ED*$!R.AQ@$KT..N.GT-1-N/0!G4!1
M(V 6R,-CGY,\].?>KQSC')8]>O3\>!Z8_P#K5$0XSPI'3L3^?;W_ "J:<8T8
M\L(0C!:MSDW+I=NZ=_F[;]3.Z22JJ=:5_BBFN6]ND6O^ KZE<*(59@2R9'!^
M8J3][YNK#OCIUQ3AO^=<;5(4JP&<9QD!?QJ;Y=N&& >HX _/_P"MR/T#ST.T
M=OQQC'^>:<8R]K&45%4^7>_Q;--17NZ='KON5&4).<752IR@HJ+TE3:W]Y7:
M;T2[)]R++1QX)+$'[VW&1V'X?X^G+&5\@[2VX+G!P!SSQTY]NN.1S5G:VW'!
M'N0!_P#6/ZTOS <G!SC'MS^GZ5'OTJE:I*JJL)64:+LN5WCVUO;Y:_)CIT[K
MW4XJ*4??G=O^9I/5KNW=]3.02-(%()"DE6QM"*1T(!YQ[]:L*&),66*X)9\=
M>.0.N,8[?_KE9ESM#8Y)Z<_X_7&>>M.1D7'S$GOQW/N34VPJDJLDO:2MRQ<Y
M-1;MTV3Z;?AM-%<E*=.I7]O=^ZFVG35TTN9/F?S?Z$(#8"C=LZ'>,G ZDYY)
M;M2X8 %0& )VJ5 *]N,>GMC S5EO4\@YQCKCZX_3^M(<$X7.?0CZ\YSUJDJ\
MIR3G'V+]Y-7YDKVY=+6M9/337:Q;5/V:II^SNU:4=6Y=&V[MOIK=;=-3/>V2
M>5'=7 B)*C) #=^!US_.K0RJA?NHAVGN'X]<=?SX/IS3BZ !&/S-W [8Z=OP
M_/%."@C!S@9/^/?C/\^U%[Q]K2FY*'NVDW*-M.:SEIS+]-TT/GJ2C[-UU4G1
M^%:)13MT7:_K=]W<@+L20J?.3A3U7;GDOGI_^J@#,C JVU<$L<\N>JJ,G<GZ
M=ZD$J9VY(QG^'KC_ #ZU,H5CZ\=<X_(#_&IYL/4=U'VDGUYI;JSO?96M^3TT
M%3D_MU5-]HO^OF[^GG6.\' 7G^%MN-L?7;Z'Z?CUIXR<L !W!'&X].@]_?H*
M>XW'YN,>G:H\A7V*QW<$@CWQ^'^>]7^\NE3C1DE\46VG&#MJGJ[WT::2OZ"Y
MG*2:I2M!\WNMN4G9?$F]O._<KD3$X4DN3N=?X2/0'L0!C%/WL P9"JA/NJ,C
M.?3H3SW'YYJW@]\ _@/ZX_''7\:9F3O@@_I[@GG_ /5VI5(0J5/:0G&-6+TU
MT5K:<KT\K/M]VC<ZKC)2Y8IW=)PBN9:-IZ?+71+3R([3S?WGF* N0(VSRZXZ
ME>B[>F*NTQ!@'KSZC'2GUHG)ZR:D^KBK)^BZ?UONTW=W45'^ZMEIY=]_F%%%
M% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D()&!Q2T4 ,"#^
M( _A_7K2A<>A_#%.HH\NGEI^7H%E>]E?O9#67=WQBD"'U'_?(/\ .GT4DDME
MVWUVM;>_9"MK?6_JU^HT*._/X8_E2% 1QQ_GOWI]%2Z<7NGZ7=ON_K=E7=K7
M=OF1+&0<ELCT//ZT[9P1GC.1[=?\:?13<(N/*U[O;^OT)2459?BV_P [C-G(
M.?3C'I_C30AR22".<#'K^'_ZJEHII)));)67I:PWJTWT::U:U6WK\R%8BJA<
M]">?K0T1S\I"CKCI_G_.:FHH:NHJ[]QIJS:U7>V_HPE[W->_O6YNE[6[>G2Q
M'L/3/!YZ?YQ^%-$7WB6)+=,] /IT]?7'O4U%5=]^M]--?E8.C71KE?FNW]?Y
MD'DY*,S99,D$=,D8R1QGZ>U(T+,8R7.4))[!B<=0./\ /Y6**EJ[B^L59>7^
M;\WZ[V"'N?#^.O2SWVT[6\AFSG@X],#_ #^?>@)@'GKCM3Z*$DER]//7\7=B
MMK?K\^UOR(MC8_H3_P#KI60L!SR#UQV_7W_,U)13Z)65ELK+3[AOWE9[?=^*
MUZ$00YSD8QR,?Y^F?QI^W@#T.?K_ )]:=13N[):V0+2]F]7?=O6R6E]MAF&R
M.<@8]OY>U&S/?].?SI]%+JGU6B?W?Y(.WEMO^/?YW(V0LH /W3G/^?2C8<=>
M>G^2.OY5)14QBHSE-:2DK-[Z*W?T$U?O][&A1C! /X?Y_.C:.P_K_.G442A&
M6KBGY[?D.[6FI$T;-T;W_P X_P BE6/ PWS?Y-244N2-T[:K;5Z;>?D)*TG)
M7N_-^73Y$93LN /\].O^>N:55([\Y],\?IUI]%597O:[M;7733OZ(+:WUOMN
M[=.GR&[>23SZ>WM3=IR3GUQ^6/PJ2BBVC71_/\_0>]K]-AA#''..!D?S^OTZ
M4FP ' ^@Z8]:DHIK1<JT7970*ZU5U??Y$+QEMN&QM &?7'?_ #TIPCX )Y]<
M9_SZU)10O=5ELG?75].K].A*BE)S5^9JV[\NG?1:D>P@Y!Q_3\*7;[C_ +Y%
M/HH>N]GI;9>77Y(:BH[76M]W_GY7]1NU>N/\_3I3#&<\'C_/M_A4M%1[.-[V
M=UU;;[?Y?BQOWM&W][Z._P"A'M.6XQG_ !&/Y4",  $9P??I@XJ2BK:NK-77
M9Z[>OH'VN;[5K7\B(1G<Q)R#V//;&?K_ (4",@ ;B<'OZ?XC_.*EHI-7Y;W]
MW;6W;[]NHDDHN*^%N[5V]=^NJ]%H,V\DGD'\Q_\ JHV#/3C&/7K]:?13>N^M
MMO+^K(>_W6VZ=B(QG! ; [8]?Z?X4HCZ9P2.^!^?OZXJ2BFVWN*RMRVT3NEV
M?]?(9LXP?7J!V],TSRVSDE3GLPSC\^]344>6ENUE;ITM;HA]]%KOI=.WD]!@
M4#T^FT#^5*02.#C'8=Z=12#;9$>TG[W/'?GD=,_Y-/  Z 8] ,#O2T4FDU9K
M3MT'=_U\O\D-*YZ' QT[?SI-I X//?\ SU%/HI<D7]E:>7:W^27H+[]?7^NA
M7\C&2K'<QRQ)S^ ]!3EB(.<C/<X!/3OQS^)J:BJ>J<7LW=VT;?KOT)4(J2DK
MII**]Z5K+;2_];[D>PGN/RQ^@H*-TW9'OG_Z]2441]U63?S=_P [_P# &XI]
M_O?2WGY(:%QUP?P_K05STP/PIU%#5W=K7N-::+^OZ_R[#"@)STQTX_K33'DM
MD?>Z_3IC'T_SZ2T4^9]_R%9>\K?%I+S79_UY;%5H&\Q65B%4=.@/U'7^?6IR
MN!P,G/MZ>AX_"GT42?-OK\ET=_GKW*O=16EHJT=%HON_,A,7! .,^W^?RI^W
M"@#DCU Y_/I_GUI]%#;>^O\ 5B4DERI65[V\^Y$(SCDY-.V$XR>G'KW/>GT4
M<S[@TG>ZW:;Z7:MKIZ(BV%@<GG! SS^M-6'!W'KC&3S_ #'&?KQ^%3T4DK?\
M'7MWOV0-)VNEI)26EO>6B>F_S(1&PZL#_G]:E [$Y'T%+13O_5K?D4VWO^0Q
MESC 7\5'^!I-C8/(ZYQV_P#K5)126FNE^]E?[]R;*S5E9[Z+\]QA3(Z].G^>
MO^%($QU.>0?P].,=:DHJ5%1;DKW;ONWKIM?;;H/:S5U:Z6KZV_R(6C)Z$ =L
MC/\ ,'^=.1'4Y+DCTYQ^5244[:\UVWZNVR6VW3YO5D\D;WU[VN[=.E[=/ZT(
MC&Q(.>.<]><TK(2!@XP !D>G>I**;UY;_9V\MO\ );EW>GEL-5=HYY/KC'UI
M-ISR<C/3KG\.@I]% A@7!SG\,4UHV/1L#\1_+^?4U+13ZI]5Y?UKY[^8+W7=
M?CK^=R$PCJ0&; Y([YZ_Y_PH2)D/WR0<^O'';Z>E344K*[=E=];+_((^ZI**
M2YG>6BU?>]KC=HQCC/KC/\Z N.^1Z8P/RZ4ZBIY$WS:WO?=V^Z]NGS 9M]QW
M_A ZBFE&X / YZ=?\^O^%2T57R7W)_F@6C3[;?U\AJJ1W^O']>M*0#G@<^P-
M+10&_P#PQ%Y9Z@A3_L@#]<?TIP7CYOF[<\_KBGT5+C%[K3MT^[:XDDG=:/RT
M_#Y# @!;"@>AQGZ_K2%"2>F#[8X^E24544H?"K7[!)<VDKOY_P!?,8$(! ;'
M'';'^>E,\LXQN/!R.<_4'@=:FHI2BI--WNO/S3VVZ E9IK2RLK;6]-A@7CGK
M@C/\C]??K1L]#^G?'Z4^BFM/EHOZ8_\ .^Q&$(.2>XP,>E'EKDG\N.G^.*DH
MH>MK]+6MI:VVU@>MKI.VVBT&;3_>/XC(_+_/Z4% >G'X4^BC^M@V;:ZC0H'H
M3ZD5"T+,RMNQM.<#O]:L44=&NC5OEV)G",TE)-I--:M:K;9D>PY)!ZDD>V>H
M_P ^O2E*\C]3CN.Y]<T^BDE;1?UI;\BM=]=K?+T&[1SG&/IC'XBD9,]./;^O
MUI]%-ZJSV%;2W3YC-G&#U]<=/:FO&3]TA?PY].O7\<^U2T5/)%I1:NEKKKKW
M!JZY=;>3:[==^B&*N.N#^&?UI=J]<?Y^G2G44Y)2^)7]?Z\AJ\59-V7FQA4G
MH<<CCI_D_A2;#Z\]^O\ /_ZU244N2-N6VE[V\_Z_R%:[OK][\O/R(O+/J*>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU
M<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EW
MBG_H9-8_\"?_ *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_
M *U'_"7>*?\ H9-8_P# G_ZU<[10!T7_  EWBG_H9-8_\"?_ *U'_"7>*?\
MH9-8_P# G_ZU<[0.^%!.WDD=5S@@'ID=?7KZT =$?%WBD'!\2:P#Z&YP?RQF
MC_A+O%/_ $,FL?\ @3_]:N<+95UB$<J[QF9R#/C^^@ZE0<KQ]*4?G[\\_G0!
MT7_"7>*?^ADUC_P)_P#K4?\ "7>*?^ADUC_P)_\ K5SM% '1?\)=XI_Z&36/
M_ G_ .M1_P )=XI_Z&36/_ G_P"M7.T4 =%_PEWBG_H9-8_\"?\ ZU'_  EW
MBG_H9-8_\"?_ *U<[10!T7_"7>*?^ADUC_P)_P#K4?\ "7>*?^ADUC_P)_\
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MBG_H9-8_\"?_ *U<[10!T7_"7>*?^ADUC_P)_P#K4?\ "7>*?^ADUC_P)_\
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MBG_H9-8_\"?_ *U<[10!T7_"7>*?^ADUC_P)_P#K4?\ "7>*?^ADUC_P)_\
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MWBG_ *&36/\ P)_^M7.T4 =%_P )=XI_Z&36/_ G_P"M1_PEWBG_ *&36/\
MP)_^M7.T4 =%_P )=XI_Z&36/_ G_P"M1_PEWBG_ *&36/\ P)_^M7.T4 =%
M_P )=XI_Z&36/_ G_P"M1_PEWBG_ *&36/\ P)_^M7.T4 =%_P )=XI_Z&36
M/_ G_P"M1_PEWBG_ *&36/\ P)_^M7.T4 =%_P )=XI_Z&36/_ G_P"M1_PE
MWBG_ *&36/\ P)_^M7.T4 =%_P )=XI_Z&36/_ G_P"M1_PEWBG_ *&36/\
MP)_^M7.T4 =%_P )=XI_Z&36/_ G_P"M1_PEWBG_ *&36/\ P)_^M7.T4 =%
M_P )=XI_Z&36/_ G_P"M1_PEWBG_ *&36/\ P)_^M7.T4 =%_P )=XI_Z&36
M/_ G_P"M1_PEWBG_ *&36/\ P)_^M7.T4 =%_P )=XI_Z&36/_ G_P"M1_PE
MWBG_ *&36/\ P)_^M7.T4 =%_P )=XI_Z&36/_ G_P"M1_PEWBG_ *&36/\
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MW'[0?P!B^.\&N:A:6V@63&)5T>XDFB6.4M*P \ERKL,Y(4@<U[3XS_::\ ?
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M^"/A)H?A+Q1IT?A/5!XDM_'LGVVPT'Q-8WEM$8K#3+B,PI)Y>\.4\Q^AXY%
M']+JWEK-I\FJ6=Q;ZA8);RW<5W8S)=6MU;PQM(TMM<0EHYE(4\HQ'O7YR?![
M_@I?\.OC+^TEKG[-&D_#KQ%H_B+1]1N-.@\17>HVL]AJ3V^[?,EK&WFP(=IQ
MY@'/'6O'O^"='[=.D?$7PY\/?V=1\(/B1X?E\'>#Y+.\^(&JVMT/">JQ6\4C
M2&UGGAQ,;A0T0<2OGGFMGX"_M(_LH>+/VN/&_P .?A_^RRO@OXN:%)J<E_\
M$]GMWFU:6U$K.T81BZ&Y93L# -EU'U /UM8QJ9!O8F.0Q8$;X9P<%0>G'KWH
M W2^4A#.8]ZY^53ZKN/ (S7YR?!__@I/X"^+?[0VL?LU3_#KQ9X$\6:5?7.G
M+K6MWUJ^FZMJ=O)(#':VB@3H9DCWJ&' 8$BO5/VROVSO!O[&?ACPQXC\8^$-
M6\6?\)7X@BT*QTO1[R""^M[R3:L=Q/O.3:L[*H  ^8\T ?8RE,E9&\M@"6!4
ML0!U''\6>B]3G(XYI,D)'*PVQR-@-D,P_NDQCY^>_'%?,]]^U;\-/"_P"T'X
M_P#Q0>3X8Z!XBTXZA:>'M9FCN?$-U?F+?:VUL82!ON49$C(4J X!&:_.I/\
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M=/VH[?QI^W9;?M KX!\;>'+3PIXCT5?^$"N7U&+6]6AT>9E_T&R!1"U^.4S
MVX]CP* /[("#MW*,A6"OVV'(#]>NSV^]V]D)7]\R2(8H0&,TK""/8/\ 62,T
MA 18QRQ8XQWKY<_94_:JTS]K3PMK7B^P^%_C7X5QZ7<&V&D>-K>2WOIY-P5)
MX4DBA+1/P20#UKZ3UG2HM<TC5]&NS))#J^ESZ7?/;,8Y+>WNXS'++:L"#YR+
M\P*]&'K0!\F?%+_@H%^QQ\%O%T_@3XC_ !LT'2/%5E!'<ZAI]BG]KQ6<,_\
MQ[E[NSE>%I)""#$IWH?O"O3_ ()_M-? C]HZQN]1^"?Q!T[QG!8.T=["%.GW
M\3C^Y8W+?:)D/_/1%*]\XKYUT']AO]@+X:>'/$6G^+O#_P .?$MZ\FJZUJOB
M'XBZS977C*UBN<RW4S_:+T7#16PRUA"$RAX"\5^(?[!7AG5A_P %$]3;X#_V
MM<_"O0]>\2*=<MX+J+P]+HF=MG!)*%^QLJKQ"&8GCK0!_5SD$[5^9AG>!QL8
M#[I]_P#$5X/\;_VG_@-^S9;Z5=?&[QW#X*AUQI(]),EC<7K7DD2[I$C2#!RH
M_&O>G25IC&2L:R-&\DJG ;'+X.><]R/<]*_GG_X+E1V]UK_[/D%S&TMI-X@O
M8HBV"D(*+ND8'C;(#M&1SSWH _9OX'?M2_ #]I,ZFOP4^(-KXPET6))]6A^R
M3:?+9P2'"2.ER0S;CT4#->]%@(YY#@) KRDL0N;>,;FGP>0@7+<]AUK^5O\
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M6OZ-] U(ZUX=\/:T6$AUC1-.U,R#HYO(%EW#U!SU[T :E%%% !1110 4444
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M ^B0^+/%OA7[#IUQX4@9(97M].NHKV*\+2D)MDDB5&'4\\T ?<'[;?BF_P#
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MH)_P51_9.\;_ +0_@/PEXP^#WAR?Q!\5/ NHI<Z=IME)%!=WD4C84+-*0O\
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M'_%GQE_P3VT?X0>%_!MYJWQ,M_#UK9S>%8IH4NH[F.&!7B,S$1$J58$YQD4
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MT+3KM[6>98M,L+^Y8F:"?8(HKIW'\*-\V <XSBN]\11_\%9M#^"^G?L[^%?
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M5K9,#%I=H6BG^SW=K(5:2:0(A'? JC^P5^RO^T+\)_VU?BG\3/B-\,]2\,^
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MY^%F@SW'P=^.T#I=Z++=R1RWEA-9AYS%'+#N0"_""T/)_P!9Z"OEOQY\2?\
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M]X(W$>YI-\D3H1/$#F63>,*8F;.)$/WSQGZ5_/-XX_9,_;4_9._:XUG]H/\
M96\$:9\9K+QC<ZSJDFG731)9:.^K'=/;:DLV7>X  6)H<88Y[4 ?#G[<7C+]
MJ_QA\7?@_JW[5WPB\*?";7%UW3/[&3PG9VUH;P13J29EM8XQMAY:)B,C!(/>
MOU._X*P2R77[ O@&XG>266;1] \QI229%1,I*2>2QQG))/K7R!^T9^S/_P %
M)OVHO%7PY^-_Q1^&=DFK#7+;3[SX9:!<1)/X+TK2)@RZS*TQ$3IJ29P(_GQU
MR:_1?_@HC\!?B_\ &#]CCP7\-OAAX+O_ !=XWTS2-&@O=!MYX(;FUFMTQ/"\
MDI$9,)X../2@#DO@4Q_X=3ZNV?F;PEJ:D^JBQG 'IT[]?>OGW_@AAX,\'7&A
M>/?&-UX8TB^\6V>HW%M8^(+RSBNKRS@:ZD5HXA<I+$!MZ?)GM7VC\(_@E\5O
M#W_!.[4?@]K7@^\L/B;-X<O[*+PI)-"UT]U-:S1QQ"93Y66=@ <XYZUYS_P2
M*_9Y^-?[//@?QWIGQJ\!WW@74=5U26?3;>_N(+AKB%KEG#H8"0/D.[GI0!^>
MO[6%I!\/_P#@JOX&U3P[:0Z;=7\VB3W0L8X[=9I[Z]MH[F4K$JJK2J=K[54$
M<8K^H5]S^5,_RGR[41P]H]UO&Q4'V+9SFOP)_:Q_9,_:.\?_ /!0#P1\7?!G
MPRU/7?ASIIT'^T/%,%U;1VMK]EO;=[G=%(PF/EQJS' Y _&OWVW & '+XCME
M8GHI6WB1_P F!!^E '\N?_!6G3M9U3]M[X?:=H=__9.M7WAOP];Z3K60%TB_
MN-1@CM[V0=6\F5DD^7GY..:P/VZ?@+^WA\$?AOX;U/XX?M%:Y\<?A!K!TR77
M[?09I8;?1],:"";R)D*AOM*P,8(&)V"1%)R!7UY^WY^R9^T7\6OVS_AK\2_A
MO\-=3\5>!]"M?#8U;7H;NWCL+<V.IV]Q<PO#(PE9X8D=VP""!ZFOV#^._P )
M-,^.'P-\6_"_5[>&)O$?A>&VM@4#-8:M::<ODHA?(3==(L1*D _2@#YE_89O
M_P!G_3/V-E\1?LZZ/<V/A^/PQJM_XK6X*-XG7Q=%I-PTKZU.I*SZBLB&13'@
M"+;E1BOY^_V0O&O[5DG[2'Q3^)W[//PB\-?&WXB7TVKRZM#XR^S7B:)9)J5U
M%'K#17@DS.JJD)"J!A<8Z5^I7_!+?X&_M4_LZ>*?BA\)/C-\,]5TWX)>)8-3
MNM,U]KNVEA_M>\>XM&FM(5)9/-T^0!0WR@GD=J\=\7?L1_MB_L;?M#ZO\<OV
M-M,MOBCH'BO5+F;_ (0LW'V=[32;F1KA].\3!V\N=/M#O(%A'.>: /&OV@/@
M-_P4S_:F^)G@'XB^.?V5]&\)>)_!E]I2KKOP[FT_1VN]-@U*VGN)W2)8L&*)
M7+\!F56&2#7OW_!;!+N+X=_L\0:C_P A&VNO#,&H \LE];6]C#<J[?Q21S(Z
MNW\3 GG)->_^"O%O_!6/]H#QUX4TCXE>!_#?[,G@_P .:O%K^L^(]'F8S>)+
M.,JLOAUUC;.V9 QY&W<W-1?\%:/V<OC?^T!X=^$]E\&O .H>.[SP]J^FSZX+
M*XMX#;K;F#[3=N9V 82.DDN!S@T ._:E+_\ #JO2=C;7?PI9@L<=X8.YZ>Y&
M*\5_8Y\4:AX'_P""4GQBU[1Y)8-9M- NP)8R5C@\U/+-TD@QM?8Y4$'N!Q7U
M[^T%\$/BOXO_ .">>F?!_P -^#+O5_B9!X=MK*7PDDT*7"W20Q*T33,1$2K*
M>01T]ZH_L"_LP^,_#_[%WB#X _'_ ,)WOA"^\4VEUIVJ:/>S0W#&">-A$Y>$
MX*QR[&Z]%QZ4 ?CC_P $[O&/[;O@KPYX^\2?LI_L_P#@CXJVWB#6!-XC\7>-
M(K+4KS2+^=&D?3T6Y69]EUO9UX&"1@]:]]\"_LU_M^>.?VVOA[^TK\1/V<X?
MAC&GBG3;CQW>>#KNSL]$CTV!&2:\NK6 KYEJP;>\*I@Y&5KHOAQ^SI_P4=_X
M)[_$3Q-;_LW^!-#^./@?Q5+=W;VR7!A\/VV9I!8-<6TSF0ZE;6Q6+S%&SY3Z
MU]U_L]7O_!2/XR?%?2?'?[1.F:-\ _ ?A"VDL;WX>Z-,SQ^/5G8R&X?:2N^'
MB,;N#CT&* /CG_@NXT9/P?:**V03R^9))!;0PO,3J49#/+'&LC^VYCP:_:W]
MGE(V^!GPM\N"S@D/@S00)8+2UMW9AIUO@S20Q1O(/4LS$Y)-?E__ ,%=OV:O
MCI^T/_PJ\_!+X=:CXW30V!U6.QN+>#^SU^W1RA7\]EW;8QGY>N.*_5/X+:)J
MWAGX2_#[P_KM@;#6M)\+:38:E83$,]G=V]C#%-$S+\I>-U921P2M 'F'[8'Q
M7^#_ ,'?@=K_ (N^.7AM/''@CSHM,D\"2*OG>(M2N%_T6W!;"&%WVY)X 7!Y
M//Y#>#OVO?\ @HG\7?AEK&H_ 7]C_P"%MU\")K#4M*\.YT.PM+C3O#,*M#]E
MN)+JV#336-N(XWEC9M[@E&QS7ZI?MS_LSWW[5?P!U/X9Z)JD.FZ]97\7B+3;
MO402MW>Z>NZ#3(=F,).PP2W?O7Y6_!:S_P""L_P\^%%C^R=IGP0T/1OA_=7.
MI:#'\5]3FA_M'0-+U)]LVJDV^&>"-5#6XR7",,\T <+_ ,$5YM4_X7_\8X;Z
MW73KVZGOY?$6D1J/L=IJ:.WG6<4(&QXK63,<6590HXP!7)_M2(I_X*V>$TC@
ML2K:_P"#4ALDM[=;2X<N0WFP+'Y1D;K\R<D\]Q7U=_P2^_9*_:+_ &=OCC\5
M-9^,OA&[T_2]0DO;;3O&GGPR0^)&W%3J%M&A+H+W'FIYHW -SSTH?\%!_P!C
M']H;4OVEO!W[4/[-G@ZT\>ZU97FE7UQX;AE6%[6\T1B8)M3,YPZ7)PS"(?AW
MH _>*<1)*%@M8K5,B+9#;6]L4N0.8F6WBC4Q;@0"5)QT(IL7FK*B( ]Q!(&V
MJ?D>20X,<9)P<'AN2!Z8S7RS^RKX\_:B^(G@R]UO]JCX<Z)\+_&@OA#::'HV
M##+9(P7[5(5_Y:.F6SZD5[_XQTG5]=\)>*M#\,ZH/#^NZGH>IZ?X=UN0G_B5
M:Q>1%+75),?,4MI<2  Y&* /ST^//_!)_P" O[0?Q'U_XF^+O'/Q<T;Q7XCA
M^RMINC^(9K/08)XP<?Z(MQ&#"I/[X!,2)P!Z_D9\%?'_ ,3?^"<G[9LG[/L>
MNV7BKX?:]KFFZ8]BUNA4V>JW*PV$YF9&G-T"V9R)2"<DBOO23XD?\%A_@PQ^
M&^E?!GP3\?-,T<;X?BG.P2[U<DGRXXA)A@8UVABQY]?3SC]F+_@GU^T!\6?C
MN/VJOVQ5MO#&IP:]<ZE;?#2X99]5AGMY5ET^2":(^0-.CD7-NA&]1G=0!^^A
M1&"E00TRPW&Q\^7"KHLC)'TPN&QC.?K7\\__  7)'_$[^ 6<K"=>F/'1MH4J
MHSSA3R,?2OZ&V/FH@D("$!%C7.Z)$7:H8]_E %?BM_P5K_9H^//[06I?!F?X
M-?#W4/'=OX2U66XUG[!<V]O]CA."KR>>1NSZ+Z&@#YQ_X*2_"R_@_9H_9-_:
M(\/VX.I>"-&\/G4[V)2)Q%IX673XYW49\H3Q@+GKTYKQ7]J[]I_5/VUF_9/^
M"/AJXCOKLP^&=4\71VN]C/JUQ+;VVIV5RBY#+# -Q5NG)^O[I?$7X#ZE\5/V
M(K;X+:UI+6WBP?#C3[9-(E*--9^)=,@DDCL]_P!P223A(]P(!)R>!7Y-_P#!
M,7_@GW\:OAI\?=0^)?Q_^&%SX,TWP?8R3>%3J-Q;W::UJ<\IB8VZQEO+\N%4
ME&X8';TH J?\%=_">G_#^']E'P5IL"P6WAK4/#6FQ0PJ!;JZM:;W"CIM9V.
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M ,,U^TK\JI9MR(PVN?\ 6OG&5EQ@$D\Y ^M '\Y?_!;V59/B5^SR1PQ2[*Q
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M:<)90NP2.$Z;0S;?^^<X_2G^1+_SRN/_  &G_P#B*/(E_P">5Q_X#3__ !%
M$:LR'*LRGU4D'\Q3S/.P(::5@>H,CD'Z@G!I?(E_YY7'_@-/_P#$4>1+_P \
MKC_P&G_^(H B5F4AE)4CH5)!'T(YJ0SSL,--*P/4&1R#^!.*7R)?^>5Q_P"
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M[(<HS*?525/YC!I6DD?[[N^.FYF;^9-/\B7_ )Y7'_@-/_\ $4>1+_SRN/\
MP&G_ /B* (@2"""01R"."/H:E^T7'_/>;_OX_P#C1Y$O_/*X_P# :?\ ^(H\
MB7_GE<?^ T__ ,10!#FI%FF4;5ED4>BNP'Y XIWD2_\ /*X_\!I__B*/(E_Y
MY7'_ (#3_P#Q% #!+( 0)' 8Y8!F 8^I ."?K3*F\B7_ )Y7'_@-/_\ $4>1
M+_SRN/\ P&G_ /B* &+(Z9V.Z9Z[6*Y^N"*0.X;>&8-_>#$-^><U)Y$O_/*X
M_P# :?\ ^(H\B7_GE<?^ T__ ,10!&SNYR[,Q]6)8_F<FE\V4KL,C[/[NYMO
M_?.<?I3_ ")?^>5Q_P" T_\ \11Y$O\ SRN/_ :?_P"(H AIZRRH"$D= >H5
MF4'Z@$4_R)?^>5Q_X#3_ /Q%'D2_\\KC_P !I_\ XB@"'-%3>1+_ ,\KC_P&
MG_\ B*/(E_YY7'_@-/\ _$4 ,:61P \CL!T#,S ?0$FF5-Y$O_/*X_\  :?_
M .(H\B7_ )Y7'_@-/_\ $4 -6:9!M2615'9791^0(%-9W<Y=F8^K$L?S.34G
MD2_\\KC_ ,!I_P#XBCR)?^>5Q_X#3_\ Q% #$DDCSL=TSUV,RY^N"*2261Q^
M\D=P <;V9@/S)_&I/(E_YY7'_@-/_P#$4&"7!_=7 ]_LT_'_ (Y0!^5?[>O[
M _Q&_:T^(_PP\:^#?&_@WPQ8>!KN*[O[/Q%%<O=WD<3;V2Q,)"JS 87?7Z:>
M$-+O/"_A#POX;GN1)<:)HECI]Q+ [B.:2WB\MW09'[LD97O@\UT)BF(P(9P2
MH4L+6;) [\IP<4&&8A08K@[1@?Z-/G'_ 'Q0!"22<G))ZD\FG++(GW)'3/7:
MS+_(BG^1+_SRN/\ P&G_ /B*/(E_YY7'_@-/_P#$4 ,:65^'D=P.FYF;^9--
M!*G()!]02#^8J7R)?^>5Q_X#3_\ Q%'D2_\ /*X_\!I__B* $,\Y&#-*1Z&1
MR/RS488J05)4CH02"/H1R*E\B7_GE<?^ T__ ,11Y$O_ #RN/_ :?_XB@!K2
MRN,/)(X]&=F'Y$FD,LK+M,CE1T4LQ4?@3BG^1+_SRN/_  &G_P#B*/(E_P">
M5Q_X#3__ !% $2LRD,I*L.A4D$?0CFG/+))C?([XZ;V9L?3)-/\ (E_YY7'_
M (#3_P#Q%'D2_P#/*X_\!I__ (B@"($@Y&01T(X-2_:+C_GO-_W\?_XJCR)?
M^>5Q_P" T_\ \11Y$O\ SRN/_ :?_P"(H B)).3DD]2>30"5(*D@CD$$@CZ$
M=*E\B7_GE<?^ T__ ,11Y$O_ #RN/_ :?_XB@ ^T7!X,TQ'_ %T?_&H:F\B7
M_GE<?^ T_P#\11Y$O_/*X_\  :?_ .(H C5W0Y1F0],JQ4_F"*>9YV!#32D'
M@@R.0?J">:7R)?\ GE<?^ T__P 11Y$O_/*X_P# :?\ ^(H C5W0Y1F0^JDJ
M?S&#3S/.PPTTK ]09'(/X$XI?(E_YY7'_@-/_P#$4>1+_P \KC_P&G_^(H A
MHJ;R)?\ GE<?^ T__P 11Y$O_/*X_P# :?\ ^(H C5W0Y1F0],JQ4_F"*0LS
M'+$L3U)))/XFI?(E_P">5Q_X#3__ !%'D2_\\KC_ ,!I_P#XB@!@EE"[!(X0
M]5#,%/\ P'./TIE3>1+_ ,\KC_P&G_\ B*/(E_YY7'_@-/\ _$4 ,:61@%:1
MV4=%9F('T!.*%ED3[DCIGKM9E_D13_(E_P">5Q_X#3__ !%'D2_\\KC_ ,!I
M_P#XB@!/.FR6\V7<1@MO;)'H3G./:F!W5MRNRM_>#$-^8.:D\B7_ )Y7'_@-
M/_\ $4>1+_SRN/\ P&G_ /B* (R[,=S,S-_>))/YGFI/M%QT\Z;'3'F/_C1Y
M$O\ SRN/_ :?_P"(H\B7_GE<?^ T_P#\10!#FOG7]JOX!Z?^TO\ !'QC\*)K
MBUT_5]8L3_PC^K7H8VNG:AG_ %L^/X"N =IW>U?2'D2_\\KC_P !I_\ XBD>
MWE==C17!3(.W[-,.0<@Y"9_#- 'P]^P5^SC\4_V5_@[=?"OXF^-?"_C&.WUA
MI_"MWX>2[6+3-"V$?8;C[03B0R_.1'A3Q7W")YE&U9I0HX&)' QVP,^E/:.=
MRVZ.X*,X<)]EF"J0 .,(#V]:;Y$O_/*X_P# :?\ ^(H B9F8EF)9CU+$DGZD
M\TJLRG*LRGU4D'\Q4GD2_P#/*X_\!I__ (BCR)?^>5Q_X#3_ /Q% #6FF<8>
M61AZ,[,/R)-,!*D%201R""01]".E2^1+_P \KC_P&G_^(H\B7_GE<?\ @-/_
M /$4 1L[N<NS,?5B6/YG)I%9E.5)4^JD@_F*E\B7_GE<?^ T_P#\11Y$O_/*
MX_\  :?_ .(H 8\LDF-\COCIO9FQ],DXIE3>1+_SRN/_  &G_P#B*/(E_P">
M5Q_X#3__ !% $:NZ'*,R'IE6*G\P10S,YW,S,3U+$D_F>:D\B7_GE<?^ T__
M ,11Y$O_ #RN/_ :?_XB@"&GK+*G"2.@/7:S+_(BG^1+_P \KC_P&G_^(H\B
M7_GE<?\ @-/_ /$4 -\Z;);S9,D8)WMDCT)SDCV--5W0[E9E8_Q*2#^8YJ3R
M)?\ GE<?^ T__P 11Y$O_/*X_P# :?\ ^(H C+N6WEF+?WB3N_/.:5I)'Y=W
M<CIN8M_,FG^1+_SRN/\ P&G_ /B*/(E_YY7'_@-/_P#$4 ,$LJKM$CA3U4,P
M4_@#BF5-Y$O_ #RN/_ :?_XBCR)?^>5Q_P" T_\ \10 Q9954JLCJIZJKL%/
MU .*9FIO(E_YY7'_ (#3_P#Q%'D2_P#/*X_\!I__ (B@!K2RN-K22,H_A9V(
M_(G%(DDB?<=TSUV,RY_(BG^1+_SRN/\ P&G_ /B*/(E_YY7'_@-/_P#$4 -:
M65QAY)''HSLP_(DTBR.F=CNF>NUBN?K@BG^1+_SRN/\ P&G_ /B*/(E_YY7'
M_@-/_P#$4 1AW#;PS!O[P8AOSSFAG=SEV9CZL2Q_,Y-2>1+_ ,\KC_P&G_\
MB*/(E_YY7'_@-/\ _$4 -665!A))$'HKLH_($4CR228WN[XZ;V9L?3).*?Y$
MO_/*X_\  :?_ .(H\B7_ )Y7'_@-/_\ $4 ,621/N.Z9Z[69?Y$4TDDY.23U
M)Y-2^1+_ ,\KC_P&G_\ B*/(E_YY7'_@-/\ _$4 0YJ4SSD;3-*5(QM,CD8]
M,9QBE\B7_GE<?^ T_P#\11Y$O_/*X_\  :?_ .(H 8TDC *SNP'0,S$#Z G
M_"A9)$Y1W0GKM8K_ "(I_D2_\\KC_P !I_\ XBCR)?\ GE<?^ T__P 10!&S
MNYR[,Y]68L?S)--J;R)?^>5Q_P" T_\ \11Y$O\ SRN/_ :?_P"(H 19ID&U
M995 Z!78#\@<4QG=SEV9STRS%C^9)J3R)?\ GE<?^ T__P 11Y$O_/*X_P#
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M /Q% #%ED0DK(ZD]2K,"?J01FFEB3N)).<Y).<^N>N:E\B7_ )Y7'_@-/_\
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M*X_\!I__ (B@"&BIO(E_YY7'_@-/_P#$4>1+_P \KC_P&G_^(H AHJ;R)?\
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M/_XFC[+;?\^\'_?F/_XFIZ* (/LMM_S[P?\ ?F/_ .)H^RVW_/O!_P!^8_\
MXFIZ* (/LMM_S[P?]^8__B:/LMM_S[P?]^8__B:GHH @^RVW_/O!_P!^8_\
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M:/LMM_S[P?\ ?F/_ .)J>B@"#[+;?\^\'_?F/_XFC[+;?\^\'_?F/_XFIZ*
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MO!_WYC_^)H^RVW_/O!_WYC_^)J>B@"#[+;?\^\'_ 'YC_P#B:/LMM_S[P?\
M?F/_ .)J>B@"#[+;?\^\'_?F/_XFC[+;?\^\'_?F/_XFIZ* (/LMM_S[P?\
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M/_XFC[+;?\^\'_?F/_XFIZ* (/LMM_S[P?\ ?F/_ .)H^RVW_/O!_P!^8_\
MXFIZ* (/LMM_S[P?]^8__B:/LMM_S[P?]^8__B:GHH @^RVW_/O!_P!^8_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %1.6RN#CV[$^C>@]ZEIC%L\9P1@^W7E?5AW'H* (A*=P!9%;[I1G
MW?[2#.X]ATYS5BOS8^.6HZI!^W;^S=80ZIJ=OI\^EW1N+"VOKB*RO&\^4;[N
MS1Q#, 1C=(K8K])Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I#GL.>?Y''ZXI:1AE2.F0>?3W_"@"$2ML&X 3;=QB4@OC) (4
MG..^?8BIER ,DGW/7\:^=H-9U]OVH+K0FEF/AI/A);ZBD>'\@ZJVO^2S@_<\
MPV_;[VWVKZ(7&T8SCWZ]: '4444 %%%% !1110 4444 %%%% !1110 4444
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M[?9)]F2\SRZ/Q8_"1V^*O37Q-*.\OM.44O-H^DJ*S#K.E@$F^M<#O]HA[?\
M;2D&M:61D7UMCU^T0_\ QRE[&M_SZJ?^ 2\O+S_JP_[2R^]OKN%OO;V]/;:_
MQ&I168-9TP]+VV/_ &\0_P#QRG_VKIW_ #^VO_@1#_\ %TO8U>M.:OWB_+R\
MRHX_ RUCC,-)+>U:F[?^3>9H45F'6=,'!O;8?]O$'_QRG'5]- S]MM>?^GB'
MO_VTH]C5T_=SUV]UZ[>7G_5A+,,"[VQF&TW_ ']/3U][0T:*RCK>E X-_:@^
MGVB'_P".4\:OIIZ7MMQ_T\0?_'*?L:W6E45^\)>7EYBCF67S;4<;A9-:.U>F
M[/L_>WU6AI45F'6=,'6]MO\ P(@_^.4C:UI:@,U]:A3T/VB#'_HRCV%9_P#+
MJIKHO<EY>7F#S++U=O&X565W^_IZ+35^]INC4HK)_MS2?^?^U_[_ ,/_ ,<J
M1=8TQNE[;'O_ ,?$/_QSK1["M_SZJ?\ @$O+R\P699?)VCC<*WO95Z;W_P"W
MC2HK+_MG2SG_ $ZVXZ_Z1#Q_Y$I?[9TS&?MMKC_KX@_^.4>QK?\ /JI_X!+K
M;R\_ZLP_M++W_P QN%Z_\OZ?1V?VNC_K1FG16:=8TT#)O;;'K]H@_P#CE1_V
MYI)./M]KGT^T0_\ QRA4*SVI5'_VY+R\O,3S/+HV3QV%3>UZ]-7OMO+S-:BL
MLZSI8ZWML/\ MO#_ /'*3^V]*(S]NM<?]?$/_P <H]A6_P"?53_P"7EY>:#^
MT\NV^O87_P 'T_\ Y+S-6BLLZUI8&3?6P'_7Q#_\<H_MK2\;OMUMCU\^'_XY
M1[&M_P ^JG_@$O+R\_ZL']IY=_T'8717?[^GMW^(U**S&UG3% 8WUJ ?^GB'
M_P".=Z0:UI9Z7UJ?^WB'_P".4>QK?\^JG_@$O+R\_P"K#>99>G9XW"INSLZ]
M.]GL_B-%R0 P#'!'RJ,YR0/T'--\PED$>UQN*RD$'80,X.#PV>QJC_:VF%E_
MTVVZ\?Z1!WXYQ)_G\*^?_@;XCU:]NOB\/$NH1>59_%C7[70_,NX&!T2..W-L
M(MLSCRLEMIR <' R#35"NTVJ-5J-N9\DK+F=E=VLKO37KH#S++TTGCL*G*_*
MG7IIRY4I2M>6O+%IOLMSZ3'045FIJ^FO]V]MC_V\0_\ QRD.LZ8N<WML,=?]
M(A_I)4^QJMV]G._;E=^GEY_U8?\ :& Y5+ZYAN5JZE[:G:WKS6ZFG166-:TL
MC(OK8CU\^'_XY2C6=,()%[;8'4^?#_\ ',T_8UO^?53M\$O+R\_ZLQ+,LO>V
M.PKTOI7I[::_%LKJ_8TZ*RQK6EMTOK4_]O$/_P <H_MK2\X^W6N?3[1#_P#'
M*/85O^?53_P"7EY>?]6%_:>7-)K'85J6S]O3L[VV?-;JOO-2BLS^V-,_Y_;;
M_O\ P_\ QRC^V-,_Y_;;_O\ P_\ QRCV-;_GU4_\ ?\ EY_U9C_M'+_^@W"_
M^#Z?E_>\T:=%9G]L:9_S^VW_ '_A_P#CE']L:9_S^VW_ '_A_P#CE'L:W_/J
MI_X _P#+S_JS#^TLO_Z#<+_X/I^7][S1IT5F?VQIG_/[;?\ ?^'_ ..4?VQI
MG_/[;?\ ?^'_ ..4>QK?\^JG_@#_ ,O/^K,/[2R__H-PO_@^GY?WO-&G169_
M;&F?\_MM_P!_X?\ XY1_;&F?\_MM_P!_X?\ XY1[&M_SZJ?^ /\ R\_ZLP_M
M++_^@W"_^#Z?E_>\T:=%9G]L:9_S^VW_ '_A_P#CE']L:9_S^VW_ '_A_P#C
ME'L:W_/JI_X _P#+S_JS#^TLO_Z#<+_X/I^7][S1IT5F?VQIG_/[;?\ ?^'_
M ..4?VQIG_/[;?\ ?^'_ ..4>QK?\^JG_@#_ ,O/^K,/[2R__H-PO_@^GY?W
MO-&G169_;&F?\_MM_P!_X?\ XY1_;&F?\_MM_P!_X?\ XY1[&M_SZJ?^ /\
MR\_ZLP_M++_^@W"_^#Z?E_>\T:=%9G]L:9_S^VW_ '_A_P#CE']L:9_S^VW_
M '_A_P#CE'L:W_/JI_X _P#+S_JS#^TLO_Z#<+_X/I^7][S1?E+*A*XSZG@
M=VST&T<\\<4V)G8GD-&!\K\'><\G(XQ]/YUQ_C'7+>+PAXKEL+V 7T7AO7)+
M/9<0!_M::9<FVVGS!AO.V8.1@\YKA?@;XAN;SX/?#^Y\0W\?]NS^'[>74_/N
M86F^T&:7=YK>:WS;0 >3QUZ8I_5Z_+S>QJ\MU'FY)6YFKI7M:]KNW9/LQ?VG
MEUU'Z_A+M<UOK%._+=+FMS7M=I/3J>W@@C@Y['Z^_O2UEC6-+Y(O+;!)/^OA
MY/<_ZRE_MC3/^?VV_P"_\/\ \<I>QK?\^JG_ ( _\O/^K,?]I9?_ -!N%_\
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M]YHTZ*S/[8TS_G]MO^_\/_QRC^V-,_Y_;;_O_#_\<H]C6_Y]5/\ P!_Y>?\
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M\T:=%9G]L:9_S^VW_?\ A_\ CE']L:9_S^VW_?\ A_\ CE'L:W_/JI_X _\
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M]C6_Y]5/_ '_ )>?]68?VEE__0;A?_!]/R_O>:-.BLS^V-,_Y_;;_O\ P_\
MQRC^V-,_Y_;;_O\ P_\ QRCV-;_GU4_\ ?\ EY_U9A_:67_]!N%_\'T_+^]Y
MHTZ*S/[8TS_G]MO^_P##_P#'*/[8TS_G]MO^_P##_P#'*/8UO^?53_P!_P"7
MG_5F']I9?_T&X7_P?3\O[WFC3HK,_MC3/^?VV_[_ ,/_ ,<H_MC3/^?VV_[_
M ,/_ ,<H]C6_Y]5/_ '_ )>?]68?VEE__0;A?_!]/R_O>:-.BLS^V-,_Y_;;
M_O\ P_\ QRC^V-,_Y_;;_O\ P_\ QRCV-;_GU4_\ ?\ EY_U9A_:67_]!N%_
M\'T_+^]YHTZ*S/[8TS_G]MO^_P##_P#'*/[8TS_G]MO^_P##_P#'*/8UO^?5
M3_P!_P"7G_5F']I9?_T&X7_P?3\O[WFC3HK,_MC3/^?VV_[_ ,/_ ,<H_MC3
M/^?VV_[_ ,/_ ,<H]C6_Y]5/_ '_ )>?]68?VEE__0;A?_!]/R_O>:-.BLS^
MV-,_Y_;;_O\ P_\ QRC^V-,_Y_;;_O\ P_\ QRCV-;_GU4_\ ?\ EY_U9A_:
M67_]!N%_\'T_+^]YHTZ*S/[8TS_G]MO^_P##_P#'*/[8TS_G]MO^_P##_P#'
M*/8UO^?53_P!_P"7G_5F']I9?_T&X7_P?3\O[WFC2R,@9Y]/\?Z579Y X&5#
M!AM0D#S%.<D=R5'/ X[U1?6--Z+>VP8E>?M$.< \_P ?89_#->"^.O$>IQ?'
M'X*6NFWZ?\(]>V?C4Z]LNK=8"\.FQM8>>IF&6\XGR_E/.<<\4UAZ\M(T:LG9
MRM&G)NT5S2=DMHQNWV2?9B>:9:M7C\(M5'6O36LFHQ6LMVY));ZGTC169_;&
MF?\ /[;?]_X?_CE']L:9_P _MM_W_A_^.4O8UO\ GU4_\ ?^7G_5F/\ M++_
M /H-PO\ X/I^7][S1IT5F?VQIG_/[;?]_P"'_P".4?VQIG_/[;?]_P"'_P".
M4>QK?\^JG_@#_P O/^K,/[2R_P#Z#<+_ .#Z?E_>\T:=%9G]L:9_S^VW_?\
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M/?'5S)O+Z?,_BC52;*?;B24?Z2=N]/EXQ^77WKX>?LC?$SXA>"=*\?\ ]O\
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MKQN]6>2#Q[\0_P#HHOCD#K_R-NKXZXR!]IQ_];IUH_X3[XAX(/Q%\<\D\?\
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M/B+4JRR]X[/X1PU6DZ[GF564(T\1.+E.7O645S6U>JLNFG!GQ]\17=97\?\
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M].I_X3[XA_\ 11?''_A6ZM_\D?\ Z^U)_P )]\0_^BB^.?\ PK-7_P#DC_\
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M*S5__DBN7P/0?E1@>@_*C_5S)/\ H395T_YA:/EY>7^70%QCQ5I_QD.:=/\
MF*K_ -WS\OZOIU/_  GWQ#_Z*+XY_P#"LU;_ .2*/^$^^(?_ $47QS_X5FK?
M_)%<M@>@_*C ]!^5'^KF2:?\(V5=/^86CV6GP^6OFM'L"XQXJT_XR+-.G_,5
M7_N^?DOO\].I_P"$^^(?_11?'/\ X5FK?_)%'_"??$/_ **+XY_\*S5O_DBN
M6P/0?E1@>@_*C_5S)/\ H3Y5T_YA:/1+^[Y+Y]07&/%6G_&19IT_YBJ_]WS\
ME]_GIU'_  GWQ#_Z*+XY_P#"LU?_ .2/_P!7>E_X3[XA_P#11?''_A6ZM_\
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MY; ]!^5&!Z#\J/\ 5S)/^A/E7_A+1\O[OE_6@?ZX\5:?\9#FGI]:KWTY//\
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MT)_P4&^)UA*\WB3Q%?>%?A9;W\;R66E:-8W<T$=_H?G+MBCEMXEPT6T9;Z4
M?M#J^M?#W]DS]GPZAJ<EEH'@?X2^";:V\M$2WMI9-,L8X88H0-JB2_O5   '
MSS,V.,'\V/\ @G-\)O&_QD\=?%+_ (*%?'71_LGC?XK1:CH'PBT6Y:.7_A%O
MAC;O-':&T1G<6DNI+%%() 8V9'<Y S7WY^V-^S3:_M>? 7Q9\#KKQI>^"8/$
M\<4%QK^G6D-]=6S1,' %G/)'$^6 8!G&" 17XPV__!!SXG:'I%K9Z1_P4?\
MV@-(TO2+(0K9V9>+3H[*UA/[B"WBU+;;0K&AW+ C$+N"J>A /2O^"+D<R_%/
M]N=04,/_  N6]\QE=))/--S=X+MN+9 SD*",X)/2ON_XU_L.:QXP^.:_M&_
M3XQZG^S]\7[S0)?"OC+6[+PSI_BS3O%FE.0\'VO3-5FBM5N+8 +%<(&=2@.
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M_AU)5\W61*9H8,0[BDDZ@J$#,$TW:W=?/4:O]VOW?U_P;G[*_LS_ +0?@_\
M:7^$/ASXK^#HKFUMM6$]AJFF7D?EW&C>(M-98-;TF3))*6=_YD$$I'[]$63'
M->R>)]7;0_#FLZS%9S:G<:9IEW>PV%FGF7=[);Q&06UN@Y:20J%0#J3TK\T_
M^"1_PY\4^ OV69;OQ5I^IZ"?&_Q!\8>+=(T?5X'@NX-&UC5GO--N?*D^81ZC
M:SK<1L.-A!'6OU#FV8",.&.Q0BY//TZ ?Q'OD]36LI0AB\-.<;TX33<&VE/6
M+<&U9J^L=-4GH[G-B(UJ]#&.G+EJ5:$X4GNX2:E&,U?25KJ23^)+JKM_Q5?M
M8_'CXC?'KXP^)==\=+=:.NBZC<Z;I'A:[#J?#MI;2-%$!;2<?:+I,&<XR''4
MU\S!3S'OF_>/ON;B8%5V=E7/J..O ^A%?T7_ /!3']@X>-+"_P#CO\*-(2S\
M:Z7;M<>+]$L( R^)+2U4E+N*)%PMW;QY:38-T[8+'=DU_.C(6B$J7D<@*RB*
M\@8%7LI@<3PNI /F*WRM&1\AR*_TL\(>(,BXDX4R_#Y%A8X.>$DL/B\!"O34
MZ<Z<8<SM&UXR^*#:]Z+YM7>W^+'CYP9Q=PGQOFM;B#&5<QCFM26(PN8.G5I4
MI4*LVX892J-KGI+2?O::15K7;1G^X$4<1XYW1C[K?B/TH8G!VDAL9&!DY]AW
MYZ4X]3@80?ZO_KG_  <=N.WXTUN%)YSCJHRWU [GN!ZU^K*K*GB'AZ=?V=!0
M<9P;YKSMHN9=9/17ZM>=_P $FVU&A*I5]O3UA449O#TTK:5(I)5+O>SL[]K$
M-PRF&4Q0IL^R2I=2W!\O:2N&81GY<C!XZ?C7[)?M#:%\"M9_9I_92F^,/Q%\
M7>"KBT\/.GA^3POX<365U'_12'6XC. @C7F(]6/3UK\;[E5GMI8HT!61-DIE
M8K-M/#E8N[8[>HQ]/LS]H_XY> ?BM\&_V??!7A0ZG-K?PQL)['Q"E_:&TM8B
MT'E6YM9B<2?/][ Z'GM7Y[QQDN,S7-N#*F%KX_!TZ&.K4L3B,/.G*I@_]CK?
MO&ZE.K3BJCY:5W3=W)+J?K/ '%&5Y7DW&M3'TLNQ-6ODV PN'PE7"3^J8G$4
M<9"<INBI0<I6ULI?9O9W/IKQ'HOPFTG_ ()G_$JS^$?C7Q1XQ\/-XSANKK4?
M$NB+H=^NI?:=TL/V9?O0Y 4'."/6M_X\?!75?C)^RA^RI'9^*OAKX6.F6+2S
MS_$+7XM!>7SK?:BZ6TBDW"J2"T7 VC%?'^C_ !P\!6G[%/CC]GVXDU8?$/7_
M !)'K%N/L;?V28%G\P*UZ#A05.&;&0"3VJ3]HCXV?#OXI? G]GKX>>'C>W?B
M/X8P3IXJ@U*T$&G6[M;>5&UA>'/VL"3E.FX<<U^>QX?S[#XO#T<+4Q$L91X]
MS"O3S'&X:&-3H/*H16+K4Z<:%-PG**I*:C"+G&"M=(_2<;QAPEC,GS%X^A2G
M0QG >28>66Y95>6N&+CFG-/"TJDW5E&5.%IR6KY7\SS[PKXN^)7[*OQ)U*T\
M!^+?"4FOWL4.C:AXA\,P6NLZ;#83L(KF?2]0VC[/<30L09(2&7&0>!7TI_P4
M#N#J_CO]GY[Z=[_^T?A?X1.HWUS,S3W*WEQ&;FZ,CDM(PWNS@_>7Y3P":^+O
MAAI/PJOM3,GQ5\;>(? >@V\\4VF7GAS01KEQ?WD3!I(KJW(_<P@  ?PGI7V)
M^U7\1/V6/C1:^$=5\(?%7QY;>*/ '@C3/#.FZ9=>"UATO7'T\ 1W<U\>+)V(
M#&)/NG/6O;XGPU2CQGPWC:^6XK%X^6"JX7'YC@,KQ%'#SE7PLJ6'G.O&G*FX
MTZDY2G!5)*BFU)Q5V?/\)5,2N$.,\'B,9#!\-SQF$Q>2X3%9OA7BU&CB:%6K
M%4Y3C.<G1CRIQ@G5?NQO+W2W_P %%R='E^ ?A'3M0:;PSH'PFT/6=#LH1Y-B
MNHLBNVH01I^[$^>"RC<",^@&C^VDBZU^S_\ LE>-M1N&D\0W7@FSTN_%PHDN
M[RRA!,,JRN?,*9 &3P>.!G%<MK/Q<_9U_:#^'GPKTGXXZ_XI^&OCOX510:(^
MI^'-"_X2&U\:>$;'9]F2=VXL)[C:QE0<H&Z]!7D'[3_QQTGXP^(-!T;P397-
MG\-?AKX>M?#?@NVOE:WFU.QM=NW59T.?LTTS!B8QC&X=.*X^%<#F*S7A+"+*
M<1@Z_"N)S.>98RI2E3I8]5_;0IRH5[.G6E75:G)J,YRC&,I5(Q:Y3OXKQF62
MP'&F-PF84\3@N*\!@Z.74(8FDYX&6'EAYSG6I<RG1M[*2BN6/,Y*VEF?-%A;
M6]SK_AYY8TF=M;T4/,J M%MU"W;R<8^27'<<]*^_/^"F4$,OQ/\ A=*($/E?
M!W28HE<"680A(FV2LPW;QU&>O'/I\"V$D=IJFDW3QDQ6^H:;J5R\;'?;PV]Y
M%+*\,8XN)0B' /)QBOJ;]LCXU>"/COXQ\&^)?AZ^I7=AX?\  5GX6U%]7M3I
MTLNJVX42QK$22(U"G;-D;NP .!]CGV6XC$<7\.XUX*I4H4</F-/%5DG*$:E2
ME35-SDKQC*?-RTK^]+E:2UD?!\,9A3CPIGN$A5DZE6%#]V\3!2E.%6#;I;<L
M4EK'57:UOH?8OCSQ%\#_  U^R?\ LUW_ ,4_ UU\3;F[T"TMM \*/?S>';*W
ME>]"W&J7&JVO[TRQQ'$5BWR.V..:\R\?_LA^ _$WQY^!?A3X975WX/\ !'QJ
MT"W\3^3<L][=^&+>,(]WI5F9AOO7E"R112OEB&4\9Y\'^,GQB\$^//@E\"?A
MSX?&I3^)/AU8P6^O6][;&#389TG$CM!>DGSL+]WCG%>O>+/VO?#.G^.OV9O&
MG@*QN]=N?A!X/BT3Q3I5ZALQ=7+NL=TNGW'!D6&$R/',O.]%%?FG]B\49%&M
M/(ZN;TL7F%3.85X5JE6>#HPMBY8)K#37L:3G5AAY4JZBIR]HU4J2A-H_4L)Q
M!P9FT<+A.(\)DD(Y50PE2DZ5*C'-<;.,J4*D*^,UG53@YN5.3Y5\2BFF>\6O
M[,?PO\7_ !6U_P"#%E^R3\1/ ^B36UQI/A;]H*XO[R:%]:L[=V.KZGH\LIMK
M:PN98"4W+L_?+Z UX[\,?@+\&/"GP6^.7Q!^-/AS4/%>O?"GXDR^&[2.SNI;
M;_A)[*"-Q#I,_E9%A;W3()6NHSF,'WJAXZ^)GP$\;>(]>\66/[7O[1?@NV\1
MS-?#P+9:=J5]8Z->31%YK.&Z:8;[$73-&''RJG3K7FOA;XY^#-&_9A^+7P@U
M?5-<UCQQXL\;G6="U"[@=X]4L$C,4-]?7;-E;EXP'DC;)#MU'&>/*<JXTKT\
M-0K9OGZISS'+8XU.EF^'KX>E.I46,KPQ&.J3C*ER\L*L<'-4:2C[2"4JD9/U
M<WS/@>"^M?ZJ9+EV(GE^)>5<N+RK$X>NXQBJ'M\'@5&HJUY.:GB/?FUR2349
M1)_A=!\#_B%K'BOQ'8?L[^,O%.IVMD)?#?P.\)W-[J6EM%M&-<U3Q2&6>WF5
M@(_LK/@D[L5W_P"T=^SMX6T3X#?#SXXZ%\)M>^ ^NWWBJP\,^*?AGKUW/?17
M)O[R,I=KJ-PS2*%@9D$8.,C.":P?V<?CY\)_"?P-\9?"#Q_KOBCX8ZYXFU2&
MYT[XF> +"2\\21;(PIL)IH"LT%KN!DV[MA./45UGQO\ VC?A!XJ_9C\,_L_>
M#O'/Q ^(/BGPU\0- UJX\7^/+.Y2;7[."YB$LQGN'=H6C)6-(EQG:6YW<>CB
M)<5T^,<'6PF(S_ZE@<PH9?6PU>IF6)I5,M^J^_F$\3*7U%PYO<=.HJN-C)NM
M5J/XH\.74N#,7P'B(YE@LB6.Q67U,=2S' QR["5X9BL="$<K^J17UR+=)RJN
MI#V>&E%<L8+X7TOQE\(_L:_L]^(_ VA:Y\*-9\?W7Q!T?P]J/B#SM9O-)@\*
M6M]:P+<_V=Y7_(2EDGF\^,O\R!0HXXKJ]._8\^"MG\7/B)\&KFQGU.;Q7\._
M^$[^!>KW5]);SZ*9M/:\31[F#@7<B.R &4%V$?J2:ZG]JY_V6KSQI\(;[XP:
MWXO\)>*/#?@_PQ-(= T5M<T[Q1I\6GVLPBN@?DL)%=%C#+R4.^OC_P ;_M+W
MWC[]K7P1\4O!=C=V^F>%]5T'2O#6EQ3R"2\TFRB6P6$@'+FZ@;?-:=-V5[5Y
M.4_ZT9E@YU,/B^(*7/E&82JUL3C,6J$\;''4:F7SP\Y-4>25.%>-6.#C;V<D
ML3&51I/U\\CPKE6/>"JY3P]6=?-\KA0A@\%AHXJGE]7+81Q+KJ'[UR5:2FG7
MEK/6BU!-JU\*_@7X$TGX!_'3XL_%W1I[F\\,:[+X&\ #[5);K%KXWV\EX1E1
M,$N4)V$%?X?<?.7[/VC1^)/C5\*- N[:*2#4_&NCVT_FMN*[Y-WS;L90E<E>
MG./:OT)_X*;>//"UK?\ @?X,> [9-$TA+.+QM\0M"@/D1R>)-;0:C#+(5^].
MC2,&0@X;CWK\W_A7XCB\&_%/X>>++II5M=!\3Z=J;P,/)^SB"7"7,LPY)C5A
MB)N'!YS7Z)PJLZSG@_-\UG7QD*N>X6M6RW"8BM*2PKI48X>A%IR<'[6=.6)Y
MHJ-X58QGS2C<_*>-,OR+)>/,AR'V5+$4LDJ0CFF+PU6G3HXV&+FL4I4IN,73
ME1A4C0:DY.\'RMIGVI^U+\1KGX;?M['QNUE:W<?P\U#PJRVC/L!LM)@,?E C
M_5F2/[A7&./:O1OB-\$_!O[6>I>-/VAOV5OB5J%OX]O]/GU'Q?\ "G6Y?[-U
M\0I"9=;FL[[<+S4;-WWFUM23"Z87N!7FG[8 \#:+^U\_B[XA^'+WQ+\-/&6B
M^%=4NX;::2U>[AU"Q\^XOK.XBYG:SW?Z@$C/!J3X8_%+]E;]G#7?&'Q-^$7C
M3QWX[\9ZCINIZ/X=\):WH#Z%8Z+;:HK+AM0&#J']GC:J*Y_?#!(XKY"K@\16
MR/A3-,HP.8TLXPN1SP6$K4L)];RS&IXN+K8+,:3C*%!2G&<U6JU<.H74HUI\
MLH'W.#Q4*><<2Y%GWU27">*QV%QV:*MBJ>&S#"58X91PN,RZ3E[3$RITI1C6
MIT*59U&]4K\R].^$>@?#J^_X)\^/O#WQF\2:YX0T&S^(-DNI:KH^B)K.KVFH
MPW/[NV.G29#%I!M=CS&:^&;#0_A!H?QC^%K?"?Q7X@\8:(?%VBQSW7B+0X_#
M]^D[7(!5K2, 3+D#RF;/J,5]%_#GXW? GQ1^SCXW^#OQH\8>+?!VN>+_ !M+
MXPGU7P_X=_M<6L@NOM"QR+D#:3E2N#VYZ@_/FKV?P'\$^,?A]K_PO^)/BSXA
MV>E>)-/UKQ5/K?A@:&VF:?ILPE$U@%_X^Y]N2(?XB,=*Z\CH5,'G'$^%Q4N(
MHXK-%.<</3I5GEDO^$_"-595H89P<W4C5I17MTM%2<)2<#DS7'QQ&7<+U\+'
MAJEDN58J<<3C*M;#_P!K2HK&552HRI/$*I&,Z7LYU%[#WK*=TN8_7_\ :$%A
M^T5XE^+W[*.N7BVWB;1O &A>-OA#.T2372ZA:67VO5=-61P60:AA8=BD$CCF
MOB_]O#3+S0_@7^RSHNNV8M;[2]$O]/UNTN(Q^ZN;:U\JXAMHV!VRQ;>549)P
M.<#'D7QK_:=TS7/VJ-&_:&^$5]J\]CIMGX:MHEU.T;2]1U :3M_M.SDM0<BU
MF"["2<.O7N*^B/VHOVM?V=/VD?'?[/>NZA%K5CX;\#:H^N_$?25TDB%;Z1(9
M)+*R!9A>+/<++'(,!6C"[AW/S.5\,\49'B^'ZU3*<?B\JJ2J9M6ITX2C++L1
M##3CB,/.E*"E#ZRJBE3YE%?6(RNN>H?2YEQ-PIQ;D.=81YGA,#Q33J4,EI5,
M3)5)YI@\6XN%:5>-DZ.%A&-.TFVJ5N5VB<A\*M)T[]D/]FO5OC/XBTRRM?C5
M\6K*XT3X46$B(M_I'ABXC,4^O;2/,M7N[7+QR*5.0.M>)_L1_#R^^+'[1&E7
M>J65SXA@\/+J'C35[J5/M%Y=ZGIBC4+2.1'.))+^91%%([;I6QSZ^S?M%>.O
MV1OVB/'$GC2_^/GQ+T&PLM-L=(\/>%[?X?J=.\,Z98J%CM+"$$QDR(""P W#
MK7GG@/XS?"3X%_"3XQ:#\,/%7BO4?BA\0GM--\,>(I=';3)[/0[*8D7)N$*M
M87$T1Y16!7V[_39?C,ZQF19Y6P^7X^GQ!Q!7HX6I5Q.68N%/ X2O*.$I4*-2
MM1I*5#+Z+=:K&,OWD_K%9*,JQ\MFD<+@.(N'J,\=ET.&N#\/3Q5&C@L=A<17
MS"O0I0Q&*IOV-2;C+&XA.%*4X.-).$&VJ;/L.Z\$?&']H#X0?M/Z'X^\ ^,?
M"K^'=>O?B)\/=0\3:9Y<<%M+(7O-/TMWDD9(TMH#N2, *C=*_*CP_P# KXU>
M)](;Q#H'PJ\9ZOH5PDA%_IVG-=6TTENS^;/%(7&$^0L<#^E>U_LV_M3^,_AI
M\5-'U_XF>/O&WB3P#+8:EH_C+2]0UJ^UJ"ZL-3MVMR\%A<2F-YH0[L5&-P..
MIS7E_CSXJ:O8^-_%%O\ "KXE?$32OASJ&L7=UX?T^'5M0TR&WTJZ;>D4ME%*
ML=K%EF!P,8KUN$\AXPRC%8_):E; NG66#QV#DL)C(94X1@Z6*PTZ<*JG'$IP
MI54Y22J.K5J:M3/"XSSW@;BO+<MXC>6YS&I[7&X?-L&\TPJS&4W7O@:M%RIM
M/#TJ=XM1IZ)1BFM&?=/[,6A^$+C]B[]HS0/BUJFK^$?#:ZM:V_B&^T_3%U36
MM)N8;PD0G2),I+('&UL[MO'.:^"_$?A[X):'XK\#2_"/QKXE\8V">(]%6]E\
M2>'H_#MW#(VH0 %(8P/M,)XV;\@'IFOI/X#_ !I^#.F_ #XN_!GXR^+?$WAO
M6?B'?17EMXA\.Z0?$MP]M!/YWGR!LFXNI>?-+EF Y)-?._C[0?@3X9M/#VK_
M  ?^*/BOQSKJZE%=/9>)O# T.TACLW6>WE>?^&19TXC/!(QSFL\DP.(PO%7%
M6'Q4\]@\Q?L</0PU"O')ZO-EV'@\17KQH3I)TYPE22>(IV=-1E%WC?TN(\QH
MU.&>$5A:>4XO+L%4I5YU*^*H/-\+!5E+V4J<JZG42C:[6'=XIM/=GTQ_P4M=
MD^+W@J,#RL?"+29!;A/,:1##'^\9B/E?'&WV'XZ_[2,<+?L%_LO8,\D1U6>0
M,-RSI*+:0H-N?W:A\'*\$=>*I?$#XP_LV?M0Z!X UKXV>(?%GPN^*?A'38/"
M^L7/AC03K]KXJ\.V83;(P)VVD\H#*Q7E0,]\'RK]ICX^>&?BAH?@CX1?"C19
M;#X7_#"TCTOPK=:E*T.I^(I63RCJMU;M\T5U+(S9@[ @=*\[)\MS6L^'<IJX
M#,<-5R;&XO&YI7J0JQPE"AAH8BG0>&Q$X1IXAXKVT9T_8SFX1OSQ23MT9K7P
M.7X;B+-J&;X7$QS?#9;A,GHTZD9598K$TXQFI4%)U*"PL_=G[2,%*WNMW1[5
M^T):IXI_8G_9H\:7KK]ITK48O!VKWC1*;A-+CQ*ZP=6F:%,R1IT9P.N:YCQ+
MXZ_94G_9FA^#&A_$SXDW>OZ=XB'C;3KV?PBL,%YJ+6ZP'1+IL_+;!MV+GJJ#
M/I71_M9ZO9^$?V8/V5_@RT;67B!=%C\=:RG\5T+G="(A!QNE"MD$C=CD&OSB
M1D*AH=XBY,9D&QV!)#%AV.1@CT_&O>X6X:CG^2X:M6Q6-PM#"\39KC<)2IU*
M,:>)I4<PG[/VL)4:LK)QJ/W94W+VDF[2LUXG&G%>)X>SQ4L)0P6)JXCA3*,'
MCJWLI2=+$3P$:<YP<*L%.?,[M-S2M:UKW>8U#'8(HXY%+^;')YD$<H.U464G
M_7.F&:+^%CU%-_7W'>@* OE@*$#[@@(VAR,EMN<;C_>Z]O:C(]1C&>HZ=/Z5
M^Q^PC&5)T>>$:<5%Q=2][<O9:+3:_KOK^%QJN;]I7ITJE;VCFYJA)?$TU^&B
M:M\^I^=%'Y=<=1U_.C(]1TSU'2JY-7[L7=W]Z5W]GJK=[_\ #HSOSWG6E5YG
M)V5*+A!+3E5N^WKH%%'Y=<=1U_.CWR.YZCMU[T<G]R&OF_+_ #_#S0*-+^;$
M].KWTVT]&O)(**/;(Z@=1WZ=Z/?([GJ.W7O1R?W(?>_+_-_=YH.6E_-B>G5[
MV6VGS7DD%%&1ZCMW'?I1^7?N.W7O1R?W(?>_+_-_=YH.6C_-B>G5[Z;:>EO*
MP449'J.W<=^E'XCOW';KWHY/[D/O?E_F_N\T'+2Z2Q/WORVT]'Z)!11^([=Q
MWZ=Z/Q'?N.W7O1R?W(?>_+_-_=YH.6E_-B>EM7V7E\_1(**/R[=QWZ=Z,CU'
M?N.W6CD_N0Z=7UM_F_N\T"C2[XGRLWY>7I^ 44?EV[COT[T>V1U(ZCMU[T<G
M]R'3J^MO\W]WF@4:7\V)^][:>7I\K!11[Y'8]1WZ=Z/;(ZD=1VZ]Z.3^Y#IU
M?6W^;^[S#EI?S8G[WM9>7]*P449'J.F>HZ4?EUQU'7\Z.3^Y#IU?6W^;^[S#
MEH_S8G[W:VENGI^ 449'J.F>HZ4?EUQU'7\Z.3^Y#IU?6W^;^[S#EH_S8G[W
M:VENGI^ 449'J/7J/7'\Z7'TZXZCTSZ^E')_<ATZOK;_ #?W>8<M+^;$KOJ]
M/AMT^_Y"449'J.F>HZ4?EUQU'7\Z.3^Y#[WY?YO[O-!RTN^)^]^5NGI^ 449
M'J.F>HZ4?EUQU'7\Z.3^Y#[WY?Y_AYH.6EWQ/WORMT]/P"BCWR.YZCMU[T>V
M1U ZCOT[T<E_L0^]^7^;^[S0<M+^;$_>][Q\NFWK8**/?([GJ.W7O1D>H[=Q
MWZ4<E_L0^]^7^;^[S0<M+^;$_>]]/+IHO6P44?EW[CMU[T9'J.W<=^E')?[$
M/O?E_F_N\T'+1_FQ/E9O?3R]/G8**/Q'?N.W7O1^([=QWZ=Z.2_V(?>_+_-_
M=YH.6E_-B>EM7W7E\O6P44?B._<=NO>C\NW<=^G>CD_N0Z=7UM_F_N\T'+2Z
M2Q/3J_+R]%ZV"BC(]1W[CMUH_+MW'?IWHY/[D/O?E_G^'F@Y:7?$].K\O+TM
M\@HH]LCJ1U';KWH]\CL>H[].]')_<A][\O\ /\/-!RTM/>Q/3J]KK;3[O-(*
M*/;(ZD=1VZ]Z,CU'3/4=*.3^Y#[WY?Y_AYH.6EI[V)^]WMIY>EO0**/RZXZC
MK^=&1ZCIGJ.E')_<A][\O\_P\T"C1T][$]-F[VT\O2WR\@HI<?3KCJ/3/KZ4
MF1ZCUZCUQ_.CD_N0^]^7^?X>:!1I:7EB>E[-^6VG7IZ(**7'TZXZCTSZ^E)D
M>HZ9ZCI1R?W(?>_+_/\ #S0*-+^;$]-F_*W3KI;T"BC\NN.HZ_G1D>HZ9ZCI
M1R?W(:^;\O\ /\/- HTN^)Z;-^7EZ6^044>V1U ZCOT[T>^1W/4=NO>CD_N0
MU\WY?Y_AYH.6E_-B>G5[V6VGS7DD%%'MD=0.H[].]'OD=SU';KWHY/[D/O?E
M_F_N\T'+2_FQ/3J][+;3YKR2"BC(]1V[COTH_+OW';KWHY/[D/O?E_F_N\T'
M+1_FQ/3J]]-M/2WE8**/Q';N._3O1^([]QVZ]Z.3^Y#[WY?YO[O-!RTOYL3T
MMJ^R\OGZ)!11^([=QWZ=Z/Q'?N.W7O1R?W(?>_+_ #?W>:#EI?S8GI;5]EY?
M/T2"BC\NW<=^G>C(]1W[CMUHY/[D.G5];?YO[O- HTN^)\K-^7EZ?@%%'OD=
MCU'?IWH]LCJ1U';KWHY/[D.G5];?YO[O-!RTOYL3][VLO+^E8**/?(['J._3
MO1[9'4CJ.W7O1R?W(=.KZV_S?W>8<M+^;$_>]K+R_I6"BC(]1TSU'2C\NN.H
MZ_G1R?W(=.KZV_S?W>8<M'^;$_>[6TMT]/P"BC(]1TSU'2EQ].N.H],^OI1R
M?W(=.KZV_P W]WF'+2T][$_>_P"[;I_7NV$HHR/4>O4>N/YTN/IUQU'IGU]*
M.3^Y#IU?6W^;^[S#EI?S8E=]7I\-NGW_ "$HHR/4=,]1TH_+KCJ.OYT<G]R'
MWOR_S?W>:#EI=\3][\K=/3\ HHR/4=,]1TH]LCJ!U'?IWHY/[D/O?E_G^'F@
MY:7?$_>][QMT[?CRA11[Y'<]1VZ]Z/;(Z@=1WZ=Z.2_V(?>_+_-_=YH.6E_-
MB?O>]X^73;UL%%'OD=SU';KWHR/4=NX[]*.2_P!B'WOR_P W]WF@Y:7\V)^]
M[Z>731>M@HH_+OW';KWH_$=NX[].]')?[$/O?E_F_N\T'+2Z2Q/2VK[KR[?C
M8**/Q'?N.W7O1^([=QWZ=Z.3^Y#IU?6W^;^[S0<M+^;$]+:ONO+Y>M@HH_$=
M^X[=>]'Y=NX[].]')_<ATZOK;_-_=YH.6ETEB>G5^7EZ+UL%%&1ZCOW';K1[
MY'8]1WZ=Z.3^Y#[WY?Y_AYH.6EIKB>G5[76VGI;SL%%'MD=2.H[=>]'OD=CU
M'?IWHY/[D/O?E_G^'F@Y:6GO8GIU>UUMI]WFD%%'MD=2.H[=>]&1ZCIGJ.E'
M)_<A][\O\_P\T'+2T][$_>[VT\O2WH%%'Y=<=1U_.C(]1TSU'2CD_N0^]^7^
M?X>:!1HZ>]B>FS=[:>7I;Y>044N/IUQU'IGU]*3(]1Z]1ZX_G1R?W(?>_+_/
M\/- HTM+RQ/2]F_+;3KT]$%%+CZ=<=1Z9]?2DR/4=,]1THY/[D/O?E_G^'F@
M4:7\V)Z;-^5NG72WH%%'Y=<=1U_.C(]1TSU'2CD_N0U\WY?Y_AYH%&EWQ/39
MOR\O2WR"BCVR.H'4=^G>CWR.YZCMU[T<G]R&OF_+_/\ #S0<M+^;$].KWLMM
M/FO)(**/;(Z@=1WZ=Z/?([GJ.W7O1R?W(?>_+_-_=YH.6E_-B>G5[V6VGS7D
MD%%&1ZCMW'?I1^7?N.W7O1R?W(?>_+_-_=YH.6C_ #8GIU>^FVGI;RL%%'XC
MMW'?IWH_$=^X[=>]')_<A][\O\W]WF@Y:7\V)Z6U?9>7S]$@HH_$=NX[].]'
MXCOW';KWHY/[D/O?E_G^'F@Y:7\V)Z6U?9>7S]$@HH_+MW'?IWHR/4=^X[=:
M.3^Y#IU?6W^;^[S0*-+OB?*S?EY>GX!11[Y'8]1WZ=Z/;(ZD=1VZ]Z.3^Y#I
MU?6W^;^[S0<M+^;$_>]K+R_I6"BCWR.QZCOT[T?EUQU'7\Z.3^Y#IU?6W^;^
M[S#EI?S8G?N[6]VW3^E8**,CU'3/4=*/RZXZCK^=')_<ATZOK;_-_=YART?Y
ML3][M;2W3T_ **,CU'3/4=*7'TZXZCTSZ^E')_<ATZOK;_-_=YARTM/>Q/WO
M^[;I_7NV$HHR/4>O4>N/YT?EUQU'7\Z.3^Y#7S?E_G^'F@Y:7?$_>_[MNG]>
MZ%%&1ZCIGJ.E'Y=<=1U_.CD_N0^]^7^;^[S0<M+OB?O?E;IZ?@%%&1ZCIGJ.
ME'MD=0.H[].]')_<A][\O\_P\T'+2[XG[WO>-NG;\>4**/?([GJ.W7O1[9'4
M#J._3O1R7^Q#[WY?YO[O-!RTOYL3][WO'RZ;>M@HH_+OW';KWHR/4=NX[]*.
M2_V(?>_+_-_=YH.6C_-B?*S>^GEZ?.P'I1_G_/2C\N_<=J*2BW.G!TX<O,JC
ME=6TMIKU_#J:T*OL:J4*U6,)Q:E&2;;VU3M9)+3U78:W;_>%?27['^/^&F?A
M%T_Y&S3L?^!4?X^N?ZXKYN/\.?[P[<GZ=/;//0U])?L??\G,?"/_ +&O3^<'
MG-TG8_G^(Z5\-XFTXSX#XOFX0IQP^3XJ*D[>_P \%+W?3S^[M^E^"DH2\4>!
MZD:LY2AQ3E_+3M*]2]3=/2SZ;/S9_;?1117^5Y_NN%%%% !2'J/K_0TM(>H^
MO]#0!^9_QW_Y/X_9I_[ UY_Z5S5^F-?F=\=_^3^/V:?^P->?^E<U?IC0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %12[MHV,%.
M>FW.X>@_^M4M1R8QD]L]O;/WOX?3- 'FJ> ;%?BO+\2/[1_XF,G@Y/"W]D8C
MQ]E2_%[]L+9W_?\ W6-NW  SGBO31T'(;W'0_J:X&"'PV/'32G4_^*SD\/(H
MTP7FY8M#6YREP;+[K9G^7[3C+'"\5WJ\*.,>U #J*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "L_5K2/4-*U+3Y9/*BOK"\LI)< ^
M6EU;R0/)@\'8LA;!XXYXK0JGJ(MVT^]6[?R[1K2X6ZDW^7Y=LT3BXD\S^#9$
M7;?_  XSVH XKX9>#[3P#X#\,^#]-U(:E9:!926T6H%4_P!+CDN[FX+90L@(
M>8J=K'[@_#O0O!9"-S8RV,9P3R1T/IT]ZXWP?:>';3PMH5OX6OGU#P]:QO\
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M:^)+J.WBDG8NT5K"J%8(%)Q'$IVH.!D51N/^"1'[&YVF#PCXDQT8-XFO ?\
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MOD$N222@W %5'W>GO7]6I_X)#_L:J2#X4\1ESDJH\3WN#QTSL [_ *<5"/\
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MO8D#'FCGS&7^,^WM7]7!_P""1'[&X4@>$O$1(!V_\51=GG_OCC\JA3_@D/\
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ME_\ "GO?_B:2^D]PG_T*\S_\%T>\6[?O>]_N7S/^)*?$[3_A:RGI]NI_=O\
MJ?RC[AZC\Z-R[XD+*#*2%R0 ,==Q[>U?U<?\.A?V-O\ H4?$O_A3WO\ \33'
M_P""0G[&C*5/A+Q".ARWB:]W#!SUV''^'UIKZ3W"?_0KS/I_R[H_W=KUN]_N
M%_Q)3XG?]#K*7MHIU+_9].S/Y24971W5AB.0QD'ABR]2 >JGL?\ &EW#U'YU
M_5!??\$I?V(;'4]*TR\\.Z];WVMO-!IEN?%%VK73VJ>9,(QLY95QNQG^M;'_
M  Z%_8V_Z%'Q+_X4][_\31_Q,]PFK7RK,^G_ "[HO9K_ *>Z6?-IY?>_^)*/
M$]6OG.4K;>53^[?\F_GW9_*/N'J/SHW#U'YU_5Q_PZ%_8V_Z%'Q+_P"%/>__
M !-'_#H7]C;_ *%'Q+_X4][_ /$T?\3/\)Z?\)69=/\ EW1_NO\ Y^^OW+YG
M_$E/B=I_PM93T^W4_NW_ %/Y1]P]1^=&X>H_.OZN/^'0O[&W_0H^)?\ PI[W
M_P")H_X="_L;?]"CXE_\*>]_^)I?\3/<)Z?\)69=/^7='^[_ -/>FOW(/^)*
M?$[3_A:RGI]NI_=O^I_*/N'J/SHW#U'YU_5Q_P .A?V-O^A1\2_^%/>__$T?
M\.A?V-O^A1\2_P#A3WO_ ,33_P")G^$]/^$K,NG_ "[H]+?]/=;:_<OF?\24
M^)VG_"UE/3[=3^[?]3^4?</4?G1N'J/SK^KC_AT+^QM_T*/B7_PI[W_XFC_A
MT+^QM_T*/B7_ ,*>]_\ B:7_ !,]PGI_PEYGT_Y=T>EO^GNMM?N0?\24^)VG
M_"UE/3[=3^[?]3^4?</4?G1N'J/SK^KC_AT+^QM_T*/B7_PI[W_XFC_AT+^Q
MM_T*/B7_ ,*>]_\ B::^D_PG_P!"O,^G_+NC_=Z>UZ:_<@_XDI\3M/\ A:RG
MI]NI_=O^I_*/N'J/SHW#U'YU_5Q_PZ%_8V_Z%'Q+_P"%/>__ !-'_#H7]C;_
M *%'Q+_X4][_ /$TO^)GN$]/^$O,^G_+NC_=7_/WIK]R#_B2GQ.T_P"%K*>G
MVZG]V_ZG\H^X>H_.C</4?G7]7'_#H7]C;_H4?$O_ (4][_\ $T?\.A?V-O\
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M-P]1^=?U<?\ #H7]C;_H4?$O_A3WO_Q-'_#H7]C;_H4?$O\ X4][_P#$T?\
M$S_">G_"5F?_ (+H]XM_\O>]_N0?\24^)VG_  M93T^W4_NW_4_E'W#U'YT;
MAP,CD@?GZ^U?U<?\.A?V-O\ H4?$O_A3WO\ \356]_X)(_L6Z=9W5_>>%O$4
M%K902W5Q-)XHO D<,"F21V)7&%123["A?2>X3T_X2LSZ?\NZ-MXO;VO>_P!P
MO^)*?$[_ *'64]/M5/[O_!/Y425$DD990T2"1SGY=I[*>[?[/7ZT@=6564C:
MZAASS@^OH?45_53IW_!)C]BC6--L]0T_PSK]Q8ZA%'>VMPOBB\99H9.48'8<
MJ<9QSWS6B?\ @D-^QJ22/"/B/KT3Q->A1^&T8H_XF>X36^5YGNO^7=%VMRO_
M )_.UM?6WE8/^)*?$_KG.4K;>53^[?S[OT?FS^4;</4?G1N'J/SK^KC_ (="
M_L;?]"CXE_\ "GO?_B:/^'0O[&W_ $*/B7_PI[W_ .)H7TG^$]/^$K,^G_+N
MCT:?_/WU^Y#_ .)*?$[3_A:RGI]NI_=O^I_*/N'J/SHW#U'YU_5Q_P .A?V-
MO^A1\2_^%/>__$T?\.A?V-O^A1\2_P#A3WO_ ,31_P 3/\)Z?\)69=/^7='^
MZ_\ G[Z_<OF?\24^)VG_  M93T^W4_NW_4_E'W#U'YT;AZC\Z_JX_P"'0O[&
MW_0H^)?_  I[W_XFC_AT+^QM_P!"CXE_\*>]_P#B:7_$SW">G_"5F73_ )=T
M?[O_ $]Z:_<@_P")*?$[3_A:RGI]NI_=O^I_*/N'J/SHW#U'YU_5Q_PZ%_8V
M_P"A1\2_^%/>_P#Q-'_#H7]C;_H4?$O_ (4][_\ $T_^)G^$_P#H59GT_P"7
M='I;_I[TU^Y!_P 24^)VG_"UE/3[=3^[?]3^4?</4?G1N'J/SK^KC_AT+^QM
M_P!"CXE_\*>]_P#B:/\ AT+^QM_T*/B7_P *>]_^)I?\3/<)Z?\ "7F?3_EW
M1Z6_Z>ZVU^Y!_P 24^)VG_"UE/3[=3^[?]3^4?</4?G1N'J/SK^KC_AT+^QM
M_P!"CXE_\*>]_P#B:/\ AT+^QM_T*/B7_P *>]_^)IKZ3_"?_0KS/I_R[H_W
M>GM>FOW(/^)*?$[3_A:RGI]NI_=O^I_*/N'J/SHW#U'YU_5Q_P .A?V-O^A1
M\2_^%/>__$T?\.A?V-O^A1\2_P#A3WO_ ,30OI/\)Z?\)69]/^7='LE_S]Z:
M_<@_XDI\3M/^%K*>GVZG]V_ZG\H^X>H_.C</4?G7]7'_  Z%_8V_Z%'Q+_X4
M][_\31_PZ%_8V_Z%'Q+_ .%/>_\ Q-"^D_PG_P!"K,NG_+NCY+_G[TU^Y?,_
MXDI\3M/^%K*>GVZG]V_ZG\H^X>H_.C</4?G7]7'_  Z%_8V_Z%'Q+_X4][_\
M31_PZ%_8V_Z%'Q+_ .%/>_\ Q-+_ (F>X3_Z%69=/^7='^ZM/WNG7;L@_P")
M*?$[3_A:RGI]NI_=O^I_*/N'J/SHW#U'YU_5Q_PZ%_8V_P"A1\2_^%/>_P#Q
M-'_#H7]C;_H4?$O_ (4][_\ $T_^)G^$]/\ A*S/_P %T>T4_P#E[VO]R#_B
M2GQ.T_X6LIZ?;J?W;_J?RC@J7CCWJ&EW;<L /ESU/;.#CUI$=7C:13\JN8R#
MPVY>I [KSP?YU_5PW_!(;]C4KM_X1+Q"/F5LMXGO=PV\CG8<#\?YUDWG_!*7
M]B"TU;3-(NO#VNP:EK2W!TZU/BB[5[E;)0TYC79R44@L1V/6C_B9[A/3_A+S
M/SM3HZ:+K[;M?[MFQ?\ $E/B=_T.<JZ7?/4M?33UT=_7[OY7MP]1^=&X>H_.
MOZN/^'0O[&W_ $*/B7_PI[W_ .)H_P"'0O[&W_0H^)?_  I[W_XFE_Q,]PGI
M_P )>9_*G1_N_P#3WR?W+YO_ (DI\3M/^%K*>GVZG]V_ZG\H^X>H_.C</4?G
M7]7'_#H7]C;_ *%'Q+_X4][_ /$T?\.A?V-O^A1\2_\ A3WO_P 33_XF?X3_
M .A5F?\ X+H]5%/_ )>^OW+YG_$E/B=I_P +64]/MU/[M_U/Y1]P]1^=&X>H
M_.OZN/\ AT+^QM_T*/B7_P *>]_^)H_X="_L;?\ 0H^)?_"GO?\ XFC_ (F?
MX3_Z%69?^"Z/]V^GM?7[E\S_ (DI\3M/^%K*>GVZG]V_ZG\H^X>H_.C</4?G
M7]7'_#H7]C;_ *%'Q+_X4][_ /$T?\.A?V-O^A1\2_\ A3WO_P 31_Q,_P )
M_P#0JS+_ ,%T?[M]/:^OW+YG_$E/B=I_PM93T^W4_NW_ %/Y1]P]1^=&X>H_
M.OZN/^'0O[&W_0H^)?\ PI[W_P")H_X="_L;?]"CXE_\*>]_^)I?\3/<)_\
M0JS+S_=T?[M_^7OK;M96\S_B2GQ.T_X6LIZ?;J?W;_J?RC[AZC\Z-P]1^=?U
M<?\ #H7]C;_H4?$O_A3WO_Q-'_#H7]C;_H4?$O\ X4][_P#$T_\ B9_A/_H5
MYGY_NZ/]V_\ R]];=K*WF?\ $E/B=I_PM93T^W4_NW_4_E'W#U'YT;AZC\Z_
MJX_X="_L;?\ 0H^)?_"GO?\ XFC_ (="_L;?]"CXE_\ "GO?_B:7_$SW"?\
MT*\S_P#!='^[_P!/?)_<OF?\24^)VG_"UE/3[=3^[?\ 4_E'W#U'YT;AZC\Z
M_JX_X="_L;?]"CXE_P#"GO?_ (FC_AT+^QM_T*/B7_PI[W_XFG_Q,_PG_P!"
MO,__  71_N]?:^OW+YG_ !)3XG:?\+64]/MU/[M_U/Y1]P]1^=&X>H_.OZN/
M^'0O[&W_ $*/B7_PI[W_ .)H_P"'0O[&W_0H^)?_  I[W_XFC_B9_A/_ *%6
M9_\ @NCWBW_R]]?N7S/^)*?$[3_A:RGI]NI_=O\ J?RC[AZC\Z-P]1^=?U<?
M\.A?V-O^A1\2_P#A3WO_ ,31_P .A?V-O^A1\2_^%/>__$T?\3/\)_\ 0JS+
MY4Z*_EOM5]?N7S/^)*?$[3_A:RGI]NI_=O\ J?RCY'J/SI?\<=?I_C^-?U;'
M_@D-^QO@D>$?$F0._B>]_3Y#_P#JS40_X)$?L=,@QX1\2;B3_P S1>=QUQL]
MJUI_2@X0Y9P>69FIR@^5*%!-.ZU:]M\-V[NVGF*/T*?$1.?UC-,MJ2=&2@X5
M*B497BM?=>N_6[7D?RE2.JJ#U^=5"KRV2<<#^?(Q7TM^Q^&_X:9^$8X^7Q7I
MI;'.,W,>!GL1WYZ\&OZ'F_X)$?L=#84\)>(BX8<_\)3>9!!R>-G8?7WYKYE^
M,?[%GP,_9>^+O[-^L_"W0=9L-2USX@Q07L][J\^HQ"-)X7'RRJ,<L>#QC YK
MYSB[Z0_"W$/"N;Y!1R['4Z^88*M2YZD:?+=P23?)4G+>R6C3;UWN?7>'OT2.
M->$>-^%N(<1C<'/"Y'FV#QN(C"<W*4834I/WDHZ)ZW>B5S]ZJ***_C _TL"B
MBB@ I#U'U_H:6D/4?7^AH _,_P"._P#R?Q^S3_V!KS_TKFK],:_,[X[_ /)_
M'[-/_8&O/_2N:OTQH **** "D.<' R>P]Z6F.,HP.>1VX-%KZ7M?2_:_7Y <
M%\0OB)X>^%G@GQ#\0?&5Y+:>&/"VFW&KZS=PV[3SP65MCS62!</*PR, 8SG%
M?FA_P^S_ &#"55/&_C%A(2J2'P5?B,G/9_-(QV!/!%?4G[>SLG[(?QY<#>I\
M ZN4&.5 C3Y3QDDD9_2OYOO^"3W[$GP)_:ZT7XDW?QFTO7[Z3PI?Z;9:8-)U
MF72[=8[NV\YV?RT<>:I7"@C.,GC;S^Q<!\'\(9GPEGO%/%M7.88?),90PWL<
MGG056NJLH132JTZBYKRYKN:2C:^J/P;Q#X_XQRGC3)N#N$J&52Q&<X5XA8K-
M:526'H247+E<HSI)?"ERZN][7U/Z%O@)_P %)OV3_P!I+7Y_"WPY^(+0:[#/
M%;P6'BBP/A^75KB4_)::2+V7_3[F0?=BA^<G(52>*^ZS,QSG,>0&7(Y((/!X
M^4C@'/-?Q'_M[_LT>$/V/?VH/"'AOX#>)+RXQ-INN>&-(6_:ZU_PMK22HUO;
MW-XNV5Y+XEI+:1U4JAX4 U_9A\)KO5=0^%OPYO/$1D_MR]\%>'+C5OM!W3G4
M)M)M7NVE)Y:0S,^]OXFR>]>9XC<'Y1D.&R/.>&*^,GE&?X;V^&HYM[.>,IN%
M.-1QJ.E"E&TE.*OR7B[V;35O5\+N.\[XFQ7$&2<44<+#->':\:6)Q>5)PP-;
MVM25)*G>=6\H2@WI.2MNC@?VBOVG?A-^RQX&'Q%^,.MWVC^&S?VVF(=,TZ75
MKZ6ZNVVQ&.RB*R&)2/WD@)" Y->1?LY_\%#OV:/VJ?$U[X0^#WBK5-4UW3[?
M[7<6NK:-/I+& #>S1>>Y\S Z@8QG''2OQV_X+&>/[[XP_M$_!G]EKPU/,P?4
MK*UUV&V<NHNM<;-G+<(A.U8%'5AQR<U\3^ ;'5_^"<G_  4$\$^'KHR76CRG
M0]#U*\F)MH+JT\4 "\NV9L++'8 _?R0HQSS7VG#7A1P]FW!M3'8S&8^GQAC\
MLQ69Y5EM+$488:I0H0YZ=25%TI5I1E%QNX3C[TK:V9\/Q/XS<099QM3RO 8?
M 3X4P.94<LS;,*F'K3Q$*[J1ISBJT:CIQDY<T5[O2]]3^SLRR;MI.W#  @!M
MWJ.,XQ@\_P"1YA\5_C9\./@GH,_B;XF>,-"\(Z3!:7UW%_:M_;V]WJ:6$)GN
M(=+MI766]N40#;# &=V91P"#77WOB?2-.\,3^,I;I#H%MH\FN37D6'']GI;&
MZ:>/;DNIB&\$=<^M?QC_ !H\3_%#_@IA^VW<> ].UB>#2FUVZT;PA:W!>YT/
M0O#.E2B&Z\11:5N\M;N2U FNN"TK=:_/_#S@*IQ9B\=]=QBRW*,DPTL3F^/K
M1<I4U!2;HTTU;VL^1JS3<5JDY.Q^C^)/B-_J?EV AEV$>99WG=6-+*,'1^&<
M:G)R8BH^M/W]+-<S3VC&5_WT/_!;/]@WRFF/C;Q>%5BJJ/!M]OF(./W*^:#+
MGMCK7WQX#_:/^$WQ+^&MU\6?!'BJR\0^#K'0I_$-_-8NDNI:=96UJUY/%?Z<
MCF:VO(HD;?;2[7#+M/4-7YIZ#_P1"_8ZM]"TF#Q+8>+];\0VEE:Q:EK-OXDG
MTZWO=22)1=7MK8K$ZV<<LH+)"K-L!QG@"O6/@G^Q/IO[%OP"_:2\/:!XL;Q/
MH?BGP]XSU/1K:XM?(N=%L9M(O/)LKJY+,;V6$-AISM+D9VC.*ZLVP'AS6IT*
M/#F+SSZ^\=AL/*&91I.CBZ56O"E4EAI4J494FHR<TZW*[)1Y6[V\O(LX\7:%
M6OB.*\KR2&4QR[&8M5L!=5L)4HX:=:E"O%U9*JW.*@U2O'=WM9OV#]G/_@HG
M^S1^U/XQU3P'\(O$>O:GXCT999+Z+4O#USIEO&D1(?9/*Q24<':0.V<]17KG
M[17[5'P=_98\*VOC'XQ^)FT/2;ZY:TL(K6U^VW]_<*%9X[6TC822^4I#2;?N
M@Y)(K^8C_@CAXET3P5\?OBEXJUZ^BM-#\->'-7U+6+Z<B"*VAM4EE9$4X$TK
M[2(T'S.W R36;\2/$WQ%_P""N?[8UKX(\+0:EIOPB\-WLD-I= R3V6EZ':2A
M;G6;E1E-/O-6MTD2+?AF;:%YZ?=YUX/Y+E?&&+P]7%YC1X3R3*Z&.SC,:U6,
M:GMJ_M4L/AY^QC3<G.$-/9RY8[ZSB?$8+QMSK%<*9?.C1R_&\7Y[FM3 Y3EV
M%I2DJ="/LOW^*I\\I:)RUYDI-W:23O\ U%_LU?M1_"S]JSP7=>/OA)>:QJ/A
MFVU2XTAK[6-)GTAI+ZV_UT5O%.2TR1C_ ):*<'KSFOHZO'?@A\&O!WP'^''A
M;X9^!;""QT/PW806I,<2I)?7<<2I/J-R5QYEU<,"\LK99LXKV*OP;-/J'U_%
M?V6JRR_VTUA%B&I5_8*35.55QC&//**4FE%6O9I,_H_*(YC'*\#_ &O.C/,G
MAZ;QGL(\M*-=Q3E&*O+17MHW?<****X#T0J.0\8P26R ,<$XZ-Z U)4<NXJ=
MO!Y^;J%P,Y9>X]ORH \0A\ ZO_PONX^)+I;KHC_#6+PL$61?M:ZBFK"\=5C^
M]Y(A^428V[A7N8_SWKDTTW4V\2-J[ZLITJ31$L1I(@VSB]%P':_\S.0C*"GE
MXP#@UU:G*@^WUH 6BBB@ HHHH JK*Q)9<MO/[N-E",H7&XG/)&>A/Y]JFRYP
M1@ 8R.N?7![?7M^=9VI7]GI5E?:GJ-[:Z996$33W>HWTD<-K:6L8WRRS33,D
M<<2@99F8*/6ORB^)'_!;K_@G5\+/&NN> ?%/QBOFUOPU="TU&?1?#E]JND-,
M203!J-HY@F0,I!8!<9'8B@#];2[ @97."63/(7^\#WQQGZTR681H2=Y^7<&5
M-WX[?;]>M>%_ #]I#X/?M0> K'XD?!GQ98^*_#E^I#A&C@U?3QN8+'J>FF1[
MFQDF $D2S!=\3*RD_,%]LDG\J%Y;IX[:&WCDGEG:54C@BA7=OE8D#8J@L[$X
M4 YXH M!Y&561=P*YR<*=V!\I!Z;O7MFF>?\JE70Y.W(/R^9P!%D'KDX)SGV
MK\_O@[_P4Y_9"^/'QQU/]GOX8^/M6USXF:=-J]O=V;^';N#2DET&<VNHK'J<
MA$$FR52%*@AQ\RX'%>A_M7?M6Z'^S!HWA2UCT3_A-OB3\2/$%EX7^&?PTLIX
MK*\\2ZY>3&/SGOI%D6SLH'VFXNG0I$').,< 'V")?GVD'L#QT8CH,9W8/!]/
MYL=Y/,$8^3.2AQN#@#)!_N'^=?G;\%?VWO%FM?&]/V;_ -IGX._\,_?%?Q%H
M[^(/AYIMMXHL_&6B^,M(MH&EU26WU[3XHK6TN[-QY8M&W22OE<@K@_0G[4?[
M27@[]E+X/^)/BWXWW7,6EHEEH/AVWF3^T_%6NW(*:9HNFH07-U>2_N_E1\'&
M0,@$ ^BI;AEX0C<"H;=\JC=V5NY'/'6G>9*<X^Z>,$89<=SW.>P^GN*\1^ 7
MQ%\7_%WX2>#_ (C^,_AU-\-=8\5V%OK">#;[48M0N]/T^^C2:TFO)HTC$=VT
M+AY+=D#QG@\U[7\Y&5)V*2Q)ZOC'S _PJOIT./Q,].1RC'$2?OQOI%72NETT
MM?;7YAS*=)Z./*W>2TD_)77Z+YW%\Z3Y6!W(#@X'S,>PVCGKSGT_7RSXP_&7
MP=\$?!&O>.O&^JQ6.F:-92W(1V"/<S!&:"TA''F3328C&.A()XKK?&7BO0_
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M_KXK\&P3T!3IG[H/"]3ZX!_*E.X$A@H. WW<$ C@D>A!_P YK6'T=_#N5O\
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MG3E4PM"2K*+4>:+45HFK:+[S]X7_ ."X6I-D#X"2+_W-$/3'_7,=O_K4U?\
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M*/\ X3T.G+TY/3^K6_>+_A^%J/\ T0.;_P *J+_XW1_P_"U'_H@<W_A51?\
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MB_\ C='_  _!U'_H@<W_ (5,7_QNOP<YZ_+U)^[Z]>]&#_L],?=[?G27T?\
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MKQ'XFB<G)ZD>7T%?@WS_ +/;^'TZ=Z4;AG:VV1@RK@ +AP0[-SU4<CC]*/\
MB7[PV_Z%6,?3_?<5VC_T]?;\5U!?2N\8=_[8HZ-/_=Z'3E?\GDM.WEM^R_PV
M_P""OEY\.+3Q;9+\$YM6;Q'XTU?QAO@\1H!:0:W)&39DOO\ FLPC<#'!/UKT
MU_\ @N#?!V$?P&G>,$;'/BF(%QQAB#'D$G(P?UK\&D B 5-\$,.-Q0@M<,V
MI;!SASP^>B]>V5(8'Y@BMDD@*"!GW!QT_P YIR\ ?#>3<GE.*NVG[N+Q$8W2
MCM&-1):K96W[L4?I5^,$(QBLWI6BK)NA2D[7YK<SBV]7U;>ROHK?O%_P_!U'
M_H@<W_A4Q?\ QNC_ (?A:C_T0.;_ ,*J+_XW7X.<]/E[#[OIT[T<]?EZD_=]
M>O>E_P 2_P#AM?\ Y%6,M_V&8F_V;?\ +WR7WC_XFN\8?^AQ1_\ ">AT2?\
M)IT_JUOWC_X?@ZC_ -$#F_\ "IB_^-T?\/PM1_Z('-_X547_ ,;K\','_9Z8
M^[V_.CG_ &>N?N]_SH_XE_\ #:__ "*L9;_L,Q-_LV_Y>^2^\/\ B:[QA_Z'
M%'_PGH=+?W/)?TE;]X_^'X6H_P#1 YO_  JHO_C='_#\'4?^B!S?^%3%_P#&
MZ_!S!_V>F/N]OSI>?]GKG[H],>OI0OH_^&W_ $*L9;I_MF)_NV_Y>^7XH/\
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M#_B:[QA_Z'%'2W_,/0[I?R>G]6M^\?\ P_"U'_H@<W_A51?_ !NC_A^#J/\
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M547?I_RSK\'.?]GM_#Z<^M&#_L]_X?7KWI?\2_\ AM_T*L9T_P"8W%?W;?\
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MOAG.(RW#X[ PP>70C7]C/#4)?6/8UJRY/:.&'J3E)2M&&R/H/3_A1^S;\/\
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MI]_H%%%&:.5Z>^^GVEK\'Y_J')4_Y^TO_ 'Y?GI]_H%%&:,T<DOYWI_?3O\
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MK\PY*G_/RE_X _+^OGZ!11D_Y]^M%')+^=O_ +?7]U]^NWJ_/0Y*G_/VE_X
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M?P_[PKZ2_8^_Y.8^$(_ZFS3_ /TJCZ^G^1ZU\W'^'V8$]?7Z_P"%?27['_\
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M8UCQAE)SG)KI"6+,)%WIG*@<8'4$GU _R*D!21V1CEEV,H VY'5 6/#'V/\
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MJUMJVIAK9BKN7\L@_,A#(1P?UU**PPR@C.[GU]?K00.3CD X/UH _,K]C/\
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M\8IRU<DK<R/9OVO/B]=_'#]H3X@>.+AHYK$:I+X=TL0L'C&DZ3(;:TN8]N5
MGB 8D=>M<K^SC\1F^$WQL^'WC3?LTZRUNVLM2FE!^31YY%2];G&0L63UK@U^
M'GQ&!9D^&WQ +.<N1X2U@ECGDD_9SD^N>O?O2GX>_$C(!^&WQ! 7.TGPEK V
MY]/]&!Y/ZGM7T4*'"E#A[ \.4<=E4<+2P+P=&2QN$7/0E0]C&M./M+*HT[ZQ
M5GK;0^<QU;C'->)<5Q='*.(OKF,QU/,,3B%@,6HJ;K1J5:<+T+JFTK*+WN_,
M^K/BQXY\3_L\_M/>-?&GPRUW0->L/&GVGQ(MN7M]3\,ZOH/B11(^E:M9)O66
M>*+<DL1(>(]<9(KSCX@?M5_$GX@>$;KP3#X>\$?#?POJ4I;6=-^'&CKH#ZQ#
M]Z--4>//VN)"2R(QRC$]^OC"_#KXC<*/AQ\0B4+%-WA36G(+_> +0$@'N,@<
M\8I__"O/B3P3\-_B"#R #X2UGTY&/LW(Z'\_2N+ \.\"X2C@:>:5\DQN-P^"
MPU&EFKQN'YXNBUROD>(DKJ.SDIM2]Z+B[6[JV?\ B+5QV>2RO#<287*<QKSQ
M-?"1RW%JU6MRQG&,UAEH_P"ZTG>UK;_1'A_]M'XFZ)X T/X:WG@SX5>-_"/A
M08\/1>,O"RZK/8.P"R,A?!>4+]]E'S=^U<)'^TAXTT_XH:/\8_#7A[P!X0\3
M^&K9;:SM_#WAW['X?N5?".9](0EOM&,?O3CG##'->9#X>_$A2K+\-OB#E22I
M_P"$2U@!2>N/]&ZD=??'X.7X??$DL[CX;_$ ,PP[?\(CJ_/L?]&P<>XXXK;"
M9+X?X2>95Z?]@UY9E7K0KXB>-H)U85E&52,J;Q"C^]EK*7LTVWO??DKYCXEY
MA0P67U(\2X>EEL*7U"BLNQ2Y8TG[LU-8:[<8WM[UK7TVMT$'Q;\>6?Q<N?C9
MI=ZNB_$"[UP^)GO=/?[/:27TS(TL"0CA;:;8$E@/WHRR]\5[;-^W+\=)/C&_
MQZGC\%7GCTZ''X<WS:*#IUC91@+(((#RMQ*F5>0$,P;BOF__ (5W\1CC/PV^
M(!PV_P#Y%+6,AO[PS;9.,?X4'X=?$8+M;X;>/R"X<C_A$=8Y<CEB/LX.317R
MC@7&58UZ]'AZ<X8.6414L7A'_LDHI3H?QE>G*-DX_<U8>&SKQ.PBY*57BF.$
M69RQTTL!C;2Q?L^18YQ^K-.HTW!;NU[))GT;J?[97B[6SJDE]\&?@#->ZKY]
MSJVIR^!HS>R_;%,9N6E+;I+U68N&^\K!3C&*\O\ 'WQ]\?\ Q$^'?AKX6:W;
MZ!9>$?"FJ3:MI=IHMA]B:6ZN%96FFVX$BA6PL9R0!7!GX??$C<&/PW^(3%6W
M ?\ "(ZP5;>,-D?9N2!R/0C\E;X>?$Q2CM\-_'^Y)&-@/^$1U?YP1\QG_P!&
M/09V[NY^M1@<D\/,#4BLMADU#%8>JL2\7/'8>4,/5C%PBZ495Y6<54G:RVDU
M8689CXGYO&K0QU+B7&8.O2]AB\-]0Q4)5Z=X3Y746'A]J,):MVY?D=5\'/C5
MXY^!FKZOK?@(Z6;G7])G\/:F=7M?M6FW-A.C)(MQ9\[BJNS*S <\UY5?N;RZ
MOKB=8K?[3<W$TZVJ!86-Q(\TEQIZ+_J(_,D*A/05U8^'7Q)(;_BV_P 0#OSO
M_P"*2U<YSG(_X]\=S2+\//B0-H7X;?$$;%*K_P 4CK'RKZ#_ $?H3V^M>O#$
M\*4<3.=7&Y/'%8E4G6Q=+$X9/&4Z?-R4ZK51JT/:5.5.S]YJ[5D>16H<<4L-
M&C4R;B:KA:$'2PV&6$Q<N1MPDZJ:HM-6@DTGNEHM3L-=^.WCKQ'\)/#_ ,&-
M5DT>Y\$>&=3.K:=]BL/LVK^:R&$?:KIO]8P#'/&3^-37_P =_']]\(M-^!FH
M_P!BZEX'TC4O[7T>:XLQ<:UIUR4_U27'WOLZKDA!P&^:N)'P[^)&#_Q;;X@+
MNX;_ (I'6!D9R03]F[^O]:1/AW\1X7,L?PV^($;_ //0>$M8R>QP?LQS_7]:
MY90X'YH^SJ91&C#&O,J%%8S#7IYA)*$L3=55><DVWK+1ZJQU+%\?PH\T,LXE
MHUJF&^KXBK+ 8M^TR_FC;#6]AHE-)KHK7[,]K\!?M8?$[P+X,A^'\^G^#OB7
MX1AO!J&BZ9\2M''B"'071"AMM,67YK2,'YA#D^V*X_XK?'SQM\9+/1M*UZR\
M.:!X7T0M%;^#?"&FIHOAH7;'*ZB-. R+U 2BS%B O;I7!_\ "O?B,,@?#CQ_
M@MYC8\):QS)P-W_'MU]P<&G?\*]^)#DD_#?X@9/))\(ZOSQC_GWY_P#K?GE3
MP/ ]'$/'8>CD4\<Y.=;&?7<+"3E/EYYJ'MU#G>[E&"ES7ES-RN^EX_Q)Q-&&
M43IY_' RBI\DLNQ<G3M:*C[3ZNVUVC=Q2T6R1UVN_'#QSKOPAT#X#7[:>O@G
MPIJ2ZKI*P6^R_2Y!9TQ?XP8QO;Y 223R,5]._L;:S:?"OP'\>OC8^K:5IGB#
M3/!=_P"#O#=A=7L"ZA=ZIJ";X[Z&P9A/<1(CE2\:$9Y^OQF?A[\1]GE?\*W\
M?F/)/E_\(EK&-V<@\VV<^O/%(WPZ^([R"1_AQ\0]P7!_XI36PN !P4\@*W P
M,@^W6N3-,OX:KY7B,HPV=93E^&S3$4\1C*=+%8:2JOV]*M6BXJLK2K.FE*K[
MS6MXRV.G)<5QWE6;X7.9Y%G>;U<HISI81UL!BWR<T'!-*=&UH*5TDELDK6N<
MJ]Q/?SW.HW3[[K49YM1NFQ@-<W;F>8@=MTDA..HZ4S+9Q_#C(Z__ *O6NN'P
M\^)&!_Q;?Q__ .$EK(_E:XH_X5Y\2/\ HFWC_P#\)+6?_D6OIJ6=9)3ITZ?]
MHY6_9PA!-8W"I-0C&.WM?[M^GROI\I7R;B3$5ZV(EDF<1E7JU*TE_9>.=I59
M\[7\'HY;^3[LY*BNM_X5Y\2/^B;>/_\ PDM9_P#D6C_A7GQ(_P"B;>/_ /PD
MM9_^1:O^W<D_Z&&5_P#A=A7V_P"GJ[/U^9E_8'$7_0ESC_PU8[R_Z<_UKYG)
M45UO_"O/B1_T3;Q__P"$EK/_ ,BT?\*\^)'_ $3;Q_\ ^$EK/_R+1_;N2?\
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M=8WP]^)&-O\ PK?Q^"2"#_PB.L\;3GO:]^AIX^'GQ);+1_#?QZSN[%T;PEK
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M7_3Y=NWYZ']@<1?]"3./_#7CO+_IS_6OF<E176_\*\^)'_1-O'__ (26L_\
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MYQ_X:L=Y?].?ZUOU.2HKK?\ A7GQ(_Z)MX__ /"2UG_Y%H_X5Y\2/^B;>/\
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M+L+Y?]/?)O=?BP_L#B+_ *$N<=/^95CO+_IS_6OF<E1FNM_X5Y\2/^B;>/\
M_P )+6?_ )%IK?#WXD< ?#;Q_DD,#_PB6L]5(.#_ *+T;H:/[=R33_A0RO\
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MY)_T,,K_ /"["^7_ $]\K;?FP_L#B+_H2YQT_P"95CO+_IS_ %KYG)45UO\
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M[UM_5]!9!Q%I_P (N<=/^95CO+_IS_6OF<E176_\*\^)'_1-O'__ (26L_\
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M.5_^%V%?1?\ 3Y=5W_,/[ XB_P"A+G'_ (:L=Y?].?3\?,Y*BNM_X5Y\2/\
MHFWC_P#\)+6?_D6C_A7GQ(_Z)MX__P#"2UG_ .1:/[=R33_A0ROSOCL-Y?\
M3Y=G_3#^P.(O^A)G'_AKQWE_TY_K7S.2HKK?^%>?$C_HFWC_ /\ "2UG_P"1
M:/\ A7GQ(_Z)MX__ /"2UG_Y%H_MW)/^AAE?_A=A?+_I[Y/U^>A_8'$7_0ES
MC_PU8[R_Z<_UK?J<E176_P#"O/B1_P!$V\?_ /A):S_\BT?\*\^)'_1-O'__
M (26L_\ R+1_;N2?]#'*_P#PNPOE_P!/?)]-;^>A_8'$7_0ESC_PU8[R_P"G
M/]:WZG)45UO_  KSXD?]$V\?_P#A):S_ /(M'_"O/B1_T3;Q_P#^$EK/_P B
MT?V[DG_0PRO_ ,+L+_=_Z>^3Z:W\P_L#B+_H2YQ_X:L=Y?\ 3G^M;]3DJ*ZW
M_A7GQ(_Z)MX__P#"2UG_ .1:/^%>?$C_ *)MX_\ _"2UG_Y%H_MW)/\ H8Y7
M_P"%V%_N_P#3WR?K?I</[ XBT_X1<X_\-6.\K?\ +G^M?,Y*BNM_X5Y\2/\
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MG_/M;_\ ?B'_ .-U:HHYI_\ /R?W_P# #V%#_GQ1_P#!4/+^[Y+[BK]BM/\
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MAU#_ .0:_D.\N/\ YYI_WR/\*/+C_P">:?\ ?(_PHYY_SR^]A["A_P ^*/\
MX*AY?W?)?<?UX_\ #SS]AC_HK6E_^"'4/_D&C_AYY^PQ_P!%:TO_ ,$.H?\
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M #XH_P#@J'E_=\E]Q_7C_P ///V&/^BM:7_X(=0_^0:/^'GG[#'_ $5K2_\
MP0ZA_P#(-?R'>7'_ ,\T_P"^1_A1Y<?_ #S3_OD?X4<\_P">7WL/84/^?%'_
M ,%0\O[ODON/Z\?^'GG[#'_16M+_ /!#J'_R#1_P\\_88_Z*UI?_ ((=0_\
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MO^'#V%#_ )\4?_!4/+^[Y+[C^O'_ (>>?L,?]%:TO_P0ZA_\@T?\///V&/\
MHK6E_P#@AU#_ .0:_D.\N/\ YYI_WR/\*/+C_P">:?\ ?(_PHYY_SR^]A["A
M_P ^*7_@N'_R/DON/Z\?^'GG[#'_ $5K2_\ P0ZA_P#(-'_#SS]AC_HK6E_^
M"'4/_D&OY#O+C_YYI_WR/\*/+C_YYI_WR/\ "CGG_/+[V'L*'_/BC_X*AY?W
M?)?<?UX_\///V&/^BM:7_P""'4/_ )!H_P"'GG[#'_16M+_\$.H?_(-?R'>7
M'_SS3_OD?X4>7'_SS3_OD?X4<\_YY?>P]A0_Y\4?_!4/+^[Y+[C^O'_AYY^P
MQ_T5K2__  0ZA_\ (-'_  \\_88_Z*UI?_@AU#_Y!K^0[RX_^>:?]\C_  H\
MN/\ YYI_WR/\*.>?\\OO8>PH?\^*/_@J'E_=\E]Q_7C_ ,///V&/^BM:7_X(
M=0_^0:/^'GG[#'_16M+_ /!#J'_R#7\AWEQ_\\T_[Y'^%'EQ_P#/-/\ OD?X
M4<\_YY?>P]A0_P"?%'_P5#R_N^2^X_KO;_@I]^PP./\ A;&FGW&@7Y_ YLN_
MT^IZ5S>H?\%3?V-;;Q%X?L+'Q[:7VB:A'J3:YK2:'<K%HK6\"/IR2(ULDLOV
MV<O"=L<GEA0V3G _DT\N/_GFG_?(_P *78@&-BX/4;1@_I1SS_GE][#ZO0_Y
M\4?_  53_6)_7A_P\\_88_Z*UI?_ ((=0_\ D&C_ (>>?L,?]%:TO_P0ZA_\
M@U_(=Y<?_/-/^^1_A1Y<?_/-/^^1_A1SS_GE][#V%#_GQ2_\%P_^1\E]Q_7C
M_P ///V&/^BM:7_X(=0_^0:/^'GG[#'_ $5K2_\ P0ZA_P#(-?R'>7'_ ,\T
M_P"^1_A1Y<?_ #S3_OD?X4<\_P">7WL/84/^?%'_ ,%0_P#D?)?<?UX_\///
MV&/^BM:7_P""'4/_ )!H_P"'GG[#'_16M+_\$.H?_(-?R'>7'_SS3_OD?X4>
M7'_SS3_OD?X4<\_YY?>P]A0_Y\4?_!4/_D?)?<?UX_\ #SS]AC_HK6E_^"'4
M/_D&C_AYY^PQ_P!%:TO_ ,$.H?\ R#7\AWEQ_P#/-/\ OD?X4>7'_P \T_[Y
M'^%'//\ GE][#V%#_GQ1_P#!4/\ Y'R7W']>/_#SS]AC_HK6E_\ @AU#_P"0
M:/\ AYY^PQ_T5K2__!#J'_R#7\AWEQ_\\T_[Y'^%'EQ_\\T_[Y'^%'//^>7W
ML/84/^?%'_P5#_Y'R7W']>/_  \\_88_Z*UI?_@AU#_Y!H_X>>?L,?\ 16M+
M_P#!#J'_ ,@U_(=Y<?\ SS3_ +Y'^%'EQ_\ /-/^^1_A1SS_ )Y?>P]A0_Y\
M4O\ P7#_ .1\E]Q_7C_P\\_88_Z*UI?_ ((=0_\ D&C_ (>>?L,?]%:TO_P0
MZA_\@U_(=Y<?_/-/^^1_A1Y<?_/-/^^1_A1SS_GE][#V%#_GQ2_\%P_^1\E]
MQ_7C_P ///V&/^BM:7_X(=0_^0:/^'GG[#'_ $5K2_\ P0ZA_P#(-?R'>7'_
M ,\T_P"^1_A1Y<?_ #S3_OD?X4<\_P">7WO^O^'#V%#_ )\4O_!</_D?)?<?
MUX_\///V&/\ HK6E_P#@AU#_ .0:/^'GG[#'_16M+_\ !#J'_P @U_(=Y<?_
M #S3_OD?X4>7'_SS3_OD?X4<\_YY?>P]A0_Y\4?_  5#R_N^2^X_KQ_X>>?L
M,?\ 16M+_P#!#J'_ ,@T?\///V&/^BM:7_X(=0_^0:_D.\N/_GFG_?(_PH\N
M/_GFG_?(_P *.>?\\OO8>PH?\^*/_@J'E_=\E]Q_7C_P\\_88_Z*UI?_ ((=
M0_\ D&FM_P %/?V%VRO_  MC2^H_Y@&H''?O9?Y[5_(AY<?_ #S3_OD?X4>7
M'_SS3_OD?X4G*?\ S\FM.DFNVNENWXZ6$\/AVFG0HM-6_A0\O[OE^NY_78?^
M"GO["Y!S\6=-(!&!_P (_?\ /7Y1_H?7ZXYKY/\ CY^UK^SW^T/\6_V;-%^#
MOC&W\3ZEI?C^.?4[:VTR:Q\BWF>V6)WFGAB9SY@?]VN5&,@G<17\X+1Q_+^[
M3[P_A'^%?2O[':JO[3/PAVJ%_P"*MT[H /\ E[B]*<I.4>23E*+7+).3M)-6
M=[6>OJ_N*C1I4YJI3I4Z=2+BXSC3AS1<5HTW%I/SMIZZG]N%%%%2:!1110 4
MAZCZ_P!#2TAZCZ_T- 'YG_'?_D_C]FG_ + UY_Z5S5^F-?F=\=_^3^/V:?\
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M::A:0WD"WMS*^D29NR019(X$7RD #(R#76_\%%/VZOA+^W'=>#-4\)?#[7_
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M&WRMPQCKWZ8KUL9P,YS[T +1110 4444 %%%% !1110 4444 %%%% !1110
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M&7Q/\!? KQQXE^$.AG7?&ECIDQLH I=[2%HI%GU".)0S2R6H*NB(K-GD#C(
M/SQ_X*:?MYQ_"G0[[X'_  IU2&Z^(NN68M_%.KV$P<^%K&ZC'[M98R?+O[A,
MD$',7W6PVX5_,_))<33O=W4T\UY++)<7%Q/(9)[BYF8O-<2R-N+/*Y+L<]2<
M<5JZ]K>M>(]=U_Q!XFN;ZYUS6K^:YUZ^OGD>[_M-G)GA=9<R1P12[E$1 * 8
MQ6.!@8R3[DYS[CV]!U'>@ QDC))0%B(S]P.^<OC^]DYZ]:6C-% '<_#GPMX:
M\:>*;7P_XK^(&D_##2+F*623QAKEG<7^FVDD?W+>6WMOWK/.?NL.!CGM7VP/
MV$?ATWPXG^+B_MG?#%OAS::@NEW?B9?#&LM;Q:@[&-+40C,A=G& 1D<]#Q7Y
MVE/,POR-@[G2<9A,2_ZPX_YZX_U?OUK](;-0O_!+#7DABMH[9OB;:&-/+&]U
M%\-[<]) /N9XS[4 ?"OQ.\/^#/ ?B:;1_"OQ-T3XHZ%##;N/%.AV<^GVDTT_
MWH/L]T?-B:#^)I %;/%<$;F"/+O+&R,V5 =4VQD\'<QQ(6''R9P>M?J?X'A^
M#OPF_85\%_&_4?@WX3\=_$VY\9>(=)M9O$ML9]!U2R$R1Q1^)X4.ZXDMD#FP
M,(&R3&[H:YKX#6NL_$#1O%_CCX9?LC^"OB%\0+[4&;5++QG<6NC_  @\*Z;,
MQ^Q6WA6/49+=I+XJ-LVV1PIZXH _-E)(W19HW29)'91''(AD@5?XY2"0<]E'
M->G_  0\(Z#\2OB[X&\ ZY>RQZ/XE\0Z=I6IRZ=<QPW]M:7=U%!)+ 6;_6;6
M<J!DA@N>]?I+^U)^ROI5WXB_9;U%/ OAGX0>+_B_JMIX6\=>#O#%S#=>&;$0
M.B7NI:;+;2RP_:65PRMOQG'?.>[TOXF? GX=_MC>"/V=] _9[\"#PGX/US1O
M#DWQ$6SEB^(NH^+=/EM1'J\5ZS" V<MVXDNE.2\?"C- 'Y;?M"?#W1?A-\;O
MB1\,O#L][<:'X4\0W&EZ'J&I.)+F>TA2-E^VLO6?YB"W0\5XW(PCCDF?*I&-
MGE@%Y'?G]X O1/0$9(Z=:^E_VTI%@_:J^.7G7"S&7QQJ#."1&F"(?+BA#D$E
M5V_=[GFOFDK(?+DC?RMXD215'^D;MG"R$Y553.48@+GG- 'V_H?[%<4'@+P7
MXR^+WQV\$?!*^^(XCF\!^&_$=A<ZE?\ B"RN.+*\!M&Q907KXC1[@ (3N8X%
M>"Z;\!OB+XB^,DOP-\':8GBSQ@NI26<-QI4T<FES6406275FO5+V\-G';-]H
M9G<#:"I.0:^X_!?Q0_9K_:^\"_#'X+_'BXU/X<?%#X>Z8/"WP]^)EG-N\.ZN
MS[8-&TKQ% C"1IDGDQ)+%M&2I!X->D_L^?!;QE^S%=?MD^%M5U&'6/B1X;^&
MD-QX7\1Z.Q=I=!OI95_M'1Y)C)<HL]FZK*0^\+G) H ^6S^QI\.F\1S> H/V
MO_A:_P 3;6.:";P,VE7J$ZW;0^;-HPU]G&EK+O'D+,THCWGJ<''(?#?]C[7?
M%?ASQ]XW^)'Q"\-?!7P#\.];D\.ZOXM\0QMK%E<ZW$Y#:;I\5@Q>]8P@7 N+
M??%L8+U!KX]:59%N)9W+2WE]=S7DHF<7*A[B1GNWO0PEW[]V2),@]3VK[U_9
MP_:+^#3_  KU[]F']HO2M?O?AEXBUA=6T;Q]H-VC:KX5U)SLDO;QI"QN+(1$
MK\Y=\KDG% 'S7\8?A,OPFU?2;;3/&F@_$SPUXBTQ-9\/^+_#C"VL]0TYV"J[
MV4SFXM)=Q ,,X63OBO(21T#9E50SVY4AR">,.?E!/OZ9KZW_ &I/V5'^ /\
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M_CO_ ,G\?LT_]@:\_P#2N:OTQK\SOCO_ ,G\?LT_]@:\_P#2N:OTQH ****
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MX=?X80Z!!J F8P_VFNL?:&M&B#%25B'F>9MSU&[M7OJY  .2??K^E "T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4]157L+Q'=X
MD>VF22:-@KPQO&RO,K-@*T*$R!CP"H)P!FKE8WB.UFOO#VNV5NA>XO-&U2U@
M0':7FN+&>&)0>Q9W4 ]B<T 9?A>VM;+P_I-M8ZU<ZS96<3B#6)KB.Y?4T,LA
M+S3QDK,49FC!7M& <8-=5&<J,%F Z,V<L.N>>>^*\:^!7A75O!OPB\ ^%M=M
M38:OH^FW%M=VK2F5X)7U"\N!^\9F:1C'*K98G&_'88]E0,!EB<GG'9?0#TH
M?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!,V,99
MD[ C."6X[=QU&>AP?KR.N6=I-J?A>2ZUR[L+C3]0GFL+%+J*(>(IV@*M:3QL
M=UTD"?O1''DJ3N]*Z^56.<$[2,,.PQSD>F>A]J\(^)_@W6_$?CSX$:UI5DUS
MI_@_Q=J^J:U.DS(MC:7.E+;0R,H8"96E!C*L& QD#/- 'OM%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UCC!YZXP.^?\.M<
M5H-A8:>VO"TUFZ\0?:]=N;N]CDNHKDZ3<.%\S3X]A/DPP ;A W[Q3UKM6#97
M:>AY]",C/OG&<>_6O O@EX,USPG=?%9M;LY;)/$?Q/UO7M':2<RM<Z;=1PB*
M[0,[;%E*L/+7  Z+S0![Y&RO&C(2RE002""1[BGT@Z#Z#H,"EH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,_54233;^*65[>*6
MTN(I;J-Q&]K%)$ZR72NV%1K="9@Q("E 20!6-X;M[6ST'1X+/6+C5[*TME2#
M5Y;B.Y;5(^0)IIHR5F;.0'7@[1[XE\8V%SJGA'Q3IEFAEN]1\.:W8VL2DJTM
MQ=Z;<P0QA@05,DDBH&!!&<@UPOP5\,ZGX2^$_P /O#.MVQL=6T70H+*\M6E,
MC6]Q')*Q3>[,9&VL,DEN#[4 >K9^Z 2V,@;@=S<?>4D8SV!/<9]:_.O_ (*?
M^#?V@/B1^R3XS\#_ +.>B:OKWCSQ#)!8SZ5I=[#97=WI8E5[NTEN)F51;W<8
M,4RA@S1,5[U^BVQV'+$9PPQ]Y3Z ] O .*;Y+!F=7*[CDIDA23C).,'- '\N
M/PW^,G_!;#X)_"+1_A9X,_8 ^&.C>"?!_AZ3188HKXQ7+6BV\GV[5)HH)EM[
MFZE5I9YV,;M/)PY?.*\3_P""2?Q<_;VT#XA^.?#7PL^!'ACQ-\*/%/Q9U74O
MC?XOOIVCOO!7B:5)WNM+TX(Z^9'%,TB)$VY2$!V\9']>%_I_]H65]8R3R+%J
M%I<V<K*2'BCNH'@=H#VD4.2C'H0#7R1^R+^Q5\/?V.+'XD6'P^\0^*=<C^)W
MC*^\;ZZ_B:ZCN9+?5;YY'D2R\I5"0+YK*BL"P&.>M 'X0:CH7_!6CX+?M>?'
M7XX_##]D?0/B]>^.M2_L[PUXR\=7\$]WH_AB-A,FFZ#)#()=/LS(O16C9AF-
MB58@_(O[5/QU_P""E_B?]J3]F;Q3\9?V:?"_@[XY>';Z4_!?P7:3?:+'Q=,)
MY7E%Y)N?.;KS(\,QVCY  H ']KVU\GYN_ Z<>A]_<5\8_';]B+X>_'WXY_!K
MX]^)?$_B_2/%7P2N&N?#%AHEY%#I-T[3-.PU"*1&D<%W;/ELO!/<YH ZC]D7
MQM^T;X_^#&B>(?VHOA]I7PL^+%T95U3PKI$SSV5HJ@[7\QGD.=H#<M\OM7YQ
M?M6ZWXG_ &]?VB_#'[%WPQU&_;X&_#77+#Q!^T[X[TFZ;RKN6RN1-;^"8+VW
M<6\KR(H\Z'S2Q+.'4@ #]G_&'AR;Q7X5U[PS#K>I^'I=<TJYTM==T=UBU73/
MM,;1->6$C@JETJL=K$8';FO _P!EC]DSX=?LF> K[P1X#GU;6I]>UJ[\0^+?
M%?B6<7GB/Q3K%Y-)*]_JMZ/GDEC$ACB7=L5.@% 'YD_M,^&= T[_ (*0?L$?
M"6^L[:P^%_@[PHS^#O#DD2C1KW7],O&MK%'L2HL[R[\I -LD4C.5)926-==X
MD@/@_P#X+(> K#P%IUCI</BSX$ZG?>/;'0T2VCU%+6X$=K?ZO:VH2W6YBA""
M.6:(32(-VYMV3]^?M-_LA^ OVF[7P?>ZSK/B'P/X^^'FLPZYX#^)O@V>*T\7
M>%[R(NQ_L^YF5XO*=WW-'(I7(]^,+]G/]B[PC\ _$GB3XB:IXW\:?&7XN^)U
MCM=0^*OQ,NH-0\6+I,:@#1;>:V6.W@T]R-TD<<2EC@]N0#[-J.8!HW5D617!
M5XV4,LBL,,A5LJVX$@A@01P01Q4@Z"FL@?&<_*<C''- '\WO_!3G]@I_".I7
MO[0WP>TQ_P#A%K^9KGQ[X6TZ%F73;Z1G:36+:",-MM68F2Z4)P0<<8-?B$C;
MN0P3>2RJIX(."IP<X9@>5."",8S7]].J:+I^N:7?Z/K%C:7^G:M;S6>I6=Q&
M)+>ZM)D>*2-XV!4ED;N.#SD$ U_*;_P44_83U3]G#Q3/X_\  NGW&H_"+Q)?
MO<+-;H[R>$]1N7+S66HD J+661O]#= $6+ 8A@0 #\R"N]MDA^X-RGUQZX^@
M]#2TH!9EDX$;QML<L,-@<?BV1M]>U)0 '.W&$Y( ,GW58\!B!R0/RKZKA_:#
M\.1_LBZC^S8_AO6!K]QXHB\0GQ&7C;1VCCG$P3RU_>$ <8'K7RLI5#O\I))-
MK(OF9VJK\,<#J1DD>AZ5&J;511+*@C;>H4C!8]5;=U3V]..* /JK7OC_ .&]
M3_9'\+_LV?V%JS>)- \4ZAXFNO$B21_V#<VM]-YL-O F/-$\8SNR>O7%>H^!
M?VF_@MJW[.6F_L\?'KPU\18K/0-8N];TO6?A)J,.BZU+!<-NV:G>!H'G"J?E
M1I&V] *^!PS#.-JX?>D:C]VQ;[YDSSS@;0.!Z5&R X4*H&X,[<EVYR5S_='8
M9_"@#] _C;^V5X,\9^&/@#HGPA\'^)?#A^ ?B3^UM-U'Q1=&ZO-=T^W='TU-
M2F9GDFNIB@_M)E9@RDX'IZ#/^V%^RU)\6]-_:1O/@YX^O?C.ATR;5-,N;FQ;
MX:-JR/$-3U#2[*/_ $Q+L)&9+)Y!@3@%^,U^8#.Q<L6+JB[8(G $<0/WC\O+
M$CCGH/QJ+Y _F!=LR%3$J[BA)/S'!R.,C)(Z4 ?=VF?M(_L_:G\8?VAOB7\5
MO@YJWC^P^)T%Y<^ =.G>+[3X*UF^BV1W<C<+F)PNW'0*,]Z^&S*OVMI$VPH;
MD7C170+L]NL[2PV%UL&/)9 L+E>=N1GO4(#%[AG^1T;?+$I7RI0XPA]U!P0%
MZ9_"C@*H5W5GXF<8+;5.4CC)S\N>N><4 ?=&A?%?]BF_N_!GC'Q9\(?B1HGQ
M&\)VMFQT3P'=6=OX U75-(=+FTU*_@G)N"]S/&IO-I#,C,!S63#^W%\1%_:&
MU'X]V^BZ9J%IJL+:!JG@*Y5VT*\\&E%M6TFX@8;G=;56\O<"!.2V0*^+0S;2
M!B$E]VZ+[W!^]EOXF[CIR>.U +!6"G8Q<ME1C<",-O\ <\]![T ?=EY\0?\
M@GU-XCO_ !U9?"GXU6VNM+<ZM%X+FU#3C\/5U6ZC+G3'M@1<G1UNV+E02PC8
MCBN5TCXL?LH>-/#\VE?&SX*^(_">JVGB*;5-,NO@5+!813Z-(#'%I6KC423+
M (\.YBS^]+G/I\>,%/\ "''"8?H(NX&/XB2<D]L<\4I9E ,6%=.(F(SLBYS
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M/_K(I.?NR?Q$<^] 'WYI/[< N_V@=>^,WC;PQ>7/A:;P!J/PZ\&>#=":-/\
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M6=4UJXU+5O%?Q3N+6]U'3["X+,FB^''L<K"L3L0@EZ +7JG_  3I\6:9X?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 44W<,D<[MRA1@_,&/)ST
M7/.:=@CS0PVM"1N7(.0QX8$<$?0GH: "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH :W\/\ O"OI/]CS_DYGX0?]C;IW_I7%
M7S8^ H9N%##)]/?U[U]*_L?KY?[3'PD+$ +XLTLJ<Y\SS+N,KMQZX[T ?VVT
M444 %%%% !2'J/K_ $-+2'J/K_0T ?F?\=_^3^/V:?\ L#7G_I7-7Z8U^9WQ
MW_Y/X_9I_P"P->?^E<U?IC0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %0S*2!AB,;LC^%ACHW?& >E34Q@I*[NN?E^M '*PP>(
M%\1B9+RQ7PFVC+%':()!?QZOY^YIP6^3[*8<J!G?OYQCFNL'3O\ CUKY_34?
M%#?M(7VD227/_"$K\+8+Q8"A%F==_MK8TBN,#S_L9VD9!VC/2OH!<;1@Y&!@
MT +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!=>
M>;:X%LR+<F"46[2Y\M9S&WE-)CG8)-I?'.W.*GK&\1RW,'A[7I[,LMW#HVJ2
MVK*,LMS'8SO 5'=A*%('K0!1T.WUB/1]+7Q'<6EYK:;S=SV7F"U,QD8+]EWX
M< 1% ?,_BW5TB9 PV21W/.?IBO&?V?\ 4?$&K?![P+J7BQ[F;Q)?:=<OJ\EV
MA6X-T-1O51I5(!5A"D.!CH0?2O9HU*J 1SSG\_\ "@!]%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% $$P)#?>"A3NQP&!!R/7COBN<
MU"WU\W_AQM%NK"#2HKJ;^W;:Y\WS9[+R\0K8;<CSA-DMYGR[>^>G3.N65L#
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M ,"['_XU7[1%5. 0,#I[4Z@#\6_^')/[/W_13/BI_P"!=C_\:H_X<D_L_?\
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M_ NQ_P#C5?M)10!^+?\ PY)_9^_Z*9\5/_ NQ_\ C5'_  Y)_9^_Z*9\5/\
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MS]_T4SXJ?^!=C_\ &J/^')/[/W_13/BI_P"!=C_\:K]I** /Q;_X<D_L_?\
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M\"['_P"-5^TE% 'XM_\ #DG]G[_HIGQ4_P# NQ_^-4?\.2?V?O\ HIGQ4_\
M NQ_^-5^TE% 'XM_\.2?V?O^BF?%3_P+L?\ XU1_PY)_9^_Z*9\5/_ NQ_\
MC5?M)10!^+?_  Y)_9^_Z*9\5/\ P+L?_C5'_#DG]G[_ **9\5/_  +L?_C5
M?M)10!^+?_#DG]G[_HIGQ4_\"['_ .-4?\.2?V?O^BF?%3_P+L?_ (U7[244
M ?BW_P .2?V?O^BF?%3_ ,"['_XU1_PY)_9^_P"BF?%3_P "['_XU7[244 ?
MBW_PY)_9^_Z*9\5/_ NQ_P#C5'_#DG]G[_HIGQ4_\"['_P"-5^TE% 'XM_\
M#DG]G[_HIGQ4_P# NQ_^-4?\.2?V?O\ HIGQ4_\  NQ_^-5^TE% 'XM'_@B3
M^S^!Q\3?BH/F5B3=6)!"]4/[H?*XX;D<=Q6/<?\ !$KX)G5=+>Q^)WCX:+_I
MS:S'<36S7[NT2_8%TUU78D:S;_/$FXB/ 0L>!^W+#G=@8VMN'<\8 _P_'UKY
M^\=ZEXFM?CG\$]/TQ[M?#=_9>,V\0QQ(?LI>'38VTW[20, ^>2(MW\0XYH _
M.#_AR3^S]_T4SXJ?^!=C_P#&J/\ AR3^S]_T4SXJ?^!=C_\ &J_:2B@#\6_^
M')/[/W_13/BI_P"!=C_\:H_X<D_L_?\ 13/BI_X%V/\ \:K]I** /Q;_ .')
M/[/W_13/BI_X%V/_ ,:H_P"')/[/W_13/BI_X%V/_P :K]I** /Q;_X<D_L_
M?]%,^*G_ (%V/_QJC_AR3^S]_P!%,^*G_@78_P#QJOVDHH _%O\ X<D_L_?]
M%,^*G_@78_\ QJC_ (<D_L_?]%,^*G_@78__ !JOVDHH _%O_AR3^S]_T4SX
MJ?\ @78__&J/^')/[/W_ $4SXJ?^!=C_ /&J_:2B@#\6_P#AR3^S]_T4SXJ?
M^!=C_P#&J/\ AR3^S]_T4SXJ?^!=C_\ &J_:2B@#\6_^')/[/W_13/BI_P"!
M=C_\:H_X<D_L_?\ 13/BI_X%V/\ \:K]I** /Q;_ .')/[/W_13/BI_X%V/_
M ,:H_P"')/[/W_13/BI_X%V/_P :K]I** /Q;_X<D_L_?]%,^*G_ (%V/_QJ
MC_AR3^S]_P!%,^*G_@78_P#QJOVDHH _%O\ X<D_L_?]%,^*G_@78_\ QJC_
M (<D_L_?]%,^*G_@78__ !JOVDHH _%L?\$2?V>P3GXD_%%B5*_/=V1PI&#@
M>6.?<Y KP?Q]^P)\,OV2/C/^SKK_ (&\5^+M?O-?\=6UI<0^(Y[>:"..TF@>
M-XVA"XW%R,;3]W.3GC^AIN0 >A(!^AZBOS._;Q 'Q-_95 ' ^(RXZ\8DM0/T
MH _3.BBB@ HHHH *0GI]?Z&EIC\C:#\W4#_/:@#\TOCL,_M[?LV,/NQZ-=[R
M> N;J8C)..QK]+?,C_OI_P!]#_&ORU_:@+K^VE^S\\,S02#1+K+J2#@W<HQQ
MSGC'Y5]/RW,WFR_Z5>?ZQ_\ EK)_>/O0!]5^9'_?3_OH?XT>9'_?3_OH?XU\
MH?:9O^?J\_[^R?XT?:9O^?J\_P"_LG^-7&/,KWMKV(<[.UOQ_P" ?5_F1_WT
M_P"^A_C1YD?]]/\ OH?XU\H?:9O^?J\_[^R?XT?:9O\ GZO/^_LG^-/V?G^'
M_!%[3R_'_@'U?YD?]]/^^A_C1YD?]]/^^A_C7RA]IF_Y^KS_ +^R?XT?:9O^
M?J\_[^R?XT>S\_P_X(>T\OQ_X!]7^9'_ 'T_[Z'^-'F1_P!]/^^A_C7RA]IF
M_P"?J\_[^R?XT?:9O^?J\_[^R?XT>S\_P_X(>T\OQ_X!]7^9'_?3_OH?XT>9
M'_?3_OH?XU\H?:9O^?J\_P"_LG^-'VF;_GZO/^_LG^-'L_/\/^"'M/+\?^ ?
M5_F1_P!]/^^A_C1YD?\ ?3_OH?XU\H?:9O\ GZO/^_LG^-'VF;_GZO/^_LG^
M-'L_/\/^"'M/+\?^ ?5_F1_WT_[Z'^-'F1_WT_[Z'^-?*'VF;_GZO/\ O[)_
MC1]IF_Y^KS_O[)_C1[/S_#_@A[3R_'_@'U?YD?\ ?3_OH?XT>9'_ 'T_[Z'^
M-?*'VF;_ )^KS_O[)_C1]IF_Y^KS_O[)_C1[/S_#_@A[3R_'_@'U?YD?]]/^
M^A_C1YD?]]/^^A_C7RA]IF_Y^KS_ +^R?XT?:9O^?J\_[^R?XT>S\_P_X(>T
M\OQ_X!]7^9'_ 'T_[Z'^-'F1_P!]/^^A_C7RA]IF_P"?J\_[^R?XT?:9O^?J
M\_[^R?XT>S\_P_X(>T\OQ_X!]7^9'_?3_OH?XTUY4"G#1L>@!=1G/!Y)],U\
MI?:9O^?J\_[^R?XTQYKAMK+<7)*,&^>>55'/7(8<C_&CV?G^'_!#VGE^/_ /
MHA=5N#XM?2O[%QIPT5;E?$F8?+>Z-P8SI0?/F%UB_?;>F.:ZA'C50/,0X]&'
M<YKX/7QEK+_&2?X?F3.G)X"C\4)(MS/M6Z>Y\EH\[BN_&>,[N:]#%S-_S\7:
M\D86:0@<]B2<C\:/9^?X![3R_K[CZO\ ,C_OI_WT/\:/,C_OI_WT/\:^4/M,
MW_/U>?\ ?V3_ !H^TS?\_5Y_W]D_QH]GY_A_P0]IY?C_ , ^K_,C_OI_WT/\
M:/,C_OI_WT/\:^4/M,W_ #]7G_?V3_&C[3-_S]7G_?V3_&CV?G^'_!#VGE^/
M_ /J_P R/^^G_?0_QH\R/^^G_?0_QKY0^TS?\_5Y_P!_9/\ &C[3-_S]7G_?
MV3_&CV?G^'_!#VGE^/\ P#ZO\R/^^G_?0_QH\R/^^G_?0_QKY0^TS?\ /U>?
M]_9/\:/M,W_/U>?]_9/\:/9^?X?\$/:>7X_\ ^K_ #(_[Z?]]#_&CS(_[Z?]
M]#_&OE#[3-_S]7G_ ']D_P :/M,W_/U>?]_9/\:/9^?X?\$/:>7X_P# /J_S
M(_[Z?]]#_&CS(_[Z?]]#_&OE#[3-_P _5Y_W]D_QH^TS?\_5Y_W]D_QH]GY_
MA_P0]IY?C_P#ZO\ ,C_OI_WT/\:/,C_OI_WT/\:^4/M,W_/U>?\ ?V3_ !H^
MTS?\_5Y_W]D_QH]GY_A_P0]IY?C_ , ^K_,C_OI_WT/\:/,C_OI_WT/\:^4/
MM,W_ #]7G_?V3_&C[3-_S]7G_?V3_&CV?G^'_!#VGE^/_ /J_P R/^^G_?0_
MQH\R/^^G_?0_QKY0^TS?\_5Y_P!_9/\ &C[3-_S]7G_?V3_&CV?G^'_!#VGE
M^/\ P#ZO\R/^^G_?0_QH\R/^^G_?0_QKY0^TS?\ /U>?]_9/\:/M,W_/U>?]
M_9/\:/9^?X?\$/:>7X_\ ^K_ #(_[Z?]]#_&J]W.([6YDC1+B2.WF=+<,I\]
MUC9EAP3@^:P"<\?-7RQ]IF_Y^KS_ +^R?XU4U#4+JTTS5;V*YN3+8Z9J%[&)
M)I C/:VLLX4G.?F*8&.<D4>S\_P_X(>T\OQ_X!]+^&=0GU+0-.O+_2_[!NKN
M-GFTAS$CV!$LB+&RH0H9@BRX7/#^N:Z%98R!\Z#VWJ<?B">U?"_PR\4:OXP^
M'?AGQ7?2LEQK,$]T\37,X=-EW+ %(+ CA ><<5W9FF0E?M%RO0_NYY67D>I8
M\]C[8H]GY_A_P0]IY?U]Q]7^9'_?3_OH?XT>9'_?3_OH?XU\H?:9O^?J\_[^
MR?XT?:9O^?J\_P"_LG^-'L_/\/\ @A[3R_'_ (!]7^9'_?3_ +Z'^-'F1_WT
M_P"^A_C7RA]IF_Y^KS_O[)_C1]IF_P"?J\_[^R?XT>S\_P /^"'M/+\?^ ?5
M_F1_WT_[Z'^-'F1_WT_[Z'^-?*'VF;_GZO/^_LG^-'VF;_GZO/\ O[)_C1[/
MS_#_ ((>T\OQ_P" ?5_F1_WT_P"^A_C1YD?]]/\ OH?XU\H?:9O^?J\_[^R?
MXT?:9O\ GZO/^_LG^-'L_/\ #_@A[3R_'_@'U?YD?]]/^^A_C1YD?]]/^^A_
MC7RA]IF_Y^KS_O[)_C1]IF_Y^KS_ +^R?XT>S\_P_P""'M/+\?\ @'U?YD?]
M]/\ OH?XT>9'_?3_ +Z'^-?*'VF;_GZO/^_LG^-'VF;_ )^KS_O[)_C1[/S_
M  _X(>T\OQ_X!]7^9'_?3_OH?XT>9'_?3_OH?XU\H?:9O^?J\_[^R?XT?:9O
M^?J\_P"_LG^-'L_/\/\ @A[3R_'_ (!]7^9'_?3_ +Z'^-'F1_WT_P"^A_C7
MRA]IF_Y^KS_O[)_C1]IF_P"?J\_[^R?XT>S\_P /^"'M/+\?^ ?5_F1_WT_[
MZ'^-'F1_WT_[Z'^-?*'VF;_GZO/^_LG^-'VF;_GZO/\ O[)_C1[/S_#_ ((>
MT\OQ_P" ?5_F1_WT_P"^A_C1YD?]]/\ OH?XU\H?:9O^?J\_[^R?XT?:9O\
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M?G^'_!#VGE^/_ /J_P R/^^G_?0_QH\R/^^G_?0_QKY0^TS?\_5Y_P!_9/\
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M/^_LG^-'L_/\/^"'M/+\?^ ?5_F1_P!]/^^A_C1YD?\ ?3_OH?XU\H?:9O\
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MXFE(_ DDX';-'L_/\ ]H^J_K\3ZP\R/^^G_?0_QH\R/^^G_?0_QKY0^TS?\
M/U>?]_9/\:/M,W_/U>?]_9/\:/9^?X?\$/:>7X_\ ^K_ #(_[Z?]]#_&CS(_
M[Z?]]#_&OE#[3-_S]7G_ ']D_P :/M,W_/U>?]_9/\:/9^?X?\$/:>7X_P#
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M-'VF;_GZO/\ O[)_C1[/S_#_ ((>T\OQ_P" ?5_F1_WT_P"^A_C1YD?]]/\
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M\!B&8WX\,+XD34C;1(R6)F\H6?FJ-X0N#QGKVKL,YYV[.VT'.,<=>^<9_&@
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M0, !=[2%>&9E"\YZ8'H** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG36P)V9K?4R KPH.1\F0<'M0!THZ?=*?[+###V('&:6C:4^4G<1U.<Y_'O\
M6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J:A
M;17VF:I83R&&WU#3;VQN90,F.WNH'AF?GIB-F.>W6L;P?H%CX;\(:#X>TBYE
MNM/TBT2QL90 ?,M5D9S)GORS<GI6SJ#VL>GZ@]\PCLELKDW<C,4$=OY3>:X8
M=U3)'TJGX<;26T31SX?G2ZTJYT[%A<"9F\R'<Q+L>@;.X#MQ0!LOC>X576,-
MB,N,%E 'S<=>>_>FT %$1,, HPI8Y)&>_P#*B@ HHHH **** "BBB@ HHHH
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MR?7/>@!**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBCJ0IW@,0I=%WO&#_$J=&(]#0 44K#:P>/=+;1\-(5VN[=/WB_\
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M_(NG_,55\O[O33[O(/\ B=WPIT_X2N)>G_,)1\O^GGE_6M_Z:]I_N/\ E_\
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MQ_P4?_;$'3XC:;W_ .9>L_P[_G^E!_X*/?MAGD_$;3<\?\R]9_CW].GZT?\
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M $'Y%_X55?*WV?3TMY!_Q.[X4Z?\)7$O_A)1Z<O_ $\\OZUO_39M/]Q_R_\
ML:-I_N/^7_V-?S)_\/'OVPP<CXC:;U_Z%ZSZ8Y[]:/\ AX_^V(1@_$;3>G_0
MO6?7/'?I1_Q+#QU_T'Y%_P"%57RM]GT]+>6B_P")W?"G_H5<2_\ A)1Z<O\
MT\\OZZ_TV;3_ ''_ "_^QHVM_<?\C_\ $U_,G_P\>_;#'3XC:;U_Z%ZSZ8^O
M7D^U'_#Q_P#;$XS\1M-R.G_%/6?7\^F*/^)8>.O^@_(O_"JKY?W?3[O+1_\
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M$_\ GW^-R9?3:\,*53V=3*>*E%+F7/@J"5U;56JO77MKOT/Z:]I_N/\ E_\
M8T;3_<?\O_L:_F4_X>/_ +8O_11M-ZC_ )EZS_'OZ]/UI!_P4>_;#'(^(VFY
MY_YEZS_#OZ=?TH_XEAXZ_P"@_(O_  JJ^7]WT^[R'_Q.[X4_]"KB32W_ #"4
M?[O_ $\\OZUO_39M/]Q_R_\ L:-I_N/^7_V-?S)G_@H_^V(>OQ&TWM_S+UG^
M/?\ +]:/^'CW[88Z?$;3>_\ S+UG^'?V&?TH_P")8>.O^@_(NG_,55\O[OI]
MWD'_ !.[X4_]"KB72W_,)1_N_P#3SR_K6_\ 39M/]Q_R_P#L:-I_N/\ E_\
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M!\OH/_K5YM\.O!M]X-F\?O.(I4\4>-+[Q);.3N,,-W&$$2C!QLY( K^=E?\
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M &-?S*?\/(/VQ?\ HHVF]_\ F7K/\._YTW_AX]^V'V^(VFYX_P"9>M.O?O\
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M-I_N/^7_ -C7\RG_  \?_;$[?$;3<<?\R]9]._?KZ4G_  \>_;"_Z*-IO?\
MYEZS_#OZ=?TH_P")8>.O^@_(O_"JKY?W?3[O(/\ B=WPI_Z%7$FEO^82C_=_
MZ>>7]:W_ *;-I_N/^7_V-&T_W'_+_P"QK^9,_P#!1_\ ;$/!^(VFXX_YEZS_
M ![^O3]:!_P4>_;#'(^(VFYY_P"9>L_P[^G7]*/^)8>.O^@_(O\ PJJ^7]WT
M^[R#_B=WPI_Z%7$FEO\ F$H_W?\ IYY?UK?^FS:?[C_E_P#8T;3_ ''_ "_^
MQK^9,_\ !1_]L0]?B-IO;_F7K/\ 'O\ E^M'_#Q[]L,=/B-IO?\ YEZS_#O[
M#/Z4?\2P\=?]!^1=/^8JKY?W?3[O(/\ B=WPI_Z%7$NEO^82C_=_Z>>7]:W_
M *;-I_N/^7_V-&T_W'_+_P"QK^9,_P#!1[]L,]?B-IO;_F7K/\>_Y?K0/^"C
M_P"V(.!\1M-QS_S+UG^'?UZ_I1_Q+#QU_P!!^1?^%57R_N^GW>6B_P")W?"G
M_H5<2]/^82CY?]//+^NO]-FT_P!Q_P O_L::8V)R%D#*"5!SM/3((QUX].GX
M5_,K_P /'OVPO^BC:;V_YEZS_'OZ=/UH/_!1_P#;$)4GXCZ=E"2N/#UGCGU&
M>?>C_B6'COIC\B_\*ZJ[?W/3[O(/^)W?"G_H5<2_^$='R7_/SLON[ZW_ **O
M%/A"^UOQU\+O%,;VL=OX.NM7FN;9L SB^M_*4%<?,4;D<9SQBO0RIR?D?J>Q
M_P#B:_F.D_X*,?M?R/'*_P 1=.+Q9*?\4]9!06ZY'<5+_P /'_VQ#U^(VFXR
M?^9>L^F,#OUZYH_XEAX[_P"@_(NG_,75\O[G3]/+0_XG<\*5_P RKB7I_P P
ME'R[U;+;\NUC^FO:?[C_ )?_ &-&T_W'_+_[&OYDQ_P4>_;#'3XC:;G _P"9
M>L_Q[_E0?^"CW[89Z_$;3>I_YEZSZ?GUH_XEAXZ_Z#\B_P#"JKY?W?3[O(?_
M !.[X4_]"KB3I_S"4?+_ *>>7]:W_ILVG^X_Y?\ V-&T_P!Q_P O_L:_F3_X
M>/\ [8@Z?$;3>G_0O6?7/UZ<GWH_X>/?MADY/Q&TWK_T+UGTQQWZT?\ $L/'
M7_0?D7_A55\O[OI]WD'_ !.[X4_]"KB3I_S"4?+_ *>>7]:W_ILVG^X_Y?\
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MR_N^GW>0_P#B=WPIT_X2N)>G_,)1\N]3R_K6_P#39M/]Q_R_^QHVG^X_Y?\
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M/'7_ $'Y%_X55?+^[Z?=Y"_XG=\*?^A5Q+T_YA*/E_T\\OZUO_39M/\ <?\
M+_[&C:?[C_E_]C7\R?\ P\?_ &Q#U^(VF]/^A>L^N?KTX'O0/^"CW[88Z?$;
M3>H_YEZSZ?GUH_XEAXZ_Z#\B_P#"JKY?W?3[O(/^)W?"G_H5<2]/^82CY?\
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MURPBN9:[Z:GZCX)SG4\6O#_$)\M:EQ-@:<:EHM\LJJ=GITO^O8_MPHHHK_+
M_P!V HHHH **** /RN_:C_Y/2^ '_8$N/_2N6OIV;_6R_P#71_\ T(U\Q?M1
M_P#)Z/P _P"P)<?^EDM?3LW^ME_ZZ/\ ^A&MH?"OG^;,ZG3Y_H1T4451F%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,E($;?+N)*X&,]
M^O\ C3Z<G#ALJ%&[(/5OE. /?/\ ^J@#R[^V]7_X79=^#WFSX;/P]A\0P603
M]W_:K77E/)YW WA.L?6O3\YY!R/7&/T]NE<^M[92Z_+IZZ-)%JBZ4+IO$#*?
MEL_-P+#S/[N[YMIXSQC-="Q).3CH.1T. !D8XYZT )1110 4444  .&AE_Y9
MH3L8\YD/  7^'(XR.1U'>OQX_P""HGQ_\>>#O&_P!_9R\.>+;WX8>%_C5K4<
M'C7XC6%S):7.CZ;+<>1-9I?(0UJ]U'P)_P#EGOQ7[#$%R=WRHS*T:#^':#EN
M.!^E?)W[7'['7PM_;%^'\W@CXA"[T_7K0^?X.\9Z>S)=>'-73!M;Q]@+W-O"
MPW-;9VR'D]* /-O%'_!-C]E75/V?].^'T^C2:/;>'M.G\7VOQK;5A%XX@UI(
M#=IXHU'Q@?\ 3KNPGF'GBWD;9LD '!KYI_X),_M$>+?&7@WXY_##XB>*Y_%O
MA_X'^,[G1_"_Q!UMV>WU#P[%<.AOKW6I208$B1&$K?+M.>*\G/\ P1G^/D]A
M_8NL?\%$_B9?^'7MX](O-!DBU V-QHR;8SI[0[MGV=H%$83HJGVK]1/@A^QU
M\$?@+\&-5^!/@O2;X^%O$VB2:9XRO;N[;^T_$/VB-4U.[-XP\R-KB7,EO'UA
M!""@#U=?A5\#OBJ[>-X_AI\+OBE=:H?*@\9KH.EZY#J$%N-D]NVJLI^T-""5
M12>WM7X7V_AGP1^SC_P5E\.>$_V9/$#V>@?$;3KJ7XD^ ]$NC?>'-*NOG%R+
MO3X,6T$T+<6Y89M,!5QQ7K?B;_@CSX\AU>_C^!7[;WQ9^#7PRFG>?P]\.;2]
MU*>'0V=B;MOM*,%S.V#&,<@<=:^P/V./^">'PW_9&BU'Q5J6OW_Q6^-6MRR/
MX@^+.NAY[V\@F8$0PPS R6DNW(ED4YF8ECS0!^@&K:_I_A73M9\0WVI-I6AZ
M%;W&I:IJ%U-Y-K:Z=IZE[F:4O\JC RJG_6$CJ:_(O]G_ $KQ+^W;^TUXC_:F
M^(MA>K\"OA'?W>E? CPEJN\VWB?5+)GCN/%,<4F55%EVW%A(/O#E#7VG^UM^
MSMXJ_:@\#Z9\,K+XHW?PU\(R:UIVJ>/+32[5YK[Q=H%E*'ET1;Z+YK6"^B_=
MSKR#_%SC/T#X)\)^'_AUX/\ #O@?PG86VC^&O"NGV&G:-90(!)-%91>5$TFS
M!9G4?Z0Y^\>3UH0'X[?L7_#WP5^TMXN_;8\<?'+P]IGQ0\07/BS7/!UG8^,K
M:+63X)T#3YGMK<:'#=AO[*GEB/[N> JS, V>U>W_ /!*_P 4Z[J7PE^(_@_4
M9M0OO#WPZ^*_BSPOX/>]DDN([/0M,OC#9:7%(^1&EG%\BHO'&,5T_B']A[XD
MZ!\1?B?XW_9F_: L_@=I/QH3_BY/A34_"H\3-J=V<^??:7>M@:5-(2665.0Q
MS7U-^SS\!O!_[.'PYM/A[X/DO+QY[VXUOQ5K-_,QGUOQ)?MYFI:NL;_-LO)C
MOV=$Z5,?A7S_ #9<I)I6MI:Z6VB/<"6(5]Q%PDI=9/\ EGY1ZQ-%T8$<9SZ_
MC^0O_!0W]C!?$UG??'7X;:8T6NZ?'YOB;1-)B$9U*VARTEV(XERQB \R7'WA
MPU?KU3P(=DZ2*L\$L?DWUM.HDAFAE&!&$;AUD'RRKT*Y!SQ7VO!O%N+X,SFE
MG&%2;4)4*U-V;J4*C7M*2TO>:BDG&SNE;JC\Z\1^ ,I\1>&,;PWF\N2.)_>8
M"JM\/F,8M86MT7N2;=GO<_BY+.'(<!-ZGS5D3:&<':T(4C]S+"P^<?>;&*B_
M#U_KSU]?\,5^J_\ P4#_ &,I_ 6IZA\8/AIICS>#=5N&NO%&A6L>?["O96+/
M?6RH/EMYF!_=+A8QR0*_*=6# $'(/0_T_#I7^CW!_%^$XKX>P>8X-IU.6$94
M(R_>8>3Y;J:6MMM[Z=$['^+OB!X>Y[X9<49APYG"?UE5)RPM9Q?L\?AW+]VZ
M+T3J\DEMKS.U[BT'.#W/\Z7\/\_Y-(<_Y_S_ )Z5]?4IU&J:>L*DJ=WHM96O
M?9I7[6V]4?"4I5Z=66&C0YEB(.:DU[RE3LI)M*ZE&32>ME9GZ<_ +7M?\-_L
M"?'G7O"^NZKH.L6VO"*UUC1+J2SO[=EN$#Q0M"0X;:X4N#_$/0XU?^">GQ)^
M)/C/Q7\6;'Q9X]\<>*]-MOAGJ;QZ9KNMW>HV\-PUK.HE6WN&V^:6/7&3D 5^
M94'B/Q%8:+=^'H-?U>U\)ZE*LNH:%87LL-I>7>0QDN+1#M?) S*0,_3FDT?Q
M!XA\-S74OAS7=<\/2WL;0WCZ+J4ME<7%BPP8;BXB.9D<9WQ'CD@]:_*L=X;T
M\=2XHK.IA7B\PQE.6#KU**?U:,J5&C&+F^:IS1]G.7-3<5'F5DG%W_5L!XE2
MP,,EG.6-C2RW#U,+4I0Q=54YRNDXNGS\DHRY;-2B^9K6^Q^G?[+/C;6_AO\
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M7EDY)2=O)'Z[_ GXN:]\5OVM/&/B*^^&FN_!W7M$^ .NZ7+I&MSR?V_.FGV
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M$U^;6L>)_$?B1;!/$?B+7?$5II%HNG6 U>\FO+N*!?F6&UFD):&%&P5B'
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M95:\::22B^:4FHKI=Z;+S****ZC **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#N&/$MMUZ;NG7MFE_P"':/[8'/\ Q1N@?,?F'_"26WS$<\\=:_I:W?\ 3/\
M\?I=Y_YYG_OO\/Y<4G](_C-RYW3HN;M[SPJ<OL]>?7\=^NER7T-/#622=>M*
M*;:4JTVD_).=K[W9_-'_ ,.T?VOR2?\ A#?#^2.2/$EKD@>O'08H/_!-']L
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M/$=WJ6N(CC#:S*G[YF.>2<C)H7TD.-?Y*6O+;_95IJKW_>:W5DNSU]Z]F?\
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M;T/YH_\ AV?^U]_T)GA_T_Y&2U_PI/\ AV?^U]_T)GA[U_Y&2U_PK^E[>?\
MGF?^^Z3=_P!,_P#Q^C_B9#C3^2ET_P"85?W?[_\ 7G?WC_B33PU_Z"*U]/\
ME]/_ .6>2MZ'\T?_  [/_:^_Z$SP_P"G_(R6O^%)_P .S_VOO^A,\/?^%):_
MX5_2[N/_ #S_ /'Z-W_3/_Q^C_B9#C7^2ET_YA5_=_OO]?G?WFOH:>&NE\17
MZ;5Y_A[_ )*WH?S1?\.S_P!K[_H3?#W_ (4EK_A1_P .S_VOO^A-\/?^%):_
MX5_2YG_8/_?8_P#B:,X!)7IVWKN/N!@9 YR>W\TOI(\;:?NZ/3_F&7]W^]_7
MS]ZO^)-/#+_H)Q'_ (.GY?W_ .K>A_-'_P .S_VOO^A-\/?^%):_X4?\.S_V
MOO\ H3?#W_A26O\ A7],$44L[M'#"\CJGF%4(;* 9.W'WB!U]ZLBTOL#%E<8
M[<-_04U])#C1_%&C'M_LV_P_WU^OSO[P_H:>&:_YB,1_X.FNW>?:WX'\RW_#
ML_\ :^_Z$WP]_P"%):_X4?\ #L_]K[_H3?#W_A26O^%?TT_9+[_GRN/R?_"C
M[)??\^5Q^3_X4_\ B8[C+O2Z?\PW^'_I[_6N_5?\2:>&?_01B/\ P?+R_O\
ME^"^7\RW_#L_]K[_ *$WP]_X4EK_ (4?\.S_ -K[_H3?#W_A26O^%?TT_9+[
M_GRN/R?_  H^R7W_ #Y7'Y/_ (4?\3'<9?\ 3KI_S#>G_3SU_'YG_$FGAG_T
M$8C_ ,'R\O[_ )?@OE_,M_P[/_:^_P"A-\/?^%):_P"%'_#L_P#:^_Z$WP]_
MX4EK_A7]-/V2^_Y\KC\G_P */LE]_P ^5Q^3_P"%'_$QW&7_ $ZZ?\PW^'_I
MY_6N^MS_ (DT\,_^@C$?^#Y>7]_R_!?+^9;_ (=G_M??]";X>_\ "DM?\*/^
M'9_[7W_0F^'O_"DM?\*_II^R7W_/E<?D_P#A1]DOO^?*X_)_\*/^)CN,O^G7
M_A-?^7_IX_ZOOU/^)-/#/_H(Q'_@^7E_?\OP7R_F.N_^";G[7&FV=YJ-SX,\
M/_8["UN+V](\26Q*V=M$TMRPP,[EB5B/?%4] _X)W_M5^)=#L_$&D>#/#[Z%
MJUK%<Z-,WB2V,LMHSE5D8XR79PP)]J_ISU#39+G3=3MKZUF2QN=/O(+TON -
MI+ Z3KS@9:,L ._2LOPMX?L-.\+:#IVAQ2?V'96"Q:="HP8K02.R#:#D?O"3
MC/M2_P")D.-(Z*%*6J;?U?1JRO&W.];VUN^UG>X?\29^&;_Y?XCHOXLWV72?
M3_+T/YMF_P"":'[7^>?!GAX>F/$EKT[=13?^'9_[7W_0F^'O_"DM?\*_IG-G
M>\$VEP<CJ5(_#D'MC\Z3['>?\^<_Y?\ V-)?21XVZTZ/_A,O[O\ >_7\]6OH
M:>&5O]XQ'_@Z?E_?7]+T/YF?^'9_[7W_ $)OA[_PI+7_  H_X=G_ +7W_0F^
M'O\ PI+7_"OZ:?LE]_SY7'Y/_A1]DOO^?*X_)_\ "J7TCN,M/X73_F&_P_\
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M^U]_T)OA[_PI+7_"OZ:?LE]_SY7'Y/\ X4?9+[_GRN/R?_"C_B8[C+O2Z?\
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MI+7_  H_X=G_ +7W_0F^'O\ PI+7_"OZ:?LE]_SY7'Y/_A1]DOO^?*X_)_\
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M_$?^#I+L_P"?\/3Y?S+_ /#L_P#:^_Z$WP]_X4EK_A1_P[/_ &OO^A-\/?\
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M?\*_II^R7W_/E<?D_P#A1]DOO^?*X_)_\*/^)CN,N]+_ ,)O3_I[Z_COU/\
MB33PS_Z",1_X/EY?W_+\%\OYEO\ AV?^U]_T)OA[_P *2U_PH_X=G_M??]";
MX>_\*2U_PK^FG[)??\^5Q^3_ .%'V2^_Y\KC\G_PH_XF.XR[TNG_ ##?X?\
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M_P"?*X_)_P#"C[)??\^5Q^3_ .%/_B8[C+O2Z?\ ,-Z?]/?7^MU_Q)IX9_\
M01B/_!\O+^_Y?@OE_,M_P[/_ &OO^A-\/?\ A26O^%'_  [/_:^_Z$WP]_X4
MEK_A7]-/V2^_Y\KC\G_PH^R7W_/E<?D_^%'_ !,=QEIK2Z?\PWI_T]]?Z^(_
MXDT\,_\ H(Q'_@^7E_?\OP7R_F6_X=G_ +7W_0F^'O\ PI+7_"C_ (=G_M??
M]";X>_\ "DM?\*_II^R7W_/E<?D_^%'V2^_Y\KC\G_PH_P")CN,M-:73_F&]
M/^GOD[_C_>/^)-/#/_H(Q'_@^7E_?\OP7R_F6_X=G_M??]";X>_\*2U_PH_X
M=G_M??\ 0F^'O_"DM?\ "OZ:?LE]_P ^5Q^3_P"%'V2^_P"?*X_)_P#"C_B8
M[C+3^%T_YAO3_IYZ_P!?$?\ $FGAG_T$8C_P?+R_O^7X+Y?S+?\ #L_]K[_H
M3?#W_A26O^%'_#L_]K[_ *$WP]_X4EK_ (5_33]DOO\ GRN/R?\ PH^R7W_/
ME<?D_P#A1_Q,=QE_TZZ?\PWI_P!//7^OB/\ B33PS_Z",1_X/EY?W_+\%\OY
MEO\ AV?^U]_T)OA[_P *2U_PH_X=G_M??]";X>_\*2U_PK^FG[)??\^5Q^3_
M .%'V2^_Y\KC\G_PH_XF.XR[TNG_ ##>G_3WU_KXC_B33PS_ .@C$?\ @^7E
M_?\ +\%\OYEO^'9_[7W_ $)OA[_PI+7_  H_X=G_ +7W_0F^'O\ PI+7_"OZ
M:?LE]_SY7'Y/_A1]DOO^?*X_)_\ "A?2.XR[TNG_ ##>G_3WU_KXC_B33PS_
M .@C$?\ @^7E_?\ +\%\OYEO^'9_[7W_ $)OA[_PI+7_  H_X=G_ +7W_0F^
M'O\ PI+7_"OZ:?LE]_SY7'Y/_A1]DOO^?*X_)_\ "C_B8[C+O2Z?\PW^'_I[
M_6N_4_XDT\,_^@C$?^#Y>7]_R_!?+^9;_AV?^U]_T)OA[_PI+7_"C_AV?^U]
M_P!";X>_\*2U_P *_II^R7W_ #Y7'Y/_ (4?9+[_ )\KC\G_ ,*/^)CN,N]+
M_P )O3_I[Z_EJ_B/^)-/#/\ Z",1_P"#Y>7]_P OP7R_F97_ ()H_M>@H7\&
M>'M@D49_X22VYR3P?EQ@G@\X_&N?U'_@GU^U/IGB'1/#-]X,T!=;\3&_?PU$
MGB.V\N>.P7S-0\T8PWEQG*9'!STK^H8V5X^%>SN0K9Q\KX+K]WYN,?CQ7,ZO
MX=TNY\6>#M3OX6?7M*BU1=!.TY@%Q$%OEW9^4R)Q@]30OI'<97_Y=;/_ )A[
M:VC9O]X]F[M=4FNMP_XDS\,]O;XC_P '2?;^_P#=^NQ_-Y_P[/\ VOO^A-\/
M?^%):_X4?\.S_P!K[_H3?#W_ (4EK_A7]-/V2^_Y\KC\G_PH^R7W_/E<?D_^
M%'_$QW&7_3KI_P PW^'_ *>?UKOK<_XDT\,_^@C$?^#Y>7]_R_!?+^9;_AV?
M^U]_T)OA[_PI+7_"C_AV?^U]_P!";X>_\*2U_P *_II^R7W_ #Y7'Y/_ (4?
M9+[_ )\KC\G_ ,*/^)CN,N]+_P )O3_I[Z_COU/^)-/#/_H(Q'_@^7E_?\OP
M7R_F6_X=G_M??]";X>_\*2U_PH_X=G_M??\ 0F^'O_"DM?\ "OZ:?LE]_P ^
M5Q^3_P"%'V2^_P"?*X_)_P#"C_B8[C+O2_\ ";_#_P!/?ZUWZG_$FGAG_P!!
M&(_\'R\O[_E^"^7\RW_#L_\ :^_Z$WP]_P"%):_X4?\ #L_]K[_H3?#W_A26
MO^%?TT_9+[_GRN/R?_"C[)??\^5Q^3_X4?\ $QW&7>E_X3?X?^GO]:[ZW/\
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M^R7W_/E<?D_^%'V2^_Y\KC\G_P */^)CN,N]+_PF]/\ I[Z_COU/^)-/#/\
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MH'[O_GS#[W_=\O+\O,****.:IWC_ %\@_=_\^8=/M/R\O)_<@HHHHYJG>/\
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M(Y$D[,%#@] D9Y_=_P 1'7UHYE_-^'I_P?O\D+DIZ?N8?Y?#_E_77UW_ (:
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M,DOR3LQ@ ]OPI>TE'9W6FZZ]0Y*76C'I^2_K?IUN>RM^T)\?I"3_ ,+I^(H
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M*.9?S?AZ?\'^D@Y*>G[J'3\.7_@V_P""[^S_ /#0'[0'_1:/B)_X/Y?\*/\
MAH#]H#_HM'Q$_P#!_+_A7C(NK;9-(MQ#<00?\M[>19!*#R6 4G84! *'DT])
M4EVM;NEQ%(,PNK!3(V"2A7.5([DXZ&CF7=_=Z?\ !_I*YR4]/W,.GX<O_!_I
MN_L?_#0'[0'_ $6CXB?^#^7_  H_X: _: _Z+1\1/_!_+_A7C*W-L\;JMS$)
M!F192RB+8AVR1.2<*X;(&2,]<TS^T-/D618;VV,D!43F6:.,#(S^[#,/,[8V
M_P"%',OYOP]/^#_25SDIZ?NH=/T\O7\.[/:?^&@/V@/^BT?$3_P?R_X4?\-
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M?$3_ ,'\O^%>0T4<R[O[O3_@_P!)7%"G_P ^8=/_ &W_ "?W??Z]_P - ?M
M?]%H^(G_ (/Y?\*/^&@/V@/^BT?$3_P?R_X5Y#11S+N_N]/^#_25SDI_\^8=
M/_;;_D_N^_U[_AH#]H#_ *+1\1/_  ?R_P"%'_#0'[0'_1:/B)_X/Y?\*\AH
MHYEW?W>G_!_I*YR4_P#GS#I_[;?\G]WW^O?\- ?M ?\ 1:/B)_X/Y?\ "C_A
MH#]H#_HM'Q$_\'\O^%>0T4<R[O[O3_@_TE<Y*?\ SYAT_P#;;_D_N^_U[_AH
M#]H#_HM'Q$_\'\O^%'_#0'[0'_1:/B)_X/Y?\*\AHHYEW?W>G_!_I*YR4_\
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M3_VV_P"3^[[_ %[_ (: _: _Z+1\1/\ P?R_X4?\- ?M ?\ 1:/B)_X/Y?\
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MVPG)Z^N:],Y[C!R>!VSSVH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%B\J,R(D1!63&,!R.,G'0GU[G%&<\XQGG'IGG'X4C#>!,%\I8^)(AWXSQ^-
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M[A8[%8E8K;M%IQQ@F,D@#DT >2Z7^PE^T]K6@VGB.P\)>')$N-&N/$D.G_\
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MF+2]1;SO%&E>&IKSS+6+4%.+NVC6#'E6UROF%1A>E 'Q#%^P!^U7+IE_JB^
M--22QCOIK[1+CQ+I]KXCN+;30[7=W9Z%+MO[F! A-NT41$J[=A-?']XE[I]W
M>03VIL;NVNCIUU;3H8Y;6XA8QR+*C8)D1@0RXW*>3C%?KMI_BCQCJO\ P5,T
MZ74O$&NW]S;^)+?1K>.2ZE*PZ.QGC^Q+: B,P-'A#$T;,0.>E?G3^TC'':_M
M _&A(;81QQ_$+Q&IBD*F)';4)/FAC& CMG)7@J>" >: /O;X;^&-.^$'[$FC
M?''X7_!?PG\<_'WB7Q1<Z?XTN/%N@OXKMO"-O:3[;79H]OOGMEND#,9F54"@
ML20":^$O'FH6/QQ^)]FGPI^'$VA:OX@_L[3;OP)IT!DMAXI)V7]S9VL.YK#3
M!<$&-' %I'_K,8KV;X-ZS^V'^S=<>#/&GPQT7Q/J_@[Q\9)+/PSI-O+XL\)>
M(VA!2X@\06-A!=16,FQV5!<>6V&/KFOU.M-)^$WA_P#:Q\*:UX>T70_A[\8_
MB)\#=8GU+P_I\]I%I6B>/M3TC-DD-N6*V>IW=X0&A8+,)> H- 'XY_$[]CK]
MH'X3>$M0\7^+_#.D1>&M'F5-6N_#?BC3O$.I:+<SX*QZIINGM)<VJ9(#K,J[
M,<UZ'^U);1O\*?V=;^T^ MG\+VU'0_(B\7V,T%Y>_$^9;?:+E;.V_?QSEQO1
M) 79FP.P'F>I?#G]I_19?CEJG]C^-M!M[#4[J#XH7NN->Z+HVJRR2L//@?5D
M6WU/=G*"R)/3%??WQ=FTG2O#O_!-V\\2,B:#;ZWIDS7FID&U!\V(L\C/B,6\
M75RWR*,DD#- 'QEIW["/[4&K:!:>(H?!GA^R@O-"/B.STG4/%>EV?B>[TC[.
M]S]H3PW,RZDUTT*$I"(B[.409+#/D/PU^ GQ?^+=UXGLO /A*YU?4/!1MH?%
M%F^;'4M/6\F%O$98)E\R,1N,W,C*!''\[8%?K/\ M&:S\&?!_P"U7<_$._\
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MW_#?]AOPC\2/A_\ L_>!_C%\1]2\=KI>LW/B#P/=>++NST<P99_(M%>4X/\
MRVVA>"2<8KL?@/XV^)/QI^#GQA^&/[8G@VYU7P3X \":G>^%_BW\0=&DTCQ/
MIVOVS2)#;:9J.H06KWURLL2QQ+"\CO'EAE6YYS3_ !1\:?!G_!/#P7>? S4?
M'.GZ^OQ0N+5KSP3I\]_?7N@Q[UB^TM!;7*HCQ!79F4<G&<T ?*&D>+]6^+_[
M27P4TWXC_!?P1\,Q;>((+2?P?X<\'7/A*SUVRFE,\K:YI]V$>9RQ,:.X "8%
M?5O_  4D^!GPV,5G\7?@=X;TSP[IW@C6M)\#_$3PUH5EY=MI6L:A-!-#?W%O
M!D) ;8E))F"KDDGDYKXX^$VK?%KQ1^U;\%]<^,!\=WFNZAXNL!'>>-K"XTW4
MKJW3ADACN+:V,T8D&"8U/IG%?>UM\3]*T/\ ;O\ V@/@+\26AM_AS\<9=+\-
MZK;W6U;?2-9G@#Z?JT3RXBCE0)$FX$/DX!Y% 'A7[6LWA?X#>)_V<O%7@KX9
M_#]CJ/PN@U#6=&UO1EO-$UK5'B@=;R^M W[]Y=Q=FSCFO=/V=_BQI/C3X=_$
M?XZ_'C]G[]G/2OA'X'TZ6QT6'2/ RV6J^*/%\T6_3M.T^X9P-K' =@2%Y'7&
M*O\ P4!^ 'B#QE^T/^S1^S]X8,US=ZCX;.BZ?J!1Y4@T6VN51;XS*"NT6L!'
M7(;@UXG^VQ-XQTY/#W[*GPE^&GQ!7X7?!^*VAO\ 5++P;KDB^+?%?EJ;[4[B
MXBM#'=16]TDBPL68",C!Q0!\H_ ;X?I\?_V@])TJ'3[?0?#>K^)KOQ+JNF6Z
M?)H7A-)I[IX-ZY5+>"$+"PR J\9KZU_;4\-?"[XA_"[P?\9_@?X%TSP?IG@;
MQ!JGPY\=0:);HL>JWEC>-96.JW:19"R74:";>^"^<\DYH_8XT7PS\$/@Y\7O
MVDOC!H?B$:!>1R?"O3+#2G.CZW=2ZTH%RVGSW03[+/"^Z-B?F63(.*];_9H\
M4?LS_%SP)\<?V:OA#X%^)GA/7_&_A;4/&UE)\0O$=MXAM[C7](A#0C2[:$M(
MEU<;7(5!N=CGD<T ?C-%)$/F'(9)8X<]-^?X<]2#Z?SK]2/@[KOAGX3_ +"'
MB;XR0_"WX:>-/'T'C?3-'@U+XAZ+'K%LNGW$GE7,0A9E:,E2=I/?GUKY?M;[
M]CO0?#EUX=\8_"'XWS?$W1_MVDWU_!XNM+#14U^R+0-=IILP6:&U^T*7DB8
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M\EK(,10K#DA%2-1CJ#7T9_PP+^V%_P!$=O\ _P &UA_\51_PP+^V%_T1V_\
M_!M8?_%4<C\OZ^0<\>[^[T\_7[O,^<8OB+X_A\8Q?$"'Q=K$/C>*9KM?%L4^
MW7#>Y)CNC<XQYJ%B<XQDGCFN=U34[_7=1OM6UN[GU/5-6O'O]6U&Z;?=7]Y.
M_F7-U,_&9[AR6=NF37UA_P ,"_MA?]$=O_\ P;6'_P 51_PP+^V%_P!$=O\
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M+D,.I0)@J<2\@DJ2,$%3GD5]._\ # O[87_1';__ ,&UA_\ %4?\,"_MA?\
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M+_HCM_\ ^#:P_P#BJ.1^7]?(.>/=_=Z>?K]WF?(%%?7_ /PP+^V%_P!$=O\
M_P &UA_\51_PP+^V%_T1V_\ _!M8?_%4<C\OZ^0<\>[^[T\_7[O,^0**^O\
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M]WIY^OW>9\@45]?_ /# O[87_1';_P#\&UA_\51_PP+^V%_T1V__ /!M8?\
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M^[T\_7[O,^0**^O_ /A@7]L+_HCM_P#^#:P_^*H_X8%_;"_Z([?_ /@VL/\
MXJCD?E_7R#GCW?W>GGZ_=YGR!17U_P#\,"_MA?\ 1';_ /\ !M8?_%4?\,"_
MMA?]$=O_ /P;6'_Q5'(_+^OD'/'N_N]//U^[S/D"BOK_ /X8%_;"_P"B.W__
M (-K#_XJC_A@7]L+_HCM_P#^#:P_^*HY'Y?U\@YX]W]WIY^OW>9\@45]?_\
M# O[87_1';__ ,&UA_\ %4?\,"_MA?\ 1';_ /\ !M8?_%4<C\OZ^0<\>[^[
MT\_7[O,^0**^O_\ A@7]L+_HCM__ .#:P_\ BJ/^&!?VPO\ HCM__P"#:P_^
M*HY'Y?U\@YX]W]WIY^OW>9\@45]?_P## O[87_1';_\ \&UA_P#%4?\ # O[
M87_1';__ ,&UA_\ %4<C\OZ^0<\>[^[T\_7[O,^0**^O_P#A@7]L+_HCM_\
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M/K^#/Z^Z***"@HHHH **** /RN_:C_Y/2^ '_8$N/_2N6OIV;_6R_P#71_\
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MH.0<XZG(]^*\^^%_B74?&?PZ\'^*-82W_M35+*XGOY0"A=H[N:!25."/W:
M$ ]^]>@<  +&$4#C;R'_ -KDD\^] !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 H+<@*=W5&# 9Z;@ >O'\_>L;4+R]@OM'%EI\E
MY:75W-;ZU<ML;^S;14#0W,9(.UI),(Q!&1WQG&NV".8TR,[)&)ZD8V]?7U]/
M:O-O&GBO5= \5_"3P_I\=NEGXQ\2:CINMDJ6,UK;69GC3=T4JW(8D ]!TH ]
M+.,G'3/'T[4E.<;68#H&(X]B13: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ Q&V%F8K"2"[+]X%>4P>WS>M9>DWNI737L^LZ2V
ME^5J,]M:*CQ;;RP"X@U&1%PQDD)Y;!SC&36O$ TT2/@Q22*DD9^[)N(50?3!
M/7_&O+_AGXHU7Q5)\0(]5AM?.\/>.[[PY8LFY7CTZS02PD!^&R> P!SZT >E
MJ-J@<G'KUZTZE9RY+'.3USU]*2@ HHHH **** "BBB@ HHHH *" 0 1D [@#
MZCH:** %+-O63<=ZC:K D$#TXQG\:=YLG_/1_P#OH_XTRB@!_F2?WW_[Z/\
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M_"3^'?\ H;_"_P#X4>F__)=.7Q3X?0[E\8>%P>1G_A(],[\'K=5_&9]IO_\
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M_H;_  O_ .%'IO\ \EU_&=]IO_\ H*:W_P"#;4?_ ))I1<WV0#JNM_,P1?\
MB;:A]X],_P"D\#WZ4>T\OQ_X >S\_P /^"?V8?\ "3^'?^AO\+_^%'IO_P E
MT?\ "3^'?^AO\+_^%'IO_P EU_&>;B_#,O\ :FMDIG=C5M0/3K@BYY_#-,^V
M7?3^UM;!XSG5M1 ^;[N/])Y]_3O1[3R_'_@![/S_  _X)_9G_P )/X=_Z&_P
MO_X4>F__ "71_P )/X=_Z&_PO_X4>F__ "77\:!GU!25.J:UN&W(&KZ@2-W3
MC[3GZ^G>F_:;[_H*ZWUQ_P A;4.3Z#_2>3],T>T\OQ_X >S\_P /^"?V8_\
M"3^'?^AO\+_^%'IO_P ETA\3>'""#XO\+D'@C_A(]-_^2Z_C1-Q?JN]M4US8
M.I&K:B2N>FX?:<KGW%--U>J"7U76U"A6/_$VU'.U_NE?])Y]\=!1[3R_'_@!
M[/S_  _X)_9G_P )5X?QC_A,/#&-@3'_  D>F<(O0#_2^,>W-.M_$OAD.%;Q
M?X: PY&SQ+I:\8^8,7N^<@ #GBOXS//O\A?[5UK<5W_\A?4,!1G)8_:<#\:3
M[3=L CZEK6'VN)?[6U'"J/0BY_CQBCVGE^/_   ]GY_A_P $_L:T#QIIEY:W
MB:GK?AK3%75+J"V2/Q)I"&YMHB3;7)_TH9,YX9N2PZDUK?\ "3^'_P"/Q;X7
M1OXE_P"$CTP[3Z<7>.*_C2:ZO'E$\^J:O*C+Y%O&NJZB-GE@[7(^TY!3!8L1
M^--6;4"2O]K:RY52Q8:OJ&"!W!^TX/\ .CVGE^/_   ]GY_A_P $_LO_ .$G
M\._]#?X7_P#"CTW_ .2Z/^$G\._]#?X7_P#"CTW_ .2Z_C.^U7I"L-5UK#?=
MSJ^H!N.Y!N00,@XR!GM3EGOV* :KK.7+!?\ B<7_ %098$_:L @=C].M'M/+
M\?\ @![/S_#_ ()_9?\ \)/X=_Z&_P +_P#A1Z;_ /)='_"3^'?^AO\ "_\
MX4>F_P#R77\9PNKU]^S5-=_=J&?=JNHKA6.!C-R-W/IFG>?J!W'^T];&S[V=
M6U ;<?WLW(Q^/6CVGE^/_ #V?G^'_!/[+_\ A)_#O_0W^%__  H]-_\ DNC_
M (2?P[_T-_A?_P */3?_ )+K^,\W%^H0G5-;_>+O0_VMJ."N2,Y^T\<CO1]H
MORH8:IK15NA&KZ@<_E<T>T\OQ_X >S\_P_X)_9A_PD_AW_H;_"__ (4>F_\
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M]IY?C_P ]GY_A_P3^S'_ (2?P[_T-_A?_P */3?_ )+H_P"$G\._]#?X7_\
M"CTW_P"2Z_C.^TW_ /T%-;_\&VH__)-'VF__ .@IK?\ X-M1_P#DFCVGE^/_
M   ]GY_A_P $_LQ_X2?P[_T-_A?_ ,*/3?\ Y+H_X2?P[_T-_A?_ ,*/3?\
MY+K^,[[3?_\ 04UO_P &VH__ "31]IO_ /H*:W_X-M1_^2:/:>7X_P# #V?G
M^'_!/[,?^$G\._\ 0W^%_P#PH]-_^2Z/^$G\._\ 0W^%_P#PH]-_^2Z_C.^T
MW_\ T%-;_P#!MJ/_ ,DT?:;_ /Z"FM_^#;4?_DFCVGE^/_ #V?G^'_!/[,?^
M$G\._P#0W^%__"CTW_Y+H_X2?P[_ -#?X7_\*/3?_DNOXSOM-_\ ]!36_P#P
M;:C_ /)-'VF__P"@IK?_ (-M1_\ DFCVGE^/_ #V?G^'_!/[,?\ A)_#O_0W
M^%__  H]-_\ DNC_ (2?P[_T-_A?_P */3?_ )+K^,[[3?\ _04UO_P;:C_\
MDT?:;_\ Z"FM_P#@VU'_ .2:/:>7X_\  #V?G^'_  3^S'_A)_#O_0W^%_\
MPH]-_P#DNC_A)_#O_0W^%_\ PH]-_P#DNOXSOM-__P!!36__  ;:C_\ )-'V
MF_\ ^@IK?_@VU'_Y)H]IY?C_ , /9^?X?\$_LQ_X2?P[_P!#?X7_ /"CTW_Y
M+H_X2?P[_P!#?X7_ /"CTW_Y+K^,[[3?_P#04UO_ ,&VH_\ R31]IO\ _H*:
MW_X-M1_^2:/:>7X_\ /9^?X?\$_LQ_X2?P[_ -#?X7_\*/3?_DNC_A)_#O\
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MO\+_ /A1Z;_\ET?\)/X=_P"AO\+_ /A1Z;_\EU_&=]IO_P#H*:W_ .#;4?\
MY)H^TW__ $%-;_\ !MJ/_P DT>T\OQ_X >S\_P /^"?V8_\ "3^'?^AO\+_^
M%'IO_P ET?\ "3^'?^AO\+_^%'IO_P EU_&=]IO_ /H*:W_X-M1_^2:/M-__
M -!36_\ P;:C_P#)-'M/+\?^ 'L_/\/^"?V8_P#"3^'?^AO\+_\ A1Z;_P#)
M='_"3^'?^AO\+_\ A1Z;_P#)=?QG?:;_ /Z"FM_^#;4?_DFC[3?_ /04UO\
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M_P!FV*RUS2-4EM_B#;R2+I^KV>H21HUZIP5MIY"./4'^5?S(?:+[@G4]7;#
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M-E;>&?!WAKPY>7FDVEC:VJ&#[1(-,DMA/<W2X,\DV]L\[N*]<^'FMZA\;?\
M@G_\8/#GQ!OY=5U#X/ZOHL_@;Q7J3I<ZGI"ZK/M:Q:_F+W$ENXR@229L*>E
M'P'\,/@?\6?C/<ZG;_"WP)=^+I-+2)M5EBGATW1X(I?]4+C4M0>&S:<9^>*.
M;>#P16C\2/V>/C5\&Y-#7XF>";SPY%XCN_L&AO;W=IJVGW%SD*MO]MTYY[>%
MMQ 1995.>QS7VK^V=XBO?@U\&/@#\ _A_++X0\)ZSX,T?QUXWN-%>2RU'Q7K
MFM0M/+)?:C:F*\DMUD :"-)RJ]"OI\+>&_B5\0VMO#G@.7Q;JM]X+E\7Z7>)
MH6IW+ZB'N7NXR)(+F^:>ZA(;E@KJN#B@#V*T_8-_:ZN[*'48/@_<BTU*"*[L
M)+GQ%H5A>W=C.H=+F.VO+J.002Q\A]G(/7BO)-"^!7Q8\4?$&^^$/AGP;=:I
MXZTFXGBOM$@N()EM;BR&^Y@GU2-VL(TC7GS9)UB<G"L<8K]3?VXOA!I/C+QU
MX'\37_[5G@WX1ZG;?"7P_!'X)\0:OXBM=8FCM[0',$6EW$=GLO@/*@9EW;F&
MX@5\X_L0?$GX<>#G^//PH\>^/H_!3_$_0DT+PW\7A+-)!9ZI [>2+G4)6;4(
MH-0E81-+%,LA4_,W H ^/OBC\"_BW\&+ZR@^*'@F?P[=:QL&DW4=W:ZM87;J
MWRZ>+C37G@-RI_Y8J_FACAEKN[G]CK]I6#P5_P +!D^$FHQ>%;G3TU[S9-3T
M]-2ETUP&-];Z091J1B"?.4$&X+R1@UZG\5O@[\>?V6M3^&;?$C6Q\2O@=:>.
M;/QAX;\0Z9>OKWAK5[[[7%?W_P!FO;B6[N8YKBR*_P"CW,HB5F*[.U?7'QZ^
M&OCW]HGQ3>?M4_L@?%U?%L%KX75-2^%5CJLD/BGP7FPBAU2Q@T.2X33I[*"%
M) P6T?C)7GF@#\U])^ WB'Q+\#?$GQUTKQ'I5UH_@W6CI6O^$2'7Q-IB*_E1
M:I,N=@L9)QY0#KG=7<? ;PS^S%XT&E:%\4-"_:$U'QKK.LPZ=+J'P]LTN/!U
MI!=21Q6IUB40R>0MN\@EN69TQ&K$D#->V?L$VUUXM/[2/PJUVS1SXR^'UZUU
M97RNDCZMI#75[-<)#@+%.)HVS\J_-GL<5B_LQ7'BCP5HEU>:!^V)\,O@KI%Q
MXJN(O%7P^\1Z9]M\0:Q:65^Z7MO%.]M,T#:A:I);1/$Z[7<$$$9 !\M?'?X=
MZ9\)/BWXW^&^A>(TUS2-$U;RM.U!YHKIY;22!)HX//@9XQ+&L@CE7=\LBL#@
M@UY( H5=L;6Y0;#!(<L3G/F@C(VG/'/\J]Q_:3USX<^(?B]XHU/X5:3'I?A"
M>]CV*DLLZWUWL075Z99V>7%U<"6X4!L*L@&   /$79?,D3&&5QP.5"[1P#UZ
M_AZ"@!M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6_A_WA7T
MG^QY_P G,_"#_L;=._\ 2N*OFQOX?]X5])_L>?\ )S/P@_[&W3O_ $KBH _M
MOHHHH **** "BBB@#\KOVH_^3T?@!_V!+C_TLEKZ=F_ULO\ UT?_ -"-?,7[
M4?\ R>E\ /\ L"7'_I7+7T[-_K9?^NC_ /H1K:'PKY_FS.?3Y_H1T4451F%'
M7C..O/I1119/22NGO;303O9VW\U="*HC5W4[W\U0,]L?B">IYX!]^:_#G_@K
M'^SG\=?C5X\^&6I?"?X<:QX[M]'TBZAU2XTSRO*L+F2[62*"?S&&3)&"PP,8
MY)K]QZD266//ER2)D@G8[+DCH3@C)'8FOI^#^)\9PAG='.,-&-:5"A7H4Z4]
ME"O3]F];IMQ6M[ZO4^1XTX/P7%^0ULEJSEAO;5\-7G75Y^]AZBJ?#TNUTV]=
M3Q3]GK0]<\,_!#X;Z#XHTR72=>TS0;*WU#2;@_Z5;7D$$2-;_*=N-ZG/..*^
M4_\ @IAH/QL\;_ N+P%\$_ .O>+=7\0ZO:3:O_8C1?N[&([9K2?S6&(G& X&
M0>O-?HH6+-N8EFSG<22V?7)YS3TEEC.8Y'0^J,RG]"*C+>(\1@>*(\23I0KN
M&.Q&.6$FVZ3K5FI)S7VE3DKI*S\T;XWAUXOA=<-0Q7L(/+Z>6SQ,:?ONA"'L
MY)6=TIQNFMWUN?GG_P $X?V;KWX%?L]:;8?$3P=ING_$#7;Z[O/$FDZUIUC>
MFPMTD4VD323PS.DOEY 6,[<CD"OJ+XZ?"_1?B'\&_B%X,TWPOX<35-8\-ZHF
M@);:)ID-Y+J;PD6@AECMD96\S[IW CKGC->T,[.279F+=2Q))^I.2?QIH)!!
M&05(*D<%2#D8(Y'/I6^.XOS;&Y[BL^EB\32Q=;,:6/HJE6E&%!TJD9QA&-[6
MM'D\HZ7M<X<KX"R#*^'(<.4\'0GA_J$L#6JRI1YZJE3</:7M=2NW*^KOK='X
M$_\ !,OX&?M0_L^_&?Q1HGCKX6^*/#'PU\4:3J2Z_K\S1/!<ZAIT973%@7>V
MWSFQGA>IY[#B/V?_ -E?]I'PS^WK??$S7OA!XDTGP%/XJ\27]IXGNOL_V6YL
M+FYWVDS;7RL<B<MQGGBOZ,FGG==KS2LO]UG8K^1.*#<3LH5IIBH& ID<J!Z
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M[#^N: $HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&T@!1@9[9H Z@;0,*I11T4]1['WI:,YR?<_SHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /SA_X*+_ +0/B+P'X&T#X#?">ZM4^-'QZOD\,:(US<16
MJ:1H-RYM]8U5IY7C2$VT)\Q&:1<<G-> _M<?!#PE^S=_P2Q\3_"SP[JGAR\U
MNWAT_4O$D]EK6EWE[J?BF_S)KFHW(M[J2:Y,\V73/F;2#TKZ._;&_P""<'PX
M_;/\7^%_''C'XE_$#P!J?A*"2TT\^$)(X8YEG!5A]H$D=S$QW?.8F7GFORA_
M;-_X)(_#G]G7]G?QQ\6_#WQ[^.WC;6=&D@:V\(^(=1OM4T*ZB+-YK-;K<7$T
MK@#HT3<YQWH _;O]AB_TVV_9)^"-P=7TUQ8^ -(EO)/[0LIY=/1+;,\ES;I,
M\L,./O\ GHH !K\?_B#X-UKX_?M?>+M<_P""9OB3QW\,O&,<TNG_ !?^*<2P
MCX+G6;(KG#$AY]5GFPK^2)$#@] ,U]*_\$]OV"]"\ ?L_P"J?$SP]\2_B!J_
MB;X]?".333X:\2WETOA_PU<ZEISQ*=/LYYA)9>0Q!R(8F KXI_9,_;2O/^"7
MW_"Q/V8_VFO@Q\0I$MO%6H^(/"NN^#-#NM1U3Q'!J-TTBWUU=Q6L\=Q97B'_
M $8S3-(O&0"* /6?V1?$D_P,_:SU#3/^"A&G>+-8_:<\57TOA_X<?''Q$D9\
M%3Z; T:6T6AXW0QSZHI$*'Y9"2,GFOUS^/W[)OACXY^,/!GQ"T[QOXR^#?Q:
M\#-<'PW\2?!*VI\3PVMY$%;376X_T>>REBPJ"3<0"-H!K\2/C#\=/%__  5C
M^-_P1T'X!_!WQQX4^&?P<\7:=XI\5^,O%^DRZ;K&DSQW44LMO=SSPV\CV_RX
MM5C9ANX(K]R_VHOVA]!_99^#>H>--6MM6\4^)_L5CH7@G0[&SN+S4?$/B:YA
M6STWY;>&4K'#>",W+.%41\DT ?F%\8? TGPY\477[('P/\<Z_P#%3]I[]HRX
M63XM?'7Q9Y)\2^!OAM,P-]9W,UEF"Q26SDECM59XOWN,CK7IWP>^)?Q(\(7/
MB;]E+_@G]X1^&.HZ+^SIX8#?$'QM\8A<Q+XH\3(I-_'HT^EC%SK%Q=22(7G9
M\@KS7OO[#W[-]_\ #C0O%_[1'QKEDU?XW_'*SGU[Q[?2$21>$/"5PKW$'AG3
MY)"TUK-IMOM:58B@'3 [?''[-OQ5^&O['7[07[3VD_&/5X_!W@3XF-?>/OA7
MXINM.U.\L_%NFWLCM;Z5#<V5M<,=0:12JI*PPQ7/'0 _2']D7]I!?VD/ 6HW
MFN>'SX5^)/@;Q#>^#/B%HB,#90^)]-WF[FTPGY_[.<#= S\E6&3VKZJ.9&9Y
M,*T1/T(XSTZ\=<#&*_,7_@FCX$\366E_'7XP:OHNK^'M$^,/Q0UKQ/X,M-:C
M:"ZO_#-V66SU2*%PKI%<!=R%T63:P#8K]/(URS*@VF.$+\W0Y;)R/7GJ>>/R
M (?X7CE60Q7$A,.Q5>-E88D0HP(,,B%E<,#PQXK\/O\ @H7^QD^A3ZI\<OA/
MI0?2KM_.\9:%;Q$_V=,V&FO[*&)<B!OF+;4X8DXQ7[BYZ#L.@]/I4%W96&J6
M5WI>IPI<6&H026MS#)&LL<D4J%'C:.0%&\Q6*<CC/%)JZL-.S3/XO"T<D+D/
MB!U7:N/F\X$!D([8;@@\CO3SNS\R[#@?*.<<#'KVQ7Z(_MV?L>W?P*\23?$'
MP59S3?#77[Z2>2R@C,O_  CFI7#%I+>0*#LM3O,@8@ ,>",5^=I(!P5;H#\I
MR.0#P>?7UXZ5G*/*KWOKV-8RN[6_K[@HI-P_NO\ Y_"C</[K_P"?PJ"C[Y_9
MM^)O@'PC^RW^T[X/\2>*++2_%7BZQ:/PQX?GW"[U=S&JE[0J,%P>-KG''3IB
MC\%/B%\/_#G[$/QL^&VN^)])T[QYX@\8:3JOAWPRYE-_JMC%8K'/-#@; R29
M5MQ'(P.*^$B(RP8Q$LOW6*J6'T.W(_"D(B+!S%EU&%<JI91Z!BN0/H: /TN_
M8I^('PO\,?"CXDZ/;>.O"/P2_:"N[FV'ACXG^/+&*_TBRT(PJ+K3+6*2&=3-
M+("Q9EW#H#VKU_\ :,^/F@ZA^R5H/@76_P!H+PY\<?C;X;^(>B:[?ZKX7L8;
M#2-0L+>:.=WT>&""%'AMX5V7!F4MY@..*_'*189>)8?,'_31%?\ ]"4TB)!%
M@QP",@$ HB)@'J!M48![T ?K9\7/^&<?VB_&7PZ_:+O/CQX4\!)IGAG0(O''
MPWOC<'Q]?WWANVCMGM=+A"FR\Z\:/?;[^-I&:Y_XWWG[+W[2?[93R^*/B[)X
M5^"D_P .O#L,?CC3!_I8UW2-)$5OH]VLB[5N%E"PW(C7;N!QD#G\LC%;LV]K
M96?.=YC0MGUW%,Y]\TNR#;L\@;,[MFQ-N[^]MVXS[XS0!T7B^UTS3O$GB73_
M  W?OJ>@:;K=Y8Z%J$P7S-7TJ"<I:ZA(%^4>="%?([L?Q^IO!GP#^ OQ \+^
M%?%.@?M,>'/A#XGC;R_'&F_$2XO;35+66*1?(G\,S:85=87QE=S*2/O<U\=[
ME& $? &!TX'H..!43Q6\A)DMED)QDO&C$XZ9+(>G:@#]9/B7^W)X7\/_ +0O
MPMU[PX-2\;^$/A5X$3X=>*/$4*K)?^/=%GM%L=2N-*E<%[D/&-UL;IG..O6O
M*_&?[.G[/7CGQ?<^-_AY^UE\+?"'@+Q7<#Q!?>#_ !P;V/QKH4=\3/=Z5(+9
M/LZWEIS%"JG9OZ\5^>8*J %1E"C"@  */0 #@?2H3!:DEC:QECR6,49)^I*9
M- 'V7I_P>_97\=R^+/#O@WXWW?@#7?#EY:P:!XD^+JA/!?B@K)C4KRREL%-V
M$ R^EDD-G&_M7K'Q]^*G@?P1^S%X6_93\-_$^W^-.N:=K$_BC7/&VFO+>^&M
M/CN6$EII.BW5\'O(GC.(YU5U0( H& *_-]T@D55> .J_=5T1E7_=!4@?A2HL
M4>0D.P'KL55S]<*,_C0!<M]0U2RPVGZKJ^FM=D+,--U.\TTH,_\ +=K&:$RH
MN<P!RV".@JQ_;WBE"=WBKQ<1!\L1D\4ZX#=*1CG%]PZ]4[9QGWSMP_NO^G^%
M2(2[<1@A4<C>3G..P]L#'XT ;6@7L<'BOPK?ZI>2R6R^(]'O=2O;N>6X>UMX
M+R*2::YFD>262;8&,CR,68+UK]6?%_[37PVTC]NGX:_$?1?&-GK_ ,,IOAMI
M_@CQ=J4)D/A^"SO[2.PU"UOXR TTMK$\K'>K!2I*X-?D.-J[E 7R=JM?=QM8
MXBQG_:X/0XX-- B"&,18C/)0*H0_5=NT_E0!^LGQ=_:$^#6I?MF_!G_A76N:
M=H_P ^$T%EIL&O1!SIRW?G1S7VH1HR@F)P\JL^W>0#TX%=#\+_VJ_ ?@S]IS
M]IS3;3QM!X>\'_&QY+;P/\6["VAN],\/ZE B3P:OJ$-W'(&TVXE"Q."F0%?
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M* %HI-P_NO\ Y_"C</[K_P"?PH 1OX?]X5]*?L> _P##3/P@X/\ R-NG=O\
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M=7,]M\4_'5C;SW$T\5C%;6KQ6BRR-((8W8;F2/<%4GG:HK]7**!IM;'Y._\
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MBR8"O<Y/FLGHO0#VJ[@* %S@#O0 4444 %%%% !1110 4444 %%%% !1110
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MO^@-?_\ ?EJ.:/?\_P#(.27;\O\ ,RJ*U?[!U[_H#7__ 'Y:C^P=>_Z U_\
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M:CFCW_/_ "#DEV_+_,RJ*U?[!U[_ * U_P#]^6H_L'7O^@-?_P#?EJ.:/?\
M/_(.27;\O\S*HK5_L'7O^@-?_P#?EJ/[!U[_ * U_P#]^6HYH]_S_P @Y)=O
MR_S,JBM7^P=>_P"@-?\ _?EJ/[!U[_H#7_\ WY:CFCW_ #_R#DEV_+_,RJ*U
M?[!U[_H#7_\ WY:C^P=>_P"@-?\ _?EJ.:/?\_\ (.27;\O\S*HK5_L'7O\
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M'7O^@-?_ /?EJ.:/?\_\@Y)=OR_S,JBM7^P=>_Z U_\ ]^6H_L'7O^@-?_\
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M_P"@-?\ _?EJ/[!U[_H#7_\ WY:CFCW_ #_R#DEV_+_,RJ*U?[!U[_H#7_\
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M[_H#7_\ WY:CFCW_ #_R#DEV_+_,RJ*U?[!U[_H#7_\ WY:C^P=>_P"@-?\
M_?EJ.:/?\_\ (.27;\O\S*HK5_L'7O\ H#7_ /WY:C^P=>_Z U__ -^6HYH]
M_P _\@Y)=OR_S,JBM7^P=>_Z U__ -^6H_L'7O\ H#7_ /WY:CFCW_/_ "#D
MEV_+_,RJ*U?[!U[_ * U_P#]^6H_L'7O^@-?_P#?EJ.:/?\ /_(.27;\O\S*
MHK5_L'7O^@-?_P#?EJ/[!U[_ * U_P#]^6HYH]_S_P @Y)=OR_S,JBM7^P=>
M_P"@-?\ _?EJ/[!U[_H#7_\ WY:CFCW_ #_R#DEV_+_,RJ*U?[!U[_H#7_\
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MKW_0&O\ _ORU'-'O^?\ D')+M^7^9E45J_V#KW_0&O\ _ORU']@Z]_T!K_\
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M[_H#7_\ WY:CFCW_ #_R#DEV_+_,RJ*U?[!U[_H#7_\ WY:C^P=>_P"@-?\
M_?EJ.:/?\_\ (.27;\O\S*HK5_L'7O\ H#7_ /WY:C^P=>_Z U__ -^6HYH]
M_P _\@Y)=OR_S,JBM7^P=>_Z U__ -^6H_L'7O\ H#7_ /WY:CFCW_/_ "#D
MEV_+_,RJ*U?[!U[_ * U_P#]^6H_L'7O^@-?_P#?EJ.:/?\ /_(.27;\O\S*
MHK5_L'7O^@-?_P#?EJ/[!U[_ * U_P#]^6HYH]_S_P @Y)=OR_S,JBM7^P=>
M_P"@-?\ _?EJ/[!U[_H#7_\ WY:CFCW_ #_R#DEV_+_,RJ*U?[!U[_H#7_\
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M'7O^@-?_ /?EJ.:/?\_\@Y)=OR_S,JBM7^P=>_Z U_\ ]^6H_L'7O^@-?_\
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MO^@-?_\ ?EJ.:/?\_P#(.27;\O\ ,RJ*U?[!U[_H#7__ 'Y:C^P=>_Z U_\
M]^6HYH]_S_R#DEV_+_,RJ*U?[!U[_H#7_P#WY:C^P=>_Z U__P!^6HYH]_S_
M ,@Y)=OR_P S*HK5_L'7O^@-?_\ ?EJ/[!U[_H#7_P#WY:CFCW_/_(.27;\O
M\S(;^'_>%?&O[4?_ "4[]FG_ +'R#_TK%?</]@ZX2 VCZB/X@1 2"1V)/3G%
M?%?[5>GWME\2OV8WO;2XMFF\>H LB8P4NE('X@Y^A!J)M.UM=_T#DEV_(_7>
MBBBH-@HHHH *:6YQCH-W\Q_C3J0]1]<?A@\4 ?F?\=RW_#>W[,Y RCZ1> \=
M_M,Q!_*OTQK\SOCN?^,]_P!FD=O[&O..W_'W-VK],: "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.3^%OF^4Y^5B.HQRO1OH>G
M6I*CD&=HXZ\$G&#[#O0!Y,/B/>/\97^%0TR%8$\#)XM.M"X)F$S:E]A-F;/&
MWRL983'G=@5ZXO08S_P+.>O?->8C0O T7Q+G\2&>%_B4WA%-*FB2Z8W7_"+C
M4?M".M@/E\O[7QYXYW?+FO3@<@'GH.O7\?>@!:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "LW6;YM+TC5=36,2MIVG7U^L1;:)3:
M6LMP(RW\(D\O:6_ASGJ*TJHZG#:7.FZA;W[*MA/974-\SML5;.6!TNBS_P
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M5S0+XBT'6+R\\$>?<_9GDU6>T$-TMM"#B[D%KC?$<D(=P[T >DT444 %%%%
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M>(09XI6\OISN[UW:'((P 0<8'0?3^=>:?#+P4WPU\ ^%O C:@^JOH%K)9OJ
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M?G7E/PY^'I^'L_C6X?4WU-_''C/4O%95+00"Q%_&BBR)4DN8]H+7# ,QZ]*
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M:S=R6!M-YU0:Q8I9H@<_-;^0078J,L/E/3->MT %%%% !1110 4444 %%%%
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MD7)506Z<T ?05%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,DRLC[?]6%W\5]!T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@>SM_P %8/V)(F:(_$V^)0[21X;U1AGKPPCP>O4<4 ?I#17YN?\ #V3]B/\
MZ*9?_P#A-:K_ /&Z/^'LG[$?_13+_P#\)K5?_C= 'Z1T5^;G_#V3]B/_ **9
M?_\ A-:K_P#&Z/\ A[)^Q'_T4R__ /":U7_XW0!^D=%?FY_P]D_8C_Z*9?\
M_A-:K_\ &Z/^'LG[$?\ T4R__P#":U7_ .-T ?I'17YN?\/9/V(_^BF7_P#X
M36J__&Z/^'LG[$?_ $4R_P#_  FM5_\ C= 'Z1T5^;G_  ]D_8C_ .BF7_\
MX36J_P#QNC_A[)^Q'_T4R_\ _":U7_XW0!^D=%?FY_P]D_8C_P"BF7__ (36
MJ_\ QNC_ (>R?L1_]%,O_P#PFM5_^-T ?I'17YN?\/9/V(_^BF7_ /X36J__
M !NC_A[)^Q'_ -%,O_\ PFM5_P#C= 'Z1T5^;G_#V3]B/_HIE_\ ^$UJO_QN
MC_A[)^Q'_P!%,O\ _P )K5?_ (W0!^D=%?FY_P /9/V(_P#HIE__ .$UJO\
M\;H_X>R?L1_]%,O_ /PFM5_^-T ?I'17YN?\/9/V(_\ HIE__P"$UJO_ ,;H
M_P"'LG[$?_13+_\ \)K5?_C= 'Z1UGZM'?S:9?PZ5=Q6.IS6EQ%IUY/#]HAM
M;V2)EMIY8#Q,D4I5VC/#A2IZU^=G_#V3]B/_ **9?_\ A-:K_P#&ZYGQK_P5
M5_8VU/P?XIT[1?BAJL.LWOA_6+72)+?P]J4-PNISZ?<1V)MYG0+%/]I:,1R$
MC8V&[4 ?I3HL&L6FD:39ZY?6FI:Y%:Q)JNI6L(M8;J\1!YUQ#:<&))FY$8^X
M/:MU,8.-WWCG=G.>^/;TK\H_AA_P5&_9 T;P!X.TGQ7\4-3G\4Z=X=L(M<FO
M-$U"XOC?I"!=&YN%7$T^[(=P2S8S@$XKNE_X*R?L1;1CXF:@1C@GPUJN2/\
MOW0!^DM%?FY_P]D_8C_Z*9?_ /A-:K_\;H_X>R?L1_\ 13+_ /\ ":U7_P"-
MT ?I'17YN?\ #V3]B/\ Z*9?_P#A-:K_ /&Z/^'LG[$?_13+_P#\)K5?_C=
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M  FM5_\ C= 'Z1T5^;G_  ]D_8C_ .BF7_\ X36J_P#QNC_A[)^Q'_T4R_\
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MEYVXTY;J4DKM::KR;T8IMQNHISDG'FBKJRD[)W:L^NBO^)9HJ .Q ZC\>O\
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M)O.20NY^]^Z!+$*,GV'XTY+NU>1+9+J&6:63?9B*1)'D;^)9$0DK& .XQUH
MGPO]P_FO^%&%_N'\U_PJO/>6]N)MMPD<X&)X[A<1Y0<F"1OE3(SWX^G7['\5
M? WP!H_['/@?X]:8VM-XW\5?$"\\,7J2WRS:3%IEO;>='+;6R_\ +5GX9AQC
M/?- 'R!A?[A_-?\ "C"_W#^:_P"%.7:RNLQVO& <1?*3QTX!Y->__LZ?L]>(
MOVB/%&J:78:U9>#O#7A?2I?$'C+QAJZ>;I_AW0X=^^]F@X,Y)4JL:G<6Q@T
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MO^%&%_N'\U_PI:* $PO]P_FO^%&%_N'\U_PI:* $PO\ </YK_A1A?[A_-?\
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M]Q<27\KMY5S8P,QB7:HZK\V!61_P4PO]5G_: TS1I[J>3PSIG@K0&\+V9/\
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M?BE\)O@KX*\,P:OX _:>T+XN>(!?PVTOAC2_"^I:,_\ 9DBYGN/M%V/+S$P
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M73/$WA&&^FGCU"_\+ZYK,_GR'-T/M>FPO"41ON*6+ =.M?T ?\$O?VSOC_\
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MG]XR\(6'[(7P3LKWQ=X6L[R+P9IHFMKK7]*@N(#A]RS0RW221..Z,JL._O\
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MM4UW^X?1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO3I_#TY]*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M .2*+?WI?U\O+^KL+RTTC_7+_P '73\S^*AKBR9)$-U:XD8,Q^TPYX.0!\_
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MT;[\.O\ P63?_)%%O.7]?+^OFPO+32/]<O\ D_O]3^*K[7:?\_=K_P"!$/\
M\71]KM/^?NU_\"(?_BZ_M5_X84_9"_Z-]^'7_@LF_P#DBC_AA3]D+_HWWX=?
M^"R;_P"2*+><OZ^7]?-A>6FD?ZY?\G]_J?Q5?:[3_G[M?_ B'_XNC[7:?\_=
MK_X$0_\ Q=?VJ_\ #"G[(7_1OOPZ_P#!9-_\D4?\,*?LA?\ 1OOPZ_\ !9-_
M\D46\Y?U\OZ^;"\M-(_UR_Y/[_4_BJ^UVG_/W:_^!$/_ ,71]KM/^?NU_P#
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MLCZ+KO)W;=G;E6RTM;\?/8=1114@%%%% !1110 4444 %%%% !1110 4444
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MV$1_8[Z.3$D\<6/-1(LL&.2,8H ZRBBB@ HHHH **** "BBB@ HHHH ****
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M@WQWX1^(?AG2/&/@?Q!IGBCPSKUE#J&DZQH]U'=6=Y;7$8DA9)$/R,ZM_JY
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M0@VIRY*?+%K5IOV/2VOEWNS]6O\ A[]^TA_T)GPY_P"^-0_^*H_X>_?M(?\
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M5ODO)=4^WY@O'#Q:227&^8)*R_Y<O^7O3\K7^;W9^J__  ]^_:0_Z$SX<?\
M?&H?_%4?\/?OVD/^A,^''_?&H?\ Q5?E1A?[B_K_ (T87^XOZ_XT?6*O\_\
MY+'_ .1#_B./BWI_QF^8;K_GSW7_ $Z\OS\S]5_^'OW[2'_0F?#C_OC4/_BJ
M/^'OW[2'_0F?#C_OC4/_ (JORHPO]Q?U_P :,+_<7]?\:/K%7^?_ ,EC_P#(
MC_XCCXM_]%MF'_E'R_Z=>7]79^J__#W[]I#_ *$SX<?]\W__ ,51_P /?OVD
M/^A,^'/_ 'QJ'_Q5?E1A?[B_K_C1A?[B_K_C1]8J_P __DL?_D0_XCCXM_\
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M.?\ OC4/_BJ/^'OW[2'_ $)GPX_[YO\ _P"*K\J,+_=7]?\ &C"_W%_7\?\
M/\Z/K%7^?_R6/_R(?\1Q\6]/^,WS!Z+_ )\]E_TZ_KKNS]5_^'OW[2'_ $)G
MPY_[XU#_ .*H_P"'OW[2'_0F?#C_ +YO_P#XJORHPO\ <7]?\:,+_<7]?\:/
MK%7^?_R6/_R(_P#B./BW_P!%MF'3_GSY?].OZZ[L_5?_ (>_?M(?]"9\./\
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M_P#R6/\ D'_$<?%O_HM\PW_Z<]E_TZU_X?S/U7_X>_?M(?\ 0F?#C_OC4/\
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M&%_N+^OX_P"?YT87^ZOZ_P"-'UBK_/\ ^2Q_^1#_ (CCXM_]%OF&W_3GNO\
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MRAWW>E6]HCQM<7K-B\-TAVD9C/H >"?\%._V*_@[^Q1H7PC_ &NOV5O#VG_
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M$XL[=?EA# N0 &]*^%I)E17F:0W)@+$R3C"1#KD;<%@O7'?GKBOT32"ZM/\
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M/4?7^AH _,_X[_\ )_'[-/\ V!KS_P!*YJ_3&OS.^.__ "?Q^S3_ -@:\_\
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MX) _'-_BY^RCX>T35+]+GQ+X FDT:\@$F^:UTJ,+'HX<,2<-;J0,YXK\5?\
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ME(0YO;Z67Y[:"7_5)+%\Q<$$8H [*BBB@ HHHH **** "BBB@ HHHH ****
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M^OH>V!3Z:I) )&W/./3/8^].H **** "BBB@ HHHH **** "BBB@ J%PY+9
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M_'_QMI.HZ!XG^(=U>:3J4*+J=O::;8:9+J&#PDE]8QPW;X(R^Z0[@><UJ_\
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M"0__ !='_#'G[5/_ $0OQ[_X"0__ !='U>M_S[J?^"Y^7EY_AZV/^(<<:_\
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M_P !(?\ XNC_ (8\_:I_Z(7X]_\  2'_ .+H^KUO^?=3_P %S\O+S_#UL?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***@E:0,%CY+\?]<P,?-^/;/Y\4 3T5"'/S ;G*\?= !/
MKG^=-,S9/ .T'>%.<'MCCGWH L45 TA4)N(W?Q(OS$_[OZ9Z5 6F3S"\R>46
MWB0@*T2D\1E?XLXP#G/.?2@"]15:29D"L!N!VG'1\'&?E^F3]*<CLSMM)9=V
M#N&W P.5_O#K^F: )Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<<X/&<KRN?0'OCB@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BD.2.#CWQ_C48W,.&QM."2,%B"0<CL../7O0!+141=@"V#@$8P,DCN
M ./P/?\ &D#G+$DJN!MW#'S8S[YH FHJ'S S&,%@RA69MOR'.. 3ZY!_QZ4Q
M99'+%5'#%=C?*1CHV>X8&@"QD>H].M!8#&2!DX&?6JTC-NP(P95+-&I.$<'@
MDGL<9./:O%_CN/C3<> [W3/@9'HL/C;59!9Q:UKMQ'%;Z!;RN@N-1M[:7Y;R
MXAA,GE1<?/M(R<&@#W$D#J<4M?FY_P $[/\ A-=.T+XZ^&_'WC;5/'VM>%?B
MOJ.G3Z]JTTLOG2"V,TXMHI2PLK6.4ND=LAV(BAAC-<YX4\%I^V7\5OC/K?CG
MQCXQTSP9\,_$4_PY\*>'?!7B:^\.I!?0$7$VLWLU@0;URA95$@ W<GA<$ _4
M4L!@$@$G ![GT'K2U^0VE?'SQM\ OA-^T;\.M0U^7Q+K?P:\3)X7^'6MZU<&
M;5;G0]6FC@MKF[N)B9;^ZLFNF*R.=S;0>V*M_$#]G/4/@_\ !;3OVB?#7Q(^
M)&J_&;PG8Z-XUU"XO_%NJ7GAG77U2Z@DOK*;PQ*WV-+5+6^\J.,94?9RW<
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M]K/_ (D_[9G[(FMZ;_Q+]3O[_7M/O+U>'U"R%LN+)R.61,D%3QS0!^HO)*]
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M7'A[3(M=M&O-:L9[3RTNM,C:19=0@E#_ "2P*Z@CG& 3-^S=XX\!?LZ_%/\
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M<J#]>^>_K5%75/-<"5_+'ER.V22V1RB_Q+SG(Z >PJ\G"C&,=>!CJ<]/Y^]
M#J*** "BBB@ HHHH **** "BBB@ HHHH **** "F,@8JQ)RO0=N>N1W]O3K3
MZ* /GK]H3X :5\=?#6FV7]JS>&O%OA;5(]=\$^++>!;F?P]K$<L<AN/L[,HN
M891&(Y8690Z?*>*\S\%?LQ^/+WXC:!\1_P!H'XLQ_%W4? R/+\/].L?#5KX4
MTK0-3NE$5_J5U:6DLT>I3SP 1H)0OE$!]QVX/VC10!\,>)OV5_B9H_Q#\6>,
M_@'\:_\ A5.F>/D-SXQ\.WOA:U\3V][K<C-YVLV$UW-&=/NI$.T-$NY.S8KV
MOX8? Z#X3_#35/"'AC6W3Q9KBW^HZSXVGM$DN=0\5:C&RS:[+:%MHVR,'2VW
ME5"X#<\>^44 ?/'P[_9ZT#P?\.O$?A#6;P^)/$'CJ'4G\>>,)+9+:_\ $&I:
MF)%DO BEOLT4"M']GME=DC:/<#\W'CWPK_9)\8^%/%?@J^^(OQ;;XA^#OA-+
M<W/PE\-?\([;:/=^&KNY+(UQJ6KPRO-K,BVS"!3.H.U%Y  Q]T44 )@YZ\>F
M/7WI<8_$YHHH **** "BBB@ HHHH **** "BBB@ HHH.<''7M2<DG8!I;!QQ
MT]<?Y_SZ4TN1V';OG_/^>M-(/&3R>OM28^GYC_&GRMJ_,U\M.G6S_P"'#1_;
MLT]5]WD[?UW'^9[?K_\ 6IK$D @[6!X[@YZY'TZ9_ TFT^WYC_&GHO4D ^G>
ME;^^F^UO3R_K3YNRWO?ROOM_=]?O\CY,^(WP1^-^H>.-1\8?!WX]2?#NVUNP
MM+;5-!UOPO:^,-/^T6I)6[L([Z9%LG?.'$:\@D9P36I\'?V8M$^'D/CK6?%N
MN7GQ ^(7Q3M[FT^(7BW4(_LR:M9W*-&=/T_3E9X],L8D=O*@B=E0D$#Y1GZC
MZ>W\J0'.?8X_^O1?I=7_ *Z"UWMH?G7;_L:_%C1=.UGX<>%/VA[O1_@7JVJW
M4R> I?"]K=ZQ8:#>RK)<^'[3Q,\ZW<5K(H>([44!7;Y:^F/%OP6FF^#MI\(/
MAGXDE^'-A9VMAI46IVUHEY/_ &+"X74;,(S1CS=1MVEB>?.Y#*7 .!7O;#@X
M SZ]/KS3 &XX!'OC^=5;2]_EUZ?U]X.5FO=NK;VNK[:V^_J?-_CS]FSPQXE^
M"]M\(O#%S_PB,>B?8+OPQKD-JEU<Z7K&GW*7::I-&VP7<D\RL;@.P\Q7*DX
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MU"QRVE:JE[$J1W!25FD\H 8V]37T[N8X"9!."R;=VTM]\*_M[=*<ZG)+Y"Y
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M* $P.>!SR>!S]?6@J",8&#UXI:* $(!QD [>1QT^E&!QP.#D<=#2T4 )M'7
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M@8"C'TI:* "DP.>!SR>.OUI:* #'M[=.WI1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%(3@9- 7!C@9)QSZXR>PR?6JS2[9-GS*[$$\;D*CT;H#CT[^G::3YE
M #*,L/O#.?;V.<<]JYWQ)?S:7HNJ:C!9R7\^GV=S>06,<HC>\>"-I%@63!"&
M0@J#[\=J>'I^TJ*"UFY)*-U?5Q2>K6]];VTZI7MAB:ZP]&55Z12NY.]DE9N_
MR3MYFP^YB%4E-Q8MD%MP]B<XX]^/RI&W_-MRR#8$ /(/<EN^",[>O;%?G?\
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M=>+/#NAS>"_A9\/M(UZU\677C_QGKL'V0S(MCS;66GR313S*P/EV[*9"<[B
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MYX@UCP!\,OCW\/\ 1M3USQY\%_&EAJ>FZ7I%E-?W-VMU.I+RV=L&FG2 QEE
M&%)YZUX]_P $H?"/Q \2>)?CS^UQ\7_#>MZ7XHUI/)TC2M6T6\TS5(X[**1M
M1\J&[C669+@(%MT08YP!GBOZ(PV983&\,X3C:.(P]/-\KR/_ %8IX:<H1KXG
M&SDL/2Q?(^5N$:5;FYERJ-Y<S:3/Y;QN39CA.)<9P/*E7J9-F>>OB.MBJ*G.
MEA<%2MBOJZ;NE4G[)PMO*48)+6PO_!1SQ/HGQ;_;-_9K_9GG\2:)X>\/^"-0
ML_'?C.?6;Z"PTIK B*:"SN)9F6$[HXPBQL!M.?2O.? 7B;P1^R__ ,%1H]-\
M!^)_#M]\)/C5HENE[<^']3L]0LK37Y(D6TTZ3['))$I-S@+\W (S@\5Q?P-_
M8\M?^"C'[3/[1OQ-_:<\+_$+PGX7T#7ETOP1Y<E]X;OM7TQ9W6W,=U+&':WA
M09(16!R /;)_;Z_X)E^#?V0_!7A'XW?LLZ9\1]8UCP?XJL]1\1:9)?7OBO4'
M@BEBDL&TVTAA^T I,C^<J(5V;26YP/9RN7"& 6&X)QG$&/\ ;XSAF=#,<%2P
M]%Y.LXQ%*6+56ICY5VH5*<HQ3G3HU%.<U!S;NEY6:X3BO$XO%<>87(,#3P>#
MXAISP.*JXFHLY_LRG4I8?V-+!J%JE*TG)1E-<JIMP5E*_P"D7_!6#]D;XI?M
M&^ ? 'CCX.066K^//@[K<GBC2_"VH2*EMJN$$@:%W'EB>#RM_ED%I_EB49XK
MY>_9^_X*C:3=:GX&^ _[:GP,N_!'B:&^LM(M?%VLZ*D>AWNLP21V^E26&E3P
MK*&:Y 47L+!$&)"#SGZ&^+'[:G[3/PJ^$7[._P ;/#/P5UWXE?#W5_"]O_PM
MOP_:Z=/#XXCU>YLA#:?8[-XFN;0VUXC2W0EC(D3@CL?SK^-7CWXO?\%4OB;\
M&O"O@K]F3QA\')OA_P"*(];\2^-/&NGO9SC1T>$F.VOGMH%<1*C/%%\SB0MR
M,@#YOAG"/%Y50X?XGA@)9%A'F6(PF=X;-X8;%9'6=&LIPJ4HU.:K[65*'[F4
M''E<.9S5U'Z7B3,Z-'.JW$7"D,>L^QJRZABLHQN3?6*.=4G7HR=>A6JP;IQI
MIM\U/E;E"3ARZ']-WC/55L_ GBC6K><)#:>%-:U&VN(CNQ%;Z7/<)+&Z\?=4
M,FWVQ7X=_P#!%NRLO$.M_M(?&"X4W5]XJ\;:K9R:Q<D&X>VM+]V$3%OF RGT
MQQ7[60^$Y+#X43> 8KEM3N[/P7<^'5FN&S)>W!TN2S4R@G=^^D8#)X(..<Y/
MX@_\$>]3A\(_%G]JGX!ZU;O8:UX2\47FJ75D9!';QB^U%D-O;P$@ET60,[*.
MA].OR'#<J2X3X]P]&<JCE2R]1G"+YZF#ACDG4W349>[)Q=US6YNJ/L^+U77&
M'AOBZ\8TFJ^)G"->;C26/G@9KV+O>,>63T<?>T]W^9<;\7_B'^U/^WU^V%XY
M_9O^"GQ:O?@1\.O@K<SC5/%/ATR1:C>W'$$<US)!N:\MY'RJ6XQL;YCC)KZ;
MN? '[57[,O[%W[1GAWXJ?&#5_&^LZ!975[X&^*,=X\6NS64N!YN\CSK-X\(%
M1N5.XYYY^./B4_QQ_P"";7[;WQ&^..E?";Q+\7/A5\=;JXE>P\(6%Q?7UDJE
M9H;8&WBE^Q312Y9IILK(N%P>0?K+Q'^T!\<OVM/V.OVDO%WB+X)^(/AUX5F\
M.3Z?X'\*:E9S3^+M4N8V_>O+9K$MQ*"I0@+'AB2% Q7UV:J$(\/T\KCD+X26
M&R2;J5*>!6,^MO%498E5)*+Q+Q7.YJK"5Z+HN3LW='QV6U(U,7Q)5S19_'B_
M$5\P7LZ,\9]5I818;]U9.:H1PJ:?)6C%5'/W;<J2C^>'@'PM^WQ^T#^R;/\
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M^M  7.!C)+'W)ZF@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>gu1405a4gpzj000006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu1405a4gpzj000006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -( [\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7/\ ,4A\7:=M*[)V_P"V!KJA$/X4A7_=MU']*<L3#N?P0#^E+4=T<>?%M@O
MANR!Z0__ %Z/^$LTUA\T=T/K"?Z5V7EKWWG\!_A2>3%WC!_WE'^%%F%T<C'X
MKTE&R)9$/^U W^%2#Q+HTC;C?1 G^\I7^E=,]E;R?>LX&^L2G^E5GT73I?OZ
M=;G_ +9 46871E1ZGILX_=W]LWTF7_&K4+C(,<H=?3@C]*27PEHLF=VGQC_=
MR/ZU2D\$:0>8XYHC_L28_F#19A=&C*9&Y#%&]5)H2:YCZ3,PQWQ62?"<D/\
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MQGK0KCT.B!!&0<TM8L<CP_ZMB/;/%7(M0!(65=O^T.E,1>HIJL&7*D$>HIU
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M%-729@NTY /_ *#FII_']D/N73X_Z9VI/ZFI=2"W9HJ%5[([7;2[:\[F^(<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **BFGC@0O*ZH
MH[DUSVH>*8XK9IX&BAM5X-Y<OLB_ ]6/LH-5&#EL2Y);G12S1PIND<*!ZFL:
MX\11^7(]I'YL:??G9@D2_5S\OZGZ5P^H>(VG92JM)O/R3ZA&P5_^N5LOSO\
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M^[4O<3*K9'! '>JN8F'%=2)IB10MN!FRS?\  < ?K707FH&"S@C.58R $'T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<6MLNW*B)6<]AQD#ZFKUW8K;JKQ ^4%VN,DD>A_Q_"C6UPNKV//;G3[K[6L
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M.=X_SW]Z[I=0C23SE8%"BD$'K3Y[V'R=CN:*HZ7?+?6:R _,.&J]6AF%%%%
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M^3K_ !@8$MM[>H:G$3V.CM6D,TBM(7  (S5NLS1K&]LH95OKJ*XD9@5:-"H
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M#7$=TKNK[&O]N^.)_P"Y;)_RUE[;N@[8K/N[\7*.,S&UG7+!SY<U^H_B<_\
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M.O?[M&/]?U_7W\?O59?U_7]?=D0:5#X:TYM;UK=/J,K!HH9/G8R=F8#[S#(
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MGL*=P/68E*1(I[*!3Z**T,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT50%_ ^M=%62IPY48P3G*[.C XI:**X3K"BBB@ HHHH **** "BBB@ HHHH
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M]A@/;_/%( ;(&X'JW_UL4G9-N,[C^7-*W7&?T[__ *Z08VKQC)XX[T .^7'
M[\ ?RI#P.><<?Y_.C!YZC<<=.>U)UP?;MVH 4GY1GD CDTT':,@\@CZX%/S^
M[5>HW>M-;!''?'4>O7^M #B[A0&D/'/WCTQ_^NLF]O+B$$1RD<^@P?TK2.>#
M^M8M_D*.>P'^?\]Z ,>>_N [<Q<GO G/_CM1B[F9O^60]Q"@_I44^=_'KZ4U
M<YZT :<-U<D\SR#/HV,_E6C Q8C)+>['-9$'4<\YK6M@?I0!I0\@5HZ>FZ^@
M7UD7^=9T/"CWK6T@;M4M1_TU7C\:$#/1*6BBM3,**** "BBB@ HHHH ****
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MM)Z?E0 VW'<GG'^>M!)"@G@D9Y]/\*#U';UXXI#$#'&.Q'&#2LP Z]_S I.
M"3@8( _.G-CN#U./;U_.@ [KZG';KQ_/B@9V]1@CI^%#'#'GKG!I/D/)]><^
MG((H 7D]CN)R>?:DSD#)SV/;MUI6Z[V!)P>E& 3M'( QC]#^E "?PYYY);WY
M]/RI6V_3GCVZT@R^W P6&<>G84N/F#8XSCVR*  OP,GG.2?3(H/*\=>@P?TH
MV@K@C.1Q[]>:"<9X^]@Y!H "<#.1QS@?RH;(!&.136 *YS]*4D$CYCD<?J:
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MH T8F.,5T'A8%M90GLC']*YZ+HIXKI?"2[M68^D1_I36XGL=Q1116A 4444
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M+7NIKYYFESKMU<DG.R^F&/41E?ZUU89?$SGQ#^%'H_PHA(T"YN6^]+(@/_?
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MKJR@H5.0WH0: ''.6 &<?S_SFAO;''H:SO[;TE[DVHU*T:8MM"&5?\]ZT.<
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .'\?W 1[!">$$DQ_P"
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M# C)[_AUKS?1?!UYXAM!J5_?.D<N2A8;W<>O)XK4?X:QQ@M;ZO*I'/,7^!I
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11378(A8] ,T
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MK1)!%D]%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF[6T=_ N9[9@V/4>G]/QK:C+ED95HWB8?@+4ECEETTOF-P)(3GJ,<?\ CO\
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M'<H1DC# 'H?\\_0U=KD:L['4G=7"BBBD,**** "BBB@ HHHH **** "BBB@
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MZA5..0"?<]: %B3)Z\Y["M&&,8Q4$2?+T_2KL:D8&* )XA\H-6XE+,JJ,L<
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M[K.AHI*6N8Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTK3H[9<%AR[?WF/4UB>$?#YLHA?W:8N)!^[0CE%/]375U<40V%%%%4(****
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M ?:@"7<>_K29J/S!ZTAD% $I/OVH[=,'^50^<.Y'XU)$DTYQ#!)(?]A"W\J
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M=R5MM0(AN!@;R,*WIGT^O0UE5P[CK'8UIUU+26YU-%)FEKF.@**** "BBB@
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M2,@@Y!KAG3E!VD=L)QFKH?129HS4%"TAHS10 444E !124M "&FTXTV@!K'
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MVGD#Z^M:^C^'0H 2/&>K'J:[&RTR*U4?*"U3.M?2(X4>K*&F:(J /*/PK=5
MBA5& *=17.= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV484$^M6ZPE-RW-XQ2(XH4B7:B@5)114E!1110 4444 %%%% !1110 4444
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M.G^ZPY'ZUZ<;<'L*8;8>E:TZ\X;&4Z,9[GBTT<T4N)"TC]-DQ\N;'H)/NO\
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MIZ5TEGI\$2*P7<<=36@H ' K-R;-%%(HVFEPVX&0&:M   8 Q0*6I*"BBB@
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M#OL'-77<W1X['\5HG_?QA_-:D'CNV_BMU'TG']17+-X:U>/_ )<;D#OMG?\
M^O4#Z)JR#_CUOA_VU)_FM'L:#V_,/:UEO^1V/_"=V7> _A,E+_PG=C_S[O\
M]_4_QKB#INJ)_P N]^#]0?\ V6HVL=2 YAO?R7_XFE]7I?TQ^VJ'='QW8_\
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M*IV/^JQ5P50A:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** &,,U'T-3&F,* %!S3JA!P:E!R* %IK*&&"*=2T 9MS9_P 2U@W^
ME)/DX"2>N.#77D55GM5D!P.:J,FG=$RBFM3@3-=:=<YDWJP'#CN/?^\/UK>T
M[6ED*!V6.1NA!RC?0_TJQ=V =2DB!E]ZYRZTJ:U=I+?YXS]Y",Y_#O70I1FK
M/<YW&4'>.QWL-VLGRMPU6*X'3=7>(B%\LHXV,WS#_=/?Z&NHL]1#)E6WH.OJ
M/K6,Z;B;0J*1K,H88(S5.:R# [/R-68YDD7*G-/K,T.?N-/!!7:!G^%AP:P+
MO0(BY:'=!+V*G%=Z\:N,$9JE-8Y!V@$>AK2%64=F9RIQEN>>-_:.E2F1P60\
M%XQR?J.A_2M"RUUW.%?@<OMX8?5#_2N@FLN2!Q_LM6%J&@6URVXJT$PZ.G!K
MI5:$_C1SNE*/P,W]/UQIXP0?-4=?4?U%:\%]!.!M<!CV->:O!JFFMG:;J(#_
M %JMM<?CW_&K]CX@60%9#YTF?NL!'*/Z&IGA[KFAL5&NUI(]$S2US=EJ^[B&
M7?CK%(,./PK5AU.&3AR8VZ8:N9P:.A33+]%,# C(.0>XIV:DH6BDI: "BDS2
M9H *2C-)F@".;[M5B14TY_=FL\RFDQE@D4TD56,U-:;WI 63BFG%4FN#3#<-
M0!>.*:=M4#</3#-(:!F@=M,.SVK/,DGK3293WH ODQ^HIA:/VJAME/<TTQ2'
MN:!%TR1#N*B:>(=ZK?9W/4T?8R>YHL%QYNH^U1-=)2BP%/%BM%@N59+P9P!4
M37<G9:T19)Z4X6B?W:+!<R&DF;H#4;13R'O6\+9>RBG>0/2GH&IS_P!BF8\T
MX:4Q.2:W_* I1&/2BXK&(ND)WR:F32XA_#6OM [4F.:5QV*"V,:_P@5,MJH[
M"K6W- %%PL0>2J]J<L8QTJ4T 8%(8S;2[:=2XH 9BEQ3\48H 9BEQ3L4N* &
M8I<4[%+BF W%+BG8I<4"&XHQ3L4N* &@4[%+BE H 0"G@4@%. H T;#[A%71
M5*PZ&KU4(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "FFG44 0L,4BM@U*143+B@"4&G5"K8X-2@T +28I:* (I(ED&"*SKB
MQQRHK5Q2$47"QQU[I,<Q+;0LGKC@UF"2ZTZ7]YOX^ZZGYA^/<>QKNYK59!P,
M&LJYL<@JZ;E/8UM&HUHS&5.^J*%GK*<-(X7G_6J/ESZ,/X36_!J"M@28&>C#
MH:Y"ZTF2)C+:,5.,;?\ /4>QJM:ZG)92^7(HB ZHW^K/]4/Z5?LXS5XD>TE!
MVD>C!@1D'(I:YFQU<,ZQJWERL-WDR'K]#T/X5N07D<IVGY'_ +IK"4'$WC-2
MV)Y(DD&&6J,]AD< ,OH:T :6I*.<DLBI^7@^AK)O-(L[HD7-N Q_B P:[62%
M)!\PJE/8Y' W#T-:1FXNZ(E!-69PDNE:G:K_ *-*M]$.1')PX^AZT0:TR!(9
M0\3*=IBN00WT#_XUU,MF5.5R/8U7F59D,5Y DZ$8PXY_ UNJZ?Q(P=&WPLCM
M=72/&R;R2>-DI S_ $-;4&K C$RX/^S_ (?X5S+^'H&3_B679@/_ #[W'S(?
M89Z52D74=+E'VB&:%?[R_O8S_P !Z_E1[.$_A?\ 7]>H<\X?$OZ_KT/0XYXY
M1E'#?2I :XBUUDRKO*B51UDM6W;?JOWA6U::P98U:*5)T/;/(_K^E8RI2B:Q
MJQD;M(:IQ:E;O]XF,_[73\ZL&5<9R"#W%96-;CLTA-1F9>U,::@ FSM-9["K
MCN2M5#UI,"'8::8ZLXII7F@96\JD\D9JUMHV46 K>0*40CTJR%-+MH J^4*3
MRA5K:*3:* L5O+'I1Y8]*LXI,4!8@\OVH\NIL4AZT 1>6*-@J7%(:0$>T>E&
MVI*2@!FVC%.HQ0 W%)BGXHQ0 S%)MJ3%&* (\48I^*,4 ,VT;:?BC% #-M&*
M?BC% #<48IV*7% #<48IV*,4 -Q2XIV*,4 -Q2XIV*,4 )BC%.Q1B@!,4HI<
M48H ,4X"C%.Q0,N6/WC5^L^S^^:T*I$A1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 )2$9IU(: (6&#2JV.#3R,U$5P:
M )@:45$K8XJ0'- #J0T44 )BFLBL,,,T^B@#.N+$'E:QKW38YAB1.1T8=174
MXJ*2!)!R.:I2:$XIGG5QIUU8K^[/G0#D(1P/RY4^X_*K.GZRX"0N&F'7:Q_>
M+_NGH_\ .NKN+ C)4<5@7^B17&3CRW// X)]Q_7K73&LI*TSFE1<7>!KV&KK
M+'NBD\Y <%3PR_7TK8AN8YA\C<]U/45YU+%=V,B-,"ZKTD#88?1N_P!&_.M*
MSUHLO[S,A7J5&V5?JO?ZBE.BGK$<*S6DCNLTE8UKJWFQ[HW69!U(/(^M6TN_
M.'RL/<=ZYW%K<Z%)/8M/&CCY@*IRVZ+G&TY[&GDD]6II44AF?)9HV=IVGT/2
MH3)=6R;" \9_A8;E-:VPGH*/L[8X%.Y-CE+BRL+F;S3$UI/VEA.,?CUJM)8:
MA&WF'R;^,=)!\DH_X$O]17536$;_ 'D*'U%46TR6)M\+$^ZG^E:QJR1G*E%F
M/%JY1MDDY5N@CO5V'\)!P?QJXNI" !I4EM<]&4[D;\1Q^=7,02_)?6RRCH3C
M!JN^@6V=VDWC6S'K$&P&_P" G@_I5\T)?$K?U_71F;A./PN_]?UU+,>K8 W
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MH 3%**,4X4 6+3AZT*S[;_65H4T2%%%%, HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** $I",TM% $++B@-BI2*C9: '@
MYIU0@X-/##% #Z*C+^E(23WH D) [TTN*91@]A0 %R>U5Y(%<'(JSL-.$8H
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MBLM?LKU04E0^ZMFO/[C1+^UD,L1$W/WT_=O^8X/XBJ3,P??-"4D4_?(\IO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVRWE>5J-KNC[[T$B?G6A)IJG[M5)+*6/I65F7H>;^*]5MY?%EIINE2RV\$,
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MI:6B@!**6B@ HI:* ')]X5?7[HJ@OWA5Y/NBF(=1113 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D-+10 SO3@:0BFYP:
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M4 %%%% !1110 4444 )BC I:* &[:0K3Z* (B,4VI&%-H ;12T4 -HQ2XHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1B@!M)BEQ1B@!*6BB@ HQ110 8%&!110 8I-M+1F@!-M&*=FD- #=M+BG44
M,VT;:<*6@"/%)MJ3C-+0!$12;:EQ1B@"N\*M]Y0:A:U'\#$?6KQ%)M!H RI$
MD4X(!]<=ZS9=-M)'+^489/\ GI"=A_3BNE:,$5 ]LK=J35P.?2"]@<-%<I.
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MVH1>;9W-O=1_WH) V/K5H2J3@G!]#Q0,DHI*6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@!"*2G4E "44M)0 4444 %%%% !
M1110 4M)2T )BBEHH ;BEI:* &XHQ3J* &XHQ3J* &D4F*?1B@!N*;BI*3%
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M,.5.?TJC<67F,6)(8\\U+789B2)H&J3^;-:Q1W?::$FWF!_WA@_K4ZV^K6@
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M/K2M"KC!"M_.K1 /44PQCM18#+N--BF7:1Q_=9<BJ!TRYM3NM9)(QZ*=R_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** $Q1BEHH 3%&*6B@!,48I:*
M$Q1BEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>gu1405a4gpzj000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu1405a4gpzj000003.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[@ .061O8F4 9      !_^$6<D5X:68
M $U- "H    (  P!   #     0+L   ! 0 #     0(E   ! @ #     P
M )X!!@ #     0 "   !$@ #     0 !   !%0 #     0 #   !&@ %
M 0   *0!&P %     0   *P!*  #     0 "   !,0 "    (0   +0!,@ "
M    %    -:':0 $     0   .H   $B  @ "  ( $@    !    2     $
M $%D;V)E(%!H;W1O<VAO<" R,BXS("A-86-I;G1O<V@I   R,#(Q.C W.C R
M(#$S.C,Y.C,W   $D   !P    0P,C,QH $  P    '__P  H ( !     $
M  +LH , !     $   (E          8! P #     0 &   !&@ %     0
M 7 !&P %     0   7@!*  #     0 "   " 0 $     0   8 " @ $
M 0  %.D         2     $   !(     ?_8_^T #$%D;V)E7T--  +_[@ .
M061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8
M$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .
M#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,
M# P,# P,# P,# S_P  1" !U )\# 2(  A$! Q$!_]T !  *_\0!/P   04!
M 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#
M! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84
MD:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E
M\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>W
MQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(C
MP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#
MTW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H
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MB#'A\OP=7&Q:L7&IQ:0150QM58.IVL&QL_<B;4+&R?5Y$*S 35R/:FVHL!*
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M:S.H?4U^9]JC+;6<JYMTFK=MVX+^D;?YUN[Z?VC_ ,!_X1-D?4[*?D6Y./U
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MHU1DA*151-1F@T6%)D96%Q@H_]H # ,!  (0 Q    #/X
M
M
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M-HX(ACB2]94DRP@::(3,FHLT]9:)264(0NEHDF$3ZYX[_7<QU
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M8ZSCO#X=QM/M?/>L/&.\/.'W'^6SK5WK\J_9G#E^MS&,
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M(A85-'G>6\7ZD .NEL?DKETP          $     88E=5XL1F]LL67ZT48P
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MHN;,7#F(2ZEXKU!,=L\M.O>.=A4  !A@X]7XK1E]SL67ZQ4XP
M    !BA9I^=KDK5F\\9S$/MK^2Z5$$]M>H_4J=/L,VG]S/#WUC]2?+OT M]"
MJY:,.2ELRQ%L=M\V+:RX:KE92HW2=BG:(J*7"Q&H:TVXZ&YBNO:=6(@F!$B;
M>'+2XA.L::-*4D-R;^8IZEN0O7E(FUU&WB   /GY3GQ\L5_=B;_6 B@
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M3S*/7%%]06FRUNSBL/$-;'<3>>9L5#*U4].$#YC,L8DR (O]5Q0
M       8N%Y^</J*55NW&\Q+[;_DM[ ]>=\W'X[S*D]UV*L-GY'1.]<<]V/"
MWUI]7?+WT!ZRIQRYOZ$13T?1U!3Y(3?):C'?HM;FK=+#;B3Y^DY+!G9\O8C(
M*BOL0BT>6MW,5L55?GT6@3?16RZ;N(XA.4RK:7)2A:6LG>,+C'FKF9N#2,B:
MU.V:G9U,N6+LXK=8$X?"^2.Q]AT^$)Y8+Y[+'5A\QDQB;,@Y?ZIU:
M         #%VR3\X#/CJK=N.9FGVH_*AK8-=N,6JT[8-:FHEMCR2/F[]Q_53
MS'[YZIGF>GP"F]XHK,>N:/95%[2UN:MTL-L7I;8'.'B?-J),QF*>HJ+1Y:U%
MBMBNIL4MV11VI1P*;$II-&5HK1&2GD=#RHR5\U,6>X,6KZEN]63!1F3'[BX[
M]^;KLXK8LJWLBC%N6]8#RG/91%[SV/5^8R8Q,LA]?ZGL4
M &,%=\W355JO=.,YB'VY_)AJX-=M[X]6F?;YM)KXLV3;\S?O9ZO^7??_ %N3
MY9'CG-]S%:'3[*J^T*+QEK<U;I8;82<Y/9B*]G4;<\.5NZ2,C-6T>6MP\5L/
M9/KBC@EO%Q.12KS!X3S;+\BEL<E.KF.?+BV.TU<_DA-Z^I;5MC]?,F'U#K;M
MC==G%;'F6OH8@2?38]ZT>>2?7A7T61\Q@QB3(V7^I.H                ,
M9BT_-=U-:KW;C68C]M_R6]ENL_0U3;;OVOBUVO3'P6OVGW"\/_6#U>\O?0"!
MA;GN06Y.VJ<=U;,T4%K<U;I8;>6RV$)-OH%1CXA/SK)O]+",=]"T>6MW,5O(
MD\CUN!,AE7'J6Y9'J0>CB*LR4NCCOM#Q%6QRYM41<R*Y6J.ZJ+89:W9Q6X$^
M?C-\TB*]QD= 4XIDVSSXH/F,&,1+)#9/J-QC                &-#E?-2R
MUJO>.-9BOVU_)I+( #)P^9/WS]7?+OO\<<8L:W7T[_(]6$=SC=EK<U;I8;#Q
M)3C.S:Y)DO17OJB_A:/+6[F*P   %I<E+M8[@ #&T7K]'MEEQW:Q6%M3$M7L
M;-NUT5RO%/%%/?8^?HC&(EDH1D^H<Q@               #&KR/FD9JU;NO&
M\S#[4_E%A( #);^:7WF]5/,?OH   "UN:MTL-@  !:/+6[F*P   %I<E+M8[
M@ #SF39\](,M+LXK   =+"Z9\Y<QB;,F"N3Z?S&                ,;G(^
M9UJ:U7NG&LQ7[;_DNT:ZCMGU3Z4X36;/M<N#BM7MWOWX$^QGJ[Y>^@ &/JO5
MI?:(]9YJ!:W-6Z6&P\JTVD32TSWCK7OK,"T>6MW,5NDR>ATVW,*\11":^1Z*
MHO2BTN2EVL=\<^<O<R*6?*638>7M1%.WI:;+6[.*WG@M9 Z^3:G87_5WYV^1
MW71\Q=.,.9-DY/IZ1B                &.-=\RS55JO=.-YBWVW_);I,O-
M:#>KA[!S.E-TX[M\F#)*^;_W/]7/+OT I$HM-AD]!)GTGBO:] %K<U;I8;#H
M"G?EDD]H4=@BN46CRUNYBM9U/29-BT\F=DE>D,V]R8ISY:7)2[6._G MJHXY
M-PT6_3Z/*[HM-EK=G%;I"FTR>.*8.7-@>A:+N(^8O+&&AD\SE^G1&(
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MZE>NO+-QMQT%P=/NMR=JWS)H\">R,@CQMZ1[%:C&!\Q8QAS*>G)],.,8
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MG<#@?8-F.GNWZLW7;[@>EO+NI;+[9^:O06<5\K/H_6%@^8H8PQEZK?1O5
M             'C!>?E0:W#[C>D?(7TW/-/J?:[9OW'S6:&K-O+#T%Y7M-V+
MU-D+^/\ W\   !:W-6X^&W!&\.F/;WF?<TR=O^I/2EKB[1;S+6[F*P   %G\
ME+AX[[0L[S+JWIOW#YDN+L/,+H=<]X^"O$>R<)[['?+R[/8W5UZ.I.X>L?17
M=M2[QM5P?9'C;69?<3S'Z-S@_EI]%:PL'S%#&&,P2UOHP5J
M   /&Z\8;WN#Q#>/UK\L?H#_ !<_1E0UJ\=+6)KSY1]W=%87WU1^06;/\W?J
M-[@>9_5    M;FK=+#8#B\^BT,F'F])N8%H\M;N8K    6ER4NUCN.)SZ#B=
M7MW*:;7:-Z8O>CW3"6^QOR]O%V+U=SN#54UIMVW>JV_E]WX_OV?W;\O>E\W'
MY=_0:M+!\Q0QAC,5M?Z)]:                #RC[]Z8Q6?HU\L.A^FXW]'
M7XS?>&W]L9/()W]X\B>Y>EL-?ZH?)?L]@W;Z%7R!^Q%].*\O   M;FK=+#8
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M-XYYC)2IM9HO=GRWZ)[M?,/Z!]4[(F+.>5YF?K?055 B1-<UP
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M_"^>SQ[T^5O27CG\Q_H)7>EUGN].+M53+;-6Y\S[;9<?9S5:;4(DYN#<@
M         &"W]"/"?CMZ0\[]?(X[83J+T-]43Y>_13HKVUPVXFUZW&D]D] 9
M9?SP]1^6G:G7&'?[^\?^E'/MAHK5;+Y%?-+W?#J+LW1AMB6$AMXC;HEB=MEC
M2I.WEHU:9IPTYG0- T*QM[M&$AI3;05DAIUG2-,T(21,)B2$(>O.&W0;Z_\
MS2N=V=U+R-K5?I-TXS4:'4W39->V?*>^;GORO/ 7T LVR7,RXJ.QJ]U>AUJ8
M;4M+[-[_ ,,]&]\V>XR-0WIN0            # ,]_>'/'CT;YMM:T5DNJ.\
M_JI_,3Z)]:N>\=L#RG9NCO87$_9/ROW+Y?=H]=X=OOCR%Z0=A[#0N39Z6^:'
MNV]?4?9&W-&&TM&SF=K5$XTV-HVY(GCJM$VDIHGBI;.K:3''F@F='#RV43HP
MTTZ-HF1&7$Q.W1L"4[MXI\EOKW\V+H]I].W1ZK[:['=+=QVS[3ZUISEG#-MS
MOA.7[^?3[Q=*=RV#L=CV7G<5^!I?0K;M]NVV<_FW^P^W;M<C=N&^]/(>.;@W
MYN0            # G]L^/O!/U#YAHJV*UG5_<?U6?F9]!+)<RV/SS[8XA?7
M@V_=G^K^6>6_9O7^'-[L\D>@O8G'J1S[7L_FM[FO!U5V)/1M$;>T[&$EFVAL
MJMM+:RT82PX^T*VVLN*AHS&Q3QAN8B:7%PV-T(;&)2TD:<MD:1H&UAW<T^3R
M-^O?S6NAVEU%N\^/3;ALZQSNX['W]Z*[D]/OB3]GL?G>=FK_ $&KC6M7)O3H
M\?OKN^P^F.IQ>:>P=A[[DG661=R_B-V9CDS<             &%/ZE\W8IWK
MCRAP>MI:[K3M;ZK'S7]Y6YY/LVACM8G?=MO!P+D_D_V1PC$1]Q^2^^'/-FIG
M+M7L]\U?<W9WK?G<IHHA-="+2$IHRDB)$R(TK-O5M+-'&V\QM;WT%=JG0JT3
M:)T*M.6WEHFWB-K6=E=IFVAHS-K*XL<W[ _,^XW9W4E4ZZ.\72'?W5?F7"K2
M<_ZS[3=+]G>WOQP^JO;'%DZZ8M5:"NMIMEEPY]_EK+.2[&;;Z!KMV8/RC8.Q
M6;'NR8             QF>Z>H\!_VKY%X/<M-;OK[L?ZEOSF]N5AJL?!XYI@
MM]6?+'L7AN(Q[/\ +7?7E>@V5]#]&;YN>W[R[-N<I E-,E($A*0($#2)24D)
M"4TR4D-(@2FF2FD2$AI$II&/=I[X2OUZ^:]S.S^HJJOK.9V[?K8ZK:N?WCC7
M83H_MKW0^,WU?NNI5!6T26T$41-+@+6AM7KC:,R?E.PWLSX]T1
M   .B?(^/?)W]Z^*.'W3#2?$.9_2T^?7L^O+4X?'EXO)2W]H\PN?\-Q3O7WF
MWOIJ-?W*XUN'T(O$?J.! $#3) 2FF2@D-,@0-(E($AID#2)2!I$I(2$AIDA*
M8[^FG"2^O'S9N3VCU'&U9--NFZUVV;_7;;??HSN'W7^-/U8OM,0BU9UF!Q\Q
M:VU.>FT9KU\M&8WRG8;UYL>L             "0^5![*\F=4<>Z]4.5;%] #
MP3Z]YN&XM;9(I>:^>G.N(8U/IKHSU&X3S'()XKOF5;T?VI*" -,E( E)24@2
MD"4D)24TR4E-,@2DI TR0&B0)#',T]L(WZZ_-FY':'4ET=BY!VQZX[,ZM]C]
M=6RYCPF_G1O;ON=\;?JOWBQSQ9UVO382KB,EV<<5!9UXS5L5-,R?E.PWES8X
M@             @8QG:?6F -W1UE2>OIEY^,?3E>7CGI:13<//SFW$_&GM/B
M78CEG!OIK>7O078';-P$"4E( E) 0)" )2 ($A*0)"!*:8(&F2FF"0@8^>GO
M@G_6GYQ7&[;Z<["\*YUV,Z_[/KC3:CS"]'^8^PW1_;7N-\;?JIWGBWFEJ<%;
MX[:":OI-X,>6Y:MF<V"RV1F6<HV&[^:@              V"/G0=W=0>'/,-
ME]U?+G?=2Y8Y8UH<7+IESCB/6#F.PYE6QY<D_K+L>4@ 0)00)2 )24@2DIJ$
M#3(&F2@E)02D"!*"4D.DF*WS3OH1XSV7K'ROJVPZ,ZO6U.GY+4Z#L#T?VS[G
M?'#ZH=\9MX\ZG3;*MN,.(6LS?%[_ &BU=@\N.T=Z9F/*MBN[FQ@
M   0)20E+4ZG3X"G<_55C^B^W][DK+FKK5G>XYMIROC&25O6SY.G77/YB8F!
M*3 F($I B0! @2 $H!(0)0"0$I @2D 8AG8_#,0CZ4>"JK[#X#-ECE=5H.1O
MH^^/17<?J5\>OJ)W]BU-0IN;<#BOH1DYN*5'>EE,^GM#DC,RY5L5X<V,
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M$           &F;4X4I8I,I8X X<V)M32(&J;DY Y8YXJ<JTJDYLWIJ
M         E-,T"0D)B8VY2);PHDX V0.1*C*[+CE5&Y(@           @2&W
M-F<><>; V9MC1) 3FJ;HW9OCD3?&^-P3DP              (  $#1-H;(VY
MI UC=&\-V:I$            $"!*2&F2&F2$I*"<B3DYJ$Y.3D2(
M!T)B</;'?LHC-*RTJ$   \M8GK?$^[5JCH"=B4WU1Y&Z[!6%9X:8J6LT7>)D
M5C6_H7I,E5Q,0              "!$$   1($0           #YP&')G[Y:8
M^E)I&9ZUPL/5Z+VCHW$Y&N2OA72UI89)F2MNX>3E;=>H92V2O828NR4E,4C:
M.6B:,EI9M-5F'46RSZ:\NGU52Q/*0
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M[K%GZ_\ />IN]?FWVU6U9Y6$QH$Y*1(@W!$
M                XXW1K@
M
M
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M>F< U:A!E >E["3YD-J?3O*IP[.$UA:Q3J--:YBD- 1=Q%9MEO\ BBS@>P@
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MM?#UG)#67K8(B'M!<!2$6M%7":<?96O)>A65'SNC(G&BWA2P\N@48&' #:0
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MP4*.BS)@"ZU:*A]?UE0$LO6<U[3":YS" M\PBYOV&Y #]3"4KW/ Q1$1U,
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MET@*;=/D4-(<-/O"#PT^Z ."R]8T70-6W N]45:W#O+>2C;MTXG_ !![?].
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M-V^I3[GI1COA5RA#XN=^I6@Z@/+(>V%P7S*W%=PL*)R&9-P&QE!]Z![>("
M#M/L+]IJV$24 6HYTX*AG9A5D%S4II\#N05$ZE8@M IUM,DMN6(7BK!\+G3:
MK90I!7FNJ2GE+N7X*>:W-OLA2%H;A5'72W O&H[D7JDIJQO'=8:DH6YEZ)K5
M$KOA>^6)D'61C=M95;/:4N0O>"_)8B3W0OC$T92=VKHK5Y([L7?G$N3N]<Z
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MET)3]1R^Y>3UH+F4S=VWX]C&'IJG,*A3"!S#_#_\0^Z<KDS/*'MP!<P'!M7
M3/ !<(B]@%S/YF'4)3.;5[PB\=3:F$7CP?[H"X7^\(O')>V]R[MT!:/'FCK9
MV>QLQNN/CS68]G^^;__:  @! 0 !!0#_ &5WNOQ;^P-**[L%D2&2W5[+J)GW
M4;))$-NQ6,(5#=HQX.5;=OQ_3.MN^8]H"?>%QW3(GO+XUJ@&\WC*P[SF, *!
MO/XOF,3>CQ<,4^]5BH1C[U^):9#[UN)92EWK<25##O98C)J(;V^(T0)M[S$,
MIS;WN(10/OBX@D#]<O#QQM]'#L!#?7P],)]]K$$A0WX</S,;?CPY( []&'+$
MWZ,/#G-OU8>@;]?##@2?KY8:/+OY88"'Z]^% -^OK@XXV_K@N1C;_N"8";S
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MO07N]<:FZ]2X"T\G,/.0#W6!C PB\1>SGL# YA '"YSN0L+")6^=_ 1>8!
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M"26>VW_+^"/Z\/FIT58C:"VS-]+;:MU83S,MM:=KW9ZV :YFE?;1+>;>'_\
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MB:OI.I+>U=!Q/AU]DJY41*LOIAB?1US(;AYN'^ZX+A;RDR>O.SV%YD5,A]L
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M7#JJ=6WM;"96OM);\HE1(#0,4M"JC4BL:D<Q%U!*<@0YC&-M?XFU1CS!W_W
M;-8>7TKB\^?N;=#0>VWA56QY9M.;4=1U= [>]H*8@9#D[O'V-IG;)F.&^5<E
MEU59'XLS&U=UZ$O10Q3:F*+A0[?E?F08L\)N7S2>%,-;1)5:4MF)1L368B%O
M\R58<EO-RR[%(T)C'M?4#*JTN/7JX]#?96*? Z^$60F5LGF":8WVF"!J!QFE
MPKV)3D_50^KYDSJR$@C\'*)3R<RA0E)4P4DIS@:40Y!^%)G+\*-U1E93">6/
M,M ID,:6 8RLG432/!<SP";U84H#$PI18D&!P-)2C#+(&>>%.*G@W,:'.(C
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M:"F34%H;,K#"^J[*745J5=&(,M%)]XCV(^KM_>)]B/JS?WB/8A*4) 'V6Q8
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M86M'G2P&E*:7C>02J:W2^$(V)Q)&.Q&L90G/&V1GF(@H<J2VIZIP*5YHZD+
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MM2T2<5T%+ZRDVV%6LWFWA,)*:MP*"RL=(]<V%5_6(O-\-N9A6./+2F0*U%1
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MENQ,HS8)<Q)51OVWCYI<*8U_JTL?]@J$DBX05(CJV\@CWL#W/%&YJM8K4GP
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M5,+<="!8)IEA2>D)"S7?"AP']W9;62OIUM^!Q"OPHLL,S9&[ZTV*%<P?^U3
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M\C>&<Z>7^TF-[FF:?'A8IU$"\A#JE*/'A2)R'!#V:HVJ\M22 V@$I><P2Z0
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MMHE%L+]6J.00[Y1Y_P#0YQ52WLZTB6T2 9^6FY7+8KCAQW*F4/-$_P &09_
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MU_@[DA]W'[KPH#PX1?1K_!S)@KTV"Z\*?_HO?[^J?1O):_B_=N7N^S$]FO\
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MGY*PILA;[S1*5+/K*2:$TU9,^CX'CK&5XWCTS%;#=6K>TVJTV*?*3-EP84=
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M6\M+:+@H-MI4XI2PVVG@D<@/SG;%#$A]E$C+7VI*&G5-HD-?,TY0;>2E0#J
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MYTZB!Z2/>UM>M!(6C<S"G$*!H0M%U04JY'Y)&A6YR3ZC?$^%_M:?YC7\)/\
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M[+V9D+N+\S<NW9"_&O<%F*@(@Q/HR\I2WI%P=JKK!Z4)X'C]3:O\<7_P+/\
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M'#AQU;+3%R"\1WKK<X-LCOW#';G"@M+N:GF[5+DRW6@U'@7)^.MMAT^JMQ)
MUD(P.X3+BWC5P=M\Z3(MTJ%'?=9?>BN.07GVTHDLID1UH)%"".7U-J_Q\9_!
M-Q^KE>%W'!B_BN&YKAN"W6Z0KS&E9=*N&:1E2(EXM&'M@SY]AM24UEO)_<TU
M/9JR"/E$UV-?)LJ,U<4V6XBW6Z'&N[UB1?KS+4TEJU8]-N\=;#$QTAIU:>'#
M5]9D93/"+''8F&8W8[@[#N\*5>V<<8EV*2AHHN\=Z\OI82IGJ"E>C626F\WZ
MY6RY8O9A?)L*999[4F9#1+MD&6FVM%'7.E6^9>(R'VTCJ071SXTA87B][N/T
MBN,*[RX4&Z6:X6OVAW'I/LE_MK;LMI#:KI9G"/:&:]2$J!^K=_QPR?\ "3GU
M+7AUMPV!D'7@-RW&N\RZ9)#Q\KM%KO";0]9L>:EI)O.32'%!3$5%5.< !I^4
M[<,C;N$.;"M,VPMXU=)-X9O;UJ3>[C9VHK+),J7CMI*I%P"*B,TDJ532+,[E
MZ;@T[ MLT7F':Y<_'*W:P+RR%;U7=#2H8N2\=;$Q3%?$2TI)(!--8K%-]N-O
M:S*RNWO'I5RL5PM\*7";C/RH[8=?:2&Y$Z+&6N.@C[XD<-0;;$R.ZQ'I[MK2
MV_=,>N<"$Q&OS$IZPSY<IUGPH\"]*AN-QG":.NIZ1QUMUL]M;=;A+:W W&D3
M<C<>@28*)]@PAII49+ ?"3(AS;_<X[J%CB3%((';C/E5PV66\7PGYJR#<PQE
M=#>2;CS8J9-OMLU2"/&@87;) *6E52);ZEGB!1N)&0@= 3XSH2/$?6?E%:ZU
MZ23ZHY=.DH4XTA2@>EI;J&W%5-!TI41U>]H4X)%!TJ^2HI_7'@.)[>_1 )%
M*\!3Y2N*2?E *KSY?8"30]0((5Q2*'F?0HG0QFYN%TEM9LLU;ZDR(SR3U-Q
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M6[(F;@]<)"GXST&/<7X=J;=#$=*T)ZTI%:4KJZ_Y1L@[N/WB#QX=_P"=9?\
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MHL*KWJ[=0>K;A%L:$A(5>1*L;KD, <)*41QXY4"KDDUTH>(5*/5U*Z: 5/K
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M'@:U[C4:QSC11VLBD&@411EL\.% GI%*GEK(R*T^B/Q_-\+AQIPT@T/!MH@
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M351S]D$"H/$CW2->2U;:&W5(R+<MYR2IY*%0Q]&KBUT1T]:5/B04]*R0LI"
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M Y#J(''OT%#/; FO =424!U<Z5J:<#H@9S811())C2!3L2$U-"5#75].;!0
ME(5&D!9%: ]/53B=$JS?'J4_^K20KKZ:TYUH=??,WL#8)K_6TE9Z:\2?6%>?
M+72UG&/N#F%JBR4)* .8XBHZNS0_OSQ[B*]0C2C0\NGG45(]S24#,; "4_=,
M20:=A X]7'20<QL0[@&)/$@TX'D0=<<PL /'I!CRAP2K@3Q^22*5T0K+K%U
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M!!?+F-W]OP$*(,CQ+9) BH4.M22^#T @$I*JZQ!"(QAI3A3"$0G'7''(P25
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M=2JFM :?80% !L#Y"/5!!/RE4J13GKPR2>)HDJZO5YE-312#PKQX<-$A0)*
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M,1".WDGH '/7^F'*J2#PQB*.7*M&QRU0^<"0: BHQ>*2 :\/D5&O6\X,I5
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MCJM!W5*>'N<Z'@=;6J'"NSMW!I3LR#(J$#A^N.KJ$^M2=,IPY#YPDT)][0%
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MRW5\J[5VG9'%@,*=GY)LC>5LRLL9Z$K2J0_@=PC-WAD47T0U7 )2I;B1K?\
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MS8H0#^]IBG6E#[E2::"NI)-0!QIRY#^>3\8U0\.'9P]_TBAU10^433GRH?L
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MZ3ZQ/+M/P]]-)X\Z<O3QKVZ37D>=?1]FM=>\K['Q<])]":_#P_D#D/@&N0^
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MRW%*3ZG2X .(.O+S;]O]V<*VM7LQ<-R9EU<S&SWR[-WE&<1L+9B(@"RU4PJ
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M;YMJND%[J\&;;KC&=AS8CO04K\.1&>4A5"#17 Z9C1VTM,1F6V&&D ]+;+*
0VTVFM3T(0D >Y_\ .(__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>gu1405a4gpzj000005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu1405a4gpzj000005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +& VD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,XJI
M-JVGVZR&6\A7RR _S@[<\#..E %RBJ<>IVLT22Q2>9&XW*RC@BAM00=$8T 7
M**H_;\](_P#QZD^WO_SS7\Z +]%4/MS_ -Q<_C2_;9,?<7\Z +U%41?/WB'X
M&G"^'>)OSH N456%[$1SN'U%/6YA;I(OX\4 344@(/0@_2EH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>QVENTQ^Z"%520,DUR]A?NZW#A=QDF^;##*\#''_  $UG>(-0:?SHU8A7F!
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M* "BBB@ HHHH **** "BBB@ HHHH ***@GND@X/S.>BCK0!,2 ,DX JE-?J
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MJQ%I(6SG6WE<D+E&9>>,@#/J?\*Y9HM2GNUM$1T>4;5WY7G%)/L'J=)K5_\
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M2M?W@Z7%T^T^JI\@_P#032>I<79,YS7O!MOXJT:&;Y8-6BC\LSD<.R?*5?\
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M*%(&X"7^IKTC.$4?S/!I&$97Y@"/<=L4)B//)H8%FLW^TW,+Q*V]F@*KN/\
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MCART@!)VNRXQ@_7(!S4HUA#<)$]M<1PO,8$N7 V-)R,8SN .T@$CF@9IKD@
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M_45ZI6#X/TP:9X=MU\O8\P$K+CH"/E'X* *WZSK3YIETH\L0HHHK(T"BBB@
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MCG )I )S\O;)R?4#FD[8/.%'XT _3..@[\57O;RUTZT>ZO)UB@C RY_3W)H
ML^N",XX84C=<\@$<UBV/B_0[ZXCM[?48_.D8*B,I4L>PY%:\LL4:;I'5%)X9
MF !_&F(><X8 ] ?PH;;R<?+G R?\_P"135974NK J3D$$$4[(RHST.3D_G2&
M!Z=<D&D XQSR.#[>U(&.TDD\#.*4Y7DD]SC% "9^4]>.<"D/7;C(Z<?6E(&#
MMR1CC'>D/."0=N<G!_"@!#C&0<$ CKWIQ; (.<@@_6FGIZ9.3G_/O1\V<'C.
M#_.@!3T(XP3C_/Y4;CNP>F>W3'UI,]">[<_6@CT/.,>YH ,C[Q.3WI,#D=1Z
MBE8Y![D?K]:" <<\Y[=S]?PI@(3N.0!M)[=*,X&#VZT?T'KU%+SR#_",<BD
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ML SCU'Y4GS9)[CGCWS0 8(Z<X]>^!0>F<]!Z4*>A]2<?3/;WI-V0=N<G@9H
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MS7"EP)!E47L /7WI= ZFE8^.-#OYD@\YX&=AM,Z;5)_WN171;LG)Y/) ]_\
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MP/3A175:CIT.J:=+8W.\12@!MG#'!S5?1=%MM"M&M;8NT;2%\R'+<X';Z4=
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M%<2R1")BZF/'4C'.>M7-.M$TVPM;2)V9($"[B.2!5HYP1D9%)@8ZYP>O\_\
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M5%+)L7 ^\>E $%TV]MF?E')]S5,[IW\N,9%.E8LWEKDD]:OVUN(4_P!H]30
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M=:/E& .HI,\'I@TG09!!/J>: #U.#GL,4X<$@-CGD4TGG [>OI1P1G(QVP*
M'*/ER0./>D#<8&1GM2$C:< @XZ9H/([=2<CB@ &2>1WZF@849 /IC)XI P Q
MCC/?UI6 ).1]* #/(QUI>,'&> :3(')[CI2?Q#V- #93^[;KT[^M<Y>G)X]:
MZ"=@(^YKG+LDN><^N* (%Z\U<@ R*IJ/3G\:O6Z@X_PH TH![5HQ !>M9\ /
M7'_UJO(>/3VH [?P9#^[NIL=U0']375UD^'+4VNB0!AAY!YC?C_];%:U:+8A
M[A1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'! @2)!M51VJ<&M$K$MW'T4T&G4Q!1110 4444 %%%% !1110 4444 %%%%
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M:HV#_*8<\I]WW4]*TE&![U#5F6G=#@,4X4E+2&+1110 4444 %%%% !1110
M4444 %%%% !3":4FFF@!I-1-4AJO/*(U]_2@!DLBQKEC69<7;OPIVBGRLSG)
M.:K,*EL92ER3R<U3E4FM)EJN\8-(9D2H:IR1MFMQX0:KO; TAF&\=5GB]JW7
MM*KO:'TH P7M\]JK268/:N@>T([5 UJ?2@9S4NG!OX:H3:0K?PUUS6WM4+VO
MM2$<B+>^M?\ 474R =@QQ^1J1=4U:'[_ )<P_P!I<']*Z1K0'M4#V2GM3 QE
M\1R+_KK-Q[HV?YU.OB&S/WFD3_>0U:?34/\ #56324/\(I 2C6[)^ES'^)Q4
M@U&W?[LT9^C"LN314/\ #52304_N#\J!G1"\3'# _C1]I7/6N4;0R.F1]#4+
M:5.O220?\"-%A7.Q^TKZTGVD9SFN+:PNQTFE_P"^C3#:78_Y;2_]]&G8+G;?
M:%/>C[0O3/Y5P_V:X[R2'_@1J6!+JWD$D4LB..C*Q!HL%SMU:23[D3L?]E":
MLQ6&HR_ZNQN#_P!LR/YUF:3XWURP"QSN+N(=I1\W_?0KLM.\<Z;>!5N1):O_
M +8W+^8HL%S+B\/:O)_RZA/=W J_#X/O7/[ZZ@C'^R"QKJ8+B&YC$D$J2(?X
MD8$5.IIV0KLQ+;P98J0;BZGE]EP@KI-.TG3-/P;:SB5Q_&PW-^9J-35B-\4T
MD*YJ*^>IJ0&J$<E64?-4(LT4T'BEH 6E%(*<* '"EI*6@!U**04M "T444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R218DW,?_KT -FE
M$4>X]3T'K6%<SEV(SGGD^IJ2\NR['GVX[>PJE&CW$RHHSD\^U %_3(#++YK#
MY1TK;J*WA$$00?C574[\6D.U2/-<?+[>]-)MV0F[*YD^(M21%9<YCBZ_[3=A
M7,:-;/<WIE?F21NOOW_PJ"\NVU"[6.(DQ*3M/J>[_P"%==X;T\(HF*X51A:[
M)VI4^7JSFC^\GS=$=#!&(HE0=A4M%%<1U!1110 4444 %%%% !1110 444E
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MK2.>,]>&7&"I[J1V]:JLDWSQV8J3:7+(OW-O'>V[1D_0@\J:YDS/8W4D<R@
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MHA4@H >*=3!3J '4M-I10 M+24M !1110 4444 %%%% !1110 444UG5!EB
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MFK6*6BL30**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#2"E- H
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MD?GBN#34)L8,Q!]/M07]$4?SJ5+M6YD\A_\ >66;_P!":@9Z&VIVT*9ED2/
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M TM !1110 A&:C((J6D(H 8&]:?496@$B@"2BFALTZ@ HHHH :5!J)DJ>C%
M%3:5^[^5,=5?[WRMZU;*>E1LGJ* *3;XS\PR/44])<<@U*T9 ..GIVJM)%SD
M#!H G/ERC# 9J"2T=3NB8G^?_P!?\:9O93SS4T=QVSGVH KB1XSC!4^F.#^'
M^%3)=C'(X[E?F'Y=15C,4RX8 ^QJM+89.8W(]FY_7K2 >UPI VJ/J*;O1OO*
M#3/*8#GDCK3<>M,"4P02#L/K5>72(GY"#Z@?X4_-.65U/!---BLBI]ANH?\
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M2QR;%56#848R1T/X4L0"(H7ICCWH$84+R0J]03_.EV2+L+!ADG+-&>1[>E
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M;H/PKO1&H[4X(!V%0Z\WU*5*"Z')Q>%8E RH_2KL7AN!?X!72PJ-_('Y5:
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M1A10/LUN2Z<\O(1C<?0*"<>I/M5DJ5A  /!&T ]?K3 84/&UR/F.<CK2;6.
M4#<XX/2ERX+$GJ_4C@#T%2KGNG&[C![>IH B153G:1\V!D5.K\'GH<'':K%O
M!YSG)PHY8_TJ=]/1ONRL.<X=010!3\P=SUXYI688XIT]J\*,[%=I/+H>GUST
MJ!U(SQGG@#^M %FP9&GEY&\*./;UJ_Q7/R*IE$@)5TX#C@U/'>7<8&7$H]''
M/Y]:0$VNRJFG>6>LLBJ,>@.XG\E_6J]J?+@7?P2.?;-1W.^]N%EFPJH,*HZ
M=_Q.!S[5/@A3BA 2[PW?M2\'ZXJJW?CIC&.].W-N;YN>"?:F!.7V?_7IP=\
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M/3. ,5#B5/NDX].U+]J=3\Z ^],0_85!V!2VX \]/\B@Y"L,LN7'0\G_  %
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSC_"I1.?XD/U4YJB#TQUS2AL#@\9_.@#06:-C@,,^AXI]9_FM@@\G/0]J<)
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MJMNJCYX869C_ +Y  _\ '2?PJY_:4@4EH$8CT)%9R1NUS)/(<M*VYC^& !Z
M"D,T(3B(@GFI@0=RDYSUJF.H'/!HE9HXG8-\W;%4(Z"VD,ENC$_-C!^HJ:LS
M1)'DL27.3YAYK2H 6EI*6@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 ,(I*>:;B@ HHHH 2BEI*
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M%% !1110 4444 %)BEHH ;12TF* $HI:* $HI:* $HI:* &T4M+0 VBG4$4
M-HI<4$4 )12XI* #-%&*2@!W%)WI*6@!<T9I** '4E**6@!M!IU(: &XHVTM
M+0!&125+4?>D O:F]Z=24 )4BCBF <U(!3 6BBEH 2C%+10 4444 %)BEHH
M3%&*6B@!-M&*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@!"*2BB@ HHHH **** "BBB@ HHHH 6BBB@!*,444 &*3%%% !
MBDQ110 8HHHH *<*** %I#110 @IU%% #6--Q110 II*** %45)110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>gu1405a4gpzj000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu1405a4gpzj000001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" .=!YX# 2(  A$! Q$!_\0
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MTDU=1ZM::VWZH=13=PXR<9&:=2O:U^NWF%[_ "W\@HHHHO\ U_7JOO **0D
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MZ:A?6W7MU'44W<OK_.D,B@9.?RZ4)IWLT[.SMK9]O4=GV?W#Z*;N&,__ *Z
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M F0\<9XJ,L3D$8'!7_/T]?PH8L !C*M@C /R@ $Y/<]^E5Q+(3A\$9)S@IM
M]2?U_K0_?A/DA&I=74)Z*3T:3;37;6Q<4VG=I66KO9JVMUZ?*_0FSA22,<@>
MOOV_"FF0(P&"2?;CW^N/\,XYI V]0H.06 #9R"<CK_GOBOPH_:(_X+#R?!']
ML'2OV<D^%E]JVFGQ-I'A>]U)+N-+VZN=8O[>QBO;. C<+2W:<2N^U@R@C.<5
M[N0\,9OQ-6KT\LP\7B,'@JN,Q,76C",,/1BN:*<N7G;>D8VW[;GQW%O&F2<%
M8#+L5G%>M"CF684<OPTJ.'=>4Z]5P2<DFE"*;5Y-Z=$]C]W^"P..HZ@]\<_D
M/H<TI.,<9Z]_2H(&+*K$?>17SZ;T#' _X%T_&CS-Y;&<+P 5(.?J?<?YQ7@R
MY:>D(W=[:=W_ %^&^J/L8)2L[WC)*2>SM))K3H[O8G!#>OYD=?RJ/Y6P,8P>
M.^?TZ^]"EASO!&,E!\Q''08_S^ I.=P)7:#@@?SR>GO^-+FI_%-6:TU5[-V2
MUMMT;Z"ES1:<6FKI-^MOR\NZN2,N3GMW]:<,8XZ55,A9V^7 !&23QCI[<_G3
MT?/3H>,G/'OCCM[]ZTLE%22NG:UEZ?K^5QRBH--M)RMOZ+^K=?N1.PW#'2HB
M-IZ_CTJ3=EL#GWS[?Y%*<'(S^76DG=)VM?H(!T'T%!.!FF;L9&X?W4!X.0/?
MK^'![4AD"@9.2<#Y1N&?3@U/O\UDKJ_GMIY/_A_D+F2U;5O7^NY*#D ^M%,#
M_0=LD@<_3_Z_XTJ;L?,0QR>5'&.U#<HNTE_6GST_7T&FFKII_J*Q(!--4YS^
MIS_3M^'%.;[IXSQTZ?K58R%>6^[GA54DCV..HP1G@=?QJ_=[+FZ/KTND"C*4
MDT]+6:^?X?F^A8+#.".._M^&/I2,0!QU&0..GKCTXJ#)(&&5<\_-\N5S4OS'
M/RD@<AB?IVX/KWJ5[VDHM)NROUVVOUUT^]%2C_*TW^6WYWT_$@Y(.X$X/8?-
M[_7_ #[4T3; /W;;2=N<<C/&1@?G_6G*\A9B#@(>4*XSVST_4=?3U_*__@JG
M^WGJO[%GPFTG_A!;>TO/B9X^N+O3O#"WR">VL5M(A)>7LUOD-(8XFS"!_&">
M3BO9X<X>S'B+-\'D>6455QV85'"G*M5Y(4XQA[24ZDY7484Z<93EY)I)MI'S
M'%O$N7<&Y%C,_P YQSH9?E].$JL:=.-2I4J5*D*=.E"+<7*=2I*,(I=[W5C]
M35RK%2[%&RP?< W)SLV^^?\ #I4PSGG"C/'J3^'.?;%?R:_#?PI_P6J^)WA#
M2_CEX5\1O<V>M)%K^@^'M1\206=MJNGW)$\3_8)E#00/&08H&Y93M!.:_J.^
M&LGBN?X=^ Y/'D4=OXV?PMH;>+((6W10^(7TZ ZM#&RX5D2],RH1P5 [$5[G
M%O"*X2AA^;/<ES6M4KUL/B<-E>+6)K8*K04%-8J*^!R<G%-I7E&2MH?,<!>(
MU;COZ_57"F=Y#A\+3P]7!8S.,++#4,RHXB;C&MA'.*4URKF:CO&S3U.]) 'W
M23Z@_P#UC32Y&?DZ]<'Z'W _S[8;*2@+N<+U^4_P_P NGU]*_$S]L'_@L]X$
M_98^,^L?!;3_ (3Z_P#$37/#R6G]N7FGZM;:9%;37L/GP0HEQ%(9':/IM->%
MDO#6<\3XMX#(L+4Q%:--UJD:+IP?*G%RDYU)0@M6KZW\M[?0\6\:<,\#X*&8
M\3YQ0RZA5K0HT)5(I\U:=E&$(Q4I2=]-%97MV1^VJX*],9[=3Z=?_K_IS1T'
MRC(SSCU_7)_^O7\WFE?\'#7@..<)XP_9^\7^$EFR+<W>O6<YG8M\NU5MU(!7
MY@3GJ!GO7Z6_LI_\%-/V9OVJ;Z/PYX0\5#2/'$EJMU)X5UP"SF<EMIBL+R5E
MAOY0>/+@R_<*< 'Z/,?#+C?)<)/,L;P_FE+ 4DG4K*DJ]+3><ITY3M%;RG\/
M6]F?)Y)XT^'.?8^A@,#Q'EU3'U)RIJG7J/#3<FX\L8>VC!7F]%%-MO1)GZ,\
M\X.#C@_3\1VS_P#7H5R1U)Y/)[U4$Q*HPP&DPQ4D'8G;)[Y'/&,9[CI8#-@8
M'!R3@X/Y8YS]:^&6CO%<\;WDY-\T)77N\K5[7Z=.J=M/U90G.$'S1@I\TDE9
MN4=.62EV:UT6M_2]A23V_'W^E-9NH^G/ZTQ6;=\Q(''7/((X]L^O7K^<A4')
M.?\ /X5+<>JM\NUO7^EZ%<KA9-W>FO\ PUM>I Q8L/FXP<KUW>W^?Z4BL0Z@
M# QP,_YP<8Z]*_-'_@I-^WZ_["7@WPKK5GX,?Q5J/BZ^:SM9)+A+:RLEB<"0
M32/@&60']TH([\'(KZ!_8Q_:/_X:M_9U\"?' ^'I_"\WBQ+U)=&N'$SP/97+
M6KNDJ\-',4WQL. I R<5]!6X:S7#9)A.(YT(++,PK3PV&FZJYJE:',G)TTI.
M"O3G%2:O=;)-7^/H\=\/8GBS'<'4JU66=Y9ERQF*IN@XTH4IRH\L8UVUS3:J
MP;BE:SWT=OK+.1TR?7OUJ-FVGI\I'&?\_P">G/-0B2561&&W>0%VC=C'4,1V
M(YJ=6+E\K\BG&W'4_P!X?RQ@U\^G+71*_NN*_P"?C::=_3OT[GUTXR<:?O<D
MI?O8==%R^[Z][WL[]ARL,9P#^ ']*E)V]!U_#I^%0;V#*!&&!^\Q.,?@>_MQ
M^/2IN']>/Z_A3U6ZM_GIH_/7N$8RBES/F;7E^GZV>@P,>F3R1]>O:F,<'/8D
MCZ?YY_*GR-L5L#IM'3KGOP.W^-59)-D;3%EV(N0?4C)8$9Z@ =.G-*T:DU%6
ME5I\LXQ>EG)\JU\]A2FJ475FTJ253VC>RC&/-)M]$DGZ[$^.,#CI@_G_ )--
MRS#&"F.AZ9_SGC_.?Y\?C)_P7E\$_#CXI^./AYX=^!OBGQU'X)UJ^T"ZUBRU
MVSLDOM0TZ9H+R.WM98'D BD7!8D@Y!XQ7,Z)_P '"WPOEE6W\5_!;Q+X3U!+
MFW6XTZ\\065Q/!:3C)NSLA7<J+GY H+=!7Z12\)_$/$86&*H<.5JD*U*E7I3
ME.A&,J=6*Y)*+J\^JLXI1/QJ?CUX5TZF)H5>),+!X;$RR^K9UW[.M2DHRA>-
M/E33>NOHVK,_HS;@!=VY@1[^I^G>G,C?*Z@Y')_S[>OZ]J^(/V5_^"@/[.W[
M7,-]'\+O%D$FOZ28H]5\.:I%_9^IQ23(7!L8IV5M2@3D//;*44G! -?;VYGX
MSD@<MC ]O7UP?IVZ5\/F>4YIE.+>!S;!5<OQE%^]"M!P;CM[JE9R@]U*+<):
M.,FM3]-R//LDXHR^&*R3'T,?@_=?MZ-15.25DX\S4FXSB]XRM-/1H<K 9XPP
M'/I[_7UZ]<=::N"0<8SE6_GGU)[_ -*7EMP*E<'@D_>Z\X^OK[?6A2PQ\HPH
MRS9''<<#/7_Z_P!>&,XWE[C44M'K:5DKKMO:S^>]SV8PJ1E[\U*"A*,[_:3M
MRWWV2=_EI=#]@53M7=S]WH,__KQ5)W\MLL0L?1U"EOG)P,G@=>WZ8J[OW+@9
M'.=PXS@__6%?D;_P60^-?Q+^!W[+<WB/X6>)+SPKK]SKUE;/JFGNT5VD,L@5
MQ%(O*L><G%>MPYDU?B#-<%E>&<57S&NJ,.=/E4FKJZ5Y;1M9?\$^9XMXGP7!
M_#6;9_BX.6$RS!SKU(JUK+E2M=:7OO;SU/UH1X^6 $<L@PH8Y!VY )].#]>O
M!.:E4;COP5/_ "TP/O$'@_CSQ].U?GS_ ,$Q?BGXT^,G[(W@'QI\1-5DU[Q1
M<7&HVEUJLX;S[F.SDC6&29F^:28@GS'Z.>WK\K_\% ?^"M$G[%_QF\._"BT^
M'DOB>6]BLKZ_N'NX[<WMK>%1Y&G!L$SQ;N0,DG@>A]7!\$YSF7$V/X;RZA3K
MX[+UBO;1E4]A32PD^2K*+F[:NT8IZN4HW5KM>'BO$G(,JX2RGC',*]:CEF:T
M\+&C*G2^L2E4Q<5*C%QCRVT3NTTK)OI%'[8[@<,0>>!G'7&,_I[4\$ #CG.3
M7'^"/$W_  F'@OPCXN%L;%?$_AW1O$ LIV!EM5UC3X+];9VXS+")_*; Y=>@
M%==&Q;YRIQU7WQ@9QVQ[BOE9VI3KTIIJ6'K.C52=U&HK*RW5EKJM_P 3[K#X
MB&(PV%K4FVL51AB8R<6KTZBC*,G'I)QE'3I>Q8I"<#-0L2Q^0J_.#@C*#W'7
M^6?:A9 <H2V<]2IQ^9^F1]<]JAN*7,UIH_R_';[M.ATM.VF[V]2.5PJ$@$XQ
ME?X1SC/3K]?RJ-Y (T."58KDH>%'OZ\'M_7%$[LH)^6.-4+22.1A% R68'UY
MQTQ[]OY>OVP_^"A_[4WQS_:BU']DO]CB2+3CH.KW&A75W9#[/JM]K&G,/M]T
MNK!2D.G*C@C<NU%!)/4U]=PAP?C^-<5B,+@:N#H8;#498K&XS,,1]6PV$HP]
MU.I4=K.4DVDM5JY:(_./$3Q%RGPXP.#Q>:?6\9B\UK0P>3Y5E]#ZQBL;C+J4
MH4Z:=_A:]YQ=KV2[?U!F1%<88@'I@'OC!(]CU].?2I8UE4NTIW@G*]>>N._X
MX'T[U^&O["/PU_X*B_#+X_Z9:_M*ZM;>*?@MK.AZQ/K6I7.O6^KWVEZRMMNT
MJTMHXQO2,W'R2/\ =*GT%?N8A=MVY=@#,%4G/&3@Y_VAC [8->?Q'DT,AQM/
M+Z.99?FU.I1IUOKV68A8O#Q=23BX*LKI3CRN,DMFUW/<X-XCQ/$N53S+&9+F
M.08BK7J4WE^:T71Q=-4X0<:G)*SM+F:323TMK;58R3NX^7''MP?U[?GCO3ER
M1@X!ZX^GZ<@_I29&WKQG@ ?A_P#6_E7*^-/%^C^ O"VO>,/$%U'9:)X<TNZU
M74[N7&R&UM8S+)(Q.%& -H]21ZUX-.DZTZ5&CS.K5KQP^'HQU=2HY1A&*BM9
M2;=M+O4^BJXO#X/"5\1BZO)1P]">)Q-:325*E"+G.3ET48QD]U9:W.M3.><$
M]2?0]N?R[_ER*!AB0!C/7GIW]*_ ;X2?\%V_AO\ %'XX^'OA-=_"36O"GA_Q
M%XGN/#=GX_O/$5A/8QR17,MO;7L]@D*S):W>R-T9G"KYBC)(K]ZHKH7%LEU:
M[9Q)%'(FW"K(LBJZ.C="IC;((Z@BOH.(>%^(.%IX=9WEF(R^>+IQJTH5E']Y
M2?):<73<E]I7BVI*\6XZJ_S'"G'7"O&E/%SX:S2CF=/ -4ZU2DY-QJ*ZE&TD
MFW[KU5XNS5[Z&AN4=!GWZ?TIQ/S*/UY[\5$G*Y.,E<X]\?Y_GTICD\$'IQ[>
MG<X_^N:^?M&$Y)/W;2E;K=6Z>OHOP/KZ;YTN;3F5UIZ=_O\ D6#SZ'L?4?3W
MH.0OR]OY>M0ACSM8#E1RA[9SS_%GL1GIGBE,CGL$YP,D-N'KC@CCI_\ 6I2F
MH151IM.W3?;?IU[^0]VXIZK?I;1-[[:>0_?GC')X_P \?SI0ORX/'.?TJ,2!
MLD @KQR, \<XSC\.?;K2&;";R,<\8^;(^@_SWIN:M%J#M*SV;?1?F^^ZW>@K
M.-Y2?PNU]%:]GMN3*NWW-(6P>5[Y'^/3K40E9LY0H,_*V?O# /3MUZ'^E.5]
MX8LNT*3\Q(&._O\ C]:<91;]7MLWM^/3\NXVI./,GIO=VLU\]1=Y]!3Q@C.!
MS[5&'R 53C/7&,8]L<GZ4X2 \_RY_P XX_.B<XQ:3BX[*]M-E^0HQFES.2DO
M*VFW;^NK&ELGI@<<=N*D'S+]>OL?_K4QF.<8[]QUQG]./_KU&7PW88). -QQ
MG/08QQTI*2:36O\ 2W]+JXT[N2O;EW;V_K4L8XP/3&<4Q0P/3]?Z=Z02;A]0
M2N >P.<^E(K'=C).?4],GK_G\Q2M&/O.-O-K:_+_ ,#[M-D$5[1<T97L^CW]
M?Z]!S,03@_R]*<I)'3\<YSZ_2HF=@Q&W=Z9' 'U]?;TH1FW '(_-@?Q' /2G
M[M](6V?-:]]$OEM?_@JPU3DKRYDU:_+=72\EN/=CT'&._P"%-+<=#TQD<]<>
MWM_.GLHZG/\ G\*@D>0950%4 '<W))X^7:.<^_2DI4VXQ;2;E&VZUOMIWLON
MLB9RY8MJ]UJK*]N^CT];]A@27S,AB4[CC&".>_'_ .O%.V\,/4\#O_GM_DX^
M _V]_P!O+PK^PMX'\+^*/$'AC4/&>I^,M6NM+T/P_IEY%8S2R65NMS.[W4RO
M&BI$^3E:_*:U_P"#AS1!)'/JO[,GC'2]*?RW_M5_%.GS6RPNV!(2ML!@ $CG
MGZU][DGAQQIQ)@H9KE.1XG&X"<ZE*G6IJBJ;E2FHS5YU(RYE*ZO:SZ7W/S#B
MCQD\/>%,X>39YG^$PN98.E1J5J"51U(1K0C.+FJ=.22<7=WVN?TL*4XW'#$#
MZY_GZ>E)EM^=Q*YYY^G&/KQ^?/K^*7P-_P""XO[*7Q4UVR\->*I-2^'FIZI=
MPV6F7&II]NTUYIVV*;B_B"0VD2DCS)I?D4#+<5^R>G:OI^L:9::QI%Y:ZGIE
M_!#<6%_93QW-I>1S+NCDAFA+(T3@@K(KE<=S7@YYPKQ3PMB(4>)LKKY;3Q,9
M/#U:].4(5/>2M"IK3?+]KEF[.W-T/?X6X_X3XUH5:_">;8/-W3:^L4J%1>UH
MWMK.E)*<=>KBHMZ)NUC89R$8\G!^7OP.P^O]*6,LS*V3M*@X]/7Z9]_I]&[R
MRI\BMP2V&&%;N">^/4=J6.1@.0H4C(*XVCW+<@\]AV]:^>32C*C&7OTWS+O.
M&FB3T;UWUTZ]_KY-*%)34^;FYN=7Y;]I/]'V=T6\>WZ4F,?GFF;R<%2,=<]F
M]0/QIH9SSG:,\@@MCVR.*M23\FU>SO?I_F:*+:OI;[_EI?4FI#T/T-,9\8*\
M^HZ9_$]*3.X<G!S\HZ]<<'\>!T]:47)W;5HWLM'?9;::K_A_(F^MKZ@AYY)]
MO3\:D/((]1487D@@X '?N>W3FFB52&VDX7Y<%2"&YY)]/>J3;^%7UZ_?VU_K
MH#TW:7_#7'$;1[D_RS_C0?DX'4]_\/ZU&=W!!4CG('S'/U!]QV]S[!+D$X"C
M'RY.3^(SN/\ 3TH<HQ:YD]7V^[\;6$XM4[0>CT5G?[[VUW)=V #U/X],GGT[
M4XX S@?D*KEBV,9 7^$@KD_4\<_3^IJ3]YMVKM5O4C(!ZGC/IGCKWHMHG&V_
MIII^?^97*U&-VF[+\EJ/!4YXZ>PI-X_N\?Y]J:)'W%2HPH!W YS^ SBG;CC.
M/Q]_I36B]ZWY+^FOS$TW:S_"^]O^&'C)!SWS^5-X3N>>W>H_-/S8VEAT7<,G
M\.O/Z4B,S?,R[3@G;G/;U^F340DIWT?N]UYKKJE_PPI-P<87U=MWIK;5[:_\
M/L2CYQW'T/YCI0#@A1_GO3 [;CNX7U]/YGK2YP <JS'/(].W'.3CO_\ JIWC
M\+M=='T\]?P*<9*T=WHWZ?+3R\OQ'LV/>E!!'']15?=QEC^."/SSS^)I4D;(
M'#9SE@V?IQ^G&?2B]VURNRZM.W3?3;7?;N-QLMU???ITMW)"20/?.>GL.I]_
MI48/&.V<_I_G\JSM1U2QTRPN=0U:^MM-TVUB:6ZO[V5+2TMHDR7DGEE98XHU
M')E=E4=VKFO"/Q \">.(+F?P3XR\,^,;6UE\FYE\,ZYI^M16TZL0T=Q+87%P
MD4BD8*.58$8(!S51PS<:E?DJRIQ?+=*;HI6CJVO=3OT=G;IJ<L\53H5Z="K.
MC%U(<VM6*JWZ<M/XFM.BWT[G:[CN"D8'IZ\=?Q'?_P#52C<&(/(&0/3_ #W.
M1UJ)I%7CKR-IZGYN!D=L$]^W>OPF^*7_  6-G^'?[9VE?LQQ_"R^U#3KGQAI
M?@NZU)+I%O#=ZG>):)JL<6,FRC:3>RA2-BGG/->QD^0YEGSQ=/+XTO\ 9,-/
M$3YIPIVIT[7]GS?%.5FE%7[R<4KGS7$_&>2<%0P4\\K5>7-L9#!X1TJ+JRE5
MJ./*I*+7)%7UDWI>R6Y^[8+Y);  _'C^?^?SD+ @$8'OC_\ 5_GCZUL@KNSA
MP%+*?=0QPI_WO;GZ5("7P.%& 1Z_EU[_ )>O%>'5A>G*E1TFG'FE;O9R;[N2
MMWM<^IC*,+*+JU9U(JI%.ZM%].MM+W?RW'A_WGEXR<=>HQ[>XZU.J[?<U "=
MVU>6 ^]_^OK]*?ND"C.,^NT@'K6K32C9?95[OK;7OU]/F;67NV7+=*ZO?WK*
M[^?YIDW7J*C*[>>H'8_E_GBFB1B.W\_Y<4BR,$<M\Q3VV _B1BIO+:RU\_\
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MU+E'9NVVC_#0T<7&UVG_ %^ ]3D TM(#D9I:M;:;=+;$A1110 4444 %%%%
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M2?V9M*TY])L_@5\.4LN?/@;PKIC).K8#-)N@)D)SDALD]SFOB?XH_P#!(CX
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MO@W^T;^UKIT_[,WP[\2WO@CX)6.L76O_ !*\0:5(UJ6M[RXD:2SGEB(^U_;
M6C%NX('3OSAP3X<8'B7AK.>),=G-/)\+DN)A2Q$ZT8RBZ*5"I4<8MQYJLE5E
M&FKV=3E23O8Z_$OQ@S7A#C#A_@_)N'9\08WB'!/$82-"4TU6YJJC&HX*ZIQ5
M-3G))M0YMOB/ZQ=7_P""CO[&^D^*4\(W7QL\-2:B9$0WMC>07&CJY(!,FI12
M& *I/SMT !Y(Q7V'X>\9>%?%>A6?B7P]K^F:WH5[;?:[36M-NX;G3I[; ?S%
MN8G:,HJ_>.<+WZ5^!/QO_P""$W[-6C_ ?7Y?A8NMZ5\2O#NAW6MQ:M=7\U_!
MXBO;"U>XDLI+.3Y+2+494\O,981[NW)/XX?LF_%O]M3QAIFL?L'_  @\37]F
M/$^L2VU]=EW2[\ :38S>5KL-E?;A(EE( =SKA8QC [U]'A/##A#BW),=F7!O
M$>.K/(JD9Y\L[PM'"4:&#NE/%4)TY-O2,JD(RDE*W)/DDM/C\Q\:_$+@;B'+
M,KXYX.RRFN(Z$XY##(\=7QF)JXR,;PPV*ISBHQO+EA4<7*4+\T>9.TOZT/'7
M_!0O]D3X?^)G\+:[\8O#IU:VN5L[M=,NX;ZSM+EF*F"YN8)#''*C9$JG_5MD
M-SFOISX>?%#X>_%318_$WP\\6Z%XOT24JGV_0[V"^BCF9 PAN'@9O*EVG)1P
M&'(*XK\3-#_X()_LTI\+KBP\6:IXBUKXLWFER3S>/3?S[(==GB$LUY)I63#>
M@7._][,0T@8,?FX/YL_\$S/&WQ!_8Z_X*!ZI^RYXCU>ZN]#\0ZO/X-DT![J2
M+3S?RSS2:9XBALB?+2YELHEW1J.1(<$5YT/#_@[B+(.(,7P9GV8YEF/#&&AB
M\=AL?A:.&HXG#TDY8BIA90E*2C!QERW=XM>^DG&4O4EXN>('"W$G"V$X_P"%
M<LRO+.,<=]2P5;+,=7Q>*PE6I*E&A]9A.*BFW6BZJYM$VXOF1_8/J^L:?H6F
M:CK&J745EI.F6LMW?74C );PPH7ED=B0%554DYKQOX8?M'_!OXP:!KWB/X>>
M/-&U[2?#-W<V/B"]CO8OL^E3VA<W!NW+[8HXA&[&1B% 0[JF_:.CQ\#OBLH"
M[&\&ZX7Z$M_H,W!Q[=L5_$W^Q5X'_:/_ &@=8\4_LN?!#7;OP;X(\4^,-6U_
MXF^)M+DDMKBQTI]1N(95N)HB&:"4;D$+965CL[FO,X!\.\OXMR#B+/,?GE')
M*60SP;;K1A)3I57S5[Q<KN4:<?W:4DG/E3ZGT/BOXN9KP'Q+PWD&6\/U<\?$
M5/$TZ2I.:Q4<;%QAAXQA!-?5I5&G6J6YHPNXZ[?UU>(/^"CW['/AWQ/#X3U'
MXS>&KG4GNVL_M-A<P7FE).A ???Q2>2$C;*NXR%*GDCD_67@3XD^ ?B7HB^)
M/A_XLT+QCHLDC0?VEH.IVVI6:3H 7A:2W9U26,$;XWPR]P*_&"#_ ((*?LBC
MX:S:/</XAO/B1)8N'\=#4)XHSJ90YN!HBDVP!F.YUSE\GD#Y3^2O[)GCOXJ?
M\$T/V\%_9X\5>)KN;X:>(_$BZ)J.F2NS:5J5KJMPEMH6M6=N2(]/O)9Y 9_*
M4F3 !->KA_#_ (+XHR3.\1P9Q%F6*SG(*$L57R_,L'2P]/'82BFJ]?!RIR<N
M6+5DI)2BVE.,4TW\YB_%OQ#X'S[AS"^(?"N48/)>*<3#!X+,LFQV(QGU+%59
M4XT:6-=2,(0E:2YK2=[/EDVKG]G<DL,*-+)(JQQ*9)9F81HB $EF8\;5 R2>
M!@=*^0/B=^WE^RE\*KB[M/%?QD\*?;;'>+W3=)U"UU2^MI$.'CF@MY"8Y0?^
M6;'<#Q@'%=G^U+\,_&/QJ^!OB[X<?#WQ;<^"_$7BBUBMK'Q%93-;75E"Z_OF
MCF3#C<K8(!YQ@YZ5^6/PB_X(,_LRZ5H7F?'O4_$OQ;\8W#I<WFNC4[K0Y&NG
M&^X\U[8LUYND+?/*1QU7)X^%X:R[@[ZG6QW%.=8["\F)]A2P&4X6EB<=.*49
M3K35><*=."E+EAS27,U)7O&Q^H\9YUX@O'8++^",ARC,*53"?6<7FN;8VOA<
M#0G>+ITH3H0E*<I1ES/W6[6M&VI^COPP_;P_92^+5Y9:?X3^+_A:34[]XX['
M3=5O[?3;Z\EE&8X;>WN) TLS8 $:DMGH"1@?7JR&0*RNDL<@#(4P 8VZ,"/O
M#OP>?Y?RC?\ !3O_ ()7_"']EGX3VGQV_9J?6?"-YX=UC3[?4]*N]3N+Z;9=
M2R/_ &S9ZM-B>PFL?*&V./B3>2#V'[,_\$I_CMXA^/7['GPY\2>,=1_M3Q7I
M%O/H6JW\K^9/<QV,GD64LY8DF66W12SGEV&X\L:]SBC@SAZEPQA>,.%,QS+,
M<JGCO[/Q=/-<)3PU?"UW#VD-:,Y0E:R4XKFUE%QDXIGRG 7B=Q-6X[S'PXX]
MR;+LJSZAE_\ :>6U<HQ-7&8/&X9.DG>I6C!Q;4W..D6E%Q:4]#Z\^,_[0'PF
M^ NG:9J?Q6\8Z=X2L=8U"#3=*EOYUA-U=W#I''$NX@MN=E&>V??CGOBK^U'\
M#?@OX3TSQI\1?B)H6A:'K-O%>:3YMW#)=:O9S1++'-86H82W",CJ0R<<@9SB
MOQ,_X.#OE^'/P@O9!;@V'C*UN(A<J'C9K61+D#RVX/S1#D^M?+7[('["_P 3
MO^"E0L/C=^TGXCUK1_A'X?L;7P_X"\-)&\4.J6=C'%";C38V8+;67[O'VJ(?
M-)E0O>OHLE\+L@K\#Y;QSQ!GU3+LFJU94\92I4X2Q%>LJDXT<-@M>9U)*$:D
MO=DU%3O%)77R_$OC+Q?#Q!SKP_X3X8I9OF^&I0GE]7$5ZM"C!?NY5*^,<;)4
MHIRAK97<===?Z9O@1^TO\&?VD=#NM<^#OC#3_$]I82E+N&%E2\M#G"M<6A8N
MB%N 3P6QZ\^$?$G6?V%+/X_>'=(^)FG?#!_CU(T%WH]QK%E8'7/.DE5;4R73
MCS/.$P0V\; L)-I7!Z4/V,O^"??PS_8EU3QI?_#+4]2N[/QJ(DGTZ^;>EBL4
MJRCRW8EFRPYR!Z^E?SY?M]0Q3?\ !7#X=32Q(TK:IX29F(&<C6;7!R?7/X#.
M*\OA'A3)N(>)>(*&19WFF#R; Y/B<;A\1S>QQN(A3C%?5ZT82@G&4I-26SAT
M/9X_X^XBX3X,X8S#B;AK)L1Q+C,ZPF!Q.6U$L3EN&E6J03Q&'JU(3_>1BTX6
M6ZL[=?["H\+%N).T892#@[0/E! ZC;CZX'2OF[XP_M<_L]? P2+\2OBEX9T&
M]C.7T<ZC;R:PJG/S-IZ2>=CC^(*/3O73_M$>/=0^&'P,^(GCO1H);G6?#/@C
M6=2TE(H?.\N_@TR5[6XEB/\ K(8)E2:0-QL# ]:_E?\ ^"6_[+'PN_X*'_$3
MXR_%S]JO6]3^(/B31]3MM2M-!EU6:R:&ZU>21Y9/*4D_V="RA;>W3]V0P7C-
M>7P9P?E6:93GW$W$F*S'!9%DJA"<\JPM+%XO$8FM*$*5+V=6<(TX<U2FY5)-
M1LW[UE)KW?$3Q#SO*,_X7X.X7P>4XWB#B2G6JPEFV*JX+ 8:G0HNLW.=*$G*
M<E":C32DE:-DY243^DSX4?MY_LJ?&+4$TGP5\7_#+:Q++%!;:7JUY!IFH7TL
MV/*CL[>YD5[AI?X$C)9C]T&OL-2)%W@_)*-V[=N &"1MXXW GT]J_&;QG_P1
M-_97O/$W@_QY\)'U[X5>+_"WB;3=?;5;:[EU1-1ATR7S%L1:SNBVR/\ =\Q"
M2%Z+P37ZB_$/QWHOP1^$GB+QYXGN;A]!^'GA:35-6NE0S7-Q#IEMAI(XR<O)
M,X#;"< GO7S6=8'AO$5\NH\+8O,L=/&S5%X?,<-2H5E7G.,*<*3HSG&I[23L
ME>Z35[/1?4\+9MQMAL'FN)\0,NR3+*&7858VGC<FQM?%X>K0IP=3$N7UB$)0
M=&G&^B2;O\6Y>^(?Q8^&GPJTR/6/B/XW\.>#+"4LEO-XAU2VTQ;F0+DQP_:9
M$::0C&V./+-QQS7R7;?\%*OV-;GQ''H"?&?0DNI6,:7,DJ)I9PVTG[:7\H*"
M.6Z;>OM_.%\'?AW\8O\ @LG^TKXL\2?$CQGK%K\&?"FJ3W#PQ1N-*LK-+ASH
M^C6UAN\BVU"[T[RY'E7:ZG<Q.!7[#>(?^"$?[$E[X272?#^B>(]%\2)9M#9^
M(!KMY=QBZ,94S2V$F('#2_.(\@*, $C-?I.*X(X!X5G@LKXOXDS:&=U\/2JX
M["Y/@:&(P^5.NK^RQ$ZDXU&Z2_B<L74>_LU%IGY/0\2?%/CR&,SGP\X3R/%<
M.8'$UZ>#Q6=9AB,-B<TIX=K]YAJ=.#@Y5-XZJ.J7,VFG^P?@?QWX.^(NC1^(
MO OBK1/%NAS,4CU30;ZWU"S#@!FB,]O(Z>8H8;E)##/('?KY)X8XV?>H50Q9
MRV  HRQ+=@H&6/;K[5_&9\&?'7Q;_P""37[;6E_!?QGXEU;5_@QK>JP:;+&]
MQ+]BNO#VKWB6NG:Q9:26$*7:WMQ%#+.J[MBG)Q7]B=W/!>^';JZBVFVO=%FN
MK9P<EH[FQ,J2#TRKKQG\:^0XXX(?">.R^>'QL,TR3.:*Q63YE2C&/UF@G34H
MSBFX^VIJI#G4;)\VFJ9]_P"&?BC'Q!RS-XU< \HXAX:JRP7$&68AS2PV+7.J
M;HRE><J57V4[.?O+EO8\H\$?M)_!;XE>-?%_P^\%>.]%UWQ7X%=X_$>FVMS%
M++I\T;;9@P#'*Q_+N;@#&>V:\N^)'[>_[)_PGU!=&\6_&/PL-76X6UNK#2+Z
MVU*XM+EFV>7>1VTI,#@\.K'*?Q 5_(!X<O?C[/\ MB_M!_"_]FN>ZTWQI\6_
M'>J>&]7U.PA/VFUTF*Y!N;E;I2'LDCBD9IYT.=@)(('/[J_#7_@@W^SG'\.V
M'Q@U/Q!XS^+>KP&[U?QC'JMS!]CU2ZB#S(D*Y2^^SS$@7$I#.%S]?O.(?#;@
MO@ZEE5?B7BG'T7F^"P&)PN!PN"I5,936)IPE6K8E.=J5"$IQ5**CSSY9I.3Y
M8GY1PSXS^(_B##-:?!?!&75L3D>99A@,QQ&:8ZOAL#+ZGB)TZ$,%4BG[>O6A
M3<IQE;E;U25Y/]FOA?\ &WX5?&?29-:^&/CG0/&%C;M&EV^DWUO>2V$L@W)%
M>Q1NTEM*0#A) ,X."0#CUI'^0'(8DGH-OZ?AU[U_%)\'5^(O_!,__@H_H7P:
ML=7OKSPSX@\4:/H-]8"9X]%U+PMXLF,6F:O?Q9$3ZA8VWS[W!D5B>]?VII,D
MBJ8L- Z*\<@Y#HRA@P(_A(/&.W(]_A?$K@G#\'X_+*F69A+-\@SC+HYGEN/G
M35.M4I25+FIR4?W;E3E4?PM2MRWBG<_4O!KQ*Q/B)EV>4\TRVGD^>\-9F\LS
MC+Z=2<X4JWOM2@ZMII-0:?,M]5:+25LL,'GL?;_/X]:Y/Q9XR\,>!M'N?$'B
MWQ!I/AC0[!?,OM6UJ\@L+&!#T,ES<.D<>>@RPR>QK>N[BWL[26[G<)!;0R3R
MNW"K'&K.Y)YQA5)Z>A]J_C]_:.^+/Q=_X*C_ +:4O[./PK\2ZMIGP2T+5YM)
M"PF2",Z?IUR]MK>L:[9(Y6\MX[N"2*$S[AM*XKCX$X.EQ?C<8Z^,IY;E&686
M6/S+,ZJO'#X.%E-I2]UUI-^Y&32LFV[JS]'Q0\1O]0\#E]# 8%YOQ#GN,C@,
MERJ$Y0EB:LDG[2?)><:,'I*4?>O))=9+^A77/^"D_P"QIH&MQZ->_&;0+BYF
ME\M+BPF2]L2QP!B[C?RU'(([;>1D5]1?#;XW?"GXPZ?+J'PP\>^&?&]K!Y?V
MO^P=6MKV6P+CY8[N*"1GMW!&"DB@@C S7Y->&?\ @@Y^Q/I?A"'2_$>C^)=?
M\6)8A+CQ+'KEY9K]LV!3/#IT68%VR9(3/*?+E><?C3^T3\$/BY_P2"_:$\'_
M ! ^%/C'5YOA1XAU:WOC(C/:V,EM'<HVH:)JFF(WD:C.MD)6CEERVXJX .!7
MWV7<#^'/&%;'Y1PCQ/F[SS#TJD\!2SG 4*&#S*6'@JE2-.I3G[2FY03E34HJ
M;M=PY4VOR_-?$[Q8X I8#.N.^#LBAP[B:M&.8U\FS'$XG'99'$5%3A*K3G"-
M.\96YM7!+:7,S^RWQ+XHT/PCHNH>(_$^J6FBZ#I-L;C4-3OYEMK6VB4-EYI7
MPJ+Q_$>>U?R/?\%F_CO\.?C1\;_@;#X$\:Z!XJ\-Z'<6DVH:CI5Y!JFFV:7,
MVR[$\D3,D92,'SD;D#@XYQ_3+I%S\/?VU/V9M$OM0L[FY\!_%[P;:7MW9^:U
MK=+;WL!#IO3YD=9 X ZC )')S_(U_P %)/V+?@U^RA\=?AA\./A)IVHV&@^,
M9-,_M>/4+^6\#)?W6VZVM+_JCM8D%.37?X X3(,'QE6>;XC,,-G6&CF=*AAH
MT(U:"@L*Z=6<IMWC.FU)QC=1:U74\+Z4.><18K@C!XC)<-E>*X1Q[R;$5,74
MKS^L5\57QE.6'ITX)-.C*+IN4M=>9.S5G_4A\!/VL?V88O 'PN\!:;\9O ;:
MXWASPUH=AI<.N6D,\VH_98H+>QMK0-DSR2CRQ;@;C@#M7W;M:79D%3&1DD8#
M9[^WXD?2OQ2^!?\ P1E_8XT!OA7\7M.T+Q WBW25\-^,M.N9-9NI[)-9M%CO
M5F^RL!&BF8Y"Y'3@]!7[9Q\(BL<D]\XR>/\ ZWT]Z_*^-Z7#='-*W^K>.QV8
M0G6Q$L7+'T(X>=/$^VUC2C"_-3^*TGNTNJ/W3PPK<8XCAVCA^-<IRO+J\*&$
M67?V3B:E>%7+XTH.E*M[1+EKJUVE=.[>ETA)MKQE#C<RE>O(X."/?OD9_6OX
MMOVE;&PUC_@M*^GZQIEKJNE7?Q)\&6E]IEVBS6=_;?V<RE+J!N&]E;KBO[19
M650WRG< 2,#HV#R<G/US7\7_ .T7)#'_ ,%L;>:[F:"*#XG>!KFXD<>3!' F
MED%I)20 HXSNXSVZY_1_ A5GFO$RH*U=\*YC*DUK*$TJ<G*-E=:)VEHT]=S\
M<^E++!U<LX$I5_9O#U.,,NCBI5H+D]E'$4&XRYEL]5KWW/ZM-6_90_9I\16$
M=KK'P0^&MZ9+5(Q)-X6TQKB+S(@I>&;R=\)"D@.I!!Y!S7\H'_!4G]DW3/V%
M/C_X+^*'P0U+4?#'AG7KN'Q/86]J\@ET+7[.\6>;3K2X4+MT^X@B8>0,J%<#
MM7]@VI_$GP'H6G1:IX@\7^'M+TU;92)KG5+6&,E8PP(E:7D!<_+Z FOY-?\
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MTE&+Y4E=2UN?V8?##X\?"3XSKJ?_  J[XB^&O&-QH;6_]KQ:'J-O?G3DN,B
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M(;EM^><XKBOVR_V9K3XJ?L7>-?@YI.F6\FI:#X"CC\*A8E6.SU70K&%1=VZ
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M WQ,^(6@(]SK/AWP3K6J:+Y$7VA4OTTZ66VNY(^DD$$FR9\C;L4\G-?RU?\
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MVK]+_P#@EY9:=I/["WP&M-.\AK)?#TS>;"V48RWUQ)*V_&6<R.1ZC'M7@_\
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MC[UE13YG)1O&+;6NC_NK#?O=JCYMHWJ!C'/$@[%2.,]21@5_(-_P61M8+?\
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MJ=RM'R!V/WNQ-?IE_P $'DA3]DF[1!\X\0-YAW;T "OY83L,+@$*.H%>#_\
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M5X.T74H]4.H7.U3:XU"]@9(09&E\J5<BO[$WL(=)\*R:9;JB6^F>'6L8(E
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M*C%U(8>56=249U()-+1W4K7M%VVU_M1+I@N60.&V.-Y^]R1C ZD=?3D\YK\
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M]D?\$F[B6?\ 8A^$(ED+F/2]L1;_ )9H 0%7U 'OWZ5\>_\ !?AE'[+?A@#
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MPF/Q.-QZJ*I"MCN>/UF,90]QR=1RO*-[NWO;'O?_  1T '[$'PYVY"_VCK@
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MKIYG[4'P&66.)_/A@ 691)$\2SH'4QME6#=64\<5_4%\(DA@^%GPX952-?\
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M%4$#(Z'IC%?1W_!QH2/ '[/I9L'_ (2OQ+CIQC2(^1D\FOUS_P"";X0?L9?
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M^"W.LZUI_P"PWXQL-/6+[#KM[I]CK$K+NC2R2XCE5<X^](ZA03_$![5^,?[
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M6X[YK]:9/!G_  7J<H__  M#X7F/ #Q/I&FJ&/KNQD>P'!_6O@K]E'XCWO\
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M[1VBSZ)\6/ 6C:^MRGD_VDUK#:ZS'\I"^3JT2"[4)GY5\P@8^4=C\D?M4?\
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M_P#@KY-XI_9_T^=/A?IGBSQ7J\.L:7$PTG3-'DM0(I59%2-+>_E62&*(XY/
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M98O#GAFZMXM.A,C%L+O=9#MS\K-R!WK]X4C)4Y9D9L#>,[B >F.@'\_SIS1
M8)P9!QNYY3/<9^]C]?3@U[&1\9<1\->U63YIB<L522<XT/95(5)62YG"K"I!
M2M[KDE=V7->QYG$OA_P9QK[*IQ+D=#,N2$84O;3KT:E.":M!5,/6HU.72ZBY
MR5Y-K=W_ "B_9D_X) ?LP?LW>(['QG(NK_%/QGH]X+W2?$?CCR;B\TZX#;XI
M42,M'+)&>8WE$A3G:*_51%:&)48+(>A"X7:@X0!3@!47C &,'!ZX%HQ<;4;
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M5$!P  .GIV_+ J&7!P"63=\HV]."#SW&<>GOSTJX%P2>H(_PJ,@9SCL<>O\
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MLJT77G"-6\7SK#SKO#IW7_/E6T7I0GL8+RU^RS!'L9(V@EM64;'MFB$+P%<
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MD9AC@BOTQ2-8P-COC&-XP, <(@7@#'11MZBG(O.&<'DX(R2,_7\L'CCUJ<Q
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MONWXI_"?P'\9?!>L> OB+H=KXD\,Z]:&VN["[B61 64A9XLC,<Z%M\;J058
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MM ! SCIQGMGJ3Q7Q#^U3_P $^/V:OVNXH;OXB^$;6T\4V87['XMT>)+;5X"
M<&4HJ1W#+G*F;?C')K[C$8!S(02!M7/10!@X]SW/TI@AWS?>95 _U?\ RS;W
M/?/M666YOF64XRGC\FS*K@LQPC]HIT9<KN[/EDK-26S]Z,HOJGHSMSGAS*>(
ML'B<KSO+L)F>5XJDJ6(P]9-_NX)17LW>,Z;[RIRA+LS\!9?^#?7X#R2,UO\
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MX&>>"#CIG';/7O4](5#=1FDY57LXK7HG?IIK==&)1C'6G",9=]?Z_,@&XG#
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M+Z^J>]OTT$N>*BE*^OO.6[6EFFEOIUO?\2->&X Y..G_ .KFGL,KD@9_^O\
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M\/0=_P"H_.I"H/M]*4*!CCITK37^9VM;EZ=/*]].X))7LM7O?732Z[^>Y69
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\>OM6:RJA&T[GDYE']WO].#Z4I#*<.VYAU;U[C],"DH **** "BBB@ HHHH
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M05-):SVJ++<6LUO%"F+B6XMY3ON,'Y0Q 7>S8",#A203Q0!5Z'!Z^G?\J/\
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M\=ZI/87[^*=-EOX-D<0:("%"'&7(QTSGO0!^HW.-V./7M^?2EP?0_E7Y ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ&\4^";77/$(CUBU\,W\EC;ZI:K(,PZA&@;S=RG#;B.N:^8_V'_B-X2^"?\
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M?^2%_$[_ +%;5?\ TDN*_%W_ ((?$MX<^/T2EE9KO6SNYV%1=79P2.^ ?SH
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M13MC>G\O\:-C>G\O\: &T4[8WI_+_&C8WI_+_&@!M%.V-Z?R_P :-C>G\O\
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MXYH ^9?@'^QY\!?V8]3\5:O\%?#NI^']1\8W%Q<Z]_:6M3ZO%,EV9&NTA,X
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M#YF_DQD_>VYP'Q_^NCRD*F,1NH3E'$I)D;'1@3\HZ'ZXH ^#_A9_P3,_8O\
M@[XDO?$W@_X6R2:UJ%E=6&J+XEU&3Q'91V5XDD3W%K#>(4M[D+(=DT8#1G:P
M^[FO9O@%^RM\$_V8_P#A)1\%- U;0X_%-_)?ZZM]J4VHI)=2RM.QL6E \B$.
MV B<(H '2OHL*^"A!PV2T@;YW](SS]W&?\#S2!2,$QD[>(U$FP(/H#AOQ]:
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M?0[P.UWI>NV<-[:&1HS%'<6L4RLL-XL;$Q2I\Z$9%=$8S\Y"C>Y0$C:BA$X
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M[8*%OWCQ9<!46,/M0*HP&8C[Q]0>OO3PI&6*_O)!L8[AMC3U0=,@=J /D_\
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M#R7^[SZ=?P% 'R;X/_8B_9Q^'_P=U[X!>$?".IZ?\,?%S.^N:?-J\\FHRM(
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MT^_>W.9;PVMLOERW4X/[Z4_,V.:^YC%DM$ 4C;]XT^0TCR^FPG"KT&>>*?\
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M<Q'7%>@#S!@H$CD10$<1H26'&3[L.2?>D*?,6"!7?YI7&T>8WNN<*,Y/'Y4
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M_"FYMIK:;0M?N3J;A)$99&@NKA2QFB5F:*<#<'P0>*]W'G+N5"J#M(%4L^0
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M0+9Z=IT4=M9P*!Q%';Q!8TC!)("@ &@"T?;D>HI*=M8]1S^ _3-&QO3^7^-
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M?@;_ * J?]_Y_P#XY7H=% 'GG_"J_ W_ $!4_P"_\_\ \<H_X57X&_Z J?\
M?^?_ ..5Z'10!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\ G_\ CE>A
MT4 >>?\ "J_ W_0%3_O_ #__ !RC_A5?@;_H"I_W_G_^.5Z'10!YY_PJOP-_
MT!4_[_S_ /QRC_A5?@;_ * J?]_Y_P#XY7H=% 'GG_"J_ W_ $!4_P"_\_\
M\<H_X57X&_Z J?\ ?^?_ ..5Z'10!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O
M^@*G_?\ G_\ CE>AT4 >>?\ "J_ W_0%3_O_ #__ !RC_A5?@;_H"I_W_G_^
M.5Z'10!YY_PJOP-_T!4_[_S_ /QRC_A5?@;_ * J?]_Y_P#XY7H=% 'GG_"J
M_ W_ $!4_P"_\_\ \<H_X57X&_Z J?\ ?^?_ ..5Z'10!YY_PJOP-_T!4_[_
M ,__ ,<H_P"%5^!O^@*G_?\ G_\ CE>AT4 >>?\ "J_ W_0%3_O_ #__ !RC
M_A5?@;_H"I_W_G_^.5Z'10!YY_PJOP-_T!4_[_S_ /QRC_A5?@;_ * J?]_Y
M_P#XY7H=% 'GG_"J_ W_ $!4_P"_\_\ \<H_X57X&_Z J?\ ?^?_ ..5Z'10
M!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\ G_\ CE>AT4 >>?\ "J_
MW_0%3_O_ #__ !RC_A5?@;_H"I_W_G_^.5Z'10!YY_PJOP-_T!4_[_S_ /QR
MC_A5?@;_ * J?]_Y_P#XY7H=% 'GG_"J_ W_ $!4_P"_\_\ \<H_X57X&_Z
MJ?\ ?^?_ ..5Z'10!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\ G_\
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MZ'10!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\ G_\ CE>AT4 >>?\
M"J_ W_0%3_O_ #__ !RC_A5?@;_H"I_W_G_^.5Z'10!YY_PJOP-_T!4_[_S_
M /QRC_A5?@;_ * J?]_Y_P#XY7H=% 'GG_"J_ W_ $!4_P"_\_\ \<H_X57X
M&_Z J?\ ?^?_ ..5Z'10!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\
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M?@;_ * J?]_Y_P#XY7H=% 'GG_"J_ W_ $!4_P"_\_\ \<H_X57X&_Z J?\
M?^?_ ..5Z'10!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\ G_\ CE>A
MT4 >>?\ "J_ W_0%3_O_ #__ !RC_A5?@;_H"I_W_G_^.5Z'10!YY_PJOP-_
MT!4_[_S_ /QRC_A5?@;_ * J?]_Y_P#XY7H=% 'GG_"J_ W_ $!4_P"_\_\
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M!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\ G_\ CE>AT4 >>?\ "J_
MW_0%3_O_ #__ !RC_A5?@;_H"I_W_G_^.5Z'10!YY_PJOP-_T!4_[_S_ /QR
MC_A5?@;_ * J?]_Y_P#XY7H=% 'GG_"J_ W_ $!4_P"_\_\ \<H_X57X&_Z
MJ?\ ?^?_ ..5Z'10!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\ G_\
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MZ'10!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\ G_\ CE>AT4 >>?\
M"J_ W_0%3_O_ #__ !RC_A5?@;_H"I_W_G_^.5Z'10!YY_PJOP-_T!4_[_S_
M /QRC_A5?@;_ * J?]_Y_P#XY7H=% 'GG_"J_ W_ $!4_P"_\_\ \<H_X57X
M&_Z J?\ ?^?_ ..5Z'10!YY_PJOP-_T!4_[_ ,__ ,<H_P"%5^!O^@*G_?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?#KQUK'A5M9UG4%MK2>WTR*.6"X>60\7-X6=(K1,L[J$0%F K\XA_P %_/V
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M\'GL>>*UH_1>X E+WL;GT6Z\(_\ (PP:?LW&[EKA'L[+MY-D?\3M^+2^KJ.
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M'$=ZL>:/^U8=K5+;_9--;W_X%SSJGTV/%RG6JT)8#AI2HR<9?\)>(TE=:/\
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M/CS_ ,(RZ_\ C]?RHT4+Z+_ ?_05Q!Y_[7ANZ_ZA/7\ _P")V_%S_H%X4_\
M#7B?)?\ 05UWT[^A_5=_P^)_8U_Z#/CS_P (RZ_^/T?\/B?V-?\ H,^//_",
MNO\ X_7\J-%'_$L' ?\ T%<0?^%>%_N_]0O]679V/^)V_%S_ *!.%?\ PUXG
MR[8K^K^A_5=_P^)_8U_Z#/CS_P (RZ_^/T?\/B?V-?\ H,^//_",NO\ X_7\
MJ-%"^C!P)_T%<0?^%>%7\M_^83^M.S#_ (G;\7/^@7A1_P#=+Q.NW_45UO\
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M?K^5&BC_ (E?X#NO]JX@Z?\ ,7A>R_ZA/7\ _P")V_%S_H%X4Z?\RO$];/\
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M!7$'3_F+PJ[?]0GK^#[A_P 3M>+G_0+PI_X:\3Y?]1/Y=_0_JN_X?$_L:_\
M09\>?^$9=?\ Q^C_ (?$_L:_]!GQY_X1EU_\?K^5&BC_ (E?X#_Z"N(-E?\
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M_H,^//\ PC+K_P"/U_*C11_Q+!P'=?[5Q!?3_F+POE_U">OIIYA_Q.UXN?\
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M*:V_YE>(\G_T%?EW?D?U7?\ #XG]C7_H,^//_",NO_C]'_#XG]C7_H,^//\
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M\(VGA^[O]4$,:MJ$6L6[S6\+2* \GV<+L&]CMS@ "@#U!<X&>N!GZXYI:**
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MX (8FO@[]ECX'>#/V<?^"O/_  J+P';+!HOAWX%0Q7EPX"?VAJ+VR-J-],P
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M/$/@GP;X"BU^_P!"U3Q%XQU!K%-"O;#:MP=33!\J&9V$-NX!=I"!CK4?A_\
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MS[1^Y>7^?X^@4444?NN^(^^?E_P/Z>I9]H_<O+_/\?0****/W7?$=.L_[O\
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M'[EY?Y_CZ!1111^Z[XC[Y^7_  /Z>I9]H_<O+_/\?0****/W7?$??/\ N_\
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M 'B_[ G_ ":U\./^N.I?^ETM?95?&O[ G_)K7PX_ZXZE_P"ETM?95 !1110
M4444 %%%% !1110 4444 %0R?<G_ .N;?^@&IJAD^Y/_ -<V_P#0#0!^<?\
MP3I_Y!GQ]_[*]J7\[VOTBK\W?^"=/_(,^/O_ &5[4OYWM?I%0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 0RY.W#$<\CC!4]<DC
ML,]\5Y_HGA+P[IGQ \:^++&_,OB+Q)9:#;ZY8^8C)96^E6SPZ?(L0^>-IHR7
M+-PQY'3)] F/R-G[NQLDC*9QQN ^8\XQ@]Z\]T+5_!ESXZ\8:%I;)_PFFEV6
MBW'BJ55D64VUY"S:4CNQ\LQ^5N$:J 0/O9- 'HXZ#OP.?7WI:!T%% !1110
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M_#E#]FX]/'7Q4XR=W]K6FWZ?Z@<GT^E(/^"*7[-XP&\=_%0Y/ 35[48Y'_3
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MXM%(K^(M8>);4C'EI&UX48D$AU<;2#@C'%?TJG_@BA^SA_#X\^*1.>^K6O\
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MWH?R-&#Z'\J_IH_X<G?LX?\ 0]_%/_P:VW_QBC_AR=^SA_T/?Q3_ /!K;?\
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M%/\ XF7\.E_R]SSI_P ROLU;7VWE^78/^),/&K3_ &3AW_P_4M=O[G]7^_\
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M/?Q3_P#!K;?_ !BC_B9?PZ_Y_9Y_X:^]K_\ +[R^6G;4_P"),/&K_H$X=_\
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M^5&#Z'\J_IH_X<G?LX?]#W\4_P#P:VW_ ,8H_P"')W[.'_0]_%/_ ,&MM_\
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M?S+X/H?RHP?0_E7]-'_#D[]G#_H>_BG_ .#6V_\ C%'_  Y._9P_Z'OXI_\
M@UMO_C%)?27\.=O:YY_X;/\ #?>L^WXA_P 28>-6G^R</?\ A^I:[?W/N]?O
M_F7P?0_E1@^A_*OZ:/\ AR=^SA_T/?Q3_P#!K;?_ !BC_AR=^SA_T/?Q3_\
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M,O\ :EJ<7.HW"6MLN#$OWY75<D\>YXH_XF7\.O\ G[G=_/+&EM%/:MV_,/\
MB3#QJM_NG#W_ (?:6NVGP?<O/[_YN\_*S'C$WE*N#N<?\]%_V,?CP:>5() Y
M'8@'!]QQ7],P_P""*O[-C-$P\=?%#,<950=4MN59<Y/[GL"#[4#_ ((G_LWD
M CQW\4\=O^)K;?\ QBC_ (F7\.NM;._3^S/))_\ +[M^C#_B3#QK_P"@3A[_
M ,/M+7S7NO\ X=KIH?S,8/H?RHP?0_E7]-'_  Y._9P_Z'OXI_\ @UMO_C%'
M_#D[]G#_ *'OXI_^#6V_^,4_^)E_#KI6SS2W_,KOT7_3Y]%^(?\ $F'C5_T"
M<.]/^9]2\O[G7]?O_F7P?0_E1@^A_(U_31_PY._9P_Z'OXI_^#6V_P#C%'_#
MD_\ 9O'_ #/GQ3'_ '%;8?\ M"I_XF8\.?\ G]G=]+7RSTM_R_\ +\2H_0Q\
M:5)2>$X>LFF_^%ZETM=_!\_FOG_,M_GI_+FD;)VQC[\C%47GEE&<=,#CN<5_
M31_PY0_9N&,^._BG\W3&K6O&">O[@G]>GUIA_P""*?[-VTAO'GQ3 #9++JUK
MNQG[N?(/'N!FK7TFO#>.&IQ]KG7.ZRN_[,LGS-:+]]K+RV7D/_B2OQB=?#OV
M.1.,G-S7]N4KJ[CJK05_=ZI]KGY&?\$RW5?VV/A6=W(T[Q2C>SC3#E 3P6&?
MX3TK^PR/_5I_N+_(5^87P%_X);? W]GWXJ^'OBUX3\5^/]4USPU%J$.G6.LZ
MC;SZ4W]IP"WN&FB2-7:0)R"6^5N>:_3]1M51Z #\ABOY.\8>,,DXTXJ6;9'/
M%3PWU*E2F\70>'JJK&=232@Y2]VTXV=UK>Z1_>OT=?#GB;PTX.Q.1\30PD,5
M/,:M>@L'BXXR'L7"G#WIQBE&7-%^[J+1117Y.?T"%%%% !1110 4444 %%%%
M !3&P"&)(YQD#L03@\=!C-/J.0D*< DG(^4@'D=L]^M 'G'C?PKX:\1:K\/[
M[7]1>VO/"_BR'6O#D8EC0:EJZ6\L4=J0<^8ICD8[%P?ESVQ7I=>;>+=4\$:5
M?^!(?%*0'4-1\21V7@Q9$F;9XB:*5XVA",-LWE&3YI R8SQW'I- !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X[^T#_P D0^*G
M_8D^(/\ TCEKV*O'?V@?^2(?%3_L2?$'_I'+0!XO^P)_R:U\./\ KCJ7_I=+
M7V57QK^P)_R:U\./^N.I?^ETM?95 !1110 4444 %%%% !1110 4444 %0R?
M<G_ZYM_Z :FJ&3[D_P#US;_T T ?G'_P3I_Y!GQ]_P"RO:E_.]K](J_-W_@G
M3_R#/C[_ -E>U+^=[7Z14 %%%% !5:7=YB_,P !/RG[I S\XZD-T'UJS5:5
MSXY'W6W*<'*YPK=>&Z$8Y'XU,G:SYE%IIQ3:2E*ZM%W[^6H=UJDTTVE=Q3ZZ
M:KU7<_(#]KG_ (*[>"/V3/C%J/P>U?X0>+/&FIZ7IECJ<VLZ5K>FZ=8E+^+S
M4B\N[B=]R# )+ <CIS7S7HO_  <&?"C4=7TRPN_@3XUTVTO+E(]1OY/$NC7
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M+'K6F:=%KEJA AOX-.NX?M5O%.,E8Y267'7FO@[_ (*T?&CQ1\?_ -KCP_\
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MB,\4 =M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ9H>?KQ>]J</B_\ "=E _P"%G^ BP/4^+=#''/'S7W^?Y_PC&" +N9I%7>R
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MM>[TW[?W<CXP?"<')^)O@+ Y _X2W0\#KW^V_P#U^]-/Q@^$A''Q.\!@\?\
M,VZ%_P#)O/\ A7\(H@B.[YI1AMO-W<C'7)&9ONX!Y-.%LFX*#,VY0X(NKHKM
M/\6X38Z]^V/44?\ $IU+F@EQ;B/WDXQ3_L:$>JU?^V=+[?\ #"I?3SS&=-5*
M7A]A''GY7S9U7W3L_P#F&V77HO*Y_=PWQ@^$I #?$WP%CG/_ !5FADG.#_S^
MYS_3!Z4?\+@^$@&U?B=X" ]/^$LT/_Y-Q7\(QABW*H\\ECM %S=MDGC@";IS
MZ<4&WC ;)F C)7)N;D98=54^<-S=L#D9QQ2_XE1I7C#_ %NQ/-)56X_V1'1T
MY)*_^V+66ZZI]RH_3QS5I2_XA[@>3WF_^%NKNFE?_=K-/IULM-C^[O\ X7!\
M)L ?\++\ ?7_ (2W0SSQS_Q^X_/KTIO_  M_X4 G=\3?  Z8V^+M"/ZB]X]L
M#VK^$7[.F64K<C9'YK$W%T%V]<Y\_!;_ &1SD_DK6\:+YC^<!L$@!N;G=CZ&
M?ECS@=^W>BE]%#"U&E'C6<:C3C[^4P4HNZ]V4GBW9MZ]5IL]B:GT]L;1BY5?
M#S"1O*$6_P"VJLDI-)J_^RWN[^EM.Q_=P_QB^$QVC_A9G@'I@D>+M#/X\7I]
M^M ^+GPE7)_X69X!^O\ PENA'!R"3_Q^U_"(8X,(295$HRA-S=>QY_>X4\#C
MOZ4[R8\@#SFR,G;<W1V#('[P^=\G/3GD&II?16PLHS3XY3=*JJ#C'+(3<JC7
M,HR_VJ/+IKN_Q-']/'&P5*,> L)*>*INM"FLYK*3C%J#M_LUY-\NEM/,_N\'
MQ>^%"_-_PLWP 1[^+M"X_ 7PZ>_OZ4?\+>^%#'CXE_#\C/0^+]"&#[#[;U_*
MOX1!;1<X:7 ;:3]JNMNXC(&?.ZX[#J.?>@6T19>91N!8.UU=*G ^[O,V-Y_A
M7J<X]*=3Z*>&IRA%\:SG4J64J;RJ#C3C=:JV,U[VT^1E_P 3ZXVG33?AW@XU
M>=0=&6>UE)*37O<_U1V>NS2?RT7]W!^+WPF)V_\ "S_ 0[8'BS0CSTZ_;NE2
MCXN?"H* ?B7\/RI'7_A+]!R>.O\ Q_?SS_2OX0/)A^129XW<$JCW-TLAP,DE
M?.[]LCG@4HMXCR#.V!EO])NODS_?Q-\I/OZFKJ?1,IQC4K1XPG.FI*E&7]DP
M]Y+ET2^MJRUM;5%/Z>F+I?6)U_#9.G14:=.=/-:SC)R<4HM?5=?>E;F5KW\F
MC^[L?&#X2KC_ (N;X!VCJ!XMT,\\]OMO^<>M,3XO_"<DE?B;X"SG)W>+M"!X
M]/\ 3>:_A%\J$*2//XSN N+LL@_OL!-PH_O'C]:>;5,D 32'8''E7-RX=3@Y
M0B;]X1D;L9]^>F5/Z*F$C&I!\95:<J:B^3^RH-.[2V^N72\_^"6OIW9I'D6(
M\.L+AJDZ<)QP]7.*\9RI3:4)W>$7N]6[:)6[']W ^+GPE#%Q\3/  .,9_P"$
MMT+MW_X_NOX_A0?BW\)BP?\ X69X R,\_P#"7:#GICI]NR3_ )YK^$8P1*2&
M\U& !(>YNE89Z YFR"<\ \D<4);(_F,/. C^_NN;I<^A4F?YN/0GCMUPJGT3
M\#32=/C*<V[/3*(_%.RJI6QCLX+>R[[$P^GEF$'-U/#K!T4IJFO^%RK'GYFD
MJB7U.SA)[.WI?0_N\'Q>^$_;XF^ 20?^AOT(8[_\_O;^5-_X7%\)BV/^%G>
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M /\ PK]"_P#DVOX0?L\?]Z?_ ,"KG_X]1]GC_O3_ /@5<_\ QZC_ (E1H?\
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MT?\ "X_A-_T4WP!_X5^A?_)M?P@_9X_[T_\ X%7/_P >H^SQ_P!Z?_P*N?\
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M=>+JW_AHC_=[8OS_ *N'_$^N/_Z-Y@__  ^U/+OA?7^DS^[[_A<?PF_Z*;X
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M_P#CU'_$J-#_ **ZMT_YE,7T7_47YOUMWL'_ !/IC_\ HWF#Z?\ ,]J=;/\
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M/\--P_XGTQ_7P\P?_A]J>5_^87S?X>9_=]_PN/X3?]%-\ ?^%?H7_P FT?\
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MO^%Q_";_ **;X _\*_0O_DVC_A<?PF_Z*;X _P#"OT+_ .3:_A!^SQ_WI_\
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M\_P\P_XGTQ_7P\P?_A]J>5_^87S?X>9_=]_PN/X3?]%-\ ?^%?H7_P FT?\
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M_A7Z%_\ )M'_  N/X3?]%-\ ?^%?H7_R;7\(/V>/^]/_ .!5S_\ 'J/L\?\
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M$[6O%.O?LF_$>X75(?!&CZEJ7A_4L!IM+CTV[^S76E7%V.;V 3[OLSL %C
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M<:YEX?<)<"8FAB:&+Q^;JNL36=5K"953;5"ABDURKEG[W(W;DA?9H\8^-/\
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M1/B[XK_&WXR:D+]]?^*.H>.=0TZ?4+JYN;B>W2UTR(3QVMM9121(EL)=KK$
M64&OW&F<H053)49+,=J;3QU[G...]?GW^WE^W#X7_9,\'6GAOP[I_P#PG7[0
MWQ*CDT/X0?"O0S]IUO4]:OU:UBUC4K>!C+I^B6$KK*]]($65U\H<9H _,?\
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M,V5'WNI]*KZ_\'?A]9_L5>!_CU8VE^?'^O>/[3PM=ZF+Q_LEY:SWBP.#II
M786"\\9R.E?:'[5GQ\\??"'X5?LKV'A/2OA_JEMK'P_::]7Q?X3T[Q!<1B*V
MB\M[*6]!:VC4<S(G$A^][<5\<_B'K?Q/_P""=_PZ\2>(K;0+/5)/BIID2Q>%
M-"M="TV15U"-0(+.TQ%'(!]Z1>68'-?SW@,YXFGEW#];$TJ4\MEQ9B\)+&+,
MJ\L9B*7UC&M4*V%5",8T'907[Z?)&$+IVT_J#->'> X9UQ;2PV)KULTPW!^
MKQP<\/"G@:%><,NDY1Q,:KG*24FY)TTFVUW.2^/7P\_91_9VM?A39ZO\%?%_
MCW6O'W@6W\17U^GCZ;1K6PNI4B\Z*WL-N%#O(SJP^[PN?7RS]G;X'_!_XY?$
M3Q#K7B3Q%;?"OX.:-?V<,'@:[U9-3\:Z[/=21PC0].N"1<S!G<3&^B5MH."I
M R/J_P#;4\:_!?PU:?LZVGQ"^"%Y\3_$E[\*;3^S=;7Q==^'HK&V$-NCVT]M
M""DLP?Y@[<G;ZGG\V/A;/HUW\>/ EQHFE3Z-I(\8Z8]I8R22WCZ8CW\)$#WF
M";G9G:)7P2!Z5U\/TJF9\*XVI#$9YEF9/#8R?]HXC'O%8>4H9C4;^HX:6,Q%
M'#\M&/L>:>$H."ES0IRDI6Y.+HX;*_$3+,O]ED6<9)"EE\7E6%HO"SA[3"X9
MOZUB*&'H5,3'GDW_ +Q5]Y2YG%/WN]^/GP7T?PE^TQX@^"WPU@N8-,C\1:7H
MOA2#5[IKJY2+4A:J+FXOI &+Q?:/,VLN6 "<'BOIC6?A-^QM\//BWX1_9S\8
M>&O&?B3QAJ=K9Z1XM^)EMXIGL=(T?QKJ*HD 'AL#9-;PS7,+XR ^PC^+%8?Q
MF\0:;X:_X*/#6]8BC;2M-\=^'%N_M._R]T\.F1Q2ON7RU4.V5^8X//-9?[1O
M@GQ/??\ !0-M+MM,N?MOBKX@>'O$>B[8G,=YH:7.GS->P3*K1^3$BL1(' )3
M!/%98;&8S/(<,95F6>8W!8*/"%7.88G#XB5"KB,TH4Z$8O$582A.KR\SJ2A*
M?+.;4YQGH=6(R[*\IK\4YIEF48#,<?/C)9-BLLK8>E5H8+*:M&-24Z5.<)1H
M6;Y858)3C:RDF[GRG\=/A5JGP4^)_BOX:W%XMX=&U&:VLM2'[LZAI6T/;W;1
MX!@:6)MJH>68<'D5]5_LNZ!^RE\:O'OA'X2^(O@AXQ@US5-'NCJ'BVS\?S);
M3SZ;#OF?^RE4B%;@D_)SMZ<]N/\ ^"@.OZ7X@_:?\7W.FRVDW]DV&F^']0%M
M(LI^UZ?%$)KBXV\+-GKDGGCIT/\ @GR"O[5/@YE.]WTS6CY8&TSI]G&&C(^Z
M>N['7TKZG,8U,Y\-</F.95\7'-(Y)'&SQ&'QF*P-6>)]BVI588:K2C4C91G[
M.JG!-_#%6M\7EN(H<.>)M?+LHPF7K*JN/JX3#T<5A</C80I\L))>TQ$*K=IM
MVEO;K9M/:CF_9H?X[:!\-O GP.U[PYJ>C?%S3O#5YKOB'Q>VOZ1JNG6%[)!=
MVU[HD@V,M\@7]VWW .>H(Y?]J'X,>.T^,GQ$U7P9\*_$UKX%@NV>#5?#OAN?
M_A'+*WL]ZSI 81Y4$:@9<KQ[XKF_#B?\9LZ>Y<.J?'^8RH>1*YU20K#(/XW7
M;MW'-?H7H_QL^)VM_P#!0ZZ\&7?BBZF\&--=>'[OP5!N@\/3Z7-!<HYN-+4_
M9YK@*JE[AEW,V6)R>?C\)F&:</3P=?**$,;"AD$L=BUFV8XVHW"G4]M5]CSN
MK+VDXTY*FN>-.'NZ2YG;["I@,@XHH9KEW$-2.$Q^+S^66Y9+*<MP,*,)T94X
MWJRC"FJ</>BI2C"4I^\_B2;_ !O\/^&/$_B_4_['\&>&M:\4ZQ'"[W%AHFF2
MZEJ"[7"FXE2+YK?R_ND,..1Q6CXH\#>./!-[::=XU\'>(?!NI7S)-I=EXALY
M;.XO]S"$?9;64 W)>0[0R_QX3DU^MGP=L/!7A/X,_M;:^OBC6?AU<Q?%;5=!
MUGQUX'T(:SXI\/\ A^:YN6-M:6\1%QI]KC9FYBSL)Z<5X%XY^-'P#\2_!'PQ
M\+X/BG\0OC-X_P!#^(/A_5O"/C7Q[X0FTW6M.THW]J)]'.K7 ,UU#+(?/"L>
MIR%S7I4?%'B/,\1SY?PI7Q6!A4A2K5J<,;)TZDJ%.MSU*T5]5IPA&I&\)2]H
MXM/2Z1QS\&<AR_"UO[5XHPM'-%4_V*FZM"T\&JC@X<E_;.LTGRVCRN/71V^)
MIOA'\6+6SU#4[GX8^,X=(T?$^M:M<Z'<PV,$#Q+*'GF<!;8;'60(004(;O3]
M/^$GQ;UO1X-?T7X8^.;_ $!XGO['7M.\/W5QI5S8IN\^;SE&TVL"I(_]W*'W
MK]!?V\O'_P 4=6^/7@7X>^'/%.H:7IVH>&O"NFZ?X:LKR2QTC6=1N(]/=)_$
M5O&PBOU:9Q'*UP"/LX\L_**][\!6$_A']J#X5?#_ .)_[1?Q&7XI1:5:K/\
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M!)8_3CTJ=>@YSP.?7W_&J9*X^7=$VU<L4&T@8RJCIN;D<<]:N Y (& >V,4
M+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4;G!!SV.5SC
M@Y^8_ECI4E0RGYD&[;D\_+G>HZQ@]B>M 'BOQ4^'^I^,]?\ A%JECY"1^ ?B
M!;^*=0WS>7Y=G%:30_*IYE8F3.WTR>U>X9KD=<L[B[N_#[6FK_V1';:HL]W;
M2Q(S:W J,/[-R[!LLQWC&Y@ , BNN% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5X[^T#_ ,D0^*G_ &)/B#_TCEKV*O'?V@?^
M2(?%3_L2?$'_ *1RT >+_L"?\FM?#C_KCJ7_ *72U]E5\:_L"?\ )K7PX_ZX
MZE_Z72U]E4 %%%% !1110 4444 %%%% !1110 5#)]R?_KFW_H!J:H9/N3_]
M<V_] - 'YQ_\$Z?^09\??^RO:E_.]K](J_-W_@G3_P @SX^_]E>U+^=[7Z14
M %%%% !5:10SLK$X*\<< CH0?7/^<59J-AECVXR>OZ?I4R4)+EJ)-/17WN]K
M;/[A-S5G!V::;OU2>J\K]R#$B@%AG' ('))X^8=0 >_&>*10S;P<H<'D ,H.
M#RI/4^O;L:F8G) )P /RQ[?YYJ'S RL$;:X_O#]!^?/]#2A7DXU$J51QIM03
M2NWMMKKVN_7IJJCI\\(S5",JFMVDGIR]7;U?E?IH1/OC !&\D@(R\'<1U<+P
M%P#N^OUJ5 !(8I 7+('!ZQD]-A)XSW .<C![<K&RE02=[+W&,#/KZ]/Y]B:"
M3PI^8L,@C/&.A)XQ[8S_ (S=TJ<53A45JB=2,KN7OI;MMNVJV;[)O=)0IRE[
M1SIRBFHTI1MRZ6VMH_TZ"&,;2 %!) *DX5O0+QCMZ >^*"A4 LQ3<NW*D<>X
M/TXZXIBMN!B?#RL,,HR%!SGACR./PST- "J50+E1D<$L%?T8MDX[ ]SQ5JG=
MR3YJ,I/VGN>ZY0M'=MVUZJV]^Y+E%PY*/LZW).R?Q*,].;;K:_X[#71,!&/R
MKR& P"_9V'3CJ.>M2@;0&<[RH&<#&XCN,=^X]^?:HQ("6W%=^"K)CY ?3<0>
MF.H_.FE3N1B560@@?,=H4=^>"<>OI57DK.I[1J7\*,+\SLDW>TH[]7)O\BDZ
M%2,U3=*,HI*4Y<K4)*R5U;1=NB?3>ZY;>\DBL82O[LY^9>!Y@;TST7C/OUIR
MJS)MFW\G(*'#%3_JP/5B.&Y]0:(V9F5E577YED;D-Q]W:OW?3D_E3I&.T>7(
MI;)4,W!3./NKTR!_G.*49K6"52$E)W4M^FD;MIK;5-Z?<"C'EYI.G4BHKWXI
M<FZO/2_;1=^XF/F2,@!60Y3^/Y>C9QR1T.?>B-90PW."-X*I][8@]R22Q/<\
MCI2QOO+HQ=CM"AF4*O'WMKCYCDC/3MS3E<F10$.T'8R 996SP['L.>:.;V-H
M2YES:1B_>WLVUOY:7ZM::ARPK>_3Y&XM7G'2ZBT[:VVWU5MO(MT444RPHHHH
M BDSE0JY8]\<!?XAN[$C@8]:\$\&>'_$5A\=/C!KEXMZOA[Q#I'@V/0'FD=[
M)[G3[&6'439HQ*HR2N#.% R<5[S,S 81<MAB"V1&,?WR.1R>WO7.V \1C7]:
MDOUT\^&S:V!T(V\DC7QN#&?[06Y1OD1&DV^24RS#.[F@#J%S@9.3@9/J<=?Q
MZTM(IR <8R!P>W'3\*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#RWXU>(?&'A'X6^._$WP^\.W'BSQMI/AO4+CPUX?ME,DVI:L(BMG
M%%%D"21)BLRQD@.4VG[U?R1_ #XB_P#!1;X3?&WX@_M'_%;_ ()O_$7]H;XZ
M>*[^Z32_'?BN"?3H?"&A?:F-MI/A32%>:STF&*!4"R6:QM_&FU\,/[+J* /P
MQ_89_:]_;I^(7QSU3P5\:?V'/&'PE^'WCSQ#KOB_4?B+K]W>O%X8N;FVA,&B
M6MO/))&]@C0F.WEX*B1SBO5OB3\3?V]]._X*6^ /A]X&\*:UJ'['.H>$8+GQ
M7K3>&;1]!@UIXE:8/XK)%[;SA]W^BJ-F?EZ5^J&DR^)P-9.NQZ;&!J]R-'%I
M([E]$PHM7NMWW;QFW!HU^0<8SS721-N4?*ZX &' !_(>U 'Y3_MK_%3_ (*%
M?L_?$6+XJ_L^_"G1OVBO@;'H=CHUY\'-,_T?QR/$MU$8Y-;M[J$+<OI]O<+Y
MTB[F0*=K  BOS<^)WQ._X*H?\%);6Q_9FOOV4-4_8^^'_B"3[9\0_B%XEEGN
M;.]T&U=6N=-M+F=R5O9$#"UMD4_:G<!R0%Q_3_10!Y!\!?A!HWP'^$/@+X3:
M#,]UI_@GP]8:,MY(NU[R>WMT2ZNV4<*;B</+M_A# 5Z_110!3DR68#GGH?7'
M;.>,=QW]Z\8^.GP/\%_'_P"&^M_#;QMID-U8:G:RBUO98T:;3KX(WV:]M96#
M-',DI4EE()3(!ZBO:]JAF/.[IDCH/8]R>G^':-VW0O@N3D !5!;MP >",'WP
M.:Z<'BL5E]?#XG!UYX?%8>M"O0K4VX2ISBU*,DU;5-O=^3NKGF9EEF7YM@\5
MEN/HPQN!QU"IA\5@J\8SHXB$X\LX)2V:75-..CBTTK?Q#_M&_L\^.?V:OB;J
MO@/Q;;RM#!).WAK6?)9;+6=&DD*P-'-C9+(B, 1G>,'(KP(!5 52QV#;SZ]3
MM]N>/QK^SS]KW]D[P=^U/\.+KPOJR16/BC28Y;_PAXF1$^TZ3J83"+)+C?):
M3X$4T3,556+KAJ_"=/\ @C3^U5(9'B\3?"WRFE<Q$ZAJ66CW$1DY0X8J S '
M&2?05_>/AWX]<,YCDF"AQ5F6%R?,\MY*&+JUW.4<?.*2IUZ?+";C[JO.#=HR
MNKM)-_Y5>*_T5N-,@XLQ<N ^'<9G_#^9SJ8W"TL'",L1ETG).6&J<THQ5.,I
M<M.5WSQ2EIJC\G%SQG'49.,@9]N^/0]1490R"19 K%QMBESM$; Y#&(?+@>G
M3K[X_6O_ (<R_M6<#_A*/A7QV_M#4<_C^[[4'_@C)^U9G_D:/A80>O\ IVH@
M]#W\L_3^GI^@Q\9O"_V]>I4XORIPKPY&K8CJDO\ GQZK;R/R>'T<O&SZK5B_
M#KB'VOMXUJ?N4-''5-?ONFVUS\X?B!\7?B#\5+#PAI?CC5H-6T[P)I)T;PS;
M):QV9LK'RUBE1I(OFF:4*"I?G"C&*2[^+OQ#U/X6Z1\%K[6H9?AWH6KQZ[IF
MCK9Q02Q7L,OGQ[[Y<2G#@'GOGUK]'3_P1F_:L!_Y&;X6]?\ G_U'\_\ 5C_'
MVI?^',O[5IP?^$H^%?3./M^I9Z8_YY@"O'CXG>$-/#4,%'B3)/88.O4S#"I4
M:J5/&2G)N=->PM&H_;5).:LVY2N]7?W*G@I](*O/&8JCP/Q!0Q>-P4,#BW.E
M0YJE&FJ2C!OVS;5J<;)NVB/SB^)/Q=^(7Q;;PW<>/M:35%\(Z0N@^'(H;6*W
M>QTJ,*JQMY9S+(-B@.WS$98]36Y\)_C]\3_@I%/;_#^?PS:?;YQ?7$FM^'-.
MUZ>"Y3E);:\OE:6!Q@$(APK8*\C-??\ _P .9_VK<X/B;X79YQ_I^I=.V/DS
MZ?EZ"GG_ ((S?M6JI/\ PE'PMY/*B^U'C\X\?Y^E$O$?P:J8*IDU7B#))Y=7
M5IT?9U52M*?MG:,:&C]JW.Z^TV[CCX-?2(6<4L^PW!&?4<RPE&"56M2HMRJ4
MXQ@FOWDG?D6G?IW/A;XI_M/?&+XTV3VGQ'U;P[J6;E+S^T-+\*Z7IFM/-&JI
M&9=3MD%S(8@JF,NWR%5*_=KJM/\ VU_VC=)T#2] M_%6A3KI.DOX=TO5=0\,
M:;J/B6TT<Q-$%7Q)<*VHPS!78!UD#(=K#E17UV/^"-'[5F,CQ-\+O7_C_P!1
MZGU_=^_0^G/:I?\ AS)^U8=I_P"$H^%GO_IVI<#_ +]\YZFO*EQ;X#2PN"RZ
M6:9"L/@*KQ%'W<2H*3MS4XQ5%\O/O*RM+KT/7GX9?28]OC<PH<(<0/,,TP<:
M6/J<E!*HW)0E&4O:*\U35D]=$K.RT_)NXN+BZO+R]NI9;Z]U&62;4M0NYGEN
M[FZD.^2:25R7GR3\K.3D  ]J[+X>_$3QE\)_%EAXY\!ZG#HGB72[6>UL]5-M
M'?E[>Y39- ]G-^Z0,OREADCW/7],C_P1E_:K'_,U?"L_]O\ J7ZYC_3!%)_P
MYF_:M[>*/A7TQQ?ZES_Y#QG]?>OH*WBYX28K#3PRXAR:A@L4G2J82<:]2G[%
MQ491G"=%Q<9*Z<6FG%M6:;M\U#Z/_CMA<7A,;3X XCG7P]5U55MAY3YFEJY?
M6'[R?9MI6U[?E_;>,O$MGXVB^(]O=P)XS3Q(WB_^U/+7RXM<:4W#7:V_^K=I
M)&R8C\J] 1BNOM_C?\3;3XHR?&B#6X6^([S&ZA\0FTAA"2LKK(LFGK^Y88=@
MI/7.0.!7Z(_\.9?VK<'_ (J?X5Y][_4B?_1?Y<]:8?\ @C-^U:%)_P"$G^%A
M_P"W_43R.?\ GF3^H[=>_/5\3/!Z=+ECQ-DC<:/U)ITJGOX6:494-<.DZ+3_
M (3]S=6+H^"'T@*=6I6? '$T)O,*V.A-1HIPJ55"U1.->ZE%Q4KK56T=S\^_
M!7QX^*OP^\4>)?&/@_Q)'!J_C(W3^)XM0L8=1T+7#?3FYO)+S0K@FQFD\YFV
M2NC/&@"KQ6IX_P#VD?BA\3])TS2_%;>$#9:5J=MK&G2:!X-TC0;J/4[&17M[
MC[58QI*\2,HS;L?+; R!7W>/^",W[5,@_?>)_A;$BNLB$:AJ*G<!@QYV !7Z
MD?IZJ/\ @C-^U:Q9CXF^%89CRB7^H^6F.FS]WP",$X/+=:\ZIQMX%5*D*\\\
MR7ZW34%&M36(I3C[-<L=:=):1B^5=HZ+2U_8PWA7])2G&I3AP=Q)'#U;^UA4
MIT*JK\W+S<KJ5)-2=M7>+VUTN?F_\0/BU\0OB=XDL?&/C?7%O_$=C%9VNG:E
M96T=G/;QZ<L0L]WE8\LH88]T@(9MISUQ7N?_  W3^TNL-@H\5>'XM2TFVM;>
MVU\>$]+E\00);%?+:'6V'VV0R)&L<Z^9AHP5?()KZO;_ ((S?M6C _X2?X6G
MW%_J/_QL']"?2E/_  1G_:M '_%3_"SZ?;]1S^L??O@],5OBN//!#'4L#0QF
M?Y%5P^6TI4L%1G1J2ITE*,(J,?W#<5!1C&,=%9);&6#\(_I(95]>JY7P9Q)A
MZN/JT:^+FU2=22HMR<4G6DG.IS.TH^_%MV=[M^4?LP_'J>PD_:>^(WC#QWI^
MC?$KQAH6FZEI>H7DBV$FOZ_;S^;-%:6D>8Y0X1?.M\A'&5;.2*^;/B7^U#\:
M?B_H7_")^-/$6G?\(V]TVHRZ?H&@V7AV.YO4<Y.H#3]@ORPP8VG!.3N!!K[F
M/_!&+]JF0JS^)/A42O*%[W4"5..JYCR">A(^O/6GG_@C+^U;T'B?X5L#QS?Z
ME]3G]WP>,?RYKR<%Q?X)4\[EG%3B'*-)X7V6'G2J<N!CA,-2PL%@K4&FI0IJ
M3Y_@<I*'*CWL9X:?2.K9-A\LP_!F?PPJA7CB:?LZ7M\9/&U(UZ[Q,G5<HPC.
MZ<:;Y9JSDFSS#X0?'"U^#O[$/Q0TS2/'-A/XY^)NKQZ%;^ Q,/M^DZ$Y:VU*
M]:WX""ZMV8B0<L">I-?G-'%'#&(P6(2'RS)C<SH5QCG^-. K9R*_68_\$8_V
MJ@QE_P"$C^%/F8P7^VZAOV@$$;O+W$8Y SUIX_X(S?M5D _\)/\ "SGD!K_4
M\\>PCYZ?YZ#T<HX[\(,HQ&?8FGQQ@9/.<QCC,1^[J1EB%&E3I4</>&'3Y*-.
M"C=N\I<\FVI:>1Q%X.^/7%&"R#*<9X=9Y2P^08>='!OW>6E1J5O;5N6]?XY5
M9.<5K;9+>_SA\.?&?AOQQ^R1\2_@AXN\5:;X=UGPWKECXV\$?VI-Y2:M#I\0
M-QH]E,06%_<RG**I!R*\Y\$_M=?'SP-X6T?PQI.O^'Y],T'_ $31+GQ!X;T[
MQ+KFD1R#<PL]1U$27,5NK 89''EG!4<"OM!O^",?[53D%O$GPKDV\J3>:@=I
M]5W1Y!ST(_\ KU)_PYD_:NZCQ1\+!V(^WZEP,],[.GY_2N&MQEX,5'FD<7Q3
ME694,QS&GF4</6A65+#8A8>G0FX6HW?/""<DU:[EH^9W[9^%OTA8RR=8'@'B
M# SR3+ZF5_6:5.C*>.P]2JZ[DY5*KM).7)S1]^UU='Y^>%OV@?C!X,^(=_\
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MQ/\ %KQWXP\"^$/ASXEUA;WP/X"W)X5T9;*(W-OYJ>24GO/]=.JJQ&Z3HF,
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M_P#@;J'_ ,13_P"(T^&G_1795]U?3X?^G72VGH9?\2Y^-W_1O.(/_!>'\O\
MI[Y?@C\F:*_6;_AS-^UA_P!#/\*__ W4/_B*/^',W[6'_0S_  K_ / W4/\
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MZ5^B2_Y\KS?G9#_XET\;O^C><0=/^7>'\K_\O?+3T7R_)FBOUF_X<S?M8?\
M0S_"O_P-U#_XBC_AS-^UA_T,_P *_P#P-U#_ .(I+QI\--/^,NRKITK6TY?^
MG/K]R%_Q+GXW:?\ &O.(.G_+O#^7_3WR_!?+\F:*_6;_ (<S?M8?]#/\*_\
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MRK_W?^G/D_N#_B7/QN_Z-YQ!_P""\/Y?]/>EOP7R_)FBOUF_X<S?M8?]#/\
M"O\ \#=0_P#B*/\ AS-^UA_T,_PK_P# W4/_ (BC_B-7AI_T5V5?=7[17_/K
MINO-7#_B7/QN_P"C><0?^"\/Y?\ 3WNOP7J?DS17ZS?\.9OVL/\ H9_A7_X&
MZA_\11_PYF_:P_Z&?X5_^!NH?_$4?\1I\--/^,NRKITK].7M27G]R#_B7/QN
M_P"C><0=/^7>'\O^GOE^"^7Y,T5^LW_#F;]K#_H9_A7_ .!NH?\ Q%'_  YF
M_:P_Z&?X5_\ @;J'_P 127C3X::?\9=E73I6MIR_].?7[D'_ !+GXW?]&\X@
MZ?\ +O#^7_3WRT]%\OR9HK]9O^',W[6'_0S_  K_ / W4/\ XBC_ (<S?M8?
M]#/\*_\ P-U#_P"(IKQJ\--/^,NRKITK].7_ *=6Z=NGF'_$N?C=_P!&\X@Z
M?\N\/Y?]/?+3T1^3-%?K-_PYF_:P_P"AG^%?_@;J'_Q%'_#F;]K#_H9_A7_X
M&ZA_\127C3X:+_FK\JZ;JN_Y?^G/K\E8/^)<_&[_ *-YQ!_X+P_E_P!/?+\$
M?DR>,YXP5!]B^-@/NV>*#E2 P()Z#CG'7OV[U^LJ_P#!&7]JW(SXG^%;\_O
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M+E;>D[--WU3?HD]T?[/=M'%N,9.+O=72^5_Z]%HHHK0 HHHH **** "BBB@
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M&/\ A(M7SGT_X_.M%OZUZ6_R_J["Y_>U_P ))X;_ .@]H?\ X-+#_P"/T?\
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M)'][7_"2>&_^@]H?_@TL/_C]'_"2>&_^@]H?_@TL/_C]?P2_VEK?_0Q^)O\
MPH=7_P#DRC^TM; W'Q)XF ]?^$AU?'Y_;,4<J[?TK?Y?U=A=G][7_"2>&_\
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MUQU+_P!+I:^RJ^-?V!/^36OAQ_UQU+_TNEK[*H **** "BBB@ HHHH ****
M"BBB@ J&3[D__7-O_0#4U0R?<G_ZYM_Z : /SC_X)T_\@SX^_P#97M2_G>U^
MD5?F[_P3I_Y!GQ]_[*]J7\[VOTBH **** "F/V_X%[=O\_7I3Z0C/Z]O7O\
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M)<>'+27PYI1T72&FO!;:>UFUBT3+=2BX<VS!2GG7'FR@[1O#[^=U '74444
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M* /D_P"*7@8?"KX@>+/A\_B'2O%)\)Z@=/7Q1I%S%)H^MY4/]KL9E=T,+ E
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M7\)[N_&D^&?$WBNSN-4?Q!J)<I<#1]#L\:@8[5_]9=;7AXW9 KZ1_:"T:R^
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M&E^$=&\):?I_@;;_ ,(U%+?O9;)3,HDFOIY;P"0\_P#'V\V1_"<B@#N:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:[;5S@GD#Y>O/?\
M"G44 4);:WN4EM+A!)#+YGF1@ 12Q2J5>.8<[E=,JX/# XKY#^)?[*?[)6A>
M&O&GCW4OV;/A%K5_I>E:MXFO'O/!>C23ZC=6T$EU(TL[VQ<RSLGSON#L3G/>
MOLK ]!^5<WXOM="O_#&O6'B;CP_>:1?0:R2QC0::\#+=YD'^K_<EOF XZ]J
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MG'R4 ?<UG^U5X \<_#3P[\-_VG_@S??%9O S1V_@;Q3X0U]/"?B>PT*$*O\
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M1_:%J<Y9SGK^YEY^OR<_C2?;[7 7<V%)*CR9< G@D#9QF@#[NC_;5UVX^/\
MH7QAU/P=;?\ "+^$O"^J>#O _P .-(G6PM?#WAR>S^R6=I)<*2DLEO'S)/\
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M!0!>HJE_:%K_ 'W_ ._4O_Q%']H6O]]_^_4O_P 10!=HJE_:%K_??_OU+_\
M$4?VA:_WW_[]2_\ Q% %VBJ8U"S.7>8X' "Q2C.#CG"=>.E']H6O42-@]!Y,
MN['O\F?_ -8H N452_M"U_OO_P!^I?\ XBC^T+7^^_\ WZE_^(H NT52_M"U
M_OO_ -^I?_B*/[0M?[[_ /?J7_XB@"[15+^T+7^^_P#WZE_^(H_M"U_OO_WZ
ME_\ B* +M%4O[0M?[[_]^I?_ (BC^T+7^^__ 'ZE_P#B* +M%4O[0M?[[_\
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MSMVD\L!V;O0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC_PI3X.?]$I^'/\ X17AS_Y74?\ "E/@Y_T2GX<_^$5X<_\ E=7IU% 'F/\
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MKPY_\KJ].HH \Q_X4I\'/^B4_#G_ ,(KPY_\KJ/^%*?!S_HE/PY_\(KPY_\
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M>G44 >8_\*4^#G_1*?AS_P"$5X<_^5U'_"E/@Y_T2GX<_P#A%>'/_E=7IU%
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M_6IZA_PL_4_^@3;?]_F_^*H_X6?J?_0)MO\ O\W_ ,57E^/K^9_QHQ]?S/\
MC1RKM_7]+^KL.:7=_P!?U_6IZA_PL_4_^@3;?]_F_P#BJ/\ A9^I_P#0)MO^
M_P W_P 57E^/K^9_QHQ]?S/^-'*NW]?TOZNPYI=W_7]?UJ>H?\+/U/\ Z!-M
M_P!_F_\ BJ/^%GZG_P! FV_[_-_\57E^/K^9_P :,?7\S_C1RKM_7]+^KL.:
M7=_U_7]:GJ'_  L_4_\ H$VW_?YO_BJ/^%GZG_T";;_O\W_Q5>7X^OYG_&C'
MU_,_XT<J[?U_2_J[#FEW?]?U_6IZA_PL_4_^@3;?]_F_^*H_X6?J?_0)MO\
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MF"<O9*M=^Q>U7_EV_P#MY^[^/D>G?\+/U/\ Z!-M_P!_F_\ BJ/^%GZG_P!
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M_P!6_K_ASU+_ (6?J?\ T";;_O\ -_\ %4?\+/U/_H$VW_?YO_BJ\MROJ?\
MQZERO^U_X_\ 7^5+ECV7]6_X'],.9]_ZT_K_ (=GJ/\ PL_4_P#H$VW_ '^;
M_P"*H_X6?J?_ $";;_O\W_Q5>6[E]3^;497U/_CU/E7;^OZ7]78^:7=_U_7]
M:GJ7_"S]3_Z!-M_W^;_XJC_A9^I_] FV_P"_S?\ Q5>797_:_P#'^_2DW+ZG
M\VI<L>R_JW]?\.+F??\ K3^O^'9ZE_PL_4_^@3;?]_F_^*H_X6?J?_0)MO\
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MZG\VI<L>R_K_ (;^KL7,^_\ 7]?UN>I?\+/U/_H$VW_?YO\ XJC_ (6?J?\
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MJ\MW+ZG\VHROJ?\ QZGRKM_7]+^KL?-+N_Z_K^M3U+_A9^I_] FV_P"_S?\
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MM_W^;_XJC_A9^I_] FV_[_-_\57EN5]3_P"/4N5_VO\ Q_OTI<L>R_JW]?\
M#L.9]_ZT_K_AV>H_\+/U/_H$VW_?YO\ XJC_ (6?J?\ T";;_O\ -_\ %5Y;
MN7U/YM1N7U/YM3Y5V_K^E_5V/FEW?]?U_6IZE_PL_4_^@3;?]_F_^*H_X6?J
M?_0)MO\ O\W_ ,57EV5_VO\ Q_MUI,KZG_QZERQ[+^K?\#^F+F??^M/Z_P"'
M9ZE_PL_4_P#H$VW_ '^;_P"*H_X6?J?_ $";;_O\W_Q5>6[E]3^;4N5_VO\
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M\51_PL_4_P#H$VW_ '^;_P"*KRW*^I_\>HW+ZG\VI<L>R_K_ (;^KL7,^_\
M7]?UN>I?\+/U/_H$VW_?YO\ XJC_ (6?J?\ T";;_O\ -_\ %5Y=E?\ :_\
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MHY5V_K^E_5V'-+N_Z_K^M3U#_A9^I_\ 0)MO^_S?_%4?\+/U/_H$VW_?YO\
MXJO+\?7\S_C1CZ_F?\:.5=OZ_I?U=AS2[O\ K^OZU/4/^%GZG_T";;_O\W_Q
M5'_"S]3_ .@3;?\ ?YO_ (JO+\?7\S_C1CZ_F?\ &CE7;^OZ7]78<TN[_K^O
MZU/4/^%GZG_T";;_ +_-_P#%4?\ "S]3_P"@3;?]_F_^*KR_'U_,_P"-&/K^
M9_QHY5V_K^E_5V'-+N_Z_K^M3U#_ (6?J?\ T";;_O\ -_\ %4?\+/U/_H$V
MW_?YO_BJ\OQ]?S/^-&/K^9_QHY5V_K^E_5V'-+N_Z_K^M3U#_A9^I_\ 0)MO
M^_S?_%4?\+/U/_H$VW_?YO\ XJO+\?7\S_C1CZ_F?\:.5=OZ_I?U=AS2[O\
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MMNUO]F'0R$K\VP9/?%=XYWLS\C<Q;&6_B)/K[T<J[+[A<TN[/3O^%GZG_P!
MFV_[_-_\51_PL_4_^@3;?]_F_P#BJ\OQ]?S/^-&/K^9_QHY5V_K^E_5V/FEW
M?]?U_6IZA_PL_4_^@3;?]_F_^*H_X6?J?_0)MO\ O\W_ ,57E^/K^9_QHQ]?
MS/\ C1RKM_7]+^KL.:7=_P!?U_6IZA_PL_4_^@3;?]_F_P#BJ/\ A9^I_P#0
M)MO^_P W_P 57E^/K^9_QHQ]?S/^-'*NW]?TOZNPYI=W_7]?UJ>H?\+/U/\
MZ!-M_P!_F_\ BJ/^%GZG_P! FV_[_-_\57E^/K^9_P :,?7\S_C1RKM_7]+^
MKL.:7=_U_7]:GJ'_  L_4_\ H$VW_?YO_BJ/^%GZG_T";;_O\W_Q5>7X^OYG
M_&C'U_,_XT<J[?U_2_J[#FEW?]?U_6IZA_PL_4_^@3;?]_F_^*H_X6?J?_0)
MMO\ O\W_ ,57E^/K^9_QHQ]?S/\ C1RKM_7]+^KL.:7=_P!?U_6IZA_PL_4_
M^@3;?]_F_P#BJ/\ A9^I_P#0)MO^_P W_P 57E^/K^9_QHQ]?S/^-'*NW]?T
MOZNPYI=W_7]?UJ>H?\+/U/\ Z!-M_P!_F_\ BJ/^%GZG_P! FV_[_-_\57E^
M/K^9_P :,?7\S_C1RKM_7]+^KL.:7=_U_7]:GJ'_  L_4_\ H$VW_?YO_BJ/
M^%GZG_T";;_O\W_Q5>7X^OYG_&C'U_,_XT<J[?U_2_J[#FEW?]?U_6IZA_PL
M_4_^@3;?]_F_^*H_X6?J?_0)MO\ O\W_ ,57E^/K^9_QHQ]?S/\ C1RKM_7]
M+^KL.:7=_P!?U_6IZA_PL_4_^@3;?]_F_P#BJ\O^-'Q#U"_^$'Q.MIM*@1&\
M&ZRNX.YR)+<HV1]'_/\ .C&.<$XYQD\X[=>]<!\7"?\ A5'Q&:,HJGP?JJX;
M/4Q 8'7IQG/YT6BNB^8<TN[.O_8&R?V6_AR<*,PZD<+T ^WS8 K[)KXX_8(!
M'[+GPX! !\G4?NYQS?S'O7V/6,MWM\MOZ_4U6R]$%%%%(84444 %%%% !111
M0 4444 %13_ZB;_KE)_Z :EJ*?\ U$W_ %RD_P#0#0!^0?['?^K^.'_93=2_
M]*;BOLFOC;]CO_5_'#_LINI?^E-Q7V36ZV7HOR,9OWG_ %T04444R0HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!<.$9HV <E8AV?$IP2K
M'@8QSGBL*SMK:+Q'K=U!J%S-JLEI90:KI4]Q#+#IUM$I$%RD*-F,W*_-G:-W
M?-;F%8,&/\#83<%+$C@C/=3T_P#KUYOX>\)ZOI?Q-^(WBRZA2'3O$^G>&;32
M#YV2/[.BV79=2< OW(Q[T >D<?PG*_PD=".Q'U%%&,<>G''3CTHH **** "B
MBB@ HHHH **** "BBB@ HI0"S  @?7C/H >@)[$]\5XA\<_VC/@Y^SCX0O\
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M[P\]/*Q_48/^"@/[(&#_ ,7BLNO;2;[@#_@/3I_@.Z?\/ ?V0!R/C%9GN?\
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M?U>R7_$Z/B)_T)\#TZ1\K_8_Q?>?U%_\/ OV0?\ HL5E_P""F]_#M_GVI/\
MAX#^R!_T6&Q[?\PB][?A^7I7\NODQ_W1_P!\K_\ $TGDQ_W1^0_PIOZ,W#/7
M,L0_E3[Q_N+M_5]'_P 3H^(G_0GP/2^D?[O]SR?X?+^HO_AX%^R#_P!%BL?_
M  4WOX=J7_AX%^R#_P!%BLO_  4WO^%?RY^3'_='_?*_X4OE1_W5_P"^5_\
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M+Z1_N_W/)_A\OZC/^'@7[(/_ $6*R_\ !3>_AV_S[4G_  \"_9!_Z+#8]O\
MF$WO;\/R]*_EU\J/^ZO_ 'RO_P 3_P#J[4GDQ_W1^2_X4W]&;AKKF.(?RI]U
M_<7:_P!Z[!_Q.CXB?]"? ^>D?[O]SU/ZB_\ AX#^R#_T6&Q_\%%[ZY]/\GFE
M_P"'@7[(/_18K+_P4WO^%?RY^3'_ '1^0_PI?*C_ +J_]\K_ /$_YZ]:%]&;
MAG_H8XA?*E_=[0ZV_/R#_B='Q$T_X1\#]T?[M_L==3^HH_\ !0+]D$_\UAL?
MQTF]_P /TH_X> _L@?\ 18;'O_S"+WO^'Y^M?RZ>3'_='Y+_ (4>3'_='Y#_
M  H_XEFX9_Z&.(?_ &[2_N]X>3_X%]#_ (G1\1/^A/@?NC_=O]CR?X?+^HS_
M (>!?L@_]%BLO_!3>_CV_P ^])_P\"_9!_Z+%8]_^83>_P"'Y^OM7\NOE1_W
M5_[Y7_XG_P#7WI/)C_NC_OE?\*/^)9N&O^ACB-^U/M;^3MI\_1I?\3H^(G_0
MGP/3I'^[?['^(_J+_P"'@/[('_18;'M_S"+WM^'Y>E+_ ,/ OV0?^BQ67_@I
MO?P[?Y]J_ES\F/\ NC\A_A2^5'_=7_OE?_B?_P!7:A?1FX:6V8XCINJ?9?W'
MYK\5Y/\ XG1\1/\ H3X'ITCY?W/7[U\OZB_^'@7[(/\ T6*RZ_\ 0)O?\.OO
M2?\ #P']D'_HL-C_ ."B]]<^G^3S7\NGDQ_W1_WRO^%'DQ_W1^0_PI+Z,W#.
MG_"CB.FMJ72W]R_3^KZ"^FCXB:?\(^!Z=(^7]SU^_P"[^HS_ (>!?L@_]%BL
MO_!3>_X4G_#P+]D'_HL5C_X*;W\>U?RZ^5'_ '5_[Y7_ .)_SUZTGDQ_W1_W
MRO\ A3_XEFX:LO\ A2Q%M.E/I;^YY=^_D+_B='Q$T_X1\#TZ1_N_W/4_J+_X
M> _L@?\ 18;'O_S"+WO^'Y^M+_P\"_9!_P"BQ67_ (*;W\>W^?>OY<_)C_NC
M\A_A2^3'_='_ 'RO_P 32_XEFX9_Z&.(Z=*7EVAKJOZO9'_$Z/B)_P!"? ].
MD?*_V/\ %]Y_3IK/[=7['VMV]G!/\;;:P&F7L&J&:/2]04S?9SO2W) !*2 _
M,,X.,'-:I_X* _L?RB$R_%ZT,99Y(@-*O5S$W,CL=HSL." ?;%?R[^7&4V.B
MR+G)W*I)]!G'1>P[4CHAC(VKB,'8-HPHR/E&,87/4<_C1_Q+%PW4?)_:==\U
MDE)4N5.Z>ON+MW>WF#^FCXAR5GDN E>UU9:O1V=XM.S3?W']0\7_  4!_9#E
M\I4^,5G=B:=(+6UBTN^@D:6241Q*TDBA>690"2/<U]?VT]K=VMI>V,IN+*]M
M;>]M)B"/,M[J))H7P?6-U/XCU-?Q=".-[BU5XT*G4=+PFT!8S]NMN8\ %3ZD
MXSVZBO[+_"ISX0\'$  ?\(EX<&!GMI-J!^/'-?AOC+X6X+@*O@:5#'2G&<92
M51\D;*+IQ46H<J^WHW9V3NV?U1]'/QNXE\8\PSREFV7X7"4\'3A']U:R?)#5
M6BNZ6_ST-S_/3_(HHHK\'Y;.357VJD[J7-S65EIN_P S^I?>4ZD9-R49<L;Z
MV5EHGJ%%%%,84444 %%%% !1110 4444 %%%% !1110 4444 %8/B:WL+O23
M!JVJOHNFF^L7EOTE6%A<1SJUG;[R5XN9\1%0?F!(P>*WJ\U^+OA75/&G@2ZT
M'1D5M1?7/#VH(6?8JP:;J4=S<\\$DQ*0N#U'- 'ICFX$LHF60RAAM"/&!M8*
M!TXZ8/ZTA!4D'/![G)_$BG&,M+'\BJ9(@2S2 [4BC12,]F^4_3(J,$$ KDCL
M3R2/<]S[T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
MAL@[9"I.Q]C*  ?7=WS@#KC/-%&-PD(P6CC,A5FP&4$9XSDG/<4 8&M6UM<2
M>'Y=1U6337@UQ9]#B\Z-#JNHB(J-/89!=6C^?9STZ5T!W9.X8;)W#T.>1QZ&
MO,_B#X3U7Q%J_P +;O3HE^R^%_&T?B'5%,PYT\6AB8( ?O"3) /! Z<UZ=(0
MTCL.C.Q'T+$C]* &4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>=_%O_ ))+\1?^Q3U;_P!%K7HE>=_%O_DDOQ%_[%/5O_1:U$]O
MG^C [?\ 8*_Y-=^'/_7#4?\ TNEK[%KXZ_8*_P"37?AS_P!<-1_]+I:^Q:R-
MULO1?D%%%% PHHHH **** "BBB@ HHHH *BG_P!1-_URD_\ 0#4M13_ZB;_K
ME)_Z : /R#_8[_U?QP_[*;J7_I3<5]DU\;?L=_ZOXX?]E-U+_P!*;BOLFMUL
MO1?D93WZWZ_<M@HHHID!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% "' (<JN%S\S(7V^@'N3QBLR&UOX]:U*:>\BN+&\@LY+"T9/FM&@'[
MX2+UC\TGY<_>_*M3J-KH[1$@L4."K@_NR!WPW/Y5Y=X9@UM/BI\4;V^-[+X?
MN+#PQ!X>65G\L7*18O\ 9GC[V,X[T >HYSSC&><#MGM^%%!!'!&".".O(X/-
M% !1110 4444 %%%% !1110 4444 .7+,(P%Q)D,6Z@ 9^4_WLX^M?.OC;]E
MKX*?$7XM:7\</B!X=;QGXR\/^'QH.BZ?X@)OO#6FBQ/VBWU*WTEB(H]2CD56
M^V,&W8QZ5]$': 79"X09'S% "> 2W8#.<^U68[.[GAN%@4+(;*<M\RR[XPA8
MMN)^Z02* /QQ_P""7) ^*7[9\1%M&X^,.MK%&808?+69$14VX2, *JH,8X %
M?L$4$;MN@>%XE9S^\R-ZC*LB]@#CC\*_(?\ X)96\S_%#]M=5MR(X_C)KC3F
M3;P?M*;-C$C #<C' /TK]6_%/C'PIX$T:XU[QYXIT/PAX?2X^SW6N^(]0BL;
M"V);$0EO9CLB64@A<GYL?D ?GK_P5PE\71_L+^/)/"B7D]_-JVCG5)[$2!XM
M",N=4>54&XVZQ?ZUSA57K[]=^PM\<OV4XOV4_A)IW@KX@?"GP7I</A:&TU7P
MSKNL:+H^H'5HK18_$%Y<PWK&8"^N-TBLYQ+U K[6NIO!?C#PPD.H3^'?$O@C
MQ9 EHL]W/!>>&=:TR]7:BP7+GR)END/[I5/[[(Q7Y@^-O^",7_!.JQDU_P"(
M?C/P]XG\*:4MQ?:[J%[-X\DTSPW86P=KF80Q@B"UL PV10C*I&0@XYH ^;_^
M"?7B3P%I7_!1K]J;P3\&M1LM6^%'B.TN?$L)T=U72CK\7F_;;FU*,T-S'YY<
MB2'Y2"".U?OI]3^/-?@O_P $NO W@_Q;^U/^T;\<_A3H:>'?@WX;B@^&W@B"
MRMB+#4XK*!K0ZG9W*_)=1W1C$TMTK$2EMYZU^]%*49N+DO>44[4W?67\WJD)
M\[Y?9Q55PDI5*4G9*EI>:>OO7LK::-;G+^,O&/A?P!X:U;Q=XOU2'2]#T6TD
MNKZ:>41&2.-2R00;B//FE<!%B7YANW=*_F(_:S_:7\1_M)_$"XU65I['P-H4
MTMIX.\/>8RP"VC?8M[?H#@W3J-XE<<J0HZ5_1A^T1\%-(_: ^&&K_#S5KZXT
MZ>\$MQH5W 6"QZQ'&6A%RHX>!R$7#?*"<XX%?RQ_$SX9^*_A#XWU7P#XSL+J
MQUC1FD2(S;A!JENLC)%<)(1MFB,>UT<'"L=M?UG]&K+>%<5B:E;'UHXC/(7]
MCA:T8J-/2+;B]6VO.-TDEI=W_@/Z:&?\;T*6"RW+*%; <'XE1^M5J$IR=6IT
M]JK+EBFM==EJNAP3,VZ-F N'0856&U1R,?@,C\OPHVLGRR-NE)+,%Y15.-H!
M'IGV^E%%?VDY<[]B[34793E%*W1:6Z*]GY)['^;U7ZQ.E"->;J1B[N=%<BFE
M;23BUKLW;9[A7Z%_L6?#K0?'_P *OVH&O?!5MXT\2Z1X-EE\*"XL3J6IV%^;
M0^4=%B7,JW)?YD\M2Q;M@D5^>E?IK^P%JVJZ%\(OVN]8T'4;C3-=L? LEUIN
MK:=/LFMKB&S!C,#J?W$R'JPY!Y]J^ \3*F+PO".)^J5%]9^O95'#QA6JT4W/
M'8=2C4E1M/V;NE*R;Y;^5_TSPCI9?7XUP\,PARY6LISF6*4Z<*\H>SRZK*-6
ME&K[LJD6N:*=ES).]SDOV#/@5XFU#XXP)\5O@UXBE\)KX(U27=XR\*WUOIBZ
MG%:N8WFGN8TCCNT=1Y#$@@#.*[+]FG3/!F@?#']LGXA:EX$\&>(K[X=>(M=D
M\-#Q7I UBSTH07LR16L$)90+<<#8#C !^L'_  3H^,7QB\:?'FWT/Q;\3?&O
MB_2Y_ FN3RZ=K&O2W6GO<M;2G$T3@*\J'A)"<ICCTKM_V4_$>K>"?@]^W;XC
MTK3=(U+4-(\2^()++2_$>G1ZGHTDRWTY\O4+&4B.\AQDX;(.!7Y9Q-BL^CC.
M)<)CJ=*..Q>%X/HX?"X/,<9]6A"68RA)1J54I+ZP_<J24'%+;FM9?L_!N7<+
MK"<)XO!UW7RVW&F*Q6*QN"PD<744,NA.FWAX.49^P:<Z7/)-MZ=&?!^L?&^V
M^-,WA3PWXT\._"WX7>'#JUM<ZUXN^'7A(66J0:7M$EQ;7,5N[27-O+#NP@ V
MRL#GBOM#]ICP_P#LX+^QYX+\3? 7PK%8:3IWQ&_X1X>-]1M,^(?$ACTTS37U
MY(_[X02W19%BDP%0*<+E@?A?QQ\6?''QT_L+2V\&^"K748HPNGZ=\//!,&A7
MNKWK*-UFPMB6E.=PCCQR #7W)XM^#OQ;G_X)^^#=!/PQ\:_VW;_%&YU"YT!-
M&N/[5TZP.G,!J%S8@^8UH'_Y:$8//3H/0XCPE#)*'!L,5F,\HS"CGM"$\JI9
MQ4KX1PK5[5\36JU/95:]ERV4[T*2E)*"D^=^!PE6GQ!BN-U0RB'$&38C()*A
MF%7)\-AZL:]"@_JD82@IO#U*<KMRIOVE1POS6O%\%\,-(\)? #]EB\^/^O>
MO#OCSXD?$+Q#)X4\)VGB^S34O"^AK8K]J_M)-/D(662= $;8<G..F14'QP\-
M^"?B[^S-X._:@\*^#="\#^+]*UVZ\'>/=+\+V0TWP[<26P/EZC;:<K,MK-/(
M55F)^=>/>NT?1_%/QO\ V#='\%^$]+DU?Q_\%/&]Y=>(/!^F0"[\3+I<\?V6
M&_\ [#0^?EIB(SCH1GL<9'Q%@U'X)?L+^&O@YXPMCH_C_P")OC.\\2W6@7R"
M'5=-T';YMG>:A9G]Y:R-(,88<$8Z9KBPM>E7SJABJF,K/BBMQK]2K8*EC*\H
MT\DIRJTXR=#VBC2P\Z/L:RFJ7+.?LY.7ON3]3&Y7'#Y-F>7++<+'@FCP;]:P
MV-]C25:7%$L+3E4HO'V6(G4ABW5@J/M))KF3A:.GQ?\ #3XO:E\)Y=9O]&\&
M?#WQDVIP6XFB\?: NM6UG<0Y(^Q1.R_9]['YST?&,5^D_P"TK\4]%^%/PU_9
M^\5>%O@;\"(M9^*6@W6J>+'U#P+%<VYOK>!9$_L^'S/]'0R,3G/&?2OQ_G<-
M:R*\L?E1++$S#Y1=^6OWPV>H."6[<]Z_2?\ ;?S'\$OV0/,#*R>#+[(_UN(I
M;*-E=B/5"IW'US[5]7Q_D&"Q/%605:$L3.69XJ6%Q4(8O$T[PH8&L_\ EW5C
MI%PA)V5DXQOO<^&\..(,QP/"V<X!4LMJ5*%!U<+.O@,)4K<TIT_=52=*<[KX
M>:]]/,[E?AQX[^/'[%?PTL?"&F>&;&\D\8>*]=U*6]NK7PUX3TR.74C(+%+J
MZ BM4;<5MX7?)  7';X"^)OP*^*7PD\2Z3X.\:>'D?6]=%M)H T20:S::TMV
M5\F/1KBT!2]'S@9@SA>?<?5'CJ_U6S_X)U?"BRLM0O;6PU3Q;JYO([>X86^H
MB/40(O.C0C?L'W$/ICFOIZ;7M T+5?\ @G+K?C'4X;2P@M+Y&U/5MLD$$BS"
M&W\^[D.+8(66*)W_ -5E<=*^-PW$F<\'PE]3J+$X6OC\]P]+ ^QJ3K0EAJN/
MQ$:GUN4YNI.M5PTX2I>S]U5(S]HYQE!_9OA/(>/%+#5J\,#G&&HX+$8O,^:%
M&C3A..'IO"PH0Y8<K56,N>]W;D4-4U\'ZK^Q-^T)HVC:GJUSHOA6Y?2M(CUC
M4?"ND^*M/G\66NFS1)<AW\,1$Z@M[Y3[C#L\P*'X^4UPWPX_9H^,7Q8\.:CX
MK\":%9S>&=/ULZ#J5SK>LP:5;Z3J<4>^6/4S<C%A;Q_=DEG8*LA"'!.*_2/Q
MK?6GPF_:4\8_$_0/V,_C5XN\<:?J%Q?VOCK2/&U]J?A+Q79WL$XM[@1QC[--
M8?8Y_,CM_NQ)M3L*\KTKQ-<:W^Q%^TCK^E:?>^$K37_B_<OJVC1RM#=VPN8C
M-=Z==@'=*4N&*NA_N@Y%=&5^(W%.-GA\+1J8.-7,\3@,/#%UJ&'C2P\L7.I[
M:+I8;,,7*7LXPA*C5JU*#JRFX.BE&349]X7\+Y<I5L92=+ZE@JU98# 8BI6I
M8E8=0Y<8Z]?#4?92K2DHSIPC65-/F4V^5/Y TK]EGXP:YK7B+0=+M/###PFL
M<^IZ[=^*K"+P-%=3.L36=MXF<_V?->(&W&!'+A>2*YGXA_L_?$[X6:QX8T#Q
M;I-E'=^-IK*/POJ6C:G#J?AS5GU"X6V@BAUJW!M3*\KXDC#%HH_G;CI]8?L^
M_!3P]JW[,'B[XCZ]H7CSXWZ='KYTNW^!/@37+G2A!=>5ODU[5(;?YKB>6/,2
ML^2'(.,@9^C?VGM%TC1OV?\ ]B>UTCP+JGPZMU^*VEM!X.US5#X@U;1;8S6I
M%EJ$[_O8+]"S>;:O\T2L":[Z_B3G%'B:GPY1S'ZS)8O$X&M5_LZC2I1GA\OG
MBW7C5EC)56IU:7*X?57149>YB)V3>$/"W+LQX1EQ)/#8;"T89?@<PH4O[0J2
MKSGB<RIX*6%E2]A&#]G2G[;VOMU-R3C*BCX=7]A3]HV2::RN?"_A?3M6MI;Q
M8=$U/Q/866NZA':PK,9=%L)<3ZC'L8&"2!6$K?*O3%>2R? 3XL#X?^)_BK-X
M=6+POX*UD^&_$DSWD<>LZ5J$<P@D\[3F N$0N1M=@ PY'O\ I[\=O@M\>?$/
M[<7PX\8:7'K=_P"$[?4?#UW;>+--FDU#1/#&E:6]M/JMEJ%U&1%I9^SJXGAD
MR54G=5?PK\3/#?C[]K3]HWX$6JV \'?&FTU?1],OI+A)-/@\9Z5"B6.J109\
MN87MVQ(D7.<=<\5RX;Q#XCKX)8ZC6P&:^SRS!YMF'L*$H1P%*6.6'QF#;C7G
MSU50YJ]&I.--P<7S4IQO(Z\T\+N'\)C\+EN/I8K K&YQB\CRNK&JIRQKI8..
M(PF*G"48JE"I7E&C4C&52/+=QG&3LORVC^#WQ!D^%<OQI73+7_A6XU.+0Y+N
MZNHTOK_4)W\N%[2-OGD\IN)0I^7.&ZU[!^Q-\/K+XC?M#^"=.U2**ZTOPP\_
MBG5[:Z42VDUOI22.D-P.C)PI96ZD#/(P?;/VWO*^"7A'X8_LA:3,D\_@"TD\
M2>,KBWD$EO?:OK0%U!-'MX'E-T0CY-Q&>]8G_!-B[MK?]H#5K)R&GU?X;>)K
M&RC/6>_GC9E9<]67! [\X^OU&+X@S+-.!\\SVGR^SJK$T\N]DM:N58A^PHX[
MGYV^>=%O%)KD44U!I.#;^"CPAE^0^(67\..C5GB,(H5L96DY35',\*O;5,(J
M:=ITU.,:6JO+5VUT] _9[L/#'[0G[77QD\1>/+&S\7ZUX:L_$][X"\(7TD5O
MIGB&^T*[N;31]+>%ML<MI%;JD?V7!+JGMS\P_&OXF2>([/\ X0SQ[\!]"^$_
MQ!TWQ@SZ)>^&=!;PE;OX934O(DL;K3)3YFIRR-_R^H-CJ<C(:LCP?\,/C#XK
M\?\ Q+USX23S1^*?A_X@U_4;FPTG43I7C&2.VU*8NNAZ>F;C427'S+%]\Y'7
MBONCXCZUXA\??L;76M_M8^&(=#^+.D>+-'T[X3ZKJ]@NC_$&_P!,AEAW_P!I
MQ./M=S:&;*22R?*S@=Q7R&-EALHSO)<3AJ]+-J-3+\@P5++*>9XBEFN!E[/E
MG7P^#IR5.OA*J:G632E%>]%RC[J_1<BH8SB3*<VI?5YY)+!9OGF85LPKY1A)
MY5F;A.-2K@L7B:BYL-B**4EAN52C5<N5I2LS8^/@\2_"31O@S;?!;]F#P#XP
MT_7/AU8ZQXIUN]^&-QXJFEU9O+#B?4+<E+>1P3(Z/\W?H*\X_81A\&_$3X__
M !9\1?&3X;>#YK#3/"IU'6?"(T);+2/#WEN_VJ2PTR8G[*\<,;&13R!GH>:]
M&_:[B_:A&E?L_+\%X_BPN@R?";34UN'P(]W+IC7;^4I6^6V!7[<Z-RS'>$/M
M7EG[ -AXDL?B)^T38>,;/4;/Q#!\,M8BUVUU]"=8AU"6UN?,2_$N'D<@[CNZ
M$]C7C81^TX0XJKK$4?KM3%XZ%6>$S3%SS-86KCZT9+%4_:VH2I25.-&=*[YI
M:[)/V,?/%8'B;A.O&A0CDU+!X;&5*&-R;+J6 JUZ5"A.$:%:-)NO&O9\\*B?
M-&UTU*5MBW^ 'A#PW^W+X!BM] T[7O@;\6TO_%G@_2[NR\_PS)I=VF(M,MT;
M]RUYIS!Y-F]BN 2"!S\X^(_B]J/P>^+_ ,7O!?A+X4_"GQ-8GX@ZI8Z+9^*_
M"B:M=V5JTRK;6-BVY2MNI^6.)?7 S7Z"_P#!-[QIH'QET"Q^$GC?4H#X_P#@
MGK^L>)_AUJ=PR&1M%U*ZFBN-*LXW.9%M8 6DB0_NEPW0&O'?@K\!%\9_M*_M
M'_&_Q+H6J>(?"_P@\::[J&F>%]-@-U?>+O%<+!M+@MXU^86UM=H#/&,JZ$@\
M"N3"<04\%6S+"\05<PJ1RG)Z5"I1^L8F,,7*KB?:977YI58QB\3&5.-27/S0
MK*49Z*RZ<=PM2Q:PV-X,I971H<39Q[:ECWA<)4KX!T;K-:3H.G)2IT:D[TKK
MW:7+*$8IF1^UOKWA3P-^S]X&\$>)_AE\,=+^/OCV*W\1ZO=^"_#L.B?\(KX=
MD)GTZTD 9G2\OH28W)(P1RNX9KG/V-O"7PR\!> 9OC9\9_"ND>-O#_BSQCHW
M@+P]I6MVJO'8V.I,UOJVK*LI422:?-MQ(">I((X(^;_C/X9_:3^*OC_6/B+X
M]^&'CO29O$&KI96IU3P[<VVGZ9:W4WEZ3IT<CG9LM8_EB(&%P<=Z^Q/VA?%7
MP"^"?A#X2_LW_$'X5^*_B#?>!= L/%U]<:!XSD\+BUU3Q%&FHSQW\4>[[68I
M00@<Y0<=*]V4Z>&X0R[(<!F6+SC$YOC*V99BLDQDL3B\)@U&,\6J3Q%>G&G&
MA.>%PJBJT*BA4=:*YXR9X-#VV(XOSG-\]R_+.'L/PY@J6"R>KG6$IX3 XO,D
MH0H5*TH49NO#%<E;$^_2G!/W$N6R/@[]H[X:O\*?C+XU\'""5M,DU,:OH$S
MFV31=99[S2XK0=%ACM6C5<$A5QSWK#^"EA9:U\8?AQHFL:;;ZEINI^);"UOK
M"<B6&Z@,BJT<RCJK#JN>F:_1C]IO5/A;\6/AE\!?VJ)/AEJ^H^"K6RD\#^)?
M"-GXC-IJ5I+:.+32VU/5P-]S+]FC CD?D!<@\FODSP5XD^#.N_&GX-0?"SX6
MZ[\.;B#QM83:G+JOBAO$AU)#,-L$+L!]GW+SN' K[G(N+,3F/#.7Q^J9I&M#
M XS#9MB*SC'"X6OAG.BJ5:<L2\1&O4<(5(\M.2?M(7FH-R7PF?\ !&'R_C3Z
MQ#'957P&.Q6%Q&"PZFW+,E7A3J5)82,:7LI4:<^9*,IPLHV]G=-+[?UWQOX0
M/[:A_9A_X43\(M0^'M_>VGAQCI'A..#QEIR7FE">348M5#DB2W9C*)0,+MZ=
MJ^=_ W[+'PWUG]ISXX^'];U;48/@C^S\]YXAUF6"8R:SK]K&'GM=,BU!< /]
MJ"VLJD<PAD-?8_B[X\Z;<?MI>,O@1\0/"WA71O#GBNSL_#?A[X@>&],@TCXB
MZ#JMW8126^K'Q7"3=/OD*6Q.1A'*]#7SE\#M-/PK^,_[2G[-/Q.\1QZ'??$/
M0[GP]X<\9>(KD+9ZAJDDTEWIKWFJ2D+-+?QRV\'F-DF63/7-?DV08S-\+E69
M1C4Q^72K<-8+%**QM?%U,?0JX^E''9O0J5')T,30PDJB4:46X_NW^]_=(_6,
M[PG#F.Q7#\JT\#F%/!\25\*[X6A@O98F&63GA<NJ4:*<<32GB%3LZVDI.2:7
MO->*-^UYX9G\1:K82_L[?":3X5S'4-,TS3K#PY#9>.4TAT>RM;I?$9D(35E(
M-P9RN[S"&[$'U']DCXO:!X_^-?@WX-7/P6^$<OP^OY-0AM;?7/"L5_XT%M81
M^?%<:GXA+@7M^P9M\NSL"PKY>D_9(_:*M_&>J>";CX9^([*>RO[JV3Q-<VDD
M?@U88G:4W9UU@+;["UN1,E]]T9R!\M>E_L4:-=^'?VQ/!7AV]DLYKO1+W6;&
M^NK"[2\M9)HH4#2Z?J2_)=P,V5:=/E8;ASC%?H68Y3PM6X8S191F$<=6> J9
MGS4\VQ5:I0JTJ4I7=..(:=75QE*3C.46DU9*WYMEV<\=X'B[+8Y[DN&P.!K<
MV'?M,EP--3H.3]G*4W1N[Q47>SVOJV5OCM^T#JFD_$SQSX0T#X:?"/PIIG@/
MXA-<:+J7ACPE'IWB@1Z'>++9AKW>Q9E/_'Q(5VS"O2/VOO!OBC7OBY\'/B+\
M-K6]'B?XV^$O#4VG-I'^B77_  D4=H!J%P612 GFL"\H7 SD\FOCO]H1C_PN
MSXQ*@VNWQ"\01@RKB>5!<CS42?G="03M/3'KBON;]LS5-4\#?"/]CVUTO5KG
M2O$>E>#KW4X=6L;XIK&GIJ$"36<?FIB6)-ORQYP#CCI6%#+X8"7 E++J<ZF/
MS*ACZ56E6Q%6=*HJV6JLZU1RE*I*,*M.D^3X4IRDES-,B.9X?-8>)+S*I"&%
MR;$994PM3"TX4:MOKT*?+AW25.,;Q=FU9V23LCA/CIX5\;_!;X+-\#]1T#QQ
MJNKZUK5IXR^*OC*]TV^?POINHD^?80:7J4JFWEG9"3<R02 -("V*^ UVA0$8
MNN %<]67'#'W88.?K7H_B'XO?%WQ1IJZ/XE^)OC/7-&N"))M*U?7Y[ZQNIQD
M*LL#C &<X4YQ7G.,'&T*1P0.@QG@>PZ#_(K]-X4R7'Y3EM?"9EA\#*OB<1*M
M6K8>551E*7(K\M5<RE9*"3<DH1A&[L?EO'68X',<=@<9A)9AB:="E"G1HXKE
MG))):3E&4HS5]4FM7S-I7T7WX_S['_"DY]1^7O\ 7_/KCBCFBOL>:G#DA#DI
MJ,81Y8VDFU;6_2]K,^-DYJ5ZD:RE-J?+&"IQ2;3BE&-DDM=>NFHN3[=?0?Y_
MI2?E^5%%"FM&IQZ=NC7];=?OE25_AQ'1=>G+Y^3_  #GV[]O_K_Y[8HY]NW;
M_P#7_GKFBBDJB?VUTZ+O']?S&I+33$:6[]X^?D_P\Q<_3\A_A_GM2<^W;M_]
M?_/?-%%/G2^W'N]GI>/K_3^]*273$?CWCY^3_JX#/M^7_P"O_&ES]/R'^%)1
M2YXO7GCYZ)?R_P!:=_6YS)[K$:[[_P!WS\G^ <^WY>_U_P _3BCGV[]O\_YZ
M8HHI^T7\\=6ULK7]V]OT]>H^9=L1K>^_51OU\G;Y;ZBY^GY#_#_/>DY]N_;_
M #_GICK111SI?;C]R?2/K_3];G,ETQ'X]HKJ_)_@'/MV[?\ Z_\ /7-+GZ?D
M/\/\]J2BA37\T7MO;M'^OG]ZYEI[N(TL^O:/GY/\/,.?;MV_S_GKF@9]OR__
M %_XT44O:+1<\7MT796_KSU'S)=,1T[].7S\G^'F+GZ?D/\ "D.?;\O_ -7^
M-%%/G6GOQZ=O)_+_ (/WI25_AQ'1=>G+Y^3_  #GV[]O\_YZ8I<_3\A_A_GO
M244*:?VX].B[K\_U7S.9::8C1)=>C3[^OX>8<^W?M_\ J_STQ1S[=NW^?\]<
M]:**7M%_/'3>R7=>O5?<_O:DM-,1IZ]XM]?7Y6\Q<_3\A_A_GM29/MU]!_G^
MGM113YTOM1_!_P OK_PS^]*273$?C_=??R?X!S[?E[_7_/TXI<_3\A_A244*
M:?VXOY)?R^G],.9/=8C7??\ NWZ^3M_PX'/M^7_ZO\:.?;OV_P#K_P">V***
M/:)?;C]R:VCZ]/S'S)6TQ'X]HI[OR?\ 5Q<_3\A_A_GO2<^W?M_^K_/3%%%'
M/%:\T?N79?IWOJ^^ZYEIIB-/7LEW\G^ <^W;M_\ 7_SWS1^7Y444<ZT7/%[;
MI=E_7JU\WS+33$:-/KT27?U_#;47)]NOH/\ /]*3GU'Y>_U_SZXXHHI>T6BY
MXWTZ+R_KY@I+33$=._3E\_)]>WF+D^W7T'^?Z4GY?E1134UI[T>G;R_KY_>E
M)7^'$=%UZ<OGY/\  .?;OV_^O_GMBER?;MV'^?\ /-)124T_MQZ=%WC_ %\Q
M\RTTQ&EN_>+[^3_#S%S]/R'^'^>U)S[=NW_U_P#/?-%%/G2^W'N]GI>/K_3^
M]*273$?CWCY^3_JX?E^5+GZ?D/\ "DHHYX_S1Z]O*_\ P/7KU.9?RXC7??KR
MM]?)V^0<^WY>_P!?\_3BER?;KZ#_ #_2DHHYT_MQU;Z*U_=O;[OQZ]7S)[K$
M:^O]WS\G;_AQ<_3\A_A_GO2<^W?M_G_/3'6BBCG2^W'[D^D?7^GZW.9+IB/Q
M[175^3_ .?;MV_\ U_YZYI<_3\A_A_GM244*:_FB]M[=H_U\_O7,M/=Q&EGU
M[1\_)_AYAS[=1V_S_+Z@T#/M^7_Z_P#&BBE[1:+GB]NB[*W]>>H^9+IB.G?I
MR^?D_P /,7/T_(?X4G/M^7O]?\_3BBBGSI6]^.MNU^GW>?JK^8I+MB/L]^EO
M/U_#S#GV[]O\_P">F*7/T_(?X?Y[TE%"FG]N/3HNZ_/]5\US+33$:)+KT:??
MU_#S#GV[]O\ /^>F.M'/MV[?Y_SUSUHHI>T7\\=/)=X_?MY[C4EIIB-+=^\?
M/R?X>8N?I^0_P_SVI.?;MV_S_GKFBBGSI?;C^#ZQ]?Z8E)+IB/Q[Q\_)_P!7
M#GV_+W^O^?IQ2Y^GY#_"DHH4T_MQ?R2_E]/Z8<R>ZQ&N^_\ =OU\G;_AP.?;
M\O\ ]7^-'/MW[?\ U_\ /;%%%+VB_GCOV5OLW[]M_,?,E;3$?CVBGN_)_P!7
M%S]/R'^'^>])S[=^W_ZO\],444^=+[4?P[+[]/75]]US+33$:>O9+OY/\ Y]
MNW;_ .O_ )[YI<_3\A_A_GM244*:_GB]M[=E;^O/[SF6FF(TMW[1\_)_AYBY
M/MU]!_G^E)S[?E[_ %_S].***7M%HN>-].B\OZ^8U)::8CIWZ<OGY/KV\Q<_
M3\A_A2?E^5%%-36GO1Z=O+^OG]Z4E?X<1T77IR^?D_P#GV[]O_K_ .>V*7/T
M_(?X?Y[TE%)5$_MQZ=%W2_']1\RTTQ&EN_>+[^3_  \Q<_3\A_A_GM4<GW&S
M_=/08]/ZBGTUS\C<=N_U%9UIVISM+5*_N[[QV>K_ . _F2ZD:<7+EKM+7KUY
M;[/R?X#D_P"/FTX_YB.E_E]NML?Y_P *_LK\*$_\(?X.R<8\)^'AC'3_ (E-
MKS^E?QJ)_P ?-G_V$=,XS_T_VY_^O_G-?V6>%?\ D4/!W?\ XI+P[^/_ !*;
M7G\3FOX^^E&Z-19-+EE.57#U>92<E::G2Y;==HOKU7<_T)^@]*-/$\2QP<JT
MIUHTW)RYKQ7+"ZZ]6N^O?4W****_CVE3Y*-)\G)[2/-:[?9;O4_T@E9<L;\T
MHJTW;[79^:5@HHHJB HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R=<M
M;Z\TXP:;>)8W;75FPGDX3R4F#3QYZ!I$&U1_$>!C%:U>7?&:UUR\\ W$7AI;
MLZT->\.2P?8W9'^RQZG&U]O*\E/(S[=?>@#U*0E T7R&1) FYXB,18^;/H'Z
M#/L/8AQGY0 O\( P .V!VXH=L'"+(DAAMS.9R6R5C7/7OG/?@CZTF<\\<\\=
M/P^M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$X*X5
M"=XW[EW,T1ZJOKSR12T;G!785#*V_G&X@<<?C@4 96JVM_=3:3<65Y':V]MJ
MJM=H4(^U6?EG-O'G[[[_ .'&0/85K'J<=,G'&/T[?2O+/B/::Y=:Q\*#HB:A
M_9]OXZ6Y\1?9Y&53IHM7#[P/X3+Z\>M>JR$>8^W[NYMN>N,G&??'7WH 9111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YW\6_^22_
M$7_L4]6_]%K7HE>=_%O_ ))+\1?^Q3U;_P!%K43V^?Z,#M_V"O\ DUWX<_\
M7#4?_2Z6OL6OCK]@K_DUWX<_]<-1_P#2Z6OL6LC=;+T7Y!1110,**** "BBB
M@ HHHH **** "HI_]1-_URD_] -2U%/_ *B;_KE)_P"@&@#\@_V._P#5_'#_
M +*;J7_I3<5]DU\;?L=_ZOXX?]E-U+_TIN*^R:W6R]%^1C/XG\OR04444R0H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!R@?.QR6"-L7.
M7(.TGZ'OVK(MVU<ZIJ4=[9QQZ<D%JVG3))B2[D8?Z4\@ZKY!^YG[WZUJY7^,
M[01M+#^%6X9_^ BO+O#>KZU=_%CXIZ)>SNVAZ/IGA:3P^#NV@W$.;LJ3\I\T
M\MMS[^X!Z@.@Z]._)_$^M+0.@XQ[44 %%%% !1110 4444 %%%% !1110 @
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MVJ_$?CGQ;K_B34_!7B'2?'NH>'DU#2M+A5M:T2UB1[1+B+ 65XG.][ULR2C
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MV7_#H+P9C'_"\?$V1CG^P+3G\Q]/Y$]:3_AT'X,S_P EP\3\C'&@6GK^6?\
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M^)5_%[_H6KIT]/+U_IL_#C=_LM^5&[Y9)&&V*%=TK'AL'IL7JQ/3C^E?N/\
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MO\*?_$?O#W_G]4Z?8E_=\O7]?M!_Q*OXO?\ 0M_#T\O7^FS\.-W^RWY4;O\
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M7K_39^'&[_9;\J-W^RWY5^X__#H+P;_T7#Q/_P""&R_PH_X=!>#?^BX>)_\
MP0V7^%'_ !'[P]_Y_5.GV)?W?+U_7[0?\2K^+W_0M73IZ>7K_39^'&[_ &6_
M*C=_LM^5?N/_ ,.@O!O_ $7#Q/\ ^"&R_P */^'07@W_ *+AXG_\$-E_A1_Q
M'[P]_P"?U3I]B7]WR]?U^T'_ !*OXO?]"U=.GIY>O]-GX<;O]EORHW?[+?E7
M[C_\.@O!O_1</$__ ((;+_"C_AT%X-_Z+AXG_P#!#9?X4?\ $?O#W_G]4Z?8
ME_=\O7]?M!_Q*OXO?]"U=.GIY>O]-GX<;O\ 9;\J-W^RWY5^X_\ PZ"\&_\
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M\*@?*8P Q;M7=3_\$>O!2H(HOCCXB9&\Q)P=$M0ZA#\LV>I8 =">>3VX<?I
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MBBB@ HHHH **** "BBB@ HHHH *4<]\;#OSCJ.FW/;/?_&DH)"JQ8?+C!/\
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M")]H94VR!5+;<9^;</EYSUQ6/H%XVHZ1:WYTM]&%PUPHTYXEA,)AF:-G\I0
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M!QGG!/&>M'/'^]]R\O/U^X?++S_#R\_+\%\OWPR?[J_FU&3_ '5_-J_ X_\
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M&4^%?PZ<AG4H)M05@$ZO\P'RGJ#CI0O_  5P^,SAC'\*OAU(%ZD37Z].I&X
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M?Y^O]/0M+^]_5O/^K>3M^^.3_=7\VHR?[J_FU?@=_P /</C-_P!$I^'7_?\
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M^.3_ '5_-J,G^ZOYM7X'?\/</C-_T2GX=?\ ?^__ /B:/^'N'QF_Z)3\.O\
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M/]A/S/\ A1C_ &$_,_X5^!__  ]P^,W_ $2GX=?]_P"__P#B:/\ A[C\9O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ IW.TL-YP?F1 #N7OU[_P"%-II
M+ \!L$ L2!],=._\J ,G5[R>SN="A71Y=2@U._\ L23&&.1M.F*E_MCL<F-0
M!MW\8X ]*V2,$CK@D?D<&O.?'?BO4O"^K?#ZSTU$:V\9>*U\/7AE+$QVY@,S
M-:GG;/N'#''R9KT=AM9EY^5BO/7@XY]Z &T444 %%%% !1110 4444 %%%%
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M\(]9^(NK:IXF^&OP_P!;FNFT*ZG2_'A]+N&2VDU*P:Z$UP9K=93,$:1OFC&
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M QL(+:YD:?Y@.O% 'Y"=,<8&.![=!^) YI" 1@@D<<#J<'(_#(Y]LU^F&D_
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M2W_X4GI/QL\>?%WP;\+]*\1O>R>$/#>N6U]<>(_%IL)1$;>S>$^4B2R,J R
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MW)C-G>INT\KGC<$'X?A0!UG^>.GX44<=CD=CC&1V..V1V[44 %%%% !1110
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M%E/<-H5S:L+BRO;O28\7$RR3@+(BG. 3T-?G_P#\*>^,?7_A4/Q#S_V*M_\
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M4TOQ"UWP]#_8LNK>++B97_?Q7<4S7"0Q,R,X W;>.O'QS_PI[XQ?]$A^(?\
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M_P#_ !- 'G-%>C?\*?\ C'_T2+XB?^$K?_\ Q-'_  I_XQ_]$B^(G_A*W_\
M\30!YS17HW_"G_C'_P!$B^(G_A*W_P#\31_PI_XQ_P#1(OB)_P"$K?\ _P 3
M0!YS17HW_"G_ (Q_]$B^(G_A*W__ ,31_P *?^,?_1(OB)_X2M__ /$T ><T
M5Z-_PI_XQ_\ 1(OB)_X2M_\ _$T?\*?^,?\ T2+XB?\ A*W_ /\ $T ><T5Z
M-_PI_P",?_1(OB)_X2M__P#$T?\ "G_C'_T2+XB?^$K?_P#Q- 'G-%>C?\*?
M^,?_ $2+XB?^$K?_ /Q-'_"G_C'_ -$B^(G_ (2M_P#_ !- 'G-%>C?\*?\
MC'_T2+XB?^$K?_\ Q-'_  I_XQ_]$B^(G_A*W_\ \30!YS17HW_"G_C'_P!$
MB^(G_A*W_P#\31_PI_XQ_P#1(OB)_P"$K?\ _P 30!YS17HW_"G_ (Q_]$B^
M(G_A*W__ ,31_P *?^,?_1(OB)_X2M__ /$T >=,-N[E3M7<=K \>@ Y)]AS
M2 @C((['&><'VZUWMS\)_BQI^QM1^%WCS3X#(D4$LOAB^'VB\N.8(.4^\YR
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MCGT%<]X3.AG0K7_A&[G[;HWFW9MKOSC.LLAN'-R!(>OES[T([$8H Z.BBB@
M_P#U$'D$>X[TBJJ$E%"'!'RC&-PP<>A('-+10 <C&&8$ JQSS(IXQ(?XPO\
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M.>E5=*_:,_9GL=+LM/M?C7X"CM;"%(;59O$(\TQ@EL/E.6R3DG\:+P\ON_X
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M]W_ '>?]_P#'^NB^X]W^VW7_ #V;\E_PH^VW7_/9OR7_  KP@?M,?LXD.?\
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MX1_PTQ^SE_T7#X=?^#Q/_B*/^&F/V<O^BX?#K_P>)_\ $47AY?=_P O/^_\
MC_71?<>[_;;K_GLWY+_A1]MNO^>S?DO^%>$?\-,?LY?]%P^'7_@\3_XBC_AI
MC]G+_HN'PZ_\'B?_ !%%X>7W?\ +S_O_ (_UT7W'N_VVZ_Y[-^2_X4?;;K_G
MLWY+_A7A'_#3'[.7_1</AU_X/$_^(H_X:8_9R_Z+A\.O_!XG_P 11>'E]W_
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MZ=*+P\ON_P" +W_[WXGNWVVZ_P">S?DO^%'VVZ_Y[-^2_P"%>$?\-,?LY?\
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M]>7N;S?\H$8("L S;.0,]=53O <9CC9_)02<.\Q. H _A/KBOR-_;Q\4Z_\
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M';K2I9VDAE=[-9# HED,4$ 5F8[ CH.,@C<5 )ZGUKW_ ,5_ GQ)H'[0^I?
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M:/L-G_SZV_\ WY3_ .)JU10!5^PV?_/K;_\ ?E/_ (FC[#9_\^MO_P!^4_\
MB:M44 5?L-G_ ,^MO_WY3_XFC[#9_P#/K;_]^4_^)JU10!5^PV?_ #ZV_P#W
MY3_XFC[#9_\ /K;_ /?E/_B:M44 5?L-G_SZV_\ WY3_ .)H^PV?_/K;_P#?
ME/\ XFK5% %7[#9_\^MO_P!^4_\ B:/L-G_SZV__ 'Y3_P")JU10!5^PV?\
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MO49#>PZ]:;TX P!V]/;\* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP3[CK248(X)R1P3ZD=_QHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *?&P62-F&55U+#U 8$C\13*4$*02NX @E>?F Y*\>HXH \O\
MACX?UK0)/B$NN!C)KOCG4M:T@NY)31[B-5MHUW-PH89XXKU## !6.=J@8],?
MIS[5CZ9#JUJ+Y]6GMKTWNIS3Z>\89AI^EN (+"3;]V2)@20<$9Z8K6#9R RL
MJ'8"%9<D=3SP?3UH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+P?X=^+?B2P\+6=H^GVVC01V4D8L;I?):-+ZZMY+Y%"=-EP"IR5(H UOVP/
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M'#;L8-?6_C2>\_9G_9;_ &;?AQXW>RM?'.H_&&P^)OBSPU<7$-SJ?A[PO)+
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M(SCY01^1-,/_  2D_9CP8AK?Q-\@9:,'6XC*DN.'5\>OWO45^E-%')'M^?\
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M_P#!U'7Z4T4<D>WY_P"8<TN_Y?Y'YK?\.I/V8/\ H,_$O_P=1T?\.I/V8/\
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MN_Y?Y'YK?\.I/V8/^@S\2_\ P=1T?\.I/V8/^@S\2_\ P=1U^E-%')'M^?\
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MJYA6)^/-6#I)C_5].* -X=!_AC].U%!)/).2>20,9)Y)Q[T4 %%%% !1110
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M1()4/[R(,-ZCISZ4<\OZ_K^K^@'<_P##S_\ :Y_Z#G@[_P )>'_XNC_AY_\
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M_P#M<_\ 0<\'?^$O#_\ %T?\//\ ]KG_ *#G@[_PEX?_ (NO@'<_]X?]\_\
MUZ-S_P!X?]\__7I\\OZ_K^K^@'W]_P //_VN?^@YX._\)>'_ .+H_P"'G_[7
M/_0<\'?^$O#_ /%U\ [G_O#_ +Y_^O1N?^\/^^?_ *]'/+^OZ_J_H!]_?\//
M_P!KG_H.>#O_  EX?_BZ/^'G_P"US_T'/!W_ (2\/_Q=? .Y_P"\/^^?_KT;
MG_O#_OG_ .O1SR_K^OZOZ ??W_#S_P#:Y_Z#G@[_ ,)>'_XNC_AY_P#M<_\
M0<\'?^$O#_\ %U\ [G_O#_OG_P"O1N?^\/\ OG_Z]'/+^OZ_J_H!]_?\//\
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MC;N8+G/MG-1THSD;?O9X^O;]: //OA_XQU#Q9)X[^TVZ6_\ PAWCC4?"D&%
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MXV?'W4O^$0\-6NF;YKK0=,U!?L^IZ]<QQ'S((H+.X=TD;:N]!@YQ7Y\_M\?
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ML\=^(=)OM!OK&)'T;[#96BV]PNIS/B2*7>,A8^..]=]^SC^T?\*?!/P(\;_
MCXIS_$7P;#XCUB#5;3XB?">VB_X3" +"L36MQ?%HIETX=1"LVTOM8KW !Z/^
MT9^REH]K\-?@E\1_"OP<U;]GOQ%\1_&=EX"\3?#+5M4EU=-/O[NYB!UJ#4IY
M))@JP2;8XP^UL!CC->IPZ-^R+\#_ -J'X7_ &+X/7&K>*_#%UX<B\5_&MO$6
MH+JMGXQFDLKJ*73_  W@6%S#+)+';/D_+&-X.:\.^-?[6'PKU?X)?"OX5_"J
M3XH:UJ_PG^(=AXIB\9?$&:2YU/Q1IUIY4RWFK/-+(T%\\D?V=HHF*+"2X^;%
M=AK?[3?['OBWXL>%/VD/$OA3XE7OQ:TU-%DU_P"'T%A;1_#^YUK3C:QR:Q_:
MZXU"0Q1VZSVZG(>Y&QOEYH ^9?VYY(U_:[^-QV2Q&3Q?.4E0[[AE%M:E3- V
M%CW1;#_O$CWKY2&_<@B")."\]K<3*)F*_P 2B)\J&( R!]WDBOO34OCM^RUX
M_P#CI^T1\5/B_P##SQ/XET/X@P7+?#:PM=\6H:'KQMT2VN]12$C]S#(BJW4;
M%!(;&T_"BS117<%U+#!<11W1N(K"1W6RN[?S68V5Q.O[V%I(L1L5P0<XYH _
M66.;X'?\% ]"^%>B1?$*]^#7[2OPS\*VGA;P_;:NX7P?XQN=-@$&C1:;JTO[
MS2]3F;AS:%620C!R!4'P6\+?$#]G[X _MEZSJRRV?QLT;5M-\$:YJ]O(USJE
MAHNI(T.HSZ;JS-]L\C5%'F->!PS@ECG->'>$O'?[">@>)O!WQ8?0OBSX:\<>
M$X=+U"/X9:+8VUUX F\6:6/,AOI-;F/]I):7MP UR5(V)]WFHO"G[<&II\:_
MB=XT^(?@JT\5?#?XUQR:7\0/!D=Q,(H]&4-%:W>D/U?5-,@(^S;P#(^=Q[T
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M;507BDE.;3.0J],5X;X_\4)XT^(/CSQG&@C/BOQ/J&L64?,GDVUQ.3Y?FO\
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M$@\M2%BEDM!;;3U,967?YBY)7/!/6C_AB3]K7_HAWBC\9;/_ ..U_57Y\_\
MSVE_[^/_ (T>?/\ \]I?^_C_ .-'(O/^OD'M>T)?U;]7_6I_*I_PQ)^UK_T0
M[Q1_W]L__CM'_#$G[6O_ $0[Q1_W]L__ ([7]5?GS_\ /:7_ +^/_C1Y\_\
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M'*DC!KWSSY_^>TO_ '\?_&HR2Q)8DD\DDDD_4GK22MHC*;O.2_EER^MDG?\
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M)O#?B)=7\/#_ )_-5\DQBV;U4QG?CD9Z5U[$LS,>I8D_4G)H ;1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YW\6_P#DDOQ%_P"Q
M3U;_ -%K7HE>=_%O_DDOQ%_[%/5O_1:U$]OG^C [?]@K_DUWX<_]<-1_]+I:
M^Q:^.OV"O^37?AS_ -<-1_\ 2Z6OL6LC=;+T7Y!1110,**** "BBB@ HHHH
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M\.>(+"+4M$OXANCG@G0/'EQD;RK89>H.<T ;R!?O2,%&#N7^)2?NJ<'[V>O
M]J:1($#&, C[Y#J^">GRJ<@>I/XU0UB\;3M(U?5!927,FFZ7>ZJ]A;G_ $F_
MEM(&G6"# R9)C&%C0#<2P Z\?BGK7_!9+Q;H^M:KI*?\$^_V@;X:9=RVC:Q9
MV][';:FMO(T>Y(C;$^7-MW;AD;3F@#]NQEF=5PS1A&? (7RVY8J3PQ'L<<4[
MJ X7;&S,(VW*Q;:>Z@Y7\1SVS7X=>'O^"UW]J_$#X?> /$_['7Q6\!W7Q \4
M:;X:TZ\\47C:5%:C4K@6_FV\=W%&UZEKNWR^5G8!AO?]QF0(/E"@;VP1_K!D
M [)&Z/LS@,!@D$^M!<&U+2R>N]EOLM>[L,H)V(DCD>66_>,!_P >PSC,@ZL"
M.01V]:/\XY__ %4] [R3QP*KW2J#):MCRIHL99I,\+M0$DGL/F]PRHNCAX8C
M$8M7=-.7O=EKMI:WG;KYV8Y54=W=851'E#/]R6&,%GG4_P "*JL3GI7RWK'[
M;'[+^@:IJ.AZI\3(!JNFSM;7D-MIMU/%83QG$D<DT>Y+A@01MC)(/88Q7R[^
MW;^UPOA2SN_@]\,=15M?U2U9-=UNSF4R:-;L-L]I:SJ2(Y/OC &2,\5^*A3?
M'&/-6YDE=KBXDV%+JZNV;?)<O.Y)#[B=VX_-[9!KCJXGDGRIWVVU_+\OT>G\
MD^*GTC9<*9G5R_AO"X'%8RDJ;O4C.HN9Z<LI0ERJUK.-TXNQ_1W_ ,-W_LHG
MI\4$QVW:->@X]3D<=._TI/\ AN_]E'_HJ$?H#_9%]UXX]?7MW_+^<8[9"6Q&
M=V.3%C."1C'\_7Z&FB->F(_^_9X[<?G67UM]_P!>W]??YGY8_I7^(DJ%.IB\
MFR=R;C[-1IU'J[6Y[5&[-[WTTWN[G]'7_#=_[*/_ $5"/_P47W^>/_UU%<?M
MS_LEWD$]K<_$V*>VN8);>>!M'OBCQR@*^>,Y Z'(P3FOYPFFLT+!I[5=AVMN
MVKM8?PG)X(STJ:(P3!3#)#+NW;?+17SC[^-I.<=\=.O%'UM^7X^7_ _'S-)?
M2G\2(1C*?#V2PBW&,)2P^*BI-\K2BW))M[JU[_E_1M;?MR_LEV5O!:VGQ,C@
M@MXHX(T31[\#RX@%C4\'H/>IO^&[_P!E'_HJ$?\ X*+[_//_ .JOYQ=L>"=T
M> P!/EC ;L#SP?8\DTIA0#)"8YY,7'OSG'UH^N/O^?E_DOZ9C'Z5_'\GRQR3
MA]OHE3KWT<;Z*ITT3ZWT?E_1T/V[_P!E'_HJ$9_[@]]_AUI?^&[OV4O^BGQ_
M^">__P ^]?SB;(QCF/)((_==3CC'//'YBCRT)*Y0E1EAY62!U)(SD#W/;VH^
MMO\ J_\ E_7S8_\ B:_Q!<N7^P\@<NJ5.O?[/15+]OQ/Z.?^&[_V4?\ HJ$?
M_@HOO\/PI1^W?^RB?^:H1GV_L>^_SQ7\XOEIE?N9DY3]W]_CDH ?FP/3M[4F
MR/(7,>X_*%\ODGL ,YS["CZV_P"K_P"7]?-B?TL>/T[2R7AY.]G>%=?RZ?Q-
M_P M?E_1Y_PW=^RE_P!%/C_\$]__ )Y__5BD_P"&[_V4?^BH1_\ @HON_P"'
MY5_.*41<[MBX/S9B P3V//'M^E5Q+:%Q&)[8N25"J%+$KU&T'JO4^E'UM^7X
M^7E_6OF:4_I5>(LU*5/(,CFJ:7.XT,3)034=9-3?*GIJ[;^A_2$/V[_V4?\
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M=5^#[LJ7TK/$.'LW/(<BC[17I\U'$)3C%I.4&YI2C%[R5TG=7OHOZ.C^W?\
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M[FOYPXA;R[65)1');E;B"8@F.=0/N#'.3RIYR,8XI1%P!(4+ 8R8N=O8-SU
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MU_'_ /5VH\N/_8[?\LO3IWH^MO\ J_\ E_7S8+Z5_B"O^9)P_P!OX=?72/\
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M1T!C8MT!9<8!Y'>D^8<,"".H)R?Q(X)IY+'RS@JBQI&5().Z.-49BXX4/M)
M.=GO3 01P,#TSG'MD=: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "@YVMD';C!/4$]EV]??=TQP:*,\M@?-MX/7(SRNT<Y/][IVH YCQ
M'J/AFPO?"T>O-''=ZMK"V7A:-HW/VO6O+WA!MQY)$63ODX/2NH8,&8,,,"0P
M]"#@C\#7#>-/!EQXLU+P'J$=XEJ/!'B9/$EU$\18ZG&(6@%K"1Q;."2V]N"!
M@<XKNF;<S-C&YBV.N,G.,^U #:*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "O._BW_P DE^(O_8IZM_Z+6O1*\[^+?_))?B+_ -BG
MJW_HM:B>WS_1@=O^P5_R:[\.?^N&H_\ I=+7V+7QU^P5_P FN_#G_KAJ/_I=
M+7V+61NMEZ+\@HHHH&%%%% !1110 4444 %%%% !44_^HF_ZY2?^@&I:BG_U
M$W_7*3_T T ?D'^QW_J_CA_V4W4O_2FXK[)KXV_8[_U?QP_[*;J7_I3<5]DU
MNMEZ+\C*;=_3_)!1113("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ****  !7D6,[FD9'\M,XCZ<R.>@:,<H3C!YKG[&VTN+Q%KUU::K<7>I7<
M.GPZGH37HNTTE;=<6URMJO.G"^&6:9N)L9KH"HDQ&Q.PLI94.V1PIR%!ZA3_
M !<]*\X\.^&-5TOXH_$SQ?>QVZZ-XMT[P]9:&MK(!?.^D1>7>I?QCD0JW^I=
MN"O2@#T@]3QCGIG=CVW?Q8]>_6DHZ<#H.GTHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *<N=RX4L=PPHZL<\*/<]*;4D1"R1LV=H=2
MVW[V P)V_P"UCI[T <UH%EI-D?$ T_5+O5#<ZQ//JLDFI_;?[&N7 #:; !_Q
MX>3][[(>5'Y5T.[(7!W*JA4;;\S)U#/)W8]U_AQ[UYE\,?"NI>%)_B"-66".
M/Q'XYU'Q#HWDRB7=8W<2K$^H'HUR2,-&_P!SKTKTXY'R$C(Y8(,1;CU*8X.1
MC- "4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4?Y^[OZ?
M['\7THHW%>02".ZC)_ 4 -=HW%P9!*Y:&1;J.*3:L$.Q@9(1GY)%4F3?_P L
M]I]*PO"]EIUAH=I;:3JD^M:>)+EX-4GOQJ;W!>=FD3[:.)?L['RL?\L]NP]*
MWIE!MKI,_O)K>XCM?+^5Q)/!)&IG(^^NY_F0\8Y[5YS\)/"VI^"_A_H_AW64
MACU6TNM7GNEM9?-LL7NH37,!MF'"@Q.IE4 8?@]. #T>BBB@ HHHH **** "
MO'/CEXA^#GP]\"WOQ@^->AZ3J7A3X5N/%+:WJ>E+K=]X4GM]L:ZMH-H?G74(
MMP"&,%@#7L=<;XDU/X<WMW:_#WQK?>#+VZ\7@VUCX+\5R6LQ\3#'-HFDW/RW
MD#$9+]F&.U 'X1?MH_\ !2C]F/\ ;/\ A=I_[,W[/%]:>//'WQ5UW3]*T[5/
MB%I<?A/2?!-O<20+)KQU2_"Q0W/ELT<*YW,^U%Y-?M5^SO\ "F?X)? SX7?"
M2[O5U&X\"^&;'2[N:*02QW4KP)/)>0W XF'FR$1$?>BVL.#7Q_\ M]_LH?LF
M3_LS>/[_ ,4>!? 'PFN?#FFW6K^&?%7A[3-/\,ZK;>(+.-WM;:.ZM3YUZ@EC
M0PP]%<(XY%7/^"6WC[Q5XL_8M\#:M\1]>N=2M=#CO;'3O$6NS2?;Y_#FGR7
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MT^6O[0L_),5M-%* Z_90_P KQ(3\P>Y_CD7/)]/U^^?VB=4^)GP'_:5^+WQ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB^BR1*(9;%&8K_9P()5EQCD@>OJ@V;<PE3'DJ^&9MTP_UCJ6YV$]., C Z4
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MAD$8KG-8UC5O$=])J7B#5]0UJ]O$6#4=3U:\DO[Z>(\16[W$[M)Y2#B)22%
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M^\OYC_&C>O\ >7\Q_C7]''_#"'[)?_1,#_X.K[I^77/Z4H_81_9+[_"\GO\
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M!8&3!!.X$\X[UZM(07<K]W>VW'IDX_2@!E%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7G?Q;_P"22_$7_L4]6_\ 1:UZ)7G?Q;_Y
M)+\1?^Q3U;_T6M*2YE;;4#M_V"O^37?AS_UPU'_TNEK[%KXY_8)_Y-=^'/\
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M_P#B* (Z*D^S3?\ /O??]^)/_B*/LTW_ #[WW_?B3_XB@".BI/LTW_/O??\
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MWXD_^(H^S3?\^]]_WXD_^(H CHJ3[--_S[WW_?B3_P"(H^S3?\^]]_WXD_\
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M^!KR\O7^MH,_3\A_A1GZ?D/\*G\A_P#GUOO_  '?_P")H\A_^?6^_P# =_\
MXFCVL/Y?P7E_F_N\PO/_ )\1_P# UY>7K_6T&?I^0_PHS]/R'^%3^0__ #ZW
MW_@._P#\31Y#_P#/K??^ [__ !-'M8?R_@O+_-_=YA>?_/B/_@:\O+U_K:#/
MT_(?X49^GY#_  J?R'_Y];[_ ,!W_P#B:/(?_GUOO_ =_P#XFCVL/Y?P7E_F
M_N\PO/\ Y\1_\#7EY>O];4KAYUMYS:B$WAB=;(3Y6%KQE(MEE9/F6,R[0Y&"
M!SD55TDZN-/MD\0+:1^(K?<NIBR>22SAN7.&6)I#^]0JRA6<L0WI3M?:\L_#
MWB*[LX+V.\M= U>>U?[+(Q6XBL9GB:-0A+2AP#& "=X&.:Y3X67FL:S\,? U
M]K U.?5;_2([B[DN;26.[FN/-E\W[6'C5@ZH!M#@=!1[:'\O]:7Z=_R] O/3
M]Q'S]]>7]WU^_H=P#QPVXY^8E5R&[C@8X]J7/T_(?X58,-P3^\L;V,\;0L#'
M<F/E<X7[S<Y'6D\A_P#GUOO_  '?_P")H]K3_E_#T_S?W>87G_SXC_X&O+R]
M?ZV@S]/R'^%&?I^0_P *G\A_^?6^_P# =_\ XFCR'_Y];[_P'?\ ^)H]K#^7
M\%Y?YO[O,+S_ .?$?_ UY>7K_6T&?I^0_P *,_3\A_A4_D/_ ,^M]_X#O_\
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MR_@O+_-_=YA>?_/B/_@:\O+U_K:#/T_(?X49^GY#_"I_(?\ Y];[_P !W_\
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M[WW_ 'XD_P#B*/LTW_/O??\ ?B3_ .(H CHJ3[--_P ^]]_WXD_^(H^S3?\
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MG:W"&$Y*E0,\&FJ,* &+ #&X]6QW_&K4D5S)+$1;74CI!"3&MNZHP>!&0GY
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M\11]FF_Y][[_ +\2?_$4 1T5)]FF_P"?>^_[\2?_ !%'V:;_ )][[_OQ)_\
M$4 1T5)]FF_Y][[_ +\2?_$4?9IO^?>^_P"_$G_Q% $=%2?9IO\ GWOO^_$G
M_P 11]FF_P"?>^_[\2?_ !% $=%2?9IO^?>^_P"_$G_Q%'V:;_GWOO\ OQ)_
M\10!'14GV:;_ )][[_OQ)_\ $4?9IO\ GWOO^_$G_P 10!'14GV:;_GWOO\
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M  I]% #/+C_YYI_WR/\ "CRX_P#GFG_?(_PI]% #/+C_ .>:?]\C_"CRX_\
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MLHB(N8T6X0*,JDH5OF!K4O7>"TO+I'.^TM;B5$3A7:*)Y%!'7.5V]>0:\N^
MGCG6OB-\,]'\7>(#8-JNH7>L07#:6I2Q9-/U6[LH#"I9B"((8UEY.9@YXZ
M]A\N/_GFG_?(_P */+C_ .>:?]\C_"GT4 ,\N/\ YYI_WR/\*/+C_P">:?\
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M ,\N/_GFG_?(_P */+C_ .>:?]\C_"GT4 ,\N/\ YYI_WR/\*/+C_P">:?\
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MA3Z* &>7'_SS3_OD?X4>7'_SS3_OD?X4^B@!GEQ_\\T_[Y'^%'EQ_P#/-/\
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M7DNH:%HVH3[?/O\ 2M/OI]@(3SKNTBN)=@/1/,D;:.RX%:] #/+C_P">:?\
M?(_PH\N/_GFG_?(_PI]% #/+C_YYI_WR/\*/+C_YYI_WR/\ "GT4 ,\N/_GF
MG_?(_P */+C_ .>:?]\C_"GT4 ,\N/\ YYI_WR/\*/+C_P">:?\ ?(_PI]%
M#/+C_P">:?\ ?(_PH\N/_GFG_?(_PI]% #/+C_YYI_WR/\*/+C_YYI_WR/\
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MA3Z* &>7'_SS3_OD?X4>7'_SS3_OD?X4^B@!GEQ_\\T_[Y'^%'EQ_P#/-/\
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M?B%)\4_ 6E>-I-,71_[4GU2%=.6Y6[\@:;J=WIN[[0@57\[[+YV !L#[.V2
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MHLMG'4]L&LZYBGL[JZMKRW:UN+61H)K.5BMS;7$1VSP7$9YCEB<%9$;E&&*
M/Z"O^'YGA_(#_L\>*%!.,CQ7I3]>,8%F/7K^E9NJ?\%M_!FMVEWIFJ_LVZ]?
MZ5.@6^M[OQ/I+Q3*K*ZK(AM,-AE4C/<=NE?@&B$E \BKC)<@X)!R5$?9F Q\
MO>M'1='O_$.JZ9H6G(K7NO:I;Z=8S2G"27D\BQ01S(>(X69EWR]%)YYH _?B
M#_@N-X=@AB@A_9S\210PQI%#''XLTD(D,:A(D0"SP%6,*% Z 8J7_A^7H/\
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M>'O$7BB^;2_"VAZAXGU3[+)=#3=&@>\O%A0;GE:&(;@D(SYAYP1S6MHGP_\
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M<TF8 66HZ3X9O+VSOO66*= %\L=21D8P: /V\_X?EZ#_ -&[>)__  K=*_\
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MF^(]%M+=5M?#VOQP"YN-+M[Y/EOC!$Z'>OWGRG44 ?K+_P /R]!_Z-V\3_\
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M.Z$3/T=H_,V;AP<'UK7KF?!:@>#_  ECMX9T)1]/[+M/\*Z:@ HHHH ****
M"BBB@ HHHH *X3XBW/A6T\-M-XSTB37-#&HZ9&^GQ:9)J[->R7L*Z?/]CC!)
M%M=;)3,1B#;YAQMS7=UY7\8_B-)\*_!<GBZ/2EUGRM8T/2FL&N5M-PUG4[?3
MO/\ /<,H^S^?YI0C]X%V @G- 'HX&R7#!@&12C.VY,@9(QP%*=23P?QJXIR
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M1^TS\&/%'BOXU^*H/%FO:=XHN-.M+R#2K720MI'$'5#!:#82"<9^O'8?KD.
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MO1+.69B_5F:1F9FSR3FNZ.54<#@Y9B?NCU'')Z<5SO@S0!X4\(>%_#*L)/\
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MOPM\0^,=)^'=[\;]5O?&'@[Q;XGG^Q^%K:>UD+VNGZG?88VD]R&P8@N,T >
M:-^SVFJ_LQ7_ .T2GB68ZAIOCW1O!D'@V*Q62.\_M@*$O%O/O(\3,%*C/0U]
M4>&_V1_@S\*O'GP6T#XH?'W5O#_QN\8_V+XEL?!-GX=BO?">CSW-S!=6.GZ[
MXA/-BUS:LC[G&0[8YJ]KE_\ #?X+_L7W'PNM/BEX2\=?%'0?C!X,\3>(-*\,
MWJWVAW]K:;9#>>&+LJ&U&QAMU7[:7_U=P2F"!7;_ !/T/X'_ !S^+_P\_:D7
MX_\ @CPUX$32_"NH^,?!NHWJ'XDZ;?Z!%:6$UII>@/'Y<Z-+$7P3CR,R#.*
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MW[.O[8EIXE\6Z1H>O?$634;_ ,,:%J,HMKW5Y[Z8SM;Z;&%)N,.Y^9L'(XH
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M!&.]?GD$0,SA5#-]Y@ "<>IZF@"0N'W.J$$N?,<G#22?Q,4]_P"_U;O3:**
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M _@#Q!8^)/$6B:U>3^*6L)5NK>"<PHEGI4<L)=)KB28%95B9@P("Y/7]6O\
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M[PS7[/\ _!</Q#I_BW]E?X0>(](E6>QU_P 4:-K%G-$P9&M;VPCN-A(X) D
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MH,0J"-J@FO0DP 0#SDY R0#[9YH ?1110 4444 %%%% !1110 4444 %%%%
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MO\%9O$$%N=5\)?#W7)8?#D^IIS<:NEM+J, ANKU_GG"1A=W?T]U_8L_X)C?
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MD'[V81())'S][< "HQQM!QWJ20F5&A<*UN4"B$JI ;N^<9);N#Q7])7_  Y
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M;Q#X@^-OQ,TO2M/M0=0U>X&G%;&T:6.(9,<4C8:61(\JC-\XS@<A\OG^$O\
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M\9C9@@Y5A\XQC^(Y^F:8EI:QF-HK>*(Q9V&)%C(#'+Y**"=QY.:_I2_X<@?
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M_P @NOY9?>O\C^;2BOZ2_P#AR!\!_P#HK7Q2_P"^M+_^([=O3M1_PY ^ _\
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M#/AC&\4T.+J^#3S3"5J56A)/W>>G",82G!IIRBE9.][+JM\C5X7U/3-2L8U
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M8$VK/,IL@MX!MFP26SR<U^VME;QVEM;6T,4<200K#9Q*I"Q6L2A$1 .%VH
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M"5O=V?L;2V6U]=/3^VW_ (6'X(_Z&WPU_P"#[2O_ )+H_P"%A^"/^AM\-?\
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M#V]+D?Y]^:;ON?\ G_U3_P &FH?_ "3^'_UZ/KM/_GS/_P '>G_3OR?W(/\
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M3>W+_P!.O+\'\O[:_P#A8?@C_H;?#7_@^TK_ .2Z/^%A^"/^AM\-?^#[2O\
MY+K^)3S+C'_']J?0<_VIJ'_R3_GOFF[[G_G_ -4_\&FH?_)/;_\ 71]=I_\
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M%26C2DU^=OQF^&4_P5^*&M_"Z?7!K5QH$NFQ37\5J\$,AU01L)5#9WF'S-K
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M-_\ 3E;5#4T'_'U8?]A#3?\ TY6U-;KU7YGJY%_R.\J_[#:'_IV!_;7\/_\
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M&?N*V?E/Y5:4DJI(P2!D9SC\>] #J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *:PR,=?;L1Z9Z4ZH)6=2"!\@&7/4XR. O?Z_7\ #PSXO
M^#/$7BOQ)\$]1T2Q2]M/"'Q)M?$&ON]T+8V>E165Q"UPB,R_:65W51 ,DYW8
MXKWJN7U>'Q#>7>AR:!K%KIUE8ZHLWB&*\LOM3ZKI?E$M:6DQ(^R3;R&^T#.
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M>N?K0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;)!
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MW22K'+(K',A7D\FO,?\ AEK]I7_HA'Q*/_<%D_\ BZ/^&6OVE?\ HA'Q*_\
M!+)_\<IPC5@^94VWM[]-27W3BU?L[76Z::NC*,KXUR:=:KAN$,WJU:Z2<\5D
M^)KRA)2C.-2G[2A)1G"23A)*\;)HYOQ3\5_$WCCXLQ_%OQ9MU364\066MQVZ
MC[.D$-A.LL-A$P/RIM41CT'..F/0/B-\</!_Q>^,TOQ/^(WPON=9\.3:)::1
M-X+L?$$FF3SW-C$([?47U:)=VU3AS!@ @;>QK#_X9:_:4_Z(3\2O_!+)_P#%
M]_\ ]>*/^&6OVE/^B$_$K_P2R?\ Q?;O^E*,:L6FJ<KIJ7O4^9-K:ZDFFM=4
MTT^J.B&'X\5>KB:W"6<8NK7QCQ^(EBLHQ5;ZQB6HM3JJ5%J:5E9/1NU[D_[0
M'QTN/CEK?AJ6U\-1^#?"W@S0[;1/"6A+<?;Y]'MX(1#,)+W[]T;O:K2,V,8
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M:/*U[IVF7CZ?=:2+NPM+C^Q[F*.&726:%'^Q3QQ?(DUN6,+QK\BLA"\ 5MT
M-**2"1G V\Y(P>Q'0_C36AC92I48/IQCI]W'W>G;%244 ,V+@@ C.,G)SQ[]
M>U.  Z#'T_KZGWZTM% !1110 4444 0/&A9BR;L_WN5_(\4XYP!'P1QCT'^
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M&2/&XI$=OS#J*+^OW/\ R Z8$]\]>..Q[?4=Z"V.Q_+_ #^%(H(&,#KV)/\
M/G-.HOZ_<_\ (!F_V-&\>_\ G\:-I_O'OW/X=OSI<-Z\9'7T Y[=Z+^OW/\
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ML>F>GZ?6C/L>_;T_Q[4M%%_7[G_D F?8]NWK_AWHS['OV]/\>U+11?U^Y_Y
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M)C)O9.X0^8W!'I7KE," '/4]O8>@Q]:?0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7.>*/#FF^*_#NM>&=71GTG7
MM/NM,OT0D2&VND,4H1NV03ZX_&NCII4$[N00I7\Z .!^&'PY\/?"CP9I7@7P
MK&\6AZ,LJV4<AW2*LTC2N&/^^QQ7H%-50ON3U)ZG_.>*=0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 49HJK(7$A_B0[02HR\?!& .I#_I@T 6L\X[^G>BJC
M.R2HN%*G@OG+1@D[%9>I#?, PZ8_&K= !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1G/X=?:BJ[J>< G,GS%3LPI!.23UQGMTSF@"<$'
MH0?I2YJ#;\F8^<'"X.TLH[;L^O.>](2Z!C\N\X.<87&?NENA;_ZW6@"Q144+
M!E)7=]]L[L_>XSMS_#GH>AZU+0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 49IDC%0"!D;AN]<'C@=S[#TJNH=BXP220P<G* 8'..S Y
M&W)/?@"@"WGJ.XZCTSZTF1G&1D=1W%4F9H20$=GDPBC</F'=B_3([+U Q3XD
M ?&YCY?&6)#,W<.W\8&>* +=%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !GOVHSGIS4)5B3M!0_4%#NZY&>W?CTI$619#G!C*C&.
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MD>';ZYDC_M?6_'3^.8DG0@O%!?$;$*,5#("=H/-<]\4OBA^RW#XPF\'?')/
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MM;6^GP>*M#OW"V=_K-E:+Y=MJL@&9Y7)DG<_,,C-?I(.@^@]_P!>] "T444
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M39/ENY$!#) 0=P^N:\]^*&?^&^_V<@Y8&7X>_$)HFCD0B/R;4&6&0;@0)#G
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MI(D!4M@@ X/M[G';O_+(QFHSINDD9_):' +?\LV5QD#W'0L<<$T ?FT?@_\
MM@^-OA_IO[/?Q$3X=Z;\+XC:Z#KOQ"T+6+F^\7Z[X/TRY5[."30[B-;2WNIK
M>WM89A&QVA..E?H3X>T:V\-Z+HWAS20$TO1=,L]+T]&P5>"RB6!'=C_RU98\
ME.F2>M:TE_I@9M^I6*R##!3>6Z;2!T(\P,<C).X8QUJ>"5)HDFMI(9HI>5E@
M='M^X,D4B%E/0@[3C=D'GB@"XGW5QGICGKQQ3JA#A5P-TFT=0!SSS^('/&:C
M:]M$D2&2Y@2>09C@>:-9I!C/R1%@[?@IH M45$)HRSJ"=R ,ZXY4'/)[=N<$
MUFZQKVD>'](U#7M:OX=.TC2K6:]U"_N-P@M;2!=\UQ*55F$<:99B%) '2@#7
MHKC/ ?Q$\$_%#P];^+?A_P")--\5^&KN66"VUG296FLIIH&"S1([I&V^)BH<
M%1@D"NSH **** "BBB@ HHHH **** "BBB@ HHHH **** /(/C%J'QCL- A_
MX4SX6\&^*]=N)'@O+#QIK5UHEA%:.H4SQ3VJN\LB;CF)EVL !WKY._9%^'?[
M4WP8BN_ WCSP3\+O^$(UCQ3XI\8ZEXE\/^*;^[UNWN_$-REV-/@TR:-(IH82
MIC24G."6/6OT,=-W3 8 @$]@V-V.#U IIC8$;6^5%PJ= 6 X)(Y&..GOF@"1
M/N+@$#:N >H&!P?<=#3J09P,]<#/U[TM !1110 4444 %%%% !1110 4444
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M?V6[VVT36);*#X9>3J>H+874NE6#?8L".>^2(P13'_5A9) =XR10![5\5/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(Q\'#ZME\\9"-2CAL1?WW6=)J?1:R2CI=_TX2R)%&=\A4 %V>0JNQ!DGS'.
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MGQZ^#WQST_P%X1\3:AH\_C3PX;.YGU76-,MPS:A8K,L;P1^<3BVWE0JCG!H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O/_ !A\,/ /CV^T34_&/A/2?$>H>'+Q;[P_>:C
M);C1;M3E;K3Y0RM!*#\VX'KU]_0** *XA'E&(J?*50B(#R44 #<>Y./4?K2J
MK+LPH QMV#L,\$]3]<>_TJ>B@"ND17<I+'>2Q.?E3D_*@(Z=SWSS]%V.6)!8
M8 C 8Y4J"26QZL./KS4]% %,P$H\;;RI.Y"A * X!0>V,@^HI_E-&<19P4"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>nvro-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-21T20:51:18.0872352+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 3affc067051b45aa87ab8e436534d58c -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:nvro="http://www.nevro.com/20211231" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.nevro.com/20211231" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" namespace="http://xbrl.sec.gov/country/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" namespace="http://xbrl.sec.gov/currency/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" namespace="http://xbrl.sec.gov/exch/2021" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" namespace="http://xbrl.sec.gov/sic/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd" namespace="http://fasb.org/srt-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" namespace="http://fasb.org/srt-types/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" namespace="http://xbrl.sec.gov/stpr/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" namespace="http://fasb.org/us-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" namespace="http://fasb.org/us-types/2021-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.nevro.com/20211231/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvro-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvro-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvro-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvro-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" id="Role_StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100040 - Statement - Consolidated Statements of Stockholders&apos; Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100050 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompany" id="Role_DisclosureFormationAndBusinessOfCompany">
        <link:definition>100060 - Disclosure - Formation and Business of the Company</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100070 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenue" id="Role_DisclosureRevenue">
        <link:definition>100080 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeases" id="Role_DisclosureLeases">
        <link:definition>100090 - Disclosure - Leases</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponents" id="Role_DisclosureBalanceSheetComponents">
        <link:definition>100110 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100120 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebt" id="Role_DisclosureLongTermDebt">
        <link:definition>100130 - Disclosure - Long-term Debt</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStock" id="Role_DisclosureConvertiblePreferredStock">
        <link:definition>100140 - Disclosure - Convertible Preferred Stock</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100150 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100160 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100170 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlan" id="Role_DisclosureEmployeeBenefitPlan">
        <link:definition>100180 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100190 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueTables" id="Role_DisclosureRevenueTables">
        <link:definition>100200 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables" id="Role_DisclosureLeasesTables">
        <link:definition>100210 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100220 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables" id="Role_DisclosureBalanceSheetComponentsTables">
        <link:definition>100230 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>100240 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables" id="Role_DisclosureLongTermDebtTables">
        <link:definition>100250 - Disclosure - Long-term Debt (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100260 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100270 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100280 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail" id="Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail">
        <link:definition>100290 - Disclosure - Formation and Business of the Company - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" id="Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail">
        <link:definition>100300 - Disclosure - Formation and Business of the Company - Additional Information - Public Offering (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>100310 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1">
        <link:definition>100320 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail 1)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default">
        <link:definition>100320 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail 1)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail" id="Role_DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail">
        <link:definition>100330 - Disclosure - Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" id="Role_DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail">
        <link:definition>100340 - Disclosure - Revenue - Schedule of Revenue by Major Customers by Geographic Area (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail" id="Role_DisclosureRevenueAdditionalInformationDetail">
        <link:definition>100350 - Disclosure - Revenue - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail" id="Role_DisclosureLeasesAdditionalInformationDetail">
        <link:definition>100360 - Disclosure - Leases - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail" id="Role_DisclosureLeasesScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail">
        <link:definition>100370 - Disclosure - Leases - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail" id="Role_DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail">
        <link:definition>100380 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail2" id="Role_DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail2">
        <link:definition>100390 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Detail)2</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSupplementalLeaseCostInformationDetail" id="Role_DisclosureLeasesSupplementalLeaseCostInformationDetail">
        <link:definition>100400 - Disclosure - Leases - Supplemental Lease Cost Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail" id="Role_DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail">
        <link:definition>100410 - Disclosure - Leases - Summary of Operating Lease Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail" id="Role_DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail">
        <link:definition>100420 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Lease (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail" id="Role_DisclosureFairValueMeasurementsAdditionalInformationDetail">
        <link:definition>100430 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" id="Role_DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail">
        <link:definition>100440 - Disclosure - Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" id="Role_DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail">
        <link:definition>100450 - Disclosure - Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail" id="Role_DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail">
        <link:definition>100460 - Disclosure - Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail" id="Role_DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail">
        <link:definition>100470 - Disclosure - Balance Sheet Components - Components of Inventories (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail" id="Role_DisclosureBalanceSheetComponentsAdditionalInformationDetail">
        <link:definition>100480 - Disclosure - Balance Sheet Components - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" id="Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail">
        <link:definition>100490 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" id="Role_DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail">
        <link:definition>100500 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>100510 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail">
        <link:definition>100520 - Disclosure - Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" id="Role_DisclosureLongTermDebtAdditionalInformationDetail">
        <link:definition>100530 - Disclosure - Long-term Debt - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" id="Role_DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail">
        <link:definition>100540 - Disclosure - Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" id="Role_DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail">
        <link:definition>100550 - Disclosure - Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" id="Role_DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail">
        <link:definition>100560 - Disclosure - Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail" id="Role_DisclosureConvertiblePreferredStockAdditionalInformationDetail">
        <link:definition>100570 - Disclosure - Convertible Preferred Stock - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail" id="Role_DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail">
        <link:definition>100580 - Disclosure - Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetail">
        <link:definition>100590 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" id="Role_DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail">
        <link:definition>100600 - Disclosure - Stock-Based Compensation - Summary of Shares Available for Grant (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" id="Role_DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail">
        <link:definition>100610 - Disclosure - Stock-Based Compensation - Summary of Activity under Stock Plans (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" id="Role_DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail">
        <link:definition>100620 - Disclosure - Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" id="Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail">
        <link:definition>100630 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail" id="Role_DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail">
        <link:definition>100640 - Disclosure - Stock-Based Compensation - Summary of Performance Stock Units Under Stock Plan (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail" id="Role_DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail">
        <link:definition>100650 - Disclosure - Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" id="Role_DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail">
        <link:definition>100660 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail" id="Role_DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail">
        <link:definition>100670 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" id="Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail">
        <link:definition>100680 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" id="Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail">
        <link:definition>100690 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" id="Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail">
        <link:definition>100700 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail" id="Role_DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail">
        <link:definition>100710 - Disclosure - Income Taxes - Components of Loss before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" id="Role_DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail">
        <link:definition>100720 - Disclosure - Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" id="Role_DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail">
        <link:definition>100730 - Disclosure - Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" id="Role_DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail">
        <link:definition>100740 - Disclosure - Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" id="Role_DisclosureIncomeTaxesAdditionalInformationDetail">
        <link:definition>100750 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" id="Role_DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail">
        <link:definition>100760 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail" id="Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail">
        <link:definition>100770 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail" id="Role_DisclosureNetLossPerShareAdditionalInformationDetail">
        <link:definition>100780 - Disclosure - Net Loss Per Share - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" id="Role_DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail">
        <link:definition>100790 - Disclosure - Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetail" id="Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetail">
        <link:definition>100800 - Disclosure - Employee Benefit Plan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" name="DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" name="DebtInstrumentConvertibleEquityComponentIssuanceCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" name="AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" name="ExerciseOfBondHedgeForConvertibleSeniorNotes" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" name="ExerciseOfBondHedgeValueForConvertibleSeniorNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_AmortizationOfOperatingLeaseAsset" name="AmortizationOfOperatingLeaseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" name="UnrealizedGainsAndLossesOnForeignCurrencyTranslation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_RepaymentFromInvestmentInPrivateCompany" name="RepaymentFromInvestmentInPrivateCompany" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" name="PaymentsOfConvertibleNotesDebtIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_OtherRisksAndUncertainties1PolicyTextBlock" name="OtherRisksAndUncertainties1PolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock" name="RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock" name="ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" name="ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock" name="ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" name="TwoThousandTwentyOneNotesAndConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_DebtLiabilityComponentMember" name="DebtLiabilityComponentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_DebtEquityComponentMember" name="DebtEquityComponentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" name="TwoThousandTwentyFiveNotesAndConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" name="InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_PerformanceStockUnitsMember" name="PerformanceStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_DebtInstrumentMaturityYear" name="DebtInstrumentMaturityYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" name="OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" name="OrganizationConsolidationAndPresentationOfFinancialStatementsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" name="OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" name="TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" name="DebtInstrumentAdditionalAggregatePrincipalAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" name="TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_NumberOfOperationalWhollyOwnedSubsidiaries" name="NumberOfOperationalWhollyOwnedSubsidiaries" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_PerformanceBasedRestrictedStockUnitsRSUMember" name="PerformanceBasedRestrictedStockUnitsRSUMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_BadDebtExpense1" name="BadDebtExpense1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_EmployeeStockPurchasePlanOfferingPeriod" name="EmployeeStockPurchasePlanOfferingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" name="ConcentrationRiskNumberOfCustomersExceedingThreshold" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_MajorCustomersMember" name="MajorCustomersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_PainfulDiabeticNeuropathyMember" name="PainfulDiabeticNeuropathyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_LesseeOperatingLeaseRemainingTermOfContract" name="LesseeOperatingLeaseRemainingTermOfContract" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" name="OperatingLeaseAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" name="CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_MoneyMarketFundsNetAssetValuePerShare" name="MoneyMarketFundsNetAssetValuePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_AgencyBondsMember" name="AgencyBondsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_InventoryWriteDownCashAndNonCash" name="InventoryWriteDownCashAndNonCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_AccruedClinicalAndResearchExpensesCurrent" name="AccruedClinicalAndResearchExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_LeaseCommencementPeriod" name="LeaseCommencementPeriod" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_LeaseEffectiveDate" name="LeaseEffectiveDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_OperatingLeasesExpirationDate" name="OperatingLeasesExpirationDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_LeaseCommencementDateDescription" name="LeaseCommencementDateDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" name="OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_RedwoodOfficeAgreementMember" name="RedwoodOfficeAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" name="RedwoodOfficeAgreementAdditionalExpansionPremisesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_FirstAmendmentMember" name="FirstAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_SecondAmendmentMember" name="SecondAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_FacilityLeaseAgreementThreeMember" name="FacilityLeaseAgreementThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_SupplyAgreementsMember" name="SupplyAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_MayoAndVglMember" name="MayoAndVglMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_MayoFoundationMember" name="MayoFoundationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_BostonScientificCorporationMember" name="BostonScientificCorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_PatentInfringementMember" name="PatentInfringementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_ServiceAgreementCommitmentAmountYearOne" name="ServiceAgreementCommitmentAmountYearOne" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_ServiceAgreementCommitmentAmountYearTwo" name="ServiceAgreementCommitmentAmountYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_ServiceAgreementCommitmentAmountYearThree" name="ServiceAgreementCommitmentAmountYearThree" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_ServiceAgreementCommitmentAmountYearFour" name="ServiceAgreementCommitmentAmountYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_NonCashResearchAndDevelopmentExpense" name="NonCashResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_LicenseAgreementExpirationYear" name="LicenseAgreementExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_LicenseAgreementCommitmentAmount" name="LicenseAgreementCommitmentAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" name="ContingentConsiderationPaymentSecuredByConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" name="AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_NumberOfSecuredConvertibleNotes" name="NumberOfSecuredConvertibleNotes" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" name="SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_ValueOfCertainRightsMeasuredAtCost" name="ValueOfCertainRightsMeasuredAtCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" name="ContingentConsiderationExpensesNetSecuredByConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" name="PatentInfringementLawsuitAllegationAgainstNumberOfPatents" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_DebtInstrumentMaturityMonthAndYear" name="DebtInstrumentMaturityMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_OneHundredThirtyPercentApplicableConversionPriceMember" name="OneHundredThirtyPercentApplicableConversionPriceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_NinetyEightPercentApplicableConversionPriceMember" name="NinetyEightPercentApplicableConversionPriceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" name="PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_NoteHedgesTransactionCosts" name="NoteHedgesTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" name="AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_NoteHedgesNumberOfSharesContractedToBuy" name="NoteHedgesNumberOfSharesContractedToBuy" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_PurchasePricePerCommonStock" name="PurchasePricePerCommonStock" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_ConversionPricePerShare" name="ConversionPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" name="TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_CommonStockOptionsAndAwardsOutstanding" name="CommonStockOptionsAndAwardsOutstanding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" name="CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" name="CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_TwoThousandSevenPlanMember" name="TwoThousandSevenPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_TwoThousandFourteenEquityIncentivePlanMember" name="TwoThousandFourteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_IncentiveStockOptionsMember" name="IncentiveStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_NonQualifiedStockOptionsMember" name="NonQualifiedStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_PercentageOfShareholderOptionsGranted" name="PercentageOfShareholderOptionsGranted" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" name="EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_Range1Member" name="Range1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_Range2Member" name="Range2Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_Range3Member" name="Range3Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_Range4Member" name="Range4Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_Range5Member" name="Range5Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_Range6Member" name="Range6Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_Range7Member" name="Range7Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_TargetedCompositeIndexPeriod" name="TargetedCompositeIndexPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_TargetedNumberOfSharesGrantedRatio" name="TargetedNumberOfSharesGrantedRatio" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_RecognitionPeriodOfStockBasedCompensationExpense" name="RecognitionPeriodOfStockBasedCompensationExpense" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_DeferredTaxAssetsDepreciation" name="DeferredTaxAssetsDepreciation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_DeferredTaxLiabilitiesRightOfUseAsset" name="DeferredTaxLiabilitiesRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="nvro_DeferredTaxAssetsLeaseLiabilities" name="DeferredTaxAssetsLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="nvro_IncomeTaxesLineItems" name="IncomeTaxesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_IncomeTaxesTable" name="IncomeTaxesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" name="FederalAndStateNetOperatingLossCarryForwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="nvro_RestrictedAndPerformanceStockUnitsMember" name="RestrictedAndPerformanceStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>nvro-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-21T20:51:18.0872352+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 3affc067051b45aa87ab8e436534d58c -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="nvro-20211231.xsd#TemplateLink" roleURI="http://www.nevro.com/20211231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="nvro-20211231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermDebtNoncurrent" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ShortTermBorrowings" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10200.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="10210.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10220.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="10230.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10240.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="10250.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10260.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="nvro-20211231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:type="locator" xlink:label="us-gaap_LitigationSettlementExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:type="locator" xlink:label="us-gaap_GrossProfit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10060.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InvestmentIncomeInterest" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestExpense" order="10090.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="10120.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_LitigationSettlementExpense" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10170.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="nvro-20211231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" xlink:type="locator" xlink:label="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AmortizationOfOperatingLeaseAsset" xlink:type="locator" xlink:label="nvro_AmortizationOfOperatingLeaseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RepaymentFromInvestmentInPrivateCompany" xlink:type="locator" xlink:label="nvro_RepaymentFromInvestmentInPrivateCompany" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="locator" xlink:label="us-gaap_PaymentsForHedgeFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" xlink:type="locator" xlink:label="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" order="10070.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForHedgeFinancingActivities" order="10090.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" order="10100.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="10110.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="10130.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="nvro_RepaymentFromInvestmentInPrivateCompany" order="10150.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10160.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="nvro_AmortizationOfOperatingLeaseAsset" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="10200.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10210.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="10220.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryWriteDown" order="10230.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="10240.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="10250.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" order="10260.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="10270.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="10280.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10290.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="10300.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10310.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="10320.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="10330.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="10060.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail2" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail2" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail2">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10010.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="10040.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrent" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AccruedClinicalAndResearchExpensesCurrent" xlink:type="locator" xlink:label="nvro_AccruedClinicalAndResearchExpensesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="nvro_AccruedClinicalAndResearchExpensesCurrent" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_InterestPayableCurrent" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_StandardProductWarrantyAccrualCurrent" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10070.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentGross" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentGross" order="10030.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" xlink:type="locator" xlink:label="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" xlink:type="locator" xlink:label="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" xlink:type="locator" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CommonStockOptionsAndAwardsOutstanding" xlink:type="locator" xlink:label="nvro_CommonStockOptionsAndAwardsOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="nvro_CommonStockOptionsAndAwardsOutstanding" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="10080.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="10040.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="10070.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DeferredTaxLiabilitiesRightOfUseAsset" xlink:type="locator" xlink:label="nvro_DeferredTaxLiabilitiesRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DeferredTaxAssetsDepreciation" xlink:type="locator" xlink:label="nvro_DeferredTaxAssetsDepreciation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DeferredTaxAssetsLeaseLiabilities" xlink:type="locator" xlink:label="nvro_DeferredTaxAssetsLeaseLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="nvro_DeferredTaxAssetsLeaseLiabilities" order="10030.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10050.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="nvro_DeferredTaxAssetsDepreciation" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="nvro_DeferredTaxLiabilitiesRightOfUseAsset" order="10110.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10120.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>nvro-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-21T20:51:18.0872352+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 3affc067051b45aa87ab8e436534d58c -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef xlink:type="simple" xlink:href="nvro-20211231.xsd#TemplateLink" roleURI="http://www.nevro.com/20211231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="nvro-20211231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" xlink:type="locator" xlink:label="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" xlink:type="locator" xlink:label="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" xlink:type="locator" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="10900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="11040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" order="11180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" order="11200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="11320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="11340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="11460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="11600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" order="11740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" order="11760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="11880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="12160.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtTables" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" xlink:type="locator" xlink:label="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtEquityComponentMember" xlink:type="locator" xlink:label="nvro_DebtEquityComponentMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtLiabilityComponentMember" xlink:type="locator" xlink:label="nvro_DebtLiabilityComponentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_2" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtLiabilityComponentMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtEquityComponentMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" order="10890.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:type="locator" xlink:label="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="10830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" order="10880.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:type="locator" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="locator" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="locator" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10440.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:type="locator" xlink:label="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:type="locator" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10640.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanOfferingPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_BadDebtExpense1" xlink:type="locator" xlink:label="nvro_BadDebtExpense1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:type="locator" xlink:label="us-gaap_CashUninsuredAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NumberOfOperationalWhollyOwnedSubsidiaries" xlink:type="locator" xlink:label="nvro_NumberOfOperationalWhollyOwnedSubsidiaries" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201912Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceBasedRestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="nvro_PerformanceBasedRestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_SummaryOfSignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_2" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AwardTypeAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceBasedRestrictedStockUnitsRSUMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_2" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_NumberOfOperationalWhollyOwnedSubsidiaries" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CashUninsuredAmount" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="10820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_BadDebtExpense1" order="10920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="11100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="11150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_EmployeeStockPurchasePlanOfferingPeriod" order="11200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="11300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="11370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="11390.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" xlink:href="nvro-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_SummaryOfSignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10070.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default" xlink:href="nvro-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_SummaryOfSignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10020.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember" xlink:type="locator" xlink:label="us-gaap_NonUsMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_NonUsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10140.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_GeographicConcentrationRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_2" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_GeographicConcentrationRiskMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_StatementGeographicalAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="10360.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureRevenueAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" xlink:type="locator" xlink:label="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PainfulDiabeticNeuropathyMember" xlink:type="locator" xlink:label="nvro_PainfulDiabeticNeuropathyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CreditConcentrationRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MajorCustomersMember" xlink:type="locator" xlink:label="nvro_MajorCustomersMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_MajorCustomersAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="nvro_MajorCustomersMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CreditConcentrationRiskMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_2" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="nvro_PainfulDiabeticNeuropathyMember" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10770.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LesseeOperatingLeaseRemainingTermOfContract" xlink:type="locator" xlink:label="nvro_LesseeOperatingLeaseRemainingTermOfContract" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="nvro_LesseeOperatingLeaseRemainingTermOfContract" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="10320.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:type="locator" xlink:label="us-gaap_OtherCurrentLiabilitiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherCurrentLiabilitiesMember" order="10210.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureFairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFairValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MoneyMarketFundsNetAssetValuePerShare" xlink:type="locator" xlink:label="nvro_MoneyMarketFundsNetAssetValuePerShare" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:type="locator" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="nvro_MoneyMarketFundsNetAssetValuePerShare" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="10470.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasuryBondSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateNoteSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AgencyBondsMember" xlink:type="locator" xlink:label="nvro_AgencyBondsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_2" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="nvro_AgencyBondsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryBondSecuritiesMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="10660.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasuryBondSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateNoteSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10040.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_AgencySecuritiesMember" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryBondSecuritiesMember" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10630.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_InventoryWriteDownCashAndNonCash" xlink:type="locator" xlink:label="nvro_InventoryWriteDownCashAndNonCash" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember" xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CertificatesOfDepositMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryDisclosureAbstract" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="nvro_InventoryWriteDownCashAndNonCash" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAbstract" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="10620.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10500.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="locator" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" xlink:type="locator" xlink:label="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" xlink:type="locator" xlink:label="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ValueOfCertainRightsMeasuredAtCost" xlink:type="locator" xlink:label="nvro_ValueOfCertainRightsMeasuredAtCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" xlink:type="locator" xlink:label="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NumberOfSecuredConvertibleNotes" xlink:type="locator" xlink:label="nvro_NumberOfSecuredConvertibleNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" xlink:type="locator" xlink:label="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" xlink:type="locator" xlink:label="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LicenseAgreementExpirationYear" xlink:type="locator" xlink:label="nvro_LicenseAgreementExpirationYear" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LicenseAgreementCommitmentAmount" xlink:type="locator" xlink:label="nvro_LicenseAgreementCommitmentAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NonCashResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="nvro_NonCashResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearFour" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearFour" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearThree" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearThree" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearTwo" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearTwo" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearOne" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearOne" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:type="locator" xlink:label="us-gaap_InventoryFirmPurchaseCommitmentLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperationsCommencedDate1" xlink:type="locator" xlink:label="us-gaap_OperationsCommencedDate1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LeaseCommencementDateDescription" xlink:type="locator" xlink:label="nvro_LeaseCommencementDateDescription" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" xlink:type="locator" xlink:label="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OperatingLeasesExpirationDate" xlink:type="locator" xlink:label="nvro_OperatingLeasesExpirationDate" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LeaseEffectiveDate" xlink:type="locator" xlink:label="nvro_LeaseEffectiveDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:type="locator" xlink:label="us-gaap_AreaOfLand" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LeaseCommencementPeriod" xlink:type="locator" xlink:label="nvro_LeaseCommencementPeriod" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PatentInfringementMember" xlink:type="locator" xlink:label="nvro_PatentInfringementMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_BostonScientificCorporationMember" xlink:type="locator" xlink:label="nvro_BostonScientificCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndemnificationGuaranteeMember" xlink:type="locator" xlink:label="us-gaap_IndemnificationGuaranteeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MayoFoundationMember" xlink:type="locator" xlink:label="nvro_MayoFoundationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:type="locator" xlink:label="us-gaap_LicensingAgreementsMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MayoAndVglMember" xlink:type="locator" xlink:label="nvro_MayoAndVglMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember" xlink:type="locator" xlink:label="us-gaap_ServiceAgreementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SupplyAgreementsMember" xlink:type="locator" xlink:label="nvro_SupplyAgreementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CR" xlink:type="locator" xlink:label="country_CR" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_FacilityLeaseAgreementThreeMember" xlink:type="locator" xlink:label="nvro_FacilityLeaseAgreementThreeMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SecondAmendmentMember" xlink:type="locator" xlink:label="nvro_SecondAmendmentMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_FirstAmendmentMember" xlink:type="locator" xlink:label="nvro_FirstAmendmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" xlink:type="locator" xlink:label="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RedwoodOfficeAgreementMember" xlink:type="locator" xlink:label="nvro_RedwoodOfficeAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nvro_RedwoodOfficeAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_StatementScenarioAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_2" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="nvro_FirstAmendmentMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="nvro_SecondAmendmentMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nvro_FacilityLeaseAgreementThreeMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_StatementGeographicalAxis" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CR" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nvro_SupplyAgreementsMember" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_ServiceAgreementsMember" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_CounterpartyNameAxis" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_2" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="nvro_MayoAndVglMember" order="10710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LicensingAgreementsMember" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="nvro_MayoFoundationMember" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_RangeAxis" order="11020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="11050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="11070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="11090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="11400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain_2" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="11430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_IndemnificationGuaranteeMember" order="11450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="11460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_2" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="11490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nvro_BostonScientificCorporationMember" order="11510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="nvro_PatentInfringementMember" order="11590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LeaseCommencementPeriod" order="11740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_AreaOfLand" order="11840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LeaseEffectiveDate" order="11940.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_OperatingLeasesExpirationDate" order="12040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="12140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" order="12240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LeaseCommencementDateDescription" order="12440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperationsCommencedDate1" order="12540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="12640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="12810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_StandardProductWarrantyDescription" order="13010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths" order="13060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_InventoryFirmPurchaseCommitmentLoss" order="13100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ServiceAgreementCommitmentAmountYearOne" order="13170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ServiceAgreementCommitmentAmountYearTwo" order="13190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ServiceAgreementCommitmentAmountYearThree" order="13210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ServiceAgreementCommitmentAmountYearFour" order="13230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" order="13280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="13330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_RoyaltyExpense" order="13380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="13520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_NonCashResearchAndDevelopmentExpense" order="13540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LicenseAgreementCommitmentAmount" order="13590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LicenseAgreementExpirationYear" order="13610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" order="13660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" order="13700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_NumberOfSecuredConvertibleNotes" order="13740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" order="13780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ValueOfCertainRightsMeasuredAtCost" order="13820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" order="13860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue" order="13930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" order="14050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty" order="14160.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" xlink:type="locator" xlink:label="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentGross" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" xlink:type="locator" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ConversionPricePerShare" xlink:type="locator" xlink:label="nvro_ConversionPricePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NoteHedgesTransactionCosts" xlink:type="locator" xlink:label="nvro_NoteHedgesTransactionCosts" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PurchasePricePerCommonStock" xlink:type="locator" xlink:label="nvro_PurchasePricePerCommonStock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NoteHedgesNumberOfSharesContractedToBuy" xlink:type="locator" xlink:label="nvro_NoteHedgesNumberOfSharesContractedToBuy" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" xlink:type="locator" xlink:label="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:type="locator" xlink:label="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityMonthAndYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityMonthAndYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtLiabilityComponentMember" xlink:type="locator" xlink:label="nvro_DebtLiabilityComponentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NinetyEightPercentApplicableConversionPriceMember" xlink:type="locator" xlink:label="nvro_NinetyEightPercentApplicableConversionPriceMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:type="locator" xlink:label="nvro_OneHundredThirtyPercentApplicableConversionPriceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain_2" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="nvro_OneHundredThirtyPercentApplicableConversionPriceMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="nvro_NinetyEightPercentApplicableConversionPriceMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtLiabilityComponentMember" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="11070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="11900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="11920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentMaturityMonthAndYear" order="11940.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" order="11960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="11980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="12000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="12050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="12090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity" order="12130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="12170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" order="12210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" order="12250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" order="12290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="12410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" order="12450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_NoteHedgesNumberOfSharesContractedToBuy" order="12520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_PurchasePricePerCommonStock" order="12560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_NoteHedgesTransactionCosts" order="12600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="12640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="12680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="12720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_ConversionPricePerShare" order="12760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" order="12840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" order="12910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="12930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" order="12980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentGross" order="13000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="13050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" order="13090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="13110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="13200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" order="13750.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentGross" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtLiabilityComponentMember" xlink:type="locator" xlink:label="nvro_DebtLiabilityComponentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10040.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtLiabilityComponentMember" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentGross" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="10390.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" xlink:type="locator" xlink:label="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" xlink:type="locator" xlink:label="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtEquityComponentMember" xlink:type="locator" xlink:label="nvro_DebtEquityComponentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:type="locator" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtEquityComponentMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" order="10360.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10040.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="10330.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureConvertiblePreferredStockAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10220.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RecognitionPeriodOfStockBasedCompensationExpense" xlink:type="locator" xlink:label="nvro_RecognitionPeriodOfStockBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanOfferingPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TargetedNumberOfSharesGrantedRatio" xlink:type="locator" xlink:label="nvro_TargetedNumberOfSharesGrantedRatio" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TargetedCompositeIndexPeriod" xlink:type="locator" xlink:label="nvro_TargetedCompositeIndexPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PercentageOfShareholderOptionsGranted" xlink:type="locator" xlink:label="nvro_PercentageOfShareholderOptionsGranted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:type="locator" xlink:label="srt_ManagementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NonQualifiedStockOptionsMember" xlink:type="locator" xlink:label="nvro_NonQualifiedStockOptionsMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_IncentiveStockOptionsMember" xlink:type="locator" xlink:label="nvro_IncentiveStockOptionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:type="locator" xlink:label="us-gaap_VestingAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandFourteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="nvro_TwoThousandFourteenEquityIncentivePlanMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandSevenPlanMember" xlink:type="locator" xlink:label="nvro_TwoThousandSevenPlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nvro_TwoThousandSevenPlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="nvro_TwoThousandFourteenEquityIncentivePlanMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_2" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_IncentiveStockOptionsMember" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_NonQualifiedStockOptionsMember" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ManagementMember" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="11170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="11290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="11500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="11550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" order="11570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="11640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_PercentageOfShareholderOptionsGranted" order="11660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_TargetedCompositeIndexPeriod" order="11920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_TargetedNumberOfSharesGrantedRatio" order="11940.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="12100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" order="12120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_EmployeeStockPurchasePlanOfferingPeriod" order="12160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="12260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_RecognitionPeriodOfStockBasedCompensationExpense" order="12280.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" order="10680.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range7Member" xlink:type="locator" xlink:label="nvro_Range7Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range6Member" xlink:type="locator" xlink:label="nvro_Range6Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range5Member" xlink:type="locator" xlink:label="nvro_Range5Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range4Member" xlink:type="locator" xlink:label="nvro_Range4Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range3Member" xlink:type="locator" xlink:label="nvro_Range3Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range2Member" xlink:type="locator" xlink:label="nvro_Range2Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range1Member" xlink:type="locator" xlink:label="nvro_Range1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range1Member" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range2Member" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range3Member" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range4Member" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range5Member" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range6Member" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range7Member" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="11380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="11620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="11860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="12100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="12340.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" xlink:type="locator" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" order="11280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="11390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" order="12430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" order="12540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" order="12620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" order="13100.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" xlink:type="locator" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" order="11120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" order="12110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" order="12220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" order="12300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" order="12620.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockPurchasePlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" order="10360.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockPurchasePlanMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10820.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" order="10980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="11100.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10160.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockPurchasePlanMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10180.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockPurchasePlanMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="10410.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" xlink:type="locator" xlink:label="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:type="locator" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:type="locator" xlink:label="us-gaap_ResearchMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_IncomeTaxesTable" xlink:type="locator" xlink:label="nvro_IncomeTaxesTable" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_IncomeTaxesLineItems" xlink:type="locator" xlink:label="nvro_IncomeTaxesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="nvro_IncomeTaxesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nvro_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nvro_IncomeTaxesTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_2" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="nvro_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_2" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="10790.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureNetLossPerShareAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayable" xlink:type="locator" xlink:label="us-gaap_NotesPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_NotesPayable" order="10210.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RestrictedAndPerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_RestrictedAndPerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="nvro_RestrictedAndPerformanceStockUnitsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10180.00" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>nvro-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-21T20:51:18.0872352+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 3affc067051b45aa87ab8e436534d58c -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" xlink:type="locator" xlink:label="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" />
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument convertible equity discount related to value of conversion option.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" xlink:to="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" xlink:type="locator" xlink:label="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" />
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument convertible equity component issuance cost.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" xlink:to="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well Known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Icfr Auditor Attestation Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated By Reference [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:type="locator" xlink:label="dei_AuditorFirmId" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorFirmId_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorFirmId_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm Id</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:type="locator" xlink:label="dei_AuditorName" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:type="locator" xlink:label="dei_AuditorLocation" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorLocation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorLocation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, net of allowance for doubtful accounts of $1,385 and $3,000 at December 31, 2021 and 2020, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Net Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermBorrowings_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermBorrowings_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Borrowings</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 7)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2021 and 2020, respectively; zero shares issued and outstanding at December 31, 2021 and 2020, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value, 290,000,000 shares authorized at December 31, 2021 and 2020, respectively; 35,709,570 shares issued and 35,026,654 shares outstanding at December 31, 2021; 34,583,064 shares issued and outstanding at December 31, 2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital Common Stock</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income / (loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income Loss Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, allowance for doubtful accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allowance For Doubtful Accounts Receivable Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Authorized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer Excluding Assessed Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Goods And Services Sold</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:type="locator" xlink:label="us-gaap_GrossProfit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GrossProfit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gross profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GrossProfit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gross Profit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales, general and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling General And Administrative Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:type="locator" xlink:label="us-gaap_LitigationSettlementExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certain litigation charges</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementExpense" xlink:to="us-gaap_LitigationSettlementExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Settlement Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense), net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive loss:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in foreign currency translation adjustment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in unrealized gains (losses) on short-term investments, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net change in other comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average number of common shares used to compute basic and diluted net loss per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" xlink:type="locator" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" />
    <link:label xml:lang="en-US" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital purchase of bond hedges.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" xlink:to="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" xlink:type="locator" xlink:label="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" />
    <link:label xml:lang="en-US" xlink:label="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise of bond hedge for convertible senior notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" xlink:to="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" xlink:type="locator" xlink:label="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" />
    <link:label xml:lang="en-US" xlink:label="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise of bond hedge value for convertible senior notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" xlink:to="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balances</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balances, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon underwritten public offering, net of issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon underwritten public offering, net of issuance costs, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion feature of convertible senior notes due 2025, net of allocated costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of bond hedges</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Purchase Of Bond Hedges</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Warrant Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of common stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of common stock options, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon release of restricted stock units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Restricted Stock Award Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares withheld for tax obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments Related To Tax Withholding For Share Based Compensation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares withheld for tax obligations, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Paid For Tax Withholding For Share Based Compensation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Employee Stock Purchase Plan</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Employee Stock Purchase Plans</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from conversion of convertible senior notes due 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Conversion Of Convertible Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from conversion of convertible senior notes due 2021, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercise of bond hedge for convertible senior notes due 2021</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Of Bond Hedge Value For Convertible Senior Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercise of bond hedge for convertible senior notes due 2021, shares</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Of Bond Hedge For Convertible Senior Notes</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balances</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balances, shares</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AmortizationOfOperatingLeaseAsset" xlink:type="locator" xlink:label="nvro_AmortizationOfOperatingLeaseAsset" />
    <link:label xml:lang="en-US" xlink:label="nvro_AmortizationOfOperatingLeaseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of operating lease asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_AmortizationOfOperatingLeaseAsset" xlink:to="nvro_AmortizationOfOperatingLeaseAsset_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" xlink:type="locator" xlink:label="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" />
    <link:label xml:lang="en-US" xlink:label="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrealized gains and losses on foreign currency translation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" xlink:to="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RepaymentFromInvestmentInPrivateCompany" xlink:type="locator" xlink:label="nvro_RepaymentFromInvestmentInPrivateCompany" />
    <link:label xml:lang="en-US" xlink:label="nvro_RepaymentFromInvestmentInPrivateCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Repayment from (investment in) private company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_RepaymentFromInvestmentInPrivateCompany" xlink:to="nvro_RepaymentFromInvestmentInPrivateCompany_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" xlink:type="locator" xlink:label="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments of convertible notes debt issuance costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" xlink:to="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation Depletion And Amortization</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AmortizationOfOperatingLeaseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of operating lease assets</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AmortizationOfOperatingLeaseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Operating Lease Asset</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of premium (accretion of discount) on short-term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Amortization Of Discounts And Premiums Investments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for (recovery of) doubtful accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Provision For Doubtful Accounts</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryWriteDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Write-down of inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryWriteDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Write Down</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on disposal of equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Disposition Of Assets1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt discount and issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Financing Costs And Discounts</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized gains (losses) on foreign currency transactions</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gains And Losses On Foreign Currency Translation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Receivable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Inventories</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Operating Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Noncurrent Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by / (used in) operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of short-term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Available For Sale Securities Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturity of short-term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale And Maturity Of Available For Sale Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_RepaymentFromInvestmentInPrivateCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment from (investment in) private company</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_RepaymentFromInvestmentInPrivateCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayment From Investment In Private Company</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by / (used in) investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock in public offering, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Initial Public Offering</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Convertible Debt</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Convertible notes debt issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Convertible Notes Debt Issuance Costs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Warrants</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="locator" xlink:label="us-gaap_PaymentsForHedgeFinancingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForHedgeFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of convertible note hedges</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="us-gaap_PaymentsForHedgeFinancingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForHedgeFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments For Hedge Financing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment of convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfConvertibleDebt" xlink:to="us-gaap_RepaymentsOfConvertibleDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Convertible Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Minimum tax withholding paid on behalf of employees for net share settlement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Related To Tax Withholding For Share Based Compensation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock to employees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, cash equivalents and restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash at beginning of year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash at end of year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosures of cash flow information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Paid Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant non-cash transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing And Financing Items [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of property and equipment in accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred But Not Yet Paid</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Formation and Business of the Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Leases [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Components</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:type="locator" xlink:label="us-gaap_PreferredStockTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shareholders Equity And Share Based Payments [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract" xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PostemploymentBenefitsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Postemployment Benefits [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitsAbstract" xlink:to="us-gaap_PostemploymentBenefitsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Benefit Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Compensation And Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Accounting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OtherRisksAndUncertainties1PolicyTextBlock" xlink:type="locator" xlink:label="nvro_OtherRisksAndUncertainties1PolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nvro_OtherRisksAndUncertainties1PolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Other Risks And Uncertainties Policy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_OtherRisksAndUncertainties1PolicyTextBlock" xlink:to="nvro_OtherRisksAndUncertainties1PolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_OtherRisksAndUncertainties1PolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Risks And Uncertainties</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OtherRisksAndUncertainties1PolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Risks And Uncertainties1 Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Currency Translation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transactions And Translations Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Use Of Estimates</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk and Other Risks and Uncertainties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Credit Risk</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:to="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Credit Loss Financial Instrument Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Financial Instruments Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Policy [Text Block]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock" xlink:type="locator" xlink:label="nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue recognition shipping and handling costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock" xlink:to="nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shipping and Handling Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Shipping And Handling Costs Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="locator" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for Doubtful Accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Or Disposal Of Long Lived Assets Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Accounting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Leases Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Comprehensive Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Option And Incentive Plans Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss per Share of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Revenue by Geography on Billing Address of Customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Revenue by Major Customers by Geographic Area</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Revenue By Major Customers By Reporting Segments Table [Text Block]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock" xlink:type="locator" xlink:label="nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of weighted average lease terms and discounts rates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock" xlink:to="nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Weighted Average Lease Terms and Discounts Rates</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Weighted Average Lease Terms And Discounts Rates Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Maturity of Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Maturity Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental Lease Cost Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Cost Table [Text Block]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of operating lease assets and operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" xlink:to="nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Operating Lease Assets and Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Operating Lease Assets And Operating Lease Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock" xlink:type="locator" xlink:label="nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of cash flow information related to operating lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock" xlink:to="nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Supplemental Cash Flow Information Related to Lease</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Cash Flow Information Related To Operating Lease Tables [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments Measured at Fair Value on Recurring Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Measured On Recurring Basis [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Contractual Maturities of Investment Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments Classified By Contractual Maturity Date Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Inventory Current Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property and Equipment, Net and Depreciation and Amortization Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Activities Related to Warranty Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Product Warranty Liability Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Name [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">2021 notes and convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:to="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Notes and Convertible Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty One Notes And Convertible Notes [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Longterm Debt Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Longterm Debt Type [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtLiabilityComponentMember" xlink:type="locator" xlink:label="nvro_DebtLiabilityComponentMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_DebtLiabilityComponentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt liability component.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DebtLiabilityComponentMember" xlink:to="nvro_DebtLiabilityComponentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_DebtLiabilityComponentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt, Liability Component [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtLiabilityComponentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Liability Component [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtEquityComponentMember" xlink:type="locator" xlink:label="nvro_DebtEquityComponentMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_DebtEquityComponentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt equity component.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DebtEquityComponentMember" xlink:to="nvro_DebtEquityComponentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_DebtEquityComponentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt, Equity Component [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtEquityComponentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Equity Component [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty five notes and convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025 Notes and Convertible Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Five Notes And Convertible Notes [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Carrying Amount of Convertible Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt Table [Text Block]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" xlink:type="locator" xlink:label="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest expense recognized related to convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" xlink:to="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest Expense Recognized Related to Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense Recognized Related To Convertible Notes Table [Text Block]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:type="locator" xlink:label="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of common stock reserved for future issuance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_PerformanceStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance stock units.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_PerformanceStockUnitsMember" xlink:to="nvro_PerformanceStockUnitsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_PerformanceStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PerformanceStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Performance Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Common Stock Reserved for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Common Stock Reserved For Future Issuance Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Shares Available for Grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Activity under Stock Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Options Outstanding and Vested under Stock Plans by Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Units under the Stock Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Performance Stock Units under the Stock Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Performance Based Units Vested And Expected To Vest Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Employee Stock Purchase Plan Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Employee Stock Purchase Plan Activity Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation and Monte Carlo Simulation Model</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation Expense Not Yet Recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Unrecognized Compensation Cost Nonvested Awards Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Loss before Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Expense/(Benefit) for Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Expense by Applying Statutory Federal Income Tax Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="locator" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Effects of Temporary Differences and Carryforwards that Give Rise to Significant Portions of Deferred Tax Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Operating Loss Carryforwards [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computation of Basic and Diluted Net Loss per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentMaturityYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument maturity year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DebtInstrumentMaturityYear" xlink:to="nvro_DebtInstrumentMaturityYear_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="locator" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" />
    <link:label xml:lang="en-US" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization consolidation and presentation of financial statements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="locator" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" />
    <link:label xml:lang="en-US" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization consolidation and presentation of financial statements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:type="locator" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">One point seven five percent senior convertible note due twenty twenty one.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:to="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.75% Convertible Senior Notes due 2021 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">One Point Seven Five Percent Senior Convertible Note Due Twenty Twenty One [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two point seven five percentage convertible senior notes due 2025 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2.75% Convertible Senior Notes due 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Point Seven Five Percentage Convertible Senior Notes Due2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Formation and Business of the Company [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash used in operations</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentMaturityYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument due year</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentMaturityYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Maturity Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate principal amount of convertible senior notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Face Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from the debt offering after deducting transaction costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Debt Net Of Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock in underwriting public offering</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds from common stock</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:type="locator" xlink:label="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" />
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument additional aggregate principal amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:to="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Point Seven Five Percentage Convertible Senior Notes Due 2025.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2.75% Convertible senior notes due 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Point Seven Five Percentage Convertible Senior Notes1 Due2025 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Name Of Transaction [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Over Allotment Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Over Allotment Option [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Sale Of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Rate Stated Percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional aggregate principal amount of convertible senior notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Additional Aggregate Principal Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument frequency of payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Frequency Of Periodic Payment</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NumberOfOperationalWhollyOwnedSubsidiaries" xlink:type="locator" xlink:label="nvro_NumberOfOperationalWhollyOwnedSubsidiaries" />
    <link:label xml:lang="en-US" xlink:label="nvro_NumberOfOperationalWhollyOwnedSubsidiaries_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of operational wholly owned subsidiaries.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_NumberOfOperationalWhollyOwnedSubsidiaries" xlink:to="nvro_NumberOfOperationalWhollyOwnedSubsidiaries_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_SummaryOfSignificantAccountingPoliciesLineItems_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesTable" />
    <link:label xml:lang="en-US" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">A summary of information pertaining to the "Summary Of Significant Accounting Policies" disclosure as a whole for which no other established GAAP taxonomy identified hypercube is available."</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="nvro_SummaryOfSignificantAccountingPoliciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSU&apos;s [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units R S U [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceBasedRestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="nvro_PerformanceBasedRestrictedStockUnitsRSUMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_PerformanceBasedRestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance Based Restricted Stock Units RSU.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_PerformanceBasedRestrictedStockUnitsRSUMember" xlink:to="nvro_PerformanceBasedRestrictedStockUnitsRSUMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_PerformanceBasedRestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance Based RSUs [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PerformanceBasedRestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Performance Based Restricted Stock Units R S U [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments For New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Adoption [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201912Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2019-12 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201912Member" xlink:to="us-gaap_AccountingStandardsUpdate201912Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update201912 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NumberOfOperationalWhollyOwnedSubsidiaries_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operational wholly owned subsidiaries</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NumberOfOperationalWhollyOwnedSubsidiaries_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operational Wholly Owned Subsidiaries</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of business activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operating Segments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net unrealized foreign currency transaction gains (losses)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain Loss Unrealized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized foreign currency transaction gains (losses)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain Loss Realized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:type="locator" xlink:label="us-gaap_CashUninsuredAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashUninsuredAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash held in foreign banks</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashUninsuredAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Uninsured Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unsatisfied performance obligations period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unsatisfied performance obligations description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_BadDebtExpense1" xlink:type="locator" xlink:label="nvro_BadDebtExpense1" />
    <link:label xml:lang="en-US" xlink:label="nvro_BadDebtExpense1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Bad Debt Expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_BadDebtExpense1" xlink:to="nvro_BadDebtExpense1_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_BadDebtExpense1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Bad debt expense</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_BadDebtExpense1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Bad Debt Expense1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful life of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment charges</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Impairment Charges</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Term Of Contract</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanOfferingPeriod" />
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockPurchasePlanOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan offering period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_EmployeeStockPurchasePlanOfferingPeriod" xlink:to="nvro_EmployeeStockPurchasePlanOfferingPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockPurchasePlanOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee stock purchase plan offering period</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockPurchasePlanOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan Offering Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend Yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adoption [true false]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Change In Accounting Principle Accounting Standards Update Adopted</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting standards adopted date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Change In Accounting Principle Accounting Standards Update Adoption Date</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, immaterial effect [true false]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Change In Accounting Principle Accounting Standards Update Immaterial Effect</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Geographical [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Geographical [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:label xml:lang="en-US" xlink:label="country_US_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">United States [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" />
    <link:label xml:lang="en-US" xlink:label="country_US_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">UNITED STATES</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember" xlink:type="locator" xlink:label="us-gaap_NonUsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonUsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">International [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonUsMember" xlink:to="us-gaap_NonUsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonUsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Us [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total revenue</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Benchmark</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk By Benchmark [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Benchmark</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sales Revenue Net [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk By Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_GeographicConcentrationRiskMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeographicConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographic Concentration Risk [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeographicConcentrationRiskMember" xlink:to="us-gaap_GeographicConcentrationRiskMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeographicConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Percentage1</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" xlink:type="locator" xlink:label="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" />
    <link:label xml:lang="en-US" xlink:label="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Concentration risk number of customers exceeding threshold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" xlink:to="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_MajorCustomersAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MajorCustomersAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Major Customers [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Name Of Major Customer [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MajorCustomersMember" xlink:type="locator" xlink:label="nvro_MajorCustomersMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_MajorCustomersMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Major customers.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_MajorCustomersMember" xlink:to="nvro_MajorCustomersMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_MajorCustomersMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Major Customers [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_MajorCustomersMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Major Customers [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Concentration Risk [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CreditConcentrationRiskMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CreditConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Concentration Risk [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditConcentrationRiskMember" xlink:to="us-gaap_CreditConcentrationRiskMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CreditConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Product Or Service [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Products And Services [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PainfulDiabeticNeuropathyMember" xlink:type="locator" xlink:label="nvro_PainfulDiabeticNeuropathyMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_PainfulDiabeticNeuropathyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Painful diabetic neuropathy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_PainfulDiabeticNeuropathyMember" xlink:to="nvro_PainfulDiabeticNeuropathyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_PainfulDiabeticNeuropathyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Painful Diabetic Neuropathy [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PainfulDiabeticNeuropathyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Painful Diabetic Neuropathy [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Concentration risk, percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of customers accounted 10% or more concentration risk</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Number Of Customers Exceeding Threshold</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LesseeOperatingLeaseRemainingTermOfContract" xlink:type="locator" xlink:label="nvro_LesseeOperatingLeaseRemainingTermOfContract" />
    <link:label xml:lang="en-US" xlink:label="nvro_LesseeOperatingLeaseRemainingTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease remaining term of contract.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_LesseeOperatingLeaseRemainingTermOfContract" xlink:to="nvro_LesseeOperatingLeaseRemainingTermOfContract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Lease Description [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Lease Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LesseeOperatingLeaseRemainingTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, remaining term</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LesseeOperatingLeaseRemainingTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Remaining Term Of Contract</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options to extend the lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Renewal Term</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Existence of option to extend the lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Existence Of Option To Extend</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option to extend the lease term, description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Option To Extend</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Remaining Lease Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Discount Rate Percent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Next Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Present value of lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Cost</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" xlink:type="locator" xlink:label="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease assets and liabilities abstract.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" xlink:to="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Leases:</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Assets And Liabilities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Current Statement Of Financial Position Extensible List</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Long term operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating lease liabilities</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:type="locator" xlink:label="nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash paid for amounts included in the measurement of lease liabilities abstract.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:to="nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flow from operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Payments</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MoneyMarketFundsNetAssetValuePerShare" xlink:type="locator" xlink:label="nvro_MoneyMarketFundsNetAssetValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="nvro_MoneyMarketFundsNetAssetValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Money market funds net asset value per share.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_MoneyMarketFundsNetAssetValuePerShare" xlink:to="nvro_MoneyMarketFundsNetAssetValuePerShare_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements Recurring [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Recurring [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level1 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_MoneyMarketFundsNetAssetValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net asset value of market funds</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_MoneyMarketFundsNetAssetValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds Net Asset Value Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type Categorization [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AgencyBondsMember" xlink:type="locator" xlink:label="nvro_AgencyBondsMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_AgencyBondsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agency bonds member.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_AgencyBondsMember" xlink:to="nvro_AgencyBondsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_AgencyBondsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agency Bonds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AgencyBondsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agency Bonds [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Paper [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateNoteSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateNoteSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateNoteSecuritiesMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateNoteSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Note Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasuryBondSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USTreasuryBondSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Treasury Bonds [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasuryBondSecuritiesMember" xlink:to="us-gaap_USTreasuryBondSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USTreasuryBondSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U S Treasury Bond Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level2 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level3 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments Debt And Equity Securities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AgencySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agency Bonds [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AgencySecuritiesMember" xlink:to="us-gaap_AgencySecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AgencySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agency Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Amortized Cost Basis</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Unrealized Holding Gains</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gross Unrealized Holding Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost, Amounts maturing within one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Within One Year Amortized Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost, Amounts maturing after one year through five years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Amounts maturing within one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Within One Year Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Amounts after one year through five years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities After One Through Five Years Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Fair Value, Total investment securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Raw materials</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Raw Materials Net Of Reserves</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finished goods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Finished Goods Net Of Reserves</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total inventories</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_InventoryWriteDownCashAndNonCash" xlink:type="locator" xlink:label="nvro_InventoryWriteDownCashAndNonCash" />
    <link:label xml:lang="en-US" xlink:label="nvro_InventoryWriteDownCashAndNonCash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Inventory write down cash and non cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_InventoryWriteDownCashAndNonCash" xlink:to="nvro_InventoryWriteDownCashAndNonCash_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember" xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certificates of Deposit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Certificates Of Deposit [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_InventoryWriteDownCashAndNonCash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Write down of inventory</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_InventoryWriteDownCashAndNonCash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Write Down Cash And Non Cash</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment and Software [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Furniture And Fixtures [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction in Process [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Construction In Progress [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation Depletion And Amortization Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Depreciation and amortization expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash and Cash Equivalents [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AccruedClinicalAndResearchExpensesCurrent" xlink:type="locator" xlink:label="nvro_AccruedClinicalAndResearchExpensesCurrent" />
    <link:label xml:lang="en-US" xlink:label="nvro_AccruedClinicalAndResearchExpensesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical and research expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_AccruedClinicalAndResearchExpensesCurrent" xlink:to="nvro_AccruedClinicalAndResearchExpensesCurrent_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payables And Accruals [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued payroll and related expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Related Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Income Taxes Current</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AccruedClinicalAndResearchExpensesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued clinical and research expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AccruedClinicalAndResearchExpensesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical And Research Expenses Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued warranty</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrualCurrent" xlink:to="us-gaap_StandardProductWarrantyAccrualCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Standard Product Warranty Accrual Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued liabilities</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LeaseCommencementPeriod" xlink:type="locator" xlink:label="nvro_LeaseCommencementPeriod" />
    <link:label xml:lang="en-US" xlink:label="nvro_LeaseCommencementPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease commencement period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_LeaseCommencementPeriod" xlink:to="nvro_LeaseCommencementPeriod_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LeaseEffectiveDate" xlink:type="locator" xlink:label="nvro_LeaseEffectiveDate" />
    <link:label xml:lang="en-US" xlink:label="nvro_LeaseEffectiveDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease effective date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_LeaseEffectiveDate" xlink:to="nvro_LeaseEffectiveDate_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OperatingLeasesExpirationDate" xlink:type="locator" xlink:label="nvro_OperatingLeasesExpirationDate" />
    <link:label xml:lang="en-US" xlink:label="nvro_OperatingLeasesExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating leases expiration date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_OperatingLeasesExpirationDate" xlink:to="nvro_OperatingLeasesExpirationDate_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LeaseCommencementDateDescription" xlink:type="locator" xlink:label="nvro_LeaseCommencementDateDescription" />
    <link:label xml:lang="en-US" xlink:label="nvro_LeaseCommencementDateDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease commencement date description.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_LeaseCommencementDateDescription" xlink:to="nvro_LeaseCommencementDateDescription_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" xlink:type="locator" xlink:label="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" />
    <link:label xml:lang="en-US" xlink:label="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating leases future minimum payments due in final year of lease term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" xlink:to="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Commitments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RedwoodOfficeAgreementMember" xlink:type="locator" xlink:label="nvro_RedwoodOfficeAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_RedwoodOfficeAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Redwood office agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_RedwoodOfficeAgreementMember" xlink:to="nvro_RedwoodOfficeAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_RedwoodOfficeAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redwood Office Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_RedwoodOfficeAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Redwood Office Agreement [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" xlink:type="locator" xlink:label="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Redwood office agreement additional expansion premises.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" xlink:to="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redwood Office Agreement Additional Expansion Premises [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Redwood Office Agreement Additional Expansion Premises [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementScenarioAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementScenarioAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Scenario [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Scenario Unspecified [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_FirstAmendmentMember" xlink:type="locator" xlink:label="nvro_FirstAmendmentMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_FirstAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">First amendment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_FirstAmendmentMember" xlink:to="nvro_FirstAmendmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_FirstAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_FirstAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">First Amendment [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SecondAmendmentMember" xlink:type="locator" xlink:label="nvro_SecondAmendmentMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_SecondAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Second amendment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_SecondAmendmentMember" xlink:to="nvro_SecondAmendmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_SecondAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SecondAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Second Amendment [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_FacilityLeaseAgreementThreeMember" xlink:type="locator" xlink:label="nvro_FacilityLeaseAgreementThreeMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_FacilityLeaseAgreementThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Facility lease agreement three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_FacilityLeaseAgreementThreeMember" xlink:to="nvro_FacilityLeaseAgreementThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_FacilityLeaseAgreementThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cancellable Facility Lease [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_FacilityLeaseAgreementThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Facility Lease Agreement Three [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CR" xlink:type="locator" xlink:label="country_CR" />
    <link:label xml:lang="en-US" xlink:label="country_CR_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Costa Rica [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CR" xlink:to="country_CR_lbl" />
    <link:label xml:lang="en-US" xlink:label="country_CR_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">COSTA RICA</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SupplyAgreementsMember" xlink:type="locator" xlink:label="nvro_SupplyAgreementsMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_SupplyAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Supply Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_SupplyAgreementsMember" xlink:to="nvro_SupplyAgreementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_SupplyAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supply Agreements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SupplyAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supply Agreements [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets By Major Class [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Major Class Name [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember" xlink:type="locator" xlink:label="us-gaap_ServiceAgreementsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ServiceAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServiceAgreementsMember" xlink:to="us-gaap_ServiceAgreementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ServiceAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Service Agreements [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repurchase Agreement Counterparty Name [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MayoAndVglMember" xlink:type="locator" xlink:label="nvro_MayoAndVglMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_MayoAndVglMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Mayo And VGL.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_MayoAndVglMember" xlink:to="nvro_MayoAndVglMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_MayoAndVglMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mayo And VGL [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_MayoAndVglMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Mayo And Vgl [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:type="locator" xlink:label="us-gaap_LicensingAgreementsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LicensingAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Licensing Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensingAgreementsMember" xlink:to="us-gaap_LicensingAgreementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LicensingAgreementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Licensing Agreements [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MayoFoundationMember" xlink:type="locator" xlink:label="nvro_MayoFoundationMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_MayoFoundationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Mayo Foundation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_MayoFoundationMember" xlink:to="nvro_MayoFoundationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_MayoFoundationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mayo Foundation [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_MayoFoundationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Mayo Foundation [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingency Nature</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies By Nature Of Contingency [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingency, Nature</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_LossContingencyNatureDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Nature [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndemnificationGuaranteeMember" xlink:type="locator" xlink:label="us-gaap_IndemnificationGuaranteeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IndemnificationGuaranteeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indemnification Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndemnificationGuaranteeMember" xlink:to="us-gaap_IndemnificationGuaranteeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IndemnificationGuaranteeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Indemnification Guarantee [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_BostonScientificCorporationMember" xlink:type="locator" xlink:label="nvro_BostonScientificCorporationMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_BostonScientificCorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Boston scientific corporation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_BostonScientificCorporationMember" xlink:to="nvro_BostonScientificCorporationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_BostonScientificCorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Boston Scientific Corporation [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_BostonScientificCorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Boston Scientific Corporation [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PatentInfringementMember" xlink:type="locator" xlink:label="nvro_PatentInfringementMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_PatentInfringementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent infringement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_PatentInfringementMember" xlink:to="nvro_PatentInfringementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_PatentInfringementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Infringement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PatentInfringementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Patent Infringement [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Commitments [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LeaseCommencementPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease agreement, commencement period</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LeaseCommencementPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Commencement Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:type="locator" xlink:label="us-gaap_AreaOfLand" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AreaOfLand_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Area of office space</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AreaOfLand_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Area Of Land</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LeaseEffectiveDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease agreement, effective date</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LeaseEffectiveDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Effective Date</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OperatingLeasesExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease agreement, expiration period</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OperatingLeasesExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Expiration Date</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expense, payment due</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due Current</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual lease expense payable in final year of lease term</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due In Final Year Of Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LeaseCommencementDateDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commencement date description</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LeaseCommencementDateDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Commencement Date Description</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperationsCommencedDate1" xlink:type="locator" xlink:label="us-gaap_OperationsCommencedDate1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperationsCommencedDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease commencement date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperationsCommencedDate1" xlink:to="us-gaap_OperationsCommencedDate1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperationsCommencedDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operations Commenced Date1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease agreement, expiration date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease agreement, lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyDescription" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Standard product warranty, description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyDescription" xlink:to="us-gaap_StandardProductWarrantyDescription_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Standard Product Warranty Description</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for warranty</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Standard Product Warranty Accrual Warranties Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyAccrualPayments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyAccrualPayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Utilization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="us-gaap_StandardProductWarrantyAccrualPayments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyAccrualPayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Standard Product Warranty Accrual Payments</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase commitment, amount due</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation Due In Next Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:type="locator" xlink:label="us-gaap_InventoryFirmPurchaseCommitmentLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryFirmPurchaseCommitmentLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase commitments for inventory related charge</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:to="us-gaap_InventoryFirmPurchaseCommitmentLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryFirmPurchaseCommitmentLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Firm Purchase Commitment Loss</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearOne" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearOne" />
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearOne_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Service agreement commitment amount year one.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ServiceAgreementCommitmentAmountYearOne" xlink:to="nvro_ServiceAgreementCommitmentAmountYearOne_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearTwo" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearTwo" />
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Service agreement commitment amount year two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ServiceAgreementCommitmentAmountYearTwo" xlink:to="nvro_ServiceAgreementCommitmentAmountYearTwo_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearThree" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearThree" />
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Service agreement commitment amount year three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ServiceAgreementCommitmentAmountYearThree" xlink:to="nvro_ServiceAgreementCommitmentAmountYearThree_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearFour" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearFour" />
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Service agreement commitment amount year four.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ServiceAgreementCommitmentAmountYearFour" xlink:to="nvro_ServiceAgreementCommitmentAmountYearFour_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearOne_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearOne_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Service Agreement Commitment Amount Year One</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Service Agreement Commitment Amount Year Two</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Service Agreement Commitment Amount Year Three</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ServiceAgreementCommitmentAmountYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Service Agreement Commitment Amount Year Four</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement, terms</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Arrangement Contract To Perform For Others Description And Terms</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Retainer fees</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual royalty payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Expense</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NonCashResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="nvro_NonCashResearchAndDevelopmentExpense" />
    <link:label xml:lang="en-US" xlink:label="nvro_NonCashResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncash research and development expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_NonCashResearchAndDevelopmentExpense" xlink:to="nvro_NonCashResearchAndDevelopmentExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Common stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NonCashResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Noncash research and development expense</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NonCashResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Cash Research And Development Expense</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LicenseAgreementExpirationYear" xlink:type="locator" xlink:label="nvro_LicenseAgreementExpirationYear" />
    <link:label xml:lang="en-US" xlink:label="nvro_LicenseAgreementExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement expiration year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_LicenseAgreementExpirationYear" xlink:to="nvro_LicenseAgreementExpirationYear_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LicenseAgreementCommitmentAmount" xlink:type="locator" xlink:label="nvro_LicenseAgreementCommitmentAmount" />
    <link:label xml:lang="en-US" xlink:label="nvro_LicenseAgreementCommitmentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement commitment amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_LicenseAgreementCommitmentAmount" xlink:to="nvro_LicenseAgreementCommitmentAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_LicenseAgreementCommitmentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement commitment amount</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LicenseAgreementCommitmentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Commitment Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LicenseAgreementExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement expiration year</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_LicenseAgreementExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Expiration Year</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" xlink:type="locator" xlink:label="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" />
    <link:label xml:lang="en-US" xlink:label="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent consideration payment secured by convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" xlink:to="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" xlink:type="locator" xlink:label="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" />
    <link:label xml:lang="en-US" xlink:label="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional contingent consideration payment secured by convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" xlink:to="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NumberOfSecuredConvertibleNotes" xlink:type="locator" xlink:label="nvro_NumberOfSecuredConvertibleNotes" />
    <link:label xml:lang="en-US" xlink:label="nvro_NumberOfSecuredConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of secured convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_NumberOfSecuredConvertibleNotes" xlink:to="nvro_NumberOfSecuredConvertibleNotes_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" xlink:type="locator" xlink:label="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" />
    <link:label xml:lang="en-US" xlink:label="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Secured convertible note receivable measured at amortized cost.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" xlink:to="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ValueOfCertainRightsMeasuredAtCost" xlink:type="locator" xlink:label="nvro_ValueOfCertainRightsMeasuredAtCost" />
    <link:label xml:lang="en-US" xlink:label="nvro_ValueOfCertainRightsMeasuredAtCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Value of certain rights measured at cost.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ValueOfCertainRightsMeasuredAtCost" xlink:to="nvro_ValueOfCertainRightsMeasuredAtCost_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" xlink:type="locator" xlink:label="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" />
    <link:label xml:lang="en-US" xlink:label="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent consideration expenses net secured by convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" xlink:to="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent consideration payment secured by convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration Payment Secured By Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional contingent consideration payment secured by convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Contingent Consideration Payment Secured By Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NumberOfSecuredConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of secured convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NumberOfSecuredConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Secured Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Secured convertible note, measured at amortized cost</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Secured Convertible Note Receivable Measured At Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ValueOfCertainRightsMeasuredAtCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Value of certain rights measured at cost</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ValueOfCertainRightsMeasuredAtCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Value Of Certain Rights Measured At Cost</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent consideration expenses net secured by convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration Expenses Net Secured By Convertible Notes</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Accrual At Carrying Value</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" xlink:type="locator" xlink:label="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" />
    <link:label xml:lang="en-US" xlink:label="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent infringement lawsuit allegation against number of patents.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" xlink:to="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent infringement lawsuit allegation against number of patents</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Patent Infringement Lawsuit Allegation Against Number Of Patents</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="locator" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount awarded by jury</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Settlement Amount Awarded To Other Party</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityMonthAndYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityMonthAndYear" />
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentMaturityMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The month and year (YYYY-MM) that the debt instrument maturity is due.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DebtInstrumentMaturityMonthAndYear" xlink:to="nvro_DebtInstrumentMaturityMonthAndYear_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Conversion Description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion By Unique Description [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Conversion, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="us-gaap_DebtConversionNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Name [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:type="locator" xlink:label="nvro_OneHundredThirtyPercentApplicableConversionPriceMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_OneHundredThirtyPercentApplicableConversionPriceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">One hundred thirty percent applicable conversion price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:to="nvro_OneHundredThirtyPercentApplicableConversionPriceMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_OneHundredThirtyPercentApplicableConversionPriceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">130% for Applicable Conversion Price [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_OneHundredThirtyPercentApplicableConversionPriceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">One Hundred Thirty Percent Applicable Conversion Price [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NinetyEightPercentApplicableConversionPriceMember" xlink:type="locator" xlink:label="nvro_NinetyEightPercentApplicableConversionPriceMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_NinetyEightPercentApplicableConversionPriceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Ninety eight percent applicable conversion price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_NinetyEightPercentApplicableConversionPriceMember" xlink:to="nvro_NinetyEightPercentApplicableConversionPriceMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_NinetyEightPercentApplicableConversionPriceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">98% Applicable Conversion Price [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NinetyEightPercentApplicableConversionPriceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Ninety Eight Percent Applicable Conversion Price [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentMaturityMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument due year</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentMaturityMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Maturity Month And Year</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" xlink:type="locator" xlink:label="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" />
    <link:label xml:lang="en-US" xlink:label="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of principal amount of convertible notes is equal to repurchase price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" xlink:to="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes principal amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Converted Instrument Amount1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Converted Instrument Shares Issued1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes, type of equity security issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity" xlink:to="us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Type Of Equity Security</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes, conversion price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Conversion Price1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument convertible trading days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Threshold Trading Days</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument convertible consecutive trading days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Threshold Consecutive Trading Days1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument convertible, percentage of conversion price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of closing sale price of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Price Percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of repurchase price, which is equal to principal amount of convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Principal Amount Of Convertible Notes Is Equal To Repurchase Price</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NoteHedgesTransactionCosts" xlink:type="locator" xlink:label="nvro_NoteHedgesTransactionCosts" />
    <link:label xml:lang="en-US" xlink:label="nvro_NoteHedgesTransactionCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Note hedges transaction costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_NoteHedgesTransactionCosts" xlink:to="nvro_NoteHedgesTransactionCosts_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" xlink:type="locator" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" />
    <link:label xml:lang="en-US" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital hedge and warrant transactions net cost.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" xlink:to="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NoteHedgesNumberOfSharesContractedToBuy" xlink:type="locator" xlink:label="nvro_NoteHedgesNumberOfSharesContractedToBuy" />
    <link:label xml:lang="en-US" xlink:label="nvro_NoteHedgesNumberOfSharesContractedToBuy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Note hedges number of shares contracted to buy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_NoteHedgesNumberOfSharesContractedToBuy" xlink:to="nvro_NoteHedgesNumberOfSharesContractedToBuy_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PurchasePricePerCommonStock" xlink:type="locator" xlink:label="nvro_PurchasePricePerCommonStock" />
    <link:label xml:lang="en-US" xlink:label="nvro_PurchasePricePerCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase price per common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_PurchasePricePerCommonStock" xlink:to="nvro_PurchasePricePerCommonStock_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ConversionPricePerShare" xlink:type="locator" xlink:label="nvro_ConversionPricePerShare" />
    <link:label xml:lang="en-US" xlink:label="nvro_ConversionPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion price per share.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ConversionPricePerShare" xlink:to="nvro_ConversionPricePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_NoteHedgesNumberOfSharesContractedToBuy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares purchased under convertible note hedge transactions</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NoteHedgesNumberOfSharesContractedToBuy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Note Hedges Number Of Shares Contracted To Buy</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PurchasePricePerCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase price of the shares issued under convertible note hedge transactions</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PurchasePricePerCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Price Per Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NoteHedgesTransactionCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cost of the convertible note hedge transactions</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NoteHedgesTransactionCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Note Hedges Transaction Costs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares issued for warrants under convertible note hedge transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase price of the shares issued under convertible note hedge transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ConversionPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Overall conversion price</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ConversionPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net cost of reduction to additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Hedge And Warrant Transactions Net Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt conversion, converted instrument amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Carrying Amount Of The Equity Component</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, effective interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Rate Effective Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt issuance costs attributable to the liability and equity component, total amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Finance Costs Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentGross" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt issuance costs attributable to the liability component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNoncurrentGross" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Finance Costs Noncurrent Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel">Principal amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Carrying Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Share received on option exercise</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Holders of warrants associated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Warrant Exercises</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:type="locator" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Longterm Notes Payable Current And Noncurrent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unamortized discount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Unamortized Discount</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unamortized issuance cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net carrying amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt discount related to value of conversion option</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Equity Discount Related To Value Of Conversion Option</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Debt issuance cost</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Equity Component Issuance Cost</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net carrying amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Converted Value in Excess of Principal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:to="us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible If Converted Value In Excess Of Principal</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand Twenty One And Two Thousand Twenty Five Notes [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" xlink:to="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Notes and 2025 Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty One And Two Thousand Twenty Five Notes [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contractual interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense Debt Excluding Amortization</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt discount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Debt Discount Premium</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Amortization of debt issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Financing Costs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stock By Class [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IPOMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IPO [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IPOMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">I P O [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock converted to common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Stock Shares Converted1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock shares issued for each convertible preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Shares Issued Upon Conversion</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock outstanding</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CommonStockOptionsAndAwardsOutstanding" xlink:type="locator" xlink:label="nvro_CommonStockOptionsAndAwardsOutstanding" />
    <link:label xml:lang="en-US" xlink:label="nvro_CommonStockOptionsAndAwardsOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock options and awards outstanding.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_CommonStockOptionsAndAwardsOutstanding" xlink:to="nvro_CommonStockOptionsAndAwardsOutstanding_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" xlink:type="locator" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" />
    <link:label xml:lang="en-US" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock reserved for future issuance under stock option and awards grants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" xlink:to="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" />
    <link:label xml:lang="en-US" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock reserved for future issuance under employee stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" xlink:to="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_CommonStockOptionsAndAwardsOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding stock options and awards</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_CommonStockOptionsAndAwardsOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Options And Awards Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reserved for grants of future stock options and awards</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Reserved For Future Issuance Under Stock Option And Awards Grants</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reserved for employee stock purchase plan</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Reserved For Future Issuance Under Employee Stock Purchase Plan</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total common stock reserved for future issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandSevenPlanMember" xlink:type="locator" xlink:label="nvro_TwoThousandSevenPlanMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandSevenPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">2007 Plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_TwoThousandSevenPlanMember" xlink:to="nvro_TwoThousandSevenPlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandSevenPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2007 Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandSevenPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Seven Plan [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandFourteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="nvro_TwoThousandFourteenEquityIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandFourteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">2014 Equity Incentive Plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_TwoThousandFourteenEquityIncentivePlanMember" xlink:to="nvro_TwoThousandFourteenEquityIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandFourteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2014 Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TwoThousandFourteenEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Fourteen Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:type="locator" xlink:label="us-gaap_VestingAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Award, Tranche One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Award Tranche One [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_IncentiveStockOptionsMember" xlink:type="locator" xlink:label="nvro_IncentiveStockOptionsMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_IncentiveStockOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Incentive Stock Options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_IncentiveStockOptionsMember" xlink:to="nvro_IncentiveStockOptionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_IncentiveStockOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ISO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_IncentiveStockOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Incentive Stock Options [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NonQualifiedStockOptionsMember" xlink:type="locator" xlink:label="nvro_NonQualifiedStockOptionsMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_NonQualifiedStockOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non Qualified Stock Options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_NonQualifiedStockOptionsMember" xlink:to="nvro_NonQualifiedStockOptionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_NonQualifiedStockOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NSO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_NonQualifiedStockOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Qualified Stock Options [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual With Relationship To Entity [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <link:label xml:lang="en-US" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CEO [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:type="locator" xlink:label="srt_ManagementMember" />
    <link:label xml:lang="en-US" xlink:label="srt_ManagementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Member of Management Team [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ManagementMember" xlink:to="srt_ManagementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ManagementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Management [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional awards authorized under plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock reserved for future issuance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan modification description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PercentageOfShareholderOptionsGranted" xlink:type="locator" xlink:label="nvro_PercentageOfShareholderOptionsGranted" />
    <link:label xml:lang="en-US" xlink:label="nvro_PercentageOfShareholderOptionsGranted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of shareholder options granted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_PercentageOfShareholderOptionsGranted" xlink:to="nvro_PercentageOfShareholderOptionsGranted_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options expiration period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option purchase price, percentage of fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PercentageOfShareholderOptionsGranted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of shareholder granted option</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_PercentageOfShareholderOptionsGranted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Shareholder Options Granted</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of allowance for PSU for over performance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award number of shares forfeited for tax.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments options and other than options grants in period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments options and other than options forfeited and expirations in period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock option, restricted stock units and performance stock units.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" xlink:to="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Option, RSUs and PSUs [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option Restricted Stock Units And Performance Stock Units [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Shares Available for Grant, Beginning balances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares Available for Grant, Additional shares reserved</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares Available for Grant, Allowance for PSU for over performance</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Allowance For P S U For Over Performance</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares Available for Grant, Shares forfeited for tax</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Forfeited For Tax</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares Available for Grant, Options and other than options granted</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options And Other Than Options Grants In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Available for Grant, Options and other than options forfeited or cancelled</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options And Other Than Options Forfeited And Expirations In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Shares Available for Grant, Ending balances</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:type="locator" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, options outstanding, weighted average exercise price, and additional disclosures.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Exercise Price And Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of Options, Outstanding Beginning balances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options, Options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Options, Options exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Options, Options cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of Options, Outstanding Ending balances</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options, Options exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options, Options vested, exercisable or expected to vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted Average Exercise Price, Beginning balances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Options cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted Average Exercise Price, Ending balances</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Options exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Options vested, exercisable or expected to vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Weighted-Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable, Weighted-Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vested, exercisable or expected to vest, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercised, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vested, exercisable or expected to vest, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant-date fair value of options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of options vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise Price Range</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise Price Range</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range1Member" xlink:type="locator" xlink:label="nvro_Range1Member" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Range 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_Range1Member" xlink:to="nvro_Range1Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$3.60 - $36.55 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_Range1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range1 [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range2Member" xlink:type="locator" xlink:label="nvro_Range2Member" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Range 2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_Range2Member" xlink:to="nvro_Range2Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$38.79 - $45.04 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_Range2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range2 [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range3Member" xlink:type="locator" xlink:label="nvro_Range3Member" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Range 3 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_Range3Member" xlink:to="nvro_Range3Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$45.07 - $63.23 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_Range3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range3 [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range4Member" xlink:type="locator" xlink:label="nvro_Range4Member" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range4Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Range 4 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_Range4Member" xlink:to="nvro_Range4Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range4Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$63.39 - $64.95 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_Range4Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range4 [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range5Member" xlink:type="locator" xlink:label="nvro_Range5Member" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range5Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Range 5 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_Range5Member" xlink:to="nvro_Range5Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range5Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$65.51 - $87.62 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_Range5Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range5 [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range6Member" xlink:type="locator" xlink:label="nvro_Range6Member" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range6Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Range 6 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_Range6Member" xlink:to="nvro_Range6Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range6Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$97.52 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_Range6Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range6 [Member]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range7Member" xlink:type="locator" xlink:label="nvro_Range7Member" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range7Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Range 7.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_Range7Member" xlink:to="nvro_Range7Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_Range7Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">$3.60 - $97.52 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_Range7Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range7 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Exercise Price Lower Range Limit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation shares authorized under stock option plans exercise price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:to="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Exercise Price Upper Range Limit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Weighted Average Remaining Contractual Life (in Years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Vested, Number Exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Vested, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments other than options expected to vest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted Stock Units [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of Restricted Stock Units, Outstanding Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Restricted Stock Units, Restricted stock granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Restricted Stock Units, Restricted stock released</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Restricted Stock Units, Restricted stock cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of Restricted Stock Units, Outstanding Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Restricted Stock Units, Restricted stock expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, equity instruments other than options, shares expected to vest, weighted average grant date fair value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted Average Grant Date Fair Value Outstanding, Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value, Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value, Released</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value, Cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted Average Grant Date Fair Value Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value, Restricted stock expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" xlink:type="locator" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" />
    <link:label xml:lang="en-US" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value expected to vest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" xlink:to="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Released</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Expected To Vest</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TargetedCompositeIndexPeriod" xlink:type="locator" xlink:label="nvro_TargetedCompositeIndexPeriod" />
    <link:label xml:lang="en-US" xlink:label="nvro_TargetedCompositeIndexPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Targeted composite index period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_TargetedCompositeIndexPeriod" xlink:to="nvro_TargetedCompositeIndexPeriod_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TargetedNumberOfSharesGrantedRatio" xlink:type="locator" xlink:label="nvro_TargetedNumberOfSharesGrantedRatio" />
    <link:label xml:lang="en-US" xlink:label="nvro_TargetedNumberOfSharesGrantedRatio_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Targeted number of shares granted ratio.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_TargetedNumberOfSharesGrantedRatio" xlink:to="nvro_TargetedNumberOfSharesGrantedRatio_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_TargetedCompositeIndexPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Targeted composite index period</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TargetedCompositeIndexPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Targeted Composite Index Period</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TargetedNumberOfSharesGrantedRatio_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Targeted number of shares granted ratio</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_TargetedNumberOfSharesGrantedRatio_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Targeted Number Of Shares Granted Ratio</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of Restricted Stock Units, PSU granted</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Number of Restricted Stock Units, PSU released</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Number of Restricted Stock Units, PSU cancelled</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of Restricted Stock Units, PSU expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Grant Date Fair Value, PSU Granted</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Grant Date Fair Value, PSU Released</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Grant Date Fair Value, PSU Cancelled</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Grant Date Fair Value, PSU expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate Intrinsic Value PSU Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate Intrinsic Value, PSU Released</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate Intrinsic Value, PSU Expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares available for sale</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum employee subscription rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockPurchasePlanOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Employee stock purchase plan offering period</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award value issued in period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee Stock Purchase Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_EmployeeStockPurchasePlanMember" xlink:to="nvro_EmployeeStockPurchasePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ESPP [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel">Additional shares reserved</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares available for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Employee contributions for shares issued</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Value Issued In Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RecognitionPeriodOfStockBasedCompensationExpense" xlink:type="locator" xlink:label="nvro_RecognitionPeriodOfStockBasedCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="nvro_RecognitionPeriodOfStockBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Recognition period of stock based compensation expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_RecognitionPeriodOfStockBasedCompensationExpense" xlink:to="nvro_RecognitionPeriodOfStockBasedCompensationExpense_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_RecognitionPeriodOfStockBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognition period of stock based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_RecognitionPeriodOfStockBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Recognition Period Of Stock Based Compensation Expense</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award fair value assumptions index volatility rate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share-based payment award, fair value assumptions volatility rate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award fair value assumptions correlation wirh index rate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Index volatility</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Index Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Company volatility</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Correlation with index</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Correlation With Index Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Revenue [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Sales [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, General and Administrative [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling General And Administrative Expenses [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Amortization Period (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Domestic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Domestic</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Foreign</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense Benefit Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current State And Local Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current income tax expense / (benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense Benefit Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State And Local Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Foreign Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred income tax expense / (benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense Benefit</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total income tax expense / (benefit)</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax at statutory federal rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State tax, net of federal benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation State And Local Income Taxes</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign rate differential</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tax credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Tax Credits</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Other Adjustments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Continuing Operations</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DeferredTaxAssetsDepreciation" xlink:type="locator" xlink:label="nvro_DeferredTaxAssetsDepreciation" />
    <link:label xml:lang="en-US" xlink:label="nvro_DeferredTaxAssetsDepreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets depreciation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DeferredTaxAssetsDepreciation" xlink:to="nvro_DeferredTaxAssetsDepreciation_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DeferredTaxLiabilitiesRightOfUseAsset" xlink:type="locator" xlink:label="nvro_DeferredTaxLiabilitiesRightOfUseAsset" />
    <link:label xml:lang="en-US" xlink:label="nvro_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities right of use asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DeferredTaxLiabilitiesRightOfUseAsset" xlink:to="nvro_DeferredTaxLiabilitiesRightOfUseAsset_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DeferredTaxAssetsLeaseLiabilities" xlink:type="locator" xlink:label="nvro_DeferredTaxAssetsLeaseLiabilities" />
    <link:label xml:lang="en-US" xlink:label="nvro_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_DeferredTaxAssetsLeaseLiabilities" xlink:to="nvro_DeferredTaxAssetsLeaseLiabilities_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DeferredTaxAssetsDepreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DeferredTaxAssetsDepreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Depreciation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accruals and reserves</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Reserves And Accruals</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right of use asset</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Right Of Use Asset</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Other</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gross deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Net</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Lease Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Liabilities Net</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_IncomeTaxesLineItems" xlink:type="locator" xlink:label="nvro_IncomeTaxesLineItems" />
    <link:label xml:lang="en-US" xlink:label="nvro_IncomeTaxesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income taxes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="nvro_IncomeTaxesLineItems_lbl" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_IncomeTaxesTable" xlink:type="locator" xlink:label="nvro_IncomeTaxesTable" />
    <link:label xml:lang="en-US" xlink:label="nvro_IncomeTaxesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income taxes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_IncomeTaxesTable" xlink:to="nvro_IncomeTaxesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_IncomeTaxesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_IncomeTaxesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Country [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State and Local Jurisdiction [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">State And Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Name [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:type="locator" xlink:label="us-gaap_ResearchMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Credit Carryforwards [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority Name [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority Name [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:type="locator" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California state [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">California Franchise Tax Board [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_IncomeTaxesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_IncomeTaxesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance Deferred Tax Asset Change In Amount</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" xlink:type="locator" xlink:label="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" />
    <link:label xml:lang="en-US" xlink:label="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Federal and state net operating loss carry forwards expiration year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" xlink:to="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss expiration date</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Federal And State Net Operating Loss Carry Forwards Expiration Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Tax credit carry forwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increases related to current year tax provisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increases related to prior year tax provisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Decreases related to prior year tax provisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest and penalties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Earnings Per Share Diluted By Common Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Diluted By Common Class [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareDilutedLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share Diluted [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_EarningsPerShareDilutedLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareDilutedLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Diluted [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayable" xlink:type="locator" xlink:label="us-gaap_NotesPayable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Notes Payable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Name [Domain]</link:label>
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RestrictedAndPerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_RestrictedAndPerformanceStockUnitsMember" />
    <link:label xml:lang="en-US" xlink:label="nvro_RestrictedAndPerformanceStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted and performance stock units.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nvro_RestrictedAndPerformanceStockUnitsMember" xlink:to="nvro_RestrictedAndPerformanceStockUnitsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="nvro_RestrictedAndPerformanceStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unreleased Restricted and Performance Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="nvro_RestrictedAndPerformanceStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted And Performance Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options to Purchase Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible Senior Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants Related to the Issuance of Convertible Senior Notes [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potentially dilutive securities excluded from computation of diluted shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Compensation And Retirement Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expense for matching contributions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Employer Discretionary Contribution Amount</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>nvro-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-02-21T20:51:18.0882342+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 3affc067051b45aa87ab8e436534d58c -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.nevro.com/20211231/role/TemplateLink" xlink:href="nvro-20211231.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="nvro-20211231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:type="locator" xlink:label="dei_AuditorLocation" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:type="locator" xlink:label="dei_AuditorName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:type="locator" xlink:label="dei_AuditorFirmId" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="11630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="11690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="11990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="12070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="12130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="12190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="nvro-20211231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ShortTermBorrowings" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="11630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="11670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="nvro-20211231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="nvro-20211231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:type="locator" xlink:label="us-gaap_LitigationSettlementExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:type="locator" xlink:label="us-gaap_GrossProfit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_LitigationSettlementExpense" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestExpense" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="11500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="nvro-20211231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" xlink:type="locator" xlink:label="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" xlink:type="locator" xlink:label="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" xlink:type="locator" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_li0l2" order="12290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_li0l2" order="12310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="nvro-20211231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="locator" xlink:label="us-gaap_PaymentsForHedgeFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" xlink:type="locator" xlink:label="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RepaymentFromInvestmentInPrivateCompany" xlink:type="locator" xlink:label="nvro_RepaymentFromInvestmentInPrivateCompany" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" xlink:type="locator" xlink:label="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AmortizationOfOperatingLeaseAsset" xlink:type="locator" xlink:label="nvro_AmortizationOfOperatingLeaseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="nvro_AmortizationOfOperatingLeaseAsset" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="11540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="11660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="11780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="11900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="11960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="nvro_RepaymentFromInvestmentInPrivateCompany" order="12020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="12080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="12140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="12200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="12320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="12380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts" order="12440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="12500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForHedgeFinancingActivities" order="12560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" order="12620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="12680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="12740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="12800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="12860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="12920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="12980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="13100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" order="13160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="13220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="13340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="13400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="13460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="13580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompany" xlink:href="nvro-20211231.xsd#Role_DisclosureFormationAndBusinessOfCompany" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompany">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="nvro-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenue" xlink:href="nvro-20211231.xsd#Role_DisclosureRevenue" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenue">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeases" xlink:href="nvro-20211231.xsd#Role_DisclosureLeases" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeases">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="nvro-20211231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurements">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponents" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponents" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponents">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="nvro-20211231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebt" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebt" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebt">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStock" xlink:href="nvro-20211231.xsd#Role_DisclosureConvertiblePreferredStock" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStock">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:type="locator" xlink:label="us-gaap_PreferredStockTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_PreferredStockTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensation" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensation">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxes">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShare" xlink:href="nvro-20211231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShare">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlan" xlink:href="nvro-20211231.xsd#Role_DisclosureEmployeeBenefitPlan" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlan">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract" xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PostemploymentBenefitsAbstract" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="nvro-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="locator" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock" xlink:type="locator" xlink:label="nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OtherRisksAndUncertainties1PolicyTextBlock" xlink:type="locator" xlink:label="nvro_OtherRisksAndUncertainties1PolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nvro_OtherRisksAndUncertainties1PolicyTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueTables" xlink:href="nvro-20211231.xsd#Role_DisclosureRevenueTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock" xlink:type="locator" xlink:label="nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock" xlink:type="locator" xlink:label="nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="nvro-20211231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="nvro-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" xlink:type="locator" xlink:label="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtEquityComponentMember" xlink:type="locator" xlink:label="nvro_DebtEquityComponentMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtLiabilityComponentMember" xlink:type="locator" xlink:label="nvro_DebtLiabilityComponentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtLiabilityComponentMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtEquityComponentMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:type="locator" xlink:label="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="locator" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables" xlink:href="nvro-20211231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="locator" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:type="locator" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="locator" xlink:label="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:type="locator" xlink:label="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:type="locator" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanOfferingPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_BadDebtExpense1" xlink:type="locator" xlink:label="nvro_BadDebtExpense1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:type="locator" xlink:label="us-gaap_CashUninsuredAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NumberOfOperationalWhollyOwnedSubsidiaries" xlink:type="locator" xlink:label="nvro_NumberOfOperationalWhollyOwnedSubsidiaries" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201912Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceBasedRestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="nvro_PerformanceBasedRestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nvro_SummaryOfSignificantAccountingPoliciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceBasedRestrictedStockUnitsRSUMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="nvro_SummaryOfSignificantAccountingPoliciesLineItems" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_NumberOfOperationalWhollyOwnedSubsidiaries" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CashUninsuredAmount" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_BadDebtExpense1" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="nvro_EmployeeStockPurchasePlanOfferingPeriod" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" xlink:href="nvro-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="nvro_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="nvro_SummaryOfSignificantAccountingPoliciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesTable" xlink:to="nvro_SummaryOfSignificantAccountingPoliciesLineItems" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember" xlink:type="locator" xlink:label="us-gaap_NonUsMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_StatementGeographicalAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_NonUsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskLineItems" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_GeographicConcentrationRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_GeographicConcentrationRiskMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_StatementGeographicalAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskLineItems" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureRevenueAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" xlink:type="locator" xlink:label="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PainfulDiabeticNeuropathyMember" xlink:type="locator" xlink:label="nvro_PainfulDiabeticNeuropathyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CreditConcentrationRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MajorCustomersMember" xlink:type="locator" xlink:label="nvro_MajorCustomersMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_MajorCustomersAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="nvro_MajorCustomersMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CreditConcentrationRiskMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="nvro_PainfulDiabeticNeuropathyMember" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LesseeOperatingLeaseRemainingTermOfContract" xlink:type="locator" xlink:label="nvro_LesseeOperatingLeaseRemainingTermOfContract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:type="locator" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="nvro_LesseeOperatingLeaseRemainingTermOfContract" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSupplementalLeaseCostInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesSupplementalLeaseCostInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSupplementalLeaseCostInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" xlink:type="locator" xlink:label="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_OperatingLeaseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:type="locator" xlink:label="nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureFairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFairValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MoneyMarketFundsNetAssetValuePerShare" xlink:type="locator" xlink:label="nvro_MoneyMarketFundsNetAssetValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" xlink:type="locator" xlink:label="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:type="locator" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="nvro_MoneyMarketFundsNetAssetValuePerShare" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasuryBondSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateNoteSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AgencyBondsMember" xlink:type="locator" xlink:label="nvro_AgencyBondsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="nvro_AgencyBondsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryBondSecuritiesMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBondSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasuryBondSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateNoteSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AgencySecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_AgencySecuritiesMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryBondSecuritiesMember" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryNet" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_InventoryWriteDownCashAndNonCash" xlink:type="locator" xlink:label="nvro_InventoryWriteDownCashAndNonCash" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember" xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CertificatesOfDepositMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryDisclosureAbstract" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="nvro_InventoryWriteDownCashAndNonCash" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAbstract" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrent" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AccruedClinicalAndResearchExpensesCurrent" xlink:type="locator" xlink:label="nvro_AccruedClinicalAndResearchExpensesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedIncomeTaxesCurrent" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="nvro_AccruedClinicalAndResearchExpensesCurrent" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_InterestPayableCurrent" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_StandardProductWarrantyAccrualCurrent" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="locator" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" xlink:type="locator" xlink:label="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" xlink:type="locator" xlink:label="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ValueOfCertainRightsMeasuredAtCost" xlink:type="locator" xlink:label="nvro_ValueOfCertainRightsMeasuredAtCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" xlink:type="locator" xlink:label="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NumberOfSecuredConvertibleNotes" xlink:type="locator" xlink:label="nvro_NumberOfSecuredConvertibleNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" xlink:type="locator" xlink:label="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" xlink:type="locator" xlink:label="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LicenseAgreementExpirationYear" xlink:type="locator" xlink:label="nvro_LicenseAgreementExpirationYear" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LicenseAgreementCommitmentAmount" xlink:type="locator" xlink:label="nvro_LicenseAgreementCommitmentAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NonCashResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="nvro_NonCashResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearFour" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearFour" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearThree" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearThree" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearTwo" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearTwo" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ServiceAgreementCommitmentAmountYearOne" xlink:type="locator" xlink:label="nvro_ServiceAgreementCommitmentAmountYearOne" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFirmPurchaseCommitmentLoss" xlink:type="locator" xlink:label="us-gaap_InventoryFirmPurchaseCommitmentLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperationsCommencedDate1" xlink:type="locator" xlink:label="us-gaap_OperationsCommencedDate1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LeaseCommencementDateDescription" xlink:type="locator" xlink:label="nvro_LeaseCommencementDateDescription" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" xlink:type="locator" xlink:label="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OperatingLeasesExpirationDate" xlink:type="locator" xlink:label="nvro_OperatingLeasesExpirationDate" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LeaseEffectiveDate" xlink:type="locator" xlink:label="nvro_LeaseEffectiveDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:type="locator" xlink:label="us-gaap_AreaOfLand" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_LeaseCommencementPeriod" xlink:type="locator" xlink:label="nvro_LeaseCommencementPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PatentInfringementMember" xlink:type="locator" xlink:label="nvro_PatentInfringementMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_BostonScientificCorporationMember" xlink:type="locator" xlink:label="nvro_BostonScientificCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndemnificationGuaranteeMember" xlink:type="locator" xlink:label="us-gaap_IndemnificationGuaranteeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MayoFoundationMember" xlink:type="locator" xlink:label="nvro_MayoFoundationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:type="locator" xlink:label="us-gaap_LicensingAgreementsMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_MayoAndVglMember" xlink:type="locator" xlink:label="nvro_MayoAndVglMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember" xlink:type="locator" xlink:label="us-gaap_ServiceAgreementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SupplyAgreementsMember" xlink:type="locator" xlink:label="nvro_SupplyAgreementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CR" xlink:type="locator" xlink:label="country_CR" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_FacilityLeaseAgreementThreeMember" xlink:type="locator" xlink:label="nvro_FacilityLeaseAgreementThreeMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SecondAmendmentMember" xlink:type="locator" xlink:label="nvro_SecondAmendmentMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_FirstAmendmentMember" xlink:type="locator" xlink:label="nvro_FirstAmendmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" xlink:type="locator" xlink:label="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RedwoodOfficeAgreementMember" xlink:type="locator" xlink:label="nvro_RedwoodOfficeAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OtherCommitmentsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nvro_RedwoodOfficeAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_StatementScenarioAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="nvro_FirstAmendmentMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="nvro_SecondAmendmentMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="nvro_FacilityLeaseAgreementThreeMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_StatementGeographicalAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CR" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="nvro_SupplyAgreementsMember" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_ServiceAgreementsMember" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_CounterpartyNameAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="nvro_MayoAndVglMember" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LicensingAgreementsMember" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="nvro_MayoFoundationMember" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_RangeAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="10030.14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_IndemnificationGuaranteeMember" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="nvro_BostonScientificCorporationMember" order="11500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="nvro_PatentInfringementMember" order="11580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsLineItems" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LeaseCommencementPeriod" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_AreaOfLand" order="11830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LeaseEffectiveDate" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_OperatingLeasesExpirationDate" order="12030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="12130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm" order="12230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LeaseCommencementDateDescription" order="12430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperationsCommencedDate1" order="12530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="12630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="12800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_StandardProductWarrantyDescription" order="13000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths" order="13050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_InventoryFirmPurchaseCommitmentLoss" order="13090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ServiceAgreementCommitmentAmountYearOne" order="13160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ServiceAgreementCommitmentAmountYearTwo" order="13180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ServiceAgreementCommitmentAmountYearThree" order="13200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ServiceAgreementCommitmentAmountYearFour" order="13220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" order="13270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="13320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_RoyaltyExpense" order="13370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="13510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_NonCashResearchAndDevelopmentExpense" order="13530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LicenseAgreementCommitmentAmount" order="13580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_LicenseAgreementExpirationYear" order="13600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes" order="13650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes" order="13690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_NumberOfSecuredConvertibleNotes" order="13730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost" order="13770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ValueOfCertainRightsMeasuredAtCost" order="13810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes" order="13850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue" order="13920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents" order="14040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty" order="14150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyAccrualPayments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:type="locator" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_StandardProductWarrantyAccrualCurrent" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_StandardProductWarrantyAccrualPayments" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_StandardProductWarrantyAccrualCurrent_li0l2" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" xlink:type="locator" xlink:label="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentGross" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" xlink:type="locator" xlink:label="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ConversionPricePerShare" xlink:type="locator" xlink:label="nvro_ConversionPricePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NoteHedgesTransactionCosts" xlink:type="locator" xlink:label="nvro_NoteHedgesTransactionCosts" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PurchasePricePerCommonStock" xlink:type="locator" xlink:label="nvro_PurchasePricePerCommonStock" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NoteHedgesNumberOfSharesContractedToBuy" xlink:type="locator" xlink:label="nvro_NoteHedgesNumberOfSharesContractedToBuy" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" xlink:type="locator" xlink:label="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" xlink:type="locator" xlink:label="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentMaturityMonthAndYear" xlink:type="locator" xlink:label="nvro_DebtInstrumentMaturityMonthAndYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtLiabilityComponentMember" xlink:type="locator" xlink:label="nvro_DebtLiabilityComponentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NinetyEightPercentApplicableConversionPriceMember" xlink:type="locator" xlink:label="nvro_NinetyEightPercentApplicableConversionPriceMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:type="locator" xlink:label="nvro_OneHundredThirtyPercentApplicableConversionPriceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="nvro_OneHundredThirtyPercentApplicableConversionPriceMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="nvro_NinetyEightPercentApplicableConversionPriceMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtLiabilityComponentMember" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="11890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="11910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentMaturityMonthAndYear" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentAdditionalAggregatePrincipalAmount" order="11950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="11990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="12040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="12080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="12160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" order="12200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" order="12240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" order="12280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="12400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice" order="12440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_NoteHedgesNumberOfSharesContractedToBuy" order="12510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_PurchasePricePerCommonStock" order="12550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_NoteHedgesTransactionCosts" order="12590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="12630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="12670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="12710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_ConversionPricePerShare" order="12750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost" order="12830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" order="12900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="12920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" order="12970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentGross" order="12990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="13040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes" order="13080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="13100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentMaturityYear" order="13190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" order="13740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentGross" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtLiabilityComponentMember" xlink:type="locator" xlink:label="nvro_DebtLiabilityComponentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:type="locator" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10060.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtLiabilityComponentMember" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentGross" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" xlink:type="locator" xlink:label="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" xlink:type="locator" xlink:label="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DebtEquityComponentMember" xlink:type="locator" xlink:label="nvro_DebtEquityComponentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" xlink:type="locator" xlink:label="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:type="locator" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10050.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_DebtEquityComponentMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="locator" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureConvertiblePreferredStockAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:type="locator" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" xlink:type="locator" xlink:label="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_CommonStockOptionsAndAwardsOutstanding" xlink:type="locator" xlink:label="nvro_CommonStockOptionsAndAwardsOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="nvro_CommonStockOptionsAndAwardsOutstanding" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RecognitionPeriodOfStockBasedCompensationExpense" xlink:type="locator" xlink:label="nvro_RecognitionPeriodOfStockBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanOfferingPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TargetedNumberOfSharesGrantedRatio" xlink:type="locator" xlink:label="nvro_TargetedNumberOfSharesGrantedRatio" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TargetedCompositeIndexPeriod" xlink:type="locator" xlink:label="nvro_TargetedCompositeIndexPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PercentageOfShareholderOptionsGranted" xlink:type="locator" xlink:label="nvro_PercentageOfShareholderOptionsGranted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ManagementMember" xlink:type="locator" xlink:label="srt_ManagementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_NonQualifiedStockOptionsMember" xlink:type="locator" xlink:label="nvro_NonQualifiedStockOptionsMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_IncentiveStockOptionsMember" xlink:type="locator" xlink:label="nvro_IncentiveStockOptionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:type="locator" xlink:label="us-gaap_VestingAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandFourteenEquityIncentivePlanMember" xlink:type="locator" xlink:label="nvro_TwoThousandFourteenEquityIncentivePlanMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandSevenPlanMember" xlink:type="locator" xlink:label="nvro_TwoThousandSevenPlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="nvro_TwoThousandSevenPlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="nvro_TwoThousandFourteenEquityIncentivePlanMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_IncentiveStockOptionsMember" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_NonQualifiedStockOptionsMember" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ManagementMember" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="11540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="11630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_PercentageOfShareholderOptionsGranted" order="11650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_TargetedCompositeIndexPeriod" order="11910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_TargetedNumberOfSharesGrantedRatio" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="12090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" order="12110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_EmployeeStockPurchasePlanOfferingPeriod" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="12250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_RecognitionPeriodOfStockBasedCompensationExpense" order="12270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_li0l2" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_li0l2" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:type="locator" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="12410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="12510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="12610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="13010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="13110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="13210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="13310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="13910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="14010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range7Member" xlink:type="locator" xlink:label="nvro_Range7Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range6Member" xlink:type="locator" xlink:label="nvro_Range6Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range5Member" xlink:type="locator" xlink:label="nvro_Range5Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range4Member" xlink:type="locator" xlink:label="nvro_Range4Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range3Member" xlink:type="locator" xlink:label="nvro_Range3Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range2Member" xlink:type="locator" xlink:label="nvro_Range2Member" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_Range1Member" xlink:type="locator" xlink:label="nvro_Range1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range1Member" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range2Member" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range3Member" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range4Member" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range5Member" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range6Member" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="nvro_Range7Member" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="11370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="12090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="12330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" xlink:type="locator" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" order="11700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" order="12420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" order="12530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" order="12610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" order="13090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" xlink:type="locator" xlink:label="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" order="11540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" order="12100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" order="12210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" order="12290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest" order="12610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail">
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockPurchasePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockPurchasePlanMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" xlink:type="locator" xlink:label="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockPurchasePlanMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="nvro_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_PerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_PerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_PerformanceStockUnitsMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="nvro_EmployeeStockPurchasePlanMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DeferredTaxAssetsLeaseLiabilities" xlink:type="locator" xlink:label="nvro_DeferredTaxAssetsLeaseLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DeferredTaxLiabilitiesRightOfUseAsset" xlink:type="locator" xlink:label="nvro_DeferredTaxLiabilitiesRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_DeferredTaxAssetsDepreciation" xlink:type="locator" xlink:label="nvro_DeferredTaxAssetsDepreciation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="nvro_DeferredTaxAssetsDepreciation" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="nvro_DeferredTaxLiabilitiesRightOfUseAsset" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="nvro_DeferredTaxAssetsLeaseLiabilities" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" xlink:type="locator" xlink:label="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_IncomeTaxesLineItems" xlink:type="locator" xlink:label="nvro_IncomeTaxesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:type="locator" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:type="locator" xlink:label="us-gaap_ResearchMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_IncomeTaxesTable" xlink:type="locator" xlink:label="nvro_IncomeTaxesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="nvro_IncomeTaxesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesTable" xlink:to="nvro_IncomeTaxesLineItems" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="nvro_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_li0l2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureNetLossPerShareAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayable" xlink:type="locator" xlink:label="us-gaap_NotesPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedLineItems" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" xlink:type="locator" xlink:label="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="us-gaap_EarningsPerShareDilutedLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_NotesPayable" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="nvro-20211231.xsd#nvro_RestrictedAndPerformanceStockUnitsMember" xlink:type="locator" xlink:label="nvro_RestrictedAndPerformanceStockUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="nvro_RestrictedAndPerformanceStockUnitsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetail" xlink:href="nvro-20211231.xsd#Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504971851528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 16, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NVRO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEVRO CORP.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001444380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,049,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2568057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1800 Bridge Parkway<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Redwood City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">251-0005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s Proxy Statement for the registrant&#8217;s 2022 Annual Meeting of Stockholders are incorporated by reference into Part&#160;III of this Form&#160;10-K to the extent stated herein. The Proxy Statement will be filed within 120&#160;days of the registrant&#8217;s fiscal year ended December&#160;31, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Jose, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968191064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 34,710<span></span>
</td>
<td class="nump">$ 44,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">327,317<span></span>
</td>
<td class="nump">543,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $1,385 and $3,000 at December 31, 2021 and 2020, respectively</a></td>
<td class="nump">70,475<span></span>
</td>
<td class="nump">77,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">93,517<span></span>
</td>
<td class="nump">83,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,185<span></span>
</td>
<td class="nump">4,173<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">531,204<span></span>
</td>
<td class="nump">753,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">20,664<span></span>
</td>
<td class="nump">13,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">17,577<span></span>
</td>
<td class="nump">18,142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,493<span></span>
</td>
<td class="nump">4,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">606<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">574,544<span></span>
</td>
<td class="nump">789,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">31,999<span></span>
</td>
<td class="nump">23,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">45,517<span></span>
</td>
<td class="nump">43,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">4,687<span></span>
</td>
<td class="nump">3,975<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">82,203<span></span>
</td>
<td class="nump">239,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">151,310<span></span>
</td>
<td class="nump">141,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">15,402<span></span>
</td>
<td class="nump">16,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">22,013<span></span>
</td>
<td class="nump">3,343<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">270,928<span></span>
</td>
<td class="nump">400,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2021 and 2020, respectively; zero shares issued and outstanding at December 31, 2021 and 2020, respectively</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 290,000,000 shares authorized at December 31, 2021 and 2020, respectively; 35,709,570 shares issued and 35,026,654 shares outstanding at December 31, 2021; 34,583,064 shares issued and outstanding at December 31, 2020</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">928,138<span></span>
</td>
<td class="nump">880,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income / (loss)</a></td>
<td class="num">(364)<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(624,193)<span></span>
</td>
<td class="num">(492,833)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">303,616<span></span>
</td>
<td class="nump">388,460<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 574,544<span></span>
</td>
<td class="nump">$ 789,428<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968181000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 1,385<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">290,000,000<span></span>
</td>
<td class="nump">290,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">35,709,570<span></span>
</td>
<td class="nump">34,583,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">35,026,654<span></span>
</td>
<td class="nump">34,583,064<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968267640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 386,905<span></span>
</td>
<td class="nump">$ 362,048<span></span>
</td>
<td class="nump">$ 390,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">120,863<span></span>
</td>
<td class="nump">112,146<span></span>
</td>
<td class="nump">121,905<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">266,042<span></span>
</td>
<td class="nump">249,902<span></span>
</td>
<td class="nump">268,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">47,665<span></span>
</td>
<td class="nump">45,600<span></span>
</td>
<td class="nump">59,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Sales, general and administrative</a></td>
<td class="nump">309,311<span></span>
</td>
<td class="nump">267,154<span></span>
</td>
<td class="nump">305,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Certain litigation charges</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">376,976<span></span>
</td>
<td class="nump">312,754<span></span>
</td>
<td class="nump">364,829<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(110,934)<span></span>
</td>
<td class="num">(62,852)<span></span>
</td>
<td class="num">(96,479)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">671<span></span>
</td>
<td class="nump">2,956<span></span>
</td>
<td class="nump">6,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(19,749)<span></span>
</td>
<td class="num">(21,806)<span></span>
</td>
<td class="num">(10,931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(814)<span></span>
</td>
<td class="num">(495)<span></span>
</td>
<td class="num">(697)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(130,826)<span></span>
</td>
<td class="num">(82,197)<span></span>
</td>
<td class="num">(102,087)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">534<span></span>
</td>
<td class="nump">868<span></span>
</td>
<td class="nump">1,599<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(131,360)<span></span>
</td>
<td class="num">(83,065)<span></span>
</td>
<td class="num">(103,686)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="num">(469)<span></span>
</td>
<td class="nump">991<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in unrealized gains (losses) on short-term investments, net</a></td>
<td class="num">(493)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net change in other comprehensive loss</a></td>
<td class="num">(962)<span></span>
</td>
<td class="nump">911<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (132,322)<span></span>
</td>
<td class="num">$ (82,154)<span></span>
</td>
<td class="num">$ (102,922)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted</a></td>
<td class="num">$ (3.77)<span></span>
</td>
<td class="num">$ (2.47)<span></span>
</td>
<td class="num">$ (3.37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of common shares used to compute basic and diluted net loss per share</a></td>
<td class="nump">34,823,258<span></span>
</td>
<td class="nump">33,677,641<span></span>
</td>
<td class="nump">30,803,872<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504965374376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balances at Dec. 31, 2018</a></td>
<td class="nump">$ 245,483<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 552,612<span></span>
</td>
<td class="num">$ (306,082)<span></span>
</td>
<td class="num">$ (1,077)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balances, shares at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,263,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">$ 28,607<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">28,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options, shares</a></td>
<td class="nump">828,722<span></span>
</td>
<td class="nump">828,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock upon release of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for tax obligations</a></td>
<td class="num">$ (3,057)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,057)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for tax obligations, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">6,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="nump">41,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(103,686)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103,686)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balances at Dec. 31, 2019</a></td>
<td class="nump">216,352<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">626,401<span></span>
</td>
<td class="num">(409,768)<span></span>
</td>
<td class="num">(313)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balances, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,544,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon underwritten public offering, net of issuance costs</a></td>
<td class="nump">147,144<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">147,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon underwritten public offering, net of issuance costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,868,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Conversion feature of convertible senior notes due 2025, net of allocated costs</a></td>
<td class="nump">48,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges', window );">Purchase of bond hedges</a></td>
<td class="num">(52,390)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,390)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Sales of warrants</a></td>
<td class="nump">34,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">$ 34,625<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">34,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options, shares</a></td>
<td class="nump">756,797<span></span>
</td>
<td class="nump">756,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock upon release of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for tax obligations</a></td>
<td class="num">$ (8,564)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,564)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for tax obligations, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62,782)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">7,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="nump">42,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(83,065)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83,065)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="nump">911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">911<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balances at Dec. 31, 2020</a></td>
<td class="nump">388,460<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">880,660<span></span>
</td>
<td class="num">(492,833)<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balances, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,583,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">$ 4,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options, shares</a></td>
<td class="nump">90,582<span></span>
</td>
<td class="nump">90,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock upon release of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld for tax obligations</a></td>
<td class="num">$ (8,062)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,062)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for tax obligations, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">6,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock from conversion of convertible senior notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock from conversion of convertible senior notes due 2021, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">682,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes', window );">Exercise of bond hedge for convertible senior notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes', window );">Exercise of bond hedge for convertible senior notes due 2021, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(682,916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="nump">44,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(131,360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(131,360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="num">(962)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(962)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balances at Dec. 31, 2021</a></td>
<td class="nump">$ 303,616<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 928,138<span></span>
</td>
<td class="num">$ (624,193)<span></span>
</td>
<td class="num">$ (364)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balances, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,026,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital purchase of bond hedges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of bond hedge for convertible senior notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of bond hedge value for convertible senior notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504970279256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (131,360)<span></span>
</td>
<td class="num">$ (83,065)<span></span>
</td>
<td class="num">$ (103,686)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,882<span></span>
</td>
<td class="nump">4,794<span></span>
</td>
<td class="nump">4,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_AmortizationOfOperatingLeaseAsset', window );">Amortization of operating lease assets</a></td>
<td class="nump">3,796<span></span>
</td>
<td class="nump">3,392<span></span>
</td>
<td class="nump">3,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">44,367<span></span>
</td>
<td class="nump">42,655<span></span>
</td>
<td class="nump">41,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium (accretion of discount) on short-term investments</a></td>
<td class="nump">1,510<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="num">(2,037)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for (recovery of) doubtful accounts</a></td>
<td class="num">(1,528)<span></span>
</td>
<td class="nump">2,165<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Write-down of inventory</a></td>
<td class="nump">4,257<span></span>
</td>
<td class="nump">5,366<span></span>
</td>
<td class="nump">1,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">13,263<span></span>
</td>
<td class="nump">14,946<span></span>
</td>
<td class="nump">7,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation', window );">Unrealized gains (losses) on foreign currency transactions</a></td>
<td class="nump">3,083<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="num">(450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">8,205<span></span>
</td>
<td class="nump">3,369<span></span>
</td>
<td class="num">(2,153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(17,225)<span></span>
</td>
<td class="nump">2,523<span></span>
</td>
<td class="num">(938)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,027)<span></span>
</td>
<td class="nump">5,666<span></span>
</td>
<td class="num">(3,222)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(451)<span></span>
</td>
<td class="nump">1,802<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">9,006<span></span>
</td>
<td class="nump">7,678<span></span>
</td>
<td class="num">(7,472)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">3,185<span></span>
</td>
<td class="num">(7,897)<span></span>
</td>
<td class="nump">13,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">14,156<span></span>
</td>
<td class="num">(2,351)<span></span>
</td>
<td class="num">(2,824)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by / (used in) operating activities</a></td>
<td class="num">(41,881)<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
<td class="num">(50,225)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of short-term investments</a></td>
<td class="num">(446,916)<span></span>
</td>
<td class="num">(668,371)<span></span>
</td>
<td class="num">(211,006)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">660,971<span></span>
</td>
<td class="nump">297,028<span></span>
</td>
<td class="nump">254,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_RepaymentFromInvestmentInPrivateCompany', window );">Repayment from (investment in) private company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="num">(7,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(12,340)<span></span>
</td>
<td class="num">(6,025)<span></span>
</td>
<td class="num">(3,472)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by / (used in) investing activities</a></td>
<td class="nump">201,715<span></span>
</td>
<td class="num">(369,868)<span></span>
</td>
<td class="nump">32,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock in public offering, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts', window );">Convertible notes debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Purchase of convertible note hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,390)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of convertible notes</a></td>
<td class="num">(172,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Minimum tax withholding paid on behalf of employees for net share settlement</a></td>
<td class="num">(8,062)<span></span>
</td>
<td class="num">(8,564)<span></span>
</td>
<td class="num">(3,057)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock to employees</a></td>
<td class="nump">11,181<span></span>
</td>
<td class="nump">42,137<span></span>
</td>
<td class="nump">35,150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="num">(169,381)<span></span>
</td>
<td class="nump">346,905<span></span>
</td>
<td class="nump">32,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(340)<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(9,887)<span></span>
</td>
<td class="num">(21,126)<span></span>
</td>
<td class="nump">14,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, cash equivalents and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at beginning of year</a></td>
<td class="nump">45,203<span></span>
</td>
<td class="nump">66,329<span></span>
</td>
<td class="nump">51,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at end of year</a></td>
<td class="nump">35,316<span></span>
</td>
<td class="nump">45,203<span></span>
</td>
<td class="nump">66,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">1,283<span></span>
</td>
<td class="nump">1,307<span></span>
</td>
<td class="nump">1,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">6,728<span></span>
</td>
<td class="nump">5,555<span></span>
</td>
<td class="nump">3,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Significant non-cash transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment in accounts payable</a></td>
<td class="nump">$ 526<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="nump">$ 285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_AmortizationOfOperatingLeaseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of operating lease asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_AmortizationOfOperatingLeaseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments of convertible notes debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_RepaymentFromInvestmentInPrivateCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment from (investment in) private company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_RepaymentFromInvestmentInPrivateCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrealized gains and losses on foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504969565304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Formation and Business of the Company<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Formation and Business of the Company</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. Formation and Business of the Company</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company was incorporated in Minnesota on March&#160;10, 2006 to manufacture and market innovative active implantable medical devices for the treatment of neurological disorders initially focusing on the treatment of chronic pain. Subsequently, the Company was reincorporated in Delaware on October&#160;4, 2006 and relocated to California.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since inception, the Company has incurred net losses. During the year ended December&#160;31, 2021, the Company incurred a net loss of $131.4&#160;million and had $41.9 million of cash used in operations. At December&#160;31, 2021, the Company had an accumulated deficit of $624.2&#160;million. The Company has financed operations to date primarily through private placements of equity securities, borrowings under a debt agreement, the issuance of common stock in its November 2014 initial public offering, its June 2015 underwritten public offering and its June 2016 underwritten public offering of convertible senior notes due in 2021 (2021 Notes). Additionally, in April 2020, the Company issued a total of $189.8 million aggregate principal amount of convertible senior notes due 2025 (2025 Notes).&#160;&#160;The total net proceeds from this debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $183.6 million. Concurrent with this debt offering, the Company also completed an underwritten public offering for 1,868,750 shares of its common stock, from which the Company received cash proceeds of $147.1 million, net of underwriting discounts and commissions and offering costs. The Company&#8217;s ability to continue to meet its obligations and to achieve its business objectives for the foreseeable future is dependent upon, amongst other things, generating sufficient revenues and its ability to continue to control expenses to meet its obligations as they become due. Failure to increase sales of its products, manage discretionary expenditures or raise additional financing, if required, may adversely impact the Company&#8217;s ability to achieve its intended business objectives.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Public Offerings</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75%&#160;per annum and are payable semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016.&#160;&#160;The total net proceeds from the debt offering, after deducting transaction costs, were approximately $166.2 million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, the Company issued $165.0 million aggregate principal amount of 2.75% convertible senior notes due 2025 in a registered underwritten public offering and an additional $24.8 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2025 Notes).&#160;&#160;The interest rates are fixed at 2.75% per annum and are payable semi-annually in arrears on April 1 and October 1 of each year, commencing on October 1, 2020.&#160;&#160;The total net proceeds from the debt offering, after deducting transaction costs, were approximately $183.6 million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concurrent with the 2025 Notes, the Company completed an underwritten public offering of its common stock and issued 1,868,750 shares of common stock, including 243,750 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares.&#160;&#160;The Company received cash proceeds of approximately $147.1 million, net of underwriting discounts and commissions and offering costs paid by the Company.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504973460824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S.&#160;GAAP). The consolidated financial statements include the Company&#8217;s accounts and those of its five operational wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to risks related to the public health crises such as the global pandemic associated with COVID-19, which has spread to most countries and all 50 states within the United States. The COVID-19 outbreak has negatively impacted, and continues to negatively impact, our operations, revenues and overall financial condition and demand for elective procedures remains unpredictable. Additionally, overall patient willingness to pursue elective procedures has decreased due to the pandemic. Although some restrictions on elective procedures have eased, the effect of the pandemic and recent surges in cases continue to affect patient willingness for interventional therapy for chronic pain and the number of elective procedures being performed. These challenges will likely continue for the duration of the pandemic, which is uncertain, and will affect our revenue while the pandemic continues.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the Company is also subject to risks common to medical device companies, including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, manufacturing quality and scaling, continued reimbursement from third-party payors,<span style="color:#1F497D;"> </span>uncertainty of market acceptance of products and the need to obtain additional financing. The Company is currently dependent on third-party suppliers, which, in some cases, are sole- or single-source suppliers.&#160;&#160;Although the Company is in the process of initiating the development of internal manufacturing capabilities, it will remain dependent on third-party manufacturers until such internal manufacturing capabilities are fully operational.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There can be no assurance that the Company&#8217;s products or services will continue to be accepted in its existing marketplaces, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company may choose to raise additional funds to further enhance its research and development efforts, for product expansion opportunities or to acquire a new business or products that are complementary to its business. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Segments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates.&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.&#160;&#160;In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company&#8217;s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-lived assets and operating income outside the United States are not material; therefore, disclosures have been limited to revenue.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries in Europe and Australia use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">during the yea</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">r ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span>0.3<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million during the year en</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ded December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of $</span>1.0<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million during the year ended December&#160;31, 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other in</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">come (expense), net</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The Company recorded realized foreign currency transaction </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> during the year ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span>0.2<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">during the year ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span>1.6<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million during the year ended December&#160;31, 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that the Company&#8217;s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company&#8217;s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; stock-based compensation; depreciation and amortization lives; inventory valuation; valuation of investments; loss contingencies; and accounting for income taxes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company&#8217;s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December&#160;31, 2021 and 2020, and held cash in foreign banks of approximately $8.6 million and $17.6 million at December&#160;31, 2021 and 2020, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s convertible note hedge transactions, entered into in connection with the 2025 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.&#160;&#160;The associated risk is mitigated by limiting the counterparties to major financial institutions. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company generally utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Credit Losses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, <span style="font-style:italic;">Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span>, which replaces existing incurred loss impairment guidance and establishes a single allowance framework for financial assets carried at amortized cost. The Company adopted Topic 326 on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The Company did not have any cumulative-effect adjustments.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying amounts of certain of the Company&#8217;s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations.&#160;Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12&#160;months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company&#8217;s investment securities are recorded at fair value based on the fair value hierarchy.&#160;&#160;Money market funds and treasury bonds are classified within Level 1 of the fair value hierarchy, and agency bonds, commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company&#8217;s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company&#8217;s estimation of the future demand for a particular component of the Company&#8217;s products may vary and may result in changes in estimates in any particular period.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shipping and Handling Costs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shipping and handling costs are expensed as incurred and are included in cost of revenue.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes </p>
<p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">revenue at the point in time when it transfers control of promised goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#8217;s goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For a majority of sales, where the Company&#8217;s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the remaining sales, which are sent from the Company&#8217;s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.&#160;&#160;These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection.<span style="color:#FF0000;"> </span>To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note&#160;7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.&#160;&#160;Product revenue is recorded net of such incentive offers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Practical Expedients and Exemptions<span style="font-weight:bold;font-style:normal;"> - </span><span style="font-style:normal;">The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.&#160;&#160;As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year</span>.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Allowance for Doubtful Accounts</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company makes estimates of the collectability of accounts receivable and provide an allowance for accounts receivable considered uncollectible based on current expected credit losses. In doing so, the Company analyzes historical bad debt trends, customer concentrations, customer credit worthiness, the age of the receivable, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts. For the years ended December 31, 2021, 2020 and 2019, the Company recognized bad debt expenses of $0.1 million, $2.8 million and $1.3 million, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets&#8217; estimated useful lives of three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cash flows to the related asset group&#8217;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">no</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> impairment charges, or changes in estimated useful lives</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> recorded through December&#160;31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Lease Accounting</p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has operating leases for office space, warehouse, research and development facilities, manufacturing facilities and equipment. Leases with terms of 12 months or less are not recorded on the balance sheet, as the related lease expenses are recognized on a straight-line basis over the lease term.&#160;&#160;The Company accounts for lease components (such as fixed payments) separately from nonlease components (such as common area expenses).<span style="color:#000000;"> Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.&#160;&#160;The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.&#160;&#160;Lease cost is recognized on a straight-line basis over the expected lease term.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#8217;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records uncertain tax positions on the basis of a two-step process whereby (1)&#160;a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2)&#160;for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company&#8217;s policy is to recognize interest and penalties related to income taxes as a component of income tax expense.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Comprehensive Income (Loss)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income (loss) represents all changes in stockholders&#8217; equity except those resulting from distributions to stockholders. The Company&#8217;s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Research and Development</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, <span style="font-style:italic;">Compensation&#8212;Stock Compensation.</span> ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, <span style="font-style:italic;">Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting</span>, which the Company adopted on January 1, 2017.&#160;&#160;Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.&#160;&#160;ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of subjective variables. The expected term that the award will remain outstanding is based on the Company&#8217;s own historical data. The expected volatility over the term of the awards is based on the Company&#8217;s own common stock volatility and those of its peer group. The risk-free interest rate is based on the U.S. Treasury yield for zero-coupon U.S. Treasury notes with maturities.&#160;&#160;The expected dividend is zero, as the Company has never paid dividends and has no current plans to do so.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive <span style="-sec-ix-hidden:F_000478">six-month</span> offering periods and the Company uses its own historical volatility data in the valuation.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company&#8217;s common stock on the grant date.&#160;&#160;These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.&#160;&#160;Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company additionally grants performance stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.&#160;&#160;The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation </p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.&#160;&#160;The e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">xpected volatility of our stock </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the target composite index</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">zero</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Stock-based compensation for these </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">performance</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> stock units is recognized over the specified performance measurement period</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net Loss per Share of Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units, common stock options and the conversion spread for the Company&#8217;s outstanding convertible senior notes are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Pronouncements Recently Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This ASU eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The Company adopted ASU 2019-12 on January 1, 2021.&#160;&#160;The adoption of ASU 2019-12 did not have a material effect on the consolidated financial statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Pronouncements Not Yet Effective</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, the FASB issued ASU No. 2020-06, <span style="font-style:italic;">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span>.&#160;&#160;This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity&#8217;s own equity.&#160;&#160;The ASU also modifies the impact on the diluted EPS calculations from particular convertible instruments and certain contracts that may be settled in cash or shares. The ASU is effective for public entities for annual reporting period beginning after December 15, 2021, with early adoption permitted for annual periods beginning after December 15, 2020. The Company does not expect to early adopt this guidance and has not determined the potential effects of the guidance on its consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504969539672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3. Revenue</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents revenue by geography, based on the billing address of the customer (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,216</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">311,873</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,012</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60,689</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,175</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,243</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386,905</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">362,048</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">390,255</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The United States is the only country that accounts for 10% or more of the revenue during the periods presented:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no customers that accounted for <span>10%</span> or more of the Company&#8217;s revenue for each of the years ended December&#160;31, 2021, 2020 and 2019.&#160;&#160;Additionally, there were no customers that accounted for <span>10%</span> or more of the Company&#8217;s accounts receivable balance as of December 31, 2021 and 2020.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In July 2021, the Company received FDA approval of its proprietary 10 kHz Therapy for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with painful diabetic neuropathy (PDN). For the year ended December 31, 2021, worldwide revenue includes approximately $5.7&#160;million of revenue for PDN indication since the July 2021 FDA approval</span>.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972649784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4. Leases</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the Company has leases with remaining terms of 3 year to 10 years, some of which may include options to extend the lease term for up to 5 years.</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average lease terms and discounts rates are as follows:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Lease Term and Discount Rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.20 years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.32 years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, t<span style="color:#000000;">he maturity of lease liabilities are as follows (in thousands):</span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,720</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,201</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,849</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">405</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,979</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,173</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Interest</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,183</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,990</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental lease cost information are as follows (in thousands):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease cost</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,243</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,936</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental balance sheet information are as follows (in thousands):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,577</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,142</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,588</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,876</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long term operating lease liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,402</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,689</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,990</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,565</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow information are as follows (in thousands):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flow from operating leases</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,253</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,923</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 7 for further details of the Company&#8217;s lease commitments.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972292408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5. Fair Value Measurements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level&#160;1 &#8212; Observable inputs, such as quoted prices in active markets for identical assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level&#160;2 &#8212;&#160;Observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Level&#160;3 &#8212;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash Equivalents and Short Term Investments</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s cash equivalents include investments in money market funds that which are unrestricted as to withdrawal or use and are classified as Level&#160;1 of the fair value hierarchy. To value its money market funds, the Company values the funds at $1 stable net asset value, which is the quoted price in active markets for identical assets that the Company has the ability to access. At December&#160;31, 2021 and 2020, the Company&#8217;s cash equivalents were held in institutions in the United States. The Company&#8217;s cash equivalents and short-term investments also includes agency bonds, commercial paper, corporate notes and treasury bonds, which have been classified within Level 1 or Level&#160;2 of the fair value hierarchy because of the sufficient observable inputs for revaluation. The Company&#8217;s Level&#160;2 investments are valued using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades of any broker/dealer quotes on the same or similar investments, issuer credit spreads, benchmark investments, prepayment/default projections based on historical data and other observable inputs. The following table sets forth the Company&#8217;s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,562</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,562</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds (ii)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,538</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,538</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (ii)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (iii)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,351</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,351</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds (ii)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,552</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,552</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">207,114</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134,773</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">341,887</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,273</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,273</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds (ii)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210,302</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210,302</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (ii)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277,602</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277,602</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (ii)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,395</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,395</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds (ii)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,074</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,074</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,347</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">513,299</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">559,646</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:58.64%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in cash and cash equivalents on the consolidated balance sheets.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in short-term investments on the consolidated balance sheets.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.</p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Convertible Senior Notes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 1, 2021, the Company settled the 2021 Notes at maturity, and as of December 31, 2021, the 2021 Notes were no longer outstanding. As of December 31, 2020, the fair value of the 1.75% convertible senior notes due 2021 was $312.8 million. As of December 31, 2021 and 2020, the fair value of the 2.75% convertible senior notes due 2025 was $212.0 million and $348.1 million, respectively. The fair value was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972319752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6. Balance Sheet Components</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the Company&#8217;s cash equivalents and short-term investments approximates their respective carrying amounts due to their short-term maturity. The following is a summary of the gross unrealized gains and unrealized losses on the Company&#8217;s investment securities (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,546</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,538</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,886</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,884</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,371</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,351</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,889</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(339</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,552</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">332,692</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(371</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">332,325</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210,225</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210,302</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277,593</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277,602</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,364</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,395</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,064</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">543,246</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">543,373</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Realized gains or losses from the sale of investments and other-than-temporary impairments, if any, on available-for-sale securities are reported in other income (expense), net as incurred. The cost of securities sold was determined based on the specific identification method. The amount of realized gains and realized losses on investments for the periods presented have not been material.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amortized costs and estimated fair values of the Company&#8217;s available-for-sale securities by contractual maturities as of December 31, 2021 were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts maturing within one year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305,844</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305,535</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts after one year through five years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,848</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,790</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total investment securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">332,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">332,325</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories (in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.78%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,160</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,405</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,357</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,891</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventories</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,517</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83,296</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically evaluates the carrying value of inventory on hand for potential excess amount over demand using the same lower of cost or net realizable value approach as that has been used to value the inventory. </p>
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also periodically evaluates inventory quantities in consideration of actual loss experience. As a result of these evaluations, for the year ended December&#160;31, 2021, the Company recognized total write-downs of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million for its inventories.&#160;&#160;For the years ended December 31, 2020 and 2019, the Company recognized total write-downs of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million and $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, respectively, for its inventories.</span></p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment, Net (in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,722</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,072</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,349</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,671</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,215</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,918</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,316</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,289</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in process</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,717</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,354</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,319</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,304</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation and amortization</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,655</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,773</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,664</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,531</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization expense for the years ended December&#160;31, 2021, 2020 and 2019 was $4.9 million, $4.8 million and $4.6 million, respectively.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Restricted Cash</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash as of December 31, 2021 and 2020 includes certificates of deposit of $0.6 million representing collateral for the Company&#8217;s Redwood City, CA building lease pursuant to an agreement dated March 5, 2015.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Accrued Liabilities (in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and related expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,957</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,971</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional fees</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,547</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,101</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,191</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued clinical and research expenses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">668</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,305</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,548</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued warranty</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">664</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">699</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,665</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,127</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,517</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972292408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7. Commitments and Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2015, the Company entered into a lease agreement for approximately 50,740 square feet of office space located in Redwood City, California for a period beginning in <span style="-sec-ix-hidden:F_000667">June 2015</span> through May 2022 with initial annual payments of approximately $2.0 million, increasing to $2.4 million annually during the final year of the lease term. In December 2016, the Company entered into an amendment for an additional approximately 49,980 square feet of office space adjacent to the premises under the original lease (the Expansion Premises), with initial annual payments of $1.2 million, increasing to $2.9 million in the final year of the amended lease term.&#160; <span style="color:#000000;">The lease for the Expansion Premises commenced on June 1, 2018. </span>&#160;&#160;The amendment also extends the lease term for the original premises to terminate on the same date as the amended lease, which is May 31, 2025.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2017, the Company entered into a separate non-cancellable facility lease for warehouse space beginning March 1, 2017 through February 28, 2022, under which the Company is obligated to pay approximately $0.4 million in lease payments over the term of the lease.&#160;&#160;In October 2021, the Company entered into an amendment to extend the lease term to May 31, 2025. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, the Company entered into a lease for approximately 35,411 square feet of space for a manufacturing facility in Costa Rica for a period of <span style="-sec-ix-hidden:F_000682">April 2021</span> through June 2031, under which it is obligated to pay approximately $3.9 million in lease payments over the term of the lease.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 4 for further discussion on Leases.</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warranty Obligations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company warrants that its products will operate substantially in conformity with product specifications and provides a limited one- to five-year warranty.&#160;&#160;Activities related to warranty obligations were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning Balance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">699</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,178</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision for warranty</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,846</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,881</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,629</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending Balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">664</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">699</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supply Agreements</p>
<p id="OLE_LINK1" style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has entered into supply agreements with certain of the Company&#8217;s suppliers that required certain minimum annual purchase agreements.&#160;&#160;As of December 31, 2021, the Company had $0.9 million of annual purchase commitments. As of December 31, 2020, the Company had no annual purchase commitments. For the year ended December 31, 2019, the Company recorded a charge of $3.6 million related to the cancellation of firm purchase commitments for inventory related items.</p>
<p id="OLE_LINK2" style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also entered into a service agreement in January 2020 for which it is committed to pay $<span>2.5 million</span> annually in each of the next four years. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">License Agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2006, the Company entered into an amended and restated license agreement with the Mayo Foundation for Medical Education and Research (Mayo) and Venturi Group&#160;LLC (VGL), which provides the Company access to the certain know how and licensed patents owned by Mayo and VGL for treatment of central, autonomic and peripheral nervous system disorders, including pain, using devices to modulate nerve signaling. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per terms of the license, the Company is required to pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty will be based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum royalty payment will be based on royalty periods as defined in the agreement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2011, the Company entered into a Phase&#160;II License Agreement with Mayo which provides the Company access to the certain know how and licensed patents owned by Mayo. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per terms of the license, the Company is required to:</span></p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Pay a retainer fee of $40,000 per annum starting March 2011 and ending February 2013;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;">Pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty is based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum annual royalty payment is $200,000.</span></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Mayo License terminates upon the expiration of (1)&#160;the last to expire of the licensed patents or (2)&#160;our obligation to pay royalties, whichever is later. Such obligations may be subject to change if: (1) additional relevant patents issue that are subject to the Mayo License; or (2) we launch an SCS product, which is subject to the Mayo License, in another country. As of Jan. 1, 2021, the Company does not have an existing obligation to pay royalties under the Mayo License. Therefore, there were no royalties expenses during the year ended December 31, 2021.&#160;&#160;Royalties expenses during the years ended December&#160;31, 2020 and 2019 were $3.1 million and $3.2 million, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2014, the Company issued Mayo 20,833 shares of common stock owed in connection with the IPO pursuant to the terms of the license, and recorded noncash research and development expense of $0.5 million for the fair value of the shares on the date of issuance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2017, the Company entered into a license agreement for which it is committed to pay $0.1 million over the remaining term of this license agreement, which ends in 2022.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Contingent Consideration</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2019, the Company entered into an agreement with a privately-held company to, among other things, provide the privately-held company financing in the form of a secured convertible note.&#160;&#160;Through March 31, 2020, the Company has provided financing totaling $8.5 million in the form of two secured convertible notes. The agreement additionally provides the Company with the exclusive right, but not the obligation, to acquire the privately-held company.&#160;&#160;As of December 31, 2019, the value of the secured convertible notes, measured at amortized cost, was $7.9 million, while the value of certain rights in relation to the agreement, measured at cost and monitored for impairment on an ongoing basis, was $1.0 million.&#160;&#160;These amounts are reported in Other Assets on the Condensed Consolidated Balance Sheet.&#160;&#160;The accretion of amortized cost is recorded in Interest Income, while any changes in value from impairment assessment are recorded in Other Income (Expense) in the Consolidated Statements of Operations and Comprehensive Income.&#160;&#160;The Company concluded that the privately-held company is a variable interest entity; however, the Company is not the primary beneficiary as it does not retain power to direct the activities that most significantly impact its economic performance.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, the Company elected not to exercise its option to make a further investment in the privately-held company pursuant to the agreement.&#160;&#160;In connection with this decision, the Company no longer has the exclusive right to acquire the privately-held company.&#160;&#160;In June 2020, the privately-held company paid off the outstanding principal and accrued interest of its secured convertible notes in full.&#160;&#160;As a result of these two events, the Company recorded a net expense of $0.4 million in Other Income (Expense) in the Consolidated Statements of Operations and Comprehensive Income in the year ended December 31, 2020.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Contingencies</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been no contingent liabilities requiring accrual at December&#160;31, 2021 and 2020.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Indemnification</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for losses suffered or incurred by the indemnified party, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including, among other circumstances, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#8217;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has director and officer insurance coverage that reduces the Company&#8217;s exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Legal Matters</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Boston Scientific Litigations</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">California Litigation Related to High Frequency</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 28, 2016, the Company filed a lawsuit for patent infringement against Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation (collectively, Boston Scientific). The lawsuit, filed in the U.S. District Court for the Northern District of California (the California Court), asserted that Boston Scientific was infringing, or would soon begin infringing, seven of the Company&#8217;s patents covering inventions relating to the Senza system and 10 kHz Therapy. Shortly after the Company filed this lawsuit in 2016, Boston Scientific cancelled its original launch plan and modified its SCS system to avoid infringing the asserted patents. On July 24, 2018, the California Court issued an order on claim construction and summary judgment.&#160;&#160;In the order, the California Court ruled that the Company&#8217;s asserted method claims were patent eligible and not invalid as indefinite.&#160;&#160;Collectively, the asserted method claims cover methods for delivering SCS therapy at frequencies between 1.5 kHz and 100 kHz.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The California Court, however, found that Boston Scientific was not currently infringing the six upheld method claims because Boston Scientific cancelled its original launch plans and ultimately never practiced the asserted method claims in the United States.&#160;&#160;Specifically, the California Court found that Boston Scientific's sale of the Spectra WaveWriter systems for commercial use in the United States did not infringe the upheld method claims because Boston Scientific modified the Spectra WaveWriter systems to prevent them from being programmed to generate signals above 1.2 kHz. The California Court also found that the Company&#8217;s asserted system claims were invalid as indefinite.&#160; As discussed below, the California Court&#8217;s finding of invalidity was overturned by the U.S. Court of Appeals for the Federal Circuit (the Federal Circuit).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 31, 2018, the parties entered into an agreement to dismiss the Company&#8217;s declaratory judgment claims, without prejudice, so that the Company and Boston Scientific could each appeal portions of the California Court&#8217;s July 24th ruling to the Federal Circuit.&#160;&#160;On April 9, 2020, the Federal Circuit returned its ruling, which vacated and remanded the California Court&#8217;s judgment of invalidity.&#160;&#160;As a result of the Federal Circuit&#8217;s ruling, the system claims invalidated by the California Court were reinstated, and thus all of the Company&#8217;s asserted claims remain valid and enforceable.&#160;&#160;On December 14, 2020, the parties agreed to the final dismissal of all remaining claims before the California Court based on Boston Scientific&#8217;s assertion to the court that it did not have any current plans to commercially launch a high frequency SCS system in the United States.&#160;&#160;The California Court entered the agreed upon dismissal on December 16, 2020.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Delaware Litigations Unrelated to High Frequency</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 9, 2016, Boston Scientific filed a patent infringement lawsuit alleging the Company&#8217;s manufacture, use and sale of the Senza system infringes ten of Boston Scientific&#8217;s patents covering spinal cord stimulation technology related to stimulation leads, rechargeable batteries and telemetry (the <span style="font-style:italic;">Delaware I</span> litigation). On April 27, 2018, Boston Scientific filed a second lawsuit alleging patent infringement of nine patents, trade secret misappropriation and tortious interference with contract (the <span style="font-style:italic;">Delaware II</span> litigation).&#160; Both lawsuits were filed in the U.S. District Court for the District of Delaware.&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In relation to the <span style="font-style:italic;">Delaware I</span> litigation, the Company filed petitions for <span style="font-style:italic;">inter partes</span> review at the U.S. Patent and Trademark Office (USPTO), which resulted in the invalidation of all of the asserted claims of Boston Scientific&#8217;s U.S. Patent Nos. 7,587,241 and 6,895,280, in February 2019.&#160;&#160;The invalidity rulings by the Patent Trial and Appeal Board (PTAB) at the USPTO were later affirmed by the Federal Circuit on May 18, 2020 and May 29, 2020, respectively.&#160;&#160; In relation to the <span style="font-style:italic;">Delaware II</span> litigation, the Company filed seven petitions for <span style="font-style:italic;">inter partes</span> review at the PTAB against seven of the nine patents asserted by Boston Scientific.&#160;&#160;As a result of those petitions, in January 2021, the PTAB invalidated all but two of the challenged Boston Scientific claims across the seven <span style="font-style:italic;">inter partes</span> reviews. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Through various orders from the court, portions of Boston Scientific&#8217;s <span style="font-style:italic;">Delaware I</span> case were dismissed, and portions of Boston Scientific&#8217;s <span style="font-style:italic;">Delaware II </span>case have been stayed for future litigation.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In relation to the <span style="font-style:italic;">Delaware I</span> case, of the ten patents originally asserted on December 9, 2016, Boston Scientific proceeded to trial with four patents directed to SCS leads and lead manufacturing techniques. On November 1, 2021, a Delaware jury found that the Company infringed Boston Scientific&#8217;s patents U.S. 7,891,085 (&#8220;the &#8216;085 patent&#8221;) and U.S. 8,019,439, and that the Company did not infringe Boston Scientific&#8217;s patents U.S. 8,646,172 and U.S. 8,650,747.&#160;&#160;With regard to the &#8216;085 patent, the jury found that the infringement was willful, though the infringement of the &#8216;085 patent was only directed to a limited number of SCS leads that the Company sold internationally between 2012 and 2014.&#160;&#160;Boston Scientific does not assert that the Company continues to infringe the &#8216;085 patent.&#160;&#160;The Delaware jury awarded Boston Scientific $20.0 million.&#160;&#160;The Company disagrees with this decision and plans to appeal, which could take approximately 18-24 months to resolve.&#160;&#160;The jury award will not be paid until after the conclusion of the appeal process.&#160;&#160;The Company recorded a liability of $20.0 million in relation to the aforementioned <span style="font-style:italic;">Delaware I</span> case.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In relation to the <span style="font-style:italic;">Delaware II</span> litigation, the Company also filed counterclaims against Boston Scientific, alleging patent infringement of five Nevro patents.&#160;&#160;In March 2021, on the basis of Boston Scientific&#8217;s petition, the PTAB initiated <span style="font-style:italic;">inter partes</span> reviews of two of Nevro&#8217;s five counterclaim patents.&#160;&#160;The Delaware court later stayed Nevro&#8217;s five counterclaim patents for future litigation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 23, 2021, the Company filed a patent infringement lawsuit against Boston Scientific alleging that its January 2021 launch of the WaveWriter Alpha&#8482; SCS System infringes five of the Company&#8217;s patents covering spinal cord stimulation technology related to delivering paresthesia-free therapy at frequencies below 1,200 Hz.&#160;&#160;The lawsuit, filed in the U.S. District Court for the District of Delaware (<span style="font-style:italic;">the Delaware III</span> litigation), seeks unspecified damages and attorney&#8217;s fees, as well as preliminary and/or permanent injunctive relief against further infringement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, <span style="color:#000000;">the Company recorded a liability of $20.0 million in relation to the aforementioned </span><span style="font-style:italic;color:#000000;">Delaware I</span><span style="color:#000000;"> case</span>.&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Stimwave Litigation</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 14, 2019, the Company filed a lawsuit for patent infringement against Stimwave Technologies, Inc. (Stimwave) in the Delaware Court asserting that Stimwave was infringing the Company&#8217;s patents covering inventions related to its 10 kHz Therapy and the Senza system, as well as a claim for false advertising under the Lanham Action Section 43(a), 15 U.S.C. &#167; 1125(a).&#160;&#160;In relation to this lawsuit, on July 24, 2019, the Delaware Court granted the Company&#8217;s motion for preliminary injunction, and issued an order barring Stimwave, and all affiliated persons and entities, from infringing patent claims covering frequencies between 3 kHz and 10 kHz. On February 27, 2020, the Company and Stimwave entered into a Settlement Agreement, in which Stimwave agreed to cease commercialization of all high frequency spinal cord stimulation systems worldwide.&#160;&#160;Stimwave also agreed to entry of a permanent injunction in the Delaware Court, under which Stimwave&#8217;s products will not deliver spinal cord </p>
<p style="margin-bottom:0pt;margin-top:6pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">stimulation therapy that includes pulse frequencies between 1,500 Hz and 100,000 Hz. The permanent injunction w</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">filed with the Delaware </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">C</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ourt</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and entered on March 2, 2020</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&#160;&#160;A</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fter the Delaware C</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ourt enter</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ed </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the permanent injunction, the case (including Stimwave&#8217;s appeal of the preliminary injunction order) </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">were </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dismissed.&#160;&#160;As part of the permanent injunction filing, Stimwave acknowledge</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the validity of the patents Nevro asserted in the litigation.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company&#8217;s</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> request, the </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">permanent injunction</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> order does not enjoin Stimwave from providing follow-up care and programming for any patients who were already programmed with high frequency therapy</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the United States prior to March 6, 2020, and in the rest of the world prior to April 30, 2020</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Nalu Litigation</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 28, 2020, the Company filed a lawsuit in the Delaware Court for patent infringement against Nalu Medical, Inc. (Nalu) asserting that Nalu is infringing the Company&#8217;s patents covering inventions related to its 10 kHz Therapy and the Senza system.<span style="font-size:12pt;color:#000000;"> </span>The Company&#8217;s patent infringement assertions were based, in part, on Nalu imbedding a high frequency SCS therapy in a version of its &#8220;PSP&#8221; waveform.&#160;&#160;During the litigation, Nalu modified its PSP waveform so that it no longer included an imbedded high frequency signal.&#160;&#160;As a result, on December 21, 2021, the Company announced that it had reached a favorable settlement agreement with Nalu to terminate the litigation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is and may from time to time continue to be involved in various legal proceedings to defend its intellectual property, including several pending European patent oppositions at the European Patent Office (EPO) initiated by the Company&#8217;s competitors Medtronic and Boston Scientific, an entitlement action filed by Boston Scientific in Germany, and an invalidity proceeding in China.&#160;&#160;In addition, the Company is and may from time to time also be involved in various legal proceedings of a character normally incident to the ordinary course of business, such as employment matters, product liability matters, and professional liability matters, which the Company does not deem to be material to its business and condensed consolidated financial statements at this stage.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504969562248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-term Debt</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8. Long-term Debt</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2021 Notes and Convertible Note Hedge and Warrant Transactions</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due in June 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75%&#160;per annum and are payable semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016.&#160;&#160;The total net proceeds from the debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $166.2 million.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each $1,000 principal amount of the 2021 Notes will initially be convertible into 10.3770 shares of the Company&#8217;s common stock, which is equivalent to an initial conversion price of approximately $96.37 per share, subject to adjustment upon the occurrence of specified events. The 2021 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding December 1, 2020, only under the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on September&#160;30, 2016 (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2)&#160;during the five business day period after any ten consecutive trading day period (the measurement period) in which the trading price (as defined in the indenture to the 2021 Notes) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company&#8217;s common stock and the conversion rate on each such trading day; or (3)&#160;upon the occurrence of specified corporate events.&#160; On or after December&#160;1, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2021 Notes at any time, regardless of the foregoing circumstances.&#160;&#160;Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s election.&#160;&#160;If the Company undergoes a fundamental change prior to the maturity date, holders of the notes may require the Company to repurchase for cash all or any portion of their notes at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In </p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">addition, if specific corporate events occur prior to the applicable maturity date, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event in certain circumstances.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the offering of the 2021 Notes, the Company entered into convertible note hedge transactions with certain bank counterparties in which the Company has the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of the Company&#8217;s common stock at a price of approximately $96.37 per share. The total cost of the convertible note hedge transactions was $45.1 million.&#160;&#160;In addition, the Company sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of the Company&#8217;s common stock at a price of $127.28 per share. The Company received $33.1 million in cash proceeds from the sale of these warrants.&#160;&#160;Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of these notes and to effectively increase the overall conversion price from $96.37 to $127.28 per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded in stockholders&#8217; equity&#160;and are not accounted for as derivatives. The net cost of $12.0 million incurred in connection with the convertible note hedge and warrant transactions was recorded as a reduction to additional paid-in capital on the consolidated balance sheet.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the issuance of the convertible senior notes, the Company separated the 2021 Notes into liability and equity components.&#160;&#160;The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was $32.9 million and was determined by deducting the fair value of the liability component from the par value of the 2021 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (debt discount) is amortized to interest expense over the term of the 2021 Notes expense at an effective interest rate of 6.29% over the contractual terms of the notes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the debt issuance costs of&#160;$6.2 million&#160;related to the 2021 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2021 Notes based on their relative values. Issuance costs attributable to the liability component were $5.0 million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2021 Notes. &#160;Issuance costs attributable to the equity component were netted with the equity component in stockholders&#8217; equity.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 1, 2021, the 2021 Notes matured and the Company settled the 2021 Notes.&#160;&#160;The Company paid $172.5 million to settle the outstanding principal and issued 682,912 shares of common stock to holders who elected to convert the 2021 Notes. In addition, the Company exercised its option under the bond hedge and received 682,916 shares of common stock from the bank counterparties. None of the holders of the warrants associated with the 2021 Notes exercised the option to purchase shares.&#160;&#160;As of December 31, 2021, the 2021 Notes were no longer outstanding. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,182</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized issuance cost</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(542</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">168,776</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt discount related to value of conversion option</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,945</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,179</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,766</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2025 Notes and Convertible Note Hedge and Warrant Transactions</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2020, the Company issued $165.0 million aggregate principal amount of 2.75% convertible senior notes due 2025 in a registered underwritten public offering and an additional $24.8 million aggregate principal amount of such notes pursuant to underwriters&#8217; exercise in full of their option to purchase additional 2025 Notes. The interest rates are fixed at 2.75%&#160;per annum and are payable semi-annually in arrears on April 1 and October&#160;1 of each year, commencing on October 1, 2020.&#160;&#160;The total net proceeds from the debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $183.6 million. &#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each $1,000 principal amount of the 2025 Notes will initially be convertible into 9.5238 shares of the Company&#8217;s common stock, which is equivalent to an initial conversion price of approximately $105.00 per share, subject to adjustment upon the occurrence of specified events. The 2025 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding October 1, 2024, only under the following circumstances: <span style="Background-color:#FFFFFF;">(1)&#160;during any calendar quarter commencing after the calendar quarter ending on June&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2)&#160;during the five business day period after any ten consecutive trading day period (the measurement period) in which the trading price (as defined in the indenture to the 2025 Notes) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company&#8217;s common stock and the conversion rate on each such trading day; or (3)&#160;upon the occurrence of specified corporate events.&#160;</span> <span style="color:#000000;">On or after October&#160;1, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2025 Notes at any time, regardless of the foregoing circumstances.&#160;&#160;</span>Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s election.&#160;&#160;<span style="Background-color:#FFFFFF;">If the Company undergoes a fundamental change prior to the maturity date, holders of the notes may require the Company to repurchase for cash all or any portion of their notes at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. </span>In addition, if specific corporate events occur prior to the applicable maturity date, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event in certain circumstances.<span style="Background-color:#FFFFFF;"> </span>During the three months ended December 31, 2021 the conditions allowing holders of the 2025 Notes to convert have not been met. Therefore, the 2025 Notes may not be converted during the three months ended March 31, 2022. As of December 31, 2021, the if-converted value of the 2025 Notes did not exceeded the principal value of those notes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the offering of the 2025 Notes, the Company entered into convertible note hedge transactions with certain bank counterparties in which the Company has the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of the Company&#8217;s common stock at a price of approximately $105.00 per share. The total cost of the convertible note hedge transactions was $52.4 million.&#160;&#160;In addition, the Company sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of the Company&#8217;s common stock at a price of $147.00 per share. The Company received $34.9 million in cash proceeds from the sale of these warrants.&#160;&#160;Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of these notes and to effectively increase the overall conversion price from $105.00 to $147.00 per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded in stockholders&#8217; equity&#160;and will not be subsequently remeasured as long as they continue to meet the conditions for equity classification. The net </p>
<p style="margin-top:12pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cost of $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.5</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million incurred in connection with the convertible note hedge and warrant transactions was recorded as a reduction to additional paid-in capital on the consolidated balance sheet.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the issuance of the convertible senior notes, the Company separated the 2025 Notes into liability and equity components.&#160;&#160;The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was $49.9 million and was determined by deducting the fair value of the liability component from the par value of the 2025 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (debt discount) is amortized to interest expense over the term of the 2025 Notes expense at an effective interest rate of 10.2% over the contractual terms of the notes.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the debt issuance costs of&#160;$6.1 million&#160;related to the 2025 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2025 Notes based on the same proportion as the accounting for the proceeds from the issuance of the 2025 Notes.&#160;&#160;Issuance costs attributable to the liability component were $4.5 million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2025 Notes.<span style="font-weight:bold;"> </span>&#160;Issuance costs attributable to the equity component were netted with the equity component in stockholders&#8217; equity.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the liability component of the 2025 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(35,079</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(43,919</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized issuance cost</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,361</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,060</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,310</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141,771</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the equity component of the 2025 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt discount related to value of conversion option</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,947</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,947</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,607</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,607</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,340</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,340</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the interest expense recognized related to the 2021 Notes and 2025 Notes (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.06%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual interest expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,484</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,860</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,308</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,843</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,240</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,634</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,063</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total interest expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,747</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,802</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,925</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972287144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Convertible Preferred Stock</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9. Convertible Preferred Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to its initial public offering, the Company had outstanding 15,208,048 shares of convertible preferred stock. Each share of preferred stock was convertible to one share of common stock. Upon the closing of the Company&#8217;s initial public offering on November&#160;11, 2014, all shares of outstanding redeemable convertible preferred stock were automatically converted to 15,208,048 shares of the Company&#8217;s common stock.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504969594152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10. Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock reserved for future issuance as of December 31, 2021 was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.8%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding stock options and awards</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,713,145</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for grants of future stock options and awards</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,078,869</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for employee stock purchase plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,567,514</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total common stock reserved for future issuance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,359,528</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Plans</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s Board of Directors (Board) and stockholders previously approved the 2007 Stock Option Plan (the 2007 Plan). In October 2014, the Board adopted the 2014 Equity Incentive Award Plan (the 2014 Plan and, together with the 2007 Plan, the Stock Plans).&#160;&#160;As of the effective date of the 2014 Plan, the Company suspended the 2007 Plan and no additional awards may be granted under the 2007 Plan. Any shares of common stock covered by awards granted under the 2007 Plan that terminate after the effective date of the 2014 Plan by expiration, forfeiture, cancellation or other means without the issuance of such shares, will be added to the 2014 Plan reserve.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the 2014 Plan, 1,854,166 shares of common stock were initially reserved for issuance, plus the number of shares remaining available for future awards under the 2007 Plan, as of the pricing of the IPO. The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i)&#160;the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii)&#160;an annual increase on January&#160;1 of each year.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the 2014 Plan, the Company may grant awards such as incentive stock options, nonstatutory stock options, restricted stock units, performance stock units and stock appreciation rights. Incentive stock options (ISO) may be granted only to Company employees (including directors who are also employees). Nonqualified stock options (NSO) may be granted to Company employees, directors and consultants.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Options</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options under the 2014 Plan may be granted for periods of up to ten years and at prices no less than 100% of the estimated fair market value of the shares on the date of grant as determined by the Board, provided, however, that the exercise price of an ISO or an NSO granted to a 10% stockholder shall not be less than 110% of the estimated fair market value of the shares on the date of grant. Upon the exercise of options, the Company issues new common stock from its authorized shares. The vesting provisions of individual options vary but are generally over four years, with the exception of performance based stock options.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the 2014 Plan, the Company granted performance based stock options to the Company&#8217;s former CEO in March 2016. This performance based stock option award was subject to the CEO&#8217;s continued service to the Company through each applicable vesting date. Upon the former CEO&#8217;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of shares available for grant under the Stock Plans is as follows:</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Available</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Grant</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,980,762</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,210,541</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(277,778</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,696</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,077,178</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">527,963</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,403,006</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,261,774</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(43,966</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,782</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(341,901</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">258,486</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,600,181</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,383,322</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,830</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,787</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(425,266</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140,101</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,732,295</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock option activity under the Stock Plans is as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options&#160;Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise&#160;Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Term</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,529,740</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.72</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000883">6.7</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,866</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">244,075</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.71</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(828,722</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34.52</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,695</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(298,908</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.22</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.80</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000884">6.3</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109,870</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(756,797</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45.75</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,367</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76,238</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.38</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">813,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.69</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000885">5.9</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,286</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(90,582</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,948</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,914</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43.52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">700,654</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.93</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000886">4.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,287</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable as of December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">599,295</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.06</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000887">4.4</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,656</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested, exercisable or expected to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; vest as of December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">696,003</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.92</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000888">4.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,173</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of the Company&#8217;s common stock at the date of exercise and the exercise price for in-the-money options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The weighted-average grant-date fair value of options granted during the year ended December&#160;31, 2019 was $27.91 per share. No options were granted during the years ended December 31, 2021 and 2020.&#160;&#160;The total fair value of options vested during the years ended December 31, 2021, 2020 and 2019 was approximately $3.1 million, $6.6 million and $8.3 million, respectively, based on the grant date fair value.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The options outstanding and vested under the Stock Plans by exercise price, at December&#160;31, 2021, were as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="8" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.84%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Vested</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Exercise Price</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000902">$3.60 &#8212; $36.55</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,179</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000922">3.15</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.18</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,929</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.52</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000903">$38.79 &#8212; $45.04</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114,032</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000923">5.52</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47.12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,094</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42.08</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000904">$45.07 &#8212; $63.23</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,883</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000924">4.48</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.56</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,344</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.12</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000905">$63.39 &#8212; $64.95</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141,004</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000925">6.94</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.28</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,835</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000906">$65.51 &#8212; $87.62</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,556</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000926">3.95</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79.37</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,093</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79.36</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$97.52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000927">4.62</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97.52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97.52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000907">$3.60 &#8212; $97.52</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">700,654</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000928">4.81</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.93</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">599,295</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.06</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Stock Units</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2015, the Company began granting restricted stock units (RSUs) under the 2014 Plan.&#160;&#160;Holders of RSUs do not have stockholder rights.&#160;&#160;Upon the release of RSUs, the Company issues new common stock from its authorized shares. RSUs generally vest four years from the date of grant.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of RSU activity under the Stock Plans was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant&#160;Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock&#160;Units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in&#160;thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,002,161</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72.55</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,974</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">721,992</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58.37</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(321,858</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.89</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,064</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(225,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.51</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,177,221</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.70</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138,371</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">252,703</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123.31</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(395,971</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.42</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,789</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(180,976</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71.26</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">852,977</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79.87</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147,650</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">368,230</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">146.64</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(346,602</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76.26</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,902</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(110,799</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98.76</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">763,806</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110.96</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,922</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock expected to vest as of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December&#160;31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">696,348</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109.78</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,453</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of RSUs released is calculated using the fair market value of the Company&#8217;s common stock at the date of release. The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company&#8217;s common stock as of the date outstanding.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Performance Stock Units</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the 2014 Plan, the Company granted performance based RSUs to the former CEO in March 2016. The performance based RSUs are subject to the former CEO&#8217;s continued service to the Company through each applicable vesting date. If a performance metric is not met within the time limits specified in the RSU agreement, the shares subject to vesting under the vesting tranche for that performance metric will be cancelled. Upon the former CEO&#8217;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2019, the Company granted performance stock units (PSUs) to the current CEO, subject to his continued service to the Company and based on the total shareholder return (the TSR) of the Company&#8217;s common stock price compared to the S&amp;P Healthcare Equipment Select Industry Index (the Index) over a <span style="-sec-ix-hidden:F_000986">three-year</span> period.&#160;&#160;The number of shares to be issued upon vesting of these PSUs range from <span style="-sec-ix-hidden:F_000987_2">0 to 3.5 times</span> the target number of shares granted, depending on the Company&#8217;s performance against the targeted composite index.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the Company granted PSUs to certain members of the management team.&#160;&#160;The number of shares to be issued upon vesting was based on the total shareholder return of the Company&#8217;s common stock compared to the Index, as well as certain performance criteria related to a specific financial target over a two-year performance period. For the three months ended March 31, 2020, the Company determined that the achievement status for these PSUs was not possible, and therefore did not record stock-based compensation expenses related to these grants.&#160;&#160;During the three months ended June 30, 2020, the Company modified the performance criteria for these PSUs to reflect the changed market conditions as a result of the COVID-19 pandemic, such that the remaining performance criteria is based on total shareholder return compared to the Index.&#160;&#160;The Company also granted PSUs that incorporated the same modified performance criteria to the Company&#8217;s Chief Executive Officer PSUs. Additional similar PSUs were issued to new members of management in the year ended December 31, 2020.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, the Company granted PSUs to certain member of the management team, subject to continued service to the Company and based on the TSR of the Company&#8217;s common stock price compared to the Index over a <span style="-sec-ix-hidden:F_000989">three-year</span> period.&#160;&#160;The number of shares to be issued upon vesting of these PSUs range from 0 to 1.5 times the target number of shares granted, depending on the Company&#8217;s performance against the targeted composite index.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of PSU activity under the Stock Plans was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant&#160;Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock&#160;Units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in&#160;thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,962</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.50</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">310</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,111</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67.29</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU released</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,981</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.50</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,981</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.50</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,111</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67.29</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,060</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89,198</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128.71</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,272</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125.27</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,037</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94.20</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,453</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,036</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183.20</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,388</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136.77</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248,685</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113.35</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,161</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU expected to vest as of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December&#160;31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">247,815</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113.22</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,090</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of outstanding PSUs is calculated based on the closing price of the Company&#8217;s common stock as of the date outstanding.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014 Employee Stock Purchase Plan</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2014, the Board adopted the 2014 Employee Stock Purchase Plan (the ESPP). A total of 196,666 shares of common stock were initially available for future issuance under the 2014 Employee Stock Purchase Plan, subject to an annual increase on January&#160;1 of each year. The ESPP provides eligible employees with an opportunity to purchase shares of the Company&#8217;s common stock through payroll deductions of up to 15% of their eligible compensation, subject to plan limitations.&#160;&#160;Under the ESPP, the purchase price of the Company stock is equal to 85%&#160;of the lower of its fair market value at the start and end of a&#160;<span style="-sec-ix-hidden:F_001024">six-month</span> purchase period.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of ESPP activity was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.46%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,590</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315,443</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">302,635</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issued</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,197</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,967</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">164,960</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future issuance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,567,514</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,397,121</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,161,645</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee contributions for shares issued (in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,849</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,513</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,544</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimated the fair value of stock options granted to employees and shares purchased by employees under the ESPP using the Black-Scholes option valuation model. The fair value is amortized on a straight-line basis over the requisite service period of the awards, with the exception of performance based stock options whose fair value is recorded as expenses based on the probability that the performance metrics will be achieved. The following assumptions were used in estimating the fair value:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.1%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Options:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001037">5.7</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001038">51%&#160;&#8212;&#160;52%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001040">1.4%&#160;&#8212;&#160;2.6%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESPP:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001043">0.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001044">0.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001045">0.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001046">36% &#8212; 49%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001047">39% &#8212; 68%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001048">48% &#8212; 61%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1% &#8212; 0.2%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6% &#8212; 2.4%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for RSUs at their fair value, based on the closing market price of the Company&#8217;s common stock on the grant date. The fair value is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting term of four years.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2016, the Company granted performance based RSUs to its former CEO that only vest upon the achievement of specific operational performance criteria.&#160;&#160;The stock-based compensation for these performance based RSUs are recognized as expenses when it is determined that achieving the performance metrics are probable. Upon the former CEO&#8217;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the former CEO&#8217;s resignation in March 2019, the Company amended the terms of his then vested nonqualified stock options such that they remain exercisable through the second anniversary of his separation date.&#160;&#160;This modification resulted in a charge of $1.6 million in stock-based compensation.&#160;&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2019, the Company granted PSUs to its current CEO that only vest based on the total shareholder return (TSR) of the Company common stock price relative to that of the Index.&#160;&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2020 and 2021, the Company granted PSUs to the CEO and other members of its management team that vest based on the total shareholder return of the Company common stock price relative to that of the Index.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The company estimates the grant-date fair value of these PSUs based on the Monte Carlo simulation model and records the related stock-based compensation over the period for which the TSR is measured against the Index, which is generally two to three years. The use of the Monte Carlo simulation model requires the input the following assumptions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="7" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.22%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Index volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001064">51% &#8212; 53%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001065">44% &#8212; 51%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001068">49% &#8212; 54%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001069">57% &#8212; 59%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001072">0.1% &#8212; 0.3%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001073">0.1% &#8212; 0.2%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.4%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Correlation with index</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001076">0.32 &#8212; 0.35</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001077">0.38 &#8212; 0.41</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.28</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock-based compensation expense by line items in the consolidated statements of operations is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,637</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,433</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,061</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,455</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,141</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,323</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, general and administrative</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,273</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,081</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,313</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,365</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,655</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,697</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,997</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,289</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,312</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,234</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,977</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,854</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Performance stock units</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,017</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,694</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,991</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,117</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,695</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,540</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,365</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,655</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,697</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, total stock-based compensation expense not yet recognized, net of estimated forfeitures, are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization&#160;Period</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,597</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001118">1.2</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,107</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001119">2.1</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Performance stock units</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,389</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001120">0.7</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,219</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001121">0.4</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504969553608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">11. Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the Company&#8217;s income / (loss) before income taxes were as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129,135</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,893</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(106,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,691</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,696</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,923</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loss before income taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(130,826</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(82,197</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(102,087</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the expense / (benefit) for income taxes are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(103</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">244</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">187</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">585</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">656</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,644</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current income tax expense / (benefit)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">829</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">844</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,728</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(295</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred income tax expense / (benefit)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(295</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax expense / (benefit)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">534</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">868</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,599</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax at statutory federal rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax, net of federal benefit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,614</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127,347</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,087</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,919</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">650</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">662</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,969</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,390</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accruals and reserves</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,404</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,531</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,225</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,055</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,130</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">869</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206,079</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">169,773</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(201,088</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(164,278</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,991</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,495</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,660</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,459</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,660</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,459</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,331</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,036</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, substantially all of the net deferred tax assets have been offset by a valuation allowance. The valuation allowance increased by $36.8 million and $32.5 million for the years ended December&#160;31, 2021 and 2020, respectively.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, the Company had federal net operating loss carryforwards (NOLs) of approximately $588.4&#160;million, of which $329.4 million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the 2017 Tax Act, as well as state NOLs of approximately $336.5 million, of which $54.3 million may be carried forward indefinitely. If not utilized, the remaining federal NOLs will begin to expire in 2026, and the remaining state NOLs will begin to expire in 2022.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, the Company had research and development credit carryforwards of approximately $20.5&#160;million and $13.9&#160;million for federal and California state income tax purposes, respectively. The federal credit carryforward begins expiring in 2026, and the state credits carry forward indefinitely.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under Section&#160;382 of the Internal Revenue Code of 1986, as amended, the Company&#8217;s ability to utilize NOLs or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, a Section 382 &#8220;ownership change.&#8221; A Section&#160;382 &#8220;ownership change&#8221; generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company&#8217;s stock, increase their ownership by a greater than 50 percentage point change (by value) over a rolling three-year period. Similar rules may apply under state tax laws. As a result of the Company&#8217;s June 2015 underwritten public offering, the Company experienced a Section 382 &#8220;ownership change.&#8221;&#160;&#160;The Company currently estimates that this &#8220;ownership change&#8221; will not inhibit its ability to utilize its NOLs.  However, the Company may, in the future, experience one or more additional Section&#160;382 &#8220;ownership changes&#8221; as a result of subsequent changes in its stock ownership, some of which changes are outside the Company&#8217;s control.&#160;&#160;If so, the Company may not be able to utilize a material portion of its NOLs and tax credits, even if the Company achieves profitability.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had unrecognized tax benefits (UTBs) of approximately $10.4&#160;million as of December&#160;31, 2021. The following table summarizes the activity related to UTBs (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,611</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">572</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,383</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">891</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(54</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,220</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,412</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">860</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(62</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,430</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If these UTBs were recognized, approximately $10.4 million would affect the effective tax rate before consideration of the valuation allowance. The Company files U.S. federal and state income tax and foreign income tax returns with varying statutes of limitations. The Company&#8217;s U.S. federal and the majority of state tax years from inception in 2006 onward will remain open to examination due to the carryover of the unused NOLs and tax credits. The Company does not have any material active tax audits or other proceedings pending, and believes it has provided adequate reserves for all tax deficiencies or reductions in tax benefits that could result from federal, state and foreign tax audits. The Company does not expect any material changes to the estimated amount of liability associated with its uncertain tax positions within the next twelve months.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC 740, <span style="font-style:italic;">Income Taxes</span>, the Company is classifying interest and penalties as a component of tax expense. There was $0.2 million, $0.1 million and $0.1 million of interest and penalties accrued at each of December 31, 2021, 2020 and 2019, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972302024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">12. Net Loss Per Share</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(131,360</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,065</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(103,686</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute basic and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; diluted net loss per share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,823,258</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,677,641</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,803,872</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3.77</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2.47</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3.37</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period, determined using the treasury-stock method, if inclusion of these is dilutive. <span style="color:#000000;">The conversion spread for the Company&#8217;s outstanding convertible senior notes will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company&#8217;s common stock for a given period exceeds the conversion price of $105.00 for the 2025 Notes.</span> This condition was not met in the three months ended December 31, 2021.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the issuance of the 2021 Notes and 2025 Notes, the Company entered into convertible bond hedges. The convertible bond hedges are not included for purposes of calculating the number of diluted shares outstanding for the periods presented, as their effect would be anti-dilutive. The convertible bond hedges are generally expected, but not guaranteed, to reduce the potential dilution and/or offset the cash payments the Company is required to make upon conversion of the 2021 Notes and 2025 Notes. When the 2021 Notes matured on June 1, 2021, the Company exercised its option under the bond hedge. As of December 31, 2021, the bond hedges related to the 2021 Notes are no longer outstanding. <span style="color:#000000;">Because the Company has reported a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unreleased restricted and performance stock units</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,012,491</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,052,014</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,288,332</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options to purchase common stock</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">700,654</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">813,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible senior notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,807,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,597,174</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants related to the issuance of convertible senior notes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,807,141</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,597,174</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,327,427</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,059,512</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,514,583</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504969558408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13. Employee Benefit Plan.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2007, the Company adopted a 401(K) plan for its employees whereby eligible employees may contribute up to the maximum amount permitted by the Internal Revenue Code of 1986, as amended.&#160;&#160;In June 2016, the Company adopted a policy to match a portion of employee contributions for all qualified employees participating in the 401(k) plan.&#160;&#160;For the years ended December 31, 2021, 2020 and 2019, the Company recorded expenses of $2.9 million, $2.6 million and $3.1 million for matching contributions, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968655992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S.&#160;GAAP). The consolidated financial statements include the Company&#8217;s accounts and those of its five operational wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_OtherRisksAndUncertainties1PolicyTextBlock', window );">Other Risks And Uncertainties</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to risks related to the public health crises such as the global pandemic associated with COVID-19, which has spread to most countries and all 50 states within the United States. The COVID-19 outbreak has negatively impacted, and continues to negatively impact, our operations, revenues and overall financial condition and demand for elective procedures remains unpredictable. Additionally, overall patient willingness to pursue elective procedures has decreased due to the pandemic. Although some restrictions on elective procedures have eased, the effect of the pandemic and recent surges in cases continue to affect patient willingness for interventional therapy for chronic pain and the number of elective procedures being performed. These challenges will likely continue for the duration of the pandemic, which is uncertain, and will affect our revenue while the pandemic continues.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the Company is also subject to risks common to medical device companies, including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, manufacturing quality and scaling, continued reimbursement from third-party payors,<span style="color:#1F497D;"> </span>uncertainty of market acceptance of products and the need to obtain additional financing. The Company is currently dependent on third-party suppliers, which, in some cases, are sole- or single-source suppliers.&#160;&#160;Although the Company is in the process of initiating the development of internal manufacturing capabilities, it will remain dependent on third-party manufacturers until such internal manufacturing capabilities are fully operational.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There can be no assurance that the Company&#8217;s products or services will continue to be accepted in its existing marketplaces, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company may choose to raise additional funds to further enhance its research and development efforts, for product expansion opportunities or to acquire a new business or products that are complementary to its business. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Segments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates.&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.&#160;&#160;In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company&#8217;s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-lived assets and operating income outside the United States are not material; therefore, disclosures have been limited to revenue.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries in Europe and Australia use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.3</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">during the yea</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">r ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span>0.3<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million during the year en</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ded December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of $</span>1.0<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million during the year ended December&#160;31, 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other in</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">come (expense), net</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The Company recorded realized foreign currency transaction </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gains</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> during the year ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span>0.2<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">during the year ended December 31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">losses</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span>1.6<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million during the year ended December&#160;31, 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that the Company&#8217;s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company&#8217;s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; stock-based compensation; depreciation and amortization lives; inventory valuation; valuation of investments; loss contingencies; and accounting for income taxes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Other Risks and Uncertainties</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company&#8217;s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December&#160;31, 2021 and 2020, and held cash in foreign banks of approximately $8.6 million and $17.6 million at December&#160;31, 2021 and 2020, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s convertible note hedge transactions, entered into in connection with the 2025 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.&#160;&#160;The associated risk is mitigated by limiting the counterparties to major financial institutions. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company generally utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock', window );">Credit Losses</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Credit Losses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, <span style="font-style:italic;">Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span>, which replaces existing incurred loss impairment guidance and establishes a single allowance framework for financial assets carried at amortized cost. The Company adopted Topic 326 on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The Company did not have any cumulative-effect adjustments.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying amounts of certain of the Company&#8217;s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment Securities</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations.&#160;Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12&#160;months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company&#8217;s investment securities are recorded at fair value based on the fair value hierarchy.&#160;&#160;Money market funds and treasury bonds are classified within Level 1 of the fair value hierarchy, and agency bonds, commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company&#8217;s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company&#8217;s estimation of the future demand for a particular component of the Company&#8217;s products may vary and may result in changes in estimates in any particular period.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shipping and Handling Costs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shipping and handling costs are expensed as incurred and are included in cost of revenue.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes </p>
<p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">revenue at the point in time when it transfers control of promised goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#8217;s goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For a majority of sales, where the Company&#8217;s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the remaining sales, which are sent from the Company&#8217;s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.&#160;&#160;These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection.<span style="color:#FF0000;"> </span>To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note&#160;7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.&#160;&#160;Product revenue is recorded net of such incentive offers.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Practical Expedients and Exemptions<span style="font-weight:bold;font-style:normal;"> - </span><span style="font-style:normal;">The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.&#160;&#160;As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year</span>.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Allowance for Doubtful Accounts</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Allowance for Doubtful Accounts</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company makes estimates of the collectability of accounts receivable and provide an allowance for accounts receivable considered uncollectible based on current expected credit losses. In doing so, the Company analyzes historical bad debt trends, customer concentrations, customer credit worthiness, the age of the receivable, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts. For the years ended December 31, 2021, 2020 and 2019, the Company recognized bad debt expenses of $0.1 million, $2.8 million and $1.3 million, respectively.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets&#8217; estimated useful lives of three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cash flows to the related asset group&#8217;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">no</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> impairment charges, or changes in estimated useful lives</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> recorded through December&#160;31, 20</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lease Accounting</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Lease Accounting</p>
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has operating leases for office space, warehouse, research and development facilities, manufacturing facilities and equipment. Leases with terms of 12 months or less are not recorded on the balance sheet, as the related lease expenses are recognized on a straight-line basis over the lease term.&#160;&#160;The Company accounts for lease components (such as fixed payments) separately from nonlease components (such as common area expenses).<span style="color:#000000;"> Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.&#160;&#160;The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.&#160;&#160;Lease cost is recognized on a straight-line basis over the expected lease term.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#8217;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records uncertain tax positions on the basis of a two-step process whereby (1)&#160;a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2)&#160;for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company&#8217;s policy is to recognize interest and penalties related to income taxes as a component of income tax expense.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Other Comprehensive Income (Loss)</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Comprehensive Income (Loss)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income (loss) represents all changes in stockholders&#8217; equity except those resulting from distributions to stockholders. The Company&#8217;s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Research and Development</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, <span style="font-style:italic;">Compensation&#8212;Stock Compensation.</span> ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, <span style="font-style:italic;">Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting</span>, which the Company adopted on January 1, 2017.&#160;&#160;Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.&#160;&#160;ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of subjective variables. The expected term that the award will remain outstanding is based on the Company&#8217;s own historical data. The expected volatility over the term of the awards is based on the Company&#8217;s own common stock volatility and those of its peer group. The risk-free interest rate is based on the U.S. Treasury yield for zero-coupon U.S. Treasury notes with maturities.&#160;&#160;The expected dividend is zero, as the Company has never paid dividends and has no current plans to do so.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive <span style="-sec-ix-hidden:F_000478">six-month</span> offering periods and the Company uses its own historical volatility data in the valuation.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company&#8217;s common stock on the grant date.&#160;&#160;These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.&#160;&#160;Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company additionally grants performance stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.&#160;&#160;The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation </p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.&#160;&#160;The e</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">xpected volatility of our stock </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the target composite index</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is&#160;</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">zero</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Stock-based compensation for these </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">performance</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> stock units is recognized over the specified performance measurement period</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share of Common Stock</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net Loss per Share of Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units, common stock options and the conversion spread for the Company&#8217;s outstanding convertible senior notes are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Pronouncements Recently Adopted</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This ASU eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The Company adopted ASU 2019-12 on January 1, 2021.&#160;&#160;The adoption of ASU 2019-12 did not have a material effect on the consolidated financial statements.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Pronouncements Not Yet Effective</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, the FASB issued ASU No. 2020-06, <span style="font-style:italic;">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span>.&#160;&#160;This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity&#8217;s own equity.&#160;&#160;The ASU also modifies the impact on the diluted EPS calculations from particular convertible instruments and certain contracts that may be settled in cash or shares. The ASU is effective for public entities for annual reporting period beginning after December 15, 2021, with early adoption permitted for annual periods beginning after December 15, 2020. The Company does not expect to early adopt this guidance and has not determined the potential effects of the guidance on its consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_OtherRisksAndUncertainties1PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Risks And Uncertainties Policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_OtherRisksAndUncertainties1PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue recognition shipping and handling costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 35<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515542&amp;loc=SL120269220-210453<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3D<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267969-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922895-210455<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 35<br> -Paragraph 13A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515542&amp;loc=SL120267917-210453<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 35<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=124266218&amp;loc=SL120267834-210445<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 30<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=124256539&amp;loc=SL120269210-210444<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919260-210447<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL120267845-210446<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919272-210447<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 30<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=124256539&amp;loc=SL120254536-210444<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3C<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267966-210447<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 30<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=124268681&amp;loc=SL120267897-210452<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3D<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267862-210455<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.M.Q4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122651532&amp;loc=SL122037091-237805<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3C<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267859-210455<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267853-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossFinancialInstrumentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504973475128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of Revenue by Geography on Billing Address of Customer</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents revenue by geography, based on the billing address of the customer (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,216</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">311,873</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,012</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60,689</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,175</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,243</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386,905</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">362,048</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">390,255</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Revenue by Major Customers by Geographic Area</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The United States is the only country that accounts for 10% or more of the revenue during the periods presented:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968213928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock', window );">Schedule of Weighted Average Lease Terms and Discounts Rates</a></td>
<td class="text">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average lease terms and discounts rates are as follows:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Lease Term and Discount Rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.20 years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.32 years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Lease Liabilities</a></td>
<td class="text">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, t<span style="color:#000000;">he maturity of lease liabilities are as follows (in thousands):</span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,720</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,201</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,849</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">405</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,979</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,173</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Interest</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,183</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,990</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Supplemental Lease Cost Information</a></td>
<td class="text">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental lease cost information are as follows (in thousands):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease cost</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,243</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,936</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock', window );">Schedule Of Operating Lease Assets and Liabilities</a></td>
<td class="text">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental balance sheet information are as follows (in thousands):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,577</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,142</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,588</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,876</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long term operating lease liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,402</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,689</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,990</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,565</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock', window );">Schedule of Supplemental Cash Flow Information Related to Lease</a></td>
<td class="text">
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow information are as follows (in thousands):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flow from operating leases</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,253</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,923</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of cash flow information related to operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of operating lease assets and operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of weighted average lease terms and discounts rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972309944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Financial Instruments Measured at Fair Value on Recurring Basis</a></td>
<td class="text">The following table sets forth the Company&#8217;s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,562</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,562</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds (ii)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,538</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,538</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (ii)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (iii)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,351</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,351</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds (ii)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,552</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,552</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">207,114</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134,773</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">341,887</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,273</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,273</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds (ii)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210,302</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210,302</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (ii)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277,602</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277,602</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (ii)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,395</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,395</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds (ii)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,074</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,074</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,347</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">513,299</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">559,646</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:58.64%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in cash and cash equivalents on the consolidated balance sheets.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in short-term investments on the consolidated balance sheets.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.78%;white-space:nowrap" valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.</p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504971848200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds</a></td>
<td class="text">The following is a summary of the gross unrealized gains and unrealized losses on the Company&#8217;s investment securities (in thousands):
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,546</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,538</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,886</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,884</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,371</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,351</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,889</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(339</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,552</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">332,692</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(371</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">332,325</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210,225</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210,302</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277,593</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277,602</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,364</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,395</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Treasury bonds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,064</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">543,246</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">543,373</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Summary of Contractual Maturities of Investment Securities</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amortized costs and estimated fair values of the Company&#8217;s available-for-sale securities by contractual maturities as of December 31, 2021 were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts maturing within one year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305,844</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305,535</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts after one year through five years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,848</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,790</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total investment securities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">332,692</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">332,325</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Components of Inventories</a></td>
<td class="text">
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories (in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.78%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,160</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,405</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,357</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,891</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventories</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,517</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83,296</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net and Depreciation and Amortization Expense</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment, Net (in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,722</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,072</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,349</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,671</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,215</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,918</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,316</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,289</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in process</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,717</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,354</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,319</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,304</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation and amortization</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,655</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,773</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,664</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,531</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Summary of Accrued Liabilities</a></td>
<td class="text">
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Accrued Liabilities (in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and related expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,957</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,971</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional fees</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,547</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,101</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,191</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued clinical and research expenses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">668</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,305</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,548</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued warranty</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">664</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">699</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,665</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,127</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,517</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504969597320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Activities Related to Warranty Obligations</a></td>
<td class="text">Activities related to warranty obligations were as follows (in thousands):
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning Balance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">699</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,178</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision for warranty</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,846</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,881</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,629</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending Balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">664</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">699</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968242568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock', window );">Interest Expense Recognized Related to Convertible Notes</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the interest expense recognized related to the 2021 Notes and 2025 Notes (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.06%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual interest expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,484</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,860</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,023</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,308</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,843</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,240</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,634</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,063</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total interest expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,747</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,802</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,925</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | Debt, Liability Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Net Carrying Amount of Convertible Debt</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,500</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,182</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized issuance cost</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(542</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">168,776</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | Debt, Equity Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Net Carrying Amount of Convertible Debt</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt discount related to value of conversion option</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,945</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,179</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,766</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | Debt, Liability Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Net Carrying Amount of Convertible Debt</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the liability component of the 2025 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(35,079</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(43,919</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized issuance cost</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,361</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,060</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,310</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141,771</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | Debt, Equity Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Net Carrying Amount of Convertible Debt</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the equity component of the 2025 Notes was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt discount related to value of conversion option</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,947</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,947</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,607</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,607</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,340</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,340</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense recognized related to convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=nvro_DebtLiabilityComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=nvro_DebtLiabilityComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=nvro_DebtEquityComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=nvro_DebtEquityComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972546600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Summary of Common Stock Reserved for Future Issuance</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock reserved for future issuance as of December 31, 2021 was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.8%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding stock options and awards</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,713,145</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for grants of future stock options and awards</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,078,869</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for employee stock purchase plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,567,514</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total common stock reserved for future issuance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,359,528</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock', window );">Summary of Shares Available for Grant</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of shares available for grant under the Stock Plans is as follows:</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Available</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Grant</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,980,762</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,210,541</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(277,778</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,696</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,077,178</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">527,963</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,403,006</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,261,774</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(43,966</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,782</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(341,901</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">258,486</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,600,181</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,383,322</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,830</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,787</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(425,266</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options, RSUs and PSUs cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">140,101</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,732,295</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Activity under Stock Plans</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock option activity under the Stock Plans is as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options&#160;Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise&#160;Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Term</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,529,740</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.72</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000883">6.7</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,866</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">244,075</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.71</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(828,722</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34.52</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,695</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(298,908</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.22</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.80</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000884">6.3</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109,870</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(756,797</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45.75</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,367</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76,238</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.38</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">813,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.69</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000885">5.9</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,286</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(90,582</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,948</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,914</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43.52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">700,654</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.93</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000886">4.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,287</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable as of December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">599,295</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.06</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000887">4.4</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,656</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested, exercisable or expected to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; vest as of December 31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">696,003</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.92</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000888">4.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,173</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Options Outstanding and Vested under Stock Plans by Exercise Price</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The options outstanding and vested under the Stock Plans by exercise price, at December&#160;31, 2021, were as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="8" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.84%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Vested</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Exercise Price</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000902">$3.60 &#8212; $36.55</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,179</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000922">3.15</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.18</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,929</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.52</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000903">$38.79 &#8212; $45.04</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114,032</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000923">5.52</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47.12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,094</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42.08</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000904">$45.07 &#8212; $63.23</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,883</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000924">4.48</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.56</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,344</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.12</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000905">$63.39 &#8212; $64.95</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141,004</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000925">6.94</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.28</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,835</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000906">$65.51 &#8212; $87.62</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,556</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000926">3.95</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79.37</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,093</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79.36</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$97.52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000927">4.62</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97.52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97.52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000907">$3.60 &#8212; $97.52</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">700,654</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000928">4.81</span></p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55.93</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">599,295</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.06</p></td>
<td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Stock Units under the Stock Plan</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of RSU activity under the Stock Plans was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant&#160;Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock&#160;Units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in&#160;thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,002,161</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72.55</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,974</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">721,992</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58.37</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(321,858</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.89</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,064</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(225,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.51</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,177,221</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.70</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138,371</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">252,703</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123.31</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(395,971</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.42</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,789</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(180,976</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71.26</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">852,977</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79.87</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147,650</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">368,230</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">146.64</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(346,602</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76.26</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,902</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(110,799</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98.76</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">763,806</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110.96</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,922</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock expected to vest as of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December&#160;31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">696,348</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109.78</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,453</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock', window );">Schedule of Employee Stock Purchase Plan Activity</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of ESPP activity was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.46%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,590</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315,443</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">302,635</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issued</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,197</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,967</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">164,960</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future issuance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,567,514</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,397,121</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,161,645</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee contributions for shares issued (in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,849</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,513</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,544</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation and Monte Carlo Simulation Model</a></td>
<td class="text">The following assumptions were used in estimating the fair value:
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.1%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Options:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001037">5.7</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001038">51%&#160;&#8212;&#160;52%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001040">1.4%&#160;&#8212;&#160;2.6%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESPP:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001043">0.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001044">0.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001045">0.5</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001046">36% &#8212; 49%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001047">39% &#8212; 68%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001048">48% &#8212; 61%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1% &#8212; 0.2%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6% &#8212; 2.4%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations</a></td>
<td class="text">
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock-based compensation expense by line items in the consolidated statements of operations is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,637</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,433</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,061</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,455</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,141</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,323</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, general and administrative</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,273</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,081</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,313</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,365</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,655</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,697</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of Stock-Based Compensation Expense</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,997</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,289</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,312</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,234</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,977</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,854</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Performance stock units</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,017</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,694</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,991</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,117</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,695</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,540</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,365</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,655</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,697</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Summary of Stock-Based Compensation Expense Not Yet Recognized</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2021, total stock-based compensation expense not yet recognized, net of estimated forfeitures, are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization&#160;Period</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,597</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001118">1.2</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,107</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001119">2.1</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Performance stock units</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,389</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001120">0.7</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,219</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001121">0.4</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember', window );">Performance Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock', window );">Summary of Performance Stock Units under the Stock Plan</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of PSU activity under the Stock Plans was as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant&#160;Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock&#160;Units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair&#160;Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in&#160;thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,962</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.50</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">310</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,111</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67.29</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU released</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,981</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.50</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,981</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.50</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,111</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67.29</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,060</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU granted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89,198</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128.71</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU cancelled</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,272</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125.27</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,037</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94.20</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,453</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,036</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183.20</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU cancelled</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,388</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136.77</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248,685</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113.35</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,161</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PSU expected to vest as of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December&#160;31, 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">247,815</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113.22</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,090</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation and Monte Carlo Simulation Model</a></td>
<td class="text">The company estimates the grant-date fair value of these PSUs based on the Monte Carlo simulation model and records the related stock-based compensation over the period for which the TSR is measured against the Index, which is generally two to three years. The use of the Monte Carlo simulation model requires the input the following assumptions:
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="7" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.22%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Index volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001064">51% &#8212; 53%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001065">44% &#8212; 51%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company volatility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001068">49% &#8212; 54%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001069">57% &#8212; 59%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001072">0.1% &#8212; 0.3%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001073">0.1% &#8212; 0.2%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.4%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Correlation with index</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001076">0.32 &#8212; 0.35</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001077">0.38 &#8212; 0.41</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.28</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of common stock reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of employee stock purchase plan activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504965346952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Components of Loss before Income Taxes</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the Company&#8217;s income / (loss) before income taxes were as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129,135</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,893</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(106,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,691</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,696</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,923</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loss before income taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(130,826</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(82,197</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(102,087</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components of Expense/(Benefit) for Income Taxes</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the expense / (benefit) for income taxes are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(103</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">244</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">187</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">585</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">656</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,644</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current income tax expense / (benefit)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">829</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">844</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,728</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(295</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred income tax expense / (benefit)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(295</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax expense / (benefit)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">534</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">868</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,599</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Income Tax Expense by Applying Statutory Federal Income Tax Rate</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax at statutory federal rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax, net of federal benefit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Tax Effects of Temporary Differences and Carryforwards that Give Rise to Significant Portions of Deferred Tax Assets and Liabilities</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,614</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127,347</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,087</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,919</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">650</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">662</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,969</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,390</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accruals and reserves</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,404</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,531</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,225</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,055</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,130</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">869</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206,079</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">169,773</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(201,088</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(164,278</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,991</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,495</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,660</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,459</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,660</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,459</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,331</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,036</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Summary of Unrecognized Tax Benefits</a></td>
<td class="text">The following table summarizes the activity related to UTBs (in thousands):
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,611</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">572</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,383</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">891</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(54</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,220</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,412</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">860</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(62</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,430</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968858616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Net Loss per Share</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(131,360</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,065</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(103,686</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute basic and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; diluted net loss per share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,823,258</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,677,641</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,803,872</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3.77</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2.47</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3.37</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unreleased restricted and performance stock units</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,012,491</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,052,014</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,288,332</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options to purchase common stock</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">700,654</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">813,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible senior notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,807,141</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,597,174</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants related to the issuance of convertible senior notes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,807,141</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,597,174</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,327,427</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,059,512</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,514,583</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504965176936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Formation and Business of the Company - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Formation and Business of the Company [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,360,000<span></span>
</td>
<td class="nump">$ 83,065,000<span></span>
</td>
<td class="nump">$ 103,686,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash used in operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,881,000)<span></span>
</td>
<td class="nump">1,191,000<span></span>
</td>
<td class="num">$ (50,225,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 624,193,000<span></span>
</td>
<td class="nump">492,833,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock in underwriting public offering</a></td>
<td class="nump">1,868,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from common stock</a></td>
<td class="nump">$ 147,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember', window );">1.75% Convertible Senior Notes due 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Formation and Business of the Company [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentMaturityYear', window );">Debt instrument due year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021<span></span>
</td>
<td class="text">2021<span></span>
</td>
<td class="text"> 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds from the debt offering after deducting transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 166,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member', window );">2.75% Convertible Senior Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Formation and Business of the Company [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentMaturityYear', window );">Debt instrument due year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of convertible senior notes</a></td>
<td class="nump">189,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds from the debt offering after deducting transaction costs</a></td>
<td class="nump">$ 183,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentMaturityYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument maturity year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentMaturityYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization consolidation and presentation of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972018184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Formation and Business of the Company - Additional Information - Public Offering (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock in underwriting public offering</a></td>
<td class="nump">1,868,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock in public offering, net</a></td>
<td class="nump">$ 147,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,144,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock in underwriting public offering</a></td>
<td class="nump">1,868,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,868,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock in underwriting public offering</a></td>
<td class="nump">243,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember', window );">1.75% Convertible Senior Notes due 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentMaturityYear', window );">Debt instrument due year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021<span></span>
</td>
<td class="text">2021<span></span>
</td>
<td class="text"> 2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentAdditionalAggregatePrincipalAmount', window );">Additional aggregate principal amount of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument frequency of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds from the debt offering after deducting transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 166,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member', window );">2.75% Convertible senior notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of convertible senior notes</a></td>
<td class="nump">$ 165,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentMaturityYear', window );">Debt instrument due year</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentAdditionalAggregatePrincipalAmount', window );">Additional aggregate principal amount of convertible senior notes</a></td>
<td class="nump">$ 24,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument frequency of payment</a></td>
<td class="text">semi-annually in arrears on April 1 and October 1 of each year, commencing on October 1, 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds from the debt offering after deducting transaction costs</a></td>
<td class="nump">$ 183,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentAdditionalAggregatePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument additional aggregate principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentAdditionalAggregatePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentMaturityYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument maturity year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentMaturityYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972026888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2014</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Subsidiary </div>
<div>Business</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_NumberOfOperationalWhollyOwnedSubsidiaries', window );">Number of operational wholly owned subsidiaries | Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business activities | Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Net unrealized foreign currency transaction gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,300,000)<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Realized foreign currency transaction gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(1,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash held in foreign banks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="nump">17,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Unsatisfied performance obligations description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.&#160;&#160;As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_BadDebtExpense1', window );">Bad debt expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_EmployeeStockPurchasePlanOfferingPeriod', window );">Employee stock purchase plan offering period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member', window );">ASU 2019-12 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in accounting principle, accounting standards update, adoption [true false]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Accounting standards adopted date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect [true false]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_PerformanceBasedRestrictedStockUnitsRSUMember', window );">Performance Based RSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member', window );">2.75% Convertible Senior Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentMaturityYear', window );">Debt instrument due year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_BadDebtExpense1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bad Debt Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_BadDebtExpense1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentMaturityYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument maturity year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentMaturityYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_EmployeeStockPurchasePlanOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee stock purchase plan offering period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_EmployeeStockPurchasePlanOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_NumberOfOperationalWhollyOwnedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operational wholly owned subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_NumberOfOperationalWhollyOwnedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123341672&amp;loc=SL120154346-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 33: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123341672&amp;loc=SL120154346-209984<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31010-122693<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of when remaining performance obligation is expected to be recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_PerformanceBasedRestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_PerformanceBasedRestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972245496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail 1)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Unsatisfied performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968658072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 386,905<span></span>
</td>
<td class="nump">$ 362,048<span></span>
</td>
<td class="nump">$ 390,255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">326,216<span></span>
</td>
<td class="nump">311,873<span></span>
</td>
<td class="nump">326,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 60,689<span></span>
</td>
<td class="nump">$ 50,175<span></span>
</td>
<td class="nump">$ 64,243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504973407288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Schedule of Revenue by Major Customers by Geographic Area (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue [Member] | Geographic Concentration Risk [Member] | United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue</a></td>
<td class="nump">84.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
<td class="nump">84.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504971798824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue | $</a></td>
<td class="nump">$ 386,905<span></span>
</td>
<td class="nump">$ 362,048<span></span>
</td>
<td class="nump">$ 390,255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nvro_PainfulDiabeticNeuropathyMember', window );">Painful Diabetic Neuropathy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue | $</a></td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nvro_MajorCustomersMember', window );">Major Customers [Member] | Customer Concentration Risk [Member] | Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold', window );">Number of customers accounted 10% or more concentration risk | Customer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nvro_MajorCustomersMember', window );">Major Customers [Member] | Credit Concentration Risk [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold', window );">Number of customers accounted 10% or more concentration risk | Customer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration risk number of customers exceeding threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nvro_PainfulDiabeticNeuropathyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nvro_PainfulDiabeticNeuropathyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nvro_MajorCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nvro_MajorCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504965198248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend', window );">Existence of option to extend the lease</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Option to extend the lease term, description</a></td>
<td class="text">As of December 31, 2021, the Company has leases with remaining terms of 3 year to 10 years, some of which may include options to extend the lease term for up to 5 years.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LesseeOperatingLeaseRemainingTermOfContract', window );">Operating lease, remaining term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LesseeOperatingLeaseRemainingTermOfContract', window );">Operating lease, remaining term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Options to extend the lease term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_LesseeOperatingLeaseRemainingTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease remaining term of contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_LesseeOperatingLeaseRemainingTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether lessee has option to extend operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504974496248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">4 years 3 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972603256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturity of Lease Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 5,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">6,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">6,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">2,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">23,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="num">(3,183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 19,990<span></span>
</td>
<td class="nump">$ 20,565<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972245496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Lease Cost Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 5,243<span></span>
</td>
<td class="nump">$ 4,936<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968221544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Operating Lease Assets and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_OperatingLeaseAssetsAndLiabilitiesAbstract', window );"><strong>Operating Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 17,577<span></span>
</td>
<td class="nump">$ 18,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 4,588<span></span>
</td>
<td class="nump">$ 3,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherCurrentLiabilitiesMember<span></span>
</td>
<td class="text">us-gaap:OtherCurrentLiabilitiesMember<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long term operating lease liabilities</a></td>
<td class="nump">$ 15,402<span></span>
</td>
<td class="nump">$ 16,689<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 19,990<span></span>
</td>
<td class="nump">$ 20,565<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_OperatingLeaseAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease assets and liabilities abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_OperatingLeaseAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972325864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Supplemental Cash Flow Information Related to Lease (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flow from operating leases</a></td>
<td class="nump">$ 5,253<span></span>
</td>
<td class="nump">$ 4,923<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid for amounts included in the measurement of lease liabilities abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504971788360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember', window );">1.75% Convertible Senior Notes due 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentMaturityYear', window );">Debt instrument due year</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">2021<span></span>
</td>
<td class="text"> 2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member', window );">2.75% Convertible Senior Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentMaturityYear', window );">Debt instrument due year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 212.0<span></span>
</td>
<td class="nump">$ 348.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements Recurring [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_MoneyMarketFundsNetAssetValuePerShare', window );">Net asset value of market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentMaturityYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument maturity year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentMaturityYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_MoneyMarketFundsNetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Money market funds net asset value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_MoneyMarketFundsNetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968491624">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail) - Fair Value Measurements Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 341,887<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 559,646<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">207,114<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">46,347<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">134,773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">513,299<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money Market Funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,562<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money Market Funds [Member] | Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,562<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Agency Bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">42,538<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">210,302<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Agency Bonds [Member] | Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">42,538<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">210,302<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Commercial Paper [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">61,884<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">277,602<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Commercial Paper [Member] | Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">61,884<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">277,602<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,351<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">25,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate Notes [Member] | Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,351<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">25,395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Treasury Bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">197,552<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30,074<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Treasury Bonds [Member] | Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 197,552<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 30,074<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Included in cash and cash equivalents on the consolidated balance sheets.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Included in short-term investments on the consolidated balance sheets.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=nvro_AgencyBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=nvro_AgencyBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968486616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 332,692<span></span>
</td>
<td class="nump">$ 543,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Holding Gains</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Holding Losses</a></td>
<td class="num">(371)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">332,325<span></span>
</td>
<td class="nump">543,373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_AgencySecuritiesMember', window );">Agency Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">42,546<span></span>
</td>
<td class="nump">210,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Holding Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Holding Losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">42,538<span></span>
</td>
<td class="nump">210,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">61,886<span></span>
</td>
<td class="nump">277,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Holding Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Holding Losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">61,884<span></span>
</td>
<td class="nump">277,602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember', window );">Corporate Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">30,371<span></span>
</td>
<td class="nump">25,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Holding Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Holding Losses</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">30,351<span></span>
</td>
<td class="nump">25,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBondSecuritiesMember', window );">Treasury Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">197,889<span></span>
</td>
<td class="nump">30,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Holding Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Holding Losses</a></td>
<td class="num">(339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">$ 197,552<span></span>
</td>
<td class="nump">$ 30,074<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968223976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments Debt And Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Amortized Cost, Amounts maturing within one year</a></td>
<td class="nump">$ 305,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Amortized Cost, Amounts maturing after one year through five years</a></td>
<td class="nump">26,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">332,692<span></span>
</td>
<td class="nump">$ 543,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Fair Value, Amounts maturing within one year</a></td>
<td class="nump">305,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Fair Value, Amounts after one year through five years</a></td>
<td class="nump">26,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value, Total investment securities</a></td>
<td class="nump">$ 332,325<span></span>
</td>
<td class="nump">$ 543,373<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504965300504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Components of Inventories (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 50,160<span></span>
</td>
<td class="nump">$ 34,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">43,357<span></span>
</td>
<td class="nump">48,891<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 93,517<span></span>
</td>
<td class="nump">$ 83,296<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504965213048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_InventoryWriteDownCashAndNonCash', window );">Write down of inventory</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">4,882<span></span>
</td>
<td class="nump">4,794<span></span>
</td>
<td class="nump">$ 4,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract', window );"><strong>Restricted Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">606<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract', window );"><strong>Restricted Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_InventoryWriteDownCashAndNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory write down cash and non cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_InventoryWriteDownCashAndNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504971791816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 43,319<span></span>
</td>
<td class="nump">$ 31,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(22,655)<span></span>
</td>
<td class="num">(17,773)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">20,664<span></span>
</td>
<td class="nump">13,531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">8,722<span></span>
</td>
<td class="nump">7,072<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment and Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">16,349<span></span>
</td>
<td class="nump">12,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">4,215<span></span>
</td>
<td class="nump">3,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">10,316<span></span>
</td>
<td class="nump">4,289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Process [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 3,717<span></span>
</td>
<td class="nump">$ 3,354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968714456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Summary of Accrued Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">$ 30,957<span></span>
</td>
<td class="nump">$ 30,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">6,547<span></span>
</td>
<td class="nump">2,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued taxes</a></td>
<td class="nump">1,074<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_AccruedClinicalAndResearchExpensesCurrent', window );">Accrued clinical and research expenses</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualCurrent', window );">Accrued warranty</a></td>
<td class="nump">664<span></span>
</td>
<td class="nump">699<span></span>
</td>
<td class="nump">$ 1,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">4,665<span></span>
</td>
<td class="nump">6,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 45,517<span></span>
</td>
<td class="nump">$ 43,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_AccruedClinicalAndResearchExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical and research expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_AccruedClinicalAndResearchExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504960122392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 31, 2015 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Nov. 30, 2014 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>ConvertibleNote</div>
</th>
<th class="th">
<div>Apr. 27, 2018 </div>
<div>Patent</div>
</th>
<th class="th">
<div>Dec. 09, 2016 </div>
<div>Patent</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDescription', window );">Standard product warranty, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">limited one- to five-year warranty<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Retainer fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,665,000<span></span>
</td>
<td class="nump">$ 45,600,000<span></span>
</td>
<td class="nump">$ 59,017,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,868,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes', window );">Contingent consideration payment secured by convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_NumberOfSecuredConvertibleNotes', window );">Number of secured convertible notes | ConvertibleNote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost', window );">Secured convertible note, measured at amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ValueOfCertainRightsMeasuredAtCost', window );">Value of certain rights measured at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes', window );">Contingent consideration expenses net secured by convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=nvro_BostonScientificCorporationMember', window );">Boston Scientific Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents', window );">Patent infringement lawsuit allegation against number of patents | Patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Amount awarded by jury</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember', window );">Indemnification Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=nvro_PatentInfringementMember', window );">Patent Infringement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ServiceAgreementCommitmentAmountYearOne', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ServiceAgreementCommitmentAmountYearTwo', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ServiceAgreementCommitmentAmountYearThree', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ServiceAgreementCommitmentAmountYearFour', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Annual royalty payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LicenseAgreementCommitmentAmount', window );">License agreement commitment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LicenseAgreementExpirationYear', window );">License agreement expiration year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements [Member] | Mayo And VGL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms', window );">License agreement, terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements [Member] | Mayo Foundation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Retainer fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_NonCashResearchAndDevelopmentExpense', window );">Noncash research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements [Member] | Mayo Foundation [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Annual royalty payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=nvro_SupplyAgreementsMember', window );">Supply Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Purchase commitment, amount due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFirmPurchaseCommitmentLoss', window );">Purchase commitments for inventory related charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CR', window );">Costa Rica [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LeaseCommencementPeriod', window );">Lease agreement, commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2020-08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of office space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LeaseEffectiveDate', window );">Lease agreement, effective date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_OperatingLeasesExpirationDate', window );">Lease agreement, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2031-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease agreement, lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=nvro_RedwoodOfficeAgreementMember', window );">Redwood Office Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LeaseCommencementPeriod', window );">Lease agreement, commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2015-03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of office space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LeaseEffectiveDate', window );">Lease agreement, effective date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_OperatingLeasesExpirationDate', window );">Lease agreement, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2022-05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Lease expense, payment due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm', window );">Annual lease expense payable in final year of lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember', window );">Redwood Office Agreement Additional Expansion Premises [Member] | Amendment 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of office space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Lease expense, payment due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm', window );">Annual lease expense payable in final year of lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LeaseCommencementDateDescription', window );">Commencement date description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The lease for the Expansion Premises commenced on June 1, 2018. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperationsCommencedDate1', window );">Lease commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun.  01,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease agreement, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=nvro_FacilityLeaseAgreementThreeMember', window );">Non-cancellable Facility Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_LeaseEffectiveDate', window );">Lease agreement, effective date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  01,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease agreement, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 28,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease agreement, lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=nvro_FacilityLeaseAgreementThreeMember', window );">Non-cancellable Facility Lease [Member] | Amendment 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease agreement, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration expenses net secured by convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration payment secured by convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_LeaseCommencementDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease commencement date description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_LeaseCommencementDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_LeaseCommencementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease commencement period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_LeaseCommencementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_LeaseEffectiveDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease effective date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_LeaseEffectiveDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_LicenseAgreementCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement commitment amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_LicenseAgreementCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_LicenseAgreementExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement expiration year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_LicenseAgreementExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_NonCashResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_NonCashResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_NumberOfSecuredConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of secured convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_NumberOfSecuredConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_OperatingLeasesExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating leases expiration date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_OperatingLeasesExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating leases future minimum payments due in final year of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patent infringement lawsuit allegation against number of patents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Secured convertible note receivable measured at amortized cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ServiceAgreementCommitmentAmountYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Service agreement commitment amount year four.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ServiceAgreementCommitmentAmountYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ServiceAgreementCommitmentAmountYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Service agreement commitment amount year one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ServiceAgreementCommitmentAmountYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ServiceAgreementCommitmentAmountYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Service agreement commitment amount year three.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ServiceAgreementCommitmentAmountYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ServiceAgreementCommitmentAmountYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Service agreement commitment amount year two.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ServiceAgreementCommitmentAmountYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ValueOfCertainRightsMeasuredAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of certain rights measured at cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ValueOfCertainRightsMeasuredAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFirmPurchaseCommitmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss recognized on firm purchase commitment for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4578-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFirmPurchaseCommitmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperationsCommencedDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the operations of the entity commenced, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperationsCommencedDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=nvro_BostonScientificCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=nvro_BostonScientificCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=nvro_PatentInfringementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=nvro_PatentInfringementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nvro_MayoAndVglMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nvro_MayoAndVglMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nvro_MayoFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nvro_MayoFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nvro_SupplyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nvro_SupplyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=nvro_RedwoodOfficeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=nvro_RedwoodOfficeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=nvro_FirstAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=nvro_FirstAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=nvro_FacilityLeaseAgreementThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=nvro_FacilityLeaseAgreementThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504971806248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualCurrent', window );">Beginning balance</a></td>
<td class="nump">$ 699<span></span>
</td>
<td class="nump">$ 1,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Provision for warranty</a></td>
<td class="nump">2,846<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Utilization</a></td>
<td class="num">(2,881)<span></span>
</td>
<td class="num">(2,629)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualCurrent', window );">Ending balance</a></td>
<td class="nump">$ 664<span></span>
</td>
<td class="nump">$ 699<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504962539320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 01, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,933,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentMaturityMonthAndYear', window );">Debt instrument due year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentAdditionalAggregatePrincipalAmount', window );">Additional aggregate principal amount of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument frequency of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds from the debt offering after deducting transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Convertible notes principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Convertible notes, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.3770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity', window );">Convertible notes, type of equity security issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Convertible notes, conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt instrument convertible, percentage of conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice', window );">Percentage of repurchase price, which is equal to principal amount of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_NoteHedgesNumberOfSharesContractedToBuy', window );">Number of shares purchased under convertible note hedge transactions | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_PurchasePricePerCommonStock', window );">Purchase price of the shares issued under convertible note hedge transactions | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_NoteHedgesTransactionCosts', window );">Total cost of the convertible note hedge transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost', window );">Net cost of reduction to additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Debt conversion, converted instrument amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.29%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs attributable to the liability and equity component, total amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentGross', window );">Debt issuance costs attributable to the liability component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | Debt, Liability Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Convertible notes, shares issued | shares</a></td>
<td class="nump">682,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentGross', window );">Debt issuance costs attributable to the liability component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="nump">$ 172,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes', window );">Share received on option exercise | shares</a></td>
<td class="nump">682,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Holders of warrants associated</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares issued for warrants under convertible note hedge transactions | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Purchase price of the shares issued under convertible note hedge transactions | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | 130% for Applicable Conversion Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt instrument convertible trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt instrument convertible consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | 98% Applicable Conversion Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt instrument convertible trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt instrument convertible consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Percentage of closing sale price of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | Maximum [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ConversionPricePerShare', window );">Overall conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | Minimum [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ConversionPricePerShare', window );">Overall conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentAdditionalAggregatePrincipalAmount', window );">Additional aggregate principal amount of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument frequency of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">semi-annually in arrears on April 1 and October&#160;1 of each year, commencing on October 1, 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds from the debt offering after deducting transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Convertible notes principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Convertible notes, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.5238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity', window );">Convertible notes, type of equity security issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Convertible notes, conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt instrument convertible, percentage of conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice', window );">Percentage of repurchase price, which is equal to principal amount of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_NoteHedgesNumberOfSharesContractedToBuy', window );">Number of shares purchased under convertible note hedge transactions | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_PurchasePricePerCommonStock', window );">Purchase price of the shares issued under convertible note hedge transactions | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_NoteHedgesTransactionCosts', window );">Total cost of the convertible note hedge transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost', window );">Net cost of reduction to additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Debt conversion, converted instrument amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentMaturityYear', window );">Debt instrument due year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Converted Value in Excess of Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | Debt, Liability Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentGross', window );">Debt issuance costs attributable to the liability component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,361,000<span></span>
</td>
<td class="nump">4,060,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,750,000<span></span>
</td>
<td class="nump">$ 189,750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares issued for warrants under convertible note hedge transactions | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Purchase price of the shares issued under convertible note hedge transactions | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | 130% for Applicable Conversion Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt instrument convertible trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt instrument convertible consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | 98% Applicable Conversion Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt instrument convertible trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt instrument convertible consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Percentage of closing sale price of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | Maximum [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ConversionPricePerShare', window );">Overall conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | Minimum [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ConversionPricePerShare', window );">Overall conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital hedge and warrant transactions net cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ConversionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ConversionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentAdditionalAggregatePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument additional aggregate principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentAdditionalAggregatePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentMaturityMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The month and year (YYYY-MM) that the debt instrument maturity is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentMaturityMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentMaturityYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument maturity year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentMaturityYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of bond hedge for convertible senior notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_NoteHedgesNumberOfSharesContractedToBuy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note hedges number of shares contracted to buy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_NoteHedgesNumberOfSharesContractedToBuy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_NoteHedgesTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note hedges transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_NoteHedgesTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of convertible notes is equal to repurchase price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_PurchasePricePerCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price per common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_PurchasePricePerCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the type of equity security or securities into which conversion will be made (for example, common stock or preferred shares).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=nvro_DebtLiabilityComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=nvro_DebtLiabilityComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=nvro_OneHundredThirtyPercentApplicableConversionPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=nvro_OneHundredThirtyPercentApplicableConversionPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=nvro_NinetyEightPercentApplicableConversionPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=nvro_NinetyEightPercentApplicableConversionPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504963469656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentGross', window );">Unamortized issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,500)<span></span>
</td>
<td class="num">$ (5,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember', window );">2021 Notes and Convertible Notes [Member] | Debt, Liability Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172,500<span></span>
</td>
<td class="nump">$ 172,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentGross', window );">Unamortized issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(542)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | Debt, Liability Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal</a></td>
<td class="nump">$ 189,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="num">(35,079)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,919)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentGross', window );">Unamortized issuance cost</a></td>
<td class="num">(3,361)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,060)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying amount</a></td>
<td class="nump">$ 151,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=nvro_DebtLiabilityComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=nvro_DebtLiabilityComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968513688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember', window );">1.75% Convertible Senior Notes due 2021 [Member] | Debt, Equity Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption', window );">Debt discount related to value of conversion option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost', window );">Debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member] | Debt, Equity Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption', window );">Debt discount related to value of conversion option</a></td>
<td class="nump">$ 49,947<span></span>
</td>
<td class="nump">49,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost', window );">Debt issuance cost</a></td>
<td class="num">(1,607)<span></span>
</td>
<td class="num">(1,607)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Net carrying amount</a></td>
<td class="nump">$ 48,340<span></span>
</td>
<td class="nump">$ 48,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument convertible equity component issuance cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument convertible equity discount related to value of conversion option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=nvro_DebtEquityComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=nvro_DebtEquityComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504973008616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail) - 2021 Notes and 2025 Notes [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="nump">$ 6,484<span></span>
</td>
<td class="nump">$ 6,860<span></span>
</td>
<td class="nump">$ 3,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">12,023<span></span>
</td>
<td class="nump">13,308<span></span>
</td>
<td class="nump">6,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">1,240<span></span>
</td>
<td class="nump">1,634<span></span>
</td>
<td class="nump">1,063<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense</a></td>
<td class="nump">$ 19,747<span></span>
</td>
<td class="nump">$ 21,802<span></span>
</td>
<td class="nump">$ 10,925<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504973624040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock - Additional Information (Detail) - shares<br></strong></div></th>
<th class="th"><div>Nov. 11, 2014</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 10, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,208,048<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Convertible preferred stock converted to common stock</a></td>
<td class="nump">15,208,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common stock shares issued for each convertible preferred stock</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504971803704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_CommonStockOptionsAndAwardsOutstanding', window );">Outstanding stock options and awards</a></td>
<td class="nump">1,713,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants', window );">Reserved for grants of future stock options and awards</a></td>
<td class="nump">6,078,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan', window );">Reserved for employee stock purchase plan</a></td>
<td class="nump">1,567,514<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">9,359,528<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_CommonStockOptionsAndAwardsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock options and awards outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_CommonStockOptionsAndAwardsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock reserved for future issuance under employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock reserved for future issuance under stock option and awards grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504965043384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,359,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_EmployeeStockPurchasePlanOfferingPeriod', window );">Employee stock purchase plan offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,365<span></span>
</td>
<td class="nump">42,655<span></span>
</td>
<td class="nump">41,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Employee Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Option purchase price, percentage of fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum employee subscription rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember', window );">Performance Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,017<span></span>
</td>
<td class="nump">5,694<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember', window );">Performance Stock Units [Member] | CEO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_TargetedCompositeIndexPeriod', window );">Targeted composite index period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember', window );">Performance Stock Units [Member] | Member of Management Team [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_TargetedCompositeIndexPeriod', window );">Targeted composite index period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,234<span></span>
</td>
<td class="nump">$ 27,977<span></span>
</td>
<td class="nump">$ 26,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Performance Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_RecognitionPeriodOfStockBasedCompensationExpense', window );">Recognition period of stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Performance Stock Units [Member] | CEO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_TargetedNumberOfSharesGrantedRatio', window );">Targeted number of shares granted ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Performance Stock Units [Member] | Member of Management Team [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_TargetedNumberOfSharesGrantedRatio', window );">Targeted number of shares granted ratio</a></td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Performance Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_RecognitionPeriodOfStockBasedCompensationExpense', window );">Recognition period of stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Performance Stock Units [Member] | CEO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_TargetedNumberOfSharesGrantedRatio', window );">Targeted number of shares granted ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Performance Stock Units [Member] | Member of Management Team [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_TargetedNumberOfSharesGrantedRatio', window );">Targeted number of shares granted ratio</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvro_TwoThousandSevenPlanMember', window );">2007 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional awards authorized under plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvro_TwoThousandFourteenEquityIncentivePlanMember', window );">2014 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,854,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">Plan modification description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i)&#160;the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii)&#160;an annual increase on January&#160;1 of each year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvro_TwoThousandFourteenEquityIncentivePlanMember', window );">2014 Plan [Member] | ISO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_PercentageOfShareholderOptionsGranted', window );">Percentage of shareholder granted option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvro_TwoThousandFourteenEquityIncentivePlanMember', window );">2014 Plan [Member] | NSO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_PercentageOfShareholderOptionsGranted', window );">Percentage of shareholder granted option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvro_TwoThousandFourteenEquityIncentivePlanMember', window );">2014 Plan [Member] | Share-based Compensation Award, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvro_TwoThousandFourteenEquityIncentivePlanMember', window );">2014 Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock options expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Option purchase price, percentage of fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nvro_TwoThousandFourteenEquityIncentivePlanMember', window );">2014 Plan [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Option purchase price, percentage of fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_EmployeeStockPurchasePlanOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee stock purchase plan offering period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_EmployeeStockPurchasePlanOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_PercentageOfShareholderOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of shareholder options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_PercentageOfShareholderOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_RecognitionPeriodOfStockBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recognition period of stock based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_RecognitionPeriodOfStockBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_TargetedCompositeIndexPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Targeted composite index period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_TargetedCompositeIndexPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_TargetedNumberOfSharesGrantedRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Targeted number of shares granted ratio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_TargetedNumberOfSharesGrantedRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvro_TwoThousandSevenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvro_TwoThousandSevenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nvro_TwoThousandFourteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nvro_TwoThousandFourteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_IncentiveStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_IncentiveStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504973023352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Shares Available for Grant (Detail) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant, Beginning balances</a></td>
<td class="nump">4,600,181<span></span>
</td>
<td class="nump">3,403,006<span></span>
</td>
<td class="nump">2,980,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Shares Available for Grant, Additional shares reserved</a></td>
<td class="nump">1,383,322<span></span>
</td>
<td class="nump">1,261,774<span></span>
</td>
<td class="nump">1,210,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance', window );">Shares Available for Grant, Allowance for PSU for over performance</a></td>
<td class="num">(24,830)<span></span>
</td>
<td class="num">(43,966)<span></span>
</td>
<td class="num">(277,778)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax', window );">Shares Available for Grant, Shares forfeited for tax</a></td>
<td class="nump">58,787<span></span>
</td>
<td class="nump">62,782<span></span>
</td>
<td class="nump">38,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant, Ending balances</a></td>
<td class="nump">5,732,295<span></span>
</td>
<td class="nump">4,600,181<span></span>
</td>
<td class="nump">3,403,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember', window );">Employee Stock Option, RSUs and PSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod', window );">Shares Available for Grant, Options and other than options granted</a></td>
<td class="num">(425,266)<span></span>
</td>
<td class="num">(341,901)<span></span>
</td>
<td class="num">(1,077,178)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod', window );">Shares Available for Grant, Options and other than options forfeited or cancelled</a></td>
<td class="nump">140,101<span></span>
</td>
<td class="nump">258,486<span></span>
</td>
<td class="nump">527,963<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments options and other than options forfeited and expirations in period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments options and other than options grants in period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of allowance for PSU for over performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award number of shares forfeited for tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504970319128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Activity under Stock Plans (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract', window );"><strong>Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Exercise Price And Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Beginning balances</a></td>
<td class="nump">813,150<span></span>
</td>
<td class="nump">1,646,185<span></span>
</td>
<td class="nump">2,529,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Options exercised</a></td>
<td class="num">(90,582)<span></span>
</td>
<td class="num">(756,797)<span></span>
</td>
<td class="num">(828,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Options cancelled</a></td>
<td class="num">(21,914)<span></span>
</td>
<td class="num">(76,238)<span></span>
</td>
<td class="num">(298,908)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Ending balances</a></td>
<td class="nump">700,654<span></span>
</td>
<td class="nump">813,150<span></span>
</td>
<td class="nump">1,646,185<span></span>
</td>
<td class="nump">2,529,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Options exercisable</a></td>
<td class="nump">599,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Options, Options vested, exercisable or expected to vest</a></td>
<td class="nump">696,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning balances</a></td>
<td class="nump">$ 54.69<span></span>
</td>
<td class="nump">$ 50.80<span></span>
</td>
<td class="nump">$ 46.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options exercised</a></td>
<td class="nump">47.82<span></span>
</td>
<td class="nump">45.75<span></span>
</td>
<td class="nump">34.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options cancelled</a></td>
<td class="nump">43.52<span></span>
</td>
<td class="nump">59.38<span></span>
</td>
<td class="nump">66.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Ending balances</a></td>
<td class="nump">55.93<span></span>
</td>
<td class="nump">$ 54.69<span></span>
</td>
<td class="nump">$ 50.80<span></span>
</td>
<td class="nump">$ 46.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options exercisable</a></td>
<td class="nump">56.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Options vested, exercisable or expected to vest</a></td>
<td class="nump">$ 55.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Term</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable, Weighted-Average Remaining Contractual Term</a></td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options vested, exercisable or expected to vest, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 18,287<span></span>
</td>
<td class="nump">$ 96,286<span></span>
</td>
<td class="nump">$ 109,870<span></span>
</td>
<td class="nump">$ 21,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised, Aggregate Intrinsic Value</a></td>
<td class="nump">6,948<span></span>
</td>
<td class="nump">$ 62,367<span></span>
</td>
<td class="nump">$ 42,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">15,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options vested, exercisable or expected to vest, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 18,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, options outstanding, weighted average exercise price, and additional disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504965471704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range1Member', window );">$3.60 - $36.55 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Exercise Price Lower Range Limit</a></td>
<td class="nump">$ 3.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Exercise Price Upper Range Limit</a></td>
<td class="nump">$ 36.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">116,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Life (in Years)</a></td>
<td class="text">3 years 1 month 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 19.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Vested, Number Exercisable | shares</a></td>
<td class="nump">111,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Vested, Weighted Average Exercise Price</a></td>
<td class="nump">$ 18.52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range2Member', window );">$38.79 - $45.04 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Exercise Price Lower Range Limit</a></td>
<td class="nump">38.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Exercise Price Upper Range Limit</a></td>
<td class="nump">$ 45.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">114,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Life (in Years)</a></td>
<td class="text">5 years 6 months 7 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 47.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Vested, Number Exercisable | shares</a></td>
<td class="nump">94,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Vested, Weighted Average Exercise Price</a></td>
<td class="nump">$ 42.08<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range3Member', window );">$45.07 - $63.23 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Exercise Price Lower Range Limit</a></td>
<td class="nump">45.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Exercise Price Upper Range Limit</a></td>
<td class="nump">$ 63.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">156,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Life (in Years)</a></td>
<td class="text">4 years 5 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 57.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Vested, Number Exercisable | shares</a></td>
<td class="nump">129,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Vested, Weighted Average Exercise Price</a></td>
<td class="nump">$ 59.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range4Member', window );">$63.39 - $64.95 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Exercise Price Lower Range Limit</a></td>
<td class="nump">63.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Exercise Price Upper Range Limit</a></td>
<td class="nump">$ 64.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">141,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Life (in Years)</a></td>
<td class="text">6 years 11 months 8 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 64.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Vested, Number Exercisable | shares</a></td>
<td class="nump">91,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Vested, Weighted Average Exercise Price</a></td>
<td class="nump">$ 64.21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range5Member', window );">$65.51 - $87.62 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Exercise Price Lower Range Limit</a></td>
<td class="nump">65.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Exercise Price Upper Range Limit</a></td>
<td class="nump">$ 87.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">152,556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Life (in Years)</a></td>
<td class="text">3 years 11 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 79.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Vested, Number Exercisable | shares</a></td>
<td class="nump">152,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Vested, Weighted Average Exercise Price</a></td>
<td class="nump">$ 79.36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range6Member', window );">$97.52 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice', window );">Options Outstanding, Exercise Price</a></td>
<td class="nump">$ 97.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Life (in Years)</a></td>
<td class="text">4 years 7 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 97.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Vested, Number Exercisable | shares</a></td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Vested, Weighted Average Exercise Price</a></td>
<td class="nump">$ 97.52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range7Member', window );">$3.60 - $97.52 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Exercise Price Lower Range Limit</a></td>
<td class="nump">3.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Exercise Price Upper Range Limit</a></td>
<td class="nump">$ 97.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">700,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted Average Remaining Contractual Life (in Years)</a></td>
<td class="text">4 years 9 months 21 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 55.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Vested, Number Exercisable | shares</a></td>
<td class="nump">599,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Vested, Weighted Average Exercise Price</a></td>
<td class="nump">$ 56.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation shares authorized under stock option plans exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=nvro_Range7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504959997208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail) - Restricted Stock Units [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Restricted Stock Units, Outstanding Beginning Balance</a></td>
<td class="nump">852,977<span></span>
</td>
<td class="nump">1,177,221<span></span>
</td>
<td class="nump">1,002,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Restricted Stock Units, Restricted stock granted</a></td>
<td class="nump">368,230<span></span>
</td>
<td class="nump">252,703<span></span>
</td>
<td class="nump">721,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Restricted Stock Units, Restricted stock released</a></td>
<td class="num">(346,602)<span></span>
</td>
<td class="num">(395,971)<span></span>
</td>
<td class="num">(321,858)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Restricted Stock Units, Restricted stock cancelled</a></td>
<td class="num">(110,799)<span></span>
</td>
<td class="num">(180,976)<span></span>
</td>
<td class="num">(225,074)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Restricted Stock Units, Outstanding Ending Balance</a></td>
<td class="nump">763,806<span></span>
</td>
<td class="nump">852,977<span></span>
</td>
<td class="nump">1,177,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest', window );">Number of Restricted Stock Units, Restricted stock expected to vest</a></td>
<td class="nump">696,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value Outstanding, Beginning Balance</a></td>
<td class="nump">$ 79.87<span></span>
</td>
<td class="nump">$ 64.70<span></span>
</td>
<td class="nump">$ 72.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Granted</a></td>
<td class="nump">146.64<span></span>
</td>
<td class="nump">123.31<span></span>
</td>
<td class="nump">58.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Released</a></td>
<td class="nump">76.26<span></span>
</td>
<td class="nump">66.42<span></span>
</td>
<td class="nump">70.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Cancelled</a></td>
<td class="nump">98.76<span></span>
</td>
<td class="nump">71.26<span></span>
</td>
<td class="nump">70.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value Outstanding, Ending Balance</a></td>
<td class="nump">110.96<span></span>
</td>
<td class="nump">$ 79.87<span></span>
</td>
<td class="nump">$ 64.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Restricted stock expected to vest</a></td>
<td class="nump">$ 109.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregate Intrinsic Value Outstanding</a></td>
<td class="nump">$ 61,922<span></span>
</td>
<td class="nump">$ 147,650<span></span>
</td>
<td class="nump">$ 138,371<span></span>
</td>
<td class="nump">$ 38,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Aggregate Intrinsic Value, Released</a></td>
<td class="nump">22,902<span></span>
</td>
<td class="nump">$ 23,789<span></span>
</td>
<td class="nump">$ 4,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest', window );">Aggregate Intrinsic Value, Expected to vest</a></td>
<td class="nump">$ 56,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, equity instruments other than options, shares expected to vest, weighted average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968678024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Performance Stock Units Under Stock Plan (Detail) - Performance Stock Units [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Restricted Stock Units, Outstanding Beginning Balance</a></td>
<td class="nump">199,037<span></span>
</td>
<td class="nump">111,111<span></span>
</td>
<td class="nump">7,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Restricted Stock Units, PSU granted</a></td>
<td class="nump">57,036<span></span>
</td>
<td class="nump">89,198<span></span>
</td>
<td class="nump">111,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Restricted Stock Units, PSU released</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,981)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Restricted Stock Units, PSU cancelled</a></td>
<td class="num">(7,388)<span></span>
</td>
<td class="num">(1,272)<span></span>
</td>
<td class="num">(3,981)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Restricted Stock Units, Outstanding Ending Balance</a></td>
<td class="nump">248,685<span></span>
</td>
<td class="nump">199,037<span></span>
</td>
<td class="nump">111,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest', window );">Number of Restricted Stock Units, PSU expected to vest</a></td>
<td class="nump">247,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value Outstanding, Beginning Balance</a></td>
<td class="nump">$ 94.20<span></span>
</td>
<td class="nump">$ 67.29<span></span>
</td>
<td class="nump">$ 54.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, PSU Granted</a></td>
<td class="nump">183.20<span></span>
</td>
<td class="nump">128.71<span></span>
</td>
<td class="nump">67.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, PSU Released</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, PSU Cancelled</a></td>
<td class="nump">136.77<span></span>
</td>
<td class="nump">125.27<span></span>
</td>
<td class="nump">54.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value Outstanding, Ending Balance</a></td>
<td class="nump">113.35<span></span>
</td>
<td class="nump">$ 94.20<span></span>
</td>
<td class="nump">$ 67.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, PSU expected to vest</a></td>
<td class="nump">$ 113.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregate Intrinsic Value PSU Outstanding</a></td>
<td class="nump">$ 20,161<span></span>
</td>
<td class="nump">$ 34,453<span></span>
</td>
<td class="nump">$ 13,060<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest', window );">Aggregate Intrinsic Value, PSU Expected to vest</a></td>
<td class="nump">$ 20,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, equity instruments other than options, shares expected to vest, weighted average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504965199880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail) - ESPP [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares reserved</a></td>
<td class="nump">235,590<span></span>
</td>
<td class="nump">315,443<span></span>
</td>
<td class="nump">302,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued</a></td>
<td class="nump">65,197<span></span>
</td>
<td class="nump">79,967<span></span>
</td>
<td class="nump">164,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future issuance</a></td>
<td class="nump">1,567,514<span></span>
</td>
<td class="nump">1,397,121<span></span>
</td>
<td class="nump">1,161,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod', window );">Employee contributions for shares issued</a></td>
<td class="nump">$ 6,849<span></span>
</td>
<td class="nump">$ 7,513<span></span>
</td>
<td class="nump">$ 6,544<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award value issued in period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504971873544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember', window );">ESPP [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504970401256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail) - Performance Stock Units [Member]<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate', window );">Index volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate', window );">Company volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate', window );">Correlation with index</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.28%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate', window );">Index volatility</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate', window );">Company volatility</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate', window );">Correlation with index</a></td>
<td class="nump">0.32%<span></span>
</td>
<td class="nump">0.38%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate', window );">Index volatility</a></td>
<td class="nump">53.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate', window );">Company volatility</a></td>
<td class="nump">54.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate', window );">Correlation with index</a></td>
<td class="nump">0.35%<span></span>
</td>
<td class="nump">0.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award fair value assumptions correlation wirh index rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award fair value assumptions index volatility rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share-based payment award, fair value assumptions volatility rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504970326744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 44,365<span></span>
</td>
<td class="nump">$ 42,655<span></span>
</td>
<td class="nump">$ 41,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
<td class="nump">3,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">6,455<span></span>
</td>
<td class="nump">6,141<span></span>
</td>
<td class="nump">6,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 36,273<span></span>
</td>
<td class="nump">$ 34,081<span></span>
</td>
<td class="nump">$ 32,313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504959995816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,365<span></span>
</td>
<td class="nump">$ 42,655<span></span>
</td>
<td class="nump">$ 41,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,997<span></span>
</td>
<td class="nump">6,289<span></span>
</td>
<td class="nump">10,312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">29,234<span></span>
</td>
<td class="nump">27,977<span></span>
</td>
<td class="nump">26,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember', window );">Performance Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,017<span></span>
</td>
<td class="nump">5,694<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,117<span></span>
</td>
<td class="nump">$ 2,695<span></span>
</td>
<td class="nump">$ 2,540<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504963457256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized Compensation</a></td>
<td class="nump">$ 2,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Amortization Period (in years)</a></td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized Compensation</a></td>
<td class="nump">$ 61,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Amortization Period (in years)</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember', window );">Performance Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized Compensation</a></td>
<td class="nump">$ 10,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Amortization Period (in years)</a></td>
<td class="text">8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized Compensation</a></td>
<td class="nump">$ 1,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Amortization Period (in years)</a></td>
<td class="text">4 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_PerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nvro_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504974594728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Loss before Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (129,135)<span></span>
</td>
<td class="num">$ (83,893)<span></span>
</td>
<td class="num">$ (106,010)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(1,691)<span></span>
</td>
<td class="nump">1,696<span></span>
</td>
<td class="nump">3,923<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (130,826)<span></span>
</td>
<td class="num">$ (82,197)<span></span>
</td>
<td class="num">$ (102,087)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968628232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (103)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">$ 244<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">585<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="nump">1,644<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense / (benefit)</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">844<span></span>
</td>
<td class="nump">1,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(295)<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax expense / (benefit)</a></td>
<td class="num">(295)<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense / (benefit)</a></td>
<td class="nump">$ 534<span></span>
</td>
<td class="nump">$ 868<span></span>
</td>
<td class="nump">$ 1,599<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968609848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax at statutory federal rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax, net of federal benefit</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">9.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(23.30%)<span></span>
</td>
<td class="num">(33.60%)<span></span>
</td>
<td class="num">(26.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="num">(2.20%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504970400216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 154,614<span></span>
</td>
<td class="nump">$ 127,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">25,087<span></span>
</td>
<td class="nump">18,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DeferredTaxAssetsDepreciation', window );">Depreciation</a></td>
<td class="nump">650<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">6,969<span></span>
</td>
<td class="nump">7,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals and reserves</a></td>
<td class="nump">13,404<span></span>
</td>
<td class="nump">9,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DeferredTaxLiabilitiesRightOfUseAsset', window );">Right of use asset</a></td>
<td class="nump">4,225<span></span>
</td>
<td class="nump">5,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="nump">869<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">206,079<span></span>
</td>
<td class="nump">169,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(201,088)<span></span>
</td>
<td class="num">(164,278)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">4,991<span></span>
</td>
<td class="nump">5,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_DeferredTaxAssetsLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(3,660)<span></span>
</td>
<td class="num">(4,459)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(3,660)<span></span>
</td>
<td class="num">(4,459)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 1,331<span></span>
</td>
<td class="nump">$ 1,036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DeferredTaxAssetsDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DeferredTaxAssetsDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DeferredTaxAssetsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DeferredTaxAssetsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_DeferredTaxLiabilitiesRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities right of use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_DeferredTaxLiabilitiesRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504968501432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 36,800<span></span>
</td>
<td class="nump">$ 32,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">54,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">10,430<span></span>
</td>
<td class="nump">8,220<span></span>
</td>
<td class="nump">$ 7,383<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research and Development Credit Carryforwards [Member] | California state [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forwards</a></td>
<td class="nump">13,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 588,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear', window );">Net operating loss expiration date</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member] | Research and Development Credit Carryforwards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forwards</a></td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 336,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear', window );">Net operating loss expiration date</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal and state net operating loss carry forwards expiration year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvro_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvro_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972814392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Unrecognized Tax Benefits (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 8,220<span></span>
</td>
<td class="nump">$ 7,383<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax provisions</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">891<span></span>
</td>
<td class="nump">1,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year tax provisions</a></td>
<td class="nump">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior year tax provisions</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 10,430<span></span>
</td>
<td class="nump">$ 8,220<span></span>
</td>
<td class="nump">$ 7,383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504970266328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (131,360)<span></span>
</td>
<td class="num">$ (83,065)<span></span>
</td>
<td class="num">$ (103,686)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of common shares used to compute basic and diluted net loss per share</a></td>
<td class="nump">34,823,258<span></span>
</td>
<td class="nump">33,677,641<span></span>
</td>
<td class="nump">30,803,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted</a></td>
<td class="num">$ (3.77)<span></span>
</td>
<td class="num">$ (2.47)<span></span>
</td>
<td class="num">$ (3.37)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504973850568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Net Loss Per Share - Additional Information (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share Diluted [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes outstanding | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember', window );">2025 Notes and Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share Diluted [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Convertible notes, conversion price | $ / shares</a></td>
<td class="nump">$ 105.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504964997928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from computation of diluted shares outstanding</a></td>
<td class="nump">5,327,427<span></span>
</td>
<td class="nump">9,059,512<span></span>
</td>
<td class="nump">6,514,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvro_RestrictedAndPerformanceStockUnitsMember', window );">Unreleased Restricted and Performance Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from computation of diluted shares outstanding</a></td>
<td class="nump">1,012,491<span></span>
</td>
<td class="nump">1,052,014<span></span>
</td>
<td class="nump">1,288,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to Purchase Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from computation of diluted shares outstanding</a></td>
<td class="nump">700,654<span></span>
</td>
<td class="nump">813,150<span></span>
</td>
<td class="nump">1,646,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from computation of diluted shares outstanding</a></td>
<td class="nump">1,807,141<span></span>
</td>
<td class="nump">3,597,174<span></span>
</td>
<td class="nump">1,790,033<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants Related to the Issuance of Convertible Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from computation of diluted shares outstanding</a></td>
<td class="nump">1,807,141<span></span>
</td>
<td class="nump">3,597,174<span></span>
</td>
<td class="nump">1,790,033<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvro_RestrictedAndPerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nvro_RestrictedAndPerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140504972278424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Compensation And Retirement Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Expense for matching contributions</a></td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>nvro-10k_20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:nvro="http://www.nevro.com/20211231"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="nvro-20211231.xsd" xlink:type="simple"/>
    <context id="C_0001444380_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_20220216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <instant>2022-02-16</instant>
        </period>
    </context>
    <context id="C_0001444380_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0001444380_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-06-30</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160601_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMinimumMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceBasedRestrictedStockUnitsRSUMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceBasedRestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201912Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_countryUS_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_countryUS_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_countryUS_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nvro:MajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtProductOrServiceAxis_nvroPainfulDiabeticNeuropathyMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nvro:PainfulDiabeticNeuropathyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nvro:AgencyBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nvro:AgencyBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nvro:AgencyBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nvro:AgencyBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_us-gaapCertificatesOfDepositMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_us-gaapCertificatesOfDepositMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-03-31</instant>
        </period>
    </context>
    <context id="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nvro:FirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150301_20150331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-03-01</startDate>
            <endDate>2015-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nvro:FirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161201_20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nvro:FirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20170201_20170228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:FacilityLeaseAgreementThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-01</startDate>
            <endDate>2017-02-28</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20211031_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">nvro:FirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">nvro:FacilityLeaseAgreementThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-31</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-31</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nvro:SupplyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nvro:SupplyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nvro:SupplyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_srtCounterpartyNameAxis_nvroMayoAndVglMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nvro:MayoAndVglMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nvro:MayoFoundationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_srtRangeAxis_srtMinimumMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nvro:MayoFoundationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20141101_20141130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nvro:MayoFoundationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-11-01</startDate>
            <endDate>2014-11-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20170731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-07-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20170701_20170731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2017-07-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_us-gaapIndemnificationGuaranteeMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20161209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nvro:BostonScientificCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-09</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20180427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nvro:BostonScientificCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-27</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20211101_20211101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">nvro:BostonScientificCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-01</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_nvroPatentInfringementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">nvro:PatentInfringementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-06-30</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">nvro:OneHundredThirtyPercentApplicableConversionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">nvro:NinetyEightPercentApplicableConversionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-06-30</instant>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-06-30</instant>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-06-30</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601_20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">nvro:OneHundredThirtyPercentApplicableConversionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">nvro:NinetyEightPercentApplicableConversionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtLiabilityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:DebtEquityComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nvro:TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20141110_20141111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-11-10</startDate>
            <endDate>2014-11-11</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20141111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-11-11</instant>
        </period>
    </context>
    <context id="C_0001444380_20141110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <instant>2014-11-10</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandSevenPlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandSevenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20141031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-10-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroIncentiveStockOptionsMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:IncentiveStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroNonQualifiedStockOptionsMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nvro:TwoThousandFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">nvro:Range7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-10-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141001_20141031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-10-01</startDate>
            <endDate>2014-10-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_20141001_20141031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
        </entity>
        <period>
            <startDate>2014-10-01</startDate>
            <endDate>2014-10-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190301_20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nvro:PerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapIncomeTaxAuthorityNameAxis_us-gaapCaliforniaFranchiseTaxBoardMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapLongtermDebtTypeAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">nvro:TwoThousandTwentyFiveNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvro:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvro:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nvro:RestrictedAndPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="U_xbrlishares">
        <measure>shares</measure>
    </unit>
    <unit id="U_iso4217USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_iso4217USD_xbrlishares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_xbrlipure">
        <measure>pure</measure>
    </unit>
    <unit id="U_nvroSubsidiary">
        <measure>nvro:Subsidiary</measure>
    </unit>
    <unit id="U_nvroBusiness">
        <measure>nvro:Business</measure>
    </unit>
    <unit id="U_nvroCustomer">
        <measure>nvro:Customer</measure>
    </unit>
    <unit id="U_utrsqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_nvroConvertibleNote">
        <measure>nvro:ConvertibleNote</measure>
    </unit>
    <unit id="U_nvroPatent">
        <measure>nvro:Patent</measure>
    </unit>
    <unit id="U_utrD">
        <measure>utr:D</measure>
    </unit>
    <dei:AmendmentFlag contextRef="C_0001444380_20210101_20211231" id="F_000001">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="C_0001444380_20210101_20211231" id="F_000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_0001444380_20210101_20211231" id="F_000007">0001444380</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="C_0001444380_20210101_20211231" id="F_000008">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20211231"
      id="F_000481">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20211231"
      id="F_000483">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend contextRef="C_0001444380_20210101_20211231" id="F_000510">true</us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend>
    <nvro:TargetedNumberOfSharesGrantedRatio
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331"
      decimals="INF"
      id="F_000987"
      unitRef="U_xbrlipure">0.00</nvro:TargetedNumberOfSharesGrantedRatio>
    <nvro:TargetedNumberOfSharesGrantedRatio
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331"
      decimals="INF"
      id="F_000988"
      unitRef="U_xbrlipure">3.50</nvro:TargetedNumberOfSharesGrantedRatio>
    <nvro:TargetedNumberOfSharesGrantedRatio
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331"
      decimals="INF"
      id="F_000991"
      unitRef="U_xbrlipure">1.50</nvro:TargetedNumberOfSharesGrantedRatio>
    <nvro:RecognitionPeriodOfStockBasedCompensationExpense
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331"
      id="F_001062">P2Y</nvro:RecognitionPeriodOfStockBasedCompensationExpense>
    <nvro:EmployeeStockPurchasePlanOfferingPeriod contextRef="C_0001444380_20210101_20211231" id="F_000478">P6M</nvro:EmployeeStockPurchasePlanOfferingPeriod>
    <nvro:LeaseEffectiveDate
      contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150301_20150331"
      id="F_000667">2015-06-30</nvro:LeaseEffectiveDate>
    <nvro:LeaseEffectiveDate
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831"
      id="F_000682">2021-04-30</nvro:LeaseEffectiveDate>
    <nvro:TargetedCompositeIndexPeriod
      contextRef="C_0001444380_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331"
      id="F_000986">P3Y</nvro:TargetedCompositeIndexPeriod>
    <nvro:TargetedNumberOfSharesGrantedRatio
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331"
      decimals="INF"
      id="F_000987_2"
      unitRef="U_xbrlipure">0.00</nvro:TargetedNumberOfSharesGrantedRatio>
    <nvro:TargetedCompositeIndexPeriod
      contextRef="C_0001444380_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331"
      id="F_000989">P3Y</nvro:TargetedCompositeIndexPeriod>
    <nvro:EmployeeStockPurchasePlanOfferingPeriod contextRef="C_0001444380_20141001_20141031" id="F_001024">P6M</nvro:EmployeeStockPurchasePlanOfferingPeriod>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001444380_20211231"
      id="F_000076"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001444380_20201231"
      id="F_000077"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001444380_20211231"
      id="F_000078"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001444380_20201231"
      id="F_000079"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="C_0001444380_20211231" id="F_000531">http://fasb.org/us-gaap/2021-01-31#OtherCurrentLiabilitiesMember</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="C_0001444380_20201231" id="F_000532">http://fasb.org/us-gaap/2021-01-31#OtherCurrentLiabilitiesMember</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_0001444380_20180101_20181231" id="F_000883">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_0001444380_20190101_20191231" id="F_000884">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_0001444380_20200101_20201231" id="F_000885">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_0001444380_20210101_20211231" id="F_000886">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="C_0001444380_20210101_20211231" id="F_000887">P4Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="C_0001444380_20210101_20211231" id="F_000888">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20210101_20211231"
      decimals="INF"
      id="F_000902"
      unitRef="U_iso4217USD_xbrlishares">3.60</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20210101_20211231"
      decimals="INF"
      id="F_000908"
      unitRef="U_iso4217USD_xbrlishares">36.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20210101_20211231"
      id="F_000922">P3Y1M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20210101_20211231"
      decimals="INF"
      id="F_000903"
      unitRef="U_iso4217USD_xbrlishares">38.79</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20210101_20211231"
      decimals="INF"
      id="F_000909"
      unitRef="U_iso4217USD_xbrlishares">45.04</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20210101_20211231"
      id="F_000923">P5Y6M7D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20210101_20211231"
      decimals="INF"
      id="F_000904"
      unitRef="U_iso4217USD_xbrlishares">45.07</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20210101_20211231"
      decimals="INF"
      id="F_000910"
      unitRef="U_iso4217USD_xbrlishares">63.23</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20210101_20211231"
      id="F_000924">P4Y5M23D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20210101_20211231"
      decimals="INF"
      id="F_000905"
      unitRef="U_iso4217USD_xbrlishares">63.39</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20210101_20211231"
      decimals="INF"
      id="F_000911"
      unitRef="U_iso4217USD_xbrlishares">64.95</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20210101_20211231"
      id="F_000925">P6Y11M8D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20210101_20211231"
      decimals="INF"
      id="F_000906"
      unitRef="U_iso4217USD_xbrlishares">65.51</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20210101_20211231"
      decimals="INF"
      id="F_000912"
      unitRef="U_iso4217USD_xbrlishares">87.62</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20210101_20211231"
      id="F_000926">P3Y11M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20210101_20211231"
      id="F_000927">P4Y7M13D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20210101_20211231"
      decimals="INF"
      id="F_000907"
      unitRef="U_iso4217USD_xbrlishares">3.60</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20210101_20211231"
      decimals="INF"
      id="F_000913"
      unitRef="U_iso4217USD_xbrlishares">97.52</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20210101_20211231"
      id="F_000928">P4Y9M21D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <nvro:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20210101_20211231"
      decimals="INF"
      id="F_000914"
      unitRef="U_iso4217USD_xbrlishares">97.52</nvro:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      id="F_001037">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_001038"
      unitRef="U_xbrlipure">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_001040"
      unitRef="U_xbrlipure">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      id="F_001043">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      id="F_001044">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      id="F_001045">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="INF"
      id="F_001046"
      unitRef="U_xbrlipure">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_001047"
      unitRef="U_xbrlipure">0.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="INF"
      id="F_001048"
      unitRef="U_xbrlipure">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_001039"
      unitRef="U_xbrlipure">0.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_001041"
      unitRef="U_xbrlipure">0.026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="INF"
      id="F_001049"
      unitRef="U_xbrlipure">0.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_001050"
      unitRef="U_xbrlipure">0.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="INF"
      id="F_001051"
      unitRef="U_xbrlipure">0.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_001053"
      unitRef="U_xbrlipure">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="INF"
      id="F_001054"
      unitRef="U_xbrlipure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_001055"
      unitRef="U_xbrlipure">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="INF"
      id="F_001056"
      unitRef="U_xbrlipure">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="2"
      id="F_001064"
      unitRef="U_xbrlipure">0.51</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="2"
      id="F_001065"
      unitRef="U_xbrlipure">0.44</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="2"
      id="F_001068"
      unitRef="U_xbrlipure">0.49</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="2"
      id="F_001069"
      unitRef="U_xbrlipure">0.57</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="3"
      id="F_001072"
      unitRef="U_xbrlipure">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="3"
      id="F_001073"
      unitRef="U_xbrlipure">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="4"
      id="F_001076"
      unitRef="U_xbrlipure">0.0032</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="4"
      id="F_001077"
      unitRef="U_xbrlipure">0.0038</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="2"
      id="F_001066"
      unitRef="U_xbrlipure">0.53</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="2"
      id="F_001067"
      unitRef="U_xbrlipure">0.51</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="2"
      id="F_001070"
      unitRef="U_xbrlipure">0.54</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="2"
      id="F_001071"
      unitRef="U_xbrlipure">0.59</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="3"
      id="F_001074"
      unitRef="U_xbrlipure">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="3"
      id="F_001075"
      unitRef="U_xbrlipure">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="4"
      id="F_001078"
      unitRef="U_xbrlipure">0.0035</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="4"
      id="F_001079"
      unitRef="U_xbrlipure">0.0041</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231"
      id="F_001118">P1Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      id="F_001119">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      id="F_001120">P8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      id="F_001121">P4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <dei:DocumentType contextRef="C_0001444380_20210101_20211231" id="F_000000">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="C_0001444380_20210101_20211231" id="F_000031">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="C_0001444380_20210101_20211231" id="F_000002">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="C_0001444380_20210101_20211231" id="F_000003">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_0001444380_20210101_20211231" id="F_000032">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_0001444380_20210101_20211231" id="F_000022">001-36715</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_0001444380_20210101_20211231" id="F_000006">NEVRO CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001444380_20210101_20211231" id="F_000023">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001444380_20210101_20211231" id="F_000024">56-2568057</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001444380_20210101_20211231" id="F_000025">1800 Bridge Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0001444380_20210101_20211231" id="F_000026">Redwood City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001444380_20210101_20211231" id="F_000027">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001444380_20210101_20211231" id="F_000028">94065</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001444380_20210101_20211231" id="F_000029">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001444380_20210101_20211231" id="F_000030">251-0005</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="C_0001444380_20210101_20211231" id="F_000020">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001444380_20210101_20211231" id="F_000005">NVRO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001444380_20210101_20211231" id="F_000021">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="C_0001444380_20210101_20211231" id="F_000009">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="C_0001444380_20210101_20211231" id="F_000011">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="C_0001444380_20210101_20211231" id="F_000010">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="C_0001444380_20210101_20211231" id="F_000019">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="C_0001444380_20210101_20211231" id="F_000012">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="C_0001444380_20210101_20211231" id="F_000013">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001444380_20210101_20211231" id="F_000014">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="C_0001444380_20210101_20211231" id="F_000018">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="C_0001444380_20210101_20211231" id="F_000015">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_0001444380_20210630"
      decimals="-6"
      id="F_000017"
      unitRef="U_iso4217USD">5695000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_0001444380_20220216"
      decimals="INF"
      id="F_000016"
      unitRef="U_xbrlishares">35049108</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000033">Portions of the registrant&#x2019;s Proxy Statement for the registrant&#x2019;s 2022 Annual Meeting of Stockholders are incorporated by reference into Part&#160;III of this Form&#160;10-K to the extent stated herein. The Proxy Statement will be filed within 120&#160;days of the registrant&#x2019;s fiscal year ended December&#160;31, 2021.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId contextRef="C_0001444380_20210101_20211231" id="F_000034">238</dei:AuditorFirmId>
    <dei:AuditorName contextRef="C_0001444380_20210101_20211231" id="F_000035">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="C_0001444380_20210101_20211231" id="F_000036">San Jose, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000037"
      unitRef="U_iso4217USD">34710000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000038"
      unitRef="U_iso4217USD">44597000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000039"
      unitRef="U_iso4217USD">327317000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000040"
      unitRef="U_iso4217USD">543373000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000092"
      unitRef="U_iso4217USD">1385000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000093"
      unitRef="U_iso4217USD">3000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000041"
      unitRef="U_iso4217USD">70475000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000042"
      unitRef="U_iso4217USD">77667000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000043"
      unitRef="U_iso4217USD">93517000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000044"
      unitRef="U_iso4217USD">83296000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000045"
      unitRef="U_iso4217USD">5185000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000046"
      unitRef="U_iso4217USD">4173000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000047"
      unitRef="U_iso4217USD">531204000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000048"
      unitRef="U_iso4217USD">753106000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000049"
      unitRef="U_iso4217USD">20664000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000050"
      unitRef="U_iso4217USD">13531000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000051"
      unitRef="U_iso4217USD">17577000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000052"
      unitRef="U_iso4217USD">18142000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000053"
      unitRef="U_iso4217USD">4493000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000054"
      unitRef="U_iso4217USD">4043000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000055"
      unitRef="U_iso4217USD">606000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000056"
      unitRef="U_iso4217USD">606000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:Assets
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000057"
      unitRef="U_iso4217USD">574544000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000058"
      unitRef="U_iso4217USD">789428000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000059"
      unitRef="U_iso4217USD">31999000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000060"
      unitRef="U_iso4217USD">23109000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000061"
      unitRef="U_iso4217USD">45517000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000062"
      unitRef="U_iso4217USD">43305000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000063"
      unitRef="U_iso4217USD">168776000</us-gaap:ShortTermBorrowings>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000064"
      unitRef="U_iso4217USD">4687000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000065"
      unitRef="U_iso4217USD">3975000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000066"
      unitRef="U_iso4217USD">82203000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000067"
      unitRef="U_iso4217USD">239165000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000068"
      unitRef="U_iso4217USD">151310000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000069"
      unitRef="U_iso4217USD">141771000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000070"
      unitRef="U_iso4217USD">15402000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000071"
      unitRef="U_iso4217USD">16689000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000072"
      unitRef="U_iso4217USD">22013000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000073"
      unitRef="U_iso4217USD">3343000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000074"
      unitRef="U_iso4217USD">270928000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000075"
      unitRef="U_iso4217USD">400968000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000094"
      unitRef="U_iso4217USD_xbrlishares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000095"
      unitRef="U_iso4217USD_xbrlishares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000096"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000097"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000098"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000099"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000100"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000101"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000102"
      unitRef="U_iso4217USD_xbrlishares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000103"
      unitRef="U_iso4217USD_xbrlishares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000104"
      unitRef="U_xbrlishares">290000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000105"
      unitRef="U_xbrlishares">290000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000106"
      unitRef="U_xbrlishares">35709570</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000108"
      unitRef="U_xbrlishares">35026654</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000107"
      unitRef="U_xbrlishares">34583064</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000109"
      unitRef="U_xbrlishares">34583064</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000080"
      unitRef="U_iso4217USD">35000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000081"
      unitRef="U_iso4217USD">35000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000082"
      unitRef="U_iso4217USD">928138000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000083"
      unitRef="U_iso4217USD">880660000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000084"
      unitRef="U_iso4217USD">-364000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000085"
      unitRef="U_iso4217USD">598000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000086"
      unitRef="U_iso4217USD">-624193000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000087"
      unitRef="U_iso4217USD">-492833000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000088"
      unitRef="U_iso4217USD">303616000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000089"
      unitRef="U_iso4217USD">388460000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000090"
      unitRef="U_iso4217USD">574544000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000091"
      unitRef="U_iso4217USD">789428000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000110"
      unitRef="U_iso4217USD">386905000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000111"
      unitRef="U_iso4217USD">362048000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000112"
      unitRef="U_iso4217USD">390255000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000113"
      unitRef="U_iso4217USD">120863000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000114"
      unitRef="U_iso4217USD">112146000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000115"
      unitRef="U_iso4217USD">121905000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000116"
      unitRef="U_iso4217USD">266042000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000117"
      unitRef="U_iso4217USD">249902000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000118"
      unitRef="U_iso4217USD">268350000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000119"
      unitRef="U_iso4217USD">47665000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000120"
      unitRef="U_iso4217USD">45600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000121"
      unitRef="U_iso4217USD">59017000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000122"
      unitRef="U_iso4217USD">309311000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000123"
      unitRef="U_iso4217USD">267154000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000124"
      unitRef="U_iso4217USD">305812000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000125"
      unitRef="U_iso4217USD">20000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000126"
      unitRef="U_iso4217USD">376976000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000127"
      unitRef="U_iso4217USD">312754000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000128"
      unitRef="U_iso4217USD">364829000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000129"
      unitRef="U_iso4217USD">-110934000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000130"
      unitRef="U_iso4217USD">-62852000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000131"
      unitRef="U_iso4217USD">-96479000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000132"
      unitRef="U_iso4217USD">671000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000133"
      unitRef="U_iso4217USD">2956000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000134"
      unitRef="U_iso4217USD">6020000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000135"
      unitRef="U_iso4217USD">19749000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000136"
      unitRef="U_iso4217USD">21806000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000137"
      unitRef="U_iso4217USD">10931000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000138"
      unitRef="U_iso4217USD">-814000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000139"
      unitRef="U_iso4217USD">-495000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000140"
      unitRef="U_iso4217USD">-697000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000141"
      unitRef="U_iso4217USD">-130826000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000142"
      unitRef="U_iso4217USD">-82197000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000143"
      unitRef="U_iso4217USD">-102087000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000144"
      unitRef="U_iso4217USD">534000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000145"
      unitRef="U_iso4217USD">868000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000146"
      unitRef="U_iso4217USD">1599000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000147"
      unitRef="U_iso4217USD">-131360000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000148"
      unitRef="U_iso4217USD">-83065000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000149"
      unitRef="U_iso4217USD">-103686000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000150"
      unitRef="U_iso4217USD">-469000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000151"
      unitRef="U_iso4217USD">991000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000152"
      unitRef="U_iso4217USD">449000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000153"
      unitRef="U_iso4217USD">-493000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000154"
      unitRef="U_iso4217USD">-80000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000155"
      unitRef="U_iso4217USD">315000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000156"
      unitRef="U_iso4217USD">-962000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000157"
      unitRef="U_iso4217USD">911000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000158"
      unitRef="U_iso4217USD">764000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000159"
      unitRef="U_iso4217USD">-132322000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000160"
      unitRef="U_iso4217USD">-82154000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000161"
      unitRef="U_iso4217USD">-102922000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001444380_20210101_20211231"
      decimals="2"
      id="F_000162"
      unitRef="U_iso4217USD_xbrlishares">-3.77</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001444380_20200101_20201231"
      decimals="2"
      id="F_000163"
      unitRef="U_iso4217USD_xbrlishares">-2.47</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001444380_20190101_20191231"
      decimals="2"
      id="F_000164"
      unitRef="U_iso4217USD_xbrlishares">-3.37</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001444380_20210101_20211231"
      decimals="0"
      id="F_000165"
      unitRef="U_xbrlishares">34823258</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001444380_20200101_20201231"
      decimals="0"
      id="F_000166"
      unitRef="U_xbrlishares">33677641</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001444380_20190101_20191231"
      decimals="0"
      id="F_000167"
      unitRef="U_xbrlishares">30803872</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231"
      decimals="INF"
      id="F_000168"
      unitRef="U_xbrlishares">30263536</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231"
      decimals="-3"
      id="F_000169"
      unitRef="U_iso4217USD">30000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231"
      decimals="-3"
      id="F_000170"
      unitRef="U_iso4217USD">552612000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231"
      decimals="-3"
      id="F_000171"
      unitRef="U_iso4217USD">-306082000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20181231"
      decimals="-3"
      id="F_000172"
      unitRef="U_iso4217USD">-1077000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_20181231"
      decimals="-3"
      id="F_000173"
      unitRef="U_iso4217USD">245483000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000174"
      unitRef="U_xbrlishares">828722</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000175"
      unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000176"
      unitRef="U_iso4217USD">28606000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000177"
      unitRef="U_iso4217USD">28607000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000178"
      unitRef="U_xbrlishares">325839</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000179"
      unitRef="U_xbrlishares">38696</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000180"
      unitRef="U_iso4217USD">3057000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000181"
      unitRef="U_iso4217USD">3057000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000182"
      unitRef="U_xbrlishares">164960</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000183"
      unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000184"
      unitRef="U_iso4217USD">6544000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000185"
      unitRef="U_iso4217USD">6545000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000186"
      unitRef="U_iso4217USD">41696000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000187"
      unitRef="U_iso4217USD">41696000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000188"
      unitRef="U_iso4217USD">-103686000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000189"
      unitRef="U_iso4217USD">-103686000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000190"
      unitRef="U_iso4217USD">764000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000191"
      unitRef="U_iso4217USD">764000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="INF"
      id="F_000192"
      unitRef="U_xbrlishares">31544361</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="-3"
      id="F_000193"
      unitRef="U_iso4217USD">32000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231"
      decimals="-3"
      id="F_000194"
      unitRef="U_iso4217USD">626401000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231"
      decimals="-3"
      id="F_000195"
      unitRef="U_iso4217USD">-409768000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231"
      decimals="-3"
      id="F_000196"
      unitRef="U_iso4217USD">-313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_20191231"
      decimals="-3"
      id="F_000197"
      unitRef="U_iso4217USD">216352000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000198"
      unitRef="U_xbrlishares">1868750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000199"
      unitRef="U_iso4217USD">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000200"
      unitRef="U_iso4217USD">147142000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000201"
      unitRef="U_iso4217USD">147144000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000202"
      unitRef="U_iso4217USD">48340000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000203"
      unitRef="U_iso4217USD">48340000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <nvro:AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000204"
      unitRef="U_iso4217USD">-52390000</nvro:AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges>
    <nvro:AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000205"
      unitRef="U_iso4217USD">-52390000</nvro:AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000206"
      unitRef="U_iso4217USD">34933000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000207"
      unitRef="U_iso4217USD">34933000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000208"
      unitRef="U_xbrlishares">756797</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000209"
      unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000210"
      unitRef="U_iso4217USD">34624000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000211"
      unitRef="U_iso4217USD">34625000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000212"
      unitRef="U_xbrlishares">395971</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000213"
      unitRef="U_xbrlishares">62782</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000214"
      unitRef="U_iso4217USD">8564000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000215"
      unitRef="U_iso4217USD">8564000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000216"
      unitRef="U_xbrlishares">79967</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000217"
      unitRef="U_iso4217USD">7513000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000218"
      unitRef="U_iso4217USD">7513000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000219"
      unitRef="U_iso4217USD">42661000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000220"
      unitRef="U_iso4217USD">42661000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000221"
      unitRef="U_iso4217USD">-83065000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000222"
      unitRef="U_iso4217USD">-83065000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000223"
      unitRef="U_iso4217USD">911000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000224"
      unitRef="U_iso4217USD">911000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="INF"
      id="F_000225"
      unitRef="U_xbrlishares">34583064</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="-3"
      id="F_000226"
      unitRef="U_iso4217USD">35000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231"
      decimals="-3"
      id="F_000227"
      unitRef="U_iso4217USD">880660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231"
      decimals="-3"
      id="F_000228"
      unitRef="U_iso4217USD">-492833000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231"
      decimals="-3"
      id="F_000229"
      unitRef="U_iso4217USD">598000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000230"
      unitRef="U_iso4217USD">388460000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000231"
      unitRef="U_xbrlishares">90582</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000232"
      unitRef="U_iso4217USD">4331000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000233"
      unitRef="U_iso4217USD">4331000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000234"
      unitRef="U_xbrlishares">346602</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000235"
      unitRef="U_xbrlishares">58787</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000236"
      unitRef="U_iso4217USD">8062000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000237"
      unitRef="U_iso4217USD">8062000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000238"
      unitRef="U_xbrlishares">65197</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000239"
      unitRef="U_iso4217USD">6849000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000240"
      unitRef="U_iso4217USD">6849000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000241"
      unitRef="U_xbrlishares">682912</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000242"
      unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000243"
      unitRef="U_iso4217USD">-1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <nvro:ExerciseOfBondHedgeForConvertibleSeniorNotes
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="INF"
      id="F_000244"
      unitRef="U_xbrlishares">682916</nvro:ExerciseOfBondHedgeForConvertibleSeniorNotes>
    <nvro:ExerciseOfBondHedgeValueForConvertibleSeniorNotes
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000245"
      unitRef="U_iso4217USD">1000</nvro:ExerciseOfBondHedgeValueForConvertibleSeniorNotes>
    <nvro:ExerciseOfBondHedgeValueForConvertibleSeniorNotes
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000246"
      unitRef="U_iso4217USD">-1000</nvro:ExerciseOfBondHedgeValueForConvertibleSeniorNotes>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000247"
      unitRef="U_iso4217USD">44360000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000248"
      unitRef="U_iso4217USD">44360000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231"
      decimals="-3"
      id="F_000249"
      unitRef="U_iso4217USD">-131360000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000250"
      unitRef="U_iso4217USD">-131360000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20210101_20211231"
      decimals="-3"
      id="F_000251"
      unitRef="U_iso4217USD">-962000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000252"
      unitRef="U_iso4217USD">-962000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231"
      decimals="INF"
      id="F_000253"
      unitRef="U_xbrlishares">35026654</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231"
      decimals="-3"
      id="F_000254"
      unitRef="U_iso4217USD">35000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231"
      decimals="-3"
      id="F_000255"
      unitRef="U_iso4217USD">928138000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231"
      decimals="-3"
      id="F_000256"
      unitRef="U_iso4217USD">-624193000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20211231"
      decimals="-3"
      id="F_000257"
      unitRef="U_iso4217USD">-364000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000258"
      unitRef="U_iso4217USD">303616000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000259"
      unitRef="U_iso4217USD">-131360000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000260"
      unitRef="U_iso4217USD">-83065000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000261"
      unitRef="U_iso4217USD">-103686000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000262"
      unitRef="U_iso4217USD">4882000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000263"
      unitRef="U_iso4217USD">4794000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000264"
      unitRef="U_iso4217USD">4563000</us-gaap:DepreciationDepletionAndAmortization>
    <nvro:AmortizationOfOperatingLeaseAsset
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000265"
      unitRef="U_iso4217USD">3796000</nvro:AmortizationOfOperatingLeaseAsset>
    <nvro:AmortizationOfOperatingLeaseAsset
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000266"
      unitRef="U_iso4217USD">3392000</nvro:AmortizationOfOperatingLeaseAsset>
    <nvro:AmortizationOfOperatingLeaseAsset
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000267"
      unitRef="U_iso4217USD">3237000</nvro:AmortizationOfOperatingLeaseAsset>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000268"
      unitRef="U_iso4217USD">44367000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000269"
      unitRef="U_iso4217USD">42655000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000270"
      unitRef="U_iso4217USD">41697000</us-gaap:ShareBasedCompensation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000271"
      unitRef="U_iso4217USD">-1510000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000272"
      unitRef="U_iso4217USD">-320000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000273"
      unitRef="U_iso4217USD">2037000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000274"
      unitRef="U_iso4217USD">-1528000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000275"
      unitRef="U_iso4217USD">2165000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000276"
      unitRef="U_iso4217USD">-27000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryWriteDown
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000277"
      unitRef="U_iso4217USD">4257000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000278"
      unitRef="U_iso4217USD">5366000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000279"
      unitRef="U_iso4217USD">1456000</us-gaap:InventoryWriteDown>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000280"
      unitRef="U_iso4217USD">-12000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000281"
      unitRef="U_iso4217USD">13263000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000282"
      unitRef="U_iso4217USD">14946000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000283"
      unitRef="U_iso4217USD">7912000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <nvro:UnrealizedGainsAndLossesOnForeignCurrencyTranslation
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000284"
      unitRef="U_iso4217USD">-3083000</nvro:UnrealizedGainsAndLossesOnForeignCurrencyTranslation>
    <nvro:UnrealizedGainsAndLossesOnForeignCurrencyTranslation
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000285"
      unitRef="U_iso4217USD">184000</nvro:UnrealizedGainsAndLossesOnForeignCurrencyTranslation>
    <nvro:UnrealizedGainsAndLossesOnForeignCurrencyTranslation
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000286"
      unitRef="U_iso4217USD">450000</nvro:UnrealizedGainsAndLossesOnForeignCurrencyTranslation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000287"
      unitRef="U_iso4217USD">-8205000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000288"
      unitRef="U_iso4217USD">-3369000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000289"
      unitRef="U_iso4217USD">2153000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000290"
      unitRef="U_iso4217USD">17225000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000291"
      unitRef="U_iso4217USD">-2523000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000292"
      unitRef="U_iso4217USD">938000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000293"
      unitRef="U_iso4217USD">1027000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000294"
      unitRef="U_iso4217USD">-5666000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000295"
      unitRef="U_iso4217USD">3222000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000296"
      unitRef="U_iso4217USD">451000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000297"
      unitRef="U_iso4217USD">-1802000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000298"
      unitRef="U_iso4217USD">-514000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000299"
      unitRef="U_iso4217USD">9006000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000300"
      unitRef="U_iso4217USD">7678000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000301"
      unitRef="U_iso4217USD">-7472000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000302"
      unitRef="U_iso4217USD">3185000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000303"
      unitRef="U_iso4217USD">-7897000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000304"
      unitRef="U_iso4217USD">13205000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000305"
      unitRef="U_iso4217USD">14156000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000306"
      unitRef="U_iso4217USD">-2351000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000307"
      unitRef="U_iso4217USD">-2824000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000308"
      unitRef="U_iso4217USD">-41881000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000309"
      unitRef="U_iso4217USD">1191000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000310"
      unitRef="U_iso4217USD">-50225000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000311"
      unitRef="U_iso4217USD">446916000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000312"
      unitRef="U_iso4217USD">668371000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000313"
      unitRef="U_iso4217USD">211006000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000314"
      unitRef="U_iso4217USD">660971000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000315"
      unitRef="U_iso4217USD">297028000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000316"
      unitRef="U_iso4217USD">254308000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <nvro:RepaymentFromInvestmentInPrivateCompany
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000317"
      unitRef="U_iso4217USD">-7500000</nvro:RepaymentFromInvestmentInPrivateCompany>
    <nvro:RepaymentFromInvestmentInPrivateCompany
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000318"
      unitRef="U_iso4217USD">7500000</nvro:RepaymentFromInvestmentInPrivateCompany>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000319"
      unitRef="U_iso4217USD">12340000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000320"
      unitRef="U_iso4217USD">6025000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000321"
      unitRef="U_iso4217USD">3472000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000322"
      unitRef="U_iso4217USD">201715000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000323"
      unitRef="U_iso4217USD">-369868000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000324"
      unitRef="U_iso4217USD">32330000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000325"
      unitRef="U_iso4217USD">147144000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000326"
      unitRef="U_iso4217USD">189750000</us-gaap:ProceedsFromConvertibleDebt>
    <nvro:PaymentsOfConvertibleNotesDebtIssuanceCosts
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000327"
      unitRef="U_iso4217USD">6105000</nvro:PaymentsOfConvertibleNotesDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000328"
      unitRef="U_iso4217USD">34933000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000329"
      unitRef="U_iso4217USD">52390000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000330"
      unitRef="U_iso4217USD">172500000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000331"
      unitRef="U_iso4217USD">8062000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000332"
      unitRef="U_iso4217USD">8564000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000333"
      unitRef="U_iso4217USD">3057000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000334"
      unitRef="U_iso4217USD">11181000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000335"
      unitRef="U_iso4217USD">42137000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000336"
      unitRef="U_iso4217USD">35150000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000337"
      unitRef="U_iso4217USD">-169381000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000338"
      unitRef="U_iso4217USD">346905000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000339"
      unitRef="U_iso4217USD">32093000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000340"
      unitRef="U_iso4217USD">-340000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000341"
      unitRef="U_iso4217USD">646000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000342"
      unitRef="U_iso4217USD">259000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000343"
      unitRef="U_iso4217USD">-9887000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000344"
      unitRef="U_iso4217USD">-21126000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000345"
      unitRef="U_iso4217USD">14457000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000346"
      unitRef="U_iso4217USD">45203000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001444380_20191231"
      decimals="-3"
      id="F_000347"
      unitRef="U_iso4217USD">66329000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001444380_20181231"
      decimals="-3"
      id="F_000348"
      unitRef="U_iso4217USD">51872000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000349"
      unitRef="U_iso4217USD">35316000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000350"
      unitRef="U_iso4217USD">45203000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0001444380_20191231"
      decimals="-3"
      id="F_000351"
      unitRef="U_iso4217USD">66329000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000352"
      unitRef="U_iso4217USD">1283000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000353"
      unitRef="U_iso4217USD">1307000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000354"
      unitRef="U_iso4217USD">1338000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000355"
      unitRef="U_iso4217USD">6728000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000356"
      unitRef="U_iso4217USD">5555000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000357"
      unitRef="U_iso4217USD">3019000</us-gaap:InterestPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000358"
      unitRef="U_iso4217USD">526000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000359"
      unitRef="U_iso4217USD">850000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000360"
      unitRef="U_iso4217USD">285000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000361">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;1. Formation and Business of the Company&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company was incorporated in Minnesota on March&#160;10, 2006 to manufacture and market innovative active implantable medical devices for the treatment of neurological disorders initially focusing on the treatment of chronic pain. Subsequently, the Company was reincorporated in Delaware on October&#160;4, 2006 and relocated to California.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Since inception, the Company has incurred net losses. During the year ended December&#160;31, 2021, the Company incurred a net loss of $131.4&#160;million and had $41.9 million of cash used in operations. At December&#160;31, 2021, the Company had an accumulated deficit of $624.2&#160;million. The Company has financed operations to date primarily through private placements of equity securities, borrowings under a debt agreement, the issuance of common stock in its November 2014 initial public offering, its June 2015 underwritten public offering and its June 2016 underwritten public offering of convertible senior notes due in 2021 (2021 Notes). Additionally, in April 2020, the Company issued a total of $189.8 million aggregate principal amount of convertible senior notes due 2025 (2025 Notes).&#160;&#160;The total net proceeds from this debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $183.6 million. Concurrent with this debt offering, the Company also completed an underwritten public offering for 1,868,750 shares of its common stock, from which the Company received cash proceeds of $147.1 million, net of underwriting discounts and commissions and offering costs. The Company&#x2019;s ability to continue to meet its obligations and to achieve its business objectives for the foreseeable future is dependent upon, amongst other things, generating sufficient revenues and its ability to continue to control expenses to meet its obligations as they become due. Failure to increase sales of its products, manage discretionary expenditures or raise additional financing, if required, may adversely impact the Company&#x2019;s ability to achieve its intended business objectives.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Public Offerings&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75%&#160;per annum and are payable semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016.&#160;&#160;The total net proceeds from the debt offering, after deducting transaction costs, were approximately $166.2 million.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2020, the Company issued $165.0 million aggregate principal amount of 2.75% convertible senior notes due 2025 in a registered underwritten public offering and an additional $24.8 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2025 Notes).&#160;&#160;The interest rates are fixed at 2.75% per annum and are payable semi-annually in arrears on April 1 and October 1 of each year, commencing on October 1, 2020.&#160;&#160;The total net proceeds from the debt offering, after deducting transaction costs, were approximately $183.6 million.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Concurrent with the 2025 Notes, the Company completed an underwritten public offering of its common stock and issued 1,868,750 shares of common stock, including 243,750 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares.&#160;&#160;The Company received cash proceeds of approximately $147.1 million, net of underwriting discounts and commissions and offering costs paid by the Company.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_000435"
      unitRef="U_iso4217USD">-131400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_000436"
      unitRef="U_iso4217USD">-41900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001444380_20211231"
      decimals="-5"
      id="F_000437"
      unitRef="U_iso4217USD">-624200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <nvro:DebtInstrumentMaturityYear
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20210101_20211231"
      id="F_000438">2021</nvro:DebtInstrumentMaturityYear>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200430"
      decimals="-5"
      id="F_000439"
      unitRef="U_iso4217USD">189800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200401_20200430"
      decimals="-5"
      id="F_000440"
      unitRef="U_iso4217USD">183600000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001444380_20200401_20200430"
      decimals="INF"
      id="F_000441"
      unitRef="U_xbrlishares">1868750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_0001444380_20200401_20200430"
      decimals="-5"
      id="F_000442"
      unitRef="U_iso4217USD">147100000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630"
      decimals="INF"
      id="F_000443"
      unitRef="U_iso4217USD">150000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630"
      decimals="INF"
      id="F_000444"
      unitRef="U_xbrlipure">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <nvro:DebtInstrumentMaturityYear
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160601_20160630"
      id="F_000445">2021</nvro:DebtInstrumentMaturityYear>
    <nvro:DebtInstrumentAdditionalAggregatePrincipalAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630"
      decimals="-5"
      id="F_000446"
      unitRef="U_iso4217USD">22500000</nvro:DebtInstrumentAdditionalAggregatePrincipalAmount>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20210101_20211231"
      id="F_000447">semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160601_20160630"
      decimals="-5"
      id="F_000448"
      unitRef="U_iso4217USD">166200000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200430"
      decimals="INF"
      id="F_000449"
      unitRef="U_iso4217USD">165000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200430"
      decimals="4"
      id="F_000450"
      unitRef="U_xbrlipure">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <nvro:DebtInstrumentAdditionalAggregatePrincipalAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200430"
      decimals="-5"
      id="F_000451"
      unitRef="U_iso4217USD">24800000</nvro:DebtInstrumentAdditionalAggregatePrincipalAmount>
    <nvro:DebtInstrumentMaturityYear
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200401_20200430"
      id="F_000452">2025</nvro:DebtInstrumentMaturityYear>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200401_20200430"
      id="F_000453">semi-annually in arrears on April 1 and October 1 of each year, commencing on October 1, 2020</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member_20200401_20200430"
      decimals="-5"
      id="F_000454"
      unitRef="U_iso4217USD">183600000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200401_20200430"
      decimals="INF"
      id="F_000455"
      unitRef="U_xbrlishares">1868750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapOverAllotmentOptionMember_20200401_20200430"
      decimals="INF"
      id="F_000456"
      unitRef="U_xbrlishares">243750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_0001444380_20200401_20200430"
      decimals="-5"
      id="F_000457"
      unitRef="U_iso4217USD">147100000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000362">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2. Summary of Significant Accounting Policies&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S.&#160;GAAP). The consolidated financial statements include the Company&#x2019;s accounts and those of its five operational wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other Risks and Uncertainties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is subject to risks related to the public health crises such as the global pandemic associated with COVID-19, which has spread to most countries and all 50 states within the United States. The COVID-19 outbreak has negatively impacted, and continues to negatively impact, our operations, revenues and overall financial condition and demand for elective procedures remains unpredictable. Additionally, overall patient willingness to pursue elective procedures has decreased due to the pandemic. Although some restrictions on elective procedures have eased, the effect of the pandemic and recent surges in cases continue to affect patient willingness for interventional therapy for chronic pain and the number of elective procedures being performed. These challenges will likely continue for the duration of the pandemic, which is uncertain, and will affect our revenue while the pandemic continues.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In addition, the Company is also subject to risks common to medical device companies, including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, manufacturing quality and scaling, continued reimbursement from third-party payors,&lt;span style="color:#1F497D;"&gt; &lt;/span&gt;uncertainty of market acceptance of products and the need to obtain additional financing. The Company is currently dependent on third-party suppliers, which, in some cases, are sole- or single-source suppliers.&#160;&#160;Although the Company is in the process of initiating the development of internal manufacturing capabilities, it will remain dependent on third-party manufacturers until such internal manufacturing capabilities are fully operational.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There can be no assurance that the Company&#x2019;s products or services will continue to be accepted in its existing marketplaces, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company may choose to raise additional funds to further enhance its research and development efforts, for product expansion opportunities or to acquire a new business or products that are complementary to its business. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Segments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates.&#160;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.&#160;&#160;In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company&#x2019;s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-lived assets and operating income outside the United States are not material; therefore, disclosures have been limited to revenue.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign Currency Translation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries in Europe and Australia use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;losses&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;of $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.3&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;during the yea&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;r ended December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;gains&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/span&gt;0.3&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million during the year en&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ded December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;gains&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of $&lt;/span&gt;1.0&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million during the year ended December&#160;31, 201&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other in&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;come (expense), net&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. The Company recorded realized foreign currency transaction &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;gains&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.6&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; during the year ended December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;losses&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/span&gt;0.2&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;during the year ended December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;losses&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/span&gt;1.6&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million during the year ended December&#160;31, 201&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To the extent that the Company&#x2019;s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company&#x2019;s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Use of Estimates&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; stock-based compensation; depreciation and amortization lives; inventory valuation; valuation of investments; loss contingencies; and accounting for income taxes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company&#x2019;s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December&#160;31, 2021 and 2020, and held cash in foreign banks of approximately $8.6 million and $17.6 million at December&#160;31, 2021 and 2020, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s convertible note hedge transactions, entered into in connection with the 2025 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.&#160;&#160;The associated risk is mitigated by limiting the counterparties to major financial institutions. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company generally utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Credit Losses&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, &lt;span style="font-style:italic;"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;, which replaces existing incurred loss impairment guidance and establishes a single allowance framework for financial assets carried at amortized cost. The Company adopted Topic 326 on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The Company did not have any cumulative-effect adjustments.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying amounts of certain of the Company&#x2019;s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Securities&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations.&#160;Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12&#160;months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company&#x2019;s investment securities are recorded at fair value based on the fair value hierarchy.&#160;&#160;Money market funds and treasury bonds are classified within Level 1 of the fair value hierarchy, and agency bonds, commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company&#x2019;s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company&#x2019;s estimation of the future demand for a particular component of the Company&#x2019;s products may vary and may result in changes in estimates in any particular period.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shipping and Handling Costs&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shipping and handling costs are expensed as incurred and are included in cost of revenue.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;revenue at the point in time when it transfers control of promised goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#x2019;s goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For a majority of sales, where the Company&#x2019;s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the remaining sales, which are sent from the Company&#x2019;s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.&#160;&#160;These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection.&lt;span style="color:#FF0000;"&gt; &lt;/span&gt;To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note&#160;7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.&#160;&#160;Product revenue is recorded net of such incentive offers.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Practical Expedients and Exemptions&lt;span style="font-weight:bold;font-style:normal;"&gt; - &lt;/span&gt;&lt;span style="font-style:normal;"&gt;The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.&#160;&#160;As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for Doubtful Accounts&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company makes estimates of the collectability of accounts receivable and provide an allowance for accounts receivable considered uncollectible based on current expected credit losses. In doing so, the Company analyzes historical bad debt trends, customer concentrations, customer credit worthiness, the age of the receivable, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts. For the years ended December 31, 2021, 2020 and 2019, the Company recognized bad debt expenses of $0.1 million, $2.8 million and $1.3 million, respectively.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and Equipment&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets&#x2019; estimated useful lives of three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Impairment of Long-Lived Assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;cash flows to the related asset group&#x2019;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;no&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; impairment charges, or changes in estimated useful lives&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; recorded through December&#160;31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease Accounting&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has operating leases for office space, warehouse, research and development facilities, manufacturing facilities and equipment. Leases with terms of 12 months or less are not recorded on the balance sheet, as the related lease expenses are recognized on a straight-line basis over the lease term.&#160;&#160;The Company accounts for lease components (such as fixed payments) separately from nonlease components (such as common area expenses).&lt;span style="color:#000000;"&gt; Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.&#160;&#160;The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.&#160;&#160;Lease cost is recognized on a straight-line basis over the expected lease term.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#x2019;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1)&#160;a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2)&#160;for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company&#x2019;s policy is to recognize interest and penalties related to income taxes as a component of income tax expense.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other Comprehensive Income (Loss)&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other comprehensive income (loss) represents all changes in stockholders&#x2019; equity except those resulting from distributions to stockholders. The Company&#x2019;s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and Development&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, &lt;span style="font-style:italic;"&gt;Compensation&#x2014;Stock Compensation.&lt;/span&gt; ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, &lt;span style="font-style:italic;"&gt;Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting&lt;/span&gt;, which the Company adopted on January 1, 2017.&#160;&#160;Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.&#160;&#160;ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of subjective variables. The expected term that the award will remain outstanding is based on the Company&#x2019;s own historical data. The expected volatility over the term of the awards is based on the Company&#x2019;s own common stock volatility and those of its peer group. The risk-free interest rate is based on the U.S. Treasury yield for zero-coupon U.S. Treasury notes with maturities.&#160;&#160;The expected dividend is zero, as the Company has never paid dividends and has no current plans to do so.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive &lt;span style="-sec-ix-hidden:F_000478"&gt;six-month&lt;/span&gt; offering periods and the Company uses its own historical volatility data in the valuation.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company&#x2019;s common stock on the grant date.&#160;&#160;These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.&#160;&#160;Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company additionally grants performance stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.&#160;&#160;The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.&#160;&#160;The e&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;xpected volatility of our stock &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and the &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and the target composite index&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is&#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;zero&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Stock-based compensation for these &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;performance&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; stock units is recognized over the specified performance measurement period&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Loss per Share of Common Stock&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units, common stock options and the conversion spread for the Company&#x2019;s outstanding convertible senior notes are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Accounting Pronouncements Recently Adopted&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This ASU eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The Company adopted ASU 2019-12 on January 1, 2021.&#160;&#160;The adoption of ASU 2019-12 did not have a material effect on the consolidated financial statements.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Accounting Pronouncements Not Yet Effective&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August 2020, the FASB issued ASU No. 2020-06, &lt;span style="font-style:italic;"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;.&#160;&#160;This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity&#x2019;s own equity.&#160;&#160;The ASU also modifies the impact on the diluted EPS calculations from particular convertible instruments and certain contracts that may be settled in cash or shares. The ASU is effective for public entities for annual reporting period beginning after December 15, 2021, with early adoption permitted for annual periods beginning after December 15, 2020. The Company does not expect to early adopt this guidance and has not determined the potential effects of the guidance on its consolidated financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000374">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S.&#160;GAAP). The consolidated financial statements include the Company&#x2019;s accounts and those of its five operational wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <nvro:NumberOfOperationalWhollyOwnedSubsidiaries
      contextRef="C_0001444380_20210101_20211231"
      decimals="INF"
      id="F_000458"
      unitRef="U_nvroSubsidiary">5</nvro:NumberOfOperationalWhollyOwnedSubsidiaries>
    <nvro:OtherRisksAndUncertainties1PolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000375">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other Risks and Uncertainties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is subject to risks related to the public health crises such as the global pandemic associated with COVID-19, which has spread to most countries and all 50 states within the United States. The COVID-19 outbreak has negatively impacted, and continues to negatively impact, our operations, revenues and overall financial condition and demand for elective procedures remains unpredictable. Additionally, overall patient willingness to pursue elective procedures has decreased due to the pandemic. Although some restrictions on elective procedures have eased, the effect of the pandemic and recent surges in cases continue to affect patient willingness for interventional therapy for chronic pain and the number of elective procedures being performed. These challenges will likely continue for the duration of the pandemic, which is uncertain, and will affect our revenue while the pandemic continues.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In addition, the Company is also subject to risks common to medical device companies, including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, manufacturing quality and scaling, continued reimbursement from third-party payors,&lt;span style="color:#1F497D;"&gt; &lt;/span&gt;uncertainty of market acceptance of products and the need to obtain additional financing. The Company is currently dependent on third-party suppliers, which, in some cases, are sole- or single-source suppliers.&#160;&#160;Although the Company is in the process of initiating the development of internal manufacturing capabilities, it will remain dependent on third-party manufacturers until such internal manufacturing capabilities are fully operational.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There can be no assurance that the Company&#x2019;s products or services will continue to be accepted in its existing marketplaces, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company may choose to raise additional funds to further enhance its research and development efforts, for product expansion opportunities or to acquire a new business or products that are complementary to its business. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.&lt;/p&gt;</nvro:OtherRisksAndUncertainties1PolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000376">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Segments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates.&#160;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.&#160;&#160;In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company&#x2019;s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-lived assets and operating income outside the United States are not material; therefore, disclosures have been limited to revenue.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_0001444380_20210101_20211231"
      decimals="INF"
      id="F_000459"
      unitRef="U_nvroBusiness">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000377">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign Currency Translation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries in Europe and Australia use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;losses&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;of $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.3&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;during the yea&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;r ended December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;gains&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/span&gt;0.3&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million during the year en&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ded December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;gains&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of $&lt;/span&gt;1.0&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million during the year ended December&#160;31, 201&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other in&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;come (expense), net&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. The Company recorded realized foreign currency transaction &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;gains&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.6&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; during the year ended December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;losses&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/span&gt;0.2&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;during the year ended December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;losses&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/span&gt;1.6&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million during the year ended December&#160;31, 201&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To the extent that the Company&#x2019;s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company&#x2019;s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_000460"
      unitRef="U_iso4217USD">-3300000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="C_0001444380_20200101_20201231"
      decimals="-5"
      id="F_000461"
      unitRef="U_iso4217USD">300000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="C_0001444380_20190101_20191231"
      decimals="-5"
      id="F_000462"
      unitRef="U_iso4217USD">1000000.0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_000463"
      unitRef="U_iso4217USD">2600000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_0001444380_20200101_20201231"
      decimals="-5"
      id="F_000464"
      unitRef="U_iso4217USD">-200000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_0001444380_20190101_20191231"
      decimals="-5"
      id="F_000465"
      unitRef="U_iso4217USD">-1600000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:UseOfEstimates contextRef="C_0001444380_20210101_20211231" id="F_000378">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Use of Estimates&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; stock-based compensation; depreciation and amortization lives; inventory valuation; valuation of investments; loss contingencies; and accounting for income taxes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="C_0001444380_20210101_20211231" id="F_000379">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company&#x2019;s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December&#160;31, 2021 and 2020, and held cash in foreign banks of approximately $8.6 million and $17.6 million at December&#160;31, 2021 and 2020, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s convertible note hedge transactions, entered into in connection with the 2025 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.&#160;&#160;The associated risk is mitigated by limiting the counterparties to major financial institutions. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company generally utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashUninsuredAmount
      contextRef="C_0001444380_20211231"
      decimals="-5"
      id="F_000466"
      unitRef="U_iso4217USD">8600000</us-gaap:CashUninsuredAmount>
    <us-gaap:CashUninsuredAmount
      contextRef="C_0001444380_20201231"
      decimals="-5"
      id="F_000467"
      unitRef="U_iso4217USD">17600000</us-gaap:CashUninsuredAmount>
    <nvro:DebtInstrumentMaturityYear
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20210101_20211231"
      id="F_000468">2025</nvro:DebtInstrumentMaturityYear>
    <us-gaap:CreditLossFinancialInstrumentPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000380">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Credit Losses&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, &lt;span style="font-style:italic;"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;, which replaces existing incurred loss impairment guidance and establishes a single allowance framework for financial assets carried at amortized cost. The Company adopted Topic 326 on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance of retained earnings to be recognized on the date of adoption with prior periods not restated. The Company did not have any cumulative-effect adjustments.&lt;/p&gt;</us-gaap:CreditLossFinancialInstrumentPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="C_0001444380_20210101_20211231" id="F_000381">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying amounts of certain of the Company&#x2019;s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000382">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000383">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Securities&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations.&#160;Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12&#160;months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company&#x2019;s investment securities are recorded at fair value based on the fair value hierarchy.&#160;&#160;Money market funds and treasury bonds are classified within Level 1 of the fair value hierarchy, and agency bonds, commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000384">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company&#x2019;s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company&#x2019;s estimation of the future demand for a particular component of the Company&#x2019;s products may vary and may result in changes in estimates in any particular period.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <nvro:RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000385">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shipping and Handling Costs&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shipping and handling costs are expensed as incurred and are included in cost of revenue.&lt;/p&gt;</nvro:RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000386">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;revenue at the point in time when it transfers control of promised goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#x2019;s goods to its customers.&#160;&#160;Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For a majority of sales, where the Company&#x2019;s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For the remaining sales, which are sent from the Company&#x2019;s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.&#160;&#160;These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection.&lt;span style="color:#FF0000;"&gt; &lt;/span&gt;To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note&#160;7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.&#160;&#160;Product revenue is recorded net of such incentive offers.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Practical Expedients and Exemptions&lt;span style="font-weight:bold;font-style:normal;"&gt; - &lt;/span&gt;&lt;span style="font-style:normal;"&gt;The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.&#160;&#160;As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year&lt;/span&gt;.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation contextRef="C_0001444380_20210101_20211231" id="F_000470">The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.&#160;&#160;As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year.</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_0001444380_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231"
      id="F_000469">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="C_0001444380_20210101_20211231" id="F_000387">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for Doubtful Accounts&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company makes estimates of the collectability of accounts receivable and provide an allowance for accounts receivable considered uncollectible based on current expected credit losses. In doing so, the Company analyzes historical bad debt trends, customer concentrations, customer credit worthiness, the age of the receivable, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts. For the years ended December 31, 2021, 2020 and 2019, the Company recognized bad debt expenses of $0.1 million, $2.8 million and $1.3 million, respectively.&lt;/p&gt;</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <nvro:BadDebtExpense1
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_000471"
      unitRef="U_iso4217USD">100000</nvro:BadDebtExpense1>
    <nvro:BadDebtExpense1
      contextRef="C_0001444380_20200101_20201231"
      decimals="-5"
      id="F_000472"
      unitRef="U_iso4217USD">2800000</nvro:BadDebtExpense1>
    <nvro:BadDebtExpense1
      contextRef="C_0001444380_20190101_20191231"
      decimals="-5"
      id="F_000473"
      unitRef="U_iso4217USD">1300000</nvro:BadDebtExpense1>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000388">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and Equipment&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets&#x2019; estimated useful lives of three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_20210101_20211231"
      id="F_000474">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_20210101_20211231"
      id="F_000475">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000389">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Impairment of Long-Lived Assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;cash flows to the related asset group&#x2019;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;no&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; impairment charges, or changes in estimated useful lives&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; recorded through December&#160;31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_0001444380_20210101_20211231"
      decimals="INF"
      id="F_000476"
      unitRef="U_iso4217USD">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000390">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease Accounting&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has operating leases for office space, warehouse, research and development facilities, manufacturing facilities and equipment. Leases with terms of 12 months or less are not recorded on the balance sheet, as the related lease expenses are recognized on a straight-line basis over the lease term.&#160;&#160;The Company accounts for lease components (such as fixed payments) separately from nonlease components (such as common area expenses).&lt;span style="color:#000000;"&gt; Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.&#160;&#160;The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.&#160;&#160;Lease cost is recognized on a straight-line basis over the expected lease term.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_20211231"
      id="F_000477">P12M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000391">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#x2019;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1)&#160;a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2)&#160;for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company&#x2019;s policy is to recognize interest and penalties related to income taxes as a component of income tax expense.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000392">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other Comprehensive Income (Loss)&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other comprehensive income (loss) represents all changes in stockholders&#x2019; equity except those resulting from distributions to stockholders. The Company&#x2019;s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="C_0001444380_20210101_20211231" id="F_000393">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and Development&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="C_0001444380_20210101_20211231" id="F_000394">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, &lt;span style="font-style:italic;"&gt;Compensation&#x2014;Stock Compensation.&lt;/span&gt; ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, &lt;span style="font-style:italic;"&gt;Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting&lt;/span&gt;, which the Company adopted on January 1, 2017.&#160;&#160;Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.&#160;&#160;ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of subjective variables. The expected term that the award will remain outstanding is based on the Company&#x2019;s own historical data. The expected volatility over the term of the awards is based on the Company&#x2019;s own common stock volatility and those of its peer group. The risk-free interest rate is based on the U.S. Treasury yield for zero-coupon U.S. Treasury notes with maturities.&#160;&#160;The expected dividend is zero, as the Company has never paid dividends and has no current plans to do so.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive &lt;span style="-sec-ix-hidden:F_000478"&gt;six-month&lt;/span&gt; offering periods and the Company uses its own historical volatility data in the valuation.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company&#x2019;s common stock on the grant date.&#160;&#160;These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.&#160;&#160;Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company additionally grants performance stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.&#160;&#160;The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.&#160;&#160;The e&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;xpected volatility of our stock &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and the &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and the target composite index&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is&#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;zero&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Stock-based compensation for these &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;performance&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; stock units is recognized over the specified performance measurement period&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      id="F_000479">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceBasedRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="2"
      id="F_000480"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000395">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Loss per Share of Common Stock&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units, common stock options and the conversion spread for the Company&#x2019;s outstanding convertible senior notes are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000396">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Accounting Pronouncements Recently Adopted&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This ASU eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The Company adopted ASU 2019-12 on January 1, 2021.&#160;&#160;The adoption of ASU 2019-12 did not have a material effect on the consolidated financial statements.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Accounting Pronouncements Not Yet Effective&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August 2020, the FASB issued ASU No. 2020-06, &lt;span style="font-style:italic;"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;.&#160;&#160;This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity&#x2019;s own equity.&#160;&#160;The ASU also modifies the impact on the diluted EPS calculations from particular convertible instruments and certain contracts that may be settled in cash or shares. The ASU is effective for public entities for annual reporting period beginning after December 15, 2021, with early adoption permitted for annual periods beginning after December 15, 2020. The Company does not expect to early adopt this guidance and has not determined the potential effects of the guidance on its consolidated financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20211231"
      id="F_000482">2021-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000363">
&lt;p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;3. Revenue&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents revenue by geography, based on the billing address of the customer (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;326,216&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;311,873&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;326,012&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;International&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;60,689&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50,175&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64,243&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;386,905&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;362,048&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;390,255&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The United States is the only country that accounts for 10% or more of the revenue during the periods presented:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;84&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;86&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;84&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There were no customers that accounted for &lt;span&gt;10%&lt;/span&gt; or more of the Company&#x2019;s revenue for each of the years ended December&#160;31, 2021, 2020 and 2019.&#160;&#160;Additionally, there were no customers that accounted for &lt;span&gt;10%&lt;/span&gt; or more of the Company&#x2019;s accounts receivable balance as of December 31, 2021 and 2020.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In July 2021, the Company received FDA approval of its proprietary 10 kHz Therapy for the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, associated with painful diabetic neuropathy (PDN). For the year ended December 31, 2021, worldwide revenue includes approximately $5.7&#160;million of revenue for PDN indication since the July 2021 FDA approval&lt;/span&gt;.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000397">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents revenue by geography, based on the billing address of the customer (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;326,216&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;311,873&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;326,012&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;International&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;60,689&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50,175&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64,243&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;386,905&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;362,048&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;390,255&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_20210101_20211231"
      decimals="-3"
      id="F_000484"
      unitRef="U_iso4217USD">326216000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_20200101_20201231"
      decimals="-3"
      id="F_000485"
      unitRef="U_iso4217USD">311873000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_20190101_20191231"
      decimals="-3"
      id="F_000486"
      unitRef="U_iso4217USD">326012000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20210101_20211231"
      decimals="-3"
      id="F_000487"
      unitRef="U_iso4217USD">60689000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20200101_20201231"
      decimals="-3"
      id="F_000488"
      unitRef="U_iso4217USD">50175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_srtStatementGeographicalAxis_us-gaapNonUsMember_20190101_20191231"
      decimals="-3"
      id="F_000489"
      unitRef="U_iso4217USD">64243000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000490"
      unitRef="U_iso4217USD">386905000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000491"
      unitRef="U_iso4217USD">362048000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000492"
      unitRef="U_iso4217USD">390255000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000398">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The United States is the only country that accounts for 10% or more of the revenue during the periods presented:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;84&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;86&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;84&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20210101_20211231"
      decimals="2"
      id="F_000493"
      unitRef="U_xbrlipure">0.84</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20200101_20201231"
      decimals="2"
      id="F_000494"
      unitRef="U_xbrlipure">0.86</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20190101_20191231"
      decimals="2"
      id="F_000495"
      unitRef="U_xbrlipure">0.84</us-gaap:ConcentrationRiskPercentage1>
    <nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231"
      decimals="INF"
      id="F_000502"
      unitRef="U_nvroCustomer">0</nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold>
    <nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231"
      decimals="INF"
      id="F_000503"
      unitRef="U_nvroCustomer">0</nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold>
    <nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231"
      decimals="INF"
      id="F_000501"
      unitRef="U_nvroCustomer">0</nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20210101_20211231"
      decimals="INF"
      id="F_000496"
      unitRef="U_xbrlipure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231"
      decimals="INF"
      id="F_000497"
      unitRef="U_xbrlipure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231"
      decimals="INF"
      id="F_000498"
      unitRef="U_xbrlipure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20210101_20211231"
      decimals="INF"
      id="F_000504"
      unitRef="U_nvroCustomer">0</nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold>
    <nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20200101_20201231"
      decimals="INF"
      id="F_000505"
      unitRef="U_nvroCustomer">0</nvro:ConcentrationRiskNumberOfCustomersExceedingThreshold>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20210101_20211231"
      decimals="INF"
      id="F_000499"
      unitRef="U_xbrlipure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001444380_srtMajorCustomersAxis_nvroMajorCustomersMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAccountsReceivableMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCreditConcentrationRiskMember_20200101_20201231"
      decimals="INF"
      id="F_000500"
      unitRef="U_xbrlipure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001444380_srtProductOrServiceAxis_nvroPainfulDiabeticNeuropathyMember_20210101_20211231"
      decimals="-5"
      id="F_000506"
      unitRef="U_iso4217USD">5700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000364">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;4. Leases&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, the Company has leases with remaining terms of 3 year to 10 years, some of which may include options to extend the lease term for up to 5 years.&lt;/p&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The weighted average lease terms and discounts rates are as follows:&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating Lease Term and Discount Rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average remaining lease term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.20 years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.32 years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average discount rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, t&lt;span style="color:#000000;"&gt;he maturity of lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating Leases&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,720&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,201&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,849&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;405&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,979&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total lease payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,173&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,183&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Present value of lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,990&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Supplemental lease cost information are as follows (in thousands):&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,243&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,936&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Supplemental balance sheet information are as follows (in thousands):&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating Leases:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,577&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,142&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other current liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,588&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,876&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long term operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,402&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,689&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,990&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,565&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Supplemental cash flow information are as follows (in thousands):&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating cash flow from operating leases&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,253&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;See Note 7 for further details of the Company&#x2019;s lease commitments.&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseOptionToExtend contextRef="C_0001444380_20210101_20211231" id="F_000511">As of December 31, 2021, the Company has leases with remaining terms of 3 year to 10 years, some of which may include options to extend the lease term for up to 5 years.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <nvro:LesseeOperatingLeaseRemainingTermOfContract
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_20210101_20211231"
      id="F_000507">P3Y</nvro:LesseeOperatingLeaseRemainingTermOfContract>
    <nvro:LesseeOperatingLeaseRemainingTermOfContract
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_20210101_20211231"
      id="F_000508">P10Y</nvro:LesseeOperatingLeaseRemainingTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_20211231"
      id="F_000509">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000399">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The weighted average lease terms and discounts rates are as follows:&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating Lease Term and Discount Rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average remaining lease term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.20 years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.32 years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average discount rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0001444380_20211231" id="F_000512">P4Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0001444380_20201231" id="F_000513">P4Y3M25D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0001444380_20211231"
      decimals="3"
      id="F_000514"
      unitRef="U_xbrlipure">0.070</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0001444380_20201231"
      decimals="3"
      id="F_000515"
      unitRef="U_xbrlipure">0.070</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000400">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, t&lt;span style="color:#000000;"&gt;he maturity of lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating Leases&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,720&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,201&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,849&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;405&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,979&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total lease payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,173&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,183&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Present value of lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,990&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000516"
      unitRef="U_iso4217USD">5720000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000517"
      unitRef="U_iso4217USD">6019000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000518"
      unitRef="U_iso4217USD">6201000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000519"
      unitRef="U_iso4217USD">2849000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000520"
      unitRef="U_iso4217USD">405000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000521"
      unitRef="U_iso4217USD">1979000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000522"
      unitRef="U_iso4217USD">23173000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000523"
      unitRef="U_iso4217USD">3183000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000524"
      unitRef="U_iso4217USD">19990000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000401">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Supplemental lease cost information are as follows (in thousands):&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,243&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,936&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000525"
      unitRef="U_iso4217USD">5243000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000526"
      unitRef="U_iso4217USD">4936000</us-gaap:OperatingLeaseCost>
    <nvro:ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000402">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Supplemental balance sheet information are as follows (in thousands):&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating Leases:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,577&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,142&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other current liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,588&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,876&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long term operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,402&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,689&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total operating lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,990&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,565&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</nvro:ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000527"
      unitRef="U_iso4217USD">17577000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000528"
      unitRef="U_iso4217USD">18142000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000529"
      unitRef="U_iso4217USD">4588000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000530"
      unitRef="U_iso4217USD">3876000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000533"
      unitRef="U_iso4217USD">15402000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000534"
      unitRef="U_iso4217USD">16689000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000535"
      unitRef="U_iso4217USD">19990000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000536"
      unitRef="U_iso4217USD">20565000</us-gaap:OperatingLeaseLiability>
    <nvro:ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000403">
&lt;p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Supplemental cash flow information are as follows (in thousands):&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating cash flow from operating leases&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,253&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</nvro:ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000537"
      unitRef="U_iso4217USD">5253000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000538"
      unitRef="U_iso4217USD">4923000</us-gaap:OperatingLeasePayments>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000365">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;5. Fair Value Measurements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level&#160;1 &#x2014; Observable inputs, such as quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level&#160;2 &#x2014;&#160;Observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Level&#160;3 &#x2014;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash Equivalents and Short Term Investments&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s cash equivalents include investments in money market funds that which are unrestricted as to withdrawal or use and are classified as Level&#160;1 of the fair value hierarchy. To value its money market funds, the Company values the funds at $1 stable net asset value, which is the quoted price in active markets for identical assets that the Company has the ability to access. At December&#160;31, 2021 and 2020, the Company&#x2019;s cash equivalents were held in institutions in the United States. The Company&#x2019;s cash equivalents and short-term investments also includes agency bonds, commercial paper, corporate notes and treasury bonds, which have been classified within Level 1 or Level&#160;2 of the fair value hierarchy because of the sufficient observable inputs for revaluation. The Company&#x2019;s Level&#160;2 investments are valued using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades of any broker/dealer quotes on the same or similar investments, issuer credit spreads, benchmark investments, prepayment/default projections based on historical data and other observable inputs. The following table sets forth the Company&#x2019;s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance as of December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds (i)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,562&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,562&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,538&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,538&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate notes (iii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,351&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,351&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Treasury bonds (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;207,114&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;134,773&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;341,887&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance as of December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds (i)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210,302&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210,302&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;277,602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;277,602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate notes (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Treasury bonds (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,347&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;513,299&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;559,646&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:58.64%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Included in cash and cash equivalents on the consolidated balance sheets.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(ii)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Included in short-term investments on the consolidated balance sheets.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(iii)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Convertible Senior Notes&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On June 1, 2021, the Company settled the 2021 Notes at maturity, and as of December 31, 2021, the 2021 Notes were no longer outstanding. As of December 31, 2020, the fair value of the 1.75% convertible senior notes due 2021 was $312.8 million. As of December 31, 2021 and 2020, the fair value of the 2.75% convertible senior notes due 2025 was $212.0 million and $348.1 million, respectively. The fair value was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy.&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <nvro:MoneyMarketFundsNetAssetValuePerShare
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20210101_20211231"
      decimals="0"
      id="F_000539"
      unitRef="U_iso4217USD_xbrlishares">1</nvro:MoneyMarketFundsNetAssetValuePerShare>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000404">The following table sets forth the Company&#x2019;s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance as of December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds (i)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,562&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,562&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,538&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,538&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate notes (iii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,351&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,351&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Treasury bonds (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;207,114&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;134,773&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;341,887&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance as of December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds (i)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210,302&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210,302&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;277,602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;277,602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate notes (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Treasury bonds (ii)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,347&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;513,299&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;559,646&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:58.64%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(i)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Included in cash and cash equivalents on the consolidated balance sheets.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(ii)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Included in short-term investments on the consolidated balance sheets.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(iii)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"&gt;Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231"
      decimals="-3"
      id="F_000540"
      unitRef="U_iso4217USD">9562000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20211231"
      decimals="-3"
      id="F_000541"
      unitRef="U_iso4217USD">9562000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20211231"
      decimals="-3"
      id="F_000542"
      unitRef="U_iso4217USD">42538000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20211231"
      decimals="-3"
      id="F_000543"
      unitRef="U_iso4217USD">42538000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231"
      decimals="-3"
      id="F_000544"
      unitRef="U_iso4217USD">61884000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231"
      decimals="-3"
      id="F_000545"
      unitRef="U_iso4217USD">61884000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231"
      decimals="-3"
      id="F_000546"
      unitRef="U_iso4217USD">30351000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231"
      decimals="-3"
      id="F_000547"
      unitRef="U_iso4217USD">30351000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000548"
      unitRef="U_iso4217USD">197552000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000549"
      unitRef="U_iso4217USD">197552000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000550"
      unitRef="U_iso4217USD">207114000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000551"
      unitRef="U_iso4217USD">134773000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231"
      decimals="-3"
      id="F_000552"
      unitRef="U_iso4217USD">341887000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231"
      decimals="-3"
      id="F_000553"
      unitRef="U_iso4217USD">16273000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231"
      decimals="-3"
      id="F_000554"
      unitRef="U_iso4217USD">16273000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20201231"
      decimals="-3"
      id="F_000555"
      unitRef="U_iso4217USD">210302000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_nvroAgencyBondsMember_20201231"
      decimals="-3"
      id="F_000556"
      unitRef="U_iso4217USD">210302000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000557"
      unitRef="U_iso4217USD">277602000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000558"
      unitRef="U_iso4217USD">277602000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231"
      decimals="-3"
      id="F_000559"
      unitRef="U_iso4217USD">25395000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231"
      decimals="-3"
      id="F_000560"
      unitRef="U_iso4217USD">25395000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231"
      decimals="-3"
      id="F_000561"
      unitRef="U_iso4217USD">30074000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231"
      decimals="-3"
      id="F_000562"
      unitRef="U_iso4217USD">30074000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000563"
      unitRef="U_iso4217USD">46347000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000564"
      unitRef="U_iso4217USD">513299000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000565"
      unitRef="U_iso4217USD">559646000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20201231"
      decimals="INF"
      id="F_000566"
      unitRef="U_xbrlipure">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <nvro:DebtInstrumentMaturityYear
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20200101_20201231"
      id="F_000567">2021</nvro:DebtInstrumentMaturityYear>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20201231"
      decimals="-5"
      id="F_000568"
      unitRef="U_iso4217USD">312800000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20201231"
      decimals="INF"
      id="F_000570"
      unitRef="U_xbrlipure">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20211231"
      decimals="INF"
      id="F_000569"
      unitRef="U_xbrlipure">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <nvro:DebtInstrumentMaturityYear
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200101_20201231"
      id="F_000572">2025</nvro:DebtInstrumentMaturityYear>
    <nvro:DebtInstrumentMaturityYear
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20210101_20211231"
      id="F_000571">2025</nvro:DebtInstrumentMaturityYear>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20211231"
      decimals="-5"
      id="F_000573"
      unitRef="U_iso4217USD">212000000.0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20201231"
      decimals="-5"
      id="F_000574"
      unitRef="U_iso4217USD">348100000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000366">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;6. Balance Sheet Components&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of the Company&#x2019;s cash equivalents and short-term investments approximates their respective carrying amounts due to their short-term maturity. The following is a summary of the gross unrealized gains and unrealized losses on the Company&#x2019;s investment securities (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,546&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,538&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,886&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,371&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,351&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Treasury bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197,889&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(339&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;332,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(371&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;332,325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210,225&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210,302&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;277,593&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(14&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;277,602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,364&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Treasury bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,064&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;543,246&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;152&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(25&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;543,373&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Realized gains or losses from the sale of investments and other-than-temporary impairments, if any, on available-for-sale securities are reported in other income (expense), net as incurred. The cost of securities sold was determined based on the specific identification method. The amount of realized gains and realized losses on investments for the periods presented have not been material.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The amortized costs and estimated fair values of the Company&#x2019;s available-for-sale securities by contractual maturities as of December 31, 2021 were as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amounts maturing within one year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;305,844&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;305,535&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amounts after one year through five years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,848&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,790&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total investment securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;332,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;332,325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories (in thousands)&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.78%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50,160&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,405&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Finished goods&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,357&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;48,891&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total inventories&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;93,517&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;83,296&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company periodically evaluates the carrying value of inventory on hand for potential excess amount over demand using the same lower of cost or net realizable value approach as that has been used to value the inventory. &lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company also periodically evaluates inventory quantities in consideration of actual loss experience. As a result of these evaluations, for the year ended December&#160;31, 2021, the Company recognized total write-downs of $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.3&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million for its inventories.&#160;&#160;For the years ended December 31, 2020 and 2019, the Company recognized total write-downs of $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.4&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million and $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, respectively, for its inventories.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and Equipment, Net (in thousands)&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,722&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,072&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment and software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,349&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,671&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and fixtures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,918&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,316&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,289&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction in process&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,717&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,354&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,319&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;31,304&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Accumulated depreciation and amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(22,655&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,773&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,664&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,531&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation and amortization expense for the years ended December&#160;31, 2021, 2020 and 2019 was $4.9 million, $4.8 million and $4.6 million, respectively.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted Cash&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted cash as of December 31, 2021 and 2020 includes certificates of deposit of $0.6 million representing collateral for the Company&#x2019;s Redwood City, CA building lease pursuant to an agreement dated March 5, 2015.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued Liabilities (in thousands)&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued payroll and related expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,957&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,971&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued professional fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,547&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,101&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,191&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued clinical and research expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,548&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued warranty&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;664&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,665&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,127&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accrued liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45,517&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000405">The following is a summary of the gross unrealized gains and unrealized losses on the Company&#x2019;s investment securities (in thousands):
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,546&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,538&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,886&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,371&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,351&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Treasury bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197,889&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(339&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;197,552&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;332,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(371&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;332,325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gains&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Agency bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210,225&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210,302&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;277,593&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(14&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;277,602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,364&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,395&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Treasury bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,064&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;543,246&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;152&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(25&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;543,373&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231"
      decimals="-3"
      id="F_000575"
      unitRef="U_iso4217USD">42546000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231"
      decimals="-3"
      id="F_000583"
      unitRef="U_iso4217USD">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20211231"
      decimals="-3"
      id="F_000588"
      unitRef="U_iso4217USD">42538000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231"
      decimals="-3"
      id="F_000576"
      unitRef="U_iso4217USD">61886000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231"
      decimals="-3"
      id="F_000580"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231"
      decimals="-3"
      id="F_000584"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20211231"
      decimals="-3"
      id="F_000589"
      unitRef="U_iso4217USD">61884000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231"
      decimals="-3"
      id="F_000577"
      unitRef="U_iso4217USD">30371000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231"
      decimals="-3"
      id="F_000585"
      unitRef="U_iso4217USD">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20211231"
      decimals="-3"
      id="F_000590"
      unitRef="U_iso4217USD">30351000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000578"
      unitRef="U_iso4217USD">197889000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000581"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000586"
      unitRef="U_iso4217USD">339000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20211231"
      decimals="-3"
      id="F_000591"
      unitRef="U_iso4217USD">197552000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000579"
      unitRef="U_iso4217USD">332692000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000582"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000587"
      unitRef="U_iso4217USD">371000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000592"
      unitRef="U_iso4217USD">332325000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231"
      decimals="-3"
      id="F_000593"
      unitRef="U_iso4217USD">210225000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231"
      decimals="-3"
      id="F_000598"
      unitRef="U_iso4217USD">79000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231"
      decimals="-3"
      id="F_000603"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapAgencySecuritiesMember_20201231"
      decimals="-3"
      id="F_000607"
      unitRef="U_iso4217USD">210302000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000594"
      unitRef="U_iso4217USD">277593000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000599"
      unitRef="U_iso4217USD">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000604"
      unitRef="U_iso4217USD">14000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000608"
      unitRef="U_iso4217USD">277602000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231"
      decimals="-3"
      id="F_000595"
      unitRef="U_iso4217USD">25364000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231"
      decimals="-3"
      id="F_000600"
      unitRef="U_iso4217USD">40000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231"
      decimals="-3"
      id="F_000605"
      unitRef="U_iso4217USD">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapCorporateNoteSecuritiesMember_20201231"
      decimals="-3"
      id="F_000609"
      unitRef="U_iso4217USD">25395000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231"
      decimals="-3"
      id="F_000596"
      unitRef="U_iso4217USD">30064000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231"
      decimals="-3"
      id="F_000601"
      unitRef="U_iso4217USD">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_us-gaapInvestmentTypeAxis_us-gaapUSTreasuryBondSecuritiesMember_20201231"
      decimals="-3"
      id="F_000610"
      unitRef="U_iso4217USD">30074000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000597"
      unitRef="U_iso4217USD">543246000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000602"
      unitRef="U_iso4217USD">152000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000606"
      unitRef="U_iso4217USD">25000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000611"
      unitRef="U_iso4217USD">543373000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000406">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The amortized costs and estimated fair values of the Company&#x2019;s available-for-sale securities by contractual maturities as of December 31, 2021 were as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amounts maturing within one year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;305,844&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;305,535&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amounts after one year through five years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,848&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,790&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total investment securities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;332,692&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;332,325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000612"
      unitRef="U_iso4217USD">305844000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000615"
      unitRef="U_iso4217USD">305535000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000613"
      unitRef="U_iso4217USD">26848000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000616"
      unitRef="U_iso4217USD">26790000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000614"
      unitRef="U_iso4217USD">332692000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000617"
      unitRef="U_iso4217USD">332325000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000407">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories (in thousands)&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.78%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50,160&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,405&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.8%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Finished goods&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,357&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;48,891&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.78%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total inventories&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;93,517&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;83,296&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.8%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000618"
      unitRef="U_iso4217USD">50160000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000619"
      unitRef="U_iso4217USD">34405000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000620"
      unitRef="U_iso4217USD">43357000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000621"
      unitRef="U_iso4217USD">48891000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000622"
      unitRef="U_iso4217USD">93517000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000623"
      unitRef="U_iso4217USD">83296000</us-gaap:InventoryNet>
    <nvro:InventoryWriteDownCashAndNonCash
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_000624"
      unitRef="U_iso4217USD">4300000</nvro:InventoryWriteDownCashAndNonCash>
    <nvro:InventoryWriteDownCashAndNonCash
      contextRef="C_0001444380_20200101_20201231"
      decimals="-5"
      id="F_000625"
      unitRef="U_iso4217USD">5400000</nvro:InventoryWriteDownCashAndNonCash>
    <nvro:InventoryWriteDownCashAndNonCash
      contextRef="C_0001444380_20190101_20191231"
      decimals="-5"
      id="F_000626"
      unitRef="U_iso4217USD">1600000</nvro:InventoryWriteDownCashAndNonCash>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000408">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and Equipment, Net (in thousands)&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,722&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,072&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment and software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,349&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,671&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and fixtures&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,918&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,316&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,289&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction in process&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,717&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,354&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,319&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;31,304&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less: Accumulated depreciation and amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(22,655&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,773&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,664&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,531&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20211231"
      decimals="-3"
      id="F_000627"
      unitRef="U_iso4217USD">8722000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231"
      decimals="-3"
      id="F_000628"
      unitRef="U_iso4217USD">7072000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20211231"
      decimals="-3"
      id="F_000629"
      unitRef="U_iso4217USD">16349000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20201231"
      decimals="-3"
      id="F_000630"
      unitRef="U_iso4217USD">12671000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20211231"
      decimals="-3"
      id="F_000631"
      unitRef="U_iso4217USD">4215000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20201231"
      decimals="-3"
      id="F_000632"
      unitRef="U_iso4217USD">3918000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20211231"
      decimals="-3"
      id="F_000633"
      unitRef="U_iso4217USD">10316000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231"
      decimals="-3"
      id="F_000634"
      unitRef="U_iso4217USD">4289000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231"
      decimals="-3"
      id="F_000635"
      unitRef="U_iso4217USD">3717000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231"
      decimals="-3"
      id="F_000636"
      unitRef="U_iso4217USD">3354000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000637"
      unitRef="U_iso4217USD">43319000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000638"
      unitRef="U_iso4217USD">31304000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000639"
      unitRef="U_iso4217USD">22655000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000640"
      unitRef="U_iso4217USD">17773000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000641"
      unitRef="U_iso4217USD">20664000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000642"
      unitRef="U_iso4217USD">13531000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_000643"
      unitRef="U_iso4217USD">4900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001444380_20200101_20201231"
      decimals="-5"
      id="F_000644"
      unitRef="U_iso4217USD">4800000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001444380_20190101_20191231"
      decimals="-5"
      id="F_000645"
      unitRef="U_iso4217USD">4600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_0001444380_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_us-gaapCertificatesOfDepositMember_20211231"
      decimals="-5"
      id="F_000646"
      unitRef="U_iso4217USD">600000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_0001444380_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_us-gaapCertificatesOfDepositMember_20201231"
      decimals="-5"
      id="F_000647"
      unitRef="U_iso4217USD">600000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000409">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued Liabilities (in thousands)&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued payroll and related expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,957&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,971&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued professional fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,547&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,101&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,191&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued clinical and research expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,548&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued warranty&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;664&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,665&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,127&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accrued liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45,517&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000648"
      unitRef="U_iso4217USD">30957000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000649"
      unitRef="U_iso4217USD">30971000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000650"
      unitRef="U_iso4217USD">6547000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000651"
      unitRef="U_iso4217USD">2101000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000652"
      unitRef="U_iso4217USD">1074000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000653"
      unitRef="U_iso4217USD">1191000</us-gaap:AccruedIncomeTaxesCurrent>
    <nvro:AccruedClinicalAndResearchExpensesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000654"
      unitRef="U_iso4217USD">305000</nvro:AccruedClinicalAndResearchExpensesCurrent>
    <nvro:AccruedClinicalAndResearchExpensesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000655"
      unitRef="U_iso4217USD">668000</nvro:AccruedClinicalAndResearchExpensesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000656"
      unitRef="U_iso4217USD">1305000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000657"
      unitRef="U_iso4217USD">1548000</us-gaap:InterestPayableCurrent>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000658"
      unitRef="U_iso4217USD">664000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000659"
      unitRef="U_iso4217USD">699000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000660"
      unitRef="U_iso4217USD">4665000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000661"
      unitRef="U_iso4217USD">6127000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000662"
      unitRef="U_iso4217USD">45517000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000663"
      unitRef="U_iso4217USD">43305000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000367">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;7. Commitments and Contingencies&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating Leases&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2015, the Company entered into a lease agreement for approximately 50,740 square feet of office space located in Redwood City, California for a period beginning in &lt;span style="-sec-ix-hidden:F_000667"&gt;June 2015&lt;/span&gt; through May 2022 with initial annual payments of approximately $2.0 million, increasing to $2.4 million annually during the final year of the lease term. In December 2016, the Company entered into an amendment for an additional approximately 49,980 square feet of office space adjacent to the premises under the original lease (the Expansion Premises), with initial annual payments of $1.2 million, increasing to $2.9 million in the final year of the amended lease term.&#160; &lt;span style="color:#000000;"&gt;The lease for the Expansion Premises commenced on June 1, 2018. &lt;/span&gt;&#160;&#160;The amendment also extends the lease term for the original premises to terminate on the same date as the amended lease, which is May 31, 2025.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2017, the Company entered into a separate non-cancellable facility lease for warehouse space beginning March 1, 2017 through February 28, 2022, under which the Company is obligated to pay approximately $0.4 million in lease payments over the term of the lease.&#160;&#160;In October 2021, the Company entered into an amendment to extend the lease term to May 31, 2025. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August 2020, the Company entered into a lease for approximately 35,411 square feet of space for a manufacturing facility in Costa Rica for a period of &lt;span style="-sec-ix-hidden:F_000682"&gt;April 2021&lt;/span&gt; through June 2031, under which it is obligated to pay approximately $3.9 million in lease payments over the term of the lease.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;See Note 4 for further discussion on Leases.&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warranty Obligations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company warrants that its products will operate substantially in conformity with product specifications and provides a limited one- to five-year warranty.&#160;&#160;Activities related to warranty obligations were as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning Balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,178&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Provision for warranty&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,846&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Utilization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,881&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,629&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;664&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Supply Agreements&lt;/p&gt;
&lt;p id="OLE_LINK1" style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has entered into supply agreements with certain of the Company&#x2019;s suppliers that required certain minimum annual purchase agreements.&#160;&#160;As of December 31, 2021, the Company had $0.9 million of annual purchase commitments. As of December 31, 2020, the Company had no annual purchase commitments. For the year ended December 31, 2019, the Company recorded a charge of $3.6 million related to the cancellation of firm purchase commitments for inventory related items.&lt;/p&gt;
&lt;p id="OLE_LINK2" style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company also entered into a service agreement in January 2020 for which it is committed to pay $&lt;span&gt;2.5 million&lt;/span&gt; annually in each of the next four years. &lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;License Agreements&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2006, the Company entered into an amended and restated license agreement with the Mayo Foundation for Medical Education and Research (Mayo) and Venturi Group&#160;LLC (VGL), which provides the Company access to the certain know how and licensed patents owned by Mayo and VGL for treatment of central, autonomic and peripheral nervous system disorders, including pain, using devices to modulate nerve signaling. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Per terms of the license, the Company is required to pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty will be based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum royalty payment will be based on royalty periods as defined in the agreement.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2011, the Company entered into a Phase&#160;II License Agreement with Mayo which provides the Company access to the certain know how and licensed patents owned by Mayo. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Per terms of the license, the Company is required to:&lt;/span&gt;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Pay a retainer fee of $40,000 per annum starting March 2011 and ending February 2013;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.78%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:10pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"&gt;Pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty is based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum annual royalty payment is $200,000.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Mayo License terminates upon the expiration of (1)&#160;the last to expire of the licensed patents or (2)&#160;our obligation to pay royalties, whichever is later. Such obligations may be subject to change if: (1) additional relevant patents issue that are subject to the Mayo License; or (2) we launch an SCS product, which is subject to the Mayo License, in another country. As of Jan. 1, 2021, the Company does not have an existing obligation to pay royalties under the Mayo License. Therefore, there were no royalties expenses during the year ended December 31, 2021.&#160;&#160;Royalties expenses during the years ended December&#160;31, 2020 and 2019 were $3.1 million and $3.2 million, respectively.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November 2014, the Company issued Mayo 20,833 shares of common stock owed in connection with the IPO pursuant to the terms of the license, and recorded noncash research and development expense of $0.5 million for the fair value of the shares on the date of issuance.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In July 2017, the Company entered into a license agreement for which it is committed to pay $0.1 million over the remaining term of this license agreement, which ends in 2022.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contingent Consideration&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2019, the Company entered into an agreement with a privately-held company to, among other things, provide the privately-held company financing in the form of a secured convertible note.&#160;&#160;Through March 31, 2020, the Company has provided financing totaling $8.5 million in the form of two secured convertible notes. The agreement additionally provides the Company with the exclusive right, but not the obligation, to acquire the privately-held company.&#160;&#160;As of December 31, 2019, the value of the secured convertible notes, measured at amortized cost, was $7.9 million, while the value of certain rights in relation to the agreement, measured at cost and monitored for impairment on an ongoing basis, was $1.0 million.&#160;&#160;These amounts are reported in Other Assets on the Condensed Consolidated Balance Sheet.&#160;&#160;The accretion of amortized cost is recorded in Interest Income, while any changes in value from impairment assessment are recorded in Other Income (Expense) in the Consolidated Statements of Operations and Comprehensive Income.&#160;&#160;The Company concluded that the privately-held company is a variable interest entity; however, the Company is not the primary beneficiary as it does not retain power to direct the activities that most significantly impact its economic performance.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2020, the Company elected not to exercise its option to make a further investment in the privately-held company pursuant to the agreement.&#160;&#160;In connection with this decision, the Company no longer has the exclusive right to acquire the privately-held company.&#160;&#160;In June 2020, the privately-held company paid off the outstanding principal and accrued interest of its secured convertible notes in full.&#160;&#160;As a result of these two events, the Company recorded a net expense of $0.4 million in Other Income (Expense) in the Consolidated Statements of Operations and Comprehensive Income in the year ended December 31, 2020.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contingencies&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been no contingent liabilities requiring accrual at December&#160;31, 2021 and 2020.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Indemnification&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;for losses suffered or incurred by the indemnified party, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;including, among other circumstances, &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#x2019;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has director and officer insurance coverage that reduces the Company&#x2019;s exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Legal Matters&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="text-decoration:underline;"&gt;Boston Scientific Litigations&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;California Litigation Related to High Frequency&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On November 28, 2016, the Company filed a lawsuit for patent infringement against Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation (collectively, Boston Scientific). The lawsuit, filed in the U.S. District Court for the Northern District of California (the California Court), asserted that Boston Scientific was infringing, or would soon begin infringing, seven of the Company&#x2019;s patents covering inventions relating to the Senza system and 10 kHz Therapy. Shortly after the Company filed this lawsuit in 2016, Boston Scientific cancelled its original launch plan and modified its SCS system to avoid infringing the asserted patents. On July 24, 2018, the California Court issued an order on claim construction and summary judgment.&#160;&#160;In the order, the California Court ruled that the Company&#x2019;s asserted method claims were patent eligible and not invalid as indefinite.&#160;&#160;Collectively, the asserted method claims cover methods for delivering SCS therapy at frequencies between 1.5 kHz and 100 kHz.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The California Court, however, found that Boston Scientific was not currently infringing the six upheld method claims because Boston Scientific cancelled its original launch plans and ultimately never practiced the asserted method claims in the United States.&#160;&#160;Specifically, the California Court found that Boston Scientific's sale of the Spectra WaveWriter systems for commercial use in the United States did not infringe the upheld method claims because Boston Scientific modified the Spectra WaveWriter systems to prevent them from being programmed to generate signals above 1.2 kHz. The California Court also found that the Company&#x2019;s asserted system claims were invalid as indefinite.&#160; As discussed below, the California Court&#x2019;s finding of invalidity was overturned by the U.S. Court of Appeals for the Federal Circuit (the Federal Circuit).&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On July 31, 2018, the parties entered into an agreement to dismiss the Company&#x2019;s declaratory judgment claims, without prejudice, so that the Company and Boston Scientific could each appeal portions of the California Court&#x2019;s July 24th ruling to the Federal Circuit.&#160;&#160;On April 9, 2020, the Federal Circuit returned its ruling, which vacated and remanded the California Court&#x2019;s judgment of invalidity.&#160;&#160;As a result of the Federal Circuit&#x2019;s ruling, the system claims invalidated by the California Court were reinstated, and thus all of the Company&#x2019;s asserted claims remain valid and enforceable.&#160;&#160;On December 14, 2020, the parties agreed to the final dismissal of all remaining claims before the California Court based on Boston Scientific&#x2019;s assertion to the court that it did not have any current plans to commercially launch a high frequency SCS system in the United States.&#160;&#160;The California Court entered the agreed upon dismissal on December 16, 2020.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Delaware Litigations Unrelated to High Frequency&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On December 9, 2016, Boston Scientific filed a patent infringement lawsuit alleging the Company&#x2019;s manufacture, use and sale of the Senza system infringes ten of Boston Scientific&#x2019;s patents covering spinal cord stimulation technology related to stimulation leads, rechargeable batteries and telemetry (the &lt;span style="font-style:italic;"&gt;Delaware I&lt;/span&gt; litigation). On April 27, 2018, Boston Scientific filed a second lawsuit alleging patent infringement of nine patents, trade secret misappropriation and tortious interference with contract (the &lt;span style="font-style:italic;"&gt;Delaware II&lt;/span&gt; litigation).&#160; Both lawsuits were filed in the U.S. District Court for the District of Delaware.&#160;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In relation to the &lt;span style="font-style:italic;"&gt;Delaware I&lt;/span&gt; litigation, the Company filed petitions for &lt;span style="font-style:italic;"&gt;inter partes&lt;/span&gt; review at the U.S. Patent and Trademark Office (USPTO), which resulted in the invalidation of all of the asserted claims of Boston Scientific&#x2019;s U.S. Patent Nos. 7,587,241 and 6,895,280, in February 2019.&#160;&#160;The invalidity rulings by the Patent Trial and Appeal Board (PTAB) at the USPTO were later affirmed by the Federal Circuit on May 18, 2020 and May 29, 2020, respectively.&#160;&#160; In relation to the &lt;span style="font-style:italic;"&gt;Delaware II&lt;/span&gt; litigation, the Company filed seven petitions for &lt;span style="font-style:italic;"&gt;inter partes&lt;/span&gt; review at the PTAB against seven of the nine patents asserted by Boston Scientific.&#160;&#160;As a result of those petitions, in January 2021, the PTAB invalidated all but two of the challenged Boston Scientific claims across the seven &lt;span style="font-style:italic;"&gt;inter partes&lt;/span&gt; reviews. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Through various orders from the court, portions of Boston Scientific&#x2019;s &lt;span style="font-style:italic;"&gt;Delaware I&lt;/span&gt; case were dismissed, and portions of Boston Scientific&#x2019;s &lt;span style="font-style:italic;"&gt;Delaware II &lt;/span&gt;case have been stayed for future litigation.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In relation to the &lt;span style="font-style:italic;"&gt;Delaware I&lt;/span&gt; case, of the ten patents originally asserted on December 9, 2016, Boston Scientific proceeded to trial with four patents directed to SCS leads and lead manufacturing techniques. On November 1, 2021, a Delaware jury found that the Company infringed Boston Scientific&#x2019;s patents U.S. 7,891,085 (&#x201c;the &#x2018;085 patent&#x201d;) and U.S. 8,019,439, and that the Company did not infringe Boston Scientific&#x2019;s patents U.S. 8,646,172 and U.S. 8,650,747.&#160;&#160;With regard to the &#x2018;085 patent, the jury found that the infringement was willful, though the infringement of the &#x2018;085 patent was only directed to a limited number of SCS leads that the Company sold internationally between 2012 and 2014.&#160;&#160;Boston Scientific does not assert that the Company continues to infringe the &#x2018;085 patent.&#160;&#160;The Delaware jury awarded Boston Scientific $20.0 million.&#160;&#160;The Company disagrees with this decision and plans to appeal, which could take approximately 18-24 months to resolve.&#160;&#160;The jury award will not be paid until after the conclusion of the appeal process.&#160;&#160;The Company recorded a liability of $20.0 million in relation to the aforementioned &lt;span style="font-style:italic;"&gt;Delaware I&lt;/span&gt; case.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In relation to the &lt;span style="font-style:italic;"&gt;Delaware II&lt;/span&gt; litigation, the Company also filed counterclaims against Boston Scientific, alleging patent infringement of five Nevro patents.&#160;&#160;In March 2021, on the basis of Boston Scientific&#x2019;s petition, the PTAB initiated &lt;span style="font-style:italic;"&gt;inter partes&lt;/span&gt; reviews of two of Nevro&#x2019;s five counterclaim patents.&#160;&#160;The Delaware court later stayed Nevro&#x2019;s five counterclaim patents for future litigation.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On February 23, 2021, the Company filed a patent infringement lawsuit against Boston Scientific alleging that its January 2021 launch of the WaveWriter Alpha&#x2122; SCS System infringes five of the Company&#x2019;s patents covering spinal cord stimulation technology related to delivering paresthesia-free therapy at frequencies below 1,200 Hz.&#160;&#160;The lawsuit, filed in the U.S. District Court for the District of Delaware (&lt;span style="font-style:italic;"&gt;the Delaware III&lt;/span&gt; litigation), seeks unspecified damages and attorney&#x2019;s fees, as well as preliminary and/or permanent injunctive relief against further infringement.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, &lt;span style="color:#000000;"&gt;the Company recorded a liability of $20.0 million in relation to the aforementioned &lt;/span&gt;&lt;span style="font-style:italic;color:#000000;"&gt;Delaware I&lt;/span&gt;&lt;span style="color:#000000;"&gt; case&lt;/span&gt;.&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="text-decoration:underline;"&gt;Stimwave Litigation&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On February 14, 2019, the Company filed a lawsuit for patent infringement against Stimwave Technologies, Inc. (Stimwave) in the Delaware Court asserting that Stimwave was infringing the Company&#x2019;s patents covering inventions related to its 10 kHz Therapy and the Senza system, as well as a claim for false advertising under the Lanham Action Section 43(a), 15 U.S.C. &#xa7; 1125(a).&#160;&#160;In relation to this lawsuit, on July 24, 2019, the Delaware Court granted the Company&#x2019;s motion for preliminary injunction, and issued an order barring Stimwave, and all affiliated persons and entities, from infringing patent claims covering frequencies between 3 kHz and 10 kHz. On February 27, 2020, the Company and Stimwave entered into a Settlement Agreement, in which Stimwave agreed to cease commercialization of all high frequency spinal cord stimulation systems worldwide.&#160;&#160;Stimwave also agreed to entry of a permanent injunction in the Delaware Court, under which Stimwave&#x2019;s products will not deliver spinal cord &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;stimulation therapy that includes pulse frequencies between 1,500 Hz and 100,000 Hz. The permanent injunction w&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;as &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;filed with the Delaware &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;C&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ourt&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and entered on March 2, 2020&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&#160;&#160;A&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;fter the Delaware C&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ourt enter&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;ed &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the permanent injunction, the case (including Stimwave&#x2019;s appeal of the preliminary injunction order) &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;were &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;dismissed.&#160;&#160;As part of the permanent injunction filing, Stimwave acknowledge&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;d&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; the validity of the patents Nevro asserted in the litigation.&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Per &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the Company&#x2019;s&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; request, the &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;permanent injunction&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; order does not enjoin Stimwave from providing follow-up care and programming for any patients who were already programmed with high frequency therapy&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; in the United States prior to March 6, 2020, and in the rest of the world prior to April 30, 2020&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="text-decoration:underline;"&gt;Nalu Litigation&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On February 28, 2020, the Company filed a lawsuit in the Delaware Court for patent infringement against Nalu Medical, Inc. (Nalu) asserting that Nalu is infringing the Company&#x2019;s patents covering inventions related to its 10 kHz Therapy and the Senza system.&lt;span style="font-size:12pt;color:#000000;"&gt; &lt;/span&gt;The Company&#x2019;s patent infringement assertions were based, in part, on Nalu imbedding a high frequency SCS therapy in a version of its &#x201c;PSP&#x201d; waveform.&#160;&#160;During the litigation, Nalu modified its PSP waveform so that it no longer included an imbedded high frequency signal.&#160;&#160;As a result, on December 21, 2021, the Company announced that it had reached a favorable settlement agreement with Nalu to terminate the litigation.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is and may from time to time continue to be involved in various legal proceedings to defend its intellectual property, including several pending European patent oppositions at the European Patent Office (EPO) initiated by the Company&#x2019;s competitors Medtronic and Boston Scientific, an entitlement action filed by Boston Scientific in Germany, and an invalidity proceeding in China.&#160;&#160;In addition, the Company is and may from time to time also be involved in various legal proceedings of a character normally incident to the ordinary course of business, such as employment matters, product liability matters, and professional liability matters, which the Company does not deem to be material to its business and condensed consolidated financial statements at this stage.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <nvro:LeaseCommencementPeriod
      contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20210101_20211231"
      id="F_000664">2015-03</nvro:LeaseCommencementPeriod>
    <us-gaap:AreaOfLand
      contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150331"
      decimals="INF"
      id="F_000665"
      unitRef="U_utrsqft">50740</us-gaap:AreaOfLand>
    <nvro:OperatingLeasesExpirationDate
      contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150301_20150331"
      id="F_000668">2022-05</nvro:OperatingLeasesExpirationDate>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150331"
      decimals="-5"
      id="F_000669"
      unitRef="U_iso4217USD">2000000.0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <nvro:OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm
      contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementMember_20150331"
      decimals="-5"
      id="F_000671"
      unitRef="U_iso4217USD">2400000</nvro:OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm>
    <us-gaap:AreaOfLand
      contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161231"
      decimals="INF"
      id="F_000666"
      unitRef="U_utrsqft">49980</us-gaap:AreaOfLand>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161231"
      decimals="-5"
      id="F_000670"
      unitRef="U_iso4217USD">1200000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <nvro:OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm
      contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161231"
      decimals="-5"
      id="F_000672"
      unitRef="U_iso4217USD">2900000</nvro:OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm>
    <nvro:LeaseCommencementDateDescription
      contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20210101_20211231"
      id="F_000673">The lease for the Expansion Premises commenced on June 1, 2018. </nvro:LeaseCommencementDateDescription>
    <us-gaap:OperationsCommencedDate1
      contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161201_20161231"
      id="F_000674">2018-06-01</us-gaap:OperationsCommencedDate1>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroRedwoodOfficeAgreementAdditionalExpansionPremisesMember_20161201_20161231"
      id="F_000675">2025-05-31</us-gaap:LeaseExpirationDate1>
    <nvro:LeaseEffectiveDate
      contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20170201_20170228"
      id="F_000676">2017-03-01</nvro:LeaseEffectiveDate>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20170201_20170228"
      id="F_000677">2022-02-28</us-gaap:LeaseExpirationDate1>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001444380_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20170201_20170228"
      decimals="-5"
      id="F_000678"
      unitRef="U_iso4217USD">400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_0001444380_srtStatementScenarioAxis_nvroFirstAmendmentMember_us-gaapLeaseContractualTermAxis_nvroFacilityLeaseAgreementThreeMember_20211031_20211031"
      id="F_000679">2025-05-31</us-gaap:LeaseExpirationDate1>
    <nvro:LeaseCommencementPeriod
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831"
      id="F_000680">2020-08</nvro:LeaseCommencementPeriod>
    <us-gaap:AreaOfLand
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831"
      decimals="INF"
      id="F_000681"
      unitRef="U_utrsqft">35411</us-gaap:AreaOfLand>
    <nvro:OperatingLeasesExpirationDate
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831"
      id="F_000683">2031-06</nvro:OperatingLeasesExpirationDate>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0001444380_srtStatementGeographicalAxis_countryCR_20200831_20200831"
      decimals="-5"
      id="F_000684"
      unitRef="U_iso4217USD">3900000</us-gaap:OperatingLeaseExpense>
    <us-gaap:StandardProductWarrantyDescription contextRef="C_0001444380_20210101_20211231" id="F_000685">limited one- to five-year warranty</us-gaap:StandardProductWarrantyDescription>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000410">Activities related to warranty obligations were as follows (in thousands):
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning Balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,178&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Provision for warranty&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,846&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Utilization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,881&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,629&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ending Balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;664&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;699&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000686"
      unitRef="U_iso4217USD">699000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="C_0001444380_20191231"
      decimals="-3"
      id="F_000687"
      unitRef="U_iso4217USD">1178000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000688"
      unitRef="U_iso4217USD">2846000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000689"
      unitRef="U_iso4217USD">2150000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000690"
      unitRef="U_iso4217USD">2881000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000691"
      unitRef="U_iso4217USD">2629000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000692"
      unitRef="U_iso4217USD">664000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:StandardProductWarrantyAccrualCurrent
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000693"
      unitRef="U_iso4217USD">699000</us-gaap:StandardProductWarrantyAccrualCurrent>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20211231"
      decimals="-5"
      id="F_000694"
      unitRef="U_iso4217USD">900000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20201231"
      decimals="INF"
      id="F_000695"
      unitRef="U_iso4217USD">0</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:InventoryFirmPurchaseCommitmentLoss
      contextRef="C_0001444380_us-gaapTypeOfArrangementAxis_nvroSupplyAgreementsMember_20200101_20201231"
      decimals="-5"
      id="F_000696"
      unitRef="U_iso4217USD">3600000</us-gaap:InventoryFirmPurchaseCommitmentLoss>
    <nvro:ServiceAgreementCommitmentAmountYearTwo
      contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231"
      decimals="-5"
      id="F_000698"
      unitRef="U_iso4217USD">2500000</nvro:ServiceAgreementCommitmentAmountYearTwo>
    <nvro:ServiceAgreementCommitmentAmountYearThree
      contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231"
      decimals="-5"
      id="F_000699"
      unitRef="U_iso4217USD">2500000</nvro:ServiceAgreementCommitmentAmountYearThree>
    <nvro:ServiceAgreementCommitmentAmountYearOne
      contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231"
      decimals="-5"
      id="F_000697"
      unitRef="U_iso4217USD">2500000</nvro:ServiceAgreementCommitmentAmountYearOne>
    <nvro:ServiceAgreementCommitmentAmountYearFour
      contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapServiceAgreementsMember_20211231"
      decimals="-5"
      id="F_000700"
      unitRef="U_iso4217USD">2500000</nvro:ServiceAgreementCommitmentAmountYearFour>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms
      contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoAndVglMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231"
      id="F_000701">The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL.</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231"
      decimals="0"
      id="F_000702"
      unitRef="U_iso4217USD">40000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:RoyaltyExpense
      contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_srtRangeAxis_srtMinimumMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231"
      decimals="INF"
      id="F_000703"
      unitRef="U_iso4217USD">200000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20210101_20211231"
      decimals="INF"
      id="F_000704"
      unitRef="U_iso4217USD">0</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20200101_20201231"
      decimals="-5"
      id="F_000705"
      unitRef="U_iso4217USD">3100000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20190101_20191231"
      decimals="-5"
      id="F_000706"
      unitRef="U_iso4217USD">3200000</us-gaap:RoyaltyExpense>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20141101_20141130"
      decimals="INF"
      id="F_000707"
      unitRef="U_xbrlishares">20833</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <nvro:NonCashResearchAndDevelopmentExpense
      contextRef="C_0001444380_srtCounterpartyNameAxis_nvroMayoFoundationMember_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20141101_20141130"
      decimals="-5"
      id="F_000708"
      unitRef="U_iso4217USD">500000</nvro:NonCashResearchAndDevelopmentExpense>
    <nvro:LicenseAgreementCommitmentAmount
      contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20170731"
      decimals="-5"
      id="F_000709"
      unitRef="U_iso4217USD">100000</nvro:LicenseAgreementCommitmentAmount>
    <nvro:LicenseAgreementExpirationYear
      contextRef="C_0001444380_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20170701_20170731"
      id="F_000710">2022</nvro:LicenseAgreementExpirationYear>
    <nvro:ContingentConsiderationPaymentSecuredByConvertibleNotes
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_000711"
      unitRef="U_iso4217USD">8500000</nvro:ContingentConsiderationPaymentSecuredByConvertibleNotes>
    <nvro:NumberOfSecuredConvertibleNotes
      contextRef="C_0001444380_20191231"
      decimals="INF"
      id="F_000712"
      unitRef="U_nvroConvertibleNote">2</nvro:NumberOfSecuredConvertibleNotes>
    <nvro:SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost
      contextRef="C_0001444380_20191231"
      decimals="-5"
      id="F_000713"
      unitRef="U_iso4217USD">7900000</nvro:SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost>
    <nvro:ValueOfCertainRightsMeasuredAtCost
      contextRef="C_0001444380_20191231"
      decimals="-5"
      id="F_000714"
      unitRef="U_iso4217USD">1000000.0</nvro:ValueOfCertainRightsMeasuredAtCost>
    <nvro:ContingentConsiderationExpensesNetSecuredByConvertibleNotes
      contextRef="C_0001444380_20200101_20201231"
      decimals="-5"
      id="F_000715"
      unitRef="U_iso4217USD">400000</nvro:ContingentConsiderationExpensesNetSecuredByConvertibleNotes>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000716"
      unitRef="U_iso4217USD">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000717"
      unitRef="U_iso4217USD">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_us-gaapIndemnificationGuaranteeMember_20211231"
      decimals="INF"
      id="F_000718"
      unitRef="U_iso4217USD">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <nvro:PatentInfringementLawsuitAllegationAgainstNumberOfPatents
      contextRef="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20161209"
      decimals="INF"
      id="F_000719"
      unitRef="U_nvroPatent">10</nvro:PatentInfringementLawsuitAllegationAgainstNumberOfPatents>
    <nvro:PatentInfringementLawsuitAllegationAgainstNumberOfPatents
      contextRef="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20180427"
      decimals="INF"
      id="F_000720"
      unitRef="U_nvroPatent">9</nvro:PatentInfringementLawsuitAllegationAgainstNumberOfPatents>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="C_0001444380_us-gaapRelatedPartyTransactionAxis_nvroBostonScientificCorporationMember_20211101_20211101"
      decimals="-5"
      id="F_000721"
      unitRef="U_iso4217USD">20000000.0</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_nvroPatentInfringementMember_20211231"
      decimals="-5"
      id="F_000722"
      unitRef="U_iso4217USD">20000000.0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_0001444380_us-gaapLossContingenciesByNatureOfContingencyAxis_nvroPatentInfringementMember_20211231"
      decimals="-5"
      id="F_000723"
      unitRef="U_iso4217USD">20000000.0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:DebtDisclosureTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000368">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;8. Long-term Debt&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021 Notes and Convertible Note Hedge and Warrant Transactions&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due in June 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75%&#160;per annum and are payable semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016.&#160;&#160;The total net proceeds from the debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $166.2 million.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Each $1,000 principal amount of the 2021 Notes will initially be convertible into 10.3770 shares of the Company&#x2019;s common stock, which is equivalent to an initial conversion price of approximately $96.37 per share, subject to adjustment upon the occurrence of specified events. The 2021 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding December 1, 2020, only under the following circumstances: (1)&#160;during any calendar quarter commencing after the calendar quarter ending on September&#160;30, 2016 (and only during such calendar quarter), if the last reported sale price of the Company&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2)&#160;during the five business day period after any ten consecutive trading day period (the measurement period) in which the trading price (as defined in the indenture to the 2021 Notes) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company&#x2019;s common stock and the conversion rate on each such trading day; or (3)&#160;upon the occurrence of specified corporate events.&#160; On or after December&#160;1, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2021 Notes at any time, regardless of the foregoing circumstances.&#160;&#160;Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company&#x2019;s common stock or a combination of cash and shares of the Company&#x2019;s common stock, at the Company&#x2019;s election.&#160;&#160;If the Company undergoes a fundamental change prior to the maturity date, holders of the notes may require the Company to repurchase for cash all or any portion of their notes at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;addition, if specific corporate events occur prior to the applicable maturity date, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event in certain circumstances.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with the offering of the 2021 Notes, the Company entered into convertible note hedge transactions with certain bank counterparties in which the Company has the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of the Company&#x2019;s common stock at a price of approximately $96.37 per share. The total cost of the convertible note hedge transactions was $45.1 million.&#160;&#160;In addition, the Company sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of the Company&#x2019;s common stock at a price of $127.28 per share. The Company received $33.1 million in cash proceeds from the sale of these warrants.&#160;&#160;Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of these notes and to effectively increase the overall conversion price from $96.37 to $127.28 per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded in stockholders&#x2019; equity&#160;and are not accounted for as derivatives. The net cost of $12.0 million incurred in connection with the convertible note hedge and warrant transactions was recorded as a reduction to additional paid-in capital on the consolidated balance sheet.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In accounting for the issuance of the convertible senior notes, the Company separated the 2021 Notes into liability and equity components.&#160;&#160;The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was $32.9 million and was determined by deducting the fair value of the liability component from the par value of the 2021 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (debt discount) is amortized to interest expense over the term of the 2021 Notes expense at an effective interest rate of 6.29% over the contractual terms of the notes.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In accounting for the debt issuance costs of&#160;$6.2 million&#160;related to the 2021 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2021 Notes based on their relative values. Issuance costs attributable to the liability component were $5.0 million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2021 Notes. &#160;Issuance costs attributable to the equity component were netted with the equity component in stockholders&#x2019; equity.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On June 1, 2021, the 2021 Notes matured and the Company settled the 2021 Notes.&#160;&#160;The Company paid $172.5 million to settle the outstanding principal and issued 682,912 shares of common stock to holders who elected to convert the 2021 Notes. In addition, the Company exercised its option under the bond hedge and received 682,916 shares of common stock from the bank counterparties. None of the holders of the warrants associated with the 2021 Notes exercised the option to purchase shares.&#160;&#160;As of December 31, 2021, the 2021 Notes were no longer outstanding. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Principal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;172,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,182&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(542&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;168,776&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt discount related to value of conversion option&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,945&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,179&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;31,766&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025 Notes and Convertible Note Hedge and Warrant Transactions&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2020, the Company issued $165.0 million aggregate principal amount of 2.75% convertible senior notes due 2025 in a registered underwritten public offering and an additional $24.8 million aggregate principal amount of such notes pursuant to underwriters&#x2019; exercise in full of their option to purchase additional 2025 Notes. The interest rates are fixed at 2.75%&#160;per annum and are payable semi-annually in arrears on April 1 and October&#160;1 of each year, commencing on October 1, 2020.&#160;&#160;The total net proceeds from the debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $183.6 million. &#160;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Each $1,000 principal amount of the 2025 Notes will initially be convertible into 9.5238 shares of the Company&#x2019;s common stock, which is equivalent to an initial conversion price of approximately $105.00 per share, subject to adjustment upon the occurrence of specified events. The 2025 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding October 1, 2024, only under the following circumstances: &lt;span style="Background-color:#FFFFFF;"&gt;(1)&#160;during any calendar quarter commencing after the calendar quarter ending on June&#160;30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company&#x2019;s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2)&#160;during the five business day period after any ten consecutive trading day period (the measurement period) in which the trading price (as defined in the indenture to the 2025 Notes) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company&#x2019;s common stock and the conversion rate on each such trading day; or (3)&#160;upon the occurrence of specified corporate events.&#160;&lt;/span&gt; &lt;span style="color:#000000;"&gt;On or after October&#160;1, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2025 Notes at any time, regardless of the foregoing circumstances.&#160;&#160;&lt;/span&gt;Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company&#x2019;s common stock or a combination of cash and shares of the Company&#x2019;s common stock, at the Company&#x2019;s election.&#160;&#160;&lt;span style="Background-color:#FFFFFF;"&gt;If the Company undergoes a fundamental change prior to the maturity date, holders of the notes may require the Company to repurchase for cash all or any portion of their notes at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. &lt;/span&gt;In addition, if specific corporate events occur prior to the applicable maturity date, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event in certain circumstances.&lt;span style="Background-color:#FFFFFF;"&gt; &lt;/span&gt;During the three months ended December 31, 2021 the conditions allowing holders of the 2025 Notes to convert have not been met. Therefore, the 2025 Notes may not be converted during the three months ended March 31, 2022. As of December 31, 2021, the if-converted value of the 2025 Notes did not exceeded the principal value of those notes.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with the offering of the 2025 Notes, the Company entered into convertible note hedge transactions with certain bank counterparties in which the Company has the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of the Company&#x2019;s common stock at a price of approximately $105.00 per share. The total cost of the convertible note hedge transactions was $52.4 million.&#160;&#160;In addition, the Company sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8&#160;million shares of the Company&#x2019;s common stock at a price of $147.00 per share. The Company received $34.9 million in cash proceeds from the sale of these warrants.&#160;&#160;Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of these notes and to effectively increase the overall conversion price from $105.00 to $147.00 per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded in stockholders&#x2019; equity&#160;and will not be subsequently remeasured as long as they continue to meet the conditions for equity classification. The net &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;cost of $&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17.5&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million incurred in connection with the convertible note hedge and warrant transactions was recorded as a reduction to additional paid-in capital on the consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In accounting for the issuance of the convertible senior notes, the Company separated the 2025 Notes into liability and equity components.&#160;&#160;The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was $49.9 million and was determined by deducting the fair value of the liability component from the par value of the 2025 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (debt discount) is amortized to interest expense over the term of the 2025 Notes expense at an effective interest rate of 10.2% over the contractual terms of the notes.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In accounting for the debt issuance costs of&#160;$6.1 million&#160;related to the 2025 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2025 Notes based on the same proportion as the accounting for the proceeds from the issuance of the 2025 Notes.&#160;&#160;Issuance costs attributable to the liability component were $4.5 million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2025 Notes.&lt;span style="font-weight:bold;"&gt; &lt;/span&gt;&#160;Issuance costs attributable to the equity component were netted with the equity component in stockholders&#x2019; equity.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The net carrying amount of the liability component of the 2025 Notes was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Principal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;189,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;189,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(35,079&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(43,919&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,361&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,060&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;151,310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;141,771&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The net carrying amount of the equity component of the 2025 Notes was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt discount related to value of conversion option&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;49,947&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;49,947&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;48,340&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;48,340&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table sets forth the interest expense recognized related to the 2021 Notes and 2025 Notes (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.06%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual interest expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,484&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of debt discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,308&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,843&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of debt issuance costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,240&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,634&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,063&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total interest expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,747&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,802&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,925&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="INF"
      id="F_000724"
      unitRef="U_iso4217USD">150000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="INF"
      id="F_000725"
      unitRef="U_xbrlipure">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <nvro:DebtInstrumentMaturityMonthAndYear
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      id="F_000726">2021-06</nvro:DebtInstrumentMaturityMonthAndYear>
    <nvro:DebtInstrumentAdditionalAggregatePrincipalAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="-5"
      id="F_000727"
      unitRef="U_iso4217USD">22500000</nvro:DebtInstrumentAdditionalAggregatePrincipalAmount>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20210101_20211231"
      id="F_000728">semi-annually in arrears on June 1 and December&#160;1 of each year, commencing on December 1, 2016</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="-5"
      id="F_000729"
      unitRef="U_iso4217USD">166200000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="INF"
      id="F_000730"
      unitRef="U_iso4217USD">1000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="INF"
      id="F_000731"
      unitRef="U_xbrlishares">10.3770</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleTypeOfEquitySecurity
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20210101_20211231"
      id="F_000732">common stock</us-gaap:DebtInstrumentConvertibleTypeOfEquitySecurity>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="2"
      id="F_000733"
      unitRef="U_iso4217USD_xbrlishares">96.37</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="INF"
      id="F_000734"
      unitRef="U_utrD">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="INF"
      id="F_000735"
      unitRef="U_utrD">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="2"
      id="F_000736"
      unitRef="U_xbrlipure">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="INF"
      id="F_000737"
      unitRef="U_utrD">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="INF"
      id="F_000738"
      unitRef="U_utrD">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="INF"
      id="F_000739"
      unitRef="U_xbrlipure">0.98</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <nvro:PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="INF"
      id="F_000740"
      unitRef="U_xbrlipure">1</nvro:PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice>
    <nvro:NoteHedgesNumberOfSharesContractedToBuy
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="-5"
      id="F_000741"
      unitRef="U_xbrlishares">1800000</nvro:NoteHedgesNumberOfSharesContractedToBuy>
    <nvro:PurchasePricePerCommonStock
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="INF"
      id="F_000742"
      unitRef="U_iso4217USD_xbrlishares">96.37</nvro:PurchasePricePerCommonStock>
    <nvro:NoteHedgesTransactionCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="-5"
      id="F_000743"
      unitRef="U_iso4217USD">45100000</nvro:NoteHedgesTransactionCosts>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630"
      decimals="-5"
      id="F_000744"
      unitRef="U_xbrlishares">1800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630"
      decimals="INF"
      id="F_000745"
      unitRef="U_iso4217USD_xbrlishares">127.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="-5"
      id="F_000746"
      unitRef="U_iso4217USD">33100000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <nvro:ConversionPricePerShare
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630"
      decimals="INF"
      id="F_000747"
      unitRef="U_iso4217USD_xbrlishares">96.37</nvro:ConversionPricePerShare>
    <nvro:ConversionPricePerShare
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20160630"
      decimals="INF"
      id="F_000748"
      unitRef="U_iso4217USD_xbrlishares">127.28</nvro:ConversionPricePerShare>
    <nvro:AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160601_20160630"
      decimals="-5"
      id="F_000749"
      unitRef="U_iso4217USD">12000000.0</nvro:AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="-5"
      id="F_000750"
      unitRef="U_iso4217USD">32900000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="4"
      id="F_000751"
      unitRef="U_xbrlipure">0.0629</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="-5"
      id="F_000752"
      unitRef="U_iso4217USD">6200000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNoncurrentGross
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630"
      decimals="-5"
      id="F_000753"
      unitRef="U_iso4217USD">5000000.0</us-gaap:DeferredFinanceCostsNoncurrentGross>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601"
      decimals="-5"
      id="F_000754"
      unitRef="U_iso4217USD">172500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601_20210601"
      decimals="INF"
      id="F_000755"
      unitRef="U_xbrlishares">682912</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <nvro:ExerciseOfBondHedgeForConvertibleSeniorNotes
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601_20210601"
      decimals="INF"
      id="F_000756"
      unitRef="U_xbrlishares">682916</nvro:ExerciseOfBondHedgeForConvertibleSeniorNotes>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210601_20210601"
      decimals="-3"
      id="F_000757"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210101_20211231"
      id="F_000411">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Principal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;172,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,182&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(542&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;168,776&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231"
      decimals="-3"
      id="F_000758"
      unitRef="U_iso4217USD">172500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231"
      decimals="-3"
      id="F_000759"
      unitRef="U_iso4217USD">3182000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNoncurrentGross
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231"
      decimals="-3"
      id="F_000760"
      unitRef="U_iso4217USD">542000</us-gaap:DeferredFinanceCostsNoncurrentGross>
    <us-gaap:LongTermDebt
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231"
      decimals="-3"
      id="F_000761"
      unitRef="U_iso4217USD">168776000</us-gaap:LongTermDebt>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20210101_20211231"
      id="F_000412">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt discount related to value of conversion option&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,945&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,179&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;31,766&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231"
      decimals="-3"
      id="F_000762"
      unitRef="U_iso4217USD">32945000</nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption>
    <nvro:DebtInstrumentConvertibleEquityComponentIssuanceCost
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231"
      decimals="-3"
      id="F_000763"
      unitRef="U_iso4217USD">1179000</nvro:DebtInstrumentConvertibleEquityComponentIssuanceCost>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231"
      decimals="-3"
      id="F_000764"
      unitRef="U_iso4217USD">31766000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430"
      decimals="INF"
      id="F_000765"
      unitRef="U_iso4217USD">165000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430"
      decimals="INF"
      id="F_000766"
      unitRef="U_xbrlipure">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <nvro:DebtInstrumentMaturityYear
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      id="F_000767">2025</nvro:DebtInstrumentMaturityYear>
    <nvro:DebtInstrumentAdditionalAggregatePrincipalAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430"
      decimals="-5"
      id="F_000768"
      unitRef="U_iso4217USD">24800000</nvro:DebtInstrumentAdditionalAggregatePrincipalAmount>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20210101_20211231"
      id="F_000769">semi-annually in arrears on April 1 and October&#160;1 of each year, commencing on October 1, 2020</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="-5"
      id="F_000770"
      unitRef="U_iso4217USD">183600000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="INF"
      id="F_000771"
      unitRef="U_iso4217USD">1000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="INF"
      id="F_000772"
      unitRef="U_xbrlishares">9.5238</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleTypeOfEquitySecurity
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20210101_20211231"
      id="F_000773">common stock</us-gaap:DebtInstrumentConvertibleTypeOfEquitySecurity>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430"
      decimals="2"
      id="F_000774"
      unitRef="U_iso4217USD_xbrlishares">105.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="INF"
      id="F_000775"
      unitRef="U_utrD">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroOneHundredThirtyPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="INF"
      id="F_000776"
      unitRef="U_utrD">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="2"
      id="F_000777"
      unitRef="U_xbrlipure">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="INF"
      id="F_000778"
      unitRef="U_utrD">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="C_0001444380_us-gaapDebtConversionByUniqueDescriptionAxis_nvroNinetyEightPercentApplicableConversionPriceMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="INF"
      id="F_000779"
      unitRef="U_utrD">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="INF"
      id="F_000780"
      unitRef="U_xbrlipure">0.98</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <nvro:PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="INF"
      id="F_000781"
      unitRef="U_xbrlipure">1</nvro:PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20210101_20211231"
      decimals="0"
      id="F_000782"
      unitRef="U_iso4217USD">0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <nvro:NoteHedgesNumberOfSharesContractedToBuy
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430"
      decimals="-5"
      id="F_000783"
      unitRef="U_xbrlishares">1800000</nvro:NoteHedgesNumberOfSharesContractedToBuy>
    <nvro:PurchasePricePerCommonStock
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430"
      decimals="INF"
      id="F_000784"
      unitRef="U_iso4217USD_xbrlishares">105.00</nvro:PurchasePricePerCommonStock>
    <nvro:NoteHedgesTransactionCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="-5"
      id="F_000785"
      unitRef="U_iso4217USD">52400000</nvro:NoteHedgesTransactionCosts>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430"
      decimals="-5"
      id="F_000786"
      unitRef="U_xbrlishares">1800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430"
      decimals="INF"
      id="F_000787"
      unitRef="U_iso4217USD_xbrlishares">147.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="-5"
      id="F_000788"
      unitRef="U_iso4217USD">34900000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <nvro:ConversionPricePerShare
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430"
      decimals="INF"
      id="F_000789"
      unitRef="U_iso4217USD_xbrlishares">105.00</nvro:ConversionPricePerShare>
    <nvro:ConversionPricePerShare
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200430"
      decimals="INF"
      id="F_000790"
      unitRef="U_iso4217USD_xbrlishares">147.00</nvro:ConversionPricePerShare>
    <nvro:AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200401_20200430"
      decimals="-5"
      id="F_000791"
      unitRef="U_iso4217USD">17500000</nvro:AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430"
      decimals="-5"
      id="F_000792"
      unitRef="U_iso4217USD">49900000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20200430"
      decimals="3"
      id="F_000793"
      unitRef="U_xbrlipure">0.102</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20200430"
      decimals="-5"
      id="F_000794"
      unitRef="U_iso4217USD">6100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNoncurrentGross
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20200430"
      decimals="-5"
      id="F_000795"
      unitRef="U_iso4217USD">4500000</us-gaap:DeferredFinanceCostsNoncurrentGross>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20210101_20211231"
      id="F_000413">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The net carrying amount of the liability component of the 2025 Notes was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Principal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;189,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;189,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(35,079&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(43,919&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,361&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,060&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;151,310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;141,771&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231"
      decimals="-3"
      id="F_000796"
      unitRef="U_iso4217USD">189750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231"
      decimals="-3"
      id="F_000797"
      unitRef="U_iso4217USD">189750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231"
      decimals="-3"
      id="F_000798"
      unitRef="U_iso4217USD">35079000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231"
      decimals="-3"
      id="F_000799"
      unitRef="U_iso4217USD">43919000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNoncurrentGross
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231"
      decimals="-3"
      id="F_000800"
      unitRef="U_iso4217USD">3361000</us-gaap:DeferredFinanceCostsNoncurrentGross>
    <us-gaap:DeferredFinanceCostsNoncurrentGross
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231"
      decimals="-3"
      id="F_000801"
      unitRef="U_iso4217USD">4060000</us-gaap:DeferredFinanceCostsNoncurrentGross>
    <us-gaap:LongTermDebt
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20211231"
      decimals="-3"
      id="F_000802"
      unitRef="U_iso4217USD">151310000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231"
      decimals="-3"
      id="F_000803"
      unitRef="U_iso4217USD">141771000</us-gaap:LongTermDebt>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20210101_20211231"
      id="F_000414">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The net carrying amount of the equity component of the 2025 Notes was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt discount related to value of conversion option&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;49,947&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;49,947&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,607&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;48,340&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;48,340&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20211231"
      decimals="-3"
      id="F_000804"
      unitRef="U_iso4217USD">49947000</nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption>
    <nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231"
      decimals="-3"
      id="F_000805"
      unitRef="U_iso4217USD">49947000</nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption>
    <nvro:DebtInstrumentConvertibleEquityComponentIssuanceCost
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20211231"
      decimals="-3"
      id="F_000806"
      unitRef="U_iso4217USD">1607000</nvro:DebtInstrumentConvertibleEquityComponentIssuanceCost>
    <nvro:DebtInstrumentConvertibleEquityComponentIssuanceCost
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231"
      decimals="-3"
      id="F_000807"
      unitRef="U_iso4217USD">1607000</nvro:DebtInstrumentConvertibleEquityComponentIssuanceCost>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20211231"
      decimals="-3"
      id="F_000808"
      unitRef="U_iso4217USD">48340000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231"
      decimals="-3"
      id="F_000809"
      unitRef="U_iso4217USD">48340000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000415">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table sets forth the interest expense recognized related to the 2021 Notes and 2025 Notes (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.06%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual interest expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,484&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of debt discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,308&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,843&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of debt issuance costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,240&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,634&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,063&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total interest expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,747&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,802&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,925&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231"
      decimals="-3"
      id="F_000810"
      unitRef="U_iso4217USD">6484000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231"
      decimals="-3"
      id="F_000811"
      unitRef="U_iso4217USD">6860000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231"
      decimals="-3"
      id="F_000812"
      unitRef="U_iso4217USD">3019000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231"
      decimals="-3"
      id="F_000813"
      unitRef="U_iso4217USD">12023000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231"
      decimals="-3"
      id="F_000814"
      unitRef="U_iso4217USD">13308000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231"
      decimals="-3"
      id="F_000815"
      unitRef="U_iso4217USD">6843000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231"
      decimals="-3"
      id="F_000816"
      unitRef="U_iso4217USD">1240000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231"
      decimals="-3"
      id="F_000817"
      unitRef="U_iso4217USD">1634000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231"
      decimals="-3"
      id="F_000818"
      unitRef="U_iso4217USD">1063000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231"
      decimals="-3"
      id="F_000819"
      unitRef="U_iso4217USD">19747000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20200101_20201231"
      decimals="-3"
      id="F_000820"
      unitRef="U_iso4217USD">21802000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20190101_20191231"
      decimals="-3"
      id="F_000821"
      unitRef="U_iso4217USD">10925000</us-gaap:InterestExpenseDebt>
    <us-gaap:PreferredStockTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000369">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;9. Convertible Preferred Stock&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior to its initial public offering, the Company had outstanding 15,208,048 shares of convertible preferred stock. Each share of preferred stock was convertible to one share of common stock. Upon the closing of the Company&#x2019;s initial public offering on November&#160;11, 2014, all shares of outstanding redeemable convertible preferred stock were automatically converted to 15,208,048 shares of the Company&#x2019;s common stock.&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapIPOMember_20141110_20141111"
      decimals="INF"
      id="F_000822"
      unitRef="U_xbrlishares">15208048</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20141111"
      decimals="INF"
      id="F_000823"
      unitRef="U_xbrlishares">1</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001444380_20141110"
      decimals="INF"
      id="F_000824"
      unitRef="U_xbrlishares">15208048</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000370">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;10. Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Common stock reserved for future issuance as of December 31, 2021 was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.8%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding stock options and awards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,713,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reserved for grants of future stock options and awards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,078,869&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reserved for employee stock purchase plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,567,514&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total common stock reserved for future issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,359,528&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock Plans&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s Board of Directors (Board) and stockholders previously approved the 2007 Stock Option Plan (the 2007 Plan). In October 2014, the Board adopted the 2014 Equity Incentive Award Plan (the 2014 Plan and, together with the 2007 Plan, the Stock Plans).&#160;&#160;As of the effective date of the 2014 Plan, the Company suspended the 2007 Plan and no additional awards may be granted under the 2007 Plan. Any shares of common stock covered by awards granted under the 2007 Plan that terminate after the effective date of the 2014 Plan by expiration, forfeiture, cancellation or other means without the issuance of such shares, will be added to the 2014 Plan reserve.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the 2014 Plan, 1,854,166 shares of common stock were initially reserved for issuance, plus the number of shares remaining available for future awards under the 2007 Plan, as of the pricing of the IPO. The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i)&#160;the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii)&#160;an annual increase on January&#160;1 of each year.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the 2014 Plan, the Company may grant awards such as incentive stock options, nonstatutory stock options, restricted stock units, performance stock units and stock appreciation rights. Incentive stock options (ISO) may be granted only to Company employees (including directors who are also employees). Nonqualified stock options (NSO) may be granted to Company employees, directors and consultants.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Stock Options&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options under the 2014 Plan may be granted for periods of up to ten years and at prices no less than 100% of the estimated fair market value of the shares on the date of grant as determined by the Board, provided, however, that the exercise price of an ISO or an NSO granted to a 10% stockholder shall not be less than 110% of the estimated fair market value of the shares on the date of grant. Upon the exercise of options, the Company issues new common stock from its authorized shares. The vesting provisions of individual options vary but are generally over four years, with the exception of performance based stock options.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pursuant to the 2014 Plan, the Company granted performance based stock options to the Company&#x2019;s former CEO in March 2016. This performance based stock option award was subject to the CEO&#x2019;s continued service to the Company through each applicable vesting date. Upon the former CEO&#x2019;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of shares available for grant under the Stock Plans is as follows:&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Available&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;for Grant&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,980,762&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additional shares reserved&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,210,541&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for PSU for overperformance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(277,778&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares forfeited for tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,696&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,077,178&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;527,963&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,403,006&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additional shares reserved&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,261,774&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for PSU for overperformance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(43,966&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares forfeited for tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,782&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(341,901&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;258,486&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,600,181&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additional shares reserved&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,383,322&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for PSU for overperformance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(24,830&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares forfeited for tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58,787&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(425,266&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;140,101&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,732,295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of stock option activity under the Stock Plans is as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&#160;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&#160;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&#160;Term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,529,740&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46.72&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000883"&gt;6.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,866&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;244,075&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56.71&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(828,722&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,695&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(298,908&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66.22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,646,185&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50.80&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000884"&gt;6.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;109,870&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(756,797&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45.75&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,367&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(76,238&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59.38&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;813,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54.69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000885"&gt;5.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;96,286&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(90,582&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,948&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,914&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;700,654&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55.93&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000886"&gt;4.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,287&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercisable as of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;599,295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56.06&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000887"&gt;4.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,656&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options vested, exercisable or expected to&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; vest as of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;696,003&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55.92&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000888"&gt;4.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,173&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of the Company&#x2019;s common stock at the date of exercise and the exercise price for in-the-money options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The weighted-average grant-date fair value of options granted during the year ended December&#160;31, 2019 was $27.91 per share. No options were granted during the years ended December 31, 2021 and 2020.&#160;&#160;The total fair value of options vested during the years ended December 31, 2021, 2020 and 2019 was approximately $3.1 million, $6.6 million and $8.3 million, respectively, based on the grant date fair value.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The options outstanding and vested under the Stock Plans by exercise price, at December&#160;31, 2021, were as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="8" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.84%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual Term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="text-decoration:underline;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000902"&gt;$3.60 &#x2014; $36.55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;116,179&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000922"&gt;3.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.18&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;111,929&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000903"&gt;$38.79 &#x2014; $45.04&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;114,032&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000923"&gt;5.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;94,094&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42.08&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000904"&gt;$45.07 &#x2014; $63.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;156,883&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000924"&gt;4.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57.56&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;129,344&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000905"&gt;$63.39 &#x2014; $64.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;141,004&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000925"&gt;6.94&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91,835&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000906"&gt;$65.51 &#x2014; $87.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;152,556&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000926"&gt;3.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;152,093&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79.36&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$97.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000927"&gt;4.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;97.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;97.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000907"&gt;$3.60 &#x2014; $97.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;700,654&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000928"&gt;4.81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55.93&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;599,295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56.06&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Restricted Stock Units&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2015, the Company began granting restricted stock units (RSUs) under the 2014 Plan.&#160;&#160;Holders of RSUs do not have stockholder rights.&#160;&#160;Upon the release of RSUs, the Company issues new common stock from its authorized shares. RSUs generally vest four years from the date of grant.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of RSU activity under the Stock Plans was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant&#160;Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock&#160;Units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in&#160;thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,002,161&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;72.55&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,974&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;721,992&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock released&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(321,858&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;70.89&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,064&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(225,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;70.51&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,177,221&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64.70&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;138,371&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;252,703&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;123.31&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock released&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(395,971&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66.42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(180,976&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;71.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;852,977&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79.87&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147,650&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;368,230&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;146.64&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock released&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(346,602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;76.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(110,799&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98.76&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;763,806&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;110.96&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,922&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock expected to vest as of&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;696,348&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;109.78&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The aggregate intrinsic value of RSUs released is calculated using the fair market value of the Company&#x2019;s common stock at the date of release. The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company&#x2019;s common stock as of the date outstanding.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"&gt;Performance Stock Units&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pursuant to the 2014 Plan, the Company granted performance based RSUs to the former CEO in March 2016. The performance based RSUs are subject to the former CEO&#x2019;s continued service to the Company through each applicable vesting date. If a performance metric is not met within the time limits specified in the RSU agreement, the shares subject to vesting under the vesting tranche for that performance metric will be cancelled. Upon the former CEO&#x2019;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2019, the Company granted performance stock units (PSUs) to the current CEO, subject to his continued service to the Company and based on the total shareholder return (the TSR) of the Company&#x2019;s common stock price compared to the S&amp;amp;P Healthcare Equipment Select Industry Index (the Index) over a &lt;span style="-sec-ix-hidden:F_000986"&gt;three-year&lt;/span&gt; period.&#160;&#160;The number of shares to be issued upon vesting of these PSUs range from &lt;span style="-sec-ix-hidden:F_000987_2"&gt;0 to 3.5 times&lt;/span&gt; the target number of shares granted, depending on the Company&#x2019;s performance against the targeted composite index.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2020, the Company granted PSUs to certain members of the management team.&#160;&#160;The number of shares to be issued upon vesting was based on the total shareholder return of the Company&#x2019;s common stock compared to the Index, as well as certain performance criteria related to a specific financial target over a two-year performance period. For the three months ended March 31, 2020, the Company determined that the achievement status for these PSUs was not possible, and therefore did not record stock-based compensation expenses related to these grants.&#160;&#160;During the three months ended June 30, 2020, the Company modified the performance criteria for these PSUs to reflect the changed market conditions as a result of the COVID-19 pandemic, such that the remaining performance criteria is based on total shareholder return compared to the Index.&#160;&#160;The Company also granted PSUs that incorporated the same modified performance criteria to the Company&#x2019;s Chief Executive Officer PSUs. Additional similar PSUs were issued to new members of management in the year ended December 31, 2020.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2021, the Company granted PSUs to certain member of the management team, subject to continued service to the Company and based on the TSR of the Company&#x2019;s common stock price compared to the Index over a &lt;span style="-sec-ix-hidden:F_000989"&gt;three-year&lt;/span&gt; period.&#160;&#160;The number of shares to be issued upon vesting of these PSUs range from 0 to 1.5 times the target number of shares granted, depending on the Company&#x2019;s performance against the targeted composite index.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of PSU activity under the Stock Plans was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant&#160;Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock&#160;Units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in&#160;thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,962&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;111,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;67.29&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU released&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;111,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;67.29&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,060&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89,198&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;128.71&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,272&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125.27&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,037&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;94.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;183.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7,388&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;136.77&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;248,685&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;113.35&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,161&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU expected to vest as of&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;247,815&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;113.22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,090&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The aggregate intrinsic value of outstanding PSUs is calculated based on the closing price of the Company&#x2019;s common stock as of the date outstanding.&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014 Employee Stock Purchase Plan&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In October 2014, the Board adopted the 2014 Employee Stock Purchase Plan (the ESPP). A total of 196,666 shares of common stock were initially available for future issuance under the 2014 Employee Stock Purchase Plan, subject to an annual increase on January&#160;1 of each year. The ESPP provides eligible employees with an opportunity to purchase shares of the Company&#x2019;s common stock through payroll deductions of up to 15% of their eligible compensation, subject to plan limitations.&#160;&#160;Under the ESPP, the purchase price of the Company stock is equal to 85%&#160;of the lower of its fair market value at the start and end of a&#160;&lt;span style="-sec-ix-hidden:F_001024"&gt;six-month&lt;/span&gt; purchase period.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of ESPP activity was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.46%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additional shares reserved&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;235,590&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;315,443&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;302,635&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares issued&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;65,197&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79,967&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;164,960&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for future issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,567,514&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,397,121&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,161,645&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee contributions for shares issued (in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,849&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,513&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,544&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company estimated the fair value of stock options granted to employees and shares purchased by employees under the ESPP using the Black-Scholes option valuation model. The fair value is amortized on a straight-line basis over the requisite service period of the awards, with the exception of performance based stock options whose fair value is recorded as expenses based on the probability that the performance metrics will be achieved. The following assumptions were used in estimating the fair value:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.1%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock Options:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001037"&gt;5.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001038"&gt;51%&#160;&#x2014;&#160;52%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001040"&gt;1.4%&#160;&#x2014;&#160;2.6%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend Yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;ESPP:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001043"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001044"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001045"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001046"&gt;36% &#x2014; 49%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001047"&gt;39% &#x2014; 68%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001048"&gt;48% &#x2014; 61%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1% &#x2014; 0.2%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6% &#x2014; 2.4%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend Yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for RSUs at their fair value, based on the closing market price of the Company&#x2019;s common stock on the grant date. The fair value is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting term of four years.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2016, the Company granted performance based RSUs to its former CEO that only vest upon the achievement of specific operational performance criteria.&#160;&#160;The stock-based compensation for these performance based RSUs are recognized as expenses when it is determined that achieving the performance metrics are probable. Upon the former CEO&#x2019;s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with the former CEO&#x2019;s resignation in March 2019, the Company amended the terms of his then vested nonqualified stock options such that they remain exercisable through the second anniversary of his separation date.&#160;&#160;This modification resulted in a charge of $1.6 million in stock-based compensation.&#160;&#160;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2019, the Company granted PSUs to its current CEO that only vest based on the total shareholder return (TSR) of the Company common stock price relative to that of the Index.&#160;&#160;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2020 and 2021, the Company granted PSUs to the CEO and other members of its management team that vest based on the total shareholder return of the Company common stock price relative to that of the Index.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The company estimates the grant-date fair value of these PSUs based on the Monte Carlo simulation model and records the related stock-based compensation over the period for which the TSR is measured against the Index, which is generally two to three years. The use of the Monte Carlo simulation model requires the input the following assumptions: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="7" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.22%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Index volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001064"&gt;51% &#x2014; 53%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001065"&gt;44% &#x2014; 51%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Company volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001068"&gt;49% &#x2014; 54%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001069"&gt;57% &#x2014; 59%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001072"&gt;0.1% &#x2014; 0.3%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001073"&gt;0.1% &#x2014; 0.2%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.4%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Correlation with index&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001076"&gt;0.32 &#x2014; 0.35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001077"&gt;0.38 &#x2014; 0.41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend Yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of stock-based compensation expense by line items in the consolidated statements of operations is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,637&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,433&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,061&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,455&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,323&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sales, general and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,081&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,313&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total stock-based compensation expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44,365&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,655&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41,697&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,997&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,289&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,312&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,234&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,977&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,854&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Performance stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,017&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,694&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee stock purchase plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,117&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,695&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,540&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total stock-based compensation expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44,365&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,655&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41,697&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2021, total stock-based compensation expense not yet recognized, net of estimated forfeitures, are as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&#160;Period&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,597&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001118"&gt;1.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,107&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001119"&gt;2.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Performance stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001120"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee stock purchase plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,219&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001121"&gt;0.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000416">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Common stock reserved for future issuance as of December 31, 2021 was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.8%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding stock options and awards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,713,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reserved for grants of future stock options and awards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,078,869&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reserved for employee stock purchase plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,567,514&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total common stock reserved for future issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,359,528&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <nvro:CommonStockOptionsAndAwardsOutstanding
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000825"
      unitRef="U_xbrlishares">1713145</nvro:CommonStockOptionsAndAwardsOutstanding>
    <nvro:CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000826"
      unitRef="U_xbrlishares">6078869</nvro:CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants>
    <nvro:CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000827"
      unitRef="U_xbrlishares">1567514</nvro:CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000828"
      unitRef="U_xbrlishares">9359528</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandSevenPlanMember_20210101_20211231"
      decimals="INF"
      id="F_000829"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20141031"
      decimals="INF"
      id="F_000830"
      unitRef="U_xbrlishares">1854166</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
      contextRef="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000831">The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i)&#160;the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii)&#160;an annual increase on January&#160;1 of each year.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231"
      id="F_000832">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000833"
      unitRef="U_xbrlipure">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <nvro:PercentageOfShareholderOptionsGranted
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroIncentiveStockOptionsMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000834"
      unitRef="U_xbrlipure">0.10</nvro:PercentageOfShareholderOptionsGranted>
    <nvro:PercentageOfShareholderOptionsGranted
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroNonQualifiedStockOptionsMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231"
      decimals="2"
      id="F_000835"
      unitRef="U_xbrlipure">0.10</nvro:PercentageOfShareholderOptionsGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_20210101_20211231"
      decimals="INF"
      id="F_000836"
      unitRef="U_xbrlipure">1.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001444380_us-gaapPlanNameAxis_nvroTwoThousandFourteenEquityIncentivePlanMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20210101_20211231"
      id="F_000837">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000417">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of shares available for grant under the Stock Plans is as follows:&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Available&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;for Grant&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,980,762&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additional shares reserved&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,210,541&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for PSU for overperformance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(277,778&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares forfeited for tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,696&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,077,178&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;527,963&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,403,006&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additional shares reserved&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,261,774&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for PSU for overperformance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(43,966&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares forfeited for tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,782&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(341,901&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;258,486&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,600,181&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additional shares reserved&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,383,322&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for PSU for overperformance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(24,830&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares forfeited for tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58,787&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(425,266&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options, RSUs and PSUs cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;140,101&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,732,295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231"
      decimals="INF"
      id="F_000838"
      unitRef="U_xbrlishares">2980762</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_000839"
      unitRef="U_xbrlishares">1210541</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_000840"
      unitRef="U_xbrlishares">277778</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_000841"
      unitRef="U_xbrlishares">38696</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20190101_20191231"
      decimals="INF"
      id="F_000842"
      unitRef="U_xbrlishares">1077178</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20190101_20191231"
      decimals="INF"
      id="F_000843"
      unitRef="U_xbrlishares">527963</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231"
      decimals="INF"
      id="F_000844"
      unitRef="U_xbrlishares">3403006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_000845"
      unitRef="U_xbrlishares">1261774</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_000846"
      unitRef="U_xbrlishares">43966</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_000847"
      unitRef="U_xbrlishares">62782</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20200101_20201231"
      decimals="INF"
      id="F_000848"
      unitRef="U_xbrlishares">341901</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20200101_20201231"
      decimals="INF"
      id="F_000849"
      unitRef="U_xbrlishares">258486</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231"
      decimals="INF"
      id="F_000850"
      unitRef="U_xbrlishares">4600181</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231"
      decimals="INF"
      id="F_000851"
      unitRef="U_xbrlishares">1383322</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231"
      decimals="INF"
      id="F_000852"
      unitRef="U_xbrlishares">24830</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231"
      decimals="INF"
      id="F_000853"
      unitRef="U_xbrlishares">58787</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20210101_20211231"
      decimals="INF"
      id="F_000854"
      unitRef="U_xbrlishares">425266</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember_20210101_20211231"
      decimals="INF"
      id="F_000855"
      unitRef="U_xbrlishares">140101</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20211231"
      decimals="INF"
      id="F_000856"
      unitRef="U_xbrlishares">5732295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000418">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of stock option activity under the Stock Plans is as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&#160;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&#160;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&#160;Term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,529,740&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46.72&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000883"&gt;6.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,866&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;244,075&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56.71&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(828,722&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,695&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(298,908&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66.22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,646,185&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50.80&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000884"&gt;6.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;109,870&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(756,797&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45.75&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,367&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(76,238&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59.38&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;813,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54.69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000885"&gt;5.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;96,286&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(90,582&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,948&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,914&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;700,654&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55.93&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000886"&gt;4.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,287&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercisable as of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;599,295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56.06&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000887"&gt;4.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,656&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options vested, exercisable or expected to&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; vest as of December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;696,003&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55.92&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000888"&gt;4.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,173&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001444380_20181231"
      decimals="INF"
      id="F_000857"
      unitRef="U_xbrlishares">2529740</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001444380_20181231"
      decimals="2"
      id="F_000870"
      unitRef="U_iso4217USD_xbrlishares">46.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001444380_20181231"
      decimals="-3"
      id="F_000889"
      unitRef="U_iso4217USD">21866000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001444380_20190101_20191231"
      decimals="INF"
      id="F_000858"
      unitRef="U_xbrlishares">244075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001444380_20190101_20191231"
      decimals="2"
      id="F_000871"
      unitRef="U_iso4217USD_xbrlishares">56.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001444380_20190101_20191231"
      decimals="INF"
      id="F_000859"
      unitRef="U_xbrlishares">828722</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0001444380_20190101_20191231"
      decimals="2"
      id="F_000872"
      unitRef="U_iso4217USD_xbrlishares">34.52</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_000890"
      unitRef="U_iso4217USD">42695000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0001444380_20190101_20191231"
      decimals="INF"
      id="F_000860"
      unitRef="U_xbrlishares">298908</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0001444380_20190101_20191231"
      decimals="2"
      id="F_000873"
      unitRef="U_iso4217USD_xbrlishares">66.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001444380_20191231"
      decimals="INF"
      id="F_000861"
      unitRef="U_xbrlishares">1646185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001444380_20191231"
      decimals="2"
      id="F_000874"
      unitRef="U_iso4217USD_xbrlishares">50.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001444380_20191231"
      decimals="-3"
      id="F_000891"
      unitRef="U_iso4217USD">109870000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001444380_20200101_20201231"
      decimals="INF"
      id="F_000862"
      unitRef="U_xbrlishares">756797</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0001444380_20200101_20201231"
      decimals="2"
      id="F_000875"
      unitRef="U_iso4217USD_xbrlishares">45.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_000892"
      unitRef="U_iso4217USD">62367000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0001444380_20200101_20201231"
      decimals="INF"
      id="F_000863"
      unitRef="U_xbrlishares">76238</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0001444380_20200101_20201231"
      decimals="2"
      id="F_000876"
      unitRef="U_iso4217USD_xbrlishares">59.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001444380_20201231"
      decimals="INF"
      id="F_000864"
      unitRef="U_xbrlishares">813150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001444380_20201231"
      decimals="2"
      id="F_000877"
      unitRef="U_iso4217USD_xbrlishares">54.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_000893"
      unitRef="U_iso4217USD">96286000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001444380_20210101_20211231"
      decimals="INF"
      id="F_000865"
      unitRef="U_xbrlishares">90582</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0001444380_20210101_20211231"
      decimals="2"
      id="F_000878"
      unitRef="U_iso4217USD_xbrlishares">47.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_000894"
      unitRef="U_iso4217USD">6948000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0001444380_20210101_20211231"
      decimals="INF"
      id="F_000866"
      unitRef="U_xbrlishares">21914</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0001444380_20210101_20211231"
      decimals="2"
      id="F_000879"
      unitRef="U_iso4217USD_xbrlishares">43.52</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000867"
      unitRef="U_xbrlishares">700654</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001444380_20211231"
      decimals="2"
      id="F_000880"
      unitRef="U_iso4217USD_xbrlishares">55.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000895"
      unitRef="U_iso4217USD">18287000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000868"
      unitRef="U_xbrlishares">599295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_0001444380_20211231"
      decimals="2"
      id="F_000881"
      unitRef="U_iso4217USD_xbrlishares">56.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000896"
      unitRef="U_iso4217USD">15656000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001444380_20211231"
      decimals="INF"
      id="F_000869"
      unitRef="U_xbrlishares">696003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_0001444380_20211231"
      decimals="2"
      id="F_000882"
      unitRef="U_iso4217USD_xbrlishares">55.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_000897"
      unitRef="U_iso4217USD">18173000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_20190101_20191231"
      decimals="2"
      id="F_000898"
      unitRef="U_iso4217USD_xbrlishares">27.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_000899"
      unitRef="U_iso4217USD">3100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_0001444380_20200101_20201231"
      decimals="-5"
      id="F_000900"
      unitRef="U_iso4217USD">6600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_0001444380_20190101_20191231"
      decimals="-5"
      id="F_000901"
      unitRef="U_iso4217USD">8300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000419">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The options outstanding and vested under the Stock Plans by exercise price, at December&#160;31, 2021, were as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="8" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.84%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual Term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="text-decoration:underline;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000902"&gt;$3.60 &#x2014; $36.55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;116,179&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000922"&gt;3.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.18&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;111,929&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000903"&gt;$38.79 &#x2014; $45.04&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;114,032&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000923"&gt;5.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;94,094&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42.08&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000904"&gt;$45.07 &#x2014; $63.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;156,883&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000924"&gt;4.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57.56&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;129,344&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;59.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000905"&gt;$63.39 &#x2014; $64.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;141,004&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000925"&gt;6.94&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91,835&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000906"&gt;$65.51 &#x2014; $87.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;152,556&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000926"&gt;3.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;152,093&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79.36&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$97.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000927"&gt;4.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;97.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;97.52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000907"&gt;$3.60 &#x2014; $97.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;700,654&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.92%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000928"&gt;4.81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55.93&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;599,295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.92%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56.06&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231"
      decimals="INF"
      id="F_000915"
      unitRef="U_xbrlishares">116179</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231"
      decimals="2"
      id="F_000929"
      unitRef="U_iso4217USD_xbrlishares">19.18</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231"
      decimals="INF"
      id="F_000936"
      unitRef="U_xbrlishares">111929</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231"
      decimals="2"
      id="F_000943"
      unitRef="U_iso4217USD_xbrlishares">18.52</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231"
      decimals="INF"
      id="F_000916"
      unitRef="U_xbrlishares">114032</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231"
      decimals="2"
      id="F_000930"
      unitRef="U_iso4217USD_xbrlishares">47.12</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231"
      decimals="INF"
      id="F_000937"
      unitRef="U_xbrlishares">94094</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange2Member_20211231"
      decimals="2"
      id="F_000944"
      unitRef="U_iso4217USD_xbrlishares">42.08</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231"
      decimals="INF"
      id="F_000917"
      unitRef="U_xbrlishares">156883</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231"
      decimals="2"
      id="F_000931"
      unitRef="U_iso4217USD_xbrlishares">57.56</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231"
      decimals="INF"
      id="F_000938"
      unitRef="U_xbrlishares">129344</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange3Member_20211231"
      decimals="2"
      id="F_000945"
      unitRef="U_iso4217USD_xbrlishares">59.12</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231"
      decimals="INF"
      id="F_000918"
      unitRef="U_xbrlishares">141004</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231"
      decimals="2"
      id="F_000932"
      unitRef="U_iso4217USD_xbrlishares">64.28</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231"
      decimals="INF"
      id="F_000939"
      unitRef="U_xbrlishares">91835</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange4Member_20211231"
      decimals="2"
      id="F_000946"
      unitRef="U_iso4217USD_xbrlishares">64.21</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231"
      decimals="INF"
      id="F_000919"
      unitRef="U_xbrlishares">152556</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231"
      decimals="2"
      id="F_000933"
      unitRef="U_iso4217USD_xbrlishares">79.37</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231"
      decimals="INF"
      id="F_000940"
      unitRef="U_xbrlishares">152093</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange5Member_20211231"
      decimals="2"
      id="F_000947"
      unitRef="U_iso4217USD_xbrlishares">79.36</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231"
      decimals="INF"
      id="F_000920"
      unitRef="U_xbrlishares">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231"
      decimals="2"
      id="F_000934"
      unitRef="U_iso4217USD_xbrlishares">97.52</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231"
      decimals="INF"
      id="F_000941"
      unitRef="U_xbrlishares">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange6Member_20211231"
      decimals="2"
      id="F_000948"
      unitRef="U_iso4217USD_xbrlishares">97.52</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231"
      decimals="INF"
      id="F_000921"
      unitRef="U_xbrlishares">700654</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231"
      decimals="2"
      id="F_000935"
      unitRef="U_iso4217USD_xbrlishares">55.93</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231"
      decimals="INF"
      id="F_000942"
      unitRef="U_xbrlishares">599295</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange7Member_20211231"
      decimals="2"
      id="F_000949"
      unitRef="U_iso4217USD_xbrlishares">56.06</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000420">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of RSU activity under the Stock Plans was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant&#160;Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock&#160;Units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in&#160;thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,002,161&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;72.55&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,974&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;721,992&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock released&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(321,858&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;70.89&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,064&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(225,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;70.51&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,177,221&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;64.70&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;138,371&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;252,703&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;123.31&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock released&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(395,971&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66.42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,789&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(180,976&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;71.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;852,977&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79.87&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147,650&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;368,230&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;146.64&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock released&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(346,602&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;76.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(110,799&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98.76&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;763,806&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;110.96&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,922&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock expected to vest as of&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;696,348&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;109.78&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231"
      decimals="INF"
      id="F_000950"
      unitRef="U_xbrlishares">1002161</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231"
      decimals="2"
      id="F_000964"
      unitRef="U_iso4217USD_xbrlishares">72.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231"
      decimals="-3"
      id="F_000978"
      unitRef="U_iso4217USD">38974000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="INF"
      id="F_000951"
      unitRef="U_xbrlishares">721992</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="2"
      id="F_000965"
      unitRef="U_iso4217USD_xbrlishares">58.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="INF"
      id="F_000952"
      unitRef="U_xbrlishares">321858</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="2"
      id="F_000966"
      unitRef="U_iso4217USD_xbrlishares">70.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="-3"
      id="F_000979"
      unitRef="U_iso4217USD">4064000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="INF"
      id="F_000953"
      unitRef="U_xbrlishares">225074</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="2"
      id="F_000967"
      unitRef="U_iso4217USD_xbrlishares">70.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231"
      decimals="INF"
      id="F_000954"
      unitRef="U_xbrlishares">1177221</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231"
      decimals="2"
      id="F_000968"
      unitRef="U_iso4217USD_xbrlishares">64.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231"
      decimals="-3"
      id="F_000980"
      unitRef="U_iso4217USD">138371000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="INF"
      id="F_000955"
      unitRef="U_xbrlishares">252703</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="2"
      id="F_000969"
      unitRef="U_iso4217USD_xbrlishares">123.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="INF"
      id="F_000956"
      unitRef="U_xbrlishares">395971</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="2"
      id="F_000970"
      unitRef="U_iso4217USD_xbrlishares">66.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="-3"
      id="F_000981"
      unitRef="U_iso4217USD">23789000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="INF"
      id="F_000957"
      unitRef="U_xbrlishares">180976</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="2"
      id="F_000971"
      unitRef="U_iso4217USD_xbrlishares">71.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231"
      decimals="INF"
      id="F_000958"
      unitRef="U_xbrlishares">852977</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231"
      decimals="2"
      id="F_000972"
      unitRef="U_iso4217USD_xbrlishares">79.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231"
      decimals="-3"
      id="F_000982"
      unitRef="U_iso4217USD">147650000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="INF"
      id="F_000959"
      unitRef="U_xbrlishares">368230</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="2"
      id="F_000973"
      unitRef="U_iso4217USD_xbrlishares">146.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="INF"
      id="F_000960"
      unitRef="U_xbrlishares">346602</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="2"
      id="F_000974"
      unitRef="U_iso4217USD_xbrlishares">76.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="-3"
      id="F_000983"
      unitRef="U_iso4217USD">22902000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="INF"
      id="F_000961"
      unitRef="U_xbrlishares">110799</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="2"
      id="F_000975"
      unitRef="U_iso4217USD_xbrlishares">98.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231"
      decimals="INF"
      id="F_000962"
      unitRef="U_xbrlishares">763806</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231"
      decimals="2"
      id="F_000976"
      unitRef="U_iso4217USD_xbrlishares">110.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231"
      decimals="-3"
      id="F_000984"
      unitRef="U_iso4217USD">61922000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231"
      decimals="INF"
      id="F_000963"
      unitRef="U_xbrlishares">696348</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231"
      decimals="2"
      id="F_000977"
      unitRef="U_iso4217USD_xbrlishares">109.78</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue>
    <nvro:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231"
      decimals="-3"
      id="F_000985"
      unitRef="U_iso4217USD">56453000</nvro:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest>
    <nvro:TargetedNumberOfSharesGrantedRatio
      contextRef="C_0001444380_srtRangeAxis_srtMinimumMember_srtTitleOfIndividualAxis_srtManagementMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210301_20210331"
      decimals="INF"
      id="F_000990"
      unitRef="U_xbrlipure">0</nvro:TargetedNumberOfSharesGrantedRatio>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      id="F_000421">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of PSU activity under the Stock Plans was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&#160;Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant&#160;Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock&#160;Units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&#160;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in&#160;thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,962&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;111,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;67.29&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU released&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;54.50&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;111,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;67.29&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,060&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;89,198&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;128.71&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,272&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125.27&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,037&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;94.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;183.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU cancelled&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7,388&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;136.77&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;248,685&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;113.35&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,161&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;PSU expected to vest as of&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;247,815&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;113.22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,090&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20181231"
      decimals="INF"
      id="F_000992"
      unitRef="U_xbrlishares">7962</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20181231"
      decimals="2"
      id="F_001004"
      unitRef="U_iso4217USD_xbrlishares">54.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20181231"
      decimals="-3"
      id="F_001016"
      unitRef="U_iso4217USD">310000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="INF"
      id="F_000993"
      unitRef="U_xbrlishares">111111</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="2"
      id="F_001005"
      unitRef="U_iso4217USD_xbrlishares">67.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="INF"
      id="F_000994"
      unitRef="U_xbrlishares">3981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="2"
      id="F_001006"
      unitRef="U_iso4217USD_xbrlishares">54.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="INF"
      id="F_000995"
      unitRef="U_xbrlishares">3981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="2"
      id="F_001007"
      unitRef="U_iso4217USD_xbrlishares">54.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20191231"
      decimals="INF"
      id="F_000996"
      unitRef="U_xbrlishares">111111</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20191231"
      decimals="2"
      id="F_001008"
      unitRef="U_iso4217USD_xbrlishares">67.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20191231"
      decimals="-3"
      id="F_001017"
      unitRef="U_iso4217USD">13060000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="INF"
      id="F_000997"
      unitRef="U_xbrlishares">89198</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="2"
      id="F_001009"
      unitRef="U_iso4217USD_xbrlishares">128.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="INF"
      id="F_000998"
      unitRef="U_xbrlishares">1272</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="2"
      id="F_001010"
      unitRef="U_iso4217USD_xbrlishares">125.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20201231"
      decimals="INF"
      id="F_000999"
      unitRef="U_xbrlishares">199037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20201231"
      decimals="2"
      id="F_001011"
      unitRef="U_iso4217USD_xbrlishares">94.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20201231"
      decimals="-3"
      id="F_001018"
      unitRef="U_iso4217USD">34453000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="INF"
      id="F_001000"
      unitRef="U_xbrlishares">57036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="2"
      id="F_001012"
      unitRef="U_iso4217USD_xbrlishares">183.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="INF"
      id="F_001001"
      unitRef="U_xbrlishares">7388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="2"
      id="F_001013"
      unitRef="U_iso4217USD_xbrlishares">136.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231"
      decimals="INF"
      id="F_001002"
      unitRef="U_xbrlishares">248685</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231"
      decimals="2"
      id="F_001014"
      unitRef="U_iso4217USD_xbrlishares">113.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231"
      decimals="-3"
      id="F_001019"
      unitRef="U_iso4217USD">20161000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231"
      decimals="INF"
      id="F_001003"
      unitRef="U_xbrlishares">247815</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231"
      decimals="2"
      id="F_001015"
      unitRef="U_iso4217USD_xbrlishares">113.22</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue>
    <nvro:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231"
      decimals="-3"
      id="F_001020"
      unitRef="U_iso4217USD">20090000</nvro:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141031"
      decimals="INF"
      id="F_001021"
      unitRef="U_xbrlishares">196666</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141031"
      decimals="INF"
      id="F_001022"
      unitRef="U_xbrlipure">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_0001444380_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20141001_20141031"
      decimals="INF"
      id="F_001023"
      unitRef="U_xbrlipure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000422">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of ESPP activity was as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.46%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additional shares reserved&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;235,590&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;315,443&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;302,635&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares issued&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;65,197&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;79,967&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;164,960&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares available for future issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,567,514&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,397,121&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,161,645&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee contributions for shares issued (in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,849&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,513&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,544&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="INF"
      id="F_001025"
      unitRef="U_xbrlishares">235590</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_001026"
      unitRef="U_xbrlishares">315443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="INF"
      id="F_001027"
      unitRef="U_xbrlishares">302635</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="INF"
      id="F_001028"
      unitRef="U_xbrlishares">65197</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_001029"
      unitRef="U_xbrlishares">79967</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="INF"
      id="F_001030"
      unitRef="U_xbrlishares">164960</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20211231"
      decimals="INF"
      id="F_001031"
      unitRef="U_xbrlishares">1567514</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20201231"
      decimals="INF"
      id="F_001032"
      unitRef="U_xbrlishares">1397121</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20191231"
      decimals="INF"
      id="F_001033"
      unitRef="U_xbrlishares">1161645</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="-3"
      id="F_001034"
      unitRef="U_iso4217USD">6849000</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="-3"
      id="F_001035"
      unitRef="U_iso4217USD">7513000</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="-3"
      id="F_001036"
      unitRef="U_iso4217USD">6544000</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000423">The following assumptions were used in estimating the fair value:
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.1%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock Options:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001037"&gt;5.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001038"&gt;51%&#160;&#x2014;&#160;52%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001040"&gt;1.4%&#160;&#x2014;&#160;2.6%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend Yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;ESPP:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001043"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001044"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001045"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001046"&gt;36% &#x2014; 49%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001047"&gt;39% &#x2014; 68%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001048"&gt;48% &#x2014; 61%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1% &#x2014; 0.2%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6% &#x2014; 2.4%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend Yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="2"
      id="F_001042"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="INF"
      id="F_001052"
      unitRef="U_xbrlipure">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="2"
      id="F_001057"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="2"
      id="F_001058"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="2"
      id="F_001059"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      id="F_001060">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190301_20190331"
      decimals="-5"
      id="F_001061"
      unitRef="U_iso4217USD">1600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      id="F_000424">The company estimates the grant-date fair value of these PSUs based on the Monte Carlo simulation model and records the related stock-based compensation over the period for which the TSR is measured against the Index, which is generally two to three years. The use of the Monte Carlo simulation model requires the input the following assumptions:
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="7" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.22%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Index volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001064"&gt;51% &#x2014; 53%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001065"&gt;44% &#x2014; 51%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Company volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001068"&gt;49% &#x2014; 54%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001069"&gt;57% &#x2014; 59%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001072"&gt;0.1% &#x2014; 0.3%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001073"&gt;0.1% &#x2014; 0.2%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.4%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Correlation with index&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001076"&gt;0.32 &#x2014; 0.35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001077"&gt;0.38 &#x2014; 0.41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.28&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.9%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividend Yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <nvro:RecognitionPeriodOfStockBasedCompensationExpense
      contextRef="C_0001444380_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190301_20190331"
      id="F_001063">P3Y</nvro:RecognitionPeriodOfStockBasedCompensationExpense>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="2"
      id="F_001083"
      unitRef="U_xbrlipure">0.36</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="2"
      id="F_001084"
      unitRef="U_xbrlipure">0.45</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="3"
      id="F_001085"
      unitRef="U_xbrlipure">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="4"
      id="F_001086"
      unitRef="U_xbrlipure">0.0028</nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="2"
      id="F_001080"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="2"
      id="F_001081"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="2"
      id="F_001082"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000425">
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of stock-based compensation expense by line items in the consolidated statements of operations is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,637&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,433&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,061&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,455&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,323&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sales, general and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,081&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,313&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total stock-based compensation expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44,365&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,655&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41,697&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231"
      decimals="-3"
      id="F_001087"
      unitRef="U_iso4217USD">1637000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231"
      decimals="-3"
      id="F_001088"
      unitRef="U_iso4217USD">2433000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231"
      decimals="-3"
      id="F_001089"
      unitRef="U_iso4217USD">3061000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231"
      decimals="-3"
      id="F_001090"
      unitRef="U_iso4217USD">6455000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_001091"
      unitRef="U_iso4217USD">6141000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231"
      decimals="-3"
      id="F_001092"
      unitRef="U_iso4217USD">6323000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20210101_20211231"
      decimals="-3"
      id="F_001093"
      unitRef="U_iso4217USD">36273000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231"
      decimals="-3"
      id="F_001094"
      unitRef="U_iso4217USD">34081000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231"
      decimals="-3"
      id="F_001095"
      unitRef="U_iso4217USD">32313000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001096"
      unitRef="U_iso4217USD">44365000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001097"
      unitRef="U_iso4217USD">42655000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001098"
      unitRef="U_iso4217USD">41697000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000426">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,997&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,289&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,312&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,234&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,977&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,854&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Performance stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,017&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,694&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee stock purchase plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,117&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,695&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,540&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total stock-based compensation expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44,365&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,655&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41,697&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231"
      decimals="-3"
      id="F_001099"
      unitRef="U_iso4217USD">2997000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="-3"
      id="F_001100"
      unitRef="U_iso4217USD">6289000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="-3"
      id="F_001101"
      unitRef="U_iso4217USD">10312000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210101_20211231"
      decimals="-3"
      id="F_001102"
      unitRef="U_iso4217USD">29234000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20200101_20201231"
      decimals="-3"
      id="F_001103"
      unitRef="U_iso4217USD">27977000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20190101_20191231"
      decimals="-3"
      id="F_001104"
      unitRef="U_iso4217USD">26854000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20210101_20211231"
      decimals="-3"
      id="F_001105"
      unitRef="U_iso4217USD">10017000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20200101_20201231"
      decimals="-3"
      id="F_001106"
      unitRef="U_iso4217USD">5694000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231"
      decimals="-3"
      id="F_001107"
      unitRef="U_iso4217USD">1991000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="-3"
      id="F_001108"
      unitRef="U_iso4217USD">2117000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="-3"
      id="F_001109"
      unitRef="U_iso4217USD">2695000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="-3"
      id="F_001110"
      unitRef="U_iso4217USD">2540000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001111"
      unitRef="U_iso4217USD">44365000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001112"
      unitRef="U_iso4217USD">42655000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001113"
      unitRef="U_iso4217USD">41697000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000427">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2021, total stock-based compensation expense not yet recognized, net of estimated forfeitures, are as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&#160;Period&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,597&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001118"&gt;1.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,107&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001119"&gt;2.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Performance stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001120"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee stock purchase plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,219&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001121"&gt;0.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20211231"
      decimals="-3"
      id="F_001114"
      unitRef="U_iso4217USD">2597000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20211231"
      decimals="-3"
      id="F_001115"
      unitRef="U_iso4217USD">61107000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20211231"
      decimals="-3"
      id="F_001116"
      unitRef="U_iso4217USD">10389000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20211231"
      decimals="-3"
      id="F_001117"
      unitRef="U_iso4217USD">1219000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000371">
&lt;p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;11. Income Taxes&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of the Company&#x2019;s income / (loss) before income taxes were as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Domestic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(129,135&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(83,893&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(106,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,691&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,696&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total loss before income taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(130,826&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(82,197&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(102,087&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of the expense / (benefit) for income taxes are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(103&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;244&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;188&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;187&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;585&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;656&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,644&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current income tax expense / (benefit)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;829&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;844&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,728&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(129&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred income tax expense / (benefit)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(129&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total income tax expense / (benefit)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;534&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;868&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,599&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax at statutory federal rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State tax, net of federal benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign rate differential&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(23.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(33.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(26.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;154,614&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;127,347&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,087&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,919&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;650&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;662&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,969&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,390&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accruals and reserves&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,404&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,531&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Right of use asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,225&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,055&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,130&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;869&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;206,079&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;169,773&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(201,088&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(164,278&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,495&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,660&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,459&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,660&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,459&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,331&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, substantially all of the net deferred tax assets have been offset by a valuation allowance. The valuation allowance increased by $36.8 million and $32.5 million for the years ended December&#160;31, 2021 and 2020, respectively.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2021, the Company had federal net operating loss carryforwards (NOLs) of approximately $588.4&#160;million, of which $329.4 million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the 2017 Tax Act, as well as state NOLs of approximately $336.5 million, of which $54.3 million may be carried forward indefinitely. If not utilized, the remaining federal NOLs will begin to expire in 2026, and the remaining state NOLs will begin to expire in 2022.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2021, the Company had research and development credit carryforwards of approximately $20.5&#160;million and $13.9&#160;million for federal and California state income tax purposes, respectively. The federal credit carryforward begins expiring in 2026, and the state credits carry forward indefinitely.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under Section&#160;382 of the Internal Revenue Code of 1986, as amended, the Company&#x2019;s ability to utilize NOLs or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, a Section 382 &#x201c;ownership change.&#x201d; A Section&#160;382 &#x201c;ownership change&#x201d; generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company&#x2019;s stock, increase their ownership by a greater than 50 percentage point change (by value) over a rolling three-year period. Similar rules may apply under state tax laws. As a result of the Company&#x2019;s June 2015 underwritten public offering, the Company experienced a Section 382 &#x201c;ownership change.&#x201d;&#160;&#160;The Company currently estimates that this &#x201c;ownership change&#x201d; will not inhibit its ability to utilize its NOLs.  However, the Company may, in the future, experience one or more additional Section&#160;382 &#x201c;ownership changes&#x201d; as a result of subsequent changes in its stock ownership, some of which changes are outside the Company&#x2019;s control.&#160;&#160;If so, the Company may not be able to utilize a material portion of its NOLs and tax credits, even if the Company achieves profitability.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company had unrecognized tax benefits (UTBs) of approximately $10.4&#160;million as of December&#160;31, 2021. The following table summarizes the activity related to UTBs (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to current year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,611&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;572&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decreases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,383&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to current year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;891&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decreases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(54&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,220&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to current year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,412&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decreases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(62&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,430&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If these UTBs were recognized, approximately $10.4 million would affect the effective tax rate before consideration of the valuation allowance. The Company files U.S. federal and state income tax and foreign income tax returns with varying statutes of limitations. The Company&#x2019;s U.S. federal and the majority of state tax years from inception in 2006 onward will remain open to examination due to the carryover of the unused NOLs and tax credits. The Company does not have any material active tax audits or other proceedings pending, and believes it has provided adequate reserves for all tax deficiencies or reductions in tax benefits that could result from federal, state and foreign tax audits. The Company does not expect any material changes to the estimated amount of liability associated with its uncertain tax positions within the next twelve months.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In accordance with ASC 740, &lt;span style="font-style:italic;"&gt;Income Taxes&lt;/span&gt;, the Company is classifying interest and penalties as a component of tax expense. There was $0.2 million, $0.1 million and $0.1 million of interest and penalties accrued at each of December 31, 2021, 2020 and 2019, respectively.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000428">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of the Company&#x2019;s income / (loss) before income taxes were as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Domestic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(129,135&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(83,893&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(106,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,691&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,696&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total loss before income taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(130,826&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(82,197&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(102,087&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001122"
      unitRef="U_iso4217USD">-129135000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001123"
      unitRef="U_iso4217USD">-83893000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001124"
      unitRef="U_iso4217USD">-106010000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001125"
      unitRef="U_iso4217USD">-1691000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001126"
      unitRef="U_iso4217USD">1696000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001127"
      unitRef="U_iso4217USD">3923000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001128"
      unitRef="U_iso4217USD">-130826000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001129"
      unitRef="U_iso4217USD">-82197000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001130"
      unitRef="U_iso4217USD">-102087000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000429">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of the expense / (benefit) for income taxes are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(103&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;244&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;188&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;187&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;585&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;656&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,644&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current income tax expense / (benefit)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;829&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;844&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,728&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(129&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred income tax expense / (benefit)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(295&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(129&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total income tax expense / (benefit)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;534&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;868&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,599&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001131"
      unitRef="U_iso4217USD">-103000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001132"
      unitRef="U_iso4217USD">244000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001133"
      unitRef="U_iso4217USD">188000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001134"
      unitRef="U_iso4217USD">187000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001135"
      unitRef="U_iso4217USD">585000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001136"
      unitRef="U_iso4217USD">656000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001137"
      unitRef="U_iso4217USD">1644000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001138"
      unitRef="U_iso4217USD">829000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001139"
      unitRef="U_iso4217USD">844000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001140"
      unitRef="U_iso4217USD">1728000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001141"
      unitRef="U_iso4217USD">-295000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001142"
      unitRef="U_iso4217USD">24000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001143"
      unitRef="U_iso4217USD">-129000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001144"
      unitRef="U_iso4217USD">-295000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001145"
      unitRef="U_iso4217USD">24000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001146"
      unitRef="U_iso4217USD">-129000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001147"
      unitRef="U_iso4217USD">534000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001148"
      unitRef="U_iso4217USD">868000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001149"
      unitRef="U_iso4217USD">1599000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000430">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax at statutory federal rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State tax, net of federal benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign rate differential&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(23.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(33.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(26.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001444380_20210101_20211231"
      decimals="INF"
      id="F_001150"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001444380_20200101_20201231"
      decimals="INF"
      id="F_001151"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001444380_20190101_20191231"
      decimals="INF"
      id="F_001152"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0001444380_20210101_20211231"
      decimals="3"
      id="F_001153"
      unitRef="U_xbrlipure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0001444380_20200101_20201231"
      decimals="3"
      id="F_001154"
      unitRef="U_xbrlipure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0001444380_20190101_20191231"
      decimals="3"
      id="F_001155"
      unitRef="U_xbrlipure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_0001444380_20210101_20211231"
      decimals="3"
      id="F_001156"
      unitRef="U_xbrlipure">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_0001444380_20200101_20201231"
      decimals="3"
      id="F_001157"
      unitRef="U_xbrlipure">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_0001444380_20190101_20191231"
      decimals="3"
      id="F_001158"
      unitRef="U_xbrlipure">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_0001444380_20210101_20211231"
      decimals="3"
      id="F_001159"
      unitRef="U_xbrlipure">-0.030</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_0001444380_20200101_20201231"
      decimals="3"
      id="F_001160"
      unitRef="U_xbrlipure">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_0001444380_20190101_20191231"
      decimals="3"
      id="F_001161"
      unitRef="U_xbrlipure">-0.030</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0001444380_20210101_20211231"
      decimals="3"
      id="F_001162"
      unitRef="U_xbrlipure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0001444380_20200101_20201231"
      decimals="3"
      id="F_001163"
      unitRef="U_xbrlipure">0.098</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0001444380_20190101_20191231"
      decimals="3"
      id="F_001164"
      unitRef="U_xbrlipure">0.038</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001444380_20210101_20211231"
      decimals="3"
      id="F_001165"
      unitRef="U_xbrlipure">-0.233</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001444380_20200101_20201231"
      decimals="3"
      id="F_001166"
      unitRef="U_xbrlipure">-0.336</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001444380_20190101_20191231"
      decimals="3"
      id="F_001167"
      unitRef="U_xbrlipure">-0.264</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0001444380_20210101_20211231"
      decimals="3"
      id="F_001168"
      unitRef="U_xbrlipure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0001444380_20200101_20201231"
      decimals="3"
      id="F_001169"
      unitRef="U_xbrlipure">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0001444380_20190101_20191231"
      decimals="3"
      id="F_001170"
      unitRef="U_xbrlipure">-0.022</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001444380_20210101_20211231"
      decimals="3"
      id="F_001171"
      unitRef="U_xbrlipure">-0.004</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001444380_20200101_20201231"
      decimals="3"
      id="F_001172"
      unitRef="U_xbrlipure">-0.011</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0001444380_20190101_20191231"
      decimals="3"
      id="F_001173"
      unitRef="U_xbrlipure">-0.016</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000431">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;154,614&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;127,347&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,087&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,919&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;650&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;662&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,969&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,390&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accruals and reserves&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,404&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,531&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Right of use asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,225&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,055&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,130&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;869&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;206,079&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;169,773&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(201,088&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(164,278&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,495&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,660&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,459&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,660&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,459&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,331&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001174"
      unitRef="U_iso4217USD">154614000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001175"
      unitRef="U_iso4217USD">127347000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001176"
      unitRef="U_iso4217USD">25087000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001177"
      unitRef="U_iso4217USD">18919000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <nvro:DeferredTaxAssetsDepreciation
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001178"
      unitRef="U_iso4217USD">650000</nvro:DeferredTaxAssetsDepreciation>
    <nvro:DeferredTaxAssetsDepreciation
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001179"
      unitRef="U_iso4217USD">662000</nvro:DeferredTaxAssetsDepreciation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001180"
      unitRef="U_iso4217USD">6969000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001181"
      unitRef="U_iso4217USD">7390000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001182"
      unitRef="U_iso4217USD">13404000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001183"
      unitRef="U_iso4217USD">9531000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <nvro:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001184"
      unitRef="U_iso4217USD">-4225000</nvro:DeferredTaxLiabilitiesRightOfUseAsset>
    <nvro:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001185"
      unitRef="U_iso4217USD">-5055000</nvro:DeferredTaxLiabilitiesRightOfUseAsset>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001186"
      unitRef="U_iso4217USD">1130000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001187"
      unitRef="U_iso4217USD">869000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001188"
      unitRef="U_iso4217USD">206079000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001189"
      unitRef="U_iso4217USD">169773000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001190"
      unitRef="U_iso4217USD">201088000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001191"
      unitRef="U_iso4217USD">164278000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001192"
      unitRef="U_iso4217USD">4991000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001193"
      unitRef="U_iso4217USD">5495000</us-gaap:DeferredTaxAssetsNet>
    <nvro:DeferredTaxAssetsLeaseLiabilities
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001194"
      unitRef="U_iso4217USD">-3660000</nvro:DeferredTaxAssetsLeaseLiabilities>
    <nvro:DeferredTaxAssetsLeaseLiabilities
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001195"
      unitRef="U_iso4217USD">-4459000</nvro:DeferredTaxAssetsLeaseLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001196"
      unitRef="U_iso4217USD">3660000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001197"
      unitRef="U_iso4217USD">4459000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001198"
      unitRef="U_iso4217USD">1331000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001199"
      unitRef="U_iso4217USD">1036000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_001200"
      unitRef="U_iso4217USD">36800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001444380_20200101_20201231"
      decimals="-5"
      id="F_001201"
      unitRef="U_iso4217USD">32500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20211231"
      decimals="-5"
      id="F_001202"
      unitRef="U_iso4217USD">588400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20181231"
      decimals="-5"
      id="F_001204"
      unitRef="U_iso4217USD">329400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20211231"
      decimals="-5"
      id="F_001203"
      unitRef="U_iso4217USD">336500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001444380_20211231"
      decimals="-5"
      id="F_001205"
      unitRef="U_iso4217USD">54300000</us-gaap:OperatingLossCarryforwards>
    <nvro:FederalAndStateNetOperatingLossCarryForwardsExpirationYear
      contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_20210101_20211231"
      id="F_001206">2026</nvro:FederalAndStateNetOperatingLossCarryForwardsExpirationYear>
    <nvro:FederalAndStateNetOperatingLossCarryForwardsExpirationYear
      contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20210101_20211231"
      id="F_001207">2022</nvro:FederalAndStateNetOperatingLossCarryForwardsExpirationYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_0001444380_us-gaapIncomeTaxAuthorityAxis_us-gaapDomesticCountryMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20211231"
      decimals="-5"
      id="F_001208"
      unitRef="U_iso4217USD">20500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_0001444380_us-gaapIncomeTaxAuthorityNameAxis_us-gaapCaliforniaFranchiseTaxBoardMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20211231"
      decimals="-5"
      id="F_001209"
      unitRef="U_iso4217USD">13900000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001444380_20211231"
      decimals="-5"
      id="F_001210"
      unitRef="U_iso4217USD">10400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000432">The following table summarizes the activity related to UTBs (in thousands):
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to current year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,611&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;572&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decreases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,383&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to current year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;891&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decreases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(54&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,220&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to current year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,412&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Decreases related to prior year tax provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(62&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,430&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001444380_20181231"
      decimals="-3"
      id="F_001211"
      unitRef="U_iso4217USD">5200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001212"
      unitRef="U_iso4217USD">1611000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001213"
      unitRef="U_iso4217USD">572000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001444380_20191231"
      decimals="-3"
      id="F_001214"
      unitRef="U_iso4217USD">7383000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001215"
      unitRef="U_iso4217USD">891000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001216"
      unitRef="U_iso4217USD">54000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001444380_20201231"
      decimals="-3"
      id="F_001217"
      unitRef="U_iso4217USD">8220000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001218"
      unitRef="U_iso4217USD">1412000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001219"
      unitRef="U_iso4217USD">860000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001220"
      unitRef="U_iso4217USD">62000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001221"
      unitRef="U_iso4217USD">10430000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001444380_20211231"
      decimals="-5"
      id="F_001222"
      unitRef="U_iso4217USD">10400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_0001444380_20211231"
      decimals="-5"
      id="F_001223"
      unitRef="U_iso4217USD">200000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_0001444380_20201231"
      decimals="-5"
      id="F_001224"
      unitRef="U_iso4217USD">100000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_0001444380_20191231"
      decimals="-5"
      id="F_001225"
      unitRef="U_iso4217USD">100000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerShareTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000372">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;12. Net Loss Per Share&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(131,360&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(83,065&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(103,686&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares used to compute basic and&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; diluted net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,823,258&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,677,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,803,872&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3.77&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2.47&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period, determined using the treasury-stock method, if inclusion of these is dilutive. &lt;span style="color:#000000;"&gt;The conversion spread for the Company&#x2019;s outstanding convertible senior notes will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company&#x2019;s common stock for a given period exceeds the conversion price of $105.00 for the 2025 Notes.&lt;/span&gt; This condition was not met in the three months ended December 31, 2021.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with the issuance of the 2021 Notes and 2025 Notes, the Company entered into convertible bond hedges. The convertible bond hedges are not included for purposes of calculating the number of diluted shares outstanding for the periods presented, as their effect would be anti-dilutive. The convertible bond hedges are generally expected, but not guaranteed, to reduce the potential dilution and/or offset the cash payments the Company is required to make upon conversion of the 2021 Notes and 2025 Notes. When the 2021 Notes matured on June 1, 2021, the Company exercised its option under the bond hedge. As of December 31, 2021, the bond hedges related to the 2021 Notes are no longer outstanding. &lt;span style="color:#000000;"&gt;Because the Company has reported a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unreleased restricted and performance stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,012,491&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,052,014&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,288,332&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options to purchase common stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;700,654&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;813,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,646,185&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Convertible senior notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,807,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,597,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,790,033&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants related to the issuance of convertible senior notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,807,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,597,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,790,033&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,327,427&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,059,512&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,514,583&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000433">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(131,360&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(83,065&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(103,686&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares used to compute basic and&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; diluted net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,823,258&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33,677,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,803,872&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share, basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3.77&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2.47&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3.37&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20210101_20211231"
      decimals="-3"
      id="F_001226"
      unitRef="U_iso4217USD">-131360000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20200101_20201231"
      decimals="-3"
      id="F_001227"
      unitRef="U_iso4217USD">-83065000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001444380_20190101_20191231"
      decimals="-3"
      id="F_001228"
      unitRef="U_iso4217USD">-103686000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001444380_20210101_20211231"
      decimals="0"
      id="F_001229"
      unitRef="U_xbrlishares">34823258</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001444380_20200101_20201231"
      decimals="0"
      id="F_001230"
      unitRef="U_xbrlishares">33677641</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001444380_20190101_20191231"
      decimals="0"
      id="F_001231"
      unitRef="U_xbrlishares">30803872</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001444380_20210101_20211231"
      decimals="2"
      id="F_001232"
      unitRef="U_iso4217USD_xbrlishares">-3.77</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001444380_20200101_20201231"
      decimals="2"
      id="F_001233"
      unitRef="U_iso4217USD_xbrlishares">-2.47</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001444380_20190101_20191231"
      decimals="2"
      id="F_001234"
      unitRef="U_iso4217USD_xbrlishares">-3.37</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_0001444380_us-gaapLongtermDebtTypeAxis_nvroTwoThousandTwentyFiveNotesAndConvertibleNotesMember_20211231"
      decimals="2"
      id="F_001235"
      unitRef="U_iso4217USD_xbrlishares">105.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:NotesPayable
      contextRef="C_0001444380_20211231"
      decimals="-3"
      id="F_001236"
      unitRef="U_iso4217USD">0</us-gaap:NotesPayable>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000434">
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unreleased restricted and performance stock units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,012,491&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,052,014&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,288,332&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options to purchase common stock&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;700,654&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;813,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,646,185&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Convertible senior notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,807,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,597,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,790,033&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants related to the issuance of convertible senior notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,807,141&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,597,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,790,033&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,327,427&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,059,512&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,514,583&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20210101_20211231"
      decimals="INF"
      id="F_001237"
      unitRef="U_xbrlishares">1012491</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20200101_20201231"
      decimals="INF"
      id="F_001238"
      unitRef="U_xbrlishares">1052014</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_nvroRestrictedAndPerformanceStockUnitsMember_20190101_20191231"
      decimals="INF"
      id="F_001239"
      unitRef="U_xbrlishares">1288332</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20210101_20211231"
      decimals="INF"
      id="F_001240"
      unitRef="U_xbrlishares">700654</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20200101_20201231"
      decimals="INF"
      id="F_001241"
      unitRef="U_xbrlishares">813150</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapEmployeeStockOptionMember_20190101_20191231"
      decimals="INF"
      id="F_001242"
      unitRef="U_xbrlishares">1646185</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20210101_20211231"
      decimals="INF"
      id="F_001243"
      unitRef="U_xbrlishares">1807141</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20200101_20201231"
      decimals="INF"
      id="F_001244"
      unitRef="U_xbrlishares">3597174</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20190101_20191231"
      decimals="INF"
      id="F_001245"
      unitRef="U_xbrlishares">1790033</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20210101_20211231"
      decimals="INF"
      id="F_001246"
      unitRef="U_xbrlishares">1807141</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20200101_20201231"
      decimals="INF"
      id="F_001247"
      unitRef="U_xbrlishares">3597174</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20190101_20191231"
      decimals="INF"
      id="F_001248"
      unitRef="U_xbrlishares">1790033</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_20210101_20211231"
      decimals="INF"
      id="F_001249"
      unitRef="U_xbrlishares">5327427</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_20200101_20201231"
      decimals="INF"
      id="F_001250"
      unitRef="U_xbrlishares">9059512</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001444380_20190101_20191231"
      decimals="INF"
      id="F_001251"
      unitRef="U_xbrlishares">6514583</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="C_0001444380_20210101_20211231" id="F_000373">
&lt;p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;13. Employee Benefit Plan.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.78%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2007, the Company adopted a 401(K) plan for its employees whereby eligible employees may contribute up to the maximum amount permitted by the Internal Revenue Code of 1986, as amended.&#160;&#160;In June 2016, the Company adopted a policy to match a portion of employee contributions for all qualified employees participating in the 401(k) plan.&#160;&#160;For the years ended December 31, 2021, 2020 and 2019, the Company recorded expenses of $2.9 million, $2.6 million and $3.1 million for matching contributions, respectively.&lt;/p&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0001444380_20210101_20211231"
      decimals="-5"
      id="F_001252"
      unitRef="U_iso4217USD">2900000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0001444380_20200101_20201231"
      decimals="-5"
      id="F_001253"
      unitRef="U_iso4217USD">2600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0001444380_20190101_20191231"
      decimals="-5"
      id="F_001254"
      unitRef="U_iso4217USD">3100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_000554"
          xlink:label="F_000554"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000541"
          xlink:label="F_000541"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000553"
          xlink:label="F_000553"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000540"
          xlink:label="F_000540"
          xlink:type="locator"/>
        <link:footnote id="FNT_000000" xlink:label="FNT_000000" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Included in cash and cash equivalents on the consolidated balance sheets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000554"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000541"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000553"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000540"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000558"
          xlink:label="F_000558"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000556"
          xlink:label="F_000556"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000559"
          xlink:label="F_000559"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000548"
          xlink:label="F_000548"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000561"
          xlink:label="F_000561"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000555"
          xlink:label="F_000555"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000549"
          xlink:label="F_000549"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000557"
          xlink:label="F_000557"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000562"
          xlink:label="F_000562"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000543"
          xlink:label="F_000543"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000545"
          xlink:label="F_000545"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000544"
          xlink:label="F_000544"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000560"
          xlink:label="F_000560"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000542"
          xlink:label="F_000542"
          xlink:type="locator"/>
        <link:footnote id="FNT_000001" xlink:label="FNT_000001" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Included in short-term investments on the consolidated balance sheets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000558"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000556"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000559"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000548"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000561"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000555"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000549"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000557"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000562"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000543"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000545"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000544"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000560"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000542"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000547"
          xlink:label="F_000547"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000546"
          xlink:label="F_000546"
          xlink:type="locator"/>
        <link:footnote id="FNT_000002" xlink:label="FNT_000002" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000547"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000546"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>101
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0G(C##=;,A;9?+)Q:9*OLR%Y_^X#>4>X('<\BN"VOF@9&-Q"M()\H.ML(._
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M..T[]![-)R$W@LP8U5*PD(RU3IBJY(=C_F :XU8JN(MK\"Z@N?>F;"V527/
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M"^^1!U'M.QS2[3D.N58\A(D[H>II0[<(5;\L"OY11:&@.K!7$.I':"2K:-;
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M$-L8R# 549A$UH9?N7"$1H/,NG"A']-DA!3M2=%)4D9NMX)7)V*@RDY"=!#
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M\FU]<7OS1M2%]F, G1X#OINK,MAUZ1$F32C(^E ] %,X8$-%5F;S 6>)#A)
MBILZ!<K#'.C=:&7*F9:A^'LP,WLTB.W,.)!>&$&1#DK9@<0Q]N+(7O[YV=U9
MQ>"PHN\@)9 ZU*JY;>I^[>XYWYO;/>OW6W*];FXK>S?-Y>DG. /I!E:R+;C$
M5Q&$)9K[R.9!\;VYH7O@2O'*?,U9FC&A ?#_+>?J]*!?T-T*+_\'4$L#!!0
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M.MV5XG>^_P<;)A1V_C)>MOU?L!]L@QG(=JW@U3!8*JB*^O":?AD"<3( 8L<
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M"Y)0ZI!P<32BS":!]):Q=(;#I/#$+_%?6KD79?&BZ,.:*[V3[;C+M2=[(:Y
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M: ))MQ/V8]=1VMAVB./XNYVM"A>HL>! :QQ*!"D1J92VB;95I*3\: 6%YL_
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MIPZ611>X\ O<..TNPQ&'J[=6&11Q%EUO#_YD)H.XI,%GE^=HGU7;K?42U("
M$4@U6>-*T0Y*:ZR[<X9M #R]CWQ3,L(5&YTVR">^;"PSCWOI  (#79VK,65
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M<=&R GW?&N/' SLXON'KOP%02P,$%     @ IX975)3>T0\(!   LPD  !D
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M(S1=\K99TJL*I3&@^4*0R*%C HSOM/7?4$L#!!0    ( *>&5U3-<1-QX0<
M $05   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;*586W/;N!5^]Z_
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M*2B>8?Z<6AS\,/?I]K_9B -(R;%NQ4+!E>\'ZDS3A-()<$E]&W>%@D"I#_2
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M/0I'^X5'N5I;6IC<7&WX2CP)^]OF0>-N,F@I92T:(U7#M%A>C^;AI]N$Y)W
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M@0(U">BT(--A%_C?PJ1:N3+!O[E-L99@JH\Z>[06")IZ,U(W26X L3") %9
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M MR"@5%NX\!>,KLD5)4;@8!IWK#>E\ '/M+1YTP3<QG;-2QDSCX:,&!2S;)
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M]W0W=-VM&82 [ P_HL"WL0+'!",U;VHV/_2PM3@C$HTD99=\@'9[LM? U+Z
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M4B9?<3\_.TY.1FIZP1)T,U;__,?T\OE+-9W.+O!DO*WV;5H^DM=[VIS8,V=
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MYMK3'S".H"FM?H%O\ ?, ^#D.4/_JXK</MXS&VP >@1ICE@M+KX6YV$M&,.
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M26WS6BL1ZK;_#]<OF8Q^\K$RI3PTE^JR>W7)A=KAGU2>O+HSTQDB6TFB2?M
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M[[A]N&E;>WEH0I_,6_4%D8#6#%I>\]<..K&'WJE!YV!D:I<W5V(^16][^GN
M_[QP,?I:LU;FEK])4;8%P_[#S7YT_]GKTG_MN9ONOYG]* WW$XU:8FDTF6=G
MPOCO4/[!Z0U_^UEHY_2:;U<*1C8T >^76KOA@3;8?PQ\^W]02P,$%     @
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M_F(U.>,KLUDDCY:S9'6U6D[,]\@AXA'/]VADOJ$=__?UNFEK(IS_F5C@6[?
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M]#@HU%^4KQ#ZS;8F2:L(./J?IJ[F1'6P1.-GI)F(V35HX(PQD-D>$EH.,[G
M873? #N/+#+M\XT6HB+][U*T<ADI,4E&)E(E*TU0=S]*94] *P/T$@<M["IU
ME-%B%([>2$&39L==L<)9(=[>Z& YT%GRL<21N1 IS07);V>P %QT3<>U-USH
M89K 2[R<C0;5%B)2AF2LK08*:X2BGC55M@*7,"([JB[X3MO9FAS!FI[#&'0N
M2"PG>++??BCR073F+;\)($P:-C-IQ=.8C!3&=FL)&[6Z?V[7T[+V<*6).V+&
MX#T7@:X<Q=Z6+\V2#00N-V)XS>1+2[U<9A)[9T>]PXU4/C X) @3*P@A7LD@
M$T@G)XP"+AQ4T\MJF_S3G /VG/IN3]&=+ZJA\-8"$K]^%_TN1HEXA$C1UI*@
MU]XUM'(&W4>N;-%8Y!@HI3.V"LYCF7/H0.%#/&NYE<E&P,>.R4%*95.^^)S#
M>9C'QN'"?8[;'JY*3N\V\15<B#L5A2,ZYVU,)"%&5[&BP+XR@0UC'"UN0VZ&
M\#Z+)3"JOOR5\*H+QR[0"=6!CA>^RVS746/[J+XX&3,FL8)4HJ^&#X67U6U;
MO-I 2Q B1*+CEZFTZ8EJD1:#B&,%8U<(XG8I+A>_=3=#N*!<^$:7Z/YZM+[0
ML9_1H!Y<8T9-H"_1)'P2%=?WUO[V?P8U^S^5W1)O%:O 63@"R1W'$P- @I.4
M>PEY?"[WWD\J+=>]:M'-*_2..;@^4ZBRB4[B,Z>K=PR%%F%TCD'?7AK6&,-U
MU<8EAIR<*_-)#BMU]V?8*.RY'!(24'![V?)3(.+Q_BF#.SH*LD+R@[ZFPEJY
M#J^^.VLPN>XN@9PI[6NZ*"^/71#@'C0EM_SJD  _L['G)*0*O"B]!9B92>>R
M@K\V[9W1.LK Z.XMY$+@P\B>C5J;]E;AR"BTQF+RN4U.KWIFRIX9Y2^#C4X\
M;)]!\;M#R)=A(+FGT1U4($<6MW;^1"'>OG1ULG[,UI:IU.).)H3.H.2+V'-$
M\'FN"P>&]H.*"ZWW2C,UA7#OY,T'ZQYSBX-I2#*O(>_6-/_,]B0&47-.[F3T
MUR;7%(Y<A ^#+933P6L16.5-W0(Y'K,ZBV]+YC[L 0X#XMJ1(2;024I>CC!\
MJZXIHK),S.Q?8P)W9\YO0.+2YLG8CV\87$VW^*%3&V%LH%\B"'QIDA@+3 :#
M4: _.RFN=B55X**W1PD%LX7"SZ.&*2TV6LBW/@FM2O!2Q^@[3.[X]8<FF]N;
MQ;U['\[81)[ZV77C,^8>M+#'+5;1I5[(G.:%VM4N)(Y[#XHN"D9C.WX?MH#S
M7[(+SKE, Q3MU*I?J\;>]%XXPG[8./SV$&R1[X"]->O9EH&!IDR$IC .E\K[
MV7HO<?%1BP#L\-(_LK!A: 17D?CJ-C&7/GM"+\PFM1U"<?>FO6#$;SXOATW\
MV3">^F3+TBX]<%!J_1DJ]VE&76V2J7WWZ^IS?:N;7NSO75V5%7*WH[>0_<DI
M)WZ1H70RUY#IA+ZWI:_)\V7IB)FZD"E)? V*?C=?KF9)5'9CPZ'?7EU^G]R@
M:2W?GBP[7\=WV(8#H?WH@#"Y>]%BX^P\R;=IL#!Z5Z&[?5M?)U>GJJLXA5K8
ME[C,U"5&40^_KTQ\<<M _LT@KMZ"[]V&BW&PVL\7'8_7__2+?NR+1L0GLU?>
M;N*,;&BAW9$GQA8+O %QN[6&/+I"*4CTQ:^VC"UW.5/5T3@MV$E_3<L.]3/:
MAZ#W7I[K='X^RS/VLKE:)?7.MKUA_9Y7,B\F:/!O-/U_$1N^YBDEAYM<=[N.
M["RY '6<!%=7\ZLG,R+9=9O,Y3]Y Z47;/[.W5^5A"YNNG7+9/KMTZOYZNI2
M,W9U?LN9'<'O7_0F\CDFT\XIO+:$7\/@Y.*O=Z4-WOAIGRT?SXD!AN3%P^"E
MO =#1B=>/=S(3:+R?E[W;6)?;WPM+_7UC\N[D7\AFQ7)XL)L:>C5XBDI_EI>
M-RP?"!A^Q>^Z:MOJP'_N2<:;&@_0[]N*1+-^P +NI<\__2]02P,$%     @
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M+W=O<FMS:&5E=',O<VAE970R,RYX;6RE5M]OVS80?O=?06C#T !:]-NR4]M
MG+18@ 4(TJQ[&/9 2V>+"$6Z)!77__V.E*S*;N)BZ(O((^^^^^Z.1VJVD^I9
M5P"&?*VYT'.O,F9[%02ZJ*"F^E)N0>#.6JJ:&A35)M!;!;1T1C4/XC <!S5E
MPEO,W-J#6LQD8S@3\*"(;NJ:JOT2N-S-O<@[+#RR367L0K"8;>D&/H'Y:_N@
M4 IZE)+5(#23@BA8S[WKZ&J96GVG\)G!3@_FQ$:RDO+9"G?EW LM(>!0&(M
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M$&.K1S2@3VQ<4Q&#VS>RWE*Q_^V721SE[W&GY\@&'$V%Y':@@-0#MFO+]N7
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M0;$T^X@27^^7Y,,O'R>V0EI:N1TW%.8U!?<(!4IN>:&VDEP5"20]^.4;>'=
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M>)*^QE>?9U/RZN?7UQV#AEIUG:@R:E(:Q0X81<D'*<Q*DWL10]R"GQ[!,X^
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MLC4Y?K$:LN0M%Z+@:?IL^9 K/-(IW&0+@AM#(-3MO7&7YECGUY_H(/R-6IW
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MCX/*!=C]4DISFKA;,/[#LG]02P,$%     @ IX975'N^L7#J @  ZP@  !D
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M3G"%"P-V+R4SAWL4NAI'_>@XL>3;TOF)>#+:L2VNT/W:+0Q%<<M2<(G*<JW
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M$%'2&U(7FOHEJ .G=Z&9UMI1:X9A28\G&I] ZQNMW3'P_=D^QY/_4$L#!!0
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M'>&N43DVZK72=RP3QV+'>9^-HR1._?UQ.?YU2F[BR>#4)>@?W; *U,X-GL;
MC3!=:P;K,-LS=Z5?V.<X\]V(_J'I'HQ[JG9,:)2T1<I@=#WVB.J&L-L86;M[
MO)$&I\(M2WRW0%D'/-]*:0X;&V!X";/?4$L#!!0    ( *>&5U1CUIV P0(
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M9N;6!64#S/I*2GR9V,9>W^.C/U!+ P04    " "GAE=4392=ZW4"  !\!0
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M_BM'HZ[42FSFD@L!)9$@:;54!"$0W8>J#T[F)+'PV%G;D[12?WR//<,DT,D
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MC.R7*WKWH'87Z/M"4<Z6&R>@>DF-?@%02P,$%     @ IX975+#^F2IH!0
M'1\  !D   !X;"]W;W)K<VAE971S+W-H965T-#0N>&ULS5E-;]LX$/TKA-%#
M"[212.K##AP#<1)C R2+(/W80] #(S,V44ET22II@/WQ2\FJ*%L2I=1[\"61
MJ'FCF7GT/)&<OG#Q0ZXI5>!7$J?R;+16:G/J.#):TX3($[ZAJ7[RQ$5"E+X5
M*T=N!"7+ I3$#G+=P$D(2T>S:3%V)V93GJF8I?1. )DE"1&O<QKSE[,1'/T>
MN&>KM<H'G-ET0U;T,U5?-W="WSF5ER5+:"H93X&@3V>C<WBZ\' .*"R^,?HB
M:]<@3^61\Q_YS?7R;.3F$=&81BIW0?2_9WI!XSCWI./X63H=5>_,@?7KW]X7
M1?(ZF4<BZ06/_V%+M3X;C4=@29](%JM[_O(7+1/R<W\1CV7Q%[R4MNX(1)E4
M/"G!.H*$I=O_Y%=9B"$ 5 +0'@!Z'0!< O ^ '< O!+@#7V#7P+\H6\(2D!0
MU'Y;K*+2ET21V53P%R!R:^TMORCH*M"ZP"S-9]9G)?13IG%JMB!,@&\DSBBX
MI41F@NIIHR3X!!8L)6G$2 RN4ZE$MATOC9: *%##ZCER3Z-,"):NP)Q()L'[
M2ZH(BS_DKCI>8B /MS1YI.*[-O[Z^1*\?_<!O ,L!5_6/),D7<JIHW2V><Q.
M5&9VL<T,=61V2:,3@.%'@%P$6^!7P^'N+MS1-:X*C:I"H\(?[BWT1W N)=7I
MZ[S #2./+&:*T5IM=ZJ96_W-4[%7WH<;_0)PK6@BOUO"PU5XN C/ZPCO"U>:
M:5($UE;K+3HHT'FW>IYA#X['X=1YKM>T:>;[D\ +*K.=X+PJ.,\:W U]IC&
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MDC]N@:U & /]?<WU_E4.S#U3=:\X_P]02P,$%     @ IX975!7-7JO1 @
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M5$U/XS 0_2M6Q &D7?)=6M1&@E9H.:R$*.P>5GMPDVECX7BRMMO OU_;2:-
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M%QIO5#O,\)4$TAC@]X40^FUB'-3OKM$?4$L#!!0    ( *>&5U0LA;U DP,
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M4)$3J&X@ND0NOD#$(;C'?7Z^N[/O;NO^-$TB39-(&<\]$>^Y^@NTT-U2^TU
M_]QK<W2G()7?!I*Y33*W3.;]1[(R"[2MW@@N>UM9A0O*<.:M?9AYKHO'$_NA
MV[%C*Q>[CM=8[6'U&JS>(-9[D/(*?8BB(BT2JB#6;Y!6DXC1ZAW5%="4"\5^
MEC?ZT%<)_ ZN]X0$OG\ O\<,AV'H]N/W&_S^+_4Z ]6'U3\"09P@\ Z@'EMA
MUW=Q/]*@01H,=YJNN*"*BZ?NR?L,Z0K$T*D+F_CAZQ_Q49-L]+)'?'34TE%(
MR$'?CXU")R3];1\W2,>#2(T@%@I$IQ<&\Y*OU8X*.(<![+12[+P^![BC_/AE
M6:CC[9WLP/4.E:;/C 3AB1< MR*,R2#>VT)D3!6ZZP;P+7LT:WD6!:WV8O<W
M4-#*)Q[6S_]/P;$.>@0?BF6/E3O&HQ,$M&*)A]7R'O2\M.5)C.[27/ '2,M)
MX1P"6IG#P6\@H%4]'+XP >'QX79<'!PR<&SFD='X! .M;N)AX9SS3"I15!.P
M'K$T_$C_!9]%02MY>/SZ%)!6]8CSLA34\?9&F1"'!PST6;G^X;QC=R9G\]GR
MF8H-RR1*8*W=G,M0,RBJ+X%JHWA>#M,KKO1H7BZW^NL)A#'0S]><J^>-F<^;
M[['9OU!+ P04    " "GAE=4F&/V\ D#  "C"0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6R-EEUOVC 4AO^*%>VBE;;F.R$5(%'0M$F;A$J[74R[
M,.% K#HVLTV!?S\["2DEILI-XH_W/7Y\[,0>[KEXD06 0H>2,CER"J6V]ZXK
M\P)*+._X%ICN67-18J6K8N/*K0"\JDPE=0//2]P2$^:,AU7;7(R'?*<H83 7
M2.[*$HOC U"^'SF^<VIX))M"F09W/-SB#2Q /6_G0M?<-LJ*E, DX0P)6(^<
MB7\_\SUCJ!2_".SE61F9J2PY?S&5[ZN1XQDBH) K$P+KURM,@5(327/\:X(Z
M[9C&>%X^1?]:35Y/9HDE3#G]35:J&#D#!ZU@C7=4/?+]-V@F%)MX.:>R>J)]
MH_4<E.^DXF5CU@0E8?4;'YI$G!G\Z(HA: Q!7T/8&,*^AJ@Q1%5FZJE4>9AA
MA<=#P?=(&+6.9@I5,BNWGCYA9MT72NA>HGUJ_( I9CF@1;7)IKS<<@9,2?0%
M+>JM@/@:3?)<[&"%?A"\))0H A+=S$!A0F^U\GDQ0S>?;M$G1!AZ*OA.8K:2
M0U=I0#.,FS<P#S5,< 5F!OD="OW/*/ "WV*?]K=[%ONLM]W/WMM=G=4VM4&;
MVJ"*%UZ)-\='O*0Z4Q.VJC.(J41_)DNIA-[N?S\8(FR'"*LAHBM#G-9EBX^"
M4XITVO7'2+'2;7#0_P8)UF6HHR955/-G>!V'7A:G0_?U/-M65>JWJG?(48L<
M]4,6? W2_#XP16NP<]:AXC.")(XN,;NBP/>N4,8M9=R+4N&#G2SN#.I[:71!
M9A'YV16RI"5+>I'ENH/D^+3F$K#(BP\7/>G0A%Y\0=S5),G #IRVP&DO8,(4
M:$YE0TN[B>JR641Q= 5NT,(->L'ML1"8J:,-;F#)R>5*6S19]EXS&W0^)]]/
MK_!G+7_6BY^K H0-/NN 14ERF=FN*/&#U$[F>V\GB_<AVQ-79GLVA/3MZ+ >
M#%XG.U$<^Y??NDT6GF^5FM4].Q#-]>4G%AO")**PUC[O+M5S%?6-H*XHOJW.
MR"57^L2MBH6^18$P MV_YER=*N;8;>]EX_]02P,$%     @ IX975&"4,0#D
M"0  [#(  !D   !X;"]W;W)K<VAE971S+W-H965T-3$N>&ULM5O;<MLX$GV>
M_0J4=FMKMLJV>*>4M5WEV''BQ'9<\4SV86H?8!*2N"$)#0C:T=9\_#1(BJ!,
MLDFE1B^V+NC&05].-P#J](6+;]F*,4F^)W&:G4U64J[?3*=9L&()S4[XFJ7P
MS8*+A$IX*Y;3;"T8#0NA))Y:AN%-$QJED_/3XK,'<7[*<QE'*7L0),N3A(K-
M6Q;SE[.).=E^\"5:KJ3Z8'I^NJ9+]LCDK^L' >^FM98P2EB:13PE@BW.)A?F
MF\_^3 D4([Y&["5KO"9J*4^<?U-O;L*SB:$0L9@%4JF@\.^97;(X5IH Q^^5
MTDD]IQ)LOMYJORX6#XMYHAF[Y/%_HE"NSB:S"0G9@N:Q_,)?/K!J0:[2%_ X
M*_Z2EVJL,2%!GDF>5,* ((G2\C_]7AFB(6"9/0)6)6"]$H")NP7L2L!^/8/3
M(^!4 LYK@;XUN)6 .W8-7B7@C17P*P%_[!IFE<!LK,"\$IB_%O#['&=L/6>\
M$NGW=>WLT=XVM^XV7_O;]OI$M@XW6Q[O!;9UN3G:Y^;6Z67 3\N(+]+EBDIZ
M?BKX"Q%J/.A3+XJ<*^0A2Z)4T<.C%/!M!'+R_)(G220AWV5&:!J22Y[**%VR
M-(A81H[)11A&*H]I3&[2DHU45O]\Q22-XG^=3B6 4*JF037AVW)"JV?">_Y\
M0@SSB%B&9?[Z>$5^_D>7EDM<R^= GA"[TM(A?H6+7^3+6MRH0"SD/_]N^K-_
M=VA[-Z!M+4";46K+5E2PK$/)-:[D8QYO(9E^OUW>XUJNV=,)L69#6C[@6JY8
M4&/QALUS@VN[HZ+6Y@YK^S@B?DICFTZEK=?FGT:O$XO%V_%:C'XM=^-M/J^T
M0#(^,R&CIYC=<\DZE-Z/B$S++Y3.'JB$-.]0\GD$,F->1D.7DBEP3DT\5DT\
M5J'5[LM@N6*"-.GGMUL80FXD2[+_(A/8]01V,8'3,\&C!#ZC(B1KP<,\D.2%
M"D%3N3F"]B$+1+163-85-+C>. +$+"0\9<=$<K* ]N9XPZBH)T# .S5X!YWD
MBZ+7% RT8-V!78I[A;AJ 9_/'=_S7,,P3J?/S=CM&.AZAM$:>-<>Z,Z!1)H#
M=Y;BUDMQT:4H%T/%@%H6?#LB9:J2*,MRL.$?I#=UWY5:W08><^;-?+<'CE?#
M\0;@5 5.DH!#EQLR49:T-=VH."09"W(!V)XV:L V_T@*"=CI":^%<^;NVG<'
MIU_C]%&<]WGR!/[GBQI0"PV8;Y@A[OP6/JL;V:Q&-L,3JP?/$4D8S8JOJ"0T
MX?#=_XMQ61?KW,U: >?/$</-:WAS%-Y7&N=,V2T <)!$1*@=0K8#K@_2O!US
M!@+)-'279?Q8U+'OL-'+P)<IVSOT;JM)FW@=#&ZC*33'PHTC^A3%T /V%%BS
M!>$U Z%#=@'JXF%:*,"WX$"PWB-TJ8!T$060"6+-*Z/^=L=4\F!5Q-1EQ+0/
M4ZA,3?8FSO9E4251NA#*Z@4-Q?0ERR/(HSAFRW)9= GAG$F2UM2P+@05$?06
M]_MJ[J;YY[L>^MPQQ.QSD:9]$^?]BX3GL X*53$L8_I_N=AT;AC<%A-8!IIW
MFNQ-G.UOTI EJ0J0TH072\%*^XZ)$<W5IG^@&-&D:^*LNT=*SD;GF^94$R?5
M*D)OFA$ZPH*6)DC+.(P%+4UJUE]%:E:;L?" M!I=+TY<CTP\1P';+Q M35;6
M@<C*TF1EX635L^/^9+5)Q,(:(4LSB84S"<QH=<[8;A'Q&35M6#AMP(QVYXSM
M9@^?43.(A;=[,*/3.6-'^X;.J G%P@GE%L(0.I%TJ6,Q&Q6,FC2L^8&V>)HV
M;+RONDC3G,9$\ V-Y6;;PW=NZHQ6D7G=J-CM=LHVN[9*';IL"W&*K3G*QCFJ
M= J#4K^EAZ VGVJI\\[%75=:O9T"CN#1=&7C=-7& PUK5+59:M/;B0;7V4[G
M77"-#3Z^$T<C&'JB.[KAY"(-R=?WMV,BV]8<:#L'BFQ->C9.>BW+'Q')1-)9
MKP94_;)J.O EBN-"591"42?Y&CP)RX&&$UI+R4L'LZJU)'2]CJOFZ8CD:<RR
M3 N'!"(@CI@X(;MS!#0E3ZPYD*8;(J,$!BW@4Y@0AA8!E)&%X GX2@0KHBZU
M5*=8>(X+Y;@3S)J:T&V<T$>%RC6D5SAZ!V%K;K</U!W:FLQMG,P'SXOL]F[;
M00A"<[R--X8_>+KST6YOM2UC9MO=>!Q=$!R\(-SS-*#9BL"TK @I=:D1LF<6
M\_66OU1>=6%RVK2.E5I'L[HSAM7WCS[U591&29Z,"4A'L[ISH+-71W.S@W/S
M^,)<*6HWVSU6;QRAXHWJ8P[<M=FSNW$T03ON@8RH6<O!6>LAAPBF4 1T$W!4
M=0$DS+MB^%.EL1G#\XX6YM9I=[)]!M<\Y^ ]; =<8'>@\2A]AM=<;" MXZ(<
MP#BQ[%K ;37'3F_E8?&@.=(9VD%GDI(O4,U&!8*F0.= ;:ZK6<W%6>V6T=U6
M0%F8I4%9;==,1#SLN@4=4*LNK(Z-&091<YR+<]R%8%0=2?'%0NUOLS6%OW\0
MY*+ORFUOLVW7,<V>^P9-;^Y T_K:6FRQ8,5C* 0(MBOJK@8T;F]X__;33^WM
M[RY*S9#N0/?:0JD[:\2CN%++L,UCP\, :OYT<?YL 8R+#_H+Z)7;OD.RL2-]
MMW&'A+>P7UCXPGE(/I?1M=?IB:OYUO4.E,F:(UV<(W\PDS\-J%57Z\>&C4'4
M/.GB/+E_)M^X[2-'U_"=/K=K:G7Q[G+_3+X9T/@Q3W4FFRYB,$^SL[<G.X_)
MY)L!I6J7?&R@ #4W>P/]9S-QC^J;SNX6XL9K'R98V.&GIXG9&Z#1LBG<X1&%
MAJI;KB@EBT@]9U3<I4/\E</4'K(3I=5&B5U^>9J8/9Q#>[FF\2S4N^]K6CXB
M^2!8$JD+O$;3?@'#PT+$'$-0GJ9D[T#G#IYF6F_@VF;O[/_@M<]AG?E\UN>(
MQDW]P*9]G[#]X+4[7Q/;2'B:LSV<7/_"L/W@M=M;"RN1GJ9M;ZB];102Q8Y#
MC[G@^M1SR6\*[Y]-UFHW+9[9I#A**A>H^GIU;-21"=N2IIZ1(4"XC)2/-<U.
M"!:BNBIX8ZI"\'J]G>8>40W,JAA@?;"OBX'_X\6@#^6 RCNZ44^&E<TG5A%\
M71%\O"+<\_0XH&"]."ZB^)H&ZCYL0TKX(TC+UZSO'^BTP=>4[>_;2P_U">\'
M-!8/+6XCP\= :O+V]^RGAR/C_8#*[>.>96A@I^J^+@#^P,'SOFW_>[]]?X]5
M8E\7 !\O ".C=/^*ZS>>PCK0V:VOB=L?N(C;/RXN!U0.,\:T\<BX^AT(Q/LR
M2C-P]@(T&B?*IZ+\:47Y1O)U\13Y$Y>2)\7+%:,A$VH ?+_@7&[?J ?3ZQ^X
MG/\)4$L#!!0    ( *>&5U2U+K=4PP(  #,'   9    >&PO=V]R:W-H965T
M<R]S:&5E=#4R+GAM;(V5WV_:,!#'_Q4KVD,KK<T/($ %2/S8M#U40V5='Z8]
MF.0@5AV;V0ZT^^MW=D)&(;"^0&S??>]S/OL\V$GUK#, 0UYR+O30RXS9W/F^
M3C+(J;Z5&Q"XLI(JIP:':NWKC0*:.J><^U$0Q'Y.F?!& S<W5Z.!+ QG N:*
MZ"+/J7J= )>[H1=Z^XD'MLZ,G?!'@PU=PP+,XV:N<.37*BG+06@F!5&P&GKC
M\&[:M?;.X >#G3[X)C:3I93/=O U'7J!!0(.B;$*%/^V, 7.K1!B_*XTO3JD
M=3S\WJM_=KEC+DNJ82KY$TM--O1Z'DEA10MN'N3N"U3Y=*Q>(KEVOV17V08>
M20IM9%XY(T'.1/E/7ZI].' (XS,.4>40'3NTSSBT*H>62[0D<VG-J*&C@9([
MHJPUJMD/MS?.&[-APE9Q812N,O0SHZG,<V:P+$83*E(RE<(PL0:1,-#DABSP
MV*0%!R)79&RWG!F[\ "<&DB)D>2)*D6%>27?EIRMJ2V.)E<S,)3Q:U1X7,S(
MU8=K\H$P0;YGLM 81P]\@_26P4\JTDE)&ITA#2-RCW"9)I]$"NE; 1_3KG./
M]KE/HHN*,TAN22O\2*(@"AN IN]W#R[@M.I2M)Q>ZQVE&)^48L9TPJ4N%)"?
MXZ4V"B_ KPM1VW74MHO:/A-U FLF!,;!V\"I2*"I,J5$["1L7]B.XGY_X&\/
M-^O4)@R[O=KH#5RGANM<A)LKN66N86"_(KOJI#41ECJ=@^A1KQT?(388A9V@
M&3&N$>.+B(^&<?;''?LFKO@DY$W4ZX5'8$U6<=1O)NO69-V+9'A-_E/6[FE9
MX_816H--_QC,/^@_.:BU:\N:)+(0IKR.]6S=^<>NX1W-3_!%*!OX/YGR.;FG
M"L^I)AQ6*!G<=G&S5-FBRX&1&]?EEM)@SW2?&;YJH*P!KJ^D-/N!#5"_DZ._
M4$L#!!0    ( *>&5U3I2Y0M*@H  *]    9    >&PO=V]R:W-H965T<R]S
M:&5E=#4S+GAM;,U<87.C-A/^*YJ\O7?:F<0& 0+:)#,Y<IE>Y^Z:Z;UM/W3Z
M0<%RS!P&%^1+,M,?_TI O#C  HE)VP^M[:#5:G?U/"L]=D_OTNQ+OA)"DOMU
MG.1G1RLI-]_/YWFX$FN>S]*-2-1?EFFVYE*]S6[G^283?%$,6L=S:AALON91
M<G1^6GQVG9V?IEL91XFXSDB^7:]Y]O!6Q.G=V9%Y]/C!+]'M2NH/YN>G&WXK
M/@OYZ^8Z4^_F.RN+:"V2/$H3DHGEV=&%^?V5:10CBD=^B\1=7GM-]%INTO2+
M?O-^<79D:)=$+$*I;7#UGZ\B$'&L32E'_JJL'NTFU0/KKQ^M7Q6K5ZNYX;D(
MTOCW:"%79T?>$5F()=_&\I?T[D=1K<C1]L(TSHM_D[OJ6>.(A-M<INMJL/)@
M'27E?_E]%8G: .IV#*#5 /ID@.5U#+"J =;0 78UP'XRH',-3C7 >;H&LV,
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MI"P 16T<1?<OML(XS76@<Q[7Z*'[CK(*/3Z%[_5<6-F JC;>9[\D'^.:#@>
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M8\JN;OI;$Z#:NA-_J9#ZAQMNZ)< M 70\Y6BP[@-[ NZGXSY'U!+ P04
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M@E5U/U6&D:4;P&MI<)R[98Y7.BCK@.<;*<W1L#.]^9.0_ 902P,$%     @
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MQ6O+@@Y_]W.V.="Y5FB:)"^O&[YJ<9UW"DQ-/O!<[S;_C\4**0$>8LGT_CV
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M(JM[O]47)1;EM=,'H91(R\<YHZ!8N@#\/A-"K;[H"IK;UZ=_ 5!+ P04
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M0M T?]P0'!&F!.3W9TK%\45-4/T+8/H?4$L#!!0    ( *>&5U1*^=VIMP8
M .,I   9    >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;,V:76_;-A2&_PIA
MY&(#4EG\E%4X 9*TPPJT:Y"@+89B%[+-Q$+UX4ETW!3[\2,E690K4Y)I;T@N
M8DL6SSD\/'I>D>)TDV;?\B7G GR/HR2_&"V%6+T>C_/YDL=![J0KGLA?'M(L
M#H0\S!['^2KCP:)H%$=CY+IL' =A,KJ<%N=NL\MINA91F/#;#.3K. ZRYVL>
MI9N+$1QM3]R%CTNA3HPOIZO@D=]S\6EUF\FC<6UE$<8\R<,T 1E_N!A=P=?7
MC*@&Q16?0[[)&]^!ZLHL3;^I@W>+BY&K(N(1GPME(I ?3_R&1Y&R)./XNS(Z
MJGVJALWO6^N_%9V7G9D%.;])HR_A0BPO1I,16/"'8!V)NW3S.Z\Z1)6]>1KE
MQ7^PJ:YU1V"^SD4:5XUE!'&8E)_!]RH1C0;8U !5#5 1=^FHB/)-((++:99N
M0*:NEM;4EZ*K16L97)BH4;D7F?PUE.W$Y;U(Y]]>7<M^+<!-&LO!SH,B7:_
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MHKCW*1X4W^87&W.N%$_RX8;1)1,90+]?<:[>'[(%JMNWT7]02P,$%     @
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MR64Q\!8++?9V!%P);09*>[D#DH+,'S#W-T+HUT7^@NK?#K-_ 5!+ P04
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M5P#,$U\H'.3)-2JLK#E_*A;WR<3Q"D7 (%8%!=$_SS #Q@HFK>/?BM2IWUD
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MPJ<23<.3BG-(+A#![U$8A+@GH-GY]*"'/C^;CJ].9$,:PXG3(T?T;HHR%X\
M: ERQQ+SS*@$U./M=9Z+I!I^7Z,%)&+#V7\&=0>2"0M6QM!?!]]_GP@O:L*+
M7'C1R?.X<M$D[6B@.FE]!Z)2C)VB_<[M)E%$XL'(W[5=ZD&%\:"#FO>@<'PU
M;%!_)35HDAJ<3,I6RI[\!>R ;P']NH5B!?)4O>)&.GZ-=@Z;\(8O;F>E.&A9
M@&,R[+CY'!1&A'3,? XB08S[O;QL,KH\F=$"%%"99,A\GM#<&)J+TG[:SC'U
MJMGCZC6:BH/#I1&\N*VU9-N-..K^_V9]*!SACK%]*!*2?F=QZR[$I],R[0?C
MF_?H,W!S1^7.X^O47+M,:7MG[<[Z[^+PL&'X*HT^7!:8O+S1Y-DWE,3AD'2=
M[H%%P>4SJWM@(<%=K_U6"U2 W+A64IF8MUQ75WVSVK2KUZY)ZZQ/;1OK6JN#
M3-4#WU*Y8:9IR6%M)(.+H3E^LFHKJXD6I6NT5D*;MLT-,].*@[0 \WXMA'Z:
MV V:YG[R/U!+ P04    " "GAE=4W] H%90#  !;#@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V.2YX;6S-5TUOVS@0_2N$T$,+M)&H+UN%;2#^6&R!!C7B
MS>YAL0=:&EM$)-$EZ3CMKR])R;*LR*H7R"$7BY3F/<[,&WK(T8'Q1Y$"2/2<
M9X486ZF4N\^V+>(4<B)NV X*]67#>$ZDFO*M+78<2&) >6:[CA/:.:&%-1F9
M=TL^&;&]S&@!2X[$/L\)_S&%C!W&%K:.+^[I-I7ZA3T9[<@65B ?=DNN9G;-
MDM <"D%9@3ALQM8M_KS H088B[\I'$1CC'0H:\8>]>1+,K8<[1%D$$M-0=3C
M"6:099I)^?&](K7J-36P.3ZR_V&"5\&LB8 9R_ZAB4S'UM!""6S(/I/W[/ G
M5 $%FB]FF3"_Z%#9.A:*]T*RO (K#W):E$_R7"6B 5 \W0"W KAM0'@!X%4
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M/]BGB>][83"RGYHJ=5BY8="R6G18X3 :U%9G005U4,'O@T+?=CH0E;$[R-?
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M3-52\A_.[OTE6L:+$W@'7,*77*T-DYD9Q-;1]L'C=$=Q4E*D1R@2"M=*VMS
ME<PP^QD@=OE62=-]TA/:B'B)Z1FTR >@"26WLTMX_^ZD ;95U;(58-M-M82_
M5[XR!KY=HYBC_MX W*Z VP&X=0PX9QI/YX_+/]::R26ZM\3"? N'=E.V#<?C
M#=,9?/O30<)GB\(T$3JO")TW9GHK=7W1AXR>NMT2JA.@?).X']'S?G<0WS]!
MH%,1Z#02^!K>-LQ.Q_>H7?> L5#:\A]E6::HN7(*=+K;(M/FY"E:S0%(\ 0*
MHI2>$V'&MJ:A=MV*>K<1^0:-U3QUY,O7"FXEM\^22Z^*T'L;<NE7A/J_3R[]
M1W+I$)(<T0M)ZCZ7O+9B?A&!EJY 2LU YU>*(0=-FC1".WKA!UBF^%+1$%H'
MH6]#-J1NJ*2YH[Y(.#NL0^60I-7K'U%.W7Q)^]65TQRA]_PN0^H639I[])58
M%6J+>\%,USK-W9W!M&#R6<*I>S'IO!'AU#V6-#?9EPFG^U@XE!S33=V%2>_5
M==,<H;W7#6T?U4U\,!L*U,LP 1M(U5K:<DRL3JLI>US.EK5Y.:)?,[WD;K(I
M<.%<D[.N$Z NI]YR8]4J3)IS9=W<&I:Y^Z> VANXYPNE['[C U3_/4;_ U!+
M P04    " "GAE=4O+\,J:P"  !*!P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970W,2YX;6R-55UOFS 4_2L6ZD,KK>4KH4E%D)JP:956J>K']C#MP8&;8!7L
MS'::[-_OVA"64)+U!6QSS[GG7./K>"/DJRH --E6)5<3I]!Z=>.Z*BN@HNI*
MK(#CEX60%=4XE4M7K230W(*JT@T\+W(KRKB3Q';M02:Q6.N2<7B01*VKBLH_
M4RC%9N+XSF[AD2T+;1;<)%[1)3R!?ED]2)RY+4O.*N"*"4XD+";.K7^31B;>
M!GQGL%%[8V*<S(5X-9.[?.)X1A"4D&G#0/'U!C,H2T.$,GXWG$Z;T@#WQSOV
M+]8[>IE3!3-1_F"Y+B;.R"$Y+.BZU(]B\Q4:/T/#EXE2V2?9-+&>0[*UTJ)J
MP*B@8KQ^TVU3ASV 'QT!! T@Z (&1P!A P@_"A@T@(&M3&W%UB&EFB:Q%!LB
M332RF8$MID6C?<;-MC]IB5\9XG1RQS-1 7FF6U#DDLQ$M1(<N%9$+,@WH129
M _Y<0 X"SU/0E)47B'AY2LGYV04Y(XR3YT*L%>6YBEV-XDP*-VN$3&LAP1$A
M?D#N!=>%(I]Y#ODA@8NN6FO!SMHT.,F80G9%0O\3";S [Q$T^SC<ZX&G'X;[
MXQ-NPG:C0LL7_G>C2,I45@JUQEWY>3M76N+A^74BQ:!-,; I!L<D8P*E6=:W
M>34RLDC32MZ22S\8^^$P=M_V:]H3-PI'X_ P+.VC\R+/]]JX P?#UL'PI -L
M!7C0>9^!&C@\R!B-_8[\]U$8%'7$OP\*QT'8KSQJE4<GE>\?-59OM39'K<]*
MU%.\T!L%'9VSGKA1X(^O.W;ZZ/"7'UUW'+E[7:8"N;3=6I%,K+FN3V6[VEX(
MM[8/=M:G>%'4??T?37W+W%.Y9%R1$A9(Z5U=8Y%EW;GKB18KV\OF0F-GM,,"
M+SN0)@"_+X30NXE)T%Z?R5]02P,$%     @ IX975/V !E4? P  8PH  !D
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M!%X$J/<Q8_(P*!+4?>7L'U!+ P04    " "GAE=4"-3J96(#   -#0  &0
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MG/9F1R8@)TJZA/O!:5<J^&&Q4>T2_>9H!Y+/6LEG/8G L_M/YE[-D3Y]S(6
MS77MTN]G\NQ_/W \.',[X(>E+V$'#HQ;!\9>GGF)V0H08>@!TPVN:Q6JJR7,
M,N>1Z*<[3M)!VN%##S)-!Z..#.B+.7+DSH$;<?1<+D1>LF^J!.&\W/TXS_KW
M(*/!V+T!^B(FCHB'JO>*I-B?^ERY3[L>7/>I->]#QH[3N]'=BWRY3VK=X5Z=
M6(%8V7I;ZLS>,%675>UH6].?VTKVO_$+4^O;^O.9IOY0N,9B19A$% I-J<]>
M?4F)NO:N.XJO;36ZY$K7MK99ZN\5$.8%_;S@7#UU3(#V"VCV#U!+ P04
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M8$6V)^#V08N=/42NA(8CJ;W=PK\&)HT ?%\+H9\?S+FT^Q\R^Q]02P,$%
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M1SGE"73=8N4B+%V8BK(:19Z)SVH[LFVCOA_YNT9QVZB'I:HQVI'0:R3TCDK
M*&'I4_B2)>14X[O5 I-(2N":O .51&, %U*LF"E;G>^T.J&WQ<L-7&]/8=LH
MNG;W!'8X"EVW6V#8" S_7>!",B%/E1>VF8=[]Q>W;7I]KYMXOR'>/TH<\^$_
MB?=;I"[#_6OIL.D%W<2CAGATE#B6HP]2(FH]9-<)_/V<:%NU$R=N&^TD3B7
MWBKV!<AYV3052<22ZZH\-JM-7[XMV]'>^AC[==5>_[JIFOT#E5@+%,EAABZ=
MJSZ&5%8-M)IHL2A;RE1H;%#E,,-O#I#& /=G0NC-Q!S0?,6,_@!02P,$%
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MI).:!(#!$8#WW"BA-H=29T)N'1;P>$NY,'=8V6\GD 8=TB @71TS53NRAD;
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M8+-K)$CWL.B!D<86$8ET22K._OL=4HK\)1L&>O'%%JF9X9MYSQS/>"/5JRX
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ME6JFKF9AY-K-(2_2X%3C'@N<5$%9 WR_E$A%N[ '=+/O]!=02P,$%     @
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MU.*F2_]<EG"+EFNDSK.0<U,(95J-\&N^-E93%_U^Q^=X\#GV/L?''L63<XE
M=:>W9HN*RRT45"7-UZT]5N>.\\)SNFGSF"4CRL#C8>K?LIF\M,G_MTE'\6#3
M"0H/7GR->NLGAZ$86VF[ES*<#L-I[GORU?F"AE8W8_[1=!/OANDMEP8$;H@R
M&GTY#T!W4Z3;6-7XOEHK2UWJEQ4-7M3.@.XW2MG]QCD81GGV%U!+ P04
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M)8D? <RO((HP!-Y&',$4@ 8,B:)J']S;C\+-/A6VOX*-?P-02P,$%     @
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M-VVKZBSD?3775I;+'^TL?W#T\3]02P,$%     @ IX975+3%"JYH @  1R\
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M[?+7Y==.O%^LKCC7]Q7#\U]02P,$%     @ IX975"P!9SL; @  #BX  !,
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( *>&5U34 TOY[@   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( *>&5U297)PC$ 8  )PG   3
M      "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ IX97
M5'_+_ZW<!@  XQL  !@              ("!#0@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( *>&5U2ZJ"YD/08  %D9   8
M      " @1\/  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M" "GAE=4X &QF@\#   8"@  &               @(&2%0  >&PO=V]R:W-H
M965T<R]S:&5E=#,N>&UL4$L! A0#%     @ IX975+MLX,'=!0  (18  !@
M             ("!UQ@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4
M Q0    ( *>&5U3K)_4PM <  /,G   8              " @>H>  !X;"]W
M;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "GAE=4 ,83IS\)  #\
M)P  &               @('4)@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
M4$L! A0#%     @ IX975.ZBNU#=!@  4A,  !@              ("!23
M 'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( *>&5U2?+;-I
M)R,  .-M   8              " @5PW  !X;"]W;W)K<VAE971S+W-H965T
M."YX;6Q02P$"% ,4    " "GAE=4K=TUM;0#  #/!P  &
M@(&Y6@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ IX97
M5)3>T0\(!   LPD  !D              ("!HUX  'AL+W=O<FMS:&5E=',O
M<VAE970Q,"YX;6Q02P$"% ,4    " "GAE=4S7$3<>$'  !$%0  &0
M        @('B8@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0
M   ( *>&5U21;1/=#0@  !(3   9              " @?IJ  !X;"]W;W)K
M<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ IX975%E\,"<7%@  [D(
M !D              ("!/G,  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q0
M2P$"% ,4    " "GAE=4PYYQHAH-   +.@  &0              @(&,B0
M>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( *>&5U1;)>_Z
MD (  !4&   9              " @=V6  !X;"]W;W)K<VAE971S+W-H965T
M,34N>&UL4$L! A0#%     @ IX975.CGZM>_%   ?$,  !D
M ("!I)D  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "G
MAE=4H_D7B9@*   8'   &0              @(&:K@  >&PO=V]R:W-H965T
M<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( *>&5U0="KXJJ@4  ! .   9
M          " @6FY  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#
M%     @ IX975%^<QX'K @  9P8  !D              ("!2K\  'AL+W=O
M<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "GAE=4G<^+K*<D
M>@  &0              @(%LP@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM
M;%!+ 0(4 Q0    ( *>&5U2Q6!=R' ,   D'   9              " @4KG
M  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ IX975$A$
M?<H<!   @@L  !D              ("!G>H  'AL+W=O<FMS:&5E=',O<VAE
M970R,BYX;6Q02P$"% ,4    " "GAE=40HYB0;P#  !,"0  &0
M    @('P[@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (
M *>&5U0$T(E.- 8  +4/   9              " @>/R  !X;"]W;W)K<VAE
M971S+W-H965T,C0N>&UL4$L! A0#%     @ IX975)DW V>/ @  ;@4  !D
M             ("!3OD  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"
M% ,4    " "GAE=4]C_QK%\$   "$   &0              @($4_   >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( *>&5U0\\X2M20P
M +PG   9              " @:H  0!X;"]W;W)K<VAE971S+W-H965T,C<N
M>&UL4$L! A0#%     @ IX975&&+R^$Z!@  C1$  !D              ("!
M*@T! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " "GAE=4
MW=P *MP#  #9"   &0              @(&;$P$ >&PO=V]R:W-H965T<R]S
M:&5E=#(Y+GAM;%!+ 0(4 Q0    ( *>&5U14U56T5 0  $00   9
M      " @:X7 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%
M  @ IX975(\"A5<*!0  "14  !D              ("!.1P! 'AL+W=O<FMS
M:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " "GAE=4W=I,V9T&  #6&0
M&0              @(%Z(0$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+
M 0(4 Q0    ( *>&5U0E,R<4,P(  ,\$   9              " @4XH 0!X
M;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ IX975'N^L7#J
M @  ZP@  !D              ("!N"H! 'AL+W=O<FMS:&5E=',O<VAE970S
M-"YX;6Q02P$"% ,4    " "GAE=4'H30,60"  !W!@  &0
M@('9+0$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( *>&
M5U28*,*S: ,  ,L,   9              " @70P 0!X;"]W;W)K<VAE971S
M+W-H965T,S8N>&UL4$L! A0#%     @ IX975'0EL93A @  %@D  !D
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M=#0Q+GAM;%!+ 0(4 Q0    ( *>&5U1-E)WK=0(  'P%   9
M  " @>Y! 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @
MIX975"!R]G:B P  50T  !D              ("!FD0! 'AL+W=O<FMS:&5E
M=',O<VAE970T,RYX;6Q02P$"% ,4    " "GAE=4L/Z9*F@%   ='P  &0
M            @(%S2 $ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4
M Q0    ( *>&5U1M4Q".B00  &,4   9              " @1). 0!X;"]W
M;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ IX975!7-7JO1 @
MZ <  !D              ("!TE(! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX
M;6Q02P$"% ,4    " "GAE=42*^F E8"  "^!0  &0              @(':
M50$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( *>&5U0;
M!4'H+ ,  (,)   9              " @6=8 0!X;"]W;W)K<VAE971S+W-H
M965T-#@N>&UL4$L! A0#%     @ IX975"R%O4"3 P  FPT  !D
M     ("!REL! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *>&5U2D/-M =@,  /D,   9              "
M@4IZ 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ IX97
M5%T7,6PT P  W H  !D              ("!]WT! 'AL+W=O<FMS:&5E=',O
M<VAE970U-2YX;6Q02P$"% ,4    " "GAE=4P(56/08#  !P"   &0
M        @(%B@0$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0
M   ( *>&5U0EV^>]EP(  # (   9              " @9^$ 0!X;"]W;W)K
M<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ IX975/?B&^"( @   P8
M !D              ("!;8<! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q0
M2P$"% ,4    " "GAE=4T_0EF/('  ")+0  &0              @($LB@$
M>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( *>&5U01?S$Y
MV ,  #D-   9              " @562 0!X;"]W;W)K<VAE971S+W-H965T
M-C N>&UL4$L! A0#%     @ IX975#NB#?J%!0  #A@  !D
M ("!9)8! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " "G
MAE=42OG=J;<&  #C*0  &0              @($@G $ >&PO=V]R:W-H965T
M<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( *>&5U0W'?LGV@0  (D3   9
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M970V-RYX;6Q02P$"% ,4    " "GAE=4 Q Q?F8#  #H"P  &0
M    @(%#N $ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    (
M *>&5U3?T"@5E ,  %L.   9              " @>"[ 0!X;"]W;W)K<VAE
M971S+W-H965T-CDN>&UL4$L! A0#%     @ IX975%[937=7 P  APP  !D
M             ("!J[\! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"
M% ,4    " "GAE=4O+\,J:P"  !*!P  &0              @($YPP$ >&PO
M=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( *>&5U3]@ 95'P,
M &,*   9              " @1S& 0!X;"]W;W)K<VAE971S+W-H965T-S(N
M>&UL4$L! A0#%     @ IX975 C4ZF5B P  #0T  !D              ("!
M<LD! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    " "GAE=4
M?=F#2-4#  "3#   &0              @($+S0$ >&PO=V]R:W-H965T<R]S
M:&5E=#<T+GAM;%!+ 0(4 Q0    ( *>&5U3GR&T;_0,  "@/   9
M      " @1?1 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%
M  @ IX975-#:?>+W @  T0@  !D              ("!2]4! 'AL+W=O<FMS
M:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " "GAE=4CI()O>\"  #8!P
M&0              @(%YV $ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+
M 0(4 Q0    ( *>&5U0?,?TG50(  '<%   9              " @9_; 0!X
M;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ IX975,U8Y/^_
M P  !P\  !D              ("!*]X! 'AL+W=O<FMS:&5E=',O<VAE970W
M.2YX;6Q02P$"% ,4    " "GAE=4%N0IHVX"  #6!0  &0
M@($AX@$ >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( *>&
M5U1&P![D*@,  !(3   -              "  <;D 0!X;"]S='EL97,N>&UL
M4$L! A0#%     @ IX975)>*NQS     $P(   L              ( !&^@!
M %]R96QS+RYR96QS4$L! A0#%     @ IX975$(""Z:V!0  ]#0   \
M         ( !!.D! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *>&5U2T
MQ0JN: (  $<O   :              "  >?N 0!X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( *>&5U0L 6<[&P(   XN   3
M      "  8?Q 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !8 %@ 'Q@
' -/S 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>284</ContextCount>
  <ElementCount>553</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>91</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Disclosure - Formation and Business of the Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompany</Role>
      <ShortName>Formation and Business of the Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Long-term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebt</Role>
      <ShortName>Long-term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStock</Role>
      <ShortName>Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenue</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureLeases</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponents</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Long-term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables</Role>
      <ShortName>Long-term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebt</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxes</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Formation and Business of the Company - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail</Role>
      <ShortName>Formation and Business of the Company - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Formation and Business of the Company - Additional Information - Public Offering (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail</Role>
      <ShortName>Formation and Business of the Company - Additional Information - Public Offering (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail</Role>
      <ShortName>Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Revenue - Schedule of Revenue by Major Customers by Geographic Area (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail</Role>
      <ShortName>Revenue - Schedule of Revenue by Major Customers by Geographic Area (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Revenue - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail</Role>
      <ShortName>Revenue - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Leases - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail</Role>
      <ShortName>Leases - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Leases - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail</Role>
      <ShortName>Leases - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail</Role>
      <ShortName>Leases - Schedule of Maturity of Lease Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Leases - Supplemental Lease Cost Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSupplementalLeaseCostInformationDetail</Role>
      <ShortName>Leases - Supplemental Lease Cost Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Leases - Summary of Operating Lease Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail</Role>
      <ShortName>Leases - Summary of Operating Lease Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Lease (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail</Role>
      <ShortName>Leases - Schedule of Supplemental Cash Flow Information Related to Lease (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail</Role>
      <ShortName>Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail</Role>
      <ShortName>Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Balance Sheet Components - Components of Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail</Role>
      <ShortName>Balance Sheet Components - Components of Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Balance Sheet Components - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail</Role>
      <ShortName>Balance Sheet Components - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail</Role>
      <ShortName>Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail</Role>
      <ShortName>Balance Sheet Components - Summary of Accrued Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Long-term Debt - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail</Role>
      <ShortName>Long-term Debt - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail</Role>
      <ShortName>Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail</Role>
      <ShortName>Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail</Role>
      <ShortName>Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Convertible Preferred Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail</Role>
      <ShortName>Convertible Preferred Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Stock-Based Compensation - Summary of Shares Available for Grant (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Shares Available for Grant (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Stock-Based Compensation - Summary of Activity under Stock Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Activity under Stock Plans (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Stock-Based Compensation - Summary of Performance Stock Units Under Stock Plan (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Performance Stock Units Under Stock Plan (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail</Role>
      <ShortName>Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100660 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail</Role>
      <ShortName>Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>100670 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail</Role>
      <ShortName>Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>100680 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>100690 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>100700 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>100710 - Disclosure - Income Taxes - Components of Loss before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Components of Loss before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>100720 - Disclosure - Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>100730 - Disclosure - Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail</Role>
      <ShortName>Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>100740 - Disclosure - Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>100750 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>100760 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Summary of Unrecognized Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>100770 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail</Role>
      <ShortName>Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>100780 - Disclosure - Net Loss Per Share - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail</Role>
      <ShortName>Net Loss Per Share - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>100790 - Disclosure - Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail</Role>
      <ShortName>Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="nvro-10k_20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>100800 - Disclosure - Employee Benefit Plan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetail</Role>
      <ShortName>Employee Benefit Plan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="nvro-10k_20211231.htm">nvro-10k_20211231.htm</File>
    <File>nvro-20211231.xsd</File>
    <File>nvro-20211231_cal.xml</File>
    <File>nvro-20211231_def.xml</File>
    <File>nvro-20211231_lab.xml</File>
    <File>nvro-20211231_pre.xml</File>
    <File>nvro-ex1013_296.htm</File>
    <File>nvro-ex211_7.htm</File>
    <File>nvro-ex231_297.htm</File>
    <File>nvro-ex311_6.htm</File>
    <File>nvro-ex312_9.htm</File>
    <File>nvro-ex321_10.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>gu1405a4gpzj000001.jpg</File>
    <File>gu1405a4gpzj000002.jpg</File>
    <File>gu1405a4gpzj000003.jpg</File>
    <File>gu1405a4gpzj000004.jpg</File>
    <File>gu1405a4gpzj000005.jpg</File>
    <File>gu1405a4gpzj000006.jpg</File>
    <File>gu1405a4gpzj000007.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1062">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>107
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "nvro-10k_20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 35,
   "contextCount": 284,
   "dts": {
    "calculationLink": {
     "local": [
      "nvro-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "nvro-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "nvro-10k_20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nvro-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nvro-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nvro-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 712,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 60,
    "http://www.nevro.com/20211231": 24,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 88
   },
   "keyCustom": 74,
   "keyStandard": 479,
   "memberCustom": 38,
   "memberStandard": 50,
   "nsprefix": "nvro",
   "nsuri": "http://www.nevro.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Leases",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Fair Value Measurements",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Balance Sheet Components",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponents",
     "shortName": "Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Commitments and Contingencies",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Long-term Debt",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebt",
     "shortName": "Long-term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Convertible Preferred Stock",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStock",
     "shortName": "Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Stock-Based Compensation",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Income Taxes",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Net Loss Per Share",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Employee Benefit Plan",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlan",
     "shortName": "Employee Benefit Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "role": "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Revenue (Tables)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Leases (Tables)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Balance Sheet Components (Tables)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables",
     "shortName": "Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Long-term Debt (Tables)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables",
     "shortName": "Long-term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Net Loss Per Share (Tables)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Formation and Business of the Company - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
     "shortName": "Formation and Business of the Company - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member_20200430",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20200401_20200430",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Formation and Business of the Company - Additional Information - Public Offering (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
     "shortName": "Formation and Business of the Company - Additional Information - Public Offering (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200401_20200430",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nvro:NumberOfOperationalWhollyOwnedSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_nvroSubsidiary",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nvro:NumberOfOperationalWhollyOwnedSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_nvroSubsidiary",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation",
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail 1)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation",
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail",
     "shortName": "Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_srtStatementGeographicalAxis_countryUS_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20210101_20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Revenue - Schedule of Revenue by Major Customers by Geographic Area (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail",
     "shortName": "Revenue - Schedule of Revenue by Major Customers by Geographic Area (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20210101_20211231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Revenue - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
     "shortName": "Revenue - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_srtProductOrServiceAxis_nvroPainfulDiabeticNeuropathyMember_20210101_20211231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseOptionToExtend",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Leases - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail",
     "shortName": "Leases - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseOptionToExtend",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Leases - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail",
     "shortName": "Leases - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail",
     "shortName": "Leases - Schedule of Maturity of Lease Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "role": "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Leases - Supplemental Lease Cost Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSupplementalLeaseCostInformationDetail",
     "shortName": "Leases - Supplemental Lease Cost Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Leases - Summary of Operating Lease Assets and Liabilities (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail",
     "shortName": "Leases - Summary of Operating Lease Assets and Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nvro:ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Lease (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail",
     "shortName": "Leases - Schedule of Supplemental Cash Flow Information Related to Lease (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nvro:ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20201231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail",
     "shortName": "Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail",
     "shortName": "Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Balance Sheet Components - Components of Inventories (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail",
     "shortName": "Balance Sheet Components - Components of Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "nvro:InventoryWriteDownCashAndNonCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Balance Sheet Components - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail",
     "shortName": "Balance Sheet Components - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "nvro:InventoryWriteDownCashAndNonCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail",
     "shortName": "Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20181231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20181231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail",
     "shortName": "Balance Sheet Components - Summary of Accrued Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StandardProductWarrantyAccrualCurrent",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail",
     "shortName": "Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:StandardProductWarrantyAccrualWarrantiesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfWarrants",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Long-term Debt - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
     "shortName": "Long-term Debt - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20160630",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_20200430",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredFinanceCostsNoncurrentGross",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
     "shortName": "Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneNotesAndConvertibleNotesMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail",
     "shortName": "Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail",
     "shortName": "Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroTwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesIssued",
       "us-gaap:PreferredStockSharesIssued",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Convertible Preferred Stock - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail",
     "shortName": "Convertible Preferred Stock - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20141110",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nvro:CommonStockOptionsAndAwardsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail",
     "shortName": "Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nvro:CommonStockOptionsAndAwardsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20190101_20191231",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Stock-Based Compensation - Summary of Shares Available for Grant (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail",
     "shortName": "Stock-Based Compensation - Summary of Shares Available for Grant (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Stock-Based Compensation - Summary of Activity under Stock Plans (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail",
     "shortName": "Stock-Based Compensation - Summary of Activity under Stock Plans (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20190101_20191231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail",
     "shortName": "Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail",
     "shortName": "Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Stock-Based Compensation - Summary of Performance Stock Units Under Stock Plan (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
     "shortName": "Stock-Based Compensation - Summary of Performance Stock Units Under Stock Plan (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20181231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail",
     "shortName": "Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100660 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail",
     "shortName": "Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100670 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
     "shortName": "Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceStockUnitsMember_20190101_20191231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100680 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail",
     "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100690 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail",
     "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100060 - Disclosure - Formation and Business of the Company",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompany",
     "shortName": "Formation and Business of the Company",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100700 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail",
     "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100710 - Disclosure - Income Taxes - Components of Loss before Income Taxes (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail",
     "shortName": "Income Taxes - Components of Loss before Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20190101_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100720 - Disclosure - Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail",
     "shortName": "Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20190101_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100730 - Disclosure - Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail",
     "shortName": "Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100740 - Disclosure - Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail",
     "shortName": "Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100750 - Disclosure - Income Taxes - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100760 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail",
     "shortName": "Income Taxes - Summary of Unrecognized Tax Benefits (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100770 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail",
     "shortName": "Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100780 - Disclosure - Net Loss Per Share - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail",
     "shortName": "Net Loss Per Share - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100790 - Disclosure - Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail",
     "shortName": "Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100070 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100800 - Disclosure - Employee Benefit Plan - Additional Information (Detail)",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetail",
     "shortName": "Employee Benefit Plan - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Revenue",
     "role": "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "nvro-10k_20211231.htm",
      "contextRef": "C_0001444380_20210101_20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 91,
   "tag": {
    "country_CR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COSTA RICA",
        "terseLabel": "Costa Rica [Member]"
       }
      }
     },
     "localname": "CR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States [Member]"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm Id",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated By Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well Known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r736",
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Icfr Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "nvro_AccruedClinicalAndResearchExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical and research expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Clinical And Research Expenses Current",
        "terseLabel": "Accrued clinical and research expenses"
       }
      }
     },
     "localname": "AccruedClinicalAndResearchExpensesCurrent",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional contingent consideration payment secured by convertible notes.",
        "label": "Additional Contingent Consideration Payment Secured By Convertible Notes",
        "terseLabel": "Additional contingent consideration payment secured by convertible notes"
       }
      }
     },
     "localname": "AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital hedge and warrant transactions net cost.",
        "label": "Adjustments To Additional Paid In Capital Hedge And Warrant Transactions Net Cost",
        "terseLabel": "Net cost of reduction to additional paid-in capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital purchase of bond hedges.",
        "label": "Adjustments To Additional Paid In Capital Purchase Of Bond Hedges",
        "terseLabel": "Purchase of bond hedges"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_AgencyBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency bonds member.",
        "label": "Agency Bonds [Member]",
        "terseLabel": "Agency Bonds [Member]"
       }
      }
     },
     "localname": "AgencyBondsMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_AmortizationOfOperatingLeaseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10190.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of operating lease asset.",
        "label": "Amortization Of Operating Lease Asset",
        "terseLabel": "Amortization of operating lease assets"
       }
      }
     },
     "localname": "AmortizationOfOperatingLeaseAsset",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_BadDebtExpense1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bad Debt Expense.",
        "label": "Bad Debt Expense1",
        "terseLabel": "Bad debt expense"
       }
      }
     },
     "localname": "BadDebtExpense1",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_BostonScientificCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boston scientific corporation.",
        "label": "Boston Scientific Corporation [Member]",
        "terseLabel": "Boston Scientific Corporation [Member]"
       }
      }
     },
     "localname": "BostonScientificCorporationMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for amounts included in the measurement of lease liabilities abstract.",
        "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nvro_CommonStockOptionsAndAwardsOutstanding": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock options and awards outstanding.",
        "label": "Common Stock Options And Awards Outstanding",
        "terseLabel": "Outstanding stock options and awards"
       }
      }
     },
     "localname": "CommonStockOptionsAndAwardsOutstanding",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock reserved for future issuance under employee stock purchase plan.",
        "label": "Common Stock Reserved For Future Issuance Under Employee Stock Purchase Plan",
        "terseLabel": "Reserved for employee stock purchase plan"
       }
      }
     },
     "localname": "CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock reserved for future issuance under stock option and awards grants.",
        "label": "Common Stock Reserved For Future Issuance Under Stock Option And Awards Grants",
        "terseLabel": "Reserved for grants of future stock options and awards"
       }
      }
     },
     "localname": "CommonStockReservedForFutureIssuanceUnderStockOptionAndAwardsGrants",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration risk number of customers exceeding threshold",
        "label": "Concentration Risk Number Of Customers Exceeding Threshold",
        "terseLabel": "Number of customers accounted 10% or more concentration risk"
       }
      }
     },
     "localname": "ConcentrationRiskNumberOfCustomersExceedingThreshold",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "nvro_ContingentConsiderationExpensesNetSecuredByConvertibleNotes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration expenses net secured by convertible notes.",
        "label": "Contingent Consideration Expenses Net Secured By Convertible Notes",
        "terseLabel": "Contingent consideration expenses net secured by convertible notes"
       }
      }
     },
     "localname": "ContingentConsiderationExpensesNetSecuredByConvertibleNotes",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration payment secured by convertible notes.",
        "label": "Contingent Consideration Payment Secured By Convertible Notes",
        "terseLabel": "Contingent consideration payment secured by convertible notes"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentSecuredByConvertibleNotes",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_ConversionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion price per share.",
        "label": "Conversion Price Per Share",
        "terseLabel": "Overall conversion price"
       }
      }
     },
     "localname": "ConversionPricePerShare",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "nvro_DebtEquityComponentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt equity component.",
        "label": "Debt Equity Component [Member]",
        "terseLabel": "Debt, Equity Component [Member]"
       }
      }
     },
     "localname": "DebtEquityComponentMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_DebtInstrumentAdditionalAggregatePrincipalAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument additional aggregate principal amount.",
        "label": "Debt Instrument Additional Aggregate Principal Amount",
        "terseLabel": "Additional aggregate principal amount of convertible senior notes"
       }
      }
     },
     "localname": "DebtInstrumentAdditionalAggregatePrincipalAmount",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument convertible equity component issuance cost.",
        "label": "Debt Instrument Convertible Equity Component Issuance Cost",
        "negatedLabel": "Debt issuance cost"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleEquityComponentIssuanceCost",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument convertible equity discount related to value of conversion option.",
        "label": "Debt Instrument Convertible Equity Discount Related To Value Of Conversion Option",
        "terseLabel": "Debt discount related to value of conversion option"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_DebtInstrumentMaturityMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The month and year (YYYY-MM) that the debt instrument maturity is due.",
        "label": "Debt Instrument Maturity Month And Year",
        "terseLabel": "Debt instrument due year"
       }
      }
     },
     "localname": "DebtInstrumentMaturityMonthAndYear",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "nvro_DebtInstrumentMaturityYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument maturity year.",
        "label": "Debt Instrument Maturity Year",
        "terseLabel": "Debt instrument due year"
       }
      }
     },
     "localname": "DebtInstrumentMaturityYear",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearItemType"
    },
    "nvro_DebtLiabilityComponentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt liability component.",
        "label": "Debt Liability Component [Member]",
        "terseLabel": "Debt, Liability Component [Member]"
       }
      }
     },
     "localname": "DebtLiabilityComponentMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_DeferredTaxAssetsDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets depreciation.",
        "label": "Deferred Tax Assets Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DeferredTaxAssetsDepreciation",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_DeferredTaxAssetsLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets lease liabilities.",
        "label": "Deferred Tax Assets Lease Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiabilities",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_DeferredTaxLiabilitiesRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10110.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities right of use asset.",
        "label": "Deferred Tax Liabilities Right Of Use Asset",
        "negatedLabel": "Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAsset",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock option, restricted stock units and performance stock units.",
        "label": "Employee Stock Option Restricted Stock Units And Performance Stock Units [Member]",
        "terseLabel": "Employee Stock Option, RSUs and PSUs [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionRestrictedStockUnitsAndPerformanceStockUnitsMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "ESPP [Member]",
        "verboseLabel": "Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_EmployeeStockPurchasePlanOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock purchase plan offering period.",
        "label": "Employee Stock Purchase Plan Offering Period",
        "terseLabel": "Employee stock purchase plan offering period",
        "verboseLabel": "Employee stock purchase plan offering period"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanOfferingPeriod",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nvro_ExerciseOfBondHedgeForConvertibleSeniorNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of bond hedge for convertible senior notes.",
        "label": "Exercise Of Bond Hedge For Convertible Senior Notes",
        "negatedLabel": "Exercise of bond hedge for convertible senior notes due 2021, shares",
        "positiveLabel": "Share received on option exercise"
       }
      }
     },
     "localname": "ExerciseOfBondHedgeForConvertibleSeniorNotes",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_ExerciseOfBondHedgeValueForConvertibleSeniorNotes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of bond hedge value for convertible senior notes.",
        "label": "Exercise Of Bond Hedge Value For Convertible Senior Notes",
        "negatedLabel": "Exercise of bond hedge for convertible senior notes due 2021"
       }
      }
     },
     "localname": "ExerciseOfBondHedgeValueForConvertibleSeniorNotes",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_FacilityLeaseAgreementThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility lease agreement three.",
        "label": "Facility Lease Agreement Three [Member]",
        "terseLabel": "Non-cancellable Facility Lease [Member]"
       }
      }
     },
     "localname": "FacilityLeaseAgreementThreeMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal and state net operating loss carry forwards expiration year.",
        "label": "Federal And State Net Operating Loss Carry Forwards Expiration Year",
        "terseLabel": "Net operating loss expiration date"
       }
      }
     },
     "localname": "FederalAndStateNetOperatingLossCarryForwardsExpirationYear",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearItemType"
    },
    "nvro_FirstAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First amendment.",
        "label": "First Amendment [Member]",
        "terseLabel": "Amendment 1 [Member]"
       }
      }
     },
     "localname": "FirstAmendmentMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_IncentiveStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive Stock Options.",
        "label": "Incentive Stock Options [Member]",
        "terseLabel": "ISO [Member]"
       }
      }
     },
     "localname": "IncentiveStockOptionsMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income taxes.",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nvro_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income taxes.",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense recognized related to convertible notes.",
        "label": "Interest Expense Recognized Related To Convertible Notes Table [Text Block]",
        "terseLabel": "Interest Expense Recognized Related to Convertible Notes"
       }
      }
     },
     "localname": "InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nvro_InventoryWriteDownCashAndNonCash": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory write down cash and non cash.",
        "label": "Inventory Write Down Cash And Non Cash",
        "terseLabel": "Write down of inventory"
       }
      }
     },
     "localname": "InventoryWriteDownCashAndNonCash",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_LeaseCommencementDateDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease commencement date description.",
        "label": "Lease Commencement Date Description",
        "terseLabel": "Commencement date description"
       }
      }
     },
     "localname": "LeaseCommencementDateDescription",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nvro_LeaseCommencementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease commencement period.",
        "label": "Lease Commencement Period",
        "terseLabel": "Lease agreement, commencement period"
       }
      }
     },
     "localname": "LeaseCommencementPeriod",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "nvro_LeaseEffectiveDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease effective date.",
        "label": "Lease Effective Date",
        "terseLabel": "Lease agreement, effective date"
       }
      }
     },
     "localname": "LeaseEffectiveDate",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "nvro_LesseeOperatingLeaseRemainingTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease remaining term of contract.",
        "label": "Lessee Operating Lease Remaining Term Of Contract",
        "terseLabel": "Operating lease, remaining term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingTermOfContract",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nvro_LicenseAgreementCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement commitment amount.",
        "label": "License Agreement Commitment Amount",
        "terseLabel": "License agreement commitment amount"
       }
      }
     },
     "localname": "LicenseAgreementCommitmentAmount",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_LicenseAgreementExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement expiration year.",
        "label": "License Agreement Expiration Year",
        "terseLabel": "License agreement expiration year"
       }
      }
     },
     "localname": "LicenseAgreementExpirationYear",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearItemType"
    },
    "nvro_MajorCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major customers.",
        "label": "Major Customers [Member]",
        "terseLabel": "Major Customers [Member]"
       }
      }
     },
     "localname": "MajorCustomersMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_MayoAndVglMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mayo And VGL.",
        "label": "Mayo And Vgl [Member]",
        "terseLabel": "Mayo And VGL [Member]"
       }
      }
     },
     "localname": "MayoAndVglMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_MayoFoundationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mayo Foundation.",
        "label": "Mayo Foundation [Member]",
        "terseLabel": "Mayo Foundation [Member]"
       }
      }
     },
     "localname": "MayoFoundationMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_MoneyMarketFundsNetAssetValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money market funds net asset value per share.",
        "label": "Money Market Funds Net Asset Value Per Share",
        "terseLabel": "Net asset value of market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsNetAssetValuePerShare",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "nvro_NinetyEightPercentApplicableConversionPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ninety eight percent applicable conversion price.",
        "label": "Ninety Eight Percent Applicable Conversion Price [Member]",
        "terseLabel": "98% Applicable Conversion Price [Member]"
       }
      }
     },
     "localname": "NinetyEightPercentApplicableConversionPriceMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_NonCashResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash research and development expense.",
        "label": "Non Cash Research And Development Expense",
        "verboseLabel": "Noncash research and development expense"
       }
      }
     },
     "localname": "NonCashResearchAndDevelopmentExpense",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_NonQualifiedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Qualified Stock Options.",
        "label": "Non Qualified Stock Options [Member]",
        "terseLabel": "NSO [Member]"
       }
      }
     },
     "localname": "NonQualifiedStockOptionsMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_NoteHedgesNumberOfSharesContractedToBuy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note hedges number of shares contracted to buy.",
        "label": "Note Hedges Number Of Shares Contracted To Buy",
        "terseLabel": "Number of shares purchased under convertible note hedge transactions"
       }
      }
     },
     "localname": "NoteHedgesNumberOfSharesContractedToBuy",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_NoteHedgesTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note hedges transaction costs.",
        "label": "Note Hedges Transaction Costs",
        "terseLabel": "Total cost of the convertible note hedge transactions"
       }
      }
     },
     "localname": "NoteHedgesTransactionCosts",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_NumberOfOperationalWhollyOwnedSubsidiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operational wholly owned subsidiaries.",
        "label": "Number Of Operational Wholly Owned Subsidiaries",
        "terseLabel": "Number of operational wholly owned subsidiaries"
       }
      }
     },
     "localname": "NumberOfOperationalWhollyOwnedSubsidiaries",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "nvro_NumberOfSecuredConvertibleNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of secured convertible notes.",
        "label": "Number Of Secured Convertible Notes",
        "terseLabel": "Number of secured convertible notes"
       }
      }
     },
     "localname": "NumberOfSecuredConvertibleNotes",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "nvro_OneHundredThirtyPercentApplicableConversionPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One hundred thirty percent applicable conversion price.",
        "label": "One Hundred Thirty Percent Applicable Conversion Price [Member]",
        "terseLabel": "130% for Applicable Conversion Price [Member]"
       }
      }
     },
     "localname": "OneHundredThirtyPercentApplicableConversionPriceMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One point seven five percent senior convertible note due twenty twenty one.",
        "label": "One Point Seven Five Percent Senior Convertible Note Due Twenty Twenty One [Member]",
        "terseLabel": "1.75% Convertible Senior Notes due 2021 [Member]"
       }
      }
     },
     "localname": "OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_OperatingLeaseAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease assets and liabilities abstract.",
        "label": "Operating Lease Assets And Liabilities [Abstract]",
        "terseLabel": "Operating Leases:"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesAbstract",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nvro_OperatingLeasesExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating leases expiration date.",
        "label": "Operating Leases Expiration Date",
        "terseLabel": "Lease agreement, expiration period"
       }
      }
     },
     "localname": "OperatingLeasesExpirationDate",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating leases future minimum payments due in final year of lease term.",
        "label": "Operating Leases Future Minimum Payments Due In Final Year Of Lease Term",
        "terseLabel": "Annual lease expense payable in final year of lease term"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements.",
        "label": "Organization Consolidation And Presentation Of Financial Statements [Line Items]",
        "terseLabel": "Formation and Business of the Company [Line Items]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements.",
        "label": "Organization Consolidation And Presentation Of Financial Statements [Table]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements [Table]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "nvro_OtherRisksAndUncertainties1PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Risks And Uncertainties Policy.",
        "label": "Other Risks And Uncertainties1 Policy [Text Block]",
        "terseLabel": "Other Risks And Uncertainties"
       }
      }
     },
     "localname": "OtherRisksAndUncertainties1PolicyTextBlock",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nvro_PainfulDiabeticNeuropathyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Painful diabetic neuropathy.",
        "label": "Painful Diabetic Neuropathy [Member]",
        "terseLabel": "Painful Diabetic Neuropathy [Member]"
       }
      }
     },
     "localname": "PainfulDiabeticNeuropathyMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent infringement lawsuit allegation against number of patents.",
        "label": "Patent Infringement Lawsuit Allegation Against Number Of Patents",
        "terseLabel": "Patent infringement lawsuit allegation against number of patents"
       }
      }
     },
     "localname": "PatentInfringementLawsuitAllegationAgainstNumberOfPatents",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "nvro_PatentInfringementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent infringement.",
        "label": "Patent Infringement [Member]",
        "terseLabel": "Patent Infringement [Member]"
       }
      }
     },
     "localname": "PatentInfringementMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_PaymentsOfConvertibleNotesDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10070.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments of convertible notes debt issuance costs.",
        "label": "Payments Of Convertible Notes Debt Issuance Costs",
        "negatedLabel": "Convertible notes debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfConvertibleNotesDebtIssuanceCosts",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount of convertible notes is equal to repurchase price.",
        "label": "Percentage Of Principal Amount Of Convertible Notes Is Equal To Repurchase Price",
        "terseLabel": "Percentage of repurchase price, which is equal to principal amount of convertible notes"
       }
      }
     },
     "localname": "PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nvro_PercentageOfShareholderOptionsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of shareholder options granted.",
        "label": "Percentage Of Shareholder Options Granted",
        "terseLabel": "Percentage of shareholder granted option"
       }
      }
     },
     "localname": "PercentageOfShareholderOptionsGranted",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nvro_PerformanceBasedRestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Restricted Stock Units RSU.",
        "label": "Performance Based Restricted Stock Units R S U [Member]",
        "terseLabel": "Performance Based RSUs [Member]"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitsRSUMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_PerformanceStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance stock units.",
        "label": "Performance Stock Units [Member]",
        "terseLabel": "Performance Stock Units [Member]"
       }
      }
     },
     "localname": "PerformanceStockUnitsMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_PurchasePricePerCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price per common stock.",
        "label": "Purchase Price Per Common Stock",
        "terseLabel": "Purchase price of the shares issued under convertible note hedge transactions"
       }
      }
     },
     "localname": "PurchasePricePerCommonStock",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "nvro_Range1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 1 [Member]",
        "label": "Range1 [Member]",
        "terseLabel": "$3.60 - $36.55 [Member]"
       }
      }
     },
     "localname": "Range1Member",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_Range2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 2 [Member]",
        "label": "Range2 [Member]",
        "terseLabel": "$38.79 - $45.04 [Member]"
       }
      }
     },
     "localname": "Range2Member",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_Range3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 3 [Member]",
        "label": "Range3 [Member]",
        "terseLabel": "$45.07 - $63.23 [Member]"
       }
      }
     },
     "localname": "Range3Member",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_Range4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 4 [Member]",
        "label": "Range4 [Member]",
        "terseLabel": "$63.39 - $64.95 [Member]"
       }
      }
     },
     "localname": "Range4Member",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_Range5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 5 [Member]",
        "label": "Range5 [Member]",
        "terseLabel": "$65.51 - $87.62 [Member]"
       }
      }
     },
     "localname": "Range5Member",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_Range6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 6 [Member]",
        "label": "Range6 [Member]",
        "terseLabel": "$97.52 [Member]"
       }
      }
     },
     "localname": "Range6Member",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_Range7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 7.",
        "label": "Range7 [Member]",
        "terseLabel": "$3.60 - $97.52 [Member]"
       }
      }
     },
     "localname": "Range7Member",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_RecognitionPeriodOfStockBasedCompensationExpense": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition period of stock based compensation expense.",
        "label": "Recognition Period Of Stock Based Compensation Expense",
        "terseLabel": "Recognition period of stock based compensation expense"
       }
      }
     },
     "localname": "RecognitionPeriodOfStockBasedCompensationExpense",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redwood office agreement additional expansion premises.",
        "label": "Redwood Office Agreement Additional Expansion Premises [Member]",
        "terseLabel": "Redwood Office Agreement Additional Expansion Premises [Member]"
       }
      }
     },
     "localname": "RedwoodOfficeAgreementAdditionalExpansionPremisesMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_RedwoodOfficeAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redwood office agreement.",
        "label": "Redwood Office Agreement [Member]",
        "terseLabel": "Redwood Office Agreement [Member]"
       }
      }
     },
     "localname": "RedwoodOfficeAgreementMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_RepaymentFromInvestmentInPrivateCompany": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10150.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment from (investment in) private company.",
        "label": "Repayment From Investment In Private Company",
        "negatedLabel": "Repayment from (investment in) private company"
       }
      }
     },
     "localname": "RepaymentFromInvestmentInPrivateCompany",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_RestrictedAndPerformanceStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted and performance stock units.",
        "label": "Restricted And Performance Stock Units [Member]",
        "terseLabel": "Unreleased Restricted and Performance Stock Units [Member]"
       }
      }
     },
     "localname": "RestrictedAndPerformanceStockUnitsMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognition shipping and handling costs.",
        "label": "Revenue Recognition Shipping And Handling Costs Policy [Text Block]",
        "terseLabel": "Shipping and Handling Costs"
       }
      }
     },
     "localname": "RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash flow information related to operating lease.",
        "label": "Schedule Of Cash Flow Information Related To Operating Lease Tables [Text Block]",
        "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Lease"
       }
      }
     },
     "localname": "ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of common stock reserved for future issuance.",
        "label": "Schedule Of Common Stock Reserved For Future Issuance Table [Text Block]",
        "terseLabel": "Summary of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of operating lease assets and operating lease liabilities.",
        "label": "Schedule Of Operating Lease Assets And Operating Lease Liabilities Table [Text Block]",
        "terseLabel": "Schedule Of Operating Lease Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of weighted average lease terms and discounts rates.",
        "label": "Schedule Of Weighted Average Lease Terms And Discounts Rates Table [Text Block]",
        "terseLabel": "Schedule of Weighted Average Lease Terms and Discounts Rates"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nvro_SecondAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second amendment.",
        "label": "Second Amendment [Member]",
        "terseLabel": "Amendment 2 [Member]"
       }
      }
     },
     "localname": "SecondAmendmentMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured convertible note receivable measured at amortized cost.",
        "label": "Secured Convertible Note Receivable Measured At Amortized Cost",
        "terseLabel": "Secured convertible note, measured at amortized cost"
       }
      }
     },
     "localname": "SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_ServiceAgreementCommitmentAmountYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service agreement commitment amount year four.",
        "label": "Service Agreement Commitment Amount Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "ServiceAgreementCommitmentAmountYearFour",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_ServiceAgreementCommitmentAmountYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service agreement commitment amount year one.",
        "label": "Service Agreement Commitment Amount Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "ServiceAgreementCommitmentAmountYearOne",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_ServiceAgreementCommitmentAmountYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service agreement commitment amount year three.",
        "label": "Service Agreement Commitment Amount Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "ServiceAgreementCommitmentAmountYearThree",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_ServiceAgreementCommitmentAmountYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service agreement commitment amount year two.",
        "label": "Service Agreement Commitment Amount Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "ServiceAgreementCommitmentAmountYearTwo",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments options and other than options forfeited and expirations in period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options And Other Than Options Forfeited And Expirations In Period",
        "terseLabel": "Shares Available for Grant, Options and other than options forfeited or cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments options and other than options grants in period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options And Other Than Options Grants In Period",
        "negatedLabel": "Shares Available for Grant, Options and other than options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options expected to vest.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest",
        "terseLabel": "Number of Restricted Stock Units, Restricted stock expected to vest",
        "verboseLabel": "Number of Restricted Stock Units, PSU expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, shares expected to vest, weighted average grant date fair value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value, Restricted stock expected to vest",
        "verboseLabel": "Weighted Average Grant Date Fair Value, PSU expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award fair value assumptions correlation wirh index rate.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Correlation With Index Rate",
        "terseLabel": "Correlation with index"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award fair value assumptions index volatility rate.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Index Volatility Rate",
        "terseLabel": "Index volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share-based payment award, fair value assumptions volatility rate.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Volatility Rate",
        "terseLabel": "Company volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of allowance for PSU for over performance.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Allowance For P S U For Over Performance",
        "negatedLabel": "Shares Available for Grant, Allowance for PSU for over performance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award number of shares forfeited for tax.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Forfeited For Tax",
        "verboseLabel": "Shares Available for Grant, Shares forfeited for tax"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award value issued in period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Value Issued In Period",
        "verboseLabel": "Employee contributions for shares issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation shares authorized under stock option plans exercise price.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price",
        "terseLabel": "Options Outstanding, Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePrice",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value expected to vest.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Expected To Vest",
        "terseLabel": "Aggregate Intrinsic Value, Expected to vest",
        "verboseLabel": "Aggregate Intrinsic Value, PSU Expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, options outstanding, weighted average exercise price, and additional disclosures.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Exercise Price And Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract",
     "nsuri": "http://www.nevro.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nvro_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1"
     ],
     "xbrltype": "stringItemType"
    },
    "nvro_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of information pertaining to the \"Summary Of Significant Accounting Policies\" disclosure as a whole for which no other established GAAP taxonomy identified hypercube is available.\"",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1"
     ],
     "xbrltype": "stringItemType"
    },
    "nvro_SupplyAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supply Agreements [Member]",
        "label": "Supply Agreements [Member]",
        "terseLabel": "Supply Agreements [Member]"
       }
      }
     },
     "localname": "SupplyAgreementsMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_TargetedCompositeIndexPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Targeted composite index period.",
        "label": "Targeted Composite Index Period",
        "terseLabel": "Targeted composite index period"
       }
      }
     },
     "localname": "TargetedCompositeIndexPeriod",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "nvro_TargetedNumberOfSharesGrantedRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Targeted number of shares granted ratio.",
        "label": "Targeted Number Of Shares Granted Ratio",
        "terseLabel": "Targeted number of shares granted ratio"
       }
      }
     },
     "localname": "TargetedNumberOfSharesGrantedRatio",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "nvro_TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Point Seven Five Percentage Convertible Senior Notes Due 2025.",
        "label": "Two Point Seven Five Percentage Convertible Senior Notes1 Due2025 [Member]",
        "terseLabel": "2.75% Convertible senior notes due 2025 [Member]"
       }
      }
     },
     "localname": "TwoPointSevenFivePercentageConvertibleSeniorNotes1Due2025Member",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two point seven five percentage convertible senior notes due 2025 [Member]",
        "label": "Two Point Seven Five Percentage Convertible Senior Notes Due2025 [Member]",
        "terseLabel": "2.75% Convertible Senior Notes due 2025 [Member]"
       }
      }
     },
     "localname": "TwoPointSevenFivePercentageConvertibleSeniorNotesDue2025Member",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_TwoThousandFourteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2014 Equity Incentive Plan.",
        "label": "Two Thousand Fourteen Equity Incentive Plan [Member]",
        "terseLabel": "2014 Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandFourteenEquityIncentivePlanMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_TwoThousandSevenPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2007 Plan.",
        "label": "Two Thousand Seven Plan [Member]",
        "terseLabel": "2007 Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandSevenPlanMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_TwoThousandTwentyFiveNotesAndConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty five notes and convertible notes.",
        "label": "Two Thousand Twenty Five Notes And Convertible Notes [Member]",
        "terseLabel": "2025 Notes and Convertible Notes [Member]"
       }
      }
     },
     "localname": "TwoThousandTwentyFiveNotesAndConvertibleNotesMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty One And Two Thousand Twenty Five Notes [Member].",
        "label": "Two Thousand Twenty One And Two Thousand Twenty Five Notes [Member]",
        "terseLabel": "2021 Notes and 2025 Notes [Member]"
       }
      }
     },
     "localname": "TwoThousandTwentyOneAndTwoThousandTwentyFiveNotesMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_TwoThousandTwentyOneNotesAndConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 notes and convertible notes.",
        "label": "Two Thousand Twenty One Notes And Convertible Notes [Member]",
        "terseLabel": "2021 Notes and Convertible Notes [Member]"
       }
      }
     },
     "localname": "TwoThousandTwentyOneNotesAndConvertibleNotesMember",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10260.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized gains and losses on foreign currency translation.",
        "label": "Unrealized Gains And Losses On Foreign Currency Translation",
        "negatedLabel": "Unrealized gains (losses) on foreign currency transactions"
       }
      }
     },
     "localname": "UnrealizedGainsAndLossesOnForeignCurrencyTranslation",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nvro_ValueOfCertainRightsMeasuredAtCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of certain rights measured at cost.",
        "label": "Value Of Certain Rights Measured At Cost",
        "terseLabel": "Value of certain rights measured at cost"
       }
      }
     },
     "localname": "ValueOfCertainRightsMeasuredAtCost",
     "nsuri": "http://www.nevro.com/20211231",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "CEO [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r68",
      "r70",
      "r137",
      "r138",
      "r332",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r214",
      "r400",
      "r404",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major Customers [Axis]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ManagementMember": {
     "auth_ref": [
      "r215",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management [Member]",
        "terseLabel": "Member of Management Team [Member]"
       }
      }
     },
     "localname": "ManagementMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r331",
      "r373",
      "r422",
      "r424",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r681",
      "r685",
      "r729",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r331",
      "r373",
      "r422",
      "r424",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r681",
      "r685",
      "r729",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r214",
      "r400",
      "r404",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Of Major Customer [Domain]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r211",
      "r400",
      "r402",
      "r633",
      "r680",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Or Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r211",
      "r400",
      "r402",
      "r633",
      "r680",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products And Services [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r331",
      "r373",
      "r412",
      "r422",
      "r424",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r681",
      "r685",
      "r729",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r331",
      "r373",
      "r412",
      "r422",
      "r424",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r681",
      "r685",
      "r729",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r69",
      "r70",
      "r137",
      "r138",
      "r332",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase Agreement Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r152",
      "r157",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario Unspecified [Domain]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r400",
      "r403",
      "r683",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r400",
      "r403",
      "r683",
      "r714",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r152",
      "r157",
      "r297",
      "r423",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Scenario [Axis]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r215",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual With Relationship To Entity [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201912Member": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.",
        "label": "Accounting Standards Update201912 [Member]",
        "terseLabel": "ASU 2019-12 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201912Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r52",
      "r619"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10130.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r31",
      "r216",
      "r217"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10240.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable Net Current",
        "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $1,385 and $3,000 at December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10210.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion Amortization Of Discounts And Premiums Investments",
        "negatedLabel": "Amortization of premium (accretion of discount) on short-term investments"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r24",
      "r642",
      "r667"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes Current",
        "terseLabel": "Accrued taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10140.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r54"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r50",
      "r288"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment",
        "negatedLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r73",
      "r74",
      "r75",
      "r670",
      "r693",
      "r697"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10070.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
        "terseLabel": "Accumulated other comprehensive income / (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r72",
      "r75",
      "r83",
      "r84",
      "r85",
      "r141",
      "r142",
      "r143",
      "r535",
      "r688",
      "r689",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10060.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid In Capital Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r467",
      "r468",
      "r469",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r145",
      "r146",
      "r147",
      "r148",
      "r157",
      "r221",
      "r222",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r252",
      "r315",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r508",
      "r509",
      "r510",
      "r511",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r568",
      "r569",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r612",
      "r635",
      "r636",
      "r637",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Adjustments For New Accounting Pronouncements [Axis]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Adjustments Related To Tax Withholding For Share Based Compensation",
        "negatedLabel": "Shares withheld for tax obligations"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": {
     "auth_ref": [
      "r379",
      "r388",
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.",
        "label": "Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature",
        "terseLabel": "Conversion feature of convertible senior notes due 2025, net of allocated costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r426",
      "r428",
      "r473",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value",
        "terseLabel": "Stock based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r327",
      "r379",
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments To Additional Paid In Capital Warrant Issued",
        "terseLabel": "Sales of warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AgencySecuritiesMember": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities issued by government sponsored entities.",
        "label": "Agency Securities [Member]",
        "terseLabel": "Agency Bonds [Member]"
       }
      }
     },
     "localname": "AgencySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r428",
      "r458",
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r38",
      "r218",
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance For Doubtful Accounts Receivable Current",
        "terseLabel": "Accounts receivable, allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r97",
      "r116",
      "r351",
      "r588"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization Of Debt Discount Premium",
        "terseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r91",
      "r116",
      "r351",
      "r590"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization Of Financing Costs",
        "verboseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r116",
      "r351",
      "r365",
      "r366",
      "r590"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10250.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization Of Financing Costs And Discounts",
        "terseLabel": "Amortization of debt discount and issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "terseLabel": "Potentially dilutive securities excluded from computation of diluted shares outstanding"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfLand": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of land held.",
        "label": "Area Of Land",
        "terseLabel": "Area of office space"
       }
      }
     },
     "localname": "AreaOfLand",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Arrangements And Nonarrangement Transactions [Member]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r116",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r132",
      "r194",
      "r203",
      "r209",
      "r242",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r530",
      "r536",
      "r567",
      "r617",
      "r619",
      "r640",
      "r666"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r67",
      "r132",
      "r242",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r530",
      "r536",
      "r567",
      "r617",
      "r619"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10170.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Fair Value Disclosure",
        "terseLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax",
        "terseLabel": "Gross Unrealized Holding Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r230"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax",
        "negatedLabel": "Gross Unrealized Holding Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r227",
      "r269"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Amortized Cost Basis",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost",
        "terseLabel": "Amortized Cost, Amounts maturing after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r231",
      "r234",
      "r657"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Available For Sale Securities Debt Maturities After One Through Five Years Fair Value",
        "terseLabel": "Fair Value, Amounts after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Available For Sale Securities Debt Maturities Within One Year Amortized Cost",
        "terseLabel": "Amortized Cost, Amounts maturing within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r231",
      "r233",
      "r656"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Available For Sale Securities Debt Maturities Within One Year Fair Value",
        "terseLabel": "Fair Value, Amounts maturing within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r224",
      "r228",
      "r269",
      "r646"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Securities Debt Securities",
        "terseLabel": "Aggregate Fair Value",
        "totalLabel": "Fair Value, Total investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r226",
      "r269"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10230.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Available For Sale Securities Debt Securities Current",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r429",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis Of Accounting Policy Policy [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of California.",
        "label": "California Franchise Tax Board [Member]",
        "terseLabel": "California state [Member]"
       }
      }
     },
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r121",
      "r122",
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred But Not Yet Paid",
        "terseLabel": "Purchases of property and equipment in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r47",
      "r118"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10220.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r18",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash And Cash Equivalents Policy [Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r111",
      "r118",
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r111",
      "r579"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashUninsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash Uninsured Amount",
        "terseLabel": "Cash held in foreign banks"
       }
      }
     },
     "localname": "CashUninsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates Of Deposit [Member]",
        "terseLabel": "Certificates of Deposit [Member]"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "auth_ref": [
      "r0",
      "r1",
      "r141",
      "r142",
      "r144",
      "r221",
      "r222",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r315",
      "r463",
      "r464",
      "r465",
      "r508",
      "r541",
      "r542",
      "r543",
      "r568",
      "r570",
      "r571",
      "r572",
      "r575",
      "r576",
      "r595",
      "r612",
      "r635",
      "r636",
      "r686",
      "r687",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether accounting standards update was adopted.",
        "label": "Change In Accounting Principle Accounting Standards Update Adopted",
        "terseLabel": "Change in accounting principle, accounting standards update, adoption [true false]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "auth_ref": [
      "r0",
      "r1",
      "r141",
      "r142",
      "r151",
      "r221",
      "r222",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r315",
      "r463",
      "r464",
      "r465",
      "r508",
      "r541",
      "r542",
      "r543",
      "r544",
      "r547",
      "r568",
      "r570",
      "r571",
      "r572",
      "r575",
      "r576",
      "r595",
      "r612",
      "r635",
      "r636",
      "r686",
      "r687",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.",
        "label": "Change In Accounting Principle Accounting Standards Update Adoption Date",
        "terseLabel": "Accounting standards adopted date"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "auth_ref": [
      "r145",
      "r156",
      "r223",
      "r250",
      "r470",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.",
        "label": "Change In Accounting Principle Accounting Standards Update Immaterial Effect",
        "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect [true false]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class Of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1",
        "terseLabel": "Purchase price of the shares issued under convertible note hedge transactions"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights",
        "terseLabel": "Number of shares issued for warrants under convertible note hedge transactions"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r60",
      "r296",
      "r647",
      "r674"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10020.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies (Note 7)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r293",
      "r294",
      "r295",
      "r303",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments And Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock Capital Shares Reserved For Future Issuance",
        "terseLabel": "Common stock reserved for future issuance",
        "totalLabel": "Total common stock reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r141",
      "r142",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock Shares Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r30",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock Shares Outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r30",
      "r619"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10050.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "terseLabel": "Common stock, $0.001 par value, 290,000,000 shares authorized at December 31, 2021 and 2020, respectively; 35,709,570 shares issued and 35,026,654 shares outstanding at December 31, 2021; 34,583,064 shares issued and outstanding at December 31, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r410",
      "r411",
      "r425",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation And Employee Benefit Plans [Text Block]",
        "terseLabel": "Employee Benefit Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation And Retirement Disclosure [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r78",
      "r80",
      "r81",
      "r89",
      "r650",
      "r676"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income Net Of Tax",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income Policy Policy [Text Block]",
        "terseLabel": "Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment and Software [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r181",
      "r182",
      "r214",
      "r564",
      "r565",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r181",
      "r182",
      "r214",
      "r564",
      "r565",
      "r698",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk By Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r181",
      "r182",
      "r214",
      "r564",
      "r565",
      "r698",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk By Type [Axis]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r175",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk Credit Risk",
        "terseLabel": "Concentration of Credit Risk and Other Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r181",
      "r182",
      "r214",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk Percentage1",
        "terseLabel": "Revenue",
        "verboseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r178",
      "r181",
      "r182",
      "r183",
      "r564",
      "r566",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r181",
      "r182",
      "r214",
      "r564",
      "r565",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress [Member]",
        "terseLabel": "Construction in Process [Member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r121",
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion Of Stock Shares Converted1",
        "verboseLabel": "Convertible preferred stock converted to common stock"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "verboseLabel": "Convertible Senior Notes [Member]"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "Convertible Debt Table [Text Block]",
        "terseLabel": "Net Carrying Amount of Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Longterm Notes Payable Current And Noncurrent [Abstract]"
       }
      }
     },
     "localname": "ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r28",
      "r29",
      "r377",
      "r380",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock Shares Issued Upon Conversion",
        "terseLabel": "Common stock shares issued for each convertible preferred stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateNoteSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest).",
        "label": "Corporate Note Securities [Member]",
        "terseLabel": "Corporate Notes [Member]"
       }
      }
     },
     "localname": "CorporateNoteSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r93",
      "r633"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10170.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost Of Goods And Services Sold",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost Of Sales [Member]",
        "terseLabel": "Cost of Revenue [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.",
        "label": "Credit Concentration Risk [Member]",
        "terseLabel": "Credit Concentration Risk [Member]"
       }
      }
     },
     "localname": "CreditConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.",
        "label": "Credit Loss Financial Instrument Policy [Text Block]",
        "terseLabel": "Credit Losses"
       }
      }
     },
     "localname": "CreditLossFinancialInstrumentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r503",
      "r515"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense Benefit",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r503"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense Benefit",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r503",
      "r515",
      "r517"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense Benefit",
        "totalLabel": "Total current income tax expense / (benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense Benefit Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r503",
      "r515"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State And Local Tax Expense Benefit",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r179",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionByUniqueDescriptionAxis": {
     "auth_ref": [
      "r121",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction.",
        "label": "Debt Conversion By Unique Description [Axis]",
        "terseLabel": "Debt Conversion Description"
       }
      }
     },
     "localname": "DebtConversionByUniqueDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r121",
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion Converted Instrument Amount1",
        "terseLabel": "Convertible notes principal amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r121",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion Converted Instrument Shares Issued1",
        "terseLabel": "Convertible notes, shares issued"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtConversionNameDomain": {
     "auth_ref": [
      "r121",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion Name [Domain]",
        "terseLabel": "Debt Conversion, Name"
       }
      }
     },
     "localname": "DebtConversionNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r129",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r345",
      "r352",
      "r353",
      "r355",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r131",
      "r139",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r363",
      "r364",
      "r365",
      "r366",
      "r591",
      "r641",
      "r644",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r25",
      "r357",
      "r644",
      "r665"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Debt Instrument Carrying Amount",
        "positiveTerseLabel": "Principal amount",
        "terseLabel": "Principal"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument Convertible Carrying Amount Of The Equity Component",
        "terseLabel": "Debt conversion, converted instrument amount",
        "totalLabel": "Net carrying amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r330",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument Convertible Conversion Price1",
        "terseLabel": "Convertible notes, conversion price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.",
        "label": "Debt Instrument Convertible If Converted Value In Excess Of Principal",
        "terseLabel": "Converted Value in Excess of Principal"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument Convertible Threshold Consecutive Trading Days1",
        "terseLabel": "Debt instrument convertible consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger",
        "terseLabel": "Debt instrument convertible, percentage of conversion price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument Convertible Threshold Trading Days",
        "terseLabel": "Debt instrument convertible trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity": {
     "auth_ref": [
      "r57",
      "r380",
      "r384",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of equity security or securities into which conversion will be made (for example, common stock or preferred shares).",
        "label": "Debt Instrument Convertible Type Of Equity Security",
        "terseLabel": "Convertible notes, type of equity security issued"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleTypeOfEquitySecurity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r328",
      "r363",
      "r364",
      "r589",
      "r591",
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument Face Amount",
        "terseLabel": "Aggregate principal amount of convertible senior notes"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r343",
      "r363",
      "r364",
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument Fair Value",
        "terseLabel": "Fair value of notes"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r58",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument Frequency Of Periodic Payment",
        "terseLabel": "Debt instrument frequency of payment"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r56",
      "r361",
      "r589",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument Interest Rate Effective Percentage",
        "terseLabel": "Debt instrument, effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r56",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument Interest Rate Stated Percentage",
        "terseLabel": "Debt instrument interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r58",
      "r131",
      "r139",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r363",
      "r364",
      "r365",
      "r366",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument Redemption Price Percentage",
        "terseLabel": "Percentage of closing sale price of common stock"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r58",
      "r131",
      "r139",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r354",
      "r363",
      "r364",
      "r365",
      "r366",
      "r380",
      "r385",
      "r386",
      "r387",
      "r588",
      "r589",
      "r591",
      "r592",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Debt Instrument [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r341",
      "r588",
      "r592"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument Unamortized Discount",
        "negatedLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities Available For Sale Table [Text Block]",
        "terseLabel": "Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r504",
      "r515"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense Benefit",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r51",
      "r341",
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Deferred Finance Costs Net",
        "terseLabel": "Debt issuance costs attributable to the liability and equity component, total amount"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentGross": {
     "auth_ref": [
      "r51",
      "r590"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Deferred Finance Costs Noncurrent Gross",
        "negatedLabel": "Unamortized issuance cost",
        "verboseLabel": "Debt issuance costs attributable to the liability component"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r504",
      "r515"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense Benefit",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r116",
      "r133",
      "r504",
      "r515",
      "r516",
      "r517"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense Benefit",
        "totalLabel": "Total deferred income tax expense / (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense Benefit Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r26",
      "r27",
      "r493",
      "r643",
      "r664"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Income Tax Liabilities",
        "negatedTotalLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r504",
      "r515"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State And Local Income Tax Expense Benefit",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r494"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Gross",
        "totalLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r496"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets Liabilities Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r496"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Net",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r501",
      "r502"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r501",
      "r502"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10120.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r499",
      "r501",
      "r502"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r501",
      "r502"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10090.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r501",
      "r502"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10100.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals",
        "terseLabel": "Accruals and reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan Employer Discretionary Contribution Amount",
        "terseLabel": "Expense for matching contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r116",
      "r192"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10180.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation Depletion And Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation Of Revenue [Line Items]",
        "terseLabel": "Disaggregation Of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation Of Revenue [Table]",
        "terseLabel": "Disaggregation Of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation Of Revenue Table [Text Block]",
        "terseLabel": "Summary of Revenue by Geography on Billing Address of Customer"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Country [Member]",
        "terseLabel": "Federal [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Basic And Diluted",
        "terseLabel": "Net loss per share, basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share Diluted [Line Items]",
        "terseLabel": "Earnings Per Share Diluted [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share Policy [Text Block]",
        "terseLabel": "Net Loss per Share of Common Stock"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r579"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10040.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Continuing Operations",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r135",
      "r483",
      "r519"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate",
        "terseLabel": "Tax at statutory federal rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r483",
      "r519"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r483",
      "r519"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r483",
      "r519"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r483",
      "r519"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation Other Adjustments",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r483",
      "r519"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation State And Local Income Taxes",
        "terseLabel": "State tax, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r483",
      "r519"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation Tax Credits",
        "negatedLabel": "Tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee Related Liabilities Current",
        "terseLabel": "Accrued payroll and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
        "terseLabel": "Weighted-Average Amortization Period (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options",
        "terseLabel": "Unrecognized Compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options",
        "terseLabel": "Unrecognized Compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock [Member]"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Options to Purchase Common Stock [Member]",
        "verboseLabel": "Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r83",
      "r84",
      "r85",
      "r141",
      "r142",
      "r143",
      "r146",
      "r153",
      "r155",
      "r170",
      "r249",
      "r379",
      "r388",
      "r467",
      "r468",
      "r469",
      "r510",
      "r511",
      "r550",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r688",
      "r689",
      "r690",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r553",
      "r554",
      "r555",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value Assets Measured On Recurring Basis [Text Block]",
        "terseLabel": "Financial Instruments Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r343",
      "r363",
      "r364",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r554",
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value By Fair Value Hierarchy Level [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r553",
      "r554",
      "r556",
      "r557",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Fair Value By Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r343",
      "r413",
      "r414",
      "r419",
      "r421",
      "r554",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value Inputs Level1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r343",
      "r363",
      "r364",
      "r413",
      "r414",
      "r419",
      "r421",
      "r554",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value Inputs Level2 [Member]",
        "terseLabel": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r343",
      "r363",
      "r364",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r554",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value Inputs Level3 [Member]",
        "terseLabel": "Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Fair Value Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r343",
      "r363",
      "r364",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r421",
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Measurements Fair Value Hierarchy [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r558",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value Measurements Recurring [Member]",
        "terseLabel": "Fair Value Measurements Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r561",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value Of Financial Instruments Policy",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r280",
      "r281",
      "r283",
      "r284",
      "r634",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite Lived Intangible Assets By Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r280",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite Lived Intangible Assets Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r577",
      "r578"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain Loss Realized",
        "terseLabel": "Realized foreign currency transaction gains (losses)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r117",
      "r577",
      "r578"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain Loss Unrealized",
        "terseLabel": "Net unrealized foreign currency transaction gains (losses)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions And Translations Policy [Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture And Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10240.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain Loss On Disposition Of Assets1",
        "negatedLabel": "Loss on disposal of equipment"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r180",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk [Member]"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r92",
      "r132",
      "r194",
      "r202",
      "r205",
      "r208",
      "r210",
      "r242",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r567"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10110.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "I P O [Member]",
        "terseLabel": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r285",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment Or Disposal Of Long Lived Assets Policy [Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r134",
      "r518"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r87",
      "r194",
      "r202",
      "r205",
      "r208",
      "r210",
      "r639",
      "r648",
      "r652",
      "r678"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10050.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r134",
      "r518"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r290",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority Name [Axis]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority Name [Domain]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r135",
      "r484",
      "r491",
      "r498",
      "r513",
      "r520",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r154",
      "r155",
      "r193",
      "r482",
      "r514",
      "r521",
      "r679"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10060.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense Benefit",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total income tax expense / (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r82",
      "r480",
      "r481",
      "r491",
      "r492",
      "r497",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax Policy [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid Net",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10310.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase Decrease In Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10270.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase Decrease In Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10320.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase Decrease In Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10280.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase Decrease In Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10330.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase Decrease In Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10300.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase Decrease In Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10290.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndemnificationGuaranteeMember": {
     "auth_ref": [
      "r304",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.",
        "label": "Indemnification Guarantee [Member]",
        "terseLabel": "Indemnification Agreement [Member]"
       }
      }
     },
     "localname": "IndemnificationGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r86",
      "r191",
      "r587",
      "r590",
      "r651"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10090.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r97",
      "r349",
      "r362",
      "r365",
      "r366"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense Debt",
        "totalLabel": "Total interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r99",
      "r350",
      "r365",
      "r366"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense Debt Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r109",
      "r112",
      "r120"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid Net",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r15",
      "r16",
      "r54"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r40",
      "r278"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory Finished Goods Net Of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFirmPurchaseCommitmentLoss": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss recognized on firm purchase commitment for inventory.",
        "label": "Inventory Firm Purchase Commitment Loss",
        "terseLabel": "Purchase commitments for inventory related charge"
       }
      }
     },
     "localname": "InventoryFirmPurchaseCommitmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r65",
      "r619"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10250.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r17",
      "r66",
      "r126",
      "r169",
      "r274",
      "r276",
      "r279",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory Policy [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r41",
      "r278"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory Raw Materials Net Of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r275"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10230.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write Down",
        "terseLabel": "Write-down of inventory"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r96",
      "r190"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10080.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r241",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment Policy [Text Block]",
        "terseLabel": "Investment Securities"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investment Type Categorization [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified By Contractual Maturity Date Table [Text Block]",
        "terseLabel": "Summary of Contractual Maturities of Investment Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments Debt And Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease Cost Table [Text Block]",
        "terseLabel": "Supplemental Lease Cost Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date1",
        "terseLabel": "Lease agreement, expiration date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee Lease Description [Line Items]",
        "terseLabel": "Lessee Lease Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee Lease Description [Table]",
        "terseLabel": "Lessee Lease Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee Leases Policy [Text Block]",
        "terseLabel": "Lease Accounting"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether lessee has option to extend operating lease.",
        "label": "Lessee Operating Lease Existence Of Option To Extend",
        "terseLabel": "Existence of option to extend the lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee Operating Lease Liability Maturity Table [Text Block]",
        "terseLabel": "Schedule of Maturity of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r609"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee Operating Lease Liability Payments Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r609"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r609"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r609"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r609"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r609"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r609"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r609"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail2": {
       "order": 10010.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee Operating Lease Liability Undiscounted Excess Amount",
        "negatedLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee Operating Lease Option To Extend",
        "terseLabel": "Option to extend the lease term, description"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Renewal Term",
        "terseLabel": "Options to extend the lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Term Of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r53",
      "r132",
      "r204",
      "r242",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r531",
      "r536",
      "r537",
      "r567",
      "r617",
      "r618"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10010.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r37",
      "r132",
      "r242",
      "r567",
      "r619",
      "r645",
      "r672"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r55",
      "r132",
      "r242",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r531",
      "r536",
      "r537",
      "r567",
      "r617",
      "r618",
      "r619"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10090.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licensing Agreements [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement Amount Awarded To Other Party",
        "terseLabel": "Amount awarded by jury"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10150.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement Expense",
        "terseLabel": "Certain litigation charges"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r25",
      "r342",
      "r358",
      "r363",
      "r364",
      "r644",
      "r669"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt",
        "totalLabel": "Net carrying amount"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10100.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt Noncurrent",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Longterm Debt Type [Axis]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r58",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Longterm Debt Type [Domain]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtTables",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingencies By Nature Of Contingency [Axis]",
        "terseLabel": "Loss Contingency Nature"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual At Carrying Value",
        "terseLabel": "Contingent liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds [Member]"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10030.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10020.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash provided by / (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r111",
      "r113",
      "r117"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10010.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "terseLabel": "Cash used in operations",
        "totalLabel": "Net cash provided by / (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r76",
      "r79",
      "r85",
      "r88",
      "r117",
      "r132",
      "r145",
      "r149",
      "r150",
      "r151",
      "r152",
      "r154",
      "r155",
      "r160",
      "r194",
      "r202",
      "r205",
      "r208",
      "r210",
      "r242",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r552",
      "r567",
      "r649",
      "r675"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10010.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "negatedLabel": "Net loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements Policy Policy [Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non Us [Member]",
        "terseLabel": "International [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing And Financing Items [Abstract]",
        "terseLabel": "Significant non-cash transactions"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r25",
      "r644",
      "r669"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes outstanding"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number Of Operating Segments",
        "terseLabel": "Number of business activities"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10120.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r194",
      "r202",
      "r205",
      "r208",
      "r210"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10070.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r604",
      "r610"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSupplementalLeaseCostInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r599"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease Expense",
        "terseLabel": "Lease agreement, lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r597"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail2": {
       "order": 10020.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease Liability",
        "totalLabel": "Total operating lease liabilities",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfMaturityOfLeaseLiabilitiesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r597"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease Liability Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease Liability Current Statement Of Financial Position Extensible List",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r597"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10110.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease Liability Noncurrent",
        "terseLabel": "Long-term operating lease liabilities",
        "verboseLabel": "Long term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r600",
      "r605"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease Payments",
        "terseLabel": "Operating cash flow from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10190.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease Right Of Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r607",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease Weighted Average Discount Rate Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r606",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease Weighted Average Remaining Lease Term1",
        "terseLabel": "Weighted-average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r593",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases Future Minimum Payments Due Current",
        "terseLabel": "Lease expense, payment due"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperationsCommencedDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the operations of the entity commenced, in YYYY-MM-DD format.",
        "label": "Operations Commenced Date1",
        "terseLabel": "Lease commencement date"
       }
      }
     },
     "localname": "OperationsCommencedDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Formation and Business of the Company"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompany"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r54"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities Current",
        "terseLabel": "Accrued other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10200.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r528",
      "r529",
      "r534"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10040.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent",
        "terseLabel": "Changes in unrealized gains (losses) on short-term investments, net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r528",
      "r529",
      "r534"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10030.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent",
        "terseLabel": "Changes in foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r77",
      "r80",
      "r528",
      "r529",
      "r534"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10020.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent",
        "terseLabel": "Other comprehensive loss",
        "totalLabel": "Net change in other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r54",
      "r619"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10160.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10120.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10100.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income Expense",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over Allotment Option [Member]",
        "terseLabel": "Over Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables And Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r108",
      "r114"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10090.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments For Hedge Financing Activities",
        "negatedLabel": "Purchase of convertible note hedges"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10110.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payments Related To Tax Withholding For Share Based Compensation",
        "negatedLabel": "Minimum tax withholding paid on behalf of employees for net share settlement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r100",
      "r102",
      "r225"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10130.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments To Acquire Available For Sale Securities Debt",
        "negatedLabel": "Purchases of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10160.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r429",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock Par Or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r29",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "verboseLabel": "Convertible preferred stock outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r29",
      "r619"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10040.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value",
        "terseLabel": "Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2021 and 2020, respectively; zero shares issued and outstanding at December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r45",
      "r46"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10260.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense And Other Assets Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10060.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds From Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds From Debt Net Of Issuance Costs",
        "terseLabel": "Net proceeds from the debt offering after deducting transaction costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10050.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds From Issuance Initial Public Offering",
        "terseLabel": "Proceeds from issuance of common stock in public offering, net",
        "verboseLabel": "Net proceeds from common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r104",
      "r462"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10120.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options",
        "terseLabel": "Proceeds from issuance of common stock to employees"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10080.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds From Issuance Of Warrants",
        "terseLabel": "Proceeds from issuance of warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r100",
      "r101",
      "r225"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10140.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds From Sale And Maturity Of Available For Sale Securities",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds From Warrant Exercises",
        "terseLabel": "Holders of warrants associated"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r76",
      "r79",
      "r85",
      "r110",
      "r132",
      "r145",
      "r154",
      "r155",
      "r194",
      "r202",
      "r205",
      "r208",
      "r210",
      "r242",
      "r316",
      "r317",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r528",
      "r532",
      "r533",
      "r538",
      "r539",
      "r552",
      "r567",
      "r652"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10170.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Profit Loss",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment [Abstract]",
        "terseLabel": "Property Plant And Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r50",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property Plant And Equipment By Type [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r49",
      "r287"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property Plant And Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r289",
      "r619",
      "r658",
      "r673"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10180.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r48",
      "r289",
      "r718",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Policy [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r19",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property Plant And Equipment [Text Block]",
        "terseLabel": "Schedule of Property and Equipment, Net and Depreciation and Amortization Expense"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r19",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property Plant And Equipment Useful Life",
        "terseLabel": "Estimated useful life of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r90",
      "r259"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10220.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Provision For Doubtful Accounts",
        "terseLabel": "Provision for (recovery of) doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation Due In Next Twelve Months",
        "terseLabel": "Purchase commitment, amount due"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r39",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy",
        "terseLabel": "Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r420",
      "r613",
      "r614",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10100.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments Of Convertible Debt",
        "negatedLabel": "Repayment of convertible notes"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms": {
     "auth_ref": [
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.",
        "label": "Research And Development Arrangement Contract To Perform For Others Description And Terms",
        "terseLabel": "License agreement, terms"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r476",
      "r632",
      "r731"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10130.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research And Development Expense",
        "terseLabel": "Research and development",
        "verboseLabel": "Retainer fees"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and Development [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research And Development Expense Policy",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research [Member]",
        "terseLabel": "Research and Development Credit Carryforwards [Member]"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash And Cash Equivalents [Abstract]",
        "terseLabel": "Restricted Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage.",
        "label": "Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Axis]",
        "terseLabel": "Restricted Cash and Cash Equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r12",
      "r21",
      "r118",
      "r124",
      "r715"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10210.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash And Cash Equivalents Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units R S U [Member]",
        "terseLabel": "RSU's [Member]",
        "verboseLabel": "Restricted Stock Units [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r33",
      "r388",
      "r470",
      "r619",
      "r671",
      "r692",
      "r697"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10080.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings Accumulated Deficit",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r141",
      "r142",
      "r143",
      "r146",
      "r153",
      "r155",
      "r249",
      "r467",
      "r468",
      "r469",
      "r510",
      "r511",
      "r550",
      "r688",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue From Contract With Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r188",
      "r189",
      "r201",
      "r206",
      "r207",
      "r211",
      "r212",
      "r214",
      "r399",
      "r400",
      "r633"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10160.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue From Contract With Customer Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r397",
      "r398",
      "r401",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue From Contract With Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition Policy [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of when remaining performance obligation is expected to be recognized as revenue.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation",
        "terseLabel": "Unsatisfied performance obligations description"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1",
        "terseLabel": "Unsatisfied performance obligations period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Annual royalty payment"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale Of Stock Name Of Transaction [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r181",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Sales Revenue Net [Member]",
        "terseLabel": "Revenue [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueScheduleOfRevenueByMajorCustomersByGeographicAreaDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule Of Accrued Liabilities Table [Text Block]",
        "terseLabel": "Summary of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]",
        "terseLabel": "Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule Of Available For Sale Securities [Line Items]",
        "terseLabel": "Schedule of Available-for-sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r232",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule Of Available For Sale Securities [Table]",
        "terseLabel": "Schedule Of Available For Sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]",
        "terseLabel": "Components of Expense/(Benefit) for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]",
        "terseLabel": "Computation of Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r158",
      "r159",
      "r161",
      "r163",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule Of Earnings Per Share Diluted By Common Class [Table]",
        "terseLabel": "Schedule Of Earnings Per Share Diluted By Common Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]",
        "terseLabel": "Income Tax Expense by Applying Statutory Federal Income Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r428",
      "r457",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r428",
      "r457",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]",
        "terseLabel": "Components of Loss before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r17",
      "r42",
      "r43",
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule Of Inventory Current Table [Text Block]",
        "terseLabel": "Components of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule Of Product Warranty Liability Table [Text Block]",
        "terseLabel": "Schedule of Activities Related to Warranty Obligations"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r50",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule Of Property Plant And Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule Of Revenue By Major Customers By Reporting Segments Table [Text Block]",
        "terseLabel": "Schedule of Revenue by Major Customers by Geographic Area"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.",
        "label": "Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value Table [Text Block]",
        "terseLabel": "Summary of Shares Available for Grant"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Performance Based Units Vested And Expected To Vest Table [Text Block]",
        "terseLabel": "Summary of Performance Stock Units under the Stock Plan"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r429",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of employee stock purchase plan activity.",
        "label": "Schedule Of Share Based Compensation Employee Stock Purchase Plan Activity Table [Text Block]",
        "terseLabel": "Schedule of Employee Stock Purchase Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block]",
        "terseLabel": "Summary of Restricted Stock Units under the Stock Plan"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Text Block]",
        "terseLabel": "Summary of Options Outstanding and Vested under Stock Plans by Exercise Price"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r435",
      "r446",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]",
        "terseLabel": "Summary of Activity under Stock Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]",
        "terseLabel": "Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation and Monte Carlo Simulation Model"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r61",
      "r130",
      "r171",
      "r172",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r380",
      "r381",
      "r382",
      "r385",
      "r386",
      "r387",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule Of Stock By Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Schedule Of Unrecognized Compensation Cost Nonvested Awards Table [Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense Not Yet Recognized"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r490",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]",
        "terseLabel": "Summary of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting Policy Policy [Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10140.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling General And Administrative Expense",
        "terseLabel": "Sales, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling General And Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service Agreement [Member]"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10200.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1",
        "terseLabel": "Vesting term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period",
        "negatedLabel": "Number of Restricted Stock Units, Restricted stock cancelled",
        "negatedTerseLabel": "Number of Restricted Stock Units, PSU cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value, Cancelled",
        "verboseLabel": "Weighted Average Grant Date Fair Value, PSU Cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period",
        "terseLabel": "Number of Restricted Stock Units, Restricted stock granted",
        "verboseLabel": "Number of Restricted Stock Units, PSU granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value, Granted",
        "verboseLabel": "Weighted Average Grant Date Fair Value, PSU Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number",
        "periodEndLabel": "Number of Restricted Stock Units, Outstanding Ending Balance",
        "periodStartLabel": "Number of Restricted Stock Units, Outstanding Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted Average Grant Date Fair Value Outstanding, Ending Balance",
        "periodStartLabel": "Weighted Average Grant Date Fair Value Outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period",
        "negatedLabel": "Number of Restricted Stock Units, Restricted stock released",
        "negatedTerseLabel": "Number of Restricted Stock Units, PSU released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value, Released",
        "verboseLabel": "Weighted Average Grant Date Fair Value, PSU Released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
        "terseLabel": "Dividend Yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate",
        "terseLabel": "Maximum employee subscription rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized",
        "positiveVerboseLabel": "Additional shares reserved",
        "terseLabel": "Additional awards authorized under plan",
        "verboseLabel": "Shares Available for Grant, Additional shares reserved"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant",
        "periodEndLabel": "Shares Available for Grant, Ending balances",
        "periodStartLabel": "Shares Available for Grant, Beginning balances",
        "terseLabel": "Number of shares available for sale",
        "verboseLabel": "Shares available for future issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number",
        "terseLabel": "Number of Options, Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value",
        "terseLabel": "Options exercised, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period",
        "negatedLabel": "Number of Options, Options cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
        "terseLabel": "Number of Options, Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant-date fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
        "terseLabel": "Options Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r437",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
        "periodEndLabel": "Number of Options, Outstanding Ending balances",
        "periodStartLabel": "Number of Options, Outstanding Beginning balances"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price, Ending balances",
        "periodStartLabel": "Weighted Average Exercise Price, Beginning balances"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value",
        "terseLabel": "Options vested, exercisable or expected to vest, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number",
        "terseLabel": "Number of Options, Options vested, exercisable or expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Options vested, exercisable or expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms",
        "terseLabel": "Plan modification description"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period",
        "terseLabel": "Shares issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r427",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Options cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share Based Compensation Award Tranche One [Member]",
        "terseLabel": "Share-based Compensation Award, Tranche One [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r429",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share Based Compensation Option And Incentive Plans Policy",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit",
        "terseLabel": "Options Outstanding, Exercise Price Lower Range Limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options",
        "terseLabel": "Options Vested, Number Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options",
        "terseLabel": "Number of Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit",
        "terseLabel": "Options Outstanding, Exercise Price Upper Range Limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding",
        "terseLabel": "Aggregate Intrinsic Value Outstanding",
        "verboseLabel": "Aggregate Intrinsic Value PSU Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested",
        "terseLabel": "Aggregate Intrinsic Value, Released",
        "verboseLabel": "Aggregate Intrinsic Value, PSU Released"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfPerformanceStockUnitsUnderStockPlanDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period",
        "terseLabel": "Stock options expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r453",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1",
        "terseLabel": "Options exercisable, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1",
        "terseLabel": "Options exercisable, Weighted-Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
        "terseLabel": "Options Outstanding, Weighted-Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1",
        "terseLabel": "Options vested, exercisable or expected to vest, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1",
        "terseLabel": "Fair value of options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent",
        "terseLabel": "Option purchase price, percentage of fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1",
        "terseLabel": "Options Vested, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1",
        "terseLabel": "Options Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2",
        "terseLabel": "Options Outstanding, Weighted Average Remaining Contractual Life (in Years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r389",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders Equity And Share Based Payments [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares Outstanding",
        "periodEndLabel": "Ending balances, shares",
        "periodStartLabel": "Beginning balances, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Shares Paid For Tax Withholding For Share Based Compensation",
        "negatedLabel": "Shares withheld for tax obligations, shares"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r22",
      "r619",
      "r641",
      "r668"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10150.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short Term Borrowings",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r125",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual Current",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accrued warranty"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual Payments",
        "negatedLabel": "Utilization"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual Warranties Issued",
        "terseLabel": "Provision for warranty"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyDescription": {
     "auth_ref": [
      "r307",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.",
        "label": "Standard Product Warranty Description",
        "verboseLabel": "Standard product warranty, description"
       }
      }
     },
     "localname": "StandardProductWarrantyDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State And Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r64",
      "r83",
      "r84",
      "r85",
      "r141",
      "r142",
      "r143",
      "r146",
      "r153",
      "r155",
      "r170",
      "r249",
      "r379",
      "r388",
      "r467",
      "r468",
      "r469",
      "r510",
      "r511",
      "r550",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r688",
      "r689",
      "r690",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Statement Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r170",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r63",
      "r346",
      "r379",
      "r380",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period Shares Conversion Of Convertible Securities",
        "terseLabel": "Issuance of common stock from conversion of convertible senior notes due 2021, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r29",
      "r30",
      "r379",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period Shares Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under employee stock purchase plan, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r29",
      "r30",
      "r379",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period Shares New Issues",
        "positiveLabel": "Common stock, shares issued",
        "terseLabel": "Issuance of common stock upon underwritten public offering, net of issuance costs, shares",
        "verboseLabel": "Common stock in underwriting public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r379",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period Shares Restricted Stock Award Gross",
        "terseLabel": "Issuance of common stock upon release of restricted stock units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r29",
      "r30",
      "r379",
      "r388",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Shares Stock Options Exercised",
        "negatedLabel": "Number of Options, Options exercised",
        "terseLabel": "Exercise of common stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r64",
      "r379",
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period Value Conversion Of Convertible Securities",
        "terseLabel": "Issuance of common stock from conversion of convertible senior notes due 2021"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r29",
      "r30",
      "r379",
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period Value Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r29",
      "r30",
      "r379",
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of common stock upon underwritten public offering, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r64",
      "r379",
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period Value Stock Options Exercised",
        "terseLabel": "Exercise of common stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r30",
      "r35",
      "r36",
      "r132",
      "r220",
      "r242",
      "r567",
      "r619"
     ],
     "calculation": {
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10030.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders Equity",
        "periodEndLabel": "Ending balances",
        "periodStartLabel": "Beginning balances",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]",
        "terseLabel": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Subsidiary Sale Of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary Sale Of Stock [Line Items]",
        "terseLabel": "Subsidiary Sale Of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Summary Of Operating Loss Carryforwards [Text Block]",
        "terseLabel": "Tax Effects of Temporary Differences and Carryforwards that Give Rise to Significant Portions of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward Amount",
        "positiveLabel": "Tax credit carry forwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r145",
      "r146",
      "r147",
      "r148",
      "r157",
      "r221",
      "r222",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r252",
      "r315",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r508",
      "r509",
      "r510",
      "r511",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r568",
      "r569",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r612",
      "r635",
      "r636",
      "r637",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Type Of Adoption [Member]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Type Of Arrangement [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USTreasuryBondSecuritiesMember": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities greater than ten and as long as thirty years, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "U S Treasury Bond Securities [Member]",
        "terseLabel": "Treasury Bonds [Member]"
       }
      }
     },
     "localname": "USTreasuryBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r479",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions",
        "negatedLabel": "Decreases related to prior year tax provisions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued",
        "terseLabel": "Accrued interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions",
        "terseLabel": "Increases related to current year tax provisions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions",
        "terseLabel": "Increases related to prior year tax provisions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r173",
      "r174",
      "r176",
      "r177",
      "r184",
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use Of Estimates",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance Deferred Tax Asset Change In Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrant [Member]",
        "verboseLabel": "Warrants Related to the Issuance of Convertible Senior Notes [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail",
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number Of Share Outstanding Basic And Diluted",
        "terseLabel": "Weighted average number of common shares used to compute basic and diluted net loss per share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.nevro.com/20211231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail",
      "http://www.nevro.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31010-122693"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124256539&loc=SL120269210-210444"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124256539&loc=SL120254536-210444"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124266218&loc=SL120267834-210445"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL120267845-210446"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919260-210447"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919272-210447"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267966-210447"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267969-210447"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 6.M.Q4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122651532&loc=SL122037091-237805"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124268681&loc=SL120267897-210452"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13A",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=125515542&loc=SL120267917-210453"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=125515542&loc=SL120269220-210453"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267859-210455"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267862-210455"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4578-108314"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123389529&loc=d3e10037-110241"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e13051-110250"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e34017-109320"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL120154346-209984"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r732": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r733": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r734": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r735": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r736": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r737": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r738": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r739": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r740": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r741": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>108
<FILENAME>0001564590-22-006312-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-006312-xbrl.zip
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MHM*?_GQUD%X;LV\*MBB8Y&(Q63?N')*-_VJ5B*'MUYTS;VI^%S=^_&H8!=,
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MGE@EDC?4F.TOAXB(_.G3T(7"$16G@^RZ+N]FIIKF( \/D2M?5Y93&Q8&L*3
MA!*F&1S<Y.8]P:ZPDT?<0KP"ZV'($;BFS"N+>IZ;6=_@EVKX_)N4IJS=]/S,
M@W-7O$1[6__D'@%5BUCL<Z9F70&/N&?J_/*/\,JB6Y1Z=R7H:%/F+U=8U?YV
M76\O'SW2'W6\%==J*I8V)4Y02ZDM2+D B#"D#$OT*<>>J1K@0R&$\:6HN]%
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M#"82!10>'VK0A(QI6]9KZEL*^;G:WJX]:H[B.R&&DA,GW7,W1K:>F[DM2/&
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MPX:KA03[[WQ5,T$%;:U/5P)S'RY>FZL/YR+#-^;3>Q=$"A4Y,@]WM@@GB$]
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M]#],"!8T>BB$54&7)ZPH)H?@? [P8Q< APX#1C7G]HPB5#4I4[Y+T3*?)>P
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M9$>KOO8]+SSHV8]57D;ZJ/R.]NQMG<Y5\1[_OBF%WMBP;=+^_EK!2;[+P6)
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M28E-S90'H67#>C6F_%?K.4D#%S2J?9MY#?LMM>T.10A?"<J;L]EUGX2[EEG
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MAHJ=":8$32_HI.:]R]S$LDL5@&L3(-T7-+^V^W*RWATC&;9MX4V._&W3+K'
M^HR.N)#BYNF3&T7WZ&#MV==FE]X9*QT%1S.0[:)ZG0\\X)"<OOL_)G*%DLO?
M?3VHT%%/RA O[;(?+RXK$7PS)?.R3-\6<#?5MRF)>UB4/F:;(*@GG05P9/L;
MQ2;?8ZQ1\*YR:,>7#3/*'SN8FZ_"(:&XMZAF<W)"89<BQ9%5L"OO5K@U^;?
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M<=K;@_\5G0GN1Z7!4U^#"$X/90]68-*_9.BWZ5P;<R\=6GX4$!!98C\K.Z$
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MNR1*L,K"Y'$H;TRY,9..=VA70-2AAG%>M\\T*/PW'/,6WC2;F3S?KT#V)U2
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MB9[V"B  XW]?[G\HH??:.;L%^_ZFX_-:2A]D ;/GCUB.27D$^#NL\"\4/%1
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ME,O5#. :!,&. 6SS_1S@ADAI/XGJR>]J*XD*:.:029>J3%^Q"U'^EU(HLM0
M8X7W65%X?=::-O<V,<A%NL_MOK[NN$_&IL3&W';SU^53^W^Z6UMGWF:]DG1#
M&D^$?,\?]PJ^AGH+3.-V1NR-G]) XDP)IA6^BN< -@I7GW).C1%[>9Q]QBK-
M[PS]!P5[LA-^U%2"_#2-VM*)#J2*%YJF_=@/?P[*;@^NDTI6;T14)4T\-2TA
M6C:V/0H7W+;*=9?Z9>5K$T:X*:/FQ(%#QMNG$=D55CGZO3AYD]N\W8,XB\)K
M'B5<]9RX?M OZRWB,[%D]9^F- ,RPON,D=HWP!.GO)#YSQ0^4H!2.V5JZFB<
M3J,8N8?W*_.?L9@X)!,DW7+>!9<5(GN!_6""R^'I'*F.4#^RL9<A4.&=?LMT
M:*:&\QS &)4#5H;WW8+[@:]11E8E2%FG<K!O'+:]5^,LB"8KE,*Z'<(77Z_J
M'>6OB]#\OV;RL?GSP3K-GXG[X%417N*9>/6>]:DJ@[R_']F5H')L)1MYX%3Z
MF"%+_Q)<;G)?X6KD+9EV!G[A)X7#P-106G3L08D+!U#<KIY?/<->TV+$;4>'
MD17R6N_0!NZ;-_S,4"G AGS!;TB@Z A!V-$(E<S5:UGH25FB*O)H.^1TS;=/
M[K<.*KFM4_7 ^$=[R9N?E57/UMP)P..+P!P;#%LJ8S[K#)-9C,;GH>.+C#\Y
M@N<U@Y'>*O M[H3CAB=-&HMVC7>2 ^3:WIKE49LYG.Q0Z$;[S7X<R-9_I4Y6
M/&!F6K/."^U,<]]:JX*]@(J<?00]06> V928$N TE%O>%!6B=ND[^--E]-O1
MO^H6>H=4'(@V@Z+7__(*^(*&4=H@3$\2L&G9<]WN(D'- >7#([SO/NC;.52F
M!F9VI&81K\4,\DL0G*'G "ICZ;I8B"2?)G>YIF:-&U[GAPW6QO)]!:W1MORZ
MH3][S5]-@WZH4#^%!O(B$<O;;]].)]OO3E1=CGI?J].N40:R3_-D"OXR$])3
M$=T=O<3_]T*[A0%@@T#&9S]ECC,Z =MW#]U50661R%$P2?J]R'$-Z<JCY[A;
M5JSID]+NBQ7+FREG%\$H5NW"+R?RD<+L'TC4^+Y)BYG>O"\WPAL3/8__2^:P
M=3VKZ;VLP*N27X_83ZWL&X%7FTHL8VC>0Y801G^MMC<;S4PL!T? 7Q!BN 05
MF8J"ZVZXDIA64O"]<.,?C@<N!>WCEB</.V>4^"2.'[?,_.FD7RS-[.>3QDT!
M'LB$:"I=NBZ'?A2<]FP(S@7\4(8X?>R[!H1)_X?JU '835*J8*](%_$IT:22
M@\79V\)WVECI4ZX*%2?'ZU^1KCPYX"7;Y[O3EB0E3#1=&F<;4Q*,KZU 0$V!
M!)M3Z-L9+V. WP%?)SO77LAF*3BF$G9!VP0$8W4P9I\=[!/E432C['\<C62"
M%%@76',GY&:\Y6(U]:[(<.M4SW5[84<R2<]M1K(<:%ZCHGF]R;FHU/3C(;^X
M>)4F5/2QFE=\J3)^[T[Q<0J'J65P=#%D_WF>)+YO^93O]>.0^B0Z6^GQ0\V1
MZXCV\3PG22]>3RZ'F8W&"NZ,.2.'+??]0-)]$.93<_HWLCGI<5(0BZYT^CN)
MX1#YQYP:>''3#4'7LA+;<<1%SL.4@@A6,HL&N([GO;?)H;.:EW!:OOW<B2_\
MO6H6)OBSI<*,&0+6K#X^P+9?$LKC\BB\=[J? (+,_ZG!PI?HCKV)B>F!2%(T
M7B8V4/'T]6R^>=W=!E;UR$0Q&XN,;.%G7:_NNM[=<@$WP/ONHSQ69(97N4G!
M[D1+7:)(FJ9Y@W2J6R4DX-<V1_Z\A3_/[X* V9<%YGDB-1A&W\T0F!*NI*Q7
M@#DG2-I:EXM76X!V1U=LT+).AUULC+V@?2/-=8;'(F2C)RRB6;M%G;#V7*'^
M)AT=@I3WVOU#SA#6UPW[<D(4)V;=0-/_CN]4Q")P48HE.[:YP,3R),+Y0U<S
MR;S.SF59:6(=\2)02KJQ=ZO,-X;EP7K.TW_ZFSKZ6CO_//\#+YO9TAI>SE6V
MQ=<;4=GLUC(OLK,TK71F#YG2.P?$LPYE.$+@=+Z2E<]IF-Z9CID]Y&OXYGXH
M.']0\!];S$7V]HGE3+KA#0ARZFU^#+_:T=^*@:XV^$P@V\RZD9+O^FN?/,D*
M-KSXD8B%8EZ.D4JST:)06 HQH"2((@*YS2LB?2?H*Y'MMGB&22T;H48_Y%E4
M9X/'4>#DR-'PY>9U;;?)57E;[<VR:J3EU@Z;S^C7O=*)/J<_CX(8U:EV,CY.
MV.G]J @$N,; 1^:+T@N\E]4D@R)_(8:F57>FX\[@S+G+@9Q&/".+SKW1*CP^
M7:@#T/OR/5[7*D[Q;$/32G#_VQR?/9?5HH@6S3C\R! =4QR0NO<.U&C&Z*R@
MC\(U<S35+'L?L=N^NQ/8^2<B*Q<@'Z*OY4MZ=Y:,\I-)N&B "T<#XH--K7&'
MH=D@M3N#V3L1)]>__:DY"FPRJP%_B7C\)-S@H+*C/5>/<_2S1D9PRMF%R(D]
M@GW;P02^6+U)$JOP,7/'R21WU4>]>%#E>>J25#GVN'>ZRMKMM&[@SC7;SQK4
M5^9;+]@G#7J<F02C.\N&TD03); ;+^HAT\,V$\@=%>[)+$_(MWM!2W]^E*L\
M&C6_6J$_QM%HRL1^QM77)M]+0UCC06Q^C/%SP#M9.]71\&KI&3/S\K-\;\2;
M6\77'![:S!%SC,;(8^> (8JHFVK<$(C[H)<3V_.$E8;Q\OC[S7")QTA-T'&Z
M%]ID$B%D%ZH3]GY(A/ILW0-]L_L<$/<<[CG^7MJ_B@ :W&SK[,CF6@71K3[8
MH2>V6ES+''<J4>-$ZP3O@!/ U.< [\ K9*F+^L<_10"UN9=\')CZ2WUQM$"2
MP?[>N^DVCN]M6_$L4GMUE4]4]?:FO^K3QLKK^YY:F"T4'T/O?8 *$&ZO1O1"
M-:HN?U7E&GK#J?7@5XR\+X&.0E=^*D:R[:/0DB*((UAX?-@9K;.(;:;NO "!
M4AKH[1_HQ7W6.&_QT1CR-MU&HO+^ZH# T]^^WPDC+TE47*5X53/1<;F/UMH2
MXTUJUK8I@]%1UA*UEE:6&PWF_::6)5;9AJ'V2X4M(T1$+-2Q*M=C.;J8R&];
M//Z<^$<AXD6?15 -=W"=4?A&]5&4R8)Y^DS5YI4]Y)]R[89K=5C'].B''IWV
M9*W@6GM#YN7L?T7!W<\E9!@K\SY/:J10=%"8LFD@\T4'.Y/-<2;!\Z=!I.J1
MB#NKGI?ARM$VB2:%&LE6C\QNX9%<R#4FDE#@R!)XD>Y8@Z#T]>15+Y$I[D+Q
M8:\3G0?3/[V;V;V1^)CSM[C_SQ3-K+C6^4/4Z;US0+_M!4Q_7S1ZI0OTZ4Q8
MY.\P/K,ACC*9Z;DY+MB$3'R/_G='<.T8VUVOV+5)CTS8WL#O>6!BH:<?O\(@
MY4K:;<E]GMP-+IA#M6B_=6]M$]NZ$4/WH8VUM]$W5,1; R2>XX;5I/P:%?EA
MNCCBQVO-?8FO"B7.HM$.G.J09*SX3(+=RL)TGOJ'C>Q5&>O04_V8Y/Z#P?Q[
M&??45@[<&5K#1! -MH7?^6_SVXW5.UZGA>UZM*9GYB7"S)?Q4[U*A$ RF\BQ
M#A$5)TD.KR;[$3S+"J5+&8Y6/AV18D_-I&YD.T:3[(T--*_D%EH[7N&]R8Z'
M7P%AJH'704^1BV\H:!!UZ\X:FW?0+_5>9"U9MR-YZ>[:.]T-O:MI&'^W$,-'
MGC_0?719X$1I%ERGKG)=\MC_L7:>;TTT7Q^/HB)-E-ZCTKO2>VR @!#IG4CO
M730()"H"TJ4C+2HETJ47Z:%($^F])*%(3T!"("$\W+^_X7FQ>^V;W6OWS)SO
M^9S9,S/^<F[.5;G/G+;16\^1#XU>Y0@K]_(<-+MK206D;UH;GSH3DSI-G=/0
M(G@I.N98#(T1:BTSE.&I>:F1*297V2#'I%!';G)-_H9M66$@?IQ"5Y'GNOL0
MQ^F<('R(?GOU\Y,D-3T5:F-N9PM%,^,^UK.'H7>?OB!:XM!I1O_-<@=V#5:9
M>]"[$2)>?4<_& &\X@#X0X:HR>PF8K")=@"WXV>UM)F3LS]Q"U+DEZ@;ZLI'
MPW#P15K, >IJCWKP=CZ4%>UU"O_%-7(ED*+M<:;7[5'''MG&;L7D'PE)2'7(
M_:IJ5I0S9BWO;;>?9K6!Y6,)!/<F<BX4'V"<8P9%C4O-[GNF*WEX+B9/[?8T
M"9"/-*[\-X-JJ[DB@\08JFNK.@R:\^^Q#Q,++>5-+:C1$>%AN6H2^,G@AOCJ
M,E'Q6&?,^QS@ @;:6I5P#X/[DH:+Y;SH3K:1=R]W!/*MTO4%G1Z>%I.<0SFR
ML>> G7$\&.T=^R0+&:TF'<:6))%_ET%+@-GZEQ)I-JX['SF2P "7N<A%*^>E
M'YQ]O!#E)V=Y(#=FZ?>U^J^[90>%*DNUY1O'U'2<Q=W[I?+7BV9JYTLM/B3U
M ^R;TGYH!OFU<=EHKRRS.)VH@\M<E>@/(IVM+QG\AL8)N(^'_OD@+9; H/-]
MUO-:QN,1/#4P'"U=('T%KQ7RR"(TGQ5%C*O@+'^Z3!-^0?=*VXK0\;KQU+'F
MN(EFQ(P4[DOZ55.M2:6N!!3"N$_^OVV0 _Z=:<P3QHG\I>XGWM"_2\R).W]P
M!]=#-7GJRY[#RS3\N%^'C2FMMW^3ODE9 E5#(D.E0;%'B?&4ZRIR?NKD:^KZ
M LD8^;AFE"=3<;!SYMLD42JI#J<;VH=WU#=B_OLU L<9+G)WY[&.!7DR1L+H
M)[VXQB%Y<T\R]'#PR".1.G%1Z4;2;97"(6FNJZ]2RTJ3IFIPON+#U1(;]S!>
M4W$'Y!JA_L#K&+S%EOR]?YY@9LVQ2+ZL'*92H;/UY%&A?Z^>G-UMS!;"V+&C
M*3?0S?]D]^YBI.X.>JS\((I]ZFEF<3,U%7,45C'P27UI"/YLNR0EZ@&WTJ =
MP^(;.H$WW&"R-8K/B8@.LU/P1^\]&D8)E8142=_;:4U.[B_2/MU3#5?DN,U%
M<:7(P3ME09Z(F7Q,>A4^@\ W7:?OB0JT&?EN\9?MZL:4U[?/<>TS#6\>O PW
M_5'3:6WIH\C$>)M/_-2$.(M/[(340+J\73&N<5_;-6[A<NOBS$<WV3"8OZ4[
M]5HQ3 _F.3D=KM,JJS,$(U&@>03!@EB#S@8S$\&8_0B7NI^1;(VU31-?Z]JK
M<B.M?I]R*G#LW7$P,N6^0-W;TP,XQ"V\F29$KF^-4]UF\,ZPORQJ'<J5Z>YP
MCV.F.,Q!Z<V?@EQ=@_LEY6*AY84N(S^QE%LK"4)?/SDMZ'5;>(7'!DC4,,0.
MUHAQ%$8,^04\CQ=U*%:IR%7YDX-6&DB=;V@5M_U)D8<- G%6^QR;=FIC;?24
MV65&GU#>\O(A+O6-N)ZR]->?MC)NW-6>>OF-;6F@WVE!($_X!<N><B?KV15H
M0U<;$[$?-V^'*ZJX/=7"C6=$!<[\M\C8OER8W;2H>DN,;!TF23!Z&MBEW7 0
M?9'XM>+W.WQC04P:K&X(JL+14&.\ED[E#MDP<.47)F\=H]?$;RLT]F^^MR@D
M/6S-)L.98_#&.>"/"P*/0K573>_XXE)Z(5P;4\(U8Z%W5N+93;.69O3@R"6[
M3;-M'L7[/MS\5;0.N?U77_$NQ)Q6WH2^%H^T[+(Q1UE:HX>V0=TF@>@LGTH%
MX*W('&=MUJAX'974XHGO^6(>/C>>IRE\0<AHB'?E20]ON;0$=I+=\^R52B,;
M?:E''L?RYMR'/NLEOIE1,RGN?!18J-,XDI+;:[Z6'9]-YL*? \C,(X3U"T$*
M#=6<AHE1^F!W)EIL5]P%LC"2XD\?AY2"'?:<V+@2(Q7+<SMJ/L:^;/,[\#(*
MS#KM(ZA?W#6Z3$SI.P5W^LZA.HU"0?BPQ=VV:/:8+^^P=8V3MMTAH=K>4K]J
M.[AO[2<&4)^$Q)S!B7"2.V4(<8NL3!W=HGC1"<V;;1?NZ^I,WHE?<>=GDF^=
M,-H1EPB)"_@62;OR5A\N#<29+[.268DC)/-0T3&0JT@MG!7:8X;2QS^AT#QG
MVK<)>S4'9?-W9I+(>#X7SO_[M<*M\/MKB:.K'''F'^L\<<<\?K5F&I&0N')*
M71^-,77L-]Q$KIZ#"]H@]VF36T9+H3#<=3]0&PVMH8K 9="EX\$1H=ZBSASD
M8^D(G^N5L9'2='8< [BXC<CG:;K_RBI.K)#];&GCRR2Q2#?7!/'L8&RZZ$J"
MWFNM:YQWTLR>KCWS>_S5S$CV4Z#QU9-H@=7#]R$)V)1W.^+#;2R;;]+C<>,=
M5F8-0?)3I45$Q\<-;;G3QRDV?47S_+TG%)&G,\'],SK]E<\NZ5(S-%4=)/6&
M',9=BL,V@&VF#\VD(K@XFB=R)M^8>)A^!=_B[KTAMX[)LMLV+.8V4!MMCJVI
M2]R-:[]90]]^-;;4X*7'%&JT>PJE'I:F^RGNA">KI<EI-;NMV;V8/ 7O[#F0
ML*,^RQ5TLKP"D\ SR_"QO"L2G0O3,$ZT.LD@N%TT[5.R'W$95]H!4QO[;X=>
M=NCC+IC$J/>1R#\]7@^"4BU)O.>D_':=SA--UH=4_%\W+\1C&>?_E;\#6+/I
M<@'D'RJ[&S=[Y3Z><*IEG05>/-#W [ JHZ.8)\,%I_'I\;U.T$\OGAL+?"HP
MUC,0I6[#YOZ*.8V>:+D!HF[D_NCQCW^>NV9UFLZ&ZL'?RI;2#1:G\9H^5 -*
MI$WY7I;#.58/^WNS&M:#484QY9%IYCR\'*2Q0I'Z<IASB.K<MED;/9'Q M'N
M$#EQI%X]K'1L^\T6??SO=<8:L'<^,7).W%K/>C" CSIY790KY%?:.R'.22.#
M. 4</* VD7'3BBW%_IN[@K_[G%FVMZ^CLZ-'[!6%J:FJC^7HZ.> *A37!U,J
M */7Y R*76JX4YC'<>^4Y+B957T#W? *9D\^I,#3 R$CP<=L&PM@,_F:G8%Z
MH;'$*B3(52N5J3I#B.^#Z&AX:X9,;,ZWNI2GE&HT(R-1^[V[22$J^ 90-,U2
MQZQTV*A-K'E[]SXKTJ@,BU04+QZH=$I9/KE]8<;EQ]RP62 5ZZ2SSIT:1I:2
MZIZ:W1][8,GJQL!D\@O$&\KW-AX4.UE\Y-*'."WF+ACW?0%'AZ]<FL6][.\_
M.+Z__U;%_ !UH6=ME^!>E>_$WIPH1*DG^'Z[H(=)R"0[Z@4<#8'RA.=2;N+V
M)C7"=6KYVM]6CI.U#3.BEM@>FOMD$+140F.L3: ?51JF#5R:@OZ63Y ?=TXJ
M$6NPCFG22W#OE7Q<Y:M8E+B.CK"T:XBML,M2<<VA,85.O'2+ *P2[J:S51#E
M&C&&>AU%:@K">BTA,M_17YFN"K\R<53:_Z^ [PKCC[&==F<0T["3=U%K"_%=
MD 920(+SZFQ5]*-*X,]Y#N#MOTL;\J=Z)%\R>_/9%Y#S<BR$[N4LDZ2G'6YQ
MFB")DC(-XK:Q*8#UFD1_NQK2R%FYCJ70\)(\H.8$.3PBH=T5-'?#'"<<>:0.
MV]J;MIC 9M'QLG?C=*=2>*TL4W58<Q=;1.RADZFJHK>G?>G18JX4>KR"<;H(
M6&Y0MDS!64W 6?AC-WKB=L'F>/RBI71PH2=LSUU1(.50"<NN]X&29'.GFW-/
M3.X@9SE*S%FN*@U#*8_H";&4IU95&FNN+?CW*MD7,WY*Z'[@ZJBL]4(W;JW5
MXJ5D@K+\_XI$W/]M<_O.3Z^L%Q:^V(Y$=>P+Z+[:N^\I0K"N^DW(!.3*/+C<
MGL_(3EF"5+]^3Y96C),'QU,8O$4L]4,\6>L+>:J7(J(+GNZRLH>,:%SQRX\8
MO$=O$@#Z',9(88(3Q1K(+"GZ^*EW^1[U<'HUWN+-E'. CWS+-W%I>J+=F3P#
MEZ3F0!F=__>AA)([+HZ-EZGE[:ZO618]S':Q,<Y";SN=:)DGN<CA&TO^>=AO
M3I9&?Q7S0XT3/B76><]9V6J=MKFX__N(\0%B>$JCB'IW\]@_'NZ,@ ;O*]D(
M61IQQ#1J:K4XBTT*ZU"V])R:ZN-RRYW. >620-04@@E&OVG'@<_]G#?=PW<Y
M7!LO&%<QJDMHKDBNS_A1!93YV;OSKG,!F30,EX&SP5>R@?7P'5G\8S-B.XF)
M&/4<S_B!;D0R,ASYM1G/4%ZV8_LRN_RFBO6V0OJ+8#^;1?8@<';X^*DI<1M?
MV@FLT>X* V.B$KY.4$>$2A.X]49V&I\<^PN4W=8Q!<7(S2?KK#CA[4)P(X35
MLTP-<:+/>#>,A=B.IBG;VUWY7+XQ\?4]9;) \P*"8FS?JWX0=HIIHEUD"'U]
M'2_,@B,?JJ&$!D!UU1(#K<\40%+E4>G"U+'Z3225).1K \-X\"O=N2"?OD7\
M\76<-G-9A@2&A\+)R.D,%5/*N>'ZJ.7>#/EN'#^G6=Q6HU:!H)COXH;1NO[!
M'DR%,@#"63/>ZL$N"J\@=Y-P%&R'U4Y&>A8-/JDA?7;:NO&35GFE^VX]@\HX
MU#G=(E8BF%>;E32*=R",':*IX^OT95XVUTZT<'^WG;/M[O)T+Z^0VQ2,A#87
M)/5SBU?(E!4$\4S_#W7*\'T=RW$0KC86MW; ,FI)G)@JB## JX]$I%E65/KL
MWU4)BNBOC=;L_48,2 E=>\,^(G\FX]8L58->GIDW^$,&^P=JU!21V:MBC5R>
M2WU-4E-FRC9"@EKK0(W>"\D?LD[WY-&_>5%2 $P+0BSO82R&WIECG9/AU<*]
M\:_17W*M>(8GX\42S'5#&Y!&V:MQ.=]"V2-MK'MFB,32CI/Z8'#,CYS[J0Z%
M*7A!D6*S4NU;4977G_?HWC,IT=?BY=D5^3V6ZK5\N'8A)#RV[;7G@%W:^2?2
M!,C-_>??[OLMSQ_><W.T*>FE'C*%2L@\5*K<FO!QJ%#X 4@7\VM]VO]"QL*5
M)X9R"VX/FI=^?A8+=P<R0?=(J#'/]AODQQA>3Q2?[,T^N08NC;3 \F%QCRFF
MWLKL[S20^U)/HUY\<HTS/T+Y7ICPYEF"(.XV,9:Q#WA5\TO_91M=B&'/@)U\
M(X*D-.\E35AP8>8J!JN^/1MYG; @W&V$6=#PC>KW5RIKN#]8W2+%5L$56ZYC
MBOH3+U;E0VL4;F">*&/P^EBY;&SE]+[_,0VZ1:UGM9$\?S5MW1)\<T.I+(Q'
MT^)/3BI>K$!8RY3'45'*VB1.WLS*<H$2 EII^F2M2?(CT[56NS$;43IP'Z&6
MK#J^Q&?>'V1]J0*?[M?+[[68;_J2V80M\2Q G $I3&%K0#/6HA97XME=DU:O
M\,=J&)@52!H>2Z#:D&CL@2EN+=V9;E\IAN.,$F]X+'&.5V9TV/%.[PJ,'HF7
M6E*Y\S'ACLCFA&.NXN?>V)#Y;*,_FHW) D8FR9ZG__U-BX"-G/;MLI+XR$^)
MENC-K_5X*C>SN<@,"?R>CA#N@*ZO/NX20F%/]?5["<;VNPGB"R/^)HT@X$J1
M-L(@O-NI)%(62#NV#E4)CO"0%S4NSG<W.E[(T-:<=4O\C&YI9^V=?3W&_5&&
M5JE$#IHX;U\]\"D\7J+GA3N&95*@+B4G+,=ZS69I7J\>K@+_D1@)7RE1R>C(
M53@DZ.+W46?4:+73]6*"*J^O0576@;J[6M&DU;J.UM\/C7%:K;.1;_ $*"Z#
MS%YBZK#,3&%?H9> S\PY2E%3EQS^_$3]!K]/Y(_:'<&1""%C:N8D*3)TH@^U
MZ17ZL,1C3G#C8[JUJJJW5K""AYEYLFXV]M5!_L&]0CT>'JI&^.,&8-WK'2QR
M\_YV Y"CA3X+DNK#=F#K<(G[P>"G7]]GG:ER4B5DQPN#\^ZZ6%88]YRT<N T
M]+.>]SA0&MX-\:=-]H1Y1(I-NDWDW65<+AV4-Z@@I HZ39U1F''G@!LN"\SI
M.M"T;*>C'Q;N+VIXO@6GJ4D37DDS"--.%(\6&S$8KR>J\=89F;]N;:?[;WQ_
M&6< FKNX0.Q>Q <&:CR2<NNCW%D@&.^\$2//R_=OP6[+:O_C\DCCO!?,0G)O
M3:#YSOQ-]!OSH7, SN;G8.YK0C-1_ZM'QZS;J7-A*E?8*J+YX[RMW6/)K3M_
MNP>H.;8,].':D"OMWKZSYP!")'[C8QM?J#"^KC(A"$C_2%K>5ONIH\+GR_>D
M[K)SV%1C.?IL@BI[I(G2QQU %H]7[;1P-V_:V?71T#L2>=QXEE<W]0/A$G.Y
M<XONXP*&I9CKY'2F9P\..M;>]OAVA%IFK?-)KAX1\ZD^#%1-!B#3[$6T$).;
MC1.%H8JU\69;6D:)>_EAIFA6CJ*Q=B8E8%1UXA7\1*,B<\R(C(K:PZCA0ZY-
MDKN^87:D9*_)M'2-J5")?I]VZ;H[<)2Q:P9;1_3%G7*\=>/'*4;R?_AZ#K!D
M<JOW*$^(NDUENR/35<+M,Q7ZK91Q:6?D-BEE)H\%QDK<)%%=!'H#"E6H#5%T
M99^>_ 2_'KT"B6YC'MU1 Y6Y-1_]JO)^Q" UZ[U;*3?-[_6)SLV1_6JF4N:]
MSE\5I83W%S[4#!L&4M?QTG51KDQ)PJ2AQ]TJZXC\B@RT*!]E7C_Y8(\;)&O\
MTE# SN)3VQV&M&?IJ]/8$P0 [WO:$S_@YFQ1[%CLZ)\W.Y"K&?G2T:C0U4XI
MNN1E:^J7B>(!8[L-R6G9*M(Q([$4?2;%/EA#@V>C5>)J?,8@II96W+RT/#.:
M?Z1LG_^FI+J8G2U7(WNV&&A&67RA21((]:'R0! ?[[4,$_E==H[XKV!OPVOO
M[T+BVW&^?A"B)DR1A0]"!@M#,?Y18CX%MCN@* $F%I@=H@Y89Q<.Q[,33(D9
M!9;S:AF4.T2X_#^S7]RPPQ?R_#[YW U:+!7J57$YYH?%%](N>U:DP4X6FFZ3
M)JL3TS#>TIT96:T+TW.:4TWW:DG.JV\*_N@C^]:E'C^)7F<-:^+98#UNX<YP
MD&6D@>[%7S?K66?Q)^KHT44FUJ6N%(:O9^5S3R37BLU^EW?3@[PR(R=VJYF9
MOSM]#'5$N#06ONL<_[4UBH2P@QPC"HW*JJ1H"[4F189+JD;[W<;^4&H-?YO2
M[@6P2P#$J&'@+QM\D^00RL20-85.>(6@=0U$U%&[PQEW=A34'ALHL^+-R7-K
M<Z3A"((;Q[IV5<9I6YP#(BRQY52]X0]:0M1#2$S[NX^?_?RM]CGF[=?P5]Q1
MZIXG!F?%.F"B1&)X?BJ,#$WIDK(!4'5/CYY L5<2#Y=*.U5D42XYUF!6K7*N
M*G1HJ"U7DE^NLDJ NX%,C:WBM''^IFAL8:;3 E4TJMDB!KB=<+GLOISKKH@!
M4VF4.5)@M9 M-\.E_ ^EA:SSU7U)\$]0&)59@UZYK/FXC]P\R?V:$69L;_%;
MEA#O=>CL.VPKG ]8HY#_G=(%PIF6^W98K09:$ -[VH3:<)-IQ4,*T470@2V=
M6NL(FQ(U,S\QJCNDO+2SU+ UOK_M)3$4&]!*2_M5><8K1!(:N*N#ONY4E:4Z
M&*;8K=+MV;#3/)SZO?FZ5.-MG9M)-YYN('FFI=]GGK+6A$Z'!]ZP? 'M$^E=
M41::3)=F?%1N(_ M+V>@9'0YB*5!/;' 0-^<,765[\[:=*1]QVPZ'=<&7?$@
M573EHW0QAI[E]/OZM;6Z 3]U@$_@G6_:W2S(PCCSSO:K_R0?Z7F'8!0:/$M:
MIO:LA_Y(($F"$_0Q<&C-H$HH\G8$CT/;UH6_68<",@BPLR0-'C>NO&S>C&@U
M<)$F!L+\-.9N\D'8 \X='\&.W^> 'X,W :LK2;_4X(KI,.5)^$H1HD&[0_\&
M%OSS)PX>_K*2WMHSW?QV36?19OJ?<T#70^C@KUNVRUU"9LHW;H#50;6M0KWS
MNN,OS[B&U4J]A0VJQW:3M%@E=\K'YI;DM[MZN-XE^JQNM'?'\1#%PY5\44WM
MA).I;M?/NR+JHB-,Q1*2RDK]O3;U/F:IR6DB_0)%(SDX<ZX6(SQ=7(M9FM@@
M37A^1+_2*[CCK+%Q@LR &>Q,GJ/R-;I4TB?M') H391D^XK1=R3L$^&.[H(5
MB!)W+H-LYQ72\+-SP+?/@I.WLT:[O5/=>K^-5JG+=JZWC8V3.2]@!TN20LAG
M]$A'_)GM=_68>O8R7GXU>6;^"2YXZ.'M$T'3Q !&6 N"S)Y"",;G9L1HL,$F
M\SCK0W:%NY)FH;YVM35U(:4_@U],YD^N3&P\T1+UB&7J&KO49 WXQ #+@_4B
M<$8CLUAL1E<B3:XO1NH=&@%T?V.:D(&1OK'=X#\+87CT>TG$*6^6QRO$\M&>
MF< ]P=0$&5B&\N^JQGT&)6K6%-P2M6K'&DM5L(_LW,J2C,4SX],6WN(Q@^>G
MW9O*)CX:_U*Y7__4$!?HO^>'3^GV0GXDQLJAZ7TT*NAD^S>BNLL$Z?L8I;V-
M"L&>1OY&:5R!X45-R;K&UG/2!_E8QIW%"PL@B6<KMK[HQ)Y$GE Y/.-[LL&/
MGC+WI)E9]\J[UL\:;EYI?1M<'.WX2#?/'U*"P.F< V8AF(:=-)+"<J@2L54J
M.8^_%5_14-[C_,VN_JNCMV/8V@E3;-1)RXENH@RH.5M+J3)?XPYEH;TZ \4K
MAC7#)_:V4UETL@0,L]"5%#0P!S]UNM]5%?RNP+M #"?;&V)>0>8@#J\@$D&,
MM971",8]YS9<6UU3+0D9AYSCC[O(N>)X7!2!03_#3V#.W3;FW1=Q*5T/$O6C
MB9UQ1.9K7-G?%V(K:#5OCI"*\;H-D9!J_W#8EH&9&<AW90FP0BY-\/#GE9+N
M]M>^5592SY72X[#I4#+6.:DW+^7A\THOB!U45Y>M;NZ;WL]_7R*?)^ I/R?_
MQ#^J.OWU4.QJ8*/K;?^$2_V$O?N09$2]-IG5N -4+=U[#J /99LD TN)%_'-
M-/Q9^V2EQ.AGN6U>&X28G_:57F4Q'>R77<AW& O^*C)63?8+,?O9H5%?MXH!
MHGSFI.5^W43YV#KK"_^HF>W&%X[*IV0^1U1P'N3]P*&:-\UHU\8M:$Y;;8Y5
MI6YJJA"699^5W;ED>VEC:]:5W:FIUS7;V=)'(T&1-6D@G5OFJUXV@MK*WSA"
M>5'2J=Y6PVW+\AUCPQ4^&75MR%0;XX4<9/F3&"E_^J;1ZT@$Z<3[3'P/.Y!S
MXWXGYVK2"!:Q ;D.[WS6 ?RQO,O8&+8<E947UA[FG8-%8L>:&S5%\!#&0+=T
M[[>M)#4[X.O \.Y,DL%E3 3KJX,XVV1SGW_I_;;+11FM(_V51$7[A5!9XF^'
M?LM0\Z):[[-_7'Y&.KN1 ,9-R%AH^)!M>=>J+*L2U1^GEP)Q?!K[=7"A9=SC
M_;FH%>V=$]PAIA#1"XK)8R&&O:[8/@U;3RG:;M#WY;>,!23*L"8\F/T4/O/B
MWPKV./2"1G3;[4VH@;4-*!UZA!)DU[+)<#"HH?>>[#Q?VJEY/*=0T$<\(Z@R
M?75F2)-F$C7 :A_9;5*T'_EE?]=]/%5Q5]CE9Q%,\E\09HEM,%3R%RZ3<K=C
MI0IJB>4WIHGN06^:(+U,M9UURS4U]E2\G>KFU]N)DK]KRMTO)',YSDON*'9'
M97</X5BF.]@L5ZWW<<WTM\:_A*\/0=W4=;#[E X*^X71\Q?)#'4( @B__[9%
M&5<$ONFA<RVW8L9B8;&GHLQ? 2DYE'(97_;3D>8,^X.+\@[N&0_LA#<D[NCC
MC5'+5]3LOT*[QFW'"A!/IE\6:TP[$G8Y(_,%"QA_W&M*5^+BZ/WS^E?32A;9
MX;\"#M@\Y=)9MJ2:,TDJ-'BBD BSQ[,A2_\>4P02]/1";,UTKI@3,L9T?V(/
MV3B&K@:4;UT2" -?P_K3=4F< \2ZG#AX^I3Z#_^Z*"?0W4.1W,\,RL5>FFRB
MG5+7S.+61#5U1$6,\\I)R"XHXNT@WDX%-^6?Z:\A&U4ML1WE^'Z F"A5V<_A
MB#8K*(R"%I(0KF8Y)BXG99-/%BL#%Y:[$#B[6:K/;<)DZ>?%!^^^;>9JV[W*
MG6_J^!M<\9IPZ>+U V S[=?/ 5Y$N!LB7A]M4CWU!6]0B,G5UFX[K-B7'[G)
M<)BYT]=/KUB=?G@+9C&Q8K[7T[<+(2G/;1IZII"=<8\VM615E@;+.AP5U@*;
M'G@/OSM;(U\- %T#>2-FMPGOB.\JR')$,#8;PNNQQ/L6XI$Q]YBS=A Z\OLN
MZ<%UQ=O<NKO*ZC2L>'!L8S9#ZH9<P![SX,&"E"RUA(:K7:2E.0.G_>J<;F Q
M'SC :#W.ZE7*^O/1FG\J;3PX(<=NLGSB4(O64.!"GW1W5[W>V^+,L0ID;)0
MTM0X7[EN5[3K5LJK6!WQO^7X/C);-B'L I_Z20+;=J*CM7CI6 V.A3Z,IW7G
MY=8A+H:BS:!,?@X)MB<TN05^K0Q^$-QCT-SE<8SBSM? %6O2YVP3HFH(0;RO
M)35ZO7Z2/\/HW?NF!?YWEV)!00%?DF+.DO'(#[65?%!0-^SF]$H"]BE>(_&[
MV_0?QL\N-2WO,,YW?E8K6*N]K,0HHH][I=GAG<KG #?07&F';%&A-U\-^AS
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M9MQJE3E@8;[C4QBB,V?4UC)MTSYK]_-5<]1;>5O-!X;?B8\(N)S52T$%:NC
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M-0Z"E4HLT@_ZYC9FMSG76WK%8+,(HF3X8CI27I#-1=7AU<ECJE\]P4L,H^G
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M5AR^UTC;Q >\I1*L(*9;(<S 64B;QBXL44C-YS+^P6LB [4:PE'!@5ZP@W_
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MGW\'Q#T[O\NMYB=>%!^ Q.+H:P,2I;'L'P+PK'1_?.F[!W"_-BME(5>0G/
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M,N_?BMD'LMV5X<0P=,@H:)OYQA&5.8H^*2A%=>H1[-*@\)=F!@??A\YV9G_
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MX9<OB,^VS-[]EM"1CV;^*KQ&O=$I#;'CQ[!E].0O^"*!"1WBF/?].*ZYBWL
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M-F^78A+ C=P#:M>^W -L.J/( GDQ/C?AJTRFUQ=* ?< WD)Q*@#/]XCK!VG
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M4CN]]P!:LPC<#)H]/#"\;68$1&>N+$DF4M-(-WX/,!J?3^"^$+=<Q+?,F.U
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M)$&38=]J+!,D;5V@Y!(_-^X.?*+]T9P72@U^NV/S&2#Z<SOJ8!D$=GRC5AS
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M8)A6@Y3OQT&K2+;.8%8QSBSTFINHBXN+ZY1Y1(Q4Z=+B2^.18.OL>_)!A&%
MG/PQX%Q_MQN9X_<Q8.L;E!0*_48B3AXQ[D(/B3":2VR7 2 .]!_F/\Q_F/\P
M_V'^P_R'^0_S'^8_S'^8_S#_8?[#_(?Y_Q2CIZL>Z5$L<-Z><:KS-="M"%YS
MA8J=C5NC)U=S]21\4Y&^T16]$(1NB.VTT.@+^K-'H7E[2C>QA6?*GTM,7.*1
M:(S4D63<.M286,*<R[6UW[R:$6H'X'&X:ZP9G<*R5ECGT*)^#$BU?1U3HMH3
M;_OKY'6--$#RW8O_P8I>E3%#2!JT%0:3SD&Q^Y2M#>>"E[&6[K/IBF9#S1><
M6V[4/_T\->9^+G%% &CM>#"#\'K[Q_S]S$ U]UD'[F+E;'\MR^ H"3)EKD.)
MY/8B(-:Z>NC]C(Q*:G"^+0TFP[*H3A@_%;E'+F,;=G,8#QLB[ H9*4Z97PE-
M3[W*,' WJ>P;GK2VX?#IPU-_K5(+3^#T%AE_8/7J>^!&\S/;W4W0G;.F_Q<K
M_W_2<OU7L G:L7 6B<1!PJ@CX,XNA5^W>_R (T1O.6N@;U,#3P;=6ALK'$7&
M&)]J;V.OO9I>96)C>,_BH@9P9B5*>W)G%GH,."UVU!;K?V@:>0R@0*DL>'#R
MC%@'<2]514>F>T*SM/!A>WL=NK&^P[\'=4TT;9/QO3+#$>LQP*)>F)V#)2FI
M:QDN?-3N1[P+[;(X!OC)_T7.S>3A$5@$OB^YW+NP"3TSMMQ)Z;BM>BDZ9[W@
M7LNX B6&_,5ZV<R3,>I78LHI5&B;PIP0;R_F4M(<F UW#5$>F?]-R-VLE;/.
M3 X66>I?T7%_WU*(8Q,/TO82V>D%/-[KAUJ0FQ[/L^@H),&^?ZJ"O;_:EM(W
M%[KXYJI11MB*3=Z?^SV@Q3(AOTQ2.^(Y0EMH[I#C+/AJY(>=6^V9-YN/ ;:R
MNX9/7X9)=@>^\<!P?AE<\+C+8B=V\5MK58I][OQ2MIK!,OPZ8!F)\'V)^T+8
M<LL_!A#!6RDH9']BK#OI\AZE\[>V0<BLK,$6KFMHSN41[EY"ZY3QXXXA-@5#
MDGRV]4,NT[139W@.2B>0G'W"9E'Y6@G< _C]&*5O6&BP6XL1*"+M+I.Z"/X)
M1Y7&+L&D- B';G?*'MD^?7JVY>;FHR=S3E'ZWB]>81>DF?S2$IQX[C[(^*,@
M]IB_XO%Z'H!I[AJD'5?E#=BEK&V4OB$/"Z6NLX_%,-,).IE(1]J__XXJB,?
M>%$>YY5F_;>^"0#/K)Z?USH\-".3'A6HK$G5@V_X>W2R@9*F F66AF"83/HY
M81B'TUP]E('."4JL^'F%9--8?;H^F.57J;P.I/8ZK]*0PO-+&3P"OUM#RSBF
MUP6]6 #XXL S*[KU25E9 R.*&OSD>=3)M0^.DD 0H7.4[\2).O^X,F?JK3F)
MQ/DO2;V.SMD2?W:G33>,BF(J'9^(?6U$YD@,Y7HR,\;$/S6"A 4OR7A&>74_
MU+JM>\<HW'";D;DXP4*_#VP*R!0I/G5F1 &G^WH-YNM:$A=$/8B+5'D8Z=E@
MK=WX%7O[@HABU]5!V2[\IV#%9*ZZ8#&0Y(*-IP/W]7/-FWK"CFI;+U*& IJR
M]*WFK^BKDSO+6 "]67KB%7,J@/R<HZ[?*+Q&M7B*-T#)0$R/K%@NHD&^#D#(
M4K>"$)$Q>%2/B_N= LNQ71>E[LOI(UG5O8*O7 AJ)OY*-<-YW7(C]FR<K8T*
M;KEN1"-8.HR'+K\"X_6D(DFB/1T@?QG'MOJQ^4DOM3J?1?EEXWR1YT^EDQG3
M\&$$/6##O8C^8$66V.AY]$QEX=BFDH +9O@-P"9#7*'B%T?+]QY_NW-[.R.:
MB1;&GDV*^Z;H>D9?UJMQOXP2L\3*>()96(1 KYF$2X]TZ*7U;*5).D:"Y+7]
M"'+E67<3;K$QOC<,@F]X1@*_W%A5VIO,5AIVNJ0VZY#^J?;YNYOWDV=OLY?5
M18VT"F;$=G)81<XE2.VJ"\).*C</L S7::(@\D"/.3 (XZ.,#CZ?8P!WFS[>
M/Z3O(&P"Y5\>5V#<G-$762L7LMCV]8YJ2T*4J,@NP15V"(IU:*0>$:'?4/S*
M6^=6A?G1VNYPG(O/@<O44(ALD8CWSRF7/C:&MB4K!FT@7$2XAPB^?$;LB4<:
M.6LN[!;YX5OP\ETROXY.3'S8/B_1>A9,XW8R.?H:JS^WE8I!O) [!CPJ*EIK
M_B0;)AL^L682<W7[]4/T)ROQ[+]/N*^\>3Y_"N7*)=%<I$H:&+RJ3/&VV+57
MXSPD [Z\ MS,M-1CZQ+*U%%?TV<2JK@0J2[*PO*VWS7F'N)!Z(7ZQCW4H]A]
MKGTKP]5.0</O=@K5#^HOX9/6[J0I)]_(,0L=6IQBI#<RI%U_H%"@D C+C8ZY
MRZ@TX#:GP]M\P%[U)&@R(VA4\"!DIO8H8V/I@FRYTH='E[P=M08*&/=^L$Z1
M/J]P!ZWUWB2"V7&ZV$$'@:&_$0+\9CF]/<'$#T -P-'43R86Z4##,_P HO%N
MUS*W%TWRG&@J(]>DPF<['^C$N4#0(DS/<.8URTR'[A$"Y2^?#/V">_JX 2%@
MH/9<VZBV OYMYO38DG%8T0I:X:C1Q^%S5LV0_,!0@7/R8C(@+FD4?BMI/7I^
M+6,\PG(Z@SO"?:6\&F1*DR3:;3B<$'\BM7GV"TEB%KF^0YP  M: ?JB?7J33
MA826DL:L"]GVUSK0 =^FG:?.>=SCZJL,X$L2CCB["_NS1C_[!M@+ ]XBJE%2
MB1$T&4@Z\_:\\9=Q@U;[%<=&%..@8&%858G<8/VDIYNBULMDSH'D\*2FNRSK
M@H'#JEO7^#W_[K4U35/F:S?*YH5W^=G8645VNIB$-8EQ6I-S$C2>O7EP'_CI
M94077P=/K E)/O&BRV2-;)A]&RCT>LH'8>,[?:2_#A[(;-4'?0Q3@19^N\<
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MDJBPSX<6FC*P%@PX[5_ZR4%/F?*^\+36[\6R JIBF<)+&5C&FK#'@NKENT2
M*(^$EOOH@D3-X7B2@$[\JGJ+;?'\@(NX'C[2V?-5BD"7JYYPL4*2:P!8$MYA
M>:)*XF9>L0\0GO;U*'$TTIF\'P]J]#6;-;\+V=0VU)F@P2#KS#O@A.OR\<K
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M%V'.Y!3F.N@;J3RD?-WA[NT,/X"4-KT#B4C5W_MOPD-)W%9],  94:E<80Z
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MKA4QKO%F?&EQ^RG=>JIECI<S6F3UE0]W29K!/YHM<*@S;.$<4/<)6',M#UU
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MD+E/SS:FF$.3?=>;LR[ 7),7.,.O=ZP*4V#_W7&$UA#=*7]U'"[&RE_V"C
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M%.+B+C_\+, SRC\\=#=YSX)3Y<L;,\!<BP=PL^%&=:? U4OQ2_/S$%L!)MN
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MU15=VP+6\.UN%4(#)Y">BZ#.\+] GF-'U%>G'4:TT,>CJ5:&T7(GD/][[MY
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MJ%DO, ?+'?3\D%8[0GR>--8TUGM ?),@$N74_5Q:5VV.JZSU2JI8\N[%N A
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MKO]LS)GS90;_U,A]\T[ U?-F-7=-CJ2[9QGM"^AE"")4-'#/^L;K^E?6=6N
MCK@[[SX!N\=9_#.##D^?9CY[4:(PQ+ 9/2OTE?;0W.2_)Z)@[<U^" _$+$E^
M.N8X9KWAR,(4G3C0+R\Z]U#)V3>C^K><$R%'OGD4JR]S%&0X6N_/OH5WD(H[
M6M0T')=[EC#715U>E[KOX[Y5$[+>5^/O,JJP?ZSY7467/,.[)O*3HYRYH3?D
MRQ^=)Z]_B(2__+>KN*?CT'\MSO6KH960;^_#7I.(@F$E&BP]B7M@A;S<"YJ5
M[U-1L4EW]EYBRP'QS5XHEE4)OWO:I*]BX6 ;%!T521]^($^0@/>8"J%/=A-]
ML43G:&V'S795VS8@3B>OHO,$MSB_;1F6YOAX;O'FN-<ZM+J86\AVQ';[+QX[
MZ*.<V=/LS3N=\,Y)#\*#F9OFSYDR<?\;RO% +3CM<D22C4XBRIR)8.<D]:;E
M.@K))+=3L9S*]F]*PWB;4[K3*"3K7;<$I(\F5V*$?O,D";Z2 ?^>VLU^>4=4
M=EJ'$VSP=2>T$[^W?!\G,I3HYJ]XX6?=N&_:?4Y>S6BIBS3@QR0^ BTV#@_!
M]B!?4S@(.L-=X<'USO?F7M]+WPE/NM_T?$)9\4M$@U6OA$[F;N*&OY=D=WH=
M:_6%K_&Z?7_HE\3"CS=RQ*55+@SQJ86(![FF!][N95R=B[I\8*25,;$J<0Y(
M'6M[3OX,<H6_0C8H.?.8)RT)3K3H 5_O.Q/O:K@WZ63*VDI<"@A@ <2+6RCR
M_% CR6PY)6^E!J2 '/S?Z^VE*H!P#QAD5Q?#+RSVGXW07UQF_6]SETV<<&_N
M\2&$ 1+9HIBC=%"?WIB$S87+(3[X<X69=4CTZ@7>\NF%>\!G!O 0<J8_U+R<
MQ('-/(E%0!U%6AS6>ZLJ32M_FAC("<XP3L*& N'AXEHIK)$FA\<*^_\>N&'Y
M7_?]9;/U=]88"W/3G5$LKCG(];DH?Y+0;[;;5.8-.'V]*K_KCZ5?/4F!2N'$
MT:&Q#9'F/?F7\IF7V;UMY@9[/WK6SN>-GGZ_QV04N\UV>[PD@O(3!62!%'1U
M=2Y)C"C!.0C>/B_K!?7+?7E+RN[6&*SK[]7)2/^P)M:M!C;]5:]^_91)W%HV
M/LMT_X?K@?5GB2<O@<:/DF+$8+M_@J[K_K)F>7+CY;!501DWS>GG_\1Y)#GJ
M6$2?^.@'P0.1.+]XY]CQIV\+&%HY[0S/=YCZ;2T;@C,BUL?#'O):E<"B(5+M
M.FR$(-0.B)Y*Z8*VL2^%'.TP*]_'9%&U*6CI)[P[VCN=]+E0+&+_IK"_NVQ?
M5?!=,9''-R7N7[E)1QM#V5A8B17.V,E_+_$\7>8S!%]N8[GT)#?@--%CSV.^
MU)-VW?P2I?L<4(?H6D[*&:8*4D:"K6T]X6.UJ413<^;R6[]JV;7F0 ?]E,'I
M@2XZ,6FQ$+I&I"=X5G[% V.1#TQ=M8T]-O4;[N+KLQH[!]0JAQW]]QBUXD5
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M;*5OW%=PJ'$BN12W]VVB/O?G,EMR, SL[U<3ZM!9>)NVR"C,=!]!X!CU.J/
M"!"^&/)RV79*067Q#OW_RPG@?S].\%CKW= MG@4H$'KG1CD/GFA/K3,H;IS"
M-RC@%!21V0XTK9>3V>#!M4_@MBU.JS#9PFGC+\N5ER:LAOJ^[%VX'KMA*OIM
M#:Z'%VW8")N^.F)MY^EHTC22[#WP4-&'-_;GE(F,[#< N>S8RLO%Z:18:,]I
M63 "C?UK;']&4R%?EK-!3WNOX=A!R+.>,WLG -OM>6?/BDM0^U'N:!0L '\)
M-><<Q 7"GPV34"I8\M65&%>_I)Z9HUL2'!OC9AD[NG2'JY/]DI(UNRH'XOX
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M"82OHNPA/;OHAP5;WF3:00K@:B\"O6M0+KKH!\G4!6@K7?PKQS&&EMTWM5;
M18Y$F6^-\,O@1#=?LYW/Z?QXEF#?BTD3T6D5"4X[HR4/KXU8IERW?+AQ?+WJ
MMAH=R.I].Z_MLD.1AVBK2^:Y;RX/%:-D@2.UB";PN:*=W@CD>3*75$J3PZP9
MN#$YJ?*P4FIQ=R<U6>+>+ Z4EFZ^^G/AI4)@!-^'XW_Q."MXM[ZBC@((#GDA
M:53&[5 T93+5+9(N#"\7L=R<,%.6HF/L<H\ZYM$2B96562Q1YI4%<&R?Y%*
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M!B>HF 4@EU@5J9R(3KS-&,<R: ML;H:-M9L^.9]6(1"]?OA:[$(_W]TXL^K
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M%%WUF&&QW?7M3DS/.U8^)+RV87&AC66^!M;7DW\G3J(C7;#TP_%Z#A)5VKX
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ML Q68@)3[$-1 &4[2CB;P,\P<*'9S6;I2YH5NR/=0@9B>=%5S\XY+GU'%5,
MUJC7BE<)SPXOD8>XKN$""G-LR3R#(/\\A83*I(. '(X]IH(NG@>#SLWA'OEQ
M3@;GT(_U8FA1H3!U+ 40A2X+J,FP-;_ZM1)?^?JG0:1:R4!9-/#N]_$NHW)U
MPW1S'PD.CS7S=*7D@72?%@K I .WD\'@]QBC]I;0)O%-V4B3I5KW(JY$[=:B
M>Z)5I'FOWNJDABA3U)9I#6TLSM-8=DTI)BLX>-DEZ<0)T=7: -Y#S9(G+7YR
M/2P04>&\CJ %LE75GLI:UF>B$%YZM04GWX*FK66VFM6BEX[P) &58P3YE%'P
MC+'Q3Y/UI;[:3M9O2\JR;GH?F]KT*;)NW(2,:^TJX[QCB)P9=I?!+(I2*Y7-
MA-+FZALQ)1[^["J><5<^2T[^^ED>I7II?NIV'*,W_ K:IC=J(F<5@C-HV)T^
M656-!X;4/L&8:36S21I71)(^?K(3-Q&KK*[2JYNP?"%-FW2"=5GPW4BM @8^
M8; K3X#/]1Z[ KJ/!\]ZO]Y1D&B&G-7?[!C43=8<0G:4?A7V!(F)JURQ9J3_
M(B.[R++YED/SN)&F4<)PETW,W"J8;?%6CZ#6%?Q%<A8?AC>IES,\32UR#"-6
MG,4W5"AJH^_("^UH&[<>,]45VX]Q#NO$)N//@@,WZ?;-.,XR+S\Q0HSDJ;"K
MT(?E:!AG"?'*)USCLA6LV/_<H[+[;K ,'@DIM6ETGG!B8EJJYHV4,KNWTF@N
M]UZI/$RM;-A)<N%2DER\D3&/BXE:FT=,,<-#DX4>P9^(T!F. &X8)[E/Z[@I
MP6* T]P!4JE>"/5[A&>H5):]<%[(1B="B_OY"^7O./8\%'66L)U\368*Z$2?
M@5N;Z?L)(H"<.ANMBL+]+YPL:N3XZMZ8+HUX2]SE*:;5%B]BZ>W^)0%)W;LZ
M[U+SSJE0[^D:J\/K2#^ ;#O(%P_YA'-B8T71++):WV9QE3F#W6):S9=ZNJ*3
M9,;Q("?Y4$JP%6J;=3E4U<WOAL;@GH[*SREG1.%+S&K.Y23,C?N7<#Z0W1:8
MU!*&WS(34UQPWDA*#AKFE<]O;#[<#?P"KU!9.X87G#,+^T8 T=*\+#,$V>%6
M5Q1Y4[0 4#?UZ"?:*6<JS4P*3"Q8V,=@J<X@+L$3+6!:F#H>O0LFI9??P$."
M0)>?9;?G+ALC7\/\X*3P#W5KZX4";3D3KR5*EGU,WQ9B--Z+3=0.DNG8A<M&
MJ,$?W[A638]+Y^/]6I["'E;^MLDIH/=JR \+CJ=!H<MB#9_!,96G* "+F7%G
MS4-8B_Z"<O*C+S4QCT=/:'.9CMZV>/*R(,X8VF"N]D8IP"?92FHN\3E+B:DB
M4*A+3+;>4MEP(_=0!6RE+J;ZE5=K0DKCZ^"3VJ=)L27%!R*\LIVNLDGRC.G8
M4H91_E"#T#30]2XK3=,=68Z/:Q#YF(J:"(VZ&BXF//.N%:$4A\78A-:SV!MK
MH,.)VM@;%6B<_TRH*GI0BEX0*22\D,8O?V,PCO]DR<,6EP^IS]V7V'I75?!
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M(4.Z@W_^7"^-Y7?.US_CCAT@R+1Y>/5&.#/Q1#91AA">/V%$5": 3^WL-?V
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MZ+_RB6K_$/W_'>S)'(K8'@ZO>=:\7R,%5"]C_5"AH\:9J$$]I[I:\ET-Y^J
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MJXZW%[4J^X2Q^I<5G2>NOII6#S20=P/T*!!+=VE)@?6W CKA[&@[5#CZ/%G
M$#K9-,,&,_$L@MHTR?E/UWF>#7\&ZEIR]C];LFFB(F1[9]+BI,H;9<&=N C
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M"** A 05$E)=T(];Y0^N'J!"WE>YD25&8'B?JU3(NKTHDN23,8W<]E_S]?)
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M+SW 17?AG9T9'::<1%30,ZOEW%G[,OM#5TT+(YMGG[].>]-,$Q4.M@.+7>:
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MV*DY?(H_1O.$ZO#=]-R?C>H=,5*.)AA#ES7H(!]^(!@Y'H<JMGP-,'AK%MC
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M6T@;,C\(I^<Y_A%XR-U\@4:HD&3]'2K $H0=3Z/P=1,M,X&_C=OMU9HI<OH
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M !?^8?.Q^@&2-N_$FHE+\['O?MUO[7V;EFX;CU_T/?4MXLI]ELVVS!W($RH
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MWG3?')3]5]>QD)W-+4LZ[5'\.H$XK)L T?CIOOQ]^;,FPBX[:Y,E=$62-%$
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M"V\G8IPGZBP'[[]>72S]*-[_:GZ)\0O",%\JA;)+:S2_HY6($-G6!1@D<X[
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MII:ZU0#89YTGO0R,A:@MBK0#+[ _+=K</+HVT3QZ+?DVQMOFS?QLW')YEVD
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M^\2#GZ_)6L< %]='X42I*$\]/IL._E:6PN!8[8E]L,9=O=/7E/2+5DJVNG%
MMAMFO>WNPNC/X@8]WV_DV9TZ;<*[/%!?2)/!E,!6GZ-?)NQ03^D0'/.Y.4]$
MC1N36*T),CC0J^O5 _0_APM14]/#E$36Q3U,OF%]2_C"V)5D82L+BF(>GK>
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MP-UB;BD4)H'21^D6DF\,:\J?L8+2=[SPN;SPQEG!<$D<+_H2\F#JXT7Z^6-
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MF9$0<8-XN12G!6Y33?R87\;*JO*M/T7A:5)[49GPI:Q+U2%-7#M+[<< ]M]
M(!HB@&8B;6+UVX[DSK99H^/7/-PUE=]]><-/?K[P%$T\Z75;^.@>+T9\@A?&
M8>NT%D!4AG%\IH[GL@_!A<DJ2'U";A;QQ+[1%_0@<]>[0!>(]ZQ>5/'W9W)>
M^>_9>"8:-#A/=//EL<8,SZ':D#&T_@%%M)FKBP5B-X/A/*T<W7.8J,S.U&-
M'-E6*HVO@/!C;^O3G2&%D^+/UQI$ML' FATV\1L;KL[:HPM]SI5<AO?<&'^(
M1EZZ*.7J@1?/S0'=;CD]1=+''0-:Y:?.XIRBM(5(8D9$EISW-H^@UL/MASZ_
MG*GLR1K.HV6^,KKI[N\RIGO$KL$:OI6\O$J2V3.B9,.9H/G&)-LY^6@@I[;J
M+U8>4L@]4D[!973^<@NPHCY^+!!T4V#0W6.#LTHZ_N7YF2+Z[6M/RM]9X=0R
M'P@4-R0PALC.'7A/)853)N:RA7W ]W]C3I'%[(^N0@OQF_&%H^LU&C1/UX7
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MHF%?J^I;&H=CGJ=T%=T"N3@M;D*O,AS]TM+1]+&DI)+I"PK#=X_ DRG8W6-
M.[/_QEP3Z6VF+8TLGCY_,5 IP$16&:"47&QZZJ7>O5!TU,VUG'X,*!]H9];
MQJ<3HY?V?I!\W GCYB/Q20YEM(Y# -7#M5<&? PN_^AAW^[)UV+J+U2R_5G
MYX+8XT\=/;)7%0^\OLU@:^6J-2.02E)2V>/+\M$CNC0MV4&"OHV#,';>4I@O
M/C$UH$99NOBL^Q90(8]5B6"QMDQ =6F?)AU)A<)%G@//DR&$+"/ARX26JO?Z
M$@D1, <LK]C#D>N#9:#A_*;@Y=JN1YXQV5Y=3FLH//J,%<89P9)/.H5EC=%6
M)H8W)KNJYBK6!/SV!3+C>09=KM[X:OG(1G_QQ^7+"KS.M2F-36B2Y.P$59V4
M?MW,"X(SB3C<2_59"-;L5:VIS]1K>) *#8U6O<QH4N!$%B)M'X%@/#];+I*
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M2 >S(C$=Z<+N4=)@=(2C=I" LDD84(BL\!$:<'^DV>GIXH%RG*M!!?#YX*[
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M-;-A;^CVE9'K9G.L@F0EPF8[8A(QU[??Z4A0U(?,03A)-\$F3*3<]ANATL<
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M&E2=4]>*%H"9$E%DT7WA"W6D=]A-KM]LRT;%I1_X.4CA](R3? D<!1D:!;'
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M7/SEB>[S<;FK*Y?'CSMK=I9>(_EE7>Q?.\84?E;YRRP6I(EI[!!7_/62=1K
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MX HA2W0$$50L/XK::5-Z&I?WMOM;P;(MO_V=_#IK[K"6:Y\^%%*J;IZ,^O1
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MTV9W(XO8WTQ#>UI&M9YOH+#1+M;@?B ,/?\1^K^9@O\K/VSY?_#SI?^C(>M
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M"2+@";=2GDFUU AR,4FU.=( XO-V''D=0C_>-FK0L6@T^0&ZUE$]X8L;>IR
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MR?$];51.PV!7M\,.^@6"!*L-M::?!H+[>&=MDGI1<@@VOSB#K\WCWW00QYC
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M&<PX#+GA$3_P6E4F%9"X-/\JX5Q#DW1F_4%UAY*3)V=@#>A(R*H^2%HJ+PT
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M["=J*D!]2-YED@;8$:L>4F4N"E2I!4=,6=Z<7_<P5CLW6F5IJU!XQB(41YH
M?J_TJX%OWBEA*MNGBBR=]DV#L1E\A52*1G;,.YI0OV5K)SX+[UN*],*:/N@Q
M<?"R=Z\+,ADT2*E_DY'@>[MMIE$6S>,F@I]X(7W6CLC?%@9</Q$/5\9X7/*5
M>&2G,Z'!/CD$J]E!S.KV*/5&J F )XQVHN/M2\H"@>B@:Z8UR81'@PH@S@ES
MQX90[\\E7=9GVJST"[K+7P7?Y0HMW8#?,XOOP7-B6HA0##2BTM?K,1X97)V
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M>YIZ%.5 ,@S]0P8".]BU<1OFTD<#C%(/0F&/Z\YW$:.[&+*;^Y<@'_B5\D<
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M4>2O<BHG9H8A%WR+2)V(4Z.JC^A_Q^6X8Z$8Z0D[-9M77CCK(''4M/:S;E"
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MT)2"+YW:O7>[!21W?.FEJXE?C]YF<+[ZZ2EITQRN=/!4*+W0N<T'NA 416B
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M-*YAJB7[J'(K^V-A>.JJ$7XF5K!>L!G=YWOUL([YK(-!9P$+4.G,0KR_;2G
M/XZ%C+AI^S55NNXC0P+C]R78(]UO?D< &XRY2J$:4>KGXZ]&\X+L!47D: #L
M='F<[O_=K/]^)7J@^-C(V(+EVNN5*+*]N,BE\D<;V*,T '"\&F"W$EU<LF]H
MOQ/\7,C 9*1OX//DY-D^OE"A+A]7LZ%J?:,8#7TU! T0[?>L(\C28F@;&7;9
MWNC+9T>;:[J@3K[;)^7!Y951V.B\>UY8A94*!HZ[W+_"71$K9]<ILC=8_ND+
MC?[)!;]&I(=/) 4#I$3XUU(C+;:T-Y&1T TM"+U23N070W]6%V2B0(.OIJFM
MX U')!MT]74V#9 [-#Y131A?XZ(!+C;BEZAU#J!]:^F@2'.^TI0L<C#=^4=_
M/N?&0)^:Y;*_*$9]Z6#QCST\-X3>0<M1^\@8H1TC+R!%H@Y>X8AU^?,Y.PV3
M_L OO4ZH8?([ _737_Z5-TRQYGZ[VGCXQ+N/GL[*_7;FUC/]9:O^CLONEH@$
M^Z>#*SI'[2G9+BIV&+EYGK39FR8,'YXY;^=>G,UV?:SS\9 6X]'-[S'I9D>R
M?/,-1ZC"Y%MXNQDWF8SY57UVZ^6*\X]\SHT)HY3JH=BW=]NBTH_<$ R6??7R
MQAK[_6M'<*LX=8D5?Z_U8?S.5LZ_ I2\#Y97&^P_,MZ.&_&\WHW5_AA_VO7!
MJ[AND>W]I6919>Z +'?%BC)-@[I7W4C5@"$+F][QN=F@V]FF@[\:0#8_KD8'
M7-]TU-Z_,V57 ROLLXT[<6=\N.N0XZ*PX,/$DZIS/IX#%A. T*,X0/PM)8,J
MP72@QUS3$AH7J0#DUL%"U^^H1[91+R/Q_;!X<Y/YJFA!L;KE!JSTYF=&8:3#
MUN7+6DK24;*&'5YJ2#U0+K.Z7=9:#:F&UTGRXA#]BW!Z/N)UC.,AVJAW#9;Y
MSJ_43QLQ>]4TKYTV4.<.\'P4U%2SL77P#9^D=*,G*:1TO7@0T8#;#3MMH$%:
M8:HJJ;).COQU<!"3@,MXP#:UZB!WSJ355?AV!2DX:E"=FWD%9E*YTGQ6T"W3
M.[W,KW6;YR<D\=,;D>";JAQL3(*A,56)!CX!VU,4+Q3X,@WP^L1]N1L]_-L"
MFL/RB>'O/(89KVMN_(A)7I[.GV'6K=KBAPPN#BSD#%D=ASVWTZU@,)QV@WUP
MW?,;L#)5>^4[%1/G"/&L'0QKMQ(?SA0-;7N4FOUL(Q&0]?38#5?%(VF#299K
MXZR".+5KCF^S9!L/'[W<]/Y%W.B[9Y3T<58\LM,B/)K,F>>;;_P@?M>@?F0^
M3KK5TLM:;4?G+KGZX7'1^SQ*B_4Y0P[]%QL5O';9UAMK<([@TD9P;1QJ,$T\
M?V/CZ-1D];!&6\1]GO<7HK]-3M4?<3NB='3^:1K3O%P2]/V7<-R=(CGSEI_L
M+SQN#<X^)Y52":*.DY8?,!7$Y@!R9[8\P$8I_XU?\E#EN?23A^N43GR!N-7A
MV6:>A6C+!IL'/_Q\OC*334E@<_W=M4S[V;E='X?^;<?JW=IWGK5ZLVKKH5F)
MDO$?@2BA1F4AY;7B7WYD!G%-]]6S[!<V3EYF2 S"Y! VMH1+17_58+,#JK,A
M-2B[73:<KLT'/W]O/G5YE=03SZCF.$;&HTL,C'7G-H?G,G1KUJ:=\CU1FK/>
MD(<?(IM<N)TM2X6D<7U>0_O3CBNGCZRV_-)\-//]LMYW=XKWYFY 31"C_R$K
M#I$[+3YFC[E4"UXOY\M,J-\U6W)?<%7*K2ETG-&M#[39+4.^EWS8%'K;U;SF
MT]S*S_Q/#Z^Q/$OSH&SD^GP&I(@D+3QSJ!59QRWW0^Y"AH3P1GVHU]"30%4Q
M/+1M3H#07//&HJ^#%U$M$MR/.[GF6>7X*'FB^^A"S"0&X0\F2D*[GMP(09NU
M)S.DW3Q7-W+\VC?MX)O*>J'W%Y],-U?5C=6 ?5+R75HH^!8J!N*DMS-5MU\-
M882VST"N0 <O$>D%&(JCUS5TOA!1TJ?KW;=PM&9[^07 (F0P$.JM$=C?XG0H
M(-C#H)^Q(4BMEP902YNFLB4F(IN0N4L4RS%4\QR)$V2:VT-=H3J!7\%I  8/
M8D>],-JG/?G>X7BIAIA)=]=;@?5'!>6"V!T"H*V6"'G)4- )B(#[#=8EU/J"
M,V.>/Z1*0OU%VI9.W\!^Q1Y_Q29I/ 6V;;=!P?U>54-_UVS3@<Q&GP#JR$]5
M8\/ ;&]H@+)=>F=FERN$-Z67'98;X# 0VUO50SN1OZ"703)5>U@*KAX*@V]M
M20-!*W/0T68G$CJ!,DJ>*ECAEG:RA;HF0UWBY\:TC.XQUSF\.&8Z#6LZ2\[Q
M7(J+( L(X<W8HSJ98\.@;-XY>1+A&="&(RTL*S<>E^@SJ!]L*ZDEOTA61L>B
MH>U?&..$M=P3;/:25X[9)@NT\\$*6/Q:MG*_-5$7J8_Z_KAW2M]NYC?US&Z]
M3!VSX!^6=Q=(Q[Y'/J[(>U)[7H-Q,K9G/:+ZMVG(HP<O)*@+=/%UB@B4P1_=
MZ&1,:=+R%7P^P]\CWK+W@<==:4#[X<%'R$^GZQ%<@2IW6,MG!@);S^X\S 8-
MY\][P$'UT/?N?0.+&YO4DE@4/^P7_,?(DX/#):_"6]#TW+@1O[9+X(O1T_QQ
MM=^0K*VKP8Q"X5AMT'R9$$]L:BWZ67NR[*N6-!I [NJAJ=0C<=]WON0/".&"
M^L@4:/XGNC_MOW,$(?ZQ:+88J7B/CB8@F0N)-<(CF1""9TQ0%_;&6SJ:Y3JB
M./3MOET;8B=*IG09I0=*$=VU,TH0WI\VTH_LEH>,5_,3J+LSR('Q?7]ZSLFJ
M360DPP9EXR\Y#WQ*;[6-\*M4&@!% Q#D(W_[\6W^--$(O_[6O23+D=S%2*@M
MRLP6*%B*W44L4B'(X>^+= BY@%;Z%DF+OX,;=1"+42(O$F\F% 6' >F,J3^,
M3#9_BKQ_-IWEUY$CJ'RT-O0@#DU=86I<Y&OQ=WO?&FL5%$1=_K;Q]6I%#$GW
MG]I+^"<87:)*Z[>7,?%LXO:ZW5KGM_D'Z01S)?;3 '>*T>/4H^ #-SRZ22AW
M&@ $7OYI80,=;:(!BOVG=[M_1Y0'- ON+\9?HPIB"8GNJ!-4 9$[V&]R*PP^
M_DY'?+!#(?00N!*_J9 EB#ZQ:-OK1+;F]RR>URO[_VPB?5%@"B[FMW5RT ;D
M![-Y'_+U=JPBA0,6#MZEAY0&>)M-%403/E#?ZK?#270UH $Z!O^1<WMHP'XM
M/91B+G^"$XX8$-OUV(T^#A6CQ]P22"3J:2_G5*5?C/+AU!.+A"1S+@07647P
MN2C?MY'CYWS.'>Z+^S(;H?Q?Q%2V6R+Z^>U!F/^4(?JHQ>Y.[(EG;$.%B]X^
MRN'7\'K\L=PM ODZDQC/SD?ZI&"%D&-M(4L2O>J5XNY,O;9U;HVY[,-VD__0
M6(PO#1#P"[RT2KG.9NY'%;2!@(/W('O_ ZS'V0]T+OB0T F$@,"7)_<OCLC=
M4)I2:KV^F6Z;YG(0'!"4+B:O: !X).XGZ_^(Z/*^'PU@"@;.-;YE,1V7BX16
M55W=U!$H6OA0*!R=><TZ/UC,]<(YO(^'L6=C?L.P%%!&2B_6Q\N%?]?_PD?P
M6JK >X4\P)YQ43#W1U0GY!1=A-7D'P63I8E^G%SG[<QQD1H=@64?HYR-@M42
M#UX"Y4Z<YK\;'RA'#'"[W)JVHN42N/KZFX]6EQRR/?;F\.$4E4U2RE[$T(%=
M^T&STOFXN FFC?'%@4-O&8+,\#E_$^7UWZ+<^W6:RDV^-D_9B:<!XLCG:Z(D
M%5_,WT?A37'1=V\DH!7;.Z0.W7^&$'W%(\#(LW24D%GU&Z(;F]ND\#^8WX<'
M U$L_P,%=!%F<"$.*4(["XC>YMR!<6]QD1?82NY^.>?5LB142,^E&_%+BSR4
M68V_CQ-@:/+A_@D:8 [ ]<T8'[2\^0\*T$4+?R!:"#!"^0#\!7^S'87?98^B
M ;:T(0)0%!V=U(L)!Z1(\2@.I . 3T-N.@\Y;QOU,)#4 ,B)&_EO^)(&JL'R
MZ66D5A\E]6?@AG>Y?59L@X4[; !,KRA0,6RR"=]=;RX)N(W]P:S>?$:Z%*;_
M$G=3H!XY%'_E>Y0/XVF/_]W:)>H)-"'Q"CO1!,EF;BPAQU3-"E,\R^^NX>Z6
M*5'Z.Z%=1:'T?+OKR%H'6]]V?S78TW6U]K[*AOC_4"[TXM(BD4[<Y/].7 ]H
MJQ7DRJLX?#YZ6J W]\[XWEX]ZQ=2W=+T]>>_2U;_C^-TRBDG9?U0-\>U&O/,
MBGT%7,I@D_/05(4V[P(WMZF9X5)T26 '_M9%[']GW3G0?"F*)U827XMNE_B)
M<;IQ##3+PR_DT:E!UT00[^%?H!-J DM*3SA1OVR\%Z+<F;;X#7^;O+BTNNL7
M=M +#.S7EB(#-PZ,-?BCGAV))7.U8R_[1!V0%2%W! Z#;G#('9H/=EO6_$TT
M%SK1>M:.[NZ)?18"&NEG@N;H>-ZG ?1O#6U22W_W%_\$#J0.6[IZ5\S9[%YP
MI)0_M(O7Z%+\R'..EYMZ DM(&OXJQ*PFX&<9G,HR]1*0&6Y_Z,WU-P,+K/^"
M>M.[J=BNISSZ],*?_MI+_.((UTL]^.:AC<R/V%SFW\#XBHZ"TG7C+G<A)QBN
ME^,,(.PG=/\)&0=R26]>-OAT@.^1XCU3.?%+_$"UIC&-4N\=?Y/%=42:5U_?
M\SLU#7SG'A4IIA4O/@P^_I;)*4,N%=YF][NZ/_\_[+UW5)-KTS<:1 %!0*77
MJ#21)B(@+;$#(F*G$Z6(U- )$A(4Z1T$!*0)B*@0I4I+Z(A(;P)2DE!$6@(2
M;DA(3MS[>?:[WV?O;WW[_>.<=<ZWSA^!E:QDKKEG?C/SFUQSW;$N4VGN#8\J
MRG\WVA;O]N8=A"3MU\'./\8 ,9TA]BIR !P&XRV9-^6L]N@,6+" 3K%XJ4:"
MMJD'=C*LEGI78?/_(E%I,_%3WS-]3IZ)N&S_1$145EI8@G@7<?*,I!'?0=;<
M*Z@_5]F'C=PD#)YHE/"N1)VR?E)-)X$SU"XIJ/>W0=H:I -W.5T UE*R>R5@
MB\9*L_Q0$7__[[G!?T^WOY@FA,DTY?_--($,*'X5+(+[_HRFS0#AMA@@VI\J
MJV#:%N[MKR2[[O<WI?4_J<!?9?\Y_M?0=YDHFEWY[TB7^*,6%^%'=YD:,$"$
MAW\G_,\%&C;U&QP[_UJ@_[-R_IWT_XKM"ES#;X&27/U_6U$.;X?OR$!Y<&N[
MO^3PZ?]5\I_#C+[UBR5-7?N[.)O^4]:-_ZO@/Y)*:.'NVB^>6Y^%0WK].?QQ
M?W$T^#_E_JEB<QE1IW^C00$Z*&#V_VT8^O .9N@(=Y+6-AP1#;HR,K82XTR\
M%G>YY<=SO94/'R4GZT3'T8I&LHV#JJP]*=@[>X.^L<2)>Z_!'GO_8BP0C2^)
M!6AN"'C\>:'ATT1#A,V]^LKZ,? /R[R.,]U7&2"2J4FL8@_S_UN41+RF4Y*J
MTO>KKQO;A<Y(X&PJ:D9SON&^, G3UD[ MLK'W>6?VT)SU/HJ(3V_N!!2FS#X
MFPD3C-!_!$;GAI(5?Z@_?'7'I<@:9RVD,!KD/QA4/0K+@5NB '0CWX:S*KT9
MY4A3^(<"G?Z<_;"]JS\W-FAZS&XKGL*W <5?AGXU^<( A:+8&:#_D1/%,>74
M!ET:<T&F6G:[3VF]P(W?1<*8U.Q_ L]PA67ZF@D4VL(L)L(,T'VH&IW_=X&F
M,^C_6=Q]ID+K!GM[29O5:V'_NK!_210 P/^KO$+[#\#5$!=^4ZQ*"^:X]2A@
MFRY9M4L^LJ)\5^74T6=)&K;DYHZ$_FPNGBR]XZ 3L45?HDRRM7+"':%!GBN+
M,!E4.[1"/Q+M%/]TIZC5A/^[-C2\,E:AK=IBKV"MPA5*TH1E!VX+Z_'M$=UW
M,QU\'!J0[23RF/HA+O<BNUV,>/S2W:Q-:=\_']*S6]K"O%KTFI9-&N]-\W3A
M_9HD\'SM8XJ=X>>34JZ*35UV<R*Z=E*V]5N$M&A?%58  C^T:,2?YNF\HY%9
MYG&53>GNII*#(DCZTYN.S\3PA2C0S_/E1<_*I#]\XS\G*Z"!$8MG?3P4!WD6
M7MQNL*EG@A/WOKI>=3F*6M^K=*!=WW;6X''C7KZ>>2W(\T(K$&@QCHD%"Y#%
M/_C6E--?QXA[@7W^(FC59C>0Z0J-C+.*O"SOSRH:@*_ZK-%>L\J9UF?W+)P/
M]0GP/:ZNPP!]D&X7GG73MBVD?UWVLKO.-DFS"]93L(\YK#V3N"TNNI$C 6!N
MDK EI)U>XXLN<!%$"5(/X:!XU6^>54V]>,&5&G[ <_U!@T38B,/"G&W]Y@PQ
MYQ'([?_4<Z>WIC>L*WZ=.SWR3\Z=WLAYGL!YX@-TJN=4'?I0=EA-B=Y/>=US
MI9"<^Z<AQ]8KUE96KM@K2.S6/J88>0!B,0K!;*B4@7V*C7%OA$/! 7':K(-Z
MVM11@7Q$F1*LP^8,*>)]TCB,T^*A4)K_8?ZVSS^<L'IS(+NY^-K]9W)YQFJS
M53MG_!:*\(;G*(LK_^"8\J_'&X-[MV>><$">2O+..,F3BP,.L7FMOE$=53PK
MO-69R^/8LI9;O@3^:H&L$AY9!5N8GL>Y#U/B(8"'IF)THSL383YGD]2"662>
M\:Z^0.?0&SPEV<E(FQ,,T--)-U>9BN1FNEP=J:W%@25[?OA.]H-QK0?LR6M1
M*\U$IT^?+MT%B3_17F!F@-&S7/_@/OLL5[3C2V2DN!LQ5[=R]]KN<0B1;9++
M, 7R[>&J)G6R<S07KN:5/(UP%P:(8_)IQH,XF3JJ>DS$C9<)WZ#C5O*LD473
MLH$+ZM@O-U2>*UR-=CQ-M3NBLGHT0-C[VYM#F]V>:!Z:*7N<KD0A\'*D^YU;
MY?Y*8=MJG?/%[^N3!BY?SP6)$*5W,D KOQTI+G9%?L#U/(\LD_'[IO'\N4>=
MB;+9X_AFG#+4"3<!I13V0^27H'NA=IBQ_.M /G&:W>+K4K8Z63.*H$$7R.ZZ
M>>;#AP'W<?4H@AG'#8_$S[,\N:8_Y)OVVJ_JGI [C T\NLS2OK$["..E?V6
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MV>$&FSQOK2LPA*]9Z%@Z6+FQ7;YN9ANL)>INVYJDL]Q,&[@7-HYKK@=YOSA
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MR_ENB[]8O6ORK%BX%'5\-N/AO5#_7L_3'F=S-@:<S*0-LR=>/ 9&OV-6)F;
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MW]7@@K)#K.4+NQ?@7M+KQD;6/I9MSW^V$W+9X,25L$MN7W02XZ872OCMCM:
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M)C8Z&*"+T00Y^N'?0P[UV"EC:_G&#"RN-FW%!-\;)XJ+\.4R7-/UQ.<\44/
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M\JF5C;[]!]>#TE5>3T^^XG<$P^(8H)DT] >Y%MQ!X/P2)07 O>K _."SLKF
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MW4PCW&KR0/21FFY"M'A_7;29GI B39J6-LOQ^GDD2L.CT/!(>+EV4$FC0]Y
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M\#<T;!]W5.CK?[-"ZFK4!E9U3J@NJR_<5OQ1UVY&H?5IT/K7]+38T.T)I3T
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M]S:<M.&DB]Q3%'_T%?1\%T<692L$/&-]?7>PB->X@\8(.(?PSHVR(L^PZPP
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M5=ZJ7!DN'D,^$$MTR6Y?0E8-]#_/WFXS5"/4OK3.TGN51&-%KMV-NMQ\@_@
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M>QUE4P_0UZB#JL*FT:/L31':MK;,NB%) X-+H<;1*!%5ZWJ];0;<Y&,L\QF
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M^?34!I72VD_>Q0Q=&B7A45MQ?7_=AA\$L5!7VJ!O@@,-X7U1_!I6V7KUP?(
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M3^".$5'[,"GC=6-82N.3&\N3$<Z7;!<^":S49)9;O7-<QIQ*\56LL.@OO'W
M^*RI2MFO6Q^Y,U[Z74UN^LK:6-6C&?&K*<WHL1MT3_(")C& ^0Z-]65:F(R_
MGN/0/DV5&'ICLJVOLFZLU?2\CM-M([9O8?LB[E]19Q;OX54"[NM9(<J!?VZY
M^A^?3S>3 \PD-X.O;C%1\?[=VA'^IL;,.5J\/)R-=]A?G](Z636*I /.0)A5
M9\7ZP@C\*+J@!T'4A!]'J]?[=+ XRXZ=Q09&[ZU3.F)L9G5W*NPS)>Z\F/.#
M@:[63X]8E@:67@PL?)_K+5/G8^*PPGNN-"+O<[<CAB6J>G'^\X$:;FOL,XP3
M>2&2]T_.E/S]_%N/V^O;?],)?QT.HP-&;'Y_:W*/HB%_ZX7?^:L[?4CV]</H
M?R_F#<'[<:C5Y\A]II)[I^G D 4=<&*PG*]' +@![=_.9*Q(0OW;+JB1WPUU
MJ=/%X;M47L;P+YDLW*^W26?<;K1]SZ[Y65QGAU$=#/D_US'H.&!*U$=>IJE=
M?8Z;B$](RGI;6-%O4=,O3 ?"ML?B&K+"3P=<#S#C"[\ Z5?:>-]PKA5Q[VDO
M69WB'G ?,<,^:CE5YN_[X $=@'Q!Y6)(I_S6"O"!Q,*A)D0QS.G#J)(\3.]@
MY;?I;\&G@^K"/!+ZGG[Y7*P)?TF[056A6./E(7PMXB1,*^\*=V%%PK;C3SZR
MJ12?N)I2 4_->*?122@<GU(@H<=.FB7*4Q^ITH$?L]<)[B6>!&TR&HM/O\AY
MS=%I^?0;A0(#B<XT]8O#>S+BFCUK8+?I*<V..W 0P1=B+N!X,,=5[EH83')>
MZ,S]U\_+>T>S&WU6O9"/"9M,MZ$IG;Y'^_Q_""]HZ?-&VRVH24G<-;I6EN.G
M(.*K37M"A$0B*C%K6V2-D_.8#LC!/8UK9N./'VP^,1D)[CV<H/FB6MTA\8MT
M3<T=6Y6W>_:?5K-H#\">RW I^!BJ%AM/4<9G:*J)7[S<1.O#!U5!V'WD9ZIN
MUV6RDM(RVG66>HX!?LS?4278H\MUX]C8X&8)M.VSB\W#U:O9HCY&LH8=GN6Z
M/ASI1V?[3SI58N#:P21FH@D#KJ%WP1\QG9N"L!M(G.%HIP^BR^9!=)HQXG77
M+:X4:D'HR;FJUM)4Z5=SQ\%3TV(CDX=Q_"HO"-S\[B]*<)J/DKE7QA1!O(O.
M-[*3M+3+K;+.FI88&JWF];NLS1.D.@P[-24DIIN> ?ACG%5NB0/*FL%K;CO0
MD@J/,T^K"S=FY6K'EXM2]_Q+X*T(_/5R6TMDQ_YFPHZ"GZ'CA<Q]B\W.V5/(
M<,]#L(SU>ZV%7]_E7T^)/._D;X? 6T D5I%5F>L1I93C!-RI3,0LD\SCX-*+
MFIF7O^_(R9"-\W:->3(S[QMJ]GI$K5+U"]:";HN/".[Q%(*;11_J3+QER^-8
M1IM12D@,"LA2_TU?BA+10"*\AKD.Z_*%(7 ZW'PN=]4?2#I)_1R;;-/-6 ZY
MWRNVRI[T0^)&,K3B=:^N0X?'GF]HJG\(FWQ!=%] "TS<6^ 0%.'V@GSIT[O!
M(N$+P5J\U9.*K]-"3?;Z=ML2/;@6Q.3R\' I4&)?0&*PMMUG7"4TT3R#.P.3
M=L/C:KVBCU3E7B\=.'C]#AV(&<'S/'Q<*0IB/QY,_B3R7*$YA[NA%6_2QO:+
M:L2P670BH@V\$Q+,\VH0)G(TDUF^,S;5F' F6+] S^ =MIH.4/C@&&(6J6T&
ME;"?TGT8Q3%)NM?;L0^#@ZKPVQJ"#*_C:U_6K1/S#D^16Q2ON[F+'D)4<Z^M
M>A%6I_GI -,IPN.I8S4-*::VA&N>O1'^Q[[#[US_"'MK'O6K(9G_@<VQ6#'\
M]A+4/^;-[.G[LX65-5)]TP5L80;.X3UO9OL%?/:7'@C#67 O1@D:O,O6\3CV
MK9O'<<]*;%P&+-#FC:L%RUOZEQGS,''H*(%WC=B(/(R]^O$3 1)?YHN[6WN1
MJ.5V6/:E5:^*IB9[ZP:QHJ_BR0.?Q34%LBDE *\P-QJ"/4S3@5IUJH]'M)<:
MWM[/:$D<R3R@_)BL_]PJ<_)XZSJD"?01L8;U(LO#3M20K+QPRTV>_"+O"TK4
M:Q3SLFXQ7[E/@XQ9SR-D2(&C EWP'W2@\O?EL=[<1Y:R+"O*>V>X>4CP8!J&
M$-V<A<50\] :(0KN=$#6\6'W&@65[G^G*2)U&G:I_YWK"7FKPQY[2=XN9Q3J
M#BG&GI)BNZ;N>_5>DQ3<T70<[8Z8Z0Y_"?5Y>I%S)AK7%'LZ622ERDSM3-,E
M<4XW+4,%OPO73'5*&TM!.2B\H>A57[BF0T&A_\0*D2?[F6R63E<RKV2&X)+@
MC47Q*BQJ4_%BQNTB=S%A1*,$]#D5@4%U@BM#U\SSX6@11(+W6I-7V.PJ2LC%
MH3_PK;/=^ZS:I^.O3$9$[^R%GID)T/(MKHFHSZ?TV>VU$3G">_RHW>(I)-MV
M:';N/,R\"]KG*Z@8M&(^\;6S3<U2=V!#I'#S6U>YZ+ "!H7/C-W2%YX1JV!+
M@G>7R]XHBFL?^E@*MQOW"=ZM\%*;=)!]C0*#37]ON#JZ?M/5]8,Z>T!CYIG
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MH!AULX]GQC>9$0&9K[A'\X@P_^!@[RGO5- .]*;E0;%?&X*_*.#WO1MZ)8P
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MYLM$W)+JXF;KC+_5*+"9/.N+7Z#M3/33OM]ML7T2E0%LB$5A[F%%P7>0\4B
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MWKBRT.20)Q$A@(Z_M;4=W%CE_B2FPT5^Q;NJ6@*&5TYMV\[G>M71W2N66'9
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MU;J2!/)04Z<"AOAWX7/SH_)&S4.?*O-6S-\\*(8+)>LU9 :S@+)1OXBHVI5
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M$U;,7RK#Y&(J'@I6>[T7>GXDG>V[S>!G<M<WFQ700> )\#2BVD7;[*/XEXD
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M]\8Y$6&:#.')(C_#;E^1[,=[Z:79%!OY[43UADQF,:B>X8P)$L29HVTCG+]
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M1>?P!/'8BZ"S^2P&<Y2=#4YJ)^OHBV^KN$("]7&.,2 G8"3J;) _48$@=9/
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MJR_!2@L9BS9^/?D[S_/^=>L_OOCW[BU^SH$ U"7DEX&&/WS:0<5_9()<OXO
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MUL1RU=,8:@* U6#__7J5*\-V\!3=Q)YLZ5(6%A.+/]O0T @MSOY%IQ20]9H
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MPL-KHQEG3T5]4F-H>FRGNS]%H=Z=Z]HT,#RG?V_6]'W$@K:RR:+'_L+EG>W
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M]#LZL+(UMB<]C(QLN'(]%67T@NB;Y.;5H6Y<(*V->BU42=H_GS$Z*W=U F.
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MBE_4RT'K01Y-O%I[WA@K15%YEGJK4-3%><%V9N\270]=PKE$7 <YGL$73'I
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MO:!T1;H/A05<E#\-1_7754_^\CS1?W^$Y8R1+1,O8+G3L$1WSNG?FXP;VHM
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M.E/:A7M*)XV,:PMP<V=-$6V<! *YRK;J*I$+ZV>U\(Y.K.89;2O[N<8=II$
MWU_]Y8PW0<<O [1W5@*?'WI$ BQE:B2O.O&<&AQK:"G6G-CY;GI]/^0\,3A
MP?=6X'BE4>+[8U##]7OK 1H%^==?GIG<*D"W?#%T9C!(:<I+2S''C);G3CD0
M1$$4\)]3"P@"T E"R- DB$J0DP _?__M!(B0 >DJ/C4^ -=MO'/L1Q >'@#?
MAO4E[>?H*R7>V5%/GF=0G2NY=E7JK*CX:C9WG71K Y@(ZR<!+IW 1Y&0MH9
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M]!$Q]*&W5"D1(DSU5_D[<EI75I9(2Y6#BD(^MQV]<=)*J11?\(IKJ3&I=$5
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MG+4#M<;M7U>5O1PI<_X#A&5%=O2%C,)8;GA$GM00V<"V="(UP/C)MH4H,Q/
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MW65$&3L./=/K01-H:> I>EZ>6?ZKXNZ8N^!3?#I-AXU\"DY 1+;#TQ!:F\-
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MH7>C\R KCV-A+ZBG&B5=&@.,Q@E>1M)[8QY-/V^HTKBAC[?)9-=I@ X6M:=
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M W.&P$9R,Q#(4X"DDYST[=7 $2^@H];?K,?3Y5)A;5>34/ B,I+,^UY3M,0
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MWL/,:VM'U+]R^%I75E;UOI1(VN_N:?_S)91;]Y)*9IQ<J:U(N]2/EB]H3XH
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M_D?*NXC\VXZWB;P**H(2.*P:8.,Q\;,4"51Q$97K*9BIP)M7I9L;<-*C1J'
ME/R3>A_0D@-BJ_Q[BF!%+XQ/1A1M>#3R2R#:='H%2)<2QEFWA^6^4321?R=?
MUTH)=.CZ?-+4/+\MG%FQ=;J??A!40P82W0],M7#,J#'Y[D"L- 84JZI2DND:
MN,^]WT'/+BHX$^36/+G*_V:CM7=?>)@ _A^K[ ^;%OVGSVB?%GW_4]7$&]?4
MU4WBWZ]P7X[=">P#^$;IL:$0DSFL7/;EDBJKOYC6XWL7%$<_L=1\;UK98B;R
MH'.K_F&;,B\)KCHVN=TPKG>FI1+GGW[ORLS?M$DRKZ-,N?6^1WKA"BJ/#Z_1
M[%2S;L_%/GUBQ/PXE:4[RM*O0#Q5C']%$==(-&?XNZS26C%&E6\!S1-#RQ-;
M^$+PC9R^\Q<3I]1Y0MV6PX+*^/ZF+O>[-]W=8TN6/0+[4FG3<K*"7A\[R!E)
MH#PQZDIRFP>'! &[< ,UM65&YGT>P;>\#[H#^#A$:47&KZ;4R-.(=X#!=G^O
M1>V]7_L_W]2Z)X/37LF,O.>P0#_C6JS"^/%-9[N3Z:)F.Z?&.3U=%S>U/G;P
MI*=?PKZ]-"W,<3.8UBZ9C:P:I] HKU-JJ^AV?"IR 8@X,#$Y@X;'[FQG_4[!
MB=Y.[*'.6RMA&(0.8-)O:3R3%!ZL@[HRY%.,>1F]\G":ZJZ^9BA14H)]]9.5
M18HDY[I<$_GE1U8Y=&!H1/Q.1^)S-9\W8.&E2YJE1+&]^?*?IUPUQ_%UU5<)
M[JDJZ$^O*"BX 1_</J%Q5U2D2!RDK%%V!=F6KZ_L1BT5S\1Y6J'"_-L'^VW9
ME[E+K9U2[8&B\,FJP_4.YTD_D1>IKCGWE'2<_>1Q>-J%]:%/BXJ''8\/B2Z
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M5P+O7&L@.&_&J&<#$*'8J7F##A#IYN2U=N29SD:Z(-8M]HJQ6$!'"Y+:1L:
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MOI<S?K#N0E87O_FV<_QZ\+<D8>7YA_H=7)1!MJ\6HD!TF'U!67F6*-/W3()
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M;^]JR1%3)S V#% QVJ[*X3G[Q6D$E4)ZPDGBTL-2Z"2X]B]GSP@]\;&N2[#
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MS6=(6L9D&]C5>\D>_><+GPBU3\AJ0 RPQ$VL&#68CT/AB.?W-PN%"D!S0Q>
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M6DQVC<ELR4=9I*]GXE&#1[-*)//@J^\_[C3;PO_&[;^:,'XPL2@BF))O>=7
M];%,M\IIF#&9Q8TPEP0!2TXZMET 6*,>-+.$E%FR2SD:>L6 GGH+0='NY._9
M&4[#+&U=$087@*N$AC<;1T]'BNJRQ#X4D-X75/71?'KTNF@B0KKY=;^.YF>/
M&<C\)U'T;@?P!A?64*=^Q\>XU7^#9+EA7L58E?SVL/Y-0.913?WW>7LC ^,_
MHMS;XNBP_BGQS!+2';KX@]>.R:0*CD('4%_FM4<1X.Y\J(+EE&DR4-1+PM#
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M>Z5J;WU[]E3+H!]\$I)'#WBD\&_@[D?R4=:1X)!@^TZ2J]QK@,/!7_@*HO>
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M GGF[XN*C&<\BRWBRX[Y^?H6;UJ_XLSP<S%06DJ7\$NC,/I&Q$Z8**@C7UM
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M#5M\<-7R$'5U#GYN6D5VZ>+46@#1D"R5^>2YB>YCC^UGOY@^7]*%=3U5<SH
M0%FQ^BVK\+NNH7(X9"Q4JLSM8B#:[_9X%<:R+O)$I.CC.[+I.<$OCS("G$ J
M$H4X!)&L[Y*'\*IYHC'L[K\ )%F[59G;Z5PK/JJ':H;65X0^)J)>PY<_BTKL
MIW"[DH6F5^,96P0WJ5=SW@!_H6Y,OK7TCE%1;HN!<9F\+<=A$5L+,+V,%-61
MFHG(^'9,0/#T73V6P'.4Q0ACY-6V__Y[N[U:IV^)JA:247A21!&;)%0YR+MV
M5>EO8#UBR5TC83N_U'=WV@-QW[H7<1_$MDCY E7-GLE9K$E51</*I>*FE&^)
M&C=_F[,Q+5@"(%MOB913^5'.4RFG/N8[\]EZ,^JX,HP$ E(?\Y 1,)WHF:/)
M+UEP,SLJ%I7<RO2VC(MQ]"?/[K5:2#N+.6,BE-[,MX4J+UCC]!BOH!:I'%9C
MY6H96HB^!L@N]W3RM$5I??"_]S:8*>-/4S)70&"LIH3=HRYEEAC,JXT:H\RC
M[OP'K.TO)(R^;3_W[IGPX_!D81KF39VV#(05X2-69=E[")])<S8FRS48XGI7
M?M27Z+>_67SU LTF7Y%H=.KE,6+=X0?6N%@]NEN;;41%>P9"U 0%<6"00*;9
M*6U2(>_$\X&=0:+?6B< _QG-#B?%ZX[<F ^^O:6(8H'X[>EW@<ZIXZ(8U[PV
MA?<G[#&DU4$O3PM+MTS3MH,B%I@50QJ>NXK7E)CO&:JT92^9OFG3.HLAA(3J
M,GWJ>RN1F  T<7!K=!% Y4VDQ:V?&0'WAO3$)S;/6D(]PW\?HB Y,O^,-WK0
M.$.O2GV@Q/<BM2"#[Y/NB_/N[QMDF08''JY'J_[EB0W=Y> B=<#[6H]&0NW0
M,%;S!-T>Q8U<^-_SNI>GPT+;[)5AJE(Q]N(,R5Q2']4)@R.*S]?N#"COC=[!
MU3A'Y;/L5CPWR!,I+BUAXR_%9>1LA4BK//#[-QU>"2SFUP=N&Z^S]57+IK,G
M=(8I)1QYT;+_DJ=DY<5,;A(N7X_(N6/\;[WV30XZFB^;;A$&<4'$SGKI\?83
M?4&< ]$KALY_J@_V8*^37(;>+=H-H\XP//$?O6U>O_%:LIT:4?4\R>_74N Y
M&I4Q+!$R]1-$L<2F;L1_V]VKV !NE;1[AB:]CC W;2TR9 A M/ IR8#+?1"H
MW3UGYYJ>WQ&:[("/BE?C(/@$G#11J,FX,A_S1L'/,) WR>"/W\".]34@FF"!
M'B6?U0U;Y?1]-2;RC60=9M2.0+Q\':C6X<?/A8)L<I@Z1Q ?0Q@&3 T7(6K_
MVTK@(.M62,SZ;J4_]HOVX3>U[!GX4-)S/1,1&DGCPM@/E2$VHQACMV"^BCH_
MQD"&SB9/A&^L10WEG+U7'$/4Q92BWB6_;9;*7GW9Z&BK)]K2+13@PHTU$)]C
M>/V_PXN@2WEKF[_7@.X:$*L;\4&<MDN&8^8X2J! J?#IU6;N46J/_-X<,DA5
M$FKZ)Y02*HDSZUUF&/!6C4&+/M$SW!-]K=*[79MI_LW0RP9&N4L3N&4W"/K"
MA$2?R;E9*B4L,T%?-CK:%YB*KOPR5+CK_%%QDQ6^4[DJ'J[,@R/M:EW^# TL
MZZF$Z%K_2)VWK&]-0S6"U6FV[AYZV(D]C;6"O(WW 9]< ^CKH$E\\)_BI)%9
M4T=<W$.X[+RGN'@WDW(%<4]1!:N\-&_#I5-\M1/A; 7)X*U&Y]0I$ QUM!46
M6;4>N)4VU:=O6!3U80ON)*BD9!CGG9ZZU9BFIH9\*XX7A/7 YV&]JM)8^!>"
M3.6_!\OAU0S&;4D&T:+MK>]G8 [AQM[7 %'*E;JUY+*/PL<X.Y]ZKMN?1AWB
M:6@4]M4H\+ZG>E<92,>PV8N=OIR#W:FB?\R(I4<9#=< NFU+V^JK,FGO'K4"
MZ8WSA6+OT2/JWD.)49G358F?8J'XN9H%%L\R]7XINSQOM5.ED9V>QT/>S514
M6^-G$MY>E6P57B:!!_Q\@9TN90<^'=6.H7T_A:,%UEA=<)J>GT:D@AK=@$W"
M=^11\8*^P2D;7QB=!JN<@BMG^3^DO$<]]YBS^NNGHA0$.U0<YW$6,3Z4:DA4
M'U78!EP#'JPK:ZT>4$$T^]UU>Y<>CC6P"QA+9UE&%I+4/1Q0^E(GS+5X+TRH
M&YO5EQ1)E+D+N?'([#.M\7_=FNJ:UY*:'>\>]0-DUL9^KG:D5PB9E.F!1RE,
M^$B8AN"*GRW%LDS_7CQHJ;E7("OO:N^%RQA?RPB2R%CL'/I>"O=S9]O2><0;
MWJ:I:HU5C;H&5#]/925]S1;390M+!-E9QJCWW-:@;KG+D4J^DS+P3%_+88!Q
M.O]A0G'FAY>7\V5^B?(_+V?]'U+1>L=N-NJ'OD",R< ]8%E;$^/EBJ_;2P3Z
MZ:P71FSWFC;:C@*FKN89GD)3S1(_<Q64Y? DUPJM!SBNT#0/A,["F:?#7+C#
M<VC@5Q$54 .L!ZS:DXZ=O#'7KB&PI"F"C#/+VT,"-CE3OA74&%GISK21_]UB
M>=[ZH8O8[F8DFM>TR]0L9E%?G75S9QI1GK7ZO6?>N,PRQV.F'%C,P^\X:91N
M&"1\$!Q0NSD^XD-X:5<YWHO>G@2>EM@F:#%]:XOG%^0+>+<'_C=<LO)A *$V
MG?]*O_C^+"M)=#]1,7$Y0[76K*FM(-K@)2/@_[MFM@8'U#"O,T2,[X1WJ&-4
M0.<'HR7:&"2:,*SY\^"N#QD_$LD==<A6-6ECF?:E(=YP':RYWVAV>3K3&>]O
MJ*<F&+@DMJ&)#*:!?0/+G=%'V]>/PS=3WRF] ',6CS8CFJ0*%BOQ-Z8@W!O_
M;ADS0V!<MIDAF'F*50:@DQ@AE?W,,RSO9URN 7\OUO<Z<E^-[R]5<G6QVC\/
M!ZPBZY*B<R1F".08Z@<*#^0FVU4JK0*CO7Z-6XS<<0Y7^,D_L81,@N-Y_!NY
MOR!7"D.5)\0<C\Q,:G&=X:E#'Y?!<;T!ZG>#?YC#Q']LE@^'J>-?/CC&J_5Q
MF)IGO'K'_;A(-P7JW3-L[V#I'03<EOP^K[?8)U9V2#M.-]Z'_[128Y,+-*[;
MPM'PT&^D?=B,+C.B%&)<RUW+SWOKTEB4&77J@XI+_D[6+[ORAN:S"X<#YSV)
M)-N&!=KD/$'.IQ*?TK;^!!&-D8IROOV0+H**U,S.N;%=.W4,&_2'7,BMS;_A
MBO;(VZZBEOJ"=MD[PIV+IIT!!-J=[\3#])5T5Z"DOL3W.</&AM@Q\'KG16I:
MRY?W_PD^+/^YK;1YN4CK48HDO0:LU""Q!K2,Q-&X(B@YGNW[2[4^<;;^'M/.
MVK[I$C2E170LF5ZG%_]D\L&GI!'&=;(MN[;BY$3OMO?O?X4\+8X/4PWCZ0MC
M46/B5)4(ZW+XT-+HLF3%B,]"NX@U;$5E<S1=\*;^Y$G6.2O\*K9A2+8U<!MI
MC0V.^F'1'Y8XL"$?!*DBI76"Y,V9"S80$4:TFGX"?:53Y\ZD_-R16W:+[FJ;
M2<5:K)@Z5:Y?=<H5U=;WY.*E\F1US9Z6+CA]^6][/"& C=]/*!;Q.'5KV-U2
M%8:_B>BN!7X M],MBZ0+<X'-T0XLT2-Q4(F=S O-K/*%[0FR$SZ61_N%R-9Y
MEZ,8N4"#Y,>_*+ZU:YP67H6'N8GC^45:G0=@X3!6@M/J,CG$])2QI5TQ8W<N
M(K9^@R'P/Y%KP)O,OT*K%IRL8I)2RY>,B:R%VGM[?S2HJ[P'&+5C:XN!S=H8
M@P@#5@ ) /#?K9],1X@]5_256N\UH#Z@O^/)!9FC3B<'I,!\"3)&R/W><)Y#
MWOU4R)*E)Y+G4112M<D(X\Q@+U]$#I(H^UB=[%#YY^<0KSD5_]36BK>,"0N0
M_C1THH#13=@X0W-=8,=Q3CGQX84"MH#T,\ZO+J@EDSNF[C>2+GM I< YP0_L
MX-7 %!HX<5J359\/!&4*46;HFHX=P0@,9J?CB*M:XNTMXJ.9=W5)JUJ1BQ^0
M;*ZGHT<QZ>[UDT^BN1<Z__M4#)E9UTB6AZ?>=$D'2U &8K>DY$E^N=U6ZN!J
MB-IPB.Q^L$XV="*9BT53+8:8@=4BL.]5V+B$,:G*X?G4,T4-.557][=8Z\@;
M&IP29D.WV30X;LTT@?</\.*Q27C'*QD-21W^F(;5NEM'WW5"?:1VU8\?!L>>
M\/0HO-/ )+((ET3$#0D[;*]^?^,^2A+5^[927_I;#MXX/9TAB#?57]7'VAGF
M+3<&DQOQAN3$R?Y<$5P1WDA.2PB<^KDJP!_=;MFA=:]E*6_DS&-S?>:GR55]
MV$K1$@,VZ>?H'7R6'=X*2XN>SBK;ZA3 V>0O[G4L57O??D]OY58I9 WZ0"FE
MTKFAUQL),('/FQ')U7%RI\IX;Y8![DB[!^U^F& U&I"G6LS2YNO6>MQ=%K%K
MP#]$TXZK-S'%G>H_E<&4T:&SMIRKUAN\DK>P[+FD@3#M[KJ+\N=:35MNF_-H
M+^T6I^P6;+P$#/(/YRDH!9E-J34M93$778H2WB5N"&PD*--5CZ[_NL.C2Y*>
M^"5<(EGK[H>+F<*OD*)<)UL>TU\^ULQVZ8Y/1_FR5@^O >5OMX>8*)J_CO6:
M5"J,^YJX*>B#4W6,?/3U?=P+-'56IG7R\1(1&)$=R>'ZW6L 6X_$B-?7B^S(
MQTF3VSTT.V,)BA_<NNG+:+3[CLIE:XJ<&),VXM W$,M_.GE5%<J$%SY]A==P
M> PU:!])P'#'9%)+?^,F9V3&60_[M80.!ZS57K[J5G_LOD"^MZ=V/VPEXAK
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M>B4)W92_%A\L<#&S$K9W=>D A5R5(UW]KJ+#G$)</RPRLW^5AC. +U1VL0E
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METLT_+\EB(=-@.N^I)L3/R#'GV,K9&%SWI@#AJ'S"F33ASCV67OVY)PX:I<
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MWO,7^>XR+#2'!\W<>;4YCY*\ '@+$&4N  ,K<^LJ\%?@ILV^\2@=/@>5COR
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M=Z<?)G'V?&]@ICM19LRD-^31>)[=R.ZA4>VKC[>#P;7@JRA,T@J'#B/I+C&
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MXL/2+QKB&?]IX 0V^6=LE1LCO?\*XL1E.\1?_ZOI9;PGT%=-\87S+_^[OQ<
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M?>#1NQ:G -L"=XO<;'IU5>FO89OF+K5_;5;"8+Z7074+*H^;F-<[GB>^(5P
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M[T4%I'>0%A(5 0$!I4J-TGM'@@2BTKM2I:N D5Y#D4"D1KKT*I!$0)HD("%
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M>O6,AMB&([6702=(L^2&,.)%DX:)ZH7N)8:)@XKXQJL'<]ZE-C8-MTD&$)E
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M&]R?CX+1-4!+%8J0@7]E/TE2 \"T$3+^T%ME< _0E/WPV<A%M8N@HEDERZR
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MDE1;BZ =%K<>K@I. !?GR=>/#-_;NJ3*__ _87 <7^ .!*.RTUPF^@:]4B7
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M$QWRJ^<S$]#<"\!F#1("=J-D90U9/59!V.X=C_*V)%,,$/_U-19$OK@ Q%T
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MR2@7IW':"1 98WJ?_![R7]^H8B3FRP6@SK_=H0 QC>2J&P)><=V)&\*>!QE
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M"7P8?08JPHBCGFK_S"_!C(V,;YRZLL+FX;CO?UUTY(;O).E*[,GB"DY>35T
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MN%L)177F"C5/.K3&S,,VI R*:,*I?QT<,W<#I%8M_B836G\0X/($]H@V&M=
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MH.MV5T^LW';C4*ML^_?G]!7=EKJ)P,T%&H=LBR-=?HM[T;R?&.<V>)"Y,O;
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MCG?P*7USRITP_?Z[V[CB5JUE8/^2B9=DVFZS0$K(1M4?%)D9C!VI)\P<<Y/
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MY&'GH(L1'BMA:RM-_FDYZ;GGTNC:1;WU#6%PGP%..NJ ?\Z[\ LWW6!]>W8
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MI&7;S'M72%N\_I)G;9)[^\CG(VBGC4"7=="$M<)]7^\+:OOO'PO [@V47M-
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MD2F0>]U"_OZ)SN^NZ#0])FVB6IHJG0F",[E/9=_MYCKK6]K$@\;0'_Q(W Y
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M,3TJ'89\&.MG[\:7W&,JH2L/'R5VWTAJI/-W(XRGLN>BZLJ81[EFO=,2ON!
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MF,%&'JP_I&@'\ +;#F9J,.2VCN\ AJO\/]\R?$H5Z#D@>9A\I$1^G^11_J=
M$$+'6===!AOY)Y38JK/=_W\9%?Z'^3^!N?7,9:9^%#%]9G DK(JJL/UZ-IA:
M?(#(OK8@)_+L9I6G_J6ZNM9A/S^?0NR7]._G"ZL6^FL:]K.T-[]6R\@]133O
M #KMBKCR.X#4"0+_*]F%H]PO3'Z.%#("E3[)?WY0>;>N].FR\E.3!+1GQ78
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M5A=G%:CBGM.QO35<(WGUZ3 (475Z9()MBTW49P'RR-;4:P,K+^Z1?8%MQT.
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M'@S.T3 Q*)3H6OUZE2P,?"(Z$Y:[I%? ,27L56@60-'/HIW8[RE(/%.JNC]
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M/)H,S+,<J_PU]:$N(CIW!3IC4^ALS7O^DO#$VK!B&9<%XT$L.9L(W8XHAPL
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M&/1]4*K2YC2P?9-4O22618K(M1"(.;V9.8QX22=I#:3G"2CC!%3OL\U'8G<
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MZQO[Z!67OQ]I]=3=?7FJ5>C?'_O.QB\&;''AE+X]H"'E-9^R@C$L;T6.MX>
M<<]@,)<,XYJZ6JGRM7H%Y+2'5 ['&6O'=!O9T]HM"@2[SSI7)V9:KZ5MG0MR
MRG,7*7_5;)7R'=,EHD)6$HL2\ GO#V$B7B E0=P69FSQ>:/'(#?IF<K6(_T6
M)CAOT8R;8@CGT*>:, __E0F-6#Q=E<'')-,+;"IV\#8Q%07"4E^Q@\>H:NL-
M>Q7&OE>1$N7EX]:P1Y,B>UK@[U B9PU>FA[1HM_HG.>^8NMQ?7NCH]ZNXD=]
M_,? @"*['E?V^9! 9YVFZX_?JCNABZ*C[M6Y^V5<;#=(Z^,JYV?M$YX*<1 =
M,N+"G#'\UH-J6YC-)#-5XYC;T9S\^'>DU]69"%8 W_+:=DQ=SJUSX?XXW-")
M4"(Z)/I#<EE?[_$[DVOMY2T[T8&X63*S&@JX;DIO2)"$/;]>/RX/\V6"^]!U
MH(DB0;XI6C4C&SU2\$J8WEHI6X"31!P(B%^^I;-D2N1J, YO*^O]'!R]!(X,
MF1-%7C2HP>,U'P=PY @]JN<H>,ZY*\A/WV1$9F;*F79;J%YM26)9O]IV<VQD
MX=:8P84?_ %O]'I6@N<J+I-VU'?U[T _0,H01$[_5;P/3C0'5[2L'[M)%J+@
M 2-GFS=#^J7$EPJF^PD&#PZW!V9>FAM@NI$7O-]^6VKD)Y^Z0Q ,&8)4>6Z)
M8QON <Z8K9NK+3AY_Z"NQ"VIAW%@YLIRR(REN-">G>0/<2J5EJ,AAM^>E,I'
M:698BB&/4!QP#2@SS,<(VQR)S;?S,;TQZO'&RFUX;>TJ7XY!>? 7HUB!P K(
MN[M?!U0M?YH2V6N-T;@#BC//%&%&-V1M?C<+#V.&[=\'5K3E]WZV95QNJ+5"
MC),^A!*YA-6S)>J!ZCQ*LK,979PO($A9$Z6&R4(PT0F1X0O >.X/_=.U*."9
M[JYNY/#[/99KH14T*5J8 X@KN0M1MA"/<()..W<*,@[#31\M4D@'PE&5&9^@
MWVD35"-_7GO9<E12Q/EJOV*V_EMAL=Z&_,LTNPW?;**W2BBD_FD<;B>"IO6%
MG(.+X\3B'AI1<&+AM\22I/[M88_\68$9>WWW (6LCC%A4=?6#PY?-_X(8Z*W
M/+#GE@,V"01]HA$@A!$%/''47:VJ35WMTBR![#8;T1;N9C/^!?Z/[KYLW^7
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M$L=LF;9E"Y$'JZ-;C;_<GYV_S[_J9]0S83 =,\?X1X!*"RQ-D8'Z>;@1\+F
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M'R2>?1#X]PZI!^Q.Z:_ QYEM0>H)(M&^"4*Q5*_*>WIH> =OV3=?(WV&.$,
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MHIF^K&H#@I,ZL$=AAWP*YTGD2L*'XB8CY9-B'S!@%S9[,,>@TVXX]Z/!F/W
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M9JXE&N@R'/^SP 0KTL$.?%:'E*X'"184  &VKY# 6_=SR6>KQT6Z^LQF[AN
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M6(?#]QE01;,&EJ1*0D.F)VGO?<B;8]#)]>3J9T;#\U3K7.G:1Z$G5A2!8?/
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MDJVS/@]\:/]N!I-<"K@;_P-)72<LX]M'9#\)^7PTR-JD BHB!(7$=JPUY*@
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M@"P^R\<_P% ^UOS:IM/Q_0*:;'=',RN$M8TP>NYE]4$?ZA4))QNH@"-^[51
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MU67G8^((E'Y;VW^HA./6<#U]P4E!!T4E08\P+>1KK5![%=__A[VWC&NZ[?N
MYXF*H((B!CD5E!(0%6EF 0+*! D%82HB)2#=FPI*B$Q)I28"#B2FTCDZE1K=
MW;$1VV#U_(>>=9W7]7SNZ[Y]WCTO>#,.COC]OG7\-P!'D;&"[RN@O<1:?6<9
MZTI+)VM4V:8;]Y-?4*"XP_I=.;%O'=CVQ1^_EOR5E<]$*8_0;#N"W4_V'HD*
M&,.R:..1M64G"*^>>2#53'I]-$=GJ$KN>UZE7MAVU9QE\73">8=ZUH^VLY G
M#! O?,\L%J0J1>4A-XT-'_!PN$T.\#TXF1_HHY0,YAI0R3FP,>3S]*N]5,KT
M=ZG;3R;"84IDRD7R@=%8**<- \1*%R5CZA3GYG1-5:*#2DZ?4[IJGNV:,&2$
M(C^XC0MLV1[B'-,B7#YVNL2@YI:/_FJ/<@V%7V6/+#NA86[5HL=#6<V+D*BH
MB8L[H2D2B+:\KJ[K_HHF)?3-JF,T8?\M8T\=::D*_10S5XFQ5.7AW3MN:_=J
MQ:6G=6B=+[[E[O$1-XBZAJC0-@T?(SU+8FFLJY0\>='^P#?K?57@99[ #1B_
M'1$<BET4XI>D[* W]9QMV-]I^?KT0';RA[Y+?O8(MT2\4\G^[N 4 LLXYT(O
MY<:,(*BK[+Q'0 UJ=YD86>.Z7^5F3<N+<P<P?>3TJKQ[Y^O+X_/"&UDD#DY>
M:/$!B],^JJIZ6(Z]"!A!^L/8S]U^I'J8>CH'J8W/[$J1N)Q&#C:$BL[E&RZN
MJKF>"NGU^WS4!:,DTN1LW!+@%%.PIVZOT<G:,4)ABM?K=/X3[$>L[HNU>CRZ
M,LKK$1!,;(N'F"L4J%,)FDHN#W/Q"G"^P&P;GK+#!_B']T:-GO$Z-Z=N8!%<
MC0MYF')1L^/]YVR2Y:+0#@GOS$'!3LHE8W0PXCZB-ZDV.@MKW9Y[I$0@?>B<
MEOT!;217447G1ZN;9]3C><KG8Z:4M0&9T4/TQH#]>,'5+4%R7O3XL6/C=HI$
MQ*Z,TV8VDO:?!;AFLU?Z=PZ^3/CDIQK9!D2,4I0_XB%G+VRD2;W+[*CI(8B
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M0VFBU&+2SQG_0 /X=^V0G 1@4^VVI+2V_'L;_SJ.J3%YF*\K&YO PN30P3I
M87ZBXO?& ,A_/YE"[4F(ZB2:P2!7G@5#I+;&_6SW7ZAY(4F[3*3Q^X8G$_J"
M&P)(70!6*E\5WW3\5)@_<0.4D%2:48)-V4)U7>J_5X6W/_!/_+I"CWP6_!,'
M/PL.=,1E;K.?J8#\.0A@NF(3;9<UZF\_AXG]!PXS(3;$ !7;H[J+[XD"BN^U
M+EA =RG8!)1X%@73^ILX (TQ\C5#[2WR98".,0>[M.BV(YNR%$.Q\7^30G>
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MRA'A8*OXT%5[?%']>XSJW3-2XW$<2:$R-!,LE0M,/-O7[W-B3%?DD4<"B45
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M^?F?<9EMQX/;:W<HV3W9Q1.C;'^_=Z([7H:O-]]2).L"ZX TGO*T.PW@TP>
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M-0/Z^5,,C,KE0#S9M59\7?LZOJO4]5YJ;;YAM-C8R]K;'P;4#9Y9VNL3ZL<
M*#U.8(!Z;T?F 2>PX^XF9-(U70]3-36"&* UA<:$?BV@A*M 18P@D:\;&[,R
MV OJIU^KT/;R =B:WRP T E$3D#JKOAH,$ @@NR, &0 N*2OI_X3MTCRNZ4#
M  3-+  C![[OCLZUM:75'VY%5R]O"EA %#KHR]0#_RT(@ LK&4I_?CN:OCN)
MUL\ -0V;>$G'_@(V:%"O >Q=;\Q6<:<-"I;D Y0HRULS_+_CJWU+SP Z3"$
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M:(O7WKZ-(7[3(<'62/G#CM(I#B'\[2ABJ>##3)%U+SE;-4PAS;?KAYI>,8>
M/D)@W%4MW:1;T[,:5 CKC6% Z_>\K65>*W0Y5#@%#2%:5/YI&F!F5?/=I< U
M)[N?[*OHGL( <=%&,QF@B9M,>?@&C8;:VA6[FC- 01A"T D&:#?WHYBH J]#
M1=8B5)5-:5@Q*9H.#DA] 8!2#(X"<F&H%Z))>O:[V)9\BZ#+>5AQ-?L0A$]4
MGG^_&N7':B^9J^D4U:%S%QT,NYD?_GCD8ZXUW,_]B%3&&V""P&$E2Q8[:.,0
MX'P:]$!^+%F_:C@T >9U=XL4IAKEFEA.[DL08H($'L'ZCY706^?*W3K7+*9;
M1I*&VO3^B'II=@4"5)+C^]2:0&:98$ T21G+YP4G #^-S^5'-+ PW\)[Z[TV
MW<@ K;<RW?'U/)[#?)UP#=+4A*EH]J*6:E+*@':U0*,_4\KBE=I^U"]C)0X&
MW0BI+NMF?H3:A4(%@LB8;<F](D0_MWU&-$6%4[BL+BH!Z[XLRJP33(P#R"M9
M[.EBQR%<E1///.OWA\JTK&#.DH'DO<.WE(R00R9 GCG;(,?!/'."9X/N$GBW
MW>/X>!SZ^0MP?ME/B7=W<O!\A?Z&Y=TY&H_)N[3K^GN0^^/)P@4%'JJ8D$'@
M]DM=A"O;//=-+@D@]_1 JGM8VYAO5L/Q75V>ZF)4Q1*S8[D/444#RX<V>S\N
M/^S[RKJ627BA(SG-C9*6Q3JJB7P_R/HM@BNZ.!>7W77><AE,5:43Y1 2(Z?:
M:^'C^4&C>LX=(]6/+XX]9T9S&\ X&E@B5EO)'\$Z<=7P7+*\^\32+K3"4= %
M8:_I!(CQ-3#1RWR)2)U!:"SO-=O0D1E,9X#R[OM@9Y>6)['O-69-QO?HF_,/
M!>O"YS9S]TIUDQ37L0AM.$&:>IA%=P\,2/YH%>RH6( @=K4>N6+]'2A358<F
M Q2V0W3QZ=A;>.D'@72\ XKH-;U$HLY4,$"6N"7*='<70*?EO;[=M/"0HGQJ
M[7V?O%Q8<7>K[:SI./N==+FDATO=G:FV)W'8BN+\]10L<*\ [N)(VCX%+/X3
M@-!70'LY*SL0,T^!!9_KPZCV6%9/8.XL^,Q:'2;E)"=%18;D#7=!5&/)=D"L
M,E=$?'LHL?5+-B;=W]E\)4KNX>B'1-<8H+=>@K"!%7I./E!*"*LN _2!58Y^
M4 9!*(+\?<7ND6G(PGK+X/(&4Q*N^0X-QX,)TG0^:T X;C6C5OF"Z4O#I2N&
MW:G2*>XABHC*&D'4*N?E)DH"K"N*-LX4:AO(VH4IYK^[EJ;+:?S+:EL:4$@!
M9$A187:%!';OQG@=!DY990<9E>#!T<UE3),8(*AWR@K\;EGDT.E9I@)X(;ZI
M<$HO>2*,34A(YJ,2!JB-)19@2FJQ*P,4Y8*HPKN"-X\Z(T9O'F: ^'[PY.(6
M/0">%# )TUJ&I/.Y-GZ)/U][?^LM?.\44@#UNGL(9$T^"4>_-^-VW1<I/=<X
M7(+ 4[<(/TPV4.O'4+.3 $O^8\&W6/(@G./N[RQ/0A&]@0YAS-:D@5V_&%X3
MKW7)I_SH0!', P'<PBNQ4XX::&I5ZPI].GK=PF$( B0E8/ 5#@>J^ <&:/R?
MN_\&)GHC.-$Z:\[T%L3H^OS0\S4$OI_^_%9S%!#YJHE(FLI2= .P>X>MW0.7
MJ#5EU(H;K#/R?P0@!0! ^?A-EV4-R *)#C8KG0&8"2P )6O5,O\A[S<C*^:'
M\6=]4&^9!P \]G*P"F1*,. ! Q0.G?]1(H$?)=*O88!J9_[6="D:9#(>SN'\
MTT]"P+^7Z ^0"@XS4;1,4_$U&O.CGRRN!6_RZ^+HB3.>".>FS?;_;O[0/R01
M4$+@]/G7TGDFZ;W!]$7LY'(8I?6/(R@B.OX $>0.(!O=-KQ# 9E6K_"\'B^^
M),\IPN*4KW,G0/L73^2N!N^JD#@<6_KY8OF<Q/]#W9L&0KF'_\-3*862D-U4
MB*S9LIN6$R$F"2$FR1ZR93!,)4O6[(5,LDSV9,TRDST)(61GA.PSEC&8Y9FA
M.J?3.;_S>_[/B^=Y7O2FF?O^?K_7=7V6ZYI[S)[Q4>)1;9=@\GYL^</DL<SV
M%ZD\7:R7S:] @^0C\=?[A]ZX&"G>(DA4+#/?82!>X5H2CLMP\OIC;S7*2X2+
M?#R>Z!^7$5.+IP]5[!614#2,Y!W32:$ \M4NC6WVP!L V,'$>&O%<GYK"5=H
MV+"DX9*OQH)MGHO-@.] "TE,]:;SDF(F=AF^.R*_C<NIU7%8PLFC(%:K>/T^
MM2/W/";CO^NR@AL]4>@*"32-, @G5V3^'8*0 ,M[$2]@Z'KT])U[+6U2W^']
MN9!6LL-N>;:M7(]WHK6 "J"60@$NF!RT>A6%F%^%H7=$_K]136.\+/4EE_9(
M>/\<HFITA=JC$6F/&1G)#(,&I4'#Y<2:9>*5G]D $< 7,M%OOZ(S\K>:_UZC
M47^#B"=!B<I%R.'UCL+\G>WS/UVC^AJJ/:AWV62W4D4/2D.V5S!>8R8D+7$:
M$]NI.C>N=BBE1DD-E&NV'O8+:U!!#/P+RJDE-H=UIVKXTZT:M++2-K\NP=MW
MG!#ZFV$X[1>%*PH7X=VCDL._'6&29+\-ZD,_=GSK.ZA+=T!M^!/4.PKTD_]
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MGSVQRP!VN#ZB<;_$W;;[F:_=@U75?:0L^J]R I^>*-,Z)G+,=HB76HU*2"D
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M(LUK& J@_UL^=W%?M,F@;;?GF_(%] /06+$L5*"6S(GUA;%4UD .V27X:#M
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M5ZZGN[. :DMF@<$(%]D)Q.#T75*TNHH(+[QN3VXY?RM7!Y*PB6M>9MPZ1CQ
M*E:7M5<73L1?[BNMX3[(M7 ,=]O4."PX,*VJ.NDP'G-U5+Q[X]Q#K927I /
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M-),H?-!M]'"JJ]F\YDCK]-"WNQ]4R[K%,XR"6L9.2C/D%.I#K."UU.W;(8Y
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M!V,=)ZE_E679&UA:'2VT-BUPF)0TQ/7EB<*NOGSO9U)'IH$F'][<F5-IFJ0
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M3SI2>0+7L?+BE9KF>6:4YH74ZBOTT\WS'%OBCD  D2N',(&9QX\<(V6@Q$=
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M!DARQOC!>Y'S$.7G;ZL:&,2D>A+-3CO\C(,)RC(O28,[@(,5_C02R+63;70
MH9IUYQVPD]M_LJ75.L/VO._'P!*T<!2"\=>Q _ M/@3) LD-_I;L2P?0 2SR
M#&G\_.YW$K+_3D+\WR]VV,9F_)$SH'U_"90A2YOOR6"KK="-GS&#)E0T9LY
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MJR_\.-Y=OGWEZW#\PR\L.**93!.GM$%-;3#S,2GMHV7Z[2[K/;,T._P,]W2
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M4,59HRZ$L0USK./7)5"+:U"DRWVE^WMKM*CW7M(!:ET&((Q;IYL\';#_,!V
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MR=8, _08B$T'@([1 >/O?<A;QE37Q?U[AD>B'L'[SL$W#!AH .\J0U-)H71
M=/]3]0N';][TF%TT3OM>&MK!G%M$/8:.U&DGUQDNR5!_6S^(WRU]?VP:2:$@
ML70 X'_YJIW9L(DAH58@'O_O!:^G0@?,3-+H !+3PC%X5P28)",&&?V?9;]9
M!B&= %(0?ZVW?FP1S['#2;TZG[UJ71;,5QBD[B24D#WE=Q"A3 9UNJ 5--6P
MDXM=KM.5B)!4J7+2XW$P*ZG/Z9DE)_>LZ1SDMJ)54?F)E:,=>&7TDI?DQG2U
MC7M/)QV@VY][BF\H:VP6->#3]:K:=2G/X<D4REM<$,A<E.]97W4B"(?<1X+K
M$-I5ACF>9[4XIL<=LY=Z[2WS:;1S6FMS332&P>A:6&H-'7!F@P<\TP*D\)KL
ME(S&BY*RV^:JY>//8[7"?.D S'$&\__6\^S/L2S'KJ;.J&_BD7\2X[\9K/\4
M3^@ B<DZ?,&7//#,,)9&T:$#6F>?#+<\>0Z%KCH*HL(.(>R!)@_+9PZ8=& V
MSTH3=L>1S )S?2XVR9&X]EU]P4Z1_\:RY/'$KT6DE^9'Q?TNY2%E&;&[.J#N
M #H@\^ ,0<S6!&<@M] )[L[; B"^ZF!I0[U /RZ!#:V(+]YS$2R=N+FS]?,-
M/#.W\L2FY&L)3.,A@(#YV4X0I&O@>[1IA.^15J#P<]+T/@8VU;4POMUYY]0F
M'D@[?7' VUG)C5&(!#'&?YG/YJ&CTSGN>WY]R)DGTLN(0AR9 5F_@M<[/[C/
MQ\ 6<,GU:,S"!AUP0IF&X/1(!?MTF*/C='MR3ZP;G?\RY+3!US-F:_,5 ^7A
M&_C<ZI#@=/OV@; P5D7I#)NXNY!3%ZEC,"<!F?/[##],CMLQ2V>>5(9T+E-X
M5C>V$VV3S:BI('873NI+U]NAF#')WNDF[.AY:U"DDY9CLM92Q#K3IRC '@#/
M]]"10_^+:9A94<9&[1NBO<M0%3(R4N-B95%U17'%M<_+Z::G2EXDVF<\OR'!
MQC%T\(5'6ZP,BJ*UNB% ![PMRV!L$;I3#D(T'?L0J3-S:,G7@NZ2@ \E3(_9
M;J\6I@IP6PTF04Z MZ:1FQ_H@ ,!JS2GP&5*TQ?&(B0/G'!-"UT]63>Q3:0#
M0E-A3< U\U(TY> <D!*D]Z</J:E@5'$2'"M!.;8R00>D,K(2@""DI<*[%&K_
MX-7ZSLN>M:@AX&]Y3G#2D3[PUCX$R6]F09$.N.#" -X&#L:"#Z<HH7X>=$ 7
MHS_J]$BF4QA&^GMI6T"<'F.*2(7X_Q?^1<QC:&)^9#9XMV4/HP!TWL%7V$^A
MQ[.PA?7U=$!P46;JELTN.F!%O7AY 92)?L[YJ_-:OQH_@UQM7X8/4L"OO[='
M(HWUQ_:8V&[KAX]G8XOR,BMQ[=JG,>5),7'91@%)&^^21!OUWEQ@+_07E-0M
MUW?@]X%4:/*=>P3%V#-*KJD+;(?8EK6$T/9[<=+.%DR";[$]B@P:G!*A^J;_
M/E(=OT2*DGT6OEAWD58#Q\T@"S%4WCP%.F"/!L.2P]U_B!SZV?*_]L3N][!-
M]?V#16E_"!K\R)@U?+4#O/R<QO/;!'2!9Q+'_@\K$"!AM>N+/2UB()$.>"+*
M0+YG+EL<O[6O'4'SRZ*N@!MC_!B[UVV(-8922 R_GN 8!FPI5/Q/COZ;YBB-
M\<=OIJA8J4W@(.)/O&7LLU>3&L(!QB\Z!?H!O_#/@+Y^2:+I4/Y5#';:L__;
MKP0-SD6RPQNNHNVCC45O4,Y.M,OO<K&Y3^N]=*-4-ILC+>U,-S7T"N3$F!O:
MY>I1^UNYR7J"I_K@35UP.\\NBOPK.7_X36<1^.1SFA<E](5./\]$_UG:B]1?
MLNK9M36U6?B+K&#HUW\4#[Z3\S\<[7^^(_XWL/)GH?-/6+E)A3?]V&?'X>,5
M\!60X1*X /C'IE*!_X%6-'_9"O&KQ>HSE!7RE]_/C7!;\!^LNOL'?(!\\$D$
M4E9-R)/P8+%_49.<"DO_^P+@-2\31GDMZ+EDSO%KP)NI&C3:6-N<OZS FFR_
M?WO%:Q]4F;F_R@6GZ6MARDJ/J]5Y*3&_><R5L(FN[8K*<?<SNB99HH':?^Z'
MZUTPX1KT2_ZJ7L^)=638AH9N#MQASV#5[6'V$6%63)3*1IZD=[3P#Y-?'S^-
M$3@FF6_D^AT? I[3 :R.AFVQN>!":*> UYY(<>6UH^AG?IDE-[A90V*P'^3F
M!I4N% T;[S=M\ICM@VE]XCO-5-?%Y@R;C=[WD8=#BEED>?T[;%-8?I44WHM
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M'J#<K05^8QV@TT<[2(HT0)6&&L%Y9C_/G@8)59R_5JI*!\@UCGR075EB,_.
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MH#_.J#O%"F)>9NT[FPLHF[Y\W-$QJ^MY(_O4"ELOB5AH$TU:Z8#=Z-OP<)H
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MKXYOM%$LDT$Q^F8[)O+&CC_\#_GXU(Y[//<FFZF7TL/DAB\M0)ZXN@V9\V.
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MI<:L >"D>T.R%761C3]9.1M/IUES\VV,D;IJX$IAX/B/?WJ?MHP511^,%\>
M.C(V0E3L"SJ+?W#S5*8-[8^MR_E<$G/+AO"?]=N((Q38[&QN.#?F7[_4SZ[(
MAU;57%$'QE82 >V,1("]<F9#V35<&.;F16['!5>^YNI3E6O(&]UT/]IG'&Z\
M_G6LOI"B1030W3^#M_XHA#PF MJ:@ 0YZ^I[CY<NW[@9:/B1#.-.X$PY!<%&
M'^#. ]P07Q#>*1'GI;]]1@3<DT$5$2Y,GV<5G\_R/P2#6,[SBGY0U=$9TW ,
M',=J2P3T?"0"(OD)P\A#0[7KL"7+1"+@:OFLMO _LYJ!1-]-G#FE!%Z!7A=Y
M]@I>,YW-M%]T9#I[!GSM>\3EC,W(\^RSH;CA%QAG0X\^.LD X#6;B(!0 0C3
MS;2T6;^N/:!$ZL8"HHGK^^3.2PP;Y?2XMIUE1>6\_> !-0EP80!29/L/H*V:
M" $G*Z%J7!WZZH!&8/5(#9=^MRC*9/G)J?(M[B2.Z:"/(<$7^GFE%TP\K>\8
M4**0>"4A+)0(^/ .8_C;SV/"<!- ]"I\YI008]^MCZ>N( )6C$ZU[@&@XD1
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M3&V<H(^E^#94"(QS:-T<+.GUE*NR;JK6P5X8MS1^IE'E?M"5&95(0LU-N3-
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MZF)=&:.6F/75 =M")]:*:,'7?*JE)57A0DK',3:V64E_PTT=G+T!_-&([-;
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ML;YI-;-F:^%GQD)AEO*!Q5^>TVA?G @C5>3//NZA7+.PCVHVS/]QM3=$5GE
M25(2XEFRL)EF3"$@]"!CDEZUC(_?3B?D2VHO>P[=R"HCO4KV/0$1#BVK)BUV
MM?E'?[A&#NDK_XL)\A>WOW9H*!KM#^U?VFGB:BBS[:1>CK:?7$4?2LWQSR[T
M3=11:@E,,8!@UT6,Z#F6 !O\V7A4XZM;HOE"UP7LN)VR9.U5F+GZA=C*A-H)
MXN,0*X2P.8>I2^LR!T:N-U(H=GOT;IWQ)%QE2N^' DNR&C5GLM0@P-?)G,QO
M<>\,I&WFS2RF32,(!J0DNF0WC__AY4-:BJMUIB8"ZH0#&>R]IBIJ/04^=/6
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MDN167^[_XV[DGL$A-!=B589QO@2-))9P97)*<J3>0-8T[8"T)TSSYKO7@DD
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M+)WQ#<1FNU>^#><#<KK+)W?0 0[N^@.QR5.0M0YU)5,XD*"]X =:%D1KB9
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M4)3-%"4BW^=_1.2T:T2B?U(4_V+INRV'NBGP7+ZQ/.KQ\8^BS8#^UFO\^Q<
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MQ_P,2]PZ MSO@L0..7U6.WMD\5+KHS8>^)VRCN>T%0B:^=_?-LE%KDR#(T@
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MB! 47^+#]4M#(.%&!4$-;8[0W"&YP]%6>6RJQF[]C]BE,"P(<?R9]'O O23
M'>A18F?I\+'NJALXOD:C::SAXSM]<R=[G+7HAB]=QA@FJ"=*5@\]7;_V< ;
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M%:,GDIP<7YLVKWHDL,]6RDZ6;7V8V)1-#?1M^'2+I?F9/&H8B-7FE%9#$17
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M1_,%3>(< HA4^/9)-2RR@=.N?WZ%GJ[Q_I0#PB53_<!O@0Q/<A?G9=%5B21
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MDS G_0]$F2[\]P/_CBZ8Y[T%T&TYN#EN,"#Z*FC\O?\H"24'B!;7EQ_Y/GS
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M<^Y FMCZD*NJ5A'SM::."?&O2ZK%VP^.Q\@\^O1XP=IX+_-MS:E"N8/?%0.
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MU1@U_:&2_E?O]4.MW3N[.F\%W!81/9FO4.-RKV%]S ,X>2_.>5W=]&WLPB5
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MWD[Q"5 )]R8G]3 QV/N#$K<G\'9+T,FCBI.#9&RG1D/=4R']E06$0E<<Z]5
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MR<&+%+.Y*%U',0$QR0_]'F\HA=U;)NC+([7["7<TWWVX?RC^>TB/' /%AC
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MRH,X58Q+B]M4Z6T#P$R7(41+:\QN.Z;GW<U]+=HL[ S%A_@^8BIW@QMJ?;6
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M[^_T%9#U6(B!L?.8<DA4P&:4H\VH5P:9#K!I<YUH:!A1"2MNO'?LK?1]SSL
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M++O%"]<UW#,EOJ*:F7@%&[*>7!E3+YM0U:+ OOWXCMY4FZ7-^$Y_Q?F]L(!
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MAJ+>-Z$)T0&^?F[>T\'EOI+I.L)-BU6^!B79!#H 8(!$,HS9(=IG,$Z&N''
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M@*=.)K)I,XK_XDX1(^Z2^W:.GPBG&*"*?&2V9RW)4OJW"Q+[OZ75C#&MC\D
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MO0L1JB*7M-G,&"IOH#"($3?9=TLW:O8EC;%<GFMS0%[O?\,@&^)I(WP&QM^
M_4(=C6%]8]4DA,;4)%TU0@/=))L_8C)_="?LN-I^OY2:'MR_V-@#[< :'67A
MICJ&WL\<HX:H\.Q ("2V6['YVZ!\N>*3\>VRO(EU9U^_M$2C5;VK7JOB;.+M
MEUH89U!'W?B,,ZM[G_MP(NB*%/1C='B.N,$]K6'O8J$FRVINK=;&YMK[M 5V
M05"RO4PBBP2:L"[6LVJNQ7WRMM'WC,$,VL4H8<)=Z&>/,W/6%#.[06R0$_O3
MHR>Y/N#&.."9993L26G9S:M;_'(<_R62>1QEZ_FLNOD<8$(:B!#(6IJ\K;$<
M$_?BQ/U,4BB#Z UQ[:XGR6'!D:UV+W%];A?EQ:QK(F>46-4F>\Z;//&D)MD0
M5>: -60Z;#J,$>\G54P#_*,&*0V^<)'"@UT&KZG?GCU!'1<X*MEVBS'Z'%!]
MF!YQ>*6G$:<3_'[A4P!-RL\ -[X/-SZMO4@SEI'>W1]^\;8=@1J:CD(0U/*?
M:OJP+,/9I=42-7XI-"QOC7T+LFQ7EE(4Z(64AW0OE6']C*H+M5#IJ;V%.MQ9
M]:V6!B"M;PE3C>L:YP#S-^< ZAH7LTQCQS@4:LLL0[33RSU5]$?6V*1TJZ4;
MV-JH'K34\.>C'..[J:MHBRO$P#;[04Q&7((5/WP9S$$PQZ9'(5_ N4@_@76,
MX0NN'@QX1*<-3^ #57GO$--X^4!G*5KZ-H<Y_3I]QH^'6^ 7L Y/PSTZ I<#
MY4N.YM],UZY_Z@=GI*C['-H&O$74R8/>J4CO,)Y=AI!WF)X^'RI%8?,?CA.D
M7MP/F+6V6>A8";MW'<WL1VW*$Z%SUR9"KWOX.X0GQ,F^<O/+%<6!&HD;&FXV
MLO&"C-N8E1V';;'^#-=">(H:82_<4TT+Q6MG26&1K09F7(5(N#/+K31A?D^M
M9]FS.?I7Q8:.V!SI/\TB?B-X%A+^ZJX%A41BV&,]Z3(]HLNA\B4641GFK\+^
ML =P:;)$#X=4,/ H#<FO@;':GQFWI\MQP5!P"6Y09]!K4 -Y=RJ7[:1P"1C+
M+PC^]>DHEIA&<+NP-#L!A&.'!WR9G6^)+4UL6%FTM"R+E&2 ,_"6V0,"WL#T
MD4OOP\X!78I;+H6."23F'8,%R%VFSY3J=SLNO[UV@6,V/GY=$XT>G1<96R*5
M0TU*,%K&^[6\1).GG+!VN(OQTLQJ9C*T=7,K0^[0@"]+L?L1QHA=R?[V>_.G
M/7804YI[0(,-"2D!V7(:],JG8RNY3X9#"R8F$Z2F4\9]/!SW.;[S;N@5' N,
M)='O^ZDC :<%DWQ:+E:[5*CSZT?FR@=)-^/6=*/>]<,_A=O+[%_/')Z(N?A^
M&[.^R(7AK(^?D6GK"M)S'U+]I'O#>.PYQ^!4V'&]/L2!_-@5)8*D*B%/FLH9
M)QNB&C;M_J/%#F?>VLHKU?@\TO9B[.><Y4EV>Y#/109A&Y'IVRPJNGEL1+Y[
M9LJI9NDHW>V-99[N(R)<T<8XUO3XZ&\'Q^D_KJH"0#[ 1-EQ4ULEOHMJ9^LH
ME^+O=X__HU%<0:<YLS(8HDM1UY%SFX994P F3\V;V)>H QVOL_GCY6I7;./G
M)EI=V=H"2>$IB)]9T"MXJ'CYMB YW +0CYTZ>D8"5AIP#XK3*^<[O]IIK=>*
M8$N-O69SBZMCR?]XP+WFI&+L4KAPQYW@X*^4<[;'W^7[\3S=:6VWL9&1K49%
M%GUV12[U*:R1+F'A CFZTX_HKG(M"Q']O:R5E(V[Q!E>L]J*]BWCMO#__*>V
MXDJ[!ZYR6#ZYU1%+=:^Q$F6XD#KD^L0IU P[/"XAT/CM[-7(!@>_);S*AAH9
M(*:@H?WVY(WR.MN(9_.M48K5^F -;[L0VE-WM4 *SQP1G'5#Y"$2\-O4']J@
M2)*91$C4;FCV!O7+L9.\^MEU?I@K>=C>D2.;SBG:TGO0'G'M2 AV2B0&;OQS
MQK\89.V)2C().6I4EU=VE]V5OV\=L W^9G:2.ITZD@\SD;U7;D7_P#J^U"_H
M$8T43:]5)>>0R&+A6T]!/0FG4*F=*O_7 ^UJQU1)>U:@$"C8$3..>\CMEI7V
M!V+98QH$'.<4$)NW:6\IS'F:D!&3,NBY=X<O=U!9#-7T< >TNUXG>9.6@25U
MVY_H[SF9_ ]?C+C$95SPR*=B43DQ0<9>9&TI1UN%@E3WQ'5>JI-3.[_":<:M
M_O,^C[*WVX,A_3=V*]E3^^T5*H[N;R@L)-VX%!69A4R.//LDEW_,VNM6&F6B
MKE'$\5:Y4RV#^ST(K+!NDBJQ9E=#&GKG CSW#A#!L.JM<X"MA2NW%O$H$VJ,
M^78W<^9HYN:K+PWZ']].HX;J"MI[G<A/$_4P.13)/]9N+I'Q7QWM\7(5E%YH
MJLN<SQ".?_SCZB#G,U]?"[=/!::G%:F?:]'N;FL3A^]5]9/UJKD]JJ_,?E0L
MV6;E]<P\\3@2;TV6GF996BB_/6<]/P-5'A5VJGB1O(;Y8^FJV2>@=]U/V)Q!
MT>.E5X[_%*:A$S;=T /"/H/%@_D/C688EQW?$V[F0D5P:?D%$&"'#<VDE-RW
M)YUC._P/?AQ5SLVJ%D23$/ZWN'8& :""%LMYD+&BK+-%3DJ9V@WY)FOIIS7C
M0D\,YX]W'-7Z.)>/'_JX:]2MP=A)2@1!/%.AI2N20\W5$:U^FV3O]B74S:O8
MVL9:9U]-OVA:J*'AAD;Y$21#^ZZ:Z=)>9- 5R!2)9N@,0N#'@[&N&&1<*PP[
MA%FM3<L1PQ:]/]2K,WCIYY;_OB#=)+RH*7EF8<PSN?>^69>&H@ROZ72;D#/A
MHN:A>(--#R?8<)_=Q\*Z5"5]T7OAATX"+:.@.@_)?-)$2_P/](N&UN;4VYQR
M3SZH+3VB^NW8!7R_2!6D!KEG@3/J1').0\ZZ?,X!,]Q!M8GWU%-7\SO(>5I\
M1O?85?$@W]1%.;&$$3TUXP06J"G^*1:&SHY,@#ICK%7;%QEJ2P,L U3[Q]^Z
M^K9DY(;,VRJE.<K"#SW%04I74L"9;4R-M5@. IL(AA!$_4X.3N4"HMPFZ.'(
M[U7K;A\$Z&_=FE)4O&VN*5A9EVS'(\X:HR@8\?U&4ZSX60+^YA *P>CB:6GD
M>':-0#5.&OGJ5'U_^-[R7I0"AZI%YS2;?<3N3"<D_/M0!M,Z%RO9F6"N:Z91
MC)RZ>'<S_8R+BE23,W_>%Q?/'@FF3?:4X!%K(=GP-&%O0=I-QCI7EGCG*LLN
M-SJ%^L0N9S>WR[<LS+NCF2TMN[A1=.*L=Q]?Z@VV>T:W<CJ6OO:$9O;:$+CE
MW6(.9!VT?HU!PS.)2[-)AAR)MXN[:KB[8 \P/<"TF1-+SP'.>W1! VV7/SW-
MZO):YO-?,(.*H)$R%AX:NO,LQHUW]"5T4?ZKGJG\=;LD#9S\8@B!!2/-ZCPC
M3T)ZYSIS<!>VI=OF%4P4Q"@SIM2N?$AP/V%]L4T%2 'W3?6> V))4OA%'(<9
M+N%]A;O&K+>W)T-&@>$+2S>&42YKP:H0]HYHP5]7'-AB0U2X,P@:R(C%C,?S
M'LA#8I"C(&:/"Y*"88R1!W-"2HT_F4[5?2I!5.SN6K4Z5<N(-W@21^^'W?_:
MHOV,UU2BD9PLE@[^\7AEA2@[-LL*+0A7K6205J&6HL(61!8#EH*_M1\5\1<%
M4]DBWS*T!YC<Z-(SYGI)K<03)73)D(I\/!'$#RG/)N^RF(JIFP=UM ''OK3B
M^$O\>!78;ZQ1,^^:!RV7=U<D]F0E',;+$*K)N%;O,6HJG0,$BX\_BZ3-1=;G
M!#BG$KH;0YP%&M^?=,1#IAT2 $NO''H @>\8"2SG@*,>R%I3 UY&;;B#ZJ.'
M9*M^KCZ=?I:?*8OP\CTZ1%>HN)3J&1[< PHY!["V7=E4<<_ &76YHN>-S&-W
MF@-+73*#OKI_CMJ6YFU^,:;%7'+RX+OQQS]*\L>.V_E?-ZM)*'#=08/*4)2'
M0_WHC&[_5F99^BW1:)B?AUJZFY"6(8. MWO=&KC&8WL5B\(TM$M'@?@T;D.U
M<=GAZ5T&O@9CCF/;\EQU5\H]]'/Z7B;W/TAYG/,RP?+-)4T:LS=!04[D:(V
M./[EX=,@UMRD9&K FZ5S '-\*7Z]+M 5#:<,ZN,7FFS5PS@1#'#/9]'QH:RO
MI_'7)2;/ 9@C9*  I>P&;EI+LK@RKM+4A^LROVLI?N1, :I4C1=!@Q)@ES@P
M%GA7XZD=@G0YQ!23G5&-L\ZI*GZ8]&O(%: ;:OY5R;GMB2]Y?!8 :EWHG++E
M7P$OF/E1V5]BT^'H(:T?X"?UPFQBE^ITX*N9K'VE$L(4?XB]UPVL64\8:^<7
MFCB8]WH6>G^DKDF>_KKU*Z&&*4FM%:;/??LGE7DT-W];"OF;SIB> RY,4X=5
MM<8;H(&Q"^KXN$4>J =#0MG"/-ZAG#&8P.99S%E16XB[_ 18%T6GI87ZT-+
M$H.YX&!?<-KP.KZ=\KKN-^8S$)8.F9X@KQ4;E$?^9Y2:X!Y%(T E-$3'O9;L
M9'\UTIGLNJF/6=4U^^0W@2#NHZ%P9$TZ2CKNR/3TN'/HT@(D5G_T1GSO$7[1
M;$/%K76LY,\O:Y<$BF\=8F4P+\$/2E1LF">WF_L&;1,IF &O>7A+UQ-I?M\Y
M.)W:DN[\V"I\]ICTG41-S%03Q($>XN_A0CMF=O.*9YW\<_(UHK] []0U)0Y]
M/+QRL]PQH)%!(-S]BRA?L)4T*]D)##-$@?_4SGV4AY;FQ/O#&/%PP]3D8]TF
MTTP3J3NW9SGO74EK4FNWW6<V+&GT M]Q E?I[#S%! *-<)31V!A<[;SVJ.HW
MJ>/'D[7O%9\V5F7XWL=N^#9<71!KMJ<>]HM3>8$#FY$&@=0:0J@SL-4&LHX]
MP;/B(O/2: !=<FZ,2G@7Q&-F34*[V(-\P_<$,NY]R7?@M55^*2L7^[/E/?0Z
MSG39HQL1!>-H?8RC,L;%(SFBIKIO&^7KV)6 S<Q^UYNDI-@YVMLYRRGH>;Q"
M"GG6*@F215H AK >[7MQ-JJXBG+L8D<0Y90WF.=WLM67P@*,JM).4%_/ILV<
M==12Q%4E<^M4(7+1W@R<SA+\(@2;P],^X10[3?E9 Y\P>7ZYWE(W7BZ5%?<S
M<=&LM?[G",/#YYJ;>G04@;-G0M  [''TP5X"B"%(AJ /O@2]CT=]WCCU>8<+
M.F2?W1[;P&'H!1\UU])(T/AW:XZV;^XJ^\COPW?XL*"C4#Q- <2U$\1"T(7:
M89MVI0Z!D0NWJEK3S;$+1;Z06,\ (KQ$7WA@SDN?KBHM9NUU?M#X(R?RE1_B
M$VWL!'H\ M?L9K.(-@U;[&%Q>CQK4%HR7DM4W9:9Y[W_\X(677BTP)P.CL'U
M%]4VSQE8]D?HTL#PU:2S,4P"_:LL_B_  P*.-+5\!R@R:]GOY^WJ<-E-OF?G
MIX+/L BSD7I7%";B-H11L-)8)"[S$!$#! 3)$;C&6D'E4',L?QZ:7K&[3!#[
M;;  USB.^=-='-:IRU!5F;*V?IFE@VO-34VY'*^/\0E%PYDWA@I=,X'QM>]5
M3>N2G1SU>5H"\/<36R=W<;KM29'1TU[#&"04^4H?HJ%&D,$==UK.>D^H66,C
MT0T1)"&(@55"O01')8H>5PM&RNCK!E_W?65,414#(/#B';"A&(_>[*#U3B1M
M*T\)'MEM,KGGZ_G%_..DZ//[(CO:IL0YEW:[A^%WK]EGKD*-T& FB&"W"B*T
MU3)_?H-?='07:#AUX)HAZ%HN12)/C_L);U&SM;/,VP CD)4OP-BA<P C5'Q9
M]=.O@W, +VDX1S:RTT(X]_*F"8EOU-T^:R[E/:Y'R53[;;M=HMZ&S3U,PO2/
MH>6AG<"S!V!\D47+2!LW5'5"BF"\;#G/?W/7>W9+I\Y(;*AKB],WY4F:MWA5
M!Y>MYQW@1X ;YWJ"C0&5T&=QBMNZ292VNOSVE_O(X9@=L+\+L@;1 8P&TQ#\
MEH>F*PDO1PGZV"I+8YQ'>-OM#19S_5*(TX_)X7F\__V&&,7&9,AT?970_;Y>
MUP? Z:$C+[PI-AWM&P]S.@<P01]X\!#,6B*.NVS8\#Z3+LV4T4)1]?[(*).#
MT%4MS\A&&<;#!^U>/0#H.@Y^%( SZN !A1\WUU<Y5""Z%VF[,-D,] (TZXTU
M8^NVI7:>[GE? N*RLDO&U$L[?C[1'&"]R#P/"O8:<F[:9BKT871?7A%ZY;_C
MP.=ONC?5;0!"2R6=&9&Z9WRC/:!ZF'D)Z*WJ!JQ"";IQQZ%V0KKG%Y,!1E2:
M7/M5?MWL6IA5&GW,2<"R8N?0=/ZRSLZL2">0S@7(\A9\%=^ >K,1I#CACJF,
M[%(HY?_H;@*FZ7(O'NGB*6;Q^YI/AIL)!MUT0@PC68)^@LGJP+&/@@;. 907
M_(VJ&\@I*;]1^PW6,]-E 8^H3S-Y+W2<_IHZ^AMQX,/MT"T5.+HBI>LB%\"W
M37%7,)3?L(+M0&:-FY8$RYJ:YDKL7JS:G5?G +0E)+)7!6HXE>E6K47*/K)7
M__;S,3L75X*0UQU@QDJQ8-!KHP6^J^> *\!72T'R-TR,)!V$HVZR=BC)]@F6
MO=9A5VUI9@ E(I D^J ^,'T=F(Q@@VM #7%NM5T!44'MI$*_;C3+A#5$292'
ME0I_R>3$?;56"W(K23E^+F+=V[07!ZL9ZM '!>=P$3^? QSW6/&]RYW2F'X0
M[=:,3C?X>MV6P?.U79&:S/[MC-CGG<93,-R['%'R-<8H.$V; $'$C6$,XQ'F
MKB;LB0F45[N+_BW\764P"FTA7K"<_?WW.I_1@R7@ZT3>Z,M.)>12&F;6;S;Q
M2A)%\7Z<B-'%&<LEWVX@/U2?F-;&;WE!(!2[$R[P"QN4(_<)P15U6>/*J(6H
M18 EJ"98HX..=E:?T"ZVUL0(A/(08]1NED.6T=[P[H3HM O0$RZLXI>>X!XA
M<;B0Q&HUTS,-,J+J]M(:Q$8 \ZC<7,:AS<.$$"15JPX.A;JYA*"?LS!3\W=8
MJ"IU:3AA5]%.>%$VY9^Z%>=6'TR&I.,1>MY:899)LUJ;K%L X4MRSQ^:1H2L
M^-5'@KRK4ND'&1\018C1M=\/0-/'1S7X K?+S=F18;M0#E>!%]:S6N6S^;J/
M>VFOD]1X3Q]1H4B7B=DD::C9E-K37.AU["STSCD@3/K9MTIDVVA%>=D.E^2J
M4]JI_J<IW3;4+?!M 7"8H,863O_($[^.-4'I(_%YV-.]KAG#(AF5EY4-/IEM
M'X_%/(68YS<2U&244V@_ZW&P'>T16&JZ%F[B_FI1,]/09<,4XKK'#(8\X D4
MF^G$_]*3GQA(MO_1YFSW9U?1<=WY#GV?0%W>,,'Q3"FH$\D$93G3W=('1I,$
M-R<%T0E=UJ;F]3B1Z+>IU:*97[ZFEWI!W?+\&#-ULL(CQ43)5QAI23WP.N![
M**@(W] %I]T5PI)JRV9>EGN5;W ';%:!%MBO!'BQKRSS4@K.M*JB^,EQB,X+
MR+""Z&"H(A%J-S&6;,MZX_GVTLE>T9AF8_::"')Q(???=[\K(2;A\?!+02""
M'?'3.>"%DP:]T^E:Q<S+6#\V0J9B=$3<Y-.'K#W"<Y*P5\=OLEBXNZN9AH\J
M'(\2&K'P7E#<8C6H?>>I561WFS0VY?<""[[#2[C&8E[9RG+HL]7<PR0#3R_7
M4):?UMV1PGPU=X 4!"5B*M()%FO!A#,*;N-QX8YX)X&@LRC?S2]R\CG-2F)?
MB,ILK1]X$TVX/1L1%W_/=HKG(JM/]8!"N>OA^01S;% >VG6KWZ>I^DPO_L^5
M8B'K[Y*(;4+_3<WXF.H::?E#(P*K-(8C6KI-W9J@4#\A!55< H4KF"QP87TC
M6I7]_ IFS&9F\D)WF.EOZ]NI#XPN#0G-SJKM8KYYH=<:BJ%N?VV5$6RQZ]T\
M)][6]Y9(B,]#2QYLFX;I*CF)S65G%CV(-6E/X9:X7+T;KVYNW &2$6[A@3C'
M9?7!(@]L0WMZD%2*ONXGX[2;Z+&W$(%TXJ/&\3JJB($BKA-,O-L25LN)H$O,
MT9"'\J3< T?GT+1B5VP$6\XH(XZ.?3+KX9Y>B:4>1_/*ZPWA#5>9'%(- WBG
M9I#UOE&(('HH)YX<RX@F5./O=?H/A<K!^" +RUI^$G5 MJW,<4FU:K"+PA?Q
M/LG).]S4HV]*AQ%%G0L\^%0<?7FK\I(RU/+K(D0*S+'A&YWGXBM='-D4T/@]
M^<JGM9Q-9IXTVLU&I5S&Y[7$4)AK:8NH-Z<&XURLP0/JBFVA)AQ[N%V K[U*
MI/[''814?N)="6CD]'=U"$)HN(T":H;3Z>;9"]/@PKI-EBR7W\! $+6Z4M<R
MW-PE(LX^BDP(^E2^%[2!3HN8966)\SY'/H6Y2X=Q&\6U>B_!6,"DB1QZO$[)
M+%082V#"BW1S(Z/*O:/S&VJI;FD5SNDX5N,9Q2@=YILB,!30Y;.K4#V\Y](Z
M?A^;CVK32.@PPH$T#:YTP3C":O0H<DK(&Y*EO&G,ZZASQX7M6/19^Z\_W5>\
M%*RA@<_'2F,6.V*W1#5$(3=@#/.N/)0IWGSS%>5V/IN+4CE2<E,YY&^*2&:E
M)WGQ7*XM3<1XI+.9&MM%"J T"LN,LV%K&ANSV7\Q?G P7CAF1:DX>7KW@XOV
M-;CR7<JEUJ10FR*<Y=(>"C[M^A3_<I%9O@HGON1=%/^*8(=&7MU(1R @KJ9M
M9U:FQ^> E]\:TW;7E"LD8LX!^7,_!$R>MZB:3@'YV[CQQT?1.(/UG:=GUZ#6
M8/8.5[2W@3[:.+Y42.,FUN:50.2SJM![R6BYC>W<<"$Z]A%\GXU?+N- H,B2
M8A14'ZO8#>=[BV#:,+4 A7KG%[J2F*Y/=<\\%S]Y[)(BY7.%2X3_$4/3O#6J
MW8..]--&CMLD''=/DY@G#^3>4OFI\K8YLFM6KA'K7<#Q1(>M9%+X:M^*9,MW
MX::7;[M=NA-E;:;/+L]:0VI)HR#:NEDYKV7IR*ER;P=H1;)&>8'\Q/84#<.E
M'J5,A:$?2(4 7A/I[1Y/3 *%4[II)M5.-+9_J2+)$U,:U6J,/>OV=YR%WBVS
M, <WV\SVJ,X^'%;(<TFVO(]3V?&]?%7[#E4_F(_$MP&GT9#$+Z+;PC%R4W+O
M64S^U.[<78O9N,@/ES.5U/!<R\R]U=2KUHL2,>U+H3:ZE\*MJ^J:[E9V7.]G
MR3K)C7M?I.9%*)V#.:M[H8>B@J0A^4_QQ@6H0KQFP*\C,7V)K4#?*HJ)C30?
M/T_OU\*-CWAHJ\F" >3=UND_DV0B3'D9GDF-M*O[D_A#@GG^^[=KT/G;"?/J
M_Z43YCHVLO&MIX^UV(WTQ(N^U0X;'ODL#EA3?Q4T]59=''@D.PN,$BE9#PX\
M073!\>+ [77<U+)I@@:7"YB&Q.O*K]HP<A!;[*W_7O;'GS*I%RWF B$PF8B'
M22%=Y)PKF414";.Y_5"Z4'0RS:_M)L$\)4$AGQMM\% \G*N3:YYWF9YS,I66
M[??30O4/XF-''I9?YDP:VA!/5R!CH5@K<.)DG\N@F8<;F-[&>V)]SVY3#,ZH
M7S?F86W$2LRI5??J EW6X/FM(3HF/.J](WNWNF%<[E,H*=7-[S*3H"6AR%VQ
M9$@)T_;T OP_.H%XU#RP4M)D4!8LPS?,/+A;Y5O!#/)(4.NLA3-^NEQDW^RY
M""<#Y=VM@: 8=HG9CVFOUCV%Z@/?^ VH"Z?)?EQYJU'\L^A (%\2HZ9-%2/8
MG5)(N\NYK:UL=V.V8,O$16\@L-#PP88X2,[C/7HJ%NW=]:@G@%JM+<=2[:'S
MV6[8]>V5U.S1+/?,^<.FD_5SP&4T\1,BB")HR,(MLMN(RKD9UDWO<[J[WYUI
M6%=DMO#IRMLD@P(#(>S/#>GT1';9!L%$\4WI>/B5 W 4C))T'2)K@$5&LCR;
M5%/\>B,X;>9&!OU*\Z=.K=P(LYVDU-:A9M]+*NMQ4[6R-<G6&;'>$GHBFX9Z
M!.?<Q+M<%+IB.A2ZRIR"24.%'O$8PBQ/#J9FXSE.KLJ[AMOL5"S569N53RPI
MRXYS8;+63RV_<,<K4GQ)(E0<_?WUJAH?#9J4)T'O4EW([__UV9QZX8ZW>(/X
MYE[Y")[E0JM^/-?9(](0DHOP^#-D"^T1HR:#G>KA-BQH)B%E[V.M-KG?.KSM
M>>=;OZA<E<-1LEZ) 3F> Z;!1TG8H9VM0)RL#?XNQD"D_2F^M#O]*$>D^0PT
M[?Y*RMUWYN$L6)PWNM\S!X+XW5>4/>4Z("Y];/X+L6(HJLA2'>[\18SR4@9O
M,7^P>SO_O/B../[;IXEN1[,Z39D>QT8QB)J;C4?,+61;ZL[/O?*3BF032SA'
M&-;R1I?M&ZLV2//$ZQ-^AZ>W.GN:;F0;ZC]I:[Z7MK%Q DR 8TU![\"<0<J_
M%VFV2<P0*FO<STS6F9^9!_X<B1SZ'*YGV;U/"J*'^CLT6DTW.+:/\[;:6/$\
M6'B7RL(GSR^NI\#0MZKT^OJ-8A[E+QLBW7IJ5YAS[WV_Q@^#5^I(5#G^2-8]
MMO=!O9B/_U2?E!6PEM%4TUC#OKXFE+:.^&D(LSBA@W$N5\TIIV,//N?I2R),
MF2*_ENV8U#YS$'>NV''#PQT_8*7,4ST5/+L3LQ^DRL;)\TJZT+<9&WX@?BG?
M$%I(FT'M7W@;!2,QC"2]"+4WB@'5(,(.@2R6D$&N*? HX?9CH3$$DUYKYJFR
MN6#B)KE80<DZ\L$9BD3S#@O&&'6 @S,C0G&R=SYU!ET;)^@5;S[^K:BJ,>[V
M0C5D[K*PR4-['Z4#/O$#'V6AV!LBD+Z5C],I(.N"ETG9\PTULHK'&;&*:WKR
MVR^#A-?]$%2K!/&89/B1-^U;4<RLN]'T[$*694WS&-)D?KO5*K^S-4%D^:$O
M.[HV7L-;Q!20[U0D[^'C,E?:)T7\O@RZF7C)/K5>R J6K[+NRQ?J-7;RM/@S
M4OG#JES6]J;%H5!JT^K$[)^SA'%!SJ=QSF.&<DM-=ARE<28_B&ZC:"W69W&B
M--^":7M.1/LZ'@8N#P%]0>]95X04N59N*1W,>)W$BY(G\?..HM[O0JW2)6\@
M?='=PR;J?:W.24/KO/N)GSI.VC8Z+C4/I>.-4U\#Z(\C*!D"]U.LOL[A7T!&
M:O'3J!@0FILC_1:'7<-]V53MZ1S.?OA'VT2_BH*WA\='.Z>/+HUHL0(>_Q/C
MF>)CE'KV3NW//OJ)U(FRGQ_IKC>^PZ1?QFIHNQL8/)J7TW>&' ,^O:AI"BAS
M%)BV\\F._") YS7+2O9N:8]Q(X@+VQ:+)C+K@?7'KF?8]9?>U,G48Z!-9AQ<
MS]NR%E@'H#7AS1QJ9+T, 5.J:)[L2^M=F=:HB/G5X94&G]$;$D/KU[*[PZKZ
M7NDUOM'C1/EO\.P!H?P?MT$53F3_X[6I_]G0O'W'EOI5^%;C5953VX/UTRD1
M#".],W=OW5(Y^'&F9PG$\FESZVC$ 5=3#A-=\*6['O.'5U)BMMZUV\^N4I$G
MTJBV9075_7!ML.$.M<1FJ91^;TZ=+/'D"$\)D)[Q,.$=#+][Z4[5KJJN$HJ5
M;"(EV:A$9%_N0Y&R\E8*O%SXGS^A/JC=XR76K/8JC+Z0Q[-/HQ$0,"6"-J)W
MMKB\<,.->[5 0Q!',5A7?#\N@_M#?_1$L)H"U37"KXHJ;6NR(:E<LD3]-#(5
MKR[;Y7U,$YC6&N*^:^U72^7G7JZFX^M:H?"G4]*!159*-HQ'ETR;,N!EL,J[
M6CJQ#X]'C!YO!VXX#;X)'-K_Q^?104JPI<_G@%K&J%:J)3?R)<7.@-)G^!'<
MYHF:S&?Y@6Z3D@(G12FWP_?&1:G+N@:U(C^UG3EXLZ:"25/ RVK"9XJP#@FH
M$;:FJ[DH4EJ^!?*6J-^=,NUJ8;VZ6X3Y1.BK<%$46-C4JWBX[S"F\7*4\<&I
MZE'O1;9\#54BUA# :!@O!(4!=S,"7(*80_0-U/":NNAXARPVNZ-W0KXR,O/[
M'S/\UI"BL%>+>*&$+OCTU)$O#M6#9(0&X'>6W1RUDRGKL0E1WCP[3S6;HVK\
MRB:W/#WE*@"_1Q254?X 8@LQ0OI@UF-:9.E]Q\3!%+L&8%2X->5,\X??VP/]
M5T/" \T/_W0Q:)P#<F( E$@@Z1I>T0)// -#6JPN)OD2GX*"T;7:\XYNG ,X
M2#>[*Q-"ULVKQ;-DKJ]/.'ZB)>DFD8<.TTV-(K%&'K^D-;%4V^> K]"'V.-N
M9!0W,KI-'2J88J#!C9-<'<7#NDQ5TK)P-\>VUS_J.:S(4 EP?J3%%QT])-8B
M0$OIB]@JT$O0C.L2JOLF\VR/14*4FG@%7O9>\[BW$5-'\;Q<;*"W+UL9;L[<
MYOHY0%OVX:@T%R &< B?YNA.(= 1RP[I94FT3$60&C-BD9IQH'0DB1?JB6/6
MAK)I?"+73AMQ@LS3>6W&W!<-,J<1%,DD>EWH>0-OOPR/4^/"73'$(>/:Z D6
M6%DK(#U!#_M@!L[2Y>IWU63,VATTLEZ=)B%&HWB5>H8,T9T0!^)3 U\@OCU^
M$:MS%T^%]47QL^(=L5X],[XQ4--E:8Z-VQO-O2EJOH_U);_-[7=Y",X2&NO,
MIB-VJ1%SR)G8H\AAF ,\U#_RO;RKFV6/AL@96WSX4C9#[R!F_S&.,;K"SE)=
M<;4AXDE5%T1040+]3*=/CNPD'!?9/@I5QFE-;;_#@E JYX >HYF H[A&<PU)
MJ#?.,1FJO^01,79+<=)7UOSE%=:T03W[.A,(,B NOFYCD:I-F*"+#1^*1CI(
MXT6.PX(X-U6DMS?0P8M7H6ZX**ON-E'<[9N*N-]C&_8<*CT]X\G7_:;_T.[;
MG)TQ!@U<%& ,<M(<I!$@]VJ**7X1]V,P, #5,,HD9',5F]KYK9N?:VPEL7:R
MQKG^S,(X*I?OEBK4\TR!8(QW/>,+&@;7'J7@$DP3.A8NXS].+6C@33&?RE6?
MMM;@W#\%"-:UI=(/I-9U\=TM>/(UN;*+;8@/ -*%O0#/W(4Y,Y*Y*&:N1PZ%
M!PGA>;H5V^CPX9\%R1T8HP_FUW;=;L'A9\KM\^0@8;,71XBO\2]>^MTJ9P)I
M*@T9MGJW]XKO<Y!H\I>,6,R=87Q!MUQ.I1#H'99EQAYZUVX27>UDOI,4@B#K
M8_[J4#?O=462%<5<^,B+F78%\8,_\OVW<V?LPZ0'AE>KWZC[;?HM_P%$XFV4
M3>ZQ=8=U51DO.]A%7\V_1'?[NL/K=BPJAG 11"'AI%ZC/*.OT#=XHT*JT8K%
M05Q:N <3:'I,@=OU3/2Y513/FF2=TG-#&7!CTV]5AM"QC4?6TV8N::;^-D6T
M5F8N5_5<O>B2RJKZ6(L?+SNM4/#\-+GY?5GMB<MFE^& ++Y5DC>QB3&*S]1E
M>6W_'5EB_"]W:K7X@_T6T.UM):#H.B^=_U%/4!1I'EZUL]B.8#; 4768>!E@
MI\!MR7X2N7']YP#JM<+7/04-B:*JDH;[UYX#Z""";"<SNE04EKF@F]]7R#O6
MIZ;B4[/R?R "MGY-WFZI0R(:10OF0,WG@'5L_FO2UCD WIF;OP>?;L!X!$,%
MSR1)8VV,.)$8B5HD&Z2Y)Q^+BER?DSKTE?F:7BMVRXI?H0G%I_(\H<,H"LQ(
M4#Z[2GB%=ZO P_7&6OTPC)S.*HA(Z.VUI["OOWJ>5PW)*?&0"V68S.D(DL?@
M=:/Z*668^X_-OJ8![S4(8@L$!#I^FGMSFHH5?O"G%$_4B @&Z2.?PZ. 5P@R
MV'R,88+;,H*:P$S,K=AUBXS0$,'_Z14G"O1KWBIN'I-\GLPU/B 17/72NBM7
MO73J'. TE)#)D'<F[*1!,7GQ2YH!ZHF?12.C_&^TP+[B;7IYZ 4?539D*L\?
M0&Q#6"%N:.MT2@?)-?)X<=P/K0@;X<B?P(,1MG/ @;!<5*)6*.^EVV2 SP*V
M_+ENCX,#AJFV''N&\([ &>E>, /2J64H@9\5R^R<PS4L@$-U!2R_A@;" M$M
M3CLY4_IA-ZOW$=SJ1V?X&6U7.'[1[TPZ:!16_[0?DQ!;#3%=*K@(OE95NB"E
M,:I3LZFW[X6T//+GRV+KW-D?5<Y%3;DO>28J$ZIE+&L\7!T<!WT_#M<'^K(.
M!N[K5].WJ+VK4:U_9=""_-;@+KL7-TREA3FSEC7\ZY'I.8!^L:THU[EY?C4^
MO/@AQ\^)@V*1FZ[%NARK_&^O@P5;@*A-#THH.?X*CKR3Q(8S?'?V$.*%9HQ>
M]I!&<7MTZ\?.&CR9-"L "\#H!KZP>8?C4N=^Z)[-3:$"/MA>AI*]&WOW6VGI
MF1%;:UB&9)JF9S(NGR4^0R*RR 5 ?(%//WL# 7==9%[IO_H<AS[!(<,TV"!,
M&GR0_.Y'7_M@R_/L 5I5XQ5R)58<38R<\Z_<,P95#A'B./CVQIDZ9+WG6$,1
M[W=F#I7$1@:WFKY6NQNX= [@Y?E%<,W3@3X\]G\6,JTQV)"6U4-;,HU$L)VL
MT1:3/?X@VAD,H%4'D+\[*'[(7I"F4)6FEB:CK7>:G"%'=F0#QP8<F>+FVB2P
M>Z%!BO-X<FOLZFH9-U6TAE2Q$04^M^SC.$*BL/*ISU6ZMC0]^BR/'9LJW#&F
MZ!V!Z4P&8GGT%+O8?09[K[*676:$>>_5.^/:'X NUU!-8[9P5I&<P 9\SY&-
M6C?VOA,LRGD)J3A_+<G8!K")]+9F2H7-4^@"P\4D'J\(J9)M51E['7;&D>3(
MWBP^FI"HG DJ+=TH]]'\*3=ON&\@*GL.D)SI=7I8W/23K-\V/J0,Y@$II)G'
M(#B8J/J94GI4EA0?:"OW'#-\>UKO"8?N=)TA3F'ANF$MGIS7'W]?,/2*[YHE
M![X'N#EQ5'5@D+2+F^G)?:_:!$?VO,5GFU8; RPAT@+)SA4ODU;2].HI;ZO%
MF8<<(B;@'*0Q,'UMPFP1&M$=R-&KX'\.Z+K9QN-,HL;Y%-(DXH.NJ)[I;LM?
ML<1_IY>KKU(K\RVE$'NP-+6B--/R@>*/3RG8E\<,(^%(K&"\%T\O1QW"V6T6
M]^>16!C(>+:6](SLM _G>Q2&ER\)FD92PM#6KID^"5ARM!R[Q2ON@[N#60U!
M;[W +DSYHC=$&,5J=A;NJ"NQ#1.DB5\)5$M#,UY'66-N:FY4D:U 7-5*/1;4
MTW+%R?U@B''SD8 1):+XGB_ON]K9:,WNI2]W3-L1J-RJRS)1GER;[YY=/ZV8
M1Q9*"?X2_!/??HO%99M\6&K._H+MGW["V6,84;&,D6TRF49X4>E.Z:@TKQG.
MW58VM#K_0I<93AV>0S))=<%.=WU+\FDM%6?C>O7&.4>V$0\\LR"(XEE*7!=Y
M6J]C0WL7:=64J<);[=&+'/+C_FDU^1LUL:BF88K*/W%3C9#RGY$WGN0U4B(E
M3'C>7D^>9OJP^@#%G1AXEYH:], T9D%[X6AS+\X#,O*)_U.&'JK>B?RP:-D1
M!7_GL\@'LU]D)8!PLI"$=A =@<<^W_5%R 7[$%(LH<M_S/FG!_6A_(V"YTK2
MH('5N#2)#B)]M(DMVN'X$C2L08XSZEIDA7Q=?_*M9J2G;PIZW='S<RV_>V-U
M;O0C0Y+A\W4E :0@VW.KG4AW_QUCKIU!CARE+V4FFYR2U<5V$5>X 5W*77;*
M7.M4WP"!?=ASP%$P-KWC'#!K9(IOCST'T#"^DU8S^-KEJY%\96Z@P&5M;0)1
MGF;T88C55-NKT8VI!"7(MF?#C 5O#V'UE^O+SQYJG>GA95'\W-B=W4+,.8",
MH(%%SO!@*,M+-W%S0\2$\GLJL<(Q,Z[?DFO-[%85&!\0"GD [>^##P!D8WPR
M&ZC1SV9N2:'EU>+DB?VL=N\.Z:[R7D31J2 5"DR)[S\*(!:.V4S4EK.@@$QM
M0GV(WS8\Z0.*O@K,9>_YN@$A(6:A9=)9=OOQXMD-^.@E3N02?!AZVX/9LJC[
M/OY;[E8*Y#[=?-NG5]?WO6GT>*"U@)3: \HV5H';'7'W*W_W/*L\Y6L"9@-O
M[)#,%XD$^L7CR3E2+=DI$N=XE(]E#&N3(_7!6:"2&#X0JAG6A:"<V0BZW3!R
MCXC0-\^+7]AZJ/'\W5%4=]P)%^"^'^> WU0/,@1>(U6ZS!AU#F"_1OS2*EP"
MD;6J:\2YO\/N=:UAC*(F28(3Y(MZA7/EG<2$%QPLG"]G_/-ZE5#K F5Z+2]4
M%7GK)XSG BUI;P<.W+KG7O[-+1%DC5'J@BW>E3T=ID@Y\I*E?CR8]M)W+!-\
M^(,S.V(?GF:7U'J#P\<S"5P(KY*JXJ_"DA\UX9T\0!CG$HCV>H]/VD]*]\\C
MY4D6!OEK8MD:-OXX<"9/A$P=;HK7_L2TE,".[\" 0_@5P#P0>Z.ZR8) A3V]
M237EK[)2Z0BGAJA^7[O !JKO248#M>XGVJ+D%Z7%KW6,[[LV/@(3L:#6B!4R
M.MM)$L*!PPW@$=O)EI]<Y_6?GHD5Z!49T.@)?M#0UB^A*J$J:J\9^KK)/B)5
M4K(Y4X 3$LHV?=(Z7MCPWH=KM2%@^HL,<"_LFLQA^7O?1Z'6DX=&5V]D.Q19
MN,R$'Y509CNUY(ZV38@_G%3HB, YNC9JQFGO? 7Q5FYJ+W%&\+*=E3%:-W'-
M!)#W<0X @F))(T@^.3T2$^E'%4$8']_5"V+8KJCP=O5@V%0)_SCJ31U3ASCZ
M*=//ZM4OK<J6.J;V^N9%6CON!9%!,&=+P)V;2^"K^, @Z8U0?8]H?N::J%F7
MZDT2'^!NZ6;0 X';X,;;-14V5JM]-Y!*X]J?8NX_:I"L,_:U_[(M.JC^^]*M
MGN[[JJ]_LMU3G A9(=T(!AF0;D-<EQAW'&'Y!'>LQP[%$OQ=C@).,JH:'[H$
MC &[\'B7"EU10'R6_YQRI*YM<ELD(X*V*#ZUGV".?X]U74)NXTI)_<C+A#O(
MJ_((+H,OKB FTHWI]'- F.D39)V'NL1;+AZBB%L!7"+D(=W;-:2JC;@?S]NT
M?D$&<C6GGR!V39B%/_6(CY 6J^.JEK&-/Y:5(0!W!UC8$"2-ESVS)ES#FH9?
MU"/B#_'2N"(T99+#9V>2**[2<RF![;<S,,71P_UHT]UBMX_A!>.?T+')5HX+
M;&R[ A4:4Y,-TE!T K*31*WP\(<Y R2^C$\=*@HI'CX(;\6H][\LPW+,**__
MN7O2/-7W1N))\ 4%(\]-8FL_=7\:HQ4AIPTI'WG]@W/G6:\1U>KCQ&]&E,$@
M2Y"+1R2, ND,YL8;H8*XB&5!M/@G,V-_?8\5JNY5B$_<I#*NF9#[=76^0_F9
M^-'K1:%7!5775I8S\?L=0 H-6L@7&!^$HQO(0Y!'P_GP/GL>85!P249D)R/S
M3.^OM/6!N\2\]6HO+A+[BE?,B7%Y.<T5"85=/7O./_G 5JY^E@;)UB6Z'*^-
M!WTLHGJ2P5?. 1(_2IZI=X84D-T!%I/D\*E81_30]O(%=YG6,<;72?>J@VQP
M>5.MQLL>E_INY!5!-']LWH';8[=/$1F>K&EGT:F^8M3IY#-[[1Y7"(S$- W1
M>8+[&,@%3(TOZO#GA\,TTK''7>D6,="[4WEMU4R6&_[$%+;1U<:8EP);*YZ5
MO-R$LO?7H]SBR;C_^'P60*A#:*E #^[RTL[V-$>*"'<_CA29KW<'1><R3B3\
MFNV9T<Y;AL_L'T5-E,/O8XGIH776^@9_1@1"?KAY["B\MA0+_BHL/)+]S%ZX
M6OQ/Q2K%ZOS OI;K^MR"S9R^ZK6 +W4YN\[V&;=I=QT\X9AU^5UN("H[H M.
M#C7" G6&:P,,9'M54$>(J%;P]53OV2U6-YR36.Q9C3//:HI:B!;$2S%M\[?Y
M_:_,"PQT)K/:G#_:F14!KQEN&=4!KE0*=$97BWY/C3X;G(M+653BY%_[P#*(
M/AX\!&T?H#!^! J*2&^O71D2JSMP'K:/?W1I1*\1YGT.&$)KHXD7%0 H'"#)
M^BGR&$SX/WB)!R".DD&7R;U7;8R$:#BNNG-%2T4FO<_8>5]@+L2(.1[(J4:V
M\Y#*"9#'N;RB?-E_G150^^1?Y#[^F]"+6V[\32[/OPC]KW4)S+!M'-\ERRSX
MY++'\2 GB?>MX)_BB/'Y6D8AL< :WNP!4L%-]=N>68_(B_^^L@QFCS&X8*LD
M&*TBXR[RA"!*YO1?^A(F9"01#7X0A J^H,(/"=<NPOC[;)'/.:"HL70-=;/&
M;T[A>W"1J:V1,<!G#_R0A$)*[RAB,\C25BU[N+VNV;8(>-3F]4+4:[;N &>U
M_DWS6F#JXC\X%WL2>Y1_#D@9P9.= VSU$X@2:6W9GXBOD(<C%_6HH.4]-!@T
MD#&^L4^D_OTY)O_6/W-2ID#"]-U$ M!X)2B06*.O:^DT]S#X)G!S7&9K;S18
M2:D5^#I( MF=HEXTO4M@;V//')?9S\U4)NS)Y/^^;GN+!PB9@BCQR?21' DQ
MJ#->9XSCQ#F@SN%,<.-29R#+BFQ!Q_$%'Q17IC;J;Y6N=W5,.HZV)ZYMZKQ:
MCEN^]$]_/92V/) W9>,TN\ 2VK^C<&:D21!5K!^U?)'S:U\VYU>I/&\'-U?2
MJA.[KD.<X3=;7\T21;7G"JI]2NU< P#/18962="[5BKT$)6^'$L?^LQOI[NR
M_I!1_F<#50#O"D4*'Z3'I^GIL:4ON9 CUUZ"QV"U&LB1F)T_:W8.<!DHG;\/
MW/%/#H/L6L__TJV@><+V.HOENT#=,>42)0_DY,--#8+WO^X?_\_&Y>> ]E<:
M$*KF8Q328\.*(Y9PW0L#8B'(X>A8+#\30),>\J'D]=,OXH^FME?<EOVXEJYZ
M6A_MQJCUV+XI^UK@\[UO-U!]B^59=?S6L^$]RAJ%G+=GT4)MU;8QWF8VMP3K
MWNOQS"A>_PCXQ;L<>H>GS/>O?:)/I%,A^+I!;E9RH)[@1H[L7GS;P3^]H7XY
M\98>)G')SPTI>7SW"?5EKV2C*WLVGMCCCBE^V@OJ,+V>,^.+@\=Y0!^4D',$
M6 :D=A;DKK] <3KPE8X\3N*R>2J27,!A]D%6^?NO6P'N1Z<X,Q7A]"./H[&A
M4OVO1L4N-3:YL2]"#4(>7?K51O,+M_Y!27 T6)'<X^2;4WX1@D!M2[KVFOX?
M[^KDV=OVC$=?+;TKD.Q'NO;;</$1@^SW8G>W5X?4#K7C.Q*'XLK3-J[6FH,+
MI]/3#,_JOOW0NP((N,VT*68A2A;->[6G?F9R<OBKA(R6XV6?M*J['$PZ;&6T
MB9J S2H!1-WC<3EK*M,/1J7X@*[FNJ%4;F*#R?#;;T\.N62C1M=.9_S"Q((P
ME)VX=Q9RCRCT^11U1FWL\ITR%:(OG!)=:RW5_\!U@P-^T%,5P72[9-5WM\?
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M]&1YV_*I)UTL^T_=;I9/-Z)7_6Z*FTF&*R/1.0S/JUNJ76@9IEK/8(7I2 5
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MY\5<!JKT7R.+'IWF5&J27ZI[']G.F;UQD)?X$'*S\[!3Z#@_?=>5Y(OWO8]
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M APFI=9>.TRQO7M^<.PKD"2[TV[]9P'_G</U=RHA4^BZ<T)HB@?F8E+CI/"
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M1_'U6?#==T%8M7J.&X.* 0<*]!OP:RBO R9-HC4RZN,J/$!N?A:$!U8S3/'
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M8+T\_FHV)FW-[G(SKLE]28+WN+_]*%!_XW;.I$=42?KJ+MM2^A^+4W19C=?
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M_M-UNLM73_;W!BZC<[_6BZ%:U.\&(0^/0(?3N!9RM]4"73V1]^4%HO.T>5=
M4^M/';J8K8$UG?+4G-^T[I\IL4-D^5&:EPSGQV'E$[_&_\$#8RKUWC5"NPFF
M69N#6J>7T*QP24^^KUBJ[K9M=\CE<81!661S#+Y,978BVLX&_0XRG:OWVMM=
M4D315)\UZ-:7=U_D"Y\O.R](::MOO2!;90$\Y"]6YD"CUAF2^L5ZHGT^;)FG
MEE>TB7C'E0/#JQ-X!$J(*\UV3B:WZ2_\.?%K9.W)6OF5%W]P*!-(4ZL&DMTT
M^-+XW^Y5F5(^9>,V(UF9OW&.[YF*G,+=L>VGUJ=,N//Q>3\FSUTNBXA+XA<.
MC^O@:"#(IA/8HY0AI^!*G2+GOBN(D/5'+Y_K-&A)<FP.Q']R]@OT^"3'5;9;
MH7BI,QA6\./GV*>16FN_EZ*D6T%^6^GHK.9^ 3=;H\D>DSS5=C<)A9K?LYD^
M#X] +\M;9 .Q<B?7OF"<TSIX52_)ATGD)$['LO[FNBXIZ:D 3]X6GM[C.C'U
M44QXWO!KKVE8X0JDH. D-I"N\ AD\W>/8)#J-TZ.8#+>OW;==D488HHT2O^4
MS,\ A$KH;K</*?7<_NU"-T@Q.?8S(*T'S$:Q_NQV;M9M@:UIHKQ%R27-VU9N
M:R8KQL:^],?HE:0M@Y.RGVXQZS\?[)$=@PUI&00O26O9+KEH&9/TB'[XH8(V
M^LB?@Z34II@1J 69]]TMS8CR,85TQNE7+;OV"=<9#?$)B+'GO05C?_(?F8+6
MLY'#!S2+"1GV@<S=-T<@E%NP%OF!5<"LZ1'HYXGAD.Q%6I,_-E%3Q(>F9^EJ
M<<6L85\H6#N(YEM@L,#++\02[T^S;J?$:<+*TZ'!^.GI\J*[[]QV9<RL(AJ3
M*68VOI20.[5Z0C1, 3@;:03)F-W;1!&H;G)K"ILK5,3TC8G',+[ARP&[DJ:(
MSLQ(I)D&VQ3>,I"*O(/4HKU#J=5#0C!8O99%+.TZ8ID((UVGOF_3W#P,B&F[
M0F$'@HG,74$FN5.N,Y/1?ZYYU#+;JKGC3YI&2CK*'8&TU2KX[MX(E2T&=,F:
MQS>?*'1K@K0C(V@<QX03EO:$;%5+J$L3?N7&ZQ9Y5;OSY(YF^!/0 F_FLM9D
MU2Y^<K$0&-E]X;N_2>.R':2)_F2(H=A3,]OH$<%U8Y=I2A0% JHKUHX_=MT+
MR(60@QY4J^)^+ <]DVA$,WL"DI@MO@&!^JT2 B+Z)4<8-N_@IK,7P]"PNOI7
M%=*^SE3?WOHB\4\NZMGNYN1?H!\;B.FDA!*'PT6K)]O!H0+V^9\H/  ,ZQG9
M9%GMFY9>EA#A2WSLB?03X#(L-T=DS-^+"7L;"B\3_>MM3 AAUIYH%:-U9@G,
M#K?M"KG6;+S-"PNZCTHIANW?6W-LBIBM21IXDRE3)46^AFLU1CUS#/JS#1S>
M&ZX+W-N</0*A_\/ CILV; DX;2FS[RIXC3&K$947AL<Q*4/C:JAJJ<YB\;$=
M9GZ%%HJ^_1@(2V0D("..*2_OUC#!MBL9P&"=VU&G 86N^JN04^D]R4[@F1^"
MR1^60^<?SO6Z5:%:Y)(NQVMX0PT0"_.M2%%:K1 Y8(\"/OSS+].>= >!='X)
MWB#U7$WH3W]RNM[QU15>T0[-Y;& (*3.O__@V'&F^.S%ORLCN7XU)43ND9F#
MS?5_E)8K4XTZ\.<>R+O+BU\UBA,\R<SMF5*9<DU&EQ_],Y=$H<;X(:<=>M-T
MSA/P^1/;'0G<=L,ZL<6,\[@1R<2#*E<U,]!73^XBK\2:TIPC4'BV[.'&!]&
M]U&*\E??=I3K.$$#M5\\:607@C-T(#F5C5%G@"-09Y!S#$*AB"^_:63O]NGN
MDJ]GK!*&^2WY'K?'O:W,S'2\YZE&M1T8V/VM;>4IBS:8+*;P4<O':"%X).&"
M*$T^H=[ZUJVR !?_DZH?<!>WO\PU()<V? []T'B+D YD%2.?:/5:YT<&ZDW)
MXV",@0"/H=.G1 _4%J/4Q<K9/BB(4;&T%A*)4E2?B4&G[>T^:<$T[T,_;?^B
M[0)%:JK>$7%H][O):[I*$,[ :76QQ(7&G78&D:P-W1=NMQ_[G71.LVR,\OT@
MNC.VQK_7RX?>RNB$5EEMZ>)F[4R1+!1FP+-$]^-F6IO(N%:KXI*@MH.IK_'F
MS=4[7N[UQ1=5U9=.#/JMD7BHB1FK1Z#($,#79PA9+;FV2-.1_E_C>1SHM[)>
M5>\)@*,^T61.3V035C?&4RZ6>SSNJ/QEX;E1^';R%%/ K'N;.6D3J2*A=*9M
MC.%#RYMSIC3X<CIM HR- #LJ'!Y/%PI<SC@")4D?Z^&B)F)^+88((Y>J/&FW
M/RT\I[5!)P<C5@K>DEL5#FE9$%QQ^5;&M\'!'%?3563-S8;Z_9>[U\!W[I&:
MM;MID[#67 XE:H%0"@-Z\8O#]^Q:ZN?C560*Z8/^\<2P80C6:D>@B_>.0"R7
MR.>1(VT4C6,>[[A(>:O7<NQU&'0&\X")^%BA!Q2%- =*>.M*XM+\B\=59Z.1
M\,+/F&UUAEGZ#Z0,,::RB4\%WC4/;\9E(3![J "M;-H>M>0?*3JU,@,. #R/
M^4/G'$TF9,(EAU+2[&(-6)];%2;&ZUA(W@R]WCX$[UL?Z2%-!C6TU)I=P^&$
MKO3P0X;[/'SV5*B?D7]+V^*>IX+"<(.]C:MH,P5,"/B-Y+ZQ,^%5$OB,@XXQ
M&7\%'ZYJR$&A.&;N9@JX-%0R7E#C>:K=/<_Z[4'ZS9&?U+7+K96_6)%NQX5P
M!ZJ*ERJXW8FF\)@<@;YR_;M^3W4D5&%SM6,'+Y*E#5ZB%1+ODP8<XB;KAJ9Z
MEKW9;@LSL(\8T,TDU,X@A^?1M%,WCT#=DZ22?Q^V >5*X=9Q M(G$S:/J\5D
MY(X>SV[:W@ZM[9F"_,CZ& 7\\[CF,0>*C4NN=;7=GR_5-SOCU!">R'"W.7-)
MC1@T%K>2(Q\RX?J:J2:6%.WU.Y=I;?]#'W\/XR9TIO#?98O^V]QLAZ"3 X<'
M%2:D! BUGL:6[4PT\RA3Q?.F=F:6,+\/.#\48HZ)#]K+)[LW,@D<3J=8?#3W
MIK^RB+P6$B!B>*P%_0^T5"[8Y8X5 L@EZA$H@&CA*6?TC.Q>L1Y&BE8\22C9
M/SS1JZ[S!_.LYO0'#_S]-KL(C\?T%Q@D='SBYC?)%O\6,KDT/G/2C2-0;C#@
M=P1Z]15S<"$V\%@+$JHJ.U 3Y'L$8J>(MM!D=$:>W+__V]W.#*),WQA%;_H;
M&3B>#2EC]7EZ,!\ RVH?IWXZZR".2GRM2!\43Y4E6_T33;QI+G_6::( >&(8
M5XBW-"B;*-8,HR.]KRIG"TA8</#^?7MS\-K"-/<9TNRUF]7G:+ZWE# !G6M2
M!4%,_TU>D 5;4E]C'$P$C<?]W"%+HIVQ[FIW*ILPX_+0.QGNK2EY[-KC:YS)
MT3EQB_%PW/\>0VJZ0:$!=7$'.>9,]":1+=].XJ\87^A*_.J^UE54U' $NLWW
M>.>*^BE_4IDV;U=]B/"$,C6@<V:-I%.;]U#/+]\MU:K2(."Q-S.#8=G/<UX!
M19X97M?:3UF1S#^&]!R!*CU?_W&7[0I2^)(0Q7NH7UUH.[>>'A[D"#17I*C-
M5GS;F/)K/X@/?O&C/^1XX>F_\Y(0@.]'[WJRHH<V9AD7"UY-^RLV-^^VH$E!
M<JT*,Y.3T'4DG\9VC ("4K9!NTADJTNO:T4_#*Y^,"'OX3XXN+?YR-#O*@OO
MT#MIMAMOEO.=J.6##Y0#_"N7U9E]V$3!"Z</T'CS?U^5!. Q9)J9%K>/G:0Q
M_PMJY*CKQZ&JL+&E(*><L#=P!&*P RL!1;!82<.S\S8X?99>_)6UL$2&X2]]
M0N8SI)$L6[SJRY.GX7K?[!^6-LS*QE'Z\CP8QD_T_5U]_\$'I^S_Y>DOUA>W
MP3'5+]RZK7_C[3H]Y"?/KF14/A)B>1EZ;3^/[%0>(#CPU'-;,%HQZ A4'P\<
M6OW#),&9YK(].T;X2PNJUIJ"6?=OO($H4#N[>CG^1LAN0>":UJC*8$:$0H#;
M]JBAR3?-M8=KC@V))W/?!. PM<A_&_V_ ]7_!D#7O"#?/]N[5 BN=,&&7VNX
MUH88J<=[-B)>C^^<V&+G<>CRY>)38R0Y[&:Z/!X:>GWU9GOZZ&KJ0&8(WS\U
MG=6,MH;KZ#&=6T)R@V$U^,!GN2,>8J#,-3"R3!.?&III9Q/ZC0\]<UXV\>H7
MA>][8FO_'&/_([7N L7D^\=@_GN\PNR#VI6=LG%1E,A"S:O5K_<=C$LL(M2X
M(CS.3Y5VI3Y.NYAD&BCY?V&S_Y6%5+3.$P6[1=D]T2J0D_"VY8[T\AP'U;3@
MHG6K5.+#N?4T<5Y5,W6'Z*=".O-Y\7O?!HILAR]7&P;"VEP=LZ%_WM]^\?I]
MRVX25-(P,^TYY&(Z;1SY3R9\;%%D% 6UB#8'/I/M"BG4F2/0TBTPQ4X45G-<
M*C5#*8Q11Z!8--[JGSKY$<C]""2U?XCJMIK!@]=^3QZ!3IX_ N%^_1<U2#?,
M/X-5%-GS (P9/R8,TVZF/+CYJ4<IO%=^HI_K/(<+!XU9'G9W5BW.G(JKJREX
MT%^=!(K0\4XS3^QR](;.%%./0\7QE-<QD ]CV#JEQ>%CD@>Z^".0J#![2-O>
M-S=PE=H6. ^(Z@SA& ]A0*C43K88J6@FL*^[%T":**[$RX=O7K^N6^5[K^FY
M!?__31C52EUL/$:MMB/0I#Y2 /5?S):+]T?M[L..B_"S1R"BWS]E8FTCZR/'
MHBFH!20W]']2\#'%HSX_ B63CZ.VY+^(\@W^3^0=4PO]9UZ-+(?N()'%E/O_
M6<K_&]GY5W:F0;;WP#'H_RQHA-0,.2#7'H&^1".!)MK$/_+Z@K>T1N17ZK_H
MV7\6HS/I>@0"^V, #O8C$.\_XS 5+36CX$F%_W#.MO\BR."_!, F^?X_(A+!
MN6.YM.T#<,O_K-AC?G($FOV?MT*S02%M]G]ZP6:TP:3%?[F61<: Z:1_XWY#
M> *5+:'.1O0@Z%@FALA.?8\THDU@_D^I,DID9EKOAA?2>3'J VE,BI8&7JME
MDMM: 0(#_R*$15]-\Y)BC+1*GOZ9M&HC;>^CNFWM;5Z^]7[V\S'I#.[KO8&S
M =XOA]T.;4E:377(&0?LI5<NY:I B9',!3_W2.,& ,'9S,#?HRU[V"I:,;P5
M?N(2&8S0OO=&B57C<:_?ZM):V!BF"!V-<0-/DY<"VA=CCD#5PON=HI$+ @25
MW_G+ *ZYY3O>L2X)GO1 X*+[J(Y1]54&,>R[1R"7E> 5 )E& 7^SC$W/=!M(
MRL]A;+Y6K)KD-NF^N-U(EM7C,I?^ZQ_K2_\Z+3GU7T<GN]#M@I<Q%%3OUG$&
M?@0;ILJF8^[ =C7_[9H+'6>7AN4'M*M:DV2EJSNR8(.TL[Y?IU9Y4%>?NL_X
M]2)GSBDN)^U>UA@:$NDJ"IQ/BVJQ*[.'EY#\@=#L$Y@?>ZZ>>W+L7=N!\A$%
M>DII'[3 U(RZU4G?-P_H'YV@8PU[26758!!\<%)1D;VP/N?PR4?5Y?,="N]C
M:\\,][>]'V)?IM&W)4==JP=CW2;<?C8<OE?P2"KC*[+(MY9P$JAQDSIC@R^V
MV1SJ.Y"778KG7[ZC+:.EE]HI5)'D=V6L.2+(S-]S^GZ8F=6*C1ILT^$ 1JBG
MG#5?OK,@,6+0)9J03I^_U%ZD=P0Z(UR>I1#]](>M4?LNKQ$9@7;E)E[;R4MC
MXGTSN1VP54861YRG)E+.B(:U\;F>EFP*/AQ^77O:ND4/)QCZ(*\I:^I>8Z[Y
M2D\1SY7/BF?:T<66O!?/J#:Q9(<0U)?>!+V@^6[+?7ENNWWV^E;#Z1#[AJ%
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M=I#%LJ,%,2VQKJGD[!G]C,MLJS;S*/TLW=S^XO>Z-G?\'(3)L>&W4!3#1.<
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M$FXO<']S;><[I6[-&?0F6P2ZN BX?T&K_>_%. 6/494TBL[3C_90N$U7T)L
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MJ_T/"G5$"=M]S2%"X.6NLB:EYJ<>7&(O],YG\%0QN;4^6>(K1+]859NZ[W&
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M,%4!>9>ZNMB( 8Y;#6(.JE=<7Q=I&#U7D\K;0-@(\65YK6+\O9J*X>_P34M
M>DB5#->3<,BY.GN!L6)9EN'O<X.;=2 %Y&,87MBE&33)N7#V/;:\HXD>EUN
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M9D,M?*&<(H[/?,0#NZT=>"M,#[M3>IC.+C(.-4J3V';V"P9@*'7(B:\ %!F
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MS9Y\Y7YEA<FCYY6W^6QV,@,[%;JAUX9;*ZU/$_I0(3$EA)AW:2XG0A3J$_2
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M$')"<]>+V&9#,0;5:*)KOB\VPVM3+T^HL32ME;WJ\]"HA%M]'I[[#NGI9!,
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M)D?FTH@!O5@*4%<O]]OLS\"19]AOYW^&ZAH,+AA9WN@*C:2\B4XW8)QW"Z;
M9Q#AM4:+F8>)^F&XR?.J816)=SYY'57@-:Z)/D10JUS!"AGXFC93"A*(C)T#
MP8T<F('0>AWB]69SD?#D!57AP0I^OXX) XN:5$/51U4)!HMR=>\+'].S-]D*
MHY4UZ,AAUQ+PI%_VLAI9TX!'*1SU!(UL9^ST,<>N9"7O3,GA&<?9,2_@\1L<
M\F+=/05G@@FI@!DSKUT-RF&R+5&.=,N-E]S;\EHIDN)&E+I"Y(JN '$N<IIN
MU2[Y87=M[UI^7DALOS 9^67 D;[M@VZ0]KE2%0 LG%S5F<E,X R?$B(B(S;
MS YB92J-97D6GS_#B#["DL)>,57YS'4Z76=C62P)F$B* EZ"$]-F?1HC/W#2
MP2S/KGRTO*#:3=P^V@NZ<N[1-49#CZ;O:)[R0&?(6",[=:!1BAR!1; %6!'
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M;&>$!1Y60I25XB);X,4SV>P_>:*9)P;L\[[V2L5.9"A.,1U=X5KJ:>:K@<P
M]MC<\/!# 1!R"):63&V(J+  .4(4]EN;BEMKH!ADK*A0O/$\N98AEA?!J<,P
M>+?BMHP0"T/A"11WIOR38[T UF&3>/X[@R%"D46\]"\76I\FJ3<;'M5XM?.Q
MK+YTY/&RR(?JJMH/=4'"975EGO[W)'YY)%R9+'OGTQM>779%PF5&'KTF^LPC
MRHN=W!0'NG^WI!.M?Q[<=N+MS9MZ-IOX#ZN(^XNFHMQR+X_'Q*S5A;P 3M+7
M=+]AY25/$N-:IP^K<8M$5H075_!VST7I$KZ'/(RYL%)5;/7A1?^8O!&ZQS%3
MSEWZL":W$":=(DZ<7C;#@=D<(X@B,_!@-8Z91?+#S/6[PP'>KXLKG&+3BM@V
M7KZE;/5$X!_<$E&>ARA3)Q&$!"N*Q5[2!H1U@7/<97(?$*6P\>$U^9CG9J/%
MQ="*KT3TRO>$MO 5=J[=U:"I\DTP-VQH&@ 3HT@2:%$?B.21:A]@I-RK'0O0
MR'?#W@:U5,& HR[BR;BINQ?*O)V[OCG>.;(DW2R>]4R=MQU>7M7N=I(\U][(
MO)>N<?H'XI16ZZQ#@%G1(O4\;5WH<RO.R++ 8<=D[#C$Z6+K5G+O^G+WCF(G
MJ7U8 1ALCF@3)@PCVUA9%_-G,GRP&\6#G:RQX_>=Q@VG:AZ,L>GV[ -<S[*$
MN??+^H+)(K63S6\I?B&&]_=RT/SUIEONCR?$A2U5Q)$%+&BO 4N8PNP^@$6#
MXR[E"5%KV0,;J&J4<J4*>-JN;K"BU\$4IR[83E*2L51?DDG(]ZQ+TGMWQ<XP
MYQ/C&.*(ACH9WVXM2=1J=8N&'1ULY"7O UI5#@M()P]K88XTY*!#77-N!&_M
M7L$:8F]$NMH,K%Q)!#W!V!,\\":K'1)N'3[F4B^LA[&=89N7REWH.[C82T&1
MJ&6[8UX>2/,J=D<G^O"5D?LY!JFH@;A39-OV<;>8 #.LNAG.EYR&VT4S;2/X
M-$3F:Q\*"&B<(-OGE.G<QV9HC+7HG$-8CDB>W55OD^EZ)'W[NRY':E+@W(S]
M\C&<NL@=LLG,;?N9_E3"'-:LC=?1$Q6RTY<2GCWBM@DN"?/@+,@191PN+N:
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MP$3=+-LEPM?Q6L>4M^03Q*Z9]Z=&8 K?IZ3(]VFS#[46)'"%HK'VJ [6")7
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M%3!'BAC9#H?F@HKA-"((/4S\$$NRU>Z5!6MQ0F7\^VDFEN-D^&/UOM%G2?L
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M$,?Z-)M73U*C%YMR U1YA%/R?E+O>ATXU$PHG@-2!&^0HXD]*VO-Q)85\S!
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MA?;A_12.G5+?@M.0]8XJ$ROSW4?TT"'!1RFS(HUZXAV]K>O"!8+=:#$&N:0
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M)Q/>^P:)Y*8%@;4(A']>+N7_%Q1C&1M5SP'@D;Q[8N6-2T_F-H]3O4"1E'-
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M"RYSHPMXO^1N]];\DX%M7>];9TC 8KC+T8BLD?^S=F-@@).#GE9V?T6?X:V
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MFO(\AW-YQB !;)--\%*[XN6<*3PV3]?>0UC3*&9?9Z+/<@*AA>"T;$!4>E2
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M)I;@B-&.CPJ/DYB>X 87L+"4@ZIRXN? YIL)VR$Q?QH1@VAA/WM-8=)@F&9
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M4:S:/55#R"9\+O\%E;G!P[UZB%A0"/SH@Z_9FDNEE_IN1FC+S+GJ"V\VY[\
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M\,WCP/?>1%W7!P>QBD)L5E?WKR6O0N)M6U-7:^9!LHG0^HD9BZL'Y]/0:"1
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M%)MRI#06!$SJ6''L=^[<*913,&\OS&!N^^@_VR2>-^%2;S'NF%[A.=L^#8+
M\D3#H.!H26WNNBZFR4PK; 8>>Y"*+^A6E0GGK>C#S%#X6F_YOY!@EM"D[SNT
MUG39:WV^:D U@M$AT;KVO;&^0:Y@K<W7K?).M&IA\Z,)1[(!5]REEC6M5H:Y
M^-? . LCKKR\'.E;%F86%KZO\LJ\F/GY!+R/;=XR\PR,S^/ *ML%'&5M/%A&
M9YJP'7R7:T4@,U<>#DVQN.V9M/-MZ_X@1-7B [?N3,]6 =+*NRRSO10W,KT'
M#2CX?NDP64#H7U/C4/=X9NN_((#26<IO;R9GOPD0-C86WK0E7Q"[7%M0[<D:
M7S(*7\V@W:Q8W9?RQ'98P,25ET-7?_SX[4L61AQ2TK?,C JVK[%2V0MQ<:C/
M-_=?@Z>R,W1H&Q!N'SYR9'H^JKJ0:!RW$^L\!J=<$(Q>U>\)]L!*,]>C? I*
M.@R6&U[;(92_]2:MEEFYO:B9O97D&AVZO_9']D/P6L*=#CI!?_N((!EJPN4%
M54P2-M>_;=AL.204JRL<\SE5NS>9^;IFQT<.>)Q(_%-Q<J3Q:<$$O%BI]UA8
M,/-Q2%^K/\U/J3A209 LBR>7^U>5.8@\*IN:V#SG5 GZ(,XP+['N[XS(@=V"
MQ(ID"O0U+!/>L7_D;XP$;.H]B;A$97VMS/L:.%K2_STG($:9A5.E2/5ED1M<
M*W:C#;:X4MY45J&WN)QNVW?6(V\P-9Q09.1V'A'QBOTA*Z/"XPC@\2M&S/>D
MQ"S 6]*WJ ;J4$])_*Z[F[*O2]L^?WMD&:.C]7[%*6\_5MJ+H<2$OBW7ZX13
M^4EZNK-05<XMX<8"65\])83?T_A'O*L&%-\'_]GAHV.&1M0+R'R:I24;UOAZ
M.$);6V]=8WDFB+4#3:]UMT](> N0OGS\$A-@P7Q/S(@#X! +6 F+780OE6QG
M\Q]#FA U>XZTDBVMW'/"GF=NTV<?X,DB;<V<.KSM)N^*<GT0B]_,ZQ7] X@'
MPS[,O1'./AR,2DCY1PWC KW$&I8/-&31762ZYFE>9$P+]K*ZA3S37)5Q8_V1
MD1&.(LND@/;KW_A0/!31:!2(.3O7;Y;T'9JG<JIP+%W4. 80S0GBP6*YUMC>
M5(!LI]FCZLO&K4R_"H"?U,_YA/^-4LS"N*Y$%U"_U?,;]YRM;X.4&>UH$^*$
M<XLY.M>H&"L(;:;9_L+RSYM#OZ]NYR3Y:"T_H44EW@?M(A,>D\$ UKQ":E?G
M%">W6HTV1(9QB3W?-*5Y,C_!/VMKXOSM6X\IP^MNU-T["A8ZLK'%>+Z0$3'P
MSM:EO\UH;.D=6A/;/Y)C?6GH?LEY1XGVZ?,UA>+UF-NYD>ZS),*D95P=8+Q"
M5XM/O[]#8\]UN4%MP#1#>98?@[\\F)-+H.'JRB:@)>UOA+[VKGJ0-I[Q7W4*
MO7[+;AXJL++.B.>J6S--/EK-*HQ>P<TS&W]\N^.?F$=C-?%=03>_3_<;X>V9
M= VY5Z6.*H]78[Q+^NI*51P6T_[U;'0-I1%F9E96@54F@\X((0P+PF?%?3N-
MJYJ.<O]\].H.1,":WF7MTVRZ^;.W9&F%&]#TY3C!GK,%LH1_G1!@!# )R&P<
MHIOR"<S=G0AF2Y_]ZPR,"G*V\306P?GO,R*$A8M55%2>A?_5A?W$S/FD-[#O
M+E]Y7?%C *-?-PO2=5%O%_,R,T(9+AO7O$,18AV:@K*%T9*%-G][CJ_2.T.E
MQ_^21<>40AE?CN2?!@EG:E?K_:04A+KMK:SZSL^3&ZUY>2["-"M5(>[U!:'R
MJ1R.WU=60=/%EISQK<$I+2PL/')SPC9IO/IZ=9-6=-(UPX4?FP.T%,GZ_J#R
MWT*4/H2?+>=P=EE<OK0?,\6EQV0LME+^@_?]T$RF0?F"J/1XN9UBOUS&&R>3
M@%T,PE*3<>$JV1(G2?R@EJ@AS>F<CWXN9^N\<+(O)C+V=L,*_-1-I$OJ"\]Z
M2=/6*CI]UY/>72=S>WSZ7U%&.\KXG"#D4->[E+1>?MB3$,^_O5Z@:3%L?/]8
MQKS$Q9&?<I%.0_3*J[#6\#4( RC7$_KJ&T2RECADF);)$"^IT,:R0O=-LO+V
M*=%.\USMFD3MC92O^E:C53=)]S@I'%0E=9KG'<L,?U)Z+,7(] 078 +NX/1A
M2J$SXW0"<HQOI>Z0X"B@\(BMD1,>*'K2IJ=J4?0R$5(B$%/W^25GSFSN()N-
M3O&/K:2U8;]]$^T*C$Z%^88C.I^(G87N+[O[(GO5UJA<5WS+$7X.F=>JMWX7
MW/-*F)V4<8'D?R7M'V4Y>K3R_^&3_Q\* W(.P$%#!]!N $C \@41I3.&$-W>
MP^3TE[1RXD/6&#98(]JDY+3R>E];Y$3E#1X+-G>J!^$^OM4-8IR3RM >PU]J
M2'(Q@%H#@LU#'$)OEB#-0\IUA5?,UA1U&$*5(S)CZ)TWT,9DQK1'M,<(\BM0
M5ZZ(W-S/2V&( U<.'_->=>2-$QHF'8&<[\5#-S"IGTF%K(*LS&F?7^RX-46:
MAU_LOA\L=G_[B86]KEIT<,^9*D4T%"3M$PG0+P-B2K(8"8Z@]P-+*6#S<#2I
MC'3;T\&2?0*6L1_L2ITWL+"=[P'APFO !*$?1J.PP H ?9,7-&.Q=W2G/CTH
MY'JO2O74\#:7^6DK>HLZ>RK?_*D2X^$K@#IS^=Y3LC !@>0#I32,U.YZO)0"
MO\". 593-,K3],4[$0.Z T1>]L*7>)\,?Q #.FG&G7>/JT6OLP76I. 8GU-[
M8X>Z]GTSK8X]4NO38X*<IQS13R\1TM<7U,W2P7+#*\YHJC/R>)'<WFY.88,W
MVACXG,(&TK\?R9SYC[;1\;J6<$7,[AR@GT!:/P'236]]#8%0RLW4NENM2X+[
MM#"GF>\%S59FKU*Z'PH$4=11Y^74,:@D""H-#J[>^T#>8VX/8D5=3)V,3Y($
M,#&Z/WWH_B3XYJ73+?1]*J"#"O/'FU?$U#.4U%](S!Y$?D)'[T,">#/R+5(7
M$_MSCO$LMF_\L]0P@Q$9$:EH),2;N9SCTC4? (C]\X>W<Q>"14)>$%-.X&-/
M]E8'KP)3Z%C$Z*^RQ!\[YE#?^-ZM$7'S?M27PEK<5_4OHU('UGB.PYX/HV%A
M)&+K"KSW6R10#TBE#G]YRYN&5^!^@M%HXL"0/H?Z_12M?#9,ID0'Y\3CX Z^
MM<3+*36")2H';Y[8Q]284K+H@9VJ+4?C(<0EO:T:;Y;<!+/4X6*WE6K6)MTS
M^)7=RH2[R(4R1F:-<Y[LH7>]T'P/51<MU=ZB"%$/]S HA6IO09Y73&"CJCIP
M'.@30=V74#.(;L44Q\U\XBW6;VJ\8<]#232CIS@\(G]U3"CI:C.&:;Z$/ILA
MO_NSK6[V4>_7=DZ/3S5"R\;,10N< S>8=OC[8]AWZ :>;\[@Q4=&S"BFI(5\
MT'E0J$'/=;/[LGZ:P&YC,Q-7*4)W;_,"]^&I^/IX<V!MK"]-;J$EV:;13**R
M1H:RK4APGLXX7YW2_;7(L'[)[K5=ITP-7-U^'*+GNN0DCM4IA$PT W._KNZ'
M$:VO1>K%GI4VDIR0@$,G3N=,>4Q&@MWY2M6PW$U?F'ZE8D^4K2J/3O+?.R7*
M6"$3E$V6;^9Z\1CMU1VLS=1F*\?4]$(K=DSL&;:) VR>+BEN4U9T9CM_8%*P
M\SWM]^<$/XJQSI[AM5$ L)LO':JEJ/T*)NF,3!W?O[0G#2]FA$I9$!6K?A'I
M,M7B36G&IY%:<\$HE=DBJ:,(Z4938Z0SS>\K))A2PM2ZHWM3#1V#^I/:5N$2
M+F''7LKGG.;\R<E[X:5K4ZFZA>SIJA^Y@!OAW[1X'I*_9]OWM08FBZ42L0MV
MF,_?SF6K')9\K@V>HJQ6R5.V3\GGPS3JT@8E(8'(!]_\<("#.\&AVQ@>X9W5
MSZ#.6 =8CHUX'ATAZG@>\Y509\=J@TI\#B#,L&+ZA2[0BK)C[#9%<T<QE;-'
M'U1=$&7>N^C=6-L4KYRQMHBIM3D\7H7HQ*HU1T\XYGG0%D-ER.R^!<K[X51N
M9G23%,DB 6O"GN*[9;?<X;?JOX1%JX.,,FT-#ULBWO0[=7.K0_PFR%JV- $,
MW]=> 7*>/)EC)R1&XPQ+&M^<RCL3!YLU9#8':8OX'3,FF]UD^IE*#;*WM/=_
M?JO0B@2>J^R7/;13G)&^OO73W5[N?*. JMX/HHT3DI(3.72AY>T'=TNB2(3[
M,N\AWOE=O\^$J=.5OQ>6-!4]-:E7P;X>HDN@@>H97J-O/&/AI@T-YZ)2H&<<
MH:*D%)'D;"=O58#NHTC0&\>WGKJ.&$LVB,E#C]L<&?&=B=D^1"U0I4R<A6O"
M2._B&[*_N?\)M]O[+J]U4CXN!Q#G^M6Q?@3.X=5*=<#F%3:\R0&[)W8;9(9N
MS-#PF 0D]L;H@<I^*;%SV5=)4_)G."YV7KMRX=7)<CGE_''NB<^-@;22\ELN
M9T4H41_Z6OQD?2?PA_-5M=G'9] EKP =<X:SP$["X?FBP/'K"1"M@!B"-+JT
MV^<=F08W=<4MO??YI7&E!;4.#9?J/WF0$FTK0&U+BMF\)H%PW,^G@9V,8B%C
M"#^=J; @L5O?AK&\'W74P YD)RH6X9A_ZTD3G;%GSP_G)8V$+WBQ)%2'VRE$
M<?Z[^LF99FL;Q:^7!W'R>#G_PQAJ>R<D/JQJ8[Y^NX\]:=\J./JZX+)[L*]H
M1#5-7.(KW>B,[^U9;5]*SD5'OXT:2?B"F/B;RCZ5B[?H:]0,T@ORT*7]Y^\#
M]V>DUV2*VB:P7[RDEKC%19Z<L_DE/+NLAIOBA[!@.,JH#%+7D;]L4Z+3OH4+
MA3,2??-"$P]F^*S1BD%I@[,_%!V(<3Y:-7^49P)9EVEW0KW#,A6N*J,[TA9F
MUW.1@)3C:=YPQ&_%W'LEQT%.6X[^Z?U#:H+-R_6]"QS\I7N?BU0)S: 99FW1
M7<(Q<<?:^RX R3$* +<E(ENO&8F."9T9;TD)EQC<<BL]?/R]^T6SFY)8XX^O
M6E,G#>_?L7>5HZ/31V2PG) MI!_S7 @)AWM.:4]I1R($:2V)'D:5?U,WV+[Y
M:;6Q8G'9=#P94]I"[EGI(@JE)"0?1@4T1G3:>[KO4N<[0&$4YM0WB4G/SB=Z
M!G6%I1_*"?/>(S>-X\!G,GO$;FIFRATCE,,6I/2)/J[+:(<IK-G1Z@F=3?=G
M.B>-0*/]_]-/ZSA36D::CXG^_OV<#QK4TD^&=5XG&A54OD]@B6N\*1,_J&,=
MKO4HMXQST1X,NK,M+#*EW:#"3RME0D/A)V7PWF:;S>3QDTD^?BF9(+*63@TK
M+!>%K$&=?"9M_78](?NG!C*?)P2:JPHM,RCVZ]OK?\ SWDX9-^"$^TDYDP?K
MC^K@%C%8VG_UI7C'()K'Y)*[2/[A<(/\A>DG@GR 4(-*+@*?X!;>N 931:G
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M^[KH&+#SY_  ?Z2,<P <B':5U[ACF*W&#T$,UH/ME/<+7KNQ8YNJY!H6_RX
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M32<Q5V_XV(7]JL'7+CJ<J48C+Q+9Q)%534*%SXP$Y<.Z"N&E,OJ(N:2?&B\
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M5J-E(GI(CL_.C/17[:\69Q\H$;ZVE^,C<*3863?[&N^D?FK(>N+UJ=,2-SG
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MDYD-4 Y*M,RV%=R2429XVM @T!&O^SCM[H)<(G.BYM&0M-]BZVPXM+R%,*E
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M.\(H*2/M B]LJ"/D+X/_\?YQ02S2]0;C^CI-&)@;V)MZ$W<]:.0D@U$5D'_
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M#IB'E%,+UZUK8K%U-"&Y[G>>BR8KB29+61>&(GY<#ZGM\*W(EC7>+3Z?%[:
M5@X5/P92V.F$+<-LGY6N_!)<2.$(S))Y:K#+-/ ??G2-%2_G3[Z3.R?ZC>A*
M:?PG&'-0*$TQ1,/VC2NR7<0AJ0X08T()WD">*+"T8IOA9O3ZM&B&8*N?,6UM
MTU!(/(PX1T.[+?E3AAE/</S9ND\7[2=S^!88IH08E"R-(5]3+5>/<%LD7^#C
MA/ENI\>&T6[G0QNWH-ZCZ!WL@H09",O-[LVJBVGM((5'"JAL@D6/RD[T,ZF=
M*O4.;]X\:&4?8\9,ZRX$$PG?X[:/E.(OWA')B%_<T-Z0R'ES?XFYE]EE12$_
M[?"Q[HP8U-[Q+T"F6J'&P/LF)D*DAM^_(R"SW&,GLL,WXPS7^VT3-<D'XNV"
MYJ@H1T]*KUN^?:<0KA]>SNE@5I9P+D74UXS<ZP$79SX?@?+-1X 'SLZO-TRA
M;]TT?LKG@3A"V^K_%1UL$3.M(WKZ#\L^94D]]YG=K%/R]X;[$(%ATC_@=F<C
M[?EQ_3/Z_0.9+3"NE-:W.J$1*I<%&;1;, L-].(-P?<+&T9^97?P>.!$M"5E
M6UXPJ0^S0Q1NV:TB0_(OH"<NJ#P?VOM>A<%W?(?D_[2Z%);]1Q2%WQN*PQ?>
M4O@&=M*K9\JD>/_#<Y#\RS/E"&J#23Z//QV.$8'P:,4%HQBV$=>)$J2;2"0*
M1 X=M.=[(3HEF01;XIPIJ&X"L\[5YT9%NXCV+2XR+!H;FBXR*V>DR&6EEF*#
MVRT0C#33@[:]&I*CX[ VII]"LBSO]&.,M]<-K)(B4:AK1\?^@1#'ZS=NK/ _
MWA5/<-Q(3'E(<C1.!.VF%-TB7Z<XG[^#R:6M6NZ>J:?Z4<S=2R0[\@WXY/%6
MIX)@T)$5(R;^+Z#5]362.]92!GU!%_MO4*7\-Y#0N:DCGVKE%U1>4MC^>WD@
M1"=]Y!Z5"WDO29C]PRPS?(RQ,LPUQ!O#MBE4YVAXG_N.+!KNW-@?5UW\%+F&
M__B=?5<=\GHRU$CAF1-PC8=$?>5TY?OZ_^UBK6M")AQ<)O;7*=[K7_V&&588
M,7?&63NQ3&]S04$X"CCD"TXK6HFSLAFTZXJ\ZA!'5_@N-!5_/"K:-TKZ3%YO
M;/F0!!];^A;7"('IW28>$!:Q\(GAV;"],HTDV-3 3XL!MBZ7X<T1(457\0W?
MQ\=GD1(* Y1(2#6,VNLX0.'55'?R1?VGY4_Q@]F;L^]%XRRS4O8_N4TJ>G,O
MHPX9F9TMM:/7*,R/;2*6_3A&=$Z*B/OS&7V(=QP'CZ;B@V@61&+57X (B5LJ
M,GK>W@%)ME3DQ8;?!,2/ <34Z,)&"CIDM?JYG#B<Q_GE1/1,;MP5?.>:6$U5
MYJILLW<RTC?__S3DECJS_#'QZ@7Y2D#M0?@8@Z?##.G+S))V)/F03@TEM"/N
MO?"?"D?U+:&5E!6RBJ]9IR.GT8;?)V[L;Y3!/_=^BOQD1?V^_)W].WG\_>WK
M28.ONEY933JF70ZE>"HH0$0Q>=ODR9G&I;JCY_\7=#KT\+4L-:6&T&3O1'C<
MQ^76!UZD^O7;PMY;%5K\2OMQ?,HA]-:V9?&XR.[>W8"TA4/3NL,OWU'?Z]#6
MV7;DT9BDUG*TF^C9NI$\\(QBD>\Y4AJB(4C5ZPT(H(?6M+\3=!RH$NC:?7>E
M+@X.5@O.,$X[@^;;JJ=6\6G?:D2V]JQU&JHA';) (HVE7VW4N,9DP_5-0!;^
MVH$:+,N@X'?1IPVI!XE2_;>AA?U0D1 ;!J]+]9V:QK&CY@\B.G[QK(+&^%71
M3@+!2LXX LE(W' "15/[US4Y8[X[Z2+:*(&H\O1I/ZE SL:S'D)&\PK]GE0E
MH$:KRMB,!<D1(T&QA;<<[I>^QQJG4B7'98U=O1,D""([FWX;W46=X%'^T[EE
M!1^G>0?=R;<>7D^#?:L6(7R?5S*Y&_M:C9E19RN1H]SQL&:KM_D%201/:\IE
MWC+,10"T;#?G<G-R(Y3CU?CBXP#+TD__(ZI"A35QT@E35[X0V6@C_1_TC7.&
M9_NHF$66X[!<_7OW\WLR!1N9:-B=<\J\4R\F;HR\5MI\Q.49[]' 7V&XD@3I
MIPP/YAX$$E1S]>)/&NZ;9? %O/N'12N>&I'^Q4PS&_A'.*+9LY\_<@>^)$<5
MX\0*RR["AQLLSK::9,DF"HIOX\YA3T@AY1D/]>//;K[YZ+:@L*3'E0A8MD:K
M[CRU!!BU:CR;NT9;5L42F6.>_L(AQ2_VW@9[A;(:Z'MJ83/S%32&7SC;YK]D
MMG!4O/>(2QHQ>S+>?F][HA]X/[<\:1S_5?-Z\O4 WV7=O062-?SO)9",X+>]
M\G1Q+1Q5 B4K&K JE]V$O^$\@48'MCR$/I8Z!OS"2_QJ?,D--!$;0)"H*D!D
M?,+II"L:68@<"ANV/I$Q-:^V@N+"L!DL_ 5YR0"G-5T-E'051[CTZ[KCP.Y%
M;%M@R2Z(1Q8=?<X;RJ_"H*7_5D7TIFG+ Z.Z@"]M18W@,1"%H90 Y('*B:&%
MRU#7FZ%7*A[]@7E,TA7\MI_38:'5#2CIB;CT. ,B% ,S\:5:XHA4U52!K8!Q
M$Q35-E[(Z14%J@MZF<3]4$>MCZ1<&3Y>#OM$\LHC;%;9TZ,-H_+-PJ( Q'.=
M%,'G_GJ"/-?[" ;"8OJC8[6263FF="(@/@_(=N3<)QFMU*QKA5@I6+4T 32C
M>)Z3E"9\D?#%=Y#QU'DW,^( 4H,^-FSD6]$R7-+T($*?+*:[ O)J3#$V#%L9
MIJA/BKO#1A$C([X7/*40$"-6BZZL@H!6R#A!^U#$^-M9Y9H_Y%Q7#L8TCBX4
MHI'()+1(G2I._[QK_M*Q!2L4X@0CTZ]CL/<+5I76JB1%*#4?::'?<"D_KXR"
MBJYV06D_E5>]<LK@'$S-L#5'&CO/0I&KXYJ-6S$M^=-)'UK6+%QAJ=LF+(>#
M<Z.:Q]*R\1T3FO=Q0]78RR!?1H_W&XR5QU%W;*@=2R%K>.519HK)PY><<SV:
MDIW!8.8N\1P;>W*9>+D&NPZ4JJX7'%B-XL;;W"D$GDH(@%\4?^G36DE/ +S8
MO;"$DY6*^^MCMP\WR+M0LE%5O!P<.7@NT%A2V9+C+-^;S,S^4^5*6)Q+F6QD
MF!-\@\58 D^ZM.0?<PBOM;L+,",*E%!691E4\G361"M!M):3?S* H<C4FXXX
M1V$7A]BQ[!A[PD4(&JX:1)^P3^<VOO(?[Y?(\3N/]?E4E<_8FL=J)#[&;)R5
ML+?,I&$V'%Y%FGH\<-O#_$AAVK. 8@<VAZH2I,.%."$,# 7+S5%1>"/+XO*W
M/WH&_)""2?-B[6?F-F7A<U(4+@UCO&;!"AX.[40:N(Q:T:[,+/F\ )YEG=05
MF3GARF(\3HV,N/# $K>>T?? -M1OE07L-\JJD!SDF6C7BME<1FYYV6\L$EO,
M$T:K02H*"..'?]7$NL>_Y.9#YF9M&"+NS523.NT[;V8I2=&?C7^V7)Q*@'P(
M6\@+;8:X8=<>"3?E5@EMN>DI1S?7,H6-*=NR#']9*2VKJ\3,@F'7%?+H1]65
M6HZZ"_/"I!:N"QGW92-'<C*PSFG"-Y=\;FQ5[8L^;X%.R:X>\&A\]% [;'98
M#4^LWB_Q@S-J5GQ10.MA"?A>'Q4&,(+J+H=IGH7:\J0MW2>]H PMZFM"C*HB
MKY:&]\1]"!8E7+,KKUHHDSY>0 ,Y4N&:+.20-<*2DL<:L[F>PV;Z9IC:*L0!
MDQ*,.<\5!A'A>!L6!2P[85&ST3+,F#-R]-@[++.@X#1]C&B'7SF.4?J4#&GS
M4(G8;D]77RW)'83DE[_,S8[NAPT(@7D'4N@TL;9-G=KK"9;.O%[<Q1)&K49Z
M59.DI(2-Y-5<-&XOV0G!J+5^6R-P*68U8Z&AVE&VC+.=OZ"7PS8QB[]RPC6[
M JU)(E"V8\:""V\%UDJ2\12"U@0H?%W7NR-[6B9$%RHYL32<@MO>,E)("IJ<
M,!RV/@:,;_.=A/$[>'4F+<Q94[\-.;YNMZ*CH0&$#YYMQQM?=EFU72]*[V0T
MU'43&_CFSU=J\.Q8 W5%6.4-U-/G'1:($9DY2C!])>N^]D<05*KW-D^ :2QM
M#2;$2>8!%GM45E51ZJ@*EHYP"2?7F.YWGMO:GKO'V[/9GID6^F8EU=4/I>\?
M:8@RD9X4J;+&]NU$>,+(3(?9"-=WF <U$6=,@,[HOZ+@A1*YK,6 ^M)P52QH
MS#+=/A9\O6MJ6XMJ1$G.54<9T_#PE2];\_.DLOGF1QH;B*3/9#T.V,L2KA34
MZV"&:9(> 4IF>7-(FG&C. 6%K]W?HKT:H/KGJ"\X> _Q)QWZCFE-E^?;M5'M
M8K%TM% 4'!H?9UDGR0G&/:Q0UDR'G[)BDTD \EYDT O&+=W]+TZ+U]]N"^QU
M9'1RC$7+Q ?"203F#<,F!%K$.3I:=3[2^";VCAV^2/=_$5VJ@$C-*E %#<0_
M7F9&:S8;&D!]&#6HH^3J1C:8LZFY)_L:;<#RHBI)$4YC )TTY3S' )Q/[S&-
M.^[4U)I;A*H<E!"D ZQ8B9JR,6"%P3JXA3&D7=R#P)TX"-Q*H>PP A++;,F8
M4\BL>D">!</8:K[$'%5)-S9@X+L1D9%(5?1&7P//?>:;UL .'VV_.X-ZE5$&
MXSO5R:MP6Q97H,@RT:E CIK!"-6(T3+// $6PTZL"LK';B RK@"J$^F>A'%\
MBA+B;?T$#G6F3I94@"GJ[<[&3T25QO-6Y<"C#)^J@Y!EQ:54>=FQ)Y-0R(J:
MNIG:)7G@3"8AY^JVQQ&>;X>(1@V<^]NK9U&K:;O)_^)!N;?9@<$B?P&#K=_B
MXDL;GM31JIV_KM^K?9KNK"V['B!Z7(@Q\_F8>AL:,Q-#"LU<?N!109(_7\M4
M%$S5:?9F=8'!;&+%8.H82@ &LKHL:^IJ_3"<*V@/4SO[<B9Y,".5M2=Q4H<I
M]#-&QT=E "N,&@>OGE<6H(:6*#6Y!=:';00SF^K<L01=QPLGU1IB8"7S9/QC
M#2J'/88??P'#<[_Y*8:*P)8#'9YOO_A[%BG_!?3<EQ.R_5NUWNJF02H!,9&J
M\FY5*?EM[2@2^,$!O5;8=" 0E=:K(@7=\02CIK\+Y399C'HNL M,N;@ED$O^
M"-A]$#BAIT\MP\&Q]OS_P<?_</\%9+L?$3714'^W;DO:G3AQ6X3Z9J[Z8C[.
MF=MBY:_<UOB*(64!]X#5TC^4=;?B+T#RGQU53O+'O_>$C.4:H]=4M=S,ETI9
M4)P<2+3GH\VH!YZ1P\$!K=^*-/&://!/Y ?\J68'Z*5W JB?4KAJ/^2:>[CO
MTN&6P#.KH(&97*LN-\*;/ETS98EJH"4#+VG ^P!F?'8EI08Z<5F2[E@ $YMM
MMUI_2Q5+>O4/V$(F,!5'.EY)PV@Y7)[A.+^"K-V@"9KO(U!FJFD^.)=#,D%)
M39TJC!)=ABK\X]1WCOW*%SSODBMZ0#N>$*^D-0;NA^'@.!D>\O \)EYOG2U)
MSSC-:,O0Y E$Z.;H"5'RUWTO7X&0"H?[>KV-TN8YDQ6KT1\RB:16="CAPBW'
MN^&9.-#MWLX2G4S3@RRY:L\)=V$BHMK@5TJF?2N84.;N!1C!OI\,=:<C[)-O
M':8#NX-P\=HCA@#+>"KS 6"EYU1QL@<"]W@(U;WCP=(@8.NN7L!/B"K/2MH%
M5M7-_8!(<@/5GE+5.I+\P^C@G!W+XUO65E'M#;9V.8;TNI9P%%1[,^0@R$YU
M=$WTY_*OABEI>4&8C#H7&M!0-XQ<&-G*><JJ3EYCW/5M]_82-?6L0+J5U>4!
M3J>'&939.P8W:4([#H"44'K$M)NX13:'>;60>^=@.-9/N\U,043)R-M;G \V
M@(=KGXF*QGM RX5.J6UK3'3R EO=6*WH\MC1HT@CH3RQI/%2SZ8R1PG!KBSC
M)[ VU)'*6I4?YE(0[*<[)8V3!;>AR?FCDR^P'L5.[UU%'7Q 6[R=[^HN*(GB
M(-G,[IK0?BE?B3B6:NY:#9" RQT%=6]*PJU%305*>%-UQLR X*3%ZC)S+BN$
M$07G+ZB5 LZ!H&R$QG/1"RU-, DOZ<T@'HV%,[TCCKJG@3'FMGJ8^:V.#G2U
M'.W\*'FF%);&L\$KFUM>>60V-G-.WETQMVAF2H!E\@MT0<9#IYG4/XV&5J4M
M50W*6U\ABJ778K7(1UG[B]&;AI'?8"7>!@7S]X%!S=&FR)DL\1L<2SE>8&AJ
M,:BDT\O_WB'GG]TYTEHN^^#*ED?[1SRF5VR)@E6[;3OQO[90J8V6$$\^7@/%
M-B<I_M RA:E)]T\49=T1\_!17XU;E<J.C(XP[2RPV5Q.=NU8_I5S.^+XA:4S
M.23>G-35S9FZ1/$,"$.6+V  1N&JL)QU[LIX<M%\PI+!]YH^2=F\ ;L9FG'/
M+N4I"Y.:BZ"\#[X:-G$K6)";9^W_8YL'KYN"KF(O3KI\4+I#%<86JDA.K.$V
M!K:FC-D5/[+1P79 X\,:)ZM,QD-HJ+LK_5P^.Q.5KGK,NS'V:6<4UXB10)4>
M$A1S$K2(%_/7@LKM#%&X;\;>L9S;%_\R'8._&4]@\+/VC5O<01<(#RJ8/M=E
MLSCQ=_!H!CGIM)]??/\:]Z!46O;/3-F=,HBF<_HY5:% <!BY/7C5HRKB:+_V
MN<1E!5J#=7Y64CG8V,JT?0TT)>!N@%!VP6Z;ZY>/05,CO.T:D>1(U+?6SU\8
M-W23%C3_ M;!KY$/6>+'U:H?Z,JNIM(*J;'R*R?B.3/!RDN#:8?A,;J4FP0:
ML,784XWC.JV<0?Q^C\CNF_-6">DHM*N&1VHJ92VG<9TF?7P#;VXQW]F0O#:R
M"I?+DE>G8_%9!M3+TY@+?&7D!=P@YNE%$KQ[&MXVEQ?>3:S^;R.NT=#%1ZD%
M')?#8"52;]XA_AGS6&/>M@VTDTS#DX/4Y"AD**!E%O2%6+HZ"CZ(Y: :5<LA
M)^W=#M-/2V.S\TO;HJ;.HHC+V]:_!Q;S N8@5$=Q!@DE"=;[,=50*<_65?3[
M5.7A-;A,\3;5$2Q!Z%N:0>;";%W9DM$. 8/;^18CF6M_JG?JYA%YB>1T;\Z;
M_*Y.[S-PJ+^:2N:'J2@G9X,#Q%89W_/RRNW#QN)([1C9<A7Z'.TZ26^?%VC3
M=[.YK]/NU8 K(/^6^OUGBPY/?V>'$.)UF;^ +]@/&NS3W]/E,6@[B.I'(#($
M]0_P/;'PCK\$3< TMX5VZMO1=E*9$G'_O.1S*/,#Z*=0Z7 Z,*O -[@0$=6C
M6#9FXS?(CQEU"T*/,M?Z!S&<3Y\A-9@92HGIG50Z+"IT_W0J&U.BQ!\C/#S*
M.+DR8MM$'I M\NT(;#S$'LW-&VF9P\8G*BU46=F@I#RD9O0+2J+<ENS_3S:&
M?_A*]IL#?JN<*[T3RNO23B344/W*N:6"%,$["01D5\'6B"&IZ%KIA+!PF0A'
MH,FMT7C,'[>W%^P\:V\R?[4(8:Y0]E4Z.H\R='-6+X&1!#0LYK@(6?20MN[
MP,CGN'$U,44OF0+N$>&GH&0;BP[WW>@5QU:!/4I<10ZD)^"!)I>8P-=_"JWX
M%N#UBX9M.7:KS:M+*^9US#1AT* RS2ZF2;_)L;NNCV3CZ^:9:-W.RB*:-,=9
MEQF<+JDW[!-^XYFBX\C]Q;)J1"TKAD>'E%1)#/>3V$X\XEJ<]31]*G4^&4M"
M7L419JF#P3$$PA=R5F*!1/_V \F'?1*G/)YFPQ?090W$6BX5_1B!&C5.T.-X
M\FK+L,1YL3'WQZ&?WG?>O2P#@PEZ\N*)+?M:.>E]H*%BK#ZG3/])X>3\>V:M
MAK6SF5;P-5U.&E;\$H#; SC2Z$PI7^S@-@GJ]LB8.\^#-:A_/;1Q2K2"^[&S
M;=P9S)0-ECC;+I74-JN5*Z_MS*];TJ95)?#08_<4YDD[+GH,C5_HNM9AXR6%
MP#,DL[C#^8K:4W-P-]7)',7^ KHE[JUWN&0*>--TI)F;]&6RN1QLY4J38;I0
M),:)!=6G4[(2PQQCRR@Q/(7T&NJWV'^\_P(FV4WX#),^@][L6SR=;!%ZZNX(
M;>_S+'&THC5&M>5@G/I9%5=""WZBUWI@B:/N/V'I.]G,":%_ ??:(E$9HU(O
M.D!UM,3,/7!AWS<$QTWO508D;?JK=7[%A:>)9,%U>XDF&R*F^>HBTT/LNCAI
M^]6KQUZ)=*)_08,5:$T\Y+7@XTSE/@1\D# 8/(,$S*N9S0KI)QMJ+-A;7P*]
M4*@;L\7>UI2OYTAE9GF.J<VRK<:Q<H;>UU>G# @)/O(V=%D8&E>SNWR-9(L*
MEB+_ F_8DPR*G#R0L)@3:UM96Y;Y;P?;T$CE;K52>[<,25P0/=O/5N28"^>V
M:Q4 ^E@1"-66K=D:MP2W1_9#W3Z1/N!C9O\H26.SQ'85(KEO:[HS 74@78 K
M;N8L,EC^!:2X'^'#.2W!^V%L)>TNYN9/V%U D94RK*Q8?,K.!X3@45/V&S^A
M)[>!;X# $QEFTL>:N5!35U[-1W,0''SO!'NJ+IS[;#$[D O[98_7Y/7AY 7Y
MY'%/OIF"-<Q!92"%4;]0.$RDTFJ!<(B^ME([S+6Y 5=S=Y%QR/IT/%E'_SW>
M=4#>E\B4ES+HG_[:Q-JW[-YJ&"/PLY#500?_(^^M*L.CO96VC(0?DTYK[07-
M=!E+HA:FLN7\^ILP(TY.R$(EKF#B24 +HTU94!DOC$(2@>@;Q%)Z9!/:!09&
M_J^&/W.AU:\:&TT:E3PGF6)RW[B3R"_OCQQ1U\%K_AL^^C8!.L(#;ARBJYF1
MTG4]T(@VUU02B%8"$NH#.P =6@A65E%@.Q'TH1B0PD"8Y8XN <<Q&Y0:&BX]
MJ&<)9_\YE[7#2V2WGJEQE;P%P!]+3.<1&&_2B;%F,;?R*^N\E63QX5!S0U<]
MD? ?3<#/,TB\71MO1US]!6!,*OMP?[$$H==VUNR2I36EHHB_O53K[GM&8W#X
MNY5GVTK'N^T$# OP5=>JDXE=_ZP!FAK;Y9L\)J9+,.Z/VT;.?F;^,O6_N_+.
MF>>(O!\7^CAM]KG">:54FAF9WL,..ZWQ55-\;ED&^G=AT +S6HAW C ZC\2U
M+ $8F>0P_"I_=E& WXD$H2?"VG(5W:>>7V'JL]0H>=CY2ISG6WANIVX,*&!_
M86"XDCE>C^K@"^WQ7K)47#H\BU8")'%9310;J7$Y8%L6QP$UL9&>"H?/[WL5
M_>2<5$/HT_P%'#EC?JU J/LX!L_-F#FSO^LG TO^>9PR^N$,Y$?_S21,F[>M
M6PN9"$GFTVB6VN$&YQV62@B<((]B ^T32WBU?^S4L]>SUS'[,/O0C5A"=/DB
M;>Z/ZI:J%Q^I0FP'N1\PL<ENRVX+)7RSH4LALRD%JH.@'.1=G,#9S+\ _L\C
M5(8#XE<N)BQ1_AXS>N]E&:6]IL$?2(GLDH6#?T85.%-PEZ@K0O1P-_3U8G!-
MO%J(2%5:;1AF=:I $D1O?]!,BQ$!.6BZ&I[\EBUYKZ&8_^=+'+EWD8#(X0_W
MGZI,P_*4HMP2)DXL/D5B5.&P[-2]&S9TQLW%/#B+LC&T&83,H("0).[P!(ZX
MNA6X7+:U<EP%/KK04V=Z\:USXF1PC^FE1Y?$5K[[@#QP$;W^Z$*7E!VM71P+
M["*D;URC\]]>9_!9;/7:B:W\(3<[08^JXC(91FA9J.]WKA- LROM:?FY:^?C
MC*)T%&:UDJIA+&DOM=LC(I HI@HA&(.1&A\=7(T[!^+H4J&DZ.-W.T3[%5+6
MP'-H^^PSZ-=X^'+IV/7/J)[;JI-.TPGV:$W7H:)'D3O$M$],:A;E+E-D)X9T
M^/P#*##TF3G2F4S]99E+;V,9R[VG+R@X),NHNBA(>) J51FVDFN.;=EZW'6@
M8"LG POC@2_B*U>.D>"PG3BE8#]$KWZ8,^=S:MI:DHE@T;\ S:=3%FK1QE2:
M^X?<GLH)RE&J ET^ $K]L,),3B8K!CH^*2*YZ>.6\TN.K.47]BU<6GRPJE7B
MU$[3AA:2_/Z'I"-R+^5E_\RJBZ1 ;HV](+RB!WPMHN4+1F&H6;1I!!R)2--I
MC]42:.>: 2@^"L-AL>@E8H[@I:DT['*22P_Q:L9)M7)]<3FF]3EFV>QCPDZR
M-"6+W;NFFS21QS?_OMI%Q1JB/3C5SR$TQW(^>!8W N4\LR=_7\\S4,WQ?/RP
M9(N"?2?VI<FWU_PD[I&3W\BDNBU:"T-SN@GSYV7WAX18][GC<!"590C7!7@Y
M4SL%)Z<F3#O:!NDX9I+;F&-G,-A.BS;>J>=;DSZ)-TSF6Q-0.==DN8[+U^7I
M>+U2\:,F44N?Y-$D)S$413X,PS_7/HD[M= #*S1F)2L$IU.3EUC3&[PNT,21
M2LYZ7&/GT8UT]#_[0FK=J>?T!1F2&:'"PG]NSAX4C_(.+3"2L1%XF^5S[M,+
MADV\J=8-Z)J[<@RH)0R1M"'90CD_V!@?-L,LBZ/HK"Q<6;6,%_Q!.?D #N!+
M^B8<Z;'C[WZ2Z%*+8&2N4WFM/<:UM4J'R+K@D+S:T1!?CQ(LF;2/KOMVU*DW
MSYO46V[FV'Q2->".2/T9*6"/1E*B04H[)-TDY?*/J9?N_6,\!?)B<FG_;=:5
M^.>QZD/_#!(\\ .N-R]Y4_&1X/4?Y5*56T?0]#L:.?]4]DJ6?-KA6GT8)=O:
MCJ45W<MN$1'ICJ!MMSC&[7D/;1M@05I",B?/R31G-7?UTUG'V7J!!(E8N.U'
M.C/ZT%H&[T,TVZG+C_/S2QGT1(EB^?.[3CM-[W"!P+L.S@%B\P4X.M0X"&U(
M':=F>]@B-*9A;).#@89J%4HTDYIPX,Q C+V1<'25*0X\2M<$.G[%?VK1XEZ]
MS&;O@E#VW6QU,'>PY:VM=(M#%^,^2M,WP3'(R2[8K$B'2^\YV<,O(\NAZ>"\
ML/RO44\/'A*&Y1SA@1-BW_5*J.^;%2B[#SQ[*4W2KUXO70)QJ70F/P::\+"I
MIZ/?FVH%X,!OB^5AWNG/14D[U592'6H\$R7BN>)]1X(]7W\UT]A:$(K#*)9]
M4BU.I@QZ]F+OS"[UI\%?P"/5GD-H1#WM\"5S^9/CXQJOK%$9KY>W$%"%2'J7
M[K?ZHOWQ]@\A9M5\R&$M R-SU_>:^_0ZAEB^P6<R.F(%1-I=M+_0W$E%*-1&
M75GIZ/&BXNHGG_R5F:FG?0ZM<KRD!CZ\QL+"!3F 2BO0JU:KCG<%T#W;5:Y2
M/M/@_38H-8%2VT10!3A?"6+W,Y=]/3GH6^C 3;Q,QN,HF"62QBS7;. V-X2V
M?Z:>X:Z3K0'C8KMA8;B3M&?V7?S#3-6V-ZOB.'<]E]V @Y9QA_['9;W5=5H;
M8GI;Q77@HQ+J<,%:,^]$KELU]LVXH:HVZ0,\\@L6%0M:*]IUGL*.9LX!D,,G
M)O61F-@/I5.X)JH4E_EMK9 $ULJ5KIB/^Q-FE@D4AN&173 ?UL#*\3[QV'$7
MBN.#O=6SO8==O565-#JOO5\J]:=B10WGR>MUEC6-P7ISM&X%:]-.!6MDDA>A
M$&19PJSNJN;_(-P_@)KXHCX -!21JD  Z5(2(/0NTJ1#"A"2T'OOO0@("IC0
M.PF]0^@@(%U$I5>5WE&:- &E*=;G__N^-Z_,FWES9W?//7MG]]R[OSWW_.Z=
M0]<K  BP1*A[$ 9/7M(L1SJ#->A;J^H*+9^!:H> "2.*'M"7"E$\'@P%KNUU
M!"XNF33Q981\3#G)IH*3PFB<=$3&Z[<7KK?N8\Y'*H7VYS;1:7J3A"E+>9+F
M+DS%?'N=5:VSV.C44#+,(OY X;!1Q")Y7I4UT#6/)WT?DJ]=.NZ49PY9"Z7%
M@ O'JAFFD;F  K$[<$K"",:8]W[%32":A8KYMIO"C=@-N+WXBP(TMK&/D/6Z
M=A($"RP\+FZV[TELO_<<PJKA0AM'USI/=S.+/RI9H[\XTRET1W^-DYQ4=> =
MJ/W2TKQ-%%Y3[DMND>G=7#E9Y6^$9\M^0^WU=I*:/#JDEB$2I_SDQ:^YOX ;
M^1*_JS+M^>^H#7\5TF/(F;=].'G??8O]>QG8!ZQ["=UH'#EWMAZBW$Y^N<)4
MX:QK9'".,P1'B[62Z<<Q3]]2WH>[D3-(ZV>F?*^:?'@G1.2<N:\.5[A5/34D
MM=*5PVZ71PRTZ$/"['C81L<E[V7M8$@P-28CD @,VJ8L 7Y',;+5B8+^5C<^
MS#UE0!$7_A_0=DH9163N?\F;$4#AV#P3<2RCUS=U[V*&ST3,]24N%".YW+2V
M_#>FW[ <QB#T7O.LLHR+IB:D17+I#7#Z\\\G"_>!/T:+7%">ZL( *FF<J.7C
MC*]E&UH19LI2"\HM]SR0:[]G8ES'I 4ID4@A9994(Q$^]S:=[V%%+B/4[*C=
MX]7;/!#@_/VG(Q .JI3]M^<LF"H9"O=5]\%J!DVOTICY'%IG^$>PVF$+!H_H
MVHY!D4.DR5)-OW 9(:-U-#VI#B P:9F,0<D+@H@Z9_I7V5H]=&CXIR\JS?T"
MMRDSZ%?>]T^\R8.%,%MC\X*=O7Y.&Q!WQTF:U0^J&4"C8O)PVL:, ]@4<F4J
M@*;+R2C9S+=W>8BZMFF2[;:J!N,*"Q,'XC*C8:-B@+=.>A:.P>W!ZS788)2H
M>9D$+1)IQF2%L68]!B4'@A:G&QUA4_Y=8]V,8#WVK-^0\O=Z$?*&17Y5X<]/
M"R5ODIA]NC: H>?4!7)W,ZR+OK^.>>!LS;A%*WQ""=U*K&8F2)D;?'$%^N20
M^DON1Q)P\FU"3 IBP/[*3 *5U<:YJ;.L\2DUH:]#V'($L54HC(I9)=<'&O$@
M8)HQ0I#\M<(T"*T"T:&T>JEQ4L/,R@3L /,EG;!G_ :]W/974/[-W1O.;Z1B
MT3#\%W!M%"1$[Q2ZU5SDU?5@6>JE87F9.N\.G\D3\EGOQ^21[C8DG[5Z#VQ(
M[IICS#'/R!'S#!MI#76JK34_QLM7B*%\_P[5SWIS=4:70]KML"_:[;%B#:8Q
MJFT1#)<#'].:[I)'^GWG&Q\*)3=\9ZRJ]V.KEU2UVQ<$?W?[Z<G(HK(1OYGS
MV#?'H[@W_YU>\ZT,*/S8[!-ME-GYF7'YCDF:\Q%C"^C=IF:%&?P)DU96$-SV
M&4>WP5O-G$\^%4)U*/,&(SC_>2QIX4W2'W9ZMU(&$U(\2AO\T[<)$LKL;C4M
MB#ACV=EFTYGESM!<,D8"#H*(Z@O)_3"2CQR&K/0M&Y1EW."0O<#U=%<XL:LC
MQBA,5D?>#%'=P--3S3^1H 6X<^#W'M;'@B!(,4[)\JK^:!:#D #MMGC!5U/4
M LG,@0^;L!EJRV%\0_0""F_F5<5,-!(MJ=H%!DX0OQXRT-::XF_YKL\S>63?
M62KI]YH,Q5=L)!E/)W]_^A?P>BZ2>O,UL]OZPP@O8;$>"T5-(DL"F]IF;LH(
M\M6[Z4G':8VO>@+UDG^2)7"$FEN/7IIH)OJ_SK[R+*'O=PF3RWTK TXMN!27
M.,TV]#-3O7[ SDF*[O\P2,_G+A^OK[%J6 0&\VK1JH,F*SE>@TAU*2E )1O8
M4IV_ )*FHI(#T?Y0AZ4C:U9ULFS2X#>DUSHU>A#L^#'37\!8JOW/%X*3U)4K
MW"0VL!YAE8^N&]CLSX@*>:I 1F.=WYUI^5:0E"?U\+M7U-A,<7I,_.'J*/_&
MZV_*1MUU"R*H"$#N1<CF%4'N4T3;6"MCYA:C23TIGL1H@9&V*DS 4;5N"!S6
M4V"(WU-[>%SRJ MQ#?W^OOMG]A^>A,,HN<&Y#"J\7@'_DZX0VK\ F -XB(5_
MA#JW,\=*A-'U 9-??+L,P[ST;@)?Y'>R1"8Y36Z-L+B3'W=*D);1-ZK5.SST
M^EU4SIQ"^RNFBOSD-Q07@/;-.7=AC#=!4608%409_X^^%G&+0-+'.[IO;W,^
MLB6YLD-4OX[,/8!-//K:XQI3]^1SW3WQNK+/=-?KFO:ZJ#5G(37I+H@.>CM6
M6E=YG:UG)L;6+ZK.)20J9EG^V K)VU:EM4*DS_#FUL"Q$;RMV'<4A6XF7Q#6
M!)0K?[D%COEN44ISL;I*OQ.FP?A@9/LQC,9GJ?4T#AKOJ1L$-IO8JM $4>\0
M=6%_1BBZ/I(*RE,H??Z0B<@=CTA] 3F<[V6*S=B*BN&$)79TR0? 7)JRIUMI
M&VB@TN1 F="4OX _ZB4'B"L2:(>+G"'>XV?&#/>#.T(Q.C7TQ;\ O&F\R@/?
M'N4Y:V96UJ>3K^5H)_S\Z'>V.<?/6XZ*L9!0V ,,QF:CMV6V\2[=D?"NPUJW
M0_?Q]O3L^:AB#--W>\X,WDIX/4>?H;EXK0TYZR0RAZB; VX'/>DC<ZM019#A
M-?,(D2(@^60/BW2"$$  I"<0V,)C^8:Y.^OW0U-)E7$?V*-^S>359UV(AC5*
M55):"+0-0E?\54U*J&+B\&RQ+CW_$S>5]_MI&F=+K5I/B*D: QB0:2PIVHLQ
MJI]6T98VCZ34F,4)&Z%LJ()%!E7U6\\K:P@4X_WQ\G#!4!^52 TK/W)<+Q><
M"A[4R&M 7FJ/U!>!<V@ D+;C;-C!=IW?:=_^00CJ(O;QJ0*,)LY+ZZ35"2$8
MN\%*K6' <1F>#!&&#FN7HW.W<#<5A?6*RL\/%QS@S5PAXP"*MZ%2&['*V//;
MZP<H9C"99.A6:NURO<*$-6Q-[TAA,I'3(M0X&LV/]>.X=QT6GMBZI:[.$^.J
MS^^\7?N0DS]#T;5"\!N_VY,EXXP2GR/]1N-+\\1,KQ91'-% 3#=*OA#@5PRM
M!TU8%9%Y%"3>46CQX_[*W@XQ66-\%%LJD5SD&5AE3MNT6NA9X2N40>_L'V,W
M.<PIQ1_DNW?V/QVZ"8)QU*!C[*BJK5[C8VO9:%R=F]\(9VIZW(S/^RF9AC^(
M75 6 "'FF_G^ B+MOGC$51&9QD",I:ZC1:@7Q:(O-)*E=@1S'Y+TU.DFWE7/
MY9_GHQODH&P>#E9SYRB?M'&?KZ?]HOAI,EKD2U8M"TD=4)7N+B0B2'R:L& R
M!^[1VAZL"%!7!WX9MO_1HL/*_$#Y=]E(EQI02?:N%WEB^_CVFK:<V28;&!9M
M_@?RQL$JIYN0E-V47>-ZCB>D4_+$,-&-0[N>1F;$6P,I))H'4[Z^9'/Q-\,O
MNM!^KLUGZ3IZXV;67_#E7APP21JFAO_*%)/I\QX<DLQW#&)%""-'THOM_\3)
MS\M$_ZIA^VRB-S#0:M;^?(@O+5PB=F7*PZKRL4E<IM-]3AW0788M>D)++Y.3
MOV*:"].)X\LYVE(ZG\KB,Q14,)[L-NI$W.*38ZY>U/D;Q&SEE]&Q1>=0 ,_=
M$+X*U8WDZ6#SK&S$$I8?[<T39.GE =-E3S "U:K.K=R^<S-\O^-[(=0];S.U
MEAH?4;A7/@,&+E)YV1B>YE+=N7VAJK/?PA.@]27AX/66R_UR-P.0O^W'!+VG
M(XP,;QBEO(*#!PN\LK:^]">TSX9=QOV0.$MY"@0\G>!B9KBK&G$W1-% *(W<
MT%75TI$:!?@+L!S+W8]O"\ET<&WU%D;V(T4)S_FNSU8C("S)(*HO6=\BD.G0
M.566%FJS#HV/H=^=>#69:PL'CZ4YLT,_)[H+5L2>TH(JZ0V:>)PB3+XE<ZJ8
M+Z\=>/Q^)Y2>L-^FW2^:I 6\8\D2+Z"P-=JFQM^L)R+-\+C[VW?'RG('!'$(
M_R@=T>U\-,Q7$:]1QS(^$9".2:6GRQFW,OU !>W*Y?]-?KHOV:<G0 OD^GY*
MJ=R<>THI-<+I)UN?M?24NXF5?$C>Y02\PZPE9[;^/1\$^'C'T>EBME^*STYT
M^)-O))=CT)^T>S$M^+F>I6MYZQ 8-92,FJ/>T,A%3Q.GC;K!\_X'>&VGX^VQ
MLYFVFAN T!L-D@:'0T8LUQ41QUZ,J6;*+1WAH:X\%%T:N4:\%NWQB-D(",QK
MDT%R/3.A3(:^%&\A,7^+,0^BV&7X4'" A15/B6%5;OF09DK+;88([[*/2'=E
M^4 &92\M=%&QDEI,#%<TP>Q:UL/H\0FU,",2")DY*(JBU3$X\M8G80/GONN/
M3 W26U793%M/4Q7HL')JE"CF!X4PD$9X=]_GO1&N0)'<@#4)7I.RG2QWV%#'
M"A-3EIOD?U:V:G4D8';[>9L[*>8JOZ76.]+L51*K-")"<IL.S*-^3!O./*?\
M%#O.$%^9EXS**/JR99G]7MR);$C\%T;>BOJARX-'+U=/$B;4/]^\ZZ-XT^&)
MWRH+:Z=Z(0.G_PBK*Z>?6+),JD+ST-5@VU8A ZLK0.-A_:/6_)Y%=R-%C#0[
M!#YLU_-IVJV=ZKK; &:B1 V4/3VZU0W[+5(CZT9=4M QTR*?KA5M)(/& IB(
M0M:\;,!3GV-K@3_31(@$74:U!?-Y(\'Q%I/#M4Y50IDVM-L#PY]]6^*'DM23
M'X-_ ?^3B4GV?YF8&RHL!X6&]%_V>[6V?BJQ#:V7[Q]1YKYH[1%T22K_6OZV
M?Q3?.%VOU3XT'9I <[$,).2[KMWG(+(,U[K- _$>">8LE,6L/:(&*18*Y48^
M"9[3"CV@F_;!&4-54YSAXM-*[^P5\E(5GNL7)5\>;"5)S%3^G(G@&K 52#)T
MVSZNL["DA%Z5;_[\'0W-H%":EJE.5'@!0"TAHE@\L_O^ MQ+W+>G91[C_.Q,
M[_DM#F"'6GS=2CQR'(=80JS\?4^(88(%79YG#D@B1(V'*A,117H&;29I*"!_
M/+U;\C;W5^CS,.EW>XC'RH]G=E_]5R\Y$K#\=9 VDK:B_/QZ]FX:RZF Y8/K
MJ@?<\FW!R7V3NPG5C%NN#0[J?(YFA8,>J2U)@S9\W_L4IT.G(RR%CG1J>K6W
MY+2W_$.SD]IL!!D'^1MD+4.2VFSOQ!]1]H'O#+W/7H5:CDO#4%2HA"XPW[S0
M&J"M@%SOQ"7XP35[R7?_N,M[BB6_4DQ_*?Q.>?LD]Q^-'$A;6CNZ_D^3<^@3
M_&NX^@_GX^&]!Y,>3S9'/H<$_J]BY)]"^-7_*>K_,/UK8?M?"YT!J=(:8BW^
MB^K,L@T7[/5'6*4/!:H8]]^H>)PA_'4K"T;^ G(";Y?>X^:6\A(.#KY3LEFT
MJ?I'^E<!;]FDIXQ%N::8;.=")R5Y.I:H5:?&Z/R&<@.VEB/GR6OM<4!V*$?R
M'+7X5BJ)J:/F:K17([VG+KW423WL($:5T]P8?>WZA%OUA=%_%R;,UMP3,^%C
M%+YBSM<B0>5@7/'>X(XSH]27\KFAF'VRE0/E#*5!^Z]J]+D'XH*\P,6EX&3[
MHM9"?8$/QM.R27K1,QW_I5R9PM3H7!1G2[BR$IB'KLZ&)3RY?%D3/*;W85LE
M"[_J!MP>%'7:4]BETJM3,%809A'1OQ@?L,A,'HFNUUGT]N<7P;TSV;T46@+\
M&\@3BH'>_3.\]WTBN[Q>Y%('%P:-N?$:0VNK'2?QJYN=K)$M2):K.3"E'I2:
M=W X:./P)+.PP2-Z)1%YCFA-;!WG$.<5-IUBJAVLV(TA3?Z2*>%<M+MVJ%/H
M37R!_$E'U'/6;]))&>:$W=4WX J%HS)CXGD&9+M3=^;?'W.)E1FB6[ -LCE3
MM:@H#G!9H#30A+N9QU?,Q;$K)66%:+^X7&-84-FUPH+*3O)A*FJ-P70+N!.R
M"IGY [*%UFLUF:!TDJ96-E45->Y0$'8V89Y<Q <I*CS$8U]8+; >QU$=5EYE
M&U)4V7'X?E9">8FE4=A=HI2Q$EOS%)OA]<09_1AZ-XE-1%0Z=H6#:,B#)?(M
MSAEBJ(IEILIL-+I?Q#X#[5]D_.&:5(T:Z5?^^D>K,Z:V1Y@<8GP07HF54P[:
MP78=9PW7%F?PU&=_T%9J:-PM>R2I6Z78DV.&FM'-K_V&R<EF?K]49T?TV,_4
M:HP]-YZM;1A0NNA&$X3K\C0IRU\3[)W)=GH.S8>P%]'RT4)K7)L;#^6OC5T>
M]9I'JC58&!D8J<4!80V:5/#<*$$B6/BC>.(.>L*.RPS1R.K/!G])\Q= ;_Q+
M9[OQSM#T0N?SXII7\Q^G%Y+*C_]+UJ+2_@2J=YC^O[PM;53"45+YD</W'O$T
MW4>K>?);9Y,5*N6-86)15FC,N[)Y8K,3]3A*0YT'V*!VM_;G![N_@.[G?P&3
MFM>/';M>+/RF&858^B";V\0$+FJ%(V)ND]!OF#W3NG]=I@GSXMF=V[&SR&P7
M<"EW97R/8X3*:'CO)_CR7]\KG_JDN?QB(J FGX+)>AC/T^EY1HLMXY'-XR&9
M3[10]-4R_^&>2T-IN-PV"+J_R-+GFF2U-\3,)%><\"UZ7!<-KMQMFT%FZG[]
M1:F6FY&IUJ7A)OSRMNM$)4P2R]F:KR[P!?0])WS5D"HQWS22?F\W+D\3?M=E
MEJH#B^655Z7L3V?,!*G!_MDB?V6[_R',+(P4*K9[,0IAI5^+AF]94[Q/4JE#
MB9/:MG*L_YHJ^>/PWR;#1EJ-#+550D-&'5_B\,SLT,*:B# 5;$%2;\G?(+Q\
M5/J;\*<3]MZLBAFUOX"#M8%]6GCR>>ZZ_OJD"D_;3SQ&J+YB@N6 -S\\!Y57
MIKLS\SR%!D4%AO!M<CS3O_K-5Q]XS\H[KU;/8+GC*];!.*KA NE%C>ER2%X(
MUS& O=7;9LO,K&9Y)=-88Y'O!(FBU(?JB9A!\CF0J-.X@H:+J'5CLF6BP_YK
MRU3)W^H<%G$-K)"!J,MLH PSDTU '&:EF2!8+Q61VGSKY<,W_] Q_TMG2T.Q
M2@HVJI!)US*?6OK_66)0T:J;M]A^$/\7\*4J8],'_+^4<B.I<!%YO8?;DG?V
M;CO0Q>XE6*M#!/XTQDPT] C-YNXQ^U(P,6W<8VD@IR+-*Z!D'VJQ-+*U1I[/
MTPP>9A-K&C7>FT 5DB_SADRL"9_F$4:JE!;T[43AW(Q<<AKM.*PY$(+YF+#Z
MXXWI5_:$K0[%89!^AEA@:EOP_V64]DG$D'1V:6KT$A[>[@T*U[(P!@L^K!_=
MXLWBWT@2GH<4:6*_ZBZ^BWK$<'G^D7O0X?SYT_1']'[S-=SJGW47(S27XE+0
MN>]6Y026;4&4A_]O!89*NH Y*)#K?2BE[ -*B\V.0(:Y_(, F3Q^7#)#3O:M
M8N^;A.85\GH480F>"1E5X14L3?/B9&4VT$\G;&<&:5#@B\N'DC_(:,[2[D^K
M&/5<FUPNH*KB\[%SX*J_ !7-P^"4I"[BN7US,V(76Z-7$S]9[-)75<1[V1(M
M+ &8JQ+.M^$4%KX)\%JAJ[I7MG)/L_L':JD*;B@"\%WI@<U(]7JMRHKJML<]
M06#^W'3)2$2EODI4_".4K<07^LMHX;^* 6OQS-*1KN40E]N!HO/=^^^X'CD^
MVTKM3%3<$+I^QQ3\RS9$-7#H[OVMM,*OVE6J?N.*TXX9'MN-7$^8X.Y.P=O_
MVK9%G":=C+S]WO?Y_[<PV'87=/[P]L=B1V :].[F/X0C),:5]W2.IT_E@F_9
M,*,T)[QP\\K^;(!V*&88!>M(Z39 ^1.A5H*>A4H&OQ7A]F*0HCJ-DHSPTDM;
MM/M^U!AYA\8.3"]Y0J)NDKVB1M^JXZ!.WR*)6N\U'B2=/6K>U@@9GAPUDD[>
M9 H[BWW8+.)%C5=<%>>%\-82\7%7SUO<4:2W=2O5P:>SS ^>KJ1)N!M*G,A>
M#=T-U_5[1P$D5>%SS-,]_!TQ0KF4-Q$USOS;YG)O-14X='?YY/?W*SX;I[^
MW9LM=U%/SDH"5"O_I\(R_>!:_;.V.M%;S_,XL8"JI&OQ?Y[K\5VWK;K#W#WC
MY\L!TTR'I8MTN3]-B[])<->ZA?LP@U9^\'KDQA1^X>$GA.K95UP'5KS$[=/[
M>DJ:6TQ1L>.53V<Z=C[?:Z%%M6NW!_L JED.U6GT%>D-IDO+GEC1Z*5\?/;;
M(Z"N)SNJD<J=BDKB5_[Q8(-V XT,CP,U(]_W1Q=#AA\/TI,<1GNU>PPE[(>
MGX$K?0RS3@;BGX'5B>"PI'*=T<X6HT7^-9G1L'+___U3_\>V87@OG>MH=7U$
M'X'WC22Q-',%B(U)1^&V4%4D>%SSI?SQ*2G'A$6F5!_="Z;Q,@^4 5-#DW.V
M+G30@A8UMVNY,['\O*&C4C:]K8'XR>0'.KX.O=11FQ:,NY-K+7ROA?I=9AOV
M!N.L?NL6:4OM)!I>Y/0YS>RH0\9K6FEES)\6LI#'Z^:_,$,2R"I\#4Y8PB$:
M+"3BXK[]Z\]^>L)13!!"?:CR[""_?*)\VHGT1H8+=O_ EM-H)E4HO0>LQ/?F
M\#*\BW^3M4.Q.5/%1#=N,0UWI"X5@;"FFA;JE]73;E;_#*8^,VQ<4_+)^)3&
M&:[C\R;I8?U0)U6K[T>&WQ7PL#_T?KEP_3U$;-9]P&7,PU'K6^@_S9W-EM%.
MWI.)K].-@&W13J=X7N@["VI$9<BP(R4//)WQ)I-RYS<<-1H'1D?DX2^A>6TI
M5O3G\Y:O5]8#&^ [64Z-15=4EG7<7EVXD@YA;^B@2M-+Z52AF]F"32#98FOI
M.VX*Y4=\%L#2+P9BAT-]K(!U:BD5/Y+-Z2_)AE;E%J65'M$?L-=&SE^'&+$'
MDKG*&0M[T12F(=2<5"><EZ/G;A>9#W[\<R9 ZEWE3TP,L,U,J3S04DGP0]/4
M_=M,$LZ)Z S\[GW#6).)&-:Z<,+<K-*<$2S&5.06HQ9!+$" $5])8/T7IOD#
M@:S1_RCJP__ XU9H('C8(R"1>D$&?!\6Q)J;,-1BUW$+NS\89" @,2UF%+__
M74=A.TGMM#^BQFA1Z+2_3)'<7\,YR&^9PLC[_:,;*6:1_FL/8L+:PG4?_/X/
M7-'C89/.;.*>>,43+S9K.?13BCON%KQ!;M_,"BS65X +:GKS+I&&64[VU4=G
M\\WML1RO<76%/%[I+NBSF- ?/[:#SG[]!8@]DJIPE:BN#BB:HTM1:E ^+_9;
M2UX37@%!N-B2U;4NU+Q<5SN8JH0V[#OR[=O:I)2KZ=OJ'JG5,O"5Z_7(-#3O
M- DT&)75:2!Q8JTYL"^XK&D?G=4Y_07-5U7"3\@,.?VU8\3^<:YB:R"#['Z'
MPD6U85]2D-X(IR6+GVZ_2M3I8/*SA+=+SS6"1C^P[+>"Z%XF9;Z@VN,:.&7M
M4 $]B?/\@^WOTS<MTL6.3(J\=OS$_%'JG/H+ZS4NE#:BOY>"B^(OH./?>YKQ
MY1;$.Y9+W-;R6I>#KSL$B2KUF]R3652$+\7]2]DUZ2^TRG7AQ89-2K&WV);^
M^8[XMCJXP>EBQJ"FP)+I9>*I,J=@XH,VTZTK_I_:CR4<_K]%WD4/3F';E4OY
MDJ?_3U_TO$<,>]5-&?!X;Y%K /$LX]/T =^3/QO/?@#_FX%B5PI;V#3V.Q^I
MNE3(N *"XR@UG[ICY5L@R>)"FS!C,)6!/-W\3$3MKS4"/FZFJ&G>+3^<MS&I
MJV53\+866WSU)%M=E8%-9_;"M =$#VFN^3 !WU/J)X2 +;V3"9Y'J\"U9JR4
MY)B9*QLZ6J-N&K?'$+)X:.__<*C.X\+NU:E\(S=_:!<65)\IBDRBM20J I(4
M@O=[* ?Y-&;?,$Y_24T)Q M/.P4WXD&'^*W 5!6J:7Z6999UEJ10V0GM##&_
M;ZR<OP=TG^23AT/_ FZ;_J^3[6=Y^M^2)%]=_;%'FD(D%)TXW  7XBFM>>M4
M&:5+CO6E8YW";"_GHW)L;*%S1)X$^>?G@>0Q1GPNP9GZ N8_1DP_B:8C4\J;
M*Y_&Z_ESZ)+T"+=NEF"NL_9?;TGE011:-I6UM6J2$MK><OV60G]G]Y[V_LKW
MB&RB.GX0:UF^3C7M9![$K9!#;@N<K][DDA\)-[)/NJC6&H0)WADL_Y[WF4OU
MV^()Z^FY=DNQDV&7D6$N\B6L7; !KYI,C7)U 27I<L+_33!<VZ_69)Z]O'OY
M(/0O0.!=R_\?X<_7W,F7=T\^!9OF.C>:BKT_UM/SRT'AZ#6<0')N% (.8UI[
M+&IZAV\4;XOG?;!+.$I@6@;J3_M@KU@^C#6!PEL@EA2F[O]FKBJ+V^1!6 'W
M9,F:5\W2/9PY@+T3=N>1*5*&JM7M&(O 5[M9%WJ?!7RB_&E\.OX8#)Y= 8W(
M6@P=134BT_I5L'-.2C0\67;<]9O#]8&5W<B"]Z,K0G C)"]9%H-D!3Q]05$!
M]CZ-A3E@PY'NL:DM(BV(,4YM%T"TX>>P7G_'6L>#*!.DJ>6^)D(=L[7\AXH*
M$A9YWZW)&AR%5212I(.]H/>&IF-E_M>(>YDO0E47;% SC,3GV;6#QG-CFG32
M+.]7P!+">GZ5E5CFH"SNA+/.;\^5#,Z,%VL7ZO(#I<Y%8PKGB/-2//($WXYD
M6>^PL6#AP58_(D^^ [<X77ZXEE[=FQF^,6 8B^T2M\V G_N_4'UE@H VZ2RB
MJ#':UN?[M=Z3)H7R"#D*K9YLI/5^O8(3&%W3?5Y5;U10+UBYFCBI&MR^Q'-_
MC]5KE1G1D#0'E7_7;.B89X+FZW)J?]1$4("G">/G!"HH^PE";:NY$I14( N=
MOI%-[H%@=]O:J>EB3%]'K2EB%QV$]S"A#2/8$3/79!/RJKUA$'1BA@9V=.SF
M"KR!P*_IT[9I.>/]0+@RG1JS9Q9#0KY:COP=[/FF1R=+3NB+WRU&_2@;!&;:
M^9*Z:HQ\F*DXJ]C\SC5_^4VJ#B;TO*!Y'IZT4^S3I7\_M+]L6/!!-VW?E"8^
M+(:)FDLCT:^8OFT,JBI$7(^\"..7#H Z- T2=SV\#Z"0H)_&"> !>RKCJPTE
M#OLW@\K $W;7P^<Z]GD++Y]/'+!:GDJ@V-T<_ ,6<?+++.$.U3EGMWXR_ 68
M+?U*ZAM\LB#_@._T'UY3TD9??-;][>AX)O[_NNNRNKQ_JFK@_"*I7HRX0X3>
M<-,@'23PVT];6S\7H6UMW[Q32"6<OBV-E\KU?:LA/5E5E\",4#+8;WB=<]=8
M*>@2ZL8XA$Z"OIYN5QL.-C3MI7:6E3T*AOL3B9TT:MYY]EK0O65AF)4[T )3
M"F8*"Y9S_//X[ /'#507I]=LJ<+78%:7#?):$ $V0\XO'ZA8L[0=)J)6[=<U
M6LVCW(DD$?(&X)@Y)/,&@DN\5:VL??.)I0,%#B_3"G%>NRKYM:-A-%>C,HBI
M]"FX<($X#T0 E8O,;5X15;S@MF;C/GY_<L3L,^<<''PB=HA'@V3TD"RSVD_N
M(YN?97I9E/..[]756S9Y=U ?1"S/8V[:.&%8&+%5GF%5J?<RB\N]I0C.L W2
M;\7L065N[C[2.1XDEJ)='V\(A4&A)E,HE%J'SCWC[4+5>>Z J!Y3:_OA50L,
MS!(,X^*JBX8''C$PW?=D&X)QUT32@0W0/5C2$YZ9N=8\<">& *:1AVAHR%2>
M$!R?\>&V5N:JYK U. BHM"8HDRE3P47\?=']J\\F/E4J&Q.!,,6;UIH'Q@YK
M#08@Y2G6:UW(RA\VQSJQY&?.)8IF=<'06UY6RQW8'K/;O;W2'D4^E66=QJ":
M)'YY][6O!RAYSF%6O[)/<]^K8 =SY,70,'5 >:!4D?-RJM=/YCG9U> R+P6F
MMAL=*P,::(L"RRE<I8449>5Z1)S<H^/JE3#OCB-QN>39>CI-NP: M=.$6](,
MY>R7U.17(6X/O?/[ ^)D[I@<PR"?)@R],%,*IN^,A59BLSS*OJW5-S*G**S"
M[="*U4_'/7VVU2'0X9Z0JET=ML_I5)A[V4J]]CN0J@5N37A L<_L]0J[!,E3
M#_?8I4YE=1""U)FC[\U4B7WO>)[A;.,"IS>-&@R?(4<"5L!GKD0V]T "?GAM
ME75:BT$-9GM6&'-FR@>2S!&9JT/4<(^K<5;MEMQ/+XC(HS;9^1N9[1U5_7BQ
M@M">,7ZSTW'.,=:: 5V#O&X)KSV2,_5T3E!_B3\*_YH]ZM(3)P3"'WT\S048
MT@JXMZ69G@ZF[,T'"43O"=0&,2NA0@7?-"J^P28/?38_)GUZN\@3$)%5G>+.
M:+10:M!5MEXX*Q]X/'*X7KU41FS4L^3%*9AB@U ,:(/N55E% @ED0FL3N9NM
M%_B-3J'I9[X*B.Y)?7?<^UQ3[7O_2/&PX4M,.[[ZG?-S9^L;]#9H?NIY$"0T
M$ZK6#N'5^?Z(XJ@[I:V'>#LKEXY36)#H-.^@,GWXEFD>Y@XA18ZGS@^2G6UY
M1Z5#99XSOZ2*">5M+5HV\_:%-)=; O"TVFH$@)&(QN",#WENT^3R^$(/#!:D
M?-V?$4UCI&<&S,^0$H52<&>J_>FJ_47'C!>OB2UVUP/9D$9#^5-U1D=5[NY.
M=1OFO#=!S1VOTI67EXWK7AWGQY&2A'@V;W7H:!B]-)Z<-S$6VS8URIE6^.*3
M']O33/2=0S="1&!K_A!31*-0A\;JO23%BZS>M)>OV%I%+,/&7<'/?5K$*G]5
MT9N<A=@=,S(6.//Q*WJO;TT)WWU65D\,'A(CT6:.AW&I,$W0PW08@S\H3-%O
M?'7!US<:"\SK-[(VHXRJ<%3J0@6>8B#Z+4J4"11(8:2;(TFLC677=!<Q0L5K
M:*BC4NJ,2&>\!=9OYNB<GIX\T<EO&! K"\_+MH9QVMU<P-7VK\R4M4/5J$Q*
M#6E=@^<XWN3N7O\V\#MQFK>D40O)^'8P"_MA/IA9E)4L2 6+SFAC@.@<O?>)
M1)9>.$T%@R-#T;L^QG,S'6V.=/;[JB<R"1\;^&9C0G2.9%_N3V6I$YR7(_F]
MCNFKYJ1G*@QV$L-%#N@_L=U8TN]G*[^?;=^L*2OV:\LU-GI>>:K+5]A\B&.^
MQ,B5<!F<5S=CDH-/GW6'X2NQLE@BZZ>*E&4'LVR1*GO%A]N/M,575=^Q$!3.
M$S36'&F$G03RG!56H+ $'@YC]^2GPKZ*DP7C!V<7R/FV'&"<=(7[Y5S;D*U.
M@&:]$;4745L%.,#V].>;W+#.BAX*-E?A2O>MHY183Z!9#%,E78&Z.]4RIU::
M-UO3^:*OO-=1N\2< @<Z >GYMMCY&Q*'WW[3;@\&9.%42)R<7GPPM#;K'8]Y
M)EWC)697^DP6A?G#BV5D1)&*-=NJ/*#<'WO)[QKD4"]?6FHL(M:#5Q@G+5HY
M1N$JQS[6DPZ5DHBSUCV1V$"\DWA+*#9Q\9Z7;/.V"'@9K6\R3IJ.;@E+-^*C
M@BIDNHB5C3T,J?_\0;-&K/<GR=EV&H8O:G=WD*=BIQBMWFNP!5& 4I&/2_>^
MK0^3,3*$&R)6S%; ^D]A8_;M5>[Y LL'8&FH*8S3W3S;\;FQ..9-5@(7;=D(
M9Q7/YA&S@G]!/.E;KFV7-)F:!CG"6Q,Q7WM6@[$V<!N81 B&XJ"6!M1Z6*14
M,>4PSX;-BYD<"CSNM5><])G8?QNPPMF]UI?G4_:#W?5IJN*214O?Q;J_3U \
M3"L]^EBK.M_4Y^K"";&3JHB9A=?SE')IV?%82@/C1\V]P)6^J9IM FIA,\_N
MW<YOYA"3AYW=:#$GN'A]/J=@0;8MVS/*D+/1:R5BJ,CIM=,)1!!L>D!A2CI@
M4W1A=]R(O:5#X\TI8DCGH6F)"R85XP*I#Y,]@DG5RL[)=B%[P<-5ZV0R*&:9
M!+L89E>[/?*X!W[3$Q4SNM]#7NTC1,:5/]T+QBQG=IA;,.4'"=V03R>*>>QS
M)X#A1GG [6;8R_'),X?VQJ2H2O)-D6%:;"6R'J5=KOP!TN@K3?04K1:Q%E'7
M<Z[66]HRTLNJ?^-550LZS$OD'*]MAZSU/7.88:'O9/PT"2U= GWLUVC,)^D=
M_H8T1?=(3R6BC>57<]VM)>G+W+6'S*3(C_ J_QC)ET=&N\>08UO*J[#<NX,2
M6[D5%+]N%JN$CC'TFB<E[['!&YM2RT3E?TAVK.0O]X[/+6$RFV*J]!9KDE=Y
ME Y,KZQ]G$36]29J^Z?T9&X(K^H+E7QQK! 1!W'^#!5^V-H^.2!=I@]68[,6
MHK9G)!%+Z6!9!$VXD?0M1P$F[^&\8Y=MF'COX&57-+UCM%I$J'7X&W(S7IE_
M3.Y<N\:I_P78J<]ZKW#N_*,[OCFZE6E?+I_\\]AC!6^;9.[*1Y R:KHX)HI(
MOS&_KIB:!4.IJ'+R'6AK[ FE8FIO0Z,[,25-SE<%D:'><"BK7\6-G W%P<FL
M)IG)I'MES,&&,]<OE1+WKUN9'F,J2>0@=O!*)][E#U=#AA]#*B96T"M]#)_/
M16XT='^EE7K@9_>S9GUM/ $['UE3S6 P*TP3!O-MDK<C3"* T^E%7^\]E)"%
M;E<%O&/"F&)\'CNMBX@1&CWL[85@6N-X/4: +9!3-W8T,TQI95MB?SUG+D)]
MZ^D2G%9\ J2L,F H"E/A%Y.'*+VR45^@=%JE^=,<</XLN1\E<Y/Z':<+&W]W
MI(>,L(G\._E2C0)/BEGVO7D#1MJI<TX^H0UC+CMFVCOIH/+R46D)>R!O6:,3
M^?CR^)(W/FQ\?*ZRM!2B[LSE14Z6:+%[7QM]X4!$M(ZO&W51K/*(H:5O4O&P
M(9[6W0THZ^]47:IM6ST).A%Y4;?=9?-VV:.6TOE6'"2;L$TC#,//^)/_*J>&
MA3HY/EZ:XJ[1^7K\'N*JEGZLRIXLMU_E)H_&K'.)%L-3P?WEWJ@?94HZ1QS7
MW(6M.T+W<KR9@(4"WH7&GFI0V5@W8$E!4NSG3VS<&L<NWD8O+M^]3,#*EFX;
M$IGFP3?:Z5J7#ZXKTUF@S7HD+R==NST14MES;0,B='VSSWXE8L[KO>>(O$HH
M9,PT1,'8#_\OQ!1'MUY:EC7\:,PN.J>8WQ/K1"YYY+W/[K>T0]VQ/J_$0BSO
MY_C>#+O3<QLC$33@CK+RB);@RX]SP_XF&K3+Z\,/"Q)D#\5!Y%NT"8BZIZ%"
MA_3OEH-]LE,8D2OLWM7&VE;< W(88X7LF5UY/ORVM#L+7-#FW">1P=CRZI%8
MV8*U6.97U4#4-GZRLAE9L.('@6 RZ2JQ==<I5"E+ =62EH_3.,>.UAL'Q^&B
M+PRJ:,3O]-/4H 82U7P98+L.+E1R2Y:-^JSU9H/2<XSKIEJSSO$WGJ<2+O*:
M:K8L!,_'\.$FDQL3MC9?WZ/18K$$';R72/8^_((V^>9;<^]N(>7&NEA(#K,=
MF\\_ G'<]J9^LFZ@S/NEL(>)A5=KM@>[E_2/#7.DP2Q5GT<SY<6\KI%A'MIU
MV=I!6/HLX.I+6%Z$/$1'8-S6WWW01 VU"LT-",BI%'TE[?PVZ7:GQ@ ^FM*G
MTT.;3/8$^Q3C48OJP>%J[6^\>$\%+3,682;X,(%F;DKOR,I0I#Y0JJGA;0M[
M@=>B2W)?BO/*YQSBR,K?O?:\+K9']Y[,0@S1?"G!; $6J*=O*V5BBPUP/&)B
M%:P:VH>@^H??.D6\JR'2X:[%P0C5@8G&<.<%#0RV&3FN-MCQSEQ/3[\R#>L(
M'NO4#3Y,/1#&G1VC@_9K:$)+A827L[-@Z<1-2,$)?113!G]76#$TZV6>*[.K
M[*UC2 :B,\^>;/+0"NI&C&->@*M3WBI. .@2)0[YKZZ@6=)USE5YFT9&%ML*
MA4HWZ=DL$5TH@0V>BJ0RT.CNHYF1$O3IO)BWDAP8HX_#,/7-",-8491+8C1(
M^*@&=8Q\#8RD7X5_UL5^;K&,()" F\82\U]_I:HFFNG)955R!X0D!E9/#][4
M$,*)@9V1HD#]-''XXTAXJN'B*Y"@O1$L[W/M;*MF9IY[8$>%W,8(=TA;-R:[
M.*00U?-;T<M]CY5*S1MV0$7. ^79!.:YQE&5Q)*D#'G]4*LK%3N6ZJV4N&4#
M(WAJBX#-!JM0#'SE8H0N]!\W&Q[/ 5-5RUVVD;^ _9%Z$_<<X0BY!X5!AF.<
ML/1;P=[DEEX6Z0#]-4[K(ZPAYR06^39D]_(NO8XWP:<#5MT)[6AU%JYP8FX^
M3[R4,X]6DA,N9?>3CQ)B 9XE='!O<)Z+>F26+F(Z5MW@HTH4A4+.(_0_4&T*
MAP"_JO?X6K[ 7'8P]<?G7>X#$1?A>O^S+$6%"],M'+;,PQA5E55QPW'MP:91
M.'O3ET:,R(5,+1?AB4ZIZO.]VB@CMQKP8%OZ2L0.V[:W6((]*DHXHV\T(#,G
MJ(02?DNZ5]C?(#JY=NX&-L@"]A:PUDP$"#"WKLNB%\84\ *,KS4^%65*_DI<
M#)S-"#1+G,05C?OD-MZZ8R)U ;\BW(KO9_'N#P>MW[Y[FECRYC-'F%=I;[J:
M$1D]Q1>ZK?#=QUV'2<2-:<D,%<$<!#X=/4+EG)T9&Y4.4P/< MR(\M>Z',2G
MZ^#[\R+QC40:5"FE<NDD]R_K4GV^T59V= ,1IM$"2K_%K)>L\9"-44 L@]_*
MFO&.CBC_'=H(_JH 8 )-62>G,[4_A3N(%.4,B?&1;G58UI[.I;.\HRHJ(^,"
M_- A1>(4+E77M,;N\2,<V^5^$ /JF9NL,\37,TB;H02QFZ3](!C^R?BZ$"?T
MR0*F0D7\20Z[!8OR_*2Q@O60@>3*E\%:_;[F7$*Z4^V%K^+W:_XZP"8#K-[P
MTEMWB-Y!#=YLM'/"3KF9>A&N^Q=P:_$W273VB>J!Z2=";CQ?$:%!X(-/LR0_
MP4,OUG;*[6RM#&>[)\=K($CH0.T-Q\DHC\P,2>./P)WL+AF3U-39(#'XHUUZ
M9SY)T!$L4RU1]B3DPNG /?^A!1VXVATZV-XHL@I$MG-GWR$=&\&!ZNQ@Y2TV
M<693 ?,]U;:RSSJ-.SOI5TMY)42HVLA+"\@'75=+'SYN,3;<_=RV6>L[M>Y3
MJE#-G"#L+<XDIU)@KX:@0Q4J_1>C*/U/C&)]OOR)>K'5=BC6.&ZE.%1P8WAW
M9N[TK;W6+.]4Q9 (I!R4QR*I0!2"\/)LPB@%4-)YT+^ G\QY;$=+)H^D"BA^
M*[HP!Y/FA9J)8K!]M6RRY>WV)"X#2F(=BBAR*FX2%>L3(35^YKYGG,C-DJO@
M?]&'4PCL'Z+==N.X(P?+\*28<B? G4S]*,JQWYQ.<\>F+PM,97(6'(Q(>L()
M91*<\L"4<@UF%1<S)ZKJL8>F_)439]F9I.S5WG0\)*<H@&#R9&['GX%PF<;=
M=7;%A@T"W6=;E&3?M&4"5"B,U8J%H\5>IHVUZ<)CV*]RC[HII"S[0R9FBQ,&
MA;& <IABLB1),>B9UVJ@D*R)I7 +A^</5^NKQH2$;,K@"A-I+RP3J+RO23F\
M;X&8NT3A@4;S'*\R?$TLX5##PEU90MNMCO::!YW.8&]Z76W[F0; Q,YK@:]B
M_PUI547HO4"QZKI)G+Y2J(W-5%O'42T\%>@TX096![+&9W?5&QAFO&]*N&!"
M]9P5>CI9.*1<&IOR)#S7-]X+A;1ON\4@)CLC%^YQ[15-WGN<WVL_B#;8GH=6
M(VND]Z7X$VAZEZ78KAQU"8V)BJ)#*Y*M;6(2C7DW.3WI7DA68)EMU#\F_@7L
M6'UO,5 YV$M!IVF?M/=TASCLPECJ+/RP0(R4N'OM !\1A-,3RB1%#_*B_P+$
MKG5X7X__=AZ7.3?:OPLI+S_7E2=0.>&:HPJLH:A)?+2;E)0T;>/F]ND'UN ?
MU4Q.E['F1A_V4\><_%(WB3KJ/"L&96Q5UMG&=A.U,_Y"'-PR_3KE:@+N&83<
ME"[GGO8IW$<37P22"A5?,+I03K2$C&8Q4BB4?]^*"1[^35+;81BJ'._2E++;
MCIJ)26_+)("A/$0H,H.:G)22)T9 C.5Q_2E80^=ZNE/R.>^>M\!4Z1UO)+A#
MK_G7EAH49;1R6\(>=8X7K=U+9]Q*9(3-B,/&N$ )2[1#+1H?QP\&\.6(HGR7
M]U3]9"[6 * =%3[.KGC^2VJ.D(P%2YU0#J1L$ <:G42P)5'F)A[WG4X_>VNI
MZ3.%YRKGN&Z3J/ P.E9OUH-M@GG#/&\(.\FJ:WB["[C[G)3*8]=NU?@7%H@X
M$ CUC)DSC%$87R,J &)R\BAQ^\_!$Q8(7HYH]37^B[9(0E,83?5-%XVYHL)C
M!4I^\CT?-@.!>S'M.K8C+[[_6O.K6G];SVQ0.:9NJ(C2:2Y+U.)64G"DUGY?
M?(N;F]7]A+;[+X!=UZG/:$W.><[SKMM\9>7H*+'" 2\WI5NN$)."I5Q?:R5.
ME7L<HM:2\9*U@Z!)FP*ZV)^N-3HGN_AC,&UG+T(^74"-JD:/46 9(+=*0[;.
M'2K=)\B(@S_-5^$%4QT(Q-W9:!1<2#F,_!'V2B??^(9!:$@:I)TL-I"<YA*>
M+6U]L#[2[#+G$Y>.#JCTAKT\S(1A<&9(O7NYH]^>B[86-Z83!0+%NA3%Y9MD
M12'RXW9D$(9_W^5_-XZ:#&G@WUM@*H?='PM&ZK[GM!=WF9SYNGA<"AAL_Z3V
MFW6W?*9 OF8&PT>W.C%M8W[ 4*@"?_LG(C46UG;DC9THQ=O26QHKP3<M3&)N
M4\I0:-%3:X1+?V7MK O6=+;]&?AK[.E2TT/$0\I,)W*7O*II@2(:(2^A)0YH
M?TD?%_]KC'[+"R&XNK=<;G-Z*135HIRP=2<H&*:C(80$@BK"IS=^?0Y_#]V4
MJE/XR,C[VD<(F:;WU'9Y?/Z!5]XR=V:Q.YX(J9Q(GEUX4)3N(D>FJ@>S]+(3
MRF"/K0=OI^Q<//Z)?=]7HE)%OD2@%:K1" NG^7+U]/_(SM&#3-NA1/.JM9O%
MY T='#W+/U[&3ZRZQ*-W9?&C]K&H<DUW0W.M#:)":S6G45M-L=#8F<4*1KP<
M!X<;3AZ3T2ATD%LA5[Z*=4]6LT>UHF!C"D[*2 IQ&W$]) MV]]GW_D?@@-1-
MWQN./O81L]GO@W%*9W:I4HF.F<))X[P&0=C*BFF4E_1NSS69T/I\+:_(?8*D
M=$?_&<C5:0Q;@=QH^Z[\4>3;IIE/H77Y$$*C-VN*X_O*B.[GQ=L;H^?Q%S6$
M:IJ8) F9O@$SM>WM76QGK!KPOJ4XZYK5+T,G3VWAR5,?(KA"ZC539?W'%,;/
M:1+N-Z.N:D."7XW]H[Q59PC+H+)R!80E9&+D#=7'R\!^5'WS[0\)A-"7MB'"
M.Z(_P:=O/A/61)-$O5'6SN'^871$F,S6H!&U<(">8G*W+O/7%R(!@3\-"M*^
M.\&8-'3N+F#-Q*^GCT8>"SC8+("5>*W<365]Q_Z</,Q7$5'<::B8&+NY$FVB
ME[?5)Y]24XA6E@]8<^%+N2H2JF%&X(6L"'$4P'$)O'-8020L,62-,TD-N7>L
MF]4);UM@6WYN.R1E.( ]'RIR\VYYS+]QZ9'<T93Z_&VKQTI0S\!9NFF[/S4@
MG=/]=:68S+Q2?/)3R<:Z;$\;IBTS0FTU(]RG42OACIXYS.\2Q>1EX;(TQ!^E
MU:C\N(FRP?0;>NW@Z5(QK4VG7Z>NJ/:HL\\9L^**ZT=HSJF&<5!+8"#W7T!+
M.L9I.;/VP^..HAQFD!"$J)JLA[1@D2QR H12)N+T07_:2J?XH#*A%C>Y:Y!Q
M=>Y';,X[8-BUUA9-?Z:?8&6>T#@:*+^4Y3_A<<]4Q'ZKC:#2]I(%5 DP68_U
MR$],;HX6<9'GF-#.D<MARF-9\W4SYH>0]VTJ5DE^R4L .)\:3W%\_7'_--%Q
MIL,QVP22>(':?2,.$J2GJ-68_.>%R6.<_;%=5C<\92R(O.Z#^MD6^JWI1=-Z
MM#$IGH D[X/46P9FZP$%&I )ZT\F'7&#GQ6V+-K\0RS:5E>(R_-^=J9#B?ZG
MALK^_1D2>(K'K"::O?>%)@.05\M55[CVUHOF&J*]L-(](,^6EPR,*3-3D#EO
MV!&K>I +TTK'DN ZWLOQMI&7D:%0Y)OSJ:4 ,BJH=6ORZU6)5NL]!)B2O.:0
M)1>UX4])^%B<(\X@(S2P=TOTYUR:U;LAH-C<M]?<;5 )A:QADD\RR:(87JV"
M-*WO6P:MI8(1#2>WAOCL&]K3;ZR[PI(A[E0@!+8 0(J^<@R>H[]]21"+/2W6
M_G(E"Q:\)+X@;_[U0SR[B1(Y1XL4%'3VM)EV#F7,U,J4C[1SDF)$X%HS6H57
M)FLV(MB#&KWESA-1I*8X4BU@?# ,<]N4BH6S\8>OSO6L(7AN;&@)GZFK]\<G
MZ::YM>R%.K!#&RW38O*M(O+U7T!7?9'4@5N")3R'&VK,T1W\@:XC;TIMLZB2
MZNVZ2?%=)J.NO.,;EJ2F*R8"CS\[R<@HU#TAON*T\)D6LQ"_IXL96A$0)!7M
MU'K!K;!(IH5EJR(WI]I..$H23W*HB"JS96$],WX'H/1V\\/9*A3@7V<&(PQ?
M;N]T<'K)X_E,;8.OON^2SDK<Z&N2Z,JJ'SED@!\(2DU%53=,C&O:<V%Z-#))
M$WM\('SV/" !IRQ0WLRIO'LNVN?3MKB=L;&A.QJ[XI[/&%+ZI997]*F=P#Y*
M.B+V1:B(!N)#@Y$S[M%.ZUH"]-MP0!^'*^]Z879TD3I3F19)/S$&P2LNI56=
M$A/4N*D<,'!W\6<.'M-AS(=:&'--KWPX*>A2UUO<KEM7;E.]4V+.CYW4\*QE
M2IS:,&NY2IU_A1432U%;[W>DXW?7L>?SHV'<P8ZJS;T,6*R3K 4)V=!M?XL,
M5C,TE:A6O9$;)H3H;SJ%162\>" 8SSF</_$J5J?KT4XS2>]QD&_.1/G8!U=:
M(?\AQ<(F[WR_SPLY+)::_;;R5H90EHN&_3J4K0[CP"7SY[@Y/'%<=LL?+(UY
MIM=?YM1"6OF.+BH#78CVY0[YP;[/4J\H9,(3V23W=* F@52T\ ]U=T6D[I\;
M5ELJ8D+WI/.]7O0J[Q\N2DW1U4KG(AJN0B^'V.7M'.KLTEYM)>/XUS%/8$\0
M[3HO+OP'V\R#H(IR!_D->$NJKP=2O'[3$7JLK?[.'6Z%I5$%LE^UU;@W;5D@
M;UY1=V^G^IN_F)BJ>>]QWA$2CQ8ZQX*%\JTU=[;H)NTMO/06PHWR%_ZT.44S
M/7K5XCU@:&#FYZ66X<6(4[RMU2AC4POS[[KVZ"P1?AVX=?:>3;=01H;'QJ*2
M*,>#08:SPH R7ITQ'272Q#IW3ZT<!%9^FDI#.]ZW]/8MMG_1FV76#$]^3_7[
MF>#1KN8,5T#A._JXSH%';')*22_V/?(2[:?O9SL@Y3&SC/W3E*O&0A;9]/0@
M#._:8N@<88Z>,79&4GX VD*+[IQWKP211]U8R"NP[\4( WB>\C>M FY:/>.4
M'%[!N2%!')_94\[S2F+94#56Y/>]J^P%5\]61/N^^[<YGV1RYG:8X0;SQ@\\
MYNS'0QA+V[*D_3)4102WDT>-(,+#VZY.+;(*DMTI[61^%BBMH3(S0TK9GY?=
M[NBP ,+9Y]1VF9Y=D2B0M5,\$K_+=+^?FFRG5CP*Y%^9%#YLKX8C$W/]%GXH
MN?3)ZL-/\8Q;$.M(*^6;0Q$^:S.&ESBYQ8P.[?>;WB*P)^;FS1NJYG>^QB/G
M%6I\&G5\RP9!Y,PE!486B=I=R(2:,Q*O739@6]B"RSJ?.5TEBJ?+B@0"\0^P
MH%10(PTLG(S*3'8,J.L^4% SMI"\[]=,"\M_S, S:>XGN%&??V_RR4?"URQN
M0C9C8W7![CD[MLZP1@/87ZRA#LR;=ZFIYO!2FY=48[%JN>]/4\&OQG)C[B\
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MPR!QL$Y5ZJ2JI% J_80&)@EKS8RYY")Y;G50XEN"2H: UR#;*%O52TR9BA?
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M9KZHE,1OUO)*2_M^>;1H.]Y%S4[=D6 [HB"=1N>G"3&81U_;JZ[\H__S_5M
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MV2QD,@0D#/$PGYR$V[<+R$R%O3L[@G1.15IC#CSV/0QH'T>$S7$^-5S_*6W
M5C018H9;:_6G."5L--(6M% *JL.%S$,0SK840AH5',L\ATR)V'>+"Z0QK:.Y
MQ..MNXZLE4\O3A;R&(9'I"(OXA8YLZ:&0WWPO@G+2.)Q=*-PS6A_PT]03K?R
M:D+$)Z<1!HAZ[+.W@>6Z9HZ6(ZLIAW6IG6?XR^B+UU?Y%]V9X#.KUK,(P43[
M9Z;WJWXC3DD&_U(]6/!(.8[+.4RFK<XKZB$DP!3SHW#IE"]A&*ADH;,IA:T^
MN[@3P1?I1A4/E;9L,$D;I=J]UT^Q%<%IO'Y=PD6L*Y-]FGZU]R,(Z8]GBI]:
M$=V%P\/REKN':&X!=Z?^9A\HLR,4.S9R14K7K+N6'5YEEYK5B!K7]A83RZNK
MJBVG/MMBNVP;%>9A9T@_G-KL/.5+^0W+MV8,CF=H'4D:B4Z6?!G9UP"%8H2!
M+NCY6X"\4;Z>WI*NJ0IUS3P>6X2+V@ +N(APK[G(4X.$P00]VWUID%Q#0<&&
M@!:L-4J-@?1%^6?&S,\ZV24L/=:*7>JQ 0ILRS6[49>?M=7, \3>">W'* -@
M=U]_[^-=A4P/0I!^.FP<Y,N\6G;_(,;$>R K\P 12,I'\N, 5.AWOU8CHHE:
M@D@OLS=*=DOQ-#-&L_\J]Z#S+YTD&2(;M$)[J#?)X:NY0?55\#,>+2> VE3?
MT#07:D<I1WKGS+K3 >N)0^"R-]6TVNW:Q; %I0[ T;UYZ<PUW3Y#X3EE-1M=
MMJ O-L^L-K!:MX!IJ7>?ZIL35QN\*Q5@#U7#7U+,I5%9'%Z_*#\#D+S>=/QY
M<#"_Z$.VP?%X[190J*M&UK#ZZ;Q"1OZ#VX?E;S\71BP/J*Y)N]1N >_J?GKC
MC2X)/LC7I74O\OQE",J\Z;&<WMO74;XJLZ5_J".+>G-@]/VE &B8QH_;.SJ3
M=(?XU9^X )[A?_9&*0,]GFTS#.&1:W.*+.?4^:C8/@6?PR%$6HV9LJ\XW@F@
MX--VYV/<+U<%GS$*%GW>]AM4=$)-VN7X'M P9+5WAAD,9M*;E2$5"3Q/9]M)
M(50](3;GZO@LR-GE@?D6;KF0^.$B')_ @O-O7Q'TR[TGYMYEPC>AK9XXFK Y
MT,X@0_[Q!8]OQ\Q1<BJ8 $F4F2CPOJ/UJ(LO#><5"$5#.N,FLUU-+,#) T4%
MLZR8Q!_#C%ZRKUZVR,<K.67M5SKB5VD@^N'M#TAJO\>LEJ"KLSI"%,:\EUK/
M_UA\/; 3@R"1I6,>HE&IP&941!'L+O.EHVKN076@R>L[31R]RDEZ=W2(^.<S
MV/3W[/YCV5M[?P.N0-EM[OL/UDV0"W=B^HSRTW7"WCHC=WPRVDEES.^NK!,V
MM548%](R=7;/9)2HX3L=3XWB_&'X_@G\4$C3VA)B2QKJ] KC) >T2=-).'S.
M/TW?U+%L0*M0D4M,J98A5D!C=[5_L1O;<F/J]HBO@JH9IT65,3%&&Q^SG/F-
M>HRT)X%E(AF;317Y&6CTK/.^WJ?7^D;2G7@11_N!MM;'571+@_CMDYHE4G\4
M%[)CN3@^J$U5PP!\H EXRXA]U),P?.^[Z9#),.,I";2O1O0D"$Q[("6DC9 S
M#Q-^ ]\92UUOGQ5:WPO26R![R%@D=0/_?B,C_(=]X^+[ZDD?QQ7;SO;V^HVY
M:-0L$P1"6TY+ RI;3ZT]7IRTD17=B7%JGSR^UY2KK69FUUBR^+J.HF:@\:)J
M9=QJW^ SK7<%]!V&[XG[B+Z'B9:?ODD+G*4H8)?=MYD-]9%S6D6*0 OQ.5S'
MDS"&M9F.#2^]+E.KW (>"]V0S$3ZN]#PM9(R9YN6F1\LT$Z6P[\D,Q/SJCI4
M558L<_IG?E,Q-;A#P[!X5= %\>49-50'@=.6^NTQ1S,-^Q[S,#':EJT<S' K
M!6C;4 Z<S,_[F_EN$1<\BLGWJEHQ0>SFU]MO=*$%S]AI**FJEAILS>?4@PO-
MS7=T?).GLLX=NKQ\GU5JFMEMG.<BG:&$0IX"L%_(D'P/E/:84+Y31K&IN,_*
M:"L?L>:;AC4_+4G[_@9>>_3SJ>0-8QR"KW3$OJ7/182:H!%- +?NB^MS+-6)
M"#U: %>V7D!O7!"ZB%R^/*ABN+_?9%.KV(IJ^AK(6:3A20,.U3PTM*DXY'MW
M(66@")SNEO6YE?B0I#YL9NF%95,NV"80K;CDJ@NIC'<K9,1!4:(R*_'Q+GWM
MBFK/?$[LU*Z+=FF)^[(DN+\L&/^C)Z]IW<+(;D)RS[R'/=;]XIBT 0]J'."?
M@,G&T[^*2Y?><OJ?2*^6^! 2?S;%'H1\+.=B[!!W!+[]\9 P*EW-0_?3CE8I
M87ER(-BBF9PZ<;RW0"[TTR/%[P3<FR&JSZE:1V3*@K0C;^:+MT6NV&X!7Q=^
M2W\@DCT6N=:V[-6^(OF@OW"<?@NX9SGW^[_/YN4:_JX=OM0WQ4^]ZM2,P]\8
M?)10_" Q]H\0PLLN]USM_">)KO:._JREWY![G@8Z<]'EBSJE(Z&;VC%G_QCI
M0*<_-W)H$M1!G6,Q],Q[Z'C.Z>Y8G+DFU^!(QTX M#VBG2^?K44DT>*E.K!-
MHK 3^30F/:]5Q"OOR@'W;:.& ];=32.6$2K_;\]Y,5 A/<ZZB6 8'_C1JP3,
M7S>AWW_5KKG<YV:^_[1#NZ5BJ-&6S'IA(%<07,APE@:KIDRII5WAV5;W:JC9
MP8YYQ7?/D P/N"W^H4*R)?R>E$?XDPNBX@V,%^QQ3H[D&!=F,IE,/BZ55[3G
M?^O79*/MWQ=9%WXM#J]WXHD JLE7 ]E\R$I-K#/[(L5#0K_RE?"R^C2$;6G?
M+VD0J#38]B(3W _\I;OM1_RTIH'>[U#KN3:C;._$K_ QU1OW[F56U;L1E8,S
M1#6$<>O@.E+VPK>_=M$AP&PP=*'*YANK!:^OLDF\V\T2-;@9PP++%(NR,6?K
M ,MK9;05Q14*,HJ,/3=N]19/&O8!'[2D]B= :[#;\GNNM3P@A^JTM!]!S.I\
M 25AI*4K:Q-#RXT:*%4$?!<D?Y(#5?>D#R5R4LLE<#_$@YDCX25)'";4"K\N
M'^_;B]X5&1A EW<"T1$.=NUWP2FI:\2E2R*9('SF:TH1[UL )_(6</[0,F?5
MO-+PSCN+;0BRJ+ .WQEOJBXNGQ4_B=U9!8E+BK=N)O2:QU'+NR0"?R.)],C-
M3,F+TN=4$*:ERZ("7G5Z9J/NERNX)9]CTY?TA*#"]$.2<!<7\=^MNQ/J2/%
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MZ(??_YQ2]P_'O+> RDS_B$5)T,*F*RY,)F2B 3N1Z1\VL4'WA2607Q8T[32
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M9YN!6AA7Y]C$NZ1V;IZPJA ^U$1]5LT9!OXC0)?\8!K*US-#%\S745[39U4
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MM86P2YU4GI 6*1UAA@GV871+B+I)B&E23D4]?"IP$<[FKO.@[^[Y98D&7V.
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M@>ATL6D:G:E2HV)+S3I25VM\<.N@JZ #$%I86 _31\TQ;9A';90:+*YQ/U4
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M#SX&(>1._" #,E[(7V$00\UN931R@J;6Y)3I2W;2]8327$3T!6WZN>NS<!O
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M>Y,3(S=7&+ [4'.5'/,\TA6RS<RS0*:2GI%591>)*%(A1<WJITD%@=JKQ4,
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M1YJSWU3PI[)4+\D)VCAJEQ3'H'R:[JH87V;G^]XEK:/R'6T2QY"CP(;YTU2
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M^>ET\^][?6?L=4=<_>P;KC:P2S)M^Q!JDRNUW$=1J&9&SU)1P^+*R73 7LS
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M8&^=683Z"-GIK649ZRBFR?$:U/T%9,]?^S1Z52HW]9UY71]]&)?5,L)_;R"
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M!VMY;&]O[_W?^3\ SY'KY'4*);D\B?,CSO^)R8,5F?$4@\(WNJL2,1<L1G\
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MXK<W NT2W6M>[(.:+-JYW\0N5/(CVMI7%,(3%6IKO'6KIAP\$[IP7*&_Q7Y
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M8"",FNK ,@R!HL+ +#-*<^*@)(R.JS)ID"X1A?;@+U0^6%Z$$E6\NOAQY@W
M N"MZU9PP" E(K=#H,$@U6W/YU_,FZ.%<FVK)%N,RDY*VQ\<L)=EEFYVM55E
MR0<\B=4&,T8*;VR.J8;8DK],_:1O&X/5R4V5Q\8G.. - XW^M7:1BC%]IOSF
M>?<%%=OL-WO R<-7LZ+<\Z;Z2HWN"4.<]087E.VBF_.NST"X_K=RTN2"YS<V
M$T+'C-]V[-&!#2,;CY_YU=(>_ % ;N>N/ ;*/]CA;'4?)'ZIG>)^4S6A%J2,
MU3D)C[ 4:QQK3*JGGTEQ"06RI8Y@E'! UZ;FWMOY>\BWCB=UA5R?=/NE'X>L
M3C1NW];9=&I7(FII/:=3,#TP*5&&I6!U7A&>=2^^@P=,$5>:Y]GP7<N:*3,<
M_.S#OI'V4[29NV%)SPA1*46BD1Y3U"LGDY>C<)A_(:6ND29J1F!J B^^N^_V
M]X<W^E;E3:$##@T3TUDGY"O2E"*-^N/1*HFNX(V869/<-0:8CKY[MY1;T\.
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MA!G.M\ULO0%"@6W3P/DM*9QES/@,IP,0PL5>.Y.0)AWLT^/\>H\FSPS?%2M
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M] FXJ5@5&9X?7C>KP^K!6'OW6>LIJPA6GEZA V>=T$WA207T=W)0Y+GJ2VY
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M>+/];/*0Z#L=O%ZV.6?(HWE#M*4PX<^+>F#I[*D=5ZOG$ U/PLL:I][N&R"
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MB"+7>622<TN1JW/CI\7EO]G0')]T>%VHRKG6 W]?-'GUH+O$A?.+H/\#_U\
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MONGL!#_02*R7SG *3M?3[K!^?D]UL3/R(WCARY;SVXK^M)PMO#W18^J*ZAE
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MR'Y-]H^CZ;S, \?NA?C^]A+YW7FO!$ODFMYP<U.6=?@)-XCRB>@2CR;'/WF
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M)J;+O-?4^-TGH>E#;A<>X9C!V;.PSY2XH9<8E>T" JF&"WE&_NF.7.:L W*
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M; 7'P;NZ>VVPY<?@,UR*9 ]P#EMJ\TG&OF,27K8DN\!#UA-J&)A-8@7&:Z0
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M$F5Q#N2W7L$<2DO/38-F*_"#'KW56JH'G];C+YZJ3@=-A?'1:R]#SP?-N(8
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M+J(0:T $=*J8%D S @\G??6RW1.3+JDWTFN 6Y,:)X :!.=\A3R]& 7(#W+
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MD\=-V$A1@N#^!6NP&&\C4<6#RS@;!TY=%B*(7 ^>I_^=GLQ_-,FBZ^VN]#5
MI^Y(?HH;O=Z#@B?&G^%[V+W9PG@AMA OS$\W06LFJJ(#+3/92_FM]BD4)0,;
MI+U!ER5B&JN26 [$B#J'N]V6 $Y=8>U%>B*9J5,3&UAL \64=I8"="$M5(YE
MZ$['[$;F@8^"7C:9=H-&?%Q)&(]=176+.F$5]Z4CWA+_]E=R$N">0@&-8Z*K
MK)#N@ZS,.A?*C9H*%)JN-I/ME[9&GXK]Q^4+.XJK.(;/V8XA]B"J"_$D8'OS
M-N"!E?_D*.+M4?(G*";EPP;\RC[,L'1Q\\(,Y499O2'-:1R?U-H@ATCVCQ4K
M:7C )6K!] /:6A#S.P%3^OM/R>ZI=:_^0@NHC9*5#C;AWBR1M]E$J=V#\]R/
M+*D[K6_0OS>(:C-8"0L7I/J2(,K\A#K>_C:EZFH(X.+?A%J\TY'AB90Z'GW?
MM&J&[0!-57%81\])S#= 'PS5 N4Z'MK ^0Q.MW:N1IORAUZDWU-(KW3=XTP)
M3IVQG-'>32L?><[C]H[C[OFJB(_5,WQF^(W%BG2S]"]OA?52H:E,]D^15TQ2
MK1*=IZ._C5JH]*Y=V*WY-$*=A1HUA>JAZ3QIR&_ MV'>0>(!VU1.^:^8+Y-C
METGJ:U)V[Y(.KM\I2ME\[!K)'FTYB8V&SB\8.7GVAC%CTS:;C-S@"6VUD33"
M&9V3>-'O/O\.!>C*_@-P[9(A/'^NM#YU^ZX+SUY?CE)^-3,H78SG^J*N0/@,
M</UX2W]$O;3O2A.5C=/=N:_EM5?5_*03#R: 6ST#=#@A>,<),<\ \EJ:V$HZ
M24Y(!2 ("_(,6"_9D+XLRQGU. GK'1K,TI34,SN!Y$934\0(V&7?,)-9CG$_
ME#40U_9\-U'6IO6(30&%-A(-_' (((=Y!)6U*RU\)4@%76*"9071N2IUGBR\
MNV+)L><;>[&BFYCP:=T5:9:9X-5-/<\ [!;,H5RTLF-2_E+,KQCMBH06?1XE
M.AH$JZ_U3C]U9,M>GVE/Y,7YQR>7YN+VK+PN7?0^F7TZY=\.P[NXIWK;IVAG
MY5ICE."RP2(&=9HL.OT\R+L]?B,%FJ%89_Q[N;_F5]KO)S;\DZ=9+4OX(,2A
M.?V0X=K.8)6#>DB,RZI4T>J-7F+A[6(4$%;IYDB.R+*C(+O$LC\=$_N;.]S^
MH\J[Q*7/?=[T\%4#UT(1%BQOC$W X- FW7V2=FEVB$V8)H>1ZI6;5OO)6/$=
M!&B5MHS\TZ!+?Y0*9D.0%/FK17-5K?3YOB.S'%E].?'&8]&OVM<T0U%?)4&6
M4.O_:HCJ_!<0#6S4X:>Y.7<KR7OSP5THO]5.G/FP_]V8B(<4$:0;F;J2/0:R
MW@:!,>P_^P_(\2[7;PM1!4U@2'RQ2U_4\DH$1^45T0L-7U).&AU1A_0#A.4'
M%R_(KOB(4:3)T-]8W4WJ16^ ,M8374F?3KJO" '-VZ2'M^KZT4R0243*T5@0
M3M1)OH1-#UA-^(@919J)NE#=.#6%%P@K8O-A2$SQB)BOO117.MCC=@@T5IAA
MQ!IB!['+-"&ER/LN>SURQ]+1T1[*L[.OC2=F#@,;H->9C#TC#,J-:^/!@!=L
M!0Z^'R?7XED#P@.K>'.'PVF:F/+'I,<"-:;6U"3A+4%.(7I]*4D?530.*D'I
M;NC<41D'BF+;\]7V\]%[CGXB$J7LGJ9& XS -3W[#%S*B(D3>S1[L+#5_L5U
MX3@F(/ES[K;RP-@'4=!U<:S\&$S>/  E(@_S[5_%'F !/!4(#P3?] L=,GB,
M^!;3_&2P(X/Q ;S:T""!R6]Z&<,O'_9DDE:35:,Z^$K0WWCB[DNAP(1(F8H^
M/!XDXA^K_A82WD_-MOAMG&R*DO?B)#0/?@Y*4W,K+41*<AF?QTMQ-YQ]4-B^
MS -$-6T=3TP(S9,F7O6SJ&-BGN\J)IY/I8\"7B52!X+7<ZXC8*X9%%9 D43J
MH*F$E!>8JE. O)1F"D6&520B-7QAAKI!< EY=E&XFKXG3_T-A3)"2GC[/^S6
M)J+J]]QCBOW6)M18EN$\MOL+$M.?+R_*O58)6']("HA.8/S4NN^_FYF8MWN(
M/'@&[/\7S/6';NG\L]VY/40>2OXSO9,B+OE?OVO$[S^)VSP#O&>$G:YEO?7,
M3G>Y[HM;%LQ:L959R%\I/0.2Z"X(*R\+,2C2H_E3W_MESS3?0W;US^S\7%D-
M%-Q&DRVD=Q% C\G3O,3'0#@I=52UH6IG W5N$B5^-L#T10CNOOS9#O-O]#MU
MS-W/:$QB=[Y%0[ BIN"+HB>\P!![ ";H+\AO?SE=B*]C_/,$JO4V=6R\DP\,
M8FCJE6B'"4])7%5'W:8:XU89I!*!(\]@QNIRPF3OP]^*.[Q@\1H/&P,^@311
M,-5Q-13DF"_&>,29*2_X .[B#F&X8TG-XF'D9N/G>>CB\F:!N,[J(O&XSKYB
M$R@+R4K2B6%)+*O66OY84CC(%RE(R21.H3$'T?M)P/'0L8+:B/)*M99B-R4<
MC><<A"!\5.AW,S5_XH\6VI<:!KGN8*CFL*(E38M0,^/OA.$\ Y!C]T^M7&?\
M\S-$)\=/8M5=^[^> ?0FE4Y4B<MK__V*ZZI6/C5*9%0:B#3=;3P#_.XF,' <
MDB:S0SYLA;,I@ZQU;<8U0,D##9L[3@)(*O]5=0PQD-5YT9-_$7T1 /SO,  ?
M C?<'59,BU-P,"M%'?;C =SC:."IQ=Q32,:! A_(W ,13C%E?0%Y&Y%X@NDH
MF2 !(;1*_!<>@$F8D+KS\:8@M?M Y.^L.J!O&^!7#/8:P^9TYQ$EETGT9$9Y
MN3^@ZB 1\^W\8;P#L_HL#XV)E _DM:MJ'A31_R'WS!X%(B1<D ;04$[<^NXI
M#VG.0UL1N].(:HL:8]Y/;SHKHF=+"_3.>X'S&^?"V@XL#P=)+QP(Y;W!@Q6H
MHWG=9IN^,L6EA6?\>W'VY3728:2$@&7I<>&"1+#DFU/5A0%[H7&QMU)O:*W@
MW[U@8N0!W0!JWOGOO]UYQ$M0*R=NC9CB>UL'<$=AC@NY&4+'RS5',:N!=AT
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M!2WW]@0I>3G>H7<J)[E&-*UW$SKR/HP5_(*I=[_A].KMS=-1.)N_3?(#W7P
M;>[BNZ'=WV6:FQ+TM/15X YY<<,J?X/8![K6,..O)$VF&-H_D[]J!"\Y$U*+
MSX>3]&$S7I5"=MCX4N5]W]0/D?7RH"7E/7IH-TKB&NP$>F=7970NKX\&_Z'W
MH,,I6VXIUT-2B_X=&I M?P;LZ'CUV>-&\W\.67,^A,'#^?)_V$!CC,,J9-VY
M]UAEWR@(+46EB;-)8$5#)^A;F!6:H"O)[BW]%KOS+H@V2&_9RI[@*_'?Y[1X
M*>6OP?(SIWDX-6^3-Z2*H1*6@4$@A&J4GX^76Y!+"'/FWO!F/D]$TBK*.?[-
MU#RT";*+SK'QIT[IQ2 RL4UP%:4?8+8[PW11_&&;,1FME,I+AV_)=%Q7+HA%
M.<#ZA9QF1>%=U.?I2V47NFE7)IP#?78/VA%1ZIYP3A?C"[19ZE\%X'4V)P?;
M;)UXYB=;7W$,FUG_A-$I@K%[-7!/0,S.I\(/8<[ IVF:!*4<;!G/R@!7"+#
MCP^%(S>.;V&A9$TN6S#]T2";GC3L6G'?\%[*EY8Z*!!WU_@ZP5QG NFM_L;K
MDQ6K, T/4/+USF*N6+0SD? 5'P#>O@%<SP%%C:N9?HO7CZ'.$8]F80(N/S4
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MJ+O.%7+RL<+?_M&R%A]@2/=V%7K;*G13THK:(G>C=Y]0<L*=1+H>9>OA9DV
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MXD^RF S]E,K0&7:3/_Y>^UQK(2.IKVWZV8R&JWDROQ\YC_Q3Z-'3K]LL!NY
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M((=5B,AL1+E1A)._H]PZ*,2FL^HG3RIOC9.A*"P3T3GL?+<",5E;UJ5TX^=
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MJ,G7C!L47Q2J++*9DD@S5G?T.F)*+T_+!N^7QM'[YJUP1 ><7;3V#F!'V0S
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M6C_;?%_8X(CI+7QVG_#:<N=!Y=W$LEFO?:+LP*5S@,'Y+69U"%I_AQXL3$%
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MPI8<P<\BE-QF9*UZM!U_1+3!'!@\B_)^H;<)P@O:+XY+LH,.@1)=J($,.L+
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M46KJD;_W+'9J\*S@H<&8>%WA;K!(!Z'RC,;M^5?O.RE[)$G56NE(=E5>&!!
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MD]J?R0>!S&;R(6FZ1W$F%.&"U:-6[9&H_ML;NVN95ALN>Q",.5!2URA>3LY
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MX5[;*?I$+<1SI(XQ K-#>^0(T(8P)H0RL2D93#-=T-?W,Y-,1<.V\C?AC$
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M99Q7)6%JL'ZXF=+(5*[/K&*&?I,X B)*.J>BGF0B=<SX&N3#N7?F7Z,P(&*
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MU][T'QNF%I:V#Y)'O@_;CUY);5%69Q<_!+*MD'RTHZ%]A'L"'07!?DW:K7F
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M/T;,]W^)V7\F]G_P6@"@P +?!@\6$P %W#[09'HC_?_X7P,M:W#!YY*\Q>(
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MW+9-R!F4>RUCYJ_>8TP+?^ #834X^)/<)1E4\>5#N-<'4J)*GF/"2<5S9*F
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MT,M'2\2)VG]Z_0JXEG.WVE],G>+X,H(@0XNB8-=+3"@8S?*NGQ,2(?,***$
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M,O1';%B@BY;W:('_?*0,$'3_T;2;S;[+T']\BIG@2ZHH_H-?HFG IZKG;*$
MW;K+SZ%K=K/GZ2CY2VZ?931YEX9CKJR]Y.7YX3/@O/%D?<2I3_S(^F^(59*Y
M[44_DXJZ3JM3!+4!<1M"PV5S905EJBHEY7ZX45'B(D;Z^6MY-_.-SK(!$KU&
MV:_&F8P\ MH5(X4*PUMWF[5!3P^*%'*_@O,Q[;QAUCQ=<SC)_%9K]<3TK[]Y
M>O645U/&.0U_G+G8M)RH8PH$,OWJS>7BZG6?@W[&"V]^=UUXJ='+/MS\'UA[
MS["FHG5==%*#2E-! 8&@(!VD2@U%I4KO71"DMQ Z0H(H*$+H5024WD5Z!RD!
MD5ZE0X 0>DGHY;#VO?>Y]ZZ]USEK/^?\GW..,<<8W_N][_S*[$T\X/L<#UP!
MOI9[:HJ2Z_LR52P)VX]^AF(V>ZL)5GK8)2@Q,8GB=&BDINB@!YM;?"*NTZ8W
MZUX=;\T;%[8ZTP*^7X1JB)!V;V*$,IX9GW.V4\5#$M7=3FK]M:VBZQH+B>J%
MF6:VB*Y'2.=DH@R@C.\;OI&M2W8;T< H\Y+YW+OSJ=C!6,V+M7O/:J&1K<QD
MARS#A#FE979PCX<?LF=:*YV'?A874MYX%K1[!6P8!'/0+WM S9J_NL@>5GUM
MA-$7XSIBGE]\S6IC=2S@V!' Y#%>'S?4-V#QXVKR33@O'HW\R@EX,6):T"JC
M,1.3J1C^';N*O9<:-FX_.LD%9]B#].?ZPL[)P,&9E/&6B42E4'RF )N=3*-7
MJ4>O3IV0<=$?8]O:IOF8-!2S=U2F>.ZDT_WO$R]KZQHJ:U^NZML/$?;0<VOX
M<K!8IP4K(+#0_4MCEDL:<D%T 7YKRVA\JFFVPWLBM/76K;";2,9*Q!WO!G[!
M$'PW2)1SG'J&3=,%ROA$,)C?C"*2@Y6N?X%RF( UE=2A5!D@M[%+'W7I87YO
M8]>D%654D7I1/-)_0!PJG0RV71QU[>)V<E$<WG=X5-,0:GPW5,\Y8>O\&-W$
MPN?2TX]..]A1F0#'<%0)F@E*L2D""UN6DZ=GPYA5YCII\#""63@15-M]N*/.
M.@$<I%))=&_TB17&I"L=#Y(PJ2VJ8%)72C7,)EX6P.C1^Z6VZ NK3%)4KVTE
M7Q@<8[R'+Y%ZRTCE#XS58$T$SV"I S4+-P>?"<\A(*#VGIH7(1?%&>-5CJ'(
M!I$ A6O_;7EYC0FF]!_^@T'];[;*B!X>4U>%5S@<J,KLFCT9W>4D2AKE5ZN)
MFT$^B]7R1Z_('Z<[P=H/WTUK@([3\'BBB$L.CKU2^R+I'^WT/7;=IT]^R^ZA
M,WXU)%L;62E/;'__ /[  E:X!N3LG$+_G'-_BQ1H ,OOC@_OHI8@84ON7-G3
M/TDW2]WGI,<MG(X]O]C=6J'>%UQC8V7)L#&K.YHVGB,85BPI8M)1[JZHUC?U
MM#IGW;:;V<?,A*^61DP<B"4;;S^QL9'R3^@^4+X"_*J[(!\"%(-SV*.RVFR!
MN2S/]SZPB7.9=PV%5:H9W/.G=2AUR;A5VP0^&D."R7]7V=.2H'8OU#7UMV7V
M+S@)68<S@Q(DL%A\X4ZK**NP:_^]NK\G"1\\Q=Z[E'J_PN?4;NC\?@&!I:&;
MN7E,.9V'T3WDY/LI\QSBMAM1&@E/!>ZG#4<+]TB <H@$.0;!FYDFL]S]3U+Q
M#'J_0R5.E$'B;=)XK#XN\H%6>8M2DN5['KO?S2E)>9I\^[(F:R>L934E_.(8
M9$HGH<27S^HZ<TN'(R_53-;)&<UX@@]U?*.#9ZH)Z+;5U0-RLV:Q_F8O)1UB
MGC^$<QO()P#L1C[+&3#38R;EG5.M '*?C0D1@ABGG-X\<[]H\YFFFL3>QXW[
ME2VR)*IQW=M4I4[\OS&&]<-W=3Z;5?(/^0VX'J[I4]Z8;NM&:3@5, E/B'-P
M3%]3$^,:9N9A?ILG,BF.VW]4W#@)->N8[ G[O[B[51:]_/Z!?+<H89U43EJ_
M9)(I+$AV8%%=J_S[>R+'_)M *]U6N,ZSX&A)_RL@P_\YI1^1-+GG89]'3P",
MO9+8Y[Y"^LEW VE3.L2*TIDUV"QDJC[679S5R5-F'B,:7R_" [U[Z]/E[[@'
M[ZO$)\'IL @TKX;P7'*DG+SL(TO*V18&P5@ECAJ33XU7@+B@EX!SUW#+T_/3
M4VMD?-%JY3!/(3<IH;0@VU[_CMK=';D>30O!UG60:KC#HW"NQPGCXA.KMC!$
MUFBJ8__JWYS8630KE%.@ Z&IY@Y#@IID..Z237XSG[0L%0AT5[+>DOM8XN:R
MLWC_WL@-:^)\KP'M-L:ST1E:8B2ZQ.;X[?WA].=7 !\_1_0I^H\K/,$Q[6YK
MF[3U^36 O4HB)IBFO]YOBO=WU'U8"]RJ'Z&XX]J V\=>HN+BYHM!.XZ8[=S&
M*-U:%;=2/ALA NM&J@KQUA-3X+P#(\&R+RAWKZ11)C':I).B=VE\SOZYY#O-
ME*CDLPC](HI'_5U3=(ED;\<0+P[8'(O;Z<3%=XP/3V?FI^H3FH8S0]FCIZ*;
MWE:1#)Y%8+"I-1<%*VM/CPXZFQVL(SYFH6'- ED0"8C][;1$DU2EO"E>(=3A
MTQ=.^=N"#SJ:/+ZJL$;</EXJ5H#Q;9<_F#>9_17=;3!U'Q'/]TX:Y:KH[LO4
M7"5[.!G,?V?[+[H^]$74[P\=Z5;0^"G?C0$S:])LAK'\&@>;.[]ZGT0/"=U9
M4K.SUT[;&P"; %VA&[_KC"I[=J3_]K75_4RH6%DQPM"=:&S5LI8ZWBC5%FD2
M+<[6%)I6^3K9I:A'-TJ.SNL;&#54]3(%EY=,F[^(EN@Z<FD1Z&X;@#N^%31^
M[V =/L-[!?@KZ%^LPN:;KW6.K;&IO%6IR7.'FXHEN=O1CQ9DZ+W+\;(!<:9?
MR1@SL/K%(KU2%*OCLZ^?()9M=B6](* \U?(N](#\>3Y!.T)1$/D]ZHN$]0A]
MUMGD0)-H5&#3<;;P$UWI@ DQ?I_4-5'VC:DZK,P%("G3\MSD::_QX+6ZN#E2
MLZDHB<^D4)9@E2CJ.0I<CR<*-LRDC[D_&BS'G&'SA3=34WDT*.%U:H@C]RFY
M;I&NP/^),%JQYFW-E7;RH&(;UHLAU+J"RX1@25V2WNWK"9'HGFS+9GX+?J44
MTC<>ZF=$\V0IB^,*8'8;KE\TV_F@U2AL]F/U>=J%BO5YIZ?G_R7-:ZD^FD3$
M]CEDF8KMT"<JXF8T[LIJIEP!"X\:_C)9*_H\U%<T2O_5**P_:C/V9*>*J5.]
M_82Z_)(0779.2JTY5I1'<:OW2_D'/V./(TDJ FS,>A!+G+8^>__8LVG,V>>$
MJ .IM L%_QS+8UDU!KLPEXG>R0,"'GY)0AGM8T["F@W)D=44SZQ>ZN_A/*QR
M_^X2%(Y< <5@U0I]6]FF<T[+%ZA'W^*V1_OTEUM-8E)\\E:D)V19W\[6XTLV
MML,@&QFP \KF*MYLD65&*FT-MCL^<&[[+E\V))<*)G]'V>I(@XQC75([+EHF
M+UR<3B8=9XD,B FW9!^I((JPA)MI#V+R^WUI:J<\H C)X#Z1R&QR.U#9R>DP
M@;M?*V 7ZQ 9X842)SY;C;<DCTE$<4C;QO%4[E+EB0 K/>@BQM=Q.\S0REW9
M$G[H ,>/+67EKH"82YJ.)RT<&RHH8DR4ZH/,?N$U*A,Y#U_7Y#:BO).^AY]&
M0-,%5X"LB0]C*2Q<[?POI.Y<<#S"DAE=-R O!W3-8\+M46X:2F5-3S1(?:6C
M=%,54$2,[\3/[:G?M@0@-&M.\-^"G0G]6']@E4';!ZTT=@GBYY UNC0,LGDL
M!OKMT[BRS"RWL?J3+VP$^A5Q<:'2^6R$2BOA$QCB?<$+!\,DUC3&D=MA@9DJ
MT)S9=L9%_IS:Q%5ZU0N4<T1 Q!T*S7QCM2F%1@'NQL2!6\2@!X?4RJ!=M&CN
M#-$[?TN"J:1W<FT2AYF4C@$!N0TN!B]58F2F[WX$*%@^:<=YWX=,B],O?7^^
M\JJMH)_Y@<23%<OA O.LWV0?PG8Q%!.CA@:4LBS^\ P3UV%#1L\N()/24/U-
MH$G_DC,9>^+^$M\Y4:(6V4!@9L8W4>88-])O?)5B6MG5Y5/J(MH_?B_F6I*!
MMY%435YB]ZJ/E%GKWDED]3^K#Z4GFM_/YZ]LX!F+T"3UYE*8^O.>:UV<%2GI
M^7T!5DVRLYDT4%>K[92KQ.L<FR#5?]"(+OA59H*M_)M3.[QEF_%@)9@>50>,
M!90P3*WML>WRO&#Q"CX,BX#?0&<N0T-Z2HC-"ZH,'1$T!).4[Q",T%#6T8-C
MK;\W81OREXP1R,H),)>T5]M1MO!]7;?D"%PQ:"5JO!K/FBASLF-D<X"5N_N\
MGT>#JI[GZ6VL2>+Q J8$<)"?!D=5.6 W5E]-<QSE:)^.VS!25M5\X[^P'?2Z
M6)!-$F&!/$J,UAG/M?H_D1MO9I##Y?2Y1WZ+?;Z,C*?"^V8$ZD>?^\_JUP-'
MZ0)P(<R)CJ67)/DC)GYI:-VG"W=9>1,ODS;IAEN>N$@8OM,X]Q\/ 0FCF]0]
M=\@U&@ZK>O;EF9ZE&UT!\RP37^Q-8([^EQEY]>?EE_M6EZ/)/N=99"V[W&M!
MC\Q+YIK>Y F_)C/TG-RD^C-_O 1'CUDO)F3-0+;+A:Q6I&T\^7TR>KRI?C5D
MG=6+23S>&2M?R[34&5)P__K?>'%4#"N]-]&&'%5A[!50ZA@::#''3[,M$JUY
MF/Q^?G[URV?53565!BI7Q\8F[G;/PI' J7<1 :M35>\ZMET#K#E*7.9K?BM8
MI:M<<!LKWZ#;ZJ$[S(Q+!VF04@W'[?BG9?S^&MD7LQ$-X2*7_6@]<QG/:/V#
MD:J]A BJ)94N>>TEQ"\X(;)"#A^?QP;^!.BQJ3>(2=>%TP.N@+3A*X#.*L(5
MQ%%CX0!2L\X5/_7.M(8=:9;>0$WDB%#+]T"$TX:C= 1N]!PNQ;^I1[K?R":$
M[1_V].")4C4FI1>5T'*R:NC,G4[#IL:JD1+F]7VO<++6WHR1F52@8N.=,)).
M1\QLGX!QG"_J,TYJX^/6%I[N'$O'S<JE@_JQ;-#XLY/!-6:,)IT^&8 SO&:&
MA0(XT.ZWZGWH/H:(X_P*B%$W,-19;RV0(*96D&+E%AY<7K[T# 7EF44[ &C&
M?7&9N=%@Y+"*-/E2_(H?VY%X)\ >I#N!=.>B,J_MQJ+&XX-#:MBL(WRRI1>B
MO3$<H-U,8O$N^38 V83M_$$FT<URX9"7EZNA 1]H C]U]^VG.L@D@9"AB='G
MEWJN4C_\[6K4 AV$!].W!L;?0:C$47691*P[=^/FXHAB1OW##21 =>"R\7<$
M*&E,#0Q_SH5XORT!N'#4J H'ATR7@ ?]\32-^U2[$1Y<@#<*/9+#N:BRZ1^G
MQI%V>S1N/+VQ$,,$6K(G4%DX0@?OJ,6).T,'CG6V3^T8P:AK^JN>@HB(<K89
M!$D5,-:L.W$T.3IRK%KUO3FH1_#*;Y@DHJ.59%7[@OT&_$>J041,%_9$JOPA
M426>S/?5IY89ESFM3PV(+;>(<ES6=*NJ=M+R$IY),%<NE6ZR;Y;ZB]*&IFZ3
MD=-<< \[[OXXB0__^TO1;&WX>]%C? /N;:#CFX0'V[6RD>KAM?^['5UY7CWM
MO16*BVQ)@%8\.:W$)X0M)U]633BB&,P'ZE_7J8&:JEX9V\@>GX:K4?Z]AC I
M<MT"+@>$#H-)_T29; 7NP4:F^]"O3LUF 5D=KAP?*[$WL*ZJAJY1_%<3C+0F
M2W7$Z8T'Q)>WN^"2^ PRXXNX]J<9[./)])/^KLM!R> /OF,E#;-F1E-/C%=\
MZ(YX",$7Y!,MG0R=#%TA-Q&<S+_J]S1Z%!AQM-/.@33:9G;*_\O6<<I&!+'N
MW!_&BTCJ[]8R^JQQ9<_]<N'KQ9L$'+.LG\B\JRMJ\C<-^4EK.Z#1?JZN="^R
MP%'Z]RKG0!DXQ[G U+B!7K)FF'OE;.!VX8JU)20ISOB5:U/+:Y8/,QE=-<7G
MPF^<":+IOUR49B0X*]UYT6"MH,\4_QKIJ[0HWR/Q5FUY<7<,WS,+$XA@GM5<
MYO&8(JD*=AE=L7X@#]E0+?"R/1V'%7!MFW%U25$XELBJ_ICEKKP0-&:@2\(
M2-F[1IF,RTA\23Y.XER AP4G3:D9=$U)0-&D((M*Y@<<N)QUI;ZY=Q[^GOAL
M@3<+"];(C 1*_PP-2-]#5HEK^I&]G.^ZA+@KC5PWBCC3ZDA@N1LS@)Z*\YEP
MR^5JGM:@] _D0FP+URXS:W!)""+D3L(>-L?7LJV$&3")YRY3ER#S"C Y +OB
M;H?EO76G)QV2$A.>/I7&;PM">&/*Z0F21OT-\IEND1/,XXO[3#62]-[1+8Z6
M\EH\G6%#[/]%@Z:"Z::"<A6+W'*/0U1KJD89KX"LF6Q'Z_C3@DWX .TG&"S7
MT:0K)W")--'4R2GJYY2Q4NTV:QE1R_&9X7/0A^T,K8JZ47S/SO!08_=KWU^(
MN>RC_!V1)D/E<<R8IY%E W)M.WU8MS(,6Z?I=EF7^ZCL Z\HCXN!@\OFF_*A
M7!V#N77G^HP=SG4(5D?=KB,U\FQRO2QOTD3-\B.;966$9.(Y_*O9<.6%Q5D'
M5XF3-LKY!ZN2F].#[2FJQ\G(EBA<GB__G%/@(\S AZ7$ESUFQ9]"ER/<'<C-
M[^J/N9;@(3+HWRX&K<DU-;>X6+F5SR6*-ZZ N[Z?GR$EJLRY>[)LIW(?1-R3
M0<#4R\>^#;LUFA;V)2EOQQ#FKWPA)MCJ8R T=:SI+5F?./2P@/=6Y2=XFY:-
MR :<XW-)Y_*6G"#<//!*)<'Z6KFAJ:XOV<L^3$U<(BUW)QUKV(>L4^>P058D
MOYU?0Y1*[/YN7@$?$O*K4*=H)_!?'[C/<?79%8#'2MM^%QLJ8VVM"S^YS>@U
M-:O (I:A7V&*K[)C-SN%9JA=LDZ+T[K?T7P>ZZ\O-L)GJBVF]H#;9U>1[K![
M XO2X,9HM4?.!L4#$>[OV:F(SX)$(N0&^M9 UWN8'M]4C^.8B]B+[O!>#G\.
MN/_%85$6\QBL.G8$.(2$,<%-M)X_U01P1/-7P(0Z=H)QUR, <XV.<E0]1!#-
MY^&"T?)L$>CI#?4!4)G9@08H73CCFO>^/T_&B]/L]8"B&_R#9"\<;>77_>-Z
M\NP0D'WY'3E24TA >+CWB?+I48$8K%]#<+[DN0>4^48G $OJ2W(S&_<6@G>5
M662DK190MD0"9F%70)E)XD5SVK@-DY,.9<@CA,CK!>OQ>BK*1JBFL#(!B8 P
MOC3HH3E[<*[HN:YD<]][JA+1VO2N15/Z.D'VP ]@JTJW>N.@T$S)Q\MPKW;=
MH-Y JO,*#JP)3(5^O[0S)&]A5:)%4-/(E15GM>F8,<7/NC@4"BFTQU-9<!TT
M?U]6"/:2-M</Y;;'L^\,C.JI^);,B[*OO2H,ETC2DQ(:GO^V&"H3FF?Z<3K+
M>L.XQ>[3Y0:U0XM=BI\2.83KK%CT*0$HA\_Z4T[$>;=2;='M>?\?YPX>'X:^
M*1B:YD#@&HYOO%S?Z]"M_S>!G<MQ!AM'977>Z3%$=9SZ-^IP^@I0+/&2+#L/
ML3VE6N5)BHK4&)"=M[IVX@9Q1%7?P[D0A@_WF'=-?+4G9#?>Z*/RZ:VO@,R)
M5Q;0/0U-4<\B:K_$9\JG":\NDL=':==9)?L'[:06IC6ENA*U;L<X,5I>Z#RZ
MWGAPM&'ES?V=T(+#LMOK/F=!.FQO9'=4Y2Y8:=?U]JCF?^27>7)^#V\=_5<E
M YS?,]/7Q0EZ>OUO LEI^CPE&@\\.=S%MS5I(P-+A%>L,=4!<#PV,55_]LRO
M8E5$M@,=AV,JTM?XO2_DQ;]U.\F_J;/=!7$W/07<K5M2>:NHZ\YLG5R &,?^
MECE);H:+;4N#?$-##7NN'UJC)"-'S&#J!:W4QJ.FW!0G6UD?:KZ+P^6Q_J^.
M$4E7P"RM]O;7@3GV<I>FOCLOK?5+6?]QAV$ 'NRI_SAT*>BC'-[Q9ZK=.3XZ
MXTVFC<ZK[H"E/(L$R2EYZM]=0B#=/CE)'8*2X4(S3U&7PH2>A6MV?TMK.0V3
MH=K+I*BH8#^/ALK@4V&C7ELZ6D4].['"<@\\E"9R  ]?#A -)R;-YE(OE*E\
M)%Q#TI\R-&KI$,01KK@<X0DJ 0R:FVI&G&T;ZP*C?XF5@^(V004+ABG594MP
MNKD>RK1A>><TY\C#1T0C,!_1DCVA<]0;.\L(*$_E3\J46ZT7ZI[-]T=8A\^E
M[,CDV'P[?HIY_!&"9YYS5]_N; D]?Y/-,<4G"LIPTPM=3$Z#_YQU"OAE(>CR
M^M6/5_F?M=2B?PL\)BIC2O:'GQ:5,>[+L3%"1\[W+*S0O6Z;K^Z:.([[1:Y<
M8%'G.-V!5;(LJ+._&V]=STF3.@=GX/UK(U5'ZL7V<:C1^+87;+T3UN,5;1+6
MYW5VLTYN#X5V<PNW2="$VB^04_H0:C+J>/&-; S"1O5?C.'^VNY;-U?Y409I
M"\5J8@PJ*N]QT.FBKOD<T"3>=4.<;E-3)'N;#4?L*8O!*BN;';9),Z-K#K+/
M:ND6H"-E-.0V/SJ%)%^2:SY ^_^,S-LX,7C1?'?WHNU/JGDU-(V%V_?48(0B
MI\8."B'#G!^H+R]00GMHR/Z,5=[B<V"Y4QD] !(T>S;I"7ZEZ=A_!;P7KS"5
M3JV:[46Y)Y&4DBYYOR.,4L4*5Q;=C4 *R['):AD12N2YTZ3?X,B%"ZM, T1;
MQOY)'SV;N%>EG*:KD,:**UK9'T (#4G;*B**O+0(Z)IOMJ#@8' ;..>)1#^H
M9E%NXP<Y>C1(+^.IRK8$>EX$L$2FH2>:24"YL$%_K;QO> ZPVN%1]NP_"'-P
M*B ![/OC1?(0DKL"$$[T*NLWF6;<G=H=N5O!(?W0]4 NU(.*M(/I)J7N :V
MA9&*GO/6#;F;!//3C%#]4LWMB@@;/71ZIL?D:I$%>#81AY5C'/M[@N3^>;%>
MX1?\D!E/'&A/N$R4T57%AP(HJ[X H@5NPX@G'90$I3MMV,BG=K*=3_8):Y7/
M/,N>[Q9N#5%? 7Z35X J=":IO$:!QN!])&?)F/PY-ZB\.F[G1<L'X^\(8; B
M8O]#_"A%]@R'8&_#AJF>MJ6 MX7\41:;?[A"(W>09:\I_D$;8PA&0?8##T%J
MDF-[ODB.95+APFEXJCK_/0FU;X>% U:P^YR+K5N*F12."ZM<PIL.S9Y[X#E%
MZ+I$[LFP(O21T&B/)Y6[8UW#YZ0?QU4DLIU19:(N_/HMIV,*BS49L0VFHU#]
M[,JZL-4/YYU,4:09]9V%8OIC]=0.8WVEN4,R/:-9\$K9$H?G^44$!W8;ER+B
M(C=54O7TN-PCY\$FJ=F9_\8W*,+<;.'<&:K#&Z7:W2^GO7$IJ$OIW(8'"?-.
MW/[?P#E0'^,.5UE,WN4'\!5@$D=4FY.K.(TV '<0Y(T 97S'(0)N]%AH7(=@
M4<QQ WSS>Y-B(PPU(K#W=9KRQU_!@;QMTRL@O#2-NW'^6Z3/]GE?RWN!K6$W
M#LBKWSKP!:FHRS"+.#.Q7]TO@NXG7P'^RU%G*]1PU6TGR7X\O5Y"YKMPSN+(
M_SH,]$-+19PPA;?@SK8UCJG/RI&A3)_8QGNS9<DQZS['-Z%8Y,KTK/;#:Q;K
M[Y^18[6TH__%YN6^7;HO6'<NKV)XI4G&:T0$RJS"L0K?I:U\'#K^D)&,5L&I
MC\ZE[FO:T61XKU+U3T(50;:LXR^9I_IU_$/B%DZ2+ZMA;>R)/%*?3MQB-$M>
M+T^/CK%5@_DVQ.C/N1^K;%-UOS]+'0S]15?'&N"?6@D0Y3Q,&<*^/Q#)0!3%
M3"O<GY'/T!W/_8]_-"C:$["=1>(*G^>8Q%]BFQ,,J]B)& K,TH@,3?)GTAN7
MHON]KX"=O8U)?=9TR33]!G3=1UQA2-D?\0'1Q[=:&:,NFY[L+GOE1K@+(G'H
M",]LP;SY'P,T_:1&A+Z8@SR\3-J($2,2$9.6@9%C?K4GL#WN3.UY)M$5.#.1
M\SV8YKDT=_!(7J\9J&.#71![U$TY-GM++-<//-X >: 5I3_D\N3VT4D,1?L0
MH@VTUR?S;MU\$R*9>C#_:9D,-\JQ^B="?NO71&9<#!+R-,3">N\FO.88.:$1
MMNJ;129W>9:>T7OPS95\NX1-X/@9X=_?DR$#K_"!3G_>/OZF6=8'!4W-S?7I
MFZ =5DZWZ,X'1+&G+:?@T"<TEF2;?X%3?IZX8TN$R;H.+;%;A,T9(53=F<A+
M,^Q>SQNV>J\_7?9MCR00#\NG6<@9>H:D#8M+$,.\2TY?_C(^;HP\H+% I[=$
M:3B-VEBM-&^WRUI0^)6U?^RH7]G<K/L+8I[.N&9\"AW&&1I[LX55F.GEA"3>
M'L:VC_@3Y;9S"(]=VQQODJEQ<=FSS]UQ[EYT=S@7]B;#-P3NU_PA:Z5=E6%H
M/8[Q6J&^'XABGAFJ[<=T, S;,[@W^C*XS16^IZ@I#;BDO1[@1G,,\Q>2F2TV
M-\EM4Z^3&?*8.*24/M7'S?ORU5J"S<O6:S2I=B'G/+G54:3?_ C-^MQS6J/?
M: < D$"L)V5N0A121.HDEDIBP<ZJLO^+7L91'>V0:T_/\K[<T14@47H+Q4S_
MHW(8F67G6KW/FN^E09M0BUV'% 6T30Q;'.L,K4K-L0PE0GZED5_2 $Y!=WY,
M; ^O^MFIL#Z@ZU*D!\G!1@I6:WZ]U\JD*&AE1E#R_#E78.W9NS,G8O<JG>2A
M401.=.WH_FU3%%]G^_M0WH:Z-6 ]J!(X7XYU5V*T+CNYK-PDBCB-BS(YJ-X+
M;2BV4*$,L=JG]+">.\9;#SG,[R;[1BFFW#<="7F!*>U[?T&VD,I[7W++!8.\
M9?MNU9<M(/G['QO+,&?&=V3]DOH/(E]O]^HVU+!IA!=1-*_0^U6'2I5/A@Z<
M$X]W)JR4%MA1K!2=_.BNTU%B9<XJ)\UU\C6.K[PMC/%6/4BC[0^$HM!RU-B*
MIM4$.QB+0JQ]>_6?#ST8PA)"P<D]%$;[UR=B%1KM]Y$TW)QK($O9F[[8?CE<
MMN )ZGFJICMT6R)[IXV>2='!GVA=6.[6L0?L1)]G_(3N=IH'U%!^>M*G>$MN
M24AP&"$Q'7=PM/J%^J0%;,(A*X%]29=Y:Y"JOXJ%*+PO)(\5:Q)-E52&E;O_
M&N-0IKQ[ZCRXI508=Q)G ;U?IHJ[X))NXAX*?/1J1?^.C=GW<.Z>?^:_#-W%
M JW@$KTDC0\G9ED!^E.<1(]>2GWTTVUR^"3UL*W[4+1*6\6-,6M5&Y]C*3S?
M4ZM>\2@Z4,&N+UO:+X!+]0KXH:'@\-(2^T<]9LV1)%;Y"SE9H0[T;GA RJU\
M,V.5GROTD#.&\<HQ[5%J-&@D1E<L#L;<$V/$W&&@T(_02G'.YO3?X@@?4A6:
M?RYCK.2BD2@5#^U!M3A^$>U0RC<W5O^Y2 ^?8J)P-5XO7+ *P^5PNSB&,7Q:
MZ_O-3;=]1XU\(6,\M[CO?Q:O)Y:.,+S_MH$5.M)KP['KD8<3G9K@*Y)3[^QX
M?GQ$< 40TH/SLUOG1M@./'MM=U8005GA-<;,3%_Z1H"!6>L39GB)TP@!A6\&
M<EJ&=WP@)QL!GZ\$CS?]F CW71%>*H')'F Y+C\CZW]D/,!)[(%O2NV$\=3\
MFC<M@.-XX:H;1?''_K!%Z!7P2AB^IC\V3BOSU(GJ PF-MI;1/W^4T1.>X>49
MX/6_^?)S\,W3\C6>>[JB(]2-(6-1\,LJ/>O 'H]RII6-WV=:B;9H9-ZDMIUE
M^8_495+HD>'/*R!2G5';)+)C.QKO#.>.%;>M=Q6W6"WH_SWT^+EI^9MZ7O?&
MD>\_4X/,ME[YMY"D:2V@8?ZI%<:IU,\=:&2]/.9R\[['B0"5\;9?4@%O!V$5
M!8"/)B5+!.AI&:T9+O(NN@N>%37<4HF(+))9VU7DD2^2W-E.YR(8,(^V[5(R
M*=J89\XM-O\Z#'8-+*PC<O4]US2)[:#'Q'5*'2L&#!+@P*H:ROU^*!, ZFQ7
M*@G33A-DI>_IY%H7CL%G7U*#X/W1-%4020I3S=3?6!A-"(CN-W-'0/C!QY;%
M1[M,?X(?GJF'/(55)D_/(_5;!D37 P]/=0DD) 8X&$?4E+Z8O55M2+_+E/Z%
M$5;;^GIE#V>FGP$ZML!7@;>:S!EE7G;%7JS"SEVPFSQ-MY7H9V(>/97@1C#
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M'P<@ ?3Y$N*^-)Z.@X,U5[8[-[B[>V>Z[ HHC&>F60@2@0[:T6UR I<L5%=
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MC6/Q"$#&9W1 (H&GNF?5&R,M);"D/(XHDS4.2]9MI[0&MCJ,3&TFV?TR40]
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M/XT(\IS!B&_['>4L!'=CQY'0*$UMN1O1\-/9 @_!6*KAN&:R97+M24N\[ >
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MV+:6T'SU;!XXA5>?RY964UG50\:/-<W7BZ_M)40P*8A:=E08$[6_-OTD@2O
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M!M%TO37'V?].'5<NCQ V)>$J@6E:R]9O/XY%.QE3\11E?A %ERN'HHL#L->
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MK&??\^U*=,WW/N'6"_TYW6D"W3U];CE>;GH2<DB]O;P'6A=:,HZYD@55C)W
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M2,>([88&I0 A.P9GZ";IC?Z7=P;Z[T4USI0?U%A4,@:C'+KKV,W+#W)RJG7
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MK?CCWQJ %(N4X7+^FA9%Z%\]3Z\!)LVBA*YK0$###9D3EC^,XD[0#W_Z>F3
M>"_8Q>01HL_:.![_625H1=ZW6UF^;Z;6!]'ZI0]-N6:'L FP]T6,J8N)+( F
M/]_S\)6X7)KO,^:ZZ(L,[KZB.>SEVT!^9:SFN#%@D-P<+I;?F?&-ALQ6+EO&
M=MT)Q,&2.*I7S3 L=E'F&<2RWX\A WIAU"L:^#^Y=KO%X_T8B1.=,_$R\5 "
MR]FO"@DNAE)'K*<K1^A/OH,[I<"=420LC>8B#",-&(4PX5-G12<&(<#1223
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MA(*:E8Z"DIF*A(2>EX'Y"SL7%Q<Y';\P'X<0*R<7QW], H.$A(2*@DJ AD;
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MVL:8H/9.T?#+NU77+KF*?W%+ _*88!>8SAJV:*)Z?XG3LZ"/\?UZ<2;#"&\
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MI>M,(K1"E/CAJD5 XVNZ4F4G:=>[+@UA<,**7"V@.6OFR)GC3=>M4M2A7A[
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MZ(GP\$GTS85.LN2;%-TT'JLSVZFTL(&$R%:NZ+B$3IG#R[HYWN2H YP@L/W
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M!/Z=]A2'*JGUWSEE[X# 4E6MSNC7.L@591K(P96MC#7Z[D30T<Q,-:L[3O%
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M7C0-JX\O#[V%'NIJB''/$%JJ43O:LFV6JRQ6KOL$VBK"&!^^XQ#QEGUO2>B
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MEGP./=X;"*R*N=@2*7!JR3($60I!P:."H\3>(I7F$"@?S0S/LQ?LTJGNZ1_
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M]LG>[,Z3?37I_NU1C7(9?1.5N2E^YOC'8LV/:$3G3?'DW"34;?<_10G?2O<
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M7[<M)O?0MB/#\P1GF'].MT &5OLX_GPRI99OS,XSF=++E=;:P_S1Z;"EB]:
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M9>CEC'+K$PL*4="4Q4X>5R,::DY*Q/)C\42;A1B7"F'UL:P6V64NUZ"U8IC
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ML'N."F"QS&ZV0URRUJC$*T"VDYL_J"*^+J;E;E!$!)*+$=H)RP(B+"/.*+-
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M47ZO"XF5V%R[%G>*%15WS YY*UE^WCF)$Y[*%OU*4D!I? 6HX%]$IE-EU6#
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MNIJ&\@3?Z"K$M;.&?<.78>;6HG9<?D2_ID2.(#=IC=QPJ*%Q1I+&%4F=7/!
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M9\3 [\U"GRR2HV]11;G%O:<!6[GFB,6V.TR3H\/0Y?'S15.GM#UWD';L]D[
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MPRV[(C.<\%^CXNMB<E[B'R%3)"R"8'J(%_'T-YM(YO+H_ZV527B8O(*\Q#J
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MGRT3[.WT:XA4].Q3>+"**77"21[C2K_^+K;SW+!V4(.D@">=_6V_'MGK-XI
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MP>F2%;5P_77RDL9KT=0+N0J-6/X!)%Q_+3S?;=US+45U3#7.F*3Q9,="OD)
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M.\K"#"07>9A4>77??Q5YM^V8VQ"<Q1 +6VG#=]I&,8BHR\^*K;UK%L\OAM_
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MI[7VDHM8L%Z<KB7O2XG(--JF$!B14>[:F7Q#?WECVZ:[6R@#QX["@F4FQ05
MVDC=KAZA7 'YB9=@1WI/<,P?(G'L,=9$>+X\!#T!F25'*\H,N57*3=R+I\'M
MX Z>7@ (-HXU?LY!_"\ )J/9KCV@F[BZ(NF^A60A68TF;RX)^Z#2$>6\FNQH
M.0,>(X^9W/,Y(]WX!B2_+4JA[Z"7]007C<A1Y"C.HV/ !.1@<XSJICF>XD;5
M>O+I].C:[A[21 <[BO!]&K*VVE2&9@,21%1LON:%+!9HBT$?WQN#9@F7P*$O
M;>F,.C)W9.U&)@0T3+D]":.DQ+C:M)3*?+F.I2([:.QM,R<XK]'4%*_)(<6X
M>L"\$OI^G0<9G3G%\EY]Q"_U,TQSG.6A!,S]:[(3$1&^=&4(K6PL0! 8BYY'
MJ!/Q*I1E8FE3R;9EP4<90$ WQN'/GP7ZX3Z<E[7,D^#&ZD3.LN Q_']_:,XG
MP7DE_H '?QF; ?RI<2DCX<;X$Z\J(4*K6*(3"7D[?-);<KJ,X0J_]Y_=]N[_
MHA!J4L>[WTLETS<=R+/P4V/EIS:F!\32:VAP6\##&/N(<BCQ=<SCV_(?-_&=
M<!()SS<SZQ87N8TMTX8+,=&ZTPS-IT<0A[D(Y6K:JH*3W9W1+_2+MGJ3 (OW
M&*DZH\47=O*$?;[-LCVD-QNU!TT_.D5G7 "$U[<>D+5K8$U-5L.-+1<Z77N)
M/GJW[F^\X,W/+'@:KVW\8M9^S&[CP;OTR!X))^W?G?M[!4&.%K'O@WO=Q60\
MAXI?C+4%/WZ8-R Q9K;G> &0/=M0[#5\4%?3Y>\5S6!EDGMX M=*3RYFY.;/
M#-G@BPZVS_,LW@H>L622%PTM,%*J>_8^7ZS5:\79WC5-0>R+&OVS8]]<E\GT
M%0;5=_2>;/MV4 UYZ_=(V_$)CQ3I@;0G+XPX&HE:8/X!2_P%7Y,_AI:4/0-N
MJ81HSG<T+K_F:QZ)/$#>0OC@[0R2_I/#,H@#QSL@N:,(F54ZEW'7TI>] 'B2
M@S2TC921'#/7;FVA3W2+\]ALN#2L10TK9<?9EHQ20_8]0(V2#6=V\^M2 'IM
MY*@8G>KBZV;GX^$NR4?MWJ^^A7Q:(,G[_L$A:4)EP8AWX\8K$KR03J9:T^N^
M^EYQ9G2_/ZY"%7*M;O_<_4%KGBEEO3SZ*#(45[ZANU #-R=\1@'SK^#O^F'P
M<JSXZ3B"J+FLM=/B%^8,_9N?J3"5HOJF_/)]G'[[:1R$8Q8'3*)A?_LQ?Q 3
M,L1*LVB>QILXHBV,<=X,7HX8[STKB9,'%8&B3>ZX$"!EG&"?52$G,P5F7"ZR
MZYD& DVR@VO*=YQO$CA\.G"&)_!?7_IA/2$PN)K)B^_CZXH 1S"O6F:J!2\>
M))E8P%/@)ZTU3H*H@)1+8IE/@$<"S3]0S\?\08-9!O ,?[*Z]^?DR(EG%RQ
M()(D$\N!1TY#JE8VH>]-/%#P32O^AA\-N >^#@>^ZA^!QZN: :10UL2_7T4J
M,98S S@G<9OGF5=?_NGK_>@TE9M #9G'_^7V_'\J-\,0 _T2-[[-^X[ER&>/
MVQ+,+B>I^_FI4?!*4*5G/%J35Q!;)922^*7R$!QE>@ $W+E?JA=QQ<F%JZ=)
ME1H.:$EN]?,E$PLVG;:57^2#5+LO$O5Y4VD<Z3D7>W/5X'VS[Q5CNV>U9%%
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M+88<72=?? W2:#BGM)\\BAB0'1=N=US(=D[!U2US1R5?PS;9Q<M'RYV5?XF
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MXU2VAS_E&14+K15(#K2@5I6L(M!B7^UMAJWAQ013GIE;WI-]Z_Q1V"M^I7+
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M<MH7*['D[7PE[8/;-S8H5EFI&;M0.M CIQAW,KP1S_89/OI&VGO2X7[OQ%X
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MO5<VTQ6#$8NFBVY"-,/S8=EF'\$&5WK$9YH&)ECP>DF_GI%MHQ8F7FJM7SC
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ME$TTQ$P1P4V[&\:'_AB&;H%IVZ)-38.NK67;19Z:VVR/Q;1W7X8<M$U)X'2
M N&M$9+M>WSL-F[@AU;6EEA7UQL3,>Q1L$X1U,P%(-0=YVYK=VUD?N1YZW;C
M>^P%@%IO$:- <GWDP*Q;.U*%S)5!U&:7QGCT1XCL]]OZ9;4&%X"%B66AXF'7
MMC,J?JAC97.0]JDN6]FC^R=CFJ_<S)I\O&W5>#4*IG>VGDTI[E_I.^!JMH$D
MW>_L@W;F"M]=_T'4B_9R=X6>ESLT"Y;%YUO@#%[<#Q><[1"(W-?0A#4J4*9=
MRS5Z"0W,.EZ8H3H_,P[M!19"+5)1N1KKMW<F&+)7 NR=GBYC[UKEF%8%S!')
MW!7Z^182GL6"!49A_FFYLO],^:2IE4.&Y]#+39:P?W,,5_\.:76H+1; #M3L
M(X*ZXNO&H;K9>0#W^(CPKV])\&FJ$T90:6A$TZUI:MD2/'8>9>T;<KAYJ\-!
M/!V=F4J>=1MWA]B+WV8*BNQ!>U<B5NZEBWCNSY>5@3?A%I+AB$5U;L;JB>G&
MAM1* ]_5$H3@;&/TOH'N+1*4;<NMPT]M' @<9,%HP" 4I6<O^S*:L19>V=#)
MD9C,_S50R3?(M%Q0T[")8]4X0OL&0D+SL1?!2+6\N_W5S(;P@F4Q%(/:!HXC
M+XFY:QWLY<!ZQPY%W"%0-CADZ9&G"<UA":\T!LV%NYX,<QMV4[-S3SU58(^Z
M3BO/I5,IY52?4_CN]*&1H\.TOEB&0SN>05)PI<_L]'Z_+VEBZ@C93BHX!JW:
MY2=W)7M\9S])(JI@]8N7H<NO=M#LF3L@M47AQQX7"A >M<J#L#G6P7NU[[@3
M(J'"9?T'V?%\D5/Z".JC@3=&,73@5Z^8H[I<%4%<M!0Y=!3HNP-9M+]M:>=H
M60<B+4("^3E1J>1=N3X[LZ?..H\<%B+&H^O#856-F+8LVJB34-1MHO!W]D&P
M(6/A[-6(X T<_P/AVLVODZ(4G2&&K#4^<O&KEB6Z/ZD&X>B'B2).WD<Y2S]%
M$JF"T .9VR3^-,'^WXS51)3 RLV@S@:"(:<?B;,G>J^9,U@_K!B0@J;+W^/Q
M@R;)4\ML96^^J?2:,>+YZ<(;"460^CO=\,%(N@GUD[2%G:P$Q1'VEJVU$#_U
M<H^K3'UZ^%O7HBPXIJ]>>0++EQ+#6BM9;R4PR@G#W$<A:;G0UP>"$&O/ MI]
M9:3T!8#@]1K\36AJ[=*RFST71!:DZ&U6<)I^ 4!)%&VP?X?MW>K=S5*;OV9_
MM=B9YDP7*\T^,][9*,G4UF[23,[LI_(T-3U[W$YWXM-+AZ3NVB'8]$>)L9/A
M-*[(CT[>5$"*B/].8?M_*E)@\% 4'E4#_Y8PE124_@KDD\PCD7\FTPC__0@%
MQJ+[+YUN10Z85X(""SS3Q.M:->"$.X#G<?J)Q9IJ][U4,F43 3D-29-?=\7W
MV?&798]^%X,,X4I6SKLMM%[P$L2 P]ZS5(IVMTG/.TQB-"US!H-V3XS2_-3]
M$7(?V=6$68_VSS8R[H:W46I;8<P5&,^Y#'^2MS!]3\D2L!I IZBZ]FR*._2G
MY,NQ[N4]@N6O_580#>C4+?NL)-+BTRN<3<>6TY'2I6EL.[(COGLGYO[AO C#
M7G[P:\7APCVC26ZEH3?QMX,I&^>BPL?]5;,+K@<VG6![BK/D<FB[-'IWV4MV
MMHM.C8FJAUR-P"[H@"LJ+H;6D9X.69/ "B3XD])R>MD^5<A;H07^U/*)3XQJ
MA,:<6X&4QZ#M IKDWE]/ENWGY61I'[?=/0?;WV32[)&;7.:["9H-,\65II<H
M3%X7RX86=&AJCB-S*)_'D+72WCWGDFBH) :AB.C-M-IHQ8=F>&+2SBIR<FP)
MB\628+QPJ+99B%]_@(QA/5_3S8.%-0D@,Y:J*U=OB@H4;8WOH$E/P;(1HK_[
M!53%ABX BE.\CY=488H9SE;+O.;R%KW\/!YTGUELZ3-QKT:*Y=Y,V"J4QX(.
M Z@VM J^%]@"!O=+*U7[[(H=>P=D&LX:T#_6$EK8$,(7 ,S3D^%[9@](S^D]
MTRX EDR=Q_2&::NNU&]_F0R=2?('%R3>5J%UOG95.;SMCI#%6(B(Z0YWGRAW
M$:Q1+E4RFX_Y>3/&52;QI_LS4RKGM?VBAX,^3&\#%9&Z@[_R86_E!2D0=-IA
M7A9%3'G#9V*93>FV7PVD[T5Q/M@)]V.]A7SEL1RT:Z(A0H_1D-'_^ _L:/U/
M*Y% C#JAYE^IK\L,UV5B2Q$,Y94@@>+=X97T"#C@Z;^+-2DI_!5_CE<TQ+>3
MO6R7B<;CY18P[>F0UL?!8@EJOKNAV\NI$7TWG.JB7Z3[@EO)TPG:Q#$%Y!4-
MY#,]!3>H-)1Y0X;T*:J#!< Q4$:8>PQ+-M.3Y:&MT@CYUO2D2P^1G.+O)J/_
M+K0G5NK4;U.J:BR&MM/-5(F]:_T+SSX6U?P\.F)<&MQ[V/^!#98XF%X[8DYG
M^VK?=O1HTZ0]UELCY"I>?Y&7YAI(NV(JQ$U!#X*<&K].SZA_.)3C>W/7[19E
MH3B"B^'-0[!ARP]FML%X,^+!VL05G/[,O:"4-%%0??P0<NL9D"_3UXN&H>38
M%;XX:2"N%YXS^3CHM^8R[P.;[0L _;*;/J96>EYETM!(X2;4F?(+<#*MG2BL
M5@]YXBSW>$+L!1.C%2U>'Z88\V/WOAZ-RMZ.%-CXN/U#BHJ2>4":>IU*>K]P
MUBWW2Q7[%P6X(?@#W6<UR5"4U$'J!8 ,HLHU#"1(6I+WS5TDVM3=3.>5 NYO
M:/W#DP+4"?O_&Q1-[+]TG"M \[]''3C_2I=>AD5I,_YM_2C->80ZX=]F*H*=
ME?Z7[5'\)=?QO8KLY8VF,[O\,KMW%OL%Y)Q$-Y58GH:DQ.8>>-$D>GTJUS#"
M4C;W'[MTTF_:F$C#5\G!F\?:UM<52 NX[U:&HM["5/M_+28#(Y3B9 =%!^AH
MJ;80>R#%:1IB)P>G[DF4?AHWX)^9L_WG1G1X_\ .2XM_Q+> E^F=_]=?Z_^7
M<C'^/P!02P,$%     @ IX975 /]VH196@0 _#L% !8   !G=3$T,#5A-&=P
M>FHP,# P,#<N:G!G[+P'5%-1VRX8% L"(KT)*%6Z=$$D"M*%"$B'1$1*B( (
M2(1 %*0W!0$% 9'>:^@0(101$:FA2$DB(CU1@2.$9/C^N7-GS??/K'O7_6?F
MN_=?G+6>M<[)>?+DO+N\^WU/]M[T*?HBZ)R)@;$!B.'PD&.0 X'HLR"]?[OZ
MCQS_$/F/:C#0/X#83Q]W.W7W.(,HZ!@[PW%V!GH/2 0$8CCQOQ- _^5@.':<
M\<3)4Z>9SC ?$C#G0,<8CA\_QGC\Q E&QL.[H8?W08SL)S@N*MTXR6GA<DK4
MCTOYV<N\TV*ZM5W<EB-D<95[C\*9SO#P\O$+2$A*79*64553U[BBJ:5W4]_
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M4$D'S\$^6].XG=(#3)C<FK B63&^DX,VV90CV 88+H)9J 91G_@?T#A06OC
MN1!+,D^$Z&O?!CHHIK*\L9H$B\TY/[XN[W-7?:#H)UZ@,W=QR/R@&0W(39:7
MK((Q;%2.)L)0[U@R$S)^)\',UGYT0M2S>IL9%@-C_"/+7-HS\CEI+^Q-]5KZ
M3HFKDO=$]8D>_ZB8FPQ[S!1FR$$EC2-L&"H.;$GU"6[%H 7:3RWN+\3I* !*
M(N%47K:N9/:N/,_&O84$'2Y H/\F.9DJ[ZVMD%WLM1/&0)%82*8:$^U15OZ(
M)T1&RME$U3#>QCW#G<<'>>T,^Z8H)K+4!L.B8ZD\58B$9ANH:!?([^+>BE8,
MF-X\M([CI\.LP8:W$!T4A<D&6XYN,[U/6U\*D6IOR$%(O\N!.%/.6S@A0Z#A
MR%$[CQ&,D7N</DN*OD3"BKA/<92A@<PGY(47B+\VAQT1 =!!/:V^5/94VAEV
MA$?9*OL001WXDB/2K-$DT6 *XT;QDQMX7WA^KBMHA:4]GDFJ/#7U/>[*MK<!
MR<*H=WQ7V9QA7V)?#>4#).Z'SJ!,@+9%6$RG,G!Q7PLNK(#O/$_ER.T*$R8K
M419Z6E29 YHF:0I RC[1(Z(]T+OH)W:F*=YC$7O2$? USIQ9-AQWIY0C3+6#
MU7)A^[)AD\'+23I:M!%P[4*?^]=4TO+Z<OG,ZN.9'Q%+=BLP;AH;LDA(PX$,
M2:K\(RVDT #C7G%@B]66<J6H&->'PUBGUO9^9 01YG1-A6#[B@:_J@%1[[<\
M6+*9XC01F<'AI0'C\U4P/^>3K7.%:C0V45=6L?!S4GWM#3-V\&GWY9A<$12$
M(EE,4 2NV"ZJ-29JUC50=M</ @E8WAN,CTG[_F8ZQX&6\IFN)^(O!@X=;_49
M).PVQ_6OWS1V)"IKL]:'Y"Q!:-UM,GZC:=]A(>R+ED<W&H2Z.O('RQWV%=N0
MT6,F18!T05C78/#4ZV/;U\QW(;6381>1G_#FS4T3F]KLBW;;WEI;CA$F*;)M
M;?$'6D-;JFU,U=O9*IL.-!0=Y!5J:T'AI?*F[IPC^Y0&_$;ZXD1.8< <GC/N
M'Q-X6I<VTRA;EIWC3],UC5LZ4KL[A:(\^*;/OG3W[N$]@S_+L.NQ(4_R38+5
MPKJZ]@T'*89]=% #.)HF[#4OG$7*Q6UQ !#"EUS)ID4(.Y R:X!'&9,_ *>Z
MPCBPY)RV1?CVH+Q)-[Y'"QM#U02'-WCK+O0J#U3$HGS9IC2PPCJ\=E2FYH."
M(HH<A!R\0$A%07VY9F?FG/YVGH"=17=;MB8V9K- 2IR<APJ\/55+*F<M,REC
MD*3I:CY=%)IVAHG+BH8#'WII :/X?4W4W=>R)7<EFLCJ&&T.$#I).C_);K:L
M5?;L]>KE7Z1^FD0NC;6W\?EJ:P1$)"[U R=T*,1?G@1XB<PXF,Z&RLCFJIH)
MYY[-D0\XO9[]O='L[/%"<=.[KN$7V&:PT]6]8!'T Y'G-M@&;SJHEXV'-CRC
MV!/?=@!;+,9!3B-]"475PI%D.NC6Y/PL+GBY9W:+'S#MLZ4IX%$AOD7&I5Z3
MP6<K"<Y2M\@Y+=[%GM(NQ"N&\;SE!Y%@Q%KN3 1.A!,E19I3O$'NWV#:OT(U
MF*2=1063L5'5!6WD,60UKC6I,+^?!#DI_YL.\M%?1/-!/3.G1ESPE1O;LD*F
M^OB&H% 3(056#\LM\-W9*W+H>VQ3-.; 64':9_2Q+3Z74UO;(E%A_.,*CJ=+
ML&I#XY4IS(W^8MJ1V5A)L.L"AU?PX0!CN$,EZS__,8O3D0'@=! 33V4!3JC5
M<0X9C_N-XDTUF93T%1_>B;=#V1.;&WM5+88EV_RO?3*3>ZAZ5^1K!Y?%]1/_
M #<Q"'H:R)>?^-Q(![&WQX@W9QI=_"6A<TM13-7OOB1;>J05N8P.(H>C;.F@
M]QET4,HO.HC"Q;#YRC:2#NIFHL!H<3":Z>"AQ[&@@TY+]:+WI-%_%14/Q:X+
MK^@C8=0+N=QTT,_#4/Y[.Y:J+W*D=*1TI'2D=*1TI'2D=*1TI'2D=*1TI'2D
M=*3TKU2RJ8I=I(-B=K0PD?.EI*T->:WY)?&VVE_B,(QNR]Q9$Y"&WX JP]H?
M"WT0UR&X%[&\V.\/ %,ZR)5K8>\1>2)D JG8N_574(>##IKJU:"];5>[+@3N
M0O^5<A Y")S _MD*A19#[?_]1.1LJA.06("Z , HQXG5,>9SQPGXYX$+ H@J
MCE4KGD3"D$ZH[9W7^FZ^3YZHW'#UUAYD+:SL_=S+^%!//*$D+.B@V-:$<BH)
M[:(64#/98.:Q4S&NG)2^%Y51MI(9O1ZX;W]>^4KZY$[?SB0T03R<R*3))OA[
M6R.!*D3(C0ECIX"?4N'YL\B(;F'EKX$P%F2N;KN*?%'MN[5T*_A,5=:CR5]=
M#VOFIYW,?,5NJ%K)?+SU2.PICBB[,"6&ZQ02J?\100XA>O3Z,J"N A*4.P!Q
MMHOWL!X"Z2 !![C ,:HX4$J>%Q(DT$I)'ZDN1!$6T^/ WBASB-%V[]?U=JW6
M<8' Q/1Z]3>ETR 4>%\$Q?T5[9$,R YO>)"7=T*MBE$G)L) 2$@?'<2AS9TG
M)T]0C(9QJ]%!YWYFS)\CET=FNA8YJZ<&D9(Y (@>I$Z_$ CJU4I_4PP?\9QQ
MR]+?[TS5%S-Z.2#8H"#VQF(B4TJFBN-ZP:M'"57<3Z_:._)=P*>BA %N,G91
M)[;<,Y=5^YI..LJPTAF9T=MY81*S=0X8[.M4HTBL2*[U"*M1%A("G4/ZA.4F
MYOP8>8-W,&&3/$I=12O=8V:-C0W1N ;?*=O%K><Z6L#63BP02&2+![.&B:(L
ML,X0HBY2CRA9U,E%Z?C9')(+AI&38R[@_UR--G9O50_3+\3N7._HI/70/B,&
MHUX<)XG,9.WX8R@0*C=ZY^1A$9+T0M"\\'E!H)*(3IJ_,*KDDPYFHXFLS/AD
M+[)">LKJ*N3!L6K5?(AYQOJV_:NKK1TIN.(!^;Y40B]M@(1=; 2?W;XF97B0
M0@<]")4UG-S>ATWSDA:BVXU)V2KZ^XS)O+@#=$\8VZ2B6HM\=6$3(K9"VVP1
MPO+3)GQ^22RVW59MLE!D)[0=O^>QOANES4RH9G+VVDM/<Q//W(IQ&&K7)YJ9
MKRY;4X3; [:S57]NF[G3C+?<Z\=L5E=4L^7%XXU'B*W-$<:UM>&V,6O(>%SK
MJ?@&5D1WI\Q(0#4'TJ,GTYH6361C6TOG::V*K_S96EG1Z)"35K;25&OF@2Z&
M30^I52YECRO/?G,<%+?L^_BYX/B7,!64.7D!AWT&Y@Q37%A5'R;X,J$4*;"D
M68OG65DA'2IFY*'-6F^)=Q'^4"'=*P332Y6[QD'BY%Z01QH#U8\."O<(ZYW9
MZ*=RZ!'9<$+!3]JO$6&SS#@P)]6[:+!$G-</&=Q/% D/H(-.454FPH8]'L<&
M%LW_[!0A;R5%MLTYS@]Z5ZLE?FM\U">*.;@,F8I>#* QDY>[$P.U_4ELX3KG
M.L>JV]7(5_N@FGAM8W)W5P BH_UK@S?$9-PMU9:2$4&]%G W"]=YG/*CC9A[
M'$"M9)X/!D<_R"/3HGERMV=$^^+/>Y7$E,7$Y%FP7[>VM@;)E(!DGH) (*7K
M(BE@\LVYP-0=OJ^=G%Z3> ';)*Q'=5PN?Q@[U8"\],= 2 _7J1A-Y&DAQ7<H
MK_@M?9[<Z53#/-OT+FANT'@X;U^(@[CY<^F R730APR8"'BQB0[BI:DYPI4'
M%V%3NX2S$>3)A5X+4U$[9Y05)3FBL"E5_WFO<C\ZJ-A3YQH0Z5;NV/HYT[HO
MS1W_F/P-NJ*AN)==2AO* 640>>-U9)#F=% O'<2""J*<'-0?ZQ1#P,ZBK@=<
M0:$1A)\*&ZIPJL5[J(-7IT@S_L^^['3 OJ^ W8H#.DET3+1^3(PB,V5G[^BX
M"SM#XT!= V0)5ZB\9#RN!@C1HWT=5RO?"1DRM)MLOT$4NK<XMQ9VB6(;&]C6
M8=@#E:68MR"'@BJ1&3W!1<65JQE20QV=;\)?,/R,\KQ9SI"N=#7?Y$6&A:Q!
M@:Q1[7*(:+U,_=,[' R:HEAFL"\=Q @AHVEG[ ]/R <-'C43/NWLI4"2R'1Y
M?VN!8C'Z/@"QIMP_;+,HUK+58ZN(D"Q/-:/.2\BR9:O.A6MIC=F+'V)>>&6H
M/_2B@XK"Q Z2:*> \IU\LN%&9,6*P!\Z2%!'&' @=0OS3XA2=*I/1B(*G>R0
M&:;N6;B1+W(^"E80"CI&_E4-S_#.3DZ(?=7[*.1!%A'=O16-%4 Q$16C8-S:
M8OG(Y0]ALO6.0B$XA^V2UIJ.)&EB6T.VIO'Z-JO6WORLY6B@*7\E1E[*JJ%A
MO&&VW''-,23F@X[N87O/I]X8H0G2/HA@)&LKOHFSKV&9,;G1>\%<3\1;)W7$
M&W08Q^0)<=IMV)G [1Q#4"&F@7-NJ'%^W@86AUF8DNIWI9U.\]Z7<;2'%?>Q
MRA(*JWLUR-21F7DO&+F6L]^;TF8/!+^<A1FZ2.P;^Y>BM,<V+W2$V&V9515L
MA-;IMQRH1^^8 [ G92BM<6I@* D;'T^.N-TPJ<,#A_&@W$J1> ,RM*.HB[7Q
M);%@;.NF!=#4+W#^7-I7%)K"VNY*JN1PS#;8,J4(%6Z6ECHY'ZA=%V&A@[I4
M:!=_HCG!=Y.G3:%?%2(G&A/)'EUT$)LO-DA<V7$MESG@)^T\HK$.)V,HRA?H
MR^S\5UGY2=#CRA/;]4/P0,9?5-G#^EX@2^![Z*#96=H9Z7V$3JH\]CG&-T:@
M:7V7C(7]OL\#E1ZC2E3!TVGJ$ZI3Z:Z^3XK!U LB;%7>VQ"9^R'Q^VN"]HLY
MPS88D2(T>2"714XA[,)A?"%82M4%//*H#I,8& ?J%CD#!SOO13M'7HAKUZ^:
M=K1#9!Y4J+,>%"]>\W>,&M7$='@0PDH7O2'VXSFA'M:M[1.;DIWHAV2IIU1!
M<G^WP*FG8<* AR$9':$M7]Q;"*!QP:RO; 1L,ER9W.V\*_- /BF&*2&QWQ7]
M OWE\+:60WZJ=<VG'/6Y;C,<X7\=0)DI(32#X>?8'24S.JA8D=6VPS:<"J6#
M7M83% \2K- K@[@[#&/4PS@K)3"/#L([.])!YKL3JX%+N2<.0]YL3_0VWH8.
M&NO8#L[^MV#U"/]Y\/]>XO$O;^A'^.\$][((=Z<,8+B(CU"D^I%,LUX'E&NZ
M-(3/]RUL."05ESHSL1:]*?X O32_NOPI+0)RK:-!25]N5^,<CO-C.] .%62(
M[''UPZRX/'QMHJ;$]];L25F Y^U"7JTT+W,S@\O/K5YE!8M+FUR.?Y69<"_K
M55:=L<^L1_X(+ D/(UOY\M%!W@,2&3@P*QMK_)*2@[-79C["MT@NOE53C<]D
MRC!4[F+<IU:GQIU?6A&LG_IN88O13#H*2!42)&)#VVVQ?+FY+D4/7F+G?"'Z
MSHB:$3'.,5'6NI%EC7M<5M6GFBO58>Z&N*UZZK"OC%$8.$K;8''S<M^]A_QG
M?5EL5)AY+>V"&Y2NF& \2Z]\ZA3@:[WC%E-XRA<N8V*>\E;(J,M<8PE'JIEZ
M8\)5_$0?^D5!OHIB:;(2N%I5E6S^/DYV\VS-^[A+H/\G5)\ .N@@,8]NV#Y?
MT:''S(@JGR__YQF H!4:,QTTH/65#EJKJCSTR"&KVUJ_AO]Y"N#3,Y?>'^%?
M!=F!,$74 S+;AP-><SPJ%/W$ U[NQ5H$'X'OH?;2YB9F'$V#+MA=Z/N8'\?9
M"8=>2?L>R^SS4A_)]HP.\@5'Z( IN]'M)PK@\RICRQ3)=ZKE0O[0L3^.K(+[
M!IYO5W8^W\5O57>-5ST/#BP-$9?<^S$GQ",%3UU6.7N9@"I7RGOEKKEC_WQ(
M2>WA'\^E;;\[D_+CO9^4<-(69E]>(30-4P+O2#>,_:AO>4ZY$NQ_9]F&O>2;
M9438]I*/8U5&Z\1TH,[486/].=0==^G=L7]&[?8_7G= N4<5U>@@3H2 S[/W
M<$JL+\89NK, J<$8!"9JKY6_$8MUL'>^&*GAF^F1Q)?V/<"J%I:U0+8$Q_!D
M&N)@+*BK40]6YQ4I+,&]X[+#&>^0CS3Y9VZ?^N@3&#^DLMX;\_M$VN+M>4?N
MOU67B3(H:9SF\+D[B5K)\EU?*L^HN1/. "V?5!\BGQA#C6U[K?.-FXO%BV9L
M#?@R!]ET"]U3OR>.!DM);G#_3C7:W 8#E\ ?!-EX[8'',Z2>S*)XN<K#L"3Q
M00.<5W=LZ1O[>0>G@9,=H5X)Y[]]FX%#,-HM<OE88[[^G<<11%:V7BVS] Y"
M!\P<'^!LP'XMJ;30&1?B%LA."K#EV:2D5)PQ>L/&%3?RL52T+GE)IS,2.+YO
MA/R]>+95(4 V?4);%NW/"41WX4=;QM3$!2U-VW3L5H(_Z1[K*G54@ U&R0*^
MWF*.P31/@DB!^]W?]B.D\\*<^[*\]B':4%O=0JT6DQ0+DSM2-NV4UT8-A6#T
M6L!8Z153=D\7?'3TE^(-@9X^A;<Y?XACQ;^\6PP[VP?ST_O_1.NC*LGE.P/
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M</YX0[N1P6IO1[Y]TIV[]UU/^Q.D6%-06[9?>[Z\]U8Y'>5JA!A9==.(>#K
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M0I8R5"F#!<]^&!C\J?(M?O+*I?:MP$_YC3_*!R+T#.MAY'P3J'$I0EY:8U:
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M\W1!E/Z-9HG!;ZNYQ^<>-/^.)LK).+M@P071$Z/N1?GNM I[4#)3D^I:102
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MG4,7_8" 3BU$[<G+X0]1'EJ.-C7?;$PLR\!<MKGB;($7G=6UNL8*7+=IEK'
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M7 ># /K5N1[631YXC+;>-83J=R '[^=R/"EGPH,JA2,G#IS1/8@>KMHUDP(
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M6,K@.'@(U3%L!74/Q;;Q?J+$Q@3>;;$H;R]P7+'C%9$D3)10=OP3A1)?CS#
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M])+'GP J0MSH9$*QB3J///"#![_V(UZ=9UT?K&@.80(=&[>N/9(EE,NTW[Z
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MDW<)D6VVK&:JINF3DW?';S1LF8:@@NR>KRW.3;OXOL+-B5*LE?BA#;Q(=H2
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MEJN^>=S:7VY5H:/D%E\N(&OO5!525AY/(-T2HV<C4&0>5B]B$V]+J/[GAIJ
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M=8!O0(?]=XISR'GA6E/.!,K]\)<H9P]MAO/K+(_WR*Y[<N2$\Q7CSEP6>'P
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MNE.^@-OE"=^]VG)/,R\IT%:X\1*<"#E=8[VP,Q0)(0]H-*_6)XF_;IXKZ2N
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MU\]%E$;]C'$9(OHS_:Z>TUFG$*.I-76SBS2D._>=Z&'DK>.2.#)KN_)D<U
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M@$=[:L[=>&B\/1X+OA9&[T<@K*W-#CBP$+.* H-7.^..$J3A^M]K9KR;0"E
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ME/'2@;ZCKSU:'(=5M<TZ[])T]>3O^22;6/C7Y'9S$N/+[@]&I.1W+G>#LK)
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MC5Q]6JMM]"F@8L14+I[JU*E:"3DUC@W@M;*:V.[4*H/DSF16;H)NE'E[!U9
M@]BMOMLM0CB.4+[&4%^W*MM^D8)O'/<-KWW^MJ%@JO,MYA1$%B')&Y-[B(,8
M_CO-77S&C#^VXJJU;B<H$'\.521Q@*8"6!@+O%GO-*I.WB)&1M__QY"9];HA
M7*'PWG?%(KHM4%&,NE;%>!GTK>+/%N[" C]68[=@VK[/!JM-Y;\>3<P][[GU
M9#1BY]*1:.Y%+6TO_&L;S7">3=!DMT[-?'@KMSFW$$L#?#ZEA>]^<U\SH!8N
M&W[7/VR<MF]NEGXV__>RATMK9V_+#20;77/3&W99F5Y_@T(@$O@/9JK/M%:[
MM4(<@]/-S? \63-0U66Q3)_0S_,SDC#(S?^4N=#6-2UQAD+.![4=U?H[B)&*
M(L-87@5J<L**'A.[B\;FN^"6#=A7J=GN?_"A<WB689M42\[@X=W?L8F[_QX@
MR>.7K:XPW;?$I,'S^^&0IW)/,*XMI3')VZZUR6KPI1TY/*.0:GV@>"Y&X& ?
M>0^SND^@LP;!<&0(7AQ/1%8/)ZDA&V#5UJ%C/HGK(_HL!<$W2S>!=OD')VTK
MN\X/9.EC,EW81/--$X(,A\H0LR[!ZUXQ^1$+<%[*(Q)\D(]G@L)8.U@'4^[!
M:0_,G[GO"2"[2'SU?K>KA T"KS>T1<\,#UX:_3;K7[%?9\L7W>*=C/LC&"<4
M-?DH.L3@WB+Z^0N .WE^T,WV A 9;""'@;+UPH)U.F:1D#KONM+HL6&><+GA
M-9>T-?>^<?[TVR?/]=<"I9WU)HIMDYS-)YL1P9X)&F6AGL[TROS H4"IYZ-?
M3YZ(I0X*=J50:8-A12QH;T^W/I^49@@_HP8S#+NB7>!'!'8C\'MT>:T+>BG?
MIE+B KF*'9&_&H&ERO\\IX80$9BPR<$Z6<*N/('"[AR%MZN_]VV_!L/[=]0;
M/A:FCZ:802">DBT[Z 1Q<I1YX=V B*N@,2W];!,DEU']LA94H'VRYIPGX1KB
MRE*8/N#:5LAR:T-[7[^0(\>8S2P]+U>]%>07)3%,2K*9S#-+=.$XJ3]S@/>&
M0LYTPZPO#7$?=*MCQ[^G6W)*G:-"NJ_<(/22#ERURLAR@\]3(E$3SL0^-3O<
MF^>IV:A\NY]B\S(R]A< (\WE*"J7 3IQB2?,R7E!]!UQY#D19S F!&:'E<^:
M!0X:8N&]G*7*B_0\5S"*$:D16#A1?RF2OWEP(#QX13:6$KP"I_/0$&[\7HLL
MX._-6N1/7MS=TL+B)])-E=_6%56V+]AMS+P-8(:7-#(V[ GJYL2?H;;CSFZ'
M <\3":19BF3*'=A>GQ7\SF"T%;B=U%*,/YOXB_QR:]TH13?A*7'QW9'*FH9@
M%W2U(]TD)%=2Z^X_-W->7P!,Y?=88& N?#X,*AWX>:ZFT:Y(UAJH LSP@4$<
M*]XERT6I=>\HZK"*ST;).+BH_-'=D5^7,V;<_T9SMV:+M7)F>,-5-5F4,_YC
MY53?=(5EEH0C4+^P*3"\3%\F;&;5P_AU_5$@JPEX3'?W?]R&2//'^W*]Y&'5
M==W.P'6UU1O'/NYOQS'@F[)12"X!7Y=*$*3"!#4MV-(VOZKGZXP8"I#9P>3L
M8 E8&Q/!CA:(YF/T<O3B]:D#[P]H3@H\M'S<S64EA=?]K5)*N#KS4T6HYG6(
M\I)[:U.(D$5[(W*JTS#4248@1)#CZ#2J2O)1S;"F,R60.(D?[V=06M(AIR_+
MWJ \QDK+I!W-OB!51 =XL_RPM2\VE7G5/%.S]RK:N<'D5Q);:<J#YR"EUX]D
MDDK<J;S8&@59Q@TUKZA/$,L&ZXVW&DF.T'((R#.#CIG^(8/&L+BTU([C8W;)
M4)ASO.(5$P !;3FJ;D#]3CR^TG-_>/5I"Q^GE(88SV$44-'G!]WG6NW>]^7E
M"(LJHW3$J/+-5GT3OZ,X,\KQE2]HTY47;FPC?-63=21%=_RC&&E]"U+  C#_
M,.2GBU&^B(G9ZOO\-D*9E\XFQ$0[1+/?./D"<"/BIC5N4Y,C0HPLAE_H_A?%
M6*Y+*+H#.;6GUD@KA2/.^ UR':LV=SS7=-?+<R !I)#4.+87<45#U>85^K?+
M;'KSA6HJ3/7OI!BZB*;-&MJ<6K+0)@P2)/#W5>QTY-EL6B<PCN(6?4[ (3'1
MJHD2KJD\$R-#'>G2O#GY&4D\>#[F:(_L?<9&UNC=LFW,[K\ ,(=97<<3E3%;
M])4[HMVV%A(R'02&)UG.G\A.V-^#4!&<K?W2TD);\Z24US7NJ+&B?=D^-%FZ
M?AN^O.+ON9P'C]-D][:43&FT(P?WCN#'&8?\N5UO[LE2O$/Q"QZ+M*L"#/T5
MT8>BR8II8 $2LP&E/P(+;E9.@7OP)W2+D-$D.G>=VCH%I5ROU->3O&(8#=[/
MC'RI^ 4!L>#4-S6"(<)INH(&.T_7SDQ;^2%='XOB"#(/>E\1&RLR")5.#=,N
M0UQ8#Z24NG2(A9]5F>IFB9'$D+^R1 6GRLBI<R]C"?J.+U^H <]@#A\DE=A]
MNV@&B&_X7I6ULO]V!Y?\%ZLH/KGW>WN@;^:J49*V/C")MK<6-E."J*?.@IMW
MT75;H.TB_FYY"!8*:BE!:!254DQ)"]&9KTZ3?LTFN95;8^IKE-Z&(UZ\:FJ.
MO;FSDZ;R\OICR5/T!>"](<6(Q-BO^0/QY6U%0J=!+0S=STT3UPG'UT+!)+[:
M\#IH=AJ&T*5E^]E0UV)J5Z:^[A=R KD@A_WQTVB'+5'ILZA@'(!Z:=27X1PP
M44WZ$<+H59/O+ .%K)-A_GCO'<Y(QAJRKG7[E-1!0016>N!)Q:89)'A@P,94
M*-";>:&W'O*H$TO=NZ1K7LTW]>_@?W6S4AS(WJ2BP5,K##8LU'%EB7$1V@W_
M<5@Z>\ KCWE;5I??\G)AP2"\7#.J>:A>4&GXTPQU$5:H';VW?0$0Z#DIL-,(
M>8-A4WG:S=ZEJFX/T6'*.X+%#IW9B/</F1W;(J=JBCK3J9&G6D0'1F5BKZ**
ML1#&R5?5(3C3J1(C,%+E]$#Q,_%TQ@24J5DYF?GV>YF41Z:[%LZO_>ZT8%=^
M&>-&;CPI!4"=0#== /H-]9K!T6@>#3;8'LA^;B),8F7I%C2WQR)I#<)B,'FH
MNK?(Q&HZM"[2\=22*Q;^<PAUR?+N2_.Z1_[GF9J-.]WRL$,%PV#[IKR7$^J2
M91 U5&RG0=6<EE"O-X?1Q/9N=(&+%,G0T[,2:K:1&S[ZC8/]Z-C4T%M.]Y1"
M:M4/$(FKBL=@&#D@5ID>'HGV6+TIOU^&+6E6'9XB"-V3K6C\F," :T"CG8QN
M'D$^?F,XR\I >L#X?M5U#F65Y15MPEVAF\-^14V_$H4DABK+9[_"B6;>9/&(
MBC/>#2H]T;AW!'X+"N?L?#5>;X\C9^'6S;"=#Y:A_H&OVPN."BHV<RWF/=2H
M]2PX]X>[$2._-KA_'3-U:'G>74I;HM=<;BEJGLDA:6% @_U?*9($>!0:>J:<
MT"F$A]-NM(N6!W1\7'EO:/QX6J0UZP#*;58UY?EF#\E2OOEB5BUPHMD@P79'
M?G_\J.?\7R\T9 \G20 /*-F>A?/TJ7UM(D;D5=T_,TI?[F*^>5!TR\;PFM^X
MIUNP: Z$O:1Z'F0HW;BE?)K1,*J:62?R!\X1)DW:>Q>F3-SO7Y0D+A:7D(,)
M=>\J87E?<LNFM*4/%X0,9O8">#;^?63ZW%LJ<H#VKV%<(#6]"I@G;3H,0?.,
MPA#*?6O6-3KV"?4&5Z.J"SA-T0U'"ILZ&<#9I%IQ E"E3:>6<%X* <WHGC[X
MTGV-#,_P<=#+\ UZDNFLDO?PRU2R8]S@F7(.W'W%)]#W8\UM&YMQG$EMIJ.C
M)6OUJS:/26NUUFD1,=6B)5T,.&'I%E66[*U-<L/ N<FA_;E*765S'D=R$%!F
M\VP<--P+9:);"2E\-170\3LUW@&"2T(B#S-(H][!U^0Q@K)K,10VQ-$<B69[
MB#CRE.Q)'",U+\7#.3T#8TM(;)VUO'OOP[A>"31-!]8J##S[!WI:.TW8>'M]
MS6K[+P9;TW=9U-YOLW]X_S]?J7NT=_3/>2E5@#KE($\\3J:*_!P,KH>%XO<B
MU0'93"S4/,9HJ5*.]M'>R'C./8INW>(F56!*L"6:Q]WK4$]ZY[O6K=>GL.Y'
MB(3A!FN8XR(]OZE"E5FM/J**AA9U&)_:I:*?.,4AK3BJ*F96*&]:7D]2?W1@
MWN-S ;C[*Z1.3#F&V:>%N?PA3\)( YG341+#$I.DG(Y'A*I;O+7)I)VMW'):
MW;[?7/HY8J"<+Z#!Z_X?] VR_ ":M=.E!";;HW:[:466AXPR.V-/_;3A8U#I
M@6LIULSQE?^C1\NJYQM>N;2@QUN;E,\!2B[VOU[6U=\'MR3/4VF'SCQ@' -!
MW32=YT648 *#_NF$[!ND]W5(&@S=ZV_[\<-7-Y)KW%$MC4'6XHMY8\^:)<BL
MI&86.T?RYIA!R@\X68#FR[G@4H\FNZ:[O;'1>_@=CT6Q%'Q,E+=7K0 T25;[
M>W.7L@-)>B [@)2SD@!&SQX@>&:B'Z<I1T>*B;C0G#)4I/KH\,L-_U[Q_9BO
M#?Q1%0KR+=D^<8PQS3!-RW^]JE;E7R6:P1+OF[[6'2%^+BH?P;"2.!(-"Q49
M]B7?2LN>:LALHG4ZKQ-2+.!6+ ,R,H BW?&-)\:;2'%]-K'8*KH_%E6Z/UHO
M &K@AB(*D[%NV_?:,/\SQY::0.C&FWJ%HD@^SMEL(]1D\P5 =&OG?MAC$GN:
M,+H-W079$4[0)R;7ERHEOC'&'>[HVYX<[,@?[WT!,ZHS$)MZ<]W>==\E&S\A
M6D4JO,Y46&*$^1NV3"J,./M*_K0W/ I]K9VU>[1FXU6_YR:WL&0_HCC]<]_.
M0#AIS@3\R25$QCX=:TZTAO6&52L^8-:WSEVP18"&#97W_'2S\L$]-Q%")_3)
MZGHKC'<:)OM)HIY@)JUYM1]VY9&;)D-_CD>&V#Z,3*WJ,R=I+G1J&T,3JNNV
M","A8:/DHG)(NW9;,[9YBU=N:D1J;=ZX&=6(DG\QO_81XWG7Y*01/2J5%_QU
M29XY!#%EXE ]^:PF*TXFIG?8--WO\A7LE^Z)6D A'"_UZ;U/\>* _]5WG42W
M2)B:,7O]W_R#BW1@WDZ'MS")3HMBV00'W@[**G$.S3VBW;2V?SW'$*WD.VI'
M&BN!E\(D![A;LC;8*\K(MGW<R07")0$F2W,0Y6"E%,&,?U@-8DO<KM]EN\;J
M%4-F*>KK%F@CL7;+%ME-%_6;0:4)$NJZ1V=E,V.=LVB<F WW)WU47#7]!>!@
MNELO:U7F[P)A&X#C:4R,QMTZ]6A_U;44Z62;NPH2?_ 134 D"7IGHZT"%)_$
M#;U]@O7R7]>74:]%OUN)4+X F"U:L66?AZRQ]*DNHC^;5SDZ\!IGG@$[I\4.
MHT8"2O@L5T-+X>%4Q>]U82;+>^QDU['S9@2:">;F\+TV\)G]>/G/S5/[F:+K
MIS*WUYJR\%ZLKWX-W&#4IRH?7 #(HDL[J:$DO0CV$:)SWY&\3&66E89J6W-J
M!/>3"IZ26[D'$2K =MZ=Q*#A6<( =LT^XKG2?'G*>;&@3='6V?)2O%?G?_:B
M6R5YN]CLJ3L2E[XLBG<4*&7FKO?Q<6(/(:NFB;\M];P6!@9=>GALHFD/XO%X
M/O6Q,,VLP ]?\#XJ<<XNW!81*+K&(\X:EGK] I!7IKZ7;PJR:E0_.#'W@Q%[
M;I$;LT^TU8 !L,]9DK"A2SMN6C1=801$WC(M4<M8WY&86O4[,C_Q>(J-]S/4
M)_GB-3@HFA,:K&$JE[I6\[;H N.70K;O%,GR)IDYL0_:D\L-9RZ#WU;KZDNC
M]F1^N05GK86\#@[R&^SX%$_F1GI8(2R[(,-E'M-BEK5Z'<-E^FG^^;].ATV]
M# \]B\!&^1)F4<"7B1+82,ADI$7)S:? ^XFF$SH/]$0FA-;AN)*C0.+LCB'1
MK!]\4UT/AGOH09@W):['"3;;GE!D";42N' >V^2A"N39ZP</#5VJ;*2G\[-/
M'QV5.+/M9* D AE_K6]'70"NP4G9/7O)?!SD>E(V@?'=X8(D?K&#/TY=!+]T
M->GMJ:>;W23_&'&WI&X1>BKS/E?]K<7I_.;:H'&"#:1>:F=GH/BNQNN4LUGM
M<!V3@9]ZJ;_FDK6R5LZC;7/.P#6F 55&I;QO]:,%K3V:$JJ>6OP>4-A449@%
M%FCH9^<LN]I)IJ[-%=*H#+XZKWLH>Q31^ZG*E"FMQ&3F$\(L,4,2J&A7<5UA
M=S[Q!+_+WVNUHT7R-R.ODRX !%3?@JY%GB6*Q)AXB,'/E?I-X,A/!ZBAC+20
MF83>0:@S_BQ<XV8O\*2NT>XK=\AJ<!5Q_N@->8_DNJ>=\@5]LUL$%F,PLUM;
M'-/WUNH=Q0".GP^%[#+3*DH6>#&H;+S\8>LEK?@-U="KM+VOW/CAK(=$0[T9
MA==DIMBA2;*1W??M8)IX5U3M2(T#60IF^DBKCYL-.3UI[_";CWLFN?9&_AN?
M/>\2!P^0.?;WT>A?]CCHJ/MXR%GP\OC-WWP 8DJT.@/>EFTR3''Y_.ISXMB'
M5S5V( BW2"1W4-'5YTOJC2+(3B>;4E&]TB6I1.S#!^=GJB2$P)#?FR+:7E:!
MC]/6:@%B6BP&+)%EF:;%,15&2<#4 ,=;VH&R@8.,JB^1$@8XI(I_Q,,LF$W>
M6ENY6SS! ]LSF04,++9B-$T6#4G2GZXPK7VN"57]_FFE.G"%>[:*;0AFM"AQ
MID.= #-HON:/E"1='2PQS=-M:,-2Q/!HQM\^\^.UL!A0[EC0Y$&XTL..A(<J
MW]Y&Y(7"0P(#_:^QM[!SR*6H^7I#??>SMX/_^].US<[LR6AS<G %V:JOB#$L
MV*WTYQ;.*[5NP=JC/3A6(4]"(.6EFD/#JWM"II-])#N[#506>\V1UZR2V:(T
M\@_.KXAHE?(!A.X'STF:D&Z\3]$H(P;WS6@R[]:L<$''&4"0]KHX@N>_>*LS
M6:,9.%XP]^F7A$?LNPJ,PI45)Z'GA=0'6_!+C3^0$@/F.&!4,T!?@Z6-FW8V
M1LV(SBAPH7[ LI^Z^9BPV!'/%\O*%$I9&'%]ORV?3V2OM')@\F,253B4!B<+
MWN8;&S,EE<5DS[@89?&PZ&2J_5!C*?9V4U-!BI^!IH5492&*^CZ98M[EA$7E
M43(TH?$G[W.3Z">F6>QEKW]+3-7JU-I@^RV3+$]*K!A<\?JW'X3]$\B::7;V
M[5-;RG78( 9]YU)2U_/"=$UBK(B#"<V&RGUJ[&573F0.1BUG'H[HZ9__+OM3
M9E%(T]>R+_6//D+*JZ2BOM?C:4"%FH4 ,%!BS'S3+-_.C;:G=8PYH2FQ1'CJ
M$Q927EBQE9KOQCG&;!9)**/5KM(Q2>MT86_VT"O/G:@(8#71?O+D_[\]H;YH
MIK#K^*+X;@ )C>'G_M%=MGP!B(U@)G&\#S-Q9/MV9&9/AO=S&R[&(7J\0]^0
M%FSLAAQ#U>87<4.\HZ54^]'.U%%FM0N %%49>P& +)&%!E.HUS?@+**=Y(U+
MQ#HFAYX]-5BY $2!COY15W1;*6(@5_07W=)X"#,S(9H'H91Q@0M9;4JI*_\Y
MWPIC@T7>K*.P$6SW+KU?3%28[O*"EA4I*Y/_D('D3U!*)7[ P_L8X[L%'@8P
MQC@PS89!ZEH-JEZ E&,43@[M31W9,KM6?XU>3VK>EU+*0G'(LS+UW$J3*SY9
M.BJPE^SC4SV/G,9B0!.*1;BFE\-JMIO<#HAR#_Z&V9W7/E\)MK;S//,V;^^G
MT<<*_U+W_DK3&$9/7B=Z'V4015-(\&5T@H(Q#QEJB8(*3V^SZB(@\E3"YCXF
M]SSJFZ_'Z8U:-Z$G(D=Q51A/7RZE8P>#'D5D7\%@G^;)'77?"X 3/ Y],!(*
MCBMJ..ZQISF"70#>=U)GX+?A;M-JP5_LK99I(BG>)*$>$'/O(C,YD&0&)MV.
M"\<STK7:E*NY3$*4(U0NT>Q X4P8!(X),ZN"Y 85L">5VS2#6^!W+N?U,6GP
M/(XJ>CFQTCN ")M+EW]+<_7NI3O<]B'77P 05^WJD>@W2W.#UN<U%P"W<>ZP
M:]@("0_X34?2[%%X-XI0*_2$3Z"S2/=SN[V^(9T!X\[2[8>0W)9B:$5_73]?
M%>W4@<JA--W3K-/F20S)F'('0S49)391!QGC+P"GGQ6'SWW;IZ2D'&8>SL\;
M**/;#!ZRMK=%+^S)"ENZ[TA;6FGY^FTF#UT36'6Q!)9*?*'9AZ\P,E^.TN "
ML)S.\MM!DUQ  NT=$<Z3/ ]Y-5^0W]60HRHN^R9I^3FRP&/<&-D1>MDBFZ>H
MA.:1^1TMRTLWSF(':QI8I,NR7B&N-3!&R<AV*OM=9LJ/7.\?%1LH(EZNCQ0X
M5S<'U.PG##X(;AQ,5+=97G@KOA<P,O.=XK8LF5,CB^72&*G< .5"VBO_T9*;
M7X)D;ZV.WPUFW^,\')_GM[F<^3.9L* 4@E*14@>^_@Y%C@3_ ,<S3ZY*$!AY
MMQSD)F3#%/'C /)3\5_)N_L#W0JS@8\T,86,C9.V9T;K?6K)^;D1,IWE8":B
M['810?YR27S'PIV76#Q2K6&SYN?9WAH<'KEYZKD%61]6[.$]*)\'3[$@C>(R
MLG=?\-8U)JD6IRVCR33.Q6E[T'U&F<NF$9WK@5Y&P9X7BL7YBI8$DJ+__,+?
MV)A<2>E+>F0+K!ZE)CE[M?W306F])70SCG3<=P%@]HBXK/2'J(BKMNZ3>9+&
M_!'CLPX\I( [NEZ:*(7)9<V$W*X:CC2]6VE.LR!B1=3A%6$&!@S<"33/U?T-
MVR\V=0$@/EL(3#_B_-[-XC$SRVV5C':KCR_BBF"BZ!!7#W1XM3#=LC$$]K:5
MA"ZY#=_5;S-'W8K(=[N>I:W-RCZ+-F488Q=_5HW_W+SV)1O,K[F,N@!P4!5M
M(7(CR^ ?Q_C;'X@S2_TF!H+6]F%FI)0/9:AT[<A^N4%X<(6[QB-RE O"MOU;
MKL5 INML$/&GPX:RS)6S8O!XT8YQ]::&X&51_D3T\C%,RQ1Z,Y"=EX\J"(8\
M+^:8WL_:=6&['VU:X?YA'I105FZ$66$^?UOA$<!*C;:^QX/P%X!_/R@(6OP]
MPEDP4?;<H#*SQ)2MU'J_*]4FT^8+D!:0GPJ.*KH<ZGLQLN8E34I=?H-%X.1_
M>* <;DY1=!FWIU<63#DFT8UA8M7D1C";>_>-Z< K@8I=H\W<I6!6=0O_JB7O
MPN%Y(^*K9\\5#?)4%'T8)U+(XL(FQF>WJ+-Q"A!!V>U5TOM7=<5_9RU]P4T1
MGU^AJI0GJSI[5?^N4?T+7322PD_.@I.5V7$LU9L,ZA% 8X!AJ.+.-U0*OA(.
M@<AZ'E36A4THO U3@R&_"S4&I\TIJ-S.2)5^EWP3?0DZRY47@#L!\.@+P&>:
M';T:J#+MM;=[O3MN>&IA%)^>##(E3IKQG<((S"E%9N^H(-PM]8N$I^>U8W]/
M%"HSFU ;?$1+^G&9M(AMQ'#6C-4&Z8,^&0(E&5(T%8)0N=D4J6>D^3"OF0B^
MTJ#9B1]Z$5B[33"CPEFL["4(3$*K'H+?I'H]UGRN^6I>10KNQ/B#2A\XST/]
M!O]KC].19N^0/SJ":TK&]F8E6G%TJC:-OL5?2#VJ "VJZ;S$[/%6EL*A>T0A
M:D>NS6,T@&3(!8"6O;84P]MNNP!+P.R'<:3KSXAZ"X\?)5B'V1!:6_H53,9%
M._P?#1M*^2C RS6)+RZ)["U_W_@/H2/3V6;ZXD#/DC N(APSO[<P="OK=+UW
M04TSAGNGYO-PZM=H7MO>V8@7B87V"X@GX6_V0?9/U-%TE^BD3*$-)&D>'5U6
M(3X"-UXZXHV7MB7<J#U[1)&=I<Q=SXX/N!P8--<%G80T5!+Y.+\(&;\ W*3!
M;.6%FPWG\!&HIP,S,+&FZ=K'-+O_X^PN/K' Y91XN06[$6\2S]?W!G&E[_D%
MS7[U_I'797_ZZL3=0I/N$K%OBO7#3R7@)[*R%P FAPUM  Q,N5?$=@'X778)
M]YUHBC8_\7V8U07@4_8EU?^Y )#8=C->TESZA%Y:$I@:#Z8:C%P ^DS^;Z3_
M&^G_L$A@D;!+A?L^"6;;BRMOP"_%4&FGU,TJ-]22=C.5D'7@^0WNJW;6H]*=
M*% 8NR8.%(UPG7SV3,=M F0]GEO#>B]]4=,5CD/U+C6S)9Z:MWS @.\$) AW
M3%-4]D-F4$?50[=PZ)@ZNSBO-^P005N$011'^^OT_ENUP?3:X9J85:JPCQ&T
M4./NR#Y%1DRIZ_E HF-L$C?2O:7Z)8:P:1+-PN0 E,MN+ :5EG$.8?*R+']%
M/Z0WK6^(L@#FSH'TE%#ZAN)#AXW>]:[!Z/^2/BO\_Y&X5;L)V">PD.._Y*_[
M7XKX5C>9XE)"42<&QX5YUS<GE,*<GW=.[UE>X6IMM;5.T'9S;QQB-0X)U\QT
M<[N;-I!F;\RL$,OYF:)(3CH+IH20HE&5/V%N?6#BWS /&SI(^XTXE])Q?\\W
MB6%M,H=;"TKVH#6J!<ZK%%4X_+7U J#;@+*+IAPG=QK@QP#)S*J8 2??CZL2
M^$9*>Q*P-<?D@V^6:$D]F.%IYG6S8P^SVAV@<8YIF8E9-7XP8="DYT]U/C8?
MF7@O/0CD_[ YK3MOH2N]";7-\3_K#'+!\MZ\_%$<,:(4M46Z<5F>[\P:$Z7D
M 879@_FRNY'.#Q),FKE^=>=46K]8"BP%ZA?-,_[-SZO F(R^[1GFZ<*]H3SC
M7R#6#S+_P\275#<_/S_NSZHL%VF;I$'@^2BS+=.4A2IPS-<-N?[M <E'.<%.
M=O!C[H];7<X^7)G<IGWANG(5.OE;WS_HE]E)@]BVL(CMMD^;9GX5H =>'OE5
MO?Z)CO+<G&TJVOHL>B-903.2P>QY1K/3[J=SI3_^9]-< XT0(ZY';Q>9D&YW
ME?S.8NJ;1"XBJFQ^V)[HUZSVH<R>U2@AF)K3?CQ\HGC"<?8,WO,8.?H6.DX7
M=CMM!8/C;NH)7$'$JM??\>@ 0^&O<-]J%![2LC)GHYA:D')JZGHE>BQ2W7N<
MI/7;/AHT6SDSLL=(UBQ&&8S?S+<'3?&& U$T*N*]ZA-'F5MC67Q%"N;556-,
MA3_R[>]*A52/+,(95+94-44F@CU+.Q9*+P#:=>H\)(VQ16@'.OXE#C>O+7S,
MH7SSN^U\#W-V%J0\TU+E4Q);H9ZPR[.7-K& 7/+6T?OS8A[\;*3W-D69M*1/
MJD@XC*U7J-4T)CJ4N2"&2IX/SQR#LFHKK8T?=:<=7?F!F_]V ?!N[6*2LBQ?
M?-B1Y_T-S$R!DKM6>#7VGI.,^\;O0MNUC^>H<Z6;&L+37@H=18W9[L]P_G;G
M2;T=)XFW5-+,H_6TAJXQ\!=NX()*$(OSD%S#J-VJ*H=A@:;)@RV;/6^OM5?Z
M_9Z0-VGCZJ5_/?/5^?98Y:[5?A%KN-"#D"SV;MO>-EX[MA>>=!_=5TC3F7:>
MW)GSI64?>AUE#:W,<9>&_U 5.@3*R%3<40>=?%OG>AHE=MN]=7]H4:]+EHU7
MUC//VZHEMT5E#VG[*UY\]U#:P*3]9NI DP,8[+!@$&6NS6SL'^@OOPS@LRF+
M4'[H?RIT=C^B'WWGL%9GA,"8?)#'?\M]YC-R[-TG<G6_%U+:\H\%K6=X"'XK
M+R0+VSNCG$7XZ3%T_6<V!.)[/>\Q^_(9>AMR=G>1++AO2&XCF8[6=EHP*U"9
MB6&_E<FAXW$EW&/M%2JSW%QWK3>*]F]8G6GCU1J2&<0.9KJ,:3M9?IW&L)&2
MU+757S]@&EB=8W/O$:_T,\<X-5F/R55NMN=/.[\+2[[;7!;O953.K9R]"K\A
MQ)P+J7J:8%"6[V)ZO%4OF@09G1%[!PI3(6<[_@7Z07G2TM@2>SUY$8O9_JX#
MH/M+ZY8$-^!? -MCP)7O=$W_;UZ FY>FZ0FG30C7I&VG3? __E^A";.KO1<
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M07I+D!(DA(?[[)W?\\[\?\_,>_+,O =K'^W9LV?MJWP_ZUI[76>1R_-WC 6
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MJ2*W1UABX_"B_]8.486B+64Z>J@)0_GM ]JJ>%L-KA#C(8]@*ET+/M[42\N
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M(0--8'WG-+Q4WHOL>XLJ :D=M" ;:,56'H0R0-R?DJ2S TO(V2;CKZND%30
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M36]'$EG 8^T"(=F&QG\!(6^P$X/)X!J9#UY>K;Q'VE-/SVD>9SP*]F@Z44?
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MMF!@ASO][:4)?[QKR2P(^-B+L-8U&!K'RSS9RE8&F>ZCWOQQV/; <BQ@CPS
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M]FJJC@DU37H>=##A[#:STGH6)\Q-_N&3#<4(0^]7-Y$_7"053SCI KTB2>[
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M-%W9PY!0N%LZ >^QTR ]"Y(8+[XML%C;.WCKZ<L3X0YX?G3^51@GY45U&(;
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M1CDX5]6OUGB"M92Z>&&!]6YX-X@N:=J-%792SEQN969P;P)'5Z8=-NT^3&D
M I+)K^P+WB\:$_(,FIBR<HW-37#C)4DL#17"D6*?:4$G7"P'H=0^%$\.<H&>
MU_?2X9,"0)1EO9SDFHOV2C/SKW):1[[0]C;[]77O5L[?&@^;?O84_4MR0KA7
M;C2\[\B3<0"3(IU",\<^4BXUQ?A+IBDUQ_._X[%BRF!:%A/+W=)X1/;AH..!
MC#YJX8=*>K:5\I1UA-'W^MEVJU/,&\I#AY&&+#-C==WK+K*6-VS3 -_2[C0.
M$6G]O1I5)X!/*WSO'0PC>X=8XX.S]!.ZUPPJ,KPB>ES9H78!OIZPB=6L:_GY
M0J_*GU8Z@G^.C]  X"?CF0*#)< H#VU3DHZ5[]L#OP,_H+UJ;UEAP>A<"G=X
MUQ,M]WE>_)HY=1>-@0[9A<LY4R>3/V \IB1W'PR'HK9: K,R+]Y<JL2Z^Z*,
M',JC2:_E[L#V14^X+[]TW0]CUKV38X-?.='V,'A6E'IW?@G<D_;A3RE(RN97
M'&0_F2T2Q+V+71[?8?##_LDVR\P$#L"$*:+U:4O<]SB1,9:DKJ'JJ^5!=9=6
M.TK&.I<*B^KO81#3F^;(C[\>^;PTC!X/++KI6(9Z+;[RJB/%9.RWC!YR%E<H
MN>?FT1CL=^@OFUI&H\GT.TEBI5[;NK[A>EMMAC64)@_ZX9M57*4G_5N"$S/=
MQPO4J ZH 6"MG]UI" "K,/_4;,6N(L \!7T0_[YC:E]O7XND<%!,R]YA+=\8
M*+>3B-:X"P_[8TA-2CII).)?0+_Y;Y(*ENUGPL&;E_B7ZE.WEQ),ZX-OXZ+$
M6SH*]S+IVL?J,"OZH@C:?^GQ!>^ >2&N5B) O:D><Q?; "_+A(3XQ^[BE..?
MY^R0KS=4MP$7!CRS>895ID7^A^]@V)/62:\B"EO2B53)NO2S>5VR+<#8W_&3
M>!/$)ALXKA3ZX.OHS5?9?6M GI74(I.FVR6B52(L5/?H#A&ZNSXU)C( '2KZ
MSYA7%FEP9/[];W"5M^NCM,V#W5=_>!O3Z^8<'0;$]]75TQW;%);.F'AH(\&)
M%#9.3S=5-0"'?^*F,]@M)\I5Q,!B X@0R/#;YA%0=-J;W+B7(4GV*#<(!#M>
M;V2/1TM/3ZDBV^<L]=O3#"VO(GXT&$B3L*LA%*WN/1'8O:D?U*F4-O60SY[_
M\,OEODR?]K3">\O_PAC,(&HF,!V!UFGCP:QMI;/SLKR*0]?\>9UNTR[]CJK*
M#*F"\.8Z)D)8L_("40MS-K;=40;:$'?9/1\?@8RG*"Z/"C.]OSWZ?U]8]HEA
ML-!3X2HQ)X%DC$P/Z4FFNZ$Q<-K :Y>+VSY/)DHJT"6 /5>K?F;T(L.^+<P]
M:Q=#49/8!A\KK3_4?XSLGI??U1=]!VBW[G&Z%<6E7JLKW-!8"2*5W K-N7F8
M5O*Y*<WMQ>18[JE@76YPDL<Y;"R1TRA<&<NYIKR&H@;ID\Z;NI>B4-']O?H*
M"P8V2G\.>*W346F3YIY)'L<29TQ:0AGCVQ-WEA5 @>IO4M:F]&GN\0&BDNMA
M=VF7DWZ\?G::7KFI%I3> GK<AJV9PZ_LYC,G?W,S6Q4MRFVG8$7IR_VZ)CX"
MT,Z>#MG0.PN&CHHGVAA/ ?S,$YG#M%*V<%_UXIQN_M+1',EDKM29VW'F1W]/
MGC&YC,[4V7WXW$RW++%;>5?9HKV**S&)48^HS+5"NME.-I\NI=JPILGT&8CP
MZIQ^"'>7$[-F3&;_,_6[/,W#/4*7"-,-44[]NWMV(E@9XA(4Q%DM$M@!#PGQ
M>9 BKY<KD2KZ#?LKE';C9O+E&'97[I^;"R/<J"'%X?*Q1#!.4JU)Y<-YGBU;
MYM77'D:5=]A([DL&:RK*:UNE1^"F'C_/;&GZ:3N+J H+"_NZ6'-RQL3OIJE*
MC[J,1)P ZE*M31JC%KK_]&77#&JLR\E?.Z1Z*)-%A)\!&WXBFW(8_8BY?@V5
M(&5030<7_0D5_24;;D$-QX]>ID/,#2WK!,I2R:</1LUXRA,$=0*O8GIG."JD
MFOT50Y B7D.&MQ5 ; P2B&IVQA0A6A-6!%F:ES&II\?0+#$N,<9T5_*P 4&_
MAMI0('3!2T$#A+(G+6J36V_SQ07,"RR:-DUBEZ>=Z^H(<1/%C/ S)H]%NDS1
MCO'Q/W1K"ZHPG&Y/%HT$Q+![^IZHQ#C6T70PB$^V$F.!(.[-]_.G7PE5/_RF
M:M:MG$1#9ET=U7[OOKG;T=AV6A3S0/,*=4@A&J23*32E60*W%_S4=O?1,F29
M(ST)/6S")Z#4G"])1EGY%1OO6UA"1A &G=\+A4*%F_82J9^$AIBSOP_^-'+4
MPQ6N[D>)0K3UI3\E\ESR=Z$IP7D5T(-**&?T@%\_5_MA_Q$[/>&,Z9+U:9PF
M/[W.GFI51S/9LYG24"\?14!$J7%0PYX.\7$,=N=C:-F"\'N\B9I\B=>*&Z[@
M5^OQ-+GU(X6D:^L<*")V[.IYQG3]?_VJ(K1NA(-3(D1N$S3 GV><5*)_A]KK
M#K3BQG][Y!Z-C_98/=3E090LK@O4^WCYEFXV'&03S>G_YF"Z#;"@ >'H](K-
MN/*A,G!N-)PG!3F ]ARWL768+\M&:/MZN<LCR]O;_.2RBH3G=PHJLQOOR;QN
M:FWX4,HQRM%YOKYK5'9,ETUGS)>S(V'.)5O9_T'%+(F_VB4H05&(]J84/$.<
MFKG2/XU=G:A,__8!)W>9M+ML]1VG4-=.+ J]W*O@$E1N.W_8]J2@X\&@OXC0
MR(8S->>=U]5Q1")^K,!@QNL]-#ZPNFG! )?A:X:W1#);(?F=5ZRN^489P.:P
M1Z))8;'-7$W6@@R4^TQ[F/@7<FC;^FI:EW6WFV7Y]X/Q[G%X5#<9[3I9\S ^
MBW4"&_]Q->G:B%E>K_GQE EA#P<YEI,QJF_JG,#)M(:P:O:-2Q1N_CS8?=V(
MPS5$WQ^5W1^^H\WEP:)>6_'1..R4\>V,J;8S2I,+ICGN3,-&MRE23&-5&CD@
M+1THU'J+"5;S0U"H%^3J]P#'IYLDBH=<P'&(ATM+%M%7^*#$1SXUJ6Y6EW?<
M_8OFWZ&>^/-$18VBZ[=IE[75@3MNB0B/C=2]^L.N9*[O6I&@U3!;3_VZ(?9,
M[3"V1UD[,.7.\Q39JII^@;H!L>KGS_^QG9^/M;1\89L3>^V"^+\R<'SXI;="
M[)]<_(V&!)]I]ALHXE?JLE@V?[W]%#2@-EDH@GEC%-8,K+2X#0 Z]26I=SM,
M;DJ&_[54VT1&2HT8U"^VFL[5QH_O938[&:^WWBT["G9JI<HL=<;9KDQI<L.T
M)N2%;OY)@YIJQY]^</?37/1QY]Z=_ZEW_)R^L$V?T\?J$P*V6$5-:\8#T.JA
M6D8$.;E*I6,6O2Q!>W49/> "D;C =>%.]%47O9*D?RRUF=Y*0R!HR/2=EKJF
MC[ND0#;6X?J:T8M?H6Q<8P]U[Z1=O9ZH*PSY&;.\>,+S\ !$OTW[VXGNXXJ
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M:Y)Q@;@* ;+U#J O']3/OV^W7LW>]WE'^^_M1:XSIBZS,R9O'Z[-7*OR16$
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M$.L$M*R-'U5P;1I4CK_O\O^I<\-@JW!_Y?U/0Y<#H\6-J(PS)G>B+>]5-U-
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M.LD/-[B[/@DZR98\7IA$FF<MFD<9Z^OX;D6Z#BC7;RC_%!T2J\]]53FECPP
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M'X9II0[^"2PCBT<PTW#KQ]ZR[=FYMWM2;G)C4'FMX#=[<?_^]<UI%[/0>,)
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M]4+"^-WZ(=^G7R@7J2_Z+YRXME>9)DN8"CWLV&<B9B3Z!KQ]U(AL#R/<X4\
M-_)-O&"\K!H[6:FS0X@D&U_)+MPT3C$L?;X37+JHFZDLZYV)9Y<-W,N,-O4H
M6U#O39I/6EPD6)I!3^M.#J_6KH4=;/2=I70=+O@X7((B3;KS&>9$:^<ZQ.PZ
MG<MV5^5FCA-*WT--&*0OL <%+OA;,OA4NTO0MZ8V\H-D\3^SQYYXW)U5*UKW
M(0X%G=O^=T/G:M1E@>N )1F!WTH"%Y-*&I.PD-OZ^)18 1ZR3/,U#RK_M$(!
M,V!P"=)NG)@SF\WOUI\1F:B_8/ENOY8S1A1SKDM;W3IYVKW=WH-5]B9S.$@H
MJ_336O-*57#'Y3WUF?$P"_JX::#\"C6#TE<IIV<V9VH?]+E=8? L!:\F?/Y7
M813!YA6?:\;XJ"]8+I#D/U*K)CKM:8JQ*A;#ZL_V6W1MB)NA8.?'#RRVQ(V1
M)S$UB?84![)N"CQ@(W+"A8Q,I-@2CDFSF=FB,:R] D*S:G]EWTC@2Y(*U8EO
MP6[.3]8W;;Y-53AGIOFB-[S']%+_XM'%586FK[%!/'WN;./8*!X$0T04XA8X
M!.DM0=X7GJ9X$Y8D'Q74C03C+WA\:G=.>+2G:QSL[?;.L'N':8)86_=L=$+_
M(^HQX$:EE3^GA=GW+"+BB!IW],L'2E.%.^((/ES_.1ASIZV_DCJ+CD%#K3.S
MRT#_>&$?AY1J:.F_/"@;.A,MW6EYFX2<W^'1CLK,*/'(S#R+R"GU:*BVV3D+
MBLH5]_%P=7&%\EG-9F96Z_)QG,R2=6\S?=%ED1 S_:UA_M4L6<CRY^!TS;.D
M*XFZ.Y>&$A[RL$(KFZ(&N)#LQAP^AB/:_D._C#7.+)UW-]G\<;<?+K_1=RS.
MZ?D14G5-NI@46$(45E5YZZ3%FM+5IFV7;BD:CX&97Q"B:*?+*B8I^J0M"E/*
MB<]44(+D(1/%#&@G.$C,NO]H'I]$T&W7[&JJ,%.'@LKLW%E7>]U4*[3]I01&
MC_N^+ZXM&G"8'K]NO01=?W<1B6TEPPMN@T=NTQORRKD4PL[[.#)YO:3PM<GK
MW7[EJWIO#H3>"7<TRW/+^O! ]PH>'OP@>"",MC$UR.[/[&)-6A*=R@,HB(<F
M.&_2P\ZR^7LFYLGDG,OO*=XK:FQS-KTWMS$J'&5@L67 >/.SU5#A@(J.F5E)
M5INT1-H;YM-=3?/G*''AP@U!!H@;Y@/D%I5+M!-W#:Y!.L@C$?=?5\_ U8.1
MG16/"9:M?]OO<FI(IIL;HN"&8:@>Q5U.U6Z']IZP%X^\B^*YMF&\)XX7N1K<
ML/>,'' U@)U4T!DA6A\=%F;"!(-^=>2=!"?HO=%$=]GM*H8&6ENM^LMF23Z6
M\B)SQ'WJ.T ?3%N75C>YG]^O/N:L-E"0UBDX<.'U+W<\/)BLK8U">S,FY(?E
M36=JF(_\U!\"HU2;<S(A;*LN5NB+DJ=!NY<@["A\<BL#X;X9_/:@*UX,/28F
M]B4>)'ETC4KG?17GE6D$U&3?)W[M5E6]D>B&;'1@\ 186MXN[Y@H3^",(99
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M \H1RMP$<E,O#VQ[T^+ALBX3 6^0CK)6&0WO$*45-6@03>/R#()J9F]E2-%
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M^K*#'3(ZM7@]Q'W>7O-JL^CKNK#L7PR/@;\.+%/3O3LMTXC"\3WE^VBE$8:
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MAO.3V8BWWW?23XA3OK7!>QI:9#RF$:UW^B3 Z:PN(KN$5EJF6VSF8L*:4\:
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M\88SN><QLCJ<U+]H[*3HR@BGP/0LB]S[UZYW8YXO?$;0(US OW"+EZ6IHN>
M2!H#R7RM*7FL<4;MT:EVK^F,5J$%8Q<GU'<C7*0C<<D_(:AB>&70!A(T^'V5
M 7ZKP'E#*[C:Y7K?R2 RA+*QB?K*O8>;E#SK\@!Q$3L_A+.3FCBJ@>]@BFPF
ME44[)CTNP6 F%S\O\/Q$X;:/96*.AT1C":YA\D\*4>_%65J7>Y(34=S^T=$;
MRF&P7-_#3LL>:6"P;EV;U@=]%3?&:QTM$+:P26RM+;:JT]KXDN-1$ 9-$0C:
M_KHT<Z5T(Y^#9(GA^O1AZP=<DYS7SGELK/1B1.X<0&\-&]P;,*JGCS2/,6RG
M$Q9W'QR3Z_IYQKY-H*H.K@]2$AT>L;9I265</P?,3+W_3:T2^3-+Q2F<V/N,
MB*6ATG^KJJ0/=(5W6"WYB>'EQHM1L1BCJ$.3HW1QA8*O T+?$1*==R]0DY'V
M@U/O',#NU9<2V280/%[*?S>FKU,47!]K7)@5B"+LTJ?*9=$]1T9"GA<^RY-Z
M'<R#5[<U_>]P^O")A["6-;QALOJ=#74.B$Y,7U!(?F.)5E/1H,9Z/E!?V&C2
ML>OEWO5MC_"%UPX<UO+/Q\:U:#5K:(>4:Z1)I6%#*5B,B%*919_SDIAOJ%G,
M)-GL_BI_O$^>QDK):&+%038Y NEB<?=Q1"$CZC#$^N:+M<:PW(H+@R5Q%%B=
MEY^D9KBX<%1PEJYJ>BH.-_A  ">J!I!.>SOO-=<T3 :PDR2GX[P0M1*-&@=)
M8LP^\KM,E!!Q#Z=S@!XTS S2Q&F3:V1C;RLW/2@<]?M,YRRA:S$#40_<UB1]
M>$%)UW!CB<ONW7!7M+%,@*M]AH7V=#)WD9IJKWH/G\4%>Y1KI.CI'$$*.QJF
M!%HSA\SK6N.?>W@\2%[!\Z?0&!^=BFRVL6"OG56T*S+W(0F&=[4)N\Q4S62E
MU6Q#)DJ%UKCD12;:=@AD6J>+(C*SZ(T?Q,YJ,W&$'.4*M'S:@6LZL\.?G@.N
M;IR5-6K\2CF*)DT<G]19PZ4I":7K#LR4 FBH#U]GA@=RP5Z^^@-Q,Z[Z031^
M$$SGSKF K]^XG2FS)HVV%@%Z215T+9\#M$=9]@MNKOG0,YOT+L$B,F_*DXUZ
MEZ 61::\T3$*+IG:C/S/QTJ1PX>B.KKFSG<?I7?D/S!GP>Z/EB"2TV%]UG3!
M^2_KX&E6:)<G388?%A]^S(I&"S'1.5KRFF2$U*-<X.8@6:3![;R (5$"X=J9
M ^U_EP(6_/+JKH,)+RZ\+R31"H)]I1L[3#:(]H;8<,$)=NO;^P[34D/V"ZK7
M=_GRRC_Z;ZLKIJFI#TXIO[(\Q@_\:#QCZ>713^XB5$%UR!Q193U2_G/0)Q-O
M#CV$C9LES R=2]?W[:SG>JRMGS7M/X]*?_N+KK%BSP8&<W2\*P^2P?3$["P]
M>7CDGB4.P?PJ;K4):JL+ZCALC5:1[5NAM/W)=T["KEAM>6B#V9)[I\OBL4[E
M^M+SDUCS]%7SEN)TI/!.*7*G.")>I$+Y<GUCDK,NB991!FW;03H7K;7))\V7
M5;CC\R84; (_E?S\=JS8?#R=Q7*7HRFSB3R@UHL=2=6\_>CK-1.H5J?V61OM
M%F5SJ6"KC PE%& @G^ NU>O9:E.I3E)+-3SK/U1UBF 1NYBD8-6CJ:-5A[KQ
M';E_LS>(O,+Y1!%TL9ZHU/6=H8<_X:]=L@@RL-*7WBV5GIPL<7T3EM%L+#8=
MH(#:1_K%2T]RD1:6Z>9%E6E?[5HV#FM^2KP68(G)E+X5TT,4-^KIQL.R)\H,
M_&O(@8$9D#XY7'U09MQ6^%4:'DPRVTU L*I+Z;F>*L&.L4 6=0[8@] DQ:<3
M#<KJO:4P&OE!XARER#I^A<YKZ]/RVZ>$,XZ-^VPOF$/+GF2U(7NC8HH1W1J(
M1120RTM=90UX\X)-6&*GU1^2I+$R]%%R]F KG!RO:+OP$N]7)#]_1X'1N/\P
MB.BA:/TU?<TFP5TZ@*^XN2WP,\[&^J?#(ZHTR95VX]>I)=61W-!Y2^,&%4S:
M&=(/1A#^N@#-@IM0]=L_Y$H)UHS:4(4J5ZAPK#QCM&;T".:)[53JCF2UYTKM
M^+R^+C#.4W*G4FJUH2T:JC<C'N>Q\]<G?MX$VPH(CVAA!I=XKYQLD4 18&WC
M,2">ABOJ[N1?^:0@'26+YU:XW\0B6:A;HL)L2)\P_#"M3VR4,:4L&45ONBD/
M-2J+]3FJ-8G_G:'D6(Y[WY7I[F/(L_PGGS?6Y]!/]XZ/U4E]],UVLM6;KVQW
M'Q77<BF]7)72?)(G5O.E9'V@S,'=#VM2)G(.^+S5Q/'(WA:L[P*1//R8\697
MJ"E:KT(SC\FOJA%S+_N2W*OB+\+&]V^C,P0MR2FG@>'3"YP70>WBQQ *XDZD
MH]KE/4A^V'PUTDK"%XJMP71#']LL5.$DO% CUGF*^K0Z)\^=BZKAZC8^\R"/
M24C*7&)I/Y=E4_S(GI*]P*WAZA6IP?8@3\J+:DTZQF2US98)9W>1TF:L^DLH
M^0_/K+J)O)(&5[[>Y)&]2\]$CT%P(193S@'U*;WG@-A\14I>T))APCP/F26%
M:E@!:[:M'0M T T0?@:$^1*A9Q;VZGT74,,)RA4/+1N5IU;X5=FGRNU7N@BX
M90)7"YC].OD7\P6&W7T,>*"<D:N8E[5F-7O8R6YG-S-T9)^63*2!^GR23H_I
M<D:189;!J_#)_D\60;W!_/:&,>1;L#>&0F\,^*L"GN0+W["0J[6RF/V@;U)U
M?<+()*5#W>/-Z#)N<359BL8#MZ$XDV\.>.:O=O.KDU+BTWAE+^+79L_H4#/Q
MNB[)^4_QJ;_"GHTJETM+LNN[R7$MT[,#RV7M;A:*('!KB!3:!V))"5"S[5]@
MDS\',+L_=,>KQ20$,-]>Z,D\R4O"6H:\+I2*^>(6R!DT;1.&%1=[6KIIF6TV
MPH[" 9W>G:!M8*U]GUBXEO;B/PG*/+(.![+KW4K &A\Q=#67:?E#QE$/-O9^
M_*X2!L7?'>DHXM4<-"9T,;ZFRD1\+UNI*^1,PAI5:+,\037YAV6 _BD#9=PV
M6JD8UA=Y/)1A\C5CV>T/?1_+6PTZ=0VW5$KH$A#CQ4 Y!Q@TV4;A%NQQJ8?Z
M=^?*D=_;;G:\\3@<IB,&/,<V\R@4.:M&*!T_#Y12EZ'87JA*YEE")R>L']LI
M:0B8A]'X K__7,^_0RD(A2QIW*!HX=T2+5%_XZ3]?R);VMO^.$B:8K-LCBJ0
M;?1CN_['P7P7^NF&QFXNMX8_:)#A2N3@: SQ)%681"E?.*>*06-/'>DHW0W)
M!VD0^=-PZ[Y<^[3EG[E%HD2[?:DAF=3?Z+?=*[ V+FMIM_*!GB10;13WB,_9
MLJY8GNX_?B@3$Y1R#UAA'5';OY53[,81SMEXEDVC-RRTLM,)]G"L@#\D!;9?
M._CQ%"I/G0:MI);.S;FSV=K.S PC GSD?__H9C)Y,< C=H)Z&\Y^(9:FK@@4
M7(KBL0B,QH=7^/'ME#DO NEAH=U3(1F_98)OV2_@*4$&N,_MK?$LL_UJ/3IB
MFJ>-WKF689H>AHS12"$Q*_<[R^Q#W*9%!K<3/3S-ENZ,-V7:V.JG*++GNUIM
M!(@L^<%QW%J-AE"+3'%@ M:TPK( 'ZJ;OC&9ZVI:L/!?A^9C=-B3NAU_-8ZC
MM04'MQ/[.?([2?WED0*(VEA3TOSS[6%L34/?U30=P>?-?]SW5,2B7PN;9._4
M%CW_+7:__BM_?/D-I["W5Z>..I/ RW[#B4AZV*!Q8",1'[@=\,/<7-/<G*'\
M<GDI0_GGEV+OW@*N "Z]5;K32%V 3=,8_^O)'A\TM A^WWEM4OTFY*2QMZJ2
MY[ _=KL]E"CY &]=F&"68-\P21=#6&]D9YW7=-9XWXASYI6OG%8T42P KJ=L
MH<\!U\0HPJ?6\,<:C%0V@G3</"_Y53CG!-54+E\2IRI*%S'5IC^5 PUR=2U=
MHTE/-O+FX,Y0=T@2;4*5TE<Y]05K57V*%X)R*)"^X >7E?-5A'.]H0SD@(TQ
M=$S5(0@B++)TSZ HC[M;1UG*6MN275AD1(9"_9K< I;OT[OT_CM!PG)*':V;
MIVM>%N;NN:['K-S]I%(0IU,FC/QCYG)#[^!)]EJ=@-:WC(!7+QE%Q;Y%1IMP
M&["8_Y7\.=+@2R?KR=(?<TK2Q91W.BMI0 ,W3[PP"2E7*06$W1EISW9Y8I@E
M=KT8+/7/J&J3 L_*/T>/W&]4=3-H0GWQ+HVT/!^5?E5.G;L?M*%_;MW-SH\I
M%ZQMW$FM7#O>O/]PO[*1[Y$I;N>*.-.?((ZL)DNC"(W)82]51,]Z_PGK--%P
M^]W%9>$_U*5@.2:4)-*57A[+MZJ.1'U7+,\Y(%%594DY( =] ]HVTE4Z6C%<
MMIZ=G.-5[L[/(1[L%W 7[]&44K9>9SOL^:80I_^A'W'VZ%N^_&#G_1)PW^&:
M22'HCNC+?1XEG5*QAB5SR^ TE%A5NXE_6IGN>\B3+UFJHKB<7(WK_]5D+^F^
MEVD7UJK<[&FT:<EE?Z'KZ[^RWJ9W>>5SUB2^=%;,(D#XAI3.B'>BT&$SE6WA
M:'!2XPTB1EUTNO$<</TGQ1!,XJC]0H&:VC([V=M(^NI5,3#V3[_WA61['=DL
M./3#!7#FZ,PYIYFC@9#IM6MPS=,;X?T<&K7HGF'3GD>P#+CCQ4UP0KM(J; N
MAZ:&#X;C25B.,N<2B(U\^KB>=UOX)S=T3D7SJ?G9]N0RKA=R9<8*'_85'$FV
MJU,F<T"E>&,>:!_FN&Q,CA\9HPP>I7,(M6WD;HI]*"['N^=^R74DH:=;@E^/
M#?@NY^OE*)RTP:9/*TXM1>6Y0Z^6MO;DO'^]/G_375\9_N)+O/AJRJO_IYJ"
MO8*D+KIV%O(I(26ADQW^&'=O JY&G./?UP_^SJJ'^#(_S,C('*J9#?O-$3*2
M!+LW(;>9 10:;H>*#5S18;N(U@(P_ 9LZ"B \G4)$3D/:G)K7*#;9+,6VL".
M66^V/?MFMQ8NB+NB^GZ]C98A7X)R*]'*G)-B1OY(WILG<IT#?JAW7?AYBK1B
MCRLN_![U#N67L[.W!]R<$.9,6(B5+GKRIG""*ER*\*2$>=KR.G=.RNW>WA2E
MLU7DZ.3_1^R=6V\G8XIO&RRQ23G]WALM.N_$WYGU&(OLDB5Q\:%?D^G"G$?W
M-PX^0$_0:V7]2M^+$LN][4..!Y7RHQ\T\2?IA+; -Z4QAFP&C9S"0_0)W498
MQ\UNJ3>:SU\V=G#U.2B3+O*) -F+8+A5NSCZ'L02X[_+"K<CY2WO1F^'WZ/T
M"DWZ)WC%<"@T(4@)SOJ-G36MDZK6CJL.;GH//I\#?C6=:,45+S@P^YX#C#OB
M<?LI2UW;^N3-HX\YF ]4+TIDZ%(6*6Y:@W#7-DG\[_%[XUE82X4LF[K'7H0S
M<9WF?^STG%^7'LOH2W!,31UYZ_ AVUFU]P_#9\-'$23-779J$.4&:7-)LK]O
M4_J2^SF U5]951NZV*%-V#J9X&A3FSL\I@ID#1-5P-R0O8?3<L]P\N\ /VXT
M)!A==\W[@81?XVG7QOI8,;#[<+7![.3E)4!H!KD\'A,4EVYS0YEN7DCN1NZ'
MTE7S02D?BBUXRCKY2O<"_:9>?/T+.D,,Y?LFJ'<DTTNUGNWCTI1S"C*A*A;Y
M%F8GI<B92>#GM\KV0T6BHK_AD,;&9:XVMPHR$-V/-!;S A%-_(5$8"SB]J&:
MJ39%9C')1HTNU)X!MG6XP$-!;P7B<]OX2@KE&R="'%*1/QT@QZ#MO6=>*_JZ
M(QC=T.#EEHF&A8VOBUG?O-XOU*,B)&G\\+LDSX+%!::G?O)G6([QN05WGFJ4
M[QT[][:5^K)9!W?\2)&8H'?52%&H]]24]PSDR&G!L*&A,2;G+#,<L%90S_(-
M$;-P[4#O8Z, 04TH^6NUION;<P#A/MF@S$<*1=3WGFFO'V*RQ#=.#M0VY1.)
MMI*R*N(LZL\:M="?-P_S^?Y]^$N=(=)?]!S@-I(&JWQJG&=N\L4DC\MLLB]#
MT4V(KDC=(# G2..=*IAL"R*SQ>Y;X89ENC:2F."%J<NWRBRBKQ&\J\V\?T4+
MT+4*6/+%IZB+3F#[D'#%*:%HE(A)Q#L+1G%Q:^%,_,C4O&WF@I\$!_FI$&;G
M]8)*7_QXTVK@W#WGUI^K$G[N\>)KH_TY'G--"T&!!Q9@7]R/B^_[ZO^Y69GQ
ML)P%64]U3_#A8]YAN?&:Y\1X>6G!-!76TMAXZU^QYD8Z?S$ TKHX-!;_^PMN
M&-_5J-&K1'M(E2<O1%;M2K;S?8'9TEC_HW7H^LOJA(#R.?F^ C1DR@;+6SUC
MYI1I&1)0;#Q2]_PD^1>9TXN%RN%Z9%E 3 R_QN.54D3*;?LV9DFLQ+_.8HF*
M;#@'N-J[Z\L?&A.YVF7!M_.>V"O+<VVGX(7&G/^>0=C>SQ0E)L,$D]U>)PE%
MN^6]BK<J-B(/W(W55?5\+PM*JRR63;LN?T31[E/G?0V3P%LQ_#*0YHPJKQD%
MOD>9Y LS*^I/EQ#4/:W1<Z%6PH9LVMEWYT?SP,L^XM&PI4L)0YE2R2[1F&G4
M-@T5ERO\I%WY+'UBO7&8TSU_Q*+L"5JB:O3?;:HQ+(AV@W *A7U96<'IG^7!
M0STDD;^/;G?%?AF'WWN#FYG5\Q"8<:#4FXV]V97 /__T>>+-:H%A6[.,_8R]
M'E3ND<ZIZ>F5"[\@*AE^<Q-$WX? BZR?[&*';^^-6I.\WC8,]7:1=M\%0)6=
MOM9,RU=IS5XX50KZ15N2"XY0EX9@<6LVECSK&&D,;^)L V_WLA^T:R]I</C0
M76ZRO?[2-U'J@117W/(/K#:G36(1Y$?F@Z;[:"&Q[+)3!O]R V9<AK:!:6*[
M1$H/[>Z 3WKMCE7[T*W'96/)(#.A&*2%%+F*YTZIR4H9'9H%"JI]7Z74:R"3
M)KZD01&QC*QJ]SKEI/W V_>V^S5](IT:D<.^RHJKLE$X-D;[XN1>/';[I17Q
MM([UA>:/M,IO9Y_,T6\J#\55.E2,&YJZ<+O;J+JNFH[F^(V1HY$-X8B-\9TI
M_S3&'.A'09AKQ"M82=R\\JW46(U/+E;KRY_R[3\]5E3MXGO?UR>3)8B4D+J?
M%\ NKFXQIR+L"IT?==Z5H5@MD91FF?#&?8XR7-:*_*^*8HM ^BUS?H*HP&IT
MXQ@ME/TTZ-0O_'L!5]'9/UV.%1=:13&U(P/?=_)2[]VB+#TGG46MH$()" [8
MKB&I/RZ #VR$DRC*)#2<5G2'.JJ7ULAQ<"JX9Z5AS@J]5A#/@*0OX=<18[P4
M\W- ]'Z/!A6%-H[FJB+$S\^++$9<'^?Z*XI#Q#%:Z,9=8ZUW)DI+FF;/-!GB
M+Y<"+H&;7?,5)[X_XN?_+DN-,PI^\(@SON(I=X(Y(?YDBJ'D2B8;\DEZJ4'>
M72WA-+2DGH&WY^WX7.$_!L8$-54.>E"W\Z-@2^LF7N:8*#L%WI^&+(=P,YG<
M$7EQ<W-G4(.;Z!-2NX#\=Z3((+ ?O#5Y@5^]9T4:$$,&6&3O$<>)*X99W#!M
M9.%"<4SJR _>L216"^O\;OOPW%:-S73"4@^7(3D59K>>]LO.,%!RBV<#JK?<
M='9Z#HCP"N]MV]T*)6WV->6KMY(Z*\C"_0XBR;OF$U1QGU!$23<A[/:P!URQ
M^"FB#)*MO]6G\K4CR*QESMDS_J38^TU@XW[!06 \95Z2;!JGU,R8..2C8=[C
MHE1^("YQDS_-#\6DDE@VEBEF46$CU2 06[K*'E+F*^:_Q -=I_AAMA*B-PFU
M/P/ MSXYKDT6DP/*U:T'&R<V^F^B#=(SE$$/?X>8>NB,^/JYW#$&9P/]_^_2
M&X('0;+J$/7?G>DG:A+[:S;G.2G0"I7@%_G0IXMAO$]O<PC&Q>ISW]_G9+CJ
M=-<S+HZ*)QTU9?/U?=E?)[DWM>6_JU[[\,M.3^+6[J3<4$*8BI'U2_&'!4^F
M;N:A9YY5U]K/KOM8.]R0D/(L_'!R#K@(6S_,8<C\++KSWF;TX,]Y"K07S-SH
M$WP$ZYRHT$AL0#._G'VS'_AF^GNH7E3WE1_ I>@N1F*[D!TJUGVJR$&WY#X"
MGU[^1"JWU*#I?KVQ8;9ENK!^)R+PF&),*Z9<PWX,5R*AI'J<Z@X-DI\:W.6.
M1UIT33DG19MGN#1AOQI_7A.;D#&;<!,V,0MF2PI6R-5-XT*V9(K\%:^SFO\L
MFLM1*\T:F1JA?<?XLVN:#E_$_;\DOC\I%7SG,'<J [/!]0,;4KX!Z=U!'DWH
M$EC!D@:&C\T<)^WAV%G;.2X/Y'%KPE<UGN5]]YVQMQI Z?A*OVR)?R[4N&_R
M"C8D2EL^ /["',%(==>I,B3.Q?X8 =O&KAN?J5(D]7\B_CS3;7[G?\8PIXFO
M9(UJN3)RF>LM7.MC,C\AY-<9Z+ P/IHGG[\2,I2=7JYK8+QZ;)+.$3_]=;,6
MG9"ON$R[0]RKI!.XW^MJ53E-#^;6,>H;ZQXO-$AR>1QJ;9 4W*RLK+2'JS=*
M:W/6< 5&D:GL%$92#$$W:I_*2#H'8$ WD??+/[=,;3?\"P2W_XS*T-]I%CJ;
M 0SO&X0':<@<E8N@YT1-HWC,UG 6*%U6U#4\:WRBY8!@RMXN7R+V-=>L@V-\
M04.O<ZU5XNL'R*I1,)M%0(7!D.:PB6]&>\]_OTN?Q(M\OOS_YVC?).YB\H2)
MQSV[L1J,A]^E/BTM7(?2.%H*/%?J/9P-6AJ:)AROWK5;;S9YC'#_J2(E^07.
MUX+6_-)89%/-WRBAR3V8Y\X.F4*:@/Y;!C9%*76F)7XI+O#7M/&N,D#RU)JB
M+-A0)K<M$PE*+2.2 28)D.KOM%==A#X-WG/ 6@-<[!SP#<B)V"OOI*=HDH:P
M8#H-KX5(!$.[5<TYP(O"<E1!,24,_=EN'ZU="(LAQL1P3)O7R):_\#]S^'?&
M/3M4_ZZI?,8LLYSQ<QMYVB\HT3"AH$:[6R,! >SD"Q_/,H$E]'2QM5\A=EV#
ME6]L8BQ!_C:&2=6J-RK6LZNC6!+D-L\4#E?RKXY[^*.WU:0V7W1^T#%K:$U;
MLX&,NIP6L%!PV9/!)2P)M8QL[_J6E6;5.:K9+L6@3%F2\X1YI(J]R2C1'Q6<
M(+_ W$+C\;3XF ;HGMUFSVQ3]A!95?'I!J5=RCD*'1LMP.U0+$ZX9PRJC:P2
M2TUR]]#RGF+P,;\_DW5??>;";9'\#G]\B1<!H*]1.LX! JX]X%.NDG, +BNZ
M8K[B?Q:4 ]9IC.>  ="/<\!F==4Y !6Z<0C:&_V?%>5O59>66+!S;(OH'J^X
M BY5/4CI @5!"'I+M29?L:X9(T9X7"@77* 0#&T.Y+$+"N+(3"F=QSA--=W?
MVQG';<MB/:NKJJ@#2]2/C=/J,N$3_+<O\A0<'D(NZ),,_<8&#SC[(B_IW)U_
MG:*-I*KQ +OG6$S.LKJ@87J8YNSPCJ642Q2,#3D&.Z3/P6@/[ WIBN=!7)J=
MY5WS3XFV$:P0FNO?7,6"+\%<B>BWJEZD_KXFZ3*8!A'XOEUSL>".E::?6OIT
M.)"L]2'HBSO)=GY&-<C"4M;*8:3IN*E.VP^BD>7G)>CW++EK2"/IH L?1+M.
M7CH'O L!8P?0ZB!$MQJ-G_8CC7(!Y18=Q2S,UI153+@HV17#DCQ_9P+.SE<U
M?)07Y%*M7_Q?GVW:PRG_JB?B%[,D\Q1S\KJ0 +Y%432:I+H@M2Z=7:*R379!
M-)BHP90,DM<2,+Y=C?R(T)=*6NWF5Z;HDW54A9P)AL#-\8VVZ3@Y%HXU(.MG
MTO)<2D1U8P==&%"OXQ0<I<I.L)?:&'6H;8F>XA9LP<DMZ)T5H=75( 5,JI85
MM-'L+(RD=%\(, IN7(T?(*O\36:)D^O0-AX[& LK7K.8"F&)@XN?Y9W5D.WQ
ML[#D"]$PB7R*J+-#],A7]PJ2,&4DZ:6"[BZ\Z;=LC=Z+]T23&%/U(E39S%5^
ML*PQYJ\J'CU-J!B]"3WBE.FM6.-IS$VZFH5_@&)NQ+Z:F0N6OCHU?3L(R'H.
M^/TWN?\LCO;@8O));@/@TA=<4$DY)>L=99\E4;G)"4O"L4YDQ62J#G$WCG5A
MP^)$*[40W^^,A.$L<0U)()S^F$2EQ,M&G-QF:*@(%T9H=JRG'FSOX* Z+7M*
MO]U\:@.#'LE2&*NI]E/^H2D<L.@E$QR<CS3SS>)1)4]6BOI]6.PP_SO"IN6,
MQ)!GZHS#)NA[4^9QU@\W&PND5(%SJ3LCQ-&/O$!EQ=",ATGUM'Z6^'/ 28W\
MX)\N&J-\^08H9?N_I< JBI^/_U*/P_VS(C;S*?_&Y]GB9T^FB9S=:@P]&SYR
M?@*=!270D^6.<J[OM@'0;I^[A"^W .$1U">X"S^">%]0/QVGKC) CCXE OO0
MERCJQ\24A$XF[<6N:QB2,];;S4:RLWF))4J=KG9,5> <P&AKR(B"X#O^%WOO
M'=74UG>-YB@>! 2D%Y4H5;I2I$@YBH" $.F=B(B4B'2($!)%>CV"@%)5F@%"
M!!(Z1!("1ZITJ2%!.D@B+4(('\\WQC?N^,YSQWW.'W?<]QOCOB-C_YVY]IIK
MSOG;>^W?*GH.,PD_82$O-!O,/S,U!WVA8U!L#HS=;']U5(#S]@? ATFG8&R'
M?T %U\P0K% 2X2=$^?>/5,-(<N_LC4B4?F>S8/U0B[,Q@HSR HUBVFY[ET9J
MN7W94I3)[?&6R9R &?/;BXE-O"M4RQ;9\;,2^?#*0/*5B8>VR04D^=504FWA
M64E1IBUN/I>I3U/*.[D1CTZX$.,TN=8<$PPU;U<MC__!N?G%CW>""/X=IGCF
MNZBJ E(I9]&UOKCRUIZ6>)JNLV7CJ-7U4-V^S.?P+_!^\(5V"3@IK(BW78DN
M1%%.:3\+'\@U3L9NQ>NSE%/!\:WG8.$T)?-3LXJ[N.1VR7;ZV_FM2\X^S<I[
M*,HD7;DCFWEA^'%]T]"N2*OOU/"@6*K7!+.'A"UL6DA/PV% &^&TMQA)^J]#
MK;6]YH+ZIG>_[+3MB8B7<[+QYN.M? N54>S&9B@A8H3=2PJ([1OCWO"3^1Q"
MF#:SJ726'GX_H]N>V3O46LD\F^=U!LW@,]N#%DIUYJ9.=%WHS8RY4 Y*T^=5
MVWU24:EQH)[:O'1[Z^?\M11QF6X2'\,$23=C<@G0.?V*+9Z@=*(.]5VA_L2O
MMRXU,F=&0,^92KY[G]Q,)%5,DETA^$*A498_U30XCQ(A3QX?JIKQ/P=^;8.I
M'_HQQQM(=6EOJ46?@5P[4<I$,$9Y4XK&9T*WIEH3(B:F'GU5.P)9MXULA!8E
MN*E@1ZH5=R/36:""NLX6+>/SPR5)/WY0C@$6=9']2GC(D=>]PVQ<D?Y4D>TH
MS/ 8<.;[48S.A0I7G;D+U.Z.35!G[HVWM1)GJILB2V&1HVCL9:DTJZ?^CZCH
M>/>W73<,2ASS L_@L83G49.'9M#IA9P->VH ?.@GPY*&V^0F'P/B<QOBR^C+
MU,/.=CYZ</D7%)VO$RY9/X0E\<*NZ?U&!<>@&3+5=-&HH%ZK3U@:%YJBSP6:
M1UVXWT"[5PL1!U\@['%N=:?'CNN?>JKO(]MJQL<0:Z _(@GE$6_L-=CK^;^P
M)Q117U<7^Y4;\*T)"07[7'#BE),/&RUK#1E9J(=TG2\"GK QVI#_&/!I<!.:
M:90ASAP "TNSKPFS^3$X42"6Y\"%).^%[!MKU4F$/^5_,1IIQX!$KV/ RT"_
M]]K5[T:Z*254EHDZMYE>*%,T?B\[8X]DFK3<SV=<3BA/=CUU4^:98J;!\U43
MWF_"\PFG]]![$!JHFS3-2A9 ;UY T R(N+J]9)KXCV. /5V6.H(7NT#WJ>Q^
M#],?46^HI\XUT6X<=L%Y:5G'@&0L26QZ-</7"5OXLA)J;S*B(U/M[#/%[@!-
MXZ$0UXX![J"I@^6]=]3N3A(;?=_L*^SZX6WX@#X/%O>R2*Q5F5RYJL10FY.G
M_BA&>M/H(QW)L&/ ]"LHL$LH5[I>S2%T/3+*M-MJ*'3S$LDJWNREXVC+X+<;
M QS ;R_W]*-GP[J. 77 SRU=PK<.CXS)17&A'-EX.>7^X%#Y1]&;^7\-7O'R
M_Y+^;;\SMS#YA"E#1S@='G>M>NI@4KLH F]8Z7.M^VGVOILXE4$Z\WT8FYCW
M1?7HPSA0$%JM6&/.'_RE>F8P*-/L(J<PZX[R__H^E<:FT8$08]REW6A;&$QD
M2J21P+2PEH_TS$Y>(^3'M8:IPKI(I6)DOVH7;74O Q08J)S]R21<H/$!B[.$
M VC4R2C+_=UJF-.-K*?UN:$Q9@+89B]?LJV;O>ZC0K^DD8%?V3YZST3R<O=(
M<8A3>@HP</-Y.G=';G6EMZ1WM?J7!5<-0KV?"$A+*736$(4A8>[4LG&F:/#Y
MJG0)3T_V$?PBP6FX^;>D^M_?EY<6/=?QH+(:-;[IVEZ;6DYJC=BOKZA*_S[U
MS1DF.UIU+^U6FN-R8V.*<9O$B[?C)_Z>1E](92 .[D09'X;%2</47Q)-ZZU?
M+TZZJ.@)]$K)^>;HB2DI\[TY<GM]24Z]YDW5A$!\RIK5>SMV#%D_B:QTFF#?
M%T#7 >[!S12>S 2^W8M*1MY.\9#='B<NU(3:PLSODN:R+G*)E518Z#?B38NS
MF/#A=F68Y5?&52;K4"N"TJ:,SW!57-Z3BJN+](%<[''MF<:HE.R-#]]=>K:!
M*DL:6/HNU=_).V-\,;EW74R.9IS@CFV88)B@(=E[*B[FGK_75/F*YM\(FJUB
M"U6LLF_@*VW-D?5[TL#-6WROGJH0&V,9NV=&HLN@&?R"7<)^ET<07GZ/5\<>
M1#EU=S&O)HW+<@@SI]6S2\G]2AZBSV6@?N/&<@&O?O1)K&S%@ZEFZ&0KNHHP
M7)'QF+J+2Y51^#E()9F>&C1/C1,\'4E)/;5'LF\RV,XKH<ZE^HOH>QU*?4W?
M#(9E 5E;'?J*+PJ*"R#)'T?B1/-5+U(^X TXV+2L8Z]JV4:_M_ Q5;O"Y?T%
M:92$R8=O72+_4/TM-DV"CYA_R8I; ,1F&L>MW;GT)M$J1Z<TY:#=,6=!QH#5
M^)76D>?]3@VKW.*X2B5/8)^??Q>3BSJ#]D=#BV\-/\V0RI\$^]8'@-^ P[[8
M$<L./8JS'J3\^2FH1.FN^K97 LR6=G,O9:RZ70 ^"#]%0Z2.S\NMC="][HQB
M+QDQ^YI8!\P<V+TC6*IB7,"^&<X<F-_9IL9) TG+^_%W3N1)#7:Q?FR)QIJ"
M-;>GP)M"0R]M]F^E,,R0A'.9G>>-BB:9O,.MRH_W A,6[M0T)2U-_&58#_U>
MWV=\(BKQ)XMV.4&/GP[G9H>IME/]G[=J/.VCK;3S#;W_6G5NP,PD6$T4_NK4
MS&S?QK"+F\NO!GO>FU_4AN]N=.]:\![HCO0&"C^!1[ZQ1KNE^(S:>*,A%MGB
M-Y[:+,B%4&9D&*)94K;RLLWLY?+QJPS%-&HEH<J"5;<W:&:YDTOY\PC!CF [
MB"3_3#O?L^U@)"#UYL$G-4_PC7[/V$[#(Y/'\K\)5]\#U98FQ<I:,1\R?CL)
M!R%'C8RGE3>0\^ELC!OU?R*3%KJ9FD,+7D;WYSQ\F-S'@!B"7?V415?2-JB^
M\1SWC[N_*E?\O)AG-0[O3/O8U:WH"^MQ^DY]210[!IB/YG4U*Z:H//10<()7
MLL:I(_UKZF?=(]N431V=?&"D.@7VDVAU!T=]R7AX#/B0Z'<,B)I%_&Q/I]]B
M7D<,W:D_!K3_P/T"@[%6\SK1^1>]+KH^4_?WL>9=D#PL->)_?Y+L;QO/>;1G
MZ<E1:JZCXE%_>F(\E+Q>XA_1*F^7/,F(-5D23GDJ-^6V4\-?&K9KB;'?;B"3
MZ)>7-SDB2]Q<Z$4G/HN_=-K)SG]C5MX,+$1/&B"?JAY!^@ZO:/.M#OST_Z6P
M,^MN=^5B'.CZW%F$#E,!_AF')75L\<]!P9W 4^U7H#&W J[4TI0)6^SK3&UJ
M&O9BQB^[NM7<_7A,[U^G70M0@@5(XW*()1N/LEJ+8UX/<#*><?D8((Q;^>",
M((6#&>ABYGE$"GC'4A&WU8)FVH\[5/_VI=(Z)N!G)UG.<-W6)K3M Y,A-RLS
M.1(RO%82]KW(=(N'*MRS6Q<AHA05@Q+X$EW(I>4_)HGRBNN<1UEV.6UW"UUT
MC@@R+< R==7\Z=+QFV/5*S1(/;@N/?5R;2Z?]JVJ.;HSH?GS+='>>C 7_66G
MJ%?"Y3P(0'%Y1*)1Y6F"X5+EY5\M%/1G7 KB--9S2._$LVCIA/55E]+W-.G$
M9Q[E:YX>)JZ8J ==!T;8BS[BB8^'_='BB02B1%7-7\E' P@\-RV9F235<+0?
M>@SH.7B/9%RG%Z"<U.-J%A2!=C7AQI&*%F/HS4L+?B>Q=M8G"#]X@?,O(IO1
MXEUUHC.AZG3I$SWWY')G$!QS=;SDD/GC_'LI>%%;V'I?E*#S#IZ2"^W6(<4T
M(D1R&N3=?\X8>>1XB.?M7R!2*I=>RVG*;RLCK??2?:SU8W"L,-V3L-!IMAHR
M&,]DI<6G8:^RF.L5S6^=6W>3:8^Q<'V@,N6=;3_2)>W]W2&YBR5.@RT#E3X&
MGMQGGFTZM(#91Y.<Z,51Q;#?J+-]X@X2M$LU-/VT,MZS;B*LT1B441>GGGCZ
MM4+N\_1,@['-LL2'45(9U@J(D=\+J(.4N'3?;&U0JEJJ4H^*TTU=[=D-U/UZ
M#?Z&^F%*HMF#1S$L\UZE;B?+";@@=,1OYG_X8_T8D+5;QDJ8:4YY3?M609]&
M]#8:KV&*7C=Y6=79C<Q4FN^N>WXA LW2E/L^#G+C?XDY$W0.HL+YG _#@>:.
M$$-[/%F%;M*S64$_9V/CE&1O$<3(KSN1+W8&I[GBE5$]39A#\WB'V./W7F5T
M/8)98 .+=+K>VX^S769!') ,,MR*[5?E3^X]^E%LR-:W7@IWC(Y\*<-H%!9\
M4LGAMZ%I UN65&Q[<GB9B=='O9S0\G[%^I:HWTN<'-JG&GBF5[O./GV/B7PV
M)_%,?Q=W##BKWZ5\<#6;M#\[<0R07Y]'3$<RV29IP+WJD1#.D](U0D=,EZI7
M4#$)C2 Y'_I\58_4-7)06AQ1_J&(:5(.^9(ZAO&#( TN?;_.)IVV 'IS-T<0
M]X$:SPH-!"=<XX>V**0$:2>U*1B:0JL&N59MLL5* K!>]J<38N%W*;I%.GGY
M_,X%-F01=7KVLYTXVO;IK(5 '?4N6YI(<TB%U?O4'CKB@E&50$10IU7LQ3!G
M;;5%.?9R\9*5@=7;^9E91=N@0^TU_3K<2YU0OPKF$/@<S(,6CF=3;)\%$O34
MTCMH3G)L<Y03 3&+^^PK)AW^VK$4FX5+;07ZG;M-0TN-QGPE^!_!F%WMLD?I
M[;(,M:8)G.?@*;HJP>W"2*CD$,/X_23]]#UJ84OI^D/\,-V9GG2FCE3AVE8P
M>BZW+R*NSC-B5>>^;X.JXZRD_I=C ''KV\1>#IV;G)PN"K.C6Z.@UO@PIC3X
M;#U.G1F+>'305S/;[[=8EE5!<KNDLG=3EDFLOF [5%WZ$_4>!ZE,N)SYG&Y.
MVU[0^)PW:W0,('-W(OBAIZ(>?;ODKL:Q?:80?90]H5C.:6_Q5F9D5ZI6HZ'(
MRWG:<?Q*:$#%J?[+_JM]X.?MESQJ$?[DF: -G(C%_=)S?A=[VOU>$$UYT^O+
M4SM'*]]0/&RMBM2B8AT^FG<7OK3V0UQ;(IGH"ZGVD='\P57+&G@;"_3>$^KK
MVM"7R>:6A:?E\-:]*F.LFE*RHP1MK%40]*T%^S%@9FR0  ;TLJQROV (G?MI
M*$?4HI;%,&T&4GBM4 \,-H* D%,7A+7Z$>>+1!3:=6"B]/0%_=@B7ICM@IDR
M/]W#,6/0H<&??SUSTE<*,:QV]+C+OL6P;43=3#XA5%>:VIDJE?7]J4><4884
MLT+_$4*8$7+T'N?E'X<0VD4(*2570.O,1F./2F@SSL\F(K@3U/TY017.G[.M
M).TB1G-O^NX%%F-\_")%C?I%*QM>,J>+J.8X4>9HV$%XR@Y.A.XV0<'%[:RJ
M]=[<=%=^7T/32TA7[V]_606>\K&:=3;S#%<;7CE(C/MQ$XR=FYIQQFA<GW%@
M1I&KG^4$:/ OO=7@)5^3YP#S*+2(I!2*%<H<WKS6*_]0UAK)GL3GSV%5LFZ%
MD@L\M('4OS?U.8"%ONAOK(O_)))M^.:QWER6\,*G;PX/U\GC-UG32F]7(0>X
M2H3&KPA;51K:9*?:EN3HWL72(33KD_K$JXM[$DC>Q^/XZ:<-_--QW/ K/GA0
MTB89Q#E8!<61/1OB&&80SC(DI:OA1*$2('_Z-N@!L>.H914B^M:'5>W9\>)G
MR OT!R^9;(1Y%$<WKC[]\R [-/W6L(XA^3#5GJCQKR,T5NMSRU+#N5[. P4@
M0XI+>9%GB%F=@2ZK?YI?#,;3?M'P <*R8L$4]+?EO8]41'*H,LM:T8E>$9,'
MS_NDB_8+Q;7RH.GM^"6MAKQ(E*H#%9N&+EG+#C^EQ6+O%+79:72W+/:M5S2T
M^*CR7^^8$!TWVY5@L@Y,/>A/B/]IZ+[+T%/,"2@#V^@U?1XHZ,YHKG[]FM..
MHH_RGAVNROE./;+4W1]3(!>9%W6?@/CHNMH<ON'BTJI-+CQ/D?L5>BZZ3#[A
MVJ^DCBJ%:\)5%A)"^?=?>V@+R.)+'>973,O'%YY5\%\1,U5)5Q?UWYX3&= Q
M'Z"_O-)!V2Z4??_\+_D'BTZI3PCJ^/E/WYXT5TEIFG'+4=_O5MTN^[3]O7P3
M\N70M,<%ZPMLS847E*_>"/"9LHTM?%L^]2YIJAN$C>X9F+L^K*F(RM"\<FM2
MPM#RFVT/5?EOL<CX;U$"O;!8ENBHR.O*O>(E([UX\IOVJY_V#YL>:QBK(WFC
M3_W=;';^[M0L$6C&%3$.)@DL@,!?(2/HIN=5RA/UR<!A1,,0>"MV7._+T8?W
MGS1^"S@=WA\J, _^3\G-1.K"SY+J'QNHL/VGTPTS36-(ZYPIFP*+NQ\-"JUR
M) 4VSVYK] J$>U=*A;_?PMB_^#L@?3(KG7@,,.2=9AXV'P,6HU2XHSZT<OSO
MF6GH[UZS<OH?C1:P/R7_&??W?P#^?4S/M?W3BCA"ME)QK'I2,.DQT:NHULCY
M(PCAZ^R]EA&+T1^;%U>:&\%*_G/>!WB'M3^+Y*RDZVY+!-THH@@MA'\N2CIQ
MD;1=8'R1 .-Z.+D_XDNAL\F;"ZE \(C.1!K)F;I4D:2(]1/?<K_N\L>=^I]L
M"EB.2$6CN;4![DWK_WV@$PGP(5R=<J=_VDEYSXBBCCC3X*\J"B)O-6FK@!4)
MI0T).TOIMM3-8=,GO'=9M&=37UH,F?%DS)AQU"096Q^4Q[F)3\Q7/:(Z))WO
M_-Y4)G^.YC.:I=THNVV40AN5++92U[IZ<YS0PS%=85,L.NKBG+,\\ZQ#K;&2
M\YRYZ#!AZ0V[P+C 1Z,0FJ7/:!IO[5/>='5;7]MB_9GF+"FY4.M%\',$U4Q_
MJKNSB*5=GVY&SL91HLR8 JQ$/TN8#(*\WH)\JN;*W:6]\<H9ZMQY$%65MS#\
M8WF<F)U<->NLCL(<V)4K+E4H<66Z2Z%WA\#+;>*^$8(?:7<;FBWJBDF8I^4#
MM:,A_2!0HUQ/X.*,D]NDZ^U;QP![]=:3C,=1#IS<W]A$PKSIW51YLCZ1H^B2
M5 $IM97S':1A?#NYL2"4(T]X_&A,O^ZO\_W/+FX["W@9-61(FT@:V?O7T;;B
M ^@N3VT[&TU#D%4#ZM<<C@&/BP7L^6[K37,FP2KWL^3O9YF&RMTXFE&_--WT
MD\GM%4H3OM<MWCE0LIC3(UPE@PG*+(^O.,IZHKT$_WYU/$7FK"/$K123FC,3
MN@B^V"[CS!"B:]$T*,2QA#$^\HE<M=ZB)(34:4SFV+8-[ZPNCV :FB:OU)L;
MWQ<<!P6)9[US[*L\5\KBMSU(1"?4P,X.3]C36PZ-H?*?P[:=76>_3:U'M"*K
MUKY^ZWK4S,13=]N+ M&0X4Z @7_Q:L,(9I"?[8*YFB6.@MB,_U=/DR&]JS 5
MVF!'47QN3DJKM0=E'7))[D1II[ 8MTM#7$5<R/*U\-1R'WMQU\C[9HT*)//K
M:V&%0&CNDEE&#H]SE1 BBQK_NQ?,_*TGR;[G>F-*A<.&0N WDJ>VIAP45&6=
MIMCJ<E0@:\H?51RR,IH5WC.F:6IGO.)B0A2Q,WC1U6KD&?O^C3&;F\,]94SL
M/=M[QC6O/ZVZ%P]:RHY^-PV]_+'ZT;+4A;H8NLD)V,"CRDVXVHH3J1,HX",F
M1W^&AA:!L#0@8:55AKRI<6\$HVAF&3WW'>I\OZ8FOC,[_, PO[8^8RJM!=D=
MJB*S-[66TF5YY&%/-:-*$!K<E.DD:C@^V^$0G B7A9Z^W?"P:BUCK5U^^(F=
MB8! 7F_"X)+I[8*:RAO7Y ]=_RV.'\BD/5,RSEBZJ'NN2*%CL0[U@GCD*RS'
M3QU=PZ<ZG<</A""-KH5Z1-"R'A>8)F=96'U/;9?'NTS?Z _0ZMO6@<N((3VN
M,?$.%75HJ_R*$:0V+=4TS<IF%JDY;'X[;RD@:=FK?>+G]<.'\,]@3"QZ4YY6
M;$GWHUIW%RI1N1-T_*KH!((3*5XMN,)GQ(%> :;?_:& :N_\>;=H4N@@:RFM
MOK8S1W]%/N:5F]8C9NY_%C.<SGRU1E\C\%)RUR(=IB2_WF@;BXXG'OH_&O7%
MH[1K]M1E36S+>S4-&Z[^'"N@S.8>6LB1[[$*NE^CNX0^,0*N-<8GE#IS;F3=
M6;2P638_= H57^TW5<DP,<O-UUV7+B+J4^\6<"_8_ZL-07_D9Y(PC&^!^Q21
M#$H4G<6]"$F_2'=VH*9AVH'C:IORG:(YDSNS_A8C_D\QF117:_NF^M&^8&/U
MW;GR1YD+H)\/CZS_@8Q3MQESCGNA;[U4\4,=@RI$D( U=_Q2R'N[T@)C(>4(
M*Z1U+LI$U],J*'-FMQ;6Y"GBQBJ?&M'X<3Z 2KC=!HDT&2D/-5?#F)Y?+#^+
MDCA+5$S_!Q:SWJTK\?^JR>CN_?G\%LNILY>C5<[JG+\U'ZV=1-7_#X;_CGOI
M&,!D]SH&L/SZ=/3FQP?Z('7:QI')1U_H4OS0$//#O>@0]+GP\MC&KOG3*?S
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M_>4'J)<!)HUPA_KC5=F*DVZ*')(S.Z?$T:!\=>^5>*QMVMSPG+"EK:WM?0!
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M@G:)F\S8_%=42&4R-^_JDQ%HA!8QE=CCPU2FG:G-/C7)G!L9A*B/WA\$UL%
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MR/C#+.-J#4EC'[U+_(TY6<BB>;FLY^_HJ/!\NKD^J?-"%"JUN<&XN%3!*66
MY67*=CJ)%?0]9/*Z7NAA?VM_T[7%:^S3[78FJ1E5Q7'-CGDPG?5RCA["$2.C
MR5BBJW,/NT;RSFB"=4]KVGE;2KEH,=2O:PR4F0G;6UEKC)Z/DAW,TP@S*B('
M.%U.>^S[.@V2 ><>G6T&Q<E!E[4*<<:]OI0Z;C"S9Q\VTIT]G.J>V[]:3/II
M4KK7Q.G-+R[C#G*/.?5RNJU]"1VVM_+ZK^AG)<"V 0ZPR;@<;,;%P5H(4TO%
MCA:B=;T[_(Q+'SE,(]S&9G!).^?DE5'XB)>E/FFBA%UAJ2?1HN1P1+W=_.XV
M@ I\L T0X M[!-PA"O+EL1 &SWBP#UI,%/%/OW=CX_DO&EJ4\=*7B9Z>EH&*
MT HSO9X#;])](TZ/(6PV\G! 1;:+3 (VM?3N_08;S8<%UQ#*:F:+^D6,W]N'
MEJE[+90.1*E^:[=U>&E#OVU'O];(@\0R.I.S'1-;-7'3L#J;@HZ1_GSW_+5[
M]H5WC:T*;;^K3F("P@K=V* H8H5? SP"EEQ<S%/A0J<H/RV,#:+VY17YPTQ.
M!+A*DTZ\0^ZMS^BNJ1JXQ%#F=Y'3A0'LIB;Z^LE SH)JV2_-S#=N[6^;O4]*
ML9T_O\KSD(#EW7MK;WW2H=#%X9E]O+5:G;B5?[B6D.2)P:'#^G)N]^Q1K4^$
M;N79&IWY6."8>/T9JMJG./1>E*2]F]R?>_G[7T"P.BTK/^3!XMN D19#_O-:
M?:^U/U0+7A: LN!\J^&8'8Z$06^=H;L6TM)Q?R@6# '8FTO^5Y!=O,*=B(EZ
MY;9CDNC]-86.D ;"?NO9+S]&L'3FI5W15H ]41(S33."K<QF?AB_FU#AUP(<
MRVCKYQEQG7WR/B'O9"K38\GR7<&7C5V2\N8XKBX&CEY>DZ2ZP4C,9(X?6D2:
M0Y,Y93*:+'UQ)F3K]T)_IGL[D0RD>GS[^/D3;T^OYO1ECR[Q$9X9-T.O9,%)
MU<+SO)CLP4YW'Y$"*>&-%)YH^L6VI)VT[FGLUB+7E<&+O;.:K 5O[E"=&-?2
MO$*0/L73WWJ2X<<M56#!=V5?/6)=JK,[[9KS7G>C?F?U+Y*L*P/Q0;>=PHN)
M*KI?;LW4V,U^/WA&A3J+5V-^>^Y="#V0T+E8TYUF7S#?W] AG2.K-^@)OY'3
MY<M\/>9J.9?"DXCAB U#O%,.<E<<V/PR1HH8SIJ]]N4).N@NPQVCT77,G%65
ML"?-?5XZHZ8U(V>R(_1N$1WNN="O_-!@@%3Z2[R/ ?[:ULE7\7SK[N\EU-C@
M2UY!F2[.[)&/YYWS#ZG?LLXZ;9\O%#+]M2G+V(FQWSPPIQBU0WURWI:4":1.
MG1CUA5OM^%5OU?[(M.=E1NUY5MUH=[N=S]MIDPYWK-R/QJN6J:[^_NX':,"M
M8R,;M@&[P8>Y.4QB,\II7E&,E94Z&6 HUGQ3^ZMR-E->"V([@-I]S"L@\_7+
M8%3^/.=EKPTFZ%#JQ5?BUL0L^#[(5#GQ[3:@!2K=Q8"+-S+1D7'*=5VMCYC0
M6,L+"529UGZC4J6WE*$0DMV&J1#?PS\Q'5F@PPG_/#7/#H"/G7*#T;<2-J_B
M>XBL05#%2C+_(+6D+&;-\XZ"H3V+4Z9KI?PD/]8$4@1#PAP"["^4:<R'5DM[
M0P?E5&>R)X>_>GSPSWM?'6W 5P>K\;39;8T$$#:%06P./T@ 8JE-U:\ZG =\
M_6<NV8B$NH16A5ZN: S+#S!P'*?/TX:_LCQ'/YGIH6(:MBA-DP*,@Z?:*P+!
M?HDMCDPAY]PY!RI32I91KM@>D9>4=_[6$Q.'].,8Q'6C'T-ZA9;IB44#A8[?
MB**G*^*P'J!T6L.U6VNZ 8_[20YD-:<DG'>A<X^P0XEO?@P2N-_IQ73[@I%S
MQHJW]>68M3-!.SPU=BOE&O<18BH6 Y&;X/I>9UWA.28TT<2X!MW?.P7%R0^_
MM4RK+1VD?2>KUNHZ'/=75+VI=2-S87RUHRE;FU6=7'G L&7'U4@G,"D'D-*+
MF+S%2= @21]UG+]O&Y">3AO6[4)K#SQ^Y+S><K3RMOK%DAP>3V/CYN_S@A>]
M" TKB7R%3\%Y/)>WPSNFLU]N&_!0+T&4.D%AR!]Y-U=,JR8QX0]_@(19S![=
M0!=3Z%Y'X9@6^Y;N[*.G\V)+"DHL3:Z9,Q9:@U-T'_I8!,TD(APR]&:^L%1B
MWU>+^J'5.EE<\!5;$W.<Z16]@,O84 MB9<A=9>/)L6>)-Y@SJH,)'QXO:%A
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M23(YQW9M@(CKCX/V-> \,. Z9HK((NS#5H;%L-XV0/Q*7O>'T!O5RTA4T4C
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MECU8741!G=C-ZR<\O?+BE:-)15;J[2SH+=F6%M+;_1R/=TIG#)@YB#V/:-N
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M*,:-='V?W&/35^EYM-]CV<:14O,X=HI<41GA_N512GOL+<$&R&Y<P%;)-B"
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M>G3MAX-6LNWNTCR(O6I!UNFS/;.*EIF#NCQV>KXPP^) O^R 2*@R2SFQBGK
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M^K(>=>IA JE1&P<N@Q?2]U_TL7*]JK"31<F?HB>>8AE#'6LPY;O6+<NT.>Y
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MXT -@W!0^"V02]DF?T:=2*8:6BZD8C7"L-IDG^\L);L,6A9V/"2C".$'RZ,
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M.@"^%JQ,3:S!>,(DZG;)XM!7ACVP!NLPU .C^OWOC^J4ZR168M__]-7$Y'G
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M0TO.C+03?$D-C=,TIZN7FS<9N]XC_5J67\\[]%DJ'C&B.[$L20=BW"$TZ.Z
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M69,U/:[@7&9"2"([+9[[2O*ZD<F":L1AR.%W9#VHO *LSROC/)*0F5#!@A8
MH,UB5-H*C-4Y]T1Y%3(\3=:'^I52^S14#"WWU2=#IX(HT+"%N\,&KS$A' D
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MIW[CV#5>?/$\_4T7Y*ZTTDQ@=*X':4R#2,)@<@['A%$<*58G2ZQ:7,E&Q'@
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M=+/7*BNQN]7YD45O69/MI1_1<XW=O\RV!Z2&#-[-$X8%>^G=.3(6Z#[!ZCD
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M]+G8L(V3[X2MDS;,-YR",[TLFF%] 3ZRS%=<<T/QG>Q',/]1^2?GDNWW/W?
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M)HH;#!$J=P6F9Z7I2VT)=V6S\I-K+,;"O!-0Z>3-EOV,J'H0SD.;S4Z=&$I
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M+&YK_!&_ >+:2."S=VW-Y:? 5%H$,%Q#CHS74="S$O1.*4,'%\E9I.U:7?%
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M5_!9]( 0@C>?'[:3J3IU_KDR6;M\<_VM'(--W:$D!/0%")'? 98&,UE;2%Y
M6+=L8^^LD\[955B7T;MBFNH1Q9H9%SV!,WAQFF";L$S/<TIY.2J3V=P_A_AK
MZA%VL])/E>&\6?$C>8)U&$R3.50*B%*Q1P=M#:2MH=0;43O/U,XZ^J:&@1;W
M0]F@1ZYS JVG)&BF->_9LJ&11QK3CE#^5K@*"YG-XYN_=7Q?6,6?NN).=22V
MB2GS-(T%9:C*F[#\$'<>/?<>I7&P#Y$F^!:Z)EU(,XIAV8%Y#U&65^9,#4':
M'7KN5N(O AVR_-"GF"R$B9\35G"R##IC/&^TF3OO?";N*LSY2+_T^M<=G<<:
M5TQ2GH=N@S_B.(J=ZDFR_3C+EHCN>3DU$+<*V[(LT<JPJ?7(I'4W\UZ81:SH
MUMW42F5>*_,PK:[J% U"OJ9'#)]]TO'PXJ&?KL+TH+@.]"XU(K+8&-3)298N
MI&H^<[8S?Z+Z(QM? R5TJW>-S]_UVU>L]5 P^Y?\#?'3#5K=P3^G-[S[8V:_
MZS'U#8M>!&21KS0P%.=FH=;Y0W7.%ZNF_"A=;H2GL_ZA'Y+45I"N6F#71(?N
MBK RF<M#7)%NXEDG2X5JU]R*?A^)#\^L0]KB\8LRC_>#=[$;- JV@@IXJ7[$
MI+'6#BUBIDKE;EX>?P&,E#IE2 FD)5G@X(W.F+>W,D=^!._G^9/"!EI;,[&;
MKLR1OQF.C9B?MXFY[;SY8'7-'=C"!%H<ELT6%5$98=W"B6=?+K\:UT0^+-^2
M$[P/FE,XSAGF'O.JG&/I%;_I[P[>T98M?6A)W3E!/-5927RIMNQJK2_\:NC$
MATXFENKMNQ<3CR\]DM^&?"7HI"&E%T0:#$%VO4(=P*&.0&8[#,\OLXP!0LY>
M.HABBYS:[+WRXL/NH?9AH59AYVL"<A)/TDL43^L:$S>F!E.. F&IZOVD6.@#
MP-:8?3<U63.T]4WP)-8FZ-$SHG87RFG4>;,$D>DX?E]MR;[7M K;1LQ9D784
ML+-L"1LA;X[  "CJS:V8\5%_PQYSQE,D4W6NW?&&J>.=*)/$F[*"_SP-M_R
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MNRG@7QG2&NUAVX;,6(71M7)8ZR&.!-V!W*%<"Q ZJ,:S[)V2!BA+0EL3*7
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M;24]^=)H+'4]SH?GKRZ_6>.A<").J;=D*Y!]E:0]JF=JF)?B&M'X5!.#2[(
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M8;LQ<BWI,.,%;LUU/C6U:=KU/&C:B*K1&5B4+Q=@Y4]?/L*<1HL1O)_:/I?
MQ&Q1,19>SUIG(?-0?#/#5],EZ%0A#!U^8)BEYU7_E\T"R4F$S4!L)N\F_936
MP>:CSOT2>93H>QFZ6WV*$?<+)N$PZ_J#9\WV>2 YVS>+M!;RN F$B =R4V,'
M#6>Q>LK;SX7!$$.2VSU]G6>IXRMQZ$Y,>)W?77R8>HZ1APN">]U*&O< :"GS
MH8_. 7'),;FZD.L9PGS[EK_A$?]Y2K(E/K7D6MG$]&Q\W5)Q8<5$0']<8E6D
MX3>3$Y/^':EGZJ,^?0K^UEHF=D-:<4\_Z+W3^ )6T&![--#5NKW[XN!ZD'F\
M\YC5BX&MSR^=+L_F''CPY_T_/\Y>'GUR]>1^UG'-B*42(?^#/$Y5=#W?U"BY
M0[@='8'='=&S[R%";YID.^ZL)X:G^IN6FO2T=WF510B.@NWCW69[#HY\0NXD
MKNO,CQ9H!^"FC%=A38?620F3B5J<H( ^],O4YB178/^'\Z!AIU/-*V4?2U7D
M_$ML%7F/ZS6G +?M;Y76;2_!N$[M*G'QG+>15C+)KG[.NP8:68-FDD(A-S%2
MX^MPNX44%-JH?/".$KO' '5L>#';]\)0%.G,4P_'H"#BK43<Z5>-O";9<9^\
M37O'J*=9+]AM7/)8I?4_WPC>]'6P<=)HH(O;(:2STJZYC*W"YC\D5@V"-MH[
MTZ?GT(V8^U3/)D@</CO4;\<GF@Z> 99[YRR-O[%S\;@$7=R84FF CW_/GYL/
ML)SR.ON&>Y'[Z6K["W9SDOROS[P?BOF?1F8/%//?"\+[/6SU.?L]=U3]_=!]
M=O;LK^'K1+3,51C@N3"!E= X>)RX7_T&O86Y1E5>X1E:012*<^\RK474=-,]
M[$TZJ?0*J-)]Y.HHDF"K>)SY8;[@R^R*>X49S@5W?C1&D57CUS8X8>P+?JI1
MF),.T*$B2D(M).P$B>-B<H/$Y.32;AK)U[ +F2Y 0@%EQ+\D4A\$WS=7:@WO
M7"%DNBU)WV+(K:T"EW?+Q4B+S^CL@F7E#D.)ATSO)G!<-)[$/ PXR2.3W5]0
M=I%Y1KR2,JBRK_5OH^8G%4&1/E@M9W/39C-@(7-QKK =RVG.)Q\'\MHJIX0S
MV9(,&ZLZ0P\NR769G<0T$2^D%<.!OKO.%B&J0C%5ZZ,_-G71&.Z(RZ./-"5\
M>^-&:=[LNW<M;7^<W&*<U?9[:$OK'Z^CHZT>G?[48>+R7[D\.SG*<QJUA;R'
MA3OC0<^^@GPY.AF%((;X@Y2,)?,D7 L^!K^Q*]']W[I:V4//PKF^U(V9?W7Q
MOK.AU0N,/</_*0X?9J_[A(X:A*PP?2Y.:D/"/%VA3W0XKRJVVQ0ZQM0Q[#X<
MTZ8)+!"#<[&)&C(>-K) /@+I8\=*QO$\)Y4]0HMX66;>7&P^8D?5"[ UHHNT
M%BQZV*GQ6KWH5)8M=$T2@<0WY>[^Z!OO.NL?*(NH_>C[MX'4';2_2[KG64G,
M[5KYVXB2SG2J[NJ/KL 5A*:HVLIXPR^^L">I$E0C:"'F4[H2-A;AP4)Q<<-S
MI1DT'!&R_M8,'H1WUN$-*JMG>(+$L;'<%"6E_&TX19^Y$Q_K%.@IHNTF1GT2
M^]S^ _F$W"EL3LU01"K-1DE728>KE([0(Q%ZNP#2^GK=DLNUJ/P+ /;_8>]-
MHYK*OGW16#:HB 'I%(0H(*@T4>E*P$2E%)'"J$AC:%**""&&E$47)22*] C8
ME%!"0:17::) B$),A 0H"Y4>) AI*.F1O17"+M)PX_^<]]X8]]U7__/E?GAW
MG ]SC#!&,EAK[[E^S=ISSY59SW=[T> :3PBA+!-GKW02I,/._C.63?$>Q[F)
M.+ROU5?*,0[M!I>)X,VG=2"&.%NIO:8G(4/0YR_WGZW8:##W1-;XA)0*OOKK
ML 8:<ZLMYRR9+N*FVE>FZ NXJ9^5JZ%?=IKY/%]_XU#<&&UV"+@OS:*M'J(0
M@%8&'[X>4L.]!*GW14;1/F/-@\K]1(>Q8[TNQR1&5GL+KGNJ'^^3NU9,-:+*
M[)1&=\C)R_-G>^S599[&$S_*_U:P5V _8894!J!N@H_,YJY!;8,04C(DEME!
MSGS<=N4V^5'(68R$0YLEPX'0^;*/9/&WSC" LB#X$72OTR_EZ'W/U0&]I%)F
MSOC!HOMO9-[5@S,**E80AF.AY\Z )?Q174@HREY/?2]\'IM B20C6@27F?KI
M5&MJKT%HTJ([@M=X_%4-OK%*@$OF;(%JR5%"37+OR0R/GNC,4/?:7#%S&KK%
MXYB#FXLNK5H.%H\<G? !E$E/@X;S/=YY'.^U5V\Z6E,N&/_RIWK:W)]_Z!W;
MUV':SNP/(/)@0[IU_U@(?H%<PM=#:0.#J6SO)_,&I.1Z:W^^P<W;(4I>B5]
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M8"P/N6'Z>DHKTF %UO('U VJ^>#T*-Y@V:OZO)BDJS6*Y,$?>RFVHLP-(R7
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MH!N/8Y]TQGJ@OVRYY1^?O.R&,1[0KN 2(N77((]BR$?#83@(HR&_!.F#MN>
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MN;D^$->Z[,FXX>7IB6YS0B91=I6$'< ;U!14H=.);-<GY/3V9D'\^Y?E(]A
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M29D1L4S-O1 K,2VZ%M0M<U1V-CK.S@$3QX"H("N0SN?JNI9.^:"LH K0@F_
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M9SVD[. V')7'*X?[7-"JF0^LP)K1:Z,*?@IWNGPW4F+(<LQCM7=8Z^!I0);
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M)MRXB$YM7%NP/"IHEV0GY:&S* <?!TQA"PH?/@T:'5;'.U#AU _TM:COY:?
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MT OP;&J[X4_(Z+5&QV%V]E[)^!S5$,PE/F()&A2H65H'4?ZQE8V5[>F;G!]
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M?(8"9?TY]=5$9%B;=>%T<SW+#I%S^M1@EJ9\>0+,A'"Q5"H+$*&1J-HX#.\
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MT$W8'^$W65@A!;Z-4)9^$%F+#=@'U)^AE]"@.L"?-V4@IEHI4#_=%]"@B=>
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MNJJV^GO<[2 :M]#120O1ANS91J()W1#*V'<_X7.N6@G6WV*HA2TF3FFBIR/
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M=2)1;2%W6;X&?K;*<[8?H=-H$5JFEFNI0#7E7T*^: (K](<=%:B\N18J=)Y
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M.:ASV_7N^ECF42J%NF#F419J9NY2ZVT*0<57;X5!4#EU4 E6S8N"H+POG&=
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M2A.":SL^3L4T5'%1QQ^@/,$E-1(3LL: 7Y@/BA,86'#DC3[(&%A%VK,-WL#
ML9\!E*D$YX^-!BU85A&S UG6?,<!/,%L'&:,>K[C<NL%$T3JD:BK?X(8&Q:H
M+MS6@S81Y=MQIQ4XMRPP^F/2PO1:&K8:MV@SHPFX%-G@4$F:3-5!'7%2XH.X
M\NGZSA@4=O*ZPY"J8+%-U)O52!\#4")C@%H)7PCFR8?AD9 $SSPZ3SYU>HZ1
M6JZ=)&U-XA5B2A;(DS)@EF@ +,A^?4UZAF-K^@4XOS[<"RS]"]Z$,@(/@]>=
MKOXZX<N$WM"A& "Y2O"XH0'4?XX)\CRIG3^HQ/ [>B!2YF2.(485'9<A 8'8
MN)10B!3ASI)4,X"0GGQ[/4608E:YFDI:PP$)2SZFMH"R 5;X??%A^N,!J!!P
MVA..Y[W]'#B OUS]!YM"6TSSQ*\<HFF<XFY>X#_;3D6YCKD7RSD_I>$"'WH4
M%=;'G&@#9!%<#])<Y'8(03=Q[!"#C'INW)*MYCBA:8-Q@&H)QPA_8U\)5%S(
M?QPO//,O/W2@8W$#)Y$WK8"?A>1S-LR+.<3%_,6<"7@3$HS&ID;C #,*,AZZ
MFVCH0Q6.HD*=N[G_FS+!@MMNM&_$?K1JZ#NY_" 5X4@&EH4L,5EA+F8>;NP4
M)M-5\6ZD+FA-C$4Q'IJ !7#)[PHDS$3O%ENE$U=MCQQ?\72,6%6N_L/G]'$/
M&3VFHKPJ?;8RC:<R:")GS(6D!T!CSD\'U0/ B(GE<1H(1OA9I-[I<V*L9ZKO
MV1_YW4<:F#]U[+*SX(^/"D_0UZI5D9^?6<V:6AA GQ+,O6_I^#3;.?O'%?WO
M8V+%(+X:(-8+*L>MZ24#_I48P6GE](>/8IH!@5W;-'2%7Z<0KC"@L[RWJ/G;
MI7"LL@JV-894&KGBQTR*4,RV2O^+<>0DRR+=1CF35JZZ=2[-76QK5AKMQ9P+
M:+8W7/MWC1S%'0M4=G%:6EA1&LY(35<HSDA-EW.N_;LN-5T^.2,U7:$X(S5=
MSKGV[X;4=/GDC-1TA>*,U'0YY]J_FU+3Y9,S4M,5BC-2T^6<:Y2GJU>EILL=
M9Z2F*Q1GI*;+.=<H3R<U70XY(S5=H3@C-5W.N49Y.JGI<L@9J>D*Q1FIZ7+.
M-<K324V70\Y(35<HSDA-EW.N\3Q=36JZW'%&:KI"<49JNIQSC>?II*;+'V>D
MIBL49Z2FRSG7>)Y.:KK\<49JND)Q1FJZG'.-Y^FDILL?9]9KO/^&TL1W*9>4
M^IG[RC[$-N>?Q5H IBG!YG$>M.#Q::6ZHZ-B=L+*=X:EC'A;*??]KA3=?"G*
MT#J\-*S8E$X[O[JJ7IT71Z?-(_9II96%W!OLID#M0ZA9R+J2L#W:HUM=8M*_
M+G39'MG?1@'EAP__S!T+&A27O/8$B8*SI=VJG.2.,WLG''E54M(V2/A+V["O
MMN'XI+)VBDH*1]F5E+0-$O[2-NRK;3AI5NJYX\S>"4=>E92T#1+^TC;LJVTX
M/:ZLW2I&"D?9E92T#1+^TC;LJVTX;E4:N>/,W@E'7I64M T2_M(V[*MM:-4J
M:V]=E\)1=B4E;8.$O[0-^VH;3JLRI[1[+N1524G;(.$O;</>VH9FI9T[SNR=
M<.1524G;(.$O;<.^VH;C9N4X=YS9.^'(JY*2MD'"7]J&?;4-)RVYWK![+N15
M24G;(.$O;<.^V@:Y]RT/7,BKDI*V0<)?VH9]M0TG)Y5F[CBS=\*1ETY]\196
MZ[4G+15;KK&-G44=^U3S=3VO=MXWME2,V6T/WT5Z*TMKV'W7;;G@52-S)]\]
M]Q!J[?5WN92RN6]^6%/P5N:2%](D25Y)D[2Z26I56M(DY9(UTB1)7DB35!I>
M29.4/4J21Q7GDS72)$E>2)-4&EY)DY3=),DH*9^LD29)\D*:I-+P2IJDK":I
MOGZG96F22BQ:TB3EAQ?2))6 5](D96W4MG[]H[1()98L:9'RPPMID4K *VF1
ML@9)QS)OEU/62),D>2%-4FEX)4U2]H*[M7<02Y-48M&2)BD_O) FJ02\DB8I
MJTEJK-]$6YJD$HN6-$GYX84T227@E31)V1-W<J=L/EDC39+DA31)I>&5-$G9
M$W>RX"Z?K)$F2?)"FJ32\$J:I*PFJ2FCI)RR9E-M"%_;&')!&T+=]GLF4^J5
M/;).C[:GFHK#GICELUTUZYSO,.PC2_+;53A@#E(UU?PLXMY^>A1Y;4W\-JPL
MM[=Q4M]=[_MYWL9<A;E?8K=;'2KM67YX(>V9M&?2GF4['[BQN_.!I3W+L0Z5
M]BP_O)#V3-HS:<^R98.KU?57**5!*[$2E08M/[R0!DT:-&G0LAFT6G-W)ZI)
M@Y9C)2H-6GYX(0V:-&C2H&5;07M%.Q)ISTJL0Z4]RP\OI#V3]DS:LVP-']LR
M/LLI:Z0]D[R0]DS:,VG/5EI!.Y$!6DYY(PV:Y(4T:-*@28.VDD$[K1Q+@Y9+
MWDB#)GDA#9HT:-*@K;*"=B)K]G/*&FG/)"^D/9/V3-JSE0*T^OHM7*1!*[$2
ME08M/[R0!DT:-&G0LFZJEGO0\LD::<\D+Z0]D_9,VK,5 [03:= R\*:V<Q4J
M.FQ^\%2@#GRK&T^K33X^UU:EWOQA^83XU/'F^(C@K>+E-!;!OI\.J@>*QDP3
M&02L#C\+UM/GQ%C/5-^S/PKF ^%-=>RRL^"/CXH 2+7Z ^?S3'/1I1#=3!O8
M1JU27]*R=[YACRD0#7YESB8TR"J<>Q/C#O2&Z0-+Z@<Y:+%<JU6:]6P]EM^
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MX;%]0)GMN.&\5$M1!TB(L3WV37K*(7YI6(0J_,7R1SV@$8RZKQHFX@R,+SS
M&0"$F$MD2=X!<P>[S2R-X5VZH?88<0;)Q9#+&@BF8?G$@/'8=CS?0B2B!,*3
MXKBGL;-^GVE"4(AS+A\#00@F)5XMH$TP[-/?[,5PB<TQ[G-P@\:I%%R-37,8
ME ))IB NL1O&/E0\]3N090AN"](%V34E%TDE$T %?P6^_.7C>RS6-X#L,[HB
M(6YX1\^Q53U\(M#:!5"90L_8/LB:8^N^YBEC0!O.,:$XIQ010 6]+1<>YQKJ
M4=]A+'PT3F (+P55"I(J-$*@UQ R(,0::/$ALX D(WP.*96Y>@WD./6GB3*
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MAJ0%2!)9%[$F&F5U:O5@1"(U%<V!UT-AE1 E3G0?DR#NF-%T9I)1T^E#/"'
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M+.SX%C5D&2D+DWNGL<UK5,B@!D$SXA_H5UE/4RGE\(-2#$OH1*+B$*8EGKU
MP\(<?'*LO.J%KZ(2X9&J1ZAO_%%X5KT[K3/P/'G0A8-UR4_[X<0SPE>$Q]JK
MH1;E.4_ -Z6)@I76Y#GWY$Y8J(R_,TMLGW38&%&L@X#@ BJ2B&=.J)U1^* H
MM8398]I#DFY/^8GU*?HVD287;PZ.)1<?<857'84#%VZ5#C/5//',\(UBIV!
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MB!A$Q" B-E)$ -3P/VU:,5"C3?JS*7N5F9CL:K4)$F?D66#_?)F@KPZ0WB
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MN.GH5-1^:Q20"31?=F,IB'Y4(:N\.\<==///=7^>W.'^'#P/K/F#IP_$FO_
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M@RUE6TA:0 8FTCAY+4WWX)T9P<=N*KC06=YJ4QT6I#V:;Z].SQ;[^5):Y@@
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MD&&G,(!!DIT'G*[:-*O)J T,\V@ZJ.BH#!FVD%1K0^H/*RAWN#\$Y?YT03G
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M%+G\"H>%X;S5:IXR-=MKT+$I;/SBX-E]?".W3]NAZ$X T)6;Z86-P5M2M6N
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MMC571+\9*LIJUZ3[-6;'$Q*<P]8G.629U7= 2=A%=;[Z^.-)FE3D3JDIWK?
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M^1;)J'%5-!937$7MZW"ZL KB']O;Y'X(3:Z.4G4TNA7 76QL8M"7:3&3$MC
M?-F)"XD_SK 6[;OA*$0>7^5R=EVBB*1%9*AD#\YDK9&Q(Y7"*9F7=,]<2_".
MBBJ,1.?I ! G%(8S.AA*TXB= P0!T:(]UE1.VA0XVC.\='Q>N2IO8SXPD1%$
M2T^@?;0KDL(SNC>O0#<A&3&T2.:M4IZ%W^EVOS)<4JW@1#FD?D=-$G*%B:@
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M@FY[?]CA8] 40V[PO" 1&1[<>'!6N#T0C,A_%<L@#%$:@ 6"S:JGE<A,6$#
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M;ZF;FS(K-4FPP4$-T]BHS,6H(C8>2P&ENT.R)8XT%*N$32*FLO=M/%_,+64
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M 33O)'++)K/044.K\[F**74T-\$YIF@D,<D$EWE!KD)]QSVMU_3PO\Y>FI=
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MAQRXG_'\5C?YIFZ:C@S>*R ;<8!S#82C2,ITGQ7"N)5-Y4Q55!&/&W.C%JU
M#QQ5+VKR!0P919DHHI<A;Q)OH@TBR/IZQA6\9C:C4^BYY\TL[>LL[:5I"M2*
MRFRV*&Z+4@T[?51PEP,<&;\A"67*=D=*NZ[L0 ;@*2FCZPF)?DM"6D@&WV-/
MXHZ.N5A:5_S6"36#'7,F7$EG.CTYJX':Y0+L5.C=W*_T>*TF*)9NGC=2S<(1
M#V=4-@@_K=;G?N;NM;IRKJQ)BH.;6#NC",=@-46%&4R!H LVN:C&2:19*WN@
M&Q6V:?SR1'M6IV[OJ=M[ZO8^P6YOS_<JL_81K/_[""FU,R^F!? </8$"C!QR
M"ISMRV-74Q0"R709#WW$"-0W&+Z9RUBT$L(QN#(.J8UIMO-<)7ZR%9.MF&S%
M"=H*8<7DW"5'?$NCZK0.ZGO-!9D*9DUCX"% ?$XZ^GPE;=+1DXZ>=/0)ZNA=
M4TAYL'% L K=WB@G1K7 WDC-[]#%'VM3ZV?GU]0ZD=.?C&69+.]D>2?+>](G
MYW_8\GI@56Z@6L#::B,J4V08/R?R6U/D<[Y2-.G?2?].^O<$]6\N3,GDLZ,R
MP.VDOI-<^8OJG?;PQ/6$21F?KTA-RGA2QI,R/D%E'!=ER2W>SKNFE1+OCJFP
M7 (')#/67!W0?G%KVD9+N^&YI\/P8"BU=M-\WM;-W(^J>:1\?PL9CL>4@U.&
M>2;C"Q2+:&*5M!FWU%EKYV0;SE?")]LPV8;)-IR@;9")(F:0;O,EB'USF6W:
MDKU0K):("YU;E..)I-!VZSO9&3,MFE.:]/;Y2M^DMR>]/>GM$]3;#*8 F,K"
M/.?<PW(&'K+1820_B\+@=GY69E+3YRMLDYJ>U/2DID]033O#&T('O0[43XKV
M?,5E4K23HIT4[0DJVMNBZ=J9VQ5+1^I6!XWI?^1?,4+IS8__^?+YQ=57@)SC
M?L))'Y^O5$WZ>-+'DSX^07UL&(R82>T\&,.>7F*U:K-962Q<!=R5",TB,+(
MX$.^.ILS/J@@$Z2@!H:IXN$G,(;:.. 9"5*&WBR@0ME ZSY_YRI 2R7TZXT.
MW0(_N\:S*8HA)U/L6L(,LC1X&Y?O726L>0,*'^[Z!QX; SS%^!EU-9F<\STX
MD\F93,YD<D[0Y Q3XGVL(,;G#?! ] W/0;8V="%H;>3)411MI_[$CTC\)L4]
M*>Y)<9^@XFX7#84( B)C"GF?_YK0]T5(]X&Q, :M8WRY+$(*%-0Z7Q.E"SI@
M"RM0'7OQ9!*Z2:6?L6!.*GU2Z9-*/T&5[L%8?7_@SD.D,B<&\]/6TB"NT.63
M(CY?<9H4\:2()T5\BHJXKM9,B' 0F./#HIPT[3G+RZ1I)TT[:=H3U+1]\-YM
M7E3&.ZG<@HQ$XDF9M9Q9SM9= ?ZD:E+,YRQ>DV*>%/.DF,] ,0=4]7S=N(CK
M$OK.+81\BJ?<H4=;3V-D3".6HA9Z%J7BFS3W^<K?I+DGS3UI[A/4W,..CH@A
M#"R<^\V!B9.5/4JZ"HM ],ZZ?5+-YRM@DVJ>5/.DFL]"-7.?=-VGGFOSJD<C
ME&N[]2'3TM\!71M-*PQ]:)?>:Y*$&93OW&Q9AS*B(*A;'PAW]^%GN^;_LO>N
M36Y;5Y?P7T'5S#ME5T$=2XZ=9%PU56U92I3$EY'DQY]!XI"$!0(,+MVF?_V[
MU[Z<"PBV6HGG,:G"E\3J9H,'Y^RS[WNM=E>M*N'QJYHQ1B8QXDF_%E<^8@EL
M-6!H%LMQE?*_6([%<BR6XRHL!SQXGN9)&K9O/I !X\/X+7YWEM97&YBVB 1$
M6?2&0*0J='N"EULU/!7%1C:A7F5(Q97+=B"VC2GFYUC1Q7#VXV;CNBOFE?_)
M,8>Q$IN3[0>@)%ZU='>N;@_<XVG5%?JJ<5.LAY%[CM;%06 8C$PZQK$4>F2<
M"7D5H,)U*.+04P^.7SH;#SQ%$. TP\.=<IM[UL,\D&P58++NV]H]@7^! )7^
M4QC%X\_OBW=8XMAG=V/=T*'!;Z!E\$>.'E%9AYN[EGZ]MW]0Y)N@VN?D/57K
MG;;,0CCX3<TI>NCPO[S\R_,3.X7@L!: ?^0$1,S=Y+SIO\Z?-D_QM5E)?Y;3
M'C&JZ2#G0C>IKOGCZ?.BR\3S@20*&42!ON F>XQ<XI&;JNO1P/QDUX[]=,6)
MA()]F?X &E*7/?]^1WSR>=L/1?:Z6A=V^JIAP$E>;3 %CP5MQIJVBSG'W>!*
M^FQ%K^H:%C?E6\<;@8I(P%F=JA1E<F^;$Z[/TWL ,O!6<6+1A/*$KN,^(U/2
M0V5!NFC#7L'A)B>73T'VZ-S%94TY5#V=E!(HD=)CLM)2_[JEP]_R2":K/SY&
M60L]B>X--\ ,)*@((AIF>E]7AX*W@%]X/=9%5_-6TC$6O<(8@OB]C0X^SQ3*
M/(]XV?-8TH1?%5+,?Y$-;KUKR QNCR(C==\*!53#<8CKPFVF/959UI)G6:5\
M#&D*EH)TS!IXO.A\]VLQ5"][WVCG)+)I7$UBY$K9+KLLIP*N4@MQ/C%18Q-M
M6N9(@-JC<Q'4.QWDV#4 &^--C"T:[Z@_.UQ=.C_3<(X,$N:R7'W4PY*;6A<-
MHK6S5Q O&SVQ6.\JDB+>KT!:[E#^P0OX.8)[%YV^4,%'-U36&U]#NTZ"7KPM
M=*4%KSK6*>?V4J#6;&SAX4X!VE6Y9ARW%K .:]ZG(&Q)>O,F>SEVF&_FS64M
MUCB<@+Z2<$22>&"!["$<)\N,1N),)XENI"M0Z+IS;5F(I$%,B_N%@J5N96#.
M=?6.U,2N;=D5^0/R 11@8Y<VD3S0P4,W8 E %6W74..TE)OLMCD*6H>_$?(U
M/7TK+8QV_=2692_N7 ,%=R_Z=VK;(M_\8^!&^^+ZN-'.NQ6_XT:>QHB_SSJ"
M618&[\15>(0;R_>>;;@EO\1WA4]$2IBNY)YA"9IQOR*UT&Z"S\F([I'MUEO?
MNST4CA6\H9-H_8V&$Y$+%<=H5QR+O=VYV'R/O4 ZC I:<=;/&=+-2R#Q]V,O
M)N[ ?I#'B'CYS:WL<G-4E&56[M94$"EY&W\[0G^3>2-[C\>TY3$[C%T_8NJ-
M43'Z@[,9YX[^JJP&LW,0BI6+E3_4 ^2E'U<D%20=/WQ[:T@76)K2N<<KJVIU
M@8H/6R7[.N:FJW>"KYFUD219:G,ZYWU3DN 0>[5-SDL[?QST6N- J_V5M_/$
ME&JHD/T5QNG;9!$_Z'!*]LGZK]_^\&EB7R5D([$LNNC]H]_CNQ(QF-P1]:,T
M^CB__#4Y.[15B9<>/W</SQ98(CH+R0XF"R&G"4@(>!8R>$:<\Y84^1G?P<SQ
MF9/_D-/.]1WI<4<1O(F/U[NU:I@_\(:)SY,\G*\*O2 .#\Z^O0YO,2(E[TV>
M"_(XI+"IS\@A:KT$LG,J+H@$3OS,!V^XKK0H:>?@YTQ<[N"#%V!Y+2294\I/
M>7^\!\ZR\!MM.%TMTE7L]AXTU+)M.^HN38+?]/*=""H7;S99-?!U*3L9X5)W
M[/S9:+2[&?',X. ["30V%>YTK26AN_,GYT-6<??"9"\",G4A:;%V:B%@),]T
M]6&2Q.+7O7/#Y)Y^C]"\J&I^#]TO_;?MU5E)R0TIOSZ><]SY7IZ,,/OZV,QH
M<HQNM"8MS(0JN[8NZ3<Z[UPU/X_ZA#Q;DQM?AQ'HG+:H)C\PIR,D]=#TE12X
M['BQ/QN_5_W)9N$/7?4KO9\&,/3U->N,D$()858"ML'M=!UIS4;(YW'Y]9$:
M!<3IJ?2T97";KFD?!5GJLLQY(%?M>B3JBO6X]\W.9 A*N3F3>P1EDN'Q3E0:
MHFW>;B]!.7^(PC78UMP+-NYH6]?MO;<@^*JA70,A7!.-:U="")(_.B/KTA0I
MZ8M9DY-G^,>!DS&T!1N57OX3U]Q576LXY1H=)M]*BR&!X_05NS2XHQ7=Z/LF
M8J+8T!]T/@N#_9'<ST33P[7FAL]19!3Y)5HKCG9>3/DV91+2NM+I=T<::>]4
MIZ3Q^?<GQ\H9H)FSY:05SO.=.\9N=SG.)H)O).B2_WT9GRYIEF>?/7N:8XW(
M2"*0W];M"A7YB)AO7ZWI=$'2D3SJS8[?ES:K#Q^WX"*?ZF&YBF+S0-V4;<G!
M,DU'#L"<+G=E\H7?3]*+8K[BPPK[QWM'[NO/#C9+\I6"[\9%DQ@IXB15$%V'
M_[UP:E]F^7$IW"^%^Z5P?Y&%^ZC8Q6;,$#"E:XJ+,6H4'[*MOA,L<7?B'/NZ
M0+!75GTW'GQB0WQ9]IEWXC_DXLD?I0PT\9[@HI /Y),?L*II2]@"_7/-PKZ8
MB<5,+&;B LW$?(57<S0^A^;C>:Z^TM-9E[<4J]RYID11$)_F<KVD01O'B9N6
MRQ%[1V&2]B<@SI5O<=TRAW?-@KFH]$6E+RK],E4ZRG)<:R!=_#,2Q4;UBBR2
MYLHF_KR6H'HW27YQ2@JECFS+1.*<N['G]3C+IW_ZB@L(:(?:[CA!5DD1A#NW
MZ'L6/7_%TKKH^47/+WK^ O7\1($[K@BQFXT&Y*13'3[Y.Y>YKE-?/:U'14GX
MTX9);F=%"V2QYG)*7VRT:I6V9TNIP#JAXCJ+E>3Q<S2PQ/7>::_&V5HPIX\T
MU3236SK_[:CRE&XO]:49XI>3(4BI-B\VZXIOWF*S%INUV*P+M%F:;N(V+]]8
M?V1LZ<$F*:03Z\C_C%J1O$%;%//UBM>BF!?%O"CF"U3,_7TUK'<VTV3S UTZ
M(&O=C?&TUQV<='0ZPHG>RA<S]I..(SPP+ED,?EPR#$/Z&4F)6[0WRX]L=:YT
M/0<*:'9K^[Y:H<<*_?$]=TR2R__RF]L\Z;ZM7,0K.=.V*Q_)'^ARU!XR*VSS
MND-E(YK)6HS3]5ZQQ3@MQFDQ3A=HG#1J( .$W$Y@"0.^H.2!O/7B K79'O=+
MU7-8$4H:/"!'ADO:F#VZMUFSU5C5Y9-V'"R_%1FF^5'^1>%?K]@N"G]1^(O"
MOT"%'W<86:GZ/8 \!C(R-AAGY"BE P1&BLIS?CC:MZ?J)_V<'1='=##6CXR$
M<.3?0J[]6,$.OKQ\L(/%"%^8*EF,\&*$%R/\'QOA#SGRA\_U<2;Z468\;19C
M\SKRI'O5B7GF_VK<MATJ!=]B:(?>@ <.G<.4ON,)$4O"C3&\@/< ED#L>B5Y
ML0&+#5ALP 4&8HS-MQ8LGC6K7'>H2K>OUHSC3EH:_\V8%8 =Z5DC/__^OUY]
M\^3I7X#/R:[_Z;3@7("7# /6;6_3B1&"H*O8H@R.HKB.=K+FCC3Z/>T-XXHN
M1N!Z17DQ HL16(S 51B! J#(+L^:8AB[HL;P=]$/.O,G3G\QT$^Z]B#X\=:;
M^Y#:9Z@5WW-<3="CZNK.1>A7]+-Q;NIP(0*Y;E%>C,!B!!8C<(%&X"&TLTW5
M% TW0GG][\$[=D578DRCS\:&$=H5TGSL="HC;;NJ&F&&.K$ F['>5 KRSQI6
MP>)G0;P^;C*2GV9G]NGUU^_(#KH>KUGUN[A3 H!S<[W4!KVJC6S5KPE*9#HH
M4X'[!6"G!0#TZ2, EZ$52$0W09(DR4,3QCL7KR*"+N<%<Y^WA(X18EAO9^E1
M>.>P(A6)]B9[HQ-$P!,3N4371Q91_R8,+ ):SA,_BE<3NOHPH[0R;'?O:@CF
MP01.,NJ+5*A8N@-!6A5 (7U&@!BULW"9)SX 'O[:'<3K8(:0.?<FMVM"+E75
MS<XZ8<-TWDE=K)" 9:!'/B[ZU)[KHMPY8Q"!;HC?_";[:P6L]BF=A+77G*5&
MT0GD:"*M'WN\7'6.(R62(BVU\HA M$]>/@*'2'%7T,G3(Z^;'(>QOZ=<-7FZ
MN[GB(P:4[\!28Y](+_4^PN^/JMY"."'0Q(J=K9-Y*=$*ZX6NDM;>"0$!.F_)
MOA1;;JURW1V$U4^09W4K-"H)H41T?A\EQ\UM!-C.6VY[%^W]W&[S1='-*36J
M864Q.7Z>4GS4Z<>-VK4K@#Z+_R.U. ";N^-D'>TE%J>_;]S8M3TI&M&R4WD9
M7$UV=2#MNZ=%UTY!,B/%H_<Y>;$$^$6 P7MO-G*CI3G5F85_FLE.M!QNQF#5
ML'(N;BZ7G2452KY! !$_!Z2MEPG46DPV,D W@TC2P)=/32*K3D/U)7,X, '&
MJY@T*D:P'C)NY^!E)<#SC.UJ;]@%,.I ;N^;$E/]RH"=[:R^Y25X^-/35A<O
MC.IX!07_4\"*,-GB+3[]^K:;_W8/6V]^B/?(U @IEG45RSQCCYK>T*2NF0"]
M0)Q:\%F"Z?8,N[9W,T;8V!,BXI.SGU>85K5NXA@!T)FV@4'!@<+J@3,8=#]Y
MAO=U[ZO>D20,UH'DY]H4")W!^,$KTY]ZM6;<)WN6H'1GJT(QI@\%.3;T8LQ5
M1&ND\]M5]11+CR5PZT!)QJ#T[SV.-G(SZ+NJWG-BT??E@A$OG5'(;52-41$)
MZ$>Z5B4GD%_)45;=%#7DVF&@7YB+S>8P\;([=ZB+M2 8IP9Y8HB%!E<)A\PR
MO''-KZ3_COW@]CVS@)DKG"<N_UK8$OJ=*\WO-^("7&>[B@+G/KLFK=C,_4I!
MW<V37[G8<67W(8SE1"\_"X/_P#A_'/4%A/6-L".)0V[R#08,Y][-X_M7#?FH
M_+76$/"0WOI@5^B!6,%W'QR%[#X^6__@!^.#,W\C'L#E! EK*)M:P^X$"CH!
M1.=5"V6;:+;<&Y639&^DH./]E6^7&Z<O)QKD#%57[.Q$FEF^C;T;?N"J0&ZE
MFF!P?QV"#MP:"7&&@&@M@I2=C6\2&KKW13B<Z: +S2GPZ6[<.U&="<$H?73;
M:B-K(,H^V0A@D>?Z^"9:4SZ[!VGD.B,9S'C8@CV@'YAZVP^YJ;QXI' 35R4!
MB)!#/&KXE>OY5Z<T$I%.I^ S+DU(HD(3%]&V19XEHV_%>H'#)1!C,,^3>D00
M+WU0/F.;F7!A.(NK*%HA-[(]R&GH@F:#$!=AYLT53VG6+N*.8 ]X8-]\1<:O
M4;Y)K)*T._X:LSCB4Y_YP%U;CWNE6_24C*R IJ^8JZTTD3]UQFEA8BKO31BE
M-ZQ4$@W\A[F"TD4&&^'*]_"LYO-$O'F4X 0^<>4# G!E@,[IU*/YR!J[_W3Y
MC=U7F/PY6\KY;UV%^(VFSCQG1\3L&?.(;KOV?MCER;VQD6ECJO;)]^O-Y[QM
M/3^I!(BD0"A>W+:LNI'L!F-<POY%GDC'&.83 M1Q.(R#MZ_"\ NM9J&EV%7.
M)<Q0,T4N0<)$RF%M^DW'RC'9T GCE7<SS2WA -R[)J3L9MBO2#GO6ZQ_V$6D
M)S?96_:-)H2?$5VJ!^>R&1E-TXJ;(=&M;!1_"N_7,(&M)Q,-S"WZP=(^I=]V
MPC<T<60D^!V<'=NU^R$O);:6JR<)%^95$?JI&*H WKCCXZ #[RL/M= V$:UR
M[#1;L,[]U27S%#-3\KH;*\3^'<=:?&@"[Y#$?$8J/&5RZXI#)<%BO+9X_>QV
MP)^0;[!L8+FOF@H_XVP,>P=FAAEB8M.AJV3DC-^UGVI,IQTIVPEALFV:DH;:
M6<7DH3%Y=[Q=$S)M50?LY2#+9;G\>>YKRT)(-<#[/Y[AU!CZ N%4G($(+F?T
M9OHJ$7UT#OZZ!])F[A<PD;G4V+!XN*WHDNB=A=6,W3>.=\X8IVMU%E(S33?4
M\15A X2?[,@5K92)R[/T<9A)_K=4[$LG^O3*:RVO9JK3'/S*=8+X'';'GEP6
M>IK45)S$"Q)9S.P4Q04<@HMMB_X8E"D45 ^5E!^.!^31ZY  4SGE-@C.]!_&
M;KTK>D'2H2M2<)X=G+6!.U78-?G^T>D,52_D:4?_%\BXX$Y0X+0==B+IB)">
MT ?Z<6\WUQ;!I9V^8BYQ/TK33^\_'N"]C!<_/IBO >-+-0@)X,F[;G&A.>WD
MU[NJN _.OZ-FQSCLDHH"6_;DL<(=2^NF0Q..O'?\"-E 3M51!+</=1_WRQK:
M3YGO.##L!Z:UZ95F4:([DI@C6@?BNG_DMVC.%5_?-LC=D6O!$;6^._RM5K/7
MO"D3WGJ0I"4DT'C3R0:8+M1B]J-N:W97%;[B)?N:Y+J2@D.N_)\G^E:)6[WL
M<9J!"W_QJFFY)]J!PO:MY/8[KRD>T+&JMA%$N]+3VB.KD/BN$Q^ E#^9'MTU
MI!A3J8Z.!W\XP.39OOOZ8"0A*GY2,86$V;X^7&.X;$UO/0'68L,)DIY^5\.$
MCH<I-6()CZE:C>!?Y!L:#&SXW83P.BXFHXNK8R]Q'' ;3[7KE1L,,%MS 3K>
M4I):KHF6#EFW=!,#_RZ@@$W=RE69\O!&.XD\=D4/J"2T>3$BEA9B;?EZGUJ.
MO\TP].5J*(OQ">%MGAWI)R?7/:+JKCK_B$#);7HOE1%OQI@!,J$B90T#^+3F
MR6E'D.AA7$C.KFG.T\H37"@L>5L'U46"Q,"V]Y3L.7T3LF!<0+3R<[+BA+\4
M2XXX3,%\W+EMT?F !@<U2^Q]\EQSI^(KHYOO"3(ET\BUJ;H^X2F?K"1_C$<J
MQ53V1[/7$FH%DV[]9R$D/WO7V2WH]/-<K-$"5N3&:YJ2(_$67RFK8HO>B_67
M[]53)('Q9,U"\_K+P8R _W([04Z"Q*%(O\;6<U01!26I5@\1@WD&!X0C)X?C
M;8K437R9GHS%KCKH[L=&+?ICIA?B2G7OK=$JEC9-?"NZ1_2'>"SPGP*?G34)
M^$ZE+'7%?4F2@O&*X]9XG5$_1_QR>50_D+T&#.+<'THY-/G3$+[3M^+O%+(\
MC]8$M\_B=TFE(+B_(QT;8+$284K"LK:+$X)W, K)AWEIJA_XE9-F@D&<ESME
M>3)?Y53U^>:3$X>J,L]$55J>I.'B8.:\B\*![CB$_IWD @;?Y:H]!694A"3;
M)2?EI)FP=5U4^X1B-Z3IX#K74.-#M0T;%'MJ]ISJZLW_MR?MB\&N:U@XU]UE
M%N3I9]F[O_T*.]H5!X4E):6(S)M$1*<[SR(IHZK0;'(0-]EM#=VRW5F?6.XS
M:TT9:Y(\>E0%LPAS8U6Q.UH&Q5]L@+TWXC]%2JA&2UN?](M8KT0Q*?]%UTZ%
M9=5A@8-G_1S[ -A=^.JE96!5:5CZ+I!Z-^5\*8UT^@GQ]=,_RJO]>//F)GLS
M'M"DESVGYX&W 8<B&:^=*U")@,%UM (?L,O?R>?INV[YU\&%^XZV=)<]K[HU
M6=FL&VLVJ(7X+M^J#_B-^("W%&R6>T.'>OJ7/WUI_4PO7W[S_)945\E;>D S
MVF% Q#2H R*!R>D5A(*JFKNVOI-P?^)U?N1EPS]?9]EP7J?]CAMY6BC\?=8!
MBU\TTFNF/7VX=S[?DPZ,%&6+2V+S&2-B@<0=4UYXSF'[4D]DDGBDXQQBI_?K
M?SAG^,XQVH@G89Y!'G4:V 5FUR/WGL5,DS(;$?7[YL93-MKUY9?Y_JKHA?L:
M=.3>0O;#6%JKM#9^T@JUM:^WK)>\N_.6P$\/68,4;&.T>>N:5+R8NK-]@V<Y
M?%S=.[8)N:^5K-) .3213'(A:BKZY"6NW.=Y/CTJ]K3G#D 9F6I_>O.L3.GO
M/=ZZ99GY/I]]/I>=M7_[ Q_/LRQM*9$PG [YD+@]XL?1+]2<!J7P=E?UVAUD
MZ6M.2#==6]><#J='T!K(DY+!#<G+DX_  J.:*>$Y3VI4<^725"L4O3;C573O
M@XI,[A!ITEOUI"CF)!%UH?>:'/0G_AK8*6K]&\7?X,O3?U%$M?;;!QU9=L5]
MP6UEX2I)>RS.XT.(MSA_Q?>IKMZY^AB7(*6^'P$R3Z7NI#G<I )1:ZPRIOJ2
M(U!,+>JRZ"2\>NA/ULB'AT<&#ZQQ$G>:'WA>H^B^Z.S!-+?'LQ6V23Y5.O%C
M-9D51M,B&OM9I2DY)>GXK%L5SD,[.&Z<XX^D80<[HER,\FG;7=?2@TG(Q$+*
M(239 ?L([;GCV8B5=FJNW\F?\;_:YHD?".K<IM-:U*K03_V_$8 YHWER-'9X
M<V?C-\2F7T2%3P2+(H-I6(?:&D^F\HC<D80*F]9KCXGU':R+CO.X8^-[F/6&
M2C6/'FJ8==(5RQE7E:=T]$VW0G5(U(SH>Q7I-7=H]Y;Q#%)(CL*P7MLZXR/-
M*<8:V+A:>^/02O2T(;W6WF-R? $ZO<P!_07:8H&V6* M+A#:@A,\X QZ%=H3
MR%Z\)I^2UO1U"P2+[)-7K[_N/\VS%\,.^*3/N3EA</ R) \.G](&G[397QHM
MLKWCR>#>QRH2.L\,3.'O-'@2HXBD6^HQP@ .[1IMG;3K:\M!LHM\Y!P4+9N,
M1VUV5<):_9.V\YUWD\>2X4(3Q0*@=[W79#$PBX%9#,P%&AC?/ZBZ7;(0626D
MUOHO'J\B%QZ6@?LG=O3 >Z<# S*Q+G]NW1TG2GQ1WM<K@HOR7I3WHKPO67ES
M%\T=DDC;@IM78G6LO6FIB[ZP@5ZQ6"T*>5'(BT*^0(6LZ1II JQZAH8*?0$\
MH'9 &VU<W"F+H0A CO3K)R>5BK0%+& T<(-=I=AVZ0<RX:+.?26$ 8"DV%TU
MONM*FRC1E[SA+FMNU*;'K!4!(4;4T9:RL>O'9-1R=LTHF$R7'",<)&@Z^@):
M1,NBXMI);45Z 2-<36X9[<^":BYV[GIOZV+G%CNWV+D+M'/3K!'9M+&3FC@W
MAW#UFUM9I/;[9#QDVM?J02:025J4\_6*V**<%^6\*.=+5LX1/D^/P?&Q%V9+
MKX)M5((G:V5>0GK DK%+;?4) Y8:>>@$QX0YP3OJ,>T:?1$<^Y('N9U 4C[9
MM]VJ*A5SWYXM"/EJ*W@$$&&2F9.<T1]E7&%2)!8X4, 9+>7BJ[\ABVU9;,MB
M6R[0MO05^H1\\_B@@[X1(NQ$+5O#=ZY9)'PD 6M!4RP_=='7URMUB[Y>]/6B
MKR]07R>XG 80#R*KOEU7[+9S=<*=80T(RGS1T-<M9XN&7C3THJ$O4$/'"$I>
MW4Z:>01J@HNOWO-V!J@TK;SF?L99V'A.1SL5=9<3,Q%\=K_>.7!HY4I<SW_,
MX!'"W8%1+V B]CQ/H-Q%+EEK($/*S\\&;-LV*F<?&(^'>0%D]D#&'5Y_C55,
M)QH2JJP\PC*QTJ\.+O#<Y19X),W<G.-BR*[W.BZ&;#%DBR&[<$/6=MNB44:4
M?FJ/N.$)2D]Q4Y@UAJ*-H]*[><85V)/U>N21 S%!B^*^7O%;%/>BN!?%?8&*
M.QKVK1KFC(IQ;.8:.U-NEP@F/.T4#43KM*Q.$#R9:%W("ONQ%^3A"!)U]BL7
MK7^]LKMH_47K+UK_ K7^>E<T6T%!VK@2A,QYQC 0!DW%^13)H2#=PNJX&$:&
MK8[3+-SS*<"NBZ*^7G%;%/6BJ!=%?8&*FJ?&JCUKY4K8S)6W@:%-URT V!@;
MCIL[-\4=?0DT:-$+ QMPG0UANVZ;[1-XVS,#7Q^@O3]64.B_7!\H]'_#5RZV
M^L(TSF*K%UN]V.H+M-7,\,3E;AF_SJKIM'7I]A0T,4VHF6!F,HIM,!GE)8BZ
M2O%:%/.BF!?%?+&*&7RV U<67%,>VJH9 LW7W@TW'QC\7!^I=^ X#!QR/<_4
MN1*TM-BFY]__UZMOGCS]2P9N/;>OUCR79R0H_!$&6Z]VZ./BP3U  38,0"]4
MKKOL3-\QT_<*.#D PP5>D/\S0J4'<HA"EN-?(^/"-J!:$HZHF3D3AKWW:.J@
MAV.B68REH(&  0R;8Y@^Y.%"P5R_R;Z?JW+AG8TDQ&A:E*PN!-R>S"VBX27Y
MK$I)HOK"6C^!4<G?!U$/I'6P7,Y UMO'A?X)3%_*V&6[)"]D>T"?,O<#E*N1
M]R%LE+$'(A6Z1HF@%2B>V0&9PL)(*Q0E7IB##X.,B'X84PI]89Y!.O:\+N,/
M"S0H$4(.2!"%0H.WOXP!^,>'"<.OX5;^Y&+FC'"-[,:(L )4J#UI<YSB,XMH
MEC9/BZ-#RJC!GLX1.*9MI@$>"%C-=!+@A2ZE"V<8(9YMLZDK)NL4+"/7#V%R
M5WC86(I<J9VA4[RC0KSCW/]ZVU7#,4%"VI( =MR/JD/ $8OII*440PF9T3 ,
MPH.DCYI\LAIZ5V_ QT3WMSJ<=-@:Q<>L&NA==\?9M'Y=,:T*J<2BO*MZ_"4K
MJP8;QTPJS.A^REZNK'/"M+TN>B6H;'I_'?Z 1!SIA^'X9,5<4\4]8WO/4$RQ
M@L6B*N9$?65D#ND!2U?5T8]G)U^(66UZXWO::B8L]:>Y.J;;ES3W@G?B*#I9
MCD8V-["]/"0T?2PU$>WFOR?:3"LQ*]HSLCB/N_6;2Z*2:/QKQ(ZU9J\>*YSV
MYS^[]@"^X%]!OA$#9H5M?ORNL1T9A*!HU9;2HK&1"7I8AO7:'8;PQI!QY4"Q
M&Z'L*#$-TDUV"UO*9I[!N]C4_:PBNDYLA%V&6+<+T^7Q!-DK4-30.RKU+"J/
MUZ[A7]!.&$UP@#'K7 #!GR,.R[/;$9:ZK@K!?Q,#&C[]XL6MX/L7DNX_)P*;
MV,,X80LRW3,5$Z9/9I-D:/]".GZ>KG2&H$C\DXB9Z/:L1Q Q+]^!I:L@1V6;
M(KDI]TVCI)7I,(#HNW)/-XO]&W'/F"4!(!@MJ5+XI*YC4"(227':MD"6 !?J
MKFAR7>_[3D,M#N]_(#1*\? >A,/S'NMMS,7#GFKGF$1*=%BW3ZA+\TCC>5(E
MHZWFOJT^9LFMCU?,'LQW)C#28C],'0<N:]99$6_3A(YI4'JJB&9<.=N$19W9
MPWNV"/SW8\,W)D^,]7D?5ABRC(=Q2AB&=0AW)*Q6+!W1)W,Q3?BIT)GK/S;,
M<R5BL$?_7#4(*6X@>0O$@/./CB[G^1>%E88(\@A-_,>>".3A)]C1*"1D0JB5
M*R)+T/SU,2+UO7(.0]/IM %;-_Q'4D+_]]N)]F-.[3^4.C;\\DYLC!*IH37V
M[SEXR9'*_[YE";8OULN2J_+G=^FG%&+94I2\S S>DOM><M]+[OM"<]\A,K=*
MHP I:Q/0>ZR*0+G-^QFF]%?DL;JB'G9KA#;TYQO'-+G%0C5PS;*Y:/5%JR]:
M_4*U>K]N#^0NIZ4;UNM#YYHM: <VGG?:T?\64OP+21M\N$3&I%HQMZ0%''%F
M Z:A+VK73Q(^@ROV>; / ')[V$8L=N!ZI7FQ XL=6.S !=H!:.=B)?4EE/60
MX_[/O7G^7($A@D$YA"4O=>A0=%P4^?6*XZ+(%T6^*/(+5.1PZ.\K;H>S%BQN
M4Z/M<4.FH/[9H3WHY"WWEG1']KM%UQM5&)S^W;&OUO3Z0MG5N7Y-+K[3DI'_
M^*+(KU<<%T6^*/)%D5^@(O>)%NE)N2\ZWU-KU"RY4)H@BQ)I:ND[(/^]F_P"
MS6\*9?G80O CG/QEWO>+SRY_WG>QNQ>F/1:[N]C=Q>[^QW;W0X[\X7-]G%5^
M%+O-B.(XQUD)+#= D'AR"(W.U7XU=KU3=LO?VM(NZO["A'91]XNZ7]3]!899
M33&,'8CNJ[[H!^X4#35KFUU-:2A/1ENEUQOP=3(6/#9AIDT&6:IF5ZTJF:6+
MRBP4:^U;0#A8Y7NNB&+S"C8_6A]U)LG7Y&D1^-"*;(S%@^VJ'XIUK348S^6)
M7F#GW@4J3'XZ(ZQNV\S5BJX:QB@$28(^M-B=J[P]B]U9[,YB=R[0[O DZ,H/
M=/+8L%;(,<2 &OQJ*"KZ^XK66W1^.(0,E!FC;UTY=&U3K7%83__T5<_S1J34
M?_CF._]Y,4[T/![""!,4]3$9IW09MVW1@Q\>^_C(T2U>8H#ZEP*X$7GFTO$Q
M'@?6B:XR#.O P#[]+'OWMU^SMYI'U;$J##I2P,=V%F35.SXLS,V K8CMX0%'
MK#6ZNKUW75939)@X(;3QF+WN9"YHY?^!/\U/./CXZ'5@./WZ[]Z\_OJ'[)/X
MVU<DUK($_"WFL0]=Q<%HMW6=Y(.!:E+  2FK$L-%>#?^._W0ISGV!B5'.G+\
M[\J/5++821[;!1\$#SW7XVU;L7*-VU1#_]X$-=<VO3-#G[;WY[=-IH1>\9P5
MOG)L^.UY,"JZ#A^TTOB$YK+M85>4X-R^TI,D\HM-!(<N=9'=5?+9\%H'#U7A
M2+=6^&WRGG[)R0MG+\<.&Q>6PI.XT_.I>-A+>739CQRKNN2Q/F@A_/:^X@%<
MD9P<^ MHY*3U,*S)<-]V[UC#B.8X<QFFQY2LU<^"N\T&DVKB-O/\5X]9;A9I
M4@5/&"9ASV O*N8*T;(" $^V'0$; HXO]KZK05Y\Y<[-CB5P-LD^-4XWR!_8
MH3@*F8P[#, FP8O,'>#)R>%VZ5CC[+FQ)@Z#H^)_]Q&?O<I0> >)"GB3F!IA
MCPG,HRO$=&QQI5==6Y31:L^]MD# \,5V HJCDW2Y']\?HJ/TMX/5C;S&@Z-Z
M_A ,N28J2=WO6MDMKQR#2DJ_*%8Y^#Z^<SIJ'8<W,KHX:5Q0RB"2DC?/WX3H
MYMHA 6XA; KHH(JS6&'(WA\@I$*Q%^9"RX>T:SJ4.RN$4Q="H"J*L*H\F3R7
MKI(#9E1%:PI0C")68%#=E5<\;"[V!8A)(I_LO>']WSFR+;^X]8C8NI?T[[H;
M*PF^=[@2B/T=.1WMT?%$-?V5;I0-8<<P)<F^%>6=ZWID!9PAE5#\5C.@4S&P
MQM9+L:,]H8_]:Z1-8) &^H8>J##7/D;]?4 84>',2@=2&+;2S':9P[V=9%]@
MT*IF=)/C\D>%+MAJ37L4,43R68:#TAG_!P[S)KLEU:<7[<%'^S\15 _:(2C-
MR9>QO8.FYN,/A#?RL;VGU!Q[0RMCX"#^60,0KSLV7,#I((L LT7K/]04Z9ME
MCC!5\+)>1@2N[:CH70:>$2%%!(@BV.P^%]2C&$DB +T8L NKK/6NHG_9]R<:
MHUW]+"DIFQJ9 ;2X=BV>>"#[:/N#0'#DL:(X<R^0<.)MMVWC?PA\)0%U(>=L
M1/*/9!NC^7O IM@3^Z$E*PH'/O)'?X'^!@)$\H?-N%^A!7QC?W10U)[ODY6I
M$N+84@6$GED[+'CTN&,]'1IC+I% M?>-89_HCSG]6!^U+Z7J[&7T*^7M4T%"
M\.4T[*%WIC!L-.2J.V<.3=N1K\Q(*F.WW@%U4/K./723?+TNQN]#^B%=1 PU
M]? G/;(4B6H+0+9NNOB5HTA/ S1VF/DY419@CU <NWX37/A$(#3>CY697Y2X
M1+88'N-R)"VRLW*6 LTVDE.[MB4(LJ!!0Q5L*Q301B4U(_W:H(29 6/BVB_=
MC,E@IU_MQHRU4 OQ>.L@SI!:8-B$Y+<WV;>XZH^T"!H\-&Y$Q:"TWEW6B:[D
MHH.B&](& V+H*'(WLO[D2'?H@+G'>) VB0&%@Q_T3+PS)"AR %RK<%9P[0#N
M:)3,O>=LKOP*TZH)-FY?,.1<2&CY7%5VJ-=Y]C69"/JR-Q$6'KW+[0KRDOV3
MO-@.&%0,;_3])#4&4:40PU&TB@ZK]8ZO8*ZB[C@2=0T'IYHJ^RU>FE$C&7,4
MBHZQ[/"'@K)GJ;/P^5PYMNFD2+71%]Y[C%-69]SUI@"'/]Z\N=%[>).]P7/"
M%P"\S;$P"+H6'7>';:C:42UL1>]5NJFTJMSEXI' WP=XW*_N0^07P9E:'L<Z
M&R(5X-7T@UQWFJ0O3[3#1];P]_3R&_Y^ZP#J W;ZW]W6LY68_]95O*[Z=WWV
M6O$NZ2J](GEEEF'@4/[0(2X;CE$6_-^.FW[/8/6G^"87P-DR_SJ!W_+^I?K[
M[&W5Q7T_5I)N*=W&"2H5>1GLIB/WU \,#N5W[:"[ABK[0;C?8DS*%=028$49
M*DTS?=DDTQ=P?LEA##F(/,J$I=B6987 6*$ZXSB%/D;K75M(M<-Q=*?!85(;
MX>"MZ@U96G?'DB4?0?P\"9PM;H9I@]FIF@T2W-8[?J"#4*MX5[6U)'38"9;T
M&YTW&>\!$(P=EBFI)D;BNDDOU(EH6#)7$[]!QDQ &6=\ FEXFE5*<R8!Z)"3
M_IAN)5,;R41DTCNW!7(JMW\,C%"M;P!D1>^*F=ME_M9-]I,::K;0 EY+.Y<C
M_5GUP&3K.7'/;@";?%ZB(FG:AG(*CMXV^OH8-%62\" ]5Z#UJBO%TPBQF/A&
MI0CQG4JVE]3L)Z<>%'F[&XK[Y?-%%+O,Q)[[JN=Z%YUJ$>,RGQYC.&[Q$"%\
M+G(4 RA@LGB*=.+*&QW#-V[M. 3]2YX]^^SIEW,^XZ;"1A2V4RJDDDI0+26O
M%]Q20QZE+X$8"7Q1[>'<W[CF5PJ$CQ2 [OWS>D;CTTK=R2I\\=7.D'==H"W6
MNZ:MVVW 3V9/O-J; T^!,I)4JP*U:AN\HVVE5X /CY( /."'.YBR6SJ6.GOV
M)]ZH/S^T4;W#33C=FYD-9,2\C226NX(\3/I;BH$L#]72L;6(\.'-,2#J6M-,
M5B>ZR=YO)*\E5(SC#Y166HF 4G17"?BX[!(2.6+G)(41TBNDV PSUELC,49\
MVWB[HV2,X&=+(%*9LLA0E=]0%--JCYBL,98[+B<%)&LH$E=*5:?3_@)15*>&
M'Q^6@@^'!_S9W(NXQ#+(0FDF+T?=NA)$[E R],(ADC$QL4"'Y%N8<XHB]P#F
MOS!89:JV4O7 5_GG-CF8/,28'Q!?YAE"R),<T\P>^VLMVH'[,%9/_#_HQN[:
MLC='*D8XUG(>M)Q 54[#6?YV$D$^"J32;)^Q_R)!G%"":1QV+#@^9O51Z9P2
M+ SS6+VRT2,U1WG&N$D=P#TD))W&W=%IG7IZ\J"S3S![Q((1PL1@E%G>1]JJ
MV"/CC/!=4=51<PPH0UJIV?,J^B@;[OW"25U6""?DPQZ/GGXH3@L0H=GH6'JM
MVD@$[^WPM%>FH//K&,7=;R466_73U%EC%1E$YEQ\:2;.2LB45,W/8[/6!&-9
M[(MMV%<R"6W7N*-/]FTX:_1REA1 [VX+OP5.UYJ/"?L0OM8SBS D.N= 4EDQ
M>4)W5XFM%QQ9R ]?7WK)@V:3X@/7+3.7?B\9?BT61EY[4?X\<@G2E0(1[PO$
M=#P%'4DILQ%T-L>3\[B'$IDY@VO/0ZHW9CC1$^SC)(?$=57-VC)@>W/,K7'
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MG0"5#??M#'_K.0#2"*&4?6G!Y0VOZCV\%S^>W,0(@SBZE#<SW[2C#57$WT9
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M4=*+DEZ4] 4JZ6F71]2B[?&'X3K3SPMIYDCSVE."C@ OR0\XC*L:%%9,0;>
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MLZ8I;(@[<F'Z*5D,/9_\.CII^##0/'RQ\6C>?&Z422U)E+7B&ZWPA;2,KSN
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MW<\BD::&&["I&C5F,EV*ZHP,>16HB#+"=]>N?++9AE!UNO(^ MOH45)A>FI
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M;T[[M;5*R._53H2 _781SUUWNYX4: *6])Z*'4D#V]>JVVG4]KES#W!'';:
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MWYO8J?BN.9 JI>9+/,M)JC*D2?F\4CL-5BI*1U-)U SFN[5(I#A*+6?+^3?
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M+OB@LZ&1>RU.A7UBU(&C5ZML](6"=U .<'BU]24/+1]P8Z.-+/G1_H%F!08
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MAXZ+W)R1&TZ_5XMP/29PT(ULW?=,1B)C-S@5L<ZE,DXN3C'3-W7*FLHRCSC
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M@Y]Q8S@=W(1]J2LE[46<Y2/7U+,  6ZP"KP,+*!+'BT.XFE._;2E@Z%!OM,
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MOJ3_)"+)3J-FVWY;*%ERD+*BP T3_/HNJ2Z@VYT[@TT.P;6]/[_J">E:P#6
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MD29P]Z.?SGGP63 I8,/_]0/>]M,Z'C@ZZ@,3?'HX/-QK(^X>,[C'21; 4U/
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M @ J?I7=$< *:8#^3!.X&O9?P<%*RS9*)C4AKE!3).N\6,*OXWE2TNJ'P1G
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M$^3 [6=\-]J%,[T;(&G1[4RB_$:$N ;6)@ A!>9@;[AO4.$2RID]IP1O,*Q
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MVJXD9+-=B$\9@WKMG"2#+E[BTW5+-*>\@R4VEG/<;5(.6EM@X9GE09IG4]7
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M2L_%?6<UF7&@ADE AR,Q^#.L"!Z,ZB_;'73<\#PZ#Z=MYQ6:F;A*!CB\9\<
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M%P \F<J9,#!X!,<2?E,3%-5LR"NML)O#NE;V='C>R9(WJ2TD.JX,3Z,S2U$
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M/5,%B% K>6+,SECBBIL!X2".AJ;LE:03XXPD]QX;K8X!\S!(ZP_K#C<6BP(
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MIN>\IC<NH*7",.Z#67!_;+-'E*_[J&W(PS,-.'!=_\4>S6IJQ+!*G%=/]RK
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M-6I6-6FFMBE)8Q Y'C09Z\[-J@S3'/!)61[BX!_5=I!K_*(L*,<\FT"I)XO
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M%7(,Y%5$=2=@+T<\NAWP<6P\4VO5MUS?[PBA2^Z2M#;9$"4"?,1'U#$X4S.
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M>(7)X8F5&;<&@<_,_=8J5-U=C0AOGBR"]4RPRH0/ HTGLN#,[00;*W O 3*
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MV[W-NQ^V#<I0W59;H$VV.&:X\M'B*>>.;,IDT\7L@?VICOB CT>+0,ES:M#
M2QN44^)='UL!JR9L6N*S2*9=U(V<>=:7V?T\"P*CH8"@J:>:OE6!6XZ6DSI
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M[EYLXD2@$X%;@U>=OG B<,=$X,Y0^.9)+B>8,"%+AP?6+IH>+*:S-8A9/J
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MXU7FCW,M0_'U^'L01_ D@ BX17X,S/J!UUYCEU3!6>1@]$1 NBCEB&4R8Q^
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M,UC362:ZP1(U):(63DQC).@\-N=-ISON!'4S @K!F)P,#8H'IG$11>I"&?O
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MX2=3D<F8&^J,HDDN;J)B),HD@,\HN?U"AB+-KOPD^A]?!9_$,$H ?)$?"Q
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MHT1A M^Q0$&HW"HY^IM!$G&> @KD-\;3=R")_TF 3Y".I1AFZ;@!+U:;:0F
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M%Y4IU 3<D#;YWS+*U)-BKL<PE1)I$D^WQB@Z7<(H^A6$#%>OO ,\/JSA\W"
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MQ<QN#&M$4@HG8X,(2L/YE;>O$ELQD%&5EH'?Y4150%3GJ%:30G1\[&&ME+K
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MW(O]FM;D>?P+T\R-3,M[\CP\%P,KJ3](N3K[PE/U^X^BW%_F6*Z0FXT8SBS
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M@Y.MG%K6C2A6G7=U:6NXZNWQ'/E8WE::M6CVH%V@)27! "W5 "O0$FBI%NB
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MVI:A,G8=QV/'.'1OML_[VQVZ/X#6T(#M_Y@51MH7?E_.[$!M J5IZ&O4JG(
M#SJKB08.:[>+.9HYT.K3HQFJ0!U!,T X[Q%.DP+?&(WS5H% K=J,M*&3 XA'
M!7M62$U@\&#P3A17;O :,'@P>.^I0+T1@"$[>5R;#:-_=$-&J9$=#5BV#RU4
MV\EN?3E+$FHXWO+WJUQ^F>X9BG2/-@R#L19,6&C%(IDMRC>>W-AEA4<_5U<I
M)@GJ8,496P% )FMPU/J\8];0 "8)4W\[WX!4:1V@.^1.!RB 7>BM.MCE%& "
MNYPL=& 7$BB 7< N@ GL4C/HE&>78F'+ZD;X5!2VI + #8LU+X@*!R>K2\Z
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M7,^-78:BZ).B0*3):HT"'!&JR$ _2*  ;H#L*XH"N($J,M /$BB &R#[BJ(
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M^GJO4][A=3 WQ:P$2+O^EAZD71LH0=K'VF3GVI"6Q-FEI#6:NFG2.:X ICY
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M\X=W7%L>/7I;_YQ]QX3?01*SX)L._U%63R4;-;[Q6WEY\=R<V61]F".C^!F
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M_*^\J0J?U;1FX24^BTJU)VA??GN"K;H+K&M/,&0X4Z+?K@_M5JO>&7;AI_;
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M_:+TY6BTOW1>I4V0BOFI:12,>0^8(S=94]U;Z(QQ,/._<YUB;BX'/OA-=Q&
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MRY4P&NU)T">_%CDE%[@2RN[^.7-S6>R2=&_Y )'-VY*+%)#&,[!S+^'OGF&
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MF Q)GS-X$<_2%HL)G/!G?8+3P!+_-L\267[I'XT[^(*:-26FYZ#U\K\L\.L
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MLL8_L?+)L^N2.Q_Y_WLC%U!WV23B[%2_^,&YT&STNYE?WF,.COB56$"WW^@
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M0OL%; ;GFW=N8L&,/Z%T"\U^SL)?M?X?ZG'W\#2P]:5J6J]Z?EC>@] W:,+
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M/#KP1%// 3EY+H95Y.39DG\O=S=Z"LVGUQH]?WBJ^2VS/_P:PT=O9OBO4UE
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MWCR&=UJ>;<P<K_#)V"M\MK%&LK;6C&<4K?MICDA3!RR'8#Q=2"D#6@ ! L8
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M*3A52L>=%Z_(=M"'%V0[D.U ML-);(>.5K;#B4O;#[(=NF:[UAH.R7BXB)-
MQ@/Q@HP',A[(>+B46GK",WUU*.&9/KP@/",\(SP[R66XJW%:Q&%WU^ZPUNOT
MZ.ZZH^ *X52RN4Z,GR.MX??( NK ;VWG,;?Y/!'ON+HP,Y27?S#GVQ]PK@Y>
M=P>-7N>W/*E^RY"FMX$TV<W @F'=:LE"Z2 W!"/YUJ0T_/5%$\X7<UWD-ZP_
M^;?<#_]W?NO .]>:A^RU^N&-(66LV90-@ I)(;#CY#'BP^U&?V7#E!U%[9PZ
M#Y;MJ86><1TOL=4!KJ5,Q2#Q]Z#JT9:X VT$DDQ\/\*^]P(OOM[_*?3$"^/7
MS'WM6BB5S*O_<??B[2=O[,8VLPW',\96.#4LSQ8_@.YW@ "HW@T I&C*$$8X
MO%L1?&%DP8/&S BG#&"GP=6U>F]*2*X."LK@JLX6\KRW4EO1V7HK^HCL<[@V
MD%6WPV5N.%SAU ]@02R8P;]4MBB=+#I9!YRLBARMUH:CQ1PX0L$Z^ KV/W[Y
MT]=8=_SX1_&JY7BQQ:\L);0W!RN)O\IRE;P8^:Z]L]#O*UFW/E HB!Q4%W?,
M<X!\V*$ME(;Q]M*4W9 X^&<\+]\\X[]CCQEFS8#K*?P7&7_KS^#\+ RX.4<N
M\!Y_AW\5&S:LR(#[*J;L+VI<M"P0F8GQGHWY/==HYQZ6^>(3"W#RD.'ZW@-\
MSH^C,(+O@V9M&#<KG]$4SYC ]1K/;\SP0_B;-9Z!7Z/ =>;\AI]Q#/26'0/O
MV2CZY(51$*/0?_+@%, !^ '"?A>AQ']GP1C^8#ULX2G(/XL[!KS'P/_FL>^^
MXT5W[)%Y'YU')I\IQ"<C4$B>]S&[?X(_+L1_X;MKW :?OGY,G /UUHNW)ES*
M"ZZ!WW#=B<R&0F;%X"<[9I*"7V')@3/.DBJ9'(Y[6*+3%\GX?S(KT( N3;-I
MI@1ZRX5-T4'N[*WQ!/+YE]U=2871>OG=)"X?#<A0\"IU$^GHO7C;-EN-04$Z
M#% W+OQ0=O1,?K2/>0;[A;Z<SW &[Y_\E42&9V8H+$C.M100&C;=W>'P[:R+
M"L,H+H(.YB8ZM%8IH1VUDE&JEOJM4ZNE(XC*DCXJWXRI_V9,M1G!^+?XUV7=
M>B1=VR_DOQ];UYY _/-*M@5*MEFJ9+DNW8,NA=P^_>BR"7PZ@X992I>: 8IN
MSN"7C\Q=-(S[/-"@--D,[R>.!W:HO)>,K-#AD 6V]4\6&7.0/- >_BADP2._
MSD_P;N/ .ZP +C9JTR'G GP5+S8.W-[AD3QGT6CAA6D)Y*8J[5'>;M;=8C)!
M."0>"[*>3[.5]X1F_[WAGG.>.X%IFO)2,PW4#N<@$/51P*R?=6L"&WQMN4_6
M(GQA_+Z;"WC_7>:B*B5ZM5TT\^_B^=SE\3C+?2?NL'=XA4T#@>$]K.F=ZX]_
MKCE%17UH,!#R.3(_4.</9(/9-U&ZF#_ML1?].1FQ81O^4V>FW:YW.KU6?=2:
M#.O=9G<R'O:L[K@S+O5(:'XK[C4,256#DY7?'>'S7G38Q?B<>TKKUB_\<G^_
MTFR7MWN>*]9_$Q8=0Z@E2SQ#UGP>^+] T:.Y!@^#9Z<*')X4! NXS1O6S(_Q
MXVC01;[\8.:1RGW0*#7W.LU")!\1+&T5</-H@7H'9?_1#^Y@X??X\XE.,BSF
M3SS(IB2I[[K^$^X3L,0RPG@&<K!0Y'T(_# $: ==Z0)G;>/! @CB1,W\$E1/
MR!)/VS)+4I*#@:QV;+SD(.7'(3PK?/6Z:(L)Q9A%J1Q!Y1[6;+"U8T#O.-I<
M..@/<<:+9;VVXLA_L\DQ/RSURS]3+XB#FNN76AJ'I$U<;B;>^?L]G80A!>@K
M2VP9;!7U.29K8"487/GK"Q/N)HI/,\>V77:.!D.=?J.S@7>*:I7AF_+D"?XI
M=U[)$3LYZYYUI(L>#+BN>2Y7?%((?"Z+-0GXM%X\'YO*L_6;>^5Y5QN<;F9P
M"\0KT/+5^HKW?.N'T=G[SU49?L^MU?=2#:3V2>U?#5__AEZQ"JG\/Q)77X4V
M_7=X,QR9"NWX;^C;)6@G:*^P:B?(ODZ^$F178-/5@^S///)Z=LS6J1V\'HPA
M;+\0GA"V7SQ?;QX> O9@1:Q"BA^390V>+4O*7SOF;!\RS5;//F-/'QE"/0OY
MGS7GT4AS[+1KK"3@^7I;65UP6[)*M1S3E$];]AVK=D\Q37GW3&Y<8@,AC(YD
M)X2Y"#X1PEPN[PAA]& #(0PA#/&)$.;Z>$<(HP<;"&$(88A/A##7QSM"F/W"
M8B>+OA\>%C/;C;[>3+AYP'$/H# \^VQY0P3VFI&]8HIH[R$[)^. @/%JH_3N
M#>6*\W&6^N@L==E1U9I8PO@.^ZYM[C27IA+<+^8L.R5'*-+TZ>N:ZVT]#[Y5
MZQYQ+ XIC"O7VP27)/T$E]6$RP/'H]+IN'(E1=A TD_84$UL>+GS76I0:%J^
MX2XU'L>SV,5^_KRT,JTWQ)*T=PR6R.ZM7\]XP4IO4<7Q$-H):=74Q"O].$#X
M2()/^%A-?-P='@OSDY;A,<6I/%#JZ&)L$T)J)Y(5J!G4/SAZZ\]F+!@[EFO,
MK3D+]$L9(*N%,C4JRP8R7?:)DA:F"#UGE#35J-]1H1[#@NF9M<'@>$%24AK7
MK30(,DGZJ\L&@LQ];ON%V;[[.L.QI>I1G.&[X6@*EBW"2=W$45--03A)TE]=
M-A!.[A4U+HQT/GO4>%^@[!!0ZB:/>P>-"2.O2SE73? U90-AY#YWR>$Y(L>G
M<KL22FHGD515JP$3;OU@[@=@U\*OHO,UY"?#13.R5UX7:<$&,ESVB1OWSQLW
ME@KU*^C3XV; M9NU=M^D##C=)%13Y4'02=)?7380=%*EK3Y\T/*($$"0]%>7
M#000>P5.=VU=]!R!TWUN7)E,HR9=J7033"J[)2U=2<'7E T$EGLX(H<;LW%/
M$T$]J0.R2PY([213EQ+<7-ATV^FJ5QU>O0=K-XR# ]L6'X<O^:G:)V3+Q9T6
M7=(_MAF.77'%I@6K\K,+#N(664RYT.W&;B6G#-W^<:?4]3O0UL<UG<QAOS88
M#+7)0M-R"+HV@GM>O4-PK0\O"*XOGU4$UZ=*$3>U*S?>$\-UK#LFB-97UQ!$
MZ\,+@NC+9Q5!],D"]KMVT3I]P/Y@C&ZWZ2)]&?)ZMDIH N@+T/H$T!?#*@+H
M4R4);+Q#GR))X-2N[FZ7[M&7(;"Z5&&ORQVP_1B.@]%JG!RQL]0=^:Y]()_V
M3AOP(\LUPN18GBO#9HT5]7P\T?BHZ)+MI'B#1%T)RNN85TDS2]?Q)L_#23+!
M<ED'&SO=')!U<%C"9;M5ZPV/9TH="0^V!X-*Z93SX@-AM3Z\(*PFK":L/DG*
M0>NY4PZ>LP,KX?/U8@+ALSZ\('PF?"9\/DV^P:[=UP[.-]@B7T"CKFD$T5K6
M_1,Z$SI?)R\)G:\6G7=/-MAX>]XCV>!@#W>[U25XWE'@A% IF5HG?L^1*_![
MA"($O[6=Q[><ER@MCA=;@IE+OT@ELM/L_CGVHC];.](L1Z+?=CF#V5W *W'!
M*&*X?LGRO[YH@K0SUT6F@G@D_Y;BPO^=6^AK*X[\-U)@@%FN-0_9:_7#&T.J
MO:;L'U3(K'@FJ3ZH,4-&D8[AKRPXAB:MKHUS>'[J21BR3?X+9\E@&]5S5-;
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MC*T@6(#\XNF(F>%/$M?%PH #/[4\&\^@,?<C^*UCN0;[-69A:%A\>(_A/[(
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MKS<3[G$,EGZ.0(K<G,G_2BV?+H%/U/?I)#;1\1HL'E;G %:,2>$:[01*5VU
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M:V,?:Z/0_.PNLCS;"K#*S(['T3^DMN/:SW*/$836:9HTG6K-3S5A&DE_==E
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M?1+Z)XIK&!U#$A+\T&YM9P'I@W:[2%T"?+P@Q'U\=-'L!EAI[K/(L )$YDP
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MXW_YA3ZJ%6N7T*G1SG5"E"'T*YP:7A!^^TT>X!J5M7C\!WCZMEOT,A3<7]$
MR;7EC&6!%)7L<1QQ)<I;Q63$*%,:F049 HH;WR"LG,#%3WG+&6#+\41Y.+K>
M\.^#BY)A9/F.OS-D.QG(_HZGOYU\$&?GK?%^ LV]@6@T2Y*W$H@YB<G0'.&F
MEL_#A!Y; "J%U\-KOC5A%D36,1"#+<*>*-YP-@2O*Y1CVK1O4\:"_".PR-)C
M46@U2ZJB"$KZ1O#,&ZYVX/.;.3 .BU".C"EBGQS% ON\6#J%+[!8F.^+'_FK
M)+<5KR+NJ5U)S^=U)!(SK_(-NR!$"R*<]G8A!;C/:06%A,>F: F!7!#W*[QN
M)$D @]@@@.8R1F%7:#X @J5Q#8W\[40P@$,XP8L(ST[!%P4V+%2010()[OR(
MFGS$YFSBC!W\&4@5#/<XNBI*)+0%W,E#YK!!8HW%MY%(GAP>N^-G?4348+^"
M _<"LP$;@."1<+6#69ZQ;)58B/Z "W&3K@&&LQ*;@<T 3-QUEVD YHT=X!L$
MA;N(1,VC]1? 49N$'J<U;%WU@ZA;<P7N\S&$I)([35<W94$(Q^<BP!=:*'7B
MN:O-0&[!,:)*XYPRVT%G<3]RSE+P6?9"EF,#ZPC]Y8:!CW-,>)>,YX"UM;!F
MG)50*(3"P!34CCXW0'2IQD,X3L+9+*])L?;'#V>!5)F8WWD&+&'GL+^T11OS
MF'M%6HSN)F:?E#3^%[:KZ;=I!+G5+(Y32YM^QY2 T5U69 I:E^#^C4$^5MOG
M^XPJD_<>H;1Q'G,5R9APY#FXR*H:)Y[O#)23,TOI"+BY'Z,>^ J<*0^5'L@S
MSE,C[(?#_H-$N0AK/-5[ 1+ YZ$G<>\7;H+YF <%^S_ ^2+/0&HR_ 3F^H@K
M2/[X21B$O,EB@45G^+,?-\X\6K9HNN"WREPBV[$\L+; "QB!8@/9 QP%A"]3
MAP("(\;FVR<-C4+2!<<S) 0436\"(\_RO!?XD)N"6PY27.LC;7_N0K+@ .<^
MR)B.HE!;0I.BE![UC"7.BD9^::+1D(G&2@NE&SC"HS#/JA^*2DL%'GCRY7 B
M.0)-<[)OJUE)MZJ_@0AJ:G=9*PN]GM0M<E9U]##TLJ> 5!]$@O>(O50BF<--
M--XTYC'G<<2?AC=(OHA5(1XGR_IU6G6KWVFU4:/4JDZK86O<&AELT.A/S'ZC
MTV)VPV*=7J/5FDS8I&.-AJ:YM-.JG&&IK>H=&@<S%[U\4.P 2'03^)2@,0Y#
MM*.RPSP;ONC:TH+6\[Q(/#D@&RL?.]XX?$2A-T;1H]RA"RXH#_A[:&R!)O=8
MH,,5BQ<9+I4=J8 @5WK$X"NB*\VG;GDN^!58;#J?H-*6O?(SRWE$-/(;3QW/
M;G $BJ?)RH_(4<[/I O8>#IW9^Z#K&I-4F_,9T4-D@R\ ],2K D<]C#C+=8+
MAD>4%:K6#UZANG#Q91RT*GBTC,^N$A:HK%;-1I%!!X%+S W-I'6=APCBLK7,
M.+PHE&,S69S(NQW8V IYH '#">[L">U7!%$4I1'U@<+:?0![W0]RBDQ$_/DY
M1?R:V[;XH!=P@+F-B]]N9GL/JQK#63GH< 4!<.K"V(.(B+F><'7="5P<SSA$
M8$MD9H"<NO7+JIM$""KX47ACX4N-7J1?(LG600UJ!2&O+8VG@*6?@,PE'Z#'
M"3>0%NF'X+W1+.;A4O20)N%,>W1\8&8L[(PR#? 2X*79)Z+\U>P8SF?.HP,N
MV8K8YS0%B#2DX=9^Z/%H]!@3\EBX+H=4PNMFDSVQ[  7T<7HNVQB0N[S\UC&
MZ!$F^"T-0^3Q0,:7"!I1&!WC7UE'=\1F#GN2=XS=S6(ERAJX8%TLGU: SQ5]
M_B)<7'A? "$OK0=<7AA+H^B*]3TF$+@9;K,)PTD-UK,?.H%DER  X$AQF9U"
MN!+.S1V\_L&AO>>HZ")S&V#F]R]?+"2VVTGZ[JDRC9Q;^&MH\8$4;,4<L;5>
M^9>2A&L2L;%\WQT['+I<CO*02PZ\/L<=5S=Q#!;1!M^JL O^;_8 4O$W$:C:
MC\^BUQ!'<; 88;Q\^O1&[D"6"7>U]O,M2ER&SQS>I_0>V _8XQL0)M BX%K[
M-V@<V;RPWJ)8'Y=0"2H?X.%PT=RQ4F^I?4WDRK_@QMIG5'K(DP>(QQSR1?>B
M\]MTE?* ERKDYLI-G!G/JD@!S*.XTOS/V/>1#52DG ^NMY TQG5P\8HO+ 0#
M1DQ4PZO2W[C"KMZH*%PO?OFUG-(CCJ?+\TKS^'OS6U/[Z/B!YXRQP"OT@KA8
M](O+LWGSY.^@>U.D<,6AD/S.O_U:YZEHGD;GED?Q9;"*0$*&>X%8:,GM)M]U
M,3X-GV;^[F,Z:]DP[JCCAZM_43Z%R2\N=T4Q!*]PXM_]QN;_M:)9=@AHHZ7]
M]:__\LBWM0#/Z=L47AD'@LO99'DDBT)&B6<XI2"&XAO*0;]\9"\J9 =>!*2E
M["U:S*RY++ZPA:..5V&[D3P:YB>?7,=.04%D1R/ RI=N:K=1?6N'4^9 4F8.
M)U$Q/19T8$,XUC,(;Q-T,* V',>DYX>//)/^9V@_E.5A9:PQMD?S3_+"63KE
MG\=6_ :/+)BZ=F2A\)87R3-@+O**3'X<8?%@RZS-$_IS/OG+R=6^?<@P0 92
MV><(&U9\)H8LV_ X23B(@$!0 D;/)U*:\193%CRC_C::74XP@G8X\1S$QE1&
MVMV7X%1/7) )UKRO8FO$UU@LYYB]Y,G7=WYHX8*GR[-HB5S]71A).)KA3/@5
M\- Y;RQ<<&-MS.Q5Y!#)0"0HF?G-CN;_M@!#$>VX6418!8)?!9+_\7F[<"2Z
M\&Z !NW_K"?V?YZ#(D8PO"!%+##'X@IXOS#)+68.!SY?Q!-"L?!+MH1I+'76
MG G+W#U>28!7/@H7>L1$,8/[X%EP7*[\1?PHB&9\ D9&P&? +"9G$*V,J,2L
M[Q3P5DH+*1?3TF*55,">2QM\_-#'6BUP0-WG<NS%3YHXHDH#RS#$C=&Z1XI&
MB0%.QSR)L'*5*5X"+K]>+!B^<Z0T/S.;3T[]@.%,T!)7)1^^OBRA$2DA6<DI
ME5"4 UI>2\VKL/Q'QR\/2X#A/0,'CD_ C]21) &=>UMN&""%PM^ T<%,< N4
MM,2:$E$:/M'9XNB+@AIQ^])20I':%@.RX2QE6N0PG)$BMU%UU3!=E)TG%(])
M,D-))VX>=4@\66,Y.]7FW15S6W+OTF/&\,H0])KBH?R1XKM%I^%"/,.*\M[\
M=-'<@SRG<W;U&-J^>)TN!T*&\/S9;)E9%[-^',/ IA)-\CR/4\%#Q@R#0'E@
MQ^4W1B<-\(@@.0'&.QDF7*%(.K3X>?!821-++$^QJ[K\#>.!$052R[U/JC!W
MS+_)"1;+%*5<ESW@+Y$2E2H.F]]C[0 $&#6I:U/TNR)+Y25M0Z[5;:52.6+6
MN!;/%D,"4O!)P[>W07E3M?S_C^ R/&,!;<J;!R!ZJUS=>F6X>]7/<&^4H%Z5
MX9X88VO0MZU&I].:-#K,L!NC'MS ;@\FH\&P.VB-MLUPJZW?8Y8?ZDN=WB@.
M4A;[B'QFD%XL]@?R,A_.'D[ ;.?Y.K1=N4.:-J#3_GMT?W]=,\\=/T\F9)WM
MPQ07W*3.^V]QW&L\+2>B:Q&[B;I]Q#<VV#PD0V1WF,>]1V"+(\:-Q **"1!3
M<9VDP;!GF-@YNDV;$)L7H]8 Q.7ZJ1!&\1=<,6*\6L.D311Y2A+-Z;Q"^HH9
MLVP?1Q6(35 BF<OCQ%S[HO)G,P!S '8=MXY+)FVE-4%**-]$FSEFL71^S8,@
MLGJ]'QF@RZG3Q_I]NTB0952[OE&L2%MFJU*T-6AUS/YV98K.G)5,1Q2GUC,5
M$9AH!0/;<P$[270SX+9VZ(OB=RQDP?2=6+SGBN4+6]-%*6%(9_"]"W>.LV/<
M&MTX!)J.?$9/:Z[=]U@]%^ZFV#FV%U>61<@7+'"$/87077M[3AW<:&=1/@7.
M^.0 #*23QQ%W)T>_ V'=(^D!V/_2;GDV7+OZ_NWN_C9>KR*<G03QL?,2I;,3
M=R3O?JR4G>ES?'']IM;7NX.^;G9$K6U/!XM -P<M/A\JTW5<,,A3P0?A=/F1
M6R7O?^\YLH5$!![@6%@B>G5W?_W^=0P8?&U!Z7RZEF9-<-5<XJ/E?4\7]PZ\
M:,8@-8L(/S!CCS4S>"9]:FT_TMF0=D0*X. 4A%"+\S*9- -*N5@IQM0 X"N0
MP6JGV@4S)CZVGMM=)R>!\5.D/6DD1*Q7PE8>>1[0I: P0(64QC,$D5ICSY6Q
M%/$N>T!HS5*KR@FXJ#T>_^+RFB)<8R1BFK$[KF?B0,L9?@?1.,8-CYPCI2L=
M!4(._L2;J'22/S)IY_ #ZT6V^<J:G83E+BL>>1AEAN#3(_8+4/K$HPY%%F+V
MD@@&=S,7"4RA,6.R "3@HIS;/7R77'1_4=<EKL& #K>GQ3(6^"GE)8D1*V".
M._\)F4@&QJGJ>-2@%=LMVI^A][(DY![;O27BI> C<'W7!ZUFZ*U!5[OBXV[%
MM$A^;>\M?BRNYG\SWHH=:/R+ QV;_3OM810(S)VDD.+8\$ #'3QPW>B;Z4?U
MNBV]W^EG9/3_B7+:!]2;DCP*QQ:"N0Q@&0<!$P2RJ!"_P25,X2))0H5GB/3"
M?/:2P3CV@_'J/VW.'0+\>D(%!6CY[DQVD<ZM>+1#E*[$)J1HKF G X,B:<:-
MTH*FBT^*PB&^*/I,Y9\*;U8P:[(DB#_:I8IL^TY4L[#A+0G<?>-5<,D\I6OQ
MW'N7MX-RO^DT7I9I&/$($Z.U:H]E:XOA!2F.\6533K$U6NB8*(@LLAV1/2S2
M( %OW48O[4>40C4&#;.#HR&"J6ST\;'^NG" !)NB^1#)9\1$#S3 &SSRI)!"
MS /PG;B^-TZ]H$ST2V+3Q;[EI.YNIZYEL[#CX/25BDG0(!T3V'S1Z2H"*9W_
M@5F+1U$0 S#<40^2?;"%QR(RV]QM&8L!@I%]OJP 3%\;AII@O_D7!L03U_[D
M"G.B712H\^6X$CZT94W83[HF&4<$/N%NR#[N V=RX;[P8Z<R[4\L Y?2%\HH
M#9$J$YZLM&(WO.=VUFYY9H+3M\+4?)N.*;3+)DQO%)A?6IR8"ME;8@)*VH.-
M4I%2IJ?*2*YGBZD%*.H,S+?<@OF6C]MSM&U:UK==/#I5UK7 ^998]^Y8C0DN
M&UU:XS5SG\%N-ELM[5__+5#C]N639;%#[6HM4P5ITK\IC6QB223["SM%?%&@
M! >RK4?K0<;7+:!C;\X2:$X8MM2AL<I 3?,I< S-3-XQ#-_X&4M6&<ZR$03R
M)^ TX/-2L'EC$E-',M\E(:'+T@VEP\F0H58NI B.8Z\4ECG4SUY9NHME>:U
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MTRU\1D72]B%RKGPT;GIEWQOMRG@MC \[E';]BX;:$+>8:O\)L4W82]LTJ>$
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MG#\GW<\=>\C9@V9SN*+!:"XR\S830PD$_I/FD"+^EU%1;)P!%6>O3DA98+N
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M%K[V1S[,81,^2;CK_<OWN0.V]$?FCSV'$U4Z_OLOP!<X<O=3QPM>I ]^O5B
M'V<5F30;\#VI'C!+V#(04$'*]K6KYRD#G(&+P]UPA)(/4CN A[^.R,%"3@9G
M8DU$HX"Q-<&,,HQ]2!Z?0MZ&4N[BL-<NP5X*05E,)BP>\VCJ[Q%OEHNR@KP
M;0A.M27D"0@KH [0CJ *-S"N\D&M?F&+_'HZ2,):MY-O*#<X*NX]Y^&!G3O$
MDU%^Z8"748*OGR+ %VV(N7!MK9CPTOCZQ]^ZP[?:E9G5 'BC;3APW:J=T\G,
M+Z!-@Y=/Z%FIRW!I?Z4!7(8^R[/KV3Z;OWHW@0<4V3%C)T@Q*?0P:NMM<+4F
MM',F:5E]O 5LOK$4C3!XA8SV""8*B#)NJ8K/7V/@2K@+>$'T1<'/5Q80 9L
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M3#A8@N4[0C5!2C;7R9W,!;(;1H)G0'J>C@.IA'_E,W[($1P!?IGJ:R(K&7)
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M6W[FZX";'4!<& >4HN L8PM0W_A^R.SO"W>>X&(#H =6P%")?OI/Z 0O2")
M:_/ 3P,>/GUTY_Q9602LA'O#9V.$_3.H'Y_-7[V#&R^!N  X/B2",+X')]KQ
MS/612.&*% W_XV]@2O3?+B5X#;[]Q7U*[78V#%W#4^N:-9NE\)QF!  H8X^H
M %:A7WL&@T6S0I &()%!_<]>HLOADMV071A748;AV^2H*T6XX(W#LT09_#-8
MBQ76$IV9LH6S"\"X"C&S.C3]^QJ5<A[!:X@5K?""4R]ZPX7UP!HCCUE_-:P)
MO. ;:_9LO0"N?SZ+\;#,5.@7@FZ<PJ:@DT%P"%$ AC/_\+WE,_O.>D$AX1_"
MAM"D.</LZR YT!_V>![\8;3L49>-[<:P:_<:G7ZKU1C91K_!VF-K/!AT6GU[
M6%4C!-Q.86\T.$@Y*X'+PZVZ5=CJ)"UBZ.2\^3:>,CM$#9F2RU^9S[PG9G]V
MO<]A$'KL1O;AWJ,X.Z;I5P$3Z4-*2(&0%Y!">:A-.*R2IF6+"[J/;,PUA];F
M2L,TN$J'_YNXLYG[[+]98C$>FY_AD>B6H"/)E91P['YY!=P\9C-<(HEEB_'O
MTBGDOV<.^@:5UUOI%H)+-K,6/GL3_?!6$Z[CH"4'Q13*T,X7NAFTFNW\^)JE
M6F4?1Y6BGR6C@P:#D\"^(*$5V1UYRJ6>YY[]03A8A8-N<\LI0L0<Q!SG6VY[
MHEBS4,Z[-7_5E5=.EE@>K&DF(M0HNHZ]U]RP#:PV6!/1L+.O6R=-H\P:]3*W
M\)+R[*G(KXQBN L,&_D:?*A9SY9GGVW4VE;^XHE8X@31/%7;AFE77#7PU&W2
MOK@]RHN6)=*ZF5!Y*D!^*P3F]=R^YN)RTV1:L=EG;3)-[QMMW>@<KA2(]KA=
M6*=U;0V9K^GDRP-\)> )%YF&.;1I<])0^"6A2=4,1.W%E1IHV#K\3:8)F":]
M9:;)TMS]=WAS+V6]Q,;+KUQR'MANZ>FM_D ?] ZW?Y8$@6)VRV'F^.P3Y[\D
MK&2,&?:XF+DO+#)B%J$WGEH^TQ8S:W[NF7R[Q_XO"5VJ1@)H)E]E4-7=-!=#
MQM&6QE%_-^/HDY2Z_-([*7/O0.0>/*;3[?7UKD&S<*M!@:H$>E883'6>J#?>
MM"!7P:J)T[7C7T2FBYKQ56(_57&Y63:,&O*/8'D5IB&GC*\/UL(!>2T*;I9:
M8@>VM89ZNSO4NZ8Z2XVIE?X26NF7]"^IW33&V5!#C\:O=IOZ?4GSZ'O7\FS>
M<.5X;!RXGJ]=\<]>\^0?-P]E3R(VX3XY;NC/7C1KL?!<-!BQ(=5LM?JBK4X3
M07(.+.TJ_AO^^KJIW<RU6W@$=G6)-F"\0!S LMU%$-_.Z&BB 1*^@I63SA/3
M>-0]<V.XBO\*YX1;N0\,/O:T9R>8:IDGB^>DL/BZ*2A2_'L=-]:RR01 @ ^S
MK8!%G\8/RG;P^Z&_8(!8._LP#K4=5$!A<$32^)EN4KSV -,/O%O\_4NA-Y3#
M"-@;('P[N089BE^)=,=U&$Q=#XC+7M^2CF_R!8Y3-M;E&WMB<[Q@DZFL:QO2
MYVZQW=F*3RZ3S]JC]:*-F,A6 \1#C#MDX=[4KA$IJ=D!*?=F#*2*O>.CE^B&
M*^X$OUF@2ICWZ,R1#'@3\2;T@;=G/Q:.QS&EXVM/F(-:6M?&J*1G,[FGU=-<
M3JN/#*B14ZP;!OQF<1<DW-P/HPD'O@X7S68( H"-Z'#//EHZ<,T5 FJ#9NZS
M2ZCO*73$7+<]-[4+O=6'-*@VX)'/;N@%C,V%%(N%6(9KC([1VC8"-NAV=*/7
M6STT(T7X?$R"G,\ 4COCYD>DIFN+6>ASH,^YZ."T)^[GL4<+OCY_T*PGRYGQ
MCM=4B$ R4PD3Z;*-%S]<@+&1&A]Q<W?;U)8U6@_:A>E4.PM"#FW7=B;.F'_E
M(_/'GA-E<>^!P3?8++(OEO.RD2OA IS7H"@#X8CE'1\DQ.A/D$A\\LQ\[#%,
M=H$0NG)>"]6V!*<+? @7?XE 3,_@6"H4<4R(E&KP93@@;U:&Z]D/YHT=[*A'
M]0>F-T@NT:B-]TL3 9><>)^Y*Q95EPMAG=_HRHG>A"O6><@W0<@7!2+_7PL^
M\E[D=!%\1X9385Z8Y37SUNXE2L:T/8(JDFNU"*-<?5A(6Y$)E:GMTN'><T!Y
M$(+1]Y+_&XZ# Z@%\< 5%+KP^8)Y7$ A4:;^D-B*W#($@24T'??N_6;*C,O6
MEUW=?+M]G=?N[ASX $@Z>K,HK0N7P[O,0DZC=FRN/D]=3E @0MWD6C WO[CS
M_P#% /_';Q$_]TO)<\L>J:<>A.\(XL(/9P&6?JS4M7MX-()"4$4YXVTH;FN/
M1I;C5MNGD2]1*B%S^$6)"O3KN#973>$B-2BH1!$5YFMQ+3-:KXA&>47T*38*
M[_CC5V@=WPN^XNVXNH%??K-^.(_AHU0G1]))!0/=#KW80 _8G M4/R]017%H
MP"4[8'SN:C/FHQT!D%]GLBW >L@8;(5)6SL#.\Y XK$R\UD ^ B-;: />OGX
MT,\9@'*:9</$<37%C=T_Q=ZJ'\#7.&%;#O@2EO<7"S @%\:N2605BC%>D=,B
MM80/#Q9>CC $8F<<I#SX]@[X&;HV=9_!W?-TZ13A8Z6J%WC'^P&^08RC.0 _
M@6!-"U1K>U+H9-+0$FG6 TZC2P8D2;;_53QIO1G'2>/^99%@+49.NC7A9)@V
M,WC>&D;=T\ (-.C_%VE0!<!DE.VO+[!'*F2%# !N,YJ:H ?V$$\]-<73293#
M"O%4@I #B:?4],%8X."DP,@^35N^W(L !00F1\;YG7CN(Y_(:<61+_G(IH9>
MV!,>$4Q)+NU\;D7 (\"P<4#XH:L168M@=8 A$0K_YX'-F<==-0PJK; ?"KNI
M=W9D^3^_B],*"V*#49[[T8&\B7QH>A#EDK?@L@/>9#QEMW.VFZDQ@6.5VQIZ
M$M9E/\9,!)EQ[&?*'>&LEK7SJQX. V&! 8"@$._+,D"D;]= ([I+/@6 WP%*
M_O#I%HA?^\T" 85/ZB&7./Z:NPIODP]G2T4C^&,^W:9&5,IQ@QI&-]!NR)X%
M?O;<\&$J_'=P(<'WX<&FB$=1.*1D0G+D^!' UL[#7+B=G/,S(B+U7D,!O'".
M]XY%0O;T\-KBO9(HEL\6EC#BA:2:6N#-CH")HM@NLYNK1P@6!4(\17!GT9#6
M\?Z-]"_X;Q_AD#=S<.+GOC/^'<7NP<80EDR/A+<3TR.'%NN;O=:XT>OV[4:G
M.^@VAH9E-8S>9#2QQD/+Z'>73X^L $]> Z4\/J)&2$)JV>"HL*\3AS25><*@
M76Z&83%.59_AK68%AK>F![]GQK=N,2UUU;C53F?8-=J&V9A,S!$PS+#3& R,
M7F-@CEHCP^YWX=I7*TZR/>>=<'[E4,WYE:9) RS/U;4[[-1]@*5ZPZU.PPYJ
MH$3D?;7K2&73 $6U&.3\ Q11.]"8/J7T25IY$&HJJV1HA&(*;>@J<D^=IB@J
MJ&[.-T6QZ)Q<3A_3>VLF=CP$^04/QD"]5N,27^5R4*%J?S<-3ZP&GKH9C4[3
M$P_4"]8N](+MW0@@R_\CA_>SZW&S8]N" /EAIMU?I!^2DN;!MHUFICX<M/1^
M[W ;VFE0XX7U[Y_<5E(& TD'3U*[+:K#*Q'7O214J!I.K[U,4@,-PA@B6V=+
M6T>MIL?MS9WE&^O7MW*91DOO=@QE&NQ)QM0]1J0,!JZQ.H;'B3!&>O?M._\O
MEENF:M'4\P_(!"*WK+YH(!/HU;NK[6V@3BN[6'IO RB2G9]=#R0G_'L+<O,N
MD9MJV4%FOZ_W^X<;,T1BYD"D_)H"/^<#OJQ12EKMT?X)K!_J^09D\Y!+5E\T
MD,VS2]BG8QS6Y!'2\G,D+.&'>^N'6F9.>Z#WAL6Q/>I1=.T%"\5ZSC*_0]>^
M?OLN1JS<X0^RI5$]-X ,'O*^ZHL&,GAV"_*8A[%XHGY]/_!"_-!/-JK>XD#)
M^ZDU+^T(WF7X1XDI]#6>"L8__(ZCO^#9J>A2\OEALF2M?E\W*#ZD'A<H$!\Z
M0,/.)6%DB2453R>H;N_.)6%)U5 &;4"K#*JZ&_=2U=M0V\%.:Y_<3HO#5O"W
M9$YDU0VWKMG7A[VV,@$OVM1&43!U6[%6=,4-U7-TJ"N.NN(4%%EJX(FZXHYC
MF'6JW!6W?;I0[[3:>JMUN(PAQ;T4LY6H.(JZXBJ/"E4C)+6726J@@;*%.]DZ
MW6IWQ9FM:'9P:X>NN)ZA]_L=90)')&/J'B-2!@/4%:<B5E0-1-1>/*F!!C*!
M=BN8ZE6_*VX/.ZC3UH<E6U[5(^^:21D%BI[J:_]04YPBB% UW% S8:0J&LCD
MV2GJTZ]F4]P>5D[/U/N#PPU^),%"H9X+P0 UQ2F%#E6#"[672VJ@@0R>W6(\
M@QHWQ>UA-K4[ACYL'6YP),FGRXD.44L<M<15#DNJ!C*H):XRJ**6N*/%I8;4
M$G<0L\WL#O3.0)T94-021S$P=?NPEK?$F2WU'!UJB:.6. 5%EAIXHI:XHQAF
MW5:%6^)V*(G2>ZV6;@PH[J4<[5)+W+DQ0"UQRJ!"U0A)[662&FB@7.%.MHY1
M\98X(PH;&=NWQ+4';;UM4IV4<G1<VQB1,AB@EC@5L:)J(*+VXDD--) )M%.Y
M5/= ,\3/VA*WNQUD=O1!NT7!']4H68&BI_K:/]02IP@B5 TWU$P8J8H&,GEV
MBOH<:!KWR5OB=K=RN@.]/^A3J$<UXJ50S[DQ0"UQ2J%#U>!"[>62&F@@@V>W
M&$^GSBUQNYM-';.KFS0P23T>4" Z1"UQU!)7.2RI&LB@EKC*H(I:XHX6E^I2
M2]Q!S#:CT]*- TXRH):X.L3 5AETMAN.9DPSFT<W%=+05;-/SCB7][/"E*L=
M?E0-T&S0D+4*=63I*83+#1OL#H)/,@6SIF"ORDUXVZ<G]7[;U,UA5YE(VS*3
M;:FB.9/$$D0;T>PJ\CZ%Q?9S@*0%G]K.TSN.2R0N9QY: ID"N4"1X%V,$W+O
M&(,"N8^GS YG3-)M@?!3=.=? ZD\@<=SCP^_A]=X/X,_KB#L$N>"^6-K@7+(
M"UDIWA!+AKDH$TQI/+6;_<%/9RU=U_SP$<[XHKD3> 4 A.9R,&F6!!.('R!H
M#3Q!C4-1NP-3S]<<7[.PY O+-_TWB-RMJ#=#K%M!($U/\$@D'61V1*9DOE]>
MM0";;#9#]@)&C7^7C,M_SQSTC14&[EO)NL V,VOALS?1#V\UP=[#EDRE%CR-
M$[F$W5:SO7-<,J4RQ_!7YAU"9U;7#CI4H'CW</Y1$+*)O\%1,MA$"1P4-7 2
M  3@!HR5\P<F3;/9VRPN61NL2?THD'<;!GY@S1%X9X^#G<)84@,%)-,(-:M0
M8S2-0;Z>ZX)A_G_\ ,P6L+]^8I[UL',C)7''I7,':8K3 GS(I='!LE3$'G5*
M**J*F&79Q/.Y*M+M)V8Y=_-@L;6A;EB(?7A3!1_>:&44T-*44VUP)I(W G/N
M1#T.(@/M_#C(^"_$,B3FJH<SI<(").V4EW:U80Q5L5"SL.57]F@Y\S-F3H@?
MJJ;<:X.2ZX<'CSU8 >EKQ3CC;'$O56M;5$44Y;Q41HV2VH7*7(IE+F=/QM19
MV9 ,4QDU),-41]NG'\P;.SX3Z+OSG-WGBY,\J[ \JPW!JQW9(MF40M4'^!C[
ML4)K)K!VS[Q'%9B%E#\I_TM VPWPES/WG;' W^_6+#R_]J?2,H5#;%1:IK@9
M0<:<"EA09)4S(6D%DH:;U<)0L;ERF*,0@0(X($6C A9(T:B/)%(T5<4<*1H%
M<$"*1@4L&%0YGEV&X,RU%V9Y_FOU<$4<HW;LF;@'N2>8NJ%OS6T5.:C>>E^Q
M56"EH>43@?\$$W53\Y%*IAX; _7FLQYG,YLBZ%!U**XBGKXRLVT5Q=,1G'V:
M2]P:=/L'FTLLJW938E<TNZ^<VVH,MM[OKG?-H=[OT(IWY<A/4=%!>I5H_^BT
M_W?E," T)BG$)0K1\=V.:?2_?_NX3#?V6T?4C=&$!#D;(2H7YX7B6VI,\]6[
M3J_9-TDAJD9^JLIF4HAG /K)1BPH0_[_Q%!Q]*H-GXT;SH_&U+'AJ&^$B!VT
M7[T#T?7/G_%*!>45,0HI";(<R7)<8CFFK<7!\(C68MQ0P%L)MK0/&^U5 17-
M'UN(39#$IJ$/:#FZ>K1XJ$S2:9L4+@D#DB.U!]RP=K[=YZ<V5)2!OZK5.[47
M1$J@@>R5G5(_Q1U]>QHL?/]DO&O\5\_U_=6FRE N[3.&6V>!.AV]U3_<>DD2
M$9<M(DA!$O6K[,N3;CRW+[\T"V1LK2;]K?3D[IF@Y>K3?/6NVVOV#=*/JM&B
MJH*:]*,R<[<)[D3N%PIV$O8JH(%L0F510QQ2DR8993 0I3:8]#MV3FY4K0I#
M&0Q0'0:A@93URK;6';(;Q7*,P!W_=>/[(;,_AA[ 6H1?>*3&YW^4HC"*P-C'
M2EX,S('>-ZE>5SDZV[ECFG3?90G=NA$^U2"JB)7]\A;FP?,6D6(\=NJBW6EV
M23LJ1XZJRFI2D<KTLQ#<B=PO%.PU$_9D$:J(E:V[4H8'[V$N&('W;F#-MFE0
M66[[;=RITC'UWO!PU9\D-11+YQQFZ<E>&VLO"2U1CF=LS<=L-CM? \O^RYXN
M"2WJYJ WV>94<\&F!*J&&^_>JK?=M$,"J7=PR^FSZTV8$X1>8CL=K3UF.-"'
MK8$RY;]*+B%3ACK/-JB7U+$Z,IY81,G&FDWU[%:8N6A=NU_6JGWPK%6)VCU2
MWJK7:QZPJH,$RL4+>U*\ZN!B_9YP0@8Q1@UQ00I$6=R065HM?!$O'3=M5+DN
MH#0@U5V5,U0OKTJ#6<^2S*95.17 $ZW*.<J\M-[V@V .NRIGZRR0H?<Z/=T8
M4*&,<N2GJ.@@O4JTKVXNATI+E4W;=)1<E5,Z%ZW5'-#N..7(3U793 I1D=:B
ME/"MYZJ<#J[*:=.J'&*4VBH)LAQ5Q,KV34G'C*1LU8FT<P.2T1KJ@S[9D<H1
MHRH=2"=/)2F#@8,-E*/IKY5,=9,H4AL-9++LU@]4G*=SV(%R9DO6%H-ALF6B
MI]_MZ?UA7YG28Q(!Y^[L(=VG&-AK1OBT"$=%K.R7X^DJ/%!NA?(T7[WK=)NT
M*TX]<E155I.*I%TX-8([D3L)>[((R2+<+'>S_5CA8P^46V'[;9S/Z9EZNT<!
M%.7H4Y7.(!HH=YR!<H?!"_4+JUZF0@/EJH$J&BAWO 32]J-M#CQ0;I\,4T\W
MVX>;)W<@L4_MU(?-.I$VOAP13RRB9"4I#>XX;=*JI_0\N=5IJ^ZP23JW(E2J
MA+ GQ:L.+FB>G$+((,90!Q>D0)3%#9FEU<(7\=)QLT:5:P)* U+9>7)F2[VT
M*G4OGR673?/D*H GFB=WG'ERQYR9L\$\N>V30 .CK1O=PS4]4Y7,90L.TJI$
M^^IF<JBN5-FD35_%:7+E*9I.LS<DA:@:^:DJFTDA*M)75/MI<EV07<WAGM/D
MB%$NBE%JIB3(<E01*]MW)!V\KG:W:7)[=!\->[HYZ)$9J1HMJM)]=/(\DC(8
M.-@PN:H-OE4& XHVJI H4@(-9+'LU@M4G*5SX&%R1E18;&R;Y1FV].[@<&NL
M20)4O:N'5)]B8*\9X=/4=Q6QLE^&9Z#R++GENA-GR?6;I!W5(T=5936I2&4V
M"!'<B=PO%.PU$_9D$:J(E>TS-P>O@-U_EMQRVV_S67+ZL*-.VS8)#<6:@FB4
MW'%&R1T&+]0JK'J-"HV2JP:J:)3<\=)'VT^U.?0HN=WS2Z:A#XV.,L4NU$FM
MY (CTL;JB'AB$27+2&EFQVES5D.U1\FMSEJUF]W#9:U(H%R\L"?%JPXN:)2<
M0L@@QE '%Z1 E,4-F:75PA?QTG&S1L=<0&2[X6C&-+-Y=/63AJZZ\^4,!:?-
MU@Y'ZI;*K)UDM@IUE&%2!Y<;#J8["#HOV@#9(0-US!$]FPROVSKMU&^U]%[W
M<'FG8TWP7:HH2.*0'J^='B<N4;(.=H6/OSMFZJIBUZ>>!BTE!^*5)9JZW>:P
M34JV$C2IA&@G):L*)DK33!NBHO;S]'JOWG6:@SWGZ1%+71A+D>(AN[7:J-J^
MJ:LXVN8\X_AV;^ R!KHYZ),16PD"5:6M:VF4NFXS^BPD2LO7W,GA$G-5&S2L
M#&X4[0W*9>$HPZ8HGHH9-LJ>'2)[MOWXH\T:WU'V'B5[UAT.=7/85::"G+K:
MU18<I%>)^E4.)- (_W/'#);FNHPCZL8#Y[IZS19-[5>._%25S:02:?V3*NFJ
M/J:K.C5;_Z0,@E1EE9HI"K(>5<3*]AFG\FDXH_46XVB]Q9C-.!E'2SEU]5Z7
M;$GEB%&5]B_*+CTQ'QPW/9-E<CWX=<'&\ <M<!%+EPH%08?B7PZ*0V?8:"1T
M)>N,2%"KC08RZ';*CVT_:FE-#/!WKCVNY_8GJ2_N7?SHV$UGO6%/;[74J8<G
M<:&VN"!E2=2O<N"#].2Y Q]+TV;FZ57FX3O':+&6<E2IJL@F3:G,8JW:9],&
M*C1_$:LH!O::*0HR*E7$RO;9M(-/]EEO2%X_/'CLP0K8R?J[C#X%95;0JJ#'
MB!Q74>XI<FT_!YCM@4]MY^E=A+8OX2,#1V,[8&3>_:=M^#)]O)T?V6[V!UL]
M]= @OI\RS8J837,B;D-:#QGFD]QL+Q>S-<?7 OB6[4PFS&/S,=-&+'AF;,X_
M!CX&[L+\V\1R/ W>_2\6)+?#2U!H6/.7?_QM ,+FK0\\_?CHHD'ECO_"Z8W\
M[G@<N#YZK 9R0=P_^F"!3B6RMX:PG;(&W(.]1.=M:NO?+#4S,GK+U>\VGKD^
M7BT>+?)MR6'3(RC+#RLO!TG!O-D+7BC>.7/F9^E#-RSA1&L/@,B@P9_!05I
M#;\  &Z''MX3'_'"+$]C\!P[3@@*:A5906.H/</Q_[Y7@&%X\)Z57_%%EBT^
MX'_\"%#X#$!8KPV,H=Q^8 Q+0@MFOSDT"O)>6S!/XR_:U+ZX,7R?@126 =G/
M03E.NW(:@!]:S72F%A$<X ;*):@4.>V-'\+_;<E'2:1:BX7G_N \.'O9$,49
MM):G6O8HGA'J/D)KC+YUI3/+]VYV8]W=>_6NW2Q!)(C2&?R@;__^PU;Y:*63
MOW\K>O_6ZO?O-8M50M'[<\K8 03E%?>G!L$*%LZ"8- LVFX)"8#80BO3>0)^
MT#5^0LT5 ITSM983K4UA<,#]\&S./.3ONEE\ W6\869U?OKWE%6PN^5Q:!L
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MEO4J/W[BGB\6(ONMP$\B W833. J>L)2=9N962KYSY_AC;_)AU52=EZ_@XO
M8X*%DY;I.UA;#SBX/G8C!$/S?STS05(\KI\;@?OL 'VX??9IY 1NV&XF-E$1
M%3XUA&X46-JO;0:&N5M+BF<H@B!B("Z2*K;.(QF7.N [S QU FC +J]NX<>@
M%XX-@B.$A@732)8U?6SR)\EQ(4$>0(XY MEQX,I2)#1KX2:Z"](*C]B()R&*
M?X422 VIA\^@)T1**B;<R>/K'A:D#!1!=QYMJ36:Q_B+^#D0^7G,;5B)D'R#
M"RD''3+"M80/+J5_O'CI"1=B%5YWZCI#808;['N\XCE19DKN<@] *WI<UYDL
MD-JTV1\:@*;@PB#D0F +(L*3>$)%/.8%P_\ 5 NR^V-A H2XBX5$:NSQJ192
M4UH--M:>@ (<UJ:+)[8L;I1 2L$(V#STG)Y-?[P+L5?0=F;8020-R6PN[9LD
MIB"N+V0BHC\\T7\#\#A&IF!&:*-#YPEXHH]#28$?O,)=)QK<C;]P5S<](1+P
M/C@DC^.(0_#TP#+;-L$V>YK[&M_N#>_>R#U\8>(80F/"K\#B DL\F2EL/WA:
M[J.$EK]N\"U-SVD#:;[??TDZEUWEK<F^L"P';@/F<J7MO@J5YDC&&%S$5N0B
M-EN++F*],_,1NS(GO>0D,I!(*^+W.CNQ0-CB*\.R0,<F^UO"0.N!ZPK+N\)"
M+W@LON.#'9;69NQ8!FB4R_W M=F[A_N[]V]\ET6?)?1N7"Y.;3_QT$1I?OR3
M:Z#82^E(KS9!DPWQA[*9!_(SH+WXM@,O7  /(?#2V @&P1-KH3\$1DB;A+3;
M@S^'<J;@W%CCD#;;:GO)(=7'W @L?CM:[7<FYO-X8J<<^JOSW?*#L.D/\&B?
MP4K^3+-/_C;W(>8V<+TWRL'F345,Q TBHPM[*VY<^/,U_M!M_X<2;ECT2 2$
MYPQ>+/?F6XFZ= H2NXA0!,!CDG*Z(&E_B&6Q2\VU'.:9D\ *<0= B%M2C(4G
M!3YQM+VP-#]&QE6^V6PC$FT[A*\6[C7$FV!;A.<UX9H7N,(S>P0(]?RY>*[>
MF#P[0I;7[T5:,>L%T<_O0L]//$ZXG0 !$(^; M\\U[\3VQ?)47CQA_8"%)I$
M+$S)]R7@V[0+ 9>"\S7;$+E5#+S93G,C)^7&T(V$Q+2G@1^Y4^ #/ NG5YM+
M_CE[>Z\U5F-]N.,@H[$8@]@49U@;/GQKSW:T;\U<C9NB=B-"C]UXA5- B_K0
MY=K/NC:"!9YKUK/VZIVQ#^D9LM\J%[CQAAES ]SJ-7\8PCKU.D.E/>+]NM;K
M]NKM]D"I]T=JN]Y2!AVC,VCVA\9PS]C9L9\]85CAN41T2X0>I4L_!$7D[J]G
M3; 2L*T2$4!0EMGK*&8H7R^LYEP+?.=C^&L1H+2TJ<?/XS\^LC"RV&]&\?"E
M8KZC1SNCXCVU,?CE8[3*F .>8YD&"[_'I.3"A@5H?XK0/;H<RHD9HC3Z750,
M21)Y71M/R9+^+F'JXZ2W>O/TUL0T#(OGD27HM!NJNIEU,=$JP[9_"[^%7<FP
MRQ>N2P\H9&5+J:U1M*-S<);4V57+3I'\P<&OW8O-"X!/)>8*X1*Q9ENI18)=
M@JHK@8C *L%+$8C)6<D(D["IV"KKETJ=R#R2>2PT+T42A,PC.K:0>23>D7G,
MGY<BG4/F$1U;\#?ZDQ&.\IX0D6G=#'K\'[/URC':%^PB_N@'M!^UM<HN$%.I
MPR);&\IVVV>?.HF.4IW6H0UEJ4T+BMPA&;=2$9V,6QKCUCG[U&XGC-O!W;+)
MN)%Q(^-&Q@W=,=_^8L%JIF=\Y7[KS]EV*^T1WZTEK+L=[VTM']V@EH)YBRO^
MEH(ECXG$AS=P3SXL=5-'W*'W2H'G]IV!F*.3F!'6:=,<'23,PZI&9+W(>F&Q
M7H.S3YU>PGK1K%8LS,.J1F2]R'KA#%RTCQ>X0!.S:'>H)QDZ2:4ZCIP94*!Y
MC02>N:4%*@6>6UW_GKHT HPJ-K"P#ZLBD?TB^X7%?K56CC D^X6!?5@5B>P7
MV2^<P8M.(69DIXYBM!:B&&JC3:47Z&262B]R+[UPP_Z8<4]A\90O^,)[A**4
M L"R"^B*74!+348Q.I3"Q,$^K(I$]HOL%Q;[U9/VJY^P7VV%[!<.]F%5)+)?
M9+]P1C&ZQRO!2&R._@5[(WF4Y.1AC/;B?+B&VE^*8^"3V\I;;:K&."D#X@F.
M[-\FMPQ\83V"3TH"X(3/[.86'G/"ZIZ38TXP7952 "6W'62RR63C--E+<PN+
M:+*;L<ENDLDNFL1BM1UDLLEDXS39:@E,]LX'ALAD;Y+84"ICH=PDOZ<(4'V0
M8]W@W6C*&XJ)ANN'FBZ7K,V&FEY-II;SROD]=Y],$.#5"A9.>(:_;D=WLXGH
MX5C,2\?SO0>^?;YIJE&EG<1$O57#9@LP:_:"@<691).[UTX\C4;+L^$KLTR;
M,U"RB2?F4OMR1JLMNV-%0U/A?X1AD\. G2D/IX![8MJIYD6C.#WV3O[6"3S-
M-KSWYS.128[CW##*<!/A=Y/N]",6_[]J34_L]!JXAB(5UUO+:A!!JXV*(4DB
M8VJ"GIR>J#0QC$]L-QM-&I]8I/&)-$2@D,!38JX0X&!FS0QP5 QXHRB-'@VY
MV9.O&T8D$NY4P<*E4A,R@60"2\/7#6,0R016V@161@7(M)63KQM&&)[.M-$(
MP\(56X?1B/+6(8A$F<C8N/R)VP'&EG<"GRICIK"6A>P -Y6JFOHK/A8U=_,*
MMK(IH5VN>)BJ%/N8GM-6E=[W^R\+U3Z]MU4*4=D!-U97)5R%*?/M)3O7MNY,
M^'V<-_\]JF60!3S15X1QOAW=:Q;?J3Z^WCICLN;'__7,? &"!1/#\://9U4]
MK;-/2JW;ZF5V\JR$=3U%S#(3!!,$5TE;"(*+R;?](;B/#8+7GW?8&8+56KO5
M(@C&)IQ8C3]!, 8N$ 03!)>!;_M#\  9!&\XO[(S!+=JS:Y"$(Q-.-&WD2U[
M2N".>UQS]3'3; /TZHE;SE3H)K[.1"N\HA/Y0'MPIIC5 62.D+,A='3(C]G+
MCQDL=<@YH1\3V]4+V_@RMZK1'3*-[W=K[<[RH#]\,DRF! 4;"$9)]JLJ^P2C
M:6!TJ6L1/AC-($;?K2GM[ ($9$I*;DH(1DGVJRK[!*-I8'2IDQ0Z&,TBSMZM
MM=3L4MUD2I#%V0]-?* X]8^&*S+-56./W.:N9LD0O&9,3-OT?-%1Z2FW"OW#
M>P*4B4WX*Q0VG?JJN)W#P:K%2H6#V$5NU8);U<K1K;KGE@7\_D=HO\&YNEBP
MWM&MLBWG;W5K:@]/,2'*XXYHQ#E?<T0HCH<7A.(E8!6A^+%0O%TD%,\@V]!J
MUYI]//6(A.)XS1&A.!Y>$(J7@%6$XL="\:4F_XA1/)-#!6JMI=!>O!CBC.6H
MP884B.$$8MB VL@0SY56HX>;,0^.KUE;QU)@ZIQW1'853HFPI'/W[9"WP+Q*
M^F>I#W0>N[+D-*PDWVW!=^MF[KMED^]HMVNM+I[S#>M\K+584"F3@J_)+4$U
M-AM/4$U035!]"%1GWZ4PFZ1&6ZUU$1U%)*C&"P\$U7AX05!-4$U0?1RHSKZ;
M83:9B[92ZPZRZPI<%:A&/ )\GV'<2[&>^3#NI#"*7EQ?'7=YG/U\V+V7G,N]
M6J3E=.[/K]\LS7X0S_O #Q_4O1^KDYP]:.#YBKN*>Q1M OC4Y75?>]F:<A&3
MP(6M>G3@=\_:MMG>J7E"8[IW3QJV^ZBF=%;7:Y[M8' Q)$ED9#U==71SNG>L
MVJH,VVA,-PX^8!S3G1YX2LP6 AS,K%DUR3'', Q-<MR?KQOF=)\N*%%EX,G;
MPJ52$S*!9 )+P]<-<[K)!)[8!)YJL[.;":R,"I!I*R=?-\SISBWE1'.ZT30+
M6ZML43BBO$4$]R(SPYRIR,9X^$Y02GBJC)7">HZ5!I31@+(R\&W_JIJC#2B[
M>-9<X^%URI,GBZ\F4\MYY5P:Y5MIDS/MZ*76!AF6XM!H,A3I90)? M\J:0N!
M;S'YMB_X*LVC3=7:'WPS&?NA]@<$OMC$$JO9)_#%P 4"7P+?,O!M?_ ]VBRN
MO<$WBU,H2K/64E1"7VQRB:555G43 '?<\UU3![T.3VE(TY Z$W#,,6C'8,,N
MW@^-0:NN-<+!AB:-04OAP1QM#-I*#V9N1Z4/\UU8T;O[[]G&[P<UM=5&<Y:6
M[ 9RNT&82;)?5=DGS$R#F4>;<94.,S,(NZN]VJ"'I_\$V0WD=H,PDV2_JK)/
MF)D&,X\V42H59F81+5>[M7Z']IGH9)/*Y?/FP#?N2@VR=9Y%N/RDY0/DQE#R
M#I$;<^R* ')C]G-CCC92:]&-L9]<)V%%YTY,II%RI5EK*E3JCDXLL9H,@DN2
M_:K*/L%E&KC,?HI16KC,($C>J74'V>WWR6*4W&(06I+L5U7V"2W3H&7V@X12
MHF4FQ>2UP4 AM,0FE5AJR7$TLD7#EOAH1Q0OGP:N/@9U9U-+LS'U?ZPNA["F
MHW?KF5YQ&X>#58N'\ YB%WE."YY3]G.=UGI."X?POD5V6DS3R;@)C9)A9+Z4
MS?G0B"N^+LV$TMA,/Z%T85A%*'TLE#Y1G[@=43J+LOE:=X!_P#*A=/[FAE :
M#R\(I4O *D+I(Z&T<J*&<KNA=":%^K5.NTDH70AQQ5*\ORD]L78*]@%L45J-
M'F[./#B^9K%M,XKSRN]M\*^.P:[":1&67.N^ UD6F%=)!ZRXS00S824Y9PO.
M6?8-![/)5[3;M58WNU!(1G"P.Q94RJ3D"P\$U7AX05!-4$U0?1RHSKZS7C9)
MB[9:ZW8(JHLA=@35Q N":H)J@NIC0G7V#?VRR5RTE5H7T2RZHD!U*%JQ9&T2
MPE-D+C[X&E 'WC7,IT\Q+V^""7=-?3]B+*S]EWU4;.'Q%IY@I@;-MKIT_NA>
M'W,CL/CMZ+OM<MUYM.&*"YIPZ7C^C6,_<0^412;XO >QW =XU,^@0S_WBSQQ
MD/VIL$]NP/>4E"1Q6HU>?R_Z9"T,%QYS1NP+UV4>,Z1]2ZDQL=(:\W=*I<#5
M?/;*?3:G?(W9\!JN#.0&6R'&$<"CC+CI!R[W:@RTCFD>O ?FZ]D[%]S.0<#@
MED+4A7$2HA 9BU_/FB +W!)3XG4P++/7D:&1KQ<>]%P+?.=C9&I S2UMZO'S
M^(^/+#1'O69TRG8I0YA?=4*WVQB<9C!5<?WA(S8G[:I5'PH&3P)J!FQ0SV8<
MF9B&8?%<.-)J]*LTIRT)EFO4(T=FG.; *PY.;#11.?* 3!29J%Q9\B_Y -RH
M7SQQ5WM<5[=#9BHG!5E7]8;,IRTQ!U 0G8""@")?EB2#/002Z)2#3!0&+I")
MRI,E%Q/']<W_DR8J9,\W[IH.;;V1*4IN/NV" YO;Z4NL;,GC&*R C'2,*+$=
M*PZT['+LLC)L>V?:S!\[@:?9AO<^+] AA"%3AIPU9,JPLTV8LE>NN63&4#K*
MQSWR?/+(+YJ"0=E^@#E3L8'$.*6, BP(N+!#:2Y54.?+(G4!T=.SB:JC%ZJC
MET:WSMJV</?)U/GJ&NFW5:&BYG&Y<M3_-X>[Q\4RTA#?AG8XY>37A98RX:42
MC5D/Z2&#J! [[P@C&F'&"A8$V1BX0)!=##X1;N^"VR)V$J^T[G&];K[4Q[ ?
MY_9Y!-3]LT]*0_W[!_%-PJ:\&89ETDIU]_5WX'^ZIBZ.R60PAORD%10G\@W0
M3XHK>BX>C2Y@94.(_16']KVWY$MCR(^W)9]=*?S1K3_F[L-8LP_;IL]-\WS\
MW-W]]RRVZEVEIC3QS$XA"X3< A'ZDNQ75?8)?7?:6 _./JD-Y<"--2D3LHTU
M)<S3<B Q/3B+G?5)X_"$[13G0X3MQXZJ5QS;]]Y9=PN[L]X^UOV 3;72K+7Z
M TJ 8Q-PK,:'@)=DOZJR3\"[RZ9:;9Y] E)2MAH'PRA;G3<'8D<SVE%/HW%X
M;&IIZSHOE"YJCH896 .VE;=*.-A $)]F;[W47[A0>^L=1HH?L+^NJ4IVVVNR
M/R6W/X2^)/W590.A[TX;;$5LL-N4M2[P> CY6K@JIAU(9V<_\BQ0(_.!$:W>
MTC32:UMW)OQ!>_EB>KKE>(&;R20(%I$ W#E_?O,?AF[[/U2U.VKQ4:^N-[E:
M;_/^H#X<&(/ZJ-\?-@==?=CKZ2NE2A"I/UUE%5:1+1EU/E6<65$:+*0H Y)R
M;_/TCO[ZZ1WA13YSN".?LPC^Q_--_<(VOL+[8 Z..KE#D+N[E=RY3^YX&',Y
MC0.^8OMRB@=L'9C8;VCVZ]_^TH=MS4>/F2%7/K!W(.3>>S:4I(W?]@6SV#.O
MX#2.07[3.,('Z/0:750->= Z<*?JY=)HM5$Q9)<D8MX=DI0FAA9)[6:CN:6[
M5>5:)/U;M$=B5_!<QO)\)^J:A+!K4E6!!RN?\FC21Q!T2).^'(,$2JJAJ-6&
M*+$IRUGA=M>V*B-6WI8PE3J1J21361J^@JELDJE$QQ8RE27C'9G*PO-5#+(G
M4XF.+8CB(&OU+0R-5$93L)9-2$"K-A=6!MCS8TD48*\,3W8:E5+ZDA0<O$#?
M16$5:I2I@BNNO\!W]&D%4)2)\%C/#5:LNA3A (&FW!=6N[#TW=[G.E1U=1G@
M[X[G?76=R658O <DOYUR5Y8Q>F]JT;@76\/]JLX63UIX4G[JNQZY4 <UI=6A
MG@;8)#"U8TB(2(A89#80(J)D2PI$;)T,$9LQ(C8/1\1^J]8?M @0L0D@ 2(!
M8B4%GP 1)5M2 .+2#+EC :(RB !1&62P16QV:W Y0D1L$OC^\+AU_E7?96)(
M=((04\E.=9F!-0&]VU&B2ADRK*QJ+E1('<0N<H467:&EV3TI7*'(W)XP6%[K
M#A0T_8E0UH.AD<G<"BL(A8M@V@F%"\,J0N$CM2)4E]K\'PN$-\?G=\;>+F%O
M(201W\D5 F!L5IT N#"L(@ ^%@ O]0(^$@!OR0?L!,"MVD#-+BU. %R$.0:'
MIFHVI <,)Q"-V-1&AE"LM!H]W(R1?;N9:)>WJEM>7AFU#1[3,=A4..7!DMW<
M]ZSN O,JZ5*AK9TX#2M+[6ZER#HL=8=-X6]=O<#C 6],6W-?KWT^\6X<6_A>
MKF-9\--K<5J1>_X)TQ*M9JVO9A<<R0A.=L>22IFDW.H8">4)Y<O)2T)Y0OD$
MR@_0H'RFYQ+4FC+H$<@70FH)Y%&P@4"^/+PDD">0GX-\JXD%Y#,^:Z'6FGU"
M^6*([:H#&!LG6>U%B(5UIY];M>$1UC;9$H^@J(N/E'R=>.CT3YDU-Q2U%XWZ
M&;OQ"J?:(Z\/7:[]K&LC6."Y9CUKK]X9^Y ++][,,5N8(K;'(*]-D\!&@^9@
M,%);=3X:*O5VI]6K#[I#H]YKP7=&S=%0:_;WU,CL%K]Z9M?2?FT^L^MR-H0J
MGM\%AOOJ18R]Y9^YS4>F?]1Y7;L1!>F\+A[220SH&H:T>B]0:'% E[8PGXLM
M-J>C<5TG*6- -S4%[9Z-QG7AZI9(X[J*P#<:UX6##XC:5",%'JQ\*E;]>M58
M0X,5"L]7%..ZJHQ$>5LXFBU#)K#R)C#_,5QD A&:P,JH )FV<O*5QF:A9 N6
M8V)KE:WLTT\N U>(W#F^TA9J;8NU,*Q2%198^;1CY5>UJ[JP,J]B;6*QLH$@
MAB"&^$004T;F$<2@8 -!#$$,\8D@IHS,JSS$Y#/QXGBQ2OS=J[YRL!.:A:]#
M(>%\B2?%HV%#ZA.HQV[-676 [JN*2NJ1/Q]P6BD"!Y)^ @<"!US,J9AZ8+52
M! XD_00.%06'%&UGE+>]"J(2KB@TLM2=()/6,<G^,'A:\)-V;V@#4YH*2OQ1
MR7M?\SF^^#QY%I06J2X;R+U(,0^HI:[Q+J2)N["-WQU]7Q]C6Z?YF6NAMMMH
MVLZ1>B-7;P(WDO[JLH' +0VXM8X ;EL:K,_WS?T^@1LV$<*JW@1N)/W590.!
M6QIP:V</;MNBPPEPP],PG-0;6;WJX8W^2A8NCN8E8VK\<D1^%$Y+L&2P:#I]
M05C5I.GT1_)I.NMRW:$%/5(<NM/OH$EQH^P=A$:B\'50(R#%9IT)2 O#*@+2
M8P%I-U,@W37FW>UD-Q*<@+2\%H& % \O"$A+P"H"TF,!:2]+(-T27]]M7F>M
MFV'9%*%L$2+R>&NUU5ZCU<'-A ?'URRFAVJ;F$2X:E@AOAP65090/RGBTXZ.
M#_63RLCKZ:_Q>M8,Q,TF#-]7!U14@$UVL"H^X2+A(O&)</&TN+@T-_X07-PU
MJMZG8U+X9 >KXA,N$BX2GP@73XJ+[6:&N)A-D+RGTO$K=(*%I4*]TO%PK#E,
M\ERH<U)UV4!GX/#RAE0$!1L(($CZJ\L& @B\O"$50<$& @B2_NJR@0 "+V\J
MKR)EJWM%SH O?,1=EQOG^$+>!-*4::@N&PBD\?*&5 0%&P@@2/JKRP8""+R\
M(15!P08"")+^ZK*!  (O;RJO(F4KYRM ;]EP"B"^D#>A-&4:JLL&0FD:A(V'
M#SAUA!""I+^Z;""$((3 PP><.D((0=)?73800A!"X.%#V2OZ\(?ZY& W?$%O
M FG*-527#032!X,TZ4C)=800@J2_NFP@A""$P,,'G#I""$'27UTV$$(00N#A
M XZ:/AHB3T/D\3(#:\J(1O85AE5-&MFW$__>[=^-6'G;C3ANAQ#9T&-,L9'B
M5$_V(%8'-%6^&"*6>NP;@6H5+#6!:F%81:!ZK [_ZC$P==<)."H-O"V&7-%8
M>>(%P6EI6$5P>K0]:NL(>+IE<LZ*/:J2X<A50M:3[5'SJ;T]<4B^ *-TPM'R
M1J2Y2&?+DU=4A!SP#D/IR&TJ""^;NPT9)+_J"'Y5>YU?5;R@?T:&GQRJ;(/^
MA,=5L.&$Q^7A)>%Q;FF#3J9PG$.^@$"XO!:#D!@/+PB)J\!+0N+\=L;=+*$X
MWU0#@3+R5$/!JO\+D&J@R@KB!7E*U>$E>4JE8#!Y&NAY0Z"&@!<$:E7@)8%:
M*1A,H(:>-P1J"'A!H%8%7A*HE8+!!&I%Z/^\(3!L.,'0XDQM5"LP'-:@%Z[T
M_!C<*IP.X4C*[@]>"\RKI#/R5WQL3.>'I&-EJ?V0_5/KO;>I]6,4F\\RZ9T6
M_O*VM>:]4E8";7D;H2\:LTWH2^A+Z'L(^O8S0=]=:\O[W3ZA;R$DB="7>$'H
M2^A+Z'M,]!UD@;Y;RLG%8VO^KV?F"ZPRF!B.'WV^4&!>ZPSPEYAC@^90E&))
MVB1TI\@F?/ UH Z\:YA/GV)>W@03[IKZ?L186/LO^ZC4PN,M/,%,[)OM5O.M
MV-_K8VX$%K\=78U&'(3OB<\TX4[S^1T'^==-R]2$7#Z(=3[ ,WZV'/WG?G$A
M#C(_%8;(#?B>(I*D2JO1Z^]%F*REX'HY9V&80#O78R/7F3!_S)DV :7T@3R3
M:>!S@PU?F3:=6J^@;?)SS]?\P'?<5S;BH&6+F1 7R,XTN)IC6<ZS=RXXFH,0
MP2V%. L#)+@>&81?ST"$=&Y90N5A.;/7D3&1KQ<>]%R#E7Z,S FHLJ5-/7X>
M__&1A29GT(PFZ2QEYDZ40NWT&NU^VN*3!+CJ\"EWLT!7M([OQ#0,BY^B&@@7
M0Y)$'CJ6L1:8^KL 4Z:L@2<!0@!O%%"_D_%IK6?;;C9V;)A9&;;]FVN $%?P
M7 ;[PG4^&7(W9&5+J>6L:*<9%H2##[N7A%06>+ R*I>"5&+-OA"DGF&H;U2R
MJV^L#%_%9BWW0L8J0U'>%BZ5FI ))!-8&KZ*3"J90#*!%58!,FWEY*M(4^5N
MVC =4\'!%BQG5-8J6Q2@*&]EP(/VPC1_15)&9&+P50U(N"HO-PI<<U.I>AJL
M?-JQJ(8*9M84S+P,7<N<!BY/ULMTE@H'=BD7N/"_AI;T/C:M"U].>Z[D^N;K
MK(*FKH)CHS2::"IH-AF02MF'7_!Q@)"3D)/X1,AY4N143HZ<Z\^$$'(60<0(
M.<DB$W(6B4^$G,= 3O74R+GA/ <A9Q%$[)?#P^A'RUF5/HPN%$Z>8*@QF_O,
M&<WBZ%%#)WQ-\,BMR:F/9*6L$E8VA%Y+M9V231.)5GLEK31>B;2-%[;QNP,N
MQ.Q[W$L; E\QK$AX)<V&FIE30NJ?U6"BU/MY KZ26=R*23Y6-A#PI0&^I1GU
MQP.^]1%L K[BB!@!'UG<:DH^5C80\*4!OJ5I\$<#O@T!Z+7 IQ#P81.Q]QG$
MH:F<.RWUOSHN7,P.^^B$K7G@(4W-PI>>(6^$LF+590-Y(VF\D6X:;R2RB0O?
M^)(PC9G'H3N4',<F:NFWXP2 );.\%9-\K&P@ $P#@$MC:XX/@"GBT7B&W9 9
M(  DRUMIR<?*!@+ - "X-#GFZ "8)B[=(P#$)FI9Q*6I/OJ0-B.ZRPW3]_!E
M:,@/H<18==E ?DB*XUE+(W1VFR#R<AG:P"Q"SMLG[ A?I)7A42TR!7D?<B8,
M+)GQK9C@8V4#8>#^&-A-U19K5PS<+>J\&P8J&0:DR100!A:4XEB-;\4$'RL;
M" -38&"J!E<[8N".@6?:!Q96W*A4.D?BW_N._K,^U#QNR&&EW/:D=N++U)!?
M0@FRZK*!_)(4>?)NJOYA-XX8T1G UX86CV;!WX\UEW\65O(R820O'6_S>/A\
M^W>04:"RL:*2'*L=KICD8V4#P6&*;7JJOE59HN'F</8<! >-/H$@-G$C#"3C
M6TG!Q\H&PL 4&)BJA56&&+@EG)T,51,&HA,WJI[.D?B78\U^Y,RT!:4#J6Y,
MLRSG6;/UU$,:*8]>L@1NQ2P25C:0<Y(F7IVJSUAH%Z_M+WS$79<;\*4+S^.^
M]V=L)B]B*YEQL%IM-5J43\<F=M1TDZQP-24?*QL(#-. 8:HV5YF!X=X-/UJM
M1I? $)O8$1B2%:ZFY&-E X%A&C!,U?(J*S#<O_F'VJ731OC$#D-7ZH5@=3PO
M-:+NPLA4N:2I)IK3E)@EM_Z8NWGE=9+^"+$":YYW,V]H"C0B5C47ID ?Q"[R
M?Q;\GU0=SZ1QO3#^$WC^!(B >=9B1J9\=SM>*7N17P$W06P1[#9!;&%811![
MI,JX5,V\]D/87>N_FXT! 6LAI(QP%04;L!IKPM7"L(IP]4A;UUZJ#F%[ 6N*
M^#QM70LB;Q@Z=F^*V1M.,+0X4QL9HJW2:O1P<^7!\=-/D\R&'2M]GV-P [F"
M8,USSWDCB+H223<QCYPC1+Q<=(Z.RT_RGA:\IQU[RUW"_4P[ /;=3KDK7:CL
MP_UX2AK6^4QK[7^ES$A^17\$S44PYP3-Y>$E07-NT+QC=[7]H7GOVGNEH1 T
M%T+*")IQ\ &K.2=H+@\O"9IS@^8=6[WM#<W[9QH41*?B")KWSC1\\#4@#;QK
MF$^?8D;>!!/NFOI^E%A8^"_[+'3!PBT\P4SDF^W64J#H/IC ([S>CB+9MA]_
M=SSO4G/=5Z#%L^8:W@,\TV?+T7_N%RKB(-]3873<@.\I#TDJM!J]_EZ$R#R+
M,>;,UUX8E\;!8\Z(^7PR=5P@&S.BT< Z/)%F&TQ/$H[Y8\UGCV!/F&MZ<!5'
M*K\Y,G6X!8-+2%LBKFA$AX_DG31Y_$A>SS*UH6F9OBFN[W+XB(T<<1S).Q>,
MSD&VX)9"RH51$D(?&8E?SYH@'=RRA!D (9J]C@R,?+WPH.=:X#L?(Q,#ZFUI
M4X^?QW]\9*$9ZC>C0Z!+R;P3V<%NMS%(73V3P%L=/N5N%H"+UHF:F(9A\1-L
M3KHJ*H8DB3QT+&,56$F6]&..;&1>EJR!)P%" &^Z9Z=CTUI?M]7<6HD6$ZTR
M;/O"=3X9<C=D7TNIY:Q<ISGLB8/VRRJSKG*DLF"#E5%YQ,0(=O:&'?4,0XBE
MU>CW]P^Q5!N7Q#X.6P0BUUI''&S!9PE3J1.92C*5I>&K2,&2J43'%D3>_5I]
MBQS^RJA*OO&C]69/(EJUN8 R5%09EKPS;>:/G<#3;,-[CT]!*"QT^B9@^Z%&
MF9*L-]QG3IR/9);C>8N)-7P'0U< 2)D8@O4\;L5:$_X5'P=4N6&L=N71AL(C
MTW/:JM+[?O]EH?)H:<#64O/1]>486ZHPWE8<U5MG3*Q \W\],U]@P<'$</SH
M\UD14NOLD])IU[I*=J=W2.M+;GP)\TCZ"?,(\W;$O*6Q39EAWM(!F-TQ3^W5
M6NT>81XV\<IJ#W[:R&V9. !:R7303M-/O=T^:;RV3+3'>E:E\D8(!QO(_TCC
M?RQ-REKR/^"/2VGQ3K+?5CNU9C\[UX.TON1:3YA'TE]=-A#FI<&\I8%8F6#>
M ?OM?FV@9->VFK0>V7:;4M[ISP%-7= 7>;H<7_2)? \*^E67#>1[I/$]9L.H
M["?7678\D@8OQ19[[E-T.TV*WV,3%ZRJ3$!&TE]=-A"0I0&R059 MG+?G "R
M+IYQ$Z3*E(A&PH%[W]%_UH>:Q\4AE<F4V]Y!NV2*T)<L-%QYBX2##>1<I' N
M^DMSKU9%Z./WKEZ$]>.7"2MX81N?N<U'IN_=CS67?Q9V,OF%2\?SCY7"[M8&
M78KFHY-"K!:"\)&DO[IL('Q,@X]+#6M/CX_IT]V]6FN077":+ 2R/3UEN]-R
MX$+7W0!T2?8X=KG'W2=.I[KSUP,<9*^\.<+!!G)8TC@L2_.>=G!8[B(+",Y*
M;!F/=LJ[56LWZ9 W.D'#:@0( DGZJ\L&@L T$+@T5^D8$)A^5SZH=5K934(D
M&X!L5TZ9]K0<D)01TX@"CX=#B/"%JL@?H0AA==E _D@:?Z2]KH#O]_ET-<F3
MV]%WCTL/)4U%>CS7<2<GI%U3U0ZE!K )%U;%)]@CZ:\N&PCVTL!>)VO86UV_
MOA?L=6K-#L$>.N'"DA'/8 Q>F=ARZX^YFU=@ZO"Q=V5B!=8(]6[C5"MNS'"P
M2EV8K740N\C36?!TMK=VDY;T:#GUFM+"<P8=Y4@P-,*5KW$@3,7#"\+4$K"*
M,/58F+J]==P.F+KEQ'L_P]-C!)M%"! @3LXKK48/-Q/^X8I):$:DA\S77L(L
M/35HSU\=<)!]A]'-%3=;./BD[C9FFWR6_7R6_E:?19K0HW5T;W9KS1X=B$<G
M25C- *$DH23QB5#RM"@YR (E#^@!WQW4>KT6H20V2:IJ$0#^C?^?FA7(9A5,
MLRSG6;-U3AD,#(S!&A:G#$9A6$49C-WX]VYO1V>PO;?>S+!>Q';U>+$!I=;L
M]RG=40AA>T_PBH$-6&TVP6MA6$7P>C1XW=Z:;U]X/22HT*ZI/8+78@C;>RHD
MR'G8')40Y,T#K$%W2HX4@T^4'#E&<F2PO7W?3:KN #LV!1@,LNM,1(F1DIL
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M*%D,/A%*'@<EU_:(WQ\ETY>$9[OO)Y3$L\4O6AD!_GU_OF%:RF[@X05E-TK
M*LIN%(%_E I SQN") 2\($@J :L(DHK /X*D(IQFWK1_-9Q@:'&F-C)$)[77
M:'5PL^:&^UD.0#MBN]9C,*AP>H,E\K8U]+N)>97T+_Z*CXT[1O$S866I?8_]
M _W;!ZLE OU';)"FU%JM[!JD':O)ZUK37RD+@G;2.B$S&I-.R$S(3,A\"#)O
M'^:V#S(?T("]UFQU"9GWE+)0DF)!VB1SIPAO?/ UH Z\:YA/GV)>W@03[IIZ
M^%K(CFF'/?W7::4."^9NDCR*NDBNY.L$01<(]DN>:JBH?4$>6.#8C5<XU1YY
M?>AR[6==&\$"SS7K67OUSMB'_>0D_2H7./>&&3.3T&SUE!^&;OL_1H/F8#!2
M6W4^&BKU=J?5JP^Z0Z/>:\%W1LW14&OV0VL %^'&A?_V D-N='L=?5#O&3JO
MMUMP%4UM:?6.TN\.^$CMMWEW3R7)9O$K;KFC6+4:O7ZNDG7'04G^+V29,UH5
MRF*F!V]/N7Q@%DSABZ/ #US.N.;:8.>\&C-'3+-?:\P?<^:;$W@37AM,FX -
M]<5UP9SI8P:F#1!$YZZOF7:#7>@Z&$/XL@4_]8*AY\.SF9IEO8JQ@N)GXGKV
MZ@@;&VM/G TY%\\]@G?8$'XF+/K;R80-]@"76?$!,VW=%:?"#/';O^Z+=6IS
M:9[7\GR1M^AW.=;L1WYM7TC2;-F6-N'_5^]/.S.H XEO=1O+@T882),EEPN,
M2+&VI6$JV:ZM&:]M&>$7UP;0N'YM(-Y21EY!%#TF1-1@7[C.)T/NANK94FI,
M4%"20=RNQESN33E<Z(E;KXV"J^^%)]1D]9)#=;QT)E/035 7@XTXN!Z:)57*
MF<*?OM!4R_$\IFNN^PJW>]9<PV/O;FY_]]Z+2VO3J>N\ &M\H%8:.5KJ7W\;
MW_AWN.]E\K8;)";Z\:R,\R+PQXYK^J\7+Z87?_H%/O-\4[\4XN>^_B%ILH/^
M=/K]1GM)R$)B1I)6FQNQ%#1HYT\#I;]-SP8K:#!3M&?-8X_<%D\-*F:"YIGB
MMU+QF+BZU"^0-["GPAFI1<32-1MLM)0N$WX8K9()]1F90#<A5.!F\U"-X4(]
M!BL#9/!K8.?9,P<<@/\%9/ Y$T*9B4PN=8P^'C_NQ9-?V,;O#I#KGX%K>H8I
M'W-GZ6R!>5]O @\3S$XFA-A!P]J-Y?G:,^&::*_;A*3!KD=@]<#_\&'K^'_<
M"(V;RR?@20@C%ILV*2//<&&X(AANYCN,OTQ-5X ]^_O"#B))B.["V?&OX<6
M;9)]L$M=ILO7B"Y7XNH2%_\-NG \$[;H"WR"O[IO=T2U6 D3=$EHSOY4Z2&A
MRBY*M$P?]2U]J@7VX.8 Z877#4)A</!VG.E$N/#@\QJF_P;QLS"K2TD9X.>E
MO%G2DFSU#@]0E.C#U?=-_/HNHLW.1EAMKK#!"QY"6C][*5Z6,=%NX.+)I5_"
M?@\N:IL:/*2MCTU/?/VS S<Y-A&55F/Y7,PB$85#'YMR0=#YTT:6S)0+E/O
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M.,GC^0+6+%T,U :97%A\/,DZ(G \ AP6,@'D\4-YB =Z:Y[GZ*;\6$J/>,X
MV.KZ6O3XTSCL(+\0#?2V0<^8_\PMH/($U&[L-4(SN\F4)CP9,;F=NTF[EIQ/
M_?9UPA*FM[99VSU%'42&>^S&*YQJC[P^=+GVLZZ-8('GFO6LO8)I^I 'IJP?
MB]SJ*3\,,1=YR(UNKZ,/ZCU#Y_5V:ZC4-;6EU3M*OSO@([7?YMV5[L&.+,H?
MG<#FZCJX1G+#+D7\XOZ2]=K-&OL[>$%VO*[$7<!46J8>EG(($PL@P[V_?Q#?
M_K0XY=WTF&Z!"IDC:7)-(=2@;U*'P;AHEB^L@AQ1#U>:PG.&^B?T2JBN[85
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MW=U>7GT!#MTOB,E%!//;A26ZD.3\_&)9\#M/Q_@*]MJ!%KM1 ETLQPM<X;>
M97<L3P+;-]?1N0%O>\46[ =PR, .3]C?_M)7U>9'8[Y>/;G>Z6R]-?E-Y:/P
M7(T0FH6O>!=8\-Q*2ZLKG7?\O?R1TC&B5P$L-_07YS$8=O6BCS7[D;,+W0\=
MXE8[Z1"S=^('R6^]!SP=<5=.9ESS>' 3S6<:/+_!/4#2L*$!?/YD@ML-R..!
MHR!<>\V#5<H&!_(7IAW&:03?7?[?P'3#7P[A0B%-0I=>$Y,@I?\:.<@N%UYW
M=%_80XU,00AP";Q@.!';B_G:%Q9L>C,/N!8^O^>)/[U@ C(###?DRL++BP^>
M37\<W=,'(1$[#=,Q/"8<C-"5CSZ]O[H4/%)Z'^$6DBWB0F)Y7B,IT.LH:-HR
M.!;>T0E\9IFP$$F:VMH?):D-WKRX?FYTU70]F 1A-POQF&)V)SB>>K*]172W
M&:% U\ W <'S:Q$!Y"8([C-UX37LBBS8J(#P"E\N6GS\/B@!")()?SFCD:F#
M@-;$@P*#/+'GFH8S?,7U/*"DI;EL%-AZY"$*>9\"(>%R\'SB\6!_YCQ+'ENO
MTB/UY-;-Y8^:*Y]J1L>YMC;8;> F%B%EZ]$&,8HUPGY=J]%@#H0#"W: C>'.
MSQPVB#-^BN\ZL 1-"J$.F! KDV-;KZLU"I19 W>8/XFG!6J;+G.&_PG]X/#N
MSN+3VER(/X@]7!&H80GS(&C_G\!XE%\ H>"180XO"8OQ_/HP"ES(WB6"2F-S
M*NX^=3Q/;N#7+#DDUW9CMY\A6;'LZ+J)Y6]T([;[]+DCQJ*<A49",B01/@BQ
M4_#X$L@Q @6-%><V5!!)YO"SKS/EB3ZKL3'H1,1M076X-A^-0O+9(";QM7=A
MG_QR')<('9MY<$)>60CC*%R -*APK2?NQO$;L"87MAW(\(VP1PWV61,6*YB*
M8<"!/IZ)I3".*5<,"WZ2:PB3$J'"[KC"9WC6.7D8_# TGBO$T^*P"XU((A_=
M /H6UZO]],=,"F=6?(%78*#FT;?(>V.WP-P$!\)O@KX6VXU[8_RE;^&!B(9&
M4 0HN"=R%*8G@Q1"AB:::?OP7_G: $01Z&/&Y)K9+4&N.;ZY,;D:<\IN^ZI$
MY-C#F1O3X:L$R3F*>P$HX),$.Y#0U,I4DQ^&&A%JL;C09P>P,W3H 1E]1T!T
M@F 2DN A8M"VN57;:N[G@!RJG&5J0],R_5=QGU6$$'>1A@;>TMR9G9Q_%7CD
MRP<* [7 _Y#$T\ %1).NF7!NP&F4#R!-[R/81!=<AE?Q"0]#P_"5P):WC)R4
MV F,7#OA$\#UP@BRR5?ZT.>11ACF4ZP386A*).K"')_,>D6)PE_/FF=,!\]!
MI +ASK/749)1OH[3EF%J47<L2YMZ_#S^XR.+,^C-J&'JQM-$X9=#W5M.0Z[-
MD\OGWQCNZ>ZJH5&N3 M\9W=MM;CPM.H1G<YW2JNMCE^M2!#CI<^&3.+_O%GS
M_QQ$S+-/RZ&+G4RM(;9C4BO#&WY>RJ[+A>2UJ"BNLAR6V>WV0G!@X][]F C0
MK!&@LFK. NW6<'>E)*RF_F*F_.S3-^X*0)TG!@6:VO'.(-SLQ[LQV*&*'96P
MVF)OKIFNW$N-+*[+S4X"< P.5[7"?;\@4IA^"&TV.(@ #&;X1N3& D!Q?^8D
MS_:YG<$2YV7YPF+Q AE\?&)+!I\,/AE\C 9_:U1YT6"[?%[T -OP..@E2SC"
MNI&=M@8'; )JT1XDBB_ TW!SZH=8(LLP#-.?Q;V&7/QXHL6AOA7W!0J.'=?\
M/VV&0&\">R%(15LN"4+B+0*B0JH3 1$!$0%1P8 HF3@"='D"JRS!Q9UGF'RN
MQX 3V+%)EQ#RW\ ,=Q<U%GA<_"BQXXC-?;3AD*@"F&,983Q;$SDE[@KPTHPG
M[GIQG%K$9<7O5H%;8S=H*$?R1%).9'TE.7:.O;[):K #$QKS,#H;RMR&2+R%
M3R;?!&[IKBDY.8\BA]GFJ&C@;9!=AN-5^?:CS!NRKZXVX<^.^Y.]4YM*ZWU<
M0R"&#,Q+92^=B:R=E?OE>Q&^!D&$]=ZZCYJ==#+$EQ] V(UG[37\E2?"QG%R
M!IYX3N3_65S,:#]:+T2)%S,TM?5\V(^=SR+=%6=PBIX>W#TM(+)\IBTJKNUD
MB8&7.K40U1L\.9;(,H\#6"V8*\ /+OS5J!!@:IE:_!)^[04R,2L\<.D(2N]Z
MEG467Y+5BH;S+#/P7F#)^XY<9Q+=8:295IA2WOVQ-<MS9"I]R)ENNGHP$68Y
M5 3AD@9>9*+?"D/9*D25XE6(;J!LCJ1<=L[R>0YS(DI9^ +*"35PP3T!\\QU
M3?H140(ZH?42O%P>:K1K>C]#=9ZY$,+$S[? SZ9EB1$T0H$BIT;8?3=R9D(,
MT&(/!V -+CM\W2>]^9OS#)=UY6-Y?*6ADIODG["G 2/ M7#?'('3*J6/S%2#
M/8A+ 25Y3=0UP9/-JE7 "H7Y4?&D3I0K#(V;IXWX8Z#)"+(#5S4"G8N'<X+'
ML:0$%T]F X5J(<H+&C:V%V,6 5,>5E6 )(Z2S-+_![M0$I2&G(/P!(896>1O
MKJGS9R&(0&V/7SI"P#WV^^_?1#B%"2J)R$E8=?5H>K[TMJ8!.$IZ,@PS,MV)
M=!JD(,?E>J8;/1:#G;(XQ3.=RB,U\.DW#=Z]OJZQ:Y![U@]7O>3 %;> XU)6
M[<FE+M5I.*6LTY"J+QT^&QR L&C1M/?T%\/PG<@@R1K P(U+$":.)PO_A"2.
M3'%Z19SS<D5=W\8]0'A%(?JQN16!Q*B"0E9IR(*2:&_Y"C;PIS"KX<&SQ>_O
MZ?L65W@3-?6??]S>_;B^^7I[]\?%P_7MS4(Y_>==R^EO'WZ[NF.)R]#!"4Q,
MOOPAC[3\ /9<7?]CD<>7N_)X?BJ&W5W]X^+NBS@X$UV1_?/[W?7]E^M+P?M[
M]O#;Q0/[=G?UY]7- TC%_;>K\(.22(4?EOGJ(JQSV(GC5>*1>/[!!H^^;+LI
MM7B[J5/><BV[BW'H[]O%W<./Z^OKLT_BK^B8^/7U8;Y]WHN2QE5I@G&] P-W
M>W?_X^K_O[K\_G#]Y]6/K]>75_#&Y>W=M]NDO56:N]O;Z*HU-KLLN_T:7EB>
M6Y,7O[MXN&+_N/WSZDX<7\SDQ&*N)]C>ELO"YOH>I-Z$%_#->=L'$=X"@*[/
MWI@5Q\8;K#NYGQ%-_HL-.&('N?(D4NP/BQU6+%W"VXT:09BV[KA3)PQB#U_#
MXV<RG"@C@/Z;R\Z+F75M&L8(HA#Y"I[$,?#X&]8\"_-EGC&7WZG%7[J,GX;]
M0[C4LKAL=AX/N!E][3ZZE-)]I[V/NGN$-=+/-MQ:')*9;:CD)CH,BL97DML!
M&6(9A@</M/B4GUC:-]=Y>67W<3!&5BH+IQ_VSVJ\K_B#<WEM$<?W'?WG&.1?
M[)G?15TCWESC?=&CWO_B4<YKUISCV169#!O(9\0CE(U #T/*'$1.CRL!H]-.
ML)D21%QUV,R)"]LWG#A+?I@(.42?BBU<M!6SQ'<3A],\47._ZF2:C%,Q08-Y
M*6&XE&'@F3(*LV)-L_C)%/:B81A._/29#SW3E\=3QKX_/?_PX?GYN6'S)]=I
MZ,ZDP?X5GCVPY2$KT;/'&X4YH<01F$AIPPA@J&HR,-)I-#NQP;J_NF1?@2NL
M7__?1.(38$(>*I4"ZSN2 L^:*7>EH,BU,(LP.WP0GCV(EGL9K1+47RQ*$DL$
M+Y.*O[Q,\3"SEX;ARAC>[*2F-G2VI'H*LB]2E 1@7][^\>WJYGYI$ZPHNP+V
M'*63URK%GF<?"%($!&6&/3&:L&1'K"7XF9F;Y+=68,LF"-H+.$HA_NH/L#BP
M<7_X]X_;?]V 5_G;];<?X%T^7%S?_/A\=7/U=4$1U!V:<,079+,+@LO*HFLR
M><UKV6,C_%RZL7]<W%S\0_;ID"_OKGX'E_8+NW^XO?S?WVY__W)U!U]Y>("O
M5TZ7U$QUZ0INY+\NZ(CLFL:NYS]?[9")K@>O"0=,($MT8&#)09,_73S>6$WU
M:LUT28JT"("!/MS_B 3\Q\/=@GJU=NY=$FG3PE475.?A[@+0)XRYU:)N..%F
MDEW??+D";/IRE=%>L5#JU,I4G6(-N$N<WP^E7[X#5W](5% 3&FU1E_:/;W?7
M-Y?7WRY^_S'OU/3CZ]75/>#4W9_7"QVAE/:NZC*[:J+_$Q-7E8H17CF;SC^%
MTH5V%KH02_(=?"X"-'$,X&(Z=6!+%%>M72>RS'?S+/.W,,M\,=_R?37=238:
M4+;P>*M X?%CQ:KW:.5[>*SZSX50]9]%#:@F#&P'=KN_77^^?KC_,>MU]^/^
M 3P&X7O_N+_\;<' =G;?]X97E= V[Z(WNS*#*U]]^?Y[>B.;[+(=&MDD=>NY
MV]UWVGMA>D>.:'XD[)CAZ$$8ZA%E5J+[DSPT);K,K"Z$*5?#@NWN1V[YA;6'
M7$[;P'KIJ,"6XR1I*9KN ??"@$M1ZFZ91E@K/XOMSJ#9.T]Q'F)WFYJ/QM_-
M'"73"T\91B6/PM5YB5K\S<FR\B@D&((;$41F8A_02 2%0[LK2^9$%5V<+95Y
M'6?4(%-1)5.AELA4K+ .[%X?<R. .Y?02ES YL6+UA>Z D[<7S\J)@>3\2H_
ML!>JBEB4:@S[\H<_-2>S>O+HT]GV+KE'$R79+O?"HO)HL[3=%@G7#1Y!MD\"
M*P/V*RKAC8U/;<$R+:2 R!!5PA"U2F2(KE[&YM#TO1+:G'LN>LK*Y<73.(1'
M,N2P-=D]2H*^JBQF8>APY5>@%TE*6D,7/M:Y/$-]@-%[,UIKVP2MZ9OQ6=,-
M$^$&C?;R\,65,^'VF?>VJ[0E=_[B]?)\K0VAHOX1(T4S^<M I? N\B80)XQV
MF^>6I= U&YWV+[E(SQO*[C>H,4L2M-N-?G<WQ:N EGWAGNZ:,N>0AS3V*BZ,
MRLH1O%43QNM$MJS49G_X6NKES8)WI5ZEJ"3-!;G[9"S;_<H;RR]@)4G\<A"_
M?J-+TI??QJ5?]8V+TFP,2 "_BIQ_R(+?P-D0#4=7S-[>&+T^7A1'D"]=""<K
MCD@&=+?+Z;'HL2K 4):UO8D<K&5V.5=_TLWZKHL]W=8\O6KG3Z4C*OL)G4(<
M,I'<@9!,D$R\V1:02.SFNY=( -[XY9C<@GR\X9,YN_D4 H1D7OZWU5#*YFSO
MV^+_"-[VL5>W59"R[,>JL;'+1[^>)=H=>%QO/#I/'RY<?2PFP7[@QJ/F?C T
M7_N@M-OM5K_Y :R'HC3;W<Y :3=[@WZS]4%3VG6UK?:5'PI_:1E*8^Q/WA0T
MR0=+M(Z7=;"6*?O'7T3#M,-#=5'KR55-Y3==1)S3"T\G\7U_&AY>BK,^T>&F
M1-'NK")*VU055?AM3N8S-HZP <K1<<G'OO?K_UMJGQF[T+57%I4B(T_60J<H
M'Q3U@]I4VB1[><E>N).KG.CEX;<>>4.8JP4+MX-E\ELKM[',/V)2^BQ*.1>'
M,DE2W@U"WA3 &>PNKV^>-P6JQ>_<_>&\"8 A<5%<-Y62$CB2$N^&[\OFOE)>
M DU>HM-M=P9-9=!4FVUXRWYRG3I_:2D_>GNF)!+9!-GI+-&9F:U,5[SY :43
M<$?7\M\M4#JABD)7R71"YX/:%MF$ 8E>97=/E$TH@;=YHFQ"!?=I>6_ *<9?
MT,51C+]B0< JQ7SS=YCSID"U^)V[EYHW 2C&3S'^@FRMUL?XU;+YKA3@1Q/@
MWWSP0,WBX,'G5TM[?MNWFV+V^:M"_MX_Q>RK*'25C-G3$8#\92_W[1 %[4O@
M0=(1@.)O\?+>NU-ZH*"+6[%[*,O2HNU =4*#RWY16=86.=GE7%R9&1=ZJ.5<
M&\7B*19?D!W3AE@\U=L7S%DL5#A^3;V]^J.;)A*_L<">PO)(HU04EJ?0*(7E
MJ92^*J)7V:C\Z>LZ*"I_C-65? N6]]Z:8N4%71S%RLNRW#*'7"E67M"U4:R\
MF&NC6'DE8N5M:IA?+$^Q4('R;!OFST;;,M-C$\W@(FK.PR':7F+^PSPXGKQR
MCB24(?WXN= < V@U5%R9A-)8@3SV'7FN]^C^*X*8>YE,.@E)X78Y59$1BGT7
M6TA*OGG+>U=.4?:"+HX:UE2LHT65&ICD7Y:2-P6JQ>_<:T'R)@ %_BGP7_C
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M LO0X*#R+8.'-NDC]>);]0C8-=_*];#J 8!,A3=@2!'WP!MHX78$,[6K4>;
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M)"-5J(D&0*?5;;=;;B-T':_CMBL#(%CT8<_BQP\W0EK> 3@)BE3NC^0UZ9D
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MUD'?#0T.V^%8ME^&3=NCJ)?FJD? KOE6+HA5#P , 1@"AE1Q<X; N^%[<IX
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MDJW6%92J20',"$.#@QEA&:VT"4ZK%^BJ1\"N^58NBE4/ ,P(F!&&5'+S9D0
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M&2_Q\DYUW0YKP-#@8 U8Q@YM0L7J-;3J$;!KOI4+5]4# &L UH AU=:\-1#
M&C!+MIIH#70=Q^LY[3MKP.WR\W:[J\@=Z$\OIGG!FJ4]T)FS!W;&6907Z8AG
MMU^F63J%3: A-5-?7"BS";Z05K6Z9YV5-H'7\#QI$W21>M966RKW.N+8ZPA6
M@9'EGNHZ'E:!H<'!*K",)=J$CM7K:-4C8-=\*Q>OJ@< 5@&L D,JKGFK((15
M8)9L-=$JF+N+P#MW%]V3:#UW$7SQ\W$T8F?RKQ#F@(:L3'TY@7L(K,PZ*\T!
MW$.@//64UU?*S &/6B$'8\".XDYUU0YCP-#@8 Q81@YM L7J-;3J$;!KOI4+
M5]4# &, QH AU=:\,<!A#)@E6PTT!CSQ9:?E;<_>0W!QWO::"WH#2]@  SXI
M^*5\0K*\6>!1+^ X\B_'[)3',;_(HB2"': A':N+"+W& C<&$$NQEG9CL8*[
M -H-3ZS(R#.U]9)>0[&:EO\+2BW_6N=47:9I[QY96.BIKN!A$A@:'$P"RRBB
M3= 8)H%=\PV3 "8!3 (SBK=YDV!$SR0@K5K-] B:G9[KW7L$P1H,@G].$\[<
MMO0&/&?.&SA+Q9O+QPU\WF)'?G#(4VOO%E!]UJBO$'!# -7$LK+GO]NPP E0
MG5S*ZQX\&8! %EGS+&+Q/W\8<_%W&%V][ R1T;K>_>AGOY\9GWOQ_Z;T_&AN
MR]!%@./L+F$N^.8PX_ZW37\D OS@Q]_]Z_P-:RPV[<M'.3LKXB/K*2AGA W3
M3$CAW]\X;UC XUBN92)5;[^O4[?\_MZ!?O"G1?JQ^NW-((UC?Y+S#S=??&0W
M">[4Z3U7RE>!KK":KT.[&=$\C:.0"6G=GA3LK5/^4;F UUDW3.-P9KZZ+SE=
ME\W.O1_C:!@5K,X#FD$>3V5;V!,+^0J3[C&RL9Z!?3"RSUS+5C@$-0!YR8EG
MP5FVR_,@BR829JC(QC4B!"V3L>8*EB?C01*DV40R-1Z27O:'UZ3#.^,CGO$D
MX*2CW!=?*+ERKY%<Z+I82E9F^6*Y*U9)I)^"]*MHFN79IZYPF0=LEN5?S>$L
M3\#]*.9A-06?A=CX'A5CBWHR5+-@=$88&AS<>LL:_FSR.=6;Z*I'P*[Y5NYK
MJQX V,WHYS6D&>-A/V_WG?_^;V^[GM<BIUVQ]8<V;;UNK^EZ;;?M.9UNJ]L(
M>\UFS]D.RVW!O07[>@?3R22^GF_A/?+%0=2)73T1M#W7PCO3JEO^?(?+SF 6
MRI\F>9%-@T!\7/F]GX51RO,BNIS&?IAF8FQ#'K,_L^G%U+]F@ZV^+<V^>M_L
M;,M>((T^:0VK>Y+1WPVDW?!Z<MOO-O(,NX&L=H]O2IM\:YU0+]T*1/U@$"_V
M5%?Q, H,#<Y&H\"6<.VBQ&L6T:K#M6MRUZM<54=K >_70QD15X6Z6 !#6  F
MRE*C+(#ZL:#;CN-YS9G=OSUO>+[M='[9!."C$0\*<03U7A['Z56]U[=;F@$=
MF 'T<8<M9@!I+:M[BM&W KR&UY16P#;RS(Z"2J$5(,0GH>I-ZYS"QN#:5H*J
MJW[X X8&!W^ ;KAV(63X X2CA3] )3;X _;Y P'\ 1-EJ8G^0,]I.MWMSNS.
MW]YV=T%W8#_*\H+U+WD22G. %2E[WC#H3[(H9DWGB2>#PBT@AT,L<0MH[QBN
M>XK1=PNZC:XT"WI(,SNJ*^PB3CV?8!1H6Q*J+O]A%!@:'(P"NN':Q9)A%!".
M%D8!E=A@%-AF%/3>^>OOY8)#8(M#<+.)D-/;=CVG$7;%5]U6M8G0H@\'/>1^
M_N1C0(_D3D*L_<(]A/[B>3%)LX*=C$91P-FIGWW;8(>'.X#\&IQ#MD!^W!)@
M2SVB)L6:#;>+W8% ^==P2P P/]$*#5!?TU(=4-_0X #UZ89K%_<%U"<<+: ^
ME=@ ]763RZN'^@INT ;4MP7J/[DM4%-N"]3Z]<;_DO3/=_OO\J#:'JCWPMV!
M@/FU1AG _ 1TJNXI1A_S8^<?Y7EF#>;'SC_:E6VJ\\S"*D]U10_V;VAP8/]T
MP[4+#X/]$XX6[)]*;&#_]K'_ .S?*#UJ)OL74]%R[]B_>RY^MN@# <2/D_!%
MZ+_:Z*=^1O VP+_99,,2\(]-?&PI3U1MXK,-[@_NOWKN[Q*JR+3.)S!_;:L[
MU94\F+^AP8'YTPW7+BP,YD\X6C!_*K&!^=O'_$,P?Z/TJ(G,O^LX7L]IS_3[
MN^%YI[WH1O]?QU'V,NA_V^_? ?:G #<LP?[H][>E0E'6[^])[M]%GME1+*GK
M]W=5"$NP?[#_%U5Y-,MW@'Y#@WM$Z5,)#5B?TE3.2V0JP5&>N,<T)Y78+,#Q
M8.\DV;OGO*6F#T'>-2/OGOBRT_)F=]IQA^=M;]&==K[*XXWDCTM:/N 3OWK5
M4YOJ_]-/IGYVS;8E?_><9_G[;CJ]8/TXYOY55 1C4'<-SBA0=]!04/=7H>[M
MAEP%D6<Z54"JAV(UU!V[[("ZZTK=]>@KHU!H <0#Q.NMYE6'2YGG L0;&IMM
M()[N\J)>_('?J^;W[CO__=_>=CVO14Y? N1K _+KY^!V6MUVN^4V0M?Q.FZ[
M>@YN>T&,?^0GTY$?%--,C'Q%\J>327S]%,6_;:-WNR]\/.Z_Q'M(6^"(AU'@
MQ^(=<I$L%>+G5SQ.)]6G'"2!7HQ??4U.KP:PFNC;DE!6\/N>[)KO(*M ZU^3
MUJ__Z<KK+-&T3C'U]1O@O::E/>"]H<$!WE,)ES(#!KPW-#; >RK1JA=_@/?J
MX?T0\-Y$@6D4O+_=\]YSNZWN3!?^>=-==,_[1YYV*^G[HDQ_P"=%!?6;S@LW
MQP'4UQIE6 +U==@3WY:$H@_U7;?1T64+?"NRRA:H3[IRTSK#U)=U8/J:5OQ@
M^H8&!Z9/)5S*:!A,W]#8P/2I1*M>_('IJV?Z 9B^B0+31*;?%?_U6K-[VI][
MS44;\A][CNUB4+]ZO*W<T_E9C'^<9F$N,?[>[L%.__"G&'^#C;[Y /]Z\PZ
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M;)?G019-I&&E(AO7^+QE+9.QKC$M3\:#)$BSB?1->4AZV1]>DP[OC(]XQI.
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M?*]-!0=\KVEQ#WQO:'# ]U3"I4R!@>\-C0WXGDJTZL4?\+UJ?-^DIBJ![XW
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MAW8SHGD:1R$3TJL]*=A;I_RC4J?463=,XW!FOKJ3%Z#W9;-S[\<X&D8%J_.
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MF+)H ?:G$QNP/^%%""K0+NS?4E":0WM:C_T[)F!_;&!#6_ #K)/((H!UI!+
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MI- SG1(R&5'PJ0\D3I-,4F+\1X2=N!K \<<]+@:10W:YY#YXGDX5TF_:J6G
M%/?I69S'V*7/U' 'SYHV7!0A3GF;OT!R7YLK%$O3YF9U47&KK[5<C1L?Z_::
MFMS'CY[KK3:*P4CE1O^?NO8G5["UN1"S"%M)EO;DM'$CLO]>*WN5JA\7Z/KX
M)W9MI,@AC5XS[=]:A[>?-K;7_MO)\%8P+1UVIQ[L+5 ;%EXGV %?UNV2$)]K
M$JR1V22_,<@OIH-@-R AA4):2!$;A+>U\*XQ$\E+XE/1/8TDF2YI$NND@5C1
MJQ3M'P8QMQ%S_)%?S:_6D;=3Z-13;R6:N@1?Z#WYXG'C &Y R02#UY4P2"I"
MWAPE54G=G:H,06T#+K;%Q:WO6=^7GF,3QC_]&8BYL0D6"DJ;Y/^F@?QU\O^-
MUQ[_7Z1J&>2^K=Q/,5^>.]Y#HZ&?%#))^:B!E($JDF0'L9K,Z?@\R'EDO@HE
M?!)PZA(. A(:$KOZ$*Y;PB30M]*HCHF)/V)Z4C='%$&@8MI&(=U!HK4E>ANL
M5IAMA%*E"Y?.A=TCUC^6W""D[N):#!Y+K"0+15NSJ$G&[W(R#@E+79R01@EM
M%!$?!%U;T#?DGK@!*91DE&82U?N<J,*2@QQJR^$+P;QD0(5))BE\R$E!%1R$
M4'\>PY3]BIV ?!4])_Z65D'Q_%68TR"B\6%^WA)TD"2$=$J#S&K+3'<"P#SO
MN:5"*\EJDMHX)[64?P EI :QU1:;Z+05]278Y<I=3N#$+;4JJO*;!#C)"5"C
M%B[F-7J#%.O/6IZ[N"-P<G+F%\]=>@:3G%[G9S!1?.2+\@@(#()I,+S<>]CM
MF3GDFI$Y80P6SY[UO61PE>4VB>Q-P="*::&8F'*>#/*KO_Z"_CH1YIMT:A*7
MYS:G3%E-DCO*KZ^ T$A20CJI06RUQ7;ABFSD#C^6S&)ZNDE >2>'*HUD\4$H
MM85R27QPSU\3=KO$K'BIF\UC$D[>.R$HR%T )&@@260046T1?5JM'6]#R EQ
M!4_^M3"O"\54E,\DJKQW(J*"0C((Z S2ZM@YV(&3L*ZS<)SW?=1W%J)7T:]A
M9[>QW_ ."SNO6,3I' 8)3O*ND; \>J4H#,)IZDRLD$TJ@TDT>?^'*CY(IB,/
M8X6@JO*;Y)9W>Y1X&P=!=N5VK)!D90&3*/.>D3(7Y"#+3GV1%0(UES))M<AY
M4N&7'$2[G8.R:C[,9S,)+^\_23LK!VEUY?6JD%ME 9,$\PZ6,@_8(,NM7&$5
M LSG,DDM[WG1W6*#I+;VCU5(JSBG26)Y!TS>5S;(K>-3=U/;EDQB1[M=<D9\
M3)WF!_*JB)FDGW?-U#JK)_(EM>HW9- K5?& E%TBY3J8.=2ZFL\)$_9GI[@I
M)&U T>N"DS/;H6B$%!\H8F3 U:X<P4U5T?9436C*>[0:N(L'Q=0C (UW@Z"Q
M$4)YYUJ'$$+C 41/":(P\-N.L!11'R#U8B 5[CW%L@__/ME\)MZ"X?5R<^6>
M4$?4N1#=SI3-$W!?K$-9Q<S6 5D3B/*>XF@?+06GZ.-L@^*ZD4!+6#L*JY<W
MHD(&AOFM/8ZL);$#AV@2_XK_\%C4M3Q! +6FC. :&&I)TH2?O$]:PT]89P9
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MTN10)S*5;*=0>+]A!H_):PV&65*W,KJB]I)Z,$%";&7+R%31Z4"X)WL2;/+
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M<X_)XWG%-XJWH:!W34]N&R?;A/5V&NOG?V;C7+V,SJTE6>&?_Q]02P,$%
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MIW];[QIRO/$,0Q=V];0N?=V,9\4+G%//Q2S@7GZX4G*L2MXVUD1(N!!3>Y@
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M1\W.:B]H^$2OQSEKMKQ76+(D_'..?3PC(<#:D;67+V>P1E\"@I&Y99P/D[1
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MB9];X1+MWA<7">ZSS1-2/:[]V1H$2*;ZB]0<X)S9RP-U0&/3JYL#W$&D+CV
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M18)<^L'/IP<6G/+?[JSZ.4WHVNY:)"H]]@K<!@ ]1+K32O-LM$1^79[*\QH
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M;P'X]G)E!7]*V%5[L 9'DL[3DJ$BX<CLP-(DRWA];E40]* OY&>K@Z+%P\9
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MB0.U:"O#T(T$_.EU8(P08N6?\E/:;IV1%:'B2EPQ)'G]_VU64>-"QQV]B!^
M.QBP\Z1:=,7<^B5/Z_'=5Y,!JSE\(*5^%5L2RCE5)I;QU=4C29!3K3E74M'4
MCQ[IYC#/I%A0LU=&BJ8 &=5 8XHH6=Q53(*[5GWO6X"HR9R!S!:8.64?LEXT
M@UG<)Z<_N\L \KH\J!]?]\4AZ]VS>[*H/][\?<_M\^/@2-Z!29WQG<^*EY/<
MGL4IMH<D?SYN022SLH!O+4.=]*Q4:/6%(C2DN$$)'#59HC0*R")Y*S'FRBN5
MMJ9>SS<)FTIYWRDD14G-I >RC5E[C9F["$ HE*!=!T<)*3? "L$2>L[U:AW
M%[ 2<S#6@E'37BL.D&#%ZK#O7+EO^"<!.NJ@J,J77\<1"+)]+90Q7PY""0$M
M$->#<*5$P7E8_.T&F< -E#!EH8)*7,XV(C4!3. 4Y\]7LUN\1J )IMYW)Q1
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M\&V -<OP%OIVDESR6\ Y[Y<)G#[" .?KJ0"A89-=XWHI$$;W2+/)LK_NT,E
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M0;F_PFJ?:NW"J@PEB9D@_-BUS/<06;!_&^IIO08!^>G&7;D2$A)DX=$_5M[
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M<(UW5HH*/XE,X)00=@[#")TPRQ-Y4R4/*T'ZVD=B!60'_ 8CB?8_?X"D ="
MB/EYHI<<WC!.+1C%09VL8@,$+ZX-*I2H1#:CGV;S>V##A8][JB7]E? Y"5L$
M>*0BH+9NNA7&0I$?Z4MK"0-UQ<#2F)#4_75P\:$NQ -DE(0F1H[ W(J]J)QK
M++=#,^WT2J/TZZZ58XJ<R22_7P$Q-BT'UNJ6QH2TNJ"7R22@#5K-C8T(<X#3
M[J.\,#^JHN V9_4-4+;UI-,GDQ=(N<-M0!ZTT25F>"^K0>?(HGLO"ER;.&RW
M"-P_/ GYU.H C>W"QJSE,6MY='"-#J[1P34ZN$QR<(W)T&,R]-B%3#V[&A3F
M/OF:#$JW[X$WRK V=Q/=KON>^N^8DQA[X+^[A=$_0$2YIMR?5X] K_U[%:09
M8R7=0O\%744@D2[A(XPL+_]W?'9V:4A.U14,TH_P][CZYJO&S!RC5(0H"BEY
M:!8M0?"XM/QTLI,1G&]&LN<O(3=*RPR&%Q :/>RCAWWTL(\>]M'#/O8%&?N"
MC'U!!N\6'_N"C*YPTUQOHRM\=(6/KG##N#4H5W@W>H@B'P7MQ'*H\P0T>M\H
M\P^M2XLNIS.==<1\;RF*%27% 8_6&PBGCN,F.%S[Y%+!OPC%?_B :H_I,**K
MP@9_\H-L+R&$SH"/6!"%&89W *$6N0A1W]EVKIG:-K+*G"([ZXWO5LLH<494
M8"B!2$4$H!7/ X!VT[D5!!NTEXBNLH*Q'_$040M&R)=^!9RTK(>4!-V"*&W*
MX2]N8!B2=:Z2=7!G&3?IU_$/8+&[VMLLH>3E[*.3<I9K@]5!44(&;@2493R\
M8B/@ LQ!$)#]/@U#$)TO\3UY[?-O/'[8:MID6)Z+N.R[UA52 >RE&V)Y=081
MUP7:9C0#4]BJ ?,UCI9$+Q +)]3#&0PIBEMH["(AUD&C'(K2GCGB[7&4GH;2
M*T]L%S6"&AA!RDY&N5K">3!J@*@)>&'E!"DIN"+:^[]QX(:.:XL%LAM!*2$(
M;0*DJ+OV.;Z0@PT_&14 - E;&;>&YLM/'@D:+[WV%UZ+ 30YXYPY E_Q8-OU
M]UU*'#C<: I;-Q,!*QDV\$AR_?[::_^ROZ%-# LW-_VI/-JU%/>\U4\;HOL5
MV6Z\A&#C?=^GR#0/N8U:FC'Q97FRJT;)IM3JC@.QB:]FHZ.)[J*E9$Y\G$F0
MR22_7Z%N5@.ZI(O7_LG6+,&[U$JH7\G$\3I\FLF>IZV1\I*#?:+[NA;44$2)
M[\<8(BY?<;X38;.[O@\SBY@L,O$P#&6!;J-$$@OJPFP"B15F$MLZ;IIQXK-N
M94;2:Z^-?/=AT!07M97)"I12<P6Z#$K9<D_H$"QF;BA*I$*'%9_1.Q"0;#)Y
MR53\@+4G5'&@K,*C?0LC$-Y9&]X"KN)S:B(XX#FZ]L,HB+'3]!QG( :1B]9/
M?L2JY%W@VH"KQ)X#J)"+_/$5/BYA'%J^\_B*5MA<N2^ , \=X=QRY"/.JETA
MV'*HF/F=$<$ 6LEVNX'^ DG8%=XA.(6>/UQ5!4$+^KR!JO+G5?=\M)!%XR\R
M:7GA>G$$G+/-.5RMH'_N66&KCH[LX-74C9?CLZ\RL)2/-\+2TU&1E<3R%HGL
M+VS@\3D99P4VG7838W@UOJ):D5=#;!\C60VW$VQQN_8IPB7*!A9-R9B %TOO
M-P&QRJ'Z4E;H%@3=L*)HS5 _L6D523O&(ZZXBJ.TF]\=HL&/7'3S;@C):(<_
M #M&>+L@G,51&*'=CQAS^69[,3)FKQ#7"@!21A'(8L-A=:%GFE'?/>%*NM@@
MK)T]C"O1W#UW_&45DA94HJK_8>$RRX@_C73G047S4S/9CH4^Y:W(--4&4 ?0
M8*O"24+[,^!J>PE=V=@!JNEJ57H\Q7+UFV$-CB1E2<HMQ>C9IAP =R^S+M%0
M[(=J24L+%Y6<E?NP[X2\7/+6U.(-D\ZR4J^9G#UT< XUJ8<>*A*,)KKLZI+;
M5%Q6C;ROR)#K1PZ_81SLEQN560&$W#IYG]RH/&Q@,)_ZY#D5(;W1"#8G>[X;
M!NPX,?J4+]^ERB7)@25Q>DKZ.?[GV0K!?_Y_4$L#!!0    ( *>&5U3 CG7/
MB:\  .31"@ 5    ;G9R;RTR,#(Q,3(S,5]L86(N>&UL[+UY<^1&DB_X_YKM
M=XBGF?=,LJU2'6IUMS3'L^2EI@VKDD:RI-<K6VL#D9$D6DA$-H DF?WI-SPB
M<&7BB!,(4#/6HR*3"7>'_]P]+@_W?__?+YL8/>$TBTCR'U]]^/;]5P@G(5E%
MR<-_?+7+W@99&$5?H2P/DE40DP3_QU=[G'WUO__S__Z__OU_O'V+SBXN/Z-%
MF$=/^"S*PIADNQ1_??OI&_1_3FZNT%64_'8?9!B=D7"WP4F.WJ+'/-_^^.[=
M\_/SMZMUE&0DWN64>_9M2#;OT-NW!>G3% ?P!W06Y!BQ__L1?7S_\>/;]Q_?
M?OQP]_']C]]_^/'#G[]]_^<_??SN^X__S_OW/[Y_7R/P,W\M5/N_']'WW[[_
M]L.W?_KXY]H7KX/PM^ !H\NSVA>_"];K\/T?__3^^P_W?_@^"/[\I^#^S_@/
MW_WQ^^_^L/K^SV%=4K+=I]'#8XZ^#K]A(M+W31(<QWB/+J(D2,(HB-%M\:9O
MT&42?HL6<8QNX+$,W> ,IT]X]:V@&E.]_1@7RJ,8)1G[]3^^JFGOY3Z-OR7I
MP[N/[]]_]Z[X]E?BZR]'WW_^CGW[PP\__/"._;7\:A:U?9&2_?#N_WRZN@T?
M\29X2Z&B5A "@RSZ,6,?7I&0820A%^K\!OSVMOC:6_CH[8>/;[_[\.U+MOJ*
M:@,AKH^4Q/@&KQ'\^^7FLI/G#^_@&^\2_$ -9W45W..8RLQ(/*9XW?Y<G*:-
MQT".'T".#W\$.?ZEC5J^WU)_R*+--J9:>6<LZF><VY7VD*!M@:]Q&I'5>6)9
MR>UDW0A_FP>I9:UW$;;] G<TOF&[HA^3M"XTR8/8LM!')"T*K6$;^;&<IH:P
M#K)[QH8.R0]!L.6L8B#Z+GB)LC.\#G9Q?BQF1A]F,AY1H,/4AW<XSC/X!,AE
M;^&CM^\_B-#[+RV$NR5GLL!P+[X)%'M&!2X_'X-JE/%+CI,5%F&_I$W"[A?+
M</CM WEZM\(1>Z=__ %^?,M_9.]!?_W;>9)'^?Z4SD#2(+ZD+%[^"^^;O&,8
MRTA:?,A>Z#^^ZGGX75-(^#X,J/0GF#SAY.V76UEB?XOO#ZPCQ1G9I6RTE=9G
M7GGO?W(V2/!!C!&BG/[]7270L?R+-&Q($:1A(0#]<4 &\8UW(:&SA&W^-J[;
M_#HEFUYM"K9D4$OO>FTC>4H) __#1V'&\,G?SO!]?DDG,"F;A9Z2A,YY\^@^
MQN?_V%%&,'<ENR2_P3&/*#\'\0XOU_R+,(M<;F&>(V,Q=OFI&YE-_G;L<B4F
M_VRJ^-5_@FPH*H5#824=PDP\M!+RH90+B'*"GD!$1-;B^VQJ3YB4WTYKU$X,
MC+@ TH7KG)+-EJX+D_PRRW:P/C@E66[+3SJ(NW&*5F93>4!8"(,B(0W]*,MG
M8.K]!B%IUSU8]!NQQMS@E%#>BWLJ2Q!*66[+0WIS@081.Y;&0?M/1AG]6M#^
M_Z8?]MNU3#H581WF8@OJCKZB+,K-9_1 KM.P/\\K-]: _/0HMRJ9="G"%X7&
M2KHT-\4%Y;("3A=Q\"!KBP</Z>FN0<2^-9;D$="?WAS;%4TZ=>&-4F,U?=J+
MCN7>&^RZJX;)@X?-W+M!S&'@Y'P09<1.&J8WVGXHR*"6O%/[87B5UK@]L[Z@
MZZ0@_BL.T@OZ2:9JV$>/F^GX@)Q#X^:<$+!"C)<_YMT%"9'0E8?J/S1R!<W;
M-G/N7P:&WB!@0]<U@NZ-7807+\V]#9I6@S_2F)<P=!B]' +F9G^7!I"I<+O?
MW)-8UM0/'M+3:X.(?9,6Y!&G/[T1MRN:=.K"&Z7&:OJT==!T@Q\BV,Q(\L_!
M1GH:W?ZLR3%3DY:S4Z:*#0(^T]MK+PID2$.^:3S65_:T!Y)-P17.(BULZN[2
MM#'54US2=C^ON=7;0<^^3PI.C0FH/XO;05R(C+Y\Q" V4;^M@><7',?_E9#G
MY!8'&4GP"LY/<*HV G42,0F,'42=C4G [^UOP! 5'!%G.;T3R&%%I-7G+2[Q
M$23HO]0@L9;ZP]WR!F])FL,D,P]R^>5Q/PVC1*!6FN[R@41T*ODASM 7GQB
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M'B*E-2^AB-M0:(#P8333/Z4_+M,[\BQ5B[#W<0NZKLBY-WK@!7,FX.:9P;>
MTF;NA]KR$(!V4V>J7PZIWK*ELVG7,KU.R5.4A(HKB"X:%E1^0-.]X9>KA8*E
M9];?!52;"[0JSU=0VIV!P[&4@<.R1UR3+ _B_S?:JJ^HVRE84'R#HGM?X.P0
MY>?5FKD7H#8_:%&;GV"T^X T#!8N<L/KI3A0L?GF,YJ7A6LT'%S29MJDY#TQ
MXU8MDRY-^*+16$V9YL8(_4[BZT>2*&[+'S^GI\)#.O8-DW% C(4W^RR=6B=]
M6O%)P[&Z<NT5!5LDR2Z(^1U368-M?]:L!E6=EL,J8)R-N%,[O?'VHD"&-.2;
MQF,]95NLWIP&21;!IJ.>01\_;UB$^(">RPK/)2OOC+L3E</2SZW:\A&!0T-7
M4+X]8\^J@RB\.MG?X#5.,07D#K_D)Y3/;ZK6+T'0#(Q!!N[\(T-UWN@>*F4)
M[OXXBCRB1$NQLT O[@7NI 8<^A58(\:[IX>!A8KL/.'X(DHWERM9KSIX2+-X
M>)V(@XKL(I,:Z*/+L^D]H5W3I%,9WF@U;E/H:@2C5$ED;#QBI#HW:8N%]OQ(
M5FQ3,.G0@B?*C%7T:,T$BSZOBF98/6:DO8*,.W,L.'ACDD<*)ST:\4BYL:I>
M^TRTOV<E?'+8LE)\_#=V1@-SB^6Z[+]\3?C\7:73DQH]=1Q4Z-O-:"X8HN6Z
MUJ*ZX.E-YR@M0(F.8A7Z3>G;Y2++<)[I6.#AD_JVUJ3D(*8R^GZ838>^2;\V
M_-)M7%>KE&.ZM%UQ\TS?A(\(F&K[@*"[@LJ!=X;=!<:1?;?JR$O%-ZV]4/UT
M5G\:9(^+9 7_0&?*IR"&'8M%?AJDZ3Y*'EB_514OD"2H#XX4 P=>0OFA(%FA
M$'[ %6<_'$8-1Z*ESEE@%M?@HBP1^Z'&%"UR5+!%C._H \U3$%%F,;X@Z2T5
M2MR^BW &36.KWQ3NYFN3-HB1:JP<W!!])&G^EGZR05'RA+-\XX\WZD),#/4[
M,SB+P;#@C2AS!-Q1Q1"Q9M*UWXUJ QAX;<@:D6<W.,0TEE!I/^-<QT5[Z1@
MV$/7P2)(<$-IR>X-2G .Y0:".";/K*/WFL*Y(KO[?+V+45 \0K_RKQ_>?/?G
M[]EP^J_?O7G__CT*<@ITB"%G!'WWX0T"%-C?Z0_OWU VV1:S A'QQ 4,E.R!
MJ.#C,_;Q >P5)T193>63ES3N)]35]E0&%1]L/J>O]SH=!_6:!'4:]/PP^59U
MDSYU^*3:N*G5/1CNV 9[G>)M$*W.7[8XR3"=GB[S1YPVEILJ=BQ%3A\#"?+V
MK5XP19ASS=@@0( Q"CW<J%!!E&BH=@;HQ4W@!$.V^&(L47.S8])]/>W]/&O;
M298\AN1!+#SF#G[VTCD&W<"JP;LS[6D-^#HE6YSF^VNJ@IQZ%6QF;&&QJSCK
MZ:=C$FBZZ;H8'S@W-B[@@A5;?/AA]%)P$17U^0Q-?( *X\1B?\EKBHG6DDH3
M0,>I*QQD^"9Z>,R7ZR]T& 1/5G&: 4+ZT/02MN\V)3L4 S^OA@DYL(B2[KP&
M)C[$A+%"C!<D+'R!Z1.P&]UMJBGB9XJ;^IRI@X !&FT$';@'FZAZY12]4! I
M#7FI]KBN<3&SJGB,;?$W.,O3*,SQJOV,2L\-5*CJ@R3/Q;[#5+S9@:@?/J,!
M)M%7YWR BX\PZSX>G<X5>2Q07Z&;KQE=K<E]&D\.M'NT"+>S^G:P[![;#*^B
MX#Z*V5DC=1#67>61Q"L:^\!-\KU.:I@\37T 9'DXN%-?<6:K\JS&^W_]RY\_
M?OC3O[&5^M2UQ[41)KI:G@N:\3&0,#C4V2+.=\)4M9IT!EF:?52LP#5:OF9<
M\?3.KR0R-X=4YB\8+=XR?2)G<31_'>SA6-X@,^60@GE>0I.BPVR4+6?DASL,
M(-*2&]*F)S^U?Y@/(GA,F)R5[O#JV/$5[;^+B!$([42=> &P\F]<&$:'2"O,
M6R3B)@@M@\/HEP0A0?8.IYL3DJ;D.4H>E!;7K8\;7 $\)N<T)WB%[STY$.S#
M@4@HR$.=QS5U(V" *@Z3G%F81?Y.$H8;Z&-$_64C-<J[V#^$SN%!AOVX[Q2)
MQF&&!S'?S _LNH SZ^_,??+.^N4,W[[-.S9W'PR=) \P\,#M$+TSNBX*!EIO
MI>BBAFGRX-LD9P /(J<E/W4?5VKGDQUV)6FZ@[)FADKAC'O-C(UA8K9R:5J(
MNW0.<I#RY-WH((]C9^Y3ITJ]QZR8.1WD0)7\IO2O@QFC02I4!Q5[LUGW25%Q
MZ5#^.= P4#WK"\O94@Y!Z5QE3.<C-2DT5QB6YK>NUA3>&7N;QML7$197#ZZ6
M#:.7.2&;3<0K!$"Z%4E@R,%)J&B^O60,RF-TDW5P?%PQX_5,ZNS0UY])CM&?
MOO'#YF5@(PIZ]!BB^!@=EI]7YS1^F4$;R4]NTIW&3'"Z]3RA22V%R5W2TDAI
M2GZE)5VG4,T[Q3Q)2[E>5NOC1K=^#\DYN:/-F?!4OS?H7]]_^_[]![0-4O0$
M+-^@#^^AK <K[9$]!BED!N[R1Y)&_Z1/*13[^#?T3YR2@D:497"XRJZ$[_(L
MIS_ TG%VQ4/Z;(9(@.FA?<2'IL$83%-A"P91Z*2NXX_'SYI-&NJTW$SF2-+M
MAA]_L.:'WWW_YD_O?WCS_9_>MW@C_>/[CW]\\\?O_U#\<<@_*<$_O/G^S]^]
M>?_'/ZB[]WL__+C3T,B0$?AF5''#GB;TW<5JQ:H7!_%U$*TND]-@&]'U>.VM
M5;Q9AII!2M$@=0=97B5/!.4VWD8)"CE;/UQ" 3^BKDG_L8J/8 )^Z#)!@B.J
M^]@$B9*[S2Z&1C1L-Y'*LDWQ(TXR&N6A3<T&7Y$L^XSSY?HN>%%R-5721JE\
M*JR<I%H6 A2UB>HBH(C)@-ZAKV,JAR>;*;K8$T/%SPSG^!ABOO'>X(XX>P3\
M60F\Y1I1$<:_OIP'48)7YT&:0/)=3>HSO(["2/':\C UDUNO0]3=.NJ*,_'#
M&16 (^HJ]!\DX64%.U3P0W7$SH80&VO;TVR[T^Z6FJL#+]]O;?:@TKNY:7]3
MT_5FIF\WGC4/>#MHN;L3.\)1\*NXWSQP?-RC6]^Q.SYH[KK'//K"JRB*?4'2
M,U$2^[ALL\ZM-37"!I-Q%48C51P?*#7NASOJ04^,-#\KF(L55PDFM $H>*.V
MFN.35>*L'YY<!^DR90W85FRG]!JGM["/K7_ZUTW1UH%/%X<1S@C+4PD_O%(1
MR\Y3N7Z-S@.WCK,[RA0M4\39\M, 1!DCQGE:WV,B9(OR*$O?YXXIV<+LD/((
M/G9TQ.>CKW5BU^EC[9KT&Z<.G^+,T$("H?'\Z)*=NYKZ4$'%+BZ<ZGB^P\^@
M_?6; ZP&?*:N/7]QZ?>5RP%$QO.399648.HL#5)VD:F1'L]M:OD:_OI.&WX#
M#G2D3,^QZG>EI0Q*SG.R;"R<I,A92;(9;\G43.;R;+VD@E][]I.KE=)H6+7E
M2'FU1JIIPF2!U$O&"D[NET9-7_)T722#5[LOV5X1.<>FS7<F7PL=O;7Z0JB3
MA$4L7"V!6GW$I_7/$#Y]OF%GY>,4BQZ?F&;-<_2VF@N>?CH6T7"ZU&EU#^_6
M.5*8]3F*Q16.>WQZ7&;"M0W/!61SP(UF6>I.$B8M5%M)6NZFRK(@2R92]_#&
M=(\A:(BDOMZ-84<W^ DG.WQ!WP#N_0+W7Z+\\71'8] &I^<O8;P#^X;&"/1_
M*\4,;2WR)JF$RNQ<]*EA0OAAC";X$@N*G2&6<0-&! *@0@($(J!"!E0*@0HI
MILC(/B59OES_1,B*)3KA]"D*<79+8L5E13<5D_&YBZJ+V5.6([)&J4\.* $.
MD5>7OT#$-0R6:\08\4PXP0H!K[%=XZ>49-EU2M9JMQ(:C^GKO$;&?J(H(XZV
MC+H?IMZF;-*C#8\4&]=U>CV@4\<E%D4W\TQG3M]#Q$)YOD.B+GO&8L'+#],>
M!J>M7F*[OKP%(C[$H& S8:F3&YQABA-T+#RCPWI,6']G(9C:2J27D%%GQ6["
M3KI@,G;L6L"J8NB'G\C!192TYS4T\0$J,..I\2I<:/3[9#BF1!]^P@GUY9@*
MM5AMHB0")X;B&AK^(TO1X-:3% <'I;:"&&=OT /GR_PJ:'#VP[44(25ZBIT'
M?,+K!$LD>#+G:W*=RO^NHCQZ"* :PRW.\QAK#EJ]9$QN1G62=; JQRE<N$5Q
MR12%CT'ZX,O43@8JHJ [CV$1;E/Q016CJ3SE:$YKM-RQ.KMV=;F3S&61([6X
ML;ZH<;R8F<S J^HA6B9>?]R"MBMR]LV<52@!VRI,G22^F7@+&&U&?J@E#Q5_
M9.BU,C'CGTH_X8R5$N9"7"9T)D _43N6[J)A<B[=3M/^;*>@+.HQ^6'U@[ 0
M657Y"D&9&U P*;R@8#.^)W"^&I/^HT=-E-X@9:CK'[BN$_P F<>'!H^'YH_C
M6GR[^LF ;GQ1]:%9"QU/-4>'8F2?24*:8YB&;0]1,FR(TDG95:<:477O:V'\
MW[Q!"?9D*U82M,-N-0,J]!N@N(Y-G5<Q'$SD0-6<KTAGB9(=%6M93H]/\)JD
MHL#@7?""L_.7/ U(NHJ2(-U?YGC#6OQ &@IAFUYZ4RN'8IAF#3H1R]':YI[)
M4WA_#A+YX?1C&-I1_J)#Y%ZQ495C>U74LTPUXZ*B2E;$A2W"&!,7->1%3&#4
ME'C"Z:_0J@BX)SC!BCDXG21,;>*(I(LKR^0IRF"#%8I$^1HFNN$Y<O$.G7D*
M1=.U*)-BW$>"S=CN\!GG>KM_!P_JZ[M!R/ZH".6(X]X-IS'-NUW=I%<;7JDV
MKK0ZX6Z>3 'L:YQ&9$4_3Z&7ZAGF_VJEKEG@9K@Z,>+N:HG9+/,.3O:C'UYF
MT3P.%Z$6@)B_*306LS*5X!&7"A5BH4*N"?/WNI1Y06>ST4/"JRJ&^[LT2#(J
M'YTR+9(5^RUF,]_%ZN\[OJ-;JIZD[ ]YGD;WNQR*,]Z1ZT"K5_)X@MDW1R>"
M.DC_>*1O")>\V5P8)$:A$!GEE90H*,7T.[JY-5R)0.@0]]^5D0Z'5R$\*J1'
M-?%9KEGM!5#U!HV(S-\"U5\#W1'$7\278+QX"J(81*,>F@4QOL7417GA[+'#
MKS51[-NR)=&<AMA=0@?\F'7:>PBB)./=@'#V#8*R H]4JK?TR0W]:G%0FOEV
M9#&"?4I$6:M@OW);'(ZDA^*B2MY9!\[&DL!M8)1FY7CAXSRP'>PJA2RX06QK
MZWKFSYZ3+1-170J/'WM&-0>-1;!7D:-%?SJ=#GO)&%7/Z2)KWYM//?5<&8B(
M@LX\AB-N0T+XT70=!8M&;$7IS),@BT*XLQ?%NURM-MX@*7UP!DC;G]879RIH
M2T,?JP7V!MT#4W[UD[/UPX5D$22*ZO0<+>%.92/!L@HK8NSX9= AG-SXU"\X
M>GBD?!=/. T>\.<=M#)?KIETM;)E!JZFRT$?4SV.]AVSD ,%7!"4,$F@]$PH
M"OCQ^G [* B4$S9GI:(<>R\LO0]\W ^'-C0?8@>T>9I*?& E0@;$A8 QEL>(
MFAP&\2)Y2@D+ A\^BA  G_RM6E5G=Z2C$?DU?;/'(,/+]0E)5G_!JP>YVW>&
M#-11-6)H!]05"7? FVWV0J_U4AAP\*!JO;Z%UNMTM1J*UNM;(1)$AWLJ%'ID
M4GT[K9_;L1%B!9K^.H<=]GW^@M,P:I"[('2UFE!GRZ-[V!%+(I)^)KF"3:L1
MU;1C%29.;+<0H&F1+%,MK*1 &1,#)2"'#]:JA3C15KHMJV3U^9V8YA!E>_;9
MSVE,(V7=*>9HJI)FT&.O,B",4C*V+%=+YU-'375U,K\D"9KTTY9@8+G%=E&=
M&*9[Q[V O2M:K 8JT=+MN-9Y!QN_6F8HGK1@;XR2@XI%5>UKQL$W&VJJOLU8
M:HKQ2\U'_CNH8<=FS!T)=FQ) A/LQ4NDE$$^0,B"]ML(V[=Y$3<K-I[9?"].
M;2[0K3:O,3ERD"-@Z-A&N8WN,0>O?$8V090HG1VT$S#8@VXCZ-XS_'",?CB(
ME):\5'W<KG7T*V<RNMV?5AU0/F'8850\5SY\V$HO%D[,68,<WH7E5\[%D]E/
M-P[MK7#J*O).Y[&6NMT8>,>&HKJQ#Q#2!Z&7L'TGJ-@AX/?V,D&"HV<N(8<<
M45*DURC%K0 A)8!<U=&&(IQX59Q5JWM/%P63\LQM%!WX2QCN-KN8M4L]P^LH
MC'+/'&4 '2*G,S^1$#Y1L$!EML1DXTEE#ETICAICBSQ1@P@FR\2M#_4D8WX-
MV9C?>.9=ZH 3;9W/!MQ8"=>I?+7<9KBBL8-5.-':^ZH];6%SI:3F=&<7N/"B
M+IZX40\6;?M;!UKR3^_'6[W2*I>6_/! Q([D6W;/FPJ>YL)N3O!#E,"PBNX#
M*E<X?IECH^Z]5EOV.NH#*Z/THF>O)PXKTYS7>D=>MVUXI^^\RYR:-\L^VZ54
M %YU@1W/?\;/["^*HY0409, *L' 02ED2A>\HIX7RS:2=EL"-U5I5'Q.HSS'
M"=KN[N,HI%]<8Y"/74F%QZ*"1$@R?TY\5/ G6C#, NMR_ 1,.4O$>1:%2!A7
M1-GR/X\_)K4K@\<0F[YZ1-$Z@ <<9N"MGHV%:J8P[+:M@,P#]F''%:/L=)XK
MDU%<2X0[P_>\.33[" HO7N @WZ5*^3_V>)KL4=N1P<7)6\$"K3D/'BG:LS#1
MB@9^BNWW97 (8J9]:FH>C>76S8RX@O*UF%1Y0E+=G[@CJ.? I"8: ME$!_;*
M&H5X1@MV#RZ8-,K'MM\9F?LK*F-?ZF&Y1B ,^LN 'J8;C'X)TC1(<CZ:VAYU
M#HB[C04-9HZZ;8)A/W,^,QH)VC%6#/DMZIT=GLJ.+&00DTU/EH%L=<K^MMRR
M(NO%I0LE_]4@[F9UW\K,0;9A[6).8YU(MA[U>=.'7'+#ID?;LX-7=B.'?T'(
M@$HA/'%GOF9UY<^]U!TM^SWQZ!EMY)BZ]J#>YX>T]&;/'+S[!F=Y&H4Y7K&O
M+>@<<O53JMA309>#(^P[.8Z]QYOB&(M%9UK*5'PAB7R9J1L:B&P0&(!EGL8@
M'0PJ.41<8)(@)LJ$R^\;S#*5[LA=\ +[0)!;086_(&61)[R"_"6<9/P>N=Y"
M7)V-E26<*EL7[3P%_L_ 'L<K=M4^#UX0N8]%SWA/PH -JVA?NNO!,$<+Z%[.
M"T%@60\U-6NR0%7TJL@9_4I=GFF2CF"W@4KE(";HT3?-G5'C-U$4\&Q58&((
M1]E0.@#,"O36G"JV:0?>[;7']VR1G&^V,=ECOE52G!U<4P!L[>?U,'"SZ=/)
M<,RU :1^("PD$1^65<VV5!A/0H"194AN^PT ,DLKD-W^*\00*X+R<.ZZUP0F
MV"7HU)>];8(^%HZ6AMTLO0H&GLT+#.U$=K=@")R9VH3T?D%?;/ E[9-%L2IQ
M9+EN5%(K^I'8FBM(,'(S6@PR'C%<@#.*'#&6JR.1,?;!Z\"A:$.2LPI)R&9M
M+[*SC%IFUW+=R/ZJ)/(DH/#8-T9$D>;D:)R9>TR9T:3$9G!1 F_>IB,]4S&+
M+[*)EF,7T6W=Q=,H]"PY"ONH@H/R7,6[-U)'Q1@#&UI-Y)D&F!1.7GPVL,L%
M2L^T((6\'N;3)12S<'5_N.][@_^QB[(HI]I+GZ(0\]AV@T/RD# JS,!MYQ^;
MR>(VO=5$-A?U&V#\8>*PKB_#V^2^)3E;L3O%G&AS#%^[C2EG7%<B-XYK4"DT
M$E(7TZ.:W'R4M%(!XS/.JZ:1[EJD69'5BWZ7];=;:C4\]:(VR7E2SD9X@Z/A
MLB3*)Z:.*GQTBCX\-Y)LS;0!(_HG\\?E>DFYTA^3ARM(OEMD&9;JG2!+2;?9
MTA!E-UV5:EQA]DH*OHAG)@; V8<&'_(0$C6%:G6=^5(V??\)>KXOJ &SIN_+
MA$YZ<?20G.Y2&J'"_5T:)%DLG05C0%S3['28.;'$2A#T )*PIGTQDP7!#6@N
M#0J%."BOY/'!/HTL@AB#H67%-W@;[ &""_H>EW2AQB<ZE\EU&CW1Y2V,S$&R
MES9<:7J:MBI)WXEYEKSY;NC74<D>1<DW:,LE8%,'*H(/%JF*+M'1LI;=77/Z
M66-[DFT+P'7S8AOZ%(H62-N>$DU-^U/@X<0&"_Z'&_!B0PFNZC<+POA@ACI@
M$UV%C]V-ZS3('B]B\IP9-N%JH6.E]]8177<MMX 58KQ\[K35#5A[@ZT.!8YB
M9W0%#.RO4_(4K?#J9/\EPZO+I)S)+L(\>F*G)SK6IT-=WR;5N3FHIP,6NF86
MRL;P:JT3E-S],%@#Y(FYSN>'<ESM33&0"P'0R1Z!"+!-5PJ!*BFD(I4;YZ8B
MKJ/\2O$B9?TI?9@J*E/M#X[E2"U:)MUZ\$>CPJ Y670U[17 .P([U4D8T;E7
M?7/YCC@<GMSPMW1H84D>%WUJ&DW2TT).5A(.W!(^A9]#"),["(U1XO% Z-0*
MNX[,K*+[&BVN_6BL%!'!&""Z&("4\,>Y#,MG>$N=)F(+;OISC-G94[*J;R:K
MA#$Y>OI&(D/??IBI<V7[M$&-G1^10PE(HJ/0.8 6M^!5<D24)5I((^?1(59C
MR),YP;)1R'&<5XM;WFJYKH5)QA QCI/<_3:_W6W__K:CR[I':49OC].,$'Z!
MGP=R-T:]E"U_[=K-Q>H1KDY[<"UZ$88I#]R-P' 692'90?_G9'6=XDVTVV35
M(8K28E^7@U%#+ V.+C)J#Z/ZEK-%7P>%B/#I2@CV#9P09X_TD;?49S>H.ISS
M91UC9BS$#D0S,XRCMFD"^,.QL92"36@*.="EC!$XV]Q[BE@A;Y*>D=U]OM[%
M5'XFI.)V7P\=H^VJ3KH.:FL7W%A"_->P*?&$TSUUX&_02G!'@6#OA[]* 4A4
M%.HS6/$A3I"Y7[!"BT%DW#@1^&]"?6/_2QKE^(P\*\TTVY[6Q^"8FGTW8:3?
MKBAMUMFEX.B'0_2 08;5Y)_BA<F7Y!&CCX#!V'8.J5ZP3;9,Z$"V)5G$QU:V
MPLL^J-C\$"5]&/HINY@ LHU#&HI6C%\0@T] (OT6!G0_?$(2.**F1D]!:OH-
ML.)[N\L$U;C!=$SP&WT]UIB97D1)D(11\L"2@^B\L)PD*JW I&D:3*TE>;C?
M.6,)9,62BFWK^M@,4!EGHJOKN6#:L658LD6,+UL<E9S-]T,G2!QO'2B.\L:_
MYDGCWW1GC<,IYV!554]UT,2\]O), @8REP$BLY "%6*@FASC3^?I^CW(\!GF
M_];.*<4-.ITT 16J)K-062X.LM8>J7@4SN8Y/1MC^16)*+B/8H_.[#6 )OJJ
MG@^HY9*#LT,%W^8I>'&;=+HC\&.]%#L -SC$T1/<P#1ST39Z-G$\IN]DBUIP
M@2P;P<97!^P!L-?UNA3I-5@2[E9"=R,!W5A>5NQ%*-:O&B!D$ZH:81<.52/O
MJR.U8=3K04<J\Q,/"9^10F<L7[E.\3:(5F=XC>G,=G7.S^#IY)==X.<[$&9.
M),?!)IHR'%VXG>!;)#+P627AA1#8NB&7RJ&9SBF5C*'76^4AF!GP$OY=F$$A
M!A)RL"4EKXNQ&#"#T1:.($V5Y6K!V]LI6EU;M'!PX<T<*;\=MA>__K5@IQ8]
MQTIF#<B0J^5#>^)MQ63Y.MC;6_J5Q%PL)01Q!SOFQ;IARSGXZF!=D$DM]AK:
M\QX>J67>]1!<(_I2NJ.QNMJS,W:G(WJ6(3N@[\2I@,<<-C)[X!MRK58US@&J
M 0=CT%W)0#?J[/ SA9<O7JSY6A]=Z[./5CZNZMW%)'G@B;,S\$$)>(>GD#WJ
MG1.4P]/)BOF43BI?%T#%156HCE'3P))[DCR(A7M^+F[J;HN;D_=[] Y]+2[N
M?N/QS5T-R+5*5XQ7LF+:4A6>N"Q/JG=5?*:7NG6,>[BY+SX3%<SGXKDRR ][
M\*#.YX>RC$>70OAQR[VHJW9'%N$_=E&*%T]!%,,2&=J?!O5>(5!H3<6SE4D;
M7(Q08^7D[$1T76,E^7R^@*:+.#%4]US0/;@)4Q1:A(KOG#LJV?/FO$&C?0T"
M$2:X919BO,J@3B?(LTA6GX(<)-HOU]W:4O)F719&UYUT6#JYML8$X>/U1LC@
MO:,;&@6QA,1,#2 ^P!Z$X,X.QZ"%'.R:0U\\,$\M'J?6<>N@IE;J>"ZOV@2X
M>D>&<,65'X7S-SP=>L.19F?4&NF*,-]#:]><VN%Y<0_*:&+60]7BJ-W)Q?ET
M;"LXLWP6SZZ.:4#<-Q,;4/(,X!R>?Q6<68/CG(7C\V%0I]X<<;,I,LXR>8+]
MS->P*V*V&S+>+LBTNQ^>N&QY2<[)?F8O=>L8]W!SOY^Y+F\;SL1S99 ?]N!!
MG<\/91F/KNZ6^K&?65LR%ETA+J&S7A!?[^[C*%RNUQ@Z$^ON?0P0M;/8[67B
M>G\CZFK^'25HRR2A?^&BO($*PG[XMCKP'?L;$KJ?#<BM>QAE<W?!&''.J& ]
MI<O6FKLH'S?TD;&#V '9<1WQH,F/?U[7A5V'G[4JTV.<6GVIWM2Z?^-?=@ML
MO,Y2K?LFIS+-I.;TEAW;"="FJ/:JC#5#L J/I_VO.M[\9;G^)4C30+UB8"\E
MNX-817G,J/@L>/H7#'NP&YAW'&K2;YSZ9QC4RWX9A,CMUOD%2?^"5P^X9;&D
MLV?>2\Y\=[6'O,M=\K89!GH$07QQ+04T6[;'!]7J,W(=(QB<-3*.K4OPL=VM
M/$5K#NFJD_A>,OH@]9!U>VSJ[\Q=!C"BH$$?P>DXZ#V:_4V2LB-DN<$Q6,X=
MN0M>?HGRQT<20^-[2&HP[K&@S\,\'JKR=.&'GZ(DVNPV* ]>T',E V*WVTF"
M[O%C$*]9/='--B9[3-< 4)@:VF)EK+E AO,\QOZ=%FM;3<O@J(?4["RD8Q@5
M4L#Y,I4#U03AV3R>])AHG\LSZ;(OR0JGE_2#A([^D"35KC\X+<_HU^(=O!WK
M8K+<LO*'YLM*:X+87NU8$FRR/?><5+')DQ TBB4.+I*M ONJK6YPB<ZE14Q<
M5,K+\FJZPA]+O8'&&D)JQ,1&0FY_3_3=G.2/<[8[4A+.:SB^-SNV'^^X?MIC
M^K'=]'R]QF&^7)^_A*R2[0V=>"T3$!G^'U+XGH*8SPRS/(U".BV#/] XU/R@
M]LTR )V)Y@ _I62W+0IKTSB6[/!*7*)4G.CX(*V^#4XOO?TI$W\GMEP3;X52
MEGXNZB+380FBV1L>TW E.<O[3<OW8G_W(Z1-#U-;J)Q>*M,0[,L;6 KMPO+I
M7*UX(01O!(7=6<1G_ZG)BJJWX'^#N=SA9_7O5Q.YXNT0>[VJ58!X052]X=C#
MAQ%ZUSB-R.JX+H=X[;J=<&6K#!5C2Z;O%^-*ZF;&&A4U3J+YQ?N);)A,:P&_
M+WN-:VG1QH&9OP-JJ^M31.SFD,#?9%:Q62?-WA+#B2S3;3+^[R8@]F7I6\3G
M51B)U:@T77Z_K[L%<]D7F-\2:,M&P-L\2'/E&(>"'-WCARA)8* D:[3'0?H*
M I^%-?Z<5O/S,UJKT=;NXOQ5ZYT'B_-DI14J,+2[& H2;L:UV]UVRQ--@AB$
MOHC)\V6R)NF&J4=GBBQ-4M\Q)5G8G^;6&;-&I3')=BFO]L#0A/NH**I$\2/H
MJZ),-%4]$T3C%C!9] .NJ,9VVAYX9(/O@A><70?1ZC-6;4IY]+116>$#:HYN
M<[,$.<B$BQA'2*#SY1"X!P\RK"G_="]\@)-'C#X"!NASW\U:5[9.+8$.BUJ&
M?O"HB:8;I-R;.&?GBWFW0T &]..9NDNKYK0GLV@H>D[1KFJ>)*LR$^(RQQN]
M$A_R1 V22&29.)A<10])M(Y"**Z4D.0MFU#)M\L>+1U(&5NBK=[9X%CD G&N
M]7H[=&U3)0$QSI-NX['>QJRQW"K*8>I^R=L3K$YV^6>2_Q6S@*2V!2=+TV0G
M0HZ'@WSAX8)V<" :>-F72AENHJORN4!;;A#Q'M]UKJA@BRA?N)F.*&<V@H[M
MI<OT(4BB?[(EV"F-^R2.5GP9F*RNJ:2P8H-?EVL168+XEG["EG):(ZLEAOI&
M8$4 JQ92EP@U1&(AO2X4Y >58J%*+JDX/V8XL&M7Q E\[[QWL+-RV^L.O^0G
M5,3?1O.U5MX3N5V++/:'WXMR*PJ&W)-=%B4X8V-Q_BA1'G@VWM5G5+8<K1.P
MUV9 %D-X)2/Z%:1$3,S1Y^VBCR9=0ES3EP@U:V3V4=&W@6ZJ5M&LV*""CW<#
MK 1,1%YQHPR%M4V'8WFT!CA9B@:')5(<7)Q^;39!RAI0U/=J6BS3#W-4Q);H
M:7@>.!9G7OVX31KD;_ 33G985-)C@0"NQ9_NLIQL<*H3\:5)FI01D6)AN:0(
MXUG6 F0<6 T!5/#U;FQ019=HJGB446- (JUQ0YZF,V-U.'8(SK.PQ=ZA04V%
M<X%*);!,.$1<P1T$K;G_X9/ZP#0I654_)^U=Z.[0.NG7R2B!^ IG&<9ENUHN
MAU;X':)D8C!]E.V'6L[ %].1PH>H:<MO+$IG!E:U5LJ%=T\8/R^"*/TYB'>X
MVM?1BJ;]=/3AZ:-K%1Q@A!BGVA:7?Y%7"B^BHK]1HG*;&%I!>8"074-SN8U?
MF=LG&@4H-X\:=LJA-6!EUB+T",@,Q( )XW,])?DDB*%2UNTCQKFI'ZG1M9/&
M/<3'OI<)CHBQ9(=C)/''S;2P[<C$E]/MG' L]B?K.?E-/'WQ46I7FX@W7%XD
MJU-VI>@!)[!]6HFH=;=<C;!!RI$*([MY1Q5G=@;9X-TX;/1L(J8'.C'2^2A3
M-2FYM,8<5<J.[=GAN%.WZN#0JF=DO[W#CXZ2YP6I<HR:<!""TO%FHTT7!7W,
MVBE:Q89U2O)XF!B A<@I:Y3 WQ1 *\)WDK!E0RXW24GR\)9^L)'HGS:-]?1&
MXUX]>:K^+A^>,(Q"W8!\KQ,^#Y\TJ!G9H&2W?B,C[5V4[- ZZ=?)*%'QFA+#
M< F"%1;7BHJ=)$RJO;>2=#&3K;K3E$QYD74_3&<('R*I-$^Q$'Y[H/IIMR2A
M%#^T)J%F(MRRWE&@:&BBMRVI3-M@2TN1EX/T2<#RK4I/EU&W)W5Q)J8ZGANF
MQ59EC3D2(^UA[XJRW<^4'ER6D#!;,/:2L5#@PO'2L:ITX?,"4@:KMGHCDRXE
M6Z30&@[ZZ5@U,8=AOEY2Q5NCZ@WCP_KR&8M^?Y]RL1FD4 \2ZD.S,4)KV=E)
MPV !VD'3[E)4,('*TF*(]"WV#N)#9'4V2M0]%$$KY/80L6=0#H,M%.:_(EG-
MK/RTI=YX.Z O;X'H<>T)P^PUR7+>NQ"FWB<XP>M(KRS$$"6#381>RG;W$AJL
M4,'+N^@K"1M14^)89^CE8IZN ,]%XTPA$6M9J'N"KD#7Z+!5FH^#]EJ"76&:
MK,>C'S:I!2PQ4>R<0*S.RZO^G+ !T@KHM%L@)T$69<OUP2W;/?^OEF_*4M0'
M5(Z#BRQ*RA?N>-<+1/CACXHP$CUES@.RN([6<GUTFWM?_*/E=\E32I@S??@H
M7 D^^=LR?\3I393]!EDY7RA>:1Y$"33U_*#A2\HDU9%19&$'FA4)=YO"<[[Z
M3\8>,?XL/C8D$"A].ZV#Z8)+-#4\$R#K8;$71:.V!Y.\6BSQ5A^,0HBM\T?\
M +YT@[<DM3)R2Q(T.)628>#@>)&S]63/60TVHJ6]64 4-]!!)4L;H[2MZWHD
MQ=%#<@K5/Q.J@%K)91H3V*\Q[Y9BX'8&3 PND^DR=5+)#T1!A2RHQMT/ES4W
M V)-\[.%/.Y#6\C!1MJZ)#X$@2\97J[/LSS:!#E6ZD%W^*0^=DU*]GV0TH>%
M;<G!#[_KT#SIUXM?6HXK!2^E%.QJ)Y9J&ZK6@%O!K/8TQ:LHAY_4-EY[R)AL
MT762=9+*63$#J^?,V%R?W5*J3_T#M07->/NOPW 2!?UZ#%W<AAK#JH;;Z.[$
M6,/Y:ED<]C+)\I3M;AC,!=7H&J"FP,>!!W+@@+TW#J4#*#%1Z)S BX]PJQ5%
MKGC[,%LKJV34*DM7$HJIK=+R3(Z@A;H>?0R<5EXAZU8X/7%--43;JK$,*W86
MZ,5'P"T[@!...$4O<+B4W.P[:S(<RA$T:V0\R,!1PSMV(?Z@M; ?'J>&(]%2
MYRPPBVMP+5K@\F' XQW%#.>=/41,,IH[B+I(+2]8H5L<[M+(GZ7:,#Y$6F7>
M8A$?P>")9R34YDW.Q+IIF&'11M.-6P GKYRA%Q(BJR9?U1\W->\DV404H[[!
M(7E((M@0N7V,MEO>S/(O=%Y!23R<DDQK[F7*03.#09NCD\R4HMQW6HF#,B$/
MF[@]"HE0""+YD*1B;A3$#A3S-(!&PD =Z8(U8KS-\UDF?D\1GPH#KXF!RM=>
M'+VV#\/YL>(,QG4)8L8="KJ).^LB4<?3CQ%?'K7C5A)#"O0>H1YG\\*A0DQ7
MLO<QSN[28(6IV[.C+Y$PFU5_7\0Q>8:*HQ<D/2.[^WR]BXMOJ>^HVN5K8@3V
MY+#OT25/M"8I*K@6V<R>S.>=F!!Q"=%K,I<RO)2"(289&\#Y*7;!%E5?0I5E
M7;19UD2;Q]>BA3K<B<GAGD[11=U@E)>G:5+V2(Z'@P[T]:;S)5L_ H,RFD17
MHW-!+CX C7'EU\(*OCY,"BXWVR!*09IE>A9E6Y(%\7(-12&OHB>\6F09-CK2
MT:-OL-NCP<_!1EPI!1RVLA*;C#WB_/WP62/HB0V5SQ'F^ CA98H*$>"$%H1
M=;1]<'/>@XDW7C+PYEXRILVH6LDZZ@I6NR7HAS/* '34'*Q'8QZ#$1<XL+9@
MHAF8!SY25F0R.C_JHF&A4M0(YT?>5NR2.D#JTY.O^H\/5>^#*T I@Q0_XB2C
MXQ@7S?BZH3Q-L]H/,CQ<W8IM\$<"TZ\A@?(;/_Q)&5BBJ]RY@%CD_+0AY\_-
MQ!N<80HS)$*=X2<<$[: /'^!@B-89TM6@IS)UMD@>1='(IPIVQZIL?7#\50
M)!J:G %8\0%.BR9.2+"<:#^RJI9<K^.SW(HR0I?L.@J-#:R&C[K':9$W+ BM
MQNYW6>=;$_##4M\ZFIXAN'&1+U$5]FX4O>(B,,<NA1!%KZ9QZL.ZCP;3UT%2
M]JI3.I^LEL5"MV6A2K@7238;2 OQI\F%+'P])40MSTU'@4JX64LY40]FHI_Q
M<ZVL5TH2^F.(:Y=?#'Q,G;8^DJJ\7$Q8(40VZI4UQ/##![7Q)J:ZGANV<1%<
MG[LQ]6A)>19EP<-#BA_X[&$MLI;N(&= RWLE"1HT99-AX& :N]ML@G0/0V21
MV76_1S]A\I &VT?Z>8).HCAFF92K%>7&BD:>[K*<;'#JAQ>K@4VT=#X+8(63
M-CG"L5T!+6,Z;:&W\!&O=C$N]7"R_Q3\G:2%164G^[)X5E'K3-]K;7 S6,H8
M<W?@[T*F X=G<I5NG=5C0!2B18H#/US=HOD0^T#-WU3B RNIQ8Z38RNA'U65
M[@JQ3(),QQVA2CN_X.CA,<>KQ1-.@P=^D'N'TPU4_8(&,#QY$8H2J0<-:ZPT
M+XV8LW9R?:@>,9Z%8"C@DJ&8Y1M AUU>7FA52(=2$,^'NT06C8=81FKFAM(U
MKA12(2$63X- =Z65E**AF^$";7/22$OX[%7&XE@9'LS1>/+*<HNA0%7RP 2^
MBH+[*(YR.BSE<"5]KS\ITR)OFO*CQ,ZM>Q0\6?8D,X9"'&^N-IM8P%$BEX;J
M9XAV,_&K%.  X7V%O@]^3D6#*Y$FOMQ!P@3!5I(NMCZVVYCM7 6Q@ G8HLMD
M3=*-1X=Y0S@12>5YBDGI.24"+E<0S=# DYCA]E-KQ(@LK"-,&1I/$LT$<+ZF
M(&6HY(N)@.>5PSSQ\$]Q):1?*PM+1G6\OK"!W:LPH-;)%)U>'PZTB\IZI&=5
M\]-&RSJC0Q'L]F3'9"0R6VT,AEJH,'81D^?:@'J#8[K(6=V1IKKN^$U4@RAK
MP,O8/[1Y.X^M(=1X6U/14%3)AE(N',K)883U*ZJ:V\]Q0#7$:NZVTK4F;<R%
M665 $+(^%48WE=4P^6S&U(FUTA).^W5P1XZ"*A?,CW+!//9_HG+M4KQ:4EV&
MNS2ELK(^<EH+/77:%LK02O)R4$^XM1!M(0@*<E2O. QV(01#3#(_EHW:YM!6
M=E@)BKE!+_R_AJF8/96(+X\PGC:]!=_G56W0Q5,0Q1!^+DAZ&\0F62Y*= UR
M(A3X.,UY^2F%3-$O28J#./HG!?JG($J*3AGEA[RX/WR_M38K.G\)X]T*3*/Z
M>T:G7.@323!L^:6_81HR=LG*D]"@93_$!+\YV4J11D,9UU$N6;-2,\#<@SW<
MFL&=QD&61>L(KT[VIR1A_=%W05QL.)_1F8M^9##C8Z/6KSI?IY&C)D&QIQ_U
MQ @__-Z*M;26>-9%9\Z6(>)$/>97DD!R3(N-[!%(XT'@J!9?97E?WL;.X#1(
MGJ:-3*E^'BYZ;6VV=#P'F(67>U6.6AG0U@0X&:7.!;R697U5REKP]< 3.TMW
M:?F@##4'9<9&VJ=J+Q/W!L&E+WXU>IMBNG!GNS7PP6(#Z8G_Y!^(2[A^^*L"
M[#+UY*SYZ%@0"^_LK2'GQP"Y",-TAU=&A\(Z5&W$V2$N3N?(@KE_^4T:V+:.
MEG+:G0^.+2-F"X8>C)F58FC\6.W"_)<@36G\V)>)5C9<5):V#8#E>+D=71=A
M'CUQB&NG/85(:'D?1_Q.D7=NK&@%K<ZL@L#<$&]Q;,&^@K?*49S>OV'OK3IZ
M8?*H[F,?/6ZV!7E SKXCLNW&6O_17QF?'LV/O6'<A0>14)2'NH\UU3Z&P2]>
MHDS?WOG3ME0.U)Q;NX]6W@"AT\@K]?BG\"X3!PX36_CG8(//R":($GT[K].P
MI?R*IG.;?X. F8^6WP).I_T?*LQ7(#I\ =B@7SDCX]3'NV=R]TAV69"L[IXI
M]?TRP9])CB$_])0D3SC-(SJXL(\^X<T]3F6,7YNT9K*:.BLG>8R@7I0 $[:1
M%U:<^:<^Y"H: $X,M3TS<.MQD"'[N42VQE9\^BOG/##W]?EU1;2A[%'!'W$!
M$)5 O.9"\^4=W08CR0-<Y(8(>4=?7'4.VOZ\P9VC%GH."N9#^PI@@X#/&P2<
M_!B2>_$@,GKR4?=QI?92ZTSI$\U*#]]4?4[:1<&>]EW-1^=C^]V3T3Y=^8E
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M]_-89=;N;%I1%+<UG@MABC@KQ.'Y*(5 \XB\NM:E$$NUH'MEEJ02[Z2LR]/
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MC:AI4^=^QKK^2=M[-P%-Q7<1?/7V/@@%D=*0EVHO[)US.;!VSDC3WC,<?OM
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M1M-%Y?=V>A[6G"RT$7,R&>":+$=]'VI#]J) !A7DG<;KX>(H2DOMCTTK?]<
M,]56D9# PE[L("F#Y5<_:7<#D?^[L+( $D5M>@Y6; ,G1RZ5TK5.;L.A^@D9
M(-1'V($S,78S<"4IX(B2'KT&*3;'QU$G"UXY(KO!(8Z>(#-9W7NZ:1AT4^B@
MZ:S<$^0!%:P\\Y9!C(BLWGS%(S:!PMZ.P'5*5KLP7Z:W.'V*0NGTJ^YG]1:E
M;;3L&[[@PCH@"4;3[P;T0D"&U..;NN.FII=IH>@1M[D$\VR1K 3S3&V;JX>
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M#V&[ '8R<M#*N& %2TG1PZ7%!_UUOV&T!YQQ0-FS0K;?42NLZ?C'V:,[@K@
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M@D:I7OE&3E76P5JER\MU)3_S>HCSA$(:9_E-D..SW0YO65&RBV*]P8%=*7^
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MU=LSRY.Z91JG__EC0]7CX[E9)RN=F@/,3QWV%&5U9]^><9)AYI:IHXWWH8@
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MA9%"G!803/=KYK!'49O 0&HA5A5P9:8 GT7IO'A%S+CLGBI.VLS:B T/-K;
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M<*D%,>;;MH2&;GIM09475#WTVH,@-/UK2925+(^V)V2?Y.GK)_QT;WAXWS[
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MH/XO^F'Q$?W'?9#A__G_4$L#!!0    ( *>&5U1 9?4WA6P  $GI"  5
M;G9R;RTR,#(Q,3(S,5]P<F4N>&UL[;UK<^,XUB;X?2/V/^36?)F)W:JTG?>.
MMV="ON7K&:?EM9U5T_NE@B8AB5T4H>;%MOK7+P!2!"GQ H @"(%X8Z8ZTVD>
M'#P #@[.]3_^Q]LZ>/<"HMB'X=]_.?WMY)=W('2AYX?+O_^2QK\ZL>O[O[R+
M$R?TG "&X.^_;$'\R__X[__G__$?_]>OO[Z[O+ZY>S=S$_\%7/JQ&\ XC<!_
M??SQW][][_.'VW>W?OC7LQ.#=Y?03=<@3-[]^FZ5))N_O7__^OKZF[?PPQ@&
M:8)&CW]SX?K]NU]_W9&^B("#_^'=I9. =^3__O;N[.3L[->3LU_/3I_.3O[V
MZ?1OIU]_._GZ]>S#Q[/_^^3D;R<G)0*_9]-Z5_J_O[W[]-O);Z>_?3G[6OK%
M>\?]RUF"=S>7I5_\X"P6[LGG+R>?3I\_?G*<KU^<YZ_@XX?/GSY\]#Y]=<N<
MPLTV\I>KY-U_=?\;81'--PQ!$(#MNVL_=$+7=X)WC[N9_C_O;D+WMW>S('CW
M@#^+WSV &$0OP/LMIQH@W/X6[,!#:Q3&Y*]__Z6$WMMS%/P&H^7[LY.3#^]W
MO_U+_NMO![__^H'\]NFW;]_>DW\M?C7VZWX1D3U]_[]_W#ZZ*[!V?D5+A7:!
MBP>(_;_%Y(>WT"5KQ,#7N\;?P'_[=?=KO^(?_7IZ]NN'T]_>8N\7A,:[=QD>
M$0S  UB\P__[\^&F,F8(7B)(=A""__3T[,/I>_QK[Y_ >A.@_7.;39?0645@
M\?=?0O3!K[M?QD/]E[K?3;8;M.5C'_T+FOA[<6X2YPV&<+W-V-H=A]W_SD+O
M*DS\9'L3+F"T)IAVL?N "/W)0ZAY+IL([;\P(;^-9U_Y +PE(/2 MR.#)S#
M; D[.X8"Z%9FCT>+T7!DX\3 _6T)7]Y[P"<C_NLC_N.OV1\)-.BO?\Y2ST]@
MM-NA51 "_%,8[7X8.,\@^/LOM9^]'XBQ.V<-.)G*/AF*H6L_6M]XG"SM/I+.
MU&ZOQ$A4PF@#(W0PO?,M.G$@0C<4>$+;\AR-\Q<KPQP$!YO,4^2$L8_WU0-
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M!A-P]8)/1=N?,0RDQ0_C^2(/T$'_2OS\)2\/]N^(&TSYQ]#+@,K!OXKWWA\
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MX/_@4V4E^S()G\$EM@N;:*BMR2DF_VH_5\MXON1B;-./%=4)3OQEUF<7)$E
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M:I0FU]R!UQ('$6([#=TLO(#PL<W^*R2X^&F/HOOTF&$G*36MW&NKE&4ER9
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MY4=[47 $<5/8[&71)[J?XJC@$E'=L.&)O"PX,UEJO]4@4:7*EY) "7<%O#0
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MG<L\R",@&) 8D/I25J0F[#D)IY$!I5(&%8._ZS#^"*(7'T?AU[%;GA 5IO<
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M0(@K?R$)[^(1EZ!45^@1A$B7(]6%+E. J'SBK\?<:QBQ=0Q![:#9,'MED]"
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M)$0WR@4,T;,PP:_X1Q"BV^<.XL39%" JGSB;D_4=1LS"'(+:0;-A2N/B$=&
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M,ICTE/I3LX6[U)3ZD],I>1V'2JD_.9O2)2">4G_R84IRGL>ET>"IG5:E)P[
M:NVD%#5YCIYO&6HAR:3VCA(WCF"*DP_RM/ZC1Z[J,J$0R4_N@8D3:.E%W(N-
M4^)"Y!M3?_\AXWS&;7C*$!8I[ +B&T9";[_2B'ODRT4)N%P6_,2'F,?NJGL
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M*=WF8CIV2K?AU:Y4I2^TZ%4#5LTZ-B^/C$1C22I[L2IG-A=/BX02TZO(:!8
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M!\10!+##M%\".!?9T:6F" A0WD(/F*#"(Q'S?\'_>79B\-__?U!+ P04
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M<N&(0\[S]]U(,98T1'3@A@?CX[8IX=-$L&C(0(9\,IP;9AG:6C1&(P (,;L
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M,:VUP"#I<_C67FDN'?O&K!27/(<-*=+OV:P(1'@@PIY.V^+OO4TNM;""9+F
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MONM?RW<][;CWW)]VW"OU_P]02P,$%     @ IX975$8)!^=? P  )!L  !
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M6<)OU<AFK>=#\0""?X@>1_1X9U#PG%O0&<# YP1?1JHRIBLQS>WV73!O&'%
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M\>&H=@--H0PZ6KYD*<]B7[%;!ET P  ?RB%;M) JVCP%?X/!WIB"'6Y\]./
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M8-FN^WNCX[K=L%L,[#N>#Z$B(F.:24&XZ_;.++"F6J>!ZRX6"V?1<*2:N.'
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M,# P,#$N:G!G4$L! A0#%     @ IX975!9T$]"EF 4 /O,& !8
M     ( !<W4% &=U,30P-6$T9W!Z:C P,# P,BYJ<&=02P$"% ,4    " "G
MAE=4QRC[?:0A @!;*P( %@              @ %,#@L 9W4Q-# U831G<'IJ
M,# P,# S+FIP9U!+ 0(4 Q0    ( *>&5U1TVI6*D?   *W\   6
M      "  20P#0!G=3$T,#5A-&=P>FHP,# P,#0N:G!G4$L! A0#%     @
MIX975/5DGHO!M@  Y<8  !8              ( !Z2 . &=U,30P-6$T9W!Z
M:C P,# P-2YJ<&=02P$"% ,4    " "GAE=40PO]3UGN  #2!0$ %@
M        @ '>UPX 9W4Q-# U831G<'IJ,# P,# V+FIP9U!+ 0(4 Q0    (
M *>&5U0#_=J$65H$ /P[!0 6              "  6O&#P!G=3$T,#5A-&=P
M>FHP,# P,#<N:G!G4$L! A0#%     @ IX975!P5E=]WM00 G,M0 !4
M         ( !^" 4 &YV<F\M,3!K7S(P,C$Q,C,Q+FAT;5!+ 0(4 Q0    (
M *>&5U1TI#U%T1L  *D_ 0 1              "  :+6& !N=G)O+3(P,C$Q
M,C,Q+GAS9%!+ 0(4 Q0    ( *>&5U0P.4$._!4  (I8 0 5
M  "  :+R& !N=G)O+3(P,C$Q,C,Q7V-A;"YX;6Q02P$"% ,4    " "GAE=4
MS?Z\(69#   (, 4 %0              @ '1"!D ;G9R;RTR,#(Q,3(S,5]D
M968N>&UL4$L! A0#%     @ IX975,".=<^)KP  Y-$* !4
M ( !:DP9 &YV<F\M,C R,3$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( *>&5U1
M9?4WA6P  $GI"  5              "  2;\&0!N=G)O+3(P,C$Q,C,Q7W!R
M92YX;6Q02P$"% ,4    " "GAE=4PS7?@B4.  ##7P  $P
M@ '>:!H ;G9R;RUE>#$P,3-?,CDV+FAT;5!+ 0(4 Q0    ( *>&5U1&"0?G
M7P,  "0;   0              "  31W&@!N=G)O+65X,C$Q7S<N:'1M4$L!
M A0#%     @ IX975'>XGXH2 P  40@  !(              ( !P7H: &YV
M<F\M97@R,S%?,CDW+FAT;5!+ 0(4 Q0    ( *>&5U3_!D[ "P@  .0\   0
M              "  0-^&@!N=G)O+65X,S$Q7S8N:'1M4$L! A0#%     @
MIX975#>#*-,:"   .3T  !               ( !/(8: &YV<F\M97@S,3)?
M.2YH=&U02P$"% ,4    " "GAE=4 !^W8#8%  "N'P  $0
M@ &$CAH ;G9R;RUE>#,R,5\Q,"YH=&U02P4&     !, $P#D!   Z9,:

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
